Citrus Sinensis ID: 014344
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 426 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSF1 | 421 | Serine/threonine-protein | yes | no | 0.957 | 0.969 | 0.583 | 1e-131 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.774 | 0.353 | 0.367 | 3e-64 | |
| Q2RBR1 | 921 | Phototropin-1B OS=Oryza s | no | no | 0.737 | 0.340 | 0.396 | 4e-64 | |
| Q2QYY8 | 921 | Phototropin-1A OS=Oryza s | no | no | 0.737 | 0.340 | 0.396 | 4e-64 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.765 | 0.535 | 0.372 | 8e-64 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.676 | 0.314 | 0.406 | 1e-63 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.776 | 0.561 | 0.361 | 3e-63 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.776 | 0.561 | 0.361 | 4e-63 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.786 | 0.579 | 0.372 | 1e-62 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.680 | 0.319 | 0.411 | 2e-61 |
| >sp|Q9LSF1|OXI1_ARATH Serine/threonine-protein kinase OXI1 OS=Arabidopsis thaliana GN=OXI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 469 bits (1208), Expect = e-131, Method: Compositional matrix adjust.
Identities = 251/430 (58%), Positives = 313/430 (72%), Gaps = 22/430 (5%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND 65
+++ R+LDF+ L ++S LGRGAKGVVFLV+D + ++ ALKVI ++ IEKK K + D
Sbjct: 5 DEKQSRALDFNRLEVLSLLGRGAKGVVFLVRD-DDAKLLALKVILKEAIEKKKKGRESED 63
Query: 66 NGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMF 125
D+Y+R+SFEQ VL +HPL P L GVL+TDK +GYAIDYCPG++L+SLRK QSE MF
Sbjct: 64 --DEYKRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMF 121
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
SD+ IRFYAAELVLAL+YLHN GIVYRDLKP+N+MIQENGH+ML+DFDLST L+P+TPQ
Sbjct: 122 SDEIIRFYAAELVLALDYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQP 181
Query: 186 SPKTVLAANTRSGIKKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
SP + T +K+R F + FC+SGIS P S + S EKSNSF
Sbjct: 182 SPSLSKPSPTMK--RKKRLFRFTSFCNSGIS---PQESISVHSSSTLAVSDSSGEKSNSF 236
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
VGTEEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGATPFRGS+RKETFYRIL +PP+L
Sbjct: 237 VGTEEYVAPEVISGDGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFYRILSKPPNLT 296
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
GE T LR+LIRRLLEKDP++RI VEEIKGH+FF+GV+WE ++ +SRPP IPA ++
Sbjct: 297 GETTSLRDLIRRLLEKDPSRRINVEEIKGHDFFRGVDWEKVILVSRPPYIPAP-----DD 351
Query: 365 SDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKN-----EVNDEMNKNRGGEKVN--NQRHA 417
+G D ++DVE VQ IFA + E+++ N ++ N GE V N H
Sbjct: 352 GGDKGTDVNTKMDVENIVQEIFAARQEREKQSGDNNKNANMKIKDNTSGEWVKGLNNNHD 411
Query: 418 CEED-NFLVF 426
E D NFLVF
Sbjct: 412 LESDNNFLVF 421
|
Involved in oxidative burst-mediated signaling. Required for basal resistance to P.parasitica infection and root hair growth. Partly required for the activation of MPK3 and MPK6 by hydrogen peroxide and cellulase elicitor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 246 bits (627), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 143/389 (36%), Positives = 216/389 (55%), Gaps = 59/389 (15%)
Query: 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYR 71
SL ++ LG G G V+L + + ++ FA+KV+ + + ++ K
Sbjct: 532 SLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKS----------P 581
Query: 72 RISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIR 131
R E+ +L+ ++HP LP L ++D ++YCPG DLH LR++Q + F + R
Sbjct: 582 RAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAAR 641
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FY AE++LALEYLH +GI+YRDLKPENI+++E+GHIML DFDLS + A T++
Sbjct: 642 FYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRC------AVNPTLV 695
Query: 192 AANTRSGIKKRR--------SFLSKFCSSGISLEDPVHSPRIGPD-----PPSRSD---- 234
+N+ G R + + FC + S + SPR+ + P R D
Sbjct: 696 RSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRGDHLSK 755
Query: 235 --------------SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG 280
+ +SNSFVGT EY+APEII+G+GH AVDWW+ GV+L+E+LYG
Sbjct: 756 TQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYG 815
Query: 281 ATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIRRLLEKDPTKRIGVE----EI 331
TPF+G + ET ++ + +L +PL ++LIR LL K+P R+G E EI
Sbjct: 816 KTPFKGYNNDETLANVVLQ--NLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEI 873
Query: 332 KGHEFFKGVNWELLLKISRPPNIPARFEH 360
K H FF+G+NW L++ + PP +P +E+
Sbjct: 874 KRHPFFEGLNWA-LIRCAIPPELPDFYEY 901
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RBR1|PHT1B_ORYSJ Phototropin-1B OS=Oryza sativa subsp. japonica GN=PHOT1B PE=1 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 146/368 (39%), Positives = 199/368 (54%), Gaps = 54/368 (14%)
Query: 1 MNDVVNDRPIR-------SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDL 53
M D + R I+ S+ R V LG G G V LV+ + + E FA+K + + +
Sbjct: 570 MKDTASWRAIQKVLESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSI 629
Query: 54 IEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL 113
+ N +K R + E+++L ++HP LP L T + DYCPG +L
Sbjct: 630 ML----------NRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGEL 679
Query: 114 HSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173
L Q ++ +D +RFYAAE+V+ALEYLH GI+YRDLKPENI++ +GHI L DFD
Sbjct: 680 FVLLDNQPLKVLHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFD 739
Query: 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233
LS S + P+ L + KK R K S I +P+ +
Sbjct: 740 LSCLTSCR-----PQVFLPEDADE--KKGR----KNGSYPIFFAEPMRA----------- 777
Query: 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF 293
SNSFVGTEEY+APEII G GH AVDWW+LG++L+EMLYG TPFRG +R+ TF
Sbjct: 778 -------SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQRTF 830
Query: 294 YRIL---CRPPDLVGEPTPLRNLIRRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLL 346
IL R P + R L+ RLL +DP R+ G EIKGH FF+G+NW L+
Sbjct: 831 ANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFRGINWP-LI 889
Query: 347 KISRPPNI 354
+ + PP +
Sbjct: 890 RATAPPKL 897
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QYY8|PHT1A_ORYSJ Phototropin-1A OS=Oryza sativa subsp. japonica GN=PHOT1A PE=1 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 146/368 (39%), Positives = 199/368 (54%), Gaps = 54/368 (14%)
Query: 1 MNDVVNDRPIR-------SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDL 53
M D + R I+ S+ R V LG G G V LV+ + + E FA+K + + +
Sbjct: 570 MKDTASWRAIQKVLESGESIGLKHFRPVKPLGSGDTGSVHLVELLNTGEYFAMKAMDKSI 629
Query: 54 IEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL 113
+ N +K R + E+++L ++HP LP L T + DYCPG +L
Sbjct: 630 ML----------NRNKVHRATAERQILDLLDHPFLPTLYASFQTKTHICLITDYCPGGEL 679
Query: 114 HSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173
L Q ++ +D +RFYAAE+V+ALEYLH GI+YRDLKPENI++ +GHI L DFD
Sbjct: 680 FVLLDNQPLKVLHEDAVRFYAAEVVVALEYLHCQGIIYRDLKPENILLHRDGHISLTDFD 739
Query: 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233
LS S + P+ L + KK R K S I +P+ +
Sbjct: 740 LSCLTSCR-----PQVFLPEDADE--KKGR----KNGSYPIFFAEPMRA----------- 777
Query: 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF 293
SNSFVGTEEY+APEII G GH AVDWW+LG++L+EMLYG TPFRG +R+ TF
Sbjct: 778 -------SNSFVGTEEYIAPEIITGAGHTSAVDWWALGILLYEMLYGYTPFRGKTRQRTF 830
Query: 294 YRIL---CRPPDLVGEPTPLRNLIRRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLL 346
IL R P + R L+ RLL +DP R+ G EIKGH FF+G+NW L+
Sbjct: 831 ANILHKDIRFPASISVSLAARQLMYRLLHRDPANRLGSYEGANEIKGHPFFRGINWP-LI 889
Query: 347 KISRPPNI 354
+ + PP +
Sbjct: 890 RATAPPKL 897
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 140/376 (37%), Positives = 212/376 (56%), Gaps = 50/376 (13%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L+ R++ LG G G V+L + + SFA+KV+ + + + K L R
Sbjct: 224 LEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMNKTELANRKKLL----------R 273
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E+ +L++++HP LP L T+ F +++CPG DLH+LR++Q + FS+ +RF
Sbjct: 274 AQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKYFSEHAVRF 333
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
Y AE++L+LEYLH +GI+YRDLKPEN++++E+GHIML DFDLS + S SP V +
Sbjct: 334 YVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCS-----VSPTLVKS 388
Query: 193 ANT----RSGIKKRRSFLSKFCSSGISLEDP-VHSPR---------------------IG 226
+N SG + S + C P +PR +
Sbjct: 389 SNNLQTKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPKNDMHNQVT 448
Query: 227 PDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRG 286
P P ++ ++ +S SFVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G TPF+G
Sbjct: 449 PLPELIAEP-TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKG 507
Query: 287 SSRKETFYRILCRPPDLVGEPT---PLRNLIRRLLEKDPTKRI----GVEEIKGHEFFKG 339
S+ + T + ++ +P PT R+LIR LL K+P R+ G EIK H FF+
Sbjct: 508 SANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQN 567
Query: 340 VNWELLLKISRPPNIP 355
VNW L++ + PP +P
Sbjct: 568 VNWA-LIRCATPPEVP 582
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 244 bits (622), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 140/344 (40%), Positives = 197/344 (57%), Gaps = 56/344 (16%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ LG G G V LV+ + E +A+K + E T N +K R E+ ++
Sbjct: 580 IKPLGSGDTGSVHLVELKGTGELYAMKAM----------EKTMMLNRNKAHRACIEREII 629
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
++HP LP L T V D+CPG +L +L +Q ++ ++D+ RFYAAE+V+
Sbjct: 630 SLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQPMKILTEDSARFYAAEVVIG 689
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
LEYLH +GIVYRDLKPENI+++++GHI+L DFDLS + +P+ ++ A + K
Sbjct: 690 LEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTT-----CTPQLIIPA---APSK 741
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
+RR S P+ P +P S +SNSFVGTEEY+APEII G G
Sbjct: 742 RRR-----------SKSQPL--PTFVAEP--------STQSNSFVGTEEYIAPEIITGAG 780
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR--------PPDLVGEPTPLRN 312
H A+DWW+LG++L+EMLYG TPFRG +R++TF IL + P LVG R
Sbjct: 781 HTSAIDWWALGILLYEMLYGRTPFRGKNRQKTFANILHKDLTFPSSIPVSLVG-----RQ 835
Query: 313 LIRRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLLKISRPP 352
LI LL +DP+ R+ G EIK H FF+G+NW L+ +S PP
Sbjct: 836 LINTLLNRDPSSRLGSKGGANEIKQHAFFRGINWPLIRGMSPPP 879
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (619), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 139/385 (36%), Positives = 213/385 (55%), Gaps = 54/385 (14%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L S +++ LG G G V+L + + FA+KV+ + + + K L R
Sbjct: 190 LGLSHFKLLKKLGCGDIGSVYLSELSGTKSYFAMKVMDKASLASRKKLL----------R 239
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E+ +L+ ++HP LP L TDKF +++CPG DLH+LR++Q + F + ++F
Sbjct: 240 AQTEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKF 299
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
Y AE++LA+EYLH +GI+YRDLKPEN++++E+GHIML DFDLS + + SP + +
Sbjct: 300 YVAEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-----VSPTLIRS 354
Query: 193 ANTRSGIKKRRSFLSKFC--------SSGISLEDPVHSPRIGPDPPSRSDSD-------- 236
+N + ++ + +C S I + GP S+S D
Sbjct: 355 SNPDAEALRKNN--QAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVV 412
Query: 237 -------------SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP 283
S +S SFVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G TP
Sbjct: 413 NQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 472
Query: 284 FRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEF 336
F+GS + T + ++ +P P+ R+LIR LL K+P +R+G + EIK H F
Sbjct: 473 FKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPF 532
Query: 337 FKGVNWELLLKISRPPNIPARFEHE 361
F+GVNW L++ + PP +P E E
Sbjct: 533 FEGVNWA-LIRCASPPEVPRPVEIE 556
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 139/385 (36%), Positives = 213/385 (55%), Gaps = 54/385 (14%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L S +++ LG G G V+L + + FA+KV+ + + + K L R
Sbjct: 190 LGLSHFKLLKKLGCGDIGSVYLSELNGTKSYFAMKVMDKASLASRKKLL----------R 239
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E+ +L+ ++HP LP L TDKF +++CPG DLH+LR++Q + F + ++F
Sbjct: 240 AQTEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQRGKYFPEQAVKF 299
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
Y AE++LA+EYLH +GI+YRDLKPEN++++E+GHIML DFDLS + + SP + +
Sbjct: 300 YVAEILLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA-----VSPTLIRS 354
Query: 193 ANTRSGIKKRRSFLSKFC--------SSGISLEDPVHSPRIGPDPPSRSDSD-------- 236
+N + ++ + +C S I + GP S+S D
Sbjct: 355 SNPDAEALRKNN--QAYCVQPACVEPSCMIQPSCATPTTCFGPRFFSKSKKDRKPKPEVV 412
Query: 237 -------------SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP 283
S +S SFVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G TP
Sbjct: 413 NQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 472
Query: 284 FRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEF 336
F+GS + T + ++ +P P+ R+LIR LL K+P +R+G + EIK H F
Sbjct: 473 FKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEPQQRLGCKRGATEIKQHPF 532
Query: 337 FKGVNWELLLKISRPPNIPARFEHE 361
F+GVNW L++ + PP +P E E
Sbjct: 533 FEGVNWA-LIRCASPPEVPRPVEIE 556
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 142/381 (37%), Positives = 207/381 (54%), Gaps = 46/381 (12%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN 64
V R SL+ +++ LG G G V+L + + + SFA+KV+ + I + K +
Sbjct: 169 VRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLV--- 225
Query: 65 DNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM 124
R E+ +L++++HP LP L T+ +++CPG DLHSLR++Q +
Sbjct: 226 -------RAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQKQRGKY 278
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
F + RFY AE++LA+EYLH +GI+YRDLKPEN++++E+GHIML DFDLS + +
Sbjct: 279 FPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCA----- 333
Query: 185 ASPKTVLAANTRSGIKKRRSFLSKFC---SSGISLEDPVH----SPRIGPDPPSRSDSD- 236
SP V A K + C SS I D + +PR R S+
Sbjct: 334 VSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFLSKGKHRKKSND 393
Query: 237 ---------------SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGA 281
+S +S SFVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G
Sbjct: 394 MSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGI 453
Query: 282 TPFRGSSRKETFYRILCRPPDLVGEPT---PLRNLIRRLLEKDPTKRI----GVEEIKGH 334
TPFRG + T + ++ +P P R+LIR LL K+P R+ G EIK H
Sbjct: 454 TPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQH 513
Query: 335 EFFKGVNWELLLKISRPPNIP 355
FF+ VNW L++ + PP IP
Sbjct: 514 PFFQSVNWA-LIRCTSPPQIP 533
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (603), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 140/340 (41%), Positives = 191/340 (56%), Gaps = 50/340 (14%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
V LG G G V LV+ S E FA+K + KS L N K R E+ +
Sbjct: 579 VKPLGCGDTGSVHLVELQGSGELFAMKAM------DKSVMLNRN----KVHRACIEREIY 628
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
++HP LP L T V D+CPG +L ++ +Q ++F ++ RFYAAE+V+
Sbjct: 629 ALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQPMKIFREECARFYAAEVVIG 688
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
LEYLH +GI+YRDLKPENI++Q +GHI+L DFDLS + K P + + +K
Sbjct: 689 LEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTSK-----PHVI---KNSTSLK 740
Query: 201 KRRS--FLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+RRS FL PP+ S+ S SNSFVGTEEY+APE+I G
Sbjct: 741 RRRSQEFL----------------------PPTFV-SEPSTPSNSFVGTEEYIAPEVITG 777
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIR 315
GH A+DWW+LG++L+EMLYG TPFRG +RK+TFY IL + P + + LI
Sbjct: 778 AGHTSAIDWWALGILLYEMLYGRTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIH 837
Query: 316 RLLEKDPTKRI----GVEEIKGHEFFKGVNWELLLKISRP 351
LL++DP+ RI G +IK H FF+ +NW L+ +S P
Sbjct: 838 GLLQRDPSNRIGSNAGANDIKQHSFFQDINWPLIRCMSPP 877
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 426 | ||||||
| 255585618 | 430 | serine/threonine protein kinase, putativ | 0.950 | 0.941 | 0.601 | 1e-135 | |
| 224065425 | 421 | predicted protein [Populus trichocarpa] | 0.929 | 0.940 | 0.610 | 1e-134 | |
| 15230825 | 421 | serine/threonine-protein kinase OXI1 [Ar | 0.957 | 0.969 | 0.583 | 1e-130 | |
| 297831428 | 423 | oxidative signal-inducible1 [Arabidopsis | 0.946 | 0.952 | 0.599 | 1e-125 | |
| 15235548 | 372 | AGC (cAMP-dependent, cGMP-dependent and | 0.812 | 0.930 | 0.633 | 1e-123 | |
| 357513223 | 429 | Serine/threonine protein kinase OXI1 [Me | 0.859 | 0.853 | 0.593 | 1e-120 | |
| 449520237 | 430 | PREDICTED: serine/threonine-protein kina | 0.906 | 0.897 | 0.585 | 1e-120 | |
| 356560695 | 434 | PREDICTED: serine/threonine-protein kina | 0.950 | 0.933 | 0.535 | 1e-117 | |
| 356503073 | 444 | PREDICTED: serine/threonine-protein kina | 0.899 | 0.862 | 0.567 | 1e-117 | |
| 297790604 | 372 | kinase family protein [Arabidopsis lyrat | 0.814 | 0.932 | 0.628 | 1e-116 |
| >gi|255585618|ref|XP_002533496.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223526640|gb|EEF28883.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1257), Expect = e-135, Method: Compositional matrix adjust.
Identities = 261/434 (60%), Positives = 319/434 (73%), Gaps = 29/434 (6%)
Query: 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
PI +L+ CL +VSALGRGAKGVVFLVK+ + E +ALKVI RD++EKK++EL+ G+
Sbjct: 10 PILNLEDDCLTVVSALGRGAKGVVFLVKEKTNGELWALKVILRDVVEKKNRELSCT--GN 67
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
+Y+R+ FE++VL + HPLLP+LRGVL TDK +GYAID+CPGRDL+ LRKQQSE+MFS D
Sbjct: 68 EYKRVWFEKQVLSHFNHPLLPKLRGVLVTDKIIGYAIDFCPGRDLNHLRKQQSERMFSVD 127
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
IRFYAAELVLALEYLHN GI YRDLKPENI+IQENGHIMLVDFDLSTK+SP P+ SP
Sbjct: 128 IIRFYAAELVLALEYLHNQGIAYRDLKPENILIQENGHIMLVDFDLSTKISP--PKWSPN 185
Query: 189 TVLAANTRSGIKKRRSFLSKF---CSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
+ +T+ RR S+F C+SGIS +D S G + + D++EKSNSFV
Sbjct: 186 SNSPVSTQRKYSSRRKRFSRFHRCCNSGISPDD---SSENGITAVHQKEPDATEKSNSFV 242
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG 305
GTEEYVAPEII+G GH+FAVDWWSLGVVL+EMLYG TPF+GS+RKETF+RIL R PDLVG
Sbjct: 243 GTEEYVAPEIIQGYGHEFAVDWWSLGVVLYEMLYGRTPFKGSNRKETFFRILTRSPDLVG 302
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIP-ARFEHENNE 364
E TPLR+LI +LL KDP +RI VE IKGHEFFKG++W+L+L++SRPP IP A ++ NE
Sbjct: 303 ETTPLRDLIGKLLVKDPRERIKVEGIKGHEFFKGIDWKLILEMSRPPYIPLANYDCRGNE 362
Query: 365 SDGRGRDGTKEIDVEKFVQGIFAG------------GGDAEQKNEVNDEMNKNRGGEKVN 412
G +G +IDVE FVQ IF G GD EV +K G+ +N
Sbjct: 363 ----GTEGKMKIDVESFVQRIFGGEIEKQKVGDRNNNGDGNHDQEVKKIGDKGEWGKGLN 418
Query: 413 NQRHACEEDNFLVF 426
N H E NFLVF
Sbjct: 419 N--HFQETHNFLVF 430
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065425|ref|XP_002301811.1| predicted protein [Populus trichocarpa] gi|222843537|gb|EEE81084.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1244), Expect = e-134, Method: Compositional matrix adjust.
Identities = 256/419 (61%), Positives = 316/419 (75%), Gaps = 23/419 (5%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND-NGDKYR 71
L+ ++++S LGRGAKGVVFLVK+ E +ALKV+ R+ ++KK + + D G++YR
Sbjct: 21 LNMESMKVISPLGRGAKGVVFLVKEEPLGEFYALKVVSREFVKKKKRGSNDKDMEGEEYR 80
Query: 72 RISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIR 131
RI FEQ+V+ HPLLP+LRGVL+TDK + YAIDYCPGRDLH LRKQQSE+MF+ DTIR
Sbjct: 81 RIYFEQQVVSRFNHPLLPKLRGVLATDKILAYAIDYCPGRDLHFLRKQQSEKMFAIDTIR 140
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FYAAELVLALEYLH +GI YRDLKP+NIM+QENGHIMLVDFDLSTKL PK+ ASP +V+
Sbjct: 141 FYAAELVLALEYLHRLGIAYRDLKPDNIMVQENGHIMLVDFDLSTKLPPKS--ASPVSVV 198
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR-SDSDSSEKSNSFVGTEEY 250
A +KRRS L +F + G+S +D G + R S+ DS+ KSNSFVGTEEY
Sbjct: 199 ADR-----RKRRSPLHRFFNRGVSPDDS------GEELGHRLSEPDSTSKSNSFVGTEEY 247
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL 310
VAPE+I+G GHDF VDWWSLGVVL+EMLYG TPF+G SRKE+FYRIL + PDLVGE TPL
Sbjct: 248 VAPEVIQGDGHDFGVDWWSLGVVLYEMLYGVTPFKGESRKESFYRILTKKPDLVGEATPL 307
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDGRGR 370
R+LI +LL KDP +RI VE IKGH+FFKG++W+LLL+I RPP IP +N S+G G+
Sbjct: 308 RDLIGKLLIKDPKERIRVEGIKGHDFFKGIDWDLLLQILRPPYIPFM----DNWSEGEGK 363
Query: 371 DGTKEIDVEKFVQGIFAGGGDAEQKN-EVNDEMNKNRGGEKVN--NQRHACEEDNFLVF 426
+G KEIDVE FVQ IF G D ++KN + N N+N+ VN N H CE +NFLVF
Sbjct: 364 NGIKEIDVEIFVQEIFGAGDDDKKKNLDGNHHGNENK-KVWVNGLNTNHPCEAENFLVF 421
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230825|ref|NP_189162.1| serine/threonine-protein kinase OXI1 [Arabidopsis thaliana] gi|75273965|sp|Q9LSF1.1|OXI1_ARATH RecName: Full=Serine/threonine-protein kinase OXI1; AltName: Full=Protein OXIDATIVE SIGNAL-INDUCIBLE 1 gi|9294182|dbj|BAB02084.1| protein kinases-like protein [Arabidopsis thaliana] gi|119935818|gb|ABM06002.1| At3g25250 [Arabidopsis thaliana] gi|332643479|gb|AEE77000.1| serine/threonine-protein kinase OXI1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1208), Expect = e-130, Method: Compositional matrix adjust.
Identities = 251/430 (58%), Positives = 313/430 (72%), Gaps = 22/430 (5%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND 65
+++ R+LDF+ L ++S LGRGAKGVVFLV+D + ++ ALKVI ++ IEKK K + D
Sbjct: 5 DEKQSRALDFNRLEVLSLLGRGAKGVVFLVRD-DDAKLLALKVILKEAIEKKKKGRESED 63
Query: 66 NGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMF 125
D+Y+R+SFEQ VL +HPL P L GVL+TDK +GYAIDYCPG++L+SLRK QSE MF
Sbjct: 64 --DEYKRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMF 121
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
SD+ IRFYAAELVLAL+YLHN GIVYRDLKP+N+MIQENGH+ML+DFDLST L+P+TPQ
Sbjct: 122 SDEIIRFYAAELVLALDYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQP 181
Query: 186 SPKTVLAANTRSGIKKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
SP + T +K+R F + FC+SGIS P S + S EKSNSF
Sbjct: 182 SPSLSKPSPTMK--RKKRLFRFTSFCNSGIS---PQESISVHSSSTLAVSDSSGEKSNSF 236
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
VGTEEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGATPFRGS+RKETFYRIL +PP+L
Sbjct: 237 VGTEEYVAPEVISGDGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFYRILSKPPNLT 296
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
GE T LR+LIRRLLEKDP++RI VEEIKGH+FF+GV+WE ++ +SRPP IPA ++
Sbjct: 297 GETTSLRDLIRRLLEKDPSRRINVEEIKGHDFFRGVDWEKVILVSRPPYIPAP-----DD 351
Query: 365 SDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKN-----EVNDEMNKNRGGEKVN--NQRHA 417
+G D ++DVE VQ IFA + E+++ N ++ N GE V N H
Sbjct: 352 GGDKGTDVNTKMDVENIVQEIFAARQEREKQSGDNNKNANMKIKDNTSGEWVKGLNNNHD 411
Query: 418 CEED-NFLVF 426
E D NFLVF
Sbjct: 412 LESDNNFLVF 421
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297831428|ref|XP_002883596.1| oxidative signal-inducible1 [Arabidopsis lyrata subsp. lyrata] gi|297329436|gb|EFH59855.1| oxidative signal-inducible1 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 453 bits (1166), Expect = e-125, Method: Compositional matrix adjust.
Identities = 256/427 (59%), Positives = 311/427 (72%), Gaps = 24/427 (5%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
R+LDF+ L ++S LGRGAKGVVFLV+D + ++ ALKVI ++ IEKK K+ ++ D+Y
Sbjct: 10 RALDFNRLEVLSLLGRGAKGVVFLVRD-DDAKLLALKVILKEAIEKKKKKARESEE-DEY 67
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
+R+SFEQ VL +HPL P L GVL+TDK +GYAIDYCPG++L+SLRK QSE MFSDD I
Sbjct: 68 KRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMFSDDII 127
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
RFYAAELVLALEYLHN GIVYRDLKP+N+MIQENGH+ML+DFDLST L+P+TPQ SP
Sbjct: 128 RFYAAELVLALEYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQPSPSPS 187
Query: 191 LA--ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
A TR KKR S FC+SGIS P S I S EKSNSFVGTE
Sbjct: 188 KPSPATTR---KKRLFRFSSFCNSGIS---PQESISIHSSSTLAVSDSSGEKSNSFVGTE 241
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
EYVAPE+I G GHDFAVDWWSLGVVL+EMLYG TPFRGS+RKETFYRIL +PP+L GE T
Sbjct: 242 EYVAPEVITGDGHDFAVDWWSLGVVLYEMLYGTTPFRGSNRKETFYRILSKPPNLTGETT 301
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDGR 368
LR+LIRRLLEKDP++RI VEEIKGH+FFKGV+WE ++ +SRPP IPA ++ +
Sbjct: 302 SLRDLIRRLLEKDPSRRINVEEIKGHDFFKGVDWEKVILVSRPPYIPAP-----DDGGDK 356
Query: 369 GRDGTKEIDVEKFVQGIFAGGGDAEQK----NEVNDEMNKNRGGEKV----NNQRHACE- 419
G+D ++DVE VQ IFA + +++ N N + + GE V NN H E
Sbjct: 357 GKDVNTKMDVENIVQEIFAAREERDKQSGDNNNANMRIKGDNSGEWVKGLNNNNNHDLES 416
Query: 420 EDNFLVF 426
E+NFLVF
Sbjct: 417 ENNFLVF 423
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15235548|ref|NP_193036.1| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] gi|5123941|emb|CAB45499.1| putative protein [Arabidopsis thaliana] gi|7268002|emb|CAB78342.1| putative protein [Arabidopsis thaliana] gi|26450769|dbj|BAC42493.1| unknown protein [Arabidopsis thaliana] gi|28950941|gb|AAO63394.1| At4g13000 [Arabidopsis thaliana] gi|332657812|gb|AEE83212.1| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1153), Expect = e-123, Method: Compositional matrix adjust.
Identities = 242/382 (63%), Positives = 285/382 (74%), Gaps = 36/382 (9%)
Query: 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
I +L+F L I SALGRG+KGVVFLVK ++ ALKVI R+ IE K + D+
Sbjct: 12 IPTLNFDHLEIFSALGRGSKGVVFLVK--ADNKWLALKVILRESIESKKAK-------DE 62
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
Y+RISFEQ VL +HPL PRL GV+STDK +GYAIDYCPGRDL+SLRK+QSE+MFSD+
Sbjct: 63 YKRISFEQGVLSRFDHPLFPRLHGVISTDKVIGYAIDYCPGRDLNSLRKKQSEEMFSDEI 122
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
IRFYAAELV+ALEYLHN GIVYRDLKP+N+MIQENGH+MLVDFDLST L P+TPQ+S +
Sbjct: 123 IRFYAAELVIALEYLHNQGIVYRDLKPDNVMIQENGHLMLVDFDLSTNLPPRTPQSSFSS 182
Query: 190 VLAANTRSGIKKRRSF--LSKFCSSGISLEDPVHSPRIGPDPPSRSDSD--SSEKSNSFV 245
+T + KK RS S C+SGIS +D V SRS S EKSNSFV
Sbjct: 183 SPRLSTAT--KKERSIFAFSGLCNSGISPDDSV----------SRSSESEFSGEKSNSFV 230
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG 305
GTEEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGATPFRGS+RKETF +IL PP LVG
Sbjct: 231 GTEEYVAPEVITGSGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFLKILTEPPSLVG 290
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNES 365
E T LR+L+R+LLEKDP++RI VE IKGH+FFKG++W+L+LK+SRPP IPA EN E
Sbjct: 291 ETTSLRDLVRKLLEKDPSRRINVEGIKGHDFFKGLDWDLVLKVSRPPYIPAP---ENYE- 346
Query: 366 DGRGRDGTKEIDVEKFVQGIFA 387
+IDVEKFV IF
Sbjct: 347 -------ISKIDVEKFVHEIFT 361
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357513223|ref|XP_003626900.1| Serine/threonine protein kinase OXI1 [Medicago truncatula] gi|355520922|gb|AET01376.1| Serine/threonine protein kinase OXI1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 438 bits (1126), Expect = e-120, Method: Compositional matrix adjust.
Identities = 234/394 (59%), Positives = 288/394 (73%), Gaps = 28/394 (7%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVK--DVESSESFALKVIWRDLIEKKSKELTN 63
NDR ++SLDF L+++SA+GRGAKGVVFL + + S E ALKV+ + LI++K + N
Sbjct: 9 NDR-VKSLDFKTLKVISAVGRGAKGVVFLARTGNRSSEEYLALKVMSKALIDQKKSK--N 65
Query: 64 NDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
+Y+R SFEQ VLR+ +HPLLPRLRGV T+K VG+AIDYC G +LHSLRK+QSE+
Sbjct: 66 PKGCGEYKRASFEQEVLRSFDHPLLPRLRGVFETEKIVGFAIDYCNGGNLHSLRKKQSEK 125
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
MFSDD IRFYAAE+VLALEYLH++GIVYRDLKP+N+MIQENGHIMLVDFDLSTKL P TP
Sbjct: 126 MFSDDAIRFYAAEMVLALEYLHDLGIVYRDLKPDNVMIQENGHIMLVDFDLSTKLKPITP 185
Query: 184 QASPKTVLAANTRSGIKK-------RRSFLSKF--CSSGISLEDPVHSPRIGPDPPS--R 232
S L+ N+ S K + S+F C+SGIS P S + D S R
Sbjct: 186 PQS----LSHNSSSERSKPSKEKHTKNRLFSRFYRCNSGIS---PCDSDFLPTDSGSFKR 238
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292
++ +S EKS SFVGTEEYVAPEI+ GKGH F VDWWSLGVVL+EMLYG TPF G++RKET
Sbjct: 239 NEPESVEKSKSFVGTEEYVAPEIVNGKGHGFEVDWWSLGVVLYEMLYGTTPFNGTNRKET 298
Query: 293 FYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPP 352
FYRIL + P+L GE T LR+LIRRLLEKDP +RI V+EIKGH+FFKGV W+ +L+++RPP
Sbjct: 299 FYRILSKEPELTGEKTALRDLIRRLLEKDPDRRIKVDEIKGHDFFKGVKWDTVLELARPP 358
Query: 353 NIPARFEHENNESDGRGRDGTKEIDVEKFVQGIF 386
IP E EN + G R+ VE FV +F
Sbjct: 359 YIPPLIEVENENNKGYSRNY-----VEVFVHEVF 387
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520237|ref|XP_004167140.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 436 bits (1122), Expect = e-120, Method: Compositional matrix adjust.
Identities = 243/415 (58%), Positives = 304/415 (73%), Gaps = 29/415 (6%)
Query: 1 MNDVVNDRP-IRSLDFSCLRIVSALGRGAKGVVFLVKD--VESSESFALKVIWRDLIEKK 57
MN V + + I L F L +++ALGRGAKGVVFL +D + E ALKVI R+LI++K
Sbjct: 1 MNHVRDQQQEIPQLHFQNLEVLTALGRGAKGVVFLARDPTEDHGEWLALKVISRELIQRK 60
Query: 58 SKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLR 117
+K + NND G +YRR+ FE+ VLR HPLLPRL+GVL T K VGYAIDYC GRDL++LR
Sbjct: 61 AK-IVNND-GAEYRRVCFEREVLRLFRHPLLPRLQGVLDTQKVVGYAIDYCNGRDLNALR 118
Query: 118 KQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177
K+Q+E+MFSDD IRFYAAELV+ALEY+H++GIVYRDLKPEN+M+Q NGHIMLVDFDLST+
Sbjct: 119 KKQTEKMFSDDVIRFYAAELVMALEYVHSLGIVYRDLKPENVMVQHNGHIMLVDFDLSTR 178
Query: 178 LSPKTPQASPKTVLAANTRSG--IKKRRSFLSKF----------CSSGISLE--DPVHSP 223
LS ++P++SP T S I+ + S K C+SG+S E D +
Sbjct: 179 LSQRSPKSSPSPAAEVLTESKFVIEDKNSKKRKKKKRFFHFHRFCNSGVSPEESDQQATA 238
Query: 224 RIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP 283
P S+S+SSEKSNSFVGTE+YVAPEI+ GKGHDFAVDWWSLGVVL+EMLYG TP
Sbjct: 239 TEKPRSEVESESESSEKSNSFVGTEDYVAPEIVAGKGHDFAVDWWSLGVVLYEMLYGTTP 298
Query: 284 FRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343
FRG++RKETFYRIL + PDL GE T LR+LIR LLEKDP KRI VEEIK HEFFKG+ W+
Sbjct: 299 FRGTNRKETFYRILTKTPDLCGEATALRDLIRMLLEKDPGKRIEVEEIKRHEFFKGIEWD 358
Query: 344 LLLKISRPPNIPARFEHENNESDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKNEV 398
++L+I+RPP++P E E R+G K IDVE FV+ +F + E+KN++
Sbjct: 359 MVLEIARPPSLPEMGEEE--------RNGEKIIDVESFVENVFC--SEIEKKNQI 403
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356560695|ref|XP_003548625.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1104), Expect = e-117, Method: Compositional matrix adjust.
Identities = 232/433 (53%), Positives = 295/433 (68%), Gaps = 28/433 (6%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVK--DVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
+ LD LR+VSA+GRGAKGVVFL + D S E ALKVI + LI +K +L + +
Sbjct: 13 KPLDLENLRVVSAVGRGAKGVVFLARTGDRSSEECVALKVISKALIIQKKAKLNDTE--- 69
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
+Y R+SFE++VLR +HPLLPRLRGV TD+ VG+AIDYC G L SLRK+Q+E+MFSDD
Sbjct: 70 EYTRVSFEEQVLRRFDHPLLPRLRGVFETDRVVGFAIDYCHGGTLRSLRKKQTEKMFSDD 129
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
TIRFYAAELVLALEYLH +GIVYRDLKP+N+MIQENGHIMLVDFDLS KL+PK P +
Sbjct: 130 TIRFYAAELVLALEYLHKLGIVYRDLKPDNVMIQENGHIMLVDFDLSKKLNPKFPYSLSH 189
Query: 189 TVLAANTRSGIKKRRSFLS---KFCSSGISLEDPVHSPRIGPDPPSRS-DSDSSEKSNSF 244
+ RR +L+ KFC+ IS D P + +R +S+ EKSNSF
Sbjct: 190 NSSSNPNSEKKHTRRHWLTRFYKFCNWVISPYDSDSEPSLNNVNSARHIESNLVEKSNSF 249
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
VGTEEYVAPEI+ GKGHDF++DWWS G+VL+EMLYG TPF+G++RKETFYRIL + P+L
Sbjct: 250 VGTEEYVAPEIVSGKGHDFSIDWWSYGIVLYEMLYGTTPFKGANRKETFYRILTKEPELT 309
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
GE T LR+LI +LLEKDP +RI V+EIKGH+FFKGV W+++L+I RPP IP E
Sbjct: 310 GEKTALRDLIGKLLEKDPDRRIRVDEIKGHDFFKGVKWDMVLRIVRPPYIP--------E 361
Query: 365 SDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKNEVNDEMNKNRGGE---------KVNNQR 415
++ + + G + DVE FV +F GD + + + K KV+
Sbjct: 362 NEVKNKVGFGKSDVEVFVDKVFFPTGDDGGREKTKMVLEKKDSNNNGENINNMVKVDELS 421
Query: 416 HACEE--DNFLVF 426
H E D+FL+F
Sbjct: 422 HVPTEKIDDFLIF 434
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503073|ref|XP_003520336.1| PREDICTED: serine/threonine-protein kinase OXI1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 427 bits (1097), Expect = e-117, Method: Compositional matrix adjust.
Identities = 228/402 (56%), Positives = 284/402 (70%), Gaps = 19/402 (4%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVK--DVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
+ LD LR+VSA+GRGAKGVVFL + D S E ALKVI + LI +K+K + N
Sbjct: 13 KPLDLENLRVVSAVGRGAKGVVFLARTGDRSSEECVALKVIPKALILQKAKLI----NDV 68
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
+Y R+SFE++VLR +H LLPRLRGV T+K VG+ IDYC G LHSLRK+Q+E+MFSDD
Sbjct: 69 EYTRVSFEEQVLRRFDHLLLPRLRGVFETEKVVGFGIDYCHGGTLHSLRKKQTEKMFSDD 128
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA--- 185
TIRFYA ELVLALEYLHN+GIVYRDLKPEN+MIQ+NGHIMLVDFDLS KL+PK+P +
Sbjct: 129 TIRFYAVELVLALEYLHNLGIVYRDLKPENVMIQDNGHIMLVDFDLSKKLNPKSPHSLSQ 188
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR-SDSDSSEKSNSF 244
+ + T+ K+R FC+SGI D P + R ++SD EKSNSF
Sbjct: 189 NSSPSPNSKTKQTRKQRLMRFYSFCNSGILPCDSDSEPPLSSVNSVRHTESDLVEKSNSF 248
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
VGTEEYVAPEI+ GKGH F+VDWWS GVVL+EMLYG TPF+GS+RKETFYRIL + P+L
Sbjct: 249 VGTEEYVAPEIVSGKGHGFSVDWWSYGVVLYEMLYGTTPFKGSNRKETFYRILMKEPELT 308
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
GE T LR+LI +LLEK+P +RI V EIKGH FFKGV W+ +L I+RPP IP E
Sbjct: 309 GEKTALRDLIGKLLEKNPDRRIQVNEIKGHNFFKGVKWDTVLHIARPPYIP--------E 360
Query: 365 SDGRGRDGTKEIDVEKFVQGI-FAGGGDAEQKNEVNDEMNKN 405
++ + G + DVE FV + F G D +K + ++M +N
Sbjct: 361 NEVENKVGFSKSDVEVFVDNVFFPTGDDGGEKTKTLNKMYRN 402
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297790604|ref|XP_002863187.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297309021|gb|EFH39446.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1088), Expect = e-116, Method: Compositional matrix adjust.
Identities = 239/380 (62%), Positives = 282/380 (74%), Gaps = 33/380 (8%)
Query: 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
I +L+F L + SALGRG+KGVVFLVK +E ALKVI R+ IE K + D+
Sbjct: 11 IPTLNFDHLEVFSALGRGSKGVVFLVK--ADNEWLALKVILRESIETKKTK-------DE 61
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
Y+RISFEQ VL +HPL PRL GVLSTDK VGYAIDYCPGRDL+SLRK+QSE+MFSD+
Sbjct: 62 YKRISFEQGVLSRFDHPLFPRLHGVLSTDKVVGYAIDYCPGRDLNSLRKKQSEEMFSDEI 121
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
IRFYAAELV+ALEYLHN GIVYRDLKP+N+MIQENGH+MLVDFDLST L P+TPQ+S
Sbjct: 122 IRFYAAELVIALEYLHNQGIVYRDLKPDNVMIQENGHLMLVDFDLSTNLPPRTPQSSSS- 180
Query: 190 VLAANTRSGIKKRRSFL--SKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
+ + +K RS S FC+SGIS +D V S S EKSNSFVGT
Sbjct: 181 --SPRLSTATRKERSLFAFSGFCNSGISPDDSVSR--------ISESSSSGEKSNSFVGT 230
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP 307
EEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGATPFRGS+RKETF +IL PP LVGE
Sbjct: 231 EEYVAPEVITGSGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFLKILTEPPSLVGET 290
Query: 308 TPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDG 367
T LR+L+R+LLEKDP++RI VE IKGH+FF+G++W+L+LK+SRPP IPA +E
Sbjct: 291 TSLRDLVRKLLEKDPSRRINVEGIKGHDFFRGLDWDLVLKVSRPPYIPAPGNYE------ 344
Query: 368 RGRDGTKEIDVEKFVQGIFA 387
+IDVEKFV IFA
Sbjct: 345 -----ISKIDVEKFVHEIFA 359
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 426 | ||||||
| TAIR|locus:2090310 | 421 | AGC2-1 [Arabidopsis thaliana ( | 0.957 | 0.969 | 0.541 | 5e-115 | |
| TAIR|locus:2123191 | 372 | AT4G13000 [Arabidopsis thalian | 0.737 | 0.844 | 0.590 | 2.5e-97 | |
| TAIR|locus:2008331 | 404 | UCN "UNICORN" [Arabidopsis tha | 0.769 | 0.811 | 0.403 | 6e-64 | |
| TAIR|locus:2091881 | 408 | UCNL "UNICORN-like" [Arabidops | 0.800 | 0.835 | 0.385 | 5.5e-61 | |
| TAIR|locus:2098120 | 451 | AT3G44610 [Arabidopsis thalian | 0.274 | 0.259 | 0.472 | 2.5e-55 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.366 | 0.281 | 0.392 | 2.8e-55 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.274 | 0.199 | 0.464 | 8.4e-53 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.269 | 0.164 | 0.495 | 2e-52 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.274 | 0.152 | 0.472 | 4e-52 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.276 | 0.233 | 0.452 | 4.3e-52 |
| TAIR|locus:2090310 AGC2-1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1134 (404.2 bits), Expect = 5.0e-115, P = 5.0e-115
Identities = 233/430 (54%), Positives = 293/430 (68%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND 65
+++ R+LDF+ L ++S LGRGAKGVVFLV+D + ++ ALKVI ++ IEKK K + D
Sbjct: 5 DEKQSRALDFNRLEVLSLLGRGAKGVVFLVRD-DDAKLLALKVILKEAIEKKKKGRESED 63
Query: 66 NGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMF 125
D+Y+R+SFEQ VL +HPL P L GVL+TDK +GYAIDYCPG++L+SLRK QSE MF
Sbjct: 64 --DEYKRVSFEQGVLSRFDHPLFPSLHGVLATDKVIGYAIDYCPGQNLNSLRKMQSESMF 121
Query: 126 SDDTIRFXXXXXXXXXXXXHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
SD+ IRF HN GIVYRDLKP+N+MIQENGH+ML+DFDLST L+P+TPQ
Sbjct: 122 SDEIIRFYAAELVLALDYLHNQGIVYRDLKPDNVMIQENGHLMLIDFDLSTNLAPRTPQP 181
Query: 186 SPKTVLAANTRSGIKKRRSF-LSKFCSSGISLEDPVHXXXXXXXXXXXXXXXXXXXXXXF 244
SP + T +K+R F + FC+SGIS P F
Sbjct: 182 SPSLSKPSPTMK--RKKRLFRFTSFCNSGIS---PQESISVHSSSTLAVSDSSGEKSNSF 236
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
VGTEEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGATPFRGS+RKETFYRIL +PP+L
Sbjct: 237 VGTEEYVAPEVISGDGHDFAVDWWSLGVVLYEMLYGATPFRGSNRKETFYRILSKPPNLT 296
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
GE T LR+LIRRLLEKDP++RI VEEIKGH+FF+GV+WE ++ +SRPP IPA ++
Sbjct: 297 GETTSLRDLIRRLLEKDPSRRINVEEIKGHDFFRGVDWEKVILVSRPPYIPAP-----DD 351
Query: 365 SDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKN-----EVNDEMNKNRGGEKVN--NQRHA 417
+G D ++DVE VQ IFA + E+++ N ++ N GE V N H
Sbjct: 352 GGDKGTDVNTKMDVENIVQEIFAARQEREKQSGDNNKNANMKIKDNTSGEWVKGLNNNHD 411
Query: 418 CEEDN-FLVF 426
E DN FLVF
Sbjct: 412 LESDNNFLVF 421
|
|
| TAIR|locus:2123191 AT4G13000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 2.5e-97, P = 2.5e-97
Identities = 203/344 (59%), Positives = 240/344 (69%)
Query: 45 ALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYA 104
ALKVI R+ IE K + D+Y+RISFEQ VL +HPL PRL GV+STDK +GYA
Sbjct: 45 ALKVILRESIESKKAK-------DEYKRISFEQGVLSRFDHPLFPRLHGVISTDKVIGYA 97
Query: 105 IDYCPGRDLHSLRKQQSEQMFSDDTIRFXXXXXXXXXXXXHNMGIVYRDLKPENIMIQEN 164
IDYCPGRDL+SLRK+QSE+MFSD+ IRF HN GIVYRDLKP+N+MIQEN
Sbjct: 98 IDYCPGRDLNSLRKKQSEEMFSDEIIRFYAAELVIALEYLHNQGIVYRDLKPDNVMIQEN 157
Query: 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFL--SKFCSSGISLEDPVHX 222
GH+MLVDFDLST L P+TPQ+S + +T + KK RS S C+SGIS +D V
Sbjct: 158 GHLMLVDFDLSTNLPPRTPQSSFSSSPRLSTAT--KKERSIFAFSGLCNSGISPDDSV-- 213
Query: 223 XXXXXXXXXXXXXXXXXXXXXFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGAT 282
FVGTEEYVAPE+I G GHDFAVDWWSLGVVL+EMLYGAT
Sbjct: 214 ------SRSSESEFSGEKSNSFVGTEEYVAPEVITGSGHDFAVDWWSLGVVLYEMLYGAT 267
Query: 283 PFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342
PFRGS+RKETF +IL PP LVGE T LR+L+R+LLEKDP++RI VE IKGH+FFKG++W
Sbjct: 268 PFRGSNRKETFLKILTEPPSLVGETTSLRDLVRKLLEKDPSRRINVEGIKGHDFFKGLDW 327
Query: 343 ELLLKISRPPNIPARFEHENNESDGRGRDGTKEIDVEKFVQGIF 386
+L+LK+SRPP IPA EN E +IDVEKFV IF
Sbjct: 328 DLVLKVSRPPYIPAP---ENYE--------ISKIDVEKFVHEIF 360
|
|
| TAIR|locus:2008331 UCN "UNICORN" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 6.0e-64, P = 6.0e-64
Identities = 149/369 (40%), Positives = 205/369 (55%)
Query: 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNN 64
P +L+ L+++ LG+GA G VFLV D S S FALK L++K S
Sbjct: 13 PATNLNLDRLKVLKLLGKGATGTVFLVHDSVSDSSVSSPFALK-----LVDKSS------ 61
Query: 65 DNGDKYRRISFEQRVLRNVE-----HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ 119
RR +E ++LR + +P LP+L + +F+ +A+ YC G DL+ LR++
Sbjct: 62 --ASSLRRARWEIQILRRLSDDTNPNPFLPKLLASSESSEFIAWALPYCSGGDLNVLRQR 119
Query: 120 QSEQMFSDDTIRFXXXXXXXXXXXXHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
Q++ +FS I+F H MGI YRDLKPENI++QE+GH+ L DFDLS L+
Sbjct: 120 QNDGVFSSSVIKFYLAEIVCALDHLHTMGIAYRDLKPENILLQESGHVTLTDFDLSCSLN 179
Query: 180 -PKTPQ------ASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHXXXXXXXXXXX 232
P P+ P +N K R F K + + +P+
Sbjct: 180 KPTRPEFYHLSDPEPDPNPESNLSHNKKSLRIFRQKKKKTKSARVNPI--------TRRR 231
Query: 233 XXXXXXXXXXXFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292
FVGT+EY++PE+I G GHDFAVDWW+LGV+ +EM+YG TPF+G ++KET
Sbjct: 232 LSFSGGERSNSFVGTDEYISPEVIRGDGHDFAVDWWALGVLTYEMMYGETPFKGRNKKET 291
Query: 293 FYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIG----VEEIKGHEFFKGVNWELLLKI 348
F +L + P+ G+P+ L +LIRRLL KDPTKR G EIK H FFKGV WELL ++
Sbjct: 292 FRNVLVKEPEFAGKPSDLTDLIRRLLVKDPTKRFGFWRGAAEIKEHAFFKGVRWELLTEV 351
Query: 349 SRPPNIPAR 357
RPP IP R
Sbjct: 352 LRPPFIPLR 360
|
|
| TAIR|locus:2091881 UCNL "UNICORN-like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 5.5e-61, P = 5.5e-61
Identities = 141/366 (38%), Positives = 195/366 (53%)
Query: 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
P LD ++ + LG+GA G VFL DV S+ S + + L+ K S
Sbjct: 12 PPEILDLDSIKALKILGKGATGTVFLAHDVVSTSSSSSPFAVK-LVPKSS--------AS 62
Query: 69 KYRRISFEQRVLRNV-----EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
RR +E VLR + ++P LPRL + ++ +A+ YC G DL+ L +Q++
Sbjct: 63 SLRRARWEIEVLRRLSVDSNQNPFLPRLLASFESPEYFAWAVPYCSGGDLNVLLHRQNDG 122
Query: 124 MFSDDTIRFXXXXXXXXXXXXHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS-PKT 182
+FS IRF H MGI YRDLKPENI+IQ++GH+ L DFDLS L P
Sbjct: 123 VFSSSVIRFYVAEIVCALEHLHTMGIAYRDLKPENILIQQSGHVTLTDFDLSRSLKKPLR 182
Query: 183 P---QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHXXXXXXXXXXXXXXXXXX 239
P Q P+ ++ + S ++ +G+
Sbjct: 183 PHFYQPDPELIIDRKKSRSFSRLISPTAEKNKTGLK---KTRSARVNPINRRKTSFSSGE 239
Query: 240 XXXXFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299
FVGT+EYV+PE+I G GHDFAVDWW+LGV+ +EM+YG TPF+G S+KETF +L +
Sbjct: 240 RSNSFVGTDEYVSPEVIRGDGHDFAVDWWALGVLTYEMMYGETPFKGKSKKETFRNVLMK 299
Query: 300 PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEFFKGVNWELLLKISRPPNIP 355
P+ G+P L +LIRRLL KDP +R+G EIK FF GV W+LL ++ RPP IP
Sbjct: 300 EPEFAGKPNDLTDLIRRLLVKDPNRRLGCHRGAAEIKELAFFAGVRWDLLTEVLRPPFIP 359
Query: 356 ARFEHE 361
R + E
Sbjct: 360 LRDDGE 365
|
|
| TAIR|locus:2098120 AT3G44610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 298 (110.0 bits), Expect = 2.5e-55, Sum P(2) = 2.5e-55
Identities = 59/125 (47%), Positives = 81/125 (64%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
FVGT EY+APEI+ G+GH AVDWW+LG+ + E+ YG TPF+G + T I+ R +
Sbjct: 313 FVGTHEYLAPEIVSGEGHGSAVDWWTLGIFMFELFYGTTPFKGMDHELTLANIVARALEF 372
Query: 304 VGEPT-P--LRNLIRRLLEKDPTKRIG----VEEIKGHEFFKGVNWELLLKISRPPNIPA 356
EPT P ++LI +LL KDP++R+G +K H FF+GVNW LL+ +RPP +P
Sbjct: 373 PKEPTIPSAAKDLISQLLAKDPSRRLGSSLGATAVKRHPFFQGVNWALLM-CTRPPFLPP 431
Query: 357 RFEHE 361
F E
Sbjct: 432 PFRKE 436
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 311 (114.5 bits), Expect = 2.8e-55, Sum P(2) = 2.8e-55
Identities = 66/168 (39%), Positives = 99/168 (58%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRP 300
FVGT EY+APEII G+GH AVDWW+ G+ ++E+LYGATPF+G + T + ++ R
Sbjct: 380 FVGTHEYLAPEIIRGEGHGSAVDWWTFGIFIYELLYGATPFKGQGNRATLHNVIGQALRF 439
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLLKISRPPNIPA 356
P++ + R+LI+ LL K+P KRI G EIK H FF+GVNW L+ + + PP++P
Sbjct: 440 PEVPHVSSAARDLIKGLLVKEPQKRIAYKRGATEIKQHPFFEGVNWALI-RSATPPHVPE 498
Query: 357 RFE---HENNESDGRGR-DGTKEIDVEKFVQGIFAGGGDAEQKNEVND 400
+ + + + + DG + + G GGGD + + ND
Sbjct: 499 PVDFSCYASKDKESMAAVDGGGKKNNNGAGGGCSTGGGDNKPNGDCND 546
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 299 (110.3 bits), Expect = 8.4e-53, Sum P(2) = 8.4e-53
Identities = 58/125 (46%), Positives = 84/125 (67%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--- 300
FVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G TPF+GS ++T + ++ +P
Sbjct: 427 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSGNRQTLFNVVGQPLRF 486
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEFFKGVNWELLLKISRPPNIPA 356
P+ R+LIR LL K+P +R+G + E+K H FF+GVNW L+ + + PP IP
Sbjct: 487 PETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEGVNWALI-RCATPPEIPK 545
Query: 357 RFEHE 361
E E
Sbjct: 546 PVELE 550
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 309 (113.8 bits), Expect = 2.0e-52, Sum P(2) = 2.0e-52
Identities = 61/123 (49%), Positives = 81/123 (65%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--- 300
FVGT EY+APEII+G+GH AVDWW+ G+ LHE+LYG TPF+GS + T + ++ +
Sbjct: 540 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTPFKGSGNRATLFNVVGQQLKF 599
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEFFKGVNWELLLKISRPPNIPA 356
PD R+LIR LL K+P R+GV+ EIK H FF+GVNW L+ + S PP +P
Sbjct: 600 PDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPFFEGVNWALI-RCSTPPEVPR 658
Query: 357 RFE 359
E
Sbjct: 659 PVE 661
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 304 (112.1 bits), Expect = 4.0e-52, Sum P(2) = 4.0e-52
Identities = 59/125 (47%), Positives = 82/125 (65%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRP 300
FVGT EY+APEII+G+GH AVDWW+ G+ +HE+LYG TPF+GS + T + ++ +
Sbjct: 597 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLKF 656
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHEFFKGVNWELLLKISRPPNIPA 356
P+ R+LI+ LL KDP R+G + EIK H FF+GVNW L+ + S PP +P
Sbjct: 657 PESPATSYAGRDLIQALLVKDPKNRLGTKRGATEIKQHPFFEGVNWALI-RCSTPPEVPR 715
Query: 357 RFEHE 361
+ E E
Sbjct: 716 QMETE 720
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 294 (108.6 bits), Expect = 4.3e-52, Sum P(2) = 4.3e-52
Identities = 57/126 (45%), Positives = 82/126 (65%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
FVGT EY+APEII+G+GH AVDWW+ G+ L+E+L+G TPF+GS + T + ++ +P
Sbjct: 356 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRF 415
Query: 304 VGEPT---PLRNLIRRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLLKISRPPNIPA 356
P R+LIR LL K+P R+ G E+K H FF+GVNW L+ + + PP IP
Sbjct: 416 PESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQHPFFEGVNWALV-RCASPPEIPK 474
Query: 357 RFEHEN 362
++E+
Sbjct: 475 PVDYES 480
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LSF1 | OXI1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5837 | 0.9577 | 0.9691 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 426 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-139 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-75 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-69 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-65 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-60 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-55 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-55 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-54 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-53 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-53 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-52 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-51 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-50 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-49 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-49 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-49 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-48 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-47 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-47 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-46 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-46 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-46 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-44 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-43 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-42 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-41 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-38 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-38 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-38 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-37 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-36 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-36 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-36 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-35 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-35 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-34 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-33 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-32 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-32 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-31 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-31 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-29 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-29 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-28 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-28 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-27 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-27 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-23 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-22 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-21 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-17 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-17 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-16 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-15 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-15 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-11 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-09 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-05 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-04 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-04 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-04 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-04 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.001 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.001 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.002 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.002 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.003 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| pfam10707 | 199 | pfam10707, YrbL-PhoP_reg, PhoP regulatory network | 0.003 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.004 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 400 bits (1031), Expect = e-139
Identities = 146/347 (42%), Positives = 202/347 (58%), Gaps = 45/347 (12%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ + LG+G G VFLV+ + + FALKV+ + + K+ +K +R+ EQ
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR----------NKVKRVLTEQ 52
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+L ++HP LP L T+ ++ +DYCPG +L L ++Q + S++ RFYAAE+
Sbjct: 53 EILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEV 112
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+LALEYLH +GIVYRDLKPENI++ E+GHIML DFDLS + + P S +
Sbjct: 113 LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK---------A 163
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
K R S + S+ S +SNSFVGTEEY+APE+I
Sbjct: 164 LRKGSRR-----------------SSVNSIPSETFSEE-PSFRSNSFVGTEEYIAPEVIS 205
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLI 314
G GH AVDWW+LG++L+EMLYG TPF+GS+R ETF IL + P + R+LI
Sbjct: 206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLI 265
Query: 315 RRLLEKDPTKRI----GVEEIKGHEFFKGVNWELLLKISRPPNIPAR 357
R+LL KDP+KR+ G EIK H FF+GVNW L++ + PP IP
Sbjct: 266 RKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA-LIRHTTPPIIPRP 311
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (673), Expect = 3e-86
Identities = 114/318 (35%), Positives = 163/318 (51%), Gaps = 72/318 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G V LV+ ++ + +A+KV+ + I K+ + E+ +L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT----------ERNILSRI 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + +L T++ + ++Y PG +L S E FS++ RFYAAE+VLALEY
Sbjct: 51 NHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH--LSKEGRFSEERARFYAAEIVLALEY 108
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH++GI+YRDLKPENI++ +GHI L DF L+ +LS + + +
Sbjct: 109 LHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT---------------- 152
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
FC GT EY+APE++ GKG+
Sbjct: 153 -----FC-----------------------------------GTPEYLAPEVLLGKGYGK 172
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-LRNLIRRLLEKDP 322
AVDWWSLGV+L+EML G PF RKE + +IL P +P R+LI LL+KDP
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDP 232
Query: 323 TKRIG---VEEIKGHEFF 337
TKR+G EEIK H FF
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 235 bits (601), Expect = 3e-75
Identities = 102/319 (31%), Positives = 154/319 (48%), Gaps = 76/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ G V+L +D ++ + A+KVI + I+K + + E ++L+ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR------------EIKILKKL 54
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + RL V + + ++YC G DL L K++ S+D RFY +++ ALEY
Sbjct: 55 KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEY 112
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ GIV+RDLKPENI++ E+GH+ L DF L+ +L P
Sbjct: 113 LHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--------------------- 151
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
L+ F GT EY+APE++ GKG+
Sbjct: 152 -KLTTFV-----------------------------------GTPEYMAPEVLLGKGYGK 175
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-----LRNLIRRLL 318
AVD WSLGV+L+E+L G PF G + ++ + +P P ++LIR+LL
Sbjct: 176 AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLL 235
Query: 319 EKDPTKRIGVEEIKGHEFF 337
KDP KR+ EE H FF
Sbjct: 236 VKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-69
Identities = 114/346 (32%), Positives = 176/346 (50%), Gaps = 55/346 (15%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +GRGA G V+LV+D ++ + +A+KV+ D+I++ E+
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRA-----------ERD 53
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYAAE 136
+L + + P + +L ++ + ++Y PG DL +L RK F ++T RFY AE
Sbjct: 54 ILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV----FPEETARFYIAE 109
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
LVLAL+ +H +G ++RD+KP+NI+I +GHI L DF L K+
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM-------------NKAKD 156
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
S F + + R+ ++NS VGT +Y+APE++
Sbjct: 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRV--------------RANSTVGTPDYIAPEVL 202
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------LCRPPDLVGEPTPL 310
G + DWWSLGV+L+EMLYG PF + +ET+ +I L PPD
Sbjct: 203 RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPD-PPVSPEA 261
Query: 311 RNLIRRLLEKDPTKRIG-VEEIKGHEFFKGVNWELLLKISRPPNIP 355
+LI RLL DP R+G EEIK H FFKG++WE L + ++PP +P
Sbjct: 262 IDLICRLL-CDPEDRLGSFEEIKSHPFFKGIDWENLRE-TKPPFVP 305
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 6e-69
Identities = 105/336 (31%), Positives = 162/336 (48%), Gaps = 69/336 (20%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI--EKKSKELTNNDNGDKYR 71
DF + +G G+ V L K+ E+++ +A+K++ + + EKK K +
Sbjct: 2 DF---KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-------- 50
Query: 72 RISFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDT 129
E+ VL R HP + +L ++ + + ++Y P +L +RK S +
Sbjct: 51 ----EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKC 103
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
RFYAAE++LALEYLH+ GI++RDLKPENI++ ++ HI + DF + L P + S K
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
K RR + SFVGT E
Sbjct: 164 DATNIDSQIEKNRR------------------------------------RFASFVGTAE 187
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVG 305
YV+PE++ K + D W+LG ++++ML G PFRGS+ TF +IL PP+
Sbjct: 188 YVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNF-- 245
Query: 306 EPTPLRNLIRRLLEKDPTKRIGV----EEIKGHEFF 337
P ++LI +LL DP R+GV +E+K H FF
Sbjct: 246 -PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-65
Identities = 111/326 (34%), Positives = 162/326 (49%), Gaps = 68/326 (20%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWR-DLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82
+ +GA G VFL K + + +A+KVI + D+I K + ++ E+ +L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD-----------QVLTERDILSQ 49
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+ P + +L K + ++Y PG DL SL + + +D R Y AE+VLALE
Sbjct: 50 AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALE 107
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH+ GI++RDLKP+NI+I NGH+ L DF LS + G+ +R
Sbjct: 108 YLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS--------------------KVGLVRR 147
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
+ L+ D ++ VGT +Y+APE+I G+GH
Sbjct: 148 QINLN----------------------------DDEKEDKRIVGTPDYIAPEVILGQGHS 179
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLE 319
VDWWSLG +L+E L G PF G + +E F IL P+ V +LI +LL
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 320 KDPTKRIG---VEEIKGHEFFKGVNW 342
DP KR+G +EEIK H FFKG++W
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-60
Identities = 93/330 (28%), Positives = 142/330 (43%), Gaps = 80/330 (24%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
++ LG G+ G V+ K + + A+K++ + +KSK+ E
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARR---------EI 49
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAE 136
R+LR + HP + RL + ++YC G DL L + S+D + A +
Sbjct: 50 RILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQ 106
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
++ LEYLH+ GI++RDLKPENI++ ENG + + DF L+ KL
Sbjct: 107 ILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLL----------------- 149
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
K S L+ F + Y+APE++
Sbjct: 150 ----KSSSSLTTFVGT-----------------------------------PWYMAPEVL 170
Query: 257 -EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRILCRP-----PDLVGEP 307
G G+ VD WSLGV+L+E+L G PF G + + RIL P P
Sbjct: 171 LGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGS 230
Query: 308 TPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337
++LI++ L KDP+KR EEI H +F
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-55
Identities = 111/349 (31%), Positives = 166/349 (47%), Gaps = 83/349 (23%)
Query: 21 VSALGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ LG+G G VF V+ V +++ FA+KV+ KK+ + N + + E+
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVL------KKATIVRNQKDTAHTKA---ER 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+L V+HP + L T + ++Y G +L + E +F +DT FY +E+
Sbjct: 52 NILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEI 109
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
LALE+LH GI+YRDLKPENI++ GH+ L DF L
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGL----------------------- 146
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
C I H +F GT EY+APEI+
Sbjct: 147 ------------CKESIHEGTVTH---------------------TFCGTIEYMAPEILM 173
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CR---PPDLVGEPTPLRNL 313
GH AVDWWSLG ++++ML GA PF +RK+T +IL + PP L E R+L
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEA---RDL 230
Query: 314 IRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIPA 356
+++LL+++P+ R+G E++ H FF+ VNW+ LL + PP P
Sbjct: 231 LKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPL 279
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-55
Identities = 117/353 (33%), Positives = 171/353 (48%), Gaps = 83/353 (23%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
+F LR+ LG GA G VFLV+ V ++ + +A+KV+ + I +K+K +
Sbjct: 1 NFELLRV---LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---- 53
Query: 71 RRISFEQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
E++VL V P L L TD + +DY G +L + Q+ + F++
Sbjct: 54 -----ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESE 106
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+R Y AE+VLAL++LH +GI+YRD+K ENI++ GH++L DF LS + +
Sbjct: 107 VRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE------- 159
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
E+ +S F GT E
Sbjct: 160 ---------------------------EERAYS---------------------FCGTIE 171
Query: 250 YVAPEIIEGK--GHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRPPDL 303
Y+APE+I G GHD AVDWWSLGV+ E+L GA+PF S+ E RIL P
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF 231
Query: 304 VGEPTPL-RNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWELLLKISRPP 352
+ R+ I++LLEKDP KR+G +EIK H FF+G++W+ L P
Sbjct: 232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPA 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 122/358 (34%), Positives = 181/358 (50%), Gaps = 85/358 (23%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
+F L++ LG GA G VFLV+ V ++ + +A+KV+ + + +K+K + +
Sbjct: 1 NFELLKV---LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT---- 53
Query: 71 RRISFEQRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
E+ VL +V + P L L T+ + +DY G ++ + Q+ FS+D
Sbjct: 54 -----ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDE 106
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+RFY+ E++LALE+LH +GIVYRD+K ENI++ GH++L DF LS
Sbjct: 107 VRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS-------------- 152
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+ FLS + E++ SF GT E
Sbjct: 153 -------------KEFLS----------------------------EEKERTYSFCGTIE 171
Query: 250 YVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPF----RGSSRKETFYRILCRPPDLV 304
Y+APEII GK GH AVDWWSLG+++ E+L GA+PF +++ E RIL P
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP 231
Query: 305 GEPTPL-RNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
P ++L+ +LL KDP KR+ G EIK H FFKG++WE L L+ PP P
Sbjct: 232 SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRP 289
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-53
Identities = 113/339 (33%), Positives = 162/339 (47%), Gaps = 75/339 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RN 82
+G+G+ G V L K + +A+KV+ + I KK ++ + I E+ VL +N
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ----------KHIMAERNVLLKN 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
V+HP L L T + + +DY G +L Q E+ F + RFYAAE+ AL
Sbjct: 53 VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFF--HLQRERSFPEPRARFYAAEIASALG 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH++ I+YRDLKPENI++ GH++L DF L
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C GI + S+ +++F GT EY+APE++ + +D
Sbjct: 143 -------CKEGI---------------------EHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT-PLRNLIRRLLEKD 321
VDWW LG VL+EMLYG PF E + IL +P L + R+L+ LL+KD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234
Query: 322 PTKRIG----VEEIKGHEFFKGVNW-ELLLKISRPPNIP 355
TKR+G EIK H FF +NW +L+ K PP P
Sbjct: 235 RTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNP 273
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 101/328 (30%), Positives = 151/328 (46%), Gaps = 83/328 (25%)
Query: 26 RGAKGVVFLVKDVESSESFALKVIWR-DLIEKKSKELTNNDNGDKYRRISFEQRVLRN-V 83
+GA G V+L K + + FA+KV+ + D+I K ++TN + E+ ++
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN--QVTN---------VKAERAIMMIQG 54
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
E P + +L + ++ ++Y G D SL K +D + Y AE+VL +E
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVED 112
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH GI++RD+KPEN++I + GH+ L DF LS R+G++ ++
Sbjct: 113 LHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS--------------------RNGLENKK 152
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
FVGT +Y+APE I G G D
Sbjct: 153 ----------------------------------------FVGTPDYLAPETILGVGDDK 172
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTP-LRNLIRRLL 318
DWWSLG V+ E L+G PF + F IL R P ++ +P +LI RLL
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
Query: 319 EKDPTKRIG---VEEIKGHEFFKGVNWE 343
DP KR+G +EIK H FFK +NW+
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 6e-52
Identities = 94/331 (28%), Positives = 155/331 (46%), Gaps = 82/331 (24%)
Query: 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRIS 74
F LR++ G+GA G V +V+ ++ + FA+K + + +K R +
Sbjct: 2 FELLRVI---GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK----------GSVRNVL 48
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRF 132
E+R+L+ + HP L L ++ + +D G DL H +K + FS++ ++F
Sbjct: 49 NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKF 104
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+ E+VLALEYLH+ GI++RD+KP+NI++ E GH+ + DF+++TK++P T
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---------L 155
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
+ SG T Y+A
Sbjct: 156 TTSTSG------------------------------------------------TPGYMA 167
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRPPDLVGEPT 308
PE++ +G+ AVDWWSLGV +E L G P+RG SR + T
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST 227
Query: 309 PLRNLIRRLLEKDPTKRIG--VEEIKGHEFF 337
+ I +LLE+DP KR+G ++++K H +F
Sbjct: 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 9e-51
Identities = 104/355 (29%), Positives = 161/355 (45%), Gaps = 81/355 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDNGDKYRRISFEQRVLRN 82
LG+G+ G V L + + E +A+KV+ +D+I + E T E+RVL
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMT-----------EKRVLAL 51
Query: 83 V-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+HP L +L T + + ++Y G DL + Q F + RFYAAE+VL L
Sbjct: 52 AGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFYAAEIVLGL 109
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
++LH GI+YRDLK +N+++ GHI + DF + + G+
Sbjct: 110 QFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE----------------GILGGVTT 153
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
FC GT +Y+APEI+ + +
Sbjct: 154 S-----TFC-----------------------------------GTPDYIAPEILSYQPY 173
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEK 320
AVDWW+LGV+L+EML G +PF G E F IL +++++ L K
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTK 233
Query: 321 DPTKRIGV-----EEIKGHEFFKGVNWELLL--KISRP--PNIPARFEHENNESD 366
+P KR+G ++IKGH FF+ ++W+ L +I P P I RF+ N + +
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-50
Identities = 100/350 (28%), Positives = 159/350 (45%), Gaps = 85/350 (24%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R ++ LGRG G V L + ++ E +A+K + KK + D+ + E+R
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKAL------KKGDIIAR----DEVESLMCEKR 51
Query: 79 VLRNV---EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
+ HP L L T+ V + ++Y G DL + ++ FS+ FYAA
Sbjct: 52 IFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDV-FSEPRAVFYAA 108
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+VL L+YLH IVYRDLK +N+++ G + + DF L
Sbjct: 109 CVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL--------------------- 147
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
C G+ D ++++F GT E++APE+
Sbjct: 148 --------------CKEGMGFGD---------------------RTSTFCGTPEFLAPEV 172
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRN--- 312
+ + AVDWW LGV+++EML G +PF G +E F I+ D V P L
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV---NDEVRYPRFLSREAI 229
Query: 313 -LIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
++RRLL ++P +R+G E++K FF+ +NW+ LL + +PP +P
Sbjct: 230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVP 279
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-49
Identities = 108/343 (31%), Positives = 161/343 (46%), Gaps = 83/343 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V LV++ + + +A+K++ +++I K D+ E RVL+N
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLQNT 52
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLH-SLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP L L+ T + + ++Y G +L L + E++FS+D RFY AE+V AL
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALG 109
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH+ +VYRDLK EN+M+ ++GHI + DF L
Sbjct: 110 YLHSCDVVYRDLKLENLMLDKDGHIKITDFGL---------------------------- 141
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C GIS +F GT EY+APE++E +
Sbjct: 142 -------CKEGISDGA---------------------TMKTFCGTPEYLAPEVLEDNDYG 173
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLL 318
AVDWW LGVV++EM+ G PF ++ F IL P L E ++L+ LL
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA---KSLLAGLL 230
Query: 319 EKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
+KDP +R+G +EI H FF +NW+ ++ K PP P
Sbjct: 231 KKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 116/361 (32%), Positives = 175/361 (48%), Gaps = 69/361 (19%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF ++++S GA G V+LV+ E+ + FA+K I K++ L N + +++
Sbjct: 2 DFETIKLISN---GAYGAVYLVRHKETRQRFAMKKI-----NKQNLILRN-----QIQQV 48
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ +L E+P + + T + + ++Y G D +L K D R Y
Sbjct: 49 FVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA--LPVDMARMY 106
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
AE VLALEYLHN GIV+RDLKP+N++I GHI L DF LS K S T L
Sbjct: 107 FAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS-----KIGLMSLTTNLYE 161
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
K R FL K GT EY+AP
Sbjct: 162 GHIE--KDTREFLDK----------------------------------QVCGTPEYIAP 185
Query: 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PDLVGE---P 307
E+I +G+ VDWW++G++L+E L G PF G + +E F +++ P+ G+ P
Sbjct: 186 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE--GDEALP 243
Query: 308 TPLRNLIRRLLEKDPTKRIGV---EEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
++LI RLL ++P +R+G E+K H FF G++W LL+ + IP + E E++
Sbjct: 244 ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLR-QKAEFIP-QLESEDDT 301
Query: 365 S 365
S
Sbjct: 302 S 302
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 112/353 (31%), Positives = 166/353 (47%), Gaps = 80/353 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RN 82
+G+G+ G V L K +A+KV+ + I KK ++ I E+ VL +N
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQ----------NHIMAERNVLLKN 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
++HP L L T + + + +DY G +L Q E+ F + RFYAAE+ A+
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIG 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH++ I+YRDLKPENI++ GH++L DF L
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C G+ E E +++F GT EY+APE++ + +D
Sbjct: 143 -------CKEGVEPE---------------------ETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG-EPTPLRNLIRRLLEKD 321
VDWW LG VL+EMLYG PF + + IL +P L G + +L+ LL KD
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD 234
Query: 322 PTKRIGVE----EIKGHEFFKGVNWELLL--KISRP--PNI--PARFEHENNE 364
+R+G + EIK H FF +NW+ L +I+ P PN+ PA H + E
Sbjct: 235 QRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPE 287
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-48
Identities = 107/351 (30%), Positives = 178/351 (50%), Gaps = 36/351 (10%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF ++++ G+GA G V LV+ ++ + +A+K + + + KK D+ +
Sbjct: 2 DFHTVKVI---GKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK----------DQLAHV 48
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ VL + P + L +++ +++ PG DL ++ + FS+D RFY
Sbjct: 49 KAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFY 106
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
AE VLA+E +H +G ++RD+KP+NI+I GHI L DF LST + A + +L
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 194 NT-RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
+ ++ I R S + +S +D + + + + + S VGT +Y+A
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWK----------KNRRLMAYSTVGTPDYIA 216
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----CRPPDLVGEP 307
PEI +G+ DWWSLG ++ E L G PF + ET+ +I+ PD +
Sbjct: 217 PEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLS 276
Query: 308 TPLRNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWELLLKISRPPNIP 355
+LIRRL+ + R+G EIK H FF+GV+W+ + +I R P IP
Sbjct: 277 VEAEDLIRRLI-TNAENRLGRGGAHEIKSHPFFRGVDWDTIRQI-RAPFIP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 105/335 (31%), Positives = 158/335 (47%), Gaps = 74/335 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RN 82
+G+G+ G V L K + +A+KV+ + ++ + ++ + I E+ VL +N
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ----------KHIMAERNVLLKN 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
V+HP L L T + + + +D+ G +L Q E+ F + RFYAAE+ AL
Sbjct: 53 VKHPFLVGLHYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALG 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH++ IVYRDLKPENI++ GH++L DF L
Sbjct: 111 YLHSINIVYRDLKPENILLDSQGHVVLTDFGL---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C GI+ D + +F GT EY+APE+I + +D
Sbjct: 143 -------CKEGIAQSD---------------------TTTTFCGTPEYLAPEVIRKQPYD 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKD 321
VDWW LG VL+EMLYG PF E + IL +P L G +++ LLEKD
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD 234
Query: 322 PTKRIGVE----EIKGHEFFKGVNWELLLKISRPP 352
+R+G + EI+ H FF+ ++W L + PP
Sbjct: 235 RQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 6e-47
Identities = 104/356 (29%), Positives = 174/356 (48%), Gaps = 55/356 (15%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF ++++ GRGA G V LV+ ++ +A+K + +KS+ L +
Sbjct: 2 DFESIKVI---GRGAFGEVRLVQKKDTGHIYAMKKL------RKSEMLEKEQVA----HV 48
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ +L ++P + +L + ++ ++Y PG D+ +L + + F+++ RFY
Sbjct: 49 RAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFY 106
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
AE +LA++ +H +G ++RD+KP+N+++ GHI L DF L T
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT----------------- 149
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN------SFVGT 247
G+KK S + + P S + K N S VGT
Sbjct: 150 ----GLKKSHRTEFYRILSHALPSNFLDFIS---KPMSSKRKAETWKRNRRALAYSTVGT 202
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRP----PD 302
+Y+APE+ G++ DWWSLGV+++EML G PF + +ET+ +I+ + PD
Sbjct: 203 PDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD 262
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRI---GVEEIKGHEFFKGVNWELLLKISRPPNIP 355
V ++LI+RL + +R+ GV EIK H FFKGV+WE + + P IP
Sbjct: 263 EVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFKGVDWEHIRER-PAPIIP 316
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 71/317 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I+ +G+G+ G V+LV+ + + LK I +L+N ++ ++ E +
Sbjct: 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI----------DLSNMSEKEREDALN-EVK 51
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--QMFSDDTIRFYAAE 136
+L+ + HP + + + ++Y G DL K+Q + + F ++ I + +
Sbjct: 52 ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
L LAL+YLH+ I++RD+KP+NI + NG
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGL------------------------------ 141
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+K L F GIS + S + + + + VGT Y++PE+
Sbjct: 142 --VK-----LGDF---GIS----------------KVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLI 314
+ K +++ D WSLG VL+E+ PF G + E +IL PP + LRNL+
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235
Query: 315 RRLLEKDPTKRIGVEEI 331
LL+KDP +R + +I
Sbjct: 236 SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 101/351 (28%), Positives = 161/351 (45%), Gaps = 85/351 (24%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF---E 76
+ S +GRG G V +V++ + + +A+KV+ KKS L +SF E
Sbjct: 5 VKSLVGRGHFGEVQVVREKATGDIYAMKVM------KKSVLLAQ-------ETVSFFEEE 51
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
+ +L P +P+L+ + ++Y PG DL SL + +Q F +D +FY AE
Sbjct: 52 RDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAE 110
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
LVLA+ +H MG V+RD+KPEN++I GHI L DF + +L+ + K V +
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT------ANKMVNSK--- 161
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
P VGT +Y+APE++
Sbjct: 162 -------------------------LP---------------------VGTPDYIAPEVL 175
Query: 257 E-----GKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----CRPPDLVG 305
GKG + DWWSLGV+ +EM+YG +PF + +T+ I+ + P+
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPK 235
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPA 356
+ +LI+ LL +R+G E + H FF ++W ++ S PP +P
Sbjct: 236 VSSDFLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWN-NIRNSLPPFVPT 284
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 5e-46
Identities = 104/376 (27%), Positives = 166/376 (44%), Gaps = 69/376 (18%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF 75
S + +G GA G V LV+ V+++ +A+K + +K+ L N +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL------RKADVLMRNQAA----HVKA 50
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E+ +L ++ + +L + + +DY PG D+ SL + +F +D RFY A
Sbjct: 51 ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIA 108
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
EL A+E +H MG ++RD+KP+NI+I +GHI L DF L T
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF----------------- 151
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK--------------- 240
R + SK+ G H + +P +
Sbjct: 152 ------RWTHDSKYYQKG------DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199
Query: 241 -SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--- 296
++S VGT Y+APE++ G+ DWWS+GV+L+EML G PF + ET ++
Sbjct: 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
Query: 297 ---LCRPPDLVGEPTPLRNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWELLLKISR 350
L P +LI RL R+G +EIK H FFKG+++ L++ +
Sbjct: 260 ETTLHIPSQAKLSREAS-DLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQK 317
Query: 351 PPNIPARFEHENNESD 366
P IP + H + S+
Sbjct: 318 APYIP-KITHPTDTSN 332
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-46
Identities = 105/335 (31%), Positives = 164/335 (48%), Gaps = 77/335 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-N 82
LG+G+ G V L + ++E FA+K + +D++ L ++D E+RVL
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVV------LEDDDVECTM----VERRVLALA 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
EHP L L T + + + ++Y G DL + QS F + RFYAAE++ L+
Sbjct: 53 WEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQ 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH GI+YRDLK +N+++ ++GHI + DF + K + ++
Sbjct: 111 FLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMC------------KENMNGEGKA----- 153
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
S FC + PD Y+APEI++G+ ++
Sbjct: 154 ----STFCGT--------------PD---------------------YIAPEILKGQKYN 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLL 318
+VDWWS GV+L+EML G +PF G E F IL P + E + + +L
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAK---DCLSKLF 231
Query: 319 EKDPTKRIGVE-EIKGHEFFKGVNWELLLKISRPP 352
E+DPTKR+GV+ +I+ H FF+G++WE L K PP
Sbjct: 232 ERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 4e-45
Identities = 106/344 (30%), Positives = 161/344 (46%), Gaps = 85/344 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V LV++ + +A+K++ +++I K D+ E RVL+N
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNT 52
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP L L+ T + + ++Y G +L H R E++F+++ RFY AE+V AL
Sbjct: 53 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSAL 108
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
EYLH+ +VYRD+K EN+M+ ++GHI + DF L
Sbjct: 109 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL--------------------------- 141
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
C GIS + +F GT EY+APE++E +
Sbjct: 142 --------CKEGISDGATM---------------------KTFCGTPEYLAPEVLEDNDY 172
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRL 317
AVDWW LGVV++EM+ G PF + F IL P L E ++L+ L
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEA---KSLLAGL 229
Query: 318 LEKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
L+KDP +R+G +E+ H FF +NW+ ++ K PP P
Sbjct: 230 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 8e-44
Identities = 106/329 (32%), Positives = 155/329 (47%), Gaps = 80/329 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V LV++ S + +A+K++ +++I K D+ E RVL+N
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLKNT 52
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP L L+ T + + ++Y G +L E++FS+D RFY AE+V AL+Y
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDY 110
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ IVYRDLK EN+M+ ++GHI + DF L
Sbjct: 111 LHSGKIVYRDLKLENLMLDKDGHIKITDFGL----------------------------- 141
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
C GI+ + +F GT EY+APE++E +
Sbjct: 142 ------CKEGIT---------------------DAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLE 319
AVDWW LGVV++EM+ G PF ++ F IL P L + ++L+ LL
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADA---KSLLSGLLI 231
Query: 320 KDPTKRIG-----VEEIKGHEFFKGVNWE 343
KDP KR+G +EI H FF GVNW+
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 98/361 (27%), Positives = 159/361 (44%), Gaps = 88/361 (24%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRRISFE 76
+ LG G+ G V + K + E +A+K + R++++ K + ++ E
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQ-----------HVAQE 68
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAA 135
+ +L + HP + + + V + +++ G +L + LRK F +D +FY A
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHA 125
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
ELVLA EYLH+ I+YRDLKP EN +L+D K+ T
Sbjct: 126 ELVLAFEYLHSKDIIYRDLKP------EN---LLLDNKGHVKV----------------T 160
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
G K+ +++ + GT EY+APE+
Sbjct: 161 DFGFAKK----------------------------------VPDRTFTLCGTPEYLAPEV 186
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDLVGEPTPLRN 312
I+ KGH AVDWW++GV+L+E + G PF + + +IL + P+ R+
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRA--RD 244
Query: 313 LIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDG 367
L++ LL+ D TKR+ GV ++K H +F G NW+ L P IP R + D
Sbjct: 245 LVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRV---KSPGDT 301
Query: 368 R 368
Sbjct: 302 S 302
|
Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-42
Identities = 108/343 (31%), Positives = 157/343 (45%), Gaps = 79/343 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G G V+ V+ ++ +A+KV+ + I K KE+ + R I R L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIG---ERNIL--VRTLLD- 53
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
E P + L+ TD + DY G +L Q E FS+D +FY AELVLALE+
Sbjct: 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEH 111
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH IVYRDLKPENI++ GHI L DF LS K L N +
Sbjct: 112 LHKYDIVYRDLKPENILLDATGHIALCDFGLS------------KANLTDNKTT------ 153
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI-IEGKGHD 262
+ FC GT EY+APE+ ++ KG+
Sbjct: 154 ---NTFC-----------------------------------GTTEYLAPEVLLDEKGYT 175
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPLRNLIRRL 317
VD+WSLGV++ EM G +PF ++ YR + P +++ + R ++ L
Sbjct: 176 KHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-MYRNIAFGKVRFPKNVLSDEG--RQFVKGL 232
Query: 318 LEKDPTKRIG----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
L ++P R+G E+K H FF ++W+LL K PP P
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-41
Identities = 111/357 (31%), Positives = 165/357 (46%), Gaps = 88/357 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V LVK+ + +A+K++ +++I K D+ E RVL+N
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNS 52
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP L L+ T + + ++Y G +L H R E++FS+D RFY AE+V AL
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSAL 108
Query: 142 EYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+YLH+ +VYRDLK EN+M+ ++GHI + DF L
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL-------------------------- 142
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
C GI +F GT EY+APE++E
Sbjct: 143 ---------CKEGIK---------------------DGATMKTFCGTPEYLAPEVLEDND 172
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDLVGEPTPLRNLIRRL 317
+ AVDWW LGVV++EM+ G PF ++ F IL R P + ++L+ L
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEA--KSLLSGL 230
Query: 318 LEKDPTKRIG-----VEEIKGHEFFKGVNW-ELLLKISRPPNIPARFEHENNESDGR 368
L+KDP +R+G +EI H+FF G+ W ++ K PP P +E+D R
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKP----QVTSETDTR 283
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 96/351 (27%), Positives = 160/351 (45%), Gaps = 86/351 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ V LV+ ++ +A+KVI KEL N+D + + E+ V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVI--------KKELVNDDEDIDW--VQTEKHVFETA 52
Query: 84 E-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP L L T+ + + I++ G DL + Q ++ ++ RFY+AE+ LAL
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH GI+YRDLK +N+++ GHI L D+ +
Sbjct: 111 FLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C GI D +++F GT Y+APEI+ G+ +
Sbjct: 143 -------CKEGIRPGD---------------------TTSTFCGTPNYIAPEILRGEDYG 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFR--GSS------RKETFYRILCRPPDLVGEPTPLR--N 312
F+VDWW+LGV++ EM+ G +PF G S ++ ++++ + ++ +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234
Query: 313 LIRRLLEKDPTKRIG------VEEIKGHEFFKGVNWELL-LKISRPPNIPA 356
+++ L KDP +R+G +IK H FF+ ++W+LL K PP P
Sbjct: 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-38
Identities = 104/346 (30%), Positives = 162/346 (46%), Gaps = 71/346 (20%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-N 82
LG+G+ G V L + E FA+K + +D++ L ++D E+RVL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVV------LIDDD----VECTMVEKRVLALA 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
E+P L L T + + + +++ G DL + Q + F FYAAE+V L+
Sbjct: 53 WENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQ 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ GI+YRDLK +N+M+ +GHI + DF + K + + R+
Sbjct: 111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMC------------KENVFGDNRA----- 153
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
S FC + PD Y+APEI++G +
Sbjct: 154 ----STFCGT--------------PD---------------------YIAPEILQGLKYT 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT-PLRNLIRRLLEKD 321
F+VDWWS GV+L+EML G +PF G E F I P T ++++ +L E+D
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234
Query: 322 PTKRIGVE-EIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
PT+R+GV I+GH FFK +NW L K P + + ++ S+
Sbjct: 235 PTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSN 280
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 97/328 (29%), Positives = 158/328 (48%), Gaps = 77/328 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G VFL + +++ FA+K + +D++ L ++D E+RVL
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVV------LMDDD----VECTMVEKRVLSLA 52
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
EHP L L T + + + ++Y G DL + QS F FYAAE++ L+
Sbjct: 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQ 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ GIVYRDLK +NI++ +GHI + DF + K + + ++
Sbjct: 111 FLHSKGIVYRDLKLDNILLDTDGHIKIADFGMC------------KENMLGDAKT----- 153
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
FC + PD Y+APEI+ G+ ++
Sbjct: 154 ----CTFCGT--------------PD---------------------YIAPEILLGQKYN 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----CRPPDLVGEPTPLRNLIRRLL 318
+VDWWS GV+L+EML G +PF G +E F I C P L E ++++ +L
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREA---KDILVKLF 231
Query: 319 EKDPTKRIGVE-EIKGHEFFKGVNWELL 345
++P +R+GV+ +I+ H FF+ ++W L
Sbjct: 232 VREPERRLGVKGDIRQHPFFREIDWSAL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 102/359 (28%), Positives = 160/359 (44%), Gaps = 87/359 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-N 82
LG+G+ G V L + + E +A+KV+ +D+I + D E+R+L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD----------DDVDCTMTEKRILALA 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+HP L L T + + ++Y G DL + + Q + F + RFYAAE+ LAL
Sbjct: 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALM 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH G++YRDLK +NI++ GH L DF +
Sbjct: 111 FLHRHGVIYRDLKLDNILLDAEGHCKLADFGM---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C GI + + +F GT +Y+APEI++ +
Sbjct: 143 -------CKEGIL---------------------NGVTTTTFCGTPDYIAPEILQELEYG 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLR----NLIRRLL 318
+VDWW+LGV+++EM+ G PF + + F IL D V P L ++++ +
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL---HDDVLYPVWLSKEAVSILKAFM 231
Query: 319 EKDPTKRIGV-------EEIKGHEFFKGVNWELL--LKISRP--PNIPARFEHENNESD 366
K+P KR+G + IK H FFK ++W LL KI P P I + + N + D
Sbjct: 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 60/167 (35%), Positives = 94/167 (56%), Gaps = 16/167 (9%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRRISFE 76
+ LG G+ G V LV+ S + +ALK++ +++ K E N E
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-----------E 51
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAA 135
+R+L+++ HP L L G D + ++Y PG +L S LRK F + RFYAA
Sbjct: 52 KRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAA 108
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
++VLALEYLH++ IVYRDLKPEN+++ +G+I + DF + ++ +T
Sbjct: 109 QVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 71/324 (21%), Positives = 132/324 (40%), Gaps = 75/324 (23%)
Query: 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76
I+ +G+G G V+ + + + A+KVI ++ +K +I E
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-------------KLESKEKKEKIINE 47
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
++L+ +HP + + G + +++C G L L K + Q ++ I + E
Sbjct: 48 IQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKE 106
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
L+ LEYLH+ GI++RD+K NI++ +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILL--------------------------------TSD 134
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+K L F G+S + ++ N+ VGT ++APE+I
Sbjct: 135 GEVK-----LIDF---GLS-----------------AQLSDTKARNTMVGTPYWMAPEVI 169
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRN 312
GK +D+ D WSLG+ E+ G P+ + ++I P + ++
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKD 229
Query: 313 LIRRLLEKDPTKRIGVEEIKGHEF 336
+++ L+K+P KR E++ H F
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 2e-37
Identities = 104/374 (27%), Positives = 182/374 (48%), Gaps = 73/374 (19%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWR-DLIEKKSKELTNNDNGDKYRR 72
DF L+++ GRGA G V LV+ ++ +A+K++ + D++EK ++
Sbjct: 2 DFESLKVI---GRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-----------EQVAH 47
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
I E+ +L + + ++ + + +++ PG D+ +L ++ S++ +F
Sbjct: 48 IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQF 105
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
Y AE VLA++ +H +G ++RD+KP+N+++ GH+ L DF L T
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT---------------- 149
Query: 193 ANTRSGIKK--RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF------ 244
G+KK R F H+P P S + +S K+ ++
Sbjct: 150 -----GLKKAHRTEFYRNL----------THNP---PSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 245 -----VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299
VGT +Y+APE+ G++ DWWSLGV+++EML G PF + +ET+ +++
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251
Query: 300 PPDLVGEP-TPLRNLIRRLLEK---DPTKRIG---VEEIKGHEFFKGVNWELLLKISRPP 352
LV P P+ + L+ + D RIG VEEIK H FF+GV+W + + RP
Sbjct: 252 KETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE--RPA 309
Query: 353 NIPARFEHENNESD 366
IP + ++ S+
Sbjct: 310 AIPIEIKSIDDTSN 323
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-36
Identities = 99/363 (27%), Positives = 169/363 (46%), Gaps = 89/363 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ V LV+ ++ +A+KV+ KEL N+D + + E+ V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVV--------KKELVNDDEDIDW--VQTEKHVFEQA 52
Query: 84 E-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP L L T+ + + I+Y G DL + Q ++ ++ RFY+AE+ LAL
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH GI+YRDLK +N+++ GHI L D+ +
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C G+ D +++F GT Y+APEI+ G+ +
Sbjct: 143 -------CKEGLRPGD---------------------TTSTFCGTPNYIAPEILRGEDYG 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFR--GSS------RKETFYRILCRPPDLVGEPTPLR--N 312
F+VDWW+LGV++ EM+ G +PF GSS ++ ++++ + ++ +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234
Query: 313 LIRRLLEKDPTKRIGV------EEIKGHEFFKGVNWELL--LKISRP--PNIPARFEHEN 362
+++ L KDP +R+G +I+GH FF+ V+W+L+ ++ P PNI F +N
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDN 294
Query: 363 NES 365
++
Sbjct: 295 FDA 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 104/358 (29%), Positives = 161/358 (44%), Gaps = 86/358 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G V L + ES +A+KV+ +D+I + D E+R+L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD----------DDVECTMTEKRILSLA 52
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP L +L T + + +++ G DL + Q + F + RFYAAE+ AL
Sbjct: 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALM 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ GI+YRDLK +N+++ GH L DF + + GI
Sbjct: 111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM--------------------CKEGIFNG 150
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
++ S FC + PD Y+APEI++ +
Sbjct: 151 KT-TSTFCGT--------------PD---------------------YIAPEILQEMLYG 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLR----NLIRRLL 318
+VDWW++GV+L+EML G PF + + F IL D V PT L ++++ +
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---NDEVVYPTWLSQDAVDILKAFM 231
Query: 319 EKDPTKRIGV------EEIKGHEFFKGVNWELLLK--ISRP--PNIPARFEHENNESD 366
K+PT R+G E I H FFK ++WE L + I P P I +R + N + D
Sbjct: 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPD 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 8e-36
Identities = 100/386 (25%), Positives = 173/386 (44%), Gaps = 96/386 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ V LV+ ++ + +A+KV+ KEL ++D + + E+ V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVV--------KKELVHDDEDIDW--VQTEKHVFEQA 52
Query: 84 E-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+P L L T + I+Y G DL + Q ++ ++ RFYAAE+ +AL
Sbjct: 53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALN 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH GI+YRDLK +N+++ +GHI L D+ +
Sbjct: 111 FLHERGIIYRDLKLDNVLLDADGHIKLTDYGM---------------------------- 142
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
C G+ GP + +++F GT Y+APEI+ G+ +
Sbjct: 143 -------CKEGL-----------GP----------GDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 263 FAVDWWSLGVVLHEMLYGATPFR------GSSRKETFYRILCRPPDLVGEPTPLR--NLI 314
F+VDWW+LGV++ EM+ G +PF + ++ ++++ P + ++ +++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234
Query: 315 RRLLEKDPTKRIGVE------EIKGHEFFKGVNWELL-LKISRPP------------NIP 355
+ L KDP +R+G + +IK H FF+ ++W+LL K PP N
Sbjct: 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
Query: 356 ARFEHENNESDGRGRDGTKEIDVEKF 381
+F E + D K ID +F
Sbjct: 295 TQFTSEPVQLTPDDEDVIKRIDQSEF 320
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 110/369 (29%), Positives = 170/369 (46%), Gaps = 61/369 (16%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ LG GA G V L + V++ +A+K + KK L N + + E+ +L
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTL-----RKKDVLLRN-----QVAHVKAERDIL 55
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
++ + RL + + +DY PG D+ SL + +F +D RFY AEL A
Sbjct: 56 AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCA 113
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+E +H MG ++RD+KP+NI+I +GHI L DF L T
Sbjct: 114 VESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF---------------------- 151
Query: 201 KRRSFLSKFCSSGISL-----------EDPVHSPRIGP--DPPSRSDSDSSEK--SNSFV 245
R + SK+ SG + DP + R G P R + ++ ++S V
Sbjct: 152 -RWTHDSKYYQSGDHVRQDSMDFSNEWGDP-ANCRCGDRLKPLERRAARQHQRCLAHSLV 209
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------LCR 299
GT Y+APE++ G+ DWWS+GV+L+EML G PF + ET ++ L
Sbjct: 210 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHI 269
Query: 300 PPDLVGEPTPLRNLIRRLLE--KDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPAR 357
PP P +LI +L +D + G +EIK H FFK +++ L+ P IP +
Sbjct: 270 PPQAKLSPEA-SDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIP-K 327
Query: 358 FEHENNESD 366
H + S+
Sbjct: 328 ITHPTDTSN 336
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 106/363 (29%), Positives = 158/363 (43%), Gaps = 88/363 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF+ L + LG+G+ G V L + + E +A+K++ +D+I + D
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD----------DDVECT 47
Query: 74 SFEQRVLRNVEHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E+RVL P L +L T + + ++Y G DL + Q F + F
Sbjct: 48 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVF 105
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
YAAE+ + L +LH+ GI+YRDLK +N+M+ GHI + DF + K KT
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC-----KENIFGGKT--- 157
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
TR+ FC + PD Y+A
Sbjct: 158 --TRT-----------FCGT--------------PD---------------------YIA 169
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----CRPPDLVGEPT 308
PEII + + +VDWW+ GV+L+EML G PF G E F I+ P L E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV 229
Query: 309 PLRNLIRRLLEKDPTKRIGV-----EEIKGHEFFKGVNWELL--LKISRP--PNIPARFE 359
++ + LL K P KR+G +I+ H FF+ ++WE L +I P P + R
Sbjct: 230 ---SICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRS 286
Query: 360 HEN 362
EN
Sbjct: 287 AEN 289
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 85/340 (25%), Positives = 136/340 (40%), Gaps = 83/340 (24%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
RI+ LG G+ G V+L +D + ALKV+ K E + + R E +
Sbjct: 3 RILRKLGEGSFGEVYLARDRKL---VALKVL------AKKLESKSK----EVERFLREIQ 49
Query: 79 VLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL-RKQQSEQMFSDDTIRFYAAE 136
+L ++ P + +L + + ++Y G L L +K + S+ F A+
Sbjct: 50 ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQ 109
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGH-IMLVDFDLSTKLSPKTPQASPKTVLAANT 195
++ ALEYLH+ GI++RD+KPENI++ +G + L+DF L+ L
Sbjct: 110 ILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL----------------- 152
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
P S S ++ VGT Y+APE+
Sbjct: 153 ---------------------------------PDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 256 IEGKGH---DFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRPPDLVGEPT 308
+ G + D WSLG+ L+E+L G PF G +T IL P + P
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239
Query: 309 P----------LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+L+++LL KDP R+ H+
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 97/367 (26%), Positives = 163/367 (44%), Gaps = 91/367 (24%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN 64
+ +++ DF ++ +GRGA G V LV+ S + +A+K++ + + K+S
Sbjct: 35 ITKLRMKAEDF---DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS---- 87
Query: 65 DNGDKYRRISF---EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS 121
+F E+ ++ + + +L DK++ ++Y PG DL +L S
Sbjct: 88 ---------AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNL---MS 135
Query: 122 EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
+ RFY AE+VLAL+ +H+MG ++RD+KP+N ML+D
Sbjct: 136 NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN---------MLLD---------- 176
Query: 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241
+SG K F G + + D++ +
Sbjct: 177 --------------KSGHLKLADF-------GTCM---------------KMDANGMVRC 200
Query: 242 NSFVGTEEYVAPEIIEGKGHD----FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI- 296
++ VGT +Y++PE+++ +G D DWWS+GV L+EML G TPF S T+ +I
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
Query: 297 -----LCRPPDLVGEPTPLRNLIRRLLEKDPTK--RIGVEEIKGHEFFKGVNWEL-LLKI 348
L P D + ++LI L + R GV+EIK H FFK W ++
Sbjct: 261 DHKNSLTFPDD-IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRE 319
Query: 349 SRPPNIP 355
+ P +P
Sbjct: 320 TVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-35
Identities = 82/324 (25%), Positives = 138/324 (42%), Gaps = 81/324 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LGRG+ G V+L D ++ E A+K + EL+ D+ ++ + E R+L ++
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSV----------ELSG-DSEEELEALEREIRILSSL 56
Query: 84 EHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+HP + R G ++ I +Y G L SL K+ + + IR Y +++ L
Sbjct: 57 QHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGL 114
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
YLH+ GIV+RD+K NI++ +G +K
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGV--------------------------------VK- 141
Query: 202 RRSFLSKF-CSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
L+ F C+ + D ++ E + S GT ++APE+I G+
Sbjct: 142 ----LADFGCAKRLG------------------DIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF----YRILCR--PPDLVGEPTP-LRNL 313
+ A D WSLG + EM G P+ S Y+I PP++ + ++
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPW---SELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFF 337
+R+ L +DP KR +E+ H F
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 1e-34
Identities = 99/347 (28%), Positives = 164/347 (47%), Gaps = 38/347 (10%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ LG GA G V L V++ +A+K + + K++ N + + + E+ +L
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTL-------RKKDVLNRN---QVAHVKAERDIL 55
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
++ + +L + + +DY PG D+ SL + ++F + RFY AEL LA
Sbjct: 56 AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLA 113
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+E +H MG ++RD+KP+NI+I +GHI L DF L T S
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR-------------WTHNSKYY 160
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK----SNSFVGTEEYVAPEII 256
++ S + + L D V + R G + + + ++S VGT Y+APE++
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------LCRPPDLVGEPTPL 310
KG+ DWWS+GV+L EML G PF + ET ++ L PP + P
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA- 279
Query: 311 RNLIRRLL--EKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIP 355
+LI +L ++ R G ++IK H FF V++ ++ P +P
Sbjct: 280 VDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 105/363 (28%), Positives = 186/363 (51%), Gaps = 51/363 (14%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWR-DLIEKKSKELTNNDNGDKYRR 72
DF L+++ GRGA G V LV+ ++ +A+K++ + D++EK ++
Sbjct: 2 DFESLKVI---GRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-----------EQVGH 47
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLS-TDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTI 130
I E+ +L VE L ++ S DK Y I ++ PG D+ +L ++ +++
Sbjct: 48 IRAERDIL--VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEET 103
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+FY AE VLA++ +H +G ++RD+KP+N+++ GH+ L DF L T L + + +T
Sbjct: 104 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL-----KKAHRTE 158
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
N + +F + ++S R + + + S VGT +Y
Sbjct: 159 FYRNLNHSLPSDFTFQN------------MNSKR----KAETWKRNRRQLAFSTVGTPDY 202
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP-TP 309
+APE+ G++ DWWSLGV+++EML G PF + +ET+ +++ L+ P P
Sbjct: 203 IAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP 262
Query: 310 LRNLIRRLLEK---DPTKRI---GVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENN 363
+ + L+ + + RI GVEEIK + FF+GV+WE + + RP IP + ++
Sbjct: 263 ISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE--RPAAIPIEIKSIDD 320
Query: 364 ESD 366
S+
Sbjct: 321 TSN 323
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-33
Identities = 51/166 (30%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V+L +D ++ + A+K+I D+ + E +L+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII------------KKEDSSSLLEELLREIEILKKL 48
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + +L GV + + ++YC G L L K+ E S+D I +++ LEY
Sbjct: 49 NHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEY 107
Query: 144 LHNMGIVYRDLKPENIMIQE-NGHIMLVDFDLSTKLSPKTPQASPK 188
LH+ GI++RDLKPENI++ NG + L DF LS L+
Sbjct: 108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 58/159 (36%), Positives = 84/159 (52%), Gaps = 14/159 (8%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V LVK + +FALK + + I + ++ I E+ +L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ----------EHIFSEKEILEEC 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + +L K++ ++YC G +L LR + F + T RFY A +VLA E
Sbjct: 51 NHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFE 107
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
YLHN GI+YRDLKPEN+++ NG++ LVDF + KL
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 67/167 (40%), Positives = 94/167 (56%), Gaps = 16/167 (9%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRRISFE 76
L + +G G G V LV+D S +ALKV+ ++I K ++ +N E
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-----------E 51
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAA 135
+RVL+ V HP + RL +F+ ++Y PG +L S LR FS+ T FYA+
Sbjct: 52 KRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYAS 108
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
E+V ALEYLH+ IVYRDLKPENI++ + GHI L DF + KL +T
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 99/353 (28%), Positives = 156/353 (44%), Gaps = 85/353 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF+ L + LG+G+ G V L + + E +A+K++ +D++ + D
Sbjct: 1 DFNFLMV---LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECT 47
Query: 74 SFEQRVLR-NVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E+RVL + + P L +L T + + ++Y G DL + + Q F + F
Sbjct: 48 MVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHAVF 105
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
YAAE+ + L +LH+ GI+YRDLK +N+M+ GHI + DF + +
Sbjct: 106 YAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------- 150
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
N G+ + FC GT +Y+A
Sbjct: 151 -NMWDGVTTK-----TFC-----------------------------------GTPDYIA 169
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----CRPPDLVGEPT 308
PEII + + +VDWW+ GV+L+EML G PF G E F I+ P + E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229
Query: 309 PLRNLIRRLLEKDPTKRIGV-----EEIKGHEFFKGVNWELL-LKISRPPNIP 355
+ + L+ K P KR+G +IK H FF+ ++WE L K +PP P
Sbjct: 230 A---ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 52/120 (43%), Positives = 71/120 (59%), Gaps = 13/120 (10%)
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPD 302
GT EY+APEII KG+ AVDWW+LG++++EML G PF + + + +IL R P
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS 219
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL--KISRPPNIP 355
++LIR LL+ D TKR+G V +IK H +F G++W LL KI P IP
Sbjct: 220 FFSP--DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKI-EAPFIP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 6e-31
Identities = 91/335 (27%), Positives = 146/335 (43%), Gaps = 81/335 (24%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ LG+G+ G V L + + E +A+K++ +D++ + D E+RVL
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECTMVEKRVL 54
Query: 81 RNVEHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
+ P L +L T + + ++Y G DL + Q F + FYAAE+ +
Sbjct: 55 ALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISV 112
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
L +LH GI+YRDLK +N+M+ GHI + DF + + + G+
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE----------------HMVDGV 156
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
R FC GT +Y+APEII +
Sbjct: 157 TTR-----TFC-----------------------------------GTPDYIAPEIIAYQ 176
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----CRPPDLVGEPTPLRNLIR 315
+ +VDWW+ GV+L+EML G PF G E F I+ P L E ++ +
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAV---SICK 233
Query: 316 RLLEKDPTKRIGV-----EEIKGHEFFKGVNWELL 345
L+ K P+KR+G +I+ H FF+ ++W+ L
Sbjct: 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-30
Identities = 82/333 (24%), Positives = 139/333 (41%), Gaps = 85/333 (25%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L V LG+G+ GVV+ V+ + + +ALK I D E+ K+L E
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR------------EL 50
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+ LR+ E P + + G + + ++Y G L L K+ + + + A ++
Sbjct: 51 KTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQI 108
Query: 138 VLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L+YLH I++RD+KP N++I N++
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLI--------------------------------NSK 136
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+K ++ F GIS + ++ ++ N+FVGT Y++PE I
Sbjct: 137 GEVK-----IADF---GIS----------------KVLENTLDQCNTFVGTVTYMSPERI 172
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP------- 309
+G+ + +A D WSLG+ L E G PF + +F+ ++ + P P
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFL-PPGQPSFFELMQA---ICDGPPPSLPAEEF 228
Query: 310 ---LRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
R+ I L+KDP KR E+ H F K
Sbjct: 229 SPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 56/136 (41%), Positives = 79/136 (58%), Gaps = 13/136 (9%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
S+ D +K+ SF GT EY+APE++ +GH + DWWS GV++ EML G+ PF+G RK
Sbjct: 145 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
Query: 291 ETFYRI----LCRPPDLVGEPTPLRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVN 341
ET I L P L E ++L+R L +++P R+G VEEIK H FF ++
Sbjct: 205 ETMTMILKAKLGMPQFLSPEA---QSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261
Query: 342 WELLLKIS-RPPNIPA 356
W L + +PP PA
Sbjct: 262 WNKLYRREIKPPFKPA 277
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 98/364 (26%), Positives = 161/364 (44%), Gaps = 76/364 (20%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF L+++ GRGA G V +VK + + FA+K++ + + K+++ +
Sbjct: 2 DFEILKVI---GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFRE-------- 50
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ VL N ++ + L + + +DY G DL +L + E +D RFY
Sbjct: 51 --ERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFY 107
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
AE+V+A++ +H + V+RD+KP+NI++ NGHI L DF KL
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL--------------- 152
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
+ED + P ++ E A
Sbjct: 153 ----------------------MEDGTVQSSVAVGTP------------DYISPEILQAM 178
Query: 254 EIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR------PPDLVGE 306
E +GKG + DWWSLGV ++EMLYG TPF S ET+ +I+ P +
Sbjct: 179 E--DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 307 PTPLRNLIRRLL--EKDPTKRIGVEEIKGHEFFKGVNWELLLKISRP--PNIPARFEHEN 362
++LIRRL+ + + G+E+ K H FF G++W+ + P P + + + N
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSN 296
Query: 363 NESD 366
+ D
Sbjct: 297 FDVD 300
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 47/119 (39%), Positives = 75/119 (63%), Gaps = 12/119 (10%)
Query: 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK--ETFY 294
S +K+ +F GT EYVAPEII KG+DF+VD+WSLG++L+E+L G PF E +
Sbjct: 145 SGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 295 RILCRPPDLVGEPTPL----RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWEL 344
IL + + P + ++LI++LL ++P +R+G +++IK H++F G +WE
Sbjct: 205 DIL-KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWEG 262
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 72/320 (22%), Positives = 127/320 (39%), Gaps = 75/320 (23%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ LG+G+ G V+ VK + ++ +ALK + + +K +E N E R+
Sbjct: 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-----------EIRI 52
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYAAEL 137
L +V HP + + + ++Y P DL ++++ ++ + I +L
Sbjct: 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQL 112
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ L+ LH I++RDLK NI++ N + + D +S L A T+
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL----------KKNMAKTQI 162
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
G T Y+APE+ +
Sbjct: 163 G------------------------------------------------TPHYMAPEVWK 174
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLI 314
G+ + + D WSLG +L+EM A PF S ++ Y++ R PP L+N I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPIPPIYSQDLQNFI 233
Query: 315 RRLLEKDPTKRIGVEEIKGH 334
R +L+ P R ++I
Sbjct: 234 RSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 93/350 (26%), Positives = 157/350 (44%), Gaps = 84/350 (24%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN 64
+ D +++ D+ +V +GRGA G V LV+ + + +A+K++ + + K+S
Sbjct: 35 IRDLRMKAEDY---EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS---- 87
Query: 65 DNGDKYRRISFEQR-VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
+E+R ++ P + +L D+++ ++Y PG DL +L S
Sbjct: 88 -------AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL---MSNY 137
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
+ RFY AE+VLAL+ +H+MG ++RD+KP+N+++ ++GH+ L DF K++
Sbjct: 138 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN---- 193
Query: 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243
+ G+ + C + + D
Sbjct: 194 ------------KEGMVR--------CDTAVGTPD------------------------- 208
Query: 244 FVGTEEYVAPEIIEGKGHD----FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299
Y++PE+++ +G D DWWS+GV L+EML G TPF S T+ +I+
Sbjct: 209 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262
Query: 300 P-----PDLVGEPTPLRNLIRRLLEKDPTK--RIGVEEIKGHEFFKGVNW 342
PD +NLI L + R GVEEIK H FFK W
Sbjct: 263 KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 60/177 (33%), Positives = 91/177 (51%), Gaps = 15/177 (8%)
Query: 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF----- 293
+NS VG+ +Y+APE++ GKG+DF VD+WSLG +L+E L G PF GS+ ET+
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 294 YRILCRPPDLVGEPTPLRN----LIRRLLEKDPTKRIG-VEEIKGHEFFKGVNWELLLKI 348
++ + P L + LI +L+ DP++R G +E+IK H FFK V+W L +
Sbjct: 213 WKETLQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEVDWNELRE- 270
Query: 349 SRPPNIPARFEHENNESDGRGRDGTKEIDVEKFVQGIFAGGGDAEQKNEVNDEMNKN 405
+PP +P E E+ G D E D+ K+ + D N+
Sbjct: 271 LKPPFVP---ELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGANGRDPGNRR 324
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 71/317 (22%), Positives = 126/317 (39%), Gaps = 71/317 (22%)
Query: 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82
+GRGA GVV+ ++E+ + A+K I L + I E +L+N
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI----------SLEKIKEEA-LKSIMQEIDLLKN 55
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
++HP + + G + T + ++Y L + K+ F + + Y +++ L
Sbjct: 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLA 113
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH G+++RD+K NI+ ++G + L DF ++TKL+
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLN----------------------- 150
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
V +P ++APE+IE G
Sbjct: 151 --------DVSKDDASVVGTPY-------------------------WMAPEVIEMSGAS 177
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEK 320
A D WSLG + E+L G P+ + +RI+ PP G L++ + + +K
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQK 237
Query: 321 DPTKRIGVEEIKGHEFF 337
DP R +++ H +
Sbjct: 238 DPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 59/155 (38%), Positives = 90/155 (58%), Gaps = 16/155 (10%)
Query: 24 LGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
LG+G+ G VFLV+ + ++ +A+KV+ K L D R E+ +L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVL-------KKATLKVRDR----VRTKMERDIL 52
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
V HP + +L T+ + +D+ G DL + + E MF+++ ++FY AEL LA
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT--RLSKEVMFTEEDVKFYLAELALA 110
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
L++LH++GI+YRDLKPENI++ E GHI L DF LS
Sbjct: 111 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 89/328 (27%), Positives = 132/328 (40%), Gaps = 87/328 (26%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G G V+ ++++ E A+K I I+ + + I+ E +VL +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEI---RIQDNDPKT--------IKEIADEMKVLELL 56
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLALE 142
+HP L + GV + V ++YC G L L + IR Y +L+ L
Sbjct: 57 KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE---HVIRVYTLQLLEGLA 113
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH+ GIV+RD+KP NI + NG I L DF + KL + T +
Sbjct: 114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK------NNTTTMG---------- 157
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII---EGK 259
E+ S GT Y+APE+I +GK
Sbjct: 158 ------------------------------------EEVQSLAGTPAYMAPEVITGGKGK 181
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPL---- 310
GH A D WSLG V+ EM G P+ S + ++I+ P + P L
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGAGHKPPI---PDSLQLSP 235
Query: 311 --RNLIRRLLEKDPTKRIGVEEIKGHEF 336
++ + R LE DP KR E+ H F
Sbjct: 236 EGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 94/332 (28%), Positives = 149/332 (44%), Gaps = 75/332 (22%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR- 78
+V +GRGA G V LV+ S + +A+K++ + + K+S +E+R
Sbjct: 47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS-----------AFFWEERD 95
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
++ P + +L DK++ ++Y PG DL +L S + +FY AE+V
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNL---MSNYDVPEKWAKFYTAEVV 152
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
LAL+ +H+MG+++RD+KP+N+++ ++GH+ L DF K+ +G
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD----------------ETG 196
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ + C + + D + SP + S+ + + G E
Sbjct: 197 MVR--------CDTAVGTPDYI-SPEV----------LKSQGGDGYYGRE---------- 227
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------LCRPPDLVGEPTPLRN 312
DWWS+GV L EML G TPF S T+ +I L P D V +N
Sbjct: 228 ------CDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED-VEISKHAKN 280
Query: 313 LIRRLLEKDPTK--RIGVEEIKGHEFFKGVNW 342
LI L + R GVEEIK H FFK W
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 59/134 (44%), Positives = 82/134 (61%), Gaps = 13/134 (9%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPF----RGSS 288
D E++ SF GT EY+AP+I+ G GHD AVDWWS+GV+++E+L GA+PF +S
Sbjct: 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
Query: 289 RKETFYRILCRPPDLVGEPTPL-RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNW 342
+ E RIL P E + L +++I+RLL KDP KR+G +EIK H FF+ +NW
Sbjct: 217 QAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
Query: 343 E-LLLKISRPPNIP 355
+ L K P P
Sbjct: 277 DDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-26
Identities = 55/126 (43%), Positives = 80/126 (63%), Gaps = 9/126 (7%)
Query: 238 SEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL 297
+K+N+F GT EY+APE++ G G+ AVDWW+LGV+L+EML G PF + E + +IL
Sbjct: 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
Query: 298 CRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGV---EEIKGHEFFKGVNW-ELLLKISR 350
P PD ++L+ LL +DPT+R+G +EIK H FF ++W +LL+K +
Sbjct: 207 QEPLRFPDGFDRDA--KDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQ 264
Query: 351 PPNIPA 356
PP PA
Sbjct: 265 PPFKPA 270
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 80/321 (24%), Positives = 135/321 (42%), Gaps = 76/321 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDN-GDKYRRISFEQRVLRN 82
+GRGA G V+ K V + ALK+I D T +D+ D R ++ + LR
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD---------TPDDDVSDIQREVALLSQ-LRQ 58
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLAL 141
+ P + + G + ++Y G + +L K + + IR E+++AL
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR----EVLVAL 114
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+Y+H +G+++RD+K NI++ G++ L DF ++ L N S
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---------------NQNSS--- 156
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII-EGKG 260
+RS +FVGT ++APE+I EGK
Sbjct: 157 KRS--------------------------------------TFVGTPYWMAPEVITEGKY 178
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRPPDLVGE--PTPLRNLIRRL 317
+D D WSLG+ ++EM G P+ I +PP L LR +
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238
Query: 318 LEKDPTKRIGVEEIKGHEFFK 338
L+++P +R+ EE+ ++ K
Sbjct: 239 LDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/357 (22%), Positives = 134/357 (37%), Gaps = 112/357 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG--DKYRRISFE 76
+I+ +G GA G+VF KD E+ E+ ALK + L + G ++ R E
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV----------ALRRLEGGIPNQALR---E 49
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
+ L+ +HP + +L V ++Y P DL + + E+ + ++ Y
Sbjct: 50 IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRD-EERPLPEAQVKSYMRM 107
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
L+ + Y+H GI++RDLKP N++I +G + + DF L+ S +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE--------------- 152
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
E ++S + V T Y APE++
Sbjct: 153 --------------------EPRLYSHQ--------------------VATRWYRAPELL 172
Query: 257 EGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT------- 308
G D VD W++G + E+L G+ F G + E L +G P
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNEETWPGL 228
Query: 309 -----------------PLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFF 337
PL +L++ LL DP+KR+ E H +F
Sbjct: 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 74/333 (22%), Positives = 119/333 (35%), Gaps = 80/333 (24%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L + LG G GVV V + + A+K I ++ E K +I E
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK------------QILREL 50
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+L P + G + + ++Y G L + K+ + + + A +
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE-VQGRIPERILGKIAVAV 109
Query: 138 VLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L YLH I++RD+KP NI++ G I
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQI----------------------------- 140
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
K C G+S + V+S + +FVGT Y+APE I
Sbjct: 141 -----------KLCDFGVSGQ-LVNS-----------------LAKTFVGTSSYMAPERI 171
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILCR-----PPDLVGEP--T 308
+G + D WSLG+ L E+ G P+ + + +L PP L
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSP 231
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
++ + L KDP +R +E+ H F K
Sbjct: 232 DFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 53/157 (33%), Positives = 86/157 (54%), Gaps = 12/157 (7%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I++ +G+G G VFL K ++ E ALK + + L+ K ++ R + E+ +
Sbjct: 5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL----------NEVRHVLTERDI 54
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L + L +L D+++ A++Y PG D +L + + S+D RFY AE+
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTL--LNNLGVLSEDHARFYMAEMFE 112
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176
A++ LH +G ++RDLKPEN +I +GHI L DF LS
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 5e-24
Identities = 75/319 (23%), Positives = 129/319 (40%), Gaps = 75/319 (23%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ +GRGA G+V L + + +K I + + K + N E +VL
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQN-----------ECQVL 53
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ + HP + DK + ++Y PG L +++ + +DTI + +++LA
Sbjct: 54 KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA 113
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLV---DFDLSTKLSPKTPQASPKTVLAANTRS 197
L ++H I++RDLK +NI++ + H M+V DF
Sbjct: 114 LHHVHTKLILHRDLKTQNILL--DKHKMVVKIGDF------------------------- 146
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
GI K S S K+ + VGT Y++PE+ E
Sbjct: 147 GISKILS--------------------------------SKSKAYTVVGTPCYISPELCE 174
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--PTPLRNLIR 315
GK ++ D W+LG VL+E+ F ++ +I+ + + LR LI
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 316 RLLEKDPTKRIGVEEIKGH 334
+L DP+KR + +I
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 46/122 (37%), Positives = 74/122 (60%), Gaps = 17/122 (13%)
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC------R 299
GT EY+APE+I+ KGH+ AVDWW+LG++++EML G PF + + +IL R
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219
Query: 300 PPDLVGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWELLLKIS-RPPN 353
DL ++LI++LL D T+R+ G +++K H +FK V+W+ + + +PP
Sbjct: 220 HLDLY-----AKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPI 274
Query: 354 IP 355
+P
Sbjct: 275 VP 276
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-23
Identities = 81/317 (25%), Positives = 132/317 (41%), Gaps = 66/317 (20%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA G V+L DV++ A+K + + S E N + E ++L+N+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQV---PFDPDSPETKKEVNA-----LECEIQLLKNL 61
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + + G L D+ + ++Y PG + K ++ R Y +++ +EY
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEY 119
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ IV+RD+K NI+ G++ L DF G KR
Sbjct: 120 LHSNMIVHRDIKGANILRDSAGNVKLGDF-------------------------GASKR- 153
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
L CSSG ++ S GT +++PE+I G+G+
Sbjct: 154 --LQTICSSGTGMK-------------------------SVTGTPYWMSPEVISGEGYGR 186
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTP-LRNLIRRLLEK 320
D WS+G + EML P+ ++I +P P L +P RN +RR +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 321 DPTKRIGVEEIKGHEFF 337
+ KR EE+ H F
Sbjct: 247 NAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 80/350 (22%), Positives = 129/350 (36%), Gaps = 101/350 (28%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
+ +G G GVV+ +D + E A+K I K + + R I ++
Sbjct: 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKI-------KLRFESEGIPKTALREI----KL 51
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L+ + HP + +L V + ++ ++ +Q + I+ Y +L+
Sbjct: 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQ 109
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
L + H+ GI++RDLKPEN++I G + L DF L+
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLA------------------------ 145
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258
RSF P R + +V T Y APE++ G
Sbjct: 146 ---RSF----------------------GSPVRPYTH-------YVVTRWYRAPELLLGD 173
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI-----------------LCRP- 300
KG+ VD WS+G + E+L F G S + ++I L R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233
Query: 301 ----PDLVGEPTPL---------RNLIRRLLEKDPTKRIGVEEIKGHEFF 337
P G P P +L+ ++L DP KRI E+ H +F
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 57/135 (42%), Positives = 80/135 (59%), Gaps = 11/135 (8%)
Query: 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP 300
+++F GT EY+APE++ + +D VDWW LG VL+EMLYG PF + E + IL +P
Sbjct: 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP 212
Query: 301 PDLVGEPT-PLRNLIRRLLEKDPTKRIGVE----EIKGHEFFKGVNWELLL--KISRP-- 351
L T R+L+ LL+KD TKR+G + EIK H FF +NW+ L+ KI+ P
Sbjct: 213 LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFN 272
Query: 352 PNI--PARFEHENNE 364
PN+ P H + E
Sbjct: 273 PNVSGPNDLRHFDPE 287
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 8e-23
Identities = 82/318 (25%), Positives = 128/318 (40%), Gaps = 74/318 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ G V+ D +++ A+KVI DL E+ E+ + I E + L
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI--DL-EEAEDEIED---------IQQEIQFLSQC 56
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
P + + G + ++YC G L K + I F E++L LEY
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEY 113
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH G ++RD+K NI++ E G + L DF +S +L+ S + KR
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT-----------------STMSKR- 155
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
N+FVGT ++APE+I+ G+D
Sbjct: 156 --------------------------------------NTFVGTPFWMAPEVIKQSGYDE 177
Query: 264 AVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILCRPPDLVGEP--TPLRNLIRRLLEK 320
D WSLG+ E+ G P + F PP L G P ++ + L K
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237
Query: 321 DPTKRIGVEEIKGHEFFK 338
DP +R +E+ H+F K
Sbjct: 238 DPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 59/152 (38%), Positives = 85/152 (55%), Gaps = 13/152 (8%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RN 82
+G+G+ G V L + + +A+KV+ + I KK +E + I E+ VL +N
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEE----------KHIMSERNVLLKN 52
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
V+HP L L T + + +DY G +L Q E+ F + RFYAAE+ AL
Sbjct: 53 VKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALG 110
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
YLH++ IVYRDLKPENI++ GHI+L DF L
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 86/347 (24%), Positives = 143/347 (41%), Gaps = 83/347 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V + + + +A K + + ++K+ Y E+R+L V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKG----------YEGAMVEKRILAKV 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+ L T + + G DL H + F + FY A+++ L
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
E+LH I+YRDLKP EN +L+D D + ++S
Sbjct: 111 EHLHQRRIIYRDLKP------EN---VLLDNDGNVRIS---------------------- 139
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
G+++E D K+ + GT ++APE+++G+ +
Sbjct: 140 ---------DLGLAVEL----------------KDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRP---PDLVGEPTPLRNLI 314
DF+VD+++LGV L+EM+ PFR KE RIL PD + ++
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPAS--KSFC 232
Query: 315 RRLLEKDPTKRIG-----VEEIKGHEFFKGVNW-ELLLKISRPPNIP 355
LL KDP KR+G + ++ H F+ +NW +L + PP +P
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 53/137 (38%), Positives = 81/137 (59%), Gaps = 14/137 (10%)
Query: 232 RSDSDSSEKSNSFVGTEEYVAPEII----EGKGH-DFAVDWWSLGVVLHEMLYGATPFRG 286
R +D + +SN VGT +Y++PEI+ +GKG DWWSLGV ++EMLYG TPF
Sbjct: 151 RLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 287 SSRKETFYRILCR------PPDLVGEPTPLRNLIRRLLEKDPTK--RIGVEEIKGHEFFK 338
S ET+ +I+ PPD+ ++LIRRL+ T+ R G+++ K H FF+
Sbjct: 211 ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE 270
Query: 339 GVNWELLLKISRPPNIP 355
G++W+ ++ S P +P
Sbjct: 271 GIDWD-NIRNSTAPYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-22
Identities = 57/163 (34%), Positives = 93/163 (57%), Gaps = 15/163 (9%)
Query: 20 IVSALGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76
++ LG GA G VFLV+ V +S +A+KV+ + I +K+K + E
Sbjct: 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT---------E 54
Query: 77 QRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
++VL ++ + P L L TD + +DY G +L + Q+ + F + ++ Y+
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSG 112
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
E+VLALE+LH +GI+YRD+K ENI++ NGH++L DF LS +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 79/323 (24%), Positives = 125/323 (38%), Gaps = 73/323 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA VV+ + ++E A+K I DL EK + D+ R+ E + +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI--DL-EKCQTSV------DELRK---EVQAMSQC 56
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ-SEQMFSDDTIRFYAAELVLALE 142
HP + + + + Y G L + K + I E++ LE
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH+ G ++RD+K NI++ E+G + + DF +S
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA-------------------------- 150
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE-GKGH 261
SL D + + +FVGT ++APE++E G+
Sbjct: 151 ------------SLADGG--------------DRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLVGEPTP------LRNLI 314
DF D WS G+ E+ GA P+ + L PP L R +I
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMI 244
Query: 315 RRLLEKDPTKRIGVEEIKGHEFF 337
L+KDP+KR EE+ H+FF
Sbjct: 245 SLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-22
Identities = 46/128 (35%), Positives = 73/128 (57%), Gaps = 11/128 (8%)
Query: 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFY 294
+K GT Y+APE+++G+ +DF+VDW++LG L+EM+ G +PFR ++E
Sbjct: 149 KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
Query: 295 RILCRPPDLVGEPTP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELL-LK 347
R L + + +P ++L LL+KDP KR+G +E++ H FK +NW L
Sbjct: 209 RTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAG 268
Query: 348 ISRPPNIP 355
+ PP IP
Sbjct: 269 MLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 79/327 (24%), Positives = 127/327 (38%), Gaps = 81/327 (24%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ +G G G V+ +D+ + E A+KVI + GD + I E +
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIKVI-------------KLEPGDDFEIIQQEISM 53
Query: 80 LRNVEHPLLPRLRGV-LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
L+ HP + G L DK + ++YC G L + Q + S+ I + E +
Sbjct: 54 LKECRHPNIVAYFGSYLRRDK-LWIVMEYCGGGSLQDIY-QVTRGPLSELQIAYVCRETL 111
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L YLH G ++RD+K NI++ E+G + L DF +S +L+ T
Sbjct: 112 KGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT--------------AT--- 154
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE- 257
I KR SF+GT ++APE+
Sbjct: 155 IAKR---------------------------------------KSFIGTPYWMAPEVAAV 175
Query: 258 --GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRPPDLVGEP--TPL 310
G+D D W+LG+ E+ P + I PP L + +P+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235
Query: 311 -RNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ I++ L KDP KR ++ H F
Sbjct: 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 84/340 (24%), Positives = 133/340 (39%), Gaps = 87/340 (25%)
Query: 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76
+ +S LG GA G V + + FALK I D N D ++I E
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD------------PNPDLQKQILRE 49
Query: 77 QRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ-MFSDDTIRFY 133
+ ++ + P + + G + + +G A++YC G L S+ K+ ++ + +
Sbjct: 50 LEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK 109
Query: 134 AAELVL-ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
AE VL L YLH+ I++RD+KP NI++ G +
Sbjct: 110 IAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV------------------------- 144
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
K C G+S E V+S + +F GT Y+A
Sbjct: 145 ---------------KLCDFGVSGE-LVNS-----------------LAGTFTGTSFYMA 171
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET------FYRILCRPPDLVGE 306
PE I+GK + D WSLG+ L E+ PF Y + P+L E
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 307 PT-------PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
P ++ I++ LEKDPT+R ++ H + K
Sbjct: 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 68/326 (20%), Positives = 121/326 (37%), Gaps = 82/326 (25%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I+ LG G+ G V+ E+ + A+KV+ D + I E
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVV-----------PVEEDLQE----IIKEIS 50
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPG---RDLHSLRKQQSEQMFSDDTIRFYAA 135
+L+ + P + + G + + ++YC D+ + + +++ I
Sbjct: 51 ILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILY 106
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+ + LEYLH+ ++RD+K NI++ E G L DF +S +L+ A TV
Sbjct: 107 QTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT--DTMAKRNTV----- 159
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
IG T ++APE+
Sbjct: 160 -----------------------------IG--------------------TPFWMAPEV 170
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----PLR 311
I+ G++ D WSLG+ EM G P+ + I +PP + +P
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFN 230
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFF 337
+ +++ L KDP +R ++ H F
Sbjct: 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 9e-21
Identities = 52/170 (30%), Positives = 90/170 (52%), Gaps = 17/170 (10%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG G V+ + ++ + +A+K + + I+ K E ++ +R++ ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-----------TLALNERIMLSL 50
Query: 84 ----EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
+ P + + T + + +D G DLH Q +FS+ +RFYAAE++L
Sbjct: 51 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIIL 108
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
LE++HN +VYRDLKP NI++ E+GH+ + D L+ S K P AS T
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 3e-20
Identities = 54/128 (42%), Positives = 73/128 (57%), Gaps = 13/128 (10%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---P 301
+GT +Y+APE++ GK H AVDWW+LGV L E L G PF + ++ F IL R P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 302 DLVGE---PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARF 358
+ GE +N I LL DPTKR G++E+K H F GV+WE L+ P IP
Sbjct: 601 E--GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWE-NLQNQTMPFIP--- 654
Query: 359 EHENNESD 366
++E+D
Sbjct: 655 -QPDDETD 661
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 69/313 (22%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
V +G G+ G LVK E + + +K I + K +E + R+ E VL
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE--------ESRK---EVAVL 53
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
N++HP + + + + + +DYC G DL+ Q +F +D I + ++ LA
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
L+++H+ I++RD+K +NI + T+ G
Sbjct: 114 LKHVHDRKILHRDIKSQNIFL---------------------------------TKDGTI 140
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
K F GI+ R + + E + + +GT Y++PEI E +
Sbjct: 141 KLGDF-------GIA----------------RVLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRLL 318
++ D W+LG VL+EM F + K +I+ PP LRNL+ +L
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLF 237
Query: 319 EKDPTKRIGVEEI 331
+++P R V I
Sbjct: 238 KRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-20
Identities = 72/327 (22%), Positives = 130/327 (39%), Gaps = 79/327 (24%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ LG GA G V+ + E+ A K+I + +EL + E +
Sbjct: 9 IIGELGDGAFGKVYKAQHKETGLFAAAKII----QIESEEELED---------FMVEIDI 55
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L +HP + L + + I++C G L S+ + E+ ++ IR+ +++
Sbjct: 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSI-MLELERGLTEPQIRYVCRQMLE 114
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
AL +LH+ +++RDLK NI++ +G + L DF +S K +S +
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN-----------------KSTL 157
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII--- 256
+KR ++F+GT ++APE++
Sbjct: 158 QKR---------------------------------------DTFIGTPYWMAPEVVACE 178
Query: 257 --EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP----TPL 310
+ +D+ D WSLG+ L E+ P + +IL P + +P +
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFF 337
+ ++ L KDP R E+ H F
Sbjct: 239 NDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 17/170 (10%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG G V+ + ++ + +A+K + + I+ K E ++ +R++ ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-----------TLALNERIMLSL 50
Query: 84 ----EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
+ P + + T + + +D G DLH Q +FS+ +RFYA E++L
Sbjct: 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIIL 108
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
LE++HN +VYRDLKP NI++ E+GH+ + D L+ S K P AS T
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 73/340 (21%), Positives = 123/340 (36%), Gaps = 98/340 (28%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
+V +G G G V+ + ++ + A+K++ D+IE + +E I E +
Sbjct: 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEE------------IKEEYNI 55
Query: 80 LRNV-EHPLLPRLRGV------LSTDKFVGYAIDYCPG-------RDLHSLRKQQSEQMF 125
LR HP + G D + ++ C G + L K+ E+
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW- 114
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
I + E + L YLH +++RD+K +NI++ +N + LVDF +S +L
Sbjct: 115 ----IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------ 164
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
T+ NT F+
Sbjct: 165 --STLGRRNT------------------------------------------------FI 174
Query: 246 GTEEYVAPEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP 300
GT ++APE+I +D D WSLG+ E+ G P ++I P
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234
Query: 301 PDLVGEPTP----LRNLIRRLLEKDPTKRIGVEEIKGHEF 336
P + P + I L K+ +R +EE+ H F
Sbjct: 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 68/322 (21%), Positives = 123/322 (38%), Gaps = 68/322 (21%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA + +DV++ A+K + T+++ + + E R++ +
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQV-------TYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + R+ G D +++ G + L + F + I Y +L+ L Y
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLLRGLSY 118
Query: 144 LHNMGIVYRDLKPENIMIQENGHIM-LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
LH I++RD+K N++I G + + DF + +L+ K T +G
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG------------TGAG---- 162
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
E +GT ++APE++ G+ +
Sbjct: 163 ------------------------------------EFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 263 FAVDWWSLGVVLHEMLYGATPFRG---SSRKETFYRILC--RPPDLVGEPTP-LRNLIRR 316
+ D WS+G V+ EM P+ S+ ++I P + +P LR++ R
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246
Query: 317 LLEKDPTKRIGVEEIKGHEFFK 338
LE P R E+ H F+
Sbjct: 247 CLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 8e-19
Identities = 72/309 (23%), Positives = 123/309 (39%), Gaps = 71/309 (22%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I++ +G+G+ GVVF V +A+K I +L+ + ++ I E RV
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQI----------DLSKMNRREREEAID-EARV 52
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI-RFYAAELV 138
L ++ + R + ++Y DLH L K Q + +D + RF+ +++
Sbjct: 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF-IQIL 111
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L L +LH+ I++RD+K N+ + ++ + D ++ LS T ANT G
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--------NFANTIVG 163
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
T Y++PE+ E
Sbjct: 164 ------------------------------------------------TPYYLSPELCED 175
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRR 316
K ++ D W+LGVVL+E G PF +++ +I+ PP L LI +
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 317 LLEKDPTKR 325
L KD +R
Sbjct: 236 CLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 74/315 (23%), Positives = 130/315 (41%), Gaps = 73/315 (23%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF-EQRV 79
+ LG+GA G L + E V+W KE+ +K RR + E +
Sbjct: 5 IRVLGKGAFGEATLYRRTEDDS----LVVW--------KEVNLTRLSEKERRDALNEIVI 52
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L ++HP + D + ++Y G L+ +Q Q+F ++ + +Y ++V
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
A+ Y+H GI++RD+K NI + T++G+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFL---------------------------------TKAGL 139
Query: 200 KKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K F +SK S S+ + V VGT Y++PE+ +G
Sbjct: 140 IKLGDFGISKILGSEYSMAETV------------------------VGTPYYMSPELCQG 175
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRR 316
++F D W+LG VL+E+L F ++ +I+ P + + L +L+
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235
Query: 317 LLEKDPTKRIGVEEI 331
LL++DP KR +E+
Sbjct: 236 LLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 9e-19
Identities = 81/359 (22%), Positives = 125/359 (34%), Gaps = 118/359 (32%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF----E 76
LG G VV+ +D E+ A+K I K E +G I+F E
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKI-------KLGERKEAKDG-----INFTALRE 52
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF---- 132
++L+ ++HP + L V + ++ DL E++ D +I
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DL--------EKVIKDKSIVLTPAD 103
Query: 133 ---YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
Y + LEYLH+ I++RDLKP N++I +G + L DF L+ SP
Sbjct: 104 IKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF------GSPNR 157
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+ V T
Sbjct: 158 KMTHQ--------------------------------------------------VVTRW 167
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--------------KETFY 294
Y APE++ G + + VD WS+G + E+L G S E +
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 295 RILCRPPDLVG----EPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+ PD V PTPL+ +L++RLL +P KRI + H +F
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 66/319 (20%), Positives = 126/319 (39%), Gaps = 76/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G+V + D + A+K + DL +++ +EL N E ++R+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFN-----------EVVIMRDY 73
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + + + +++ G L + +++ I ++ AL +
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSF 130
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH G+++RD+K ++I++ +G + L DF ++S + P +R+
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-----------------RRK 173
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
S VGT ++APE+I +
Sbjct: 174 SL---------------------------------------VGTPYWMAPEVISRLPYGT 194
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP----LRNLIRRLLE 319
VD WSLG+++ EM+ G P+ + RI P + LR+ + R+L
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLV 254
Query: 320 KDPTKRIGVEEIKGHEFFK 338
+DP +R E+ H F
Sbjct: 255 RDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 8e-18
Identities = 76/331 (22%), Positives = 135/331 (40%), Gaps = 79/331 (23%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ LG GA G V+ K+ E+ A KVI E + + + Y E +
Sbjct: 16 IIGELGDGAFGKVYKAKNKETGALAAAKVI----------ETKSEEELEDY---MVEIEI 62
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L HP + +L G D + I++CPG + ++ + ++ ++ I+ +++
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLE 121
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
AL+YLH+M I++RDLK N+++ +G I L DF +S K N ++ +
Sbjct: 122 ALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK----------------NVKT-L 164
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII--- 256
++R S F+GT ++APE++
Sbjct: 165 QRRDS---------------------------------------FIGTPYWMAPEVVMCE 185
Query: 257 --EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP----L 310
+ +D+ D WSLG+ L EM P + +I P + +P+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
R+ ++ L+K P R ++ H F V
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 9e-18
Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 15/162 (9%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
+F IV + RGA G V+L + +S+ +A+KV+ KK+ + N ++
Sbjct: 5 EFV---IVKPISRGAFGKVYLGRKKNNSKLYAVKVV------KKADMINKN----MVHQV 51
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ L + P + L L + V ++Y G D+ SL F ++ Y
Sbjct: 52 QAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKY 109
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+E+ LAL+YLH GI++RDLKP+N++I GHI L DF LS
Sbjct: 110 ISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 10/160 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V + + + +A K + + ++K+ E + E+++L V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE----------QMALNEKKILEKV 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+ L T + + G DL E F + FYAA+++ LE+
Sbjct: 51 SSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
LH IVYRDLKPEN+++ ++G++ + D L+ +L
Sbjct: 111 LHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 49/132 (37%), Positives = 79/132 (59%), Gaps = 11/132 (8%)
Query: 237 SSEKSNSFVGTEEYVAPEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ET 292
S +K ++ VGT Y+APE+++ G +D + DW+SLG +L ++L G +PFR K E
Sbjct: 148 SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
Query: 293 FYRILCRPPDLVGEPTP-LRNLIRRLLEKDPTKRIGV-----EEIKGHEFFKGVNWE-LL 345
L +L +P L++L+ LL++D +KR+G +E+K H FFKG++W+ +
Sbjct: 208 DRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
Query: 346 LKISRPPNIPAR 357
L+ PP IP R
Sbjct: 268 LQKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 72/314 (22%), Positives = 131/314 (41%), Gaps = 73/314 (23%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
++ LR+V G G+ G LV+ V S + +A+K I + K + ++ K
Sbjct: 1 QYNVLRVV---GEGSFGRALLVQHVNSDQKYAMKEI------RLPKSSSAVEDSRK---- 47
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E +L ++HP + + D + ++YC G DL K Q ++F +DTI +
Sbjct: 48 --EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
++ L ++++H +++RD+K +NI
Sbjct: 106 FVQMCLGVQHIHEKRVLHRDIKSKNI---------------------------------- 131
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
FL++ + L D S R+ P + + ++VGT YV P
Sbjct: 132 -----------FLTQNGK--VKLGD-FGSARLLTSPGAYA--------CTYVGTPYYVPP 169
Query: 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLR 311
EI E ++ D WSLG +L+E+ PF+ +S K ++ P LR
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 312 NLIRRLLEKDPTKR 325
+LI+++ +++P R
Sbjct: 230 SLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK---YRRISFEQRVL 80
LG G GVV+ +D ++ E ALK I L N + G R IS +L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI----------RLDNEEEGIPSTALREIS----LL 52
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ ++HP + +L V+ T++ + +YC DL ++ + S + I+ +L+
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPL-SPNLIKSIMYQLLRG 110
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
L Y H+ I++RDLKP+NI+I +G + L DF L+ + + V
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-17
Identities = 46/130 (35%), Positives = 77/130 (59%), Gaps = 11/130 (8%)
Query: 237 SSEKSNSFVGTEEYVAPEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ET 292
S +K ++ VGT Y+APE+++ G +D + DW+SLG +L ++L G +PFR K E
Sbjct: 148 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
Query: 293 FYRILCRPPDLVGEPTP-LRNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWELL- 345
L +L +P LR+L+ LL++D +R+ G +E+K H FF+ ++W+++
Sbjct: 208 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVF 267
Query: 346 LKISRPPNIP 355
L+ PP IP
Sbjct: 268 LQKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 42/122 (34%), Positives = 68/122 (55%), Gaps = 11/122 (9%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRP 300
VGT Y+APE+++ + + F+ DWW LG +++EM+ G +PFR R+E R+
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 301 PDLVGEPTP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELL-LKISRPPN 353
+ + + R++ R+LL KDP R+G EE+K H FF+ N++ L + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 354 IP 355
P
Sbjct: 282 CP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 48/150 (32%), Positives = 83/150 (55%), Gaps = 15/150 (10%)
Query: 232 RSDSDSSEKSNSFVGTEEYVAPEIIE----GKG-HDFAVDWWSLGVVLHEMLYGATPFRG 286
+ + D + +S+ VGT +Y++PEI++ G G + DWWSLGV ++EMLYG TPF
Sbjct: 151 KMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 287 SSRKETFYRILCR------PPDLVGEPTPLRNLIRRLLEKDPTK--RIGVEEIKGHEFFK 338
S ET+ +I+ P + ++LI+RL+ + + G+E+ K H FF+
Sbjct: 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFE 270
Query: 339 GVNWELLLKISRP--PNIPARFEHENNESD 366
G++WE + + P P++ + + N + D
Sbjct: 271 GIDWENIRNLEAPYIPDVSSPSDTSNFDVD 300
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 74/364 (20%), Positives = 133/364 (36%), Gaps = 125/364 (34%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFE 76
++ +G GA G V+ +D+ + ALK + + ++ G R I+
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKV----------RVPLSEEGIPLSTLREIALL 52
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAID----------YCPGRDLHSLRKQQSEQMFS 126
++ L + EHP + RL D G D + +DL + + +
Sbjct: 53 KQ-LESFEHPNIVRLL-----DVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLP 105
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+TI+ +L+ +++LH+ IV+RDLKP+NI++ +G + + DF
Sbjct: 106 PETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADF-------------- 151
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
G+ + SF S V
Sbjct: 152 -----------GLARIYSFEMALTS--------------------------------VVV 168
Query: 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRILCRPPDLVG 305
T Y APE++ + VD WS+G + E+ + P FRG+S + +I D++G
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIF----DVIG 223
Query: 306 EPT---------------------PLR-----------NLIRRLLEKDPTKRIGVEEIKG 333
P+ + +L++++L +P KRI E
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
Query: 334 HEFF 337
H +F
Sbjct: 284 HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 6e-17
Identities = 53/152 (34%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ G V V+ ++ +ALK I + I +S E+T+ E+ VL V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-EVTHT---------LAERTVLAQV 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIRFYAAELVLALE 142
P + L+ + + + + + G +L H L Q E F RFY AEL+ ALE
Sbjct: 51 NCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCALE 107
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
LH ++YRDLKPENI++ GHI L DF L
Sbjct: 108 NLHKFNVIYRDLKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 6e-17
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 62/319 (19%)
Query: 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81
+ +G G+ G V+L + S E A+K + + SK+ + R I+ +L+
Sbjct: 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIA----LLK 61
Query: 82 NVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
++H + + G + ++Y PG + +L F + +R + +++ L
Sbjct: 62 ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGL 119
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
YLHN GI++RD+K NI++ G I + DF +S KL AN+ S K
Sbjct: 120 NYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE-------------ANSLST--K 164
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
P S G+ ++APE+++ +
Sbjct: 165 TNG----------------ARP-------------------SLQGSVFWMAPEVVKQTSY 189
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI----LCRPPDLVGEPTPLRNLIRRL 317
D WSLG ++ EML G PF ++ + ++I P + + + +
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA--IDFLEKT 247
Query: 318 LEKDPTKRIGVEEIKGHEF 336
E D KR E+ H F
Sbjct: 248 FEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 7e-17
Identities = 81/320 (25%), Positives = 132/320 (41%), Gaps = 78/320 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+GA G V+ DV + + A+K + +L ++ KEL N E V+R
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIIN-----------EILVMREN 73
Query: 84 EHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+HP ++ L L D+ + ++Y G SL +E + I E + ALE
Sbjct: 74 KHPNIVNYLDSYLVGDE-LWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALE 129
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ +++RD+K +NI++ +G + L DF
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----------------------------- 160
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
FC+ +I P+ RS + VGT ++APE++ K +
Sbjct: 161 ------FCA------------QITPEQSKRS---------TMVGTPYWMAPEVVTRKAYG 193
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL----RNLIRRLL 318
VD WSLG++ EM+ G P+ + Y I + P L R+ + R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 253
Query: 319 EKDPTKRIGVEEIKGHEFFK 338
E D KR +E+ H F K
Sbjct: 254 EMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 9e-17
Identities = 75/321 (23%), Positives = 129/321 (40%), Gaps = 70/321 (21%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ +G G+ G ++L K SE +K I + K KE + E +
Sbjct: 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK-----------EVIL 52
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L ++HP + + + ++YC G DL +Q +FS+D I + ++ L
Sbjct: 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL 112
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
L+++H+ I++RD I
Sbjct: 113 GLKHIHDRKILHRD---------------------------------------------I 127
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
K + FLSK +G+ ++G +R +DS E + + VGT Y++PEI + +
Sbjct: 128 KSQNIFLSK---NGMV-------AKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR 177
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRR 316
++ D WSLG VL+E+ PF G++ + +I C+ P LR+LI +
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI-CQGYFAPISPNFSRDLRSLISQ 236
Query: 317 LLEKDPTKRIGVEEIKGHEFF 337
L + P R + I F
Sbjct: 237 LFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 72/332 (21%), Positives = 137/332 (41%), Gaps = 88/332 (26%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL--TNNDNGDKYRR-----ISFE 76
+G+G G V+L +V + E A+K + EL T D ++ + E
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQV----------ELPATIAGRHDSRQKDMVKALRSE 58
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
L++++H + + G +T++++ ++Y PG + S + F + +RF+ +
Sbjct: 59 IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR--FEEQLVRFFTEQ 116
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
++ L YLH+ GI++RDLK +N+++ +G + DF
Sbjct: 117 VLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF------------------------ 152
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
GI K+ D ++++ S G+ ++APE+I
Sbjct: 153 -GISKKSD-----------------------------DIYDNDQNMSMQGSVFWMAPEVI 182
Query: 257 E--GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---YRILCR------PPDLVG 305
+G+ VD WSLG V+ EM G P+ S +E +++ + PPD+
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 306 EPTPL-RNLIRRLLEKDPTKRIGVEEIKGHEF 336
+P+ + + +P R E+ H F
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 85/348 (24%), Positives = 128/348 (36%), Gaps = 99/348 (28%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
V +G G GVV+ ++ + E ALK I D E + T R IS +L
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPST------AIREIS----LL 53
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ + HP + +L V+ T+ + ++ +DL I+ Y +L+
Sbjct: 54 KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
L + H+ +++RDLKP+N++I G I L DF L+
Sbjct: 113 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA------------------------- 147
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG-K 259
R+F G+ + H V T Y APEI+ G K
Sbjct: 148 --RAF-------GVPVRTYTHE----------------------VVTLWYRAPEILLGCK 176
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRP-----------PDLVG 305
+ AVD WSLG + EM+ F G S + +RI L P PD
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236
Query: 306 E-----PTPL-----------RNLIRRLLEKDPTKRIGVEEIKGHEFF 337
R+L+ ++L DP KRI + H FF
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 10/156 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ G V+ +++ + FA+K + + +E +++ E +L +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--------KQLEQEIALLSKL 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + + G + + ++ PG L L K+ F + IR Y +++L LEY
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEY 117
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
LH+ V+RD+K NI++ NG + L DF ++ ++
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 78/320 (24%), Positives = 132/320 (41%), Gaps = 78/320 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+GA G V+ DV + + A++ + +L ++ KEL N E V+R
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIIN-----------EILVMREN 74
Query: 84 EHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
++P ++ L L D+ + ++Y G SL +E + I E + ALE
Sbjct: 75 KNPNIVNYLDSYLVGDE-LWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALE 130
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ +++RD+K +NI++ +G + L DF
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----------------------------- 161
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
FC+ +I P+ RS VGT ++APE++ K +
Sbjct: 162 ------FCA------------QITPEQSKRST---------MVGTPYWMAPEVVTRKAYG 194
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL----RNLIRRLL 318
VD WSLG++ EM+ G P+ + Y I + P L R+ + R L
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 319 EKDPTKRIGVEEIKGHEFFK 338
+ D KR +E+ H+F K
Sbjct: 255 DMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 74/352 (21%), Positives = 120/352 (34%), Gaps = 102/352 (28%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ +G GA GVV ++ + E A+K K + D+ D + E +V
Sbjct: 5 VLGVVGEGAYGVVLKCRNKATGEIVAIK-----------KFKESEDDEDVKKTALREVKV 53
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
LR + H + L+ + +Y L L D +R Y +L+
Sbjct: 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQ 111
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
A+ Y H+ I++RD+KPENI LV KL
Sbjct: 112 AIAYCHSHNIIHRDIKPENI---------LVSESGVLKL--------------------- 141
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
C G + R P+ +D +V T Y APE++ G
Sbjct: 142 ----------CDFGFA--------RALRARPASPLTD-------YVATRWYRAPELLVGD 176
Query: 260 G-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---------------------- 296
+ VD W++G ++ E+L G F G S + Y I
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 297 -LCRPPDLVGEPTPLR----------NLIRRLLEKDPTKRIGVEEIKGHEFF 337
+ P E R + ++ L DP +R+ +E+ H +F
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 2e-16
Identities = 80/320 (25%), Positives = 131/320 (40%), Gaps = 78/320 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+GA G VF DV + + A+K I +L ++ KEL N E V++ +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIIN-----------EILVMKEL 73
Query: 84 EHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
++P ++ L L D+ ++Y G SL +E + I E + ALE
Sbjct: 74 KNPNIVNFLDSFLVGDELF-VVMEYLAG---GSLTDVVTETCMDEAQIAAVCRECLQALE 129
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH +++RD+K +N+++ +G + L DF
Sbjct: 130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFG----------------------------- 160
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
FC+ +I P+ RS + VGT ++APE++ K +
Sbjct: 161 ------FCA------------QITPEQSKRS---------TMVGTPYWMAPEVVTRKAYG 193
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL----RNLIRRLL 318
VD WSLG++ EM+ G P+ + Y I + P L R+ + R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL 253
Query: 319 EKDPTKRIGVEEIKGHEFFK 338
E D KR +E+ H F K
Sbjct: 254 EMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 54/169 (31%), Positives = 90/169 (53%), Gaps = 18/169 (10%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVI--WRDLIEKKSKELTNNDNGDKYR 71
DF L+++ GRGA G V +VK + + +A+K++ W L K E +R
Sbjct: 2 DFEILKVI---GRGAFGEVAVVKMKNTGQVYAMKILNKWEML---KRAETAC------FR 49
Query: 72 RISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIR 131
E+ VL N + + L + + +DY G DL +L + +++ +D R
Sbjct: 50 E---ERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL-PEDMAR 105
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
FY AE+VLA++ +H +G V+RD+KP+N+++ +NGHI L DF +L
Sbjct: 106 FYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 6e-16
Identities = 42/166 (25%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G+G+ G V V+ + K I + ++ EK+ ++L + E
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS------------EVN 51
Query: 79 VLRNVEHPLLPRL--RGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYA 134
+LR ++HP + R R + +++ + ++YC G DL L + ++ + ++ I
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 135 AELVLALEYLHN-----MGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+L+LAL HN +++RDLKP NI + N ++ L DF L+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 69/318 (21%), Positives = 136/318 (42%), Gaps = 76/318 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G+V + ++ S A+K++ DL +++ +EL N E ++R+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFN-----------EVVIMRDY 75
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + + + + +++ G L + S+ +++ I ++ AL Y
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI---VSQTRLNEEQIATVCESVLQALCY 132
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ G+++RD+K ++I++ +G + L DF ++S P KR+
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-----------------KRK 175
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
S VGT ++APE+I +
Sbjct: 176 ---------------------------------------SLVGTPYWMAPEVISRTPYGT 196
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV---GEPTP-LRNLIRRLLE 319
VD WSLG+++ EM+ G P+ S + R+ PP + + +P LR+ + R+L
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 320 KDPTKRIGVEEIKGHEFF 337
++P +R +E+ H F
Sbjct: 257 REPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 9e-16
Identities = 89/363 (24%), Positives = 142/363 (39%), Gaps = 116/363 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIW---RDLIEKKSKELTNNDNGDKYRRISF 75
I+ LG+GA G+V+ D + E ALK I+ R+ D +R I F
Sbjct: 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA----------TDAQRTFREIMF 59
Query: 76 EQRVLRNVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRF 132
Q L + HP + +L V+ DK + +Y DLH+ +R + D R+
Sbjct: 60 LQE-LGD--HPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRY 111
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+L+ AL+Y+H+ +++RDLKP NI++ + + L DF L+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA----------------- 154
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
RS + E+PV + +V T Y A
Sbjct: 155 ---RS-----------LSELEENPENPVLT--------------------DYVATRWYRA 180
Query: 253 PEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT--- 308
PEI+ G + VD WS+G +L EML G F G+S +I+ +++G P+
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII----EVIGPPSAED 236
Query: 309 ----------------------PLR-----------NLIRRLLEKDPTKRIGVEEIKGHE 335
PL +L+++LL +P KR+ EE H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296
Query: 336 FFK 338
+
Sbjct: 297 YVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 76/326 (23%), Positives = 134/326 (41%), Gaps = 79/326 (24%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ LG GA G V+ ++ E+ A KVI + KS+E + E +
Sbjct: 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVI-----DTKSEE--------ELEDYMVEIDI 55
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L + +HP + +L + + I++C G + ++ + E+ ++ IR + +
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAV-MLELERPLTEPQIRVVCKQTLE 114
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
AL YLH I++RDLK NI+ +G I L DF +S K NTR+ I
Sbjct: 115 ALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK----------------NTRT-I 157
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII--- 256
++R +SF+GT ++APE++
Sbjct: 158 QRR---------------------------------------DSFIGTPYWMAPEVVMCE 178
Query: 257 --EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----PL 310
+ + +D+ D WSLG+ L EM P + +I P + +P+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF 238
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEF 336
++ +++ LEK+ R ++ H F
Sbjct: 239 KDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 77/327 (23%), Positives = 135/327 (41%), Gaps = 62/327 (18%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ +G+G G V+L D S ALK I DL +N +R E ++
Sbjct: 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS----------ENPLLKKRFLREAKI 55
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAEL 137
++ HP + + + S V Y + Y G L SL K Q E + + +
Sbjct: 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 138 V-------LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ +EY+H+ G+++RDLKP+NI++ G ++++D+
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWG----------------- 158
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
AA + ++ + + + +S S VGT +Y
Sbjct: 159 -AAIFKKLEEEDLLDID------VDERNICYS--------------SMTIPGKIVGTPDY 197
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE---- 306
+APE + G + D ++LGV+L++ML + P+R ++ YR + P V
Sbjct: 198 MAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREI 257
Query: 307 PTPLRNLIRRLLEKDPTKRI-GVEEIK 332
P L + + L DP +R V+E+K
Sbjct: 258 PPFLSQIAMKALAVDPAERYSSVQELK 284
|
Length = 932 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 77/320 (24%), Positives = 132/320 (41%), Gaps = 78/320 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+GA G V+ D+ + + A+K + +L ++ KEL N E V+R
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIIN-----------EILVMREN 73
Query: 84 EHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
++P ++ L L D+ + ++Y G SL +E + I E + AL+
Sbjct: 74 KNPNIVNYLDSYLVGDE-LWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALD 129
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH+ +++RD+K +NI++ +G + L DF
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----------------------------- 160
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
FC+ +I P+ RS + VGT ++APE++ K +
Sbjct: 161 ------FCA------------QITPEQSKRS---------TMVGTPYWMAPEVVTRKAYG 193
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL----RNLIRRLL 318
VD WSLG++ EM+ G P+ + Y I + P L R+ + R L
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL 253
Query: 319 EKDPTKRIGVEEIKGHEFFK 338
E D +R +E+ H F K
Sbjct: 254 EMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 27/180 (15%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
++ +G GA GVV D + A+K I DLI+ K RI
Sbjct: 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--------------RILR 48
Query: 76 EQRVLRNVEHPLLPRLRGVL---STDKF--VGYAI-DYCPGRDLHSLRKQQSEQMFSDDT 129
E ++LR++ H + L +L S + F V Y + + DLH + K S Q +DD
Sbjct: 49 EIKLLRHLRHENIIGLLDILRPPSPEDFNDV-YIVTELMET-DLHKVIK--SPQPLTDDH 104
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
I+++ +++ L+YLH+ +++RDLKP NI++ N + + DF L+ + P + T
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 69/316 (21%), Positives = 130/316 (41%), Gaps = 74/316 (23%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ--R 78
V +G+G+ G V LV+ + + +K + N N + R + EQ +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKL-------------NLRNASRRERKAAEQEAQ 51
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+L ++HP + R + + Y + +C G DL+ K+Q ++ ++ + + ++
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI 111
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+AL+YLH I++RDLK +N+ + TR+
Sbjct: 112 AMALQYLHEKHILHRDLKTQNVFL---------------------------------TRT 138
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
I K +G +R + + +++ +GT Y++PE+
Sbjct: 139 NIIK-----------------------VGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRPPDLVGEPTP-LRNLIR 315
K +++ D W+LG ++EM F YRI+ + P + + +P L LI
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 316 RLLEKDPTKRIGVEEI 331
+L K P KR V+ I
Sbjct: 236 TMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 87/355 (24%), Positives = 134/355 (37%), Gaps = 120/355 (33%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA G+V +D + ++ A+K I + + T YR E ++L+++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT-------YR----ELKLLKHL 66
Query: 84 EHPLLPRLRGVLSTDKFVG-----YAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAEL 137
H + L +D F+ Y + G DLH L + E+ F I+++ ++
Sbjct: 67 RHENIISL-----SDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF----IQYFLYQI 117
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ L+Y+H+ G+V+RDLKP NI+I EN DL
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINEN-------CDL----------------------- 147
Query: 198 GIKKRRSFLSKFCSSGIS-LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI- 255
K C G++ ++DP + +V T Y APEI
Sbjct: 148 ----------KICDFGLARIQDP--------------------QMTGYVSTRYYRAPEIM 177
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRPPDLV-------- 304
+ + +D VD WS G + EML G F G F I L PPD V
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 305 ----------GEPTPL-----------RNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
EP P +L+ ++L DP KRI E H +
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 31/105 (29%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSR 289
S+ + + VGT Y+APE++ GKG+ D WSLGV+L+E+
Sbjct: 140 SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------ 187
Query: 290 KETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334
L++LIR++L+KDP KR +EI H
Sbjct: 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 14/165 (8%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF ++++ GRGA G V +VK + +A+K++ + + K+++ +R
Sbjct: 2 DFEIIKVI---GRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC-------FRE- 50
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E+ VL N + + L + ++ +DY G DL +L + E +D RFY
Sbjct: 51 --ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-SKFEDRLPEDMARFY 107
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
AE+VLA+ +H + V+RD+KP+N+++ NGHI L DF K+
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 75/311 (24%), Positives = 129/311 (41%), Gaps = 79/311 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G+V+ +D+ + A+K I E+ S+ + + I+ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI----PERDSRYVQ-----PLHEEIALHSYL---- 62
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL-RKQQSEQMFSDDTIRFYAAELVLALE 142
+H + + G S + F ++ PG L +L R + ++ TI FY +++ L+
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
YLH+ IV+RD+K +N+++ NT SG+ K
Sbjct: 123 YLHDNQIVHRDIKGDNVLV--------------------------------NTYSGVVK- 149
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG--KG 260
+S F + S R+ P + +F GT +Y+APE+I+ +G
Sbjct: 150 ---ISDFGT----------SKRLAGINPC---------TETFTGTLQYMAPEVIDKGPRG 187
Query: 261 HDFAVDWWSLGVVLHEMLYGATPF------RGSSRKETFYRILCRPPDLVGEPTPLRNLI 314
+ D WSLG + EM G PF + + K ++I P+ + +N I
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA--KNFI 245
Query: 315 RRLLEKDPTKR 325
R E DP KR
Sbjct: 246 LRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 77/322 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIE-KKSKELTNNDNGDKYRRISFEQRVLRN 82
LG+GA G V+L DV++ A K + D + SKE++ + E ++L+N
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVS---------ALECEIQLLKN 60
Query: 83 VEHPLLPRLRGVLS--TDKFVGYAIDYCPGRDLHSLRKQ-QSEQMFSDDTIRFYAAELVL 139
++H + + G L +K + ++Y PG S++ Q ++ ++ R Y +++
Sbjct: 61 LQHERIVQYYGCLRDRAEKTLTIFMEYMPG---GSVKDQLKAYGALTESVTRKYTRQILE 117
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
+ YLH+ IV+RD+K NI+ G++ L DF G
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDF-------------------------GA 152
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
KR L C SG + S GT +++PE+I G+
Sbjct: 153 SKR---LQTICMSGTGIR-------------------------SVTGTPYWMSPEVISGE 184
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLI 314
G+ D WSLG + EML P+ ++I +P P + E R+ +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA--RDFL 242
Query: 315 RRLLEKDPTKRIGVEEIKGHEF 336
+ + R EE+ H F
Sbjct: 243 GCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 77/337 (22%), Positives = 130/337 (38%), Gaps = 76/337 (22%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND 65
P + S L V+ +G GA G V+ V + +ALKVI+ N
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY------------GNH 111
Query: 66 NGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMF 125
R+I E +LR+V HP + + + + + +++ G L EQ
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD-EQFL 170
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+D A +++ + YLH IV+RD+KP N++I ++ + DF +S L+
Sbjct: 171 AD-----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA------ 219
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
+T+ N+ G I P R ++D
Sbjct: 220 --QTMDPCNSSVGT-------------------------IAYMSPERINTD--------- 243
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----RP 300
+ G +A D WSLGV + E G PF G R+ + ++C +P
Sbjct: 244 ---------LNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWASLMCAICMSQP 293
Query: 301 PDLVGEPTP-LRNLIRRLLEKDPTKRIGVEEIKGHEF 336
P+ + R+ I L+++P KR ++ H F
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 43/122 (35%), Positives = 70/122 (57%), Gaps = 11/122 (9%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILCRPP 301
VGT Y+APE+++ + + F+ DWW+LG +L+EM+ G +PF+ +K E R++
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 302 DLVGEP-TP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELL-LKISRPPN 353
+ E +P R+L + LL KDP +R+G E+K H FK +N++ L + PP
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
Query: 354 IP 355
P
Sbjct: 282 KP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 33/107 (30%), Positives = 62/107 (57%), Gaps = 2/107 (1%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E+++L + HP L G + ++ +++ G + + ++ + F +D FYAA
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAA 138
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
++VL EYL ++ IVYRDLKPEN+++ ++G I + DF + + +T
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185
|
Length = 340 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 81/351 (23%), Positives = 124/351 (35%), Gaps = 105/351 (29%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQ 77
V +G G GVV+ +D + E ALK I L D G R IS
Sbjct: 4 VEKIGEGTYGVVYKARDKLTGEIVALKKI----------RLETEDEGVPSTAIREISL-- 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
L+ + HP + RL V+ ++ + ++ DL I+ Y +L
Sbjct: 52 --LKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ + Y H+ +++RDLKP+N++I G + L DF L+
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLA---------------------- 146
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
R+F G+ + H V T Y APEI+
Sbjct: 147 -----RAF-------GVPVRTYTHE----------------------VVTLWYRAPEILL 172
Query: 258 G-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRP-----------PD 302
G + + VD WS+G + EM+ F G S + +RI L P PD
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232
Query: 303 LVG-----EPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFF 337
L +L+ ++L DP KRI + H +F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 3e-14
Identities = 38/161 (23%), Positives = 79/161 (49%), Gaps = 15/161 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA G V+ D + + A+K + + K++KEL N E ++++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIIN-----------EILIMKDC 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + + ++Y G L + Q +M ++ I + E++ LEY
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRM-NEPQIAYVCREVLQGLEY 131
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
LH+ +++RD+K +NI++ ++G + L DF + +L+ + +
Sbjct: 132 LHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 68/319 (21%), Positives = 130/319 (40%), Gaps = 76/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G+V + + + + A+K + DL +++ +EL N E ++R+
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFN-----------EVVIMRDY 76
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
H + + + +++ G L + + +++ I ++ AL Y
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSY 133
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LHN G+++RD+K ++I++ +G I L DF ++S + P KR+
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-----------------KRK 176
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
S VGT ++APE+I +
Sbjct: 177 S---------------------------------------LVGTPYWMAPEVISRLPYGT 197
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE----PTPLRNLIRRLLE 319
VD WSLG+++ EM+ G P+ + RI P V + + LR + +L
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 320 KDPTKRIGVEEIKGHEFFK 338
++P++R +E+ H F K
Sbjct: 258 REPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 29/175 (16%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF--- 75
++ +G G G V+ ++ ++ E ALK I + N G F
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKI----------RMENEKEG-------FPIT 44
Query: 76 ---EQRVLRNVEHPLLPRLRGVLSTDKFVG--YAI-DYCPGRDLHSLRKQQSEQMFSDDT 129
E ++L+ + HP + RL+ ++ T K G Y + +Y DL L + F++
Sbjct: 45 AIREIKLLQKLRHPNIVRLKEIV-TSKGKGSIYMVFEYMD-HDLTGLLDSPEVK-FTESQ 101
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
I+ Y +L+ L+YLH+ GI++RD+K NI+I +G + L DF L+ + +
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 8e-14
Identities = 75/313 (23%), Positives = 128/313 (40%), Gaps = 71/313 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND-NGDKYRRISFEQRVLRN 82
LG+G+ G V+LVKD ++ LKV+ KE+ + N ++ + + E ++L
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVL---------KEIPVGELNPNETVQANQEAQLLSK 58
Query: 83 VEHPLLPRLRG-VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
++HP + + L D F +YC GRDL D +
Sbjct: 59 LDHPAIVKFHASFLERDAFC-IITEYCEGRDL-------------DCKLE---------- 94
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIML-VDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
E H + EN + + ++L V + +
Sbjct: 95 ELKHTGKTL-----SENQVCEWFIQLLLGVHY--------------------------MH 123
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
+RR + I L++ + +IG SR S + + +F GT Y++PE ++ +G
Sbjct: 124 QRRILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--PTPLRNLIRRLL 318
+D D WSLG +L+EM A F G + RI+ P + E L ++++ +L
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSML 241
Query: 319 EKDPTKRIGVEEI 331
KDP+ R EI
Sbjct: 242 NKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 75/340 (22%), Positives = 126/340 (37%), Gaps = 87/340 (25%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L L +S LG G G V VK + + A KV+ I KS ++
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSS---------VRKQ 49
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
I E +++ P + G + + +++ L + K+ + +
Sbjct: 50 ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP--IPVEILGK 107
Query: 133 YAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
A +V L YL+N+ I++RD+KP NI++ G I
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI------------------------ 143
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
K C G+S E ++S +++FVGT Y+
Sbjct: 144 ----------------KLCDFGVSGE-LINS-----------------IADTFVGTSTYM 169
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-----------ETFYRILCRP 300
+PE I+G + D WSLG+ + E+ G PF S+ + +I+ P
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229
Query: 301 PDLVGE---PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337
P + P LR+ + L KDPT+R +++ F
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 9e-14
Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299
++ + GT EY+APEI+ GH A DWW+LG+ ++E+L G PF + + +IL
Sbjct: 184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL-- 241
Query: 300 PPDLVGEP----TPLRNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWELLLKISR 350
++ P ++L+++LL D TKR G + +K H +F ++W LL +
Sbjct: 242 -EGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLL--HK 298
Query: 351 PPNIPARFEHEN 362
+P + +++N
Sbjct: 299 NVEVPYKPKYKN 310
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 79/362 (21%), Positives = 135/362 (37%), Gaps = 116/362 (32%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ LG+GA G+V ++ E+SE + + K++TN + + +R
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAI----------KKITN-----VFSKKILAKRA 48
Query: 80 LRNVEHPLLPRLRG------VLSTDKFVGYAID--YCPGR----DLHSLRKQQSEQMFSD 127
LR E LL RG + D + Y DLH + + S Q +D
Sbjct: 49 LR--ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR--SGQPLTD 104
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
+ + +++ L+Y+H+ +++RDLKP N+++ + + + DF L
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGL------------- 151
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
+ G S E+P + +V T
Sbjct: 152 -----------------------ARGFS-ENPGENA---------------GFMTEYVAT 172
Query: 248 EEYVAPEI-IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD- 302
Y APEI + + + A+D WS+G +L E+L F+G + +IL P +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 303 ---------------------------LVGEPTPLR-NLIRRLLEKDPTKRIGVEEIKGH 334
+ PL +L+ +LL DPTKRI VEE H
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292
Query: 335 EF 336
+
Sbjct: 293 PY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 11/122 (9%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILCRPP 301
VGT Y+APE+I + + F+ DWW LG +++EM+ G +PFR + E R +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 302 DLVGE--PTPLRNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWELL-LKISRPPN 353
+ E +++ R LL K+P +R+ G +K H FK +N++ L + PP
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPF 281
Query: 354 IP 355
P
Sbjct: 282 CP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 39/122 (31%), Positives = 69/122 (56%), Gaps = 11/122 (9%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRP 300
VGT Y+APE++ + + + D+W LG +++EM+ G +PFRG R+E R+L
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 301 PDLVGEPTP-LRNLIRRLLEKDPTKRIGVE-----EIKGHEFFKGVNWELL-LKISRPPN 353
+ + +++ + LL KDP +R+G + E+K H FF+ +N++ L + PP
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
Query: 354 IP 355
+P
Sbjct: 282 VP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 67/319 (21%), Positives = 120/319 (37%), Gaps = 68/319 (21%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA G V+ + A+K + D + E +Y ++ E +L+++
Sbjct: 8 LGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAE-------KEYEKLQEEVDLLKSL 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + + G D + +++ PG + S+ + + Y +++ + Y
Sbjct: 60 KHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAY 117
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LHN +V+RD+K N+M+ NG I L+DF + +L+ V T S + K
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA---------WVGLHGTHSNMLK-- 166
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
S GT ++APE+I G+
Sbjct: 167 ---------------------------------------SMHGTPYWMAPEVINESGYGR 187
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------LCRPPDLVGEPTPLRNLIRRL 317
D WS+G + EM G P R + I + R PD + +
Sbjct: 188 KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI--DFVTSC 245
Query: 318 LEKDPTKRIGVEEIKGHEF 336
L +D +R ++ H+F
Sbjct: 246 LTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 75/324 (23%), Positives = 135/324 (41%), Gaps = 71/324 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ LG+GA G V+L D ++ A+K + D +S E + N + E +
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFD---PESPETSKEVNA-----LECEIQ 56
Query: 79 VLRNVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSLRKQ-QSEQMFSDDTIRFYAA 135
+L+N+ H + + G L ++ + +++ PG S++ Q +S +++ R Y
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPG---GSIKDQLKSYGALTENVTRKYTR 113
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+++ + YLH+ IV+RD+K NI+ G++ L DF
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDF----------------------- 150
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
G KR L C SG ++ S GT +++PE+
Sbjct: 151 --GASKR---LQTICLSGTGMK-------------------------SVTGTPYWMSPEV 180
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP---TPLRN 312
I G+G+ D WS+G + EML P+ ++I +P + V P R+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240
Query: 313 LIRRLLEKDPTKRIGVEEIKGHEF 336
++R+ + R +E+ H F
Sbjct: 241 FLKRIF-VEAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 84/355 (23%), Positives = 136/355 (38%), Gaps = 119/355 (33%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
+G G G VF K+ E+ E ALK + L ++D G R I +L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALREIC----LL 53
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLH----SLRKQQSEQMFSDDTIRFYAAE 136
+ ++H + RL VL +DK + +YC +DL S + ++ + +
Sbjct: 54 KELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPE-----IVKSFMFQ 107
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
L+ L + H+ +++RDLKP+N++I +NG + L DF L+
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA--------------------- 146
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
R+F GI P R S V T Y P+++
Sbjct: 147 ------RAF-------GI---------------PVRCYSAE-------VVTLWYRPPDVL 171
Query: 257 EG-KGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETF---YRILCRP----------- 300
G K + ++D WS G + E+ P F G+ + +R+L P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231
Query: 301 PDLVGEPTPL------------------RNLIRRLLEKDPTKRIGVEEIKGHEFF 337
PD P P+ R+L++ LL +P +RI EE H +F
Sbjct: 232 PDYK--PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 79/315 (25%), Positives = 122/315 (38%), Gaps = 95/315 (30%)
Query: 32 VFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91
V LV D + ++F LK + +KS E + R V P + L
Sbjct: 9 VLLVMDTRTQQTFILKGL------RKSSEYSRE------RLTIIPHCV------PNMVCL 50
Query: 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVY 151
+ ++ V + + G L S + ++ ++ +AAE+V+AL+ LH GIV
Sbjct: 51 HKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVC 108
Query: 152 RDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCS 211
RDL P +I+L + R I+ L+ F
Sbjct: 109 RDLNP--------NNILL------------------------DDRGHIQ-----LTYFSR 131
Query: 212 SGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLG 271
+ED D ++ E Y APE+ A DWWSLG
Sbjct: 132 -WSEVED-------------SCDGEAVENM--------YCAPEVGGISEETEACDWWSLG 169
Query: 272 VVLHEMLYGATPFR----GSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRI- 326
+L E+L G T G + T P+ V E R+L+++LL+ +PT+R+
Sbjct: 170 AILFELLTGKTLVECHPSGINTHTTL-----NIPEWVSEEA--RSLLQQLLQFNPTERLG 222
Query: 327 ----GVEEIKGHEFF 337
GVE+IK H FF
Sbjct: 223 AGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 75/326 (23%), Positives = 136/326 (41%), Gaps = 75/326 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ LGRGA G V+L D ++ A+K + D S+E + N + E +
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFD---PDSQETSKEVNA-----LECEIQ 56
Query: 79 VLRNVEHPLLPRLRGVLS--TDKFVGYAIDYCPGRDLHSLRKQ-QSEQMFSDDTIRFYAA 135
+L+N+ H + + G L +K + ++Y PG S++ Q ++ +++ R Y
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPG---GSIKDQLKAYGALTENVTRRYTR 113
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+++ + YLH+ IV+RD+K NI+ G++ L DF
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDF----------------------- 150
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
G KR + C SG ++ S GT +++PE+
Sbjct: 151 --GASKR---IQTICMSGTGIK-------------------------SVTGTPYWMSPEV 180
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPL 310
I G+G+ D WS+ + EML P+ ++I +P PD V +
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC-- 238
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEF 336
R+ ++++ ++ +R E + H F
Sbjct: 239 RDFLKQIFVEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 77/358 (21%), Positives = 130/358 (36%), Gaps = 100/358 (27%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYR----RISF---- 75
LG G G V D + + A+K + K E++N+ D+ I F
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-------KIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ-QSEQMFSDDTIRFYA 134
E +++ ++H + L V F+ +D L+K + ++ ++
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS----DLKKVVDRKIRLTESQVKCIL 125
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
+++ L LH ++RDL P NI I G + DF L+ + P +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY------GYPPYSDTLS 179
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+++R SK V T Y APE
Sbjct: 180 KDETMQRREEMTSK------------------------------------VVTLWYRAPE 203
Query: 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----- 308
++ G + + FAVD WS+G + E+L G F G + + RI +L+G P
Sbjct: 204 LLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF----ELLGTPNEDNWP 259
Query: 309 -----PLR-----------------------NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
PL +L++ LL+ +P +RI +E HE+FK
Sbjct: 260 QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 6e-13
Identities = 82/351 (23%), Positives = 132/351 (37%), Gaps = 118/351 (33%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L ++ LGRGA GVV ++ V + A+K I + ++ K L + + IS
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLD------IS--- 53
Query: 78 RVLRNVEHPLLPRLRGVL---------------STDKFVGYAIDYCPGRDLHSLRKQQSE 122
+R+V+ P G L S DKF +K +
Sbjct: 54 --MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKF---------------YKKVYDK 96
Query: 123 QMF-SDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS- 179
+ +D + A +V ALEYLH + +++RD+KP N++I NG + L DF +S L
Sbjct: 97 GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156
Query: 180 --PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDS 237
KT A K +A RI P+
Sbjct: 157 SVAKTIDAGCKPYMAPE-----------------------------RINPE--------- 178
Query: 238 SEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL 297
+ KG+D D WSLG+ + E+ G P+ S K F ++
Sbjct: 179 ------------------LNQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQL- 217
Query: 298 CRPPDLVGEPTP----------LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+V EP+P ++ + + L+K+ +R E+ H FF+
Sbjct: 218 ---KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 66/236 (27%), Positives = 110/236 (46%), Gaps = 27/236 (11%)
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIV--YRDLKPEN--IMIQENGHIMLVDFDLSTKLS 179
M +D+ YA + L + GIV + D K ++ ++I E G DL+ ++
Sbjct: 102 MLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS----GGDLNKQIK 157
Query: 180 PKTPQASP-----------KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPD 228
+ + P + VLA + + R+ S+ I L P ++G
Sbjct: 158 QRLKEHLPFQEYEVGLLFYQIVLALDE---VHSRKMMHRDLKSANIFLM-PTGIIKLGDF 213
Query: 229 PPSR--SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRG 286
S+ SDS S + ++SF GT Y+APE+ E K + D WSLGV+L+E+L PF+G
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
Query: 287 SSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
S++E ++L P + ++ L+ LL K+P R +++ EF K V
Sbjct: 274 PSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329
|
Length = 478 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 25/165 (15%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
+ +S +G GA G V D ++ A+K + R I K R
Sbjct: 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK--------------RTYR 63
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVG-----YAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
E R+L++++H + L V + + Y + + G DL+++ K Q SDD I
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK---LSDDHI 120
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+F +++ L+Y+H+ GI++RDLKP NI + E+ + ++DF L+
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 74/297 (24%)
Query: 39 ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL--RGVLS 96
+ A+K++ R ++ + ++RR E + + HP + L G +
Sbjct: 1 MTGHEVAIKLL-RTDAPEEEHQRA------RFRR---ETALCARLYHPNIVALLDSGE-A 49
Query: 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKP 156
+ +Y PGR L + + + +T R +++ AL HN GIV+RDLKP
Sbjct: 50 PPGLLFAVFEYVPGRTLREVLAADG-ALPAGETGRL-MLQVLDALACAHNQGIVHRDLKP 107
Query: 157 ENIMIQENG---HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSG 213
+NIM+ + G H ++DF + T L P A T+ TR+
Sbjct: 108 QNIMVSQTGVRPHAKVLDFGIGT-LLPGVRDADVATL----TRTT--------------- 147
Query: 214 ISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVV 273
+GT Y APE + G+ D ++ G++
Sbjct: 148 -----------------------------EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178
Query: 274 LHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT-----PLRNLIRRLLEKDPTKR 325
E L G +G+S E Y+ L P V P PL ++R+ L KDP +R
Sbjct: 179 FLECLTGQRVVQGASVAEILYQQL--SPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
S + ++S VGT Y++PE I G++F D WSLG +L+EM +PF G K Y
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLY 214
Query: 295 RIL-----CRPPDLVGE--PTPLRNLIRRLLEKDPTKRIGVEEI 331
+ C P L + LR+L+ R + DP KR + +
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 79/367 (21%), Positives = 127/367 (34%), Gaps = 129/367 (35%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +S +G GA G+V + A+K I + +F QR
Sbjct: 8 QNLSYIGEGAYGMVCSATHKPTGVKVAIKKI------------------SPFEHQTFCQR 49
Query: 79 VLRNVEHPLLPR--------LRGVLSTDKFVG----YAIDYCPGRDLHSLRKQQSEQMFS 126
LR E +L R + ++ F Y + DL+ L K Q S
Sbjct: 50 TLR--EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ---HLS 104
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+D I+++ +++ L+Y+H+ +++RDLKP N+++ N + + DF L+
Sbjct: 105 NDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR---------- 154
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
+ P + D + +V
Sbjct: 155 ---------------------------------IADP----------EHDHTGFLTEYVA 171
Query: 247 TEEYVAPEI-IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG 305
T Y APEI + KG+ A+D WS+G +L EML F G IL ++G
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLIL----GVLG 227
Query: 306 EPT-------------------------PLRNLIRR-------LLEK----DPTKRIGVE 329
P+ P L LL+K +P KRI VE
Sbjct: 228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287
Query: 330 EIKGHEF 336
E H +
Sbjct: 288 EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 71/334 (21%), Positives = 134/334 (40%), Gaps = 92/334 (27%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
++ +G G G V+ ++V + E A+KVI + G+ + + E
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI-------------KLEPGEDFAVVQQEI 57
Query: 78 RVLRNVEHP-LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
++++ +H ++ L DK + +++C G L + S+ I + + E
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRE 114
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L YLH+ G ++RD+K NI++ +NGH+ L DF +S +++
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT----------------- 157
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI- 255
+ I KR+ SF+GT ++APE+
Sbjct: 158 ATIAKRK---------------------------------------SFIGTPYWMAPEVA 178
Query: 256 -IEGK-GHDFAVDWWSLGVVLHEM------LYGATPFRG--SSRKETFYRILCRPP---D 302
+E K G++ D W++G+ E+ ++ P R K F +PP D
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-----QPPKLKD 233
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ + ++ L K+P KR E++ H F
Sbjct: 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 95/346 (27%), Positives = 143/346 (41%), Gaps = 86/346 (24%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G G G VFLVK + E F K I +R L E++ +L E
Sbjct: 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV------------IEVN 64
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYA-------IDYCPGRDLHSLRKQQSEQMF---SDD 128
V+R ++H + R D+F+ A +++C DL S Q+ +MF +
Sbjct: 65 VMRELKHKNIVRY-----IDRFLNKANQKLYILMEFCDAGDL-SRNIQKCYKMFGKIEEH 118
Query: 129 TIRFYAAELVLALEYLHNMG-------IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
I +L+ AL Y HN+ +++RDLKP+NI LST +
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF-------------LSTGI--- 162
Query: 182 TPQASPKTVLAANTRSG--IKKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238
+ K AN +G I K F LSK I +E HS
Sbjct: 163 --RHIGKITAQANNLNGRPIAKIGDFGLSK----NIGIESMAHS---------------- 200
Query: 239 EKSNSFVGTEEYVAPEII--EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI 296
VGT Y +PE++ E K +D D W+LG +++E+ G TPF ++
Sbjct: 201 -----CVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255
Query: 297 LCRPPDL--VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
L R PDL G+ L LI+ LL +R + G++ K V
Sbjct: 256 LKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301
|
Length = 1021 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 10/163 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESF-ALKVI-WRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81
LG GA G V+ V+ + ++ ALK I + K K + GD ++ + LR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 82 NVEHPLLPRLRGV-LSTDKF--VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
HP + R L D+ V I+ P + + K++ +Q F+++ I ++V
Sbjct: 68 ---HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMV 123
Query: 139 LALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
LAL YLH IV+RDL P NIM+ E+ + + DF L+ + P
Sbjct: 124 LALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 76/350 (21%), Positives = 138/350 (39%), Gaps = 109/350 (31%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G V+ ++ + E ALK I D ++E T + R IS +++ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLD-----AEEGTPST---AIREIS----LMKEL 55
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVLALE 142
+H + RL V+ T+ + +Y DL + D +T++ + +L+ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+ H +++RDLKP+N++I + G + L DF L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLA--------------------------- 147
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG-KGH 261
R+F GI PV ++ S+E V T Y AP+++ G + +
Sbjct: 148 RAF-------GI----PV-------------NTFSNE-----VVTLWYRAPDVLLGSRTY 178
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT------------- 308
++D WS+G ++ EM+ G F G++ ++ +I ++G PT
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF----RIMGTPTESTWPGISQLPEY 234
Query: 309 ----------PLRNLI-----------RRLLEKDPTKRIGVEEIKGHEFF 337
L+ L RLL+ +P RI + H +F
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 85/356 (23%), Positives = 135/356 (37%), Gaps = 112/356 (31%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQ 77
V +G G GVV+ +D ++E+ ALK I L D G R IS
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKI----------RLEQEDEGVPSTAIREISL-- 54
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD--TIRFYAA 135
L+ ++H + RL+ V+ ++K + +Y DL + S F+ + I+ Y
Sbjct: 55 --LKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLY 109
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
+++ + Y H+ +++RDLKP+N++I + + L DF L+
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------------------- 150
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
R+F GI + H V T Y APE
Sbjct: 151 --------RAF-------GIPVRTFTHE----------------------VVTLWYRAPE 173
Query: 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---------------- 297
I+ G H VD WS+G + EM+ F G S + ++I
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233
Query: 298 ----------CRPPDLVG-----EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P DL EP + +L+ ++L DP+KRI HE+FK
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGV-DLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 78/335 (23%), Positives = 132/335 (39%), Gaps = 89/335 (26%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ +G+G G VF V + ++ A+K++ D I +E I E +
Sbjct: 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEE------------IEAEYNI 67
Query: 80 LRNV-EHPLLPRLRGVL-STDKFVG----YAIDYCPGRDLHSLRK---QQSEQMFSDDTI 130
L+ + +HP + + G+ D G ++ C G + L K ++ E+M + I
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM-EEPII 126
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ E ++ L++LH ++RD+K NI++ G + LVDF +S +L+
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT----------- 175
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
+TR RR N+ VGT +
Sbjct: 176 ---STR----LRR--------------------------------------NTSVGTPFW 190
Query: 251 VAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG 305
+APE+I +D D WSLG+ E+ G P ++I PP +
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250
Query: 306 EP----TPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+P + IR+ L KD KR V ++ H F
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 4e-12
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 18 LRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
L + LG GA G V+ K A+K + D E++ +E
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---------- 50
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHSLRKQQSEQMFSDDTIR 131
E R++R ++HP + +L GV + ++ I +Y PG DL ++ + S +
Sbjct: 51 --EARIMRKLDHPNIVKLLGVCTEEE--PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLL 106
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+A ++ +EYL + ++RDL N ++ EN + + DF LS
Sbjct: 107 SFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 82/340 (24%), Positives = 126/340 (37%), Gaps = 93/340 (27%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G V+ +DV ++E A+K + K+S E K++ I E R L+ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQSNE--------KWQDIIKEVRFLQQL 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGR--DLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP +G + ++YC G D+ + K+ + I + L
Sbjct: 73 RHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP----LQEVEIAAICHGALQGL 128
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
YLH+ ++RD+K NI++ E G K
Sbjct: 129 AYLHSHERIHRDIKAGNILLTEP---------------------------------GTVK 155
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII----E 257
L+ F S+ SL P +NSFVGT ++APE+I E
Sbjct: 156 ----LADFGSA--SLVSP---------------------ANSFVGTPYWMAPEVILAMDE 188
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDL--VGEPTPLRNLI 314
G+ +D VD WSLG+ E+ P + Y I P L RN +
Sbjct: 189 GQ-YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV 247
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNI 354
L+K P R EE+ H F + RPP +
Sbjct: 248 DSCLQKIPQDRPSSEELLKHRF---------VLRERPPTV 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
R LG+G G V + + + +A K + + I+K+ E + E+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN----------EK 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
++L V + L T + + G DL F ++ FYAAE+
Sbjct: 52 QILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEI 111
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ LE LH VYRDLKPENI++ + GHI + D L+ K+
Sbjct: 112 LCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 7e-12
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 12/161 (7%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE-LTNNDNGDKYRRISFEQ 77
R LG+G G V + + + +A K + + I+K+ E + N E+
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-----------EK 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
++L V + L T + + G DL F ++ FYAAE+
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
LE LH IVYRDLKPENI++ + GHI + D L+ ++
Sbjct: 112 TCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 7e-12
Identities = 42/171 (24%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVI------WRDLIEKKSKELTNNDNGDKYRRI 73
++ LG G G V+L ++ E+ E A+K + W + + +
Sbjct: 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR---------------- 46
Query: 74 SFEQRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E + LR + EHP + +L+ V + + + +Y G +L+ L K + + FS+ IR
Sbjct: 47 --EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRS 103
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
+++ L ++H G +RDLKPEN+++ + + DF L+ ++ + P
Sbjct: 104 IIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 76/348 (21%), Positives = 128/348 (36%), Gaps = 86/348 (24%)
Query: 8 RPIRSLDFSCLR-------IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE 60
R + +D S LR +V +G G G V+ + V++ + A+KV+ D+ E + +E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTEDEEEE 58
Query: 61 LTNNDNGDK----YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL 116
+ N K +R I+ P D + +++C + L
Sbjct: 59 IKLEINMLKKYSHHRNIATYYGAFIKKSPP---------GHDDQLWLVMEFCGAGSVTDL 109
Query: 117 RKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176
K +D I + E++ L +LH +++RD+K +N+++ EN + LVDF +S
Sbjct: 110 VKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169
Query: 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236
+L +TV NT
Sbjct: 170 QLD--------RTVGRRNT----------------------------------------- 180
Query: 237 SSEKSNSFVGTEEYVAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE 291
F+GT ++APE+I +D+ D WSLG+ EM GA P
Sbjct: 181 -------FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 292 TFYRILCRPPDLVGE---PTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ I PP + + I L K+ R E++ H F
Sbjct: 234 ALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 89/392 (22%), Positives = 148/392 (37%), Gaps = 116/392 (29%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN--DNGDKYRRISFEQRVLR 81
+GRGA G+V K+ E++E A+K I N DN +R E ++LR
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-------------ANAFDNRIDAKRTLREIKLLR 59
Query: 82 NVEHPLLPRLRGVL---STDKFVGYAIDY-CPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+++H + ++ ++ + F I Y DLH + + S Q SDD +++ +L
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR--SSQTLSDDHCQYFLYQL 117
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ L+Y+H+ +++RDLKP N+++ N DL
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANC-------DL----------------------- 147
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE-II 256
K C G++ R+ S+ + +V T Y APE ++
Sbjct: 148 ----------KICDFGLA----------------RTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRG--------------------------SSRK 290
+ A+D WS+G + E+L F G + +
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 291 ETFYRILCRPP-----DLVGEPTPLR-NLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344
+ R L P L PL +L+ ++L DP+KRI VEE H +
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL-----AS 296
Query: 345 LLKISRPPNIPARFEHENNESDGRGRDGTKEI 376
L S P F + E D + KE+
Sbjct: 297 LHDPSDEPVCQTPFSF-DFEEDALTEEDIKEL 327
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 38/121 (31%), Positives = 61/121 (50%), Gaps = 11/121 (9%)
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDLV 304
GT Y+APEI++ + + + VDW+++G ++EM+ G TPF+ K + R D V
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 305 -----GEPTPLRNLIRRLLEKDPTKRIGVEEI----KGHEFFKGVNWELL-LKISRPPNI 354
+++ R L K P R+G E + HEFFK +N+ L + PP +
Sbjct: 216 KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275
Query: 355 P 355
P
Sbjct: 276 P 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 72/299 (24%), Positives = 113/299 (37%), Gaps = 87/299 (29%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQ 77
V+ +G GA G V+ +D S ALK S + N++G R ++ +
Sbjct: 5 VAEIGVGAYGTVYKARDPHSGHFVALK----------SVRVQTNEDGLPLSTVREVALLK 54
Query: 78 RVLRNVEHPLLPRLRGVLSTDK--------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
R L +HP + RL V +T + V +D +DL + + +T
Sbjct: 55 R-LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAET 109
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
I+ + + L++LH IV+RDLKPENI++ G + L DF
Sbjct: 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG---------------- 153
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
L++ S ++L PV V T
Sbjct: 154 ----------------LARIYSCQMAL-TPV------------------------VVTLW 172
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y APE++ + VD WS+G + EM F G+S + L + DL+G P
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ----LGKIFDLIGLPP 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 85/377 (22%), Positives = 142/377 (37%), Gaps = 126/377 (33%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN 64
+N P +S ++ + +G G+ GVV+ +++SE A+K + +D + K++EL
Sbjct: 60 INRSPNKSY-----KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIM 113
Query: 65 DN---------GDKYRRISF---EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRD 112
N D Y F E+ + NV +P+ + K++
Sbjct: 114 KNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-----TVHKYMK---------- 158
Query: 113 LHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM-LVD 171
H R + +F ++ Y+ +L AL Y+H+ I +RDLKP+N++I N H + L D
Sbjct: 159 -HYARNNHALPLF---LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214
Query: 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPS 231
F S K +LA
Sbjct: 215 F------------GSAKNLLAG-------------------------------------- 224
Query: 232 RSDSDSSEKSNSFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
++S S++ + Y APE++ G + +D WSLG ++ EM+ G F G S
Sbjct: 225 -------QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
Query: 291 ETFYRIL-------------------------CRPPDL-----VGEPTPLRNLIRRLLEK 320
+ RI+ +P DL G P N I + L+
Sbjct: 278 DQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337
Query: 321 DPTKRIGVEEIKGHEFF 337
+P KR+ E FF
Sbjct: 338 EPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 87/382 (22%), Positives = 136/382 (35%), Gaps = 134/382 (35%)
Query: 3 DVVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKV---IWRDLIEKKSK 59
DV DRPI G GA GVV+ V D + ALK ++++L+ K
Sbjct: 1 DVEPDRPI--------------GYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK-- 44
Query: 60 ELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST---DKFVG-YAIDYCPGRDLHS 115
R+ E ++L +H + +L D F Y + DLH
Sbjct: 45 ------------RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHK 92
Query: 116 LRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ S Q S D ++ + +++ L+YLH+ GI++RD+KP N+++ N + + DF L+
Sbjct: 93 I--IVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA 150
Query: 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235
+E+P
Sbjct: 151 ---------------------------------------RVEEP---------------- 155
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
D S+ V T+ Y APEI+ G H AVD WS+G + E+L F+ S +
Sbjct: 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
Query: 295 RILCRPPDLVGEPT----------------------PLR---------------NLIRRL 317
I DL+G P+ P +L+ R+
Sbjct: 216 LIT----DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRM 271
Query: 318 LEKDPTKRIGVEEIKGHEFFKG 339
L DP KRI + H +
Sbjct: 272 LVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 89/324 (27%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDL-------IEKKSKELTNNDNGDKYRR 72
I LG GA G V K V E FA+KV+ D+ + E+ N D +
Sbjct: 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVV--DMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 73 IS----FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--QMFS 126
+ F ++ RN E+ L+ + +DY DL K +++ + F
Sbjct: 94 VKCHEDFAKKDPRNPENVLM------------IALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+ +++LA+ ++H+ +++RD+K NI++ NG + L DF S
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK---------- 191
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
+ A T S R +F G
Sbjct: 192 ----MYAATVSDDVGR----------------------------------------TFCG 207
Query: 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----RPP 301
T YVAPEI K + D +SLGV+L+E+L PF G + +E ++ L PP
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 302 DLVGEPTPLRNLIRRLLEKDPTKR 325
+ E ++ ++ LL DP +R
Sbjct: 268 SISPE---MQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 79/360 (21%), Positives = 129/360 (35%), Gaps = 128/360 (35%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF-EQRVLRN 82
+G G+ G+V K E+ + A+K K L + D+ ++I+ E R+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIK-----------KFLESEDD-KMVKKIAMREIRMLKQ 56
Query: 83 VEHPLLPRLRGVLSTDK-------FVGYAI-----DYCPGRDLHSLRKQQSEQMFSDDTI 130
+ H L L V K FV + + Y G D +RK
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK------------ 104
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
Y +++ +E+ H+ I++RD+KPENI++ ++G
Sbjct: 105 --YLFQILRGIEFCHSHNIIHRDIKPENILVSQSG------------------------- 137
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
+ K C G + R+ + E +V T Y
Sbjct: 138 ---------------VVKLCDFGFA----------------RTLAAPGEVYTDYVATRWY 166
Query: 251 VAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL------------ 297
APE++ G + AVD W++G ++ EML G F G S + Y I+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226
Query: 298 --CRPPDLVG-------EPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFF 337
+ P G E PL +L ++ L DP R ++ HEFF
Sbjct: 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS-----KELTNNDNGDKYRR 72
L + LG GA G V+ K + KK K L + + +
Sbjct: 1 LTLGKKLGEGAFGEVY-------------KGKLKGKGGKKKVEVAVKTLKEDASEQQIEE 47
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIR 131
E R++R ++HP + +L GV + ++ + Y + +Y G DL S ++ ++ D +
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEPL-YIVMEYMEGGDLLSYLRKNRPKLSLSDLLS 106
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
F A ++ +EYL + ++RDL N ++ EN + + DF LS
Sbjct: 107 F-ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 71/334 (21%), Positives = 123/334 (36%), Gaps = 85/334 (25%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+V +G G G V+ + V++ + A+KV+ + GD+ I E
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--------------DVTGDEEEEIKQEI 53
Query: 78 RVLRNVEHPL-LPRLRGVL------STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
+L+ H + G D + +++C + L K ++ I
Sbjct: 54 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI 113
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ E++ L +LH +++RD+K +N+++ EN + LVDF +S +L +TV
Sbjct: 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--------RTV 165
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
NT F+GT +
Sbjct: 166 GRRNT------------------------------------------------FIGTPYW 177
Query: 251 VAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDLV 304
+APE+I +DF D WSLG+ EM GA P + I P P L
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237
Query: 305 GE--PTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ ++ I L K+ ++R E++ H F
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 10/106 (9%)
Query: 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299
K NS VGT ++APE+I+ K + VD WSLG++ EM G P+ + I +
Sbjct: 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231
Query: 300 -PPDLVGEPTP------LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P L P ++ + + L KDP KR EE+ H F K
Sbjct: 232 GIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 78/336 (23%), Positives = 126/336 (37%), Gaps = 87/336 (25%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ +G+G G V+ V + + A+K++ D I +E I E +
Sbjct: 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEE------------IEAEYNI 71
Query: 80 LRNV-EHPLLPRLRGVL-STDKFVG----YAIDYCPGRDLHSLRKQ--QSEQMFSDDTIR 131
L+++ HP + + G+ DK VG ++ C G + L K Q + I
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
+ +L L++LHN I++RD+K NI++ G + LVDF +S +L+ T L
Sbjct: 132 YILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--------STRL 183
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
NT G T ++
Sbjct: 184 RRNTSVG------------------------------------------------TPFWM 195
Query: 252 APEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE 306
APE+I + +D D WSLG+ E+ G P +T ++I PP +
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH 255
Query: 307 PTP----LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P + I + L KD R V + H F K
Sbjct: 256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 2/104 (1%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
+D+ K N+FVGT ++APE+I+ +DF D WSLG+ E+ G P +
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211
Query: 295 RI-LCRPPDLVGEPT-PLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
I PP L G+ + P + + L KDP R +E+ H+F
Sbjct: 212 LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 7e-11
Identities = 28/110 (25%), Positives = 50/110 (45%), Gaps = 6/110 (5%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
++ S + ++VGT Y++PE + +D D WSLG +++E+ + PF ++
Sbjct: 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
Query: 291 ETFYRI---LCRP-PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ +I R P L +I+ +L DP KR EE+
Sbjct: 217 QLASKIKEGKFRRIPYRYSS--ELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 8e-11
Identities = 69/338 (20%), Positives = 119/338 (35%), Gaps = 91/338 (26%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ ++ LG+G G V+ V + + A+K I +L E K + +I E
Sbjct: 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK------------FNQIIMEL 50
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAE 136
+L P + G + V ++Y L L D +R
Sbjct: 51 DILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA 110
Query: 137 LVLALEYL---HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
+V L++L HN I++RD+KP N+++ NG +
Sbjct: 111 VVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQV-------------------------- 142
Query: 194 NTRSGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
K C G+S L S K+N +G + Y+
Sbjct: 143 --------------KLCDFGVSGNLVA------------------SLAKTN--IGCQSYM 168
Query: 252 APEIIEGKG------HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCR--PP 301
APE I+ G + D WSLG+ + EM G P+ + F ++ + PP
Sbjct: 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP 228
Query: 302 DLVGEPTP-LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
L + ++ + + L K P +R ++ H +
Sbjct: 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 8e-11
Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 15/167 (8%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L + LG GA G V+ E KV + K KE + + R F +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKV----AV-KTLKEGASEEE-----REEFLE 50
Query: 78 --RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYA 134
+++ + HP + RL GV + + + +Y PG DL LRK + D ++ A
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD-LLQM-A 108
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
++ +EYL + V+RDL N ++ EN + + DF LS +
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED 155
|
Length = 258 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 76/328 (23%), Positives = 128/328 (39%), Gaps = 74/328 (22%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L + +G G G V+ ++ ++ A+K + R N ++ +RI +
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRR------------TGNKEENKRILMDL 64
Query: 78 RV-LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
V L++ + P + + G TD V ++ L L K+ + +D +
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKR-IQGPIPEDILGKMTVA 122
Query: 137 LVLALEYL-HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+V AL YL G+++RD+KP NI++ +G++ L DF +S +L A T
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----------AKT 172
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
R S C++ ++ E RI P P +Y
Sbjct: 173 R----------SAGCAAYMAPE------RIDPPDP----------------NPKY----- 195
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILC-RPPDLVGEP--TPL- 310
D D WSLG+ L E+ G P++ + E +IL PP L +P
Sbjct: 196 ------DIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+ + L KD KR E+ H F +
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 41/161 (25%), Positives = 78/161 (48%), Gaps = 15/161 (9%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF-EQRV 79
+S +G G+ GVVF ++ E+ + A+K + +++ ++I+ E R+
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK------------KFVESEDDPVIKKIALREIRM 53
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L+ ++HP L L V + + +YC L+ L K + + I+ + +
Sbjct: 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQ 111
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
A+ + H ++RD+KPENI+I + G I L DF + L+
Sbjct: 112 AVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 67/236 (28%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ---MFSDDTIRF 132
E +L+N++H + L ++ T++ + +Y L S KQ + + S ++
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKI 107
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+ +L+ L Y H I++RDLKP+N++I E G + L DF L+ S T S + V
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-- 165
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
+ PP + +G+ EY
Sbjct: 166 -------------------------------TLWYRPP-----------DVLLGSTEYST 183
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
P +D W +G +L+EM G F GS+ KE + I L+G PT
Sbjct: 184 P-----------IDMWGVGCILYEMATGRPMFPGSTVKEELHLIF----RLLGTPT 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 243 SFVGTEEYVAPEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP 301
SF G+ ++APE+I +G + A D WSLG + EM G P+ ++I R
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-GRSK 218
Query: 302 DLVGEPTPL----RNLIRRLLEKDPTKRIGVEEIKGHEF 336
+L P L ++ I + L++DP+ R E+ H F
Sbjct: 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
R LG+G G V + + + +A K + + I+K+ E + E+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN----------EK 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
++L V + L T + + G DL E F + FYAAE+
Sbjct: 52 QILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
LE LH IVYRDLKPENI++ ++GHI + D L+
Sbjct: 112 CCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA GVV D S + A+K I T +R E ++LR+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKI-----PHAFDVPTLA------KRTLRELKILRHF 61
Query: 84 EHPLLPRLRGVLSTDKFVG---YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+H + +R +L Y + DLH + S+Q +++ IR++ +L+
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI--IHSDQPLTEEHIRYFLYQLLRG 119
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
L+Y+H+ +++RDLKP N+++ E+ + + DF
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDF 151
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 43/164 (26%), Positives = 73/164 (44%), Gaps = 26/164 (15%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS----KELTNNDNGDKYRRISFEQRV 79
LG GA G V+ K + K + K L + + ++ + E RV
Sbjct: 3 LGEGAFGEVY-------------KGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARV 49
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD-DTIRF---- 132
++ + HP + RL GV T++ Y + +Y G DL LRK + + T+
Sbjct: 50 MKKLGHPNVVRLLGV-CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 133 -YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+A ++ +EYL + V+RDL N ++ E+ + + DF LS
Sbjct: 109 SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 68/331 (20%), Positives = 128/331 (38%), Gaps = 90/331 (27%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ +G G G V+ +++ + E A+K+I + GD + I E +
Sbjct: 13 LIQRVGSGTYGDVYKARNLHTGELAAVKII-------------KLEPGDDFSLIQQEIFM 59
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
++ +H + G + + + ++YC G L + S+ I + E +
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--LSELQIAYVCRETLQ 117
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
L YLH+ G ++RD+K NI++ +NG + L DF ++ K++ + I
Sbjct: 118 GLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT-----------------ATI 160
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII--- 256
KR+ SF+GT ++APE+
Sbjct: 161 AKRK---------------------------------------SFIGTPYWMAPEVAAVE 181
Query: 257 EGKGHDFAVDWWSLGVVLHEM------LYGATPFRG--SSRKETFYRILCRPPDLVGE-- 306
+ G++ D W++G+ E+ ++ P R K F +PP L +
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-----QPPKLKDKTK 236
Query: 307 -PTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+ N ++ L K+P KR E + H F
Sbjct: 237 WSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 25/174 (14%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G G+V+ +D S E ALK + D E+ +++ R I +L N+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISS------LREI----TLLLNL 63
Query: 84 EHPLLPRLRGVLSTDKFVGYAID-------YCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
HP + L+ V+ VG +D YC +DL SL FS+ ++ +
Sbjct: 64 RHPNIVELKEVV-----VGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQ 116
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
L+ L+YLH I++RDLK N+++ + G + + DF L+ +PK V
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V + + + +A K + + I+K+ E + E+R+L V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN----------EKRILEKV 57
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+ L T + + G DL F + FYAAEL LE
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
L IVYRDLKPENI++ + GHI + D L+ ++
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G V+ +DV +SE A+K + + + +K++ I E R L+ +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM----------SYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGR--DLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP + RG + ++YC G DL + K+ +++ I + L
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAVTHGALQGL 128
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK-----TPQ-ASPKTVLAAN 194
YLH+ +++RD+K NI++ E G + L DF ++ ++P TP +P+ +LA +
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMD 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 84/377 (22%), Positives = 129/377 (34%), Gaps = 123/377 (32%)
Query: 20 IVSALGRGAKGVVFLVKDVESSES--FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
I +GRG G V+ K + +A+K K KE + R I+
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF------KGDKEQYTGISQSACREIA--- 54
Query: 78 RVLRNVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSLRKQQSE---QMFSDDTIRF 132
+LR ++H + L V DK V DY DL + K + ++
Sbjct: 55 -LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMI----QENGHIMLVDFDLSTKLSPKTPQASPK 188
+++ + YLH+ +++RDLKP NI++ E G + + D L+ A K
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-----NAPLK 167
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
+ DPV V T
Sbjct: 168 PLAD------------------------LDPV------------------------VVTI 179
Query: 249 EYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRK------------ETFYR 295
Y APE++ G H A+D W++G + E+L F+G K E +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 296 ILCRP-----PDLVGEP------------------------------TPLRNLIRRLLEK 320
+L P PD+ P + +L+R+LLE
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 321 DPTKRIGVEEIKGHEFF 337
DPTKRI EE H +F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 27/166 (16%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR----DLIEKKSKELTNNDNGDKYRRIS 74
R + +G GA G V D + A+K ++R +L K++ YR
Sbjct: 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA-----------YR--- 63
Query: 75 FEQRVLRNVEHP----LLPRLRGVLSTDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDT 129
E R+L++++H LL LS D+F Y + G DL L K + S+D
Sbjct: 64 -ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK---LSEDR 119
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
I+F +++ L+Y+H GI++RDLKP N+ + E+ + ++DF L+
Sbjct: 120 IQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 53/244 (21%), Positives = 84/244 (34%), Gaps = 85/244 (34%)
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
I+ Y +L+ + YLH I++RD+K NI+I G + + DF L+
Sbjct: 117 IKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA-------------- 162
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
R + + P +P+ G + K + V T
Sbjct: 163 -------------RPY-----------DGPPPNPKGGGGG-------GTRKYTNLVVTRW 191
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y PE++ G + + AVD W +G V EM +G S + + I L G PT
Sbjct: 192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF----KLCGTPT 247
Query: 309 P------------------------LR-----------NLIRRLLEKDPTKRIGVEEIKG 333
L +L+ +LL DP KR+ +
Sbjct: 248 EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307
Query: 334 HEFF 337
H +F
Sbjct: 308 HPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 17/171 (9%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+I +G+G+ GVV D + E A+K I D+ E S RI E +
Sbjct: 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDAT----------RILREIK 51
Query: 79 VLRNVEHPLLPRLRGVL---STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
+LR + HP + ++ ++ S +F Y + DLH + K + + + +F+
Sbjct: 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD--LTPEHHQFFL 109
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+L+ AL+Y+H + +RDLKP+NI+ + + + DF L+ TP A
Sbjct: 110 YQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 13/172 (7%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V V+ + + +A K + + ++KKS E + E+ +L V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE----------KMALLEKEILEKV 50
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
P + L + + + G DL E+ + + Y+A++ + +
Sbjct: 51 NSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL---SPKTPQASPKTVLA 192
LH+M IVYRD+KPEN+++ + G+ L D L+ +L T +A +A
Sbjct: 111 LHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMA 162
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
++ +G GA G V D + A+K + R + L + RR E R+L
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-----QSLIHA------RRTYRELRLL 68
Query: 81 RNVEHP----LLPRLRGVLSTDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
++++H LL S + F Y + G DL+++ K Q SD+ ++F
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK---LSDEHVQFLIY 125
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+L+ L+Y+H+ GI++RDLKP N+ + E+ + ++DF L+
Sbjct: 126 QLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 47/188 (25%), Positives = 89/188 (47%), Gaps = 25/188 (13%)
Query: 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRIS 74
F+ LR +G G+ G V+ +DV ++E A+K + + + +K++ I
Sbjct: 27 FTDLR---EIGHGSFGAVYFARDVRTNEVVAIKKM----------SYSGKQSNEKWQDII 73
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGR--DLHSLRKQQSEQMFSDDTIRF 132
E + L+ ++HP +G + ++YC G DL + K+ +++ I
Sbjct: 74 KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAA 129
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK-----TPQ-AS 186
+ L YLH+ +++RD+K NI++ E G + L DF ++ SP TP +
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMA 189
Query: 187 PKTVLAAN 194
P+ +LA +
Sbjct: 190 PEVILAMD 197
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 34/165 (20%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+I+ +G G V + ++ + +A+K + + KS E NN R I +
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQVNN-----LREI----Q 49
Query: 79 VLRNVE-HPLLPRLRGVLSTDKFVGYAIDYCPGR----------DLHSLRKQQSEQMFSD 127
LR + HP + RL VL D GR +L+ L K + ++ +
Sbjct: 50 ALRRLSPHPNILRLIEVL---------FDRKTGRLALVFELMDMNLYELIKGR-KRPLPE 99
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
++ Y +L+ +L+++H GI +RD+KPENI+I+++ + L DF
Sbjct: 100 KRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 86/328 (26%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V+ + + A+KVI D+ + EL ++I E +L
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQ--------KQIMSELEILYKC 56
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+ P + G + + ++ G L RK + + A +V L Y
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAVVKGLTY 110
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
L ++ I++RD+KP N+++ G +
Sbjct: 111 LWSLKILHRDVKPSNMLVNTRGQV------------------------------------ 134
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
K C G+S + V+S + ++VGT Y+APE I G+ +
Sbjct: 135 ----KLCDFGVSTQ-LVNS-----------------IAKTYVGTNAYMAPERISGEQYGI 172
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----C----RPPDL-VGEPTP-LRNL 313
D WSLG+ E+ G P+ + + L C PP L VG+ + +
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
I + + K P +R E + H F N
Sbjct: 233 ITQCMRKQPKERPAPENLMDHPFIVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF------YRILCR 299
GT +Y +PE I+G +D + DWW++GV+ +E+L G PF+ E R +
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-EDEDEELDLESLLKRQQKK 226
Query: 300 PPDLVGEPTPLRNLIRRLLEKDPTKR-IGVEEIKGHEFFK 338
P + + ++ +L+ + R EI H F K
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 3e-09
Identities = 36/104 (34%), Positives = 53/104 (50%), Gaps = 2/104 (1%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
+D+ K N+FVGT ++APE+I+ +D D WSLG+ E+ G P +
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF 211
Query: 295 RI-LCRPPDLVGEPT-PLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
I PP L GE + P + I L KDP+ R +E+ H+F
Sbjct: 212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 4e-09
Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 2/104 (1%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
+D+ K N+FVGT ++APE+I+ +D D WSLG+ E+ G P + +
Sbjct: 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211
Query: 295 RI-LCRPPDLVGE-PTPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
I PP L G PL+ + L K+P+ R +E+ H+F
Sbjct: 212 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 5e-09
Identities = 41/160 (25%), Positives = 82/160 (51%), Gaps = 19/160 (11%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+S +G GA G V +F K R ++K S+ + + + R E R+L
Sbjct: 22 LSPVGSGAYGSV--------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLL 70
Query: 81 RNVEHPLLPRLRGVLSTDKFVG-----YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
++++H + L V + + + Y + + G DL+++ K Q +DD ++F
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIY 127
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+++ L+Y+H+ I++RDLKP N+ + E+ + ++DF L+
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 69/318 (21%), Positives = 128/318 (40%), Gaps = 76/318 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G+V + S + A+K + DL +++ +EL N E ++R+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFN-----------EVVIMRDY 74
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + + + +++ G L + + +++ I ++ AL
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSV 131
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH G+++RD+K ++I++ +G + L DF
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFG------------------------------ 161
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
FC+ +S E P + S VGT ++APE+I +
Sbjct: 162 -----FCAQ-VSKEVP--------------------RRKSLVGTPYWMAPELISRLPYGP 195
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDL--VGEPTP-LRNLIRRLLE 319
VD WSLG+++ EM+ G P+ + I PP L + + +P L+ + RLL
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255
Query: 320 KDPTKRIGVEEIKGHEFF 337
+DP +R E+ H F
Sbjct: 256 RDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 21/164 (12%)
Query: 21 VSALGRGAKGVVFLVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
V+ +G GA G VF +D+++ F ALK + R ++ L+ R ++ R
Sbjct: 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST------IREVAV-LRH 57
Query: 80 LRNVEHPLLPRLRGVLS---TDK-----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIR 131
L EHP + RL V + TD+ V +D +DL + + E +TI+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIK 113
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+L+ L++LH+ +V+RDLKP+NI++ +G I L DF L+
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 62/279 (22%), Positives = 106/279 (37%), Gaps = 68/279 (24%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
++ +G GA GVV + E+ E A+K ++ KE T E
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-----------EL 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
++LR ++ + L+ + +Y L L + + + +R Y +L
Sbjct: 52 KMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP--PEKVRSYIYQL 109
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ A+ + H IV+RD+KPEN++I N + L DF + L
Sbjct: 110 IKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL------------------- 150
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
S G S+++ +E +V T Y +PE++
Sbjct: 151 -------------SEG-------------------SNANYTE----YVATRWYRSPELLL 174
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI 296
G + AVD WS+G +L E+ G F G S + + I
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/132 (30%), Positives = 52/132 (39%), Gaps = 41/132 (31%)
Query: 244 FVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
+V T Y APEI+ H + VD WS+G ++ E+L G T F GS + RI+ +
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM----N 230
Query: 303 LVGEPTP----------LRNLIRR----------------------LLEK----DPTKRI 326
LVG P RN I+ LLEK DP KRI
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI 290
Query: 327 GVEEIKGHEFFK 338
E H +
Sbjct: 291 TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 22/179 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G V+ + ++E A+K + S + TN +K++ I E + L+ +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKM------SYSGKQTN----EKWQDIIKEVKFLQQL 78
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGR--DLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+HP +G + ++YC G DL + K+ +++ I + L
Sbjct: 79 KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV----EIAAITHGALQGL 134
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK-----TPQ-ASPKTVLAAN 194
YLH+ +++RD+K NI++ E G + L DF ++K SP TP +P+ +LA +
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMD 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 32/121 (26%), Positives = 47/121 (38%), Gaps = 33/121 (27%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD---- 302
Y PE++ G + VD WS+G +L E+ G F+GS+ E +I LC P
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW 226
Query: 303 -------LVGEPTPLRN-------------------LIRRLLEKDPTKRIGVEEIKGHEF 336
P + L+ +LL DP KRI ++ HE+
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
Query: 337 F 337
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 63/296 (21%), Positives = 110/296 (37%), Gaps = 88/296 (29%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E +L++++H + L ++ TDK + +Y +DL M S ++ +
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIM-SMHNVKIFLY 111
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+++ L Y H +++RDLKP+N++I E G + L DF L+ S T S + V
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
+ PP + +G+ EY
Sbjct: 167 ----------------------------TLWYRPP-----------DVLLGSSEYST--- 184
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---YRILCRP-----PDLVG-- 305
+D W +G + EM G F GS+ ++ +R+L P P +
Sbjct: 185 --------QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236
Query: 306 ----------EPTPLRN-----------LIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
+P PL N L+ + L+ + KRI EE H +F+ +
Sbjct: 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 79/354 (22%), Positives = 134/354 (37%), Gaps = 110/354 (31%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQ 77
+ +G G GVV+ ++ ++ + A+K I L + + G R IS
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKI----------RLESEEEGVPSTAIREIS--- 51
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCP---GRDLHSLRKQQSEQMFSDDTIRFYA 134
+L+ ++HP + L+ VL + + ++ + L SL K Q + ++ Y
Sbjct: 52 -LLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPK---GQYMDAELVKSYL 107
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
+++ + + H+ +++RDLKP+N++I G I L DF L+
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA------------------- 148
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
R+F GI + H V T Y APE
Sbjct: 149 --------RAF-------GIPVRVYTHE----------------------VVTLWYRAPE 171
Query: 255 IIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRPPDLV------ 304
++ G + VD WS+G + EM F G S + +RI L P + V
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 305 ----------GEPTPLRNLIRR-------LLEK----DPTKRIGVEEIKGHEFF 337
+ LR+ ++ LLEK DP KRI ++ H +F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (130), Expect = 4e-08
Identities = 32/123 (26%), Positives = 50/123 (40%), Gaps = 39/123 (31%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y APEI+ G K + AVD WS+G + EM+ G F G S + ++I ++G PT
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF----QILGTPT 219
Query: 309 P----------------------------------LRNLIRRLLEKDPTKRIGVEEIKGH 334
+L+ ++L+ +P KRI +E H
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
Query: 335 EFF 337
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 34/98 (34%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
S + ++S VGT Y++PE I G++F D WSLG +L+EM +PF G K Y
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLY 214
Query: 295 RIL-----CRPPDLVGE--PTPLRNLIRRLLEKDPTKR 325
+ C P L + LR L+ + DP KR
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 83/371 (22%), Positives = 126/371 (33%), Gaps = 130/371 (35%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+S LG G GVVF V S A R LI + K N +I E +VL
Sbjct: 10 ISELGAGNGGVVFKVSHKPSGLIMA-----RKLIHLEIKPAIRN-------QIIRELQVL 57
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYAAEL 137
P + G +D + +++ G L + K+ EQ+ +I +
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AV 112
Query: 138 VLALEYL-HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L YL I++RD+KP NI++ G I
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEI----------------------------- 143
Query: 197 SGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
K C G+S L D + +NSFVGT Y++PE
Sbjct: 144 -----------KLCDFGVSGQLIDSM--------------------ANSFVGTRSYMSPE 172
Query: 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPF-----------------------------R 285
++G + D WS+G+ L EM G P R
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232
Query: 286 GSSRKETFYRILCRPPD--------LVGEPTP----------LRNLIRRLLEKDPTKRIG 327
R + Y RPP +V EP P ++ + + L K+P +R
Sbjct: 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD 292
Query: 328 VEEIKGHEFFK 338
++++ H F K
Sbjct: 293 LKQLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 81/366 (22%), Positives = 124/366 (33%), Gaps = 122/366 (33%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ LG G GVV V S A R LI + K N +I E
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMA-----RKLIHLEIKPAIRN-------QIIREL 50
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYA 134
+VL P + G +D + +++ G L + K+ E + +I
Sbjct: 51 KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI---- 106
Query: 135 AELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
++ L YL I++RD+KP NI++ G I
Sbjct: 107 -AVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI-------------------------- 139
Query: 194 NTRSGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
K C G+S L D + +NSFVGT Y+
Sbjct: 140 --------------KLCDFGVSGQLIDSM--------------------ANSFVGTRSYM 165
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYG----------------ATPFRGSSRKETFYR 295
+PE ++G + D WSLG+ L EM G P KE+
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225
Query: 296 ILCRPPD-------------LVGEPTP----------LRNLIRRLLEKDPTKRIGVEEIK 332
+ PPD +V EP P ++ + + L+K+P +R ++E+
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 333 GHEFFK 338
H F K
Sbjct: 286 KHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 8e-08
Identities = 80/336 (23%), Positives = 120/336 (35%), Gaps = 92/336 (27%)
Query: 13 LDFSCLRIVSALGRGAKGVVFL--VKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGDK 69
+D SC++I +G G G V +K E F A+K + EK+ ++ +
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS------ 54
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
E ++ +HP + L GV++ + V ++ L S +Q Q
Sbjct: 55 ------EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ------ 102
Query: 130 IRFYAAELV-------LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
F +LV ++YL M V+RDL NI++ N + DF LS L T
Sbjct: 103 --FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160
Query: 183 PQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242
DP ++ +G P R
Sbjct: 161 ----------------------------------SDPTYTSSLGGKIPIR---------- 176
Query: 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHE-MLYGATPFRGSSRK------ETFYR 295
+ APE I + A D WS G+V+ E M YG P+ S + E YR
Sbjct: 177 -------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR 229
Query: 296 ILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
L P D PT L L+ +KD R +I
Sbjct: 230 -LPPPMDC---PTALHQLMLDCWQKDRNARPKFGQI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 9/98 (9%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
S + ++S VGT Y++PE I G++F D WSLG +L+EM +PF G K +
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD--KMNLF 214
Query: 295 RIL-----CRPPDLVGE--PTPLRNLIRRLLEKDPTKR 325
+ C P L E LR L+ + DP +R
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 81/329 (24%), Positives = 120/329 (36%), Gaps = 80/329 (24%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+D SC++I +G G G V S LK+ + I K L + R
Sbjct: 1 IDASCIKIEKVIGAGEFGEVC---------SGRLKLPGKREIPVAIKTLKAGYTEKQRRD 51
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E ++ +HP + L GV++ K V +Y L + ++ Q F
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------F 103
Query: 133 YAAELV-------LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+LV ++YL +MG V+RDL NI++ N + DF LS L P+A
Sbjct: 104 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEA 162
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
A TR G +I P R
Sbjct: 163 ------AYTTRGG-------------------------KI----PIR------------- 174
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHE-MLYGATPFRGSSRKETFYRIL--CRPPD 302
+ APE I + A D WS G+V+ E M YG P+ S ++ I R P
Sbjct: 175 ----WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
+ P L L+ +KD +R E+I
Sbjct: 231 PMDCPAALHQLMLDCWQKDRNERPKFEQI 259
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 33/142 (23%), Positives = 51/142 (35%), Gaps = 35/142 (24%)
Query: 234 DSDSSEKSN--SFVGTEEYVAPEII-EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR- 289
D D EK +V T Y APE++ + A+D WS+G + E+L F G
Sbjct: 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 290 --------------KETFYRILC------------RPP----DLVGEPTPL-RNLIRRLL 318
+E I +P L +P +L+ ++L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 319 EKDPTKRIGVEEIKGHEFFKGV 340
DP KRI +E H + +
Sbjct: 274 VFDPKKRITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 29/117 (24%), Positives = 54/117 (46%), Gaps = 2/117 (1%)
Query: 59 KELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRK 118
K N + + E ++R +HP + +L GV+ T+ V ++ P +L S +
Sbjct: 40 KTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQ 98
Query: 119 QQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ ++ Y+ +L AL YL + V+RD+ N+++ + L DF LS
Sbjct: 99 VNKYSL-DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 41/161 (25%), Positives = 77/161 (47%), Gaps = 28/161 (17%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWR----DLIEKKSKELTNNDNGDKYRRISFEQRV 79
+G GA G V D + E A+K + R ++ K++ YR E +
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA-----------YR----ELTL 67
Query: 80 LRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
L++++H + L V S D+F Y + DL + S+D +++
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP----LSEDKVQYLV 123
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+++ L+Y+H+ GI++RDLKP N+ + E+ + ++DF L+
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 15/103 (14%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFV-----GYAID-YCPGRDLHSLRKQQSEQMFSDDT 129
E +LR + HP + +L+G + +KF Y D YC L + R + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCY---LAAKRNIAICDILAIER 189
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
++ A++YLH I++RD+K ENI I G + L DF
Sbjct: 190 ------SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRRISFE 76
RI +GRG V+ + ALK + DL++ K++ D + I
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA-------DCIKEID-- 54
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRK--QQSEQMFSDDTIRFYA 134
+L+ + HP + + D + ++ DL + K ++ +++ + T+ Y
Sbjct: 55 --LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYF 112
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+L ALE++H+ +++RD+KP N+ I G + L D L S KT A
Sbjct: 113 VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 51/282 (18%), Positives = 94/282 (33%), Gaps = 66/282 (23%)
Query: 50 WRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCP 109
W++ + K L +D+ K + E + L+ + H L L V S + V +
Sbjct: 27 WKNRVRVAIKIL-KSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85
Query: 110 GRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169
L + + Q+ ++ A ++ + YL ++RDL NI++ E+ +
Sbjct: 86 KGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKV 145
Query: 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229
DF L+ +++ V+
Sbjct: 146 ADFGLAR--------------------------------------LIKEDVYLS------ 161
Query: 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSS 288
SD K + APE D WS G++L+EM YG P+ G +
Sbjct: 162 ---SDKKIPYK---------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
Query: 289 RKETFYRI-----LCRPPDLVGEPTPLRNLIRRLLEKDPTKR 325
E + +I + P P + ++ +P R
Sbjct: 210 NHEVYDQITAGYRMPCPAKC---PQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 82/347 (23%), Positives = 121/347 (34%), Gaps = 117/347 (33%)
Query: 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82
+GRGA G V + S A+K I + EK+ K L + + V+R+
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRL----------LMDLDV-VMRS 59
Query: 83 VEHPLLPRLRGVL---------------STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD 127
+ P + + G L S DKF Y Y + + +
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDISLDKF--YKYVYEVLK-----------SVIPE 106
Query: 128 DTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+ + A V AL YL + I++RD+KP NI++ NG+I
Sbjct: 107 EILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNI------------------- 147
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
K C GIS L D + R D
Sbjct: 148 ---------------------KLCDFGISGQLVDSIAKTR-----------D-------- 167
Query: 245 VGTEEYVAPEIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-- 299
G Y+APE I+ G+D D WSLG+ L+E+ G P+ + + + L +
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVV 224
Query: 300 ---PPDLVGEPT-----PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
PP L N I L KD +KR +E+ H F K
Sbjct: 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ V+ K + + ALKVI + G + I E +L+ +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-----------RLQEEEGTPFTAIR-EASLLKGL 60
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + L ++ T + + +Y DL + + ++ ++ + +L+ L Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPEN-VKLFLFQLLRGLSY 118
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+H I++RDLKP+N++I + G + L DF L+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 14/170 (8%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRRISFEQ 77
+I +G+G VV+ + ALK + ++++ K+++ E
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ-----------DCLKEI 53
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ--MFSDDTIRFYAA 135
+L+ ++HP + + + + ++ DL + K +Q + + TI Y
Sbjct: 54 DLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV 113
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+L ALE++H+ I++RD+KP N+ I G + L D L S KT A
Sbjct: 114 QLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 93/297 (31%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E +L+ ++H + L ++ T + + + +Y DL Q + + +R +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYN-VRLFMF 110
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+L+ L Y+H I++RDLKP+N++I G + L DF L A K++
Sbjct: 111 QLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGL----------ARAKSI----- 155
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
PS++ S S V T Y P++
Sbjct: 156 ----------------------------------PSQTYS-------SEVVTLWYRPPDV 174
Query: 256 IEGK-GHDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRI----------------- 296
+ G + A+D W G + EML G F G S E +I
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234
Query: 297 ----------LCRPPDL------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337
C+P L + P +L ++L P RI ++ H +F
Sbjct: 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 42/183 (22%), Positives = 80/183 (43%), Gaps = 21/183 (11%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
+ S ++ +G+G G VF + ++ + ALK + EK+ +T R I
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-LMENEKEGFPIT------ALREI 62
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVG-------YAI-DYCPGRDLHSLRKQQSEQMF 125
++L+ ++H + L + T Y + ++C DL L ++ + F
Sbjct: 63 ----KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVK-F 116
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+ I+ L+ L Y+H I++RD+K NI+I ++G + L DF L+ S
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 186 SPK 188
+
Sbjct: 177 PNR 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 21/165 (12%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
I+ +G G G V+ +D ++ E ALK + L N G I E ++
Sbjct: 11 IIGQIGEGTYGQVYKARDKDTGELVALKKV----------RLDNEKEGFPITAIR-EIKI 59
Query: 80 LRNVEHPLLPRLRGVLS---------TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
LR + H + L+ +++ DK Y + DL L + FS+D I
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-FSEDHI 118
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + +L+ L Y H ++RD+K NI++ G I L DF L+
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 29/173 (16%)
Query: 18 LRIVSALGRGAKGVVF--LVKDVESSESF---ALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ ++ LG+G+ G+V+ L K V E A+K T N+N R
Sbjct: 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIK--------------TVNENASMRER 53
Query: 73 ISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSD-- 127
I F E V++ + RL GV+ST + ++ DL S LR ++ E +
Sbjct: 54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 128 ---DTIRFY--AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+F AAE+ + YL V+RDL N M+ E+ + + DF ++
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 27/106 (25%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 72 RISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
+I F E R+L+ +HP + +L GV + + + ++ PG D S +++ +++ +
Sbjct: 36 KIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL 95
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++F A + + YL + ++RDL N ++ EN + + DF +S
Sbjct: 96 VKF-ALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 69/300 (23%), Positives = 111/300 (37%), Gaps = 99/300 (33%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ---MFSDDTIRF 132
E +L++++H + L ++ T K + +Y DL KQ + S +R
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDL----KQYMDDCGGGLSMHNVRL 107
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+ +L+ L Y H +++RDLKP+N++I E G + L DF L A K+V
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL----------ARAKSV-- 155
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
PS++ S+ V T Y
Sbjct: 156 -------------------------------------PSKTYSNE-------VVTLWYRP 171
Query: 253 PEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE----TFYRILCRP------- 300
P+++ G + ++D W +G + +EM G F GS+ E +R+L P
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231
Query: 301 ----PDLVGE------PTPLRNLIRRL-------------LEKDPTKRIGVEEIKGHEFF 337
P+ P PL N RL L+ +P KRI E H +F
Sbjct: 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 32/171 (18%), Positives = 70/171 (40%), Gaps = 21/171 (12%)
Query: 18 LRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
L+ + LG G G V L + + E A+K + E+ +
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---------- 55
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDL-HSLRKQQSEQMFSDDTI 130
E +LR ++H + + +GV + +Y P L L++ + + + +
Sbjct: 56 --EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI--NLKRL 111
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
+++++ ++YL + ++RDL NI+++ + + DF L+ L
Sbjct: 112 LLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 6e-06
Identities = 32/118 (27%), Positives = 60/118 (50%), Gaps = 8/118 (6%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE---QMFSDDTIRF 132
E +L++++H + L ++ T+K + +Y +DL KQ + + ++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDL----KQYLDDCGNSINMHNVKL 108
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ +L+ L Y H +++RDLKP+N++I E G + L DF L+ S T S + V
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV 166
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 8e-06
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ G V+ D + E A+K+I DL E + D+ I E VL
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAE----------DEIEDIQQEITVLSQC 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+ P + R G + ++Y G L L+ E+ + +R E++ L+
Sbjct: 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLD 115
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
YLH+ ++RD+K N+++ E G + L DF ++ +L+
Sbjct: 116 YLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS-KELTNNDNGDKYRRISFEQRVLRN 82
LG G+ G+VF D + + A+K I L + +S K E +++R
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIV--LTDPQSVKHALR------------EIKIIRR 58
Query: 83 VEHPLLPRLRGVLS-------------TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
++H + ++ VL T+ Y + DL ++ +Q S++
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP---LSEEH 115
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSP 180
R + +L+ L+Y+H+ +++RDLKP N+ I E+ + + DF L+ + P
Sbjct: 116 ARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 24/50 (48%), Positives = 32/50 (64%), Gaps = 2/50 (4%)
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL--SPKTPQ 184
L+ AL YLH GI++RD+K ENI + E + +L DF + KL P TPQ
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
|
Length = 392 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 39/156 (25%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ G VF D + + A+K+I DL E + D+ I E VL
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAE----------DEIEDIQQEITVLSQC 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+ P + + G D + ++Y G L + + I E++ L+Y
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDY 116
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
LH+ ++RD+K N+++ E+G + L DF ++ +L+
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRK--QQSEQMFSDDTIRFY 133
E +L+ + HP + + D + ++ DL + K ++ +++ + T+ Y
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
+L A+E++H+ +++RD+KP N+ I G + L D L S KT A
Sbjct: 112 FVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA+G+V D + A+K K S+ N + + R E +++ V
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIK--------KLSRPFQNQTHAKRAYR---ELVLMKCV 73
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVLALE 142
H + L V + K + D +L Q QM D + + + +++ ++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 133
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 57/261 (21%), Positives = 103/261 (39%), Gaps = 74/261 (28%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDY-CPGRDLHSLRKQQSEQMFSDDTIRFYA 134
E ++++ + H L +L V S ++ + +Y G L L+ + +++ + A
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM-A 109
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
A++ + YL + ++RDL NI++ EN + DF L+ +
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI---------------- 153
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
ED ++ R G P + + APE
Sbjct: 154 ----------------------EDDEYTAREGAKFPIK-----------------WTAPE 174
Query: 255 -IIEGKGHDFAV--DWWSLGVVLHEML-YGATPFRGSSRKETF------YRILCRPPDLV 304
G+ F + D WS G++L E++ YG P+ G + +E YR + RPP
Sbjct: 175 AANYGR---FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-MPRPP--- 227
Query: 305 GEPTPLRNLIRRLLEKDPTKR 325
P L +L+ + +KDP +R
Sbjct: 228 NCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 5/90 (5%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILC--RPPDLVGEPT 308
APE ++ D WS GV+L E+ GATP+ G S +E + R P P
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD 234
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
L L+ + DP R E+ E +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL--VERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 39/171 (22%), Positives = 67/171 (39%), Gaps = 56/171 (32%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ EM+ G F G+ + + +I+ +
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII----EQ 232
Query: 304 VGEPTP------------------------------------------------LRNLIR 315
+G P+ R+L+
Sbjct: 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLS 292
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
++L DP KRI V++ H + W ++ PP PA ++H +E +
Sbjct: 293 KMLVIDPEKRISVDDALQHPYIN--VWYDPSEVEAPP--PAPYDHSIDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 16 SCLRIVSALGRGA-----KGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
S +R + LG GA KG + + S+ S A+K + KE ++
Sbjct: 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL---------KENAEPKVQQEF 55
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-----EQMF 125
R+ E ++ +++HP + L GV + ++ +Y DLH + S
Sbjct: 56 RQ---EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 126 SDDTIR---------FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D+T++ A ++ +EYL + V+RDL N ++ E + + DF LS
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 10/113 (8%)
Query: 76 EQRVLRNVEHPLLPRLRGV-LSTDKFVGYA-----IDYCPGRDLHSL----RKQQSEQMF 125
E ++ +HP + RL GV L T + GY + + DLHS R Q
Sbjct: 50 EAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYL 109
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ + ++ +EYL + ++RDL N M+ EN ++ + DF LS K+
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 12/153 (7%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G GA+G+V D + A+K K S+ N + + R E +++ V
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIK--------KLSRPFQNQTHAKRAYR---ELVLMKCV 80
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVLALE 142
H + L V + K + D +L Q QM D + + + +++ ++
Sbjct: 81 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIK 140
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 66/283 (23%), Positives = 105/283 (37%), Gaps = 78/283 (27%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+S LG G GVV V+ S ++ R LI + K N +I E +VL
Sbjct: 10 ISELGAGNGGVVTKVQHKPSG-----LIMARKLIHLEIKPAIRN-------QIIRELQVL 57
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
P + G +D + +++ G L + K+ + ++ + + ++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRG 115
Query: 141 LEYL-HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
L YL I++RD+KP NI++ N+R I
Sbjct: 116 LAYLREKHQIMHRDVKPSNILV--------------------------------NSRGEI 143
Query: 200 KKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
K C G+S L D + +NSFVGT Y++PE ++
Sbjct: 144 K--------LCDFGVSGQLIDSM--------------------ANSFVGTRSYMSPERLQ 175
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP 300
G + D WS+G+ L E+ G P KE I RP
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ G VF D + + A+K+I DL E + D+ I E VL
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAE----------DEIEDIQQEITVLSQC 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+ P + + G + ++Y G L + F + I E++ L+Y
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDY 116
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
LH+ ++RD+K N+++ E G + L DF ++ +L+
Sbjct: 117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 38/156 (24%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+ +G GA+G+V D + A+K K S+ N + + R E +L
Sbjct: 26 LKPIGSGAQGIVCAAFDTVLGINVAVK--------KLSRPFQNQTHAKRAYR---ELVLL 74
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVL 139
+ V H + L V + K + D +L Q M D + + + +++
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC 134
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+++LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 22/175 (12%)
Query: 10 IRSLDFSCLRIVSALGRGAKGVVF---LVKDVESSE-SFALKVIWRDLIEKKSKELTNND 65
+R L + L+ V LG GA G V+ + D E+ + A+KV+ + K +KE+ +
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-- 58
Query: 66 NGDKYRRISFEQRVLRNVEHPLLPRLRGV--LSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
E V+ V P + RL G+ ST + V + Y G L +R+ + ++
Sbjct: 59 ----------EAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPY--GCLLDYVRENK-DR 105
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ S D + + ++ + YL + +V+RDL N++++ H+ + DF L+ L
Sbjct: 106 IGSQDLLN-WCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 55/265 (20%), Positives = 96/265 (36%), Gaps = 67/265 (25%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E +V++ + H L +L V+S + + +Y L K + + + AA
Sbjct: 51 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
++ + Y+ M V+RDL+ NI++ EN + DF L+
Sbjct: 110 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR------------------- 150
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
+ED ++ R G P + + APE
Sbjct: 151 -------------------LIEDNEYTARQGAKFPIK-----------------WTAPEA 174
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETF------YRILCRPPDLVGEPT 308
D WS G++L E+ G P+ G +E YR+ C PP+ P
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-PPEC---PE 230
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKG 333
L +L+ + K+P +R E ++
Sbjct: 231 SLHDLMCQCWRKEPEERPTFEYLQA 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 32/199 (16%)
Query: 13 LDFSCLRIVSALGRGAKGVVF----LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
L S +R + LG A G ++ + ++ ++ A+K + K++ N
Sbjct: 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTL---------KDINNPQQWG 52
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS---LRKQQSEQMF 125
++++ E ++ + HP + L GV++ ++ V +Y DLH +R S+
Sbjct: 53 EFQQ---EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGC 109
Query: 126 SDD---TIR---------FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173
S D T++ A ++ +EYL + V++DL NI+I E H+ + D
Sbjct: 110 SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLG 169
Query: 174 LSTKL-SPKTPQASPKTVL 191
LS ++ S + PK++L
Sbjct: 170 LSREIYSADYYRVQPKSLL 188
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 10/113 (8%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVG------YAIDYCPGRDLHSL----RKQQSEQMF 125
E +++ +HP + +L GV + + + DLHS R +
Sbjct: 51 EAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL 110
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
T+ + ++ L +EYL N ++RDL N M++E+ + + DF LS K+
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 22/161 (13%)
Query: 24 LGRGAKGVVFLVKDVESSES------FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
LG G+ GVV + E S S A+K + KS +L+ D D + + E
Sbjct: 3 LGDGSFGVV---RRGEWSTSGGKVIPVAVKCL-------KSDKLS--DIMDDFLK---EA 47
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
++ +++H L RL GV+ T + + P L ++ + F T+ YA ++
Sbjct: 48 AIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI 106
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ YL + ++RDL NI++ + + + DF L L
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 7e-05
Identities = 16/45 (35%), Positives = 31/45 (68%)
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
+ I+ +++ L LH +GIV+RD+KPEN+++ +G + ++DF
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 34/159 (21%), Positives = 71/159 (44%), Gaps = 23/159 (14%)
Query: 21 VSALGRGAKG--VVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G+ + +V L K ++ A+K I ++ SKE + + E
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKI---NLDSCSKE--------DLKLLQQEII 51
Query: 79 VLRNVEHP-LLPRLRGVLSTDKFVGYAI----DYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
R ++HP +LP + + + Y + Y DL L+ E + I F
Sbjct: 52 TSRQLQHPNILPYVTSFIVDSEL--YVVSPLMAYGSCEDL--LKTHFPEG-LPELAIAFI 106
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
+++ AL+Y+H+ G ++R +K +I++ +G ++L
Sbjct: 107 LKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 29/151 (19%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ EM+ G F G+ + + +++ +
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI----EQ 240
Query: 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNI--PARFEHE 361
+G P P +++L PT R VE + G ++E L P++ PA EH
Sbjct: 241 LGTPCP--EFMKKL---QPTVRTYVEN---RPKYAGYSFEKLF-----PDVLFPADSEH- 286
Query: 362 NNESDGRGR---------DGTKEIDVEKFVQ 383
N + R D +K I V++ +Q
Sbjct: 287 NKLKASQARDLLSKMLVIDASKRISVDEALQ 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 40/153 (26%), Positives = 57/153 (37%), Gaps = 37/153 (24%)
Query: 224 RIGPDPPSRSDSDSSEKSNSF----VGTEEYVAPEII-EGKGHDFAVDWWSLGVVLHEML 278
RIG +R S S + F V T Y APE++ + A+D WS+G + EML
Sbjct: 147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
Query: 279 YGATPFRGSSRKETFYRI---LCRPP---------DLV---------GEPTPL------- 310
F G + I L P D V +P P
Sbjct: 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKA 266
Query: 311 ----RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+L+ ++L+ DP +RI VE+ H F
Sbjct: 267 SPEALDLLSQMLQFDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 24/84 (28%), Positives = 46/84 (54%), Gaps = 9/84 (10%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ E++ G+ F+G+ + + +++ +
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI----EQ 237
Query: 304 VGEPT-----PLRNLIRRLLEKDP 322
+G P+ L+ +R +E P
Sbjct: 238 LGTPSAEFMNRLQPTVRNYVENRP 261
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 34/126 (26%), Positives = 46/126 (36%), Gaps = 42/126 (33%)
Query: 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y APE++ G A+D WS+G + E+L F G S + +I L+G PT
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK----LLGTPT 227
Query: 309 ------------------------PLRN-------------LIRRLLEKDPTKRIGVEEI 331
LR L+ RLL DP KRI E+
Sbjct: 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287
Query: 332 KGHEFF 337
H +F
Sbjct: 288 LKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 30/81 (37%), Positives = 36/81 (44%), Gaps = 7/81 (8%)
Query: 250 YVAPEIIEG--KGHDFAVDWWSLGVVLHEMLY-GATPF--RGSSRKETFYRILCRPPDLV 304
++APE I A D WS G L E+ G P SS KE FY+ R P
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMP- 228
Query: 305 GEPTPLRNLIRRLLEKDPTKR 325
+ L NLI + DPTKR
Sbjct: 229 -DCAELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 2e-04
Identities = 24/80 (30%), Positives = 35/80 (43%), Gaps = 9/80 (11%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPDLVG 305
APE ++ D WS GV+L E+ G P+ G S E + L +PP+
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNC-- 229
Query: 306 EPTPLRNLIRRLLEKDPTKR 325
P L L+ + +DP R
Sbjct: 230 -PPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 24/80 (30%), Positives = 37/80 (46%), Gaps = 9/80 (11%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPDLVG 305
APE ++ D WS GV+L E+ G P+ G S +E + L +PP+
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNC-- 228
Query: 306 EPTPLRNLIRRLLEKDPTKR 325
P L +L+ + +DP R
Sbjct: 229 -PPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 14/154 (9%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK-YRRISFEQRVLRN 82
+G GA+G+V D + ++ A+K K S+ N + + YR E +++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIK--------KLSRPFQNVTHAKRAYR----ELVLMKL 71
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVLAL 141
V H + L V + K + D +L Q QM D + + + +++ +
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGI 131
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL---TNNDNGDKYRRISF--EQR 78
LG G G V L + E E F K D+ + + ++ +K R F E +
Sbjct: 13 LGEGQFGEVHLC-EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDD-------T 129
++ ++ P + RL V T + +Y DL+ R + E D T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ F A ++ ++YL ++ V+RDL N ++ +N I + DF +S L
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 25/100 (25%), Positives = 50/100 (50%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E V++ ++HP L +L GV + + ++ +L ++ + Q + + + A
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ A+EYL ++RDL N ++ EN + + DF LS
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 34/139 (24%), Positives = 60/139 (43%), Gaps = 22/139 (15%)
Query: 59 KELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL-- 116
K L N + + R + E +L+ V HP + +L G S D + ++Y L S
Sbjct: 36 KMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR 95
Query: 117 --RK-----------QQSEQMFSDDT-------IRFYAAELVLALEYLHNMGIVYRDLKP 156
RK + S + + D + +A ++ ++YL M +V+RDL
Sbjct: 96 ESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155
Query: 157 ENIMIQENGHIMLVDFDLS 175
N+++ E + + DF LS
Sbjct: 156 RNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 20/169 (11%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS-----KELTNNDNGDKYRR 72
L + LG GA G V+ K +W EK K L + +
Sbjct: 9 LEKIKVLGSGAFGTVY-------------KGVWIPEGEKVKIPVAIKVLREETSPKANKE 55
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
I E V+ +V+HP + RL G+ + + V P L + + + S + +
Sbjct: 56 ILDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW 114
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
++ + YL +V+RDL N++++ H+ + DF L+ L
Sbjct: 115 -CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-04
Identities = 23/77 (29%), Positives = 32/77 (41%), Gaps = 3/77 (3%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPT 308
APE ++ D WS GV+L E+ G P+ G S +E + R P P
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPD 231
Query: 309 PLRNLIRRLLEKDPTKR 325
L L+ + DP R
Sbjct: 232 ELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 32/183 (17%)
Query: 11 RSLD-FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
RS+D + L + G GVV+ +D ++ E ALK + K KE
Sbjct: 2 RSVDEYEKLNRIE---EGTYGVVYRARDKKTGEIVALKKL------KMEKE--------- 43
Query: 70 YRRISF------EQRVLRNVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSLRKQQS 121
+ F E +L ++HP + ++ V+ S + ++Y DL SL +
Sbjct: 44 --KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK 100
Query: 122 EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL-SP 180
+ F ++ +L+ + +LH+ I++RDLK N+++ G + + DF L+ + SP
Sbjct: 101 QP-FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
Query: 181 KTP 183
P
Sbjct: 160 LKP 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 32/122 (26%), Positives = 45/122 (36%), Gaps = 38/122 (31%)
Query: 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y APE++ G H VD WS+G + EM F G S + I L+G PT
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF----KLLGTPT 232
Query: 309 P--------LRN-------------------------LIRRLLEKDPTKRIGVEEIKGHE 335
LR+ L++++L DP KRI + H
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 336 FF 337
+F
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 24/74 (32%), Positives = 40/74 (54%), Gaps = 5/74 (6%)
Query: 237 SSEKSNSFVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR 295
+ ++ +V T Y APEI+ H + VD WS+G ++ E+L G F G+ + R
Sbjct: 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227
Query: 296 ILCRPPDLVGEPTP 309
I+ ++VG P+P
Sbjct: 228 IM----EVVGTPSP 237
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 18/139 (12%)
Query: 52 DLIEKKSKELTNNDNGDKYRRISFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCP- 109
D K+ KE + D+ +R + E VL + HP + L G ++ AI+Y P
Sbjct: 36 DAAIKRMKEYASKDD---HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92
Query: 110 GRDLHSLRKQQ-------------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKP 156
G L LRK + + S + +AA++ ++YL ++RDL
Sbjct: 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 152
Query: 157 ENIMIQENGHIMLVDFDLS 175
NI++ EN + DF LS
Sbjct: 153 RNILVGENYVAKIADFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 4e-04
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
++ S L + LG G GVV L K WR I+ K + + G
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGK-------------WRAQIKVAIKAI---NEGAMSEE 44
Query: 73 ISFEQ-RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCP-GRDLHSLRKQQSEQMFSDDTI 130
E+ +V+ + HP L +L GV + K + ++ G L+ LR++Q + S D +
Sbjct: 45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK--LSKDML 102
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ +EYL ++RDL N ++ G + + DF ++
Sbjct: 103 LSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 26/82 (31%), Positives = 42/82 (51%), Gaps = 7/82 (8%)
Query: 237 SSEKSNSFVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR 295
+ ++ +V T Y APEI+ H + VD WS+G ++ E+L G T F G+ +
Sbjct: 170 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229
Query: 296 ILCRPPDLVGEPTPLRNLIRRL 317
IL LVG P L++++
Sbjct: 230 IL----RLVGTPGA--ELLKKI 245
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 38/172 (22%), Positives = 75/172 (43%), Gaps = 13/172 (7%)
Query: 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG 67
R ++ +F +++ LG GA G V+ + E + V ++L E S +
Sbjct: 2 RILKETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN----- 53
Query: 68 DKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD 127
+ I E V+ +V++P + RL G+ T V P L ++ + + S
Sbjct: 54 ---KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 109
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
+ + ++ + YL +V+RDL N++++ H+ + DF L+ L
Sbjct: 110 YLLN-WCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 47/254 (18%), Positives = 97/254 (38%), Gaps = 60/254 (23%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDY-CPGRDLHSLRKQQSEQMFSDDTIRFYA 134
E +++ ++H L RL V++ ++ + +Y G L L+ + ++ I F +
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-S 109
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
A++ + Y+ ++RDL+ N+++ E+ + DF L+
Sbjct: 110 AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR------------------ 151
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+ED ++ R G P + + APE
Sbjct: 152 --------------------VIEDNEYTAREGAKFPIK-----------------WTAPE 174
Query: 255 IIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLR 311
I D WS G++L+E++ YG P+ G S + + R P + P L
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234
Query: 312 NLIRRLLEKDPTKR 325
++++ ++ +R
Sbjct: 235 DIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 32/125 (25%), Positives = 44/125 (35%), Gaps = 40/125 (32%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y APE++ G + A+D W++G +L E+L G S E I+ L+G P
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII----QLLGTPN 229
Query: 309 ---------------------PLRNLIRR--------------LLEKDPTKRIGVEEIKG 333
P NL + LL DP KR EE
Sbjct: 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289
Query: 334 HEFFK 338
+FK
Sbjct: 290 SSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 16/47 (34%), Positives = 30/47 (63%)
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176
I+ +++ LEY+H GI + D+KPENIM+ N ++D+ +++
Sbjct: 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 23/71 (32%), Positives = 34/71 (47%), Gaps = 3/71 (4%)
Query: 106 DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI-QEN 164
DY DL L K E S+ ++ +LV AL LH I++ D+K EN++ +
Sbjct: 89 DYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK 146
Query: 165 GHIMLVDFDLS 175
I L D+ L
Sbjct: 147 DRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 8e-04
Identities = 35/127 (27%), Positives = 48/127 (37%), Gaps = 34/127 (26%)
Query: 244 FVGTEEYVAPEII-EGKGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRILC--- 298
+V T Y APEI+ + VD W+LG ++ E LY P F GSS + Y+I
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAE-LYTLRPLFPGSSEIDQLYKICSVLG 216
Query: 299 --------RPPDLVG---------EPTPLR-----------NLIRRLLEKDPTKRIGVEE 330
L PT L +LI+ +L DP KR +
Sbjct: 217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276
Query: 331 IKGHEFF 337
H +F
Sbjct: 277 ALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 8e-04
Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 7/71 (9%)
Query: 266 DWWSLGVVLHEML-YGATPFRGSSRKETFYRI----LCRPPDLVGEPTPLRNLIRRLLEK 320
D W+ GVVL E+ YG P+ G + +E Y + + PD P L NL+R K
Sbjct: 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPD--NCPLELYNLMRLCWSK 271
Query: 321 DPTKRIGVEEI 331
P+ R I
Sbjct: 272 LPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 8e-04
Identities = 34/111 (30%), Positives = 50/111 (45%), Gaps = 18/111 (16%)
Query: 70 YRRISFEQRVLRNVEHP-LLPRL--RGV-----LSTDKFVGYAIDYCPGRDLHSLRKQQS 121
Y E R+LR + HP +L L R V L K+ Y G L L Q
Sbjct: 204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL-GARLRPLGLAQ- 261
Query: 122 EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
+ A +L+ A++Y+H GI++RD+K EN+++ I L DF
Sbjct: 262 --------VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 29/89 (32%), Positives = 42/89 (47%), Gaps = 9/89 (10%)
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPDL 303
++APE I + A D W GV + E+L G PF+G + RI L PP+
Sbjct: 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNC 233
Query: 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332
P L +L+ + DP+KR E+K
Sbjct: 234 ---PPTLYSLMTKCWAYDPSKRPRFTELK 259
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 9e-04
Identities = 14/52 (26%), Positives = 31/52 (59%), Gaps = 1/52 (1%)
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM-LVDFDLSTKLS 179
TI+ + +L+ + + H G+++RDLKP+N+++ + ++ + D L S
Sbjct: 111 TIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQM--FSDDTIRFYAAELVLALEYLHNMGIVYRD 153
S DK + ++Y G DL+ KQ+ ++ F + + ++VLAL+ +H+ +++RD
Sbjct: 136 SDDKLL-LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 154 LKPENIMIQENGHIMLVDFDLSTKLS 179
LK NI + G I L DF S + S
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYS 220
|
Length = 478 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 9/84 (10%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ EM+ F G + + +++ +
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI----EQ 233
Query: 304 VGEPTP-----LRNLIRRLLEKDP 322
+G P P L+ +R +E P
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRP 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 20/174 (11%)
Query: 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+R L + L+ V LG GA G V+ V E+ + V + ++ N G K
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPV---------AIKILNETTGPK 51
Query: 70 YRRISF--EQRVLRNVEHPLLPRLRGVL--STDKFVGYAIDY-CPGRDLHSLRKQQSEQM 124
+ F E ++ +++HP L RL GV T + V + + C +H + Q+
Sbjct: 52 -ANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQL 110
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ + ++ + YL +V+RDL N++++ H+ + DF L+ L
Sbjct: 111 LLN-----WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 70/321 (21%), Positives = 122/321 (38%), Gaps = 87/321 (27%)
Query: 24 LGRGAKGVV---FLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
LG+G G V L + S + A+K++ D+ +++D + R + +
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-------SSSDIEEFLREAAC----M 55
Query: 81 RNVEHPLLPRLRGVLSTDKFVG------YAIDYCPGRDLHS--LRKQQSEQMF--SDDTI 130
+ +HP + +L GV + G + + DLH+ L + E+ F T+
Sbjct: 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL 115
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ ++ +EYL + ++RDL N M+ EN + + DF LS K+
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY----------- 164
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
SG R+ SK ++LE S +D+ + S
Sbjct: 165 ------SGDYYRQGCASKLPVKWLALE-------------SLADNVYTTHS--------- 196
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHE-MLYGATPFRGSSRKETF-YRI----LCRPPDLV 304
D W+ GV + E M G TP+ G E + Y I L +PPD +
Sbjct: 197 ---------------DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCL 241
Query: 305 GEPTPLRNLIRRLLEKDPTKR 325
+ + L+ + +P R
Sbjct: 242 ED---VYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.001
Identities = 48/186 (25%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND---------- 65
L V LG G G V L E+ L+ D EK E N D
Sbjct: 5 QPLNFVEKLGEGQFGEVHL------CEADGLQ----DFSEKAFAENDNADAPVLVAVKVL 54
Query: 66 --NGDKYRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQ 120
+ R F E ++L + P + RL GV + D + ++Y DL L+K
Sbjct: 55 RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 121 SE--------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
+E + S T+ + A ++ + YL ++ V+RDL N ++ +N I + DF
Sbjct: 115 AETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADF 174
Query: 173 DLSTKL 178
+S L
Sbjct: 175 GMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 23/100 (23%), Positives = 47/100 (47%), Gaps = 1/100 (1%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
E R+L+ HP + RL GV + + + ++ G D + + + ++ + I+
Sbjct: 43 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VE 101
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+EYL + ++RDL N ++ E + + DF +S
Sbjct: 102 NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 25/67 (37%), Positives = 35/67 (52%), Gaps = 5/67 (7%)
Query: 244 FVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
+V T Y APE+I H + VD WS+G ++ EML G T F+G + +IL
Sbjct: 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL----K 229
Query: 303 LVGEPTP 309
+ G P P
Sbjct: 230 VTGVPGP 236
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 26/160 (16%), Positives = 59/160 (36%), Gaps = 29/160 (18%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE-QR 78
+ L G V+L+ E + LK+ + R +
Sbjct: 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKIN-------------PSREKGADREREVAILQ 46
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L P+ P++ +D + +++ G L + +++ E A +L
Sbjct: 47 LLARKGLPV-PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKED---------IAEQLA 96
Query: 139 LALEYLHNM---GIVYRDLKPENIMIQENGHIMLVDFDLS 175
L LH + + + DL P NI++ + + ++D++ +
Sbjct: 97 ELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 27/109 (24%), Positives = 44/109 (40%), Gaps = 18/109 (16%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFV---------GYAIDYCPGRDLHSLRKQQSEQMFS 126
E V+ + HP L +L GV+ + G +DY R + Q + F+
Sbjct: 50 EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ-QLGFA 108
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D +EYL V+RDL N+++ E+ + DF L+
Sbjct: 109 LDVCE--------GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 49/199 (24%), Positives = 69/199 (34%), Gaps = 65/199 (32%)
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
++YL M V+RDL NI++ N + DF LS +L T+ G
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA--------TYTTKGG- 168
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
+I P R + APE I +
Sbjct: 169 ------------------------KI----PIR-----------------WTAPEAIAYR 183
Query: 260 GHDFAVDWWSLGVVLHE-MLYGATPFRGSSRK------ETFYRILCRPPDLVGEPTPLRN 312
A D WS G+V+ E M YG P+ S + E YR L P D P+ L
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR-LPPPMDC---PSALYQ 239
Query: 313 LIRRLLEKDPTKRIGVEEI 331
L+ +KD +R +I
Sbjct: 240 LMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 34/143 (23%), Positives = 54/143 (37%), Gaps = 55/143 (38%)
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+L+ A+EY+H+ +++RD+K ENI + +G I+L DF +
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAM------------------- 315
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
P R D +VGT +PEI
Sbjct: 316 -----------------------PFEKEREAFD-------------YGWVGTVATNSPEI 339
Query: 256 IEGKGHDFAVDWWSLGVVLHEML 278
+ G G+ D WS G++L +ML
Sbjct: 340 LAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 34/165 (20%), Positives = 75/165 (45%), Gaps = 26/165 (15%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
G+ KG +F E +++ A+K + +D E +E +++ E + +
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLRE--------EFKH---EAMMRSRL 65
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS---LRKQQSEQMFSDD--TIR------- 131
+HP + L GV++ ++ + YC DLH +R S+ +DD T++
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 132 --FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
++ +E+L + +V++DL N+++ + ++ + D L
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 26/82 (31%), Positives = 36/82 (43%), Gaps = 10/82 (12%)
Query: 250 YVAPEIIE-GKGHDFAVDWWSLGVVLHEMLY-GATPFRGS--SRKETFYRILCRP--PDL 303
++APE +E K A D WS G L E+ Y G P + + KE FY C P
Sbjct: 174 WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSC 233
Query: 304 VGEPTPLRNLIRRLLEKDPTKR 325
L +L+ + DP +R
Sbjct: 234 ----KELADLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 23/102 (22%), Positives = 49/102 (48%), Gaps = 5/102 (4%)
Query: 76 EQRVLRNVEHPLLPRLRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
E +L+ + H + + +G S K + ++Y P L SLR + + + +
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLLLF 112
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
A ++ + YLH+ ++RDL N+++ + + + DF L+
Sbjct: 113 AQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 57/272 (20%), Positives = 96/272 (35%), Gaps = 83/272 (30%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFV--------GYAIDYCPGRDLHSLRKQQSEQMFSD 127
E ++++ + H L L V+S + G +D+ D L+ Q M
Sbjct: 51 EAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM--- 107
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
AA++ + Y+ M ++RDL+ NI++ +N + DF L+
Sbjct: 108 ------AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR----------- 150
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
+ED ++ R G P +
Sbjct: 151 ---------------------------LIEDNEYTARQGAKFPIK--------------- 168
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETF------YRILCRP 300
+ APE D WS G++L E++ G P+ G +E YR+ C
Sbjct: 169 --WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC-- 224
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332
P G P L L++ +KDP +R E I+
Sbjct: 225 PQ--GCPESLHELMKLCWKKDPDERPTFEYIQ 254
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 7/87 (8%)
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL----CRPPDLV 304
++APE ++ D WS GVVL EM P++G S +E ++ P+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE-- 244
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEI 331
P L L+R + +P R EI
Sbjct: 245 NCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 21/153 (13%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ L G++G VF+ + LK I +K L E +
Sbjct: 70 VIKTLTPGSEGRVFVATKPGQPDPVVLK------IGQKGTTL-------------IEAML 110
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L+NV HP + R++ L + + + DL++ ++S + D + L
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILE- 168
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
L YLH I++RD+K ENI I + + + D
Sbjct: 169 GLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 44/142 (30%)
Query: 140 ALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL+Y H + +++ DLKPENI+++ + T + P T +A P
Sbjct: 243 ALDYFHTELHLMHTDLKPENILMETS----------DTVVDPVTNRALPP--------DP 284
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ R L C D HS + V T Y +PE++ G
Sbjct: 285 CRVRICDLGGCC-------DERHS------------------RTAIVSTRHYRSPEVVLG 319
Query: 259 KGHDFAVDWWSLGVVLHEMLYG 280
G ++ D WS+G +++E+ G
Sbjct: 320 LGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 24/101 (23%), Positives = 50/101 (49%), Gaps = 3/101 (2%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
E +L+ +HP + +L GV K Y + + PG L + +++ ++ ++ +
Sbjct: 42 EAEILKQYDHPNIVKLIGV-CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-S 99
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ +EYL + ++RDL N ++ EN + + DF +S
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 32/162 (19%), Positives = 67/162 (41%), Gaps = 51/162 (31%)
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
S+ I + ++ AL+Y+H+MG V+R +K +I+I +G + L
Sbjct: 99 SELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL---------------- 142
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
SG++ S ++ + + P +S ++ P
Sbjct: 143 -----------SGLRSNLSMINHGQRLRVVHDFPKYSVKVLP------------------ 173
Query: 246 GTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFR 285
+++PE+++ +G+D D +S+G+ E+ G PF+
Sbjct: 174 ----WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|151200 pfam10707, YrbL-PhoP_reg, PhoP regulatory network protein YrbL | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.003
Identities = 25/101 (24%), Positives = 35/101 (34%), Gaps = 17/101 (16%)
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAI------DYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
R ++ +PR G + TD +G D L L K +
Sbjct: 72 RGIDWSPIPRYYGFVETDLGLGLVTERIRDADGNISPTLEDLLK---NGGLTAA----LR 124
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171
L YL + IV RDL P NI+ ++LVD
Sbjct: 125 EALNEFKRYLLDNHIVARDLNPHNIVYGRRSEGEYELVLVD 165
|
This is a family of proteins that are activated by PhoP. PhoP protein controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multicomponent loop in Salmonella where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner. Length = 199 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 30/124 (24%), Positives = 48/124 (38%), Gaps = 32/124 (25%)
Query: 247 TEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGS---------------SRK 290
T+ Y +P ++ + A+D W+ G + EML G F G+ R+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240
Query: 291 ETFYRILCRPPDLV----GEP-TPLR-----------NLIRRLLEKDPTKRIGVEEIKGH 334
E +L P V GEP PLR + + ++L +P R+ EE H
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300
Query: 335 EFFK 338
+
Sbjct: 301 PYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 26/90 (28%), Positives = 39/90 (43%), Gaps = 11/90 (12%)
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETF------YRILCRPP 301
++ APE + + D WS G++L E G TP+ G S ++T YR+ P
Sbjct: 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA--P 217
Query: 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
L P + L+ + DP R EI
Sbjct: 218 QLC--PEEIYRLMLQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 426 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.7 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.14 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.22 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.15 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.09 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.94 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.84 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.8 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.78 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.72 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.65 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.23 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.07 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.06 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.04 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.03 | |
| PLN02236 | 344 | choline kinase | 97.0 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.71 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.48 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.42 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.22 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.06 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.95 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.63 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.61 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.55 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.54 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.93 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.28 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-72 Score=521.44 Aligned_cols=341 Identities=43% Similarity=0.774 Sum_probs=277.7
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
.+...|.+++|++++.||.|.-|+||+|+...++..+|+||+.|+.+.++ ..+.+++.|.+||+.++||+
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r----------kKl~Ra~tE~eIL~~lDHPF 138 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR----------KKLKRAQTEREILSLLDHPF 138 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh----------hHHHHHHHHHHHHHhcCCCc
Confidence 34577999999999999999999999999999999999999999888765 36788999999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
++.||..|+++++.|+|||||+||+|+.+++++..+.|++..+++|+++++.||+|||-+|||+||||||||||.++|||
T Consensus 139 lPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 139 LPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred cchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccc-cccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK-KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+|+||.|+.......+.............+... .+.+-+...|.+..............+.+. ........++++|||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~-~~aep~~~RSnSFVG 297 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPE-LVAEPTGARSNSFVG 297 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchh-hhcCCCCcccccccc
Confidence 999999998873221111110000000000000 001111111222211111000000011111 112345678999999
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC---HHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP---TPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~~li~~~L~~dP~ 323 (426)
|-.|+|||++.|.+++.++|||+|||++|||++|..||.|.+.++++.+|+..+..+++.+ ..++|||+++|.+||+
T Consensus 298 ThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 298 THEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred ccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999999999999999999999999999999999998888776 8899999999999999
Q ss_pred CCCC----hHHHhcCCCcCCCChhhhhhccCCCCCCCCCCC
Q 014344 324 KRIG----VEEIKGHEFFKGVNWELLLKISRPPNIPARFEH 360 (426)
Q Consensus 324 ~R~s----~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 360 (426)
+|+. |.||.+||||++++|+ +.+..+||.+|.....
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWa-Lir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWA-LIRCARPPEIPKPVDG 417 (459)
T ss_pred hhhccccchHHhhcCccccCCChh-heeccCCCcCCCcccc
Confidence 9998 9999999999999999 6688899999977543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-68 Score=492.61 Aligned_cols=275 Identities=41% Similarity=0.723 Sum_probs=250.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
....++|+++++||+|+||+||+|+.+.+++.||+|++.|..+..+ ...+....|..||..++||+||.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~----------~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK----------KEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh----------hhHHHHHHHHHHHHhCCCCcEeee
Confidence 5778999999999999999999999999999999999999887665 245678889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+..|++...+|+|+||+.||+|+..+++.+ .|+++.+++|+++|+.||.|||++||||||||||||||+.+|||+|+|
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEec
Confidence 999999999999999999999999888754 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.... .+..+.++|||+.||
T Consensus 169 FgL~k~~~~--------------------------------------------------------~~~~t~tfcGT~eYm 192 (357)
T KOG0598|consen 169 FGLCKEDLK--------------------------------------------------------DGDATRTFCGTPEYM 192 (357)
T ss_pred cccchhccc--------------------------------------------------------CCCccccccCCcccc
Confidence 999985431 223566799999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC-CCHHHHHHHHHHhccCCCCCC---
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDLVG-EPTPLRNLIRRLLEKDPTKRI--- 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~-~~~~~~~li~~~L~~dP~~R~--- 326 (426)
|||++.+.+|+.++|||||||++|||++|.+||.+.+....+.+|+..+ +..+. .+..+++||+++|.+||++|+
T Consensus 193 APEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~ 272 (357)
T KOG0598|consen 193 APEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGP 272 (357)
T ss_pred ChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCC
Confidence 9999999999999999999999999999999999999999999999877 55555 688999999999999999997
Q ss_pred -ChHHHhcCCCcCCCChhhhhhccCCCCC
Q 014344 327 -GVEEIKGHEFFKGVNWELLLKISRPPNI 354 (426)
Q Consensus 327 -s~~eil~hp~f~~~~~~~~~~~~~~~~~ 354 (426)
.+.+|.+||||++++|+.+......|.+
T Consensus 273 ~d~~~ik~HpfF~~inW~~l~~k~l~PpF 301 (357)
T KOG0598|consen 273 GDAEEIKRHPFFKGINWEKLLAKKLSPPF 301 (357)
T ss_pred CChHHhhcCcccccCCHHHHHhcCCCCCe
Confidence 5899999999999999999875554433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-68 Score=510.20 Aligned_cols=318 Identities=34% Similarity=0.596 Sum_probs=254.3
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+.+++|++++.||+|+||.||+|+.+.||+.||+|++.|+...++ .+...+..|..||...++|+||+|
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~----------~Qv~hV~aERdiL~~~ds~~vVKL 206 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK----------NQVEHVRAERDILAEVDSPWVVKL 206 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh----------hhHHHHHHHHHHhhhcCCCcEEEE
Confidence 5788999999999999999999999999999999999999877665 367889999999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+..|++..++||||||++|||+.+++.+. +.|++..+++|+++++.|++.||++|||||||||+|+|||..|||||+|
T Consensus 207 yYsFQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 207 YYSFQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred EEEecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecc
Confidence 99999999999999999999999998765 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCC--CCCCCCCCCCCC---CCCCCCCCcccccc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPV--HSPRIGPDPPSR---SDSDSSEKSNSFVG 246 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~g 246 (426)
||||+.+.......... .........++....+.. ..++.+..+... -.........+.||
T Consensus 285 FGLs~gl~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVG 350 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYR--------------LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVG 350 (550)
T ss_pred ccccchhhhhhhhhhhc--------------chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccC
Confidence 99998765432111000 000000000000000000 000000000000 00112345667899
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~d 321 (426)
||.|||||++.+.+|+..+||||||||+||||.|.+||.+.++.+++.+|+... |.-...+.+++|||.+||. |
T Consensus 351 TPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d 429 (550)
T KOG0605|consen 351 TPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-D 429 (550)
T ss_pred CccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-C
Confidence 999999999999999999999999999999999999999999999999987332 3333557899999999999 9
Q ss_pred CCCCCC---hHHHhcCCCcCCCChhhhhhccCCCCCCCC
Q 014344 322 PTKRIG---VEEIKGHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 322 P~~R~s---~~eil~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
|.+|+. ++||.+||||++++|+.+.+.. ||++|..
T Consensus 430 ~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP~v 467 (550)
T KOG0605|consen 430 PENRLGSKGAEEIKKHPFFKGVDWDHLREMP-APFVPQV 467 (550)
T ss_pred HHHhcCcccHHHHhcCCccccCCcchhhcCC-CCCCCCC
Confidence 999995 8999999999999999997765 6666644
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-67 Score=466.25 Aligned_cols=283 Identities=39% Similarity=0.705 Sum_probs=255.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
..+..+++|+++++||.|+||.|.+++++.+|..||+|++++..+.+. .+.+...+|.++|+.+.||+++
T Consensus 38 ~~~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl----------KQveH~~nEk~vL~~v~~PFlv 107 (355)
T KOG0616|consen 38 QNPYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL----------KQVEHTHNEKRVLKAVSHPFLV 107 (355)
T ss_pred CCCcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHH----------HHHHHHhhHHHHHhhccCceeE
Confidence 445899999999999999999999999999999999999999887665 2567888999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++.|.+.+.+|+||||.+||.|++++++.+ +|++..+++|++||++||+|||+++|++|||||||||+|++|++||
T Consensus 108 ~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 108 KLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred EEEEeeccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEE
Confidence 99999999999999999999999999988654 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+. .++.+.||||.
T Consensus 186 tDFGFAK~v~-----------------------------------------------------------~rT~TlCGTPe 206 (355)
T KOG0616|consen 186 TDFGFAKRVS-----------------------------------------------------------GRTWTLCGTPE 206 (355)
T ss_pred EeccceEEec-----------------------------------------------------------CcEEEecCCcc
Confidence 9999999874 24678899999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC-CCHHHHHHHHHHhccCCCCCC--
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG-EPTPLRNLIRRLLEKDPTKRI-- 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~li~~~L~~dP~~R~-- 326 (426)
|+|||++..++|+.++|||||||++|||+.|.+||...++..++.+|+.....++. .+++++|||+++|+.|-.+|.
T Consensus 207 YLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gn 286 (355)
T KOG0616|consen 207 YLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGN 286 (355)
T ss_pred ccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcC
Confidence 99999999999999999999999999999999999999999999999876655543 378999999999999999995
Q ss_pred ---ChHHHhcCCCcCCCChhhhhhc-cCCCCCCCCCCCCCC
Q 014344 327 ---GVEEIKGHEFFKGVNWELLLKI-SRPPNIPARFEHENN 363 (426)
Q Consensus 327 ---s~~eil~hp~f~~~~~~~~~~~-~~~~~~~~~~~~~~~ 363 (426)
...+|.+||||++++|+.+... ..+|..|+......+
T Consensus 287 lknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gd 327 (355)
T KOG0616|consen 287 LKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGD 327 (355)
T ss_pred cCCCccccccCcccccccHHHHhhccccCCCCCccccCCcc
Confidence 4789999999999999998764 456777755544433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-65 Score=487.48 Aligned_cols=285 Identities=35% Similarity=0.632 Sum_probs=251.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~ 90 (426)
.-..++|.+++.||.|+|++|++|+++.+++.|||||+.|..+.+.. ..+.+..|..+|.+| .||.|++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~----------KvkYV~~Ek~~l~~L~~hPgivk 138 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEK----------KVKYVTREKEALTQLSGHPGIVK 138 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhc----------ccchhhHHHHHHHHhhCCCCeEE
Confidence 45578999999999999999999999999999999999998887763 456788899999999 7999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
|+..|+++..+|+|+||+++|+|.+++++.+ .|++..+|+|++||+.||+|||++||||||||||||||+.+|++||+
T Consensus 139 Ly~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 139 LYFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred EEEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEe
Confidence 9999999999999999999999999998764 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||.|+.+.+...... .+. ..........+||||..|
T Consensus 217 DFGsAK~l~~~~~~~~-------------------------------~~~------------~~~~a~s~~~SFVGTAeY 253 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQE-------------------------------NPV------------DPNQASSRRSSFVGTAEY 253 (604)
T ss_pred eccccccCChhhcccc-------------------------------Ccc------------CcccccCcccceeeeecc
Confidence 9999999875432110 000 000011224789999999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
++||++.....++++|+||||||||+|+.|.+||.+.++.-+|++|+..... ..+.++.++|||+++|..||.+|+|++
T Consensus 254 VSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 254 VSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred cCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 9999999999999999999999999999999999999999999999865433 446689999999999999999999999
Q ss_pred HHhcCCCcCCCChhhhhhccCC
Q 014344 330 EIKGHEFFKGVNWELLLKISRP 351 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~~ 351 (426)
+|.+||||.+++|+++.+...|
T Consensus 334 qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 334 QIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHhhCcccccCChhhhhhcCCC
Confidence 9999999999999998765544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-62 Score=479.74 Aligned_cols=278 Identities=36% Similarity=0.680 Sum_probs=248.6
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcc
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLP 89 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv 89 (426)
..+.+++|+++++||+|+||+|++|..+.+++.||||+++|..+-.+ +.....+.|.+|+.... ||+++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~----------d~Ve~~~~EkrI~~la~~HPFL~ 432 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR----------DEVESLMCEKRIFELANRHPFLV 432 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc----------ccHHHHHHHHHHHHHhccCCeEe
Confidence 46889999999999999999999999999999999999988776443 45678888999999886 99999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.++.+|++.+++|+||||+.|||+..++ ..+.|++..+++|+++|+.||+|||++||||||||.+|||||.+|++||
T Consensus 433 ~L~~~fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~ki 509 (694)
T KOG0694|consen 433 NLFSCFQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKI 509 (694)
T ss_pred ecccccccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEe
Confidence 9999999999999999999999955432 3355999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||||+.... .+.++.+|||||.
T Consensus 510 ADFGlcKe~m~--------------------------------------------------------~g~~TsTfCGTpe 533 (694)
T KOG0694|consen 510 ADFGLCKEGMG--------------------------------------------------------QGDRTSTFCGTPE 533 (694)
T ss_pred cccccccccCC--------------------------------------------------------CCCccccccCChh
Confidence 99999986431 2346789999999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCC-
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIG- 327 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s- 327 (426)
|||||++.+..|+.++|||||||+|||||.|.+||.+.+..+.+..|+...+..+ ..+.++.++|++||+++|++|+.
T Consensus 534 y~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 534 FLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9999999999999999999999999999999999999999999999997766554 45889999999999999999996
Q ss_pred ----hHHHhcCCCcCCCChhhhhhcc-CCCCCCCC
Q 014344 328 ----VEEIKGHEFFKGVNWELLLKIS-RPPNIPAR 357 (426)
Q Consensus 328 ----~~eil~hp~f~~~~~~~~~~~~-~~~~~~~~ 357 (426)
+++|.+||||+.++|+.+.... .||+.|..
T Consensus 614 ~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 614 GERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred CCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence 5899999999999999998754 45555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=471.38 Aligned_cols=255 Identities=30% Similarity=0.564 Sum_probs=235.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|...+.||+|||+.||.+++..+|+.||+|++.+..+.+. ....++.+|++|.+.|+|||||+++++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~----------~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP----------KQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc----------chHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 459999999999999999999999999999999988776543 3567899999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
++.+++|||+|+|..++|..+.++ ++.++|.+|+.|++||+.||.|||+++|||||||..|+||+++.+|||+|||||
T Consensus 88 EDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLA 165 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEeccccee
Confidence 999999999999999999999874 456999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+... .++..++||||.|.|||+
T Consensus 166 t~le~~--------------------------------------------------------~Erk~TlCGTPNYIAPEV 189 (592)
T KOG0575|consen 166 TQLEYD--------------------------------------------------------GERKKTLCGTPNYIAPEV 189 (592)
T ss_pred eeecCc--------------------------------------------------------ccccceecCCCcccChhH
Confidence 987532 356778999999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+...+|++.+||||+||++|.||+|++||...+-++++.+|....... ...+.+++|||++||+.||.+|||+++||.|
T Consensus 190 l~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 190 LNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred hccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 999999999999999999999999999999999999999997654333 3558899999999999999999999999999
Q ss_pred CCcC
Q 014344 335 EFFK 338 (426)
Q Consensus 335 p~f~ 338 (426)
+||+
T Consensus 270 ~Ff~ 273 (592)
T KOG0575|consen 270 PFFK 273 (592)
T ss_pred Hhhh
Confidence 9994
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-62 Score=454.17 Aligned_cols=263 Identities=28% Similarity=0.427 Sum_probs=226.9
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
-...|.+.+.||+|+||.|-+|..+.||+.||||++.+......+.. ......+.+|++||++|+||+||++++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~------~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA------IAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc------ccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 34568899999999999999999999999999999988765443221 122345789999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEe
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLV 170 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~ 170 (426)
+|+.++..|+||||+.||+|++.+-.++ .+.+..-+.+++||+.||.|||++||+||||||+|||+..+ -.+||+
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999999999877654 48899999999999999999999999999999999999876 689999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.... ....+++||||.|
T Consensus 322 DFGlAK~~g~---------------------------------------------------------~sfm~TlCGTpsY 344 (475)
T KOG0615|consen 322 DFGLAKVSGE---------------------------------------------------------GSFMKTLCGTPSY 344 (475)
T ss_pred ccchhhcccc---------------------------------------------------------ceehhhhcCCccc
Confidence 9999987642 3467789999999
Q ss_pred ccchhhcCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC-----CCCCCCCCHHHHHHHHHHhccC
Q 014344 251 VAPEIIEGKGH---DFAVDWWSLGVVLHEMLYGATPFRGSSRKE-TFYRILCR-----PPDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 251 ~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~-----~~~~~~~~~~~~~li~~~L~~d 321 (426)
+|||++.+.++ ..++|+||+||+||-+++|.+||.+..... ...+|... ++.+...+.++.+||.+||..|
T Consensus 345 vAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~Vd 424 (475)
T KOG0615|consen 345 VAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVD 424 (475)
T ss_pred cChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeC
Confidence 99999988764 457899999999999999999999876655 56666543 3444566788999999999999
Q ss_pred CCCCCChHHHhcCCCcCCCC
Q 014344 322 PTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 322 P~~R~s~~eil~hp~f~~~~ 341 (426)
|++|||++|+|+||||+...
T Consensus 425 P~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 425 PENRPSADEALNHPWFKDAP 444 (475)
T ss_pred cccCcCHHHHhcChhhhccc
Confidence 99999999999999998654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=433.47 Aligned_cols=255 Identities=29% Similarity=0.507 Sum_probs=229.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+..++.+.++.||+|+.|+||+|+++.|++.+|+|++... .+....+.+.+|++|++.++||+||.+|
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~------------~~~~~~~Qi~rEl~il~~~~spyIV~~y 143 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN------------IDPALQKQILRELEILRSCQSPYIVGFY 143 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc------------CCHHHHHHHHHHHHHHhhCCCCCeeeEe
Confidence 4556899999999999999999999999999999998321 2344667899999999999999999999
Q ss_pred eeeecCC-eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEe
Q 014344 93 GVLSTDK-FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 93 ~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++|..+. .++|+||||+||+|.+++... +.+++.....++.+|+.||.|||+ ++||||||||+|||++..|.||||
T Consensus 144 gaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 144 GAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred EEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEec
Confidence 9999998 499999999999999998765 459999999999999999999995 999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||.++.+.. ..+++++||-.|
T Consensus 222 DFGVS~~lvn----------------------------------------------------------S~a~tfvGT~~Y 243 (364)
T KOG0581|consen 222 DFGVSGILVN----------------------------------------------------------SIANTFVGTSAY 243 (364)
T ss_pred cccccHHhhh----------------------------------------------------------hhcccccccccc
Confidence 9999987742 156889999999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCC-CCCC-C-CCHHHHHHHHHHhccCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS-----SRKETFYRILCRP-PDLV-G-EPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~-~~~~-~-~~~~~~~li~~~L~~dP 322 (426)
||||.+.+..|+.++||||||++++||++|++||... +..+.+..|+..+ |.++ + +++++++||.+||++||
T Consensus 244 MsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp 323 (364)
T KOG0581|consen 244 MSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDP 323 (364)
T ss_pred cChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999999999875 5667788888744 3443 2 68999999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
.+|++++|+++|||++.
T Consensus 324 ~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 324 SERPSAKQLLQHPFIKK 340 (364)
T ss_pred ccCCCHHHHhcCHHHhh
Confidence 99999999999999974
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-57 Score=422.87 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=226.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
..+|.+.++||+|+||+||+|+++.++..||||.+.+..+.++ ..+.+..|+.||+.++|||||.++++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k-----------~~e~L~~Ei~iLkel~H~nIV~l~d~ 77 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKK-----------LVELLLSEIKILKELKHPNIVRLLDC 77 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHH-----------HHHHHHHHHHHHHhcCCcceeeEEEE
Confidence 5689999999999999999999999999999999987765444 34567789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC------CcEE
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN------GHIM 168 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~------g~ik 168 (426)
+.+++.+|||||||.||||.+++++.+ .+++..++.++.||+.||++||+++||||||||+||||+.. -.+|
T Consensus 78 ~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LK 155 (429)
T KOG0595|consen 78 IEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLK 155 (429)
T ss_pred EecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEE
Confidence 999999999999999999999998764 49999999999999999999999999999999999999865 4689
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+.+.++ ....+.||+|
T Consensus 156 IADFGfAR~L~~~---------------------------------------------------------~~a~tlcGSp 178 (429)
T KOG0595|consen 156 IADFGFARFLQPG---------------------------------------------------------SMAETLCGSP 178 (429)
T ss_pred ecccchhhhCCch---------------------------------------------------------hHHHHhhCCc
Confidence 9999999988632 2455678999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHHHhccCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~L~~dP~~ 324 (426)
.|||||++....|+.++|+||+|+|+|+|++|++||...+..+.+..+.......+ ..+.++.+|+..+|+.+|..
T Consensus 179 lYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~ 258 (429)
T KOG0595|consen 179 LYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKD 258 (429)
T ss_pred cccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccc
Confidence 99999999999999999999999999999999999999999999887754432221 23556779999999999999
Q ss_pred CCChHHHhcCCCcCC
Q 014344 325 RIGVEEIKGHEFFKG 339 (426)
Q Consensus 325 R~s~~eil~hp~f~~ 339 (426)
|.+..+-+.|+++..
T Consensus 259 ~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 259 RISFEDFFDHPFLAA 273 (429)
T ss_pred cCchHHhhhhhhccc
Confidence 999999999999854
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=408.42 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=220.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
++.|+.+.++|+|+||+||+|+++.||+.||||.+.- ..+++...+-.++|+++|++|+|||+|.++++
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E-----------sedd~~VkKIAlREIrmLKqLkH~NLVnLiEV 69 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE-----------SEDDPVVKKIALREIRMLKQLKHENLVNLIEV 69 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeecc-----------CCccHHHHHHHHHHHHHHHhcccchHHHHHHH
Confidence 3679999999999999999999999999999999822 22344556778899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|.....+++|+|||+..-|..+ +.... .++.+.++.|+.|++.|+.|||++++||||||||||||+.+|.+||||||+
T Consensus 70 FrrkrklhLVFE~~dhTvL~eL-e~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 70 FRRKRKLHLVFEYCDHTVLHEL-ERYPN-GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred HHhcceeEEEeeecchHHHHHH-HhccC-CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchh
Confidence 9999999999999986666665 44433 399999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|+.+... +..-+.+|.|.+|+|||
T Consensus 148 AR~L~~p--------------------------------------------------------gd~YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 148 ARTLSAP--------------------------------------------------------GDNYTDYVATRWYRAPE 171 (396)
T ss_pred hHhhcCC--------------------------------------------------------cchhhhhhhhhhccChh
Confidence 9987521 12345678999999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------CCCC-----------------
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--------------RPPD----------------- 302 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------~~~~----------------- 302 (426)
++.| ..|+..+||||+||++.||++|.+.|++.++.++++.|.. ..+.
T Consensus 172 LLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~ 251 (396)
T KOG0593|consen 172 LLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLER 251 (396)
T ss_pred hhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhh
Confidence 9988 7899999999999999999999999999999888776631 1111
Q ss_pred -CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 -LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 -~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.++.+..+.||+++||..||.+|++.+++|.||||.+
T Consensus 252 k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 252 KYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred hcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 1223456889999999999999999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=464.91 Aligned_cols=278 Identities=35% Similarity=0.625 Sum_probs=245.0
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.++.++|+|+++||+|+||.|.+|+++.+++.||+|+++|....++. ...-|..|..||..-+.++|+.+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~----------~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRA----------ETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhch----------hHHHHHHHhHHHHcCCcHHHHHH
Confidence 36778999999999999999999999999999999999886554432 33568889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+.+|+++.++|+||||++||||-.++.... .+|+..+++|+++|+.||+.||+.|+|||||||+|||||..|||||+|
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeecc
Confidence 999999999999999999999999987765 599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||.|..+.... .-.+...||||.|.
T Consensus 219 FGsClkm~~dG-------------------------------------------------------~V~s~~aVGTPDYI 243 (1317)
T KOG0612|consen 219 FGSCLKMDADG-------------------------------------------------------TVRSSVAVGTPDYI 243 (1317)
T ss_pred chhHHhcCCCC-------------------------------------------------------cEEeccccCCCCcc
Confidence 99998876332 22455668999999
Q ss_pred cchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCHHHHHHHHHHhccC
Q 014344 252 APEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 252 aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~li~~~L~~d 321 (426)
|||++.. ..|+..+||||+||++|||++|..||...+-.++|.+|+.. .|.....|..+++||+++| -+
T Consensus 244 SPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~ 322 (1317)
T KOG0612|consen 244 SPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CD 322 (1317)
T ss_pred CHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cC
Confidence 9999863 45889999999999999999999999999999999999743 2233457899999999998 46
Q ss_pred CCCCCC---hHHHhcCCCcCCCChhhhhhccCCCCCCCCC
Q 014344 322 PTKRIG---VEEIKGHEFFKGVNWELLLKISRPPNIPARF 358 (426)
Q Consensus 322 P~~R~s---~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~ 358 (426)
|+.|.+ +++|.+||||.+++|+.+ +...||.+|...
T Consensus 323 ~e~RLgrngiedik~HpFF~g~~W~~i-R~~~pP~vPevs 361 (1317)
T KOG0612|consen 323 REVRLGRNGIEDIKNHPFFEGIDWDNI-RESVPPVVPEVS 361 (1317)
T ss_pred hhhhcccccHHHHHhCccccCCChhhh-hhcCCCCCCcCC
Confidence 889998 999999999999999876 556788887653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=409.98 Aligned_cols=281 Identities=35% Similarity=0.639 Sum_probs=249.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+.+++|..+++||+|.||+|.+|+.+.+++.||||++.|+.+..+ +.......|-++|+..+||++.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak----------dEVAHTlTE~RVL~~~~HPFLt 231 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK----------DEVAHTLTENRVLQNCRHPFLT 231 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh----------HHhhhhhhHHHHHHhccCcHHH
Confidence 455788999999999999999999999999999999999988877554 3456677899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.+-..|++...+|+||||+.||.|+-.+.+ .+.|++..+++|-++|++||.|||+++||+||||.+|+|+|.+|||||
T Consensus 232 ~LKYsFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 232 SLKYSFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred HhhhhhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEe
Confidence 999999999999999999999999876655 345999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.-. ..+....+|||||.
T Consensus 310 tDFGLCKE~I--------------------------------------------------------~~g~t~kTFCGTPE 333 (516)
T KOG0690|consen 310 TDFGLCKEEI--------------------------------------------------------KYGDTTKTFCGTPE 333 (516)
T ss_pred eecccchhcc--------------------------------------------------------cccceeccccCChh
Confidence 9999987532 12346788999999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCC-
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIG- 327 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s- 327 (426)
|+|||++....|+.++|||.+||++|||++|+.||...+....+..|+.....++ ..+++++.|+..+|.+||.+|+.
T Consensus 334 YLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 334 YLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred hcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCC
Confidence 9999999999999999999999999999999999999999999998876554443 45889999999999999999996
Q ss_pred ----hHHHhcCCCcCCCChhhhhhccCCCCCCCCC
Q 014344 328 ----VEEIKGHEFFKGVNWELLLKISRPPNIPARF 358 (426)
Q Consensus 328 ----~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~ 358 (426)
+.||..|+||.+++|+.+.....+|+..+..
T Consensus 414 GpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 414 GPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred CchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 8999999999999999987755554444343
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=429.54 Aligned_cols=262 Identities=34% Similarity=0.529 Sum_probs=232.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~ 90 (426)
....+.|++.+.||+|+||+|++|++..+++.||+|++.+....... ....+.+.+|+.+++.+. ||||++
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~--------~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS--------QKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc--------cccchhhHHHHHHHHHhccCCCEeE
Confidence 35677899999999999999999999999999999988776332111 123345668999999999 999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-CcEEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-GHIML 169 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g~ikL 169 (426)
+++++.+...+|+|||||.||+|++++.. .+++.+..++.+++||+.|++|||++||+||||||||||++.+ +++||
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl 162 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKL 162 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEE
Confidence 99999999999999999999999999887 3459999999999999999999999999999999999999999 99999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++.... .......++||||.
T Consensus 163 ~DFG~s~~~~--------------------------------------------------------~~~~~l~t~cGsp~ 186 (370)
T KOG0583|consen 163 SDFGLSAISP--------------------------------------------------------GEDGLLKTFCGSPA 186 (370)
T ss_pred eccccccccC--------------------------------------------------------CCCCcccCCCCCcc
Confidence 9999998652 01235667899999
Q ss_pred CccchhhcCCC-C-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC--CHHHHHHHHHHhccCCCCC
Q 014344 250 YVAPEIIEGKG-H-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--PTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 250 y~aPE~~~~~~-~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~li~~~L~~dP~~R 325 (426)
|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..|......++.. +.++++||.+||..||.+|
T Consensus 187 Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R 266 (370)
T KOG0583|consen 187 YAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTR 266 (370)
T ss_pred cCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccC
Confidence 99999999988 8 489999999999999999999999999999999988766555544 8999999999999999999
Q ss_pred CChHHHhcCCCcCC
Q 014344 326 IGVEEIKGHEFFKG 339 (426)
Q Consensus 326 ~s~~eil~hp~f~~ 339 (426)
+|+.+|+.||||+.
T Consensus 267 ~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 267 ITLLEILEHPWFQK 280 (370)
T ss_pred CCHHHHhhChhhcc
Confidence 99999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-56 Score=432.32 Aligned_cols=264 Identities=26% Similarity=0.454 Sum_probs=233.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
++-|++++.||.|+-|.|-+|++..||+..|||++.+.. .........+.+|+-||+.+.|||+++++++
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~----------~~s~s~~~~IerEIviMkLi~HpnVl~LydV 80 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS----------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDV 80 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccc----------ccccccccchhhhhHHHHHhcCCCeeeeeee
Confidence 345999999999999999999999999999999996653 1222345678899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+++.+.+|+|+||++||.|++++...+ ++++.++.++++||+.|+.|||..+|+||||||+|+||+..+.|||+|||+
T Consensus 81 we~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 81 WENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred eccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccce
Confidence 999999999999999999999987654 499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|....++ ....+.||+|.|.|||
T Consensus 159 AsLe~~g---------------------------------------------------------klLeTSCGSPHYA~PE 181 (786)
T KOG0588|consen 159 ASLEVPG---------------------------------------------------------KLLETSCGSPHYAAPE 181 (786)
T ss_pred eecccCC---------------------------------------------------------ccccccCCCcccCCch
Confidence 9765322 2344568999999999
Q ss_pred hhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 255 ~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
++.|.+| +.++||||+|||||.||+|+.||++.+....+.++.......+ ..++++.+||++||..||++|+|.+||+
T Consensus 182 IV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~ 261 (786)
T KOG0588|consen 182 IVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEIL 261 (786)
T ss_pred hhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHh
Confidence 9999998 6899999999999999999999999999988888876554433 4589999999999999999999999999
Q ss_pred cCCCcCCCChhhhhh
Q 014344 333 GHEFFKGVNWELLLK 347 (426)
Q Consensus 333 ~hp~f~~~~~~~~~~ 347 (426)
+|||+.+..-....+
T Consensus 262 kHP~l~g~~~~~~~~ 276 (786)
T KOG0588|consen 262 KHPFLSGYTSLPSSK 276 (786)
T ss_pred hCchhhcCCCCChhh
Confidence 999999876544443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=416.72 Aligned_cols=281 Identities=33% Similarity=0.630 Sum_probs=242.6
Q ss_pred cCCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc
Q 014344 4 VVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83 (426)
Q Consensus 4 ~~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 83 (426)
++.......+.+++|++.+.||+|+||.||+|++..+++.||+|++.+...... .....+..|+.+|+.+
T Consensus 6 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l 75 (329)
T PTZ00263 6 MFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM----------KQVQHVAQEKSILMEL 75 (329)
T ss_pred eeeccccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhC
Confidence 444555677889999999999999999999999999999999999976543221 2346788899999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+||||+++++++..++.+|+|||||.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 76 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~ 153 (329)
T PTZ00263 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN 153 (329)
T ss_pred CCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC
Confidence 9999999999999999999999999999999988754 34899999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
+|.+||+|||++..... ...+
T Consensus 154 ~~~~kl~Dfg~~~~~~~-----------------------------------------------------------~~~~ 174 (329)
T PTZ00263 154 KGHVKVTDFGFAKKVPD-----------------------------------------------------------RTFT 174 (329)
T ss_pred CCCEEEeeccCceEcCC-----------------------------------------------------------Ccce
Confidence 99999999999875421 1123
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCC
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP 322 (426)
.+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.......+ ..+..+++||.+||+.||
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP 254 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDH 254 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCH
Confidence 4699999999999999999999999999999999999999999888888877765544333 357789999999999999
Q ss_pred CCCCC-----hHHHhcCCCcCCCChhhhhhccCCCCCC
Q 014344 323 TKRIG-----VEEIKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 323 ~~R~s-----~~eil~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
.+|++ +++|+.||||++.+|+.+.....++..+
T Consensus 255 ~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~ 292 (329)
T PTZ00263 255 TKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292 (329)
T ss_pred HHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcC
Confidence 99997 7999999999999999887644444333
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=396.22 Aligned_cols=263 Identities=28% Similarity=0.410 Sum_probs=226.2
Q ss_pred CCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 5 ~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
+...++....+.+|+|+++||+|+||.||+|.+..+|..+|.|.+.-..+.. ...+.+..|+.+|++|+
T Consensus 8 ~~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~-----------k~rq~~v~Ei~lLkQL~ 76 (375)
T KOG0591|consen 8 MMDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA-----------KARQDCVKEISLLKQLN 76 (375)
T ss_pred ccCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH-----------HHHHHHHHHHHHHHhcC
Confidence 4445556677889999999999999999999999999999999986544333 24567888999999999
Q ss_pred CCCcceeee-eeecC-CeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccCCCC
Q 014344 85 HPLLPRLRG-VLSTD-KFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHN--MG--IVYRDLKP 156 (426)
Q Consensus 85 hp~iv~l~~-~~~~~-~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~--~g--iiHrDlKp 156 (426)
|||||++++ .|..+ +.++||||||.+|||..+++.. ..+.+++..++.|+.|++.||..+|+ .. |+||||||
T Consensus 77 HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 77 HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred CchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 999999998 45444 4599999999999999988743 35679999999999999999999999 44 99999999
Q ss_pred CCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 157 ENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 157 ~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
.||+|+.+|.+||+||||++.+...
T Consensus 157 aNIFl~~~gvvKLGDfGL~r~l~s~------------------------------------------------------- 181 (375)
T KOG0591|consen 157 ANIFLTANGVVKLGDFGLGRFLSSK------------------------------------------------------- 181 (375)
T ss_pred hheEEcCCCceeeccchhHhHhcch-------------------------------------------------------
Confidence 9999999999999999999987532
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CC--CCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LV--GEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~--~~~~~~~~l 313 (426)
...+.++||||.||+||++.+.+|++++||||+||++|||+.-++||.+.+-.+...+|...... ++ ..+..+..|
T Consensus 182 -~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~l 260 (375)
T KOG0591|consen 182 -TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLREL 260 (375)
T ss_pred -hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHH
Confidence 23466889999999999999999999999999999999999999999999988888888765332 33 347889999
Q ss_pred HHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
|..|+..||..||+. +|++.+
T Consensus 261 i~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 261 INMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred HHHHccCCcccCCCc-----chHHHH
Confidence 999999999999986 555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=420.61 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=230.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|.+.+.||+|+||.||+++.+.+.+.||||.+.|..- +....+.+.+|++|++.|+||||+.++++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-----------~~k~l~~l~~ev~i~r~lkHpniv~m~es 69 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-----------NEKELKNLRQEVRILRSLKHPNIVEMLES 69 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-----------chHHHHHHHHHHHHHHhcCCcchhhHHHh
Confidence 4679999999999999999999999999999999966432 22356789999999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|++...+|+|+|||.| +|+.++.... .++++.++.++.|++.||.|||+++|.|||+||.|||+...|++|++|||+
T Consensus 70 fEt~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 70 FETSAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred hcccceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhh
Confidence 9999999999999986 9999988654 499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|+.+..+. ...++.-|||.|||||
T Consensus 147 Ar~m~~~t--------------------------------------------------------~vltsikGtPlYmAPE 170 (808)
T KOG0597|consen 147 ARAMSTNT--------------------------------------------------------SVLTSIKGTPLYMAPE 170 (808)
T ss_pred hhhcccCc--------------------------------------------------------eeeeeccCcccccCHH
Confidence 99875422 1233456999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
++.+..|+..+|+||||||+|||.+|++||...+..+....|+..+..++ ..++.+.+||+.+|.+||.+|+|..+++.
T Consensus 171 lv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 171 LVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 99999999999999999999999999999999999999999998876554 45788999999999999999999999999
Q ss_pred CCCcCC
Q 014344 334 HEFFKG 339 (426)
Q Consensus 334 hp~f~~ 339 (426)
|||+++
T Consensus 251 HpF~k~ 256 (808)
T KOG0597|consen 251 HPFWKG 256 (808)
T ss_pred ChHHhh
Confidence 999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=399.02 Aligned_cols=268 Identities=26% Similarity=0.430 Sum_probs=235.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...++..+|++..+||.|..++||+|+...+++.||||+++.+.. ...++.+.+|+..|+.++||||+
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc------------~~~ld~l~kE~~~msl~~HPNIv 87 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC------------NNDLDALRKEVQTMSLIDHPNIV 87 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh------------hhhHHHHHHHHHHhhhcCCCCcc
Confidence 567889999999999999999999999999999999999965532 22367899999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.++..|..+..+|+||.||.+|++.++++......++|..+..++++++.||.|||++|.||||||+.||||+.+|.|||
T Consensus 88 ~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 88 TYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred eEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEE
Confidence 99999999999999999999999999998877677999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||.+..+..... ....+.++++|||+
T Consensus 168 adFgvsa~l~~~G~----------------------------------------------------R~~~rf~tfvgtp~ 195 (516)
T KOG0582|consen 168 ADFGVSASLFDSGD----------------------------------------------------RQVTRFNTFVGTPC 195 (516)
T ss_pred cCceeeeeecccCc----------------------------------------------------eeeEeeccccCccc
Confidence 99999887643210 00112278899999
Q ss_pred CccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----------CCCHHHHHHHHH
Q 014344 250 YVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-----------GEPTPLRNLIRR 316 (426)
Q Consensus 250 y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~~~~~li~~ 316 (426)
|||||++.. .+|++++||||||++..||.+|..||....+.+.+...++..+..+ ..+..++.+|..
T Consensus 196 wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~ 275 (516)
T KOG0582|consen 196 WMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIAL 275 (516)
T ss_pred ccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHH
Confidence 999999543 6799999999999999999999999999999888887776655422 124468899999
Q ss_pred HhccCCCCCCChHHHhcCCCcCCCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
||++||++|||++++|+|+||+...
T Consensus 276 CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 276 CLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HhhcCcccCCCHHHHhccHHHhhcc
Confidence 9999999999999999999998654
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=407.27 Aligned_cols=274 Identities=28% Similarity=0.518 Sum_probs=229.0
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhccc-CCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTN-NDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
...+++|++++.||+|.||+|-+|++..+++.||||++.|....+..-.... .......+.+.+|+.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3567899999999999999999999999999999999988765543221111 111122468999999999999999999
Q ss_pred eeeeeec--CCeEEEEEeccCCCChHHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 91 LRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQM-FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 91 l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~-l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++..+ .+.+|||+|||..|.+... ...++ +++.++|.|+++++.||+|||.+|||||||||.|+||+++|+|
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 9999965 4689999999999988643 23344 9999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||.+.....+... .........+||
T Consensus 250 KIsDFGVs~~~~~~~~~---------------------------------------------------~~d~~L~~tvGT 278 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDE---------------------------------------------------GSDDQLSRTVGT 278 (576)
T ss_pred EeeccceeeecccCCcc---------------------------------------------------ccHHHHhhcCCC
Confidence 99999999876433111 111112225799
Q ss_pred CCCccchhhcCCC---C-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC---CHHHHHHHHHHhcc
Q 014344 248 EEYVAPEIIEGKG---H-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE---PTPLRNLIRRLLEK 320 (426)
Q Consensus 248 ~~y~aPE~~~~~~---~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~---~~~~~~li~~~L~~ 320 (426)
|.|+|||++.+.. + +++.||||+||+||.|+.|+.||.+....+++.+|+..+..++.. ...++|||.+||++
T Consensus 279 PAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~K 358 (576)
T KOG0585|consen 279 PAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEK 358 (576)
T ss_pred ccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhc
Confidence 9999999988732 2 689999999999999999999999999999999999888766654 67899999999999
Q ss_pred CCCCCCChHHHhcCCCcCC
Q 014344 321 DPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~~ 339 (426)
||++|+++.+|..|||...
T Consensus 359 dP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 359 DPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred Chhheeehhhheecceecc
Confidence 9999999999999999863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=376.74 Aligned_cols=267 Identities=30% Similarity=0.509 Sum_probs=240.8
Q ss_pred CCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 5 ~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
+-++....+.+++|++++.||+|-||.||+|+.+.++-.||+||+.|+.+.+.. ....+.+|++|-+.|+
T Consensus 11 ~~~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~----------v~~qlrREiEIqs~L~ 80 (281)
T KOG0580|consen 11 FGSRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQ----------VEHQLRREIEIQSHLR 80 (281)
T ss_pred cccccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhc----------chhhhhheeEeecccC
Confidence 344556788999999999999999999999999999999999999888765531 2356788999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
||||.+++++|.++..+|+++||..+|+|+..+..+..+.+++..+..|++|++.||.|+|..++|||||||+|+|++..
T Consensus 81 hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~ 160 (281)
T KOG0580|consen 81 HPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA 160 (281)
T ss_pred CccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC
Confidence 99999999999999999999999999999998887777789999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
|.+||+|||.+..-. ..+..++
T Consensus 161 ~~lkiAdfGwsV~~p----------------------------------------------------------~~kR~tl 182 (281)
T KOG0580|consen 161 GELKIADFGWSVHAP----------------------------------------------------------SNKRKTL 182 (281)
T ss_pred CCeeccCCCceeecC----------------------------------------------------------CCCceee
Confidence 999999999886532 2356788
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~ 323 (426)
|||..|.+||+..+..++..+|+|++|+++||++.|.+||...+..+++.+|....... ...+..++|||.+||.++|.
T Consensus 183 cgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~ 262 (281)
T KOG0580|consen 183 CGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPI 262 (281)
T ss_pred ecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCcc
Confidence 99999999999999999999999999999999999999999999999999997544333 34578899999999999999
Q ss_pred CCCChHHHhcCCCcCC
Q 014344 324 KRIGVEEIKGHEFFKG 339 (426)
Q Consensus 324 ~R~s~~eil~hp~f~~ 339 (426)
+|.+..|++.|||+..
T Consensus 263 ~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 263 ERLALTEVMDHPWIVA 278 (281)
T ss_pred ccccHHHHhhhHHHHh
Confidence 9999999999999854
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=412.49 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=221.7
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
...++|.++++||.|+||.||+|+.+.+++.||||.|++....-. . -.-.+|+.-|++|+ ||||+++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-----------e-~~nLREvksL~kln~hpniikL 74 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-----------E-CMNLREVKSLRKLNPHPNIIKL 74 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-----------H-HHHHHHHHHHHhcCCCCcchhh
Confidence 345679999999999999999999999999999999966543211 1 12356999999999 9999999
Q ss_pred eeeeecCC-eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 92 RGVLSTDK-FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 92 ~~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
.+++.+.+ .+|+|||||+ .+|+.+++.+ ++.|+++.++.|+.||+.||+|+|.+|+.||||||||||+.....|||+
T Consensus 75 ~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 75 KEVIRDNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred HHHhhccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEec
Confidence 99998877 9999999996 8999999877 6789999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.+....+ -+.+|.|.+|
T Consensus 153 DFGLARev~SkpP---------------------------------------------------------YTeYVSTRWY 175 (538)
T KOG0661|consen 153 DFGLAREVRSKPP---------------------------------------------------------YTEYVSTRWY 175 (538)
T ss_pred ccccccccccCCC---------------------------------------------------------cchhhhcccc
Confidence 9999998764332 3456889999
Q ss_pred ccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCC-------------------CC-----
Q 014344 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRP-------------------PD----- 302 (426)
Q Consensus 251 ~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~-------------------~~----- 302 (426)
+|||++.. ..|+.++||||+|||++|+.+-++.|.|.++.+++.+|. ..| +.
T Consensus 176 RAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~ 255 (538)
T KOG0661|consen 176 RAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSP 255 (538)
T ss_pred cchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCC
Confidence 99999765 568999999999999999999999999999998888773 111 11
Q ss_pred ----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 ----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 ----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
....+.++.+||.+||.+||.+||||.++|+||||+..
T Consensus 256 l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 256 LKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 11235678899999999999999999999999999853
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=384.85 Aligned_cols=256 Identities=27% Similarity=0.479 Sum_probs=227.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
-+.|++..+||+|.|++|+.+.+..+|+.+|+|+++-..+... ..+.+.+|++|.+.|+||||+++++.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-----------~~e~l~rEarIC~~LqHP~IvrL~~t 78 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-----------DFQKLEREARICRKLQHPNIVRLHDS 78 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-----------cHHHHHHHHHHHHhcCCCcEeehhhh
Confidence 4569999999999999999999999999999999965544332 45678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~D 171 (426)
+..+...|+|+|++.|++|+.-+-.+ ..+++..+.++++||+.||.|+|.+||||||+||+|+|+.+. .-+||+|
T Consensus 79 i~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~ 156 (355)
T KOG0033|consen 79 IQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLAD 156 (355)
T ss_pred hcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecc
Confidence 99999999999999999998655443 348999999999999999999999999999999999999754 3699999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+.. +.....++|||.||
T Consensus 157 FGvAi~l~~---------------------------------------------------------g~~~~G~~GtP~fm 179 (355)
T KOG0033|consen 157 FGLAIEVND---------------------------------------------------------GEAWHGFAGTPGYL 179 (355)
T ss_pred cceEEEeCC---------------------------------------------------------ccccccccCCCccc
Confidence 999988752 22345678999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||+++..+|+..+||||.||+||-|+.|++||.+.+....|.+|.... +.+...++.+++||++||..||.+|+
T Consensus 180 aPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI 259 (355)
T KOG0033|consen 180 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI 259 (355)
T ss_pred CHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhc
Confidence 9999999999999999999999999999999999999999999997543 35556688999999999999999999
Q ss_pred ChHHHhcCCCcCCC
Q 014344 327 GVEEIKGHEFFKGV 340 (426)
Q Consensus 327 s~~eil~hp~f~~~ 340 (426)
|+.|+|+|||+.+-
T Consensus 260 ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 260 TADEALKHPWICNR 273 (355)
T ss_pred cHHHHhCCchhcch
Confidence 99999999999753
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-53 Score=402.62 Aligned_cols=267 Identities=38% Similarity=0.664 Sum_probs=231.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+++.||+|++........ .....+.+|+.+|+.++||||+++++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 70 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL----------KQEQHVHNEKRVLKEVSHPFIIRLFWTE 70 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh----------HHHHHHHHHHHHHHhCCCCcHhhhHhhh
Confidence 469999999999999999999999999999999965432211 2345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++..+|+||||+.|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 71 HDQRFLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred ccCCeEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcc
Confidence 9999999999999999999988754 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..... .....+||+.|+|||+
T Consensus 149 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~ 169 (291)
T cd05612 149 KKLRD-----------------------------------------------------------RTWTLCGTPEYLAPEV 169 (291)
T ss_pred hhccC-----------------------------------------------------------CcccccCChhhcCHHH
Confidence 75421 1123469999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCC-----hH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIG-----VE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s-----~~ 329 (426)
+.+..++.++|||||||++|+|++|+.||.+.+..+.+..+......++ ..+..+++||++||+.||.+|++ ++
T Consensus 170 ~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~ 249 (291)
T cd05612 170 IQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGAD 249 (291)
T ss_pred HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHH
Confidence 9999999999999999999999999999999988888877765544333 44778999999999999999995 99
Q ss_pred HHhcCCCcCCCChhhhhhccCCCC
Q 014344 330 EIKGHEFFKGVNWELLLKISRPPN 353 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~~~~ 353 (426)
+++.||||+.++|.........+.
T Consensus 250 ~~l~h~~~~~~~~~~~~~~~~~~~ 273 (291)
T cd05612 250 DVKNHRWFKSVDWDDVPQRKLKPP 273 (291)
T ss_pred HHhcCccccCCCHHHHhcCCCCCC
Confidence 999999999999998765443333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=405.11 Aligned_cols=281 Identities=33% Similarity=0.549 Sum_probs=247.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.+..+.|+.-++||+|+||.||.++.+.||+.||+|.+.|.++.++.. ......|..||.+++.++||.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~g----------e~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKG----------ETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhh----------hHHhhHHHHHHHHhccCcEEE
Confidence 5677788999999999999999999999999999999999988877632 346777999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+-++|++++.+|+||..|+||||.-.+.+.+...|++..+++|++||+.||++||+.+||+|||||+|||+|+.|||+|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRIS 329 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRIS 329 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEee
Confidence 99999999999999999999999988877776779999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|+|||..+..+. .....+||..|
T Consensus 330 DLGLAvei~~g~---------------------------------------------------------~~~~rvGT~GY 352 (591)
T KOG0986|consen 330 DLGLAVEIPEGK---------------------------------------------------------PIRGRVGTVGY 352 (591)
T ss_pred ccceEEecCCCC---------------------------------------------------------ccccccCcccc
Confidence 999999875432 12334899999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK----ETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R 325 (426)
||||++.+..|++++|||||||++|||+.|+.||.....+ +.-.+++..+.... ..++++++|++.+|++||++|
T Consensus 353 MAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~R 432 (591)
T KOG0986|consen 353 MAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKR 432 (591)
T ss_pred cCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHh
Confidence 9999999999999999999999999999999999865433 44556665554443 458899999999999999999
Q ss_pred CC-----hHHHhcCCCcCCCChhhhhh-ccCCCCCCCCC
Q 014344 326 IG-----VEEIKGHEFFKGVNWELLLK-ISRPPNIPARF 358 (426)
Q Consensus 326 ~s-----~~eil~hp~f~~~~~~~~~~-~~~~~~~~~~~ 358 (426)
+. ++++.+||||++++|..+.. .-.||.+|++-
T Consensus 433 LGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~ 471 (591)
T KOG0986|consen 433 LGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG 471 (591)
T ss_pred ccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence 95 78999999999999998864 66788888763
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-52 Score=409.35 Aligned_cols=299 Identities=28% Similarity=0.505 Sum_probs=230.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+.++..++||||+++++.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~~~iv~~~~~~ 70 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK----------EQVGHIRAERDILVEADSLWVVKMFYSF 70 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh----------hHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 479999999999999999999999999999999976543221 2345778899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+...+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 71 QDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred ecCCeEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCc
Confidence 9999999999999999999988764 45999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+............ . .. .+........... .................+||+.|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~-------~----~~-----~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 207 (363)
T cd05628 149 TGLKKAHRTEFYRNL-------N----HS-----LPSDFTFQNMNSK-----RKAETWKRNRRQLAFSTVGTPDYIAPEV 207 (363)
T ss_pred ccccccccccccccc-------c----cc-----ccccccccccccc-----cccchhhhccccccccccCCccccCHHH
Confidence 866432110000000 0 00 0000000000000 0000000001122346789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCC---CCCC
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPT---KRIG 327 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~---~R~s 327 (426)
+.+..++.++|||||||++|||++|+.||.+.+..+.+.++.... +.....+..+++||.+|+. +|. .||+
T Consensus 208 ~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~ 286 (363)
T cd05628 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPG 286 (363)
T ss_pred HcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence 999999999999999999999999999999998888888776421 1122356789999999875 444 4579
Q ss_pred hHHHhcCCCcCCCChhhhhhc
Q 014344 328 VEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~~ 348 (426)
++||++||||++++|+.+...
T Consensus 287 ~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 287 VEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHhC
Confidence 999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=407.34 Aligned_cols=268 Identities=29% Similarity=0.591 Sum_probs=232.8
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCC-ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESS-ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
...+.+++|++++.||+|+||.||+|.+..++ ..||+|++.+...... .....+..|+.+++.++||||
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~I 93 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQ----------KQVDHVFSERKILNYINHPFC 93 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCC
Confidence 45678889999999999999999999976654 6899999976543221 234567889999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++++++.+...+|+|||||.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 94 v~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ik 171 (340)
T PTZ00426 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIK 171 (340)
T ss_pred cceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999998764 3499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++..+.. ...+.+||+
T Consensus 172 L~DFG~a~~~~~-----------------------------------------------------------~~~~~~gt~ 192 (340)
T PTZ00426 172 MTDFGFAKVVDT-----------------------------------------------------------RTYTLCGTP 192 (340)
T ss_pred EecCCCCeecCC-----------------------------------------------------------CcceecCCh
Confidence 999999875421 112346999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI- 326 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~- 326 (426)
.|+|||++.+..++.++|||||||++|+|++|.+||.+.+....+..+....... ...+..+.++|++||+.||.+|+
T Consensus 193 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred hhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCC
Confidence 9999999999999999999999999999999999999988887777776554322 34478899999999999999996
Q ss_pred ----ChHHHhcCCCcCCCChhhhhhc
Q 014344 327 ----GVEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 327 ----s~~eil~hp~f~~~~~~~~~~~ 348 (426)
+++++++||||++++|..+...
T Consensus 273 ~~~~~~~~~~~hp~f~~~~~~~~~~~ 298 (340)
T PTZ00426 273 NLKKGAQNVKEHPWFGNIDWVSLLHK 298 (340)
T ss_pred CCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 8999999999999999987653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-52 Score=402.62 Aligned_cols=268 Identities=37% Similarity=0.655 Sum_probs=231.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||||++.+...... .....+..|+.++..++||||+++++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~h~~iv~~~~~~ 70 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL----------NEVRHVLTERDILTTTKSEWLVKLLYAF 70 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 469999999999999999999999999999999976543221 2346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.....+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 71 QDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred EcCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 9999999999999999999998654 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..... .....+||+.|+|||+
T Consensus 149 ~~~~~-----------------------------------------------------------~~~~~~gt~~y~aPE~ 169 (333)
T cd05600 149 KGIVT-----------------------------------------------------------YANSVVGSPDYMAPEV 169 (333)
T ss_pred ccccc-----------------------------------------------------------ccCCcccCccccChhH
Confidence 75421 1234569999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCC----CCCHHHHHHHHHHhccCCCCCC
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLV----GEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~----~~~~~~~~li~~~L~~dP~~R~ 326 (426)
+.+..++.++|||||||++|||++|..||.+.+..+.+..+.... +... ..+..+.+||.+||..+|.+|+
T Consensus 170 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~ 249 (333)
T cd05600 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG 249 (333)
T ss_pred hcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcC
Confidence 999999999999999999999999999999988877766654211 1111 3478899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhhhccCCCCCC
Q 014344 327 GVEEIKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
+++++++||||++++|..+. ...|+..|
T Consensus 250 s~~~ll~h~~~~~~~~~~~~-~~~~~~~~ 277 (333)
T cd05600 250 SLEDIKNHPFFKEVDWNELR-ELKPPFVP 277 (333)
T ss_pred CHHHHHhCcccCCCCHHHHh-hCCCCCCC
Confidence 99999999999999998876 33444444
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-54 Score=398.41 Aligned_cols=257 Identities=29% Similarity=0.505 Sum_probs=234.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++.++||+|.||+|-+|.+...|+.||||.+.++.+..+ +.+-.+.+|++||+.|+||||+.+|++|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde----------qDlvhIRREIeIMSsLNHPhII~IyEVF 122 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE----------QDLVHIRREIEIMSSLNHPHIIQIYEVF 122 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH----------HHHHHHHHHHHHHhhcCCCceeehhhhh
Confidence 479999999999999999999999999999999988776544 4567899999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
++.+.+.|||||..||+|++|+.... .+++.+++++++||+.|+.|||.++++|||||.+|||+|.++++||+|||++
T Consensus 123 ENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 123 ENKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLS 200 (668)
T ss_pred cCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchh
Confidence 99999999999999999999988754 4999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.. ....++|||+|.|.+||+
T Consensus 201 Nly~~---------------------------------------------------------~kfLqTFCGSPLYASPEI 223 (668)
T KOG0611|consen 201 NLYAD---------------------------------------------------------KKFLQTFCGSPLYASPEI 223 (668)
T ss_pred hhhcc---------------------------------------------------------ccHHHHhcCCcccCCccc
Confidence 87642 234678899999999999
Q ss_pred hcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 256 IEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 256 ~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+.|.+| +..+|.|||||+||.|++|..||+|.+......+|......-+..|..+.-||+.||..||++|.|+++|-.|
T Consensus 224 vNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 224 VNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 999998 6899999999999999999999999999999999876665555667888999999999999999999999999
Q ss_pred CCcCCCChhh
Q 014344 335 EFFKGVNWEL 344 (426)
Q Consensus 335 p~f~~~~~~~ 344 (426)
=|. +|.-
T Consensus 304 WWv---Nwgy 310 (668)
T KOG0611|consen 304 WWV---NWGY 310 (668)
T ss_pred hee---eccc
Confidence 775 4653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=404.79 Aligned_cols=261 Identities=36% Similarity=0.659 Sum_probs=225.7
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|++..+|+.||||++.+...... .....+..|+.+|+.++||||+++++++...+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRL 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEE
Confidence 469999999999999999999999999976543221 2345677899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
|+||||++|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 71 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 71 CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 9999999999999887654 45899999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
.......+||+.|+|||++.+..+
T Consensus 149 --------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05571 149 --------------------------------------------------------GATMKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred --------------------------------------------------------CCcccceecCccccChhhhcCCCC
Confidence 112234579999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----ChHHHhcCC
Q 014344 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKGHE 335 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~-----s~~eil~hp 335 (426)
+.++|||||||++|||++|+.||...+....+..+....... ...+..+.+||.+||..||++|| ++.+|++||
T Consensus 173 ~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~ 252 (323)
T cd05571 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHR 252 (323)
T ss_pred CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCC
Confidence 999999999999999999999999888877777766544333 34578899999999999999999 899999999
Q ss_pred CcCCCChhhhhhccC
Q 014344 336 FFKGVNWELLLKISR 350 (426)
Q Consensus 336 ~f~~~~~~~~~~~~~ 350 (426)
||++++|..+.....
T Consensus 253 ~f~~~~~~~~~~~~~ 267 (323)
T cd05571 253 FFASINWQDVVQKKL 267 (323)
T ss_pred CcCCCCHHHHHhCCC
Confidence 999999998875433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=372.10 Aligned_cols=255 Identities=26% Similarity=0.447 Sum_probs=219.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|..+++||+|.||+||+|++..||+.||||.+..... .........+|+++|+.++|+||+.+.++|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-----------kdGi~~talREIK~Lqel~h~nIi~LiD~F 70 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-----------KDGINRTALREIKLLQELKHPNIIELIDVF 70 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-----------ccCccHHHHHHHHHHHHccCcchhhhhhhc
Confidence 469999999999999999999999999999999954421 112345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
...+.+.+|+||++ .||...++... ..++...++.|+.+++.||+|||++.|+||||||.|+|++++|.+||+|||++
T Consensus 71 ~~~~~l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 71 PHKSNLSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred cCCCceEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccch
Confidence 99999999999997 89998887654 56999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+.+.. +.....|-|.+|+|||+
T Consensus 149 r~f~~p~--------------------------------------------------------~~~~~~V~TRWYRAPEL 172 (318)
T KOG0659|consen 149 RFFGSPN--------------------------------------------------------RIQTHQVVTRWYRAPEL 172 (318)
T ss_pred hccCCCC--------------------------------------------------------cccccceeeeeccChHH
Confidence 9875432 12223378999999999
Q ss_pred hcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC---------------------C-----CCCC
Q 014344 256 IEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP---------------------P-----DLVG 305 (426)
Q Consensus 256 ~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~---------------------~-----~~~~ 305 (426)
+.| ..|+..+|+||+|||+.||+.|.+-|.|.++-+++..|+. .| . -+..
T Consensus 173 LfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~a 252 (318)
T KOG0659|consen 173 LFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPA 252 (318)
T ss_pred hccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccccc
Confidence 887 5699999999999999999999999999999888776641 11 0 0112
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.+.++.||+.+||.+||.+|+|+.|+|+|+||+.
T Consensus 253 as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 253 ASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 3566889999999999999999999999999974
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=410.43 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=226.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
...|....+||+|+.|.||.|+...+++.||||.+...... ..+-+.+|+.+|+.+.|+|||.+++.
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-------------~keLilnEi~Vm~~~~H~NiVnfl~S 338 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-------------KKELLLNEILVMRDLHHPNIVNFLDS 338 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-------------chhhhHHHHHHHHhccchHHHHHHHH
Confidence 45688999999999999999999999999999999665433 33567889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|-.++.+|.||||++||+|.+.+.... ++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+
T Consensus 339 ylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGF 415 (550)
T KOG0578|consen 339 YLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGF 415 (550)
T ss_pred hcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeee
Confidence 999999999999999999999877543 99999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|..+.... .+..+++|||.|||||
T Consensus 416 caqi~~~~--------------------------------------------------------~KR~TmVGTPYWMAPE 439 (550)
T KOG0578|consen 416 CAQISEEQ--------------------------------------------------------SKRSTMVGTPYWMAPE 439 (550)
T ss_pred eecccccc--------------------------------------------------------CccccccCCCCccchh
Confidence 99875322 2566889999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
++....|++++||||||++++||+-|.+||-..++...++.|...... ....++.++|||.+||+.|+.+|++|.|
T Consensus 440 Vvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 440 VVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred hhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 999999999999999999999999999999998888888888644322 2245789999999999999999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
||.||||+
T Consensus 520 LL~HpFl~ 527 (550)
T KOG0578|consen 520 LLEHPFLK 527 (550)
T ss_pred HhcChhhh
Confidence 99999995
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=406.57 Aligned_cols=316 Identities=31% Similarity=0.516 Sum_probs=242.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
.+-+-|..++.||-|+||.|.||+...|...||+|.+.|..+-.+ .+...+..|..||...+.++||+||
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~r----------nQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMR----------NQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhh----------hhhhhhhhhhhhHhhcCCcceEEEE
Confidence 344558999999999999999999999999999999987766554 2456778899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
..|++++++|+||+|++|||+.+|+-+. +.|.|+.+|+|++++.+|+++.|..|+|||||||+|||||.+|||||+||
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDF 773 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDF 773 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeec
Confidence 9999999999999999999999987664 45999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|||+.+.=... ..++.+..+....|.-....-..++ .+... ....+..........+.|||+.|+|
T Consensus 774 GLCTGfRWTHd-------skYYq~gdH~RqDSmep~~e~~d~~---~~lkv----L~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 774 GLCTGFRWTHD-------SKYYQEGDHHRQDSMEPSPEWADIS---KCLKV----LERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred cccccceeccc-------cccccCCCccccccCCCchhhcccc---ccchH----HHHHHHhhhhhhhhhhhcCCCcccC
Confidence 99998742110 0111111111111110000000000 00000 0000000111234567899999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----RPPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++...+|+..+||||.|||||||+.|++||-..+..++.+++.. ..+.....+.++.+||+++. .+++.|+.
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLG 918 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLG 918 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhc
Confidence 9999999999999999999999999999999998888777665542 22333456888999999875 67889985
Q ss_pred ---hHHHhcCCCcCCCChhhhhhccCCCCCCC
Q 014344 328 ---VEEIKGHEFFKGVNWELLLKISRPPNIPA 356 (426)
Q Consensus 328 ---~~eil~hp~f~~~~~~~~~~~~~~~~~~~ 356 (426)
++++..||||+++||..+.+ .+.+++|.
T Consensus 919 kng~d~vKaHpfFkgIDfsslRk-q~ApYIP~ 949 (1034)
T KOG0608|consen 919 KNGADQVKAHPFFKGIDFSSLRK-QRAPYIPR 949 (1034)
T ss_pred ccchhhhhcCccccccchHhhhh-ccCCcCcc
Confidence 78899999999999999544 45567764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=406.81 Aligned_cols=319 Identities=29% Similarity=0.465 Sum_probs=232.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+.+|+.++||||+++++++
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~h~~iv~l~~~~ 70 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR----------NQVAHVKAERDILAEADNEWVVKLYYSF 70 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhcCCCCeeeeEEEE
Confidence 369999999999999999999999999999999976543222 2456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+...+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 71 QDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 9999999999999999999988754 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+...............................|..+... .................+.+||+.|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 219 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL---------KTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219 (381)
T ss_pred cccccccccccccccccccccccCccccccccccccccccc---------chhhccccccccccccccccCCccccCHHH
Confidence 75532110000000000000000000000000000000000 000000000011123356789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCHHHHHHHHHHhcc--CCCCCCCh
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPLRNLIRRLLEK--DPTKRIGV 328 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~li~~~L~~--dP~~R~s~ 328 (426)
+.+..++.++|||||||++|||++|..||...+..+....+... .+.....++++.+||.+||.. +|..|+++
T Consensus 220 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999999999999999999999988877666665421 122224578899999996654 55559999
Q ss_pred HHHhcCCCcCCCChhhhhhccCCCCCC
Q 014344 329 EEIKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 329 ~eil~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
+++++||||++++|........+|..|
T Consensus 300 ~~~l~hp~f~~~~~~~~~~~~~~~~~p 326 (381)
T cd05626 300 DDIKAHPFFSEVDFSSDIRTQPAPYVP 326 (381)
T ss_pred HHHhcCcccCCCChhHHhhcCCCCccC
Confidence 999999999999998866544445444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=405.96 Aligned_cols=317 Identities=31% Similarity=0.526 Sum_probs=234.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||+||+|++..+++.||+|++.+...... .....+..|+.+++.++||||++++++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~il~~~~h~~iv~~~~~~ 70 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLR----------NQVAHVKAERDILAEADNEWVVRLYYSF 70 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhH----------HHHHHHHHHHHHHHhCCCCcCCeEEEEE
Confidence 369999999999999999999999999999999976543221 2456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++..+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 71 QDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 9999999999999999999988654 35899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccc--cccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRS--FLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
..+........... ............. .....|..+ ....................+.+||+.|+||
T Consensus 149 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP 217 (382)
T cd05625 149 TGFRWTHDSKYYQS--GDHVRQDSMDFSNEWGDPANCRCG---------DRLKPLERRAARQHQRCLAHSLVGTPNYIAP 217 (382)
T ss_pred cccccccccccccc--cccccccccccccccccccccccc---------ccccchhhhhccccccccccccccCcccCCH
Confidence 75532110000000 0000000000000 000000000 0000000000000111233467899999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCCC-
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIG- 327 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s- 327 (426)
|++.+..++.++|||||||++|||++|++||.+.+..+....+.... +.....++.+.+||.+|+ .+|.+|++
T Consensus 218 E~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 296 (382)
T cd05625 218 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK 296 (382)
T ss_pred HHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence 99999999999999999999999999999999988877776665321 222345788999999986 59999997
Q ss_pred --hHHHhcCCCcCCCChhhhhhccCCCCCCC
Q 014344 328 --VEEIKGHEFFKGVNWELLLKISRPPNIPA 356 (426)
Q Consensus 328 --~~eil~hp~f~~~~~~~~~~~~~~~~~~~ 356 (426)
+++++.||||++++|........+|..|.
T Consensus 297 ~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~ 327 (382)
T cd05625 297 NGADEIKAHPFFKTIDFSSDLRQQSAPYIPK 327 (382)
T ss_pred CCHHHHhcCCCcCCcChHHHHhcCCCCccCc
Confidence 99999999999999987655444454443
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=393.64 Aligned_cols=258 Identities=30% Similarity=0.474 Sum_probs=216.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
..+|..++.||+|+||+||++.+..+|+.+|+|.+.... ....+.+.+|+.+|++|+|||||++++.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-------------~~~~~~l~~Ei~iL~~l~~p~IV~~~G~ 82 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-------------SPTSESLEREIRILSRLNHPNIVQYYGS 82 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-------------chhHHHHHHHHHHHHhCCCCCEEeeCCc
Confidence 566999999999999999999999999999999985431 1115678889999999999999999997
Q ss_pred eecCC--eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEEec
Q 014344 95 LSTDK--FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIMLVD 171 (426)
Q Consensus 95 ~~~~~--~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL~D 171 (426)
..... .+++.|||++||+|.+++...++ .+++..++.|++||+.||+|||++|||||||||+|||++. +|.+||+|
T Consensus 83 ~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 83 SSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred cccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEecc
Confidence 54443 79999999999999999988776 6999999999999999999999999999999999999999 79999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .......++.|||.||
T Consensus 162 FG~a~~~~~~~-----------------------------------------------------~~~~~~~~~~Gtp~~m 188 (313)
T KOG0198|consen 162 FGLAKKLESKG-----------------------------------------------------TKSDSELSVQGTPNYM 188 (313)
T ss_pred Ccccccccccc-----------------------------------------------------ccccccccccCCcccc
Confidence 99998764200 0112334567999999
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.. .....++|||||||++.||+||.+||.. ....+....+.... ..+...+.++++||.+||.+||++||
T Consensus 189 aPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp 268 (313)
T KOG0198|consen 189 APEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRP 268 (313)
T ss_pred CchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCc
Confidence 9999995 2334599999999999999999999987 45555555554332 33334578899999999999999999
Q ss_pred ChHHHhcCCCcCC
Q 014344 327 GVEEIKGHEFFKG 339 (426)
Q Consensus 327 s~~eil~hp~f~~ 339 (426)
||+++|.|||.+.
T Consensus 269 ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 269 TAEELLEHPFLKQ 281 (313)
T ss_pred CHHHHhhChhhhc
Confidence 9999999999865
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=392.05 Aligned_cols=272 Identities=31% Similarity=0.482 Sum_probs=226.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|+||.||+|.+..+++.||+|++.+...... .....+..|+.+++.++|++|+.+++++.
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~iv~~~~~~~ 70 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKRILEKVNSRFVVSLAYAYE 70 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh----------hhHHHHHHHHHHHHhcCCCcEEEEEEEEc
Confidence 48999999999999999999999999999999976543322 12345678999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+++.+++|||||+||+|..++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~ 150 (285)
T cd05631 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV 150 (285)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence 99999999999999999988765544569999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
..... ......+||+.|+|||++
T Consensus 151 ~~~~~---------------------------------------------------------~~~~~~~g~~~y~aPE~~ 173 (285)
T cd05631 151 QIPEG---------------------------------------------------------ETVRGRVGTVGYMAPEVI 173 (285)
T ss_pred EcCCC---------------------------------------------------------CeecCCCCCCCccCHhhh
Confidence 54211 011234689999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCC-CCCCCCCHHHHHHHHHHhccCCCCCCC----
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRP-PDLVGEPTPLRNLIRRLLEKDPTKRIG---- 327 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~s---- 327 (426)
.+..++.++|||||||++|+|++|+.||.+...... ...+.... ......+..+.+||++||+.||.+||+
T Consensus 174 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05631 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGN 253 (285)
T ss_pred cCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 999999999999999999999999999987654221 22222211 222345788999999999999999997
Q ss_pred -hHHHhcCCCcCCCChhhhhhc-cCCCCCC
Q 014344 328 -VEEIKGHEFFKGVNWELLLKI-SRPPNIP 355 (426)
Q Consensus 328 -~~eil~hp~f~~~~~~~~~~~-~~~~~~~ 355 (426)
++++++||||++++|..+... ..||..|
T Consensus 254 ~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05631 254 GAAGVKQHPIFKNINFKRLEANMLEPPFCP 283 (285)
T ss_pred CHHHHhcCHhhcCCCHHHHHhCcCCcCCCC
Confidence 899999999999999998754 3344443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=394.13 Aligned_cols=280 Identities=32% Similarity=0.577 Sum_probs=244.8
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~ 90 (426)
-+...+|.++.+||+|+||+|.+|..+.+.+.||||++.++.+.+. +..+-.+.|.++|.... -|+++.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd----------DDvectm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD----------DDVECTMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec----------CcccceehhhhheecCCCCchHHH
Confidence 4778899999999999999999999999999999999988776433 23344556888888876 589999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++.+|++-+.+|+||||+.||||.-.+++-+ .|.+..+.+|+++|+.||-+||++|||+||||.+|||++.+|||||+
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEee
Confidence 9999999999999999999999987776654 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+++.-. .....+.++||||.|
T Consensus 493 DFGmcKEni--------------------------------------------------------~~~~TTkTFCGTPdY 516 (683)
T KOG0696|consen 493 DFGMCKENI--------------------------------------------------------FDGVTTKTFCGTPDY 516 (683)
T ss_pred ecccccccc--------------------------------------------------------cCCcceeeecCCCcc
Confidence 999997532 123457789999999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCC--
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIG-- 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s-- 327 (426)
+|||++.-.+|+.++||||+||+||||+.|++||.+.+..+.+..|.......+ ..+.++.+++..+|.+.|.+|+.
T Consensus 517 iAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg 596 (683)
T KOG0696|consen 517 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCG 596 (683)
T ss_pred cccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCC
Confidence 999999999999999999999999999999999999999999999985544433 45788999999999999999996
Q ss_pred ---hHHHhcCCCcCCCChhhhhhccCCCCCCCCCC
Q 014344 328 ---VEEIKGHEFFKGVNWELLLKISRPPNIPARFE 359 (426)
Q Consensus 328 ---~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~ 359 (426)
-++|..||||+.++|+.+.....+|++.+..+
T Consensus 597 ~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k 631 (683)
T KOG0696|consen 597 PEGERDIREHPFFRRIDWEKLERREIQPPFKPKIK 631 (683)
T ss_pred CccccchhhCcchhhccHHHHhhccCCCCCCCccc
Confidence 46999999999999999987666665555543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=399.64 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=221.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
+...+.|+.+++||+|.||.||+|++..+|+.||+|.+..+. ..........+||.||++|+||||++|
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-----------~~~~~~~t~~REI~ILr~l~HpNIikL 181 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-----------EKEGFPITAIREIKILRRLDHPNIIKL 181 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-----------CCCcchHHHHHHHHHHHhcCCCcccce
Confidence 345678999999999999999999999999999999995543 233456677889999999999999999
Q ss_pred eeeeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 92 RGVLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 92 ~~~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.+..... ..+|||+|||+ -||.-++... .-.|++.+++.|++||+.||+|||++||.|||||..|||||.+|.+||
T Consensus 182 ~eivt~~~~~siYlVFeYMd-hDL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKi 259 (560)
T KOG0600|consen 182 EEIVTSKLSGSIYLVFEYMD-HDLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKI 259 (560)
T ss_pred eeEEEecCCceEEEEEeccc-chhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEe
Confidence 9988765 79999999997 7888776543 335999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||||+.+.... ....++.|-|.+
T Consensus 260 aDFGLAr~y~~~~-------------------------------------------------------~~~~T~rVvTLW 284 (560)
T KOG0600|consen 260 ADFGLARFYTPSG-------------------------------------------------------SAPYTSRVVTLW 284 (560)
T ss_pred ccccceeeccCCC-------------------------------------------------------CcccccceEEee
Confidence 9999999775432 112456688999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C----------CC-------------
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P----------PD------------- 302 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~----------~~------------- 302 (426)
|+|||++.| ..|+.++|+||+|||+.||++|++.|.+.++.+++..|... | +.
T Consensus 285 YRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~ 364 (560)
T KOG0600|consen 285 YRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRR 364 (560)
T ss_pred ccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccch
Confidence 999999998 56999999999999999999999999999999998887511 1 00
Q ss_pred ----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 303 ----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 303 ----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
+...+....+|+..||..||.+|.||.++|.|+||.
T Consensus 365 l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 365 LRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred HHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 012245678999999999999999999999999994
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=395.62 Aligned_cols=263 Identities=33% Similarity=0.597 Sum_probs=225.2
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|+++.+++.||||++.+...... .....+..|..++..+ +||||+++++++.....
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 70 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD----------DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR 70 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE
Confidence 469999999999999999999999999976543221 2345667788888876 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 71 LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 99999999999999887654 3499999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (320)
T cd05590 149 N--------------------------------------------------------GKTTSTFCGTPDYIAPEILQEML 172 (320)
T ss_pred C--------------------------------------------------------CCcccccccCccccCHHHHcCCC
Confidence 1 01123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCCh------HHHhc
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGV------EEIKG 333 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~------~eil~ 333 (426)
++.++|||||||++|+|++|+.||.+.+..+.+..+.......+ ..+..+.+||++||+.||.+|+++ ++++.
T Consensus 173 ~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 99999999999999999999999999998888888776544333 357889999999999999999998 99999
Q ss_pred CCCcCCCChhhhhhccCCC
Q 014344 334 HEFFKGVNWELLLKISRPP 352 (426)
Q Consensus 334 hp~f~~~~~~~~~~~~~~~ 352 (426)
||||++++|+.+.....+|
T Consensus 253 h~~f~~~~~~~~~~~~~~~ 271 (320)
T cd05590 253 HPFFKELDWEKLNRRQIEP 271 (320)
T ss_pred CCCcCCCCHHHHHhCCCCC
Confidence 9999999999876544333
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=402.86 Aligned_cols=301 Identities=31% Similarity=0.586 Sum_probs=230.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+.+|+.++||||++++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~h~~iv~~~~~~ 70 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEK----------EQVAHVRAERDILAEADNPWVVKLYYSF 70 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 479999999999999999999999999999999976533211 2345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++..+|+|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 71 QDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred EcCCeEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence 9999999999999999999988754 35999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.............. ..... ....+......... ...-.........+.+||+.|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~gt~~y~aPE~ 210 (364)
T cd05599 149 TGLKKSHRTEFYRILSH-ALPSN-------FLDFISKPMSSKRK----------AETWKRNRRALAYSTVGTPDYIAPEV 210 (364)
T ss_pred eeccccccccccccccc-ccccc-------cccccccccccccc----------ccchhhcccccccccccCccccCHHH
Confidence 87643211100000000 00000 00000000000000 00000001112335689999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCCC---
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIG--- 327 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s--- 327 (426)
+.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.... +.....+..+++||.+||. +|.+|++
T Consensus 211 ~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred HcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 999999999999999999999999999999998887777765322 1122457889999999996 9999998
Q ss_pred hHHHhcCCCcCCCChhhhhh
Q 014344 328 VEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~ 347 (426)
+++++.||||++++|+.+..
T Consensus 290 ~~~ll~h~~~~~~~~~~~~~ 309 (364)
T cd05599 290 VNEIKSHPFFKGVDWEHIRE 309 (364)
T ss_pred HHHHhcCCCcCCCCHHHHhh
Confidence 99999999999999998643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=406.27 Aligned_cols=308 Identities=33% Similarity=0.571 Sum_probs=229.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+++++.++||||++++++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~iv~~~~~~ 70 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKK----------DQLAHVKAERDVLAESDSPWVVSLYYSF 70 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHh----------HHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 479999999999999999999999999999999976543221 2456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+...+|+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 71 QDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred EcCCeeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999999988654 45999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhcccccc-ccccccc-cccccccCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCccccccCCCCcc
Q 014344 176 TKLSPKTPQASPKTVLAANTRS-GIKKRRS-FLSKFCSSGISLEDPVHSPRIGPDPPSRSD-SDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~gt~~y~a 252 (426)
+.+................... ....+.. .....+..... ... .... ........+.+||+.|+|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-~~~~~~~~~~~~~~~~gt~~y~a 216 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS-----------KDQ-IATWKKNRRLMAYSTVGTPDYIA 216 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccc-----------hhh-hhhhhhcccccccccCCCccccC
Confidence 7654321110000000000000 0000000 00000000000 000 0000 000011234689999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCC--
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKR-- 325 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R-- 325 (426)
||++.+..++.++|||||||++|||++|.+||.+.+..+.+..+.... +.....+..+.+||.+||. +|.+|
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 217 PEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred HHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999999999999999999999999888877777765321 1222357889999999997 67665
Q ss_pred -CChHHHhcCCCcCCCChhhhhhc
Q 014344 326 -IGVEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 326 -~s~~eil~hp~f~~~~~~~~~~~ 348 (426)
+++.+++.||||++++|+.+...
T Consensus 296 r~~~~~~l~hp~~~~~~~~~~~~~ 319 (377)
T cd05629 296 RGGAHEIKSHPFFRGVDWDTIRQI 319 (377)
T ss_pred CCCHHHHhcCCCcCCCCHHHHccC
Confidence 59999999999999999988543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=394.78 Aligned_cols=266 Identities=33% Similarity=0.600 Sum_probs=228.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCcceeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLLPRLRGVL 95 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~~ 95 (426)
+|++++.||+|+||.||+|++..+++.||||++.+...... .....+..|.+++..+.| ++|+.++++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~ 70 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQD----------DDVECTMVEKRVLALPGKPPFLTQLHSCF 70 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhcCCCCceeeeEEEE
Confidence 58999999999999999999999999999999976543221 234567789999999986 4688999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
...+.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 71 QTMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 9999999999999999999887654 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
...... .......+||+.|+|||+
T Consensus 149 ~~~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~ 172 (324)
T cd05587 149 KENIFG--------------------------------------------------------GKTTRTFCGTPDYIAPEI 172 (324)
T ss_pred eecCCC--------------------------------------------------------CCceeeecCCccccChhh
Confidence 643210 011234569999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh-----H
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV-----E 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~-----~ 329 (426)
+.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....... ...+..+.+||.+||.+||.+|++. +
T Consensus 173 ~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 252 (324)
T cd05587 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGER 252 (324)
T ss_pred hcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHH
Confidence 999999999999999999999999999999998888887776544332 3457889999999999999999986 8
Q ss_pred HHhcCCCcCCCChhhhhhccC
Q 014344 330 EIKGHEFFKGVNWELLLKISR 350 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~ 350 (426)
+++.||||+.++|..+.....
T Consensus 253 ~~~~hp~~~~~~~~~~~~~~~ 273 (324)
T cd05587 253 DIREHAFFRRIDWEKLERREI 273 (324)
T ss_pred HHhcCCCcCCCCHHHHHhCCC
Confidence 999999999999998865443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=401.86 Aligned_cols=299 Identities=36% Similarity=0.670 Sum_probs=236.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+.++..+.||||+++++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 70 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKR----------NQIAHVRAERDILADADSPWIVKLYYSF 70 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhc----------cHHHHHHHHHHHHHhcCCCCccchhhhe
Confidence 469999999999999999999999999999999976543221 2346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 71 QDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred ecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 9999999999999999999998765 45999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+............ ......+. ...................+||+.|+|||+
T Consensus 149 ~~~~~~~~~~~~~~~-------------~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 201 (350)
T cd05573 149 KKMNKAKDREYYLND-------------SHNLLFRD--------------NVLVRRRDHKQRRVRANSTVGTPDYIAPEV 201 (350)
T ss_pred ccCcccCcccccccc-------------cccccccc--------------cccccccccccccccccccccCccccCHHH
Confidence 876432211000000 00000000 000000001111223445679999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----CCCCCCCCCHHHHHHHHHHhccCCCCCCC-hH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----RPPDLVGEPTPLRNLIRRLLEKDPTKRIG-VE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~li~~~L~~dP~~R~s-~~ 329 (426)
+.+..++.++|||||||++|+|++|+.||...+..+.+.++.. ..+.....+..+.+||.+||. ||.+|++ ++
T Consensus 202 ~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 202 LRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 9999999999999999999999999999999988777777765 122233458899999999997 9999999 99
Q ss_pred HHhcCCCcCCCChhhhhhccCCCCCC
Q 014344 330 EIKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
++++||||++++|+.... ..++..|
T Consensus 281 ~ll~hp~~~~~~~~~~~~-~~~~~~~ 305 (350)
T cd05573 281 EIKSHPFFKGIDWENLRE-TKPPFVP 305 (350)
T ss_pred HHhcCCCcCCCCHHHHhh-CCCCcCC
Confidence 999999999999998763 3344433
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=404.50 Aligned_cols=269 Identities=31% Similarity=0.562 Sum_probs=229.4
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||.||+|++..+++.||+|++.+...... .....+..|+.+++.++||||+
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~h~~iv 106 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAHANSEWIV 106 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCcc
Confidence 456778899999999999999999999999999999999976543222 1234567899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.++..+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus 107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL 183 (370)
T cd05596 107 QLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183 (370)
T ss_pred eEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEE
Confidence 9999999999999999999999999987643 4899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... .......+||+.
T Consensus 184 ~DfG~~~~~~~~~-------------------------------------------------------~~~~~~~~gt~~ 208 (370)
T cd05596 184 ADFGTCMKMDANG-------------------------------------------------------MVRCDTAVGTPD 208 (370)
T ss_pred EeccceeeccCCC-------------------------------------------------------cccCCCCCCCcC
Confidence 9999987653210 011234579999
Q ss_pred CccchhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhcc
Q 014344 250 YVAPEIIEGK----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 250 y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~ 320 (426)
|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+.... +.....+..+.+||.+||+.
T Consensus 209 y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 288 (370)
T cd05596 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTD 288 (370)
T ss_pred eECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccC
Confidence 9999998754 37889999999999999999999999998888888776432 22224578899999999999
Q ss_pred CCCC--CCChHHHhcCCCcCCCChhhhh
Q 014344 321 DPTK--RIGVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 321 dP~~--R~s~~eil~hp~f~~~~~~~~~ 346 (426)
+|.+ |++++++++||||++.+|....
T Consensus 289 ~p~r~~R~s~~ell~h~~~~~~~~~~~~ 316 (370)
T cd05596 289 REVRLGRNGVDEIKSHPFFKNDQWTFDN 316 (370)
T ss_pred hhhccCCCCHHHHhcCcccCCCChhhHH
Confidence 9988 9999999999999998887543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=397.28 Aligned_cols=263 Identities=38% Similarity=0.664 Sum_probs=225.1
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|++..+++.||+|++.+...... .....+..|+.+|+.++||||+++++++..++.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAK----------DEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRL 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEE
Confidence 468999999999999999999999999976543221 2356778899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
|+||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 71 ~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 71 CFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 9999999999998887654 35999999999999999999999999999999999999999999999999998643210
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
.......+||+.|+|||++.+..+
T Consensus 149 --------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 172 (328)
T cd05593 149 --------------------------------------------------------AATMKTFCGTPEYLAPEVLEDNDY 172 (328)
T ss_pred --------------------------------------------------------ccccccccCCcCccChhhhcCCCC
Confidence 011234569999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----ChHHHhcCC
Q 014344 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKGHE 335 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~-----s~~eil~hp 335 (426)
+.++|||||||++|+|++|+.||.+.+..+....+...... ....+..+.+||.+||.+||++|+ ++.+|++||
T Consensus 173 ~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 99999999999999999999999988877777666544333 234578899999999999999997 899999999
Q ss_pred CcCCCChhhhhhccCCC
Q 014344 336 FFKGVNWELLLKISRPP 352 (426)
Q Consensus 336 ~f~~~~~~~~~~~~~~~ 352 (426)
||.+.+|..+......+
T Consensus 253 ~~~~~~~~~~~~~~~~~ 269 (328)
T cd05593 253 FFTGVNWQDVYDKKLVP 269 (328)
T ss_pred CcCCCCHHHHHhCCCCC
Confidence 99999999876544333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=405.53 Aligned_cols=314 Identities=30% Similarity=0.525 Sum_probs=233.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||||++.+...... .....+..|+.+|+.++||||+++++.|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~h~~iv~~~~~~ 70 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR----------NQAAHVKAERDILAEADNEWVVKLYYSF 70 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhh----------hhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 479999999999999999999999999999999966443221 1345677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 71 QDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 9999999999999999999998754 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+........... .. ........... ......... ....................+||+.|||||+
T Consensus 149 ~~~~~~~~~~~~~~--~~---------~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 215 (376)
T cd05598 149 TGFRWTHDSKYYQK--GD---------HHRQDSMEPSE-EWSEIDRCR-LKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215 (376)
T ss_pred cccccccccccccc--cc---------ccccccccccc-ccccccccc-ccchhhhhhhhcccccccccCCCccccCHHH
Confidence 75532110000000 00 00000000000 000000000 0000000000001122346789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCC---C
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRI---G 327 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~---s 327 (426)
+.+..++.++|||||||++|+|++|+.||.+.+..+....+.... +.....+..+.+||.+|+ .+|.+|+ +
T Consensus 216 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 216 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred HcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 999999999999999999999999999999988777666654321 222345788999999976 5999999 9
Q ss_pred hHHHhcCCCcCCCChhhhhhccCCCCCC
Q 014344 328 VEEIKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
+.++++||||++++|........++.+|
T Consensus 295 ~~ell~h~~~~~~~~~~~~~~~~~~~~~ 322 (376)
T cd05598 295 ADEIKAHPFFKGIDFASLIRRQKAPYIP 322 (376)
T ss_pred HHHHhCCCCcCCCCHHHHhhcCCCCCCC
Confidence 9999999999999998886444444444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=397.04 Aligned_cols=256 Identities=32% Similarity=0.498 Sum_probs=231.4
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|.+.+.||+|-|++|.+|++..||+.||||+++|..+... ....+.+|+++|+...|||||++|++..+
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-----------st~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-----------STGHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-----------hhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 8888999999999999999999999999999987654433 34578889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCCcEEEecccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENGHIMLVDFDLST 176 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g~ikL~DFgls~ 176 (426)
...+|||+|+=+||||++|+..+..+ +.++.++.|++||+.|+.|||+..+|||||||+||.+- .-|-|||+|||++.
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe~G-l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHEEG-LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhhcc-ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999999999998876544 99999999999999999999999999999999999776 46899999999998
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.++ .+.+++||+..|-|||++
T Consensus 168 kf~PG---------------------------------------------------------~kL~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 168 KFQPG---------------------------------------------------------KKLTTSCGSLAYSAPEIL 190 (864)
T ss_pred cCCCc---------------------------------------------------------chhhcccchhhccCchhh
Confidence 87643 467788999999999999
Q ss_pred cCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.|..|+ .++||||||||||.|++|++||...+..+++..|+......+ ..+.+++|||..||+.||.+|.+.+||..|
T Consensus 191 LGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 191 LGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 999996 789999999999999999999999999999999985544333 447889999999999999999999999999
Q ss_pred CCcCCCCh
Q 014344 335 EFFKGVNW 342 (426)
Q Consensus 335 p~f~~~~~ 342 (426)
+|+++++-
T Consensus 271 ~Wlq~~D~ 278 (864)
T KOG4717|consen 271 SWLQAGDR 278 (864)
T ss_pred ccccCCCC
Confidence 99998763
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=399.72 Aligned_cols=299 Identities=30% Similarity=0.549 Sum_probs=231.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+..|+.++..++||+|+++++.|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 70 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK----------EQVAHIRAERDILVEADGAWVVKMFYSF 70 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 469999999999999999999999999999999975432221 2456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|+++|+|||++
T Consensus 71 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 71 QDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred EcCCEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 9999999999999999999988654 34999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+........... ..... ........... ................+.+||+.|+|||+
T Consensus 149 ~~~~~~~~~~~~~~-~~~~~---------------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 207 (360)
T cd05627 149 TGLKKAHRTEFYRN-LTHNP---------------PSDFSFQNMNS-----KRKAETWKKNRRQLAYSTVGTPDYIAPEV 207 (360)
T ss_pred cccccccccccccc-cccCC---------------ccccccccccc-----ccccccccccccccccccCCCccccCHHH
Confidence 86643211000000 00000 00000000000 00000000011223346789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCCC---
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIG--- 327 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s--- 327 (426)
+.+..++.++|||||||++|||++|++||.+.+....+.++.... +.....+..+++||.+|+ .||.+|++
T Consensus 208 ~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 286 (360)
T cd05627 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNG 286 (360)
T ss_pred HcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCC
Confidence 999999999999999999999999999999998888877776421 112235778999999987 49999994
Q ss_pred hHHHhcCCCcCCCChhhhhhc
Q 014344 328 VEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~~ 348 (426)
++++++||||++++|+.+...
T Consensus 287 ~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 287 VEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred HHHHhcCCCCCCCCHHHHhcC
Confidence 799999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=392.62 Aligned_cols=263 Identities=33% Similarity=0.631 Sum_probs=224.3
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH---HhcCCCCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL---RNVEHPLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il---~~l~hp~iv~l~~~ 94 (426)
|++++.||+|+||.||+|.+..+++.||||++.+...... .....+..|++++ +.++||||++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~ 70 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR----------DEVESLMCEKRIFETANSERHPFLVNLFAC 70 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccccCCCChhceeeE
Confidence 7899999999999999999999999999999976543221 1344566676665 45679999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+...+|+|||||+|++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 71 ~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 71 FQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence 9999999999999999999877653 3599999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+...... .......+||+.|+|||
T Consensus 148 ~~~~~~~--------------------------------------------------------~~~~~~~~g~~~y~aPE 171 (324)
T cd05589 148 CKEGMGF--------------------------------------------------------GDRTSTFCGTPEFLAPE 171 (324)
T ss_pred CccCCCC--------------------------------------------------------CCcccccccCccccCHh
Confidence 8643211 11223457999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----Ch
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI-----GV 328 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~-----s~ 328 (426)
++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+....... ...+..+.+||.+||+.||.+|| ++
T Consensus 172 ~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 251 (324)
T cd05589 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDA 251 (324)
T ss_pred HhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence 9999999999999999999999999999999998888777776544333 34578899999999999999999 69
Q ss_pred HHHhcCCCcCCCChhhhhhcc
Q 014344 329 EEIKGHEFFKGVNWELLLKIS 349 (426)
Q Consensus 329 ~eil~hp~f~~~~~~~~~~~~ 349 (426)
.++++||||++++|.......
T Consensus 252 ~~l~~~~~f~~~~~~~~~~~~ 272 (324)
T cd05589 252 EDVKKQPFFRDINWDDLLARK 272 (324)
T ss_pred HHHhhCCCcCCCCHHHHHhCC
Confidence 999999999999998876543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-51 Score=392.11 Aligned_cols=257 Identities=37% Similarity=0.654 Sum_probs=223.1
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||+|+||+||+|++..+++.||+|++.+...... .....+..|+.+|++++||||+++++++..+..+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 70 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR----------SEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYL 70 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEE
Confidence 7999999999999999999999999976433221 234567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 71 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-- 146 (312)
T cd05585 71 VLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-- 146 (312)
T ss_pred EEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--
Confidence 99999999999988754 34999999999999999999999999999999999999999999999999998753211
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
.......+||+.|+|||++.+..++.
T Consensus 147 ------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 172 (312)
T cd05585 147 ------------------------------------------------------DDKTNTFCGTPEYLAPELLLGHGYTK 172 (312)
T ss_pred ------------------------------------------------------CCccccccCCcccCCHHHHcCCCCCC
Confidence 01223457999999999999999999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC---ChHHHhcCCCcCC
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI---GVEEIKGHEFFKG 339 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~---s~~eil~hp~f~~ 339 (426)
++|||||||++|+|++|+.||.+.+..+.+..+...+..+ ...+..+.+||.+||..||.+|| ++.+++.||||+.
T Consensus 173 ~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred ccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 9999999999999999999999988888888877655443 34578899999999999999997 4799999999999
Q ss_pred CChhhhhhc
Q 014344 340 VNWELLLKI 348 (426)
Q Consensus 340 ~~~~~~~~~ 348 (426)
.+|..+...
T Consensus 253 ~~~~~~~~~ 261 (312)
T cd05585 253 LSWKKLLMK 261 (312)
T ss_pred CCHHHHHhC
Confidence 999876543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-51 Score=393.12 Aligned_cols=260 Identities=35% Similarity=0.656 Sum_probs=224.0
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|++..+|+.||+|++.+...... .....+..|+.+++.++||||++++++|.....+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~ 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEE
Confidence 469999999999999999999999999976543221 2345677899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 71 ~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 71 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 9999999999998887654 35899999999999999999999999999999999999999999999999998643211
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
. ......+||+.|+|||++.+..+
T Consensus 149 ~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05595 149 G--------------------------------------------------------ATMKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred C--------------------------------------------------------CccccccCCcCcCCcccccCCCC
Confidence 0 11223569999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----ChHHHhcCC
Q 014344 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKGHE 335 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~-----s~~eil~hp 335 (426)
+.++|||||||++|+|++|+.||...+....+..+...... ....++.+.+||.+||..||.+|+ ++.++++||
T Consensus 173 ~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 99999999999999999999999988887777776544332 235578999999999999999998 899999999
Q ss_pred CcCCCChhhhhhcc
Q 014344 336 FFKGVNWELLLKIS 349 (426)
Q Consensus 336 ~f~~~~~~~~~~~~ 349 (426)
||.+.+|..+....
T Consensus 253 ~~~~~~~~~~~~~~ 266 (323)
T cd05595 253 FFLSINWQDVVQKK 266 (323)
T ss_pred CcCCCCHHHHHhCC
Confidence 99999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-52 Score=381.06 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=217.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|..++.||+|+||.|+.|.++.+|+.||||.+... ..+....++..+|+++|+.++|+||+.+.+++.
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-----------F~~~~~akRtlRElklLr~~~HeNIi~l~di~~ 91 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-----------FENQIDAKRTLRELKLLRHLRHENIIGLLDIFR 91 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-----------hhchHHHHHHHHHHHHHHHhcCCCcceEEeecc
Confidence 355589999999999999999999999999998422 123345788999999999999999999999996
Q ss_pred c-----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 97 T-----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 97 ~-----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
. -+.+|+|+|+| +.||...++.+. .+++..++.++.||+.||+|+|+.||+||||||.|+|++.+..+||+|
T Consensus 92 p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecc
Confidence 5 35799999999 599999888653 399999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+..... ......+.++.|.+|+
T Consensus 169 FGLAR~~~~~------------------------------------------------------~~~~~mTeYVaTRWYR 194 (359)
T KOG0660|consen 169 FGLARYLDKF------------------------------------------------------FEDGFMTEYVATRWYR 194 (359)
T ss_pred ccceeecccc------------------------------------------------------Ccccchhcceeeeeec
Confidence 9999976432 0123456778999999
Q ss_pred cchhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------------C------
Q 014344 252 APEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----------------------P------ 301 (426)
Q Consensus 252 aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------------------~------ 301 (426)
|||++. ...|+.++||||+|||+.||++|++.|.|.+...++..|+... +
T Consensus 195 APElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~ 274 (359)
T KOG0660|consen 195 APELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQP 274 (359)
T ss_pred CHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCC
Confidence 999865 5789999999999999999999999999998777666553110 1
Q ss_pred ---CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ---~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.+++.++.+.||+.+||..||.+|+|++|+|+||||+..
T Consensus 275 f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 275 FSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 123456778999999999999999999999999999863
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-51 Score=400.60 Aligned_cols=267 Identities=33% Similarity=0.581 Sum_probs=224.6
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+..++|++++.||+|+||.||+|++..+++.||+|++.+...... .....+..|+.+++.++||||++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~i~~~~~hp~iv~ 107 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAFANSPWVVQ 107 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhCCCCCEee
Confidence 34566889999999999999999999999999999999976433221 12345778999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.++..+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~ 184 (370)
T cd05621 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLA 184 (370)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999988643 38999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+.... .....+.+||+.|
T Consensus 185 DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~gt~~Y 209 (370)
T cd05621 185 DFGTCMKMDETG-------------------------------------------------------MVRCDTAVGTPDY 209 (370)
T ss_pred ecccceecccCC-------------------------------------------------------ceecccCCCCccc
Confidence 999987653110 0122355799999
Q ss_pred ccchhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccC
Q 014344 251 VAPEIIEGKG----HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 251 ~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~d 321 (426)
+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+.++.... +.....+..++++|.+||+.+
T Consensus 210 ~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~ 289 (370)
T cd05621 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDR 289 (370)
T ss_pred CCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCc
Confidence 9999997643 7889999999999999999999999998888887776432 222245788999999999866
Q ss_pred CCC--CCChHHHhcCCCcCCCChhhh
Q 014344 322 PTK--RIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 322 P~~--R~s~~eil~hp~f~~~~~~~~ 345 (426)
+.+ |+++.|+++||||+...|...
T Consensus 290 ~~r~~R~~~~e~l~hp~~~~~~~~~~ 315 (370)
T cd05621 290 EVRLGRNGVEEIKQHPFFKNDQWNWD 315 (370)
T ss_pred hhccCCCCHHHHhcCcccCCCCcChH
Confidence 554 889999999999998666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=373.77 Aligned_cols=258 Identities=27% Similarity=0.384 Sum_probs=218.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.++.|+.+.+|++|+||.||+|+++.|++.||+|.++.+. .....--.-.+|+.+|.++.|||||.+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-----------ek~GFPItsLREIniLl~~~H~NIV~vkE 142 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-----------EKEGFPITSLREINILLKARHPNIVEVKE 142 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-----------ccCCCcchhHHHHHHHHhcCCCCeeeeEE
Confidence 3567999999999999999999999999999999986543 11112234567999999999999999999
Q ss_pred eee--cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLS--TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+.. +-+.+|+|||||+ -||.+++.... ++|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|
T Consensus 143 VVvG~~~d~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 143 VVVGSNMDKIYIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred EEeccccceeeeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecc
Confidence 875 3457999999997 89999987665 6799999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+... ....+..|-|.+|+
T Consensus 221 FGLAR~ygsp--------------------------------------------------------~k~~T~lVVTLWYR 244 (419)
T KOG0663|consen 221 FGLAREYGSP--------------------------------------------------------LKPYTPLVVTLWYR 244 (419)
T ss_pred cchhhhhcCC--------------------------------------------------------cccCcceEEEeeec
Confidence 9999987532 12345668899999
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C--CCCC---------------------
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P--PDLV--------------------- 304 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~--~~~~--------------------- 304 (426)
|||++.| ..|+.++|+||+|||+.||+++++.|.|.+..+++.+|+.. | ..++
T Consensus 245 aPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~l 324 (419)
T KOG0663|consen 245 APELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNL 324 (419)
T ss_pred CHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhh
Confidence 9999988 56899999999999999999999999999998888877421 1 0000
Q ss_pred -------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 305 -------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 305 -------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
..+....+|+..+|.+||.+|.||+|.|+|+||.+.
T Consensus 325 r~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 325 RKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 112456799999999999999999999999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=396.93 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=229.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
...|++.+.||+|.||+||+|+++.+|+.+|+|++.+...... .....+.+|+.||+++. ||||+.+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~----------~~~~~v~~Ev~il~~l~~hpniv~l~~ 103 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGK----------EDREDVRREVAILQQLSGHPNIVQLKD 103 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccc----------ccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3469999999999999999999999999999999987665332 14567889999999999 999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC----CcEEE
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN----GHIML 169 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~----g~ikL 169 (426)
+|++...+++|||+|.||+|++.+... . +++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|+
T Consensus 104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 104 AFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence 999999999999999999999988766 2 9999999999999999999999999999999999999743 57999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... .......||||.
T Consensus 181 ~DFGla~~~~~---------------------------------------------------------~~~~~~~~Gtp~ 203 (382)
T KOG0032|consen 181 IDFGLAKFIKP---------------------------------------------------------GERLHTIVGTPE 203 (382)
T ss_pred eeCCCceEccC---------------------------------------------------------CceEeeecCCcc
Confidence 99999987643 234567789999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
|+|||++...+|+..+||||+||++|.|++|.+||.+.+....+..+.... +.+...+..+++||++||..||.+
T Consensus 204 y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~ 283 (382)
T KOG0032|consen 204 YVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRK 283 (382)
T ss_pred ccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCccc
Confidence 999999999999999999999999999999999999999999988887543 344556788999999999999999
Q ss_pred CCChHHHhcCCCcCCC
Q 014344 325 RIGVEEIKGHEFFKGV 340 (426)
Q Consensus 325 R~s~~eil~hp~f~~~ 340 (426)
|+|+.++|+|||+++.
T Consensus 284 R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 284 RLTAAQALQHPWIKSI 299 (382)
T ss_pred CCCHHHHhcCccccCC
Confidence 9999999999999764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=390.76 Aligned_cols=260 Identities=33% Similarity=0.609 Sum_probs=223.6
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||.||+|++..+++.||||++.+...... .....+..|.+++..+ +||||++++++|...+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~ 70 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD----------DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR 70 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe
Confidence 469999999999999999999999999976543221 2345667788898876 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 71 ~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 71 LFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999999887654 3489999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (321)
T cd05591 149 N--------------------------------------------------------GVTTTTFCGTPDYIAPEILQELE 172 (321)
T ss_pred C--------------------------------------------------------CccccccccCccccCHHHHcCCC
Confidence 1 01123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCC-------ChHHHh
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRI-------GVEEIK 332 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~-------s~~eil 332 (426)
++.++|||||||++|+|++|+.||.+.+..+.+..+.......+ ..+..+.+||.+||+.||++|+ ++++++
T Consensus 173 ~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~ 252 (321)
T cd05591 173 YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIK 252 (321)
T ss_pred CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHh
Confidence 99999999999999999999999999998888888775543332 3478899999999999999999 899999
Q ss_pred cCCCcCCCChhhhhhcc
Q 014344 333 GHEFFKGVNWELLLKIS 349 (426)
Q Consensus 333 ~hp~f~~~~~~~~~~~~ 349 (426)
+||||..++|..+....
T Consensus 253 ~hp~~~~~~~~~~~~~~ 269 (321)
T cd05591 253 QHPFFKEIDWVLLEQRK 269 (321)
T ss_pred cCCccCCCCHHHHHhCC
Confidence 99999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=390.42 Aligned_cols=266 Identities=33% Similarity=0.590 Sum_probs=227.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVL 95 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~ 95 (426)
+|++++.||+|+||.||+|++..+++.||||++.+...... .....+..|..++..+. ||+|+.+++++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~ 70 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECTMVEKRVLALSGKPPFLTQLHSCF 70 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCeEeeEEEEE
Confidence 58999999999999999999999999999999976543221 23345667888888774 89999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
...+.+|+||||++||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 71 QTMDRLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred ecCCEEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 9999999999999999999887654 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
...... .......+||+.|+|||+
T Consensus 149 ~~~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~ 172 (323)
T cd05616 149 KENMWD--------------------------------------------------------GVTTKTFCGTPDYIAPEI 172 (323)
T ss_pred eecCCC--------------------------------------------------------CCccccCCCChhhcCHHH
Confidence 643210 011234569999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh-----H
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV-----E 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~-----~ 329 (426)
+.+..++.++|||||||++|+|++|+.||.+.+....+..+....... ...+..+.+||.+||+.||.+|+++ .
T Consensus 173 ~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~ 252 (323)
T cd05616 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGER 252 (323)
T ss_pred hcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHH
Confidence 999999999999999999999999999999998888887776544332 3467889999999999999999984 8
Q ss_pred HHhcCCCcCCCChhhhhhccC
Q 014344 330 EIKGHEFFKGVNWELLLKISR 350 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~ 350 (426)
+++.||||+.++|+.+.....
T Consensus 253 ~i~~h~~~~~~~~~~~~~~~~ 273 (323)
T cd05616 253 DIKEHAFFRYIDWEKLERKEV 273 (323)
T ss_pred HHhcCCCcCCCCHHHHHhCCC
Confidence 999999999999998875443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=393.61 Aligned_cols=265 Identities=32% Similarity=0.592 Sum_probs=227.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||+||+|++..+++.||||++.+...... .....+..|+.+++.++||||+++++++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~i~~~~~~~~i~~~~~~~ 70 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ----------ETVSFFEEERDILSISNSPWIPQLQYAF 70 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCcceeeEE
Confidence 469999999999999999999999999999999976543211 2345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+...+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 71 QDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred ecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCC
Confidence 99999999999999999999987653 35999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+..... ......+||+.|+|||+
T Consensus 150 ~~~~~~~~-------------------------------------------------------~~~~~~~gt~~y~aPE~ 174 (330)
T cd05601 150 ARLTANKM-------------------------------------------------------VNSKLPVGTPDYIAPEV 174 (330)
T ss_pred eECCCCCc-------------------------------------------------------eeeecccCCccccCHHH
Confidence 76532110 01123368999999999
Q ss_pred hc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCC
Q 014344 256 IE------GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 256 ~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+. +..++.++|||||||++|+|++|+.||...+....+.+++... +.....+..+.+||.+||. +|.+
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~ 253 (330)
T cd05601 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKE 253 (330)
T ss_pred hccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-Chhh
Confidence 87 4567899999999999999999999999988887777775432 2223457889999999997 9999
Q ss_pred CCChHHHhcCCCcCCCChhhhhh
Q 014344 325 RIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 325 R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
|||++++++||||+.++|..+..
T Consensus 254 R~t~~~l~~h~~~~~~~~~~~~~ 276 (330)
T cd05601 254 RLGYEGLCCHPFFSKIDWNNIRN 276 (330)
T ss_pred CCCHHHHhCCCCcCCCCHHHHhh
Confidence 99999999999999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=398.25 Aligned_cols=279 Identities=36% Similarity=0.638 Sum_probs=247.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+.+++++++..||-|+||.|=++........+|+|+++|..+..- .+...+..|.+||..+..|+||
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt----------kQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT----------KQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch----------hHHHHHHhHHHHHHhcCchHHH
Confidence 456788999999999999999999999877666799999988766432 3456788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++|-.|.+++++|+.||-|-||+|++.++.+ +.|.+..+++|++-++.|++|||++|||+|||||||+|++.+|.+||
T Consensus 484 rLYrTfrd~kyvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KL 561 (732)
T KOG0614|consen 484 RLYRTFRDSKYVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKL 561 (732)
T ss_pred HHHHHhccchhhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEE
Confidence 9999999999999999999999999998765 44999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
.|||+|+.+. +++++++|||||.
T Consensus 562 VDFGFAKki~---------------------------------------------------------~g~KTwTFcGTpE 584 (732)
T KOG0614|consen 562 VDFGFAKKIG---------------------------------------------------------SGRKTWTFCGTPE 584 (732)
T ss_pred eehhhHHHhc---------------------------------------------------------cCCceeeecCCcc
Confidence 9999999874 3468899999999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD---LVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++..++++.++|+||||+++|||++|.+||.+.++..+|..|+..... +...+..+.+||+++...+|.+|+
T Consensus 585 YVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 585 YVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERL 664 (732)
T ss_pred cccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhh
Confidence 99999999999999999999999999999999999999999999999865322 223356678999999999999999
Q ss_pred C-----hHHHhcCCCcCCCChhhhhhccCCCCCCCC
Q 014344 327 G-----VEEIKGHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 327 s-----~~eil~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
. +.+|.+|-||.+.||+.+....-||++.+.
T Consensus 665 G~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~ 700 (732)
T KOG0614|consen 665 GYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPS 700 (732)
T ss_pred ccccCChHHHHhhhhhhcCChhhhhhccCCCCcccc
Confidence 6 889999999999999999765555444433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=386.28 Aligned_cols=263 Identities=38% Similarity=0.705 Sum_probs=221.8
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh-cCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN-VEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||||++.+...... .....+..|..++.. ++||||+++++++.....
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~ 70 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLED----------DDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence 469999999999999999999999999976543221 223445567777765 479999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 71 LFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 99999999999999887654 3499999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
.. ......+||+.|+|||++.+..
T Consensus 149 ~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05592 149 GE--------------------------------------------------------GKASTFCGTPDYIAPEILKGQK 172 (316)
T ss_pred CC--------------------------------------------------------CccccccCCccccCHHHHcCCC
Confidence 10 1223457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh-HHHhcCCCcC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV-EEIKGHEFFK 338 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~-~eil~hp~f~ 338 (426)
++.++|||||||++|+|++|+.||.+.+..+.+..+....+.. ...+..+.+||.+||..||.+|+++ .+++.||||+
T Consensus 173 ~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05592 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFR 252 (316)
T ss_pred CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccC
Confidence 9999999999999999999999999998888777776544433 3357789999999999999999986 5899999999
Q ss_pred CCChhhhhhccCCC
Q 014344 339 GVNWELLLKISRPP 352 (426)
Q Consensus 339 ~~~~~~~~~~~~~~ 352 (426)
.++|..+.+...+|
T Consensus 253 ~~~~~~~~~~~~~~ 266 (316)
T cd05592 253 GIDWERLEKREIPP 266 (316)
T ss_pred CCCHHHHHhCCCCC
Confidence 99999876544443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=391.30 Aligned_cols=259 Identities=37% Similarity=0.668 Sum_probs=222.4
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|.+..+++.||+|++.+...... .....+..|+++++.++||||+++++++.....+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~ 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEE
Confidence 469999999999999999999999999976543221 2345667899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
|+||||++||+|..++... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.....
T Consensus 71 ~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 71 CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999877654 359999999999999999999997 7999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05594 149 D--------------------------------------------------------GATMKTFCGTPEYLAPEVLEDND 172 (325)
T ss_pred C--------------------------------------------------------CcccccccCCcccCCHHHHccCC
Confidence 1 01122346999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----ChHHHhcC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKGH 334 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~-----s~~eil~h 334 (426)
++.++|||||||++|+|++|+.||.+.+.......+....... ...++.+.+||.+||++||++|+ ++.++++|
T Consensus 173 ~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 9999999999999999999999999888877777665444332 34578899999999999999997 89999999
Q ss_pred CCcCCCChhhhhhc
Q 014344 335 EFFKGVNWELLLKI 348 (426)
Q Consensus 335 p~f~~~~~~~~~~~ 348 (426)
|||.++.|......
T Consensus 253 ~~~~~~~~~~~~~~ 266 (325)
T cd05594 253 KFFAGIVWQDVYEK 266 (325)
T ss_pred CCcCCCCHHHHHhC
Confidence 99999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=386.81 Aligned_cols=259 Identities=37% Similarity=0.676 Sum_probs=219.6
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||.||+|+++.+++.||+|++.+...... ........|..++..+ +||||+++++++.+++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 70 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID----------DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH 70 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc----------chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE
Confidence 479999999999999999999999999976543211 1234566688888764 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||.||+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 71 ~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 71 LFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred EEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 99999999999999887654 3489999999999999999999999999999999999999999999999999864311
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05620 149 G--------------------------------------------------------DNRASTFCGTPDYIAPEILQGLK 172 (316)
T ss_pred C--------------------------------------------------------CCceeccCCCcCccCHHHHcCCC
Confidence 0 01223457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCCh-HHHhcCCCcC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGV-EEIKGHEFFK 338 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~-~eil~hp~f~ 338 (426)
++.++|||||||++|+|++|+.||.+.+..+.+..+....+..+ ..+..+++||.+||..||++|+++ +++++||||+
T Consensus 173 ~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~ 252 (316)
T cd05620 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK 252 (316)
T ss_pred CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcC
Confidence 99999999999999999999999999888777776654443332 357889999999999999999997 5899999999
Q ss_pred CCChhhhhhc
Q 014344 339 GVNWELLLKI 348 (426)
Q Consensus 339 ~~~~~~~~~~ 348 (426)
.++|..+...
T Consensus 253 ~~~~~~~~~~ 262 (316)
T cd05620 253 TINWTALEKR 262 (316)
T ss_pred CCCHHHHHhC
Confidence 9999977543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=393.99 Aligned_cols=267 Identities=33% Similarity=0.572 Sum_probs=224.8
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+..++|++++.||+|+||.||+|++..+++.||+|++.+...... .....+..|+.+++.++||||++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~e~~i~~~~~hp~iv~ 107 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR----------SDSAFFWEERDIMAFANSPWVVQ 107 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHhCCCCCCCe
Confidence 45677899999999999999999999999999999999976432221 12345778999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.++..+|+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+
T Consensus 108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999999987643 38999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+.... .......+||+.|
T Consensus 185 DfG~a~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y 209 (371)
T cd05622 185 DFGTCMKMNKEG-------------------------------------------------------MVRCDTAVGTPDY 209 (371)
T ss_pred eCCceeEcCcCC-------------------------------------------------------cccccCcccCccc
Confidence 999987653210 0122345799999
Q ss_pred ccchhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccC
Q 014344 251 VAPEIIEGKG----HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 251 ~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~d 321 (426)
+|||++.+.. ++.++|||||||++|+|++|++||.+.+....+.+++... +.....+..+++||.+||..+
T Consensus 210 ~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~ 289 (371)
T cd05622 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDR 289 (371)
T ss_pred cCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCCh
Confidence 9999997643 7889999999999999999999999998888888876432 222346788999999999844
Q ss_pred CCC--CCChHHHhcCCCcCCCChhhh
Q 014344 322 PTK--RIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 322 P~~--R~s~~eil~hp~f~~~~~~~~ 345 (426)
+.+ |+++++|++||||++..|+..
T Consensus 290 ~~r~~r~~~~ei~~h~~~~~~~~~~~ 315 (371)
T cd05622 290 EVRLGRNGVEEIKRHLFFKNDQWAWE 315 (371)
T ss_pred hhhcCCCCHHHHhcCcccCCCChhHH
Confidence 443 789999999999998666543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-50 Score=388.05 Aligned_cols=260 Identities=33% Similarity=0.671 Sum_probs=216.6
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||.||+|++..+++.||+|++.+...... .....+..|..+++.+ +||||++++++|.++..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~----------~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~ 70 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD----------EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR 70 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE
Confidence 468999999999999999999999999976543221 2345677899999998 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+||+|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 71 ~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 71 LFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 99999999999999887654 3599999999999999999999999999999999999999999999999999864211
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (329)
T cd05588 149 P--------------------------------------------------------GDTTSTFCGTPNYIAPEILRGED 172 (329)
T ss_pred C--------------------------------------------------------CCccccccCCccccCHHHHcCCC
Confidence 0 01223457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCC---------HHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC---
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSS---------RKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG--- 327 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~---------~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s--- 327 (426)
++.++|+|||||++|+|++|+.||.... ....+..+....... ...+..+.+||++||+.||.+|+|
T Consensus 173 ~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 252 (329)
T cd05588 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHP 252 (329)
T ss_pred CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 9999999999999999999999996321 112233344333322 245788999999999999999997
Q ss_pred ---hHHHhcCCCcCCCChhhhhhcc
Q 014344 328 ---VEEIKGHEFFKGVNWELLLKIS 349 (426)
Q Consensus 328 ---~~eil~hp~f~~~~~~~~~~~~ 349 (426)
++++++||||..++|..+....
T Consensus 253 ~~~~~~i~~hp~~~~~~~~~~~~~~ 277 (329)
T cd05588 253 QTGFRDIKSHPFFRNIDWDLLEQKQ 277 (329)
T ss_pred CCCHHHHhcCCCCCCCCHHHHHhCC
Confidence 7899999999999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=368.04 Aligned_cols=261 Identities=32% Similarity=0.495 Sum_probs=225.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
++.|.--+.||.|..++|-.+.++.+|+.+|+|++.-..-... ............+|+.||+++. ||+|+.+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~-----~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTES-----GETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccC-----CccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3567788899999999999999999999999999954321111 1112334566778999999985 999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
+|+++..+++|+|.|+.|.|++++...- .+++...+.+++|++.|++|||.++||||||||+|||++++.+|||+|||
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999999987654 39999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+|+.+.+ +++.+..||||.|+||
T Consensus 169 Fa~~l~~---------------------------------------------------------GekLrelCGTPgYLAP 191 (411)
T KOG0599|consen 169 FACQLEP---------------------------------------------------------GEKLRELCGTPGYLAP 191 (411)
T ss_pred eeeccCC---------------------------------------------------------chhHHHhcCCCcccCh
Confidence 9998854 3466778899999999
Q ss_pred hhhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCHHHHHHHHHHhccCC
Q 014344 254 EIIEG------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 254 E~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~li~~~L~~dP 322 (426)
|.+.+ .+|+..+|+||+|||+|.|+.|.+||-.....-++..|+.. .+.+.+.+...+|||.+||+.||
T Consensus 192 EtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp 271 (411)
T KOG0599|consen 192 ETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDP 271 (411)
T ss_pred hheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCc
Confidence 99875 46889999999999999999999999877766667777643 35555678889999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
.+|+|++|+|+||||..
T Consensus 272 ~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 272 TKRITAKEALAHPFFIQ 288 (411)
T ss_pred hhcccHHHHhcChHHHH
Confidence 99999999999999954
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=385.83 Aligned_cols=266 Identities=32% Similarity=0.593 Sum_probs=227.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVL 95 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~ 95 (426)
+|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..++..+. |++|+.+++++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~ 70 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD----------DDVECTMVEKRVLALQDKPPFLTQLHSCF 70 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhccCCCchhheeeEE
Confidence 48899999999999999999999999999999976543221 23456777889998886 57888999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+.+.+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 71 QTVDRLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred ecCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence 9999999999999999999987654 34999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
...... .......+||+.|+|||+
T Consensus 149 ~~~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~ 172 (323)
T cd05615 149 KEHMVD--------------------------------------------------------GVTTRTFCGTPDYIAPEI 172 (323)
T ss_pred cccCCC--------------------------------------------------------CccccCccCCccccCHHH
Confidence 643211 011234569999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC-----hH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG-----VE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s-----~~ 329 (426)
+.+..++.++||||+||++|+|++|++||.+.+....+..+....... ...+..+.+|+.+||+++|.+|++ .+
T Consensus 173 ~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 252 (323)
T cd05615 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGER 252 (323)
T ss_pred HcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHH
Confidence 999999999999999999999999999999998888877776544332 345788999999999999999997 47
Q ss_pred HHhcCCCcCCCChhhhhhccC
Q 014344 330 EIKGHEFFKGVNWELLLKISR 350 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~ 350 (426)
++++||||+.++|..+.....
T Consensus 253 ~i~~h~~f~~~~~~~~~~~~~ 273 (323)
T cd05615 253 DIREHAFFRRIDWDKLENREI 273 (323)
T ss_pred HHhcCcccCCCCHHHHhcCCC
Confidence 999999999999998866443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=371.76 Aligned_cols=281 Identities=31% Similarity=0.638 Sum_probs=235.0
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPL 87 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~ 87 (426)
..+.+.+.+|.++++||+|+|++|.+++.+.|.+.||+|+++|+.+... +...-++.|..+..+. +||+
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd----------edidwvqtek~vfe~asn~pf 312 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD----------EDIDWVQTEKHVFEQASNNPF 312 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc----------ccchhHHhhHHHHHhccCCCe
Confidence 3677899999999999999999999999999999999999977654322 3345567788888776 5999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
+|.++.+|+++..+++|.||++||+|.-.+++++. ++++.+++|..+|+.||.|||+.|||+||||.+|+|++..|++
T Consensus 313 lvglhscfqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 313 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred EEehhhhhcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCce
Confidence 99999999999999999999999999876666543 9999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|+|+++.-- ..+..+.+||||
T Consensus 391 kltdygmcke~l--------------------------------------------------------~~gd~tstfcgt 414 (593)
T KOG0695|consen 391 KLTDYGMCKEGL--------------------------------------------------------GPGDTTSTFCGT 414 (593)
T ss_pred eecccchhhcCC--------------------------------------------------------CCCcccccccCC
Confidence 999999987421 113356789999
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-------CH-HHHHHHHhcCCCCC-CCCCHHHHHHHHHHh
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS-------SR-KETFYRILCRPPDL-VGEPTPLRNLIRRLL 318 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-------~~-~~~~~~i~~~~~~~-~~~~~~~~~li~~~L 318 (426)
|.|.|||+++|..|++++|||+|||+++||+.|+.||+-- +. .-.++-|+.+.... ...+-.+..+++..|
T Consensus 415 pnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgfl 494 (593)
T KOG0695|consen 415 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFL 494 (593)
T ss_pred CcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhh
Confidence 9999999999999999999999999999999999999521 22 23344444333222 233556778999999
Q ss_pred ccCCCCCCC------hHHHhcCCCcCCCChhhhhhccCCCCCCCC
Q 014344 319 EKDPTKRIG------VEEIKGHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 319 ~~dP~~R~s------~~eil~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
.+||.+|+. +.++..|+||+.++|+.+.+....|+..+.
T Consensus 495 nkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 495 NKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ 539 (593)
T ss_pred cCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence 999999985 789999999999999999876554444333
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=384.13 Aligned_cols=260 Identities=35% Similarity=0.638 Sum_probs=220.1
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh-cCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN-VEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||||++.+...... ........|..++.. ++||||+++++++.+.+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~ 70 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN 70 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc----------chHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE
Confidence 479999999999999999999999999976543211 123455667888876 489999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+||||++||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 99999999999999987654 3489999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
.. ......+||+.|+|||++.+..
T Consensus 149 ~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05619 149 GD--------------------------------------------------------AKTCTFCGTPDYIAPEILLGQK 172 (316)
T ss_pred CC--------------------------------------------------------CceeeecCCccccCHHHHcCCC
Confidence 10 1123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChH-HHhcCCCcC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVE-EIKGHEFFK 338 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~-eil~hp~f~ 338 (426)
++.++||||+||++|+|++|..||.+.+..+.+..+....+.. ...+..+.+||.+||+.||.+|+++. ++++||||+
T Consensus 173 ~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~ 252 (316)
T cd05619 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFR 252 (316)
T ss_pred CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccC
Confidence 9999999999999999999999999988877777665443332 23577899999999999999999996 999999999
Q ss_pred CCChhhhhhcc
Q 014344 339 GVNWELLLKIS 349 (426)
Q Consensus 339 ~~~~~~~~~~~ 349 (426)
.++|..+....
T Consensus 253 ~~~~~~~~~~~ 263 (316)
T cd05619 253 EIDWSALEERE 263 (316)
T ss_pred CCCHHHHHhCC
Confidence 99999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=385.80 Aligned_cols=266 Identities=35% Similarity=0.615 Sum_probs=223.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||+|++.+...... .....+..|+.++..++||||+.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 70 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKR----------AETACFREERDVLVNGDRRWITNLHYAF 70 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hhHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 479999999999999999999999999999999976432221 2345677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++..+|+||||+.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 71 QDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCce
Confidence 99999999999999999999986543 45999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......+||+.|+|||+
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 174 (331)
T cd05597 150 LRLLADG-------------------------------------------------------TVQSNVAVGTPDYISPEI 174 (331)
T ss_pred eecCCCC-------------------------------------------------------CccccceeccccccCHHH
Confidence 7653211 011123469999999999
Q ss_pred hcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------CCCCCCCHHHHHHHHHHhccCCCC
Q 014344 256 IEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------PDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 256 ~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... +.....+..+++||++||..++.+
T Consensus 175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r 254 (331)
T cd05597 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETR 254 (331)
T ss_pred HhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccc
Confidence 974 447889999999999999999999999988877777775322 222345788999999999765444
Q ss_pred --CCChHHHhcCCCcCCCChhhhhh
Q 014344 325 --RIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 325 --R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
|++++++++||||.+++|.....
T Consensus 255 ~~r~~~~~~l~hp~~~~~~~~~~~~ 279 (331)
T cd05597 255 LGRNGLQDFKDHPFFEGIDWDNIRN 279 (331)
T ss_pred cCCCCHHHHhcCCCCCCCCHHHHhh
Confidence 78999999999999999998754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-50 Score=379.93 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=211.1
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
++++|+++++||.|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~~ 70 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE------------EGAPCTAIREVSLLKNLKHANIVTLHD 70 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc------------CCcchhHHHHHHHHHhCCCCCEeeEEE
Confidence 57889999999999999999999999999999999843211 112245677999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.++...|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 71 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG 148 (288)
T cd07871 71 IIHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFG 148 (288)
T ss_pred EEcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCc
Confidence 9999999999999997 58988876543 358899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... ......+||+.|+||
T Consensus 149 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 172 (288)
T cd07871 149 LARAKSVPT--------------------------------------------------------KTYSNEVVTLWYRPP 172 (288)
T ss_pred ceeeccCCC--------------------------------------------------------ccccCceecccccCh
Confidence 986542110 011223589999999
Q ss_pred hhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC----------------------------
Q 014344 254 EIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------------------- 301 (426)
Q Consensus 254 E~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------------------- 301 (426)
|++.+ ..++.++||||+||++|+|++|++||.+.+..+....+.. .++
T Consensus 173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07871 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLIN 252 (288)
T ss_pred HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHH
Confidence 99876 5689999999999999999999999998877665544321 000
Q ss_pred CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.....+.++.+||.+||++||.+|||++|+|+||||
T Consensus 253 ~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 253 HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=383.61 Aligned_cols=260 Identities=36% Similarity=0.660 Sum_probs=223.1
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||||++.+...... .....+..|..+++.+ +||||+++++++.+.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~ 70 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD----------DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR 70 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE
Confidence 469999999999999999999999999977643222 2345667788999888 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+|++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 71 LFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 99999999999999887654 3499999999999999999999999999999999999999999999999999864311
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~ 172 (318)
T cd05570 149 G--------------------------------------------------------GVTTSTFCGTPDYIAPEILSYQP 172 (318)
T ss_pred C--------------------------------------------------------CCcccceecCccccCHHHhcCCC
Confidence 0 01123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh-----HHHhcC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV-----EEIKGH 334 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~-----~eil~h 334 (426)
++.++|+|||||++|+|++|+.||.+.+....+..+....... ...+..+.+||++||..||.+||++ .+++.|
T Consensus 173 ~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 9999999999999999999999999888877777776544333 2457889999999999999999999 999999
Q ss_pred CCcCCCChhhhhhcc
Q 014344 335 EFFKGVNWELLLKIS 349 (426)
Q Consensus 335 p~f~~~~~~~~~~~~ 349 (426)
|||+.++|.......
T Consensus 253 ~~~~~~~~~~~~~~~ 267 (318)
T cd05570 253 PFFREIDWDKLERKE 267 (318)
T ss_pred CCcCCCCHHHHHhCC
Confidence 999999998775543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=385.56 Aligned_cols=259 Identities=40% Similarity=0.706 Sum_probs=220.3
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH-HHHhcCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR-VLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||||++.+...... .....+..|.. +++.++||||+++++++...+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~ 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh----------hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE
Confidence 469999999999999999999999999976543222 12234445544 5678999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 99999999999999887654 4599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (323)
T cd05575 149 H--------------------------------------------------------SKTTSTFCGTPEYLAPEVLRKQP 172 (323)
T ss_pred C--------------------------------------------------------CCccccccCChhhcChhhhcCCC
Confidence 0 01123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh----HHHhcCC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV----EEIKGHE 335 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~----~eil~hp 335 (426)
++.++|||||||++|+|++|..||.+.+..+.+..+...+... ...+..+.+||.+||+.||.+||++ .+++.||
T Consensus 173 ~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~ 252 (323)
T cd05575 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHV 252 (323)
T ss_pred CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCC
Confidence 9999999999999999999999999988888887777554332 3458889999999999999999997 6999999
Q ss_pred CcCCCChhhhhhc
Q 014344 336 FFKGVNWELLLKI 348 (426)
Q Consensus 336 ~f~~~~~~~~~~~ 348 (426)
||+.++|..+...
T Consensus 253 ~~~~~~~~~~~~~ 265 (323)
T cd05575 253 FFSSINWDDLVNK 265 (323)
T ss_pred CcCCCCHHHHhhc
Confidence 9999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=386.19 Aligned_cols=266 Identities=42% Similarity=0.730 Sum_probs=220.5
Q ss_pred CcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLR 92 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~ 92 (426)
+|++++.||+|+||+||+|++. .+++.||+|++.+...... ......+..|+.+++.+. ||+|+.++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~ 71 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK---------AKTVEHTRTERNVLEHVRQSPFLVTLH 71 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh---------hhHHHHHHHHHHHHHhccCCCCcccEE
Confidence 5899999999999999999874 4789999999976543222 123456778999999995 89999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|..+..+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 72 YAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred EEEecCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999999999987654 34999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.... .......+||+.|+|
T Consensus 150 G~~~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~a 174 (332)
T cd05614 150 GLSKEFLSEE-------------------------------------------------------KERTYSFCGTIEYMA 174 (332)
T ss_pred cCCccccccC-------------------------------------------------------CCccccccCCccccC
Confidence 9987643211 112234579999999
Q ss_pred chhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCC-CCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 253 PEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILCRPP-DLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 253 PE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
||++.+. .++.++|||||||++|+|++|..||.... .......+....+ .....+..+.+||.+||..||++||
T Consensus 175 PE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 254 (332)
T cd05614 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRL 254 (332)
T ss_pred HHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcC
Confidence 9999875 47889999999999999999999996432 2233334443332 2334578899999999999999999
Q ss_pred -----ChHHHhcCCCcCCCChhhhhhc
Q 014344 327 -----GVEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 327 -----s~~eil~hp~f~~~~~~~~~~~ 348 (426)
+++++++||||++.+|..+...
T Consensus 255 ~~~~~~~~~~l~h~~~~~~~~~~~~~~ 281 (332)
T cd05614 255 GAGPQGASEIKEHPFFKGLDWEALALR 281 (332)
T ss_pred CCCCCCHHHHHcCCCcCCCCHHHHHhC
Confidence 7889999999999999887543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=392.30 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=225.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
-..|..+..||+|+||.||+|.+..+++.||||++..+. ..+....+++|+.+|.+++++||.++|+.
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~------------~~deIediqqei~~Ls~~~~~~it~yygs 79 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE------------AEDEIEDIQQEISVLSQCDSPNITEYYGS 79 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh------------cchhhHHHHHHHHHHHhcCcchHHhhhhh
Confidence 345888899999999999999999999999999995543 23456789999999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|..+..++++||||.||++.++++.. ..+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.
T Consensus 80 yl~g~~LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgV 157 (467)
T KOG0201|consen 80 YLKGTKLWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGV 157 (467)
T ss_pred eeecccHHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecce
Confidence 99999999999999999999998753 3358999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+... ..+.++|+|||.|||||
T Consensus 158 a~ql~~~--------------------------------------------------------~~rr~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 158 AGQLTNT--------------------------------------------------------VKRRKTFVGTPFWMAPE 181 (467)
T ss_pred eeeeech--------------------------------------------------------hhccccccccccccchh
Confidence 9887532 23448999999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCC-CCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLV-GEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
++.+.+|+.++||||||+++|||++|.+|+....+...+..|-.. ||.+. .+++.+++||..||.+||+.||+|.++|
T Consensus 182 VI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 182 VIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred hhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 999999999999999999999999999999998886555555443 33333 3567899999999999999999999999
Q ss_pred cCCCcCCC
Q 014344 333 GHEFFKGV 340 (426)
Q Consensus 333 ~hp~f~~~ 340 (426)
+|+|++..
T Consensus 262 Kh~FIk~a 269 (467)
T KOG0201|consen 262 KHKFIKRA 269 (467)
T ss_pred hhHHHHhc
Confidence 99999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=385.16 Aligned_cols=262 Identities=37% Similarity=0.676 Sum_probs=223.4
Q ss_pred EeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 21 VSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
++.||+|+||.||+|++. .+++.||+|++.+...... ......+..|+.+|+.++||||++++++|..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~ 71 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN---------QKDTAHTKAERNILEAVKHPFIVDLIYAFQT 71 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhh---------hhhHHHHHHHHHHHHhCCCCchhceeeEEec
Confidence 468999999999999874 5788999999976543221 1123467789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
++.+|+||||+.|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 72 GGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred CCeEEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 99999999999999999987654 4588999999999999999999999999999999999999999999999999864
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
.... .......+||+.|+|||++.
T Consensus 150 ~~~~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~ 173 (323)
T cd05584 150 SIHE--------------------------------------------------------GTVTHTFCGTIEYMAPEILM 173 (323)
T ss_pred cccC--------------------------------------------------------CCcccccCCCccccChhhcc
Confidence 3211 01123456999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----ChHHH
Q 014344 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI-----GVEEI 331 (426)
Q Consensus 258 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~-----s~~ei 331 (426)
+..++.++|||||||++|||++|+.||.+.+....+..+....... ...+..+.+||.+||++||++|| +++++
T Consensus 174 ~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l 253 (323)
T cd05584 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEV 253 (323)
T ss_pred CCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHH
Confidence 9999999999999999999999999999988888777776544332 34578899999999999999999 89999
Q ss_pred hcCCCcCCCChhhhhhcc
Q 014344 332 KGHEFFKGVNWELLLKIS 349 (426)
Q Consensus 332 l~hp~f~~~~~~~~~~~~ 349 (426)
+.||||+..+|..+....
T Consensus 254 ~~h~~~~~~~~~~~~~~~ 271 (323)
T cd05584 254 QSHPFFRHVNWDDLLARK 271 (323)
T ss_pred hcCCCcCCCCHHHHhcCC
Confidence 999999999998876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=377.08 Aligned_cols=267 Identities=30% Similarity=0.476 Sum_probs=224.6
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++.+.||+|+||+||++.+..+++.||+|++.+...... .....+.+|+.+++.++||||+.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKQILEKVNSRFVVSLAYAYE 70 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh----------hhHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 48999999999999999999999999999999965443221 12345677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
++..+|+|||||.||+|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05605 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred CCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCce
Confidence 99999999999999999988766555569999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... .....+||+.|+|||++
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 151 EIPEGE---------------------------------------------------------TIRGRVGTVGYMAPEVV 173 (285)
T ss_pred ecCCCC---------------------------------------------------------ccccccCCCCccCcHHh
Confidence 542110 11234689999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR----ILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI----- 326 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~----- 326 (426)
.+..++.++||||+||++|+|++|+.||.+.+....... +...... ....+..+.+||.+||..||.+||
T Consensus 174 ~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05605 174 KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253 (285)
T ss_pred cCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCC
Confidence 998899999999999999999999999988665433222 2222222 224578899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhhhccC
Q 014344 327 GVEEIKGHEFFKGVNWELLLKISR 350 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~~~~~ 350 (426)
+++++++||||...+|+.+.+...
T Consensus 254 ~~~~l~~~~~~~~~~~~~~~~~~~ 277 (285)
T cd05605 254 GAEEVKAHPFFRTANFKRLEAGML 277 (285)
T ss_pred CHHHHhcCcCccCCCHHHHhhCCC
Confidence 899999999999999998865433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=376.61 Aligned_cols=263 Identities=30% Similarity=0.517 Sum_probs=218.3
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||+|+||+||+|.+..+++.||+|++.+...... .....+..|+++++.++||||+++.++|..+..+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~l 70 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR----------KGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCL 70 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhh----------HHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEE
Confidence 7999999999999999999999999976543221 234567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
||||++||+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 99999999998876432 2345899999999999999999999999999999999999999999999999998755321
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
. .......||+.|+|||++.+..+
T Consensus 151 ~--------------------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~ 174 (280)
T cd05608 151 Q--------------------------------------------------------SKTKGYAGTPGFMAPELLQGEEY 174 (280)
T ss_pred C--------------------------------------------------------ccccccCCCcCccCHHHhcCCCC
Confidence 1 11223468999999999999999
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----ChHHH
Q 014344 262 DFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI-----GVEEI 331 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~-----s~~ei 331 (426)
+.++|+|||||++|+|++|+.||..... ......+...+.. ....+..+.+|+.+||+.||++|| +++++
T Consensus 175 ~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 9999999999999999999999986543 2223333333222 234578899999999999999999 78999
Q ss_pred hcCCCcCCCChhhhhhccCCC
Q 014344 332 KGHEFFKGVNWELLLKISRPP 352 (426)
Q Consensus 332 l~hp~f~~~~~~~~~~~~~~~ 352 (426)
++||||++++|..+.....|+
T Consensus 255 l~h~~~~~~~~~~~~~~~~~~ 275 (280)
T cd05608 255 RTHPLFRDLNWRQLEAGMLPP 275 (280)
T ss_pred hcChhhhcCCHhHHhhccCCC
Confidence 999999999999875544443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=385.55 Aligned_cols=274 Identities=33% Similarity=0.594 Sum_probs=228.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||++++..+++.||+|++.+...... .....+..|+.++..++|++|+.+++++
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~l~~~~ 70 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKR----------AETACFREERNVLVNGDCQWITTLHYAF 70 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhh----------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 479999999999999999999999999999999976432211 2344577899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|+||||++||+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 71 ~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 71 QDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence 99999999999999999999987643 35899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......+||+.|+|||+
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 174 (331)
T cd05624 150 LKMNQDG-------------------------------------------------------TVQSSVAVGTPDYISPEI 174 (331)
T ss_pred eeccCCC-------------------------------------------------------ceeeccccCCcccCCHHH
Confidence 7653211 001123469999999999
Q ss_pred hcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------CCCCCCCHHHHHHHHHHhccCCCC
Q 014344 256 IEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------PDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 256 ~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.+ ..++.++|||||||++|+|++|+.||...+..+.+..+.... ......+..+++||.+||..++.+
T Consensus 175 ~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred HhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhh
Confidence 876 457889999999999999999999999988888777776432 222345788999999999876654
Q ss_pred --CCChHHHhcCCCcCCCChhhhhhccCCCCCCC
Q 014344 325 --RIGVEEIKGHEFFKGVNWELLLKISRPPNIPA 356 (426)
Q Consensus 325 --R~s~~eil~hp~f~~~~~~~~~~~~~~~~~~~ 356 (426)
|++++++++||||++++|+.+... .+|.+|.
T Consensus 255 ~~~~~~~~~~~h~~f~~~~~~~~~~~-~~~~~p~ 287 (331)
T cd05624 255 LGQNGIEDFKKHAFFEGIDWENIRNL-EAPYIPD 287 (331)
T ss_pred cCCCCHHHHhcCCCcCCCCHHHHhhC-CCCccCC
Confidence 468999999999999999988543 3444443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=380.16 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=210.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.+++.++||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 69 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-----------NEEVKETTLRELKMLRTLKQENIVELKEAF 69 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-----------cccchhhHHHHHHHHHhCCCccccchhhhE
Confidence 469999999999999999999999999999999854321 112345677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..++.+|+||||++++.+..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 70 RRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred ecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 999999999999998877655432 245899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......+||+.|+|||+
T Consensus 148 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~aPE~ 172 (287)
T cd07848 148 RNLSEGS-------------------------------------------------------NANYTEYVATRWYRSPEL 172 (287)
T ss_pred ccccccc-------------------------------------------------------cccccccccccccCCcHH
Confidence 7653211 011223468999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------CC--------C-----------
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR--------------PP--------D----------- 302 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--------------~~--------~----------- 302 (426)
+.+..++.++|||||||++|+|++|++||.+.+..+....+... .+ .
T Consensus 173 ~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07848 173 LLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRY 252 (287)
T ss_pred HcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhh
Confidence 99989999999999999999999999999987765443322110 00 0
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
....+..+.+||++||++||++|||++++|+||||
T Consensus 253 ~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 253 LGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00135678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=384.73 Aligned_cols=259 Identities=33% Similarity=0.679 Sum_probs=214.7
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||+|++.+..... ......+..|+.++.++ +||||+++++++...+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 70 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND----------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 70 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc----------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE
Confidence 46999999999999999999999999997654321 12345677888888876 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 71 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 99999999999998877654 3599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (329)
T cd05618 149 P--------------------------------------------------------GDTTSTFCGTPNYIAPEILRGED 172 (329)
T ss_pred C--------------------------------------------------------CCccccccCCccccCHHHHcCCC
Confidence 0 01123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCC---
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGS---------SRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIG--- 327 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s--- 327 (426)
++.++|||||||++|+|++|+.||... .....+..+...... ....+..+.+||.+||+.||.+|++
T Consensus 173 ~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~ 252 (329)
T cd05618 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHP 252 (329)
T ss_pred CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCC
Confidence 999999999999999999999999521 112223334333322 2345788999999999999999998
Q ss_pred ---hHHHhcCCCcCCCChhhhhhc
Q 014344 328 ---VEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 328 ---~~eil~hp~f~~~~~~~~~~~ 348 (426)
+.++++||||+.++|+.....
T Consensus 253 ~~~~~~i~~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 253 QTGFADIQGHPFFRNVDWDLMEQK 276 (329)
T ss_pred CCCHHHHhcCCCCCCCCHHHHHcC
Confidence 479999999999999987653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=385.22 Aligned_cols=263 Identities=37% Similarity=0.684 Sum_probs=221.2
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH-HHHhcCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR-VLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+|+.||+|++.+...... .....+..|.. +++.++||||+++++++..++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~ 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR----------KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE
Confidence 469999999999999999999999999976543221 12334455554 5677999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+||||+.||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 99999999999998877653 4599999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05604 149 Q--------------------------------------------------------SDTTTTFCGTPEYLAPEVIRKQP 172 (325)
T ss_pred C--------------------------------------------------------CCCcccccCChhhCCHHHHcCCC
Confidence 1 01123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCCh----HHHhcCC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIGV----EEIKGHE 335 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~----~eil~hp 335 (426)
++.++|||||||++|+|++|..||...+..+.+..++..... ..+.+..+.++|++||+.+|.+||++ .+++.||
T Consensus 173 ~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~ 252 (325)
T cd05604 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP 252 (325)
T ss_pred CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCC
Confidence 999999999999999999999999998888888777654432 23567889999999999999999986 5999999
Q ss_pred CcCCCChhhhhhccCCC
Q 014344 336 FFKGVNWELLLKISRPP 352 (426)
Q Consensus 336 ~f~~~~~~~~~~~~~~~ 352 (426)
||+.++|..+.....++
T Consensus 253 ~f~~~~~~~~~~~~~~~ 269 (325)
T cd05604 253 FFESLSWTDLEQKKIPP 269 (325)
T ss_pred CcCCCCHHHHHhCCCCC
Confidence 99999998876544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=383.51 Aligned_cols=266 Identities=33% Similarity=0.578 Sum_probs=224.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+++++.+++.||+|++.+...... .....+..|+.++..++|++|+.+++++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 70 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKR----------AETACFREERDVLVNGDNQWITTLHYAF 70 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHh----------hHHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 479999999999999999999999999999999966433222 1234577799999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++..+|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 71 QDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred ecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchh
Confidence 99999999999999999999987643 35899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......+||+.|+|||+
T Consensus 150 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 174 (332)
T cd05623 150 LKLMEDG-------------------------------------------------------TVQSSVAVGTPDYISPEI 174 (332)
T ss_pred eecccCC-------------------------------------------------------cceecccccCccccCHHH
Confidence 7543211 011223469999999999
Q ss_pred hcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------CCCCCCCHHHHHHHHHHhccCCCC
Q 014344 256 IEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------PDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 256 ~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.+ ..++.++|||||||++|||++|+.||.+.+..+.+.++.... ......+..+++||++||..++.+
T Consensus 175 ~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHR 254 (332)
T ss_pred HhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhh
Confidence 863 457889999999999999999999999998888888776432 222346788999999999765554
Q ss_pred --CCChHHHhcCCCcCCCChhhhhh
Q 014344 325 --RIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 325 --R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
|++++++++||||++++|+.+..
T Consensus 255 ~~r~~~~~~~~h~~f~~~~~~~~~~ 279 (332)
T cd05623 255 LGQNGIEDFKQHPFFTGIDWDNIRN 279 (332)
T ss_pred cCCCCHHHHhCCCCcCCCCHHHHhh
Confidence 68999999999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=382.61 Aligned_cols=263 Identities=33% Similarity=0.665 Sum_probs=218.6
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||+|++.+...... .....+..|+.++.++ .||+|+.+++++.+.+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 70 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD----------EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR 70 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE
Confidence 479999999999999999999999999976543221 2345678899999888 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 71 LFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 99999999999999887654 3499999999999999999999999999999999999999999999999999864321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (327)
T cd05617 149 P--------------------------------------------------------GDTTSTFCGTPNYIAPEILRGEE 172 (327)
T ss_pred C--------------------------------------------------------CCceecccCCcccCCHHHHCCCC
Confidence 0 01123457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC-----
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGS-------SRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG----- 327 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~-------~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s----- 327 (426)
++.++|||||||++|+|++|..||... .....+..+...+... ...+..+.++|.+||..||.+|++
T Consensus 173 ~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 252 (327)
T cd05617 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQT 252 (327)
T ss_pred CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCC
Confidence 999999999999999999999999532 1223334444433332 245788999999999999999998
Q ss_pred -hHHHhcCCCcCCCChhhhhhccCCC
Q 014344 328 -VEEIKGHEFFKGVNWELLLKISRPP 352 (426)
Q Consensus 328 -~~eil~hp~f~~~~~~~~~~~~~~~ 352 (426)
++++++||||+.++|+.+.+...++
T Consensus 253 ~~~~i~~h~~f~~~~~~~~~~~~~~~ 278 (327)
T cd05617 253 GFSDIKSHTFFRSIDWDLLEKKQVTP 278 (327)
T ss_pred CHHHHHcCCCCCCCCHHHHHhCCCCC
Confidence 4699999999999999887654443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=379.30 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=208.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~niv~~~~~ 71 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE------------EGTPFTAIREASLLKGLKHANIVLLHDI 71 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc------------cccchhHHHHHHHHhhCCCCCcCeEEEE
Confidence 4689999999999999999999999999999999853211 1122356679999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.++...|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 72 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 72 IHTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCc
Confidence 999999999999996 67877766543 4589999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......+||+.|+|||
T Consensus 150 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 173 (303)
T cd07869 150 ARAKSVPS--------------------------------------------------------HTYSNEVVTLWYRPPD 173 (303)
T ss_pred ceeccCCC--------------------------------------------------------ccCCCCcccCCCCChH
Confidence 86432110 0112345899999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHh---cCCC----------------C-----------
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRIL---CRPP----------------D----------- 302 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~---~~~~----------------~----------- 302 (426)
++.+ ..++.++|||||||++|+|++|..||.+... .+....+. ..+. .
T Consensus 174 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (303)
T cd07869 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQ 253 (303)
T ss_pred HHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHH
Confidence 9876 4578999999999999999999999987543 22222221 1100 0
Q ss_pred ---CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 ---LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ---~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
....+..+.+||.+||+.||++|||++|+++||||+.+.+
T Consensus 254 ~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 254 AWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred HhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0012356889999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=383.10 Aligned_cols=260 Identities=40% Similarity=0.697 Sum_probs=220.1
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHH-HHHHhcCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ-RVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||+||+|++..+++.||+|++.+...... .....+..|. .+++.++||||+++++++...+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~ 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK----------KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh----------hHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe
Confidence 469999999999999999999999999976543222 1122334444 45678999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||.|++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 71 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 71 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 99999999999999987654 3488999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05602 149 H--------------------------------------------------------NGTTSTFCGTPEYLAPEVLHKQP 172 (325)
T ss_pred C--------------------------------------------------------CCCcccccCCccccCHHHHcCCC
Confidence 1 01223457999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChH----HHhcCC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVE----EIKGHE 335 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~----eil~hp 335 (426)
++.++|||||||++|+|++|.+||.+.+..+.+..+...+... ...+..+.++|.+||+.||.+|+++. ++++|+
T Consensus 173 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 9999999999999999999999999988888877776554332 35688899999999999999999875 899999
Q ss_pred CcCCCChhhhhhcc
Q 014344 336 FFKGVNWELLLKIS 349 (426)
Q Consensus 336 ~f~~~~~~~~~~~~ 349 (426)
||...+|+.+....
T Consensus 253 ~~~~~~~~~~~~~~ 266 (325)
T cd05602 253 FFSPINWDDLINKK 266 (325)
T ss_pred ccCCCCHHHHHhCC
Confidence 99999999886533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=374.26 Aligned_cols=249 Identities=30% Similarity=0.527 Sum_probs=211.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|+-.+.+|+|+||.||.|....+++.||||.++.+. +.-.+|+.||+.++|||||++..+|.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----------------r~knrEl~im~~l~HpNIV~L~~~f~ 87 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----------------RYKNRELQIMRKLDHPNIVRLLYFFS 87 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----------------CcCcHHHHHHHhcCCcCeeeEEEEEE
Confidence 4888999999999999999999999999999986542 12234999999999999999999885
Q ss_pred c--C---CeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-CcEE
Q 014344 97 T--D---KFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-GHIM 168 (426)
Q Consensus 97 ~--~---~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g~ik 168 (426)
. + -++.+||||++ .+|...++.. .++.++.-.++-|+.||+.||.|||+.||+||||||.|+|+|.+ |.+|
T Consensus 88 ~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LK 166 (364)
T KOG0658|consen 88 SSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLK 166 (364)
T ss_pred ecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEE
Confidence 3 2 26779999997 8888887642 34569999999999999999999999999999999999999976 9999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|||||.|+.+..+. ...+...|.
T Consensus 167 icDFGSAK~L~~~e---------------------------------------------------------pniSYicSR 189 (364)
T KOG0658|consen 167 ICDFGSAKVLVKGE---------------------------------------------------------PNISYICSR 189 (364)
T ss_pred eccCCcceeeccCC---------------------------------------------------------CceeEEEec
Confidence 99999999886543 234567889
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC-----------------C------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP-----------------P------ 301 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~-----------------~------ 301 (426)
.|+|||++.| ..|+.++||||.||++.||+-|++.|.|.+...++..|.. .| +
T Consensus 190 yYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~ 269 (364)
T KOG0658|consen 190 YYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHP 269 (364)
T ss_pred cccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccccccc
Confidence 9999999887 6799999999999999999999999999998887766631 00 0
Q ss_pred ----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....++++.+|+.++|+++|.+|.++.|++.||||...
T Consensus 270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 112346789999999999999999999999999999764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=379.75 Aligned_cols=258 Identities=38% Similarity=0.684 Sum_probs=219.0
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHH-HHHHhcCCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ-RVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+.||+|+||.||+|++..+++.||+|++.+...... .....+..|. .+++.++||||+++++++.+.+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~ 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKK----------KEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh----------hHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE
Confidence 469999999999999999999999999976544322 1223444454 46788999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+|||||+|++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 99999999999998877643 4589999999999999999999999999999999999999999999999999864311
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .......+||+.|+|||++.+..
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (321)
T cd05603 149 P--------------------------------------------------------EETTSTFCGTPEYLAPEVLRKEP 172 (321)
T ss_pred C--------------------------------------------------------CCccccccCCcccCCHHHhcCCC
Confidence 0 01123456999999999999999
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh----HHHhcCC
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV----EEIKGHE 335 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~----~eil~hp 335 (426)
++.++|||||||++|+|++|..||.+.+....+..+...+... ...+..+.++|.+||+.||.+|+++ .++++||
T Consensus 173 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~ 252 (321)
T cd05603 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHV 252 (321)
T ss_pred CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCC
Confidence 9999999999999999999999999988888777777655443 3557889999999999999999975 5999999
Q ss_pred CcCCCChhhhhh
Q 014344 336 FFKGVNWELLLK 347 (426)
Q Consensus 336 ~f~~~~~~~~~~ 347 (426)
||..++|..+..
T Consensus 253 ~~~~~~~~~~~~ 264 (321)
T cd05603 253 FFSPINWDDLYH 264 (321)
T ss_pred CcCCCCHHHHhc
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=387.59 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=233.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|.+++.+|+|+||.+++++++..++.|++|.+.......+ ..+...+|+.+++++.|||||.+.+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-----------~r~~A~~E~~lis~~~hP~iv~y~d 70 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-----------ERRSAIQEMDLLSKLLHPNIVEYKD 70 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-----------hhHHHHHHHHHHHhccCCCeeeecc
Confidence 35789999999999999999999999999999999965543332 2346788999999999999999999
Q ss_pred eeecCCe-EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 94 VLSTDKF-VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 94 ~~~~~~~-~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
.|..++. +||||+||+||+|...+..+.+..|+++.+..|+.|++.||.|||+++|.|||||+.||+++.++.|+|+||
T Consensus 71 s~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 71 SFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred chhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecch
Confidence 9988887 999999999999999999888788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+.+.. ....+.+|||.||.
T Consensus 151 GlaK~l~~~~--------------------------------------------------------~~a~tvvGTp~Ymc 174 (426)
T KOG0589|consen 151 GLAKILNPED--------------------------------------------------------SLASTVVGTPYYMC 174 (426)
T ss_pred hhhhhcCCch--------------------------------------------------------hhhheecCCCcccC
Confidence 9999885421 24556789999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
||++.+.+|++++|||||||++|||++-+++|.+.+......+|.... |.....+.+++.+|..||..+|+.||++.+
T Consensus 175 PEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~ 254 (426)
T KOG0589|consen 175 PEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALE 254 (426)
T ss_pred HHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHH
Confidence 999999999999999999999999999999999999999888887544 444567899999999999999999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
+|.+|.+.
T Consensus 255 LL~~P~l~ 262 (426)
T KOG0589|consen 255 LLRRPHLL 262 (426)
T ss_pred HhhChhhh
Confidence 99999876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=393.20 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=217.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-C-----CCcce
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-H-----PLLPR 90 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h-----p~iv~ 90 (426)
+|+|++.||+|+||.|.+|.|..|++.||||+++.. ....+....|+.||..|+ | -|+|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~--------------k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vr 252 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK--------------KRFLRQAQIEIRILELLNKHDPDDKYNIVR 252 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC--------------hHHHHHHHHHHHHHHHHhccCCCCCeeEEE
Confidence 699999999999999999999999999999999432 235667778999999997 3 39999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC--cEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG--HIM 168 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g--~ik 168 (426)
++++|...+++|||+|.+ +-+|+++++.+....|+...++.++.||+.||.+||++||||+|||||||||.+.+ .||
T Consensus 253 m~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 253 MLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred eeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCcee
Confidence 999999999999999999 59999999998888899999999999999999999999999999999999998654 799
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+.... ...+.+-+.
T Consensus 332 VIDFGSSc~~~q-----------------------------------------------------------~vytYiQSR 352 (586)
T KOG0667|consen 332 VIDFGSSCFESQ-----------------------------------------------------------RVYTYIQSR 352 (586)
T ss_pred EEecccccccCC-----------------------------------------------------------cceeeeecc
Confidence 999999987532 223667888
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC-----------------------
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD----------------------- 302 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~----------------------- 302 (426)
.|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.+..+++..|.. .|+.
T Consensus 353 fYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~ 432 (586)
T KOG0667|consen 353 FYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLC 432 (586)
T ss_pred ccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeee
Confidence 99999999999999999999999999999999999999999888877630 0000
Q ss_pred --------------------------CC-C-----------CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 --------------------------LV-G-----------EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 --------------------------~~-~-----------~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.+ + ....+.|||.+||.+||.+|+|+.++|+||||.+.
T Consensus 433 ~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 433 VETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred eeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 00 0 01227899999999999999999999999999864
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=383.82 Aligned_cols=260 Identities=35% Similarity=0.603 Sum_probs=218.1
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCcceeeeeeecCCe
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~~~~~~~ 100 (426)
||+|+||+||+|++..+++.||||++.+...... ........|..++..+ +||||+.++++|.+...
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~ 70 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK----------KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD 70 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh----------hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe
Confidence 7999999999999999999999999976543322 1233445567777665 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|+||||+.||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 71 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 71 LYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 99999999999999887654 4599999999999999999999999999999999999999999999999999865321
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC-
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK- 259 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~- 259 (426)
. .......+||+.|+|||++.+.
T Consensus 149 ~--------------------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 172 (330)
T cd05586 149 D--------------------------------------------------------NKTTNTFCGTTEYLAPEVLLDEK 172 (330)
T ss_pred C--------------------------------------------------------CCCccCccCCccccCHHHHcCCC
Confidence 1 1123345799999999998764
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCHHHHHHHHHHhccCCCCCC----ChHHHhc
Q 014344 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV--GEPTPLRNLIRRLLEKDPTKRI----GVEEIKG 333 (426)
Q Consensus 260 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~----s~~eil~ 333 (426)
.++.++|||||||++|+|++|+.||.+.+..+.+..+........ ..+..+.+||++||..||.+|| ++.++++
T Consensus 173 ~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 589999999999999999999999999888887777765433332 3478899999999999999998 6899999
Q ss_pred CCCcCCCChhhhhhccCC
Q 014344 334 HEFFKGVNWELLLKISRP 351 (426)
Q Consensus 334 hp~f~~~~~~~~~~~~~~ 351 (426)
||||+..+|+.+.+....
T Consensus 253 h~~~~~~~~~~~~~~~~~ 270 (330)
T cd05586 253 HPFFADIDWDLLSKKQIT 270 (330)
T ss_pred CccccCCCHHHHHhCCCC
Confidence 999999999987654443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=382.50 Aligned_cols=259 Identities=39% Similarity=0.749 Sum_probs=222.0
Q ss_pred EeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 21 VSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
++.||+|+||.||++++. .+|+.||+|++.+...... ....+..|+.+|++++||||+++++++.+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 69 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-----------DRVRTKMERDILAEVNHPFIVKLHYAFQT 69 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhh-----------hHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 467999999999999874 5789999999976543211 23456779999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+..+|+|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 70 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 70 EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999999999887653 4599999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
.... .......+||+.|+|||++.
T Consensus 148 ~~~~--------------------------------------------------------~~~~~~~~g~~~y~aPE~~~ 171 (318)
T cd05582 148 SIDH--------------------------------------------------------EKKAYSFCGTVEYMAPEVVN 171 (318)
T ss_pred cCCC--------------------------------------------------------CCceecccCChhhcCHHHHc
Confidence 4211 01223457999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC-----hHHH
Q 014344 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG-----VEEI 331 (426)
Q Consensus 258 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s-----~~ei 331 (426)
+..++.++|||||||++|+|++|+.||.+.+..+....+....... ...+..+.+||++||+.||++||+ ++++
T Consensus 172 ~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~ 251 (318)
T cd05582 172 RRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEI 251 (318)
T ss_pred CCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 9999999999999999999999999999988888777776544333 245788999999999999999999 6779
Q ss_pred hcCCCcCCCChhhhhhc
Q 014344 332 KGHEFFKGVNWELLLKI 348 (426)
Q Consensus 332 l~hp~f~~~~~~~~~~~ 348 (426)
+.||||+.++|..+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~ 268 (318)
T cd05582 252 KRHPFFSTIDWNKLYRR 268 (318)
T ss_pred hCCCCcCCCCHHHHHhc
Confidence 99999999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=365.65 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=217.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~ 93 (426)
+..|+.+++||+|+||+||+|+.+.+|+.||+|++..+.-. ...-....+|+.+|+.|+|+| |+.+++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-----------EG~P~taiREisllk~L~~~~~iv~L~d 78 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-----------EGVPSTAIREISLLKRLSHANHIVRLHD 78 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-----------cCCCchhhHHHHHHHHhCCCcceEEEEe
Confidence 56788999999999999999999999999999998443211 112345677999999999999 999999
Q ss_pred eeecCC------eEEEEEeccCCCChHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 94 VLSTDK------FVGYAIDYCPGRDLHSLRKQQSE--QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 94 ~~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~--~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
++.+++ .+++|+||++ .||..++..... ..++...++.++.||+.||+|||++||+||||||+||||+.+|
T Consensus 79 v~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 79 VIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG 157 (323)
T ss_pred eeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC
Confidence 998887 8999999996 999999887653 3588899999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+|+...-. .+...+-+
T Consensus 158 ~lKlaDFGlAra~~ip--------------------------------------------------------~~~yt~ev 181 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIP--------------------------------------------------------MRTYTPEV 181 (323)
T ss_pred cEeeeccchHHHhcCC--------------------------------------------------------cccccccE
Confidence 9999999999865311 11234457
Q ss_pred cCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC--CCCC---------------
Q 014344 246 GTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP--PDLV--------------- 304 (426)
Q Consensus 246 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~--~~~~--------------- 304 (426)
+|..|+|||++.|. .|+..+||||+|||++||+++++.|.+.+..++..+|.. .| ..++
T Consensus 182 vTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~ 261 (323)
T KOG0594|consen 182 VTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKW 261 (323)
T ss_pred EEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCC
Confidence 99999999999886 799999999999999999999999999999888877741 11 0111
Q ss_pred -----------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 305 -----------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 305 -----------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.......+++.+||+++|.+|.|++.+|.||||...
T Consensus 262 ~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 262 PGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 001357899999999999999999999999999865
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=377.74 Aligned_cols=256 Identities=27% Similarity=0.423 Sum_probs=215.7
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
|..++|++++.||+|+||.||+|++..++..+|+|++.... .......+.+|+++|+.++||||++++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI------------KPAIRNQIIRELQVLHECNSPYIVGFY 69 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc------------CHHHHHHHHHHHHHHHHCCCCCCCeEE
Confidence 56788999999999999999999999999999999985421 112345788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEEEec
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++..++.+++||||++|++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~D 147 (331)
T cd06649 70 GAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCD 147 (331)
T ss_pred EEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEcc
Confidence 99999999999999999999999987643 489999999999999999999986 699999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+... .....+||+.|+
T Consensus 148 fg~~~~~~~~----------------------------------------------------------~~~~~~g~~~y~ 169 (331)
T cd06649 148 FGVSGQLIDS----------------------------------------------------------MANSFVGTRSYM 169 (331)
T ss_pred Cccccccccc----------------------------------------------------------ccccCCCCcCcC
Confidence 9998754211 122346899999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------------------------
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI----------------------------------- 296 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i----------------------------------- 296 (426)
|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 170 aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T cd06649 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRP 249 (331)
T ss_pred CHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccccccccccc
Confidence 999999999999999999999999999999999876554332111
Q ss_pred -----------hcC-CCC--CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 297 -----------LCR-PPD--LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 297 -----------~~~-~~~--~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
... .+. ....+.++++||.+||++||++|||+++|++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 250 AMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred chhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000 000 11246789999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=368.55 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=216.2
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||+|+||+||+|+++.+|+.||+|++.+...... .....+..|+.+++.++||||+++++++..+..+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~l 70 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK----------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCL 70 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc----------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEE
Confidence 7999999999999999999999999966443222 122345569999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
||||++|++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 71 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~- 149 (277)
T cd05607 71 VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK- 149 (277)
T ss_pred EEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-
Confidence 9999999999988766555568999999999999999999999999999999999999999999999999987653210
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
......||+.|+|||++.+..++.
T Consensus 150 --------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 173 (277)
T cd05607 150 --------------------------------------------------------TITQRAGTNGYMAPEILKEEPYSY 173 (277)
T ss_pred --------------------------------------------------------eeeccCCCCCccCHHHHccCCCCC
Confidence 111235899999999999988999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCC--CCCCCHHHHHHHHHHhccCCCCCCCh----HHHhc
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRPPD--LVGEPTPLRNLIRRLLEKDPTKRIGV----EEIKG 333 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~--~~~~~~~~~~li~~~L~~dP~~R~s~----~eil~ 333 (426)
++|+||+||++|+|++|..||..... .+....+...... ....+.++++||.+||+.||.+||++ ++++.
T Consensus 174 ~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~ 253 (277)
T cd05607 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK 253 (277)
T ss_pred chhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence 99999999999999999999976533 2233333322211 22457889999999999999999999 67889
Q ss_pred CCCcCCCChhhhhhccCC
Q 014344 334 HEFFKGVNWELLLKISRP 351 (426)
Q Consensus 334 hp~f~~~~~~~~~~~~~~ 351 (426)
||||++++|..+.....+
T Consensus 254 h~~f~~~~~~~~~~~~~~ 271 (277)
T cd05607 254 HEFFKTINFPRLEAGLIP 271 (277)
T ss_pred ChhhcCCCHHHHhcCcCC
Confidence 999999999888654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=372.36 Aligned_cols=295 Identities=48% Similarity=0.835 Sum_probs=236.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|++|+||+|.+..+++.||||.+.+..... ....+.+..|+.+++.++||||+++++.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 70 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK----------RNKVKRVLTEQEILATLDHPFLPTLYASF 70 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch----------HHHHHHHHHHHHHHHhCCCCCchhheeee
Confidence 36999999999999999999999999999999996543221 12456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
......|+||||+.|++|.+++.......+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 150 (316)
T cd05574 71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150 (316)
T ss_pred ecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchh
Confidence 99999999999999999999987665567999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
............... .....+...+.. ............+.++||..|+|||+
T Consensus 151 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~g~~~y~aPE~ 203 (316)
T cd05574 151 KQSDVEPPPVSKALR--------KGSRRSSVNSIP-------------------SETFSEEPSFRSNSFVGTEEYIAPEV 203 (316)
T ss_pred hcccccccccccccc--------cccccccccccc-------------------hhhhcccccCCCCCCcCccCCcCHHH
Confidence 766432211100000 000000000000 00000011223456789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC---CCHHHHHHHHHHhccCCCCCCC----h
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG---EPTPLRNLIRRLLEKDPTKRIG----V 328 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~s----~ 328 (426)
+.+..++.++|||||||++|+|++|..||.+.+....+..+......... .+..+.++|.+||..||++||| +
T Consensus 204 ~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 204 ISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred HcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 99999999999999999999999999999998888888777654443332 4788999999999999999999 9
Q ss_pred HHHhcCCCcCCCChhhhhh
Q 014344 329 EEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 329 ~eil~hp~f~~~~~~~~~~ 347 (426)
+++|+||||++.+|..+.-
T Consensus 284 ~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 284 AEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHHcCchhhcCChhhccc
Confidence 9999999999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=379.90 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=208.7
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 69 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-----------HVSDATRILREIKLLRLLRHPDIVEIKHIML 69 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-----------cchhHHHHHHHHHHHHhCCCCCEeeecceEe
Confidence 59999999999999999999999999999999853211 1123356788999999999999999999875
Q ss_pred cC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 97 TD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 97 ~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
.. ..+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~D 146 (338)
T cd07859 70 PPSRREFKDIYVVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICD 146 (338)
T ss_pred ccCCCCCceEEEEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEcc
Confidence 43 35899999995 7898887654 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++........ ........+||+.|+
T Consensus 147 fg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~t~~y~ 173 (338)
T cd07859 147 FGLARVAFNDTP-----------------------------------------------------TAIFWTDYVATRWYR 173 (338)
T ss_pred CccccccccccC-----------------------------------------------------ccccccCCCCCCCcC
Confidence 999875421110 001123456999999
Q ss_pred cchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------------------------cCC--
Q 014344 252 APEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---------------------------CRP-- 300 (426)
Q Consensus 252 aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---------------------------~~~-- 300 (426)
|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+. ...
T Consensus 174 aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 253 (338)
T cd07859 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPV 253 (338)
T ss_pred CHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCC
Confidence 9999876 678999999999999999999999998776543321110 000
Q ss_pred ---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 301 ---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 301 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
......++.+.+||.+||+.||++|||++|+++||||+++..
T Consensus 254 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 254 PFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred chHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 012244677899999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=385.43 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=205.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+...+|++++.||+|+||.||+|.+..+++.||||+... ..+.+|+.+|+.|+||||++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------------------~~~~~E~~il~~l~HpnIv~~~ 149 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------------------GGTATEAHILRAINHPSIIQLK 149 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------------------hhhHHHHHHHHhCCCCCCCCEe
Confidence 456789999999999999999999999999999997521 2356799999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|......++|||++. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 150 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 150 GTFTYNKFTCLILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEEECCeeEEEEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 99999999999999995 7888877654 34899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... .......+||+.|+|
T Consensus 227 G~a~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~a 251 (391)
T PHA03212 227 GAACFPVDIN-------------------------------------------------------ANKYYGWAGTIATNA 251 (391)
T ss_pred Cccccccccc-------------------------------------------------------ccccccccCccCCCC
Confidence 9986432100 012234579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHh--------------------------cC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-------RKETFYRIL--------------------------CR 299 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-------~~~~~~~i~--------------------------~~ 299 (426)
||++.+..++.++|||||||++|||++|..||.... ....+..++ ..
T Consensus 252 PE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 331 (391)
T PHA03212 252 PELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKK 331 (391)
T ss_pred hhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhc
Confidence 999999999999999999999999999998875321 111111110 00
Q ss_pred ----CCC------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 300 ----PPD------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 300 ----~~~------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
+.. ....+.++.+||.+||++||.+|||++|+|+||||+.+
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 332 SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 000 01234578899999999999999999999999999753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=369.20 Aligned_cols=264 Identities=31% Similarity=0.498 Sum_probs=220.6
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+..... ......+..|+.+++.++|++|+.+++.+.
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~ 70 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK----------RKGESMALNEKQILEKVNSRFVVSLAYAYE 70 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc----------hHHHHHHHHHHHHHHhCCCCCeeeeeEEEe
Confidence 4889999999999999999999999999999986543211 112345677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+...+|+||||+.|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~ 150 (285)
T cd05630 71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV 150 (285)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeecccee
Confidence 99999999999999999998866555569999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... .....+||+.|+|||++
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~g~~~y~aPE~~ 173 (285)
T cd05630 151 HVPEGQ---------------------------------------------------------TIKGRVGTVGYMAPEVV 173 (285)
T ss_pred ecCCCc---------------------------------------------------------cccCCCCCccccChHHH
Confidence 542110 11233689999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCC----
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIG---- 327 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s---- 327 (426)
.+..++.++|+||+||++|+|++|+.||...... +........ .......++.+.+||.+||+.||++|||
T Consensus 174 ~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~ 253 (285)
T cd05630 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGG 253 (285)
T ss_pred cCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCC
Confidence 9999999999999999999999999999865422 222222211 1122345788999999999999999999
Q ss_pred -hHHHhcCCCcCCCChhhhhh
Q 014344 328 -VEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 328 -~~eil~hp~f~~~~~~~~~~ 347 (426)
++|+++||||++++|..+..
T Consensus 254 ~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 254 GAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred chHHHHcChhhhccCHHHHhc
Confidence 89999999999999997755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=390.44 Aligned_cols=253 Identities=28% Similarity=0.493 Sum_probs=206.1
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----------------~~~~~Ei~il~~l~h~niv~l~~ 126 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----------------QYKNRELLIMKNLNHINIIFLKD 126 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----------------chHHHHHHHHHhcCCCCCcceee
Confidence 4467999999999999999999999999999999884321 12345999999999999999998
Q ss_pred eeecC--------CeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 94 VLSTD--------KFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 94 ~~~~~--------~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+|... ..+++|||||+ ++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 127 ~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~ 205 (440)
T PTZ00036 127 YYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP 205 (440)
T ss_pred eEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC
Confidence 87432 35789999997 567666543 23456999999999999999999999999999999999999996
Q ss_pred CC-cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 164 NG-HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 164 ~g-~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
++ .+||+|||+|+.+... ....
T Consensus 206 ~~~~vkL~DFGla~~~~~~---------------------------------------------------------~~~~ 228 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAG---------------------------------------------------------QRSV 228 (440)
T ss_pred CCCceeeeccccchhccCC---------------------------------------------------------CCcc
Confidence 65 7999999999865321 1122
Q ss_pred ccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC-----------------
Q 014344 243 SFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP----------------- 301 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~----------------- 301 (426)
..+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+.++... +.
T Consensus 229 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~ 308 (440)
T PTZ00036 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFP 308 (440)
T ss_pred cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCC
Confidence 34689999999998764 6899999999999999999999999998776665554321 00
Q ss_pred C----------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 302 D----------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 302 ~----------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
. ....+.++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 309 ~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 309 DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred ccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 0 012467899999999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=374.95 Aligned_cols=256 Identities=27% Similarity=0.411 Sum_probs=217.7
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCce-EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSES-FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~-vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+.+.++.....+...||+|+||+||++... |+. ||+|++........ ..+.+.+|+.+|++++|||
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~-----------~~~~f~~E~~il~~l~HpN 100 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDE-----------SRKAFRREASLLSRLRHPN 100 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChH-----------HHHHHHHHHHHHHhCCCCC
Confidence 456778888899999999999999998864 445 99999965433222 1678999999999999999
Q ss_pred cceeeeeeecCC-eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCCeeeccCC
Q 014344 88 LPRLRGVLSTDK-FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG-IVYRDLKPENIMIQENG 165 (426)
Q Consensus 88 iv~l~~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g-iiHrDlKp~NiLl~~~g 165 (426)
||.++|++.... .+++||||+++|+|..++.......++...+..++.||+.||+|||+++ ||||||||+|||++.++
T Consensus 101 IV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~ 180 (362)
T KOG0192|consen 101 IVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG 180 (362)
T ss_pred eeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC
Confidence 999999998877 7999999999999999988754566999999999999999999999999 99999999999999998
Q ss_pred -cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 166 -HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 166 -~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
++||+|||+++...... ......
T Consensus 181 ~~~KI~DFGlsr~~~~~~--------------------------------------------------------~~~~~~ 204 (362)
T KOG0192|consen 181 KTLKIADFGLSREKVISK--------------------------------------------------------TSMTSV 204 (362)
T ss_pred CEEEECCCccceeecccc--------------------------------------------------------ccccCC
Confidence 99999999998764211 111224
Q ss_pred ccCCCCccchhhc--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhc
Q 014344 245 VGTEEYVAPEIIE--GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 245 ~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~ 319 (426)
.||+.|||||++. +..|+.++||||||+++|||+||+.||.+.........+.. +++....+++.+..||.+||.
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~ 284 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWL 284 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCC
Confidence 6999999999999 66999999999999999999999999999988666555542 233333478999999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
.||..||++.+|+.
T Consensus 285 ~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 285 VDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCcCCCHHHHHH
Confidence 99999999998864
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=366.58 Aligned_cols=253 Identities=30% Similarity=0.407 Sum_probs=206.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCccee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPRL 91 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l 91 (426)
.+|++++.||+|+||+||+|++.. +++.||+|++...... ......+.+|+.+++.+ +||||+++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~hpniv~~ 69 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-----------EGMPLSTIREVAVLRHLETFEHPNVVRL 69 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-----------CCchHHHHHHHHHHHhhcccCCCCcceE
Confidence 369999999999999999999864 5688999988543211 11223445677777665 69999999
Q ss_pred eeeee-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 92 RGVLS-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 92 ~~~~~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
++++. ....+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 70 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 70 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred EEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC
Confidence 99885 3457999999996 68998887665556899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++...... .......|
T Consensus 149 ~kl~Dfg~~~~~~~~---------------------------------------------------------~~~~~~~~ 171 (290)
T cd07862 149 IKLADFGLARIYSFQ---------------------------------------------------------MALTSVVV 171 (290)
T ss_pred EEEccccceEeccCC---------------------------------------------------------cccccccc
Confidence 999999998754211 11223468
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CC-------------------
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PD------------------- 302 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~------------------- 302 (426)
|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+.... ..
T Consensus 172 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (290)
T cd07862 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQP 251 (290)
T ss_pred cccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCC
Confidence 999999999999899999999999999999999999999988777666554210 00
Q ss_pred ----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 ----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
....+..+.+||.+||+.||++|||+.|+|+||||
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 252 IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred HHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 01345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=361.89 Aligned_cols=265 Identities=29% Similarity=0.472 Sum_probs=222.7
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++.+.||+|+||+||+|.+..+++.||+|++.+...... .....+..|+.+|+.++|++|+.+++++.
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~~~~i~~~~~~~~ 70 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR----------KGESMALNEKQILEKVNSQFVVNLAYAYE 70 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh----------hHHHHHHHHHHHHHHcCCcCceeEEEEEe
Confidence 48899999999999999999999999999999865433221 12345677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.++..|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~ 150 (285)
T cd05632 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAV 150 (285)
T ss_pred cCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcce
Confidence 99999999999999999988766554569999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... ......|++.|+|||++
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 151 KIPEGE---------------------------------------------------------SIRGRVGTVGYMAPEVL 173 (285)
T ss_pred ecCCCC---------------------------------------------------------cccCCCCCcCccChHHh
Confidence 542110 11233589999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCC-CCCCCCCHHHHHHHHHHhccCCCCCCC----
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI----LCRP-PDLVGEPTPLRNLIRRLLEKDPTKRIG---- 327 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i----~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~s---- 327 (426)
.+..++.++|+|||||++|+|++|..||.+.........+ .... ......+..+.+|+.+||+.||++||+
T Consensus 174 ~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 9989999999999999999999999999887654433222 2211 222345778999999999999999999
Q ss_pred -hHHHhcCCCcCCCChhhhhhc
Q 014344 328 -VEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 328 -~~eil~hp~f~~~~~~~~~~~ 348 (426)
+.+++.|+||+..+|+.+...
T Consensus 254 ~~~~l~~~~~~~~~~~~~~~~~ 275 (285)
T cd05632 254 GAGEVKRHPFFRNMNFKRLEAG 275 (285)
T ss_pred ChHHHHcChhhhcCCHHHHhcC
Confidence 889999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=382.64 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=224.2
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|.-++.||+|+||.||.|++..+.+.||||.+.-+ .......+..+..|+++|+++.|||++.+-++|..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsyS----------GKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS----------GKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeecccc----------ccccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 77789999999999999999999999999998432 23345678999999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+...|||||||- |+-.+++.-.. +++.+-.+..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|..
T Consensus 98 e~TaWLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 98 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred cchHHHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 999999999996 77778777654 5699999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
.. -.++|+|||.|||||+|.
T Consensus 176 ~~------------------------------------------------------------PAnsFvGTPywMAPEVIL 195 (948)
T KOG0577|consen 176 MA------------------------------------------------------------PANSFVGTPYWMAPEVIL 195 (948)
T ss_pred cC------------------------------------------------------------chhcccCCccccchhHhe
Confidence 53 257899999999999986
Q ss_pred C---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---CCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 258 G---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV---GEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 258 ~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
. +.|+-++||||||+++.||.-.++|+...+....++.|....+..+ .++..+++|+..||++-|.+|||.+++
T Consensus 196 AMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 196 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred eccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 4 5689999999999999999999999999999999999986654433 457789999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
|.|+|...
T Consensus 276 l~H~fv~R 283 (948)
T KOG0577|consen 276 LKHRFVLR 283 (948)
T ss_pred hhcchhcc
Confidence 99999853
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=376.07 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=206.1
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
-..+|++++.||+|+||.||+|.+..+++.||+|++.+... ......++.+|+.+++.++||||+++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 87 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-----------NQTHAKRAYRELVLLKCVNHKNIISLLN 87 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-----------chhHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 35789999999999999999999999999999999854321 1123456778999999999999999999
Q ss_pred eeecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 94 VLSTDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 94 ~~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
+|.... .+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 88 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 88 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred eeccCCCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 986543 57999999974 5655543 238899999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++...... ......+||
T Consensus 163 kl~Dfg~a~~~~~~---------------------------------------------------------~~~~~~~~t 185 (359)
T cd07876 163 KILDFGLARTACTN---------------------------------------------------------FMMTPYVVT 185 (359)
T ss_pred EEecCCCccccccC---------------------------------------------------------ccCCCCccc
Confidence 99999998654211 012234689
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------CCCCC--
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----------------------RPPDL-- 303 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~----------------------~~~~~-- 303 (426)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+.. ..+..
T Consensus 186 ~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (359)
T cd07876 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPG 265 (359)
T ss_pred CCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCC
Confidence 999999999999999999999999999999999999988765443322210 00000
Q ss_pred -------------------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 -------------------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 -------------------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
...+..+++||.+||+.||++|||+.|+|+||||..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 266 ISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred cchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 012456899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=383.89 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=225.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|+|+..||-|+||.||+|..+.++-..|-|++.- .....+..+.-|+.||..++||+||+|++.|.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-------------kseEELEDylVEIeILa~CdHP~ivkLl~ayy 99 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-------------KSEEELEDYLVEIEILAECDHPVIVKLLSAYY 99 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-------------cchhHHhhhhhhhhhhhcCCChHHHHHHHHHh
Confidence 48999999999999999999999988889998822 23346778888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
-++.+++.+|||.||-...++-... ..+++.+++.+++|++.||.|||+++|||||||..|||++.+|.|+|+|||.+.
T Consensus 100 ~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 100 FENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred ccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence 9999999999999999988765554 569999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.... ...+..+|+|||.|||||+.
T Consensus 179 Kn~~--------------------------------------------------------t~qkRDsFIGTPYWMAPEVv 202 (1187)
T KOG0579|consen 179 KNKS--------------------------------------------------------TRQKRDSFIGTPYWMAPEVV 202 (1187)
T ss_pred cchh--------------------------------------------------------HHhhhccccCCcccccchhe
Confidence 5431 12356788999999999997
Q ss_pred cC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCC---CCCHHHHHHHHHHhccCCCCCCC
Q 014344 257 EG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-DLV---GEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 257 ~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~---~~~~~~~~li~~~L~~dP~~R~s 327 (426)
.+ .+|++++||||||++|.||.-+.+|-...++...+.+|....| .+. .++..+.||+.+||.+||..||+
T Consensus 203 mCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~ 282 (1187)
T KOG0579|consen 203 MCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP 282 (1187)
T ss_pred eeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC
Confidence 64 6799999999999999999999999999999998888875544 333 34678999999999999999999
Q ss_pred hHHHhcCCCcCCCC
Q 014344 328 VEEIKGHEFFKGVN 341 (426)
Q Consensus 328 ~~eil~hp~f~~~~ 341 (426)
+.+||+||||+.+.
T Consensus 283 aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 283 AAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHhhCcccccCC
Confidence 99999999998654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=364.04 Aligned_cols=252 Identities=29% Similarity=0.397 Sum_probs=205.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCcceeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPRLRG 93 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~ 93 (426)
+|++++.||+|+||+||+|+++.+++.||+|++...... ......+..|+.+++.+ +||||+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~ 69 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-----------DGLPLSTVREVALLKRLEAFDHPNIVRLMD 69 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-----------CCCchHHHHHHHHHHHhhhcCCCCeeeeee
Confidence 599999999999999999999999999999998542110 11122345566666655 7999999999
Q ss_pred eeec-----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 94 VLST-----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 94 ~~~~-----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++.. ...+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 70 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 70 VCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred eeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 8864 346899999997 5888887765555699999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... ......||+
T Consensus 149 l~dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~ 171 (288)
T cd07863 149 LADFGLARIYSCQM---------------------------------------------------------ALTPVVVTL 171 (288)
T ss_pred ECccCccccccCcc---------------------------------------------------------cCCCccccc
Confidence 99999987543110 112235899
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC------------------------
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP------------------------ 301 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~------------------------ 301 (426)
.|+|||++.+..++.++|||||||++|+|++|++||.+......+.++... +.
T Consensus 172 ~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (288)
T cd07863 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQ 251 (288)
T ss_pred cccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchH
Confidence 999999999999999999999999999999999999888776655444310 00
Q ss_pred -CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 -DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 -~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.....+..+.+||.+||++||.+|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 252 SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 011345668999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.90 Aligned_cols=263 Identities=38% Similarity=0.682 Sum_probs=228.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...... .....+..|+++|++++||||+++++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKL----------KQVEHVLNEKRILQSIRHPFLVNLYGSF 70 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHHhCCCCCccceeeEE
Confidence 469999999999999999999999999999999866543221 2346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.....+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 71 QDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred EcCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999999999999999999988765 45999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
...... ....+|++.|+|||.
T Consensus 149 ~~~~~~-----------------------------------------------------------~~~~~~~~~y~aPE~ 169 (290)
T cd05580 149 KRVKGR-----------------------------------------------------------TYTLCGTPEYLAPEI 169 (290)
T ss_pred cccCCC-----------------------------------------------------------CCCCCCCccccChhh
Confidence 765311 123358899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----ChH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI-----GVE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~-----s~~ 329 (426)
+.+..++.++|+||||+++|+|++|..||...+.......+...... ....+..++++|.+||+.||.+|+ +++
T Consensus 170 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~ 249 (290)
T cd05580 170 ILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVN 249 (290)
T ss_pred hcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHH
Confidence 98888899999999999999999999999988877666666544332 234578899999999999999999 899
Q ss_pred HHhcCCCcCCCChhhhhhcc
Q 014344 330 EIKGHEFFKGVNWELLLKIS 349 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~ 349 (426)
|+++||||+.++|..+....
T Consensus 250 ~l~~~~~~~~~~~~~~~~~~ 269 (290)
T cd05580 250 DIKNHPWFAGIDWIALLQRK 269 (290)
T ss_pred HHHcCcccccCCHHHHhhcc
Confidence 99999999999999886533
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=365.32 Aligned_cols=258 Identities=25% Similarity=0.393 Sum_probs=211.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
.++++|++++.||+|+||+||+|++..+++.||+|++..... ......+.+|+.+++.++||||++++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 70 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE------------EGAPCTAIREVSLLKDLKHANIVTLH 70 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc------------CCcchhHHHHHHHHHhCCCCCcceEE
Confidence 356889999999999999999999999999999999854321 11223466799999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++..++..|+||||+. ++|.+++.... ..++...++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Df 148 (309)
T cd07872 71 DIVHTDKSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADF 148 (309)
T ss_pred EEEeeCCeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcc
Confidence 99999999999999997 57877765543 44899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... ......++|+.|+|
T Consensus 149 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~a 172 (309)
T cd07872 149 GLARAKSVPT--------------------------------------------------------KTYSNEVVTLWYRP 172 (309)
T ss_pred ccceecCCCc--------------------------------------------------------cccccccccccccC
Confidence 9986542110 01122357899999
Q ss_pred chhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC--------------------C-------
Q 014344 253 PEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP--------------------P------- 301 (426)
Q Consensus 253 PE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~--------------------~------- 301 (426)
||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.. .+ .
T Consensus 173 PE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (309)
T cd07872 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLI 252 (309)
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchh
Confidence 999876 4578999999999999999999999988776544333321 00 0
Q ss_pred -CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 -DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 -~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+++||.+||+.||.+|||++|++.||||+..
T Consensus 253 ~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 253 NHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 011346678999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=373.73 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=208.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
-.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+.+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~ 90 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-----------QNQTHAKRAYRELVLMKCVNHKNIIGLLN 90 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-----------cCchhHHHHHHHHHHHHhcCCCCccccce
Confidence 3578999999999999999999999999999999985422 11223456778999999999999999999
Q ss_pred eeecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 94 VLSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 94 ~~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
++... ..+|+||||+. ++|..++.. .++...+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 165 (364)
T cd07875 91 VFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165 (364)
T ss_pred eecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcE
Confidence 88543 35799999997 566666542 38899999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++...... ......+||
T Consensus 166 kL~DfG~a~~~~~~---------------------------------------------------------~~~~~~~~t 188 (364)
T cd07875 166 KILDFGLARTAGTS---------------------------------------------------------FMMTPYVVT 188 (364)
T ss_pred EEEeCCCccccCCC---------------------------------------------------------CcccCCccc
Confidence 99999998754211 012234689
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------------CCC--
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP----------------------PDL-- 303 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------------------~~~-- 303 (426)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++... +..
T Consensus 189 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (364)
T cd07875 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 268 (364)
T ss_pred CCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCC
Confidence 99999999999999999999999999999999999999887766555443210 000
Q ss_pred -------------------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 -------------------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 -------------------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
...+..+++||.+||+.||.+|||++++|+||||..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 269 YSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred CChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 011346889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=368.97 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=213.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+..++|+++++||.|+||.||+|.+..++..+|+|++.... .......+.+|+++|+.++||||++++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 69 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI------------KPAIRNQIIRELQVLHECNSPYIVGFY 69 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc------------CHHHHHHHHHHHHHHHHCCCCccccee
Confidence 56688999999999999999999999999999999884421 112345688899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEEEec
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++|.+++.+|+||||++|++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~D 147 (333)
T cd06650 70 GAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCD 147 (333)
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEee
Confidence 9999999999999999999999988754 3489999999999999999999985 799999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+... .....+||+.|+
T Consensus 148 fg~~~~~~~~----------------------------------------------------------~~~~~~~~~~y~ 169 (333)
T cd06650 148 FGVSGQLIDS----------------------------------------------------------MANSFVGTRSYM 169 (333)
T ss_pred CCcchhhhhh----------------------------------------------------------ccccCCCCcccc
Confidence 9998654211 112346899999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------------------------------
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR------------------------------------ 295 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~------------------------------------ 295 (426)
|||++.+..++.++|+|||||++|+|++|+.||...........
T Consensus 170 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (333)
T cd06650 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPM 249 (333)
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccc
Confidence 99999998999999999999999999999999986654332111
Q ss_pred --------HhcCC-CCC--CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 296 --------ILCRP-PDL--VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 296 --------i~~~~-~~~--~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
+.... +.. ...+.++++||.+||++||++|||+.|++.||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 250 AIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred cHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 11111 111 1235678999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=375.27 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=209.1
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
....+++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++|+||++
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~ 136 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH------------EDTVRRQICREIEILRDVNHPNVVK 136 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC------------cHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4456788999999999999999999999999999999984321 1123457888999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++...+.+|+|||||++++|... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 137 ~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~ 210 (353)
T PLN00034 137 CHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIA 210 (353)
T ss_pred eeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEc
Confidence 99999999999999999999998643 236678888999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+.... ......+||+.|
T Consensus 211 DfG~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y 234 (353)
T PLN00034 211 DFGVSRILAQTM--------------------------------------------------------DPCNSSVGTIAY 234 (353)
T ss_pred ccccceeccccc--------------------------------------------------------ccccccccCccc
Confidence 999987653210 112334699999
Q ss_pred ccchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc--CCCCCCCCCHHHHHHHHHHhcc
Q 014344 251 VAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILC--RPPDLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 251 ~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~ 320 (426)
+|||++.. ...+.++|||||||++|||++|+.||...... .....+.. .+......+..+++||.+||..
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 314 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQR 314 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccC
Confidence 99998753 23457899999999999999999999743322 12222211 1222335678899999999999
Q ss_pred CCCCCCChHHHhcCCCcCCC
Q 014344 321 DPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~~~ 340 (426)
||++|||+.||++||||.+.
T Consensus 315 ~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 315 EPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ChhhCcCHHHHhcCcccccC
Confidence 99999999999999999763
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=385.84 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=223.8
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
......++|++.+.||+|+||+||+|++..+++.||||++..... .......+..|+.+|..++|+||+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~~l~~~~h~~iv 94 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-----------SEADKNRAQAEVCCLLNCDFFSIV 94 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-----------CHHHHHHHHHHHHHHhcCCCCcEE
Confidence 334556799999999999999999999999999999999855322 122345678899999999999999
Q ss_pred eeeeeeecCC--------eEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCe
Q 014344 90 RLRGVLSTDK--------FVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENI 159 (426)
Q Consensus 90 ~l~~~~~~~~--------~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~Ni 159 (426)
++++.+.... .+++||||+++|+|.+++... ....+++..+..++.|++.||+|||++||+||||||+||
T Consensus 95 ~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NI 174 (496)
T PTZ00283 95 KCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174 (496)
T ss_pred EeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 9998875432 478999999999999987643 234699999999999999999999999999999999999
Q ss_pred eeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239 (426)
Q Consensus 160 Ll~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (426)
|++.++.+||+|||+++.+..... ..
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~------------------------------------------------------~~ 200 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVS------------------------------------------------------DD 200 (496)
T ss_pred EEeCCCCEEEEecccCeecccccc------------------------------------------------------cc
Confidence 999999999999999876532110 11
Q ss_pred CccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHH
Q 014344 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 240 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~ 317 (426)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++... +.....++.+.+||.+|
T Consensus 201 ~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 280 (496)
T PTZ00283 201 VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTAL 280 (496)
T ss_pred ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 2234579999999999999999999999999999999999999999988877777766432 23345688999999999
Q ss_pred hccCCCCCCChHHHhcCCCcCCC
Q 014344 318 LEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 318 L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
|..||.+||++.++++|||++..
T Consensus 281 L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 281 LSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred cccChhhCcCHHHHHhCHHHHHh
Confidence 99999999999999999998753
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=359.59 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=225.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
-|.|+.+||.|+||.||+|.++.+|+.+|||.+.-+ ..++++..|+.||++++.|++|++|+.+.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---------------sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---------------TDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---------------chHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 378999999999999999999999999999987322 35678889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....+|+|||||..|+..++++.+ ++++++.++..+++..+.||+|||...-||||||..|||++.+|+.||+|||.+.
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAG 177 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAG 177 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccc
Confidence 999999999999999999987654 4679999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+... ..+.++.+|||.|||||++
T Consensus 178 QLTDT--------------------------------------------------------MAKRNTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 178 QLTDT--------------------------------------------------------MAKRNTVIGTPFWMAPEVI 201 (502)
T ss_pred hhhhh--------------------------------------------------------HHhhCccccCcccccHHHH
Confidence 87532 3467788999999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
..-+|+..+||||||++..||..|++||..-.+.....-|-..||... .++.++.|||++||.+.|++|.|+-+++
T Consensus 202 ~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~ 281 (502)
T KOG0574|consen 202 EEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLC 281 (502)
T ss_pred HHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHh
Confidence 999999999999999999999999999998887766555555554332 3467899999999999999999999999
Q ss_pred cCCCcCCC
Q 014344 333 GHEFFKGV 340 (426)
Q Consensus 333 ~hp~f~~~ 340 (426)
+|||.+..
T Consensus 282 ~H~FiknA 289 (502)
T KOG0574|consen 282 EHTFIKNA 289 (502)
T ss_pred hhhhhcCC
Confidence 99999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=374.23 Aligned_cols=257 Identities=27% Similarity=0.380 Sum_probs=210.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|+||+||+|.+..+++.||||++.... ......+++.+|+.+|+.++||||+++++++.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 69 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-----------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQ 69 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-----------cchHHHHHHHHHHHHHHhCCCCCcCCHhheec
Confidence 4889999999999999999999999999999884321 11123457888999999999999999999998
Q ss_pred cCC-----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 97 TDK-----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 97 ~~~-----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
... .+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 70 PPHIDPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred CCCccccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecc
Confidence 776 8999999996 6787776543 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .......++|+.|+
T Consensus 147 fg~a~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~ 171 (372)
T cd07853 147 FGLARVEEPDE-------------------------------------------------------SKHMTQEVVTQYYR 171 (372)
T ss_pred ccceeecccCc-------------------------------------------------------cccCCCCCcCCCcC
Confidence 99987543211 01112335889999
Q ss_pred cchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------------CC---C---
Q 014344 252 APEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----------------------RP---P--- 301 (426)
Q Consensus 252 aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-----------------------~~---~--- 301 (426)
|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+.. .+ +
T Consensus 172 aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (372)
T cd07853 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLP 251 (372)
T ss_pred CHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchH
Confidence 99999874 478999999999999999999999998876655443321 11 0
Q ss_pred ----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 302 ----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 302 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
.....+..+.+||.+||+.||.+|||+.|+|.||||++..+
T Consensus 252 ~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 296 (372)
T cd07853 252 VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296 (372)
T ss_pred HhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcc
Confidence 11233677899999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=383.47 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=220.3
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCC-CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVES-SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...|.+.+.||+|++|.||+|.+..+ ++.||+|.+... .......+..|+.+|+.++||||+++++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-------------~~~~~~~~~~E~~~l~~l~Hpniv~~~~ 132 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-------------DERQAAYARSELHCLAACDHFGIVKHFD 132 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-------------CHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 44599999999999999999998877 788999976322 1123456778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+|..++.+|+|||||+||+|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 133 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~D 212 (478)
T PTZ00267 133 DFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGD 212 (478)
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEe
Confidence 999999999999999999999877542 234689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+.... ........+||+.|+
T Consensus 213 Fgla~~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~ 238 (478)
T PTZ00267 213 FGFSKQYSDSV------------------------------------------------------SLDVASSFCGTPYYL 238 (478)
T ss_pred CcCceecCCcc------------------------------------------------------ccccccccCCCcccc
Confidence 99998653211 011233557999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.... .....+..+.+||.+||..||++||+++
T Consensus 239 aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 318 (478)
T PTZ00267 239 APELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQ 318 (478)
T ss_pred CHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHH
Confidence 99999999999999999999999999999999999888887777764332 2235678899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
+++.|||++.
T Consensus 319 ~~l~~~~~~~ 328 (478)
T PTZ00267 319 QLLHTEFLKY 328 (478)
T ss_pred HHHhCHHHHH
Confidence 9999999864
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=370.46 Aligned_cols=253 Identities=25% Similarity=0.420 Sum_probs=206.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
-.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||+++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 83 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-----------QNQTHAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-----------cChHHHHHHHHHHHHHHHhCCCchhceee
Confidence 4678999999999999999999999999999999985422 11223456778999999999999999999
Q ss_pred eeecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 94 VLSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 94 ~~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
++... ..+|+||||+++ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~ 158 (355)
T cd07874 84 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_pred eeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCE
Confidence 98644 357999999975 56555432 38899999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+++..... ......+||
T Consensus 159 kl~Dfg~~~~~~~~---------------------------------------------------------~~~~~~~~t 181 (355)
T cd07874 159 KILDFGLARTAGTS---------------------------------------------------------FMMTPYVVT 181 (355)
T ss_pred EEeeCcccccCCCc---------------------------------------------------------cccCCcccc
Confidence 99999998754211 112234689
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------------CCC---
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----------------------PPD--- 302 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------~~~--- 302 (426)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.. .+.
T Consensus 182 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (355)
T cd07874 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 261 (355)
T ss_pred CCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCcccc
Confidence 9999999999999999999999999999999999999887755443322110 000
Q ss_pred ------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 ------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 ------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+++||.+||..||++|||+.|+|+||||..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 262 LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred ccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 0012356789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=383.95 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=199.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC------CCCc
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE------HPLL 88 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------hp~i 88 (426)
.++|++++.||+|+||+||+|.+..+++.||||++.... ...+....|+.+++.+. |+++
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~~i 193 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--------------KYTRDAKIEIQFMEKVRQADPADRFPL 193 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--------------hhHHHHHHHHHHHHHHhhcCcccCcce
Confidence 468999999999999999999999999999999984321 11223445666766664 4568
Q ss_pred ceeeeeeecC-CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCC-
Q 014344 89 PRLRGVLSTD-KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENG- 165 (426)
Q Consensus 89 v~l~~~~~~~-~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g- 165 (426)
+.++++|..+ ..+|+|||++ |++|.+++... +.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 194 ~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 194 MKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred eeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCc
Confidence 8899988764 5789999998 78888877654 359999999999999999999998 5999999999999998765
Q ss_pred ---------------cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCC
Q 014344 166 ---------------HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230 (426)
Q Consensus 166 ---------------~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (426)
.+||+|||++....
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--------------------------------------------------- 299 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDER--------------------------------------------------- 299 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCc---------------------------------------------------
Confidence 49999999875321
Q ss_pred CCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC-----
Q 014344 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD----- 302 (426)
Q Consensus 231 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~----- 302 (426)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+.. ..+.
T Consensus 300 --------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~ 371 (467)
T PTZ00284 300 --------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGR 371 (467)
T ss_pred --------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhh
Confidence 112345799999999999999999999999999999999999999998776554433211 0000
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 -----------------------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 -----------------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.......+.|||.+||++||.+|||++|+|+||||..
T Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 372 CGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred ccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence 0001345679999999999999999999999999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=370.49 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=207.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+.+|+.++||||++++++|
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-----------IHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-----------HHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 67999999999999999999999999999999985432111 1234577899999999999999999988
Q ss_pred ecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
... ...|++|+++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEE
Confidence 543 4579999998 7899887653 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... .....+||+.
T Consensus 160 ~Dfg~~~~~~~-----------------------------------------------------------~~~~~~~t~~ 180 (343)
T cd07878 160 LDFGLARQADD-----------------------------------------------------------EMTGYVATRW 180 (343)
T ss_pred cCCccceecCC-----------------------------------------------------------CcCCcccccc
Confidence 99999875421 1123468999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C--------------------CC---
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P--------------------PD--- 302 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~--------------------~~--- 302 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... + +.
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (343)
T cd07878 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQ 260 (343)
T ss_pred ccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccc
Confidence 999999977 56899999999999999999999999887665544433210 0 00
Q ss_pred ------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 ------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 ------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
..+.++.+.+||.+||..||.+|||+.|+|.||||...
T Consensus 261 ~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 261 QDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 11235567899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=357.03 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=212.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
.++++|++++.||.|+||.||+|++..+++.||+|.+..... ......+..|+.+++.++||||++++
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~nI~~~~ 70 (301)
T cd07873 3 GKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE------------EGAPCTAIREVSLLKDLKHANIVTLH 70 (301)
T ss_pred ccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc------------cCchhHHHHHHHHHHhcCCCCcceEE
Confidence 467889999999999999999999999999999999843211 11223566799999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++..+...|+||||+. ++|..++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+||
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 148 (301)
T cd07873 71 DIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADF 148 (301)
T ss_pred EEEecCCeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcC
Confidence 99999999999999997 68888776543 35899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... .......+++.|+|
T Consensus 149 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~ 172 (301)
T cd07873 149 GLARAKSIPT--------------------------------------------------------KTYSNEVVTLWYRP 172 (301)
T ss_pred cchhccCCCC--------------------------------------------------------CcccccceeecccC
Confidence 9986542110 01112347889999
Q ss_pred chhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC-------------------CC-------
Q 014344 253 PEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP-------------------PD------- 302 (426)
Q Consensus 253 PE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~-------------------~~------- 302 (426)
||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.. .+ +.
T Consensus 173 PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (301)
T cd07873 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLH 252 (301)
T ss_pred cHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHH
Confidence 999876 4578899999999999999999999998876555433211 10 00
Q ss_pred --CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 303 --LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 303 --~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
....++.+++||.+||+.||.+|||++|+++||||+...
T Consensus 253 ~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 253 NHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 113466789999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=372.09 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=228.7
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
.....|.++++||+|.|++|.+|++.-++..||||++++...... ..+.+.+|+++|+.|+|||||+++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-----------~~~k~~rev~imk~l~HPnIvkl~ 121 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-----------KRQKLGREVDIMKSLNHPNIVKLF 121 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-----------HHHHHHHHHHHHHhcCCcceeeee
Confidence 446679999999999999999999999999999999987764332 345588899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
.+.+++..+|+||||+.+|++++++..+.. ..+..++.++.|++.|++|||+++|||||||++||||+.+..+||+||
T Consensus 122 ~v~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDf 199 (596)
T KOG0586|consen 122 SVIETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADF 199 (596)
T ss_pred eeeeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeecc
Confidence 999999999999999999999999987654 777999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.. .....++||++.|.|
T Consensus 200 gfS~~~~~---------------------------------------------------------~~~lqt~cgsppyAa 222 (596)
T KOG0586|consen 200 GFSTFFDY---------------------------------------------------------GLMLQTFCGSPPYAA 222 (596)
T ss_pred ccceeecc---------------------------------------------------------cccccccCCCCCccC
Confidence 99988752 235667899999999
Q ss_pred chhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 253 PEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 253 PE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
||++.+..| ++.+|+||+|+++|.|+.|..||++.+.++.-.+.+...... .-.+.++.+||+++|..+|.+|++.++
T Consensus 223 PEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 223 PELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred hHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHH
Confidence 999999888 689999999999999999999999998887766665333222 223678999999999999999999999
Q ss_pred HhcCCCcCCC
Q 014344 331 IKGHEFFKGV 340 (426)
Q Consensus 331 il~hp~f~~~ 340 (426)
|+.|.|....
T Consensus 303 im~~~W~n~~ 312 (596)
T KOG0586|consen 303 IMKDRWRNDL 312 (596)
T ss_pred hhhhcccchh
Confidence 9999999754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=355.19 Aligned_cols=266 Identities=27% Similarity=0.451 Sum_probs=222.0
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
-+.-+.|++++.||+|+||.||+|++..+++.+|+|++... .......+..|+.+++.++||||+++
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 74 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-------------SEEELEDYMVEIEILATCNHPYIVKL 74 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-------------CHHHHHHHHHHHHHHHhCCCCcEeee
Confidence 34456799999999999999999999999999999998432 12345677889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++.+..+..+|+||||++|++|..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred EEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEcc
Confidence 999999999999999999999988765443 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .......+++.|+
T Consensus 154 fg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ 177 (292)
T cd06644 154 FGVSAKNVKTL--------------------------------------------------------QRRDSFIGTPYWM 177 (292)
T ss_pred Cccceeccccc--------------------------------------------------------cccceecCCcccc
Confidence 99876532110 1122345888999
Q ss_pred cchhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP 322 (426)
|||++. ...++.++|+|||||++|+|++|..||...+....+.++...... ....+..+.+||.+||..+|
T Consensus 178 aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 257 (292)
T cd06644 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHP 257 (292)
T ss_pred CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCc
Confidence 999985 344678999999999999999999999887766655555433221 22446789999999999999
Q ss_pred CCCCChHHHhcCCCcCCCChhhhhh
Q 014344 323 TKRIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
++||+++++++||||..++|....+
T Consensus 258 ~~Rp~~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 258 ETRPSAAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred ccCcCHHHHhcCccccccccchhHH
Confidence 9999999999999999988876544
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.79 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=215.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|++|.||+|.+..+++.||+|.+...... ....+.+..|+.+++.++|||++++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-----------RRERKAAEQEAQLLSQLKHPNIVAYRESWE 69 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-----------HHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 499999999999999999999999999999998543321 123456788999999999999999999886
Q ss_pred c-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 97 T-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
. +..+|++|||+++++|.+++.......+++..+..++.|++.||.+||+.||+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred CCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccce
Confidence 4 457899999999999999887665566999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||+
T Consensus 150 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 173 (257)
T cd08223 150 RVLENQC--------------------------------------------------------DMASTLIGTPYYMSPEL 173 (257)
T ss_pred EEecccC--------------------------------------------------------CccccccCCcCccChhH
Confidence 7653110 01123458899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+..++.++|+|||||++|+|++|+.||...+.......+.... ......+..+.+||.+||+.+|.+||++.++++
T Consensus 174 ~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred hcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 999999999999999999999999999999887766655554332 222345788999999999999999999999999
Q ss_pred CCCc
Q 014344 334 HEFF 337 (426)
Q Consensus 334 hp~f 337 (426)
||||
T Consensus 254 ~~~~ 257 (257)
T cd08223 254 QPYI 257 (257)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=360.55 Aligned_cols=263 Identities=19% Similarity=0.306 Sum_probs=208.5
Q ss_pred EEEeeeccc--CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 19 RIVSALGRG--AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 19 ~i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+++++||+| +|++||++++..+|+.||+|++..... .......+..|+.+++.++||||++++++|.
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~ 69 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-----------TNEMVTFLQGELHVSKLFNHPNIVPYRATFI 69 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-----------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 367889999 789999999999999999999854321 1123456778999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.++..|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+.
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 70 ADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred ECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999999999876554568999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.......... .........+++..|+|||++
T Consensus 150 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 150 SMINHGQRLR-------------------------------------------------VVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred cccccccccc-------------------------------------------------ccccccccccceecccChHHh
Confidence 4321100000 000011123477889999999
Q ss_pred cC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-C--------------------------------
Q 014344 257 EG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-P-------------------------------- 301 (426)
Q Consensus 257 ~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~-------------------------------- 301 (426)
.+ ..++.++|||||||++|+|++|+.||................ +
T Consensus 181 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T cd08227 181 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV 260 (327)
T ss_pred hcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCccccc
Confidence 76 468999999999999999999999998765444332222110 0
Q ss_pred --------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 302 --------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 302 --------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.....++.+.+||.+||+.||++|||++++++||||+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 261 STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 0001245788999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=346.16 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=217.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|++|.||+|.+..+++.||+|++........ .......+.+|+.++++++||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 73 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPE--------TKKEVNALECEIQLLKNLQHERIVQYYGCL 73 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchh--------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEE
Confidence 469999999999999999999999999999999854322111 112345788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+|+|+||++|++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 74 ~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 74 RDDETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred ccCCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 9999999999999999999987754 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
......... ........|++.|+|||+
T Consensus 152 ~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~aPE~ 178 (263)
T cd06625 152 KRLQTICSS-----------------------------------------------------GTGMKSVTGTPYWMSPEV 178 (263)
T ss_pred eeccccccc-----------------------------------------------------cccccCCCcCccccCcce
Confidence 765321100 001123457889999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
+.+..++.++|||||||++|+|++|+.||...+......++.... ......+..+.++|.+||..+|.+|||+.+++
T Consensus 179 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 179 ISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred eccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 999989999999999999999999999998877666555544322 12234578899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
+||||
T Consensus 259 ~~~~~ 263 (263)
T cd06625 259 RHFFV 263 (263)
T ss_pred hCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=392.11 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=217.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
..+..+++|++++.||+|+||+||+|++..+++.||+|++...... ......+..|+.+|+.|+||||+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-----------e~~~~~~~~EI~IL~~L~HPNIV 75 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-----------EREKSQLVIEVNVMRELKHKNIV 75 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-----------HHHHHHHHHHHHHHHHcCCCCcC
Confidence 3456778999999999999999999999999999999998543221 12345788899999999999999
Q ss_pred eeeeeeec--CCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccCCCCCC
Q 014344 90 RLRGVLST--DKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNM-------GIVYRDLKPEN 158 (426)
Q Consensus 90 ~l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~-------giiHrDlKp~N 158 (426)
+++++|.. ...+|||||||++++|..++.... ...+++..++.|+.||+.||.|||+. +||||||||+|
T Consensus 76 rl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeN 155 (1021)
T PTZ00266 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQN 155 (1021)
T ss_pred eEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHH
Confidence 99999854 467999999999999999886532 34599999999999999999999985 49999999999
Q ss_pred eeecc-----------------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCC
Q 014344 159 IMIQE-----------------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVH 221 (426)
Q Consensus 159 iLl~~-----------------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (426)
|||+. .+.+||+|||++..+...
T Consensus 156 ILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---------------------------------------- 195 (1021)
T PTZ00266 156 IFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---------------------------------------- 195 (1021)
T ss_pred eEeecCccccccccccccccCCCCceEEccCCcccccccc----------------------------------------
Confidence 99964 345899999998754211
Q ss_pred CCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q 014344 222 SPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299 (426)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 299 (426)
......+||+.|+|||++.+ ..++.++||||||||+|+|++|..||...+....+...+..
T Consensus 196 -----------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~ 258 (1021)
T PTZ00266 196 -----------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR 258 (1021)
T ss_pred -----------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc
Confidence 01223469999999999865 45889999999999999999999999877665555544433
Q ss_pred CCC--CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 300 PPD--LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 300 ~~~--~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.+. ....+..+.+||..||..+|.+||++.++|.|||++.+.
T Consensus 259 ~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 259 GPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 332 235678899999999999999999999999999998654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=350.60 Aligned_cols=251 Identities=38% Similarity=0.668 Sum_probs=210.9
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++++.||+|+||+||+|.+..+++.||+|++........ .......|+.+++.++||||+++++++..
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 69 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-----------EREENIREIKILRRLRHPNIVQILDVFQD 69 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-----------HHHHHHHHHHHHHHHTBTTBCHEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-----------ccchhhhhhhccccccccccccccccccc
Confidence 8999999999999999999999999999999977654332 12233459999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
...+++||||+.+++|.+++... ..+++..+..++.||+.||++||++||+||||||+|||++.++.++|+|||.+..
T Consensus 70 ~~~~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 70 DNYLYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp SSEEEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999998743 4489999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
... .........+|+.|+|||++.
T Consensus 148 ~~~--------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 148 LSE--------------------------------------------------------NNENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp STS--------------------------------------------------------TTSEBSSSSSSGGGSCHHHHT
T ss_pred ccc--------------------------------------------------------ccccccccccccccccccccc
Confidence 411 011233456899999999998
Q ss_pred -CCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 258 -GKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 258 -~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
+..++.++|+||||+++|+|++|..||.... ......+..... ......+..+.++|.+||+.||++||++
T Consensus 172 ~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~ 251 (260)
T PF00069_consen 172 QGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSA 251 (260)
T ss_dssp TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTH
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCH
Confidence 7888999999999999999999999999873 233333332211 1111123789999999999999999999
Q ss_pred HHHhcCCCc
Q 014344 329 EEIKGHEFF 337 (426)
Q Consensus 329 ~eil~hp~f 337 (426)
.++++||||
T Consensus 252 ~~l~~~~~~ 260 (260)
T PF00069_consen 252 EELLKHPWF 260 (260)
T ss_dssp HHHHTSGGG
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=362.91 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=205.9
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEE-----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
+.+..++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+..|+.+|..+ +
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~~ 69 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA------------TASEHKALMSELKILIHIGN 69 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc------------chHHHHHHHHHHHHHHHhcc
Confidence 456678899999999999999999985 2456789999984321 112345688899999999 8
Q ss_pred CCCcceeeeeeecC-CeEEEEEeccCCCChHHHHHHhc------------------------------------------
Q 014344 85 HPLLPRLRGVLSTD-KFVGYAIDYCPGRDLHSLRKQQS------------------------------------------ 121 (426)
Q Consensus 85 hp~iv~l~~~~~~~-~~~~lV~Ey~~gg~L~~l~~~~~------------------------------------------ 121 (426)
||||+++++++... ..+|+|||||+||+|.+++....
T Consensus 70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (338)
T cd05102 70 HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRF 149 (338)
T ss_pred CcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCcccccc
Confidence 99999999988654 46899999999999999876432
Q ss_pred ------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 122 ------------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 122 ------------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 150 QPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred ccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc
Confidence 13477888999999999999999999999999999999999999999999999876532110
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
.....+..+|+.|+|||++.+..++.
T Consensus 230 ------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~ 255 (338)
T cd05102 230 ------------------------------------------------------YVRKGSARLPLKWMAPESIFDKVYTT 255 (338)
T ss_pred ------------------------------------------------------hhcccCCCCCccccCcHHhhcCCCCc
Confidence 00112234678899999999999999
Q ss_pred hhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 264 AVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 264 ~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
++|||||||++|||++ |..||.+....+.+...+.. .......+..+.+||.+||..||.+|||+.+|++
T Consensus 256 ~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999996 99999886654444333322 1222345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-46 Score=358.41 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=192.2
Q ss_pred EeeecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee--
Q 014344 21 VSALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS-- 96 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-- 96 (426)
.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.++||||++++++|.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 70 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---------------ISMSACREIALLRELKHPNVISLQKVFLSH 70 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---------------CcHHHHHHHHHHHhcCCCCCcceeeeEecC
Confidence 468999999999999976 467899999884321 1234667999999999999999999985
Q ss_pred cCCeEEEEEeccCCCChHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee----ccCC
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQ-------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----QENG 165 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~-------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl----~~~g 165 (426)
.+..+|++|||+. ++|..++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +..+
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~ 149 (317)
T cd07868 71 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred CCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC
Confidence 3567899999995 6888776532 12248999999999999999999999999999999999999 4567
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++..+..... ........+
T Consensus 150 ~~kl~DfG~a~~~~~~~~-----------------------------------------------------~~~~~~~~~ 176 (317)
T cd07868 150 RVKIADMGFARLFNSPLK-----------------------------------------------------PLADLDPVV 176 (317)
T ss_pred cEEEeecCceeccCCCCc-----------------------------------------------------cccccCCcc
Confidence 999999999976532110 001123456
Q ss_pred cCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh---cCCC-----------
Q 014344 246 GTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---------ETFYRIL---CRPP----------- 301 (426)
Q Consensus 246 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~---~~~~----------- 301 (426)
||+.|+|||++.+ ..++.++||||+||++|+|++|++||...... ..+.++. ..+.
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (317)
T cd07868 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP 256 (317)
T ss_pred ccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhcc
Confidence 8999999999987 45899999999999999999999999754321 1111111 0000
Q ss_pred -------------------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 -------------------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 -------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.....+..+.+||++||++||.+|||++|+|+||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 257 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred chhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001123568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=367.09 Aligned_cols=256 Identities=25% Similarity=0.329 Sum_probs=208.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
..+|++++.||+|+||.||+|... .+++.||+|.+... ....+|+.+|+.++||||++++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------------------~~~~~E~~il~~l~h~~iv~~~ 152 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------------------KTPGREIDILKTISHRAIINLI 152 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------------------ccHHHHHHHHHhcCCCCcccee
Confidence 346999999999999999999764 45678999987432 1234699999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|.....+|+|||++. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 153 ~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~Df 229 (392)
T PHA03207 153 HAYRWKSTVCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDF 229 (392)
T ss_pred eeEeeCCEEEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccC
Confidence 99999999999999995 788887743 345999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+..... .......+||+.|+|
T Consensus 230 G~a~~~~~~~~------------------------------------------------------~~~~~~~~gt~~y~a 255 (392)
T PHA03207 230 GAACKLDAHPD------------------------------------------------------TPQCYGWSGTLETNS 255 (392)
T ss_pred ccccccCcccc------------------------------------------------------cccccccccccCccC
Confidence 99876532110 112234579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc----------------------------CCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRILC----------------------------RPP 301 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~----------------------------~~~ 301 (426)
||++.+..|+.++|||||||++|||++|+.||.+... ...+..+.. .++
T Consensus 256 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (392)
T PHA03207 256 PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPP 335 (392)
T ss_pred HhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCC
Confidence 9999999999999999999999999999999976532 111111110 000
Q ss_pred CC-------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhh
Q 014344 302 DL-------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 302 ~~-------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
.. ...+.++.+||.+||..||.+|||+.|+|.||||+...|..+
T Consensus 336 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 336 YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 00 123456889999999999999999999999999998777665
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.76 Aligned_cols=257 Identities=31% Similarity=0.519 Sum_probs=214.7
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||+|+||+||+|.+..+++.||+|++.+...... .....+..|+.+|+.++||||+++++++...+..|+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 70 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKR----------KGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCL 70 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhh----------hhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEE
Confidence 6999999999999999999999999865432211 234456779999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
||||++|++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 71 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 149 (277)
T cd05577 71 VMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK- 149 (277)
T ss_pred EEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-
Confidence 9999999999998876655569999999999999999999999999999999999999999999999999886543110
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
......++..|+|||++.+..++.
T Consensus 150 --------------------------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~ 173 (277)
T cd05577 150 --------------------------------------------------------KIKGRAGTPGYMAPEVLQGEVYDF 173 (277)
T ss_pred --------------------------------------------------------ccccccCCCCcCCHHHhcCCCCCc
Confidence 112234788899999999888999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCC-----ChHHHhc
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRI-----GVEEIKG 333 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~-----s~~eil~ 333 (426)
++|+|||||++|+|++|+.||..... ......+...+.. ....++.+.++|.+||+.||.+|| ++.+++.
T Consensus 174 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred hhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999999999987654 2222222222222 234578899999999999999999 8888999
Q ss_pred CCCcCCCChhhhhh
Q 014344 334 HEFFKGVNWELLLK 347 (426)
Q Consensus 334 hp~f~~~~~~~~~~ 347 (426)
||||+.++|+....
T Consensus 254 h~~~~~~~~~~~~~ 267 (277)
T cd05577 254 HPLFKDLNWRRLEA 267 (277)
T ss_pred ChhhhcCChhhhhc
Confidence 99999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=349.59 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=207.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|++|.||+|++..+++.||||++.... ........+..|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-----------EEEGVPSTAIREISLLKELQHPNIVCLQDVLM 69 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-----------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe
Confidence 5899999999999999999999999999999984321 11123456778999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+..+|+||||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 70 ~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 70 QESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred eCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999999999997 68888766433 256899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......+++.|+|||+
T Consensus 149 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 172 (285)
T cd07861 149 RAFGIPV--------------------------------------------------------RVYTHEVVTLWYRAPEV 172 (285)
T ss_pred eecCCCc--------------------------------------------------------ccccCCcccccccChHH
Confidence 7542110 01112257889999999
Q ss_pred hcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC---------------------------CCCC
Q 014344 256 IEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP---------------------------PDLV 304 (426)
Q Consensus 256 ~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~---------------------------~~~~ 304 (426)
+.+. .++.++|+|||||++|+|++|++||.+.+.......+.. .+ ....
T Consensus 173 ~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (285)
T cd07861 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK 252 (285)
T ss_pred hcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcC
Confidence 8764 478899999999999999999999987765443322210 00 0012
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+.++.+||++||+.||.+|||+.+|+.||||
T Consensus 253 ~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 253 NLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred CCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 346788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=340.98 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=218.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+..|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-----------RREREEAIDEARVLAKLDSSYIIRYYESFL 69 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-----------HHHHHHHHHHHHHHHhcCCCCeehheeeec
Confidence 589999999999999999999999999999998543322 123457888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.++..|+||||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 70 DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred cCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 99999999999999999999887655679999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......|++.|+|||++
T Consensus 150 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~ 173 (256)
T cd08529 150 LLSDNT--------------------------------------------------------NFANTIVGTPYYLSPELC 173 (256)
T ss_pred eccCcc--------------------------------------------------------chhhccccCccccCHHHh
Confidence 653211 011234588999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CC-CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-DL-VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~-~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+|||||++|+|++|+.||...+.......+..... .. ...+..+.++|.+||+.+|++||++.+++.|
T Consensus 174 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 999899999999999999999999999998887666666554322 22 2457889999999999999999999999999
Q ss_pred CCc
Q 014344 335 EFF 337 (426)
Q Consensus 335 p~f 337 (426)
||+
T Consensus 254 ~~~ 256 (256)
T cd08529 254 PSL 256 (256)
T ss_pred CCC
Confidence 985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=364.70 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=199.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+...+|++++.||+|+||.||+|++..+++.||+|+..+. ....|+.+++.++||||++++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------------------~~~~E~~~l~~l~h~~iv~~~ 123 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------------------TTLIEAMLLQNVNHPSVIRMK 123 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------------------ccHHHHHHHHhCCCCCCcChh
Confidence 3445799999999999999999999999999999985221 224589999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++......|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 124 DTLVSGAITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred heEEeCCeeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecC
Confidence 99999999999999995 68888776543 45999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++...... .......||+.|+|
T Consensus 202 G~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 224 (357)
T PHA03209 202 GAAQFPVVA---------------------------------------------------------PAFLGLAGTVETNA 224 (357)
T ss_pred ccccccccC---------------------------------------------------------cccccccccccccC
Confidence 998643110 01123458999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCC-CCCCCCCHH---------HHHHHHhc----CCCCC---------------
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGA-TPFRGSSRK---------ETFYRILC----RPPDL--------------- 303 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~---------~~~~~i~~----~~~~~--------------- 303 (426)
||++.+..++.++|||||||++|||+++. ++|...... ..+..++. .+..+
T Consensus 225 PE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (357)
T PHA03209 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEY 304 (357)
T ss_pred CeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhh
Confidence 99999999999999999999999999754 444432110 11111110 01000
Q ss_pred ----------------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 ----------------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 ----------------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
...+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 305 ASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 123456778999999999999999999999999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=353.01 Aligned_cols=252 Identities=28% Similarity=0.443 Sum_probs=210.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+..|+++++.++||||++++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 68 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI------------KPAIRNQIIRELKVLHECNSPYIVGFYGAF 68 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc------------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 46999999999999999999999999999999884321 112345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.+++.+|+||||++|++|.+++... +.+++..++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+
T Consensus 69 ~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 69 YSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred eeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCC
Confidence 9999999999999999999998764 458999999999999999999997 6999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+...... .....+|++.|+|||
T Consensus 147 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~aPE 168 (308)
T cd06615 147 SGQLIDS----------------------------------------------------------MANSFVGTRSYMSPE 168 (308)
T ss_pred ccccccc----------------------------------------------------------ccccCCCCcCccChh
Confidence 7654211 112346899999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------------------
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----------------------------------- 299 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------------------- 299 (426)
++.+..++.++|+|||||++|+|++|+.||...+.......+-..
T Consensus 169 ~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (308)
T cd06615 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVN 248 (308)
T ss_pred HhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhc
Confidence 999888999999999999999999999999765533322111100
Q ss_pred --CCCC--CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 300 --PPDL--VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 300 --~~~~--~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
++.. ...+..+++||.+||..+|++|||+.++++||||..
T Consensus 249 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 249 EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 0010 123567999999999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.51 Aligned_cols=280 Identities=34% Similarity=0.576 Sum_probs=226.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||++.+..+++.||+|.+.+...... .....+..|+.+++.++||||+++++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 70 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR----------NQIQQVFVERDILTFAENPFVVSMFCSF 70 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhH----------HHHHHHHHHHHHHHhCCCCCeeeeEEEE
Confidence 469999999999999999999999999999999865432111 2345777899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+|+||||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 71 ETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred ecCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence 9999999999999999999998764 34899999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+............. ...............|++.|+|||.
T Consensus 149 ~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~~y~aPE~ 187 (305)
T cd05609 149 KIGLMSLTTNLYEG-----------------------------------------HIEKDTREFLDKQVCGTPEYIAPEV 187 (305)
T ss_pred cccCcCcccccccc-----------------------------------------ccccchhhccccCCccCccccCchh
Confidence 64321110000000 0000000011123458889999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----CCCCCCCHHHHHHHHHHhccCCCCCCC---h
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP----PDLVGEPTPLRNLIRRLLEKDPTKRIG---V 328 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~s---~ 328 (426)
+.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.... ......+..+.+||.+||..||++||+ +
T Consensus 188 ~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 267 (305)
T cd05609 188 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGA 267 (305)
T ss_pred ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCH
Confidence 998889999999999999999999999999888777666665332 111245788999999999999999998 7
Q ss_pred HHHhcCCCcCCCChhhhhhc
Q 014344 329 EEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 329 ~eil~hp~f~~~~~~~~~~~ 348 (426)
.++++||||...+|....+.
T Consensus 268 ~~ll~~~~~~~~~~~~~~~~ 287 (305)
T cd05609 268 FEVKQHRFFLGLDWNGLLRQ 287 (305)
T ss_pred HHHHhCccccCCCHHHHhhc
Confidence 99999999999999987644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=340.85 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=210.5
Q ss_pred CCCcEEE-eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 15 FSCLRIV-SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 15 ~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
.++|+|- ++||-|-.|.|-.+.++.|++.+|+|++. ......+|+++.-.. .|||||.++
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~------------------Ds~KARrEVeLHw~~s~h~~iV~Ii 121 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL------------------DSPKARREVELHWMASGHPHIVSII 121 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh------------------cCHHHHhHhhhhhhhcCCCceEEee
Confidence 3466665 68999999999999999999999999982 123456688776555 499999999
Q ss_pred eeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CC
Q 014344 93 GVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NG 165 (426)
Q Consensus 93 ~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g 165 (426)
++|++ -.++.+|||.++||+|++-++.++.+.|++.++..|++||..|+.|||+.+|+||||||||+|+.. +.
T Consensus 122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence 99854 568899999999999999999998889999999999999999999999999999999999999975 45
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+|+.-.. .....+.|
T Consensus 202 ~lKLtDfGFAK~t~~---------------------------------------------------------~~~L~TPc 224 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQE---------------------------------------------------------PGDLMTPC 224 (400)
T ss_pred ceEecccccccccCC---------------------------------------------------------CccccCCc
Confidence 799999999986432 12344557
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCCC-----CCCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK----ETFYRILCRPPDL-----VGEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~-----~~~~~~~~~li~~ 316 (426)
-||.|+|||++....|+..+|+||+||++|-|++|.+||...... .+-.+|......+ ...+..++|+|++
T Consensus 225 ~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~ 304 (400)
T KOG0604|consen 225 FTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRK 304 (400)
T ss_pred ccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999765432 2334554333333 3346789999999
Q ss_pred HhccCCCCCCChHHHhcCCCcCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
||..+|++|+|+.++++|||+.+
T Consensus 305 LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 305 LLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred HhcCCchhheeHHHhhcCchhcc
Confidence 99999999999999999999975
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=348.02 Aligned_cols=249 Identities=25% Similarity=0.449 Sum_probs=208.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+..|+.++++++||||+++++.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 68 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI------------TVELQKQIMSELEILYKCDSPYIIGFYGAF 68 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC------------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 46899999999999999999999999999999985431 112345688899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..++..++||||+++++|..+ ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 69 FVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EECCEEEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999999999999654 23789999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+... .....+||+.|+|||+
T Consensus 143 ~~~~~~----------------------------------------------------------~~~~~~~~~~y~aPE~ 164 (279)
T cd06619 143 TQLVNS----------------------------------------------------------IAKTYVGTNAYMAPER 164 (279)
T ss_pred eecccc----------------------------------------------------------cccCCCCChhhcCcee
Confidence 754311 1123468999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcC-CCC--CCCCCHHHHHHHHHHhccCCCCC
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-------ETFYRILCR-PPD--LVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~i~~~-~~~--~~~~~~~~~~li~~~L~~dP~~R 325 (426)
+.+..++.++|+|||||++|+|++|..||...... .....+... ++. ....+..+.+||.+||+.+|.+|
T Consensus 165 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 244 (279)
T cd06619 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKER 244 (279)
T ss_pred ecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhC
Confidence 99999999999999999999999999999653221 222222211 111 12356789999999999999999
Q ss_pred CChHHHhcCCCcCCC
Q 014344 326 IGVEEIKGHEFFKGV 340 (426)
Q Consensus 326 ~s~~eil~hp~f~~~ 340 (426)
|++++++.||||...
T Consensus 245 p~~~eil~~~~~~~~ 259 (279)
T cd06619 245 PAPENLMDHPFIVQY 259 (279)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.33 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=217.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||.|+||.||+|.+..+++.+|+|++.... ......+..|+.+++.++||||+++++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-------------EEELEDFMVEIDILSECKHPNIVGLYEA 70 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-------------HHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 356999999999999999999999899999999984321 1234567889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+..+..+|+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 71 YFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred EecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 999999999999999999999876543 4599999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... .......||+.|+|||
T Consensus 150 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~PE 173 (280)
T cd06611 150 SAKNKSTL--------------------------------------------------------QKRDTFIGTPYWMAPE 173 (280)
T ss_pred chhhcccc--------------------------------------------------------cccceeecchhhcCHH
Confidence 76542110 1122346899999999
Q ss_pred hhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCC
Q 014344 255 IIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 255 ~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R 325 (426)
++. ...++.++|+|||||++|+|++|++||...+......++...... ....+..+.+||.+||..+|.+|
T Consensus 174 ~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 174 VVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred HHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhC
Confidence 985 344678999999999999999999999988776666666543322 22456789999999999999999
Q ss_pred CChHHHhcCCCcCCCC
Q 014344 326 IGVEEIKGHEFFKGVN 341 (426)
Q Consensus 326 ~s~~eil~hp~f~~~~ 341 (426)
|++.++++||||....
T Consensus 254 ps~~~il~~~~~~~~~ 269 (280)
T cd06611 254 PTAAELLKHPFVSDQS 269 (280)
T ss_pred cCHHHHhcChhhcccc
Confidence 9999999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=361.28 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=217.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.++++.+.+++++.||+|-||.||++.... ...||+|.+.... .....+.+|+.+|++|.|++||
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~--------------m~~~~f~~Ea~iMk~L~H~~lV 264 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS--------------MSPEAFLREAQIMKKLRHEKLV 264 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc--------------cChhHHHHHHHHHHhCcccCeE
Confidence 466777889999999999999999999743 3479999884321 1234677899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++..+..+|||||||+.|+|.++++...+..+.......++.||+.|++||+++++|||||..+||||+++..+||
T Consensus 265 ~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 265 KLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred EEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEE
Confidence 99999999899999999999999999998866677999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||||+......-.. ....--...
T Consensus 345 sDFGLAr~~~d~~Y~~-------------------------------------------------------~~~~kfPIk 369 (468)
T KOG0197|consen 345 SDFGLARLIGDDEYTA-------------------------------------------------------SEGGKFPIK 369 (468)
T ss_pred cccccccccCCCceee-------------------------------------------------------cCCCCCCce
Confidence 9999999543221100 000113456
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|.|||++....++.+||||||||+||||.| |+.||.+.+..+....+.. +.+.+.++|+.+.++|..||..+|++||
T Consensus 370 WtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RP 449 (468)
T KOG0197|consen 370 WTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRP 449 (468)
T ss_pred ecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCC
Confidence 999999999999999999999999999996 9999999999999988864 4466778899999999999999999999
Q ss_pred ChHHHh
Q 014344 327 GVEEIK 332 (426)
Q Consensus 327 s~~eil 332 (426)
|++.+.
T Consensus 450 tF~~L~ 455 (468)
T KOG0197|consen 450 TFETLR 455 (468)
T ss_pred CHHHHH
Confidence 998664
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=337.11 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=213.8
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~ 100 (426)
..||+|+|+.|--+....+|..||||++.|. ......++.+|++++.+++ |+||+.++++|+++..
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-------------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-------------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC-------------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 6799999999999999999999999999654 2345678999999999996 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---EEEeccccccc
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVDFDLSTK 177 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---ikL~DFgls~~ 177 (426)
+|||||-+.||.|.+.+..+. .|++.++..++++|+.||++||.+||+||||||+|||.....+ |||+||.+...
T Consensus 151 FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999998887654 4999999999999999999999999999999999999986654 89999999876
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
+.......+ .+.-...+.||+..|||||+..
T Consensus 229 ~k~~~~~sp-------------------------------------------------astP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 229 IKLNNDCSP-------------------------------------------------ASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred cccCCCCCC-------------------------------------------------CCCccccCcccchhhcchhHHh
Confidence 643322111 0111234568999999999863
Q ss_pred -----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHhcCCCCCC-----CCCHHHHH
Q 014344 258 -----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---------------RKETFYRILCRPPDLV-----GEPTPLRN 312 (426)
Q Consensus 258 -----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---------------~~~~~~~i~~~~~~~~-----~~~~~~~~ 312 (426)
..-|+.++|.||||||||-||.|.+||.|.- ....|..|......++ ..+.+++|
T Consensus 260 ~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakd 339 (463)
T KOG0607|consen 260 VFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKD 339 (463)
T ss_pred hhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHH
Confidence 2458999999999999999999999997652 2234555554443333 34788999
Q ss_pred HHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 313 LIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 313 li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
||..+|..|+.+|.++.++++|||++.+.-
T Consensus 340 lisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 340 LISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHhccHHhhhhhhhccCCccccccch
Confidence 999999999999999999999999987643
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=367.43 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=202.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+++|++|+||||++++++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------------------~~~~~~E~~iL~~L~HpnIv~l~~~ 228 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------------------YASSVHEARLLRRLSHPAVLALLDV 228 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------------------ccCHHHHHHHHHHCCCCCCCcEEEE
Confidence 457999999999999999999999999999999641 1234569999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+......|+|||++. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 229 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGl 306 (461)
T PHA03211 229 RVVGGLTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGA 306 (461)
T ss_pred EEECCEEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCC
Confidence 999999999999995 78888776543 3599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
++.+..... .......+||+.|+|||
T Consensus 307 a~~~~~~~~------------------------------------------------------~~~~~~~~GT~~Y~APE 332 (461)
T PHA03211 307 ACFARGSWS------------------------------------------------------TPFHYGIAGTVDTNAPE 332 (461)
T ss_pred ceecccccc------------------------------------------------------cccccccCCCcCCcCHH
Confidence 876532110 00112356999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcC----CCC---------------------
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-------KETFYRILCR----PPD--------------------- 302 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~----~~~--------------------- 302 (426)
++.+..++.++|||||||++|||++|..|+..... ...+.+++.. ...
T Consensus 333 ~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 412 (461)
T PHA03211 333 VLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNR 412 (461)
T ss_pred HHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhccc
Confidence 99999999999999999999999998765432210 1112222110 000
Q ss_pred -----------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 -----------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 -----------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+.+||.+||+.||.+|||+.|||+||||+.
T Consensus 413 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 413 RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0022346889999999999999999999999999964
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=345.84 Aligned_cols=254 Identities=34% Similarity=0.614 Sum_probs=202.9
Q ss_pred eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHH---HHhcCCCCcceeeeeeecCC
Q 014344 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV---LRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~i---l~~l~hp~iv~l~~~~~~~~ 99 (426)
.||+|+||.||+|.+..+++.||+|++.+...... ........|..+ +....||+|+.+++++..++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 70 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK----------QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD 70 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc----------hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC
Confidence 48999999999999999999999999865432211 011222334433 33457999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..|+||||+.|++|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 71 ~~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 71 KLCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred eEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 999999999999999887654 349999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc-C
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE-G 258 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~ 258 (426)
.. ......||+.|+|||.+. +
T Consensus 149 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~ 170 (279)
T cd05633 149 KK----------------------------------------------------------KPHASVGTHGYMAPEVLQKG 170 (279)
T ss_pred cc----------------------------------------------------------CccCcCCCcCccCHHHhcCC
Confidence 11 011235899999999986 4
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH-hcCC-CCCCCCCHHHHHHHHHHhccCCCCCC-----ChH
Q 014344 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRI-LCRP-PDLVGEPTPLRNLIRRLLEKDPTKRI-----GVE 329 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i-~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~-----s~~ 329 (426)
..++.++|+||+||++|+|++|..||..... ....... .... ......+..+.++|.+||..||++|+ +++
T Consensus 171 ~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (279)
T cd05633 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQ 250 (279)
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 6689999999999999999999999975432 1222222 1111 22234578899999999999999999 699
Q ss_pred HHhcCCCcCCCChhhhh
Q 014344 330 EIKGHEFFKGVNWELLL 346 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~ 346 (426)
++++||||++++|....
T Consensus 251 ~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 251 EVKEHVFFKGIDWQQVY 267 (279)
T ss_pred HHHhCccccCCCHhHHh
Confidence 99999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=345.48 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=210.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 94 (426)
+.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ +||||++++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--------------~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 71 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--------------DEEEEIKQEINMLKKYSHHRNIATYYGA 71 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--------------ccHHHHHHHHHHHHHhcCCCCeeeEeeE
Confidence 45899999999999999999999999999999984321 1234677799999998 69999999999
Q ss_pred eecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+... ..+|+||||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred EeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEE
Confidence 8653 4689999999999999998775556699999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... .......|++
T Consensus 152 l~Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~g~~ 175 (272)
T cd06637 152 LVDFGVSAQLDRTV--------------------------------------------------------GRRNTFIGTP 175 (272)
T ss_pred EccCCCceeccccc--------------------------------------------------------ccCCcccccc
Confidence 99999987543110 1123456899
Q ss_pred CCccchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhcc
Q 014344 249 EYVAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 249 ~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~ 320 (426)
.|+|||++.+ ..++.++|+||+||++|+|++|..||...........+..... .....+..+.+||.+||..
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 255 (272)
T cd06637 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVK 255 (272)
T ss_pred cccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCC
Confidence 9999999863 4578899999999999999999999987666555444432221 1224578899999999999
Q ss_pred CCCCCCChHHHhcCCCc
Q 014344 321 DPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f 337 (426)
+|.+|||+.+++.||||
T Consensus 256 ~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 256 NHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=345.65 Aligned_cols=253 Identities=28% Similarity=0.473 Sum_probs=208.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|++|.||+|++..+++.||+|++.... ......+.+..|+.+++.++||||+++++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 69 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE-----------DDPVIKKIALREIRMLKQLKHPNLVNLIEVF 69 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc-----------cCccccHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 46999999999999999999999999999999884321 1111234577899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+++||||+++++|..+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 70 RRKRKLHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred eeCCEEEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccc
Confidence 9999999999999998888775433 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......++..|+|||+
T Consensus 148 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~aPE~ 171 (286)
T cd07847 148 RILTGPG--------------------------------------------------------DDYTDYVATRWYRAPEL 171 (286)
T ss_pred eecCCCc--------------------------------------------------------ccccCcccccccCCHHH
Confidence 7653211 01123357888999999
Q ss_pred hcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-----------------------CCC---------C
Q 014344 256 IEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-----------------------RPP---------D 302 (426)
Q Consensus 256 ~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-----------------------~~~---------~ 302 (426)
+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+.. .+. .
T Consensus 172 ~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd07847 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESK 251 (286)
T ss_pred HhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHH
Confidence 876 4578999999999999999999999988776544433211 000 0
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
....+..+.+||.+||..+|++||++.|++.||||
T Consensus 252 ~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 252 FPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred hccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 12346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=348.18 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=203.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|+||.||+|++..+|+.||+|++..... .......+..|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-----------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 69 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-----------DEGVPSSALREICLLKELKHKNIVRLYDVLH 69 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-----------cccCccchhHHHHHHHhcCCCCeeeHHHHhc
Confidence 48999999999999999999999999999999854321 1112345677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+...+|+|+||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 70 SDKKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred cCCceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 9999999999997 57877765433 459999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......+++.|+|||++
T Consensus 148 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~ 171 (284)
T cd07839 148 AFGIPV--------------------------------------------------------RCYSAEVVTLWYRPPDVL 171 (284)
T ss_pred ccCCCC--------------------------------------------------------CCcCCCccccCCcChHHH
Confidence 543110 011223578899999998
Q ss_pred cCC-CCChhhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcC---------------C---------------CCCC
Q 014344 257 EGK-GHDFAVDWWSLGVVLHEMLYGATPF-RGSSRKETFYRILCR---------------P---------------PDLV 304 (426)
Q Consensus 257 ~~~-~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~---------------~---------------~~~~ 304 (426)
.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+... + ....
T Consensus 172 ~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd07839 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVP 251 (284)
T ss_pred hCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcc
Confidence 774 4689999999999999999988875 444444433332110 0 0011
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+..+++||++||+.||.+|||+++++.||||
T Consensus 252 ~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 252 KLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=347.23 Aligned_cols=252 Identities=25% Similarity=0.424 Sum_probs=214.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+++.++||||+++++.|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-------------~~~~~~~~e~~~l~~~~h~~v~~~~~~~ 86 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-------------PKKELIINEILVMRENKNPNIVNYLDSY 86 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc-------------chHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 579999999999999999999999999999999854321 1235677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
......|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 87 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 999999999999999999998764 24889999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||.
T Consensus 164 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 187 (296)
T cd06654 164 AQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAPEV 187 (296)
T ss_pred hhccccc--------------------------------------------------------cccCcccCCccccCHHH
Confidence 7543211 01123358899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|+|++|+.||...+.......+..... .....+..+.+||.+||..+|++||++.+|
T Consensus 188 ~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ei 267 (296)
T cd06654 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (296)
T ss_pred HcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHH
Confidence 9998899999999999999999999999988776554444332221 122346789999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
+.||||..
T Consensus 268 l~~~~~~~ 275 (296)
T cd06654 268 LQHQFLKI 275 (296)
T ss_pred hhChhhhc
Confidence 99999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=344.28 Aligned_cols=259 Identities=32% Similarity=0.583 Sum_probs=208.4
Q ss_pred eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHH---HHHHHhcCCCCcceeeeeeecCC
Q 014344 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE---QRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E---~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
.||+|+||.||+|.+..+++.||+|++.+...... ........| ..+++...||+|+.++++|....
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 70 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK----------QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 70 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc----------hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 48999999999999999999999999865432211 011112223 34455568999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..|+||||+.|++|..++... ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++..+.
T Consensus 71 ~~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 71 KLSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 999999999999999887653 459999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC-
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 258 (426)
.. .....+|++.|+|||++.+
T Consensus 149 ~~----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~ 170 (278)
T cd05606 149 KK----------------------------------------------------------KPHASVGTHGYMAPEVLQKG 170 (278)
T ss_pred cc----------------------------------------------------------CCcCcCCCcCCcCcHHhcCC
Confidence 11 1122358999999999975
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCC-CCCCCCHHHHHHHHHHhccCCCCCC-----ChH
Q 014344 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILCRPP-DLVGEPTPLRNLIRRLLEKDPTKRI-----GVE 329 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~-----s~~ 329 (426)
..++.++|+||+||++|+|++|+.||.... .......+..... .....+..+.++|.+||..+|.+|+ ++.
T Consensus 171 ~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (278)
T cd05606 171 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250 (278)
T ss_pred CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHH
Confidence 468999999999999999999999998763 2333333322222 2224578899999999999999999 999
Q ss_pred HHhcCCCcCCCChhhhhhccCC
Q 014344 330 EIKGHEFFKGVNWELLLKISRP 351 (426)
Q Consensus 330 eil~hp~f~~~~~~~~~~~~~~ 351 (426)
++++||||++.+|..+.....|
T Consensus 251 ~ll~~~~~~~~~~~~~~~~~~~ 272 (278)
T cd05606 251 EVKEHPFFRSLDWQMVFLQKYP 272 (278)
T ss_pred HHHhCccccCCCchHhhhcccC
Confidence 9999999999999988655444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=344.89 Aligned_cols=253 Identities=24% Similarity=0.450 Sum_probs=210.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||++++
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------------~~~~~~~~~e~~~~~~l~h~~ii~~~ 72 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-------------GEDFAVVQQEIIMMKDCKHSNIVAYF 72 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-------------hhHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 44568999999999999999999999999999999984321 11234577899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++.....+|+||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 73 GSYLRRDKLWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEEEeCCEEEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcc
Confidence 9999999999999999999999987654 35999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.... .......||+.|+|
T Consensus 151 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~a 174 (267)
T cd06645 151 GVSAQITATI--------------------------------------------------------AKRKSFIGTPYWMA 174 (267)
T ss_pred eeeeEccCcc--------------------------------------------------------cccccccCcccccC
Confidence 9987553110 01123468999999
Q ss_pred chhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCC---CCCCCHHHHHHHHHHhccCCC
Q 014344 253 PEIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPD---LVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 253 PE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~---~~~~~~~~~~li~~~L~~dP~ 323 (426)
||++. ...++.++|+|||||++|+|++|..||............... ++. ....+..+.+||.+||..+|+
T Consensus 175 PE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 254 (267)
T cd06645 175 PEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPK 254 (267)
T ss_pred hhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCch
Confidence 99985 455788999999999999999999999765544333322211 111 123467799999999999999
Q ss_pred CCCChHHHhcCCC
Q 014344 324 KRIGVEEIKGHEF 336 (426)
Q Consensus 324 ~R~s~~eil~hp~ 336 (426)
+||++++|++|||
T Consensus 255 ~R~~~~~ll~~~~ 267 (267)
T cd06645 255 KRPTAEKLLQHPF 267 (267)
T ss_pred hCcCHHHHhcCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.48 Aligned_cols=251 Identities=40% Similarity=0.723 Sum_probs=214.9
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||.|++|.||+|++..+++.||+|++.+..... ....+.+.+|+.+++.++||||+++++.+.++..+|+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 70 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE----------TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYM 70 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh----------hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEE
Confidence 799999999999999999999999996543221 1234678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
||||++|++|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 71 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 71 LMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred EEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 99999999999988754 348999999999999999999999999999999999999999999999999987653210
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
......|++.|+|||.+.+..++.
T Consensus 148 --------------------------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~ 171 (262)
T cd05572 148 --------------------------------------------------------KTWTFCGTPEYVAPEIILNKGYDF 171 (262)
T ss_pred --------------------------------------------------------ccccccCCcCccChhHhcCCCCCC
Confidence 122345889999999998888999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc--CC-CCCCCCCHHHHHHHHHHhccCCCCCCC-----hHHHhc
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSS--RKETFYRILC--RP-PDLVGEPTPLRNLIRRLLEKDPTKRIG-----VEEIKG 333 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~--~~-~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~eil~ 333 (426)
++|+||+||++|+|++|..||.... ..+.+..+.. .. ......+..+.++|.+||+.+|++|++ ++|+++
T Consensus 172 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999999999999999999998777 5555665552 22 222234688999999999999999999 999999
Q ss_pred CCCcCCCChh
Q 014344 334 HEFFKGVNWE 343 (426)
Q Consensus 334 hp~f~~~~~~ 343 (426)
||||++.+|+
T Consensus 252 ~~~~~~~~~~ 261 (262)
T cd05572 252 HKWFNGFDWE 261 (262)
T ss_pred ChhhhCCCCC
Confidence 9999999886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=338.78 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=218.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-----------KEREESRKEVAVLSNMKHPNIVQYQESFE 69 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-----------HHHHHHHHHHHHHHhCCCCCeeeeEeeec
Confidence 5999999999999999999999999999999985432211 23457788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.....|+||||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 70 ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred CCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 99999999999999999998876554568999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... .......|++.|+|||++
T Consensus 150 ~~~~~~--------------------------------------------------------~~~~~~~~~~~~~~pe~~ 173 (256)
T cd08218 150 VLNSTV--------------------------------------------------------ELARTCIGTPYYLSPEIC 173 (256)
T ss_pred ecCcch--------------------------------------------------------hhhhhccCCccccCHHHh
Confidence 653210 011233588899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+|||||++|+|++|..||...+..+....++... +.....+..+.++|.+||..+|.+||++.+++.|
T Consensus 174 ~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 98889999999999999999999999999888777776665432 2233457889999999999999999999999999
Q ss_pred CCc
Q 014344 335 EFF 337 (426)
Q Consensus 335 p~f 337 (426)
|||
T Consensus 254 ~~~ 256 (256)
T cd08218 254 NFI 256 (256)
T ss_pred cCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.37 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=219.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.++++++|+||+++++++.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 69 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-----------EKERRDALNEIVILSLLQHPNIIAYYNHFM 69 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-----------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEe
Confidence 599999999999999999999999999999998543221 123456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....++++||||+|++|.+++.......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 70 DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 99999999999999999999876655568999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... .......|++.|+|||.+
T Consensus 150 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ape~~ 173 (256)
T cd08221 150 ILGSEY--------------------------------------------------------SMAETVVGTPYYMSPELC 173 (256)
T ss_pred Eccccc--------------------------------------------------------ccccccCCCccccCHhhc
Confidence 653211 012234589999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+|||||++|+|++|..||...+..+....+..... .....+..+.++|.+||..+|.+||++.++++|
T Consensus 174 ~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 988889999999999999999999999998888777777654322 223457889999999999999999999999999
Q ss_pred CCc
Q 014344 335 EFF 337 (426)
Q Consensus 335 p~f 337 (426)
||+
T Consensus 254 ~~l 256 (256)
T cd08221 254 PLL 256 (256)
T ss_pred cCC
Confidence 986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=346.43 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=216.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||.|++|.||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++++.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-------------QPKKELIINEILVMKELKNPNIVNFLDSF 85 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-------------CchHHHHHHHHHHHHhcCCCceeeeeeeE
Confidence 56999999999999999999999999999999884321 12345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.....+|+|+||++|++|..++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~ 162 (296)
T cd06655 86 LVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC 162 (296)
T ss_pred ecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccc
Confidence 9999999999999999999987642 4899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||.
T Consensus 163 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 186 (296)
T cd06655 163 AQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAPEV 186 (296)
T ss_pred hhccccc--------------------------------------------------------ccCCCcCCCccccCcch
Confidence 7653211 01123358899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|+|++|+.||.+.+.......+..... .....++.+.+||.+||..||.+||++.+|
T Consensus 187 ~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~i 266 (296)
T cd06655 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKEL 266 (296)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 9998899999999999999999999999998877655544432211 223457789999999999999999999999
Q ss_pred hcCCCcCCC
Q 014344 332 KGHEFFKGV 340 (426)
Q Consensus 332 l~hp~f~~~ 340 (426)
+.||||+..
T Consensus 267 l~~~~~~~~ 275 (296)
T cd06655 267 LQHPFLKLA 275 (296)
T ss_pred hhChHhhhc
Confidence 999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=345.04 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=213.1
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++++.||.|+||.||++.+..++..+|+|.+.... ......+..|+.+++.++||||+++++.+..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 73 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-------------EEELEDYMVEIDILASCDHPNIVKLLDAFYY 73 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-------------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee
Confidence 689999999999999999999999999999984321 1234567789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+...|+||||+++++|..++... ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 74 ~~~~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 152 (282)
T cd06643 74 ENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152 (282)
T ss_pred CCEEEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccc
Confidence 99999999999999998876543 34589999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
..... .......||+.|+|||++.
T Consensus 153 ~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 153 NTRTI--------------------------------------------------------QRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccc--------------------------------------------------------cccccccccccccCHhhcc
Confidence 42110 1122346899999999984
Q ss_pred -----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 258 -----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 258 -----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
+..++.++|+||+||++|+|++|.+||...+..+....+..... .....+..+.+||.+||..||.+||++
T Consensus 177 ~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTT 256 (282)
T ss_pred ccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 34577899999999999999999999998877766665543321 122457789999999999999999999
Q ss_pred HHHhcCCCcCC
Q 014344 329 EEIKGHEFFKG 339 (426)
Q Consensus 329 ~eil~hp~f~~ 339 (426)
.++++||||+.
T Consensus 257 ~~il~~~~~~~ 267 (282)
T cd06643 257 TQLLQHPFVTV 267 (282)
T ss_pred HHHhcCCCEec
Confidence 99999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=343.72 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=212.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|+||.||+|.+..+++.||+|++...... ......+..|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-----------GGIPNQALREIKALQACQHPYVVKLLDVFP 69 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-----------chhhHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 589999999999999999999999999999998543211 123457888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....+|+||||+ |++|.+++.... ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 70 HGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred cCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 999999999999 999999876544 559999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... .......|+..|+|||++
T Consensus 148 ~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07832 148 LFSEEEP-------------------------------------------------------RLYSHQVATRWYRAPELL 172 (286)
T ss_pred cccCCCC-------------------------------------------------------CccccccCcccccCceee
Confidence 6532110 011233589999999998
Q ss_pred cCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------------------------CCC
Q 014344 257 EGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-------------------------------DLV 304 (426)
Q Consensus 257 ~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------------------~~~ 304 (426)
.+. .++.++||||+||++|+|++|.+||.+.+....+..++.... ...
T Consensus 173 ~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd07832 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP 252 (286)
T ss_pred eccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCC
Confidence 754 468999999999999999999999988776665544432100 012
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
..+..+.+||++||..+|++|||+++++.||||.
T Consensus 253 ~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 253 DASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 3457789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=343.09 Aligned_cols=255 Identities=29% Similarity=0.512 Sum_probs=218.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||.|++|.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE------------AEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc------------cchHHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence 46999999999999999999999999999999985331 112345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+|+|+||+++++|.+++... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 69 LKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999999999987753 5899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......|++.|+|||.
T Consensus 146 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~PE~ 169 (274)
T cd06609 146 GQLTSTM--------------------------------------------------------SKRNTFVGTPFWMAPEV 169 (274)
T ss_pred eeecccc--------------------------------------------------------cccccccCCccccChhh
Confidence 7764211 11223468899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCC--CCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDLV--GEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~--~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
+.+..++.++|||||||++|+|++|..||...+.......+.... +... ..+..+.++|.+||..+|++|||+++++
T Consensus 170 ~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 999889999999999999999999999998877666555444332 2222 1577899999999999999999999999
Q ss_pred cCCCcCCCC
Q 014344 333 GHEFFKGVN 341 (426)
Q Consensus 333 ~hp~f~~~~ 341 (426)
+||||+...
T Consensus 250 ~~~~~~~~~ 258 (274)
T cd06609 250 KHKFIKKAK 258 (274)
T ss_pred hChhhcCCC
Confidence 999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=342.54 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=216.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
|.+..++|++++.||+|+||.||+|.++. .+..||+|.+.... .......+..|+.+++.++|
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~e~~~l~~l~~ 68 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA------------SLRERIEFLNEASVMKGFTC 68 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC------------CHHHHHHHHHHHHHHHhCCC
Confidence 34567789999999999999999997642 34579999874321 11123457789999999999
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPE 157 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~ 157 (426)
|||+++++++......|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+
T Consensus 69 ~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~ 148 (288)
T cd05061 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAAR 148 (288)
T ss_pred CCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChh
Confidence 999999999999999999999999999999987532 123466788899999999999999999999999999
Q ss_pred CeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 158 NIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDS 237 (426)
Q Consensus 158 NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (426)
|||++.++.++|+|||+++.......
T Consensus 149 nili~~~~~~~L~Dfg~~~~~~~~~~------------------------------------------------------ 174 (288)
T cd05061 149 NCMVAHDFTVKIGDFGMTRDIYETDY------------------------------------------------------ 174 (288)
T ss_pred eEEEcCCCcEEECcCCcccccccccc------------------------------------------------------
Confidence 99999999999999999875432110
Q ss_pred CCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHH
Q 014344 238 SEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLI 314 (426)
Q Consensus 238 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li 314 (426)
........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+.... ......+..+.++|
T Consensus 175 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 254 (288)
T cd05061 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLM 254 (288)
T ss_pred ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 000112235678999999999889999999999999999998 899999887776665554321 22334578899999
Q ss_pred HHHhccCCCCCCChHHHhc------CCCcCCCCh
Q 014344 315 RRLLEKDPTKRIGVEEIKG------HEFFKGVNW 342 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~------hp~f~~~~~ 342 (426)
.+||+.||++|||+.++++ ||||.+++|
T Consensus 255 ~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 255 RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 9999999999999999986 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=340.27 Aligned_cols=265 Identities=24% Similarity=0.417 Sum_probs=217.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|.+.+.||+|++|.||+|.+..+++.||+|.+......... ........+.+..|+.++++++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS----KDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccch----hHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 478899999999999999999999999999988543221110 0001123467888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.....++||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999999998764 348999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
......... ........+.|++.|+|||.+
T Consensus 155 ~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 155 KLEANSLST--------------------------------------------------KTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred ccccccccC--------------------------------------------------CccccccccCCCcCccChhHh
Confidence 664211000 000112234588999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+|||||++|+|++|+.||...+.......+... +......+..+.++|++||+.||.+||++.+|+.|
T Consensus 185 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 9988999999999999999999999999987766555554332 22233457889999999999999999999999999
Q ss_pred CCc
Q 014344 335 EFF 337 (426)
Q Consensus 335 p~f 337 (426)
|||
T Consensus 265 ~~~ 267 (267)
T cd06628 265 PFL 267 (267)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=344.59 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=211.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
..+.|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||++++
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~e~~~l~~~~~h~~i~~~~ 79 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--------------DEEEEIKLEINMLKKYSHHRNIATYY 79 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--------------HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence 3468999999999999999999999999999999984421 1234567789999998 699999999
Q ss_pred eeee------cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 93 GVLS------TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 93 ~~~~------~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++. ....+|++|||+.+|+|.+++.......+++..+..++.||+.||.|||+.||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 9984 3568899999999999999987766566899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
++|+|||++....... ......+|
T Consensus 160 ~~l~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~ 183 (282)
T cd06636 160 VKLVDFGVSAQLDRTV--------------------------------------------------------GRRNTFIG 183 (282)
T ss_pred EEEeeCcchhhhhccc--------------------------------------------------------cCCCcccc
Confidence 9999999987542110 11223468
Q ss_pred CCCCccchhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCCCCHHHHHHHHHHh
Q 014344 247 TEEYVAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD---LVGEPTPLRNLIRRLL 318 (426)
Q Consensus 247 t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~li~~~L 318 (426)
++.|+|||++. ...++.++|+|||||++|+|++|..||...........+...... ....+..+.+||++||
T Consensus 184 ~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 263 (282)
T cd06636 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263 (282)
T ss_pred cccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHh
Confidence 99999999986 345788999999999999999999999877665544443322211 1245788999999999
Q ss_pred ccCCCCCCChHHHhcCCCc
Q 014344 319 EKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 319 ~~dP~~R~s~~eil~hp~f 337 (426)
..||.+||++.||++||||
T Consensus 264 ~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 264 VKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCChhhCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=341.73 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=208.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||+|+||.||+|++..+++.||+|++.... ......+..|+.+++.++||||+++++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~ii~~~~ 73 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-------------GDDFSLIQQEIFMVKECKHCNIVAYFG 73 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-------------cchHHHHHHHHHHHHhcCCCCeeeeeE
Confidence 4567999999999999999999999999999999984321 112345778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++..+..+|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg 151 (267)
T cd06646 74 SYLSREKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFG 151 (267)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCc
Confidence 999999999999999999999987654 358999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+.... .......|++.|+||
T Consensus 152 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~P 175 (267)
T cd06646 152 VAAKITATI--------------------------------------------------------AKRKSFIGTPYWMAP 175 (267)
T ss_pred cceeecccc--------------------------------------------------------cccCccccCccccCH
Confidence 987653110 011234588999999
Q ss_pred hhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCC---CCCCCHHHHHHHHHHhccCCCC
Q 014344 254 EIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPD---LVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 254 E~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~---~~~~~~~~~~li~~~L~~dP~~ 324 (426)
|.+. ...++.++|+||+||++|+|++|..||...........+... ++. ....+..+.+||++||..+|++
T Consensus 176 E~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 255 (267)
T cd06646 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKK 255 (267)
T ss_pred hHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhh
Confidence 9985 344778999999999999999999999766544433222111 111 1234678999999999999999
Q ss_pred CCChHHHhcCCC
Q 014344 325 RIGVEEIKGHEF 336 (426)
Q Consensus 325 R~s~~eil~hp~ 336 (426)
|||+++|++|+|
T Consensus 256 Rp~~~~il~~l~ 267 (267)
T cd06646 256 RPTAERLLTHLF 267 (267)
T ss_pred CcCHHHHhcCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=336.64 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=218.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+..|+.+|+.++||||+++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-----------TKDERLAAQNECQVLKLLSHPNIIEYYENFL 69 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-----------ccHHHHHHHHHHHHHhhCCCCchhheeeeEe
Confidence 59999999999999999999999999999999854321 1234567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL~DFgls 175 (426)
.....++||||++|++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred cCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 999999999999999999998776555689999999999999999999999999999999999998654 6899999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... ......|++.|+|||.
T Consensus 150 ~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE~ 172 (256)
T cd08220 150 KILSSKS---------------------------------------------------------KAYTVVGTPCYISPEL 172 (256)
T ss_pred eecCCCc---------------------------------------------------------cccccccCCcccCchh
Confidence 7653211 1122358889999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+..++.++|+|||||++|+|++|..||...+.......+..... .....+..+.++|.+||..+|++|||+.++++
T Consensus 173 ~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 173 CEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 9988889999999999999999999999998887777666654332 22345788999999999999999999999999
Q ss_pred CCCc
Q 014344 334 HEFF 337 (426)
Q Consensus 334 hp~f 337 (426)
||||
T Consensus 253 ~p~~ 256 (256)
T cd08220 253 QPIC 256 (256)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=339.63 Aligned_cols=251 Identities=37% Similarity=0.639 Sum_probs=209.3
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH-HhcCCCCcceeeeeeecCC
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hp~iv~l~~~~~~~~ 99 (426)
++.||.|+||.||+|.+..+++.||+|++.+...... .....+..|..++ ..++|||++++++++...+
T Consensus 1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 70 (260)
T cd05611 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK----------NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD 70 (260)
T ss_pred CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH----------HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC
Confidence 3579999999999999999999999999865432211 1122334454444 4558999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
.+|+||||++|++|.+++... +.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus 71 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 71 YLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999999999999998754 348999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 259 (426)
. .....|++.|+|||.+.+.
T Consensus 149 ~------------------------------------------------------------~~~~~~~~~y~~pe~~~~~ 168 (260)
T cd05611 149 E------------------------------------------------------------NKKFVGTPDYLAPETILGV 168 (260)
T ss_pred c------------------------------------------------------------cccCCCCcCccChhhhcCC
Confidence 1 1233588899999999988
Q ss_pred CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCCCCh---HHH
Q 014344 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKRIGV---EEI 331 (426)
Q Consensus 260 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s~---~ei 331 (426)
.++.++||||||+++|+|++|..||...+....+..+..... .....+..+.++|.+||+.+|++||++ +|+
T Consensus 169 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 899999999999999999999999998887777666543321 122457889999999999999999954 799
Q ss_pred hcCCCcCCCChh
Q 014344 332 KGHEFFKGVNWE 343 (426)
Q Consensus 332 l~hp~f~~~~~~ 343 (426)
+.||||+.++|+
T Consensus 249 l~~~~~~~~~~~ 260 (260)
T cd05611 249 KSHPFFKSINWD 260 (260)
T ss_pred HcChHhhcCCCC
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.57 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=213.6
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+........ ........+..|+.+++.++|+||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVL-------AAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL 72 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchh-------hHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee
Confidence 488999999999999999986 5788999998854321110 11123467888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....+|+||||++|++|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 73 DDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 9999999999999999999986543 48999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
......... ..........|+..|+|||++
T Consensus 151 ~~~~~~~~~--------------------------------------------------~~~~~~~~~~~~~~~~~pe~~ 180 (265)
T cd06631 151 RLAWVGLHG--------------------------------------------------THSNMLKSMHGTPYWMAPEVI 180 (265)
T ss_pred hhhhccccc--------------------------------------------------cccccccccCCCccccChhhh
Confidence 653111000 000112234589999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+..++.++|+|||||++|+|++|..||...+.......+... +......+..+.+||++||..+|.+||++.+++
T Consensus 181 ~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred cCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 9999999999999999999999999999877665544443322 223334578899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
.||||
T Consensus 261 ~~~~~ 265 (265)
T cd06631 261 RHDFL 265 (265)
T ss_pred cCCCC
Confidence 99997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=346.67 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=212.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|+||.||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++++.+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 85 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-------------QPKKELIINEILVMRENKNPNIVNYLDSY 85 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-------------cchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 67999999999999999999999999999999984321 11235677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
......|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~ 162 (297)
T cd06656 86 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (297)
T ss_pred ecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccc
Confidence 999999999999999999998764 34889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||.
T Consensus 163 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 186 (297)
T cd06656 163 AQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAPEV 186 (297)
T ss_pred eEccCCc--------------------------------------------------------cCcCcccCCccccCHHH
Confidence 7543211 01123358899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-C---CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-P---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|+|++|..||...+.......+.... + .....+..+.+||.+||..+|.+||+++++
T Consensus 187 ~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999889999999999999999999999998776544333222211 1 122346778999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
+.||||+.
T Consensus 267 l~~~~~~~ 274 (297)
T cd06656 267 LQHPFLKL 274 (297)
T ss_pred hcCchhcc
Confidence 99999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=355.11 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=205.9
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~ 90 (426)
.++-..|++++.||+||.+.||+|..- ..+.||+|.+.-. ..+.....-+..|+.+|.+|+ |..||.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~-----------~~D~qtl~gy~nEI~lL~KLkg~~~IIq 424 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLL-----------EADNQTLDGYRNEIALLNKLKGHDKIIQ 424 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHh-----------hcCHHHHHHHHHHHHHHHHhcCCceEEE
Confidence 456678999999999999999999863 3456666655221 123345678899999999997 899999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++++-..++++|+||||= ..||..+++.... ..+.-.+++|..||+.|++++|++||||.||||.|+|+- .|.+||+
T Consensus 425 L~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLI 501 (677)
T KOG0596|consen 425 LYDYEVTDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLI 501 (677)
T ss_pred EeeeeccCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEee
Confidence 999999999999999975 5899998876553 355569999999999999999999999999999999985 7899999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||.|..+.+.++.. ...+.+||+.|
T Consensus 502 DFGIA~aI~~DTTsI------------------------------------------------------~kdsQvGT~NY 527 (677)
T KOG0596|consen 502 DFGIANAIQPDTTSI------------------------------------------------------VKDSQVGTVNY 527 (677)
T ss_pred eechhcccCccccce------------------------------------------------------eeccccCcccc
Confidence 999999886543211 22345899999
Q ss_pred ccchhhcCCCC-----------ChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCC--CCCCC--CHHHHHHH
Q 014344 251 VAPEIIEGKGH-----------DFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRILCRPP--DLVGE--PTPLRNLI 314 (426)
Q Consensus 251 ~aPE~~~~~~~-----------~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~--~~~~~--~~~~~~li 314 (426)
||||.+....+ +.++||||||||||+|++|++||..-. ....+..|..... .++.. ..++.+++
T Consensus 528 MsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~m 607 (677)
T KOG0596|consen 528 MSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVM 607 (677)
T ss_pred cCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHH
Confidence 99999976543 468999999999999999999997543 2233333332111 22222 34489999
Q ss_pred HHHhccCCCCCCChHHHhcCCCcCC
Q 014344 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+.||.+||.+|||+.|+|+|||++.
T Consensus 608 K~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 608 KCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHHHhcCcccCCCcHHHhcCccccc
Confidence 9999999999999999999999975
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=337.57 Aligned_cols=258 Identities=27% Similarity=0.438 Sum_probs=218.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||.|+||+||+|....++..+|+|++..... ......+..|+.+|+.++|+||+++++.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC------------QTSVDELRKEVQAMSQCNHPNVVKYYTSF 68 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc------------chHHHHHHHHHHHHHhcCCCCEEEEEEEE
Confidence 479999999999999999999988999999999843221 12456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
..+...|+||||++|++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++++++.++|+|||+
T Consensus 69 ~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred eeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccch
Confidence 999999999999999999999876533 4689999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+...... ........+|++.|+|||
T Consensus 149 ~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~~Pe 176 (267)
T cd06610 149 SASLADGGDR----------------------------------------------------TRKVRKTFVGTPCWMAPE 176 (267)
T ss_pred HHHhccCccc----------------------------------------------------cccccccccCChhhcChH
Confidence 8776432100 001123446899999999
Q ss_pred hhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-------CCCCHHHHHHHHHHhccCCCCCC
Q 014344 255 IIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-------VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 255 ~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-------~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
++... .++.++|+|||||++|+|++|..||...+....+.++....+.. ...+..+.+||.+||..||++||
T Consensus 177 ~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 256 (267)
T cd06610 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP 256 (267)
T ss_pred HHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCc
Confidence 98876 78999999999999999999999999887776666665443221 13467789999999999999999
Q ss_pred ChHHHhcCCCc
Q 014344 327 GVEEIKGHEFF 337 (426)
Q Consensus 327 s~~eil~hp~f 337 (426)
++.+|+.||||
T Consensus 257 ~~~~ll~~p~~ 267 (267)
T cd06610 257 TAEELLKHKFF 267 (267)
T ss_pred CHHHHhhCCCC
Confidence 99999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=339.62 Aligned_cols=252 Identities=35% Similarity=0.632 Sum_probs=215.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||.|+||.||+|.+..+++.||+|++.+..... ....+.+..|+.++++++||||+++++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 70 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE----------KGSVRNVLNERRILQELNHPFLVNLWYSFQ 70 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc----------hhHHHHHHHHHHHHHhCCCCChHHHHHhhc
Confidence 4899999999999999999999999999999997643221 124567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+..+|+|+||+.|++|..++... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 71 DEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 999999999999999999988764 459999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... ......|+..|+|||.+
T Consensus 149 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~~PE~~ 171 (258)
T cd05578 149 KVTPDT---------------------------------------------------------LTTSTSGTPGYMAPEVL 171 (258)
T ss_pred ccCCCc---------------------------------------------------------cccccCCChhhcCHHHH
Confidence 653211 11223478889999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh-cCCCCCCCCCHHHHHHHHHHhccCCCCCCCh--HH
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRIL-CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGV--EE 330 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~--~e 330 (426)
.+..++.++|+|||||++|+|++|..||...+. ........ ..+......+..+.++|.+||..||.+||++ +|
T Consensus 172 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 251 (258)
T cd05578 172 CRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKD 251 (258)
T ss_pred cccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHH
Confidence 988899999999999999999999999988763 33333332 2233334557889999999999999999999 99
Q ss_pred HhcCCCc
Q 014344 331 IKGHEFF 337 (426)
Q Consensus 331 il~hp~f 337 (426)
+++||||
T Consensus 252 l~~~~~~ 258 (258)
T cd05578 252 LKNHPYF 258 (258)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=335.49 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=214.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+..|+.+++.++||||+++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 68 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS------------SSAVEDSRKEAVLLAKMKHPNIVAFKESFE 68 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc------------hHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 58999999999999999999999999999999843211 123456778999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
++..+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 69 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 69 ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred ECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999999999998876555668999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......|++.|+|||++
T Consensus 149 ~~~~~~--------------------------------------------------------~~~~~~~~~~~~~aPE~~ 172 (255)
T cd08219 149 LLTSPG--------------------------------------------------------AYACTYVGTPYYVPPEIW 172 (255)
T ss_pred eecccc--------------------------------------------------------cccccccCCccccCHHHH
Confidence 553211 011234688999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+||||+++|+|++|..||...+.......+..... .....+..+.+||.+||+.||.+||++.+|+.-
T Consensus 173 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 999999999999999999999999999998887766665543322 223457789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=375.99 Aligned_cols=153 Identities=33% Similarity=0.509 Sum_probs=137.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|+++++||+|+||+||+|.+..+++.||||++.+.... .......+..|+.+++.++||||+++++
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~----------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~ 71 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI----------NKNMVHQVQAERDALALSKSPFIVHLYY 71 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc----------CHHHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence 367899999999999999999999999999999998653321 1223467888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.....+|+||||+.|++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||
T Consensus 72 ~~~~~~~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFG 149 (669)
T cd05610 72 SLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149 (669)
T ss_pred EEEECCEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence 999999999999999999999998754 348999999999999999999999999999999999999999999999999
Q ss_pred ccccC
Q 014344 174 LSTKL 178 (426)
Q Consensus 174 ls~~~ 178 (426)
+++..
T Consensus 150 ls~~~ 154 (669)
T cd05610 150 LSKVT 154 (669)
T ss_pred CCccc
Confidence 99754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=343.10 Aligned_cols=253 Identities=29% Similarity=0.431 Sum_probs=208.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|++|.||+|++..+++.||||++..... .......+..|++++++++||||+++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 69 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-----------TEGVPSTAIREISLLKELNHPNIVKLLDVIH 69 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-----------ccccchHHHHHHHHHHhcCCCCCcchhhhcc
Confidence 48999999999999999999999999999998843221 1123356788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+....++||||+. ++|.+++.......+++..++.++.||+.||+|||+.|++||||+|+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 70 TENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred cCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 9999999999996 688888776555668999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......+++.|+|||++
T Consensus 149 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~ 172 (284)
T cd07860 149 AFGVPV--------------------------------------------------------RTYTHEVVTLWYRAPEIL 172 (284)
T ss_pred hcccCc--------------------------------------------------------cccccccccccccCCeEE
Confidence 543110 011122468889999998
Q ss_pred cCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC---------------------------CCCC
Q 014344 257 EGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------------------DLVG 305 (426)
Q Consensus 257 ~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------------------~~~~ 305 (426)
.+.. ++.++|||||||++|+|++|+.||.+.+......++.. .+. ....
T Consensus 173 ~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (284)
T cd07860 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPP 252 (284)
T ss_pred ecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHccc
Confidence 7644 58899999999999999999999988776554433321 000 0112
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.+..++++|.+||+.||++|||+++++.||||
T Consensus 253 ~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 253 LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 35778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=345.41 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=210.0
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..++|++++.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++|+||+++++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-----------RDGIPISSLREITLLLNLRHPNIVELKE 73 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-----------CCCCcchhhHHHHHHHhCCCCCCcceEE
Confidence 56789999999999999999999999999999999843221 1112234556999999999999999999
Q ss_pred eeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++... +.+|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|
T Consensus 74 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~d 151 (309)
T cd07845 74 VVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIAD 151 (309)
T ss_pred EEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECc
Confidence 98755 57899999996 58888776543 4589999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .......+++.|+
T Consensus 152 fg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ 175 (309)
T cd07845 152 FGLARTYGLPA--------------------------------------------------------KPMTPKVVTLWYR 175 (309)
T ss_pred cceeeecCCcc--------------------------------------------------------CCCCccccccccc
Confidence 99987653211 0011223578899
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------------C-----
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----------------------D----- 302 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------------~----- 302 (426)
|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+..... .
T Consensus 176 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (309)
T cd07845 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNL 255 (309)
T ss_pred ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCch
Confidence 9999876 5578999999999999999999999998888776655432100 0
Q ss_pred ---CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 ---LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 ---~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+.+||.+||+.||++|||+++++.||||++
T Consensus 256 ~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 256 KHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred HHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0113667889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=339.06 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=211.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
.++|++.+.||.|++|.||+|.+..+++.+|+|++.... .....+..|+.+++++ +||||+++++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~~e~~~l~~~~~h~~i~~~~~ 70 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--------------DEEEEIKEEYNILRKYSNHPNIATFYG 70 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--------------hhHHHHHHHHHHHHHhcCCCChheEEE
Confidence 368999999999999999999999999999999985432 1235678899999999 6999999999
Q ss_pred eeecCC------eEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 94 VLSTDK------FVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 94 ~~~~~~------~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
++.... .+|+||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA 150 (275)
T ss_pred EEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC
Confidence 996544 5899999999999999876543 45699999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++....... .......
T Consensus 151 ~~~l~d~~~~~~~~~~~--------------------------------------------------------~~~~~~~ 174 (275)
T cd06608 151 EVKLVDFGVSAQLDSTL--------------------------------------------------------GRRNTFI 174 (275)
T ss_pred eEEECCCccceecccch--------------------------------------------------------hhhcCcc
Confidence 99999999987543211 1122345
Q ss_pred cCCCCccchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~ 316 (426)
|++.|+|||++.+ ..++.++|||||||++|+|++|.+||..........++........ ..+..+.+||.+
T Consensus 175 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (275)
T cd06608 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISE 254 (275)
T ss_pred ccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHH
Confidence 8999999999864 3467899999999999999999999987766666666554433221 245689999999
Q ss_pred HhccCCCCCCChHHHhcCCCc
Q 014344 317 LLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f 337 (426)
||..||++|||+.++++|||+
T Consensus 255 ~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 255 CLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HhhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=335.32 Aligned_cols=251 Identities=28% Similarity=0.480 Sum_probs=213.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||.|+||.||+|.+..+++.+|+|++.... ....+.+..|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 69 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP-------------GDDFEIIQQEISMLKECRHPNIVAYFGSY 69 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc-------------hhhHHHHHHHHHHHHhCCCCChhceEEEE
Confidence 57999999999999999999999999999999985432 12356788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.....+|++|||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 148 (262)
T cd06613 70 LRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148 (262)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccc
Confidence 99999999999999999999876642 35999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... ......+++..|+|||.
T Consensus 149 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~Pe~ 172 (262)
T cd06613 149 AQLTATI--------------------------------------------------------AKRKSFIGTPYWMAPEV 172 (262)
T ss_pred hhhhhhh--------------------------------------------------------hccccccCCccccCchh
Confidence 7653210 11223468889999999
Q ss_pred hcCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CC-C---CCCCCHHHHHHHHHHhccCCCCCC
Q 014344 256 IEGK---GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR--PP-D---LVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 256 ~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~-~---~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
+.+. .++.++|+|||||++|+|++|.+||...+.......+... .+ . ....+..+.+||.+||..+|.+||
T Consensus 173 ~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (262)
T cd06613 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP 252 (262)
T ss_pred hcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCC
Confidence 9877 7889999999999999999999999887766554444322 11 1 112356789999999999999999
Q ss_pred ChHHHhcCCC
Q 014344 327 GVEEIKGHEF 336 (426)
Q Consensus 327 s~~eil~hp~ 336 (426)
|+.+|+.|+|
T Consensus 253 t~~~il~~~~ 262 (262)
T cd06613 253 TATKLLQHPF 262 (262)
T ss_pred CHHHHhcCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=342.38 Aligned_cols=251 Identities=17% Similarity=0.212 Sum_probs=209.5
Q ss_pred CCCCCCCCcEEE--eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 10 IRSLDFSCLRIV--SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 10 ~~~l~~~~y~i~--~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
.+.++.++++.. ..||+|++|.||+|.. +|+.||||++.+... ......+.+.+|+.+|++++|||
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~n 79 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK----------GHKVLIDITENEIKNLRRIDSNN 79 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEecccccc----------ccHHHHHHHHHHHHHHHhcCCCC
Confidence 445666666666 7899999999999986 789999999854321 11123567889999999999999
Q ss_pred cceeeeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeec
Q 014344 88 LPRLRGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQ 162 (426)
Q Consensus 88 iv~l~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~ 162 (426)
|+++++++.+ ...+++|||||+||+|.+++... +.++......++.|++.||.|||+ .+++||||||+|||++
T Consensus 80 Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~ 157 (283)
T PHA02988 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT 157 (283)
T ss_pred EEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC
Confidence 9999999866 45789999999999999998754 358899999999999999999998 5999999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.++.+||+|||++..+... ..
T Consensus 158 ~~~~~kl~dfg~~~~~~~~-----------------------------------------------------------~~ 178 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSP-----------------------------------------------------------PF 178 (283)
T ss_pred CCCcEEEcccchHhhhccc-----------------------------------------------------------cc
Confidence 9999999999998754211 11
Q ss_pred ccccCCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHH
Q 014344 243 SFVGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~ 317 (426)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+... ++.....+..+.+||.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 2358899999999976 67899999999999999999999999998888777776432 222235688999999999
Q ss_pred hccCCCCCCChHHHhc
Q 014344 318 LEKDPTKRIGVEEIKG 333 (426)
Q Consensus 318 L~~dP~~R~s~~eil~ 333 (426)
|+.||++|||++|++.
T Consensus 259 l~~dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCcccCcCHHHHHH
Confidence 9999999999999985
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.90 Aligned_cols=259 Identities=40% Similarity=0.696 Sum_probs=217.9
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||.|+||.||+|++..+++.+|+|++.+..... ......+..|+.+++.++||||+++++.+......|+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 70 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR----------KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYL 70 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh----------hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEE
Confidence 699999999999999999999999986543321 1245678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
+|||+.|++|.+++.... .+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 71 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 71 VMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred EEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 999999999999987654 589999999999999999999999999999999999999999999999999875432110
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
... ...........+++.|+|||.+.+..++.
T Consensus 149 ~~~------------------------------------------------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~ 180 (265)
T cd05579 149 INL------------------------------------------------NDDEKEDKRIVGTPDYIAPEVILGQGHSK 180 (265)
T ss_pred ccc------------------------------------------------ccccccccCcccCccccCHHHhcCCCCCc
Confidence 000 00011223345888999999999888999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC---CCHHHHHHHHHHhccCCCCCCCh---HHHhcCCCc
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVG---EPTPLRNLIRRLLEKDPTKRIGV---EEIKGHEFF 337 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~li~~~L~~dP~~R~s~---~eil~hp~f 337 (426)
++|+|||||++|+|++|..||......+.+..+......... .+..+.+||.+||+.+|.+|||+ .++|+||||
T Consensus 181 ~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 999999999999999999999988888777776643333322 27889999999999999999999 999999999
Q ss_pred CCCCh
Q 014344 338 KGVNW 342 (426)
Q Consensus 338 ~~~~~ 342 (426)
++++|
T Consensus 261 ~~~~~ 265 (265)
T cd05579 261 KGIDW 265 (265)
T ss_pred cCCCC
Confidence 99988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=341.20 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=204.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|++++.||+|++|+||+|.++.+++.||||.+...... .....+.+|+.+++.++||||+++++
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~i~~~~~ 70 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE------------GAPFTAIREASLLKDLKHANIVTLHD 70 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc------------CCchhHHHHHHHHhhCCCcceeeEEE
Confidence 467899999999999999999999999999999998542210 11234567999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.++...|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 71 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 148 (291)
T cd07844 71 IIHTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG 148 (291)
T ss_pred EEecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccc
Confidence 9999999999999997 58988876554 358999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... .......+++.|+||
T Consensus 149 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~aP 172 (291)
T cd07844 149 LARAKSVPS--------------------------------------------------------KTYSNEVVTLWYRPP 172 (291)
T ss_pred cccccCCCC--------------------------------------------------------ccccccccccccCCc
Confidence 986532100 001122468889999
Q ss_pred hhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh---cCC------------------------C---
Q 014344 254 EIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRIL---CRP------------------------P--- 301 (426)
Q Consensus 254 E~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~---~~~------------------------~--- 301 (426)
|++.+ ..++.++||||+||++|+|++|+.||.+.. ..+....+. ..+ .
T Consensus 173 E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd07844 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLI 252 (291)
T ss_pred HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHH
Confidence 99876 458899999999999999999999997665 222222111 000 0
Q ss_pred -CCCCCC--HHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 -DLVGEP--TPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 -~~~~~~--~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
...... ..+.++|.+||+.+|.+|||+.+++.||||
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 253 NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000122 667899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=351.90 Aligned_cols=252 Identities=25% Similarity=0.458 Sum_probs=206.2
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
..+|++++.||+|+||+||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-----------QNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-----------cChhHHHHHHHHHHHHHhcCCCCCcceeee
Confidence 467999999999999999999999999999999984321 112234567789999999999999999999
Q ss_pred eecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
|... ...|+|||||. ++|..++... +++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 84 FTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred eccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEE
Confidence 8644 35799999996 5777766432 88999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... ......||+
T Consensus 159 L~Dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~ 181 (353)
T cd07850 159 ILDFGLARTAGTSF---------------------------------------------------------MMTPYVVTR 181 (353)
T ss_pred EccCccceeCCCCC---------------------------------------------------------CCCCCcccc
Confidence 99999987543110 122345889
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC-------------------CC----
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP-------------------PD---- 302 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~-------------------~~---- 302 (426)
.|+|||.+.+..++.++|||||||++|+|++|+.||...+....+..+.. .+ +.
T Consensus 182 ~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (353)
T cd07850 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGY 261 (353)
T ss_pred cccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCc
Confidence 99999999999999999999999999999999999987765544433321 00 00
Q ss_pred ------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 ------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 ------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+++||.+||+.||++|||+.|+|.||||+.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 262 SFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred chhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0012446789999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=347.60 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=190.9
Q ss_pred EeeecccCceEEEEEEEcC--CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee--
Q 014344 21 VSALGRGAKGVVFLVKDVE--SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS-- 96 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-- 96 (426)
..+||+|+||+||+|++.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 70 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---------------ISMSACREIALLRELKHPNVIALQKVFLSH 70 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---------------CcHHHHHHHHHHHhCCCCCeeeEEEEEecc
Confidence 3689999999999999754 56789999884321 1234667999999999999999999884
Q ss_pred cCCeEEEEEeccCCCChHHHHHHh-------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee----ccCC
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQ-------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----QENG 165 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~-------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl----~~~g 165 (426)
.+..+|+||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 71 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 149 (317)
T cd07867 71 SDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 149 (317)
T ss_pred CCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC
Confidence 4668899999996 5777765422 12348899999999999999999999999999999999999 4667
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+++....... ........+
T Consensus 150 ~~kl~DfG~a~~~~~~~~-----------------------------------------------------~~~~~~~~~ 176 (317)
T cd07867 150 RVKIADMGFARLFNSPLK-----------------------------------------------------PLADLDPVV 176 (317)
T ss_pred cEEEeeccceeccCCCcc-----------------------------------------------------cccccCcce
Confidence 999999999976532110 001123456
Q ss_pred cCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh---cCC------------
Q 014344 246 GTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---------ETFYRIL---CRP------------ 300 (426)
Q Consensus 246 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~---~~~------------ 300 (426)
||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... ....++. ..+
T Consensus 177 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (317)
T cd07867 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMP 256 (317)
T ss_pred ecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 8999999999977 45799999999999999999999999754321 1111100 000
Q ss_pred ------------------------CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 301 ------------------------PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 301 ------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 257 EYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0001123557899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=334.43 Aligned_cols=250 Identities=26% Similarity=0.461 Sum_probs=214.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||+|....+++.||+|.+.... ....+..|+++++.++||||+++++.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------------~~~~~~~e~~~~~~l~~~~i~~~~~~~ 67 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---------------DLQEIIKEISILKQCDSPYIVKYYGSY 67 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---------------HHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence 57999999999999999999999889999999984332 145788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+|+++||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++
T Consensus 68 ~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 68 FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred ecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccc
Confidence 99999999999999999999886543 45899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|+..|+|||+
T Consensus 147 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~PE~ 170 (256)
T cd06612 147 GQLTDTM--------------------------------------------------------AKRNTVIGTPFWMAPEV 170 (256)
T ss_pred hhcccCc--------------------------------------------------------cccccccCCccccCHHH
Confidence 7653211 01223347889999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|||||||++|+|++|+.||...........+....... ...+..+.++|.+||+.||++|||+.++
T Consensus 171 ~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 171 IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred HhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence 999999999999999999999999999998877655544443322211 1235689999999999999999999999
Q ss_pred hcCCCc
Q 014344 332 KGHEFF 337 (426)
Q Consensus 332 l~hp~f 337 (426)
+.||||
T Consensus 251 l~~~~~ 256 (256)
T cd06612 251 LQHPFI 256 (256)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=339.17 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=212.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||++.+..+++.||+|++....... .........+..|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 73 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTS-------SEQEEVVEALRKEIRLMARLNHPHIIRMLGATC 73 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCc-------hhHHHHHHHHHHHHHHHHHcCCCceehhhceec
Confidence 4889999999999999999999999999999985432111 011124568889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL~DFgls 175 (426)
..+..++||||+.|++|.+++.... .+++..+..++.||+.||.|||++|++||||||+||+++.++ .++|+|||++
T Consensus 74 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 74 EDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred cCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 9999999999999999999887543 589999999999999999999999999999999999998776 5999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+...... ........+||..|+|||.
T Consensus 152 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~~PE~ 179 (268)
T cd06630 152 ARLAAKGTG----------------------------------------------------AGEFQGQLLGTIAFMAPEV 179 (268)
T ss_pred ccccccccc----------------------------------------------------CCccccccccccceeCHhH
Confidence 766421100 0011223468999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc---CCCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---YRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+.+..++.++|+||+||++|+|++|..||......... .++.. .+......+..+.++|.+||..+|.+||++.
T Consensus 180 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 259 (268)
T cd06630 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR 259 (268)
T ss_pred hccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHH
Confidence 99888999999999999999999999999755432222 22211 1222224567899999999999999999999
Q ss_pred HHhcCCCcC
Q 014344 330 EIKGHEFFK 338 (426)
Q Consensus 330 eil~hp~f~ 338 (426)
++++||||+
T Consensus 260 ~ll~~~~~~ 268 (268)
T cd06630 260 ELLKHPVFR 268 (268)
T ss_pred HHhcCcccC
Confidence 999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=334.68 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=215.6
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.+...+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++||||++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~ 66 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMKEIKHPNLVQ 66 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--------------hHHHHHHHHHHHHHhCCCCChhh
Confidence 3567788999999999999999999999999999999974321 12356788999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++..+..++++|||+++++|.+++.......+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+
T Consensus 67 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~ 146 (263)
T cd05052 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 146 (263)
T ss_pred eEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeC
Confidence 99999999999999999999999999876555568999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++......... ......+++.|
T Consensus 147 df~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y 171 (263)
T cd05052 147 DFGLSRLMTGDTYT-------------------------------------------------------AHAGAKFPIKW 171 (263)
T ss_pred CCccccccccceee-------------------------------------------------------ccCCCCCcccc
Confidence 99998765321100 00111246679
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.+..+... +......+..+.++|.+||..+|++||+
T Consensus 172 ~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 251 (263)
T cd05052 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPS 251 (263)
T ss_pred CCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCC
Confidence 99999999999999999999999999998 99999988877766665532 2333456789999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
+.++++
T Consensus 252 ~~~l~~ 257 (263)
T cd05052 252 FAEIHQ 257 (263)
T ss_pred HHHHHH
Confidence 999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=336.21 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=209.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
++..+|++.+.||+|+||.||+|... ..+..||+|++.... .......+..|+.+++.++||||+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv 69 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC------------SDKQRRGFLAEALTLGQFDHSNIV 69 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC------------CHHHHHHHHHHHHHHhcCCCCCcC
Confidence 45678999999999999999999865 345689999984321 112345688899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++...+..|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+++
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l 148 (266)
T cd05064 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKI 148 (266)
T ss_pred eEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEE
Confidence 99999999999999999999999999887543 35899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||.+....... ........++..
T Consensus 149 ~dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 173 (266)
T cd05064 149 SGFRRLQEDKSEA-------------------------------------------------------IYTTMSGKSPVL 173 (266)
T ss_pred CCCcccccccccc-------------------------------------------------------hhcccCCCCcee
Confidence 9999765432100 000112235678
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++||++ +|..||...+..+....+... .+.....+..+.+++.+||+.+|.+||
T Consensus 174 y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP 253 (266)
T cd05064 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERP 253 (266)
T ss_pred ecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999999999999999999999977 599999988877666655432 233445678899999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
++++|++
T Consensus 254 ~~~~i~~ 260 (266)
T cd05064 254 RFSQIHS 260 (266)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=340.02 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=210.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++++ +|||++++++
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--------------~~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--------------DVDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--------------cHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 577999999999999999999999999999999984321 1224566789999998 7999999999
Q ss_pred eeecC-----CeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 94 VLSTD-----KFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 94 ~~~~~-----~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
++... ...|+||||++|++|.++++.. ....+++..++.++.|++.||+|||+.|++||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 98643 4689999999999999987642 2346899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++....... .......|
T Consensus 167 ~kl~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~ 190 (291)
T cd06639 167 VKLVDFGVSAQLTSTR--------------------------------------------------------LRRNTSVG 190 (291)
T ss_pred EEEeecccchhccccc--------------------------------------------------------ccccCccC
Confidence 9999999987653211 01122358
Q ss_pred CCCCccchhhcCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHH
Q 014344 247 TEEYVAPEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRL 317 (426)
Q Consensus 247 t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~ 317 (426)
++.|+|||++... .++.++|+|||||++|+|++|++||...........+....+. ....+..+.+||.+|
T Consensus 191 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 270 (291)
T cd06639 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQC 270 (291)
T ss_pred CccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHH
Confidence 8999999998653 3678999999999999999999999887776665555433222 223456799999999
Q ss_pred hccCCCCCCChHHHhcCCCcC
Q 014344 318 LEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 318 L~~dP~~R~s~~eil~hp~f~ 338 (426)
|+.+|++||++.+|++||||+
T Consensus 271 l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 271 LIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred hhcChhhCcCHHHHhcCcccC
Confidence 999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=336.39 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=210.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++.+.||+|+||.||+|.+..++..||+|++....... ........+..|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 73 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP--------ETSKEVSALECEIQLLKNLQHERIVQYYGCL 73 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc--------hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEE
Confidence 46999999999999999999999999999999885432111 1122456788899999999999999999998
Q ss_pred ec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 96 ST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 96 ~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.. ...+++++||+++++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 74 RDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCC
Confidence 65 467899999999999999886543 48999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+...... ........++..|+||
T Consensus 152 ~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~aP 178 (266)
T cd06651 152 ASKRLQTICMS-----------------------------------------------------GTGIRSVTGTPYWMSP 178 (266)
T ss_pred Ccccccccccc-----------------------------------------------------CCccccCCccccccCH
Confidence 98765321100 0011223488899999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CC-CCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PD-LVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~-~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+||+||++|+|++|+.||...........+.... +. ....+..+++|| +||..+|++||+++|
T Consensus 179 E~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 99999889999999999999999999999998876665555443322 22 123467788898 566689999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
|+.||||+
T Consensus 258 il~hp~~~ 265 (266)
T cd06651 258 LLRHPFAQ 265 (266)
T ss_pred HhcCcccc
Confidence 99999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=340.39 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=214.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCC-----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESS-----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+.+++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~------------~~~~~~~~~~ei~~l~~l~h~~ 69 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA------------EPKVQQEFRQEAELMSDLQHPN 69 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC------------CHHHHHHHHHHHHHHHhcCCcc
Confidence 46678999999999999999999986554 679999874321 1233456888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------------QMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------------~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
|+++++++......|++|||+++++|.+++..... ..++...+..++.||+.||.|||++|++|||
T Consensus 70 i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~d 149 (283)
T cd05048 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRD 149 (283)
T ss_pred cceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999999999999999999999999998875422 4588899999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+||+++.++.++|+|||++........
T Consensus 150 lkp~Nil~~~~~~~~L~dfg~~~~~~~~~~-------------------------------------------------- 179 (283)
T cd05048 150 LAARNCLVGEGLTVKISDFGLSRDIYSADY-------------------------------------------------- 179 (283)
T ss_pred cccceEEEcCCCcEEECCCcceeecccccc--------------------------------------------------
Confidence 999999999999999999999875532110
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 310 (426)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+....+.... +.....+..+
T Consensus 180 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 255 (283)
T cd05048 180 ----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARV 255 (283)
T ss_pred ----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence 011223357889999999998889999999999999999997 999999988877766665432 2234568899
Q ss_pred HHHHHHHhccCCCCCCChHHHhcC
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+|+.+||+.||.+||++.+|+++
T Consensus 256 ~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 256 YALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=325.09 Aligned_cols=258 Identities=27% Similarity=0.441 Sum_probs=218.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcc
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLP 89 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv 89 (426)
...++++.+++..||+|+.|+||+++.+.+|...|||.+.+. .+.+..+++...++++.+.. +|+||
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt------------~Nkee~kRILmDldvv~~s~dcpyIV 154 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT------------GNKEENKRILMDLDVVLKSHDCPYIV 154 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc------------CCHHHHHHHHHhhhHHhhccCCCeee
Confidence 456778899999999999999999999999999999999553 23345678888888887765 89999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++|+|..+..+++.||.|. .-+..++++. .++++|..+-++...++.||.||-+ +||||||+||.|||+|..|.||
T Consensus 155 ~c~GyFi~n~dV~IcMelMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniK 232 (391)
T KOG0983|consen 155 QCFGYFITNTDVFICMELMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIK 232 (391)
T ss_pred eeeeEEeeCchHHHHHHHHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEE
Confidence 99999999999999999983 4455555544 4669999999999999999999986 6999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|||||.+..+..+.. .+...|.+
T Consensus 233 lCDFGIsGrlvdSkA---------------------------------------------------------htrsAGC~ 255 (391)
T KOG0983|consen 233 LCDFGISGRLVDSKA---------------------------------------------------------HTRSAGCA 255 (391)
T ss_pred eecccccceeecccc---------------------------------------------------------cccccCCc
Confidence 999999988753210 11124899
Q ss_pred CCccchhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCC----CCCHHHHHHHHHHhcc
Q 014344 249 EYVAPEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILCRPPDLV----GEPTPLRNLIRRLLEK 320 (426)
Q Consensus 249 ~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~L~~ 320 (426)
.|||||.+.- ..|+-++||||||++++||.||++||.+. ..-+++.+++...|..+ +.++.+.+|+..||++
T Consensus 256 ~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~k 335 (391)
T KOG0983|consen 256 AYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTK 335 (391)
T ss_pred cccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhc
Confidence 9999999864 46899999999999999999999999985 45677778876655433 4588999999999999
Q ss_pred CCCCCCChHHHhcCCCcCC
Q 014344 321 DPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~~ 339 (426)
|+.+||...++|+|||+..
T Consensus 336 d~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 336 DHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred CcccCcchHHHhcCcceee
Confidence 9999999999999999864
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=342.48 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=209.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+... .....+.+..|+++++.++||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 69 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED-----------DKMVKKIAMREIRMLKQLRHENLVNLIEVF 69 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC-----------cchhhHHHHHHHHHHHhcCCcchhhHHHhc
Confidence 469999999999999999999999999999998743221 112345677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+...|+||||+++++|..+.... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 70 RRKKRLYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred ccCCeEEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9999999999999999988775543 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......++..|+|||+
T Consensus 148 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 171 (286)
T cd07846 148 RTLAAPG--------------------------------------------------------EVYTDYVATRWYRAPEL 171 (286)
T ss_pred eeccCCc--------------------------------------------------------cccCcccceeeccCcHH
Confidence 7653211 11223458889999999
Q ss_pred hcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------------CC
Q 014344 256 IEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--------------------------------PD 302 (426)
Q Consensus 256 ~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------------------------------~~ 302 (426)
+.+ ..++.++|||||||++|+|++|++||...+..+.+.++.... ..
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (286)
T cd07846 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR 251 (286)
T ss_pred hccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHh
Confidence 876 446889999999999999999999998776554433332100 00
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+.+..+.+||.+||..+|++||++.+++.||||
T Consensus 252 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred CCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 12446779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=342.53 Aligned_cols=254 Identities=24% Similarity=0.437 Sum_probs=211.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++||||+++++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL------------DESKFNQIIMELDILHKAVSPYIVDFYGAF 68 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc------------CHHHHHHHHHHHHHHHhcCCCcHHhhhhhe
Confidence 46999999999999999999999999999999884321 122346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
..++.+|+|||||+|++|..++.... ...+++..++.++.||+.||.|||+ .||+||||||+||+++.++.++|+|||
T Consensus 69 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg 148 (286)
T cd06622 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFG 148 (286)
T ss_pred ecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999999999998876531 2358999999999999999999997 599999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+... ......|++.|+||
T Consensus 149 ~~~~~~~~----------------------------------------------------------~~~~~~~~~~y~aP 170 (286)
T cd06622 149 VSGNLVAS----------------------------------------------------------LAKTNIGCQSYMAP 170 (286)
T ss_pred CcccccCC----------------------------------------------------------ccccCCCccCccCc
Confidence 98754211 11223588899999
Q ss_pred hhhcCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhcCC--CCCCCCCHHHHHHHHHHhccCC
Q 014344 254 EIIEGKG------HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR---ILCRP--PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 254 E~~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~--~~~~~~~~~~~~li~~~L~~dP 322 (426)
|.+.+.. ++.++|+|||||++|+|++|+.||........+.. +.... ......+..+.+||.+||+.+|
T Consensus 171 E~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (286)
T cd06622 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP 250 (286)
T ss_pred chhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCc
Confidence 9986543 47899999999999999999999987655443332 22221 2223467889999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
++||++++++.||||..
T Consensus 251 ~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 251 NRRPTYAQLLEHPWLVK 267 (286)
T ss_pred ccCCCHHHHhcChhhhh
Confidence 99999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.41 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=204.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC----------------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHH
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE----------------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 76 (426)
+..++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E 69 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA------------NKNARNDFLKE 69 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC------------CHHHHHHHHHH
Confidence 455789999999999999999998632 34479999984421 11234568889
Q ss_pred HHHHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-----------------CCCCHHHHHHHHHHHHH
Q 014344 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-----------------QMFSDDTIRFYAAELVL 139 (426)
Q Consensus 77 ~~il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-----------------~~l~~~~~~~~~~qil~ 139 (426)
+.+|.+++||||+++++++.+....|+||||+.+++|.+++..... ..++...+..++.||+.
T Consensus 70 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 149 (304)
T cd05096 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIAS 149 (304)
T ss_pred HHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999998764321 23677889999999999
Q ss_pred HHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCC
Q 014344 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDP 219 (426)
Q Consensus 140 aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (426)
||.|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 150 al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~------------------------------------ 193 (304)
T cd05096 150 GMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY------------------------------------ 193 (304)
T ss_pred HHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCce------------------------------------
Confidence 99999999999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHh
Q 014344 220 VHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY--GATPFRGSSRKETFYRIL 297 (426)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~i~ 297 (426)
........+++.|+|||++.+..++.++|||||||++|+|++ +..||...+..+....+.
T Consensus 194 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 255 (304)
T cd05096 194 ------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAG 255 (304)
T ss_pred ------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHH
Confidence 001122346788999999998889999999999999999986 678888776655443321
Q ss_pred c---------CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 298 C---------RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 298 ~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
. ........+..+.+||.+||+.||++|||+.+|.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 256 EFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 0 11122345788999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=359.71 Aligned_cols=249 Identities=27% Similarity=0.500 Sum_probs=212.5
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
-+||+|.||+||.|+|..|....|||.+.- ......+-+..|+.+.+.|.|.|||+++|.+..++++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe-------------kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~ 647 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE-------------KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFF 647 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc-------------ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeE
Confidence 479999999999999999999999998722 1223456678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCCcEEEecccccccC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMF--SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENGHIMLVDFDLSTKL 178 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l--~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g~ikL~DFgls~~~ 178 (426)
-|.||-++||+|.++++... +++ .+.++-+|.+||+.||+|||++.|||||||-+|+|++ -.|.+||+|||-++++
T Consensus 648 kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 648 KIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred EEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh
Confidence 99999999999999988765 346 8899999999999999999999999999999999997 5799999999999887
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
..-+ -.+.+|.||..|||||++..
T Consensus 727 Agin--------------------------------------------------------P~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 727 AGIN--------------------------------------------------------PCTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred ccCC--------------------------------------------------------ccccccccchhhhChHhhcc
Confidence 4322 13457789999999999975
Q ss_pred --CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-h--cCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 259 --KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRI-L--CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 259 --~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i-~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+|+.++|||||||++.||.||++||-..... ....++ + ..|+.+...+.++++||.+|+.+||.+||+|.++|
T Consensus 751 G~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 751 GPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred CCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhc
Confidence 56899999999999999999999999765433 333332 2 23444445578899999999999999999999999
Q ss_pred cCCCcCCC
Q 014344 333 GHEFFKGV 340 (426)
Q Consensus 333 ~hp~f~~~ 340 (426)
..||++..
T Consensus 831 ~DpFlq~~ 838 (1226)
T KOG4279|consen 831 QDPFLQHN 838 (1226)
T ss_pred cCcccccC
Confidence 99999864
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=333.58 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=212.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||++.+..+++.||||++...... .........+..|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 73 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPES--------PETSKEVNALECEIQLLKNLLHERIVQYYGCL 73 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCC--------cccHHHHHHHHHHHHHHHhcCCCCeeeEEeEe
Confidence 5799999999999999999999999999999988432110 01122456788899999999999999999998
Q ss_pred ec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 96 ST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 96 ~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.+ ...++++|||++|++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 74 RDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred ccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCc
Confidence 76 35788999999999999987654 348899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++........ .........|+..|+||
T Consensus 152 ~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y~aP 178 (265)
T cd06652 152 ASKRLQTICL-----------------------------------------------------SGTGMKSVTGTPYWMSP 178 (265)
T ss_pred cccccccccc-----------------------------------------------------cccccccCCCCccccCh
Confidence 9876532100 00011234588999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|++.+..++.++|+|||||++|+|++|+.||..........++...+. .....+..+.++|++||. +|++||++++
T Consensus 179 E~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred hhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 999988899999999999999999999999988766665555543322 122345678899999994 9999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
+++|||+.
T Consensus 258 il~~~~~~ 265 (265)
T cd06652 258 LLRHTFVH 265 (265)
T ss_pred HhcCcccC
Confidence 99999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=338.89 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=207.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
..++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||++++
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--------------~~~~~~~~e~~~l~~l~~h~~i~~~~ 81 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--------------DIDEEIEAEYNILKALSDHPNVVKFY 81 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--------------chHHHHHHHHHHHHHHhcCCCeeeee
Confidence 4578999999999999999999999999999999874321 1124567799999999 699999999
Q ss_pred eeee-----cCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 93 GVLS-----TDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 93 ~~~~-----~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
+++. .+...|+||||++|++|.+++... ....+++..++.++.|++.||.|||+++|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC
Confidence 9873 456799999999999999887532 234588999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++..+.... .......
T Consensus 162 ~~kl~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~ 185 (286)
T cd06638 162 GVKLVDFGVSAQLTSTR--------------------------------------------------------LRRNTSV 185 (286)
T ss_pred CEEEccCCceeecccCC--------------------------------------------------------Ccccccc
Confidence 99999999987653210 0112335
Q ss_pred cCCCCccchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~ 316 (426)
|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...........+...... ....+..+.+||.+
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 265 (286)
T cd06638 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRK 265 (286)
T ss_pred CCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHH
Confidence 8999999999853 44788999999999999999999999887665544443322211 11235679999999
Q ss_pred HhccCCCCCCChHHHhcCCCc
Q 014344 317 LLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f 337 (426)
||+.||++|||+.||++|+||
T Consensus 266 ~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 266 CLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HccCCcccCCCHHHHhhcccC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=339.72 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=206.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~ 94 (426)
++|++.+.||.|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. ||||++++++
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~ 69 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-----------EEGIPPTALREISLLQMLSESIYIVRLLDV 69 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-----------ccCCchHHHHHHHHHHHccCCCCccceeee
Confidence 469999999999999999999999999999998744311 1123356777999999996 6999999999
Q ss_pred eecCCe-----EEEEEeccCCCChHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CC
Q 014344 95 LSTDKF-----VGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NG 165 (426)
Q Consensus 95 ~~~~~~-----~~lV~Ey~~gg~L~~l~~~~~---~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g 165 (426)
+..... .|+||||+++ +|..++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 70 EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred EeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC
Confidence 977665 8999999985 7888766443 235899999999999999999999999999999999999998 88
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++..+.... .......
T Consensus 149 ~~kl~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~ 172 (295)
T cd07837 149 LLKIADLGLGRAFSIPV--------------------------------------------------------KSYTHEI 172 (295)
T ss_pred eEEEeecccceecCCCc--------------------------------------------------------cccCCcc
Confidence 99999999987553110 0111224
Q ss_pred cCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC--------------------
Q 014344 246 GTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP-------------------- 301 (426)
Q Consensus 246 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~-------------------- 301 (426)
+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+.+.++... +.
T Consensus 173 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T cd07837 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWK 252 (295)
T ss_pred cccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCccc
Confidence 7888999998865 45789999999999999999999999987766555443211 00
Q ss_pred ------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 302 ------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 302 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
.....+..+.+||.+||.+||.+||+++|++.||||+
T Consensus 253 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 253 PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0123567799999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=341.55 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=211.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|+||.||+|.+..+++.||||.+........ .......+..|+.+++.++|+||+++++++.
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~--------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEA--------KDGINFTALREIKLLQELKHPNIIGLLDVFG 72 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccc--------cchhhHHHHHHHHHHhhcCCCCChhhhheee
Confidence 48999999999999999999999999999999865432210 1123356677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+...+|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 73 HKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred cCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence 999999999999 899999987543 359999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... .......+++.|+|||.+
T Consensus 151 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 151 SFGSPN--------------------------------------------------------RKMTHQVVTRWYRAPELL 174 (298)
T ss_pred eccCCC--------------------------------------------------------ccccccccceeeeCHHHH
Confidence 653211 011122467889999998
Q ss_pred cC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------------------CCCCC
Q 014344 257 EG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----------------------------DLVGE 306 (426)
Q Consensus 257 ~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------------------~~~~~ 306 (426)
.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+.++..... .....
T Consensus 175 ~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (298)
T cd07841 175 FGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAA 254 (298)
T ss_pred hCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccc
Confidence 65 4578999999999999999999999988776554444321100 01123
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+..+.+||.+||.+||++|||+.|++.||||++
T Consensus 255 ~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 255 SDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 567889999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=339.92 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=210.3
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++.+.||.|++|+||+|.+..+++.||+|.+..... .......+..|+.+++.++||||++++++
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 69 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-----------DEGVPSTAIREISLLKEMQHGNIVRLQDV 69 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-----------cccchHHHHHHHHHHHhccCCCEeeEEEE
Confidence 4679999999999999999999999999999998743211 11234567789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEEeccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIMLVDFD 173 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL~DFg 173 (426)
+......|+||||+. ++|..++.......+++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||
T Consensus 70 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 70 VHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence 999999999999996 57877766554445788999999999999999999999999999999999985 5679999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... .......|++.|+||
T Consensus 149 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~P 172 (294)
T PLN00009 149 LARAFGIPV--------------------------------------------------------RTFTHEVVTLWYRAP 172 (294)
T ss_pred cccccCCCc--------------------------------------------------------cccccCceeecccCH
Confidence 987543110 011223578899999
Q ss_pred hhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC---------------------------C
Q 014344 254 EIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------------------D 302 (426)
Q Consensus 254 E~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------------------~ 302 (426)
|++.+. .++.++||||+||++|+|++|++||...+..+...++.. .+. .
T Consensus 173 E~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (294)
T PLN00009 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATV 252 (294)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHh
Confidence 998764 578999999999999999999999988776655544321 100 0
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
....+..+.++|.+||..+|++||++.+++.||||.++
T Consensus 253 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 253 VPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred CcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 12346778999999999999999999999999999764
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=369.04 Aligned_cols=260 Identities=22% Similarity=0.352 Sum_probs=208.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
+.-.+++|.+.|.+|||+.||+|++...+..||+|.+.. .+...++.+.+|+++|++|+ |+|||.+
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~-------------~de~~L~~v~~EI~~MK~L~gh~nIV~y 100 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV-------------NDEEALNAVKREIDIMKLLSGHKNIVSY 100 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec-------------CCHHHHHHHHHHHHHHHHhcCCCceeeE
Confidence 334568999999999999999999998889999998832 23456788999999999998 9999999
Q ss_pred eeeee------c-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeec
Q 014344 92 RGVLS------T-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQ 162 (426)
Q Consensus 92 ~~~~~------~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~ 162 (426)
++... . .-.++|.||||.||.|-+++..+....|++.++..|+.|++.|+.+||... |||||||-|||||.
T Consensus 101 idss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls 180 (738)
T KOG1989|consen 101 IDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS 180 (738)
T ss_pred eccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc
Confidence 99431 1 135789999999999999988665556999999999999999999999987 99999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.+|+.||||||.++...............+ ..-
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve-----------------------------------------------~eI 213 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVE-----------------------------------------------EEI 213 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHH-----------------------------------------------HHH
Confidence 999999999999886543221111100011 111
Q ss_pred ccccCCCCccchhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhc
Q 014344 243 SFVGTEEYVAPEII---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 243 ~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~ 319 (426)
....|+.|+|||++ .+.+.+.++|||||||+||.||+...||.......++.-. +..|.....+..+++||+.||+
T Consensus 214 ~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~-Y~~P~~p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 214 EKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN-YSFPPFPNYSDRLKDLIRTMLQ 292 (738)
T ss_pred HhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc-ccCCCCccHHHHHHHHHHHHhc
Confidence 22369999999986 5788899999999999999999999999887544322221 3334445678889999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
.||.+||++-+++.
T Consensus 293 ~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 293 PNPDERPNIYQVLE 306 (738)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999988864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=338.03 Aligned_cols=266 Identities=41% Similarity=0.724 Sum_probs=216.9
Q ss_pred CcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
+|++.+.||.|+||.||+|++. .+|+.||+|++........ ....+.+..|+.+++.+ +|++|+.++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~~i~~~~ 71 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK---------AKTTEHTRTERQVLEHIRQSPFLVTLH 71 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc---------chHHHHHHHHHHHHHhcccCCChhcee
Confidence 4899999999999999999985 4789999999865433211 12345677899999999 589999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|..+..+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 72 YAFQTDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred eEeecCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999999999999987754 34899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... ........|+..|+|
T Consensus 150 g~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~a 174 (290)
T cd05613 150 GLSKEFHEDE-------------------------------------------------------VERAYSFCGTIEYMA 174 (290)
T ss_pred ccceeccccc-------------------------------------------------------ccccccccCCcccCC
Confidence 9987643211 011223468899999
Q ss_pred chhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC-CCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 253 PEIIEGK--GHDFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCR-PPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 253 PE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~-~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
||.+.+. .++.++|||||||++|+|++|..||..... .+....+... ++.....+..+.+++.+||+.||++|
T Consensus 175 PE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 254 (290)
T cd05613 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254 (290)
T ss_pred hhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHh
Confidence 9998753 467899999999999999999999975332 2333333322 22333457889999999999999999
Q ss_pred C-----ChHHHhcCCCcCCCChhhhhhc
Q 014344 326 I-----GVEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 326 ~-----s~~eil~hp~f~~~~~~~~~~~ 348 (426)
+ ++++++.||||+..+|+.+...
T Consensus 255 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 255 LGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred cCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 7 7999999999999999887443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=340.36 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=214.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
|+.++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.++||||++++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~ 69 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA------------KSSVRKQILRELQIMHECRSPYIVSFY 69 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC------------cchHHHHHHHHHHHHHHcCCCCcceEe
Confidence 56788999999999999999999999999999999984321 122346788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEec
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+.+.....+|+||||+++++|..++... +.+++..++.++.|++.||.|||+ .|++||||||+||+++.++.++|+|
T Consensus 70 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 70 GAFLNENNICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred eeEecCCEEEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEcc
Confidence 9999999999999999999999887653 358999999999999999999997 6999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++...... .....+||..|+
T Consensus 148 ~gl~~~~~~~----------------------------------------------------------~~~~~~~~~~~~ 169 (284)
T cd06620 148 FGVSGELINS----------------------------------------------------------IADTFVGTSTYM 169 (284)
T ss_pred CCcccchhhh----------------------------------------------------------ccCccccCcccC
Confidence 9987654210 112346899999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhcCC-CCC--CCCCHHHHHHHHHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-----------ETFYRILCRP-PDL--VGEPTPLRNLIRRL 317 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----------~~~~~i~~~~-~~~--~~~~~~~~~li~~~ 317 (426)
|||++.+..++.++|+|||||++|+|++|+.||...... +....+.... +.. ...+..+.+||.+|
T Consensus 170 aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 249 (284)
T cd06620 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDAC 249 (284)
T ss_pred CHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHH
Confidence 999998888999999999999999999999999865542 2233333222 111 12567899999999
Q ss_pred hccCCCCCCChHHHhcCCCcCC
Q 014344 318 LEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 318 L~~dP~~R~s~~eil~hp~f~~ 339 (426)
|..||.+|||++|+++||||..
T Consensus 250 l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 250 LLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hcCCcccCcCHHHHhcCccccc
Confidence 9999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=331.86 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=214.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|+||.||+|.+..+++.||+|++...... .....++..|+.+++.++||||+++++.+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-----------EKEKQQLVSEVNILRELKHPNIVRYYDRII 69 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-----------HHHHHHHHHHHHHHHhcCCCccceeeeeee
Confidence 589999999999999999999999999999998543221 123457788999999999999999999775
Q ss_pred --cCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccCCCCCCeeeccCCcE
Q 014344 97 --TDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLH-----NMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 97 --~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH-----~~giiHrDlKp~NiLl~~~g~i 167 (426)
....+|++|||+++++|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+
T Consensus 70 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~ 149 (265)
T cd08217 70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149 (265)
T ss_pred cCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE
Confidence 345789999999999999987653 2346899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++....... .......|+
T Consensus 150 kl~d~g~~~~~~~~~--------------------------------------------------------~~~~~~~~~ 173 (265)
T cd08217 150 KLGDFGLAKILGHDS--------------------------------------------------------SFAKTYVGT 173 (265)
T ss_pred EEecccccccccCCc--------------------------------------------------------ccccccccC
Confidence 999999987653211 012234589
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+..... .....+..+.+++.+||..+|.+|
T Consensus 174 ~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred CCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccC
Confidence 999999999998899999999999999999999999998876655555543322 223457889999999999999999
Q ss_pred CChHHHhcCCCc
Q 014344 326 IGVEEIKGHEFF 337 (426)
Q Consensus 326 ~s~~eil~hp~f 337 (426)
|++++|++|||+
T Consensus 254 p~~~~il~~~~~ 265 (265)
T cd08217 254 PSTEELLQLPLI 265 (265)
T ss_pred CCHHHHhhCCCC
Confidence 999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=354.34 Aligned_cols=257 Identities=19% Similarity=0.305 Sum_probs=207.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCC-----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESS-----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
+.+..++|++++.||+|+||.||+|++..++ ..||+|++.... .......+.+|+.+++.+ +
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~il~~l~~ 100 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA------------HTDEREALMSELKILSHLGQ 100 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC------------CHHHHHHHHHHHHHHHhhcc
Confidence 4566778999999999999999999975443 579999984331 112345678899999999 8
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-------------------------------------------
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS------------------------------------------- 121 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~------------------------------------------- 121 (426)
||||+++++++.....+|+|||||++|+|.+++....
T Consensus 101 h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (374)
T cd05106 101 HKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT 180 (374)
T ss_pred CCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence 9999999999999999999999999999999875432
Q ss_pred -------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 122 -------------------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 122 -------------------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
...++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~ 260 (374)
T cd05106 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260 (374)
T ss_pred ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeee
Confidence 1247888999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+..... ........+++.|||||++
T Consensus 261 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 261 DIMNDSN------------------------------------------------------YVVKGNARLPVKWMAPESI 286 (374)
T ss_pred eccCCcc------------------------------------------------------eeeccCCCCccceeCHHHh
Confidence 6532110 0011122356789999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+..++.++|||||||++|+|++ |+.||........+...... +......+.++.++|.+||+.||.+|||+.+|+
T Consensus 287 ~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 287 FDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQIS 366 (374)
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 98899999999999999999997 99999876654444443322 122223478899999999999999999999997
Q ss_pred c
Q 014344 333 G 333 (426)
Q Consensus 333 ~ 333 (426)
+
T Consensus 367 ~ 367 (374)
T cd05106 367 Q 367 (374)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=335.41 Aligned_cols=243 Identities=27% Similarity=0.429 Sum_probs=199.9
Q ss_pred CCcEEEeee--cccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 16 SCLRIVSAL--GRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 16 ~~y~i~~~L--G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
++|++.+.+ |+|+||.||+++++.+++.+|+|++.+..... . |+.+...+ +||||++++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----------------~--e~~~~~~~~~h~~iv~~~ 75 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----------------I--EPMVHQLMKDNPNFIKLY 75 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----------------h--hHHHHHHhhcCCCEEEEE
Confidence 457777776 99999999999999999999999985432110 0 22223222 699999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEEec
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIMLVD 171 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL~D 171 (426)
+.|...+.+|+||||++|++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 76 YSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred EEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999999987653 599999999999999999999999999999999999999998 999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..... .....|++.|+
T Consensus 154 fg~~~~~~~------------------------------------------------------------~~~~~~~~~y~ 173 (267)
T PHA03390 154 YGLCKIIGT------------------------------------------------------------PSCYDGTLDYF 173 (267)
T ss_pred CccceecCC------------------------------------------------------------CccCCCCCccc
Confidence 998865421 11224788999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCC-CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRP-PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|+||+||++|+|++|..||........ +....... +.....++.+.+||.+||+.+|.+|+
T Consensus 174 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (267)
T PHA03390 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRL 253 (267)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCC
Confidence 99999999999999999999999999999999986543321 22222222 22335688999999999999999999
Q ss_pred C-hHHHhcCCCcC
Q 014344 327 G-VEEIKGHEFFK 338 (426)
Q Consensus 327 s-~~eil~hp~f~ 338 (426)
+ +++||+||||+
T Consensus 254 ~~~~~~l~h~~~~ 266 (267)
T PHA03390 254 TNYNEIIKHPFLK 266 (267)
T ss_pred chHHHHhcCCccc
Confidence 6 69999999996
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=330.61 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=215.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|+||.||++.++.++..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~ 69 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-----------KEKEASKKEVILLAKMKHPNIVTFFASFQ 69 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-----------hhhHHHHHHHHHHHhCCCCChhhhhheec
Confidence 5899999999999999999999999999999985543211 12346678999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc-EEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH-IMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~-ikL~DFgls 175 (426)
.....|+|+||+++++|.+++.......+++..+..++.|++.||.|||+.+++||||||+||+++.++. ++|+|||.+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 70 ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred cCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 9999999999999999999887655556899999999999999999999999999999999999998864 699999988
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||.
T Consensus 150 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~ape~ 173 (257)
T cd08225 150 RQLNDSM--------------------------------------------------------ELAYTCVGTPYYLSPEI 173 (257)
T ss_pred hhccCCc--------------------------------------------------------ccccccCCCccccCHHH
Confidence 7653211 01122358899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+..++.++|+|||||++|+|++|..||...+..+....+.... +.....+..+.++|.+||..+|++|||+.++++
T Consensus 174 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 174 CQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 988889999999999999999999999999887776666554332 222345778999999999999999999999999
Q ss_pred CCCc
Q 014344 334 HEFF 337 (426)
Q Consensus 334 hp~f 337 (426)
||||
T Consensus 254 ~~~~ 257 (257)
T cd08225 254 RPFL 257 (257)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.89 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=202.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++|+||++++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 71 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE------------EGVPFTAIREASLLKGLKHANIVLLHDI 71 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc------------CCCcHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3679999999999999999999999999999999843311 1112355679999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+..+...|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus 72 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 72 IHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred EecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccc
Confidence 999999999999996 67776654433 3478899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......++++.|+|||
T Consensus 150 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 173 (291)
T cd07870 150 ARAKSIPS--------------------------------------------------------QTYSSEVVTLWYRPPD 173 (291)
T ss_pred ccccCCCC--------------------------------------------------------CCCCCccccccccCCc
Confidence 86532110 0112235788999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc---CC-----------C-----------------
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILC---RP-----------P----------------- 301 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~---~~-----------~----------------- 301 (426)
++.+ ..++.++|+|||||++|+|++|..||.+.+.. +.+..+.. .+ +
T Consensus 174 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd07870 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRV 253 (291)
T ss_pred eeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhh
Confidence 9876 45788999999999999999999999865532 22222110 00 0
Q ss_pred --CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 --DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 --~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.....+..+.+||.+||..||++|||+++++.||||
T Consensus 254 ~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 254 VWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 001225678899999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.37 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=205.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|.+..+++.||||++.... ......++..|+.+++.++||||+++++++
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 72 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE------------HQTFCQRTLREIKILRRFKHENIIGILDII 72 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc------------cchhHHHHHHHHHHHHhCCCCCcCchhhee
Confidence 57999999999999999999999999999999984211 112345677899999999999999999887
Q ss_pred ecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 STD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 ~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
... ..+|+|+||+. ++|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 73 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 73 RPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred ecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEC
Confidence 544 35899999996 578776643 359999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........ ........+||+.|
T Consensus 149 dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y 175 (336)
T cd07849 149 DFGLARIADPEHD-----------------------------------------------------HTGFLTEYVATRWY 175 (336)
T ss_pred cccceeecccccc-----------------------------------------------------ccCCcCCcCcCCCc
Confidence 9999876532110 00012234689999
Q ss_pred ccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCC-----------------------C--
Q 014344 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRP-----------------------P-- 301 (426)
Q Consensus 251 ~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~-----------------------~-- 301 (426)
+|||.+.+ ..++.++||||+||++|+|++|++||.+.+.......+. ..+ +
T Consensus 176 ~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T cd07849 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKV 255 (336)
T ss_pred cChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcc
Confidence 99998765 568899999999999999999999998766543332221 000 0
Q ss_pred ----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+.+||.+||+.+|++|||+.+++.||||+..
T Consensus 256 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 256 PWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred cHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 012346678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=352.65 Aligned_cols=257 Identities=20% Similarity=0.319 Sum_probs=206.8
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEE-----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EH 85 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 85 (426)
.+..++|++.+.||+|+||+||+|.+ ..++..||+|++.... .......+.+|+.+|+.+ +|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~------------~~~~~~~~~~Ei~il~~l~~H 98 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA------------HLTEREALMSELKVLSYLGNH 98 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc------------CcHHHHHHHHHHHHHHHhcCC
Confidence 34456899999999999999999974 3456789999984321 112345678899999999 79
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------------------------------------
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-------------------------------------------- 121 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-------------------------------------------- 121 (426)
|||+++++++......|+|||||+||+|.+++....
T Consensus 99 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 178 (375)
T cd05104 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYV 178 (375)
T ss_pred cceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccc
Confidence 999999999999999999999999999999876432
Q ss_pred -----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 122 -----------------------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 122 -----------------------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df 258 (375)
T cd05104 179 VPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF 258 (375)
T ss_pred cccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecC
Confidence 124788889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++........ ........++..|+|
T Consensus 259 G~a~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~a 284 (375)
T cd05104 259 GLARDIRNDSN------------------------------------------------------YVVKGNARLPVKWMA 284 (375)
T ss_pred ccceeccCccc------------------------------------------------------ccccCCCCCCcceeC
Confidence 99876532110 000112235678999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
||++.+..++.++|||||||++|+|++ |..||........+.+.+.. .......+.++.+||.+||..||++|||+
T Consensus 285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 364 (375)
T cd05104 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTF 364 (375)
T ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 999999999999999999999999997 99999876654444444322 12223347789999999999999999999
Q ss_pred HHHhcC
Q 014344 329 EEIKGH 334 (426)
Q Consensus 329 ~eil~h 334 (426)
.+|++.
T Consensus 365 ~eil~~ 370 (375)
T cd05104 365 KQIVQL 370 (375)
T ss_pred HHHHHH
Confidence 999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=352.59 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=221.4
Q ss_pred cEEE--eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 18 LRIV--SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 18 y~i~--~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
|+|. ++||+|.||+||-+.++.+|+.||||+++|..+..+ +...+..|+.||+.+.||.||.+...|
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-----------qesqlR~EVaILq~l~HPGiV~le~M~ 632 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-----------QESQLRNEVAILQNLHHPGIVNLECMF 632 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-----------hHHHHHHHHHHHHhcCCCCeeEEEEee
Confidence 5554 789999999999999999999999999988877654 225677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~DF 172 (426)
++.+.++.|||-+. ||...++-....+++++...++++.||+.||.|||-++|+|.||||||||+.+. -.+|||||
T Consensus 633 ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 633 ETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred cCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence 99999999999997 555555555555679999999999999999999999999999999999999754 37999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+... ....+.+|||.|+|
T Consensus 712 GfARiIgEk---------------------------------------------------------sFRrsVVGTPAYLa 734 (888)
T KOG4236|consen 712 GFARIIGEK---------------------------------------------------------SFRRSVVGTPAYLA 734 (888)
T ss_pred cceeecchh---------------------------------------------------------hhhhhhcCCccccC
Confidence 999987532 23456799999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHH--hcCCCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRI--LCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||+++.++|..+-|+||+|||+|--+.|..||.... ..++.++. +..+..+.+.+..+.|||..+|+..-.+|.|++
T Consensus 735 PEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 735 PEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchH
Confidence 999999999999999999999999999999997543 33443332 334444556688899999999999999999999
Q ss_pred HHhcCCCcCCC-Chhhhh
Q 014344 330 EIKGHEFFKGV-NWELLL 346 (426)
Q Consensus 330 eil~hp~f~~~-~~~~~~ 346 (426)
..|.|||+++. -|.++.
T Consensus 815 k~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 815 KSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred hhccchhhhcchHHHHHH
Confidence 99999999985 465553
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=331.17 Aligned_cols=253 Identities=18% Similarity=0.301 Sum_probs=212.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.+..++|+++++||+|+||.||+|... +++.||+|.+.... ...+.+..|+.+++.++||||++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~ 65 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT--------------MSVQAFLEEANLMKTLQHDKLVR 65 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc--------------hhHHHHHHHHHHHHhCCCCCeee
Confidence 3567789999999999999999999864 56779999874321 12356788999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++......|++|||+++++|.+++.......++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+
T Consensus 66 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~ 145 (261)
T cd05072 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIA 145 (261)
T ss_pred EEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEEC
Confidence 99999999999999999999999999877655668999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........ .......++..|
T Consensus 146 dfg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y 170 (261)
T cd05072 146 DFGLARVIEDNEY-------------------------------------------------------TAREGAKFPIKW 170 (261)
T ss_pred CCccceecCCCce-------------------------------------------------------eccCCCccceec
Confidence 9999876532110 001112356789
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||.+.+..++.++|||||||++|+|++ |..||...........+... .+.....+..+.++|.+||..+|++||+
T Consensus 171 ~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 250 (261)
T cd05072 171 TAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPT 250 (261)
T ss_pred CCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence 99999998889999999999999999998 99999988776666555432 2333456788999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
++++++
T Consensus 251 ~~~i~~ 256 (261)
T cd05072 251 FDYLQS 256 (261)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=337.68 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=210.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+..|+.+++.++|+||+++++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 69 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-----------DEDVKKTALREVKVLRQLRHENIVNLKEAF 69 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-----------cccchhHHHHHHHHHHhcCCCCeeehhheE
Confidence 369999999999999999999999999999998854321 122346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..++..|+||||++++.+..+.... ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||++
T Consensus 70 ~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 70 RRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred EECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 9999999999999987777655432 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
........ ......+++..|+|||+
T Consensus 148 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~~PE~ 172 (288)
T cd07833 148 RALRARPA-------------------------------------------------------SPLTDYVATRWYRAPEL 172 (288)
T ss_pred cccCCCcc-------------------------------------------------------ccccCcccccCCcCCch
Confidence 76542110 01223468899999999
Q ss_pred hcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------CCC------------------C
Q 014344 256 IEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--------------RPP------------------D 302 (426)
Q Consensus 256 ~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------~~~------------------~ 302 (426)
+.+. .++.++|+|||||++|+|++|++||.+.+..+....+.. ... .
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (288)
T cd07833 173 LVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERR 252 (288)
T ss_pred hcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHh
Confidence 9887 889999999999999999999999987765544332210 000 0
Q ss_pred CC-CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 LV-GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ~~-~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.. ..+..+.+||++||..+|++|||+++++.||||
T Consensus 253 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 253 YPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01 126778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=335.97 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=215.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|+.++.||.|+||.||+|.+..+++.||||++..... ......+..|+.+++.+.||||+++++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA------------EDEIEDIQQEITVLSQCDSPYVTKYYGSY 71 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 358899999999999999999999999999999854321 12346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.++...|+||||+.|++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 72 LKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999999999998764 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......++..|+|||+
T Consensus 149 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~apE~ 172 (277)
T cd06640 149 GQLTDTQ--------------------------------------------------------IKRNTFVGTPFWMAPEV 172 (277)
T ss_pred eeccCCc--------------------------------------------------------cccccccCcccccCHhH
Confidence 7653211 01122357888999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCC-CCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPD-LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+..++.++|+|||||++|+|++|.+||...........+... ++. ....+..+.+||.+||..+|++||++.+++.
T Consensus 173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 99888999999999999999999999999887766655544322 121 2234678999999999999999999999999
Q ss_pred CCCcCCC
Q 014344 334 HEFFKGV 340 (426)
Q Consensus 334 hp~f~~~ 340 (426)
||||...
T Consensus 253 ~~~~~~~ 259 (277)
T cd06640 253 HKFIVKN 259 (277)
T ss_pred ChHhhhc
Confidence 9999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.52 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=205.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHH-HHhcCCCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV-LRNVEHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv~l~~~ 94 (426)
++|++++.||+|+||.||+|++..+|+.||||++.+.... .....+..|+.+ ++.++||||++++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~~iv~~~~~ 68 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS------------QEQKRLLMDLDISMRSVDCPYTVTFYGA 68 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc------------HHHHHHHHHHHHHHHHcCCCCeeeeeEE
Confidence 4799999999999999999999999999999998543211 112334445554 666789999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+..+..+|++|||++ ++|.+++... ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|
T Consensus 69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~d 147 (283)
T cd06617 69 LFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCD 147 (283)
T ss_pred EecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEee
Confidence 999999999999996 7888776542 234689999999999999999999997 999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+.... ..+...|+..|+
T Consensus 148 fg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~ 170 (283)
T cd06617 148 FGISGYLVDSV---------------------------------------------------------AKTIDAGCKPYM 170 (283)
T ss_pred ccccccccccc---------------------------------------------------------ccccccCCcccc
Confidence 99987542110 111235788999
Q ss_pred cchhhcC----CCCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC-CCC--CCCCHHHHHHHHHHhccCCC
Q 014344 252 APEIIEG----KGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILCRP-PDL--VGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 252 aPE~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~-~~~--~~~~~~~~~li~~~L~~dP~ 323 (426)
|||.+.+ ..++.++|+|||||++|+|++|+.||... ...+....+.... +.. ...+..+.+||.+||..+|.
T Consensus 171 aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 250 (283)
T cd06617 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYK 250 (283)
T ss_pred ChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChh
Confidence 9999865 45688999999999999999999999753 2233344443322 222 23578899999999999999
Q ss_pred CCCChHHHhcCCCcCCCCh
Q 014344 324 KRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 324 ~R~s~~eil~hp~f~~~~~ 342 (426)
+||++++++.||||....+
T Consensus 251 ~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 251 ERPNYPELLQHPFFELHLS 269 (283)
T ss_pred hCcCHHHHhcCchhhhccc
Confidence 9999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=339.57 Aligned_cols=254 Identities=25% Similarity=0.383 Sum_probs=208.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||++++++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 72 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-----------EGFPITSLREINILLKLQHPNIVTVKEV 72 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-----------ccchhhHHHHHHHHHhcCCCCEEEEEEE
Confidence 46799999999999999999999999999999998543211 1223456679999999999999999999
Q ss_pred eecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 95 LSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 95 ~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+... ...|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 73 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~ 150 (293)
T cd07843 73 VVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDF 150 (293)
T ss_pred EEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeec
Confidence 8877 89999999997 58988876543 35899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.... .......+++.|+|
T Consensus 151 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~a 174 (293)
T cd07843 151 GLAREYGSPL--------------------------------------------------------KPYTQLVVTLWYRA 174 (293)
T ss_pred CceeeccCCc--------------------------------------------------------cccccccccccccC
Confidence 9987653210 01122347889999
Q ss_pred chhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------------------------
Q 014344 253 PEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------------------------------- 300 (426)
Q Consensus 253 PE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------------- 300 (426)
||.+.+.. ++.++|+|||||++|+|++|.+||...+....+.++....
T Consensus 175 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (293)
T cd07843 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLR 254 (293)
T ss_pred chhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhh
Confidence 99987654 6889999999999999999999998877665544432100
Q ss_pred CCCCC--CCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 301 PDLVG--EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 301 ~~~~~--~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+.. .+..+.+||++||+.+|++|||+.|++.||||
T Consensus 255 ~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 255 KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00111 36678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.22 Aligned_cols=259 Identities=24% Similarity=0.352 Sum_probs=204.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|+++++||+|+||.||+|.+..+++.||||++..... .......+..|+.+++.++||||+++++
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 78 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-----------KEGFPITALREIKILQLLKHENVVNLIE 78 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-----------cCCchhHHHHHHHHHHhCCCCCccceEE
Confidence 45689999999999999999999999999999998843221 1112234567999999999999999999
Q ss_pred eeecCC--------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 94 VLSTDK--------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 94 ~~~~~~--------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
++.... ..|+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++|++||||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~ 156 (310)
T cd07865 79 ICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156 (310)
T ss_pred EEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC
Confidence 886543 4599999996 57877765443 3589999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++..+...... ........+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~----------------------------------------------------~~~~~~~~~ 184 (310)
T cd07865 157 ILKLADFGLARAFSLSKNS----------------------------------------------------KPNRYTNRV 184 (310)
T ss_pred cEEECcCCCcccccCCccc----------------------------------------------------CCCCccCcc
Confidence 9999999999865421100 001112345
Q ss_pred cCCCCccchhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC--------------------
Q 014344 246 GTEEYVAPEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP-------------------- 301 (426)
Q Consensus 246 gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~-------------------- 301 (426)
++..|+|||.+.+.. ++.++|+|||||++|+|++|++||.+.+.......+.. ..+
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T cd07865 185 VTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQ 264 (310)
T ss_pred cCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCC
Confidence 788999999987643 68899999999999999999999988765543322211 000
Q ss_pred C----------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 D----------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 ~----------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
. ....+..+.+||.+||..||.+|||++++++||||
T Consensus 265 ~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 265 GQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 00124567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=334.65 Aligned_cols=270 Identities=41% Similarity=0.728 Sum_probs=217.7
Q ss_pred CcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
+|++.+.||+|++|.||+|++. .+++.||||++.+.....+ ......+..|+.++..+ +||+|++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~---------~~~~~~~~~E~~~l~~~~~~~~i~~~~ 71 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQK---------AKTAEHTRTERQVLEAVRRCPFLVTLH 71 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhh---------hhHHHHHHHHHHHHHhccCCcchhhhh
Confidence 4899999999999999999864 4678999999876433221 12345677899999999 599999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+.+.....+|+||||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 72 YAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred eeeecCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEEC
Confidence 9999999999999999999999887653 34899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.... ........|++.|+|
T Consensus 150 g~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y~a 174 (288)
T cd05583 150 GLSKEFLAEE-------------------------------------------------------EERAYSFCGTIEYMA 174 (288)
T ss_pred cccccccccc-------------------------------------------------------ccccccccCCccccC
Confidence 9987653211 011123458899999
Q ss_pred chhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC-CCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 253 PEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCR-PPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 253 PE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~-~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
||.+.+.. ++.++|+||||+++|+|++|..||..... .+....+... ++.....+..+.++|.+||+.||++|
T Consensus 175 PE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 254 (288)
T cd05583 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254 (288)
T ss_pred HHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhc
Confidence 99987755 78899999999999999999999964332 2222333322 22333457889999999999999999
Q ss_pred CC---hHHHhcCCCcCCCChhhhhhccCCC
Q 014344 326 IG---VEEIKGHEFFKGVNWELLLKISRPP 352 (426)
Q Consensus 326 ~s---~~eil~hp~f~~~~~~~~~~~~~~~ 352 (426)
|| +.++|+||||+.++|+.+.....++
T Consensus 255 ~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 284 (288)
T cd05583 255 LGANGADEIKNHPFFQGIDWDDLAAKRIPA 284 (288)
T ss_pred cCcchHHHHhcCcccccCCHHHHhhhccCC
Confidence 98 5678999999999998886544443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=334.21 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=211.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
|++++|++.+.||+|+||+||+|... .++..+|+|.+.... .......+.+|+.+++.++||||
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni 69 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN------------NPQQWGEFQQEASLMAELHHPNI 69 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC------------CHHHHHHHHHHHHHHhhCCCCCe
Confidence 67789999999999999999999853 456789999884321 12234678889999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhc---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS---------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~---------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
+++++++......|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+|||
T Consensus 70 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 149 (283)
T cd05090 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKD 149 (283)
T ss_pred eeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhc
Confidence 999999999999999999999999999875332 12478889999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+|||++.++.+||+|||+++.......
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------- 179 (283)
T cd05090 150 LAARNILIGEQLHVKISDLGLSREIYSADY-------------------------------------------------- 179 (283)
T ss_pred cccceEEEcCCCcEEeccccccccccCCcc--------------------------------------------------
Confidence 999999999999999999999986532110
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~ 310 (426)
........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.......+.... +.....+..+
T Consensus 180 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (283)
T cd05090 180 ----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRM 255 (283)
T ss_pred ----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 001122346778999999998889999999999999999998 999998877665555444322 2233557889
Q ss_pred HHHHHHHhccCCCCCCChHHHhcC
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.++|.+||+.||.+||++.+|+++
T Consensus 256 ~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 256 YSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHcccCcccCcCHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.23 Aligned_cols=252 Identities=25% Similarity=0.429 Sum_probs=212.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|.....||.|+||.||++.+..+++.||||++.... ......+..|+.+++.++||||+++++.+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~ 88 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-------------QQRRELLFNEVVIMRDYHHENVVDMYNSY 88 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-------------HHHHHHHHHHHHHHHhCCCCcHHHHHHhe
Confidence 44666788999999999999999999999999884322 12345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
...+..|+||||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~ 165 (292)
T cd06658 89 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFC 165 (292)
T ss_pred ecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcch
Confidence 999999999999999999988753 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... ......+|++.|+|||.
T Consensus 166 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 189 (292)
T cd06658 166 AQVSKEV--------------------------------------------------------PKRKSLVGTPYWMAPEV 189 (292)
T ss_pred hhccccc--------------------------------------------------------ccCceeecCccccCHHH
Confidence 6542111 01123468999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-C---CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-P---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|||++|..||...+....+..+.... + .....+..+.++|.+||..||++|||++++
T Consensus 190 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 269 (292)
T cd06658 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQEL 269 (292)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 998889999999999999999999999999877766555443221 1 122346789999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
++||||..
T Consensus 270 l~~~~~~~ 277 (292)
T cd06658 270 LQHPFLKL 277 (292)
T ss_pred hhChhhhc
Confidence 99999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=363.23 Aligned_cols=271 Identities=23% Similarity=0.308 Sum_probs=201.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCC-CceEEEEEeeh---------hhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVES-SESFALKVIWR---------DLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.++|++++.||+|+||+||+|..+.. +...+.|.+.. ..+.+. ..........+.+|+.+|+.++
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~-----~~~~~~~~~~~~~Ei~il~~l~ 221 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR-----VKAGSRAAIQLENEILALGRLN 221 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHH-----hhcchHHHHHHHHHHHHHHhCC
Confidence 46799999999999999999986543 33333332110 001111 0112234557888999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI 161 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~---~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl 161 (426)
||||+++++++...+..|+|++++. ++|..++.... ........++.++.||+.||+|||++|||||||||+|||+
T Consensus 222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999999999999999995 67777654321 1224467788999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+.+|.+||+|||++..+.... ....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-------------------------------------------------------~~~~ 325 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-------------------------------------------------------EAFD 325 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-------------------------------------------------------cccc
Confidence 999999999999997653211 0112
Q ss_pred cccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCC-CCCC--CHHHHHHHHhcCC----C-------------
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP-FRGS--SRKETFYRILCRP----P------------- 301 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~--~~~~~~~~i~~~~----~------------- 301 (426)
...+||+.|+|||++.+..++.++|||||||++|||++|..+ |... .....+.+++... .
T Consensus 326 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i 405 (501)
T PHA03210 326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYI 405 (501)
T ss_pred ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHh
Confidence 345799999999999999999999999999999999998754 4332 2222222221100 0
Q ss_pred ----------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhhh
Q 014344 302 ----------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 302 ----------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~ 346 (426)
.....+..+.++|.+||++||.+|||+.|+|.||||+....+...
T Consensus 406 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 406 DSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEEIL 466 (501)
T ss_pred hhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchHHH
Confidence 001234567888999999999999999999999999987666543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=332.76 Aligned_cols=254 Identities=31% Similarity=0.490 Sum_probs=208.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||.|++|.||+|.+..+++.+|+|++.... .......+.+|+++++.++||||++++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 68 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP------------NPDLQKQILRELEINKSCKSPYIVKYYGAF 68 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC------------chHHHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 46999999999999999999999999999999985431 112346788899999999999999999988
Q ss_pred ec--CCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 96 ST--DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 96 ~~--~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
.. ...+|+||||++|++|.+++.. .....+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|
T Consensus 69 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~d 148 (287)
T cd06621 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCD 148 (287)
T ss_pred EccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEee
Confidence 54 4478999999999999987653 2335589999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .....++..|+
T Consensus 149 fg~~~~~~~~~----------------------------------------------------------~~~~~~~~~y~ 170 (287)
T cd06621 149 FGVSGELVNSL----------------------------------------------------------AGTFTGTSFYM 170 (287)
T ss_pred ccccccccccc----------------------------------------------------------cccccCCcccc
Confidence 99986542110 11234778899
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhc-CCCCCC-------CCCHHHHHHHHHHh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-----RKETFYRILC-RPPDLV-------GEPTPLRNLIRRLL 318 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~-~~~~~~-------~~~~~~~~li~~~L 318 (426)
|||.+.+..++.++|+|||||++|+|++|..||.... ..+....+.. ..+... ..+..+.+||.+||
T Consensus 171 ~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 250 (287)
T cd06621 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCL 250 (287)
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHc
Confidence 9999999999999999999999999999999998662 2333333332 111111 22467899999999
Q ss_pred ccCCCCCCChHHHhcCCCcCC
Q 014344 319 EKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 319 ~~dP~~R~s~~eil~hp~f~~ 339 (426)
..+|++|||+.|++.||||+.
T Consensus 251 ~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 251 EKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred CCCcccCCCHHHHHhCccccc
Confidence 999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=328.22 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=213.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|+..+.||+|++|+||+|.+..+++.||+|++....... ......+.+..|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ--------TGQEAVKQLEQEIALLSKLQHPNIVQYLGTER 72 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc--------cchHHHHHHHHHHHHHHhcCCCCchheeeeEe
Confidence 4788899999999999999998899999999985432110 11234567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+..+|++|||++|++|.+++.... .+++..+..++.||+.||+|||+.||+||||+|+||+++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 73 EEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred cCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999999999999987643 48899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... ......|++.|+|||.+
T Consensus 151 ~~~~~~---------------------------------------------------------~~~~~~~~~~y~~pe~~ 173 (258)
T cd06632 151 QVVEFS---------------------------------------------------------FAKSFKGSPYWMAPEVI 173 (258)
T ss_pred eccccc---------------------------------------------------------cccccCCCcceeCHHHh
Confidence 653211 11234588999999999
Q ss_pred cCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.... ++.++|+|||||++|+|++|+.||...........+.. .+......+..+.+||.+||+.+|.+||++.+++
T Consensus 174 ~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 174 AQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred cCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 8776 89999999999999999999999987765555444433 1122234568899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
.|||+
T Consensus 254 ~~~~~ 258 (258)
T cd06632 254 EHPFV 258 (258)
T ss_pred cCCCC
Confidence 99996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=328.18 Aligned_cols=249 Identities=22% Similarity=0.269 Sum_probs=207.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
+.++|++++.||+|+||.||+|..+. +..+|+|.+..... ....+..|+.+|+.++||||+++++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~~ 66 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM--------------SEEDFIEEAKVMMKLSHPKLVQLYG 66 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc--------------cHHHHHHHHHHHHHCCCCCceeEEE
Confidence 56789999999999999999998754 56799998743211 1245778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.....+|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g 145 (256)
T cd05114 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG 145 (256)
T ss_pred EEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCC
Confidence 9999999999999999999999876543 348999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++........ .......++..|+||
T Consensus 146 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~aP 170 (256)
T cd05114 146 MTRYVLDDEY-------------------------------------------------------TSSSGAKFPVKWSPP 170 (256)
T ss_pred CccccCCCce-------------------------------------------------------eccCCCCCchhhCCh
Confidence 8875431100 001112356689999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|++.+..++.++|+|||||++|+|++ |+.||...+..+....+.... ......+..+.++|.+||..+|.+||++++
T Consensus 171 E~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~ 250 (256)
T cd05114 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAE 250 (256)
T ss_pred hhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHH
Confidence 99998899999999999999999999 999999888877777765432 222334678999999999999999999999
Q ss_pred Hhc
Q 014344 331 IKG 333 (426)
Q Consensus 331 il~ 333 (426)
+++
T Consensus 251 l~~ 253 (256)
T cd05114 251 LLR 253 (256)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=331.81 Aligned_cols=274 Identities=34% Similarity=0.586 Sum_probs=223.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~ 94 (426)
++|++.+.||+|+||.||+|.+..+++.||+|++.+..+... .....+..|+.+++++. ||||++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~----------~~~~~~~~e~~~~~~l~~~~~i~~~~~~ 70 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE----------KKVKYVKIEKEVLTRLNGHPGIIKLYYT 70 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch----------HHHHHHHHHHHHHHhcccCCCchhHHHH
Confidence 479999999999999999999999999999999966433211 23456788999999998 9999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+..++..++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|.++|+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 71 FQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred hcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence 999999999999999999999887653 599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+............... .+ ...............+.|+..|+|||
T Consensus 149 ~~~~~~~~~~~~~~~~------------------~~------------------~~~~~~~~~~~~~~~~~~~~~~~~Pe 192 (280)
T cd05581 149 AKVLDPNSSPESNKGD------------------AT------------------NIDSQIEKNRRRFASFVGTAEYVSPE 192 (280)
T ss_pred ccccCCccccccCCCC------------------Cc------------------cccccccccccccccccCCccccCHH
Confidence 8876432211000000 00 00000111223445667899999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCHHHHHHHHHHhccCCCCCCCh----H
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDLVGEPTPLRNLIRRLLEKDPTKRIGV----E 329 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~s~----~ 329 (426)
++.+..++.++|+|||||++|++++|+.||...+....+..+.... ......+..+.+||.+||+.+|.+||++ +
T Consensus 193 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 272 (280)
T cd05581 193 LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYD 272 (280)
T ss_pred HhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHH
Confidence 9998889999999999999999999999999888766666655322 2233457889999999999999999999 9
Q ss_pred HHhcCCCc
Q 014344 330 EIKGHEFF 337 (426)
Q Consensus 330 eil~hp~f 337 (426)
++++||||
T Consensus 273 ~ll~~~~~ 280 (280)
T cd05581 273 ELKAHPFF 280 (280)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=331.20 Aligned_cols=262 Identities=23% Similarity=0.428 Sum_probs=212.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+......... .........+.+..|+.+++.++|||++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGR---HDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcc---cchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec
Confidence 488999999999999999999999999999988532211110 00001123456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....+++||||++|++|.+++... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 79 TEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred cCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999988765 358999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... ........|+..|+|||++
T Consensus 157 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 157 KSDDIYD------------------------------------------------------NDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred ccccccc------------------------------------------------------ccccccccCCccccCHHHh
Confidence 5421100 0112234588999999998
Q ss_pred cCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--C-----CCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 257 EGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--P-----DLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 257 ~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~-----~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
.... ++.++|+|||||++|+|++|..||......+....+.... . .....+..+.++|.+||..+|.+||+
T Consensus 183 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC
Confidence 8754 7899999999999999999999998766655444432111 1 11234788999999999999999999
Q ss_pred hHHHhcCCCc
Q 014344 328 VEEIKGHEFF 337 (426)
Q Consensus 328 ~~eil~hp~f 337 (426)
++++++||||
T Consensus 263 ~~~il~~~~~ 272 (272)
T cd06629 263 ARELLQHPFI 272 (272)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=333.54 Aligned_cols=253 Identities=29% Similarity=0.472 Sum_probs=214.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||.|+||.||+|.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 68 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN------------EAIQKQILRELDILHKCNSPYIVGFYGAF 68 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC------------hHHHHHHHHHHHHHHHCCCCchhhhheee
Confidence 368899999999999999999999999999999854321 12345778899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
..+..+|+++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 69 YNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred ecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999999987653 569999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... .....|+..|+|||
T Consensus 148 ~~~~~~~~----------------------------------------------------------~~~~~~~~~y~~PE 169 (265)
T cd06605 148 SGQLVNSL----------------------------------------------------------AKTFVGTSSYMAPE 169 (265)
T ss_pred chhhHHHH----------------------------------------------------------hhcccCChhccCHH
Confidence 86542110 01145888999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCC-CCCC-C-CCHHHHHHHHHHhccCCCCCC
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS-----SRKETFYRILCRP-PDLV-G-EPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~-~~~~-~-~~~~~~~li~~~L~~dP~~R~ 326 (426)
.+.+..++.++|+|||||++|+|++|..||... ...+....+.... +... . .+..+.++|.+||..||.+||
T Consensus 170 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 249 (265)
T cd06605 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP 249 (265)
T ss_pred HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCc
Confidence 999999999999999999999999999999765 2333334443322 2221 2 577899999999999999999
Q ss_pred ChHHHhcCCCcCC
Q 014344 327 GVEEIKGHEFFKG 339 (426)
Q Consensus 327 s~~eil~hp~f~~ 339 (426)
|+.+++.||||+.
T Consensus 250 t~~~ll~~~~~~~ 262 (265)
T cd06605 250 SYKELLEHPFIKK 262 (265)
T ss_pred CHHHHhhCchhhc
Confidence 9999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=344.98 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=204.7
Q ss_pred eeeccc--CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 22 SALGRG--AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
..||+| +||+||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||++++++|..+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~ 72 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-----------TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS 72 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-----------CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC
Confidence 456766 999999999999999999999853321 1223567888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
.+|+||||+.+++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++++||+.+....
T Consensus 73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 99999999999999999877655569999999999999999999999999999999999999999999999998654332
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 259 (426)
........ .........++..|+|||++.+.
T Consensus 153 ~~~~~~~~-------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 153 RNGQKAKV-------------------------------------------------VYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccCccccc-------------------------------------------------cccccccccCccCccChhhhcCC
Confidence 11000000 00000112356679999999764
Q ss_pred --CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------------------------
Q 014344 260 --GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----------------------------------- 302 (426)
Q Consensus 260 --~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------------------------- 302 (426)
.++.++||||+||++|+|++|+.||...........++..++.
T Consensus 184 ~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (328)
T cd08226 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGM 263 (328)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhcccc
Confidence 4789999999999999999999999887665554443322110
Q ss_pred -------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 -------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 -------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+.+||++||+.||++|||++|+|+||||+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 264 TQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred ccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 1123456899999999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.16 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=213.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|.....||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~ 87 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-------------QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-------------cchHHHHHHHHHHHHhCCCCchhhhhhhe
Confidence 44666778999999999999999999999999984321 11234577899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+...|+||||+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 88 LVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred eeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 999999999999999999987654 34899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... ......+|++.|+|||+
T Consensus 165 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 188 (297)
T cd06659 165 AQISKDV--------------------------------------------------------PKRKSLVGTPYWMAPEV 188 (297)
T ss_pred hhccccc--------------------------------------------------------ccccceecCccccCHHH
Confidence 6543211 11223468999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|+|++|+.||...+..+....+...... ....+..+.++|.+||+.+|.+||++.++
T Consensus 189 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 99988999999999999999999999999887776666555433221 22346789999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
++||||..
T Consensus 269 l~~~~~~~ 276 (297)
T cd06659 269 LDHPFLLQ 276 (297)
T ss_pred hhChhhcc
Confidence 99999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=332.10 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=201.3
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLS 96 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~ 96 (426)
|++++.||+|+||.||+|.+..+++.||+|++.+... . ........|+.+++++. ||||+++++++.
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-----------~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 68 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-----------S-LEQVNNLREIQALRRLSPHPNILRLIEVLF 68 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-----------C-chhhhHHHHHHHHhhcCCCCCccceEEEEe
Confidence 7899999999999999999999999999999854311 0 11123346888888885 999999999998
Q ss_pred cC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 97 TD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 97 ~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+. +.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.|++||||||+||+++. +.+||+|||+
T Consensus 69 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~ 145 (282)
T cd07831 69 DRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGS 145 (282)
T ss_pred cCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccc
Confidence 87 89999999997 57777765533 45899999999999999999999999999999999999999 9999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+.... ......+++.|+|||
T Consensus 146 ~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~aPE 168 (282)
T cd07831 146 CRGIYSKP---------------------------------------------------------PYTEYISTRWYRAPE 168 (282)
T ss_pred ccccccCC---------------------------------------------------------CcCCCCCCcccCChh
Confidence 87653211 111235788999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC---------------------------C
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD---------------------------L 303 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~---------------------------~ 303 (426)
.+.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+.. .+.. .
T Consensus 169 ~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (282)
T cd07831 169 CLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLL 248 (282)
T ss_pred HhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHc
Confidence 8654 4568899999999999999999999998876554443321 1000 1
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
...+..+.+||.+||.++|++||++++++.||||
T Consensus 249 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 249 PNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=333.73 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=211.8
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++..+|.+++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+++|+.++|||
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~ 69 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA------------SNDARKDFEREAELLTNFQHEN 69 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC------------CHHHHHHHHHHHHHHHhcCCCC
Confidence 45678999999999999999999874 346789999984321 1123467888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLK 155 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlK 155 (426)
|+++++++......|+||||++|++|.+++.... ...+++..+..++.||+.||.|||++|++|||||
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlk 149 (280)
T cd05049 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLA 149 (280)
T ss_pred chheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccc
Confidence 9999999999999999999999999999987542 2347889999999999999999999999999999
Q ss_pred CCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 156 PENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235 (426)
Q Consensus 156 p~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (426)
|+|||++.++.++|+|||++........
T Consensus 150 p~nili~~~~~~kl~d~g~~~~~~~~~~---------------------------------------------------- 177 (280)
T cd05049 150 TRNCLVGYDLVVKIGDFGMSRDVYTTDY---------------------------------------------------- 177 (280)
T ss_pred cceEEEcCCCeEEECCcccceecccCcc----------------------------------------------------
Confidence 9999999999999999999875421110
Q ss_pred CCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHH
Q 014344 236 DSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLVGEPTPLRN 312 (426)
Q Consensus 236 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~ 312 (426)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+..... .....+..+.+
T Consensus 178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (280)
T cd05049 178 --YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYD 255 (280)
T ss_pred --eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 001112246788999999999999999999999999999998 9999988887776666553322 22346788999
Q ss_pred HHHHHhccCCCCCCChHHHhc
Q 014344 313 LIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 313 li~~~L~~dP~~R~s~~eil~ 333 (426)
+|++||+.||++||++.|++.
T Consensus 256 li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 256 IMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=333.20 Aligned_cols=252 Identities=24% Similarity=0.443 Sum_probs=207.6
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||.|++|.||+|++..+++.||||++..... ......+..|+.++++++||||+++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 68 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE------------EGTPSTAIREISLMKELKHENIVRLHDVIH 68 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc------------ccchHHHHHHHHHHHhhcCCCEeeeeeeEe
Confidence 58999999999999999999999999999999854321 112345667999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++
T Consensus 69 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 69 TENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred eCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 9999999999998 48888766443 345899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... ......++|+.|+|||+
T Consensus 148 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~PE~ 171 (284)
T cd07836 148 RAFGIPV--------------------------------------------------------NTFSNEVVTLWYRAPDV 171 (284)
T ss_pred hhhcCCc--------------------------------------------------------cccccccccccccChHH
Confidence 7542110 01122357889999999
Q ss_pred hcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------CC----------------CC
Q 014344 256 IEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-----------PD----------------LV 304 (426)
Q Consensus 256 ~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------~~----------------~~ 304 (426)
+.+. .++.++|+|||||++|+|++|..||.+.+..+.+.++... + +. ..
T Consensus 172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd07836 172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFP 251 (284)
T ss_pred hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhh
Confidence 8764 5688999999999999999999999988766554443210 0 00 01
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+..+.++|.+||+.||.+||++.+++.||||
T Consensus 252 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 252 HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.26 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=214.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||+|+||.||++.+..+++.||+|.+.... ......+..|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~hp~i~~~~~ 83 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-------------QPKKELIINEILVMRENKHPNIVNYLD 83 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-------------chHHHHHHHHHHHHhhcCCCCeeehhh
Confidence 3578999999999999999999999999999999984321 122456788999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++......|+|+||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg 160 (293)
T cd06647 84 SYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 160 (293)
T ss_pred eeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCc
Confidence 999999999999999999999987643 38899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... .......|++.|+||
T Consensus 161 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~P 184 (293)
T cd06647 161 FCAQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAP 184 (293)
T ss_pred ceecccccc--------------------------------------------------------cccccccCChhhcCc
Confidence 887553211 111234588999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC---CCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDL---VGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|.+.+..++.++|+|||||++|+|++|+.||...+.......+.... +.. ...+..+.++|++||..+|++||+++
T Consensus 185 E~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 264 (293)
T cd06647 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK 264 (293)
T ss_pred hhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHH
Confidence 99998889999999999999999999999998876655443332211 111 12356799999999999999999999
Q ss_pred HHhcCCCcCCC
Q 014344 330 EIKGHEFFKGV 340 (426)
Q Consensus 330 eil~hp~f~~~ 340 (426)
+++.||||+..
T Consensus 265 ~il~h~~~~~~ 275 (293)
T cd06647 265 ELLQHPFLKIA 275 (293)
T ss_pred HHhcCHHHhcC
Confidence 99999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.89 Aligned_cols=252 Identities=28% Similarity=0.442 Sum_probs=207.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||.||+|.+..+++.||||++.+... .......+..|+.+|+.++||||++++++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-----------SELFAKRAYRELRLLKHMKHENVIGLLDV 82 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-----------chHHHHHHHHHHHHHHhcCCCCccceeee
Confidence 4569999999999999999999999999999999854211 11234567789999999999999999999
Q ss_pred eecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+..+. .+++||||+ |++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 97654 458999999 7899887653 3499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++...... .....+++
T Consensus 159 l~dfg~~~~~~~~-----------------------------------------------------------~~~~~~~~ 179 (343)
T cd07880 159 ILDFGLARQTDSE-----------------------------------------------------------MTGYVVTR 179 (343)
T ss_pred EeecccccccccC-----------------------------------------------------------ccccccCC
Confidence 9999998754211 11234788
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-------------------------- 301 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------------- 301 (426)
.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+..+.....
T Consensus 180 ~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07880 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFR 259 (343)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccC
Confidence 9999999876 4578999999999999999999999988766544443321110
Q ss_pred ------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+.++|.+||..||++|||+.+++.||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 260 KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 012346678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=338.17 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=210.0
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCce--EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSES--FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~ 87 (426)
+.+++++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|||
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~------------~~~~~~~~~~~Ei~~l~~l~~h~~ 69 (303)
T cd05088 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------------ASKDDHRDFAGELEVLCKLGHHPN 69 (303)
T ss_pred CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc------------CCHHHHHHHHHHHHHHHHhcCCCC
Confidence 457889999999999999999999999877764 567665321 1112345778899999999 8999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
|+++++++..++.+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+|||
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~d 149 (303)
T cd05088 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 149 (303)
T ss_pred cceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 9999999999999999999999999999886542 13588999999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+|||++.++.+||+|||++.......
T Consensus 150 lkp~Nili~~~~~~kl~dfg~~~~~~~~~--------------------------------------------------- 178 (303)
T cd05088 150 LAARNILVGENYVAKIADFGLSRGQEVYV--------------------------------------------------- 178 (303)
T ss_pred cchheEEecCCCcEEeCccccCcccchhh---------------------------------------------------
Confidence 99999999999999999999875321000
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 310 (426)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+.+..+... .......+..+
T Consensus 179 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (303)
T cd05088 179 ------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEV 252 (303)
T ss_pred ------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHH
Confidence 0111124667999999988889999999999999999998 99999888777666555432 12233457889
Q ss_pred HHHHHHHhccCCCCCCChHHHhcC
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+||.+||..+|++||++++++.+
T Consensus 253 ~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 253 YDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=367.65 Aligned_cols=270 Identities=26% Similarity=0.368 Sum_probs=208.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|+++++||+|+||.||+|++..+++.||||++..... ......+++.+|+++++.++||||++++++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~----------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v 70 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS----------ENPLLKKRFLREAKIAADLIHPGIVPVYSI 70 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc----------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEE
Confidence 4679999999999999999999999999999999854321 112235678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQS---------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~---------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
+.+.+..|+||||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.+|
T Consensus 71 ~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 71 CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC
Confidence 999999999999999999999876421 12345667888999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++............... ................+
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~--------------------------------------~~~~s~~s~~t~~g~~v 192 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDV--------------------------------------DERNICYSSMTIPGKIV 192 (932)
T ss_pred CEEEEecCcceeccccccccccccc--------------------------------------ccccccccccccCCCCC
Confidence 9999999999876321100000000 00000001112233567
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCC---CCCCCHHHHHHHHHHhccC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR-ILCRPPD---LVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~-i~~~~~~---~~~~~~~~~~li~~~L~~d 321 (426)
||+.|||||++.+..++.++|||||||++|||++|+.||........... ....+.. ....++.+.+++.+||..|
T Consensus 193 GT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~D 272 (932)
T PRK13184 193 GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVD 272 (932)
T ss_pred CCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCC
Confidence 99999999999999999999999999999999999999987665443322 2222211 2355788999999999999
Q ss_pred CCCCCChHHHh
Q 014344 322 PTKRIGVEEIK 332 (426)
Q Consensus 322 P~~R~s~~eil 332 (426)
|++|++..+.+
T Consensus 273 P~kR~ss~eeL 283 (932)
T PRK13184 273 PAERYSSVQEL 283 (932)
T ss_pred hhhCcCHHHHH
Confidence 99998754444
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=338.66 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=213.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|+||.||+|.+..+++.||+|++..... ......+..|+.+++.++||||+++++++.
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA------------EDEIEDIQQEITVLSQCDSPYITRYYGSYL 72 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc------------hHHHHHHHHHHHHHHcCCCCccHhhhcccc
Confidence 47888999999999999999999999999998843211 123457888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+...|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 73 KGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred cCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999999999988753 358999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......|+..|+|||.+
T Consensus 150 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06642 150 QLTDTQ--------------------------------------------------------IKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred cccCcc--------------------------------------------------------hhhhcccCcccccCHHHh
Confidence 653211 011223578899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC-CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDL-VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~-~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+|||||++|+|++|+.||...........+.... +.. ...+..+.++|.+||..+|++||++.++++|
T Consensus 174 ~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999999999998766555444433221 211 2346789999999999999999999999999
Q ss_pred CCcCCCC
Q 014344 335 EFFKGVN 341 (426)
Q Consensus 335 p~f~~~~ 341 (426)
|||....
T Consensus 254 ~~~~~~~ 260 (277)
T cd06642 254 KFITRYT 260 (277)
T ss_pred HHHHHHh
Confidence 9997543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=331.91 Aligned_cols=252 Identities=24% Similarity=0.438 Sum_probs=213.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|.-.+.||.|++|.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~vv~~~~~~ 85 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-------------QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-------------hhHHHHHHHHHHHHHHcCCCChheEEEEE
Confidence 35667789999999999999999999999999874321 11234577899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
......|+++||+.|++|.+++.. ..++...+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++
T Consensus 86 ~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~ 162 (285)
T cd06648 86 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFC 162 (285)
T ss_pred EcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccc
Confidence 999999999999999999998765 34899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... .......|++.|+|||.
T Consensus 163 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 186 (285)
T cd06648 163 AQVSKEV--------------------------------------------------------PRRKSLVGTPYWMAPEV 186 (285)
T ss_pred hhhccCC--------------------------------------------------------cccccccCCccccCHHH
Confidence 6542111 01123458899999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..++.++|+|||||++|+|++|+.||...+.......+....+.. ...+..+.+||++||..+|++||++.++
T Consensus 187 ~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred hcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 998889999999999999999999999998877766666555432222 1246789999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
+.||||+.
T Consensus 267 l~~~~~~~ 274 (285)
T cd06648 267 LNHPFLAK 274 (285)
T ss_pred ccCccccc
Confidence 99999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=330.44 Aligned_cols=257 Identities=21% Similarity=0.247 Sum_probs=208.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.+.-++|++.+.||+|+||+||+|.+.. ++..||+|++.... .......+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~------------~~~~~~~~~~e~~~l~~l~~~ 69 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA------------SMRERIEFLNEASVMKEFNCH 69 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC------------CHHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999998752 35679999874321 111234678899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCC
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPEN 158 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~N 158 (426)
||+++++++......++||||+++++|.+++..... ..++...+..++.|++.||.|||+.|++||||||+|
T Consensus 70 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~N 149 (277)
T cd05062 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARN 149 (277)
T ss_pred CeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchhe
Confidence 999999999999999999999999999998865321 235678888999999999999999999999999999
Q ss_pred eeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 159 iLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
||++.++.++|+|||++..+......
T Consensus 150 il~~~~~~~~l~dfg~~~~~~~~~~~------------------------------------------------------ 175 (277)
T cd05062 150 CMVAEDFTVKIGDFGMTRDIYETDYY------------------------------------------------------ 175 (277)
T ss_pred EEEcCCCCEEECCCCCccccCCccee------------------------------------------------------
Confidence 99999999999999998765321100
Q ss_pred CCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHH
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIR 315 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~ 315 (426)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ......+..+.++|.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 255 (277)
T cd05062 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMR 255 (277)
T ss_pred ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 00111246788999999999889999999999999999998 799999888776665554332 223345788999999
Q ss_pred HHhccCCCCCCChHHHhcC
Q 014344 316 RLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 316 ~~L~~dP~~R~s~~eil~h 334 (426)
+||+.||++|||+.|++++
T Consensus 256 ~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 256 MCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=337.72 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=203.4
Q ss_pred CcEEEeeecccCceEEEEEEEcC--CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVE--SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+|++++.||+|+||.||+|.+.. +++.||||++..... ........+..|+.+++.++||||++++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE----------QYTGISQSACREIALLRELKHENVVSLVEV 70 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc----------cccCccHHHHHHHHHHHhcCCCCccceEEE
Confidence 48999999999999999999988 899999999855321 111233566779999999999999999999
Q ss_pred eecC--CeEEEEEeccCCCChHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc----CC
Q 014344 95 LSTD--KFVGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE----NG 165 (426)
Q Consensus 95 ~~~~--~~~~lV~Ey~~gg~L~~l~~~~~---~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~----~g 165 (426)
+... ..+|+||||+. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 71 FLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred EeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc
Confidence 9888 88999999997 46766654322 235899999999999999999999999999999999999999 89
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++..+..... ........+
T Consensus 150 ~~kl~Dfg~~~~~~~~~~-----------------------------------------------------~~~~~~~~~ 176 (316)
T cd07842 150 VVKIGDLGLARLFNAPLK-----------------------------------------------------PLADLDPVV 176 (316)
T ss_pred eEEECCCccccccCCCcc-----------------------------------------------------cccccCCcc
Confidence 999999999886532110 001123346
Q ss_pred cCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH---h---------------
Q 014344 246 GTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE---------TFYRI---L--------------- 297 (426)
Q Consensus 246 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---------~~~~i---~--------------- 297 (426)
+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+..... .+..+ +
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (316)
T cd07842 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMP 256 (316)
T ss_pred ccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcc
Confidence 8899999998876 457899999999999999999999998654322 11110 0
Q ss_pred --------cCCCCCC------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 298 --------CRPPDLV------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 298 --------~~~~~~~------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
....... ..+..+.++|.+||+.||++|||+.|++.||||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 257 EYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000011 335678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=300.53 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=212.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|.-.++||+|.||+||+|+...+++.||+|.+..+. +....-....+|+.+|+.|+|.|||+++++..
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-----------ddegvpssalreicllkelkhknivrl~dvlh 71 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-----------DDEGVPSSALREICLLKELKHKNIVRLHDVLH 71 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-----------CCCCCcHHHHHHHHHHHHhhhcceeehhhhhc
Confidence 4667789999999999999999999999999884432 12223456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.++.+-+|+|||. .+|..+..... +.+..+.++.++.|++.||.++|++++.||||||.|+||+.+|.+||+|||+++
T Consensus 72 sdkkltlvfe~cd-qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 72 SDKKLTLVFEFCD-QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred cCceeEEeHHHhh-HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhh
Confidence 9999999999996 88888876554 559999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... -| ...-+-|..|++|.++
T Consensus 150 afgipv--------------------------rc------------------------------ysaevvtlwyrppdvl 173 (292)
T KOG0662|consen 150 AFGIPV--------------------------RC------------------------------YSAEVVTLWYRPPDVL 173 (292)
T ss_pred hcCCce--------------------------Ee------------------------------eeceeeeeeccCccee
Confidence 774211 01 1122578999999999
Q ss_pred cCC-CCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCC-----CCCC------C------------------
Q 014344 257 EGK-GHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILCRP-----PDLV------G------------------ 305 (426)
Q Consensus 257 ~~~-~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~-----~~~~------~------------------ 305 (426)
.|. -|+.+.|+||.|||+.|+. .|++.|++.+..+++.+|.... ..++ +
T Consensus 174 fgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp 253 (292)
T KOG0662|consen 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVP 253 (292)
T ss_pred eeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhh
Confidence 884 5899999999999999998 5999999999998888875211 0000 0
Q ss_pred -CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 306 -EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 306 -~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....-+||++++|.-+|..|++++++++||||.+
T Consensus 254 ~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 254 KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred hhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0122579999999999999999999999999975
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=337.51 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=208.0
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCce----EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
+.+...+|++++.||+|+||+||+|.+..+++. ||+|++.... .....+++..|+.+++.++||
T Consensus 2 ~~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ 69 (316)
T cd05108 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT------------SPKANKEILDEAYVMASVDNP 69 (316)
T ss_pred cccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC------------CHHHHHHHHHHHHHHHhCCCC
Confidence 457778999999999999999999998766664 8999874221 122345788899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++... ..++++||+++|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 70 niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~ 147 (316)
T cd05108 70 HVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH 147 (316)
T ss_pred CCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc
Confidence 999999998764 5689999999999999887643 34889999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+++.+...... .......+
T Consensus 148 ~kl~DfG~a~~~~~~~~~------------------------------------------------------~~~~~~~~ 173 (316)
T cd05108 148 VKITDFGLAKLLGADEKE------------------------------------------------------YHAEGGKV 173 (316)
T ss_pred EEEccccccccccCCCcc------------------------------------------------------eeccCCcc
Confidence 999999999866421100 00111224
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh--cCCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+..|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+. ...+.....+..+.++|.+||..+|.
T Consensus 174 ~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 253 (316)
T cd05108 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDAD 253 (316)
T ss_pred ceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 678999999999999999999999999999987 999998877655432222 12233345578899999999999999
Q ss_pred CCCChHHHhcC
Q 014344 324 KRIGVEEIKGH 334 (426)
Q Consensus 324 ~R~s~~eil~h 334 (426)
+||++.+++.+
T Consensus 254 ~Rps~~~l~~~ 264 (316)
T cd05108 254 SRPKFRELIIE 264 (316)
T ss_pred hCcCHHHHHHH
Confidence 99999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=333.27 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=207.5
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++++.||.|++|.||+|.+..+|+.||+|++...... ......+..|+.+++.++|||++++++++.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~ 69 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-----------EGVPSTAIREISLLKELNHPNIVRLLDVVHS 69 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-----------ccchhHHHHHHHHHHhcCCCCccCHhheecc
Confidence 68899999999999999999999999999998543211 1123457779999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
....|++|||+. ++|.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++..
T Consensus 70 ~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 70 ENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred CCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 999999999995 7899888765544689999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
+.... .......+++.|+|||++.
T Consensus 149 ~~~~~--------------------------------------------------------~~~~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 149 FGVPV--------------------------------------------------------RTYTHEVVTLWYRAPEILL 172 (283)
T ss_pred cCCCc--------------------------------------------------------cccCccccccCCCCCceee
Confidence 42110 0011224688899999887
Q ss_pred CC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C---------------------------CCCCCC
Q 014344 258 GK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P---------------------------PDLVGE 306 (426)
Q Consensus 258 ~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~---------------------------~~~~~~ 306 (426)
+. .++.++|+|||||++|+|++|.+||.+.+......++... + ......
T Consensus 173 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07835 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL 252 (283)
T ss_pred cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCC
Confidence 64 5788999999999999999999999887765444333210 0 001234
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
+..+.++|.+||+.||.+|||+++++.||||
T Consensus 253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 253 DEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 5778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=331.82 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=210.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++..+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+..|+.++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~ 68 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-------------DNARKDFHREAELLTNLQHEH 68 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-------------HHHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999999863 345679999884321 123456888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-----------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKP 156 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-----------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp 156 (426)
|+++++++.....+++||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp 148 (288)
T cd05093 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148 (288)
T ss_pred cceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 9999999999999999999999999999887543 12489999999999999999999999999999999
Q ss_pred CCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 157 ENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 157 ~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
+|||++.++.++|+|||++........
T Consensus 149 ~Nili~~~~~~kl~dfg~~~~~~~~~~----------------------------------------------------- 175 (288)
T cd05093 149 RNCLVGENLLVKIGDFGMSRDVYSTDY----------------------------------------------------- 175 (288)
T ss_pred ceEEEccCCcEEeccCCccccccCCce-----------------------------------------------------
Confidence 999999999999999999875532110
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~l 313 (426)
........+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||......+....+..... .....+..+.+|
T Consensus 176 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 254 (288)
T cd05093 176 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDL 254 (288)
T ss_pred -eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 001122346788999999999999999999999999999998 9999998887776666654332 223457889999
Q ss_pred HHHHhccCCCCCCChHHHhc
Q 014344 314 IRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~ 333 (426)
+.+||+.||.+|||+.++++
T Consensus 255 i~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 255 MLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.30 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=208.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||.|+||.||+|.+..+++.||+|++..... .......+..|+.+|+.++||||++++++|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 73 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-----------VPTLAKRTLRELKILRHFKHDNIIAIRDIL 73 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-----------cccchHHHHHHHHHHHhcCCCCccCHHHhc
Confidence 679999999999999999999999999999999854211 112345677899999999999999999988
Q ss_pred e----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 96 S----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 96 ~----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
. ....+|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|
T Consensus 74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 74 RPPGADFKDVYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred cccCCCCceEEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecc
Confidence 5 3457899999995 6888876543 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++......... ........+|+..|+
T Consensus 151 fg~~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~ 178 (334)
T cd07855 151 FGMARGLSSSPTE----------------------------------------------------HKYFMTEYVATRWYR 178 (334)
T ss_pred cccceeecccCcC----------------------------------------------------CCccccccccccccc
Confidence 9998765321100 001122346899999
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------------------CCCC--
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--------------------------RPPD-- 302 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------------------~~~~-- 302 (426)
|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+.. ....
T Consensus 179 ~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (334)
T cd07855 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVP 258 (334)
T ss_pred ChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCC
Confidence 9999866 4588999999999999999999999987765433222110 0000
Q ss_pred ----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 ----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 ----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
....+..+.++|.+||+.+|.+||++.+++.||||++.
T Consensus 259 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 259 WSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred HHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 12347789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.20 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=216.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ......+..|+.++..++||||+++++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD------------EEFRKQLLRELKTLRSCESPYVVKCYGAF 68 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc------------hHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 469999999999999999999999999999999854321 12456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
..+..+++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||+
T Consensus 69 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 69 YKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred ccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999999999998764 459999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... .......++..|+|||
T Consensus 147 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~pE 170 (264)
T cd06623 147 SKVLENTL--------------------------------------------------------DQCNTFVGTVTYMSPE 170 (264)
T ss_pred ceecccCC--------------------------------------------------------CcccceeecccccCHh
Confidence 87653211 0112345888999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCC--CCCC-CCHHHHHHHHHHhccCCCCCCCh
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILCRPP--DLVG-EPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~--~~~~-~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
.+.+..++.++|+||||+++|+|++|..||.... ..+....+..... .... .+..+.++|.+||..+|++||++
T Consensus 171 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~ 250 (264)
T cd06623 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSA 250 (264)
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCH
Confidence 9999889999999999999999999999998773 3444444443221 1223 57889999999999999999999
Q ss_pred HHHhcCCCcCCC
Q 014344 329 EEIKGHEFFKGV 340 (426)
Q Consensus 329 ~eil~hp~f~~~ 340 (426)
.+++.||||+..
T Consensus 251 ~~ll~~~~~~~~ 262 (264)
T cd06623 251 AELLQHPFIKKA 262 (264)
T ss_pred HHHHhCHHHHhc
Confidence 999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=337.12 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=209.7
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~ 92 (426)
..++|+.++.||+|+||.||++.+..+++.||+|.+.+.... .....+..|+.++.++. ||||++++
T Consensus 2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~------------~~~~~~~~e~~~l~~~~~~~~iv~~~ 69 (288)
T cd06616 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------------KEQKRLLMDLDVVMRSSDCPYIVKFY 69 (288)
T ss_pred cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh------------HHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 356788899999999999999999999999999998543211 23456788999999996 99999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEE
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRK---QQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~---~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++..+...+++|||+. ++|.++.. ......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.++
T Consensus 70 ~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k 148 (288)
T cd06616 70 GALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIK 148 (288)
T ss_pred eEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEE
Confidence 99999999999999996 56655432 2233569999999999999999999997 4999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++..+.... ......|++
T Consensus 149 l~dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~ 171 (288)
T cd06616 149 LCDFGISGQLVDSI---------------------------------------------------------AKTRDAGCR 171 (288)
T ss_pred EeecchhHHhccCC---------------------------------------------------------ccccccCcc
Confidence 99999987543110 112224888
Q ss_pred CCccchhhcCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC-CCC-----CCCCHHHHHHHHHHh
Q 014344 249 EYVAPEIIEGK---GHDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRP-PDL-----VGEPTPLRNLIRRLL 318 (426)
Q Consensus 249 ~y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~-----~~~~~~~~~li~~~L 318 (426)
.|+|||++.+. .++.++||||+||++|+|++|+.||..... .+...++.... +.. ...+..+.+||.+||
T Consensus 172 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 251 (288)
T cd06616 172 PYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCL 251 (288)
T ss_pred CccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHc
Confidence 99999999876 688999999999999999999999976542 22233332221 111 135678999999999
Q ss_pred ccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 319 EKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 319 ~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
+++|++|||+++|+.||||+...|..
T Consensus 252 ~~~p~~Rpt~~~i~~~~~~~~~~~~~ 277 (288)
T cd06616 252 IKDESKRPKYKELLEHPFIKDYEERN 277 (288)
T ss_pred cCChhhCcCHHHHhcChhhhchhhcc
Confidence 99999999999999999998755443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=327.28 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=207.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|+++++||+|+||.||+|.+..+ ..||+|++.+... ....+..|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~i~~~ 66 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLVQL 66 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--------------CHHHHHHHHHHHHhCCCCCcceE
Confidence 34557799999999999999999998665 4599999853211 12457789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++.+. +...|+||||+++++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~d 145 (262)
T cd05071 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 145 (262)
T ss_pred EEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEecc
Confidence 99875 45689999999999999998765445689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||.+..+..... .......++..|+
T Consensus 146 fg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 170 (262)
T cd05071 146 FGLARLIEDNEY-------------------------------------------------------TARQGAKFPIKWT 170 (262)
T ss_pred CCceeecccccc-------------------------------------------------------ccccCCcccceec
Confidence 999876532110 0011223677899
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||++.+..++.++|+|||||++|+|++ |..||.+....+....+... .+.....+..+.+||.+||+.+|++||++
T Consensus 171 ~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 250 (262)
T cd05071 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 250 (262)
T ss_pred CHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCH
Confidence 9999998889999999999999999999 89999988877776666433 22234567889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.++++
T Consensus 251 ~~~~~ 255 (262)
T cd05071 251 EYLQA 255 (262)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=329.78 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=213.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||.|+||.||+|.+.. ++.+|+|++..... .....+..|+.+++.++||||+++++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~ 69 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL-------------LKQQDFQKEVQALKRLRHKHLISLFA 69 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch-------------hhHHHHHHHHHHHhcCCCcchhheee
Confidence 34579999999999999999999977 89999999854321 12346778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++......++||||+++++|.+++.......++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g 149 (261)
T cd05148 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFG 149 (261)
T ss_pred eEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEcccc
Confidence 99999999999999999999999887666678999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... .......++..|+||
T Consensus 150 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~~P 173 (261)
T cd05148 150 LARLIKEDV--------------------------------------------------------YLSSDKKIPYKWTAP 173 (261)
T ss_pred chhhcCCcc--------------------------------------------------------ccccCCCCceEecCH
Confidence 987653211 001122356789999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+|||||++|+|++ |+.||.+.+..+.+..+... .+.....+..+.++|.+||+.||.+|||+.+
T Consensus 174 E~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (261)
T cd05148 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKA 253 (261)
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 99998889999999999999999998 89999988877777766532 2334566888999999999999999999999
Q ss_pred Hhc
Q 014344 331 IKG 333 (426)
Q Consensus 331 il~ 333 (426)
|++
T Consensus 254 l~~ 256 (261)
T cd05148 254 LRE 256 (261)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=327.83 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=208.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++.+.||+|+||.||+|++..+++.||||.+..... ........+..|+.+++.++||||++++++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM----------MDAKARQDCVKEIDLLKQLNHPNVIKYLDS 70 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc----------CCHHHHHHHHHHHHHHHhCCCcceeeeeee
Confidence 3679999999999999999999999999999998743211 112234567889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+.+.+..++||||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+||
T Consensus 71 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 71 FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred EEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999999887542 2345899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... .......|++.|+|
T Consensus 151 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~a 174 (267)
T cd08228 151 GLGRFFSSKT--------------------------------------------------------TAAHSLVGTPYYMS 174 (267)
T ss_pred ccceeccchh--------------------------------------------------------HHHhcCCCCccccC
Confidence 9987653211 01123358889999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhc--CCCCC-CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRILC--RPPDL-VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~--~~~~~-~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||.+.+..++.++|+||+||++|+|++|+.||..... ......+.. .++.. ...+..+.++|.+||..+|++||+
T Consensus 175 PE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 254 (267)
T cd08228 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPD 254 (267)
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcC
Confidence 9999988899999999999999999999999975532 233333322 11111 235678999999999999999999
Q ss_pred hHHHhcC
Q 014344 328 VEEIKGH 334 (426)
Q Consensus 328 ~~eil~h 334 (426)
+.++++.
T Consensus 255 ~~~vl~~ 261 (267)
T cd08228 255 IGYVHQI 261 (267)
T ss_pred HHHHHHH
Confidence 9999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=342.82 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=206.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|+||+||+|++..+++.||||.+..... .......+..|+.+++.++||||+++++++
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 73 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-----------NRIDAKRTLREIKLLRHLDHENVIAIKDIM 73 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-----------ccchhHHHHHHHHHHHhcCCCCccchHHhe
Confidence 469999999999999999999999999999998853211 112234567799999999999999999988
Q ss_pred ecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 STD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 ~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
... ..+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 74 PPPHREAFNDVYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred ecccccccCcEEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEC
Confidence 644 35899999995 7888877643 459999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++....... .......||..|
T Consensus 151 Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 174 (337)
T cd07858 151 DFGLARTTSEKG--------------------------------------------------------DFMTEYVVTRWY 174 (337)
T ss_pred cCccccccCCCc--------------------------------------------------------ccccccccccCc
Confidence 999987653210 112234578899
Q ss_pred ccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cC-----------------------C---
Q 014344 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CR-----------------------P--- 300 (426)
Q Consensus 251 ~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~-----------------------~--- 300 (426)
+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..+. .. .
T Consensus 175 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (337)
T cd07858 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQ 254 (337)
T ss_pred cChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCccccc
Confidence 99998865 468899999999999999999999998765433222111 00 0
Q ss_pred ---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 301 ---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 301 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
......+..+.+||++||+.+|++|||++++++||||+.+
T Consensus 255 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 255 SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0112456788999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=325.41 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=206.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCc----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSE----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+..|+++..||+|.||.||+|..+.++. .||||.+..+. +........-+|+.+++.+.||||+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-----------d~tGiS~SAcREiaL~REl~h~nvi 90 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-----------DGTGISMSACREIALLRELKHPNVI 90 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-----------CCCCcCHHHHHHHHHHHHhcCCcch
Confidence 45679999999999999999996654432 68999873321 1223345677799999999999999
Q ss_pred eeeeeeec-CCeEEEEEeccCCCChHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-
Q 014344 90 RLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQ---SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN- 164 (426)
Q Consensus 90 ~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~---~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~- 164 (426)
.+..+|.. +..+++++||++ -||..+++.+ ..+.++...++.++.||+.|+.|||++=|+||||||.|||+..+
T Consensus 91 ~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 91 SLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred hHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC
Confidence 99999977 899999999997 7888877643 23469999999999999999999999999999999999999987
Q ss_pred ---CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 165 ---GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 165 ---g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
|.|||+|||+++.+...... -...
T Consensus 170 perG~VKIaDlGlaR~~~~plkp-----------------------------------------------------l~s~ 196 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKP-----------------------------------------------------LASL 196 (438)
T ss_pred CccCeeEeecccHHHHhhccccc-----------------------------------------------------cccC
Confidence 89999999999987532110 0122
Q ss_pred cccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh---cCCC-----CC
Q 014344 242 NSFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---------ETFYRIL---CRPP-----DL 303 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~---~~~~-----~~ 303 (426)
...|-|..|+|||++.|. .|+.++||||+|||..||++-.+.|.+...+ .++.+|+ ..|. .+
T Consensus 197 d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~l 276 (438)
T KOG0666|consen 197 DPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDL 276 (438)
T ss_pred CceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhh
Confidence 345789999999999884 5899999999999999999999999765322 2333332 1111 00
Q ss_pred C------------------------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 V------------------------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 ~------------------------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
. ..++...+|+.+||++||-+|+|++++|+|+||..
T Consensus 277 kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 277 KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 0 01233679999999999999999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=337.89 Aligned_cols=251 Identities=30% Similarity=0.434 Sum_probs=208.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--C----Cc
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--P----LL 88 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p----~i 88 (426)
.++|+|++.||+|.||.|-.+.|..++..||||++..-. .......-|+++|.++.+ | -+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--------------kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--------------KYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--------------HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 456999999999999999999999999999999983211 123345669999999942 2 46
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-----
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE----- 163 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~----- 163 (426)
+.+.++|.-.+..|+|+|.+ |.++++++..+...+|+...++.+++|++.++++||+.+++|-||||||||+.+
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 78888999999999999998 679999999988889999999999999999999999999999999999999842
Q ss_pred ---------------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCC
Q 014344 164 ---------------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPD 228 (426)
Q Consensus 164 ---------------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (426)
+-.|+|+|||.|+....
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e------------------------------------------------ 264 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE------------------------------------------------ 264 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceecc------------------------------------------------
Confidence 23589999998876532
Q ss_pred CCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCCCC-
Q 014344 229 PPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE---TFYRILCRPPDLV- 304 (426)
Q Consensus 229 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~- 304 (426)
.-.+.|.|..|+|||++.+.++++.+||||+||||+|+.+|...|+..+..+ +..+|+...|...
T Consensus 265 -----------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi 333 (415)
T KOG0671|consen 265 -----------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMI 333 (415)
T ss_pred -----------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHh
Confidence 2245678999999999999999999999999999999999999999877655 4445543221100
Q ss_pred --------------C----------------C-------------CHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 305 --------------G----------------E-------------PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 305 --------------~----------------~-------------~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+ + -.++.|||++||.+||.+|+|+.|+|.||||+.
T Consensus 334 ~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 334 KKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 0 0 123789999999999999999999999999975
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=340.81 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=204.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+..|+.+++.++||||+++++++
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-------------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~ 71 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-------------PQSVKHALREIKIIRRLDHDNIVKVYEVL 71 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-------------CchHHHHHHHHHHHHhcCCCcchhhHhhh
Confidence 67999999999999999999999999999999884321 12345677899999999999999999876
Q ss_pred ecC--------------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee
Q 014344 96 STD--------------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI 161 (426)
Q Consensus 96 ~~~--------------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl 161 (426)
... ...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili 147 (342)
T cd07854 72 GPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI 147 (342)
T ss_pred cccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 543 36899999997 688877653 348999999999999999999999999999999999999
Q ss_pred cc-CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 162 QE-NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 162 ~~-~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
+. ++.++|+|||++..+...... ...
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~-----------------------------------------------------~~~ 174 (342)
T cd07854 148 NTEDLVLKIGDFGLARIVDPHYSH-----------------------------------------------------KGY 174 (342)
T ss_pred cCCCceEEECCcccceecCCcccc-----------------------------------------------------ccc
Confidence 84 567899999998765321100 000
Q ss_pred ccccccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------
Q 014344 241 SNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP------------------ 301 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------------ 301 (426)
....+|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....++...+
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (342)
T cd07854 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFV 254 (342)
T ss_pred cccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhh
Confidence 112257889999998754 5678899999999999999999999988776555444322110
Q ss_pred -------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 -------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 -------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+.+||.+||+.||.+|||+.+++.||||+.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 255 RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred hhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 012345678899999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=342.46 Aligned_cols=258 Identities=22% Similarity=0.342 Sum_probs=206.8
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
|.+..++|++++.||+|+||.||+|++. .+++.||+|++.... .....+.+..|+.+++++ +
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~------------~~~~~~~~~~E~~~~~~l~~ 69 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA------------TASEYKALMTELKILIHIGH 69 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC------------CHHHHHHHHHHHHHHHhhcc
Confidence 4556678999999999999999999754 345789999884321 112345677899999999 7
Q ss_pred CCCcceeeeeeec-CCeEEEEEeccCCCChHHHHHHhcc-----------------------------------------
Q 014344 85 HPLLPRLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQSE----------------------------------------- 122 (426)
Q Consensus 85 hp~iv~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~~----------------------------------------- 122 (426)
||||+++++++.. +..++++|||+++++|.+++.....
T Consensus 70 h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (337)
T cd05054 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIE 149 (337)
T ss_pred CcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccccccccc
Confidence 9999999998754 5678999999999999998764321
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCC
Q 014344 123 ------------------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184 (426)
Q Consensus 123 ------------------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~ 184 (426)
..++...+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~- 228 (337)
T cd05054 150 DKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD- 228 (337)
T ss_pred CcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc-
Confidence 2578999999999999999999999999999999999999999999999999986532110
Q ss_pred CCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChh
Q 014344 185 ASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFA 264 (426)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 264 (426)
........++..|+|||++.+..++.+
T Consensus 229 -----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~ 255 (337)
T cd05054 229 -----------------------------------------------------YVRKGDARLPLKWMAPESIFDKVYTTQ 255 (337)
T ss_pred -----------------------------------------------------hhhccCCCCCccccCcHHhcCCCCCcc
Confidence 001123346778999999999999999
Q ss_pred hHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 265 VDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 265 ~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+|||||||++|+|++ |..||.+....+.+...+.. .......+..+.+++.+||+.+|++||+++||++|
T Consensus 256 ~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 256 SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999997 99999876544444333322 12223457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=324.41 Aligned_cols=256 Identities=32% Similarity=0.521 Sum_probs=212.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||++.+..+++.||+|++...... ....+.+..|+.+++.++|+||+++++.+.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~ 69 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-----------PKTIKEIADEMKVLELLKHPNLVKYYGVEV 69 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-----------hHHHHHHHHHHHHHHhCCCCChhheeeeEe
Confidence 589999999999999999999999999999998544221 235678899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
....+++|+||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 70 HREKVYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccc
Confidence 999999999999999999987653 348899999999999999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
......... ........+++.|+|||++
T Consensus 148 ~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~~PE~~ 175 (264)
T cd06626 148 KLKNNTTTM----------------------------------------------------GEEVQSLAGTPAYMAPEVI 175 (264)
T ss_pred ccCCCCCcc----------------------------------------------------cccccCCcCCcCccChhhc
Confidence 764321100 0001224578899999999
Q ss_pred cCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcC-CCCC---CCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 257 EGKG---HDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCR-PPDL---VGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 257 ~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~-~~~~---~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
.+.. ++.++|||||||++|+|++|+.||..... ......+... .+.. ...+..+.+||++||+.+|.+|||+
T Consensus 176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (264)
T cd06626 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTA 255 (264)
T ss_pred cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCH
Confidence 8766 88999999999999999999999976533 3333333322 1111 2236788999999999999999999
Q ss_pred HHHhcCCCc
Q 014344 329 EEIKGHEFF 337 (426)
Q Consensus 329 ~eil~hp~f 337 (426)
.+++.|||+
T Consensus 256 ~~i~~~~~~ 264 (264)
T cd06626 256 SELLQHPFV 264 (264)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=330.49 Aligned_cols=253 Identities=29% Similarity=0.502 Sum_probs=212.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCcceeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLLPRLRG 93 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~ 93 (426)
.|++++.||+|+||.||+|.+..+++.||+|++.... .......+..|+.+++.+. |||++++++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~ 69 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT------------PDDDVSDIQREVALLSQLRQSQPPNITKYYG 69 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC------------CchhHHHHHHHHHHHHHhccCCCCCeeeEee
Confidence 5889999999999999999999999999999984321 1223456778999999996 999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++..+...|+||||++|++|.++++.. .+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||
T Consensus 70 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 70 SYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred eeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence 999999999999999999999987542 58999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+.... .......|++.|+||
T Consensus 147 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 170 (277)
T cd06917 147 VAALLNQNS--------------------------------------------------------SKRSTFVGTPYWMAP 170 (277)
T ss_pred ceeecCCCc--------------------------------------------------------cccccccCCcceeCH
Confidence 987654211 112234588999999
Q ss_pred hhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCC--CCCHHHHHHHHHHhccCCCCCCChH
Q 014344 254 EIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLV--GEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 254 E~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~--~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|.+.+ ..++.++|+|||||++|+|++|..||.+.........+... ++... ..+..+.++|.+||..||++||++.
T Consensus 171 E~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 250 (277)
T cd06917 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAE 250 (277)
T ss_pred HHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHH
Confidence 99875 45688999999999999999999999887765544433222 22222 2567899999999999999999999
Q ss_pred HHhcCCCcCCC
Q 014344 330 EIKGHEFFKGV 340 (426)
Q Consensus 330 eil~hp~f~~~ 340 (426)
+++.||||+..
T Consensus 251 ~il~~~~~~~~ 261 (277)
T cd06917 251 ELLKSKWIKAH 261 (277)
T ss_pred HHhhChHhhcc
Confidence 99999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=315.07 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=204.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
++-++|+|.+.||.|||+.||+++...+++.||+|.+.... .+..+..++|++..++++|||+++++
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-------------~~~~e~~~rEid~~rkf~s~~vl~l~ 84 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-------------QEDIEEALREIDNHRKFNSPNVLRLV 84 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-------------hHHHHHHHHHHHHHHhhCCcchHHHH
Confidence 55678999999999999999999999999999999984432 23567889999999999999999998
Q ss_pred eeeecC-----CeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeecc
Q 014344 93 GVLSTD-----KFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQE 163 (426)
Q Consensus 93 ~~~~~~-----~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~~ 163 (426)
+....+ ...|+++.|...|+|.+.++.. .+..+++.++..|+.+|+.||++||+.. ++||||||.|||+.+
T Consensus 85 dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~ 164 (302)
T KOG2345|consen 85 DHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD 164 (302)
T ss_pred HHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC
Confidence 876433 3599999999999999987644 2336999999999999999999999998 999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.++|.|||.++...-.... +........|..
T Consensus 165 ~~~~vl~D~GS~~~a~i~i~~-----------~~~a~~lQe~a~------------------------------------ 197 (302)
T KOG2345|consen 165 SGLPVLMDLGSATQAPIQIEG-----------SRQALRLQEWAE------------------------------------ 197 (302)
T ss_pred CCceEEEeccCccccceEeec-----------hHHHHHHHHHHH------------------------------------
Confidence 999999999998865321100 000000011111
Q ss_pred cccCCCCccchhhcCCCC---ChhhHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh---cCCCCCCCCCHHHHHHHH
Q 014344 244 FVGTEEYVAPEIIEGKGH---DFAVDWWSLGVVLHEMLYGATPFRGSSRK--ETFYRIL---CRPPDLVGEPTPLRNLIR 315 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~---~~~~~~~~~~~~~~~li~ 315 (426)
-..|..|+|||++..+.+ +.++|||||||++|+|++|..||...-.. .....+. ...|.....+..+.+||.
T Consensus 198 e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik 277 (302)
T KOG2345|consen 198 ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIK 277 (302)
T ss_pred HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHH
Confidence 125788999999987654 78999999999999999999999643210 0000011 112222336888999999
Q ss_pred HHhccCCCCCCChHHHhcC
Q 014344 316 RLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 316 ~~L~~dP~~R~s~~eil~h 334 (426)
.||+.||.+||++.+++.+
T Consensus 278 ~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 278 SMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHhcCCcccCCCHHHHHHH
Confidence 9999999999999999865
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=326.27 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=205.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+..+.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++|+||++++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~ 71 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-------------SRYVQPLHEEIALHSYLKHRNIVQYL 71 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-------------HHHHHHHHHHHHHHHhcCCCCeeeee
Confidence 34455556678999999999999999999999999874321 12345788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEE
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMF--SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIML 169 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l--~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL 169 (426)
+++..+...++|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 72 GSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred eeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEE
Confidence 99999999999999999999999887543 235 78889999999999999999999999999999999986 679999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... .......|++.
T Consensus 151 ~dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~ 174 (268)
T cd06624 151 SDFGTSKRLAGIN--------------------------------------------------------PCTETFTGTLQ 174 (268)
T ss_pred ecchhheecccCC--------------------------------------------------------CccccCCCCcc
Confidence 9999987543111 01112347889
Q ss_pred CccchhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH-h-cC-CCCCCCCCHHHHHHHHHHhccCCC
Q 014344 250 YVAPEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRI-L-CR-PPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 250 y~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i-~-~~-~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
|+|||++.+.. ++.++|+||+||++|+|++|+.||...... ...... . .. +......+..+.+||.+||..+|.
T Consensus 175 ~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 254 (268)
T cd06624 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPD 254 (268)
T ss_pred ccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCch
Confidence 99999987643 788999999999999999999999764322 111111 1 11 122234577899999999999999
Q ss_pred CCCChHHHhcCCCc
Q 014344 324 KRIGVEEIKGHEFF 337 (426)
Q Consensus 324 ~R~s~~eil~hp~f 337 (426)
+|||+.+++.||||
T Consensus 255 ~Rpt~~~ll~~~~~ 268 (268)
T cd06624 255 KRASAHDLLQDPFL 268 (268)
T ss_pred hCCCHHHHHhCCCC
Confidence 99999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=323.16 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=218.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+..|+++++.++|||++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 69 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-----------SEKEREDALNEVKILKKLNHPNIIKYYESFE 69 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-----------ChHHHHHHHHHHHHHHhcCCCChhheEEEEe
Confidence 58999999999999999999999999999999854321 1234556788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.....++|+||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999999887653 35699999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... .......|++.|+|||
T Consensus 150 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~pe 173 (258)
T cd08215 150 SKVLSSTV--------------------------------------------------------DLAKTVVGTPYYLSPE 173 (258)
T ss_pred eeecccCc--------------------------------------------------------ceecceeeeecccChh
Confidence 87653211 1122346889999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+.+..++.++|+||+|+++|+|++|..||...+..+.......... .....+..+.++|.+||..+|++|||+.++|
T Consensus 174 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred HhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 99988899999999999999999999999988877666665544321 2224578899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
.||||
T Consensus 254 ~~~~~ 258 (258)
T cd08215 254 QSPFI 258 (258)
T ss_pred cCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=328.56 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=211.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCC-----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVES-----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.+..++|++++.||+|+||.||+|.+... +..||+|.+.... .......+..|+.+|+.++||
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~------------~~~~~~~~~~e~~~l~~~~~~ 69 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA------------SMRERIEFLNEASVMKEFNCH 69 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc------------CHHHHHHHHHHHHHHHhCCCC
Confidence 56778999999999999999999998644 3789999974321 112345677899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCC
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPEN 158 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~N 158 (426)
||+++++++......|+||||+++++|.+++.... ...+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 70 ~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~n 149 (277)
T cd05032 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149 (277)
T ss_pred ceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChhe
Confidence 99999999999999999999999999999876532 1236788999999999999999999999999999999
Q ss_pred eeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 159 iLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
||++.++.+||+|||+++.+..... .
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------------~ 175 (277)
T cd05032 150 CMVAEDLTVKIGDFGMTRDIYETDY------------------------------------------------------Y 175 (277)
T ss_pred EEEcCCCCEEECCcccchhhccCcc------------------------------------------------------c
Confidence 9999999999999999876532110 0
Q ss_pred CCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHH
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIR 315 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~ 315 (426)
.......+|..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......+..+.++|.
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 255 (277)
T cd05032 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMR 255 (277)
T ss_pred ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 01122346788999999988889999999999999999998 999999888777666555321 223345788999999
Q ss_pred HHhccCCCCCCChHHHhc
Q 014344 316 RLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 316 ~~L~~dP~~R~s~~eil~ 333 (426)
+||+.+|++|||+.+|++
T Consensus 256 ~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 256 MCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=328.73 Aligned_cols=256 Identities=19% Similarity=0.280 Sum_probs=209.8
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.+++.++|+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~ 70 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC------------SEQDESDFLMEALIMSKFNHQN 70 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 445779999999999999999999977 77889999874321 1112346788999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-----QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-----~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~ 162 (426)
|+++++++......++||||+.|++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~ 150 (277)
T cd05036 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLT 150 (277)
T ss_pred EeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEe
Confidence 99999999999999999999999999999876532 2488999999999999999999999999999999999998
Q ss_pred cCC---cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 163 ENG---HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239 (426)
Q Consensus 163 ~~g---~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (426)
.++ .+||+|||++..+..... ..
T Consensus 151 ~~~~~~~~kl~dfg~~~~~~~~~~------------------------------------------------------~~ 176 (277)
T cd05036 151 CKGPGRVAKIADFGMARDIYRASY------------------------------------------------------YR 176 (277)
T ss_pred ccCCCcceEeccCccccccCCccc------------------------------------------------------ee
Confidence 765 699999999886532110 00
Q ss_pred CccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHH
Q 014344 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRR 316 (426)
Q Consensus 240 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~ 316 (426)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... .......+..+.++|.+
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 256 (277)
T cd05036 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTD 256 (277)
T ss_pred cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 0111224567999999998889999999999999999996 99999988776665554432 22234567889999999
Q ss_pred HhccCCCCCCChHHHhcC
Q 014344 317 LLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~h 334 (426)
||+.+|++||++.++++|
T Consensus 257 cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 257 CWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=330.50 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=213.7
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
-|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 72 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA------------EDEIEDIQQEITVLSQCDSPYVTKYYGSYL 72 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc------------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEE
Confidence 48899999999999999999999999999998743211 123467888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+...|+||||+.+++|..++.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 73 KDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred eCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999999999988763 348999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+.... .......|+..|+|||.+
T Consensus 150 ~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 150 QLTDTQ--------------------------------------------------------IKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred ecccch--------------------------------------------------------hhhccccCCccccChhhh
Confidence 553210 011233578899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C-CCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-D-LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~-~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+||+||++|+|++|..||...........+..... . ....+..+.++|.+||..+|.+||++.++++|
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 888889999999999999999999999988776655555433222 1 22457889999999999999999999999999
Q ss_pred CCcCC
Q 014344 335 EFFKG 339 (426)
Q Consensus 335 p~f~~ 339 (426)
|||..
T Consensus 254 ~~~~~ 258 (277)
T cd06641 254 KFIVR 258 (277)
T ss_pred HHHhh
Confidence 99965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.15 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=211.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
++..++|++.+.||+|++|.||+|.+. +++.||+|.+..... ..+.+..|+.++++++||||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM--------------DPKDFLAEAQIMKKLRHPKLIQL 66 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc--------------cHHHHHHHHHHHHHCCCCCccce
Confidence 466778999999999999999999975 457899999843211 13457789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++...+.+|+||||+.|++|.+++.......++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus 67 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d 146 (261)
T cd05068 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVAD 146 (261)
T ss_pred eEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECC
Confidence 99999999999999999999999998765545689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++........ .......++..|+
T Consensus 147 fg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 171 (261)
T cd05068 147 FGLARVIKEDIY-------------------------------------------------------EAREGAKFPIKWT 171 (261)
T ss_pred cceEEEccCCcc-------------------------------------------------------cccCCCcCceecc
Confidence 999887641100 0000112345799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||++.+..++.++|+|||||++|+|++ |+.||.+.+....+..+.... +.....+..+.+++.+||..+|.+||++
T Consensus 172 aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred CccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCH
Confidence 9999999899999999999999999998 999999888777666664332 2334567889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
++|+.
T Consensus 252 ~~l~~ 256 (261)
T cd05068 252 ETLQW 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=326.33 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=208.3
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|+++++||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++||+++++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--------------~~~~~~~E~~~l~~l~~~~i~~~ 66 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--------------SPESFLEEAQIMKKLRHDKLVQL 66 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--------------CHHHHHHHHHHHHhcCCCceEEE
Confidence 456678999999999999999999875 566799999854211 12457889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++. ....|++|||+.+++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|
T Consensus 67 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~d 145 (260)
T cd05070 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIAD 145 (260)
T ss_pred EeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCC
Confidence 99885 45689999999999999998765555689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+..... .......++..|+
T Consensus 146 fg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 170 (260)
T cd05070 146 FGLARLIEDNEY-------------------------------------------------------TARQGAKFPIKWT 170 (260)
T ss_pred ceeeeeccCccc-------------------------------------------------------ccccCCCCCcccc
Confidence 999876532110 0011223566799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....+... .+.....+..+.+||.+||..+|.+|||+
T Consensus 171 aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred ChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCH
Confidence 9999988889999999999999999999 99999988877776666533 22334567889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.+++.
T Consensus 251 ~~l~~ 255 (260)
T cd05070 251 EYLQS 255 (260)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=325.41 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=211.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.++|++.+.||+|+||+||+|....+ ...||+|++.... .......+..|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~ 69 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS------------SDKQRLDFLTEASIMGQFDHPNIIR 69 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC------------ChHHHHHHHHHHHHHHhCCCCCcce
Confidence 457899999999999999999998654 4579999874321 1123456778999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+
T Consensus 70 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~ 148 (266)
T cd05033 70 LEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVS 148 (266)
T ss_pred EeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEEC
Confidence 9999999999999999999999999987644 358999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+..... ........+++.|
T Consensus 149 dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y 174 (266)
T cd05033 149 DFGLSRRLEDSEA------------------------------------------------------TYTTKGGKIPIRW 174 (266)
T ss_pred ccchhhccccccc------------------------------------------------------ceeccCCCCCccc
Confidence 9999987641110 0001112356789
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||.+.+..++.++|||||||++|+|++ |..||......+....+.. ..+.....+..+.+|+.+||+.+|++||+
T Consensus 175 ~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~ 254 (266)
T cd05033 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPT 254 (266)
T ss_pred cChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 99999999899999999999999999997 9999988777666665543 22334466889999999999999999999
Q ss_pred hHHHhcC
Q 014344 328 VEEIKGH 334 (426)
Q Consensus 328 ~~eil~h 334 (426)
+.+|+++
T Consensus 255 ~~ei~~~ 261 (266)
T cd05033 255 FSQIVST 261 (266)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=332.30 Aligned_cols=256 Identities=20% Similarity=0.329 Sum_probs=212.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC-----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES-----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+++.+|++++.||+|+||+||+|.+..+ ++.||||++.... .......+..|+.+++.++|||
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~h~~ 69 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA------------EGPLREEFKHEAMMRSRLQHPN 69 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC------------CHHHHHHHHHHHHHHhcCCCCC
Confidence 5678899999999999999999987543 5789999985321 1123456788999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
|+++++++......++++||+.+++|.+++.... ...++...+..++.|++.||.|||++||+|||
T Consensus 70 iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~d 149 (283)
T cd05091 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKD 149 (283)
T ss_pred cCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 9999999999999999999999999999875321 23478889999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+|||++.++.+||+|||+++.......
T Consensus 150 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------- 179 (283)
T cd05091 150 LATRNVLVFDKLNVKISDLGLFREVYAADY-------------------------------------------------- 179 (283)
T ss_pred cchhheEecCCCceEecccccccccccchh--------------------------------------------------
Confidence 999999999999999999999876532110
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~ 310 (426)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+....+..... ...+.+..+
T Consensus 180 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 255 (283)
T cd05091 180 ----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWV 255 (283)
T ss_pred ----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 001122346788999999988889999999999999999997 9999998888777776654432 234568889
Q ss_pred HHHHHHHhccCCCCCCChHHHhcC
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+|+.+||+.+|.+||++++|+..
T Consensus 256 ~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 256 YTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHhCCCcccCCCHHHHHHH
Confidence 999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.09 Aligned_cols=247 Identities=21% Similarity=0.346 Sum_probs=207.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.++..+|++.+.||+|+||.||++.. .+..+|+|.+... ...+.+..|+.+++.++|+++++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~ 63 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---------------ATAQAFLAEASVMTQLRHSNLVQ 63 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC---------------chHHHHHHHHHHHHhCCCCCeee
Confidence 356788999999999999999999975 4788999987322 12346778999999999999999
Q ss_pred eeeee-ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 91 LRGVL-STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 91 l~~~~-~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+++++ ..+...|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus 64 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl 143 (256)
T cd05082 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKV 143 (256)
T ss_pred EEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEe
Confidence 99875 55678999999999999999987765556899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ....++..
T Consensus 144 ~dfg~~~~~~~~~-----------------------------------------------------------~~~~~~~~ 164 (256)
T cd05082 144 SDFGLTKEASSTQ-----------------------------------------------------------DTGKLPVK 164 (256)
T ss_pred cCCccceeccccC-----------------------------------------------------------CCCcccee
Confidence 9999887542110 11124567
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.... ......+..+.++|.+||..+|++||
T Consensus 165 y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 244 (256)
T cd05082 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRP 244 (256)
T ss_pred ecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCc
Confidence 999999999889999999999999999997 999999887766665554322 22335678899999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|+.++++
T Consensus 245 t~~~l~~ 251 (256)
T cd05082 245 SFLQLRE 251 (256)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=326.13 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=207.6
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
+..+|++.+.||+|+||.||+|.+. ++..+|+|++.+... ....+..|+.+++.++||||+++++
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--------------SEDDFIEEAKVMMKLSHPNLVQLYG 66 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--------------CHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 4567999999999999999999875 467899999843211 1235677999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++......|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 67 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg 145 (256)
T cd05059 67 VCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFG 145 (256)
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcc
Confidence 9999999999999999999999887544 358999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++........ .......++..|+||
T Consensus 146 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~P 170 (256)
T cd05059 146 LARYVLDDQY-------------------------------------------------------TSSQGTKFPVKWAPP 170 (256)
T ss_pred cceecccccc-------------------------------------------------------cccCCCCCCccccCH
Confidence 9875431100 000011234579999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+|||||++|+|++ |..||...+..+....+... .......+..+.+++.+||..+|++|||+.+
T Consensus 171 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 99999999999999999999999998 89999888777666665433 2233456889999999999999999999999
Q ss_pred HhcC
Q 014344 331 IKGH 334 (426)
Q Consensus 331 il~h 334 (426)
+++.
T Consensus 251 ~l~~ 254 (256)
T cd05059 251 LLSQ 254 (256)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=334.37 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=210.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|++++.||+|+||+||+|.+..+++.||+|++..... ........+..|+.+++.++||||+++++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----------~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK----------QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc----------CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 459999999999999999999999999999999843211 1123446788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+...|+||||+. |+|.+++.... +.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~ 162 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA 162 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcc
Confidence 99999999999997 66766665433 45899999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..... .....|++.|+|||+
T Consensus 163 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~ 182 (307)
T cd06607 163 SLVSP------------------------------------------------------------ANSFVGTPYWMAPEV 182 (307)
T ss_pred eecCC------------------------------------------------------------CCCccCCccccCcee
Confidence 64321 112357888999998
Q ss_pred hc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC--CCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 256 IE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PDL--VGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 256 ~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~--~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+. ...++.++|||||||++|+|++|..||.+.+.......+.... +.. ...+..+.++|.+||..+|++||++.
T Consensus 183 ~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 262 (307)
T cd06607 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSE 262 (307)
T ss_pred eeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHH
Confidence 74 3557889999999999999999999999887766655554332 221 23467899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
+|+.||||..
T Consensus 263 ~il~~~~~~~ 272 (307)
T cd06607 263 ELLKHRFVLR 272 (307)
T ss_pred HHhcChhhcc
Confidence 9999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.85 Aligned_cols=251 Identities=18% Similarity=0.251 Sum_probs=207.8
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
++.++|++++.||+|+||+||++.... +..+|+|.+..... ....+..|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~~~ 65 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM--------------SEDEFIEEAKVMMKLSHEKLVQLY 65 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc--------------cHHHHHHHHHHHhcCCCCCeeeEE
Confidence 356789999999999999999998643 45699998743211 124577899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++.....+|+||||+.+++|.+++..... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+||
T Consensus 66 ~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~ 144 (256)
T cd05113 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDF 144 (256)
T ss_pred EEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCC
Confidence 999999999999999999999998875433 5899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++........ .......++..|+|
T Consensus 145 g~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~ 169 (256)
T cd05113 145 GLSRYVLDDEY-------------------------------------------------------TSSVGSKFPVRWSP 169 (256)
T ss_pred ccceecCCCce-------------------------------------------------------eecCCCccChhhCC
Confidence 98875421100 00011235677999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||.+.+..++.++|+|||||++|+|++ |..||...+..+....+..... .....+..+.+++.+||..+|.+||++.
T Consensus 170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 249 (256)
T cd05113 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQ 249 (256)
T ss_pred HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 999998889999999999999999998 9999988877666666654322 2234578899999999999999999999
Q ss_pred HHhcC
Q 014344 330 EIKGH 334 (426)
Q Consensus 330 eil~h 334 (426)
+|+.+
T Consensus 250 ~ll~~ 254 (256)
T cd05113 250 QLLSS 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=348.25 Aligned_cols=244 Identities=27% Similarity=0.443 Sum_probs=210.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.|++.++...-++-||+|+.|.||+++. .++.||||.+.. .-..+++-|++|+||||+
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e--------------------lkETdIKHLRkLkH~NII 175 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE--------------------LKETDIKHLRKLKHPNII 175 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhh--------------------hhhhhHHHHHhccCccee
Confidence 6778888888899999999999999985 468999998721 112378889999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.+.+++...-++|||||||..|-|+..++.. ..++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||
T Consensus 176 ~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKI 253 (904)
T KOG4721|consen 176 TFKGVCTQSPCYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKI 253 (904)
T ss_pred eEeeeecCCceeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEe
Confidence 9999999999999999999999999998754 45899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||-++..... ....+|+||..
T Consensus 254 sDFGTS~e~~~~---------------------------------------------------------STkMSFaGTVa 276 (904)
T KOG4721|consen 254 SDFGTSKELSDK---------------------------------------------------------STKMSFAGTVA 276 (904)
T ss_pred ccccchHhhhhh---------------------------------------------------------hhhhhhhhhHh
Confidence 999988765321 23567899999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||||+|+..+.+.++|||||||+|||||||..||..-+...+..-+- -..+.+..+|..++=||+.||.-.|.+||
T Consensus 277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP 356 (904)
T KOG4721|consen 277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP 356 (904)
T ss_pred hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence 999999999999999999999999999999999998776654433221 12233345678899999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
++.+||.|
T Consensus 357 SFrqil~H 364 (904)
T KOG4721|consen 357 SFRQILLH 364 (904)
T ss_pred cHHHHHHH
Confidence 99999998
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=322.93 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=201.7
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|.+..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 68 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL------------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 68 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC------------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCe
Confidence 46899999999999999999999999874321 122346788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
|+||||+.+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 69 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 69 YIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence 99999999999999886543 35899999999999999999999999999999999999999999999999998754311
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
... .......++..|+|||.+.+..+
T Consensus 148 ~~~------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 148 VYA------------------------------------------------------STGGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred ccc------------------------------------------------------ccCCCCCCceeecCchhhcCCCC
Confidence 000 00001123457999999999889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 262 DFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.++|+|||||++|+|++ |..||...+.......+... .+.....+..+.+|+.+||+.+|++|||+.++++
T Consensus 174 ~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 174 SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999997 99999877766555544432 2223345788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=345.28 Aligned_cols=258 Identities=19% Similarity=0.265 Sum_probs=208.4
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCC-----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVES-----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
-++.+.++|++++.||+|+||+||+|.+... +..||||++.... .......+.+|+.+|+++.
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~------------~~~~~~~~~~Ei~~l~~l~ 98 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA------------RSSEKQALMSELKIMTHLG 98 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC------------ChHHHHHHHHHHHHHHhcC
Confidence 4567788899999999999999999987433 3469999984321 1123457888999999996
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc------------------------------------------
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS------------------------------------------ 121 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~------------------------------------------ 121 (426)
||||+++++++.....+|+|||||++|+|.+++....
T Consensus 99 ~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (400)
T cd05105 99 PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYM 178 (400)
T ss_pred CCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccc
Confidence 9999999999999999999999999999998876431
Q ss_pred ----------------------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 122 ----------------------------------------------------EQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 122 ----------------------------------------------------~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
...+++..+..++.||+.||+|||+.||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i 258 (400)
T cd05105 179 DMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC 258 (400)
T ss_pred ccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 1247788889999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
+||||||+|||++.++.+||+|||++..+.....
T Consensus 259 vH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~---------------------------------------------- 292 (400)
T cd05105 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---------------------------------------------- 292 (400)
T ss_pred eCCCCChHhEEEeCCCEEEEEeCCcceecccccc----------------------------------------------
Confidence 9999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVG 305 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~ 305 (426)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||........+...+.. .+....
T Consensus 293 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (400)
T cd05105 293 --------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDH 364 (400)
T ss_pred --------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCcc
Confidence 001123357788999999999999999999999999999997 99999876554444333222 223345
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+..+.++|.+||+.||++||++.+|.+
T Consensus 365 ~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 365 ATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred CCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 6788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=341.21 Aligned_cols=251 Identities=30% Similarity=0.462 Sum_probs=209.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.++||||++++++
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-----------SAIHAKRTYRELRLLKHMDHENVIGLLDV 82 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-----------hhhHHHHHHHHHHHHHhccCCCHHHHHHH
Confidence 4579999999999999999999999999999998853211 11234567789999999999999999998
Q ss_pred eecCCe------EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTDKF------VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~~~------~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+..... +|+|+||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 83 FTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred hhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEE
Confidence 876654 89999999 6799988764 3499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++...... .....+|+
T Consensus 159 L~dfg~~~~~~~~-----------------------------------------------------------~~~~~~~~ 179 (343)
T cd07851 159 ILDFGLARHTDDE-----------------------------------------------------------MTGYVATR 179 (343)
T ss_pred Ecccccccccccc-----------------------------------------------------------ccCCcccc
Confidence 9999998754211 12235788
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------------------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-------------------------- 301 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------------------------- 301 (426)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.....
T Consensus 180 ~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (343)
T cd07851 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMP 259 (343)
T ss_pred cccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccC
Confidence 9999999865 4678999999999999999999999988776665554432110
Q ss_pred ------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 302 ------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 302 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.....+..+.+||.+||..||.+|||+.+|+.||||+.
T Consensus 260 ~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 260 KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred CCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 01234778999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=323.53 Aligned_cols=258 Identities=25% Similarity=0.430 Sum_probs=213.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++.+.||+|+||.||+|.+..+++.||+|++...... .........+.+|+.++++++||||+++++.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--------~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 73 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS--------QETSKEVNALECEIQLLKNLRHDRIVQYYGCL 73 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCccc--------chhhHHHHHHHHHHHHHHHcCCCCcceEEEEE
Confidence 5799999999999999999999999999999987432110 01123456788899999999999999999998
Q ss_pred ecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 96 STD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 96 ~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.+. ..++++|||++|++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 74 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 74 RDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccc
Confidence 664 56899999999999999876543 48899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++........ .........|+..|+||
T Consensus 152 ~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~y~aP 178 (264)
T cd06653 152 ASKRIQTICM-----------------------------------------------------SGTGIKSVTGTPYWMSP 178 (264)
T ss_pred cccccccccc-----------------------------------------------------cCccccccCCcccccCH
Confidence 9876532100 00011234588999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+|||||++|+|++|+.||..........++...+. .....+..+.++|.+||. +|.+||++.+
T Consensus 179 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 179 EVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred hhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 999998899999999999999999999999988777666666553322 233457889999999999 5799999999
Q ss_pred HhcCCCc
Q 014344 331 IKGHEFF 337 (426)
Q Consensus 331 il~hp~f 337 (426)
++.|||.
T Consensus 258 ~~~~~~~ 264 (264)
T cd06653 258 LLRHPFV 264 (264)
T ss_pred HhcCCCC
Confidence 9999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=323.72 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=212.9
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
++..++|++.+.||+|+||+||+|.+. +++.+|||.+.... .....+..|+.+++.++||||+++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~ 66 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT--------------MSPEAFLQEAQIMKKLRHDKLVQL 66 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc--------------cCHHHHHHHHHHHhhCCCCCEeee
Confidence 567789999999999999999999975 45789999884321 123467889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++......++||||+++++|.+++.......++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|
T Consensus 67 ~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d 146 (261)
T cd05034 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIAD 146 (261)
T ss_pred eeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECc
Confidence 99999989999999999999999998776555699999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+..... .......++..|+
T Consensus 147 ~g~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 171 (261)
T cd05034 147 FGLARLIEDDEY-------------------------------------------------------TAREGAKFPIKWT 171 (261)
T ss_pred cccceeccchhh-------------------------------------------------------hhhhccCCCcccc
Confidence 999876532100 0001112456799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+.+..++.++|+||+||++|+|++ |+.||.+.+.......+... .+.....+..+.+++.+||..+|.+||++
T Consensus 172 ~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 251 (261)
T cd05034 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTF 251 (261)
T ss_pred CHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 9999999889999999999999999998 99999988877777776543 23334557889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
++++.
T Consensus 252 ~~l~~ 256 (261)
T cd05034 252 EYLQS 256 (261)
T ss_pred HHHHH
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=330.86 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=213.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCC-----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESS-----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
...+..++|++.+.||+|+||.||++.....+ ..+|+|++.... .......+..|+.+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~~E~~~l~~l~ 73 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA------------TEKDLSDLVSEMEMMKMIG 73 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC------------CHHHHHHHHHHHHHHHhhc
Confidence 45677789999999999999999999986443 689999884321 112345678899999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ--------------SEQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~--------------~~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
+||||+++++++..+..++++|||+++++|..++... ....+++..+..++.||+.||+|||++||
T Consensus 74 ~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i 153 (293)
T cd05053 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC 153 (293)
T ss_pred CCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 7999999999999999999999999999999998642 23468999999999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
+||||||+|||++.++.+||+|||++..+.....
T Consensus 154 vH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---------------------------------------------- 187 (293)
T cd05053 154 IHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY---------------------------------------------- 187 (293)
T ss_pred cccccceeeEEEcCCCeEEeCccccccccccccc----------------------------------------------
Confidence 9999999999999999999999999886542110
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGE 306 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~ 306 (426)
........++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+.+..+.... ......
T Consensus 188 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (293)
T cd05053 188 --------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNC 259 (293)
T ss_pred --------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 000111124667999999999999999999999999999997 999999887776666554332 223355
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+..+.+|+.+||..||.+|||+.+++++
T Consensus 260 ~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 260 TQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.13 Aligned_cols=254 Identities=20% Similarity=0.288 Sum_probs=210.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++..+|++.++||+|+||.||+|... .++..+|+|.+.... ......+..|+++++.++|||
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~ 68 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-------------ESARQDFQREAELLTVLQHQH 68 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-------------HHHHHHHHHHHHHHhcCCCCC
Confidence 46678999999999999999999753 356689999874321 123457888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-------------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDL 154 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-------------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDl 154 (426)
|+++++++......+++|||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dl 148 (280)
T cd05092 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDL 148 (280)
T ss_pred CceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 99999999999999999999999999998875432 24889999999999999999999999999999
Q ss_pred CCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 155 KPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSD 234 (426)
Q Consensus 155 Kp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (426)
||+|||+++++.+||+|||++........
T Consensus 149 kp~nil~~~~~~~kL~dfg~~~~~~~~~~--------------------------------------------------- 177 (280)
T cd05092 149 ATRNCLVGQGLVVKIGDFGMSRDIYSTDY--------------------------------------------------- 177 (280)
T ss_pred cHhhEEEcCCCCEEECCCCceeEcCCCce---------------------------------------------------
Confidence 99999999999999999999875532110
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHH
Q 014344 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLR 311 (426)
Q Consensus 235 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~ 311 (426)
........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+....+.... ......+..+.
T Consensus 178 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (280)
T cd05092 178 ---YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVY 254 (280)
T ss_pred ---eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHH
Confidence 001122336788999999999999999999999999999998 999998877776666554432 22335678899
Q ss_pred HHHHHHhccCCCCCCChHHHhc
Q 014344 312 NLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 312 ~li~~~L~~dP~~R~s~~eil~ 333 (426)
+||.+||+.||.+||++++|+.
T Consensus 255 ~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 255 AIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=323.65 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=207.6
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|+++++||+|+||.||+|... +++.||+|.+..... ....+.+|+.+++.++||||+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--------------SPEAFLAEANLMKQLQHPRLVRL 66 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--------------cHHHHHHHHHHHHhcCCcCeeeE
Confidence 345567999999999999999999864 567899998843211 23467789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++ ..+.+|++|||+.+++|.+++.......++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|
T Consensus 67 ~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05067 67 YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIAD 145 (260)
T ss_pred EEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEcc
Confidence 9987 456789999999999999988766556689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++........ .......++..|+
T Consensus 146 fg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 170 (260)
T cd05067 146 FGLARLIEDNEY-------------------------------------------------------TAREGAKFPIKWT 170 (260)
T ss_pred CcceeecCCCCc-------------------------------------------------------ccccCCccccccc
Confidence 999876531100 0011223567899
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||++.+..++.++|+|||||++|+|++ |++||.+.+..+....+... .+.....+..+.++|.+||..+|++||++
T Consensus 171 ~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred CHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999998889999999999999999998 99999988776665554332 22333457889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
++++.
T Consensus 251 ~~l~~ 255 (260)
T cd05067 251 EYLRS 255 (260)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.19 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=207.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|++++.||.|+||.||+|.+..+++.+|||++...... ......+.+|+.+++.++||||+++++
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-----------DGFPITALREIKILKKLKHPNVVPLID 74 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-----------CCcchhHHHHHHHHHhcCCCCccchhh
Confidence 368899999999999999999999999999999998543211 111234567999999999999999999
Q ss_pred eeec--------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 94 VLST--------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 94 ~~~~--------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
++.. ...+|+||||+. ++|...+... ...+++..++.++.||+.||+|||++||+||||||+|||+++++
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~ 152 (311)
T cd07866 75 MAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG 152 (311)
T ss_pred heecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 8743 335799999996 5676665443 34599999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++............ ............+
T Consensus 153 ~~~l~dfg~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~ 187 (311)
T cd07866 153 ILKIADFGLARPYDGPPPNPKG---------------------------------------------GGGGGTRKYTNLV 187 (311)
T ss_pred CEEECcCccchhccCCCccccc---------------------------------------------CCcccccccccce
Confidence 9999999999765422110000 0000112234457
Q ss_pred cCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC-----------C--------
Q 014344 246 GTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP-----------D-------- 302 (426)
Q Consensus 246 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~-----------~-------- 302 (426)
|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+... +. .
T Consensus 188 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (311)
T cd07866 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFT 267 (311)
T ss_pred eccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCC
Confidence 89999999988764 5789999999999999999999999988776554443210 00 0
Q ss_pred ---------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 ---------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 ---------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.......+.+||.+||+.||.+|||+.+++.||||
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 268 NYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 01223568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=338.22 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=205.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.+... .......+..|+.+++.++||||+++++++
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 83 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-----------SEIFAKRAYRELTLLKHMQHENVIGLLDVF 83 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-----------cccchhHHHHHHHHHHhcCCCCccchhhee
Confidence 579999999999999999999999999999999854211 112334677899999999999999999998
Q ss_pred ecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.... .+|+|+||+. .+|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 84 TSAVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred cccccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 6543 4699999996 5666553 234899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... ......||+.
T Consensus 159 ~dfg~~~~~~~-----------------------------------------------------------~~~~~~~~~~ 179 (342)
T cd07879 159 LDFGLARHADA-----------------------------------------------------------EMTGYVVTRW 179 (342)
T ss_pred eeCCCCcCCCC-----------------------------------------------------------CCCCceeeec
Confidence 99999864321 1122357889
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------CCC---
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----------------------PPD--- 302 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----------------------~~~--- 302 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+... .+.
T Consensus 180 y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (342)
T cd07879 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPR 259 (342)
T ss_pred ccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCccc
Confidence 999999876 45889999999999999999999999987755544333210 000
Q ss_pred ------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 ------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
....+..+.+||.+||+.||.+||++++++.||||+.+.+
T Consensus 260 ~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 260 KDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred chHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 1234567899999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.31 Aligned_cols=258 Identities=19% Similarity=0.308 Sum_probs=202.3
Q ss_pred eeccc--CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCe
Q 014344 23 ALGRG--AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 23 ~LG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+||+| ++|.||++++..+++.||||++..... .......+..|+.+++.++||||++++++|..+..
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 73 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-----------SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-----------chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence 34443 556677777778999999999854311 12345678999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
.|++|||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||.+..+..
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999999999998876555699999999999999999999999999999999999999999999999998876532
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC--
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG-- 258 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-- 258 (426)
...... ..........++..|+|||++.+
T Consensus 154 ~~~~~~-------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (314)
T cd08216 154 HGKRQR-------------------------------------------------VVHDFPKSSVKNLPWLSPEVLQQNL 184 (314)
T ss_pred cccccc-------------------------------------------------ccccccccccccccccCHHHhcCCC
Confidence 110000 00011223457888999999876
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCC----------------------------------
Q 014344 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-RPPDL---------------------------------- 303 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~---------------------------------- 303 (426)
..++.++|+||+||++|+|++|..||.............. ..+..
T Consensus 185 ~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (314)
T cd08216 185 QGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYT 264 (314)
T ss_pred CCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchh
Confidence 4588899999999999999999999987655433222111 10000
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
...+..+.+||++||++||++|||++++|+||||+.+
T Consensus 265 ~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 265 RTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0012457899999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=324.72 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=209.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
++..+|++.+.||+|+||.||+|.+..++. .+|+|.+..... ......+..|+.+++.++||||+
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~ 68 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT------------EKQRRDFLSEASIMGQFDHPNII 68 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC------------HHHHHHHHHHHHHHHhCCCCCcc
Confidence 345789999999999999999999875544 799998743211 12345778899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++..++.+|+||||++|++|.+++.... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l 147 (267)
T cd05066 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKV 147 (267)
T ss_pred eEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEe
Confidence 99999999999999999999999999987653 45899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+...... ........++..
T Consensus 148 ~dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 174 (267)
T cd05066 148 SDFGLSRVLEDDPEA-----------------------------------------------------AYTTRGGKIPIR 174 (267)
T ss_pred CCCCcccccccccce-----------------------------------------------------eeecCCCcccee
Confidence 999998765321100 000111224567
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||.+.+..++.++|+|||||++|++++ |..||...+..+....+... .+.....+..+.+++.+||+.+|.+||
T Consensus 175 y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (267)
T cd05066 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERP 254 (267)
T ss_pred ecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCC
Confidence 999999999889999999999999999886 99999887766665555432 233445678899999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
++.++++
T Consensus 255 ~~~~i~~ 261 (267)
T cd05066 255 KFEQIVS 261 (267)
T ss_pred CHHHHHH
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=337.53 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=204.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.++++++||||+++++++
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-----------IIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-----------hHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 6799999999999999999999999999999998543211 11234577899999999999999999988
Q ss_pred ecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
... ...|++++++ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEE
Confidence 543 3578888887 7899887653 34899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... ......||+.
T Consensus 162 ~dfg~~~~~~~-----------------------------------------------------------~~~~~~~~~~ 182 (345)
T cd07877 162 LDFGLARHTDD-----------------------------------------------------------EMTGYVATRW 182 (345)
T ss_pred ecccccccccc-----------------------------------------------------------cccccccCCC
Confidence 99999865321 1122357889
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------------------CCC-
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--------------------------RPP- 301 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------------------~~~- 301 (426)
|+|||++.+ ..++.++|||||||++|+|++|++||...+....+..+.. ..+
T Consensus 183 y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (345)
T cd07877 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 262 (345)
T ss_pred ccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCC
Confidence 999999876 5678899999999999999999999987665443332211 000
Q ss_pred -----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 302 -----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 302 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.....+..+.+||.+||+.||.+|+++.+++.||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 263 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhh
Confidence 01134677899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=348.32 Aligned_cols=245 Identities=29% Similarity=0.412 Sum_probs=207.6
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
..+.|++...+|.|+|++|-.+.+..+++.+|+|++.+.. .....|+.++... +||||++++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----------------~~~~~e~~~~~~~~~h~niv~~~ 382 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----------------DDNQDEIPISLLVRDHPNIVKSH 382 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-----------------cccccccchhhhhcCCCcceeec
Confidence 3667999999999999999999999999999999995541 1122366566555 699999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee-ccCCcEEEec
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVD 171 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl-~~~g~ikL~D 171 (426)
+++.+...+|+|||++.|+.|.+-+.... .....+..|++||+.|+.|||++|+|||||||+|||+ ++.|+++|+|
T Consensus 383 ~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 383 DVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred ceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence 99999999999999999998877655433 3337888899999999999999999999999999999 6999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||.++..... ..+.+-|..|.
T Consensus 460 FG~a~~~~~~-----------------------------------------------------------~~tp~~t~~y~ 480 (612)
T KOG0603|consen 460 FGFWSELERS-----------------------------------------------------------CDTPALTLQYV 480 (612)
T ss_pred echhhhCchh-----------------------------------------------------------hcccchhhccc
Confidence 9999876431 22234678899
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
|||++...+|+.++||||||++||+||+|+.||...........-+..++.....+..+++||++||+.||.+|+++.++
T Consensus 481 APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i 560 (612)
T KOG0603|consen 481 APEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEI 560 (612)
T ss_pred ChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhh
Confidence 99999999999999999999999999999999987666544444444444446678999999999999999999999999
Q ss_pred hcCCCc
Q 014344 332 KGHEFF 337 (426)
Q Consensus 332 l~hp~f 337 (426)
+.||||
T Consensus 561 ~~h~w~ 566 (612)
T KOG0603|consen 561 GAHPWF 566 (612)
T ss_pred ccCcch
Confidence 999999
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=348.02 Aligned_cols=251 Identities=23% Similarity=0.410 Sum_probs=211.5
Q ss_pred EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
+...+||+|+|-+||+|.|..+|-.||---+....+. ..+....++..|+.+|+.|+||||++++++|.+.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~---------q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVT---------QSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhh---------cChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 5668899999999999999999988886555333322 2345678999999999999999999999999765
Q ss_pred C--eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCCeeecc-CCcEEEeccc
Q 014344 99 K--FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM--GIVYRDLKPENIMIQE-NGHIMLVDFD 173 (426)
Q Consensus 99 ~--~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~--giiHrDlKp~NiLl~~-~g~ikL~DFg 173 (426)
. ++.+|+|++..|+|..|+++.+. ++...++.|++||+.||.|||++ -|||||||.+||+|+. .|.|||+|+|
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 5 48999999999999999887754 89999999999999999999998 5999999999999985 5899999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
||+..... ...+.+|||.||||
T Consensus 192 LAtl~r~s----------------------------------------------------------~aksvIGTPEFMAP 213 (632)
T KOG0584|consen 192 LATLLRKS----------------------------------------------------------HAKSVIGTPEFMAP 213 (632)
T ss_pred HHHHhhcc----------------------------------------------------------ccceeccCccccCh
Confidence 99876422 23456899999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC-CC-CCC-CCHHHHHHHHHHhccCCCCCCChH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRILCRP-PD-LVG-EPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~-~~-~~~-~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|++. ..|+..+||||||+.+.||+|+.+||.... ..++|.++.... |. +-. ..+++++||.+||.. .+.|+|+.
T Consensus 214 EmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~ 291 (632)
T KOG0584|consen 214 EMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAK 291 (632)
T ss_pred HHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHH
Confidence 9998 789999999999999999999999998755 455555655332 11 111 257799999999999 99999999
Q ss_pred HHhcCCCcCCC
Q 014344 330 EIKGHEFFKGV 340 (426)
Q Consensus 330 eil~hp~f~~~ 340 (426)
|+|.||||..-
T Consensus 292 eLL~d~Ff~~d 302 (632)
T KOG0584|consen 292 ELLKDPFFDED 302 (632)
T ss_pred HHhhChhhccc
Confidence 99999999863
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=318.46 Aligned_cols=252 Identities=29% Similarity=0.504 Sum_probs=215.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|++|.||++.+..+++.||+|.+...... ......+..|++++++++|||++++++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-----------EEALKSIMQEIDLLKNLKHPNIVKYIGSIE 69 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-----------HHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Confidence 589999999999999999999999999999998554321 134567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
++...+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 70 TSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred eCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccce
Confidence 999999999999999999988765 459999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... ......|+..|+|||.+
T Consensus 148 ~~~~~~~--------------------------------------------------------~~~~~~~~~~y~~pe~~ 171 (254)
T cd06627 148 KLNDVSK--------------------------------------------------------DDASVVGTPYWMAPEVI 171 (254)
T ss_pred ecCCCcc--------------------------------------------------------cccccccchhhcCHhhh
Confidence 7642210 01233578899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+..++.++|+||+|+++|+|++|+.||...+............ ......+..+.++|.+||..+|++|||+.+++.|
T Consensus 172 ~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred cCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 88888999999999999999999999998777655554443222 2223456889999999999999999999999999
Q ss_pred CCc
Q 014344 335 EFF 337 (426)
Q Consensus 335 p~f 337 (426)
|||
T Consensus 252 ~~~ 254 (254)
T cd06627 252 PWI 254 (254)
T ss_pred CCC
Confidence 997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=324.76 Aligned_cols=255 Identities=22% Similarity=0.301 Sum_probs=207.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
+.+...+|++++.||+|+||+||+|....+++ .||+|++.... .......+..|+.+++.+.||
T Consensus 2 ~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~------------~~~~~~~~~~e~~~l~~~~~~ 69 (279)
T cd05109 2 RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT------------SPKANKEILDEAYVMAGVGSP 69 (279)
T ss_pred cccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC------------CHHHHHHHHHHHHHHHhcCCC
Confidence 35677889999999999999999999877776 48999874321 122345678899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++.. ...++++||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 70 ~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~ 147 (279)
T cd05109 70 YVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH 147 (279)
T ss_pred CCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence 99999999865 45789999999999999876543 45899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+++.+...... .......+
T Consensus 148 ~kL~dfG~~~~~~~~~~~------------------------------------------------------~~~~~~~~ 173 (279)
T cd05109 148 VKITDFGLARLLDIDETE------------------------------------------------------YHADGGKV 173 (279)
T ss_pred EEECCCCceeecccccce------------------------------------------------------eecCCCcc
Confidence 999999998765321100 00111125
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ..+.....+..+.++|.+||..||+
T Consensus 174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 253 (279)
T cd05109 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSE 253 (279)
T ss_pred chhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChh
Confidence 678999999999999999999999999999998 9999987766554443332 2233345678899999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
+||++.+++.
T Consensus 254 ~Rp~~~~l~~ 263 (279)
T cd05109 254 CRPRFRELVD 263 (279)
T ss_pred hCcCHHHHHH
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=327.00 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=206.1
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l~~~ 94 (426)
|++.+.||+|+||.||+|++..+++.||+|++..... .......+..|+.+++++ +||||++++++
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 69 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-----------EEGIPLSTLREIALLKQLESFEHPNIVRLLDV 69 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-----------cchhhhhHHHHHHHHHHhhccCCCCcceEEEE
Confidence 7899999999999999999998999999999853321 111223455677777666 59999999999
Q ss_pred eecCCe-----EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 95 LSTDKF-----VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 95 ~~~~~~-----~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+..... ++++|||+. ++|.+++.......+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|
T Consensus 70 ~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 70 CHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred EeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEE
Confidence 988776 999999997 58888877654446899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+.... ......+++.
T Consensus 149 ~dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~ 171 (287)
T cd07838 149 ADFGLARIYSFEM---------------------------------------------------------ALTSVVVTLW 171 (287)
T ss_pred eccCcceeccCCc---------------------------------------------------------cccccccccc
Confidence 9999987653110 1112347889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------C------------------
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---------D------------------ 302 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~------------------ 302 (426)
|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+.++..... .
T Consensus 172 ~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred ccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 9999999999999999999999999999999999999887776665542100 0
Q ss_pred -CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 303 -LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 303 -~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
....+..+.++|.+||+.||.+||++++++.||||
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 01124567899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=328.57 Aligned_cols=251 Identities=21% Similarity=0.294 Sum_probs=206.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCccee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRL 91 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l 91 (426)
.++|++.+.||+|+||.||+|.+..++. .+|+|.+.... .....+.+..|+.++.++ +||||+++
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 68 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA------------SENDHRDFAGELEVLCKLGHHPNIINL 68 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC------------CHHHHHHHHHHHHHHHhhcCCCchhhe
Confidence 3679999999999999999999877765 46888763211 112345678899999999 69999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPE 157 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~ 157 (426)
++++.....+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~ 148 (297)
T cd05089 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAAR 148 (297)
T ss_pred EEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcc
Confidence 999999999999999999999999886532 124888999999999999999999999999999999
Q ss_pred CeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 158 NIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDS 237 (426)
Q Consensus 158 NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (426)
|||++.++.+||+|||++.......
T Consensus 149 Nill~~~~~~kl~dfg~~~~~~~~~------------------------------------------------------- 173 (297)
T cd05089 149 NVLVGENLASKIADFGLSRGEEVYV------------------------------------------------------- 173 (297)
T ss_pred eEEECCCCeEEECCcCCCcccccee-------------------------------------------------------
Confidence 9999999999999999875321100
Q ss_pred CCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHH
Q 014344 238 SEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLI 314 (426)
Q Consensus 238 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li 314 (426)
.......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.... +.....+..+.+||
T Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 251 (297)
T cd05089 174 --KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELM 251 (297)
T ss_pred --ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 0001123456999999999899999999999999999997 999999988877776665432 22334678899999
Q ss_pred HHHhccCCCCCCChHHHhcC
Q 014344 315 RRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~h 334 (426)
.+||..+|.+|||++++++.
T Consensus 252 ~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 252 RQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=330.18 Aligned_cols=258 Identities=19% Similarity=0.332 Sum_probs=212.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
.+++..++|++.+.||+|+||.||+|.+. .++..+|+|++.+.. .......+..|+.+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 96 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA------------HSSEREALMSELKIMSHLG 96 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC------------ChHHHHHHHHHHHHHHhcc
Confidence 34567778999999999999999999863 345689999874321 112345788899999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+||||+++++++...+.+|+||||+.+++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 97 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~ 176 (302)
T cd05055 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH 176 (302)
T ss_pred CCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC
Confidence 79999999999999999999999999999999987655445899999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.++|+|||++..+...... .....
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~------------------------------------------------------~~~~~ 202 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNY------------------------------------------------------VVKGN 202 (302)
T ss_pred CCeEEECCCcccccccCCCce------------------------------------------------------eecCC
Confidence 999999999998765321100 00112
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHHhc
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~ 319 (426)
..+++.|+|||.+.+..++.++||||+||++|+|++ |..||......+.+.+..... ......+..+.+||.+||.
T Consensus 203 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 282 (302)
T cd05055 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWD 282 (302)
T ss_pred CCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcC
Confidence 246788999999999999999999999999999998 999998877666555544322 2223457889999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
++|++|||+.+++.
T Consensus 283 ~~p~~Rpt~~ell~ 296 (302)
T cd05055 283 ADPLKRPTFKQIVQ 296 (302)
T ss_pred CCchhCcCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=328.99 Aligned_cols=255 Identities=22% Similarity=0.288 Sum_probs=208.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCC----------------ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHH
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESS----------------ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~----------------~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 76 (426)
+...+|++++.||+|+||.||+|.+..++ ..||+|++..... ......+..|
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~------------~~~~~~~~~e 69 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS------------DNAREDFLKE 69 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC------------HHHHHHHHHH
Confidence 45678999999999999999999876543 4589998854321 1245678889
Q ss_pred HHHHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc---------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS---------EQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 77 ~~il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~---------~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+++++.++||||+++++++..+...+++|||+.+++|..++.... ...+++..++.++.|++.||.|||++
T Consensus 70 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~ 149 (296)
T cd05051 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL 149 (296)
T ss_pred HHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 999999999999999999999999999999999999999887543 12589999999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
||+||||||+||+++.++.++|+|||++........
T Consensus 150 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------- 185 (296)
T cd05051 150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY-------------------------------------------- 185 (296)
T ss_pred CccccccchhceeecCCCceEEccccceeecccCcc--------------------------------------------
Confidence 999999999999999999999999999875432110
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcC------
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY--GATPFRGSSRKETFYRILCR------ 299 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~i~~~------ 299 (426)
........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||...+....+..+...
T Consensus 186 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (296)
T cd05051 186 ----------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR 255 (296)
T ss_pred ----------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccc
Confidence 001123346788999999998889999999999999999998 78899887766655544321
Q ss_pred ---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 300 ---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 300 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+.....+.++.+||.+||+.||++|||+.+|++
T Consensus 256 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 256 QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 1122344678999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.55 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=208.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++.+.||+|++|.||+|++..+++.+|||.+.+..... ......+.+|+.+++.++||||++++++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 70 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD----------AKARADCIKEIDLLKQLNHPNVIKYYAS 70 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh----------HHHHHHHHHHHHHHHHccCCchhhhhhe
Confidence 367999999999999999999999999999999885432111 1234577889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+..++..+++|||++|++|.+++... ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+||
T Consensus 71 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 71 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999999987642 2345899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+.... .......|++.|+|
T Consensus 151 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~a 174 (267)
T cd08229 151 GLGRFFSSKT--------------------------------------------------------TAAHSLVGTPYYMS 174 (267)
T ss_pred hhhhccccCC--------------------------------------------------------cccccccCCcCccC
Confidence 9887653211 01123358889999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC--CC-CCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRILCR--PP-DLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~--~~-~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||.+.+..++.++|+|||||++|+|++|..||.+... ......+... ++ .....+..+.++|.+||..||++|||
T Consensus 175 pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 254 (267)
T cd08229 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 254 (267)
T ss_pred HHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCC
Confidence 9999999999999999999999999999999976543 2333333221 11 11235678999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
+.+|+.
T Consensus 255 ~~~i~~ 260 (267)
T cd08229 255 ITYVYD 260 (267)
T ss_pred HHHHHH
Confidence 998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=329.91 Aligned_cols=261 Identities=19% Similarity=0.297 Sum_probs=211.8
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcC-------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVE-------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il 80 (426)
.+.+++..++|.+++.||+|+||.||+|++.. +...+|+|++.... .......+..|+.++
T Consensus 10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~~~e~~~l 77 (307)
T cd05098 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA------------TEKDLSDLISEMEMM 77 (307)
T ss_pred CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC------------ChHHHHHHHHHHHHH
Confidence 44566777899999999999999999998753 23469999985431 112345677899999
Q ss_pred Hhc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 014344 81 RNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------------QMFSDDTIRFYAAELVLALEYLH 145 (426)
Q Consensus 81 ~~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------------~~l~~~~~~~~~~qil~aL~~LH 145 (426)
+.+ +||||+++++++......|+||||+.+++|.+++..... ..++...+..++.||+.||+|||
T Consensus 78 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH 157 (307)
T cd05098 78 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA 157 (307)
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 999 799999999999999999999999999999999876421 24888999999999999999999
Q ss_pred HCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCC
Q 014344 146 NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRI 225 (426)
Q Consensus 146 ~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (426)
++|++||||||+|||++.++.+||+|||++........
T Consensus 158 ~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~------------------------------------------ 195 (307)
T cd05098 158 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------------------------------------------ 195 (307)
T ss_pred HCCcccccccHHheEEcCCCcEEECCCcccccccccch------------------------------------------
Confidence 99999999999999999999999999999875531100
Q ss_pred CCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CC
Q 014344 226 GPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PD 302 (426)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~ 302 (426)
........+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+....+.+..+.... ..
T Consensus 196 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T cd05098 196 ------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK 263 (307)
T ss_pred ------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCC
Confidence 000111124568999999999889999999999999999998 899998877766655554332 22
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
....+..+.+||.+||..+|.+||++.+++++
T Consensus 264 ~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 264 PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.66 Aligned_cols=280 Identities=24% Similarity=0.332 Sum_probs=212.1
Q ss_pred CCcEE-EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcc-cCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 16 SCLRI-VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELT-NNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
++|.. .+.||.|+||+||+|.+..+++.||||++............. ..........+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34764 577999999999999999999999999986543221100000 0001111235778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++..+...|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999997 6898887653 348999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++............. .. .............+++.|+||
T Consensus 165 ~~~~~~~~~~~~~~~----------------------------------~~--------~~~~~~~~~~~~~~~~~y~aP 202 (335)
T PTZ00024 165 LARRYGYPPYSDTLS----------------------------------KD--------ETMQRREEMTSKVVTLWYRAP 202 (335)
T ss_pred ceeeccccccccccc----------------------------------cc--------ccccccccccccccccCCCCC
Confidence 987654211000000 00 000001112233578899999
Q ss_pred hhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC--------------------------C
Q 014344 254 EIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD--------------------------L 303 (426)
Q Consensus 254 E~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~--------------------------~ 303 (426)
|.+.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+.. .+.. .
T Consensus 203 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (335)
T PTZ00024 203 ELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF 282 (335)
T ss_pred hhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhC
Confidence 998764 468999999999999999999999998887666554431 1100 1
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
...+..+.++|.+||..+|++|||++++|.||||+..
T Consensus 283 ~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 283 PNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred cCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 1235678999999999999999999999999999853
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=337.56 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=213.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||.|++|.||+|++..+++.||||++.+... .....+.+..|+.+++.++||||+++++++.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-----------DLIDAKRILREIKLLRHLRHENIIGLLDILR 69 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-----------cchhhhhHHHHHHHHHhcCCcchhhhhhhhc
Confidence 59999999999999999999999999999999854211 1234467888999999999999999999997
Q ss_pred cCC-----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 97 TDK-----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 97 ~~~-----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
... .+|+||||+. ++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 70 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~d 146 (330)
T cd07834 70 PPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICD 146 (330)
T ss_pred ccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 775 8999999997 58888776433 599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++......... ........+|+.|+
T Consensus 147 fg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~ 173 (330)
T cd07834 147 FGLARGVDPDEDE-----------------------------------------------------KGFLTEYVVTRWYR 173 (330)
T ss_pred cCceEeecccccc-----------------------------------------------------cccccccccccCcC
Confidence 9998865422100 01122345889999
Q ss_pred cchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---C--------------------------
Q 014344 252 APEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---P-------------------------- 301 (426)
Q Consensus 252 aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~-------------------------- 301 (426)
|||++.+. .++.++|+|||||++|+|++|++||.+.+..+.+..+.... +
T Consensus 174 aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (330)
T cd07834 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKP 253 (330)
T ss_pred CceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcch
Confidence 99999887 78999999999999999999999999888766555443210 0
Q ss_pred ---CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ---~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+.+||.+||+++|.+||++++++.||||+++
T Consensus 254 ~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 254 LSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 012246778999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=378.91 Aligned_cols=257 Identities=32% Similarity=0.484 Sum_probs=217.4
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+++-...||.|.||.||-|....+|+..|+|-+...... ....+.+..|..+|..++|||+|+++++-.
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-----------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-----------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-----------cccCcchHHHHHHHHhccCccccccCceee
Confidence 467788999999999999999999999999987443322 123456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
..+.++|.||||.||+|.++.+..+ -.++...+.|..|++.||.|||++|||||||||+||+|+.+|.||++|||.|.
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999999999977543 37889999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.+....... ....+.++|||.|||||++
T Consensus 1383 ki~~~~~~~----------------------------------------------------~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1383 KIKNNAQTM----------------------------------------------------PGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred EecCchhcC----------------------------------------------------CHHHHhhcCCchhcCchhh
Confidence 876432111 1234577899999999999
Q ss_pred cC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--cCCCCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 257 EG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 257 ~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
.+ .++.-+.|||||||++.||+||+.||...+ .....+++- ..|..+...+++.+|||.+||+.||.+|.++.|
T Consensus 1411 t~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1411 TGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred cccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 76 457889999999999999999999998754 445555543 233334456888999999999999999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
||.|.|=+
T Consensus 1491 lle~~f~~ 1498 (1509)
T KOG4645|consen 1491 LLEHAFGK 1498 (1509)
T ss_pred HHHhhccc
Confidence 99998864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=323.83 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=203.2
Q ss_pred cEEEeeecccCceEEEEEEEcCCCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
|.+.+.||+|+||.||+|+...++. .+|+|.+..... .......+..|+.+++.++||||+++++.+
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 69 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-----------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVC 69 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-----------CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 4578899999999999999887775 699998854321 122456788899999999999999999876
Q ss_pred ec------CCeEEEEEeccCCCChHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 96 ST------DKFVGYAIDYCPGRDLHSLRKQQ----SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 96 ~~------~~~~~lV~Ey~~gg~L~~l~~~~----~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
.. ....+++|||+.+|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 70 ~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 149 (272)
T cd05075 70 LQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM 149 (272)
T ss_pred ccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC
Confidence 32 23578999999999999876422 223488999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++..+...... .......
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~------------------------------------------------------~~~~~~~ 175 (272)
T cd05075 150 NVCVADFGLSKKIYNGDYY------------------------------------------------------RQGRIAK 175 (272)
T ss_pred CEEECCCCcccccCcccce------------------------------------------------------ecCCccc
Confidence 9999999998865321100 0011223
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP 322 (426)
+++.|+|||.+.+..++.++|||||||++|+|++ |+.||.+....+.+..+.... +.....+..+.++|.+||+.||
T Consensus 176 ~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 255 (272)
T cd05075 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNP 255 (272)
T ss_pred CCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCc
Confidence 6778999999999999999999999999999998 899998887776666555332 2334567889999999999999
Q ss_pred CCCCChHHHhcC
Q 014344 323 TKRIGVEEIKGH 334 (426)
Q Consensus 323 ~~R~s~~eil~h 334 (426)
.+|||+.+|+++
T Consensus 256 ~~Rps~~~l~~~ 267 (272)
T cd05075 256 KDRPSFETLRCE 267 (272)
T ss_pred ccCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=319.00 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=214.7
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||.|+||.||++.+..+++.+|+|++.+..... .....+..|+.+++.++||||+++++++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-----------KEREDAVNEIRILASVNHPNIISYKEAFL 69 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-----------HHHHHHHHHHHHHHhCCCCCchhhhhhhc
Confidence 5899999999999999999999999999999986543221 23456677999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.....|+||||+++++|.+++... ....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 70 DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred cCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 999999999999999999987652 234589999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+...... ......|++.|+|||
T Consensus 150 ~~~~~~~----------------------------------------------------------~~~~~~~~~~~~~Pe 171 (256)
T cd08530 150 SKVLKKN----------------------------------------------------------MAKTQIGTPHYMAPE 171 (256)
T ss_pred hhhhccC----------------------------------------------------------CcccccCCccccCHH
Confidence 8765321 011124788999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+.+..++.++|+||||+++|+|++|+.||...+..+....+.... +.....+..++++|.+||..+|.+||++.+++
T Consensus 172 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 172 VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred HHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 9999999999999999999999999999999888766555544322 22234578899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
+||++
T Consensus 252 ~~p~~ 256 (256)
T cd08530 252 ASPAV 256 (256)
T ss_pred cCCCC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.42 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=204.5
Q ss_pred cEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
|++++.||+|+||.||+|....+ +..||+|.+..... .......+..|+.+++.++||||++++++
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 69 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-----------TYSEIEEFLSEAACMKDFDHPNVMKLIGV 69 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-----------CHHHHHHHHHHHHHHHhCCCCCeeeEEee
Confidence 67899999999999999997653 47899999843211 12234578889999999999999999998
Q ss_pred eecCCe------EEEEEeccCCCChHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 95 LSTDKF------VGYAIDYCPGRDLHSLRKQQS----EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 95 ~~~~~~------~~lV~Ey~~gg~L~~l~~~~~----~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+..... .+++|||+++++|..++.... ...+++..+..++.|++.||.|||+.||+||||||+||+++++
T Consensus 70 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~ 149 (273)
T cd05035 70 CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED 149 (273)
T ss_pred eccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC
Confidence 755443 899999999999998875432 2358999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||+++.+..... .......
T Consensus 150 ~~~kl~dfg~~~~~~~~~~------------------------------------------------------~~~~~~~ 175 (273)
T cd05035 150 MTVCVADFGLSKKIYSGDY------------------------------------------------------YRQGRIA 175 (273)
T ss_pred CeEEECCccceeecccccc------------------------------------------------------ccccccc
Confidence 9999999999876532110 0001112
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~d 321 (426)
.++..|+|||.+.+..++.++|||||||++|||++ |.+||.+....+.+..+.... ......+..+.++|.+||+.|
T Consensus 176 ~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 255 (273)
T cd05035 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRAD 255 (273)
T ss_pred cCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCC
Confidence 24678999999998889999999999999999998 999999888777666555322 223355788999999999999
Q ss_pred CCCCCChHHHhcC
Q 014344 322 PTKRIGVEEIKGH 334 (426)
Q Consensus 322 P~~R~s~~eil~h 334 (426)
|.+|||+.|++++
T Consensus 256 p~~Rp~~~e~~~~ 268 (273)
T cd05035 256 PKDRPTFTKLREV 268 (273)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=320.87 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=207.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
++..++|++...||+|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|||++++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~ 66 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--------------MMPEAFLQEAQIMKKLRHDKLVPL 66 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--------------ccHHHHHHHHHHHHhCCCCCeeeE
Confidence 34567799999999999999999988655 469999874321 122457789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++. ....|+||||+.+++|.+++.......++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|
T Consensus 67 ~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~d 145 (260)
T cd05069 67 YAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIAD 145 (260)
T ss_pred EEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECC
Confidence 99875 45689999999999999998765555689999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++........ .......++..|+
T Consensus 146 fg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 170 (260)
T cd05069 146 FGLARLIEDNEY-------------------------------------------------------TARQGAKFPIKWT 170 (260)
T ss_pred CccceEccCCcc-------------------------------------------------------cccCCCccchhhC
Confidence 999876532110 0011123567899
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+.+..++.++|+|||||++|+|++ |..||.+....+....+.... +.....+..+.++|.+||.+||.+||++
T Consensus 171 ~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05069 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTF 250 (260)
T ss_pred CHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCH
Confidence 9999998889999999999999999999 999999888777666665432 2233567889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
+++++
T Consensus 251 ~~i~~ 255 (260)
T cd05069 251 EYIQS 255 (260)
T ss_pred HHHHH
Confidence 99875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=326.84 Aligned_cols=254 Identities=20% Similarity=0.289 Sum_probs=209.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++..+|.+.+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+.+|+.+++.++|||
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~ 68 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-------------AARKDFQREAELLTNLQHEH 68 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-------------HHHHHHHHHHHHHhcCCCCC
Confidence 45678999999999999999999864 3455689998743221 22356788999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
|+++++++......++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+|||
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 148 (291)
T cd05094 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 148 (291)
T ss_pred cceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999999999999999999999999987542 23488999999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+|||++.++.++|+|||++........
T Consensus 149 lkp~Nil~~~~~~~~l~dfg~a~~~~~~~~-------------------------------------------------- 178 (291)
T cd05094 149 LATRNCLVGANLLVKIGDFGMSRDVYSTDY-------------------------------------------------- 178 (291)
T ss_pred cCcceEEEccCCcEEECCCCcccccCCCce--------------------------------------------------
Confidence 999999999999999999999875432110
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~ 310 (426)
........|++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+..... .....+..+
T Consensus 179 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (291)
T cd05094 179 ----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEV 254 (291)
T ss_pred ----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHH
Confidence 011123347888999999999999999999999999999998 9999988877766655543222 223457889
Q ss_pred HHHHHHHhccCCCCCCChHHHhc
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+++.+||+.+|.+||+++++++
T Consensus 255 ~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 255 YDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHcccChhhCcCHHHHHH
Confidence 99999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=332.40 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=204.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCC--CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVES--SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
+|++.+.||+|+||.||+|++..+ +..||+|++.... ......+.+..|+.+++++ +||||+++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 69 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-----------SKKILAKRALRELKLLRHFRGHKNITCLYD 69 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-----------ccchhHHHHHHHHHHHHHhcCCCChheeee
Confidence 489999999999999999999888 8999999984321 1112345677899999999 5999999998
Q ss_pred eeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 94 VLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 94 ~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.+.. ...+|++++|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 70 ~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 70 MDIVFPGNFNELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred eeeeccccCCcEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEe
Confidence 7532 356889999985 7888887543 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+...... ........+||+.
T Consensus 147 ~Dfg~a~~~~~~~~~----------------------------------------------------~~~~~~~~~g~~~ 174 (332)
T cd07857 147 CDFGLARGFSENPGE----------------------------------------------------NAGFMTEYVATRW 174 (332)
T ss_pred CcCCCceeccccccc----------------------------------------------------ccccccCcccCcc
Confidence 999999865421100 0011234578999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------------------CC--
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--------------------------RP-- 300 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--------------------------~~-- 300 (426)
|+|||++.+ ..++.++|+||+||++|+|++|.+||...+....+..++. ..
T Consensus 175 y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (332)
T cd07857 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPK 254 (332)
T ss_pred ccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCC
Confidence 999998766 5689999999999999999999999987664433322211 00
Q ss_pred ----CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 301 ----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 301 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
......+..+.+||.+||+.||++|||+.+++.||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 255 KPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred cchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 011234678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=320.33 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=207.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+.+|++++++++|++|+++++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~ 71 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM----------DAKARQDCLKEIDLLKQLDHPNVIKYLASF 71 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc----------chhhHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence 5799999999999999999999999999999988542211 112356788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
..+...++||||++|++|..++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 72 IENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred ecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccc
Confidence 9999999999999999999987643 23458999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+.... .......|++.|+||
T Consensus 152 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ap 175 (267)
T cd08224 152 LGRFFSSKT--------------------------------------------------------TAAHSLVGTPYYMSP 175 (267)
T ss_pred eeeeccCCC--------------------------------------------------------cccceecCCccccCH
Confidence 987553211 011233588899999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcC--CCCCC-CCCHHHHHHHHHHhccCCCCCCCh
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRILCR--PPDLV-GEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~~~--~~~~~-~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|.+.+..++.++|+|||||++|+|++|+.||..... .+....+... ++... ..+..+.++|.+||..+|++|||+
T Consensus 176 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~ 255 (267)
T cd08224 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDI 255 (267)
T ss_pred HHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 999999999999999999999999999999965532 2233333221 11111 456789999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.+|+.
T Consensus 256 ~~il~ 260 (267)
T cd08224 256 SYVLQ 260 (267)
T ss_pred HHHHH
Confidence 99874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.07 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=209.6
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|....+||+|+||.||++....+++.||||++.... ......+..|+.+++.++||||+++++.+..
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-------------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-------------hhHHHHHHHHHHHHHhcCCcchhheeeEEEe
Confidence 444578999999999999999999999999873211 1234567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.+..|+||||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 89 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999999999999987653 3489999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
..... .......|++.|+|||.+.
T Consensus 166 ~~~~~--------------------------------------------------------~~~~~~~~~~~y~~pE~~~ 189 (292)
T cd06657 166 VSKEV--------------------------------------------------------PRRKSLVGTPYWMAPELIS 189 (292)
T ss_pred ccccc--------------------------------------------------------ccccccccCccccCHHHhc
Confidence 43110 0112345889999999998
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 258 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+..++.++|+||+||++|+|++|..||.+....+....+....+ .....+..+.++|.+||..+|.+||++.+++.
T Consensus 190 ~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 190 RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 88889999999999999999999999988776554443322111 22345788999999999999999999999999
Q ss_pred CCCcCC
Q 014344 334 HEFFKG 339 (426)
Q Consensus 334 hp~f~~ 339 (426)
||||..
T Consensus 270 ~~~~~~ 275 (292)
T cd06657 270 HPFLAK 275 (292)
T ss_pred ChHHhc
Confidence 999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=318.25 Aligned_cols=246 Identities=46% Similarity=0.803 Sum_probs=211.7
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||.|+||.||++.+..+++.||+|++.+...... .....+..|+.+++.++||||+.+++.+..+..+|+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 70 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKR----------KEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYL 70 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcch----------HHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEE
Confidence 6999999999999998999999999866543221 245678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~ 183 (426)
||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 71 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~- 147 (250)
T cd05123 71 VLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147 (250)
T ss_pred EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence 999999999999887653 48999999999999999999999999999999999999999999999999987653211
Q ss_pred CCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCCh
Q 014344 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263 (426)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 263 (426)
.......|+..|+|||.+.+...+.
T Consensus 148 -------------------------------------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~ 172 (250)
T cd05123 148 -------------------------------------------------------SRTNTFCGTPEYLAPEVLLGKGYGK 172 (250)
T ss_pred -------------------------------------------------------CcccCCcCCccccChHHhCCCCCCc
Confidence 1123345788999999999888899
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCCh---HHHhcCCCc
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGV---EEIKGHEFF 337 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~---~eil~hp~f 337 (426)
++|+|||||++|+|++|..||...+.......+........ ..+..+.++|++||..||++||++ +++++||||
T Consensus 173 ~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999999999999988877666666654333332 337889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=329.50 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=207.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
+...++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+..|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-----------~~~~~~~~~~e~~~~~~l~h~~i~~~ 71 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-----------KEGFPITAIREIKILRQLNHRNIVNL 71 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-----------ccCchHHHHHHHHHHHhCCCCCeeee
Confidence 3456789999999999999999999999999999999854321 11123456679999999999999999
Q ss_pred eeeeecCC----------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee
Q 014344 92 RGVLSTDK----------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI 161 (426)
Q Consensus 92 ~~~~~~~~----------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl 161 (426)
++++.+.. .+|+|+||+++ +|..++... ...+++..++.++.||+.||.|||+.||+||||||+||++
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 149 (302)
T cd07864 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149 (302)
T ss_pred eheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99987654 89999999985 676665543 3358999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
++++.+||+|||++..+..... ...
T Consensus 150 ~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------------~~~ 174 (302)
T cd07864 150 NNKGQIKLADFGLARLYNSEES-------------------------------------------------------RPY 174 (302)
T ss_pred CCCCcEEeCcccccccccCCcc-------------------------------------------------------ccc
Confidence 9999999999999876542210 001
Q ss_pred cccccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC----------------
Q 014344 242 NSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------- 301 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------- 301 (426)
....+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+..+.+..+.. .+.
T Consensus 175 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T cd07864 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTM 254 (302)
T ss_pred ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccc
Confidence 11246778999998865 4578899999999999999999999987766554433321 110
Q ss_pred ------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 302 ------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 302 ------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.....+..+.++|.+||..||++||++.+++.||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 255 KPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 111346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=325.93 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=219.1
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
....|++...||+|++|.||+|.+..+++.||+|++..... ....+..|+.+++.++|+||+++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~ 82 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--------------NKELIINEILIMKDCKHPNIVDYYD 82 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------------hHHHHHHHHHHHHHCCCCCeeEEEE
Confidence 34569999999999999999999998999999999853321 2456778999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.+......|+|+||++|++|.+++.... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 83 SYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccc
Confidence 9999999999999999999999987654 359999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... .......+++.|+||
T Consensus 162 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~~P 185 (286)
T cd06614 162 FAAQLTKEK--------------------------------------------------------SKRNSVVGTPYWMAP 185 (286)
T ss_pred hhhhhccch--------------------------------------------------------hhhccccCCcccCCH
Confidence 876543110 011223478899999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C---CCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-D---LVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~---~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|.+.+..++.++|+|||||++|+|++|..||...+.......+..... . ....+..+.+||.+||+.+|.+||++.
T Consensus 186 E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 265 (286)
T cd06614 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAE 265 (286)
T ss_pred hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHH
Confidence 999988899999999999999999999999998776655555433221 1 112567899999999999999999999
Q ss_pred HHhcCCCcCCCChh
Q 014344 330 EIKGHEFFKGVNWE 343 (426)
Q Consensus 330 eil~hp~f~~~~~~ 343 (426)
+++.||||+...|.
T Consensus 266 ~il~~~~~~~~~~~ 279 (286)
T cd06614 266 ELLQHPFLKKACPK 279 (286)
T ss_pred HHhhChHhhccCch
Confidence 99999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=327.27 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=209.5
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|..+++||+|+||+||+|++..+++.||+|++..... ........+..|+.+++.++|||++++++++.+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK----------QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc----------CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 7778899999999999999999999999999854321 112234567889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
....|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 93 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 93 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred CCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 999999999996 57777765433 4589999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
.. ..+...|+..|+|||++.
T Consensus 171 ~~------------------------------------------------------------~~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 171 SS------------------------------------------------------------PANSFVGTPYWMAPEVIL 190 (313)
T ss_pred cC------------------------------------------------------------CCCCccccccccChhhcc
Confidence 21 112345888999999984
Q ss_pred ---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC--CCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 258 ---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PD--LVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 258 ---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
...++.++|+|||||++|+|++|..||...+.......+.... +. ....+..+.+||.+||+++|.+||++.++
T Consensus 191 ~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3557889999999999999999999998877666555554322 21 12346779999999999999999999999
Q ss_pred hcCCCcCCCC
Q 014344 332 KGHEFFKGVN 341 (426)
Q Consensus 332 l~hp~f~~~~ 341 (426)
+.||||...+
T Consensus 271 l~~~~~~~~~ 280 (313)
T cd06633 271 LRHDFVRRDR 280 (313)
T ss_pred hcCcccCCCc
Confidence 9999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=327.54 Aligned_cols=260 Identities=18% Similarity=0.308 Sum_probs=213.4
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEc-------CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHH
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDV-------ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 81 (426)
+...+...+|++.+.||+|+||.||+|+.. ..+..||+|++.... .....+.+..|+.+++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~------------~~~~~~~~~~E~~~l~ 75 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA------------TEKDLSDLVSEMEMMK 75 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc------------chHHHHHHHHHHHHHH
Confidence 456788889999999999999999999853 234579999884321 1123467888999999
Q ss_pred hc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 014344 82 NV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHN 146 (426)
Q Consensus 82 ~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~ 146 (426)
.+ +||||+++++++.....+|+||||+.+++|.+++.... ...++...+..++.||+.||.|||+
T Consensus 76 ~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~ 155 (304)
T cd05101 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS 155 (304)
T ss_pred hhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH
Confidence 99 79999999999999999999999999999999987542 1347788899999999999999999
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIG 226 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (426)
+||+||||||+|||++.++.+||+|||++..+.....
T Consensus 156 ~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~------------------------------------------- 192 (304)
T cd05101 156 QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDY------------------------------------------- 192 (304)
T ss_pred CCeeecccccceEEEcCCCcEEECCCccceecccccc-------------------------------------------
Confidence 9999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCC
Q 014344 227 PDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDL 303 (426)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~ 303 (426)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.... ...
T Consensus 193 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 261 (304)
T cd05101 193 -----------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP 261 (304)
T ss_pred -----------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC
Confidence 001112236678999999999889999999999999999998 899999888777766664332 222
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||.+||..+|.+||++.++++.
T Consensus 262 ~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 262 ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 3457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=326.43 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=212.4
Q ss_pred CCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 5 ~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.-+.....+++++|++.+.||+|+||.||+|.+..+++.||||.+.+... ......+..|+.++.++.
T Consensus 4 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------------~~~~~~~~~e~~~~~~~~ 71 (296)
T cd06618 4 TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN------------KEENKRILMDLDVVLKSH 71 (296)
T ss_pred eecceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC------------hHHHHHHHHHHHHHHhcc
Confidence 33445678899999999999999999999999999999999999854321 122345566777666664
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeec
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQ 162 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~ 162 (426)
||||+++++++.++..+|++|||+. ++|.+++.... ..+++..+..++.||+.||.|||+ .||+||||+|+||+++
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~ 149 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD 149 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc
Confidence 9999999999999999999999985 67887766543 368999999999999999999997 6999999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.++.+||+|||++..+.... ...
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~---------------------------------------------------------~~~ 172 (296)
T cd06618 150 ASGNVKLCDFGISGRLVDSK---------------------------------------------------------AKT 172 (296)
T ss_pred CCCCEEECccccchhccCCC---------------------------------------------------------ccc
Confidence 99999999999987553211 011
Q ss_pred ccccCCCCccchhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCC----CCCCCCHHHHHH
Q 014344 243 SFVGTEEYVAPEIIEGKG----HDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRPP----DLVGEPTPLRNL 313 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~----~~~~~~~~~~~l 313 (426)
...+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... .+.+..++.... .....+..+.+|
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (296)
T cd06618 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSF 252 (296)
T ss_pred CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Confidence 224788899999987654 78899999999999999999999976433 344444443221 112357789999
Q ss_pred HHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
|.+||..||.+||++++++.||||..
T Consensus 253 i~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 253 VDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred HHHHccCChhhCCCHHHHhcChhhhc
Confidence 99999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=317.31 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=209.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|++.+.||.|+||.||+|.. .++.||+|.+..... ..+++..|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~ 65 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--------------AAQAFLAEASVMTTLRHPNLVQL 65 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--------------HHHHHHHHHHHHHhcCCcceeee
Confidence 35677899999999999999999986 478999999843321 34578889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.+....|+||||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus 66 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d 145 (256)
T cd05039 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSD 145 (256)
T ss_pred EEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcc
Confidence 99999999999999999999999998776555699999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||.+....... ....++..|+
T Consensus 146 ~g~~~~~~~~~-----------------------------------------------------------~~~~~~~~~~ 166 (256)
T cd05039 146 FGLAKEASQGQ-----------------------------------------------------------DSGKLPVKWT 166 (256)
T ss_pred ccccccccccc-----------------------------------------------------------ccCCCccccc
Confidence 99987652110 0112455799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+.+..++.++|+|||||++|+|++ |+.||...+.......+... .......+..+.++|.+||..+|++||++
T Consensus 167 ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 246 (256)
T cd05039 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTF 246 (256)
T ss_pred CchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCH
Confidence 9999988889999999999999999997 99999888776665554432 12233457889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.++++
T Consensus 247 ~~l~~ 251 (256)
T cd05039 247 KQLRE 251 (256)
T ss_pred HHHHH
Confidence 99985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=316.42 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=214.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+..|+.++++++||||+++++.+.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-----------EEELEALEREIRILSSLQHPNIVRYYGSER 69 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 488999999999999999999999999999998544221 234567888999999999999999999998
Q ss_pred cC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 97 TD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 97 ~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.. ..+++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 70 DEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred cCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccccc
Confidence 88 89999999999999999987654 599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+......... .......++..|+|||
T Consensus 148 ~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~y~~pE 173 (260)
T cd06606 148 AKRLGDIETG------------------------------------------------------EGTGSVRGTPYWMAPE 173 (260)
T ss_pred EEeccccccc------------------------------------------------------ccccCCCCCccccCHh
Confidence 8876432110 0112335888999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
.+.+..++.++|+|||||++|+|++|..||.... .......+.. .+......+..+.+||.+||+.+|.+||++.+
T Consensus 174 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ 253 (260)
T cd06606 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253 (260)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHH
Confidence 9998889999999999999999999999998776 2333333321 11222344788999999999999999999999
Q ss_pred HhcCCCc
Q 014344 331 IKGHEFF 337 (426)
Q Consensus 331 il~hp~f 337 (426)
++.||||
T Consensus 254 ll~~~~~ 260 (260)
T cd06606 254 LLQHPFL 260 (260)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=331.46 Aligned_cols=251 Identities=28% Similarity=0.463 Sum_probs=205.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
-++|++++.||.|+||.||+|.+..+++.||+|++.+... .....+.+..|+.+++.++||||++++++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-----------TPVLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-----------ccchhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 3579999999999999999999999999999998744211 11234567789999999999999999999
Q ss_pred eec-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 95 LST-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 95 ~~~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
|.. ...+|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||+|.|||++.++.++|+|||
T Consensus 78 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 78 FISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred EecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 865 56889999999 5788887653 348899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..... .....++++.|+||
T Consensus 154 ~~~~~~~-----------------------------------------------------------~~~~~~~~~~y~aP 174 (328)
T cd07856 154 LARIQDP-----------------------------------------------------------QMTGYVSTRYYRAP 174 (328)
T ss_pred cccccCC-----------------------------------------------------------CcCCCcccccccCc
Confidence 8864321 11223578889999
Q ss_pred hhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cC------------------------CC----
Q 014344 254 EIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CR------------------------PP---- 301 (426)
Q Consensus 254 E~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~------------------------~~---- 301 (426)
|.+.+ ..++.++|+|||||++|+|++|++||........+..+. .. .+
T Consensus 175 E~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (328)
T cd07856 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFS 254 (328)
T ss_pred eeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHH
Confidence 99866 568999999999999999999999998766533221110 00 00
Q ss_pred -CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 302 -DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 302 -~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.....+..+.++|++||+.+|++|||+++++.||||..
T Consensus 255 ~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 255 EKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293 (328)
T ss_pred HHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccc
Confidence 11234678999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=319.63 Aligned_cols=244 Identities=19% Similarity=0.272 Sum_probs=199.7
Q ss_pred eecccCceEEEEEEE--cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCe
Q 014344 23 ALGRGAKGVVFLVKD--VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
+||+|+||.||+|.. ..+++.+|+|++.... ......+.+..|+.+++.++||||+++++++. ...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 69 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-----------NDPALKDELLREANVMQQLDNPYIVRMIGICE-AES 69 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-----------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCC
Confidence 689999999999964 4667899999984321 11234567888999999999999999999875 456
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++..+..
T Consensus 70 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 70 WMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGA 147 (257)
T ss_pred cEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCC
Confidence 78999999999999988654 3489999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
.... ........+++.|+|||.+.+..
T Consensus 148 ~~~~-----------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 148 DENY-----------------------------------------------------YKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred CCCe-----------------------------------------------------eeecCCCCCCccccCHhHhccCC
Confidence 1100 00011123567899999998888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 261 HDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
++.++|+|||||++|||++ |..||...+..+....+... ++.....+..+.+||.+||+.||++||++++|..
T Consensus 175 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 9999999999999999997 99999988777666655432 2333456889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.26 Aligned_cols=258 Identities=19% Similarity=0.289 Sum_probs=210.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcC-------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVE-------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 82 (426)
.+.+..++|.+++.||+|+||.||+|++.. ....+|+|++.... .......+..|+.+++.
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~~~E~~~l~~ 73 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA------------TDKDLADLISEMELMKL 73 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC------------ChHHHHHHHHHHHHHHh
Confidence 345667889999999999999999998642 34579999874321 12235567889999999
Q ss_pred c-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 83 V-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 83 l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+ +||||+++++++.....+|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++
T Consensus 74 l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 153 (314)
T cd05099 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR 153 (314)
T ss_pred ccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 59999999999999999999999999999999986532 23488899999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
||+||||||+|||++.++.+||+|||+++........
T Consensus 154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------- 190 (314)
T cd05099 154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY------------------------------------------- 190 (314)
T ss_pred CeeeccccceeEEEcCCCcEEEccccccccccccccc-------------------------------------------
Confidence 9999999999999999999999999999765321100
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLV 304 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~ 304 (426)
.......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.+..+.... ....
T Consensus 191 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (314)
T cd05099 191 -----------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPS 259 (314)
T ss_pred -----------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 00111124567999999999889999999999999999998 999999888777666655432 2233
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
..+.++.+||.+||..+|++|||+.++++
T Consensus 260 ~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 260 NCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 45778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.54 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=209.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
...+|++.+.||+|+||.||+|.+..+++ .||||++.+.. .......+..|+.+++.++||||++
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~ni~~ 69 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY------------TEKQRRDFLSEASIMGQFDHPNIIH 69 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC------------CHHHHHHHHHHHHHHHhCCCcCcce
Confidence 46789999999999999999999887665 59999985321 1223467888999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.++...++||||+++++|.+++.... +.++...++.++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~ 148 (269)
T cd05065 70 LEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVS 148 (269)
T ss_pred EEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEEC
Confidence 9999999999999999999999999886543 458999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........... ........++..|
T Consensus 149 dfg~~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~y 177 (269)
T cd05065 149 DFGLSRFLEDDTSDPT---------------------------------------------------YTSSLGGKIPIRW 177 (269)
T ss_pred CCccccccccCccccc---------------------------------------------------cccccCCCcceee
Confidence 9999875532110000 0000001124579
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||.+.+..++.++|||||||++|||++ |..||...+..+....+.. ..+...+.+..+.+++.+||..+|++||+
T Consensus 178 ~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (269)
T cd05065 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPK 257 (269)
T ss_pred cCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999999886 9999988777666555543 22334466788999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
+++|+.
T Consensus 258 ~~~i~~ 263 (269)
T cd05065 258 FGQIVS 263 (269)
T ss_pred HHHHHH
Confidence 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=329.04 Aligned_cols=251 Identities=27% Similarity=0.422 Sum_probs=210.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|+..+.||+|+||.||+|++..++..+|+|++..... ........+..|+.+++.++|||++++++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 94 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK----------QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY 94 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC----------CchHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 348899999999999999999999999999999854311 1123456788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+...|+||||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 95 ~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 95 LREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCc
Confidence 99999999999997 5777766543 345899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..... .....|++.|+|||.
T Consensus 173 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~ 192 (317)
T cd06635 173 SIASP------------------------------------------------------------ANSFVGTPYWMAPEV 192 (317)
T ss_pred cccCC------------------------------------------------------------cccccCCccccChhh
Confidence 64321 112358889999999
Q ss_pred hc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 256 IE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 256 ~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+. ...++.++|+|||||++|+|++|.+||...........+..... .....+..+.+||.+||+.+|.+||++.
T Consensus 193 ~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 272 (317)
T cd06635 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSE 272 (317)
T ss_pred hhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHH
Confidence 74 35678899999999999999999999988877666666554322 2224567899999999999999999999
Q ss_pred HHhcCCCcC
Q 014344 330 EIKGHEFFK 338 (426)
Q Consensus 330 eil~hp~f~ 338 (426)
++++|+|+.
T Consensus 273 ~il~~~~~~ 281 (317)
T cd06635 273 ELLKHMFVL 281 (317)
T ss_pred HHHhChhhh
Confidence 999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=318.86 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=210.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
+..++|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .......+..|+++++.++||||+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~ 69 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY------------TEKQRQDFLSEASIMGQFSHHNII 69 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC------------CHHHHHHHHHHHHHHhcCCCCCee
Confidence 345679999999999999999999876665 69999874321 112345678899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++...+..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl 148 (268)
T cd05063 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKV 148 (268)
T ss_pred EEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEE
Confidence 99999999999999999999999999886543 45899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++......... .........++.
T Consensus 149 ~dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 175 (268)
T cd05063 149 SDFGLSRVLEDDPEG-----------------------------------------------------TYTTSGGKIPIR 175 (268)
T ss_pred CCCccceeccccccc-----------------------------------------------------ceeccCCCcCce
Confidence 999998765321100 000111123567
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+.. ..+.....+..+.+++.+||..+|++||
T Consensus 176 y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp 255 (268)
T cd05063 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRP 255 (268)
T ss_pred ecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 999999998889999999999999999997 9999988877766666543 2333445688899999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
++.+|++
T Consensus 256 ~~~~i~~ 262 (268)
T cd05063 256 RFVDIVN 262 (268)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=324.32 Aligned_cols=252 Identities=29% Similarity=0.490 Sum_probs=207.2
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++++.||.|+||.||+|.+..+++.+|+|++.... ........+..|+.+++.++|||++++++++..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 69 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-----------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS 69 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-----------ccccchHHHHHHHHHHHhccCCCeeeheeeEec
Confidence 789999999999999999999999999999996542 111234567789999999999999999999988
Q ss_pred C--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 98 D--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 98 ~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
. ...++||||++ ++|.+++.... ..+++..++.++.||+.||+|||+.|++|+||||+||++++++.++|+|||++
T Consensus 70 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~ 147 (287)
T cd07840 70 KGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLA 147 (287)
T ss_pred CCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccce
Confidence 8 89999999997 58888776542 45999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
........ .......++..|+|||.
T Consensus 148 ~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~~PE~ 172 (287)
T cd07840 148 RPYTKRNS-------------------------------------------------------ADYTNRVITLWYRPPEL 172 (287)
T ss_pred eeccCCCc-------------------------------------------------------ccccccccccccCCcee
Confidence 76642210 01112246788999998
Q ss_pred hcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----C-----------------------CC
Q 014344 256 IEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-----P-----------------------DL 303 (426)
Q Consensus 256 ~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----~-----------------------~~ 303 (426)
+.+ ..++.++|||||||++|+|++|+.||...+.......+... + + ..
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07840 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252 (287)
T ss_pred eEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHh
Confidence 765 45789999999999999999999999887765554443211 0 0 00
Q ss_pred CC-CCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 304 VG-EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 304 ~~-~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.. .+..+.++|++||..+|.+||++.+++.||||
T Consensus 253 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11 26778999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.90 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=210.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|.+.+.||+|+||.||+|.+..++..+++|++........ .......+..|+.+++.++||||+++++++.
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL--------NPNETVQANQEAQLLSKLDHPAIVKFHASFL 72 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc--------CcchHHHHHHHHHHHHhCCCCcHHHHHHHHh
Confidence 58999999999999999999988888888888743221110 1112335667899999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+....++||||+++++|.+++.. .....+++..++.++.|++.||.|||++|++||||||+||+++. +.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~ 151 (260)
T cd08222 73 ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGV 151 (260)
T ss_pred cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCc
Confidence 99999999999999999988764 23346899999999999999999999999999999999999975 6799999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... .......|++.|+|||
T Consensus 152 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~~pe 175 (260)
T cd08222 152 SRLLMGSC--------------------------------------------------------DLATTFTGTPYYMSPE 175 (260)
T ss_pred eeecCCCc--------------------------------------------------------ccccCCCCCcCccCHH
Confidence 87653211 0112334788999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+.+..++.++|+||||+++|+|++|..||...........+..... .....+..+.++|.+||..+|++||++.+++
T Consensus 176 ~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 99888899999999999999999999999988777666666543322 1234578899999999999999999999999
Q ss_pred cCCCc
Q 014344 333 GHEFF 337 (426)
Q Consensus 333 ~hp~f 337 (426)
.||||
T Consensus 256 ~~~~~ 260 (260)
T cd08222 256 RNPFI 260 (260)
T ss_pred hCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.92 Aligned_cols=255 Identities=20% Similarity=0.252 Sum_probs=204.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCce----EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
+.+...+|++++.||+|+||+||+|....+++. +|+|.+... .......++..|+.+++.++||
T Consensus 2 ~~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~~~~~~~l~~l~h~ 69 (279)
T cd05111 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR------------SGRQTFQEITDHMLAMGSLDHA 69 (279)
T ss_pred CcCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc------------cchHHHHHHHHHHHHHhcCCCC
Confidence 346678899999999999999999999888775 555554211 1112345677788899999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++. ....++++||+++|+|.+++.... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 70 ~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~ 147 (279)
T cd05111 70 YIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI 147 (279)
T ss_pred CcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc
Confidence 9999999875 456789999999999999987543 45899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+++.+..... ........+
T Consensus 148 ~kl~Dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~~ 173 (279)
T cd05111 148 VQIADFGVADLLYPDDK------------------------------------------------------KYFYSEHKT 173 (279)
T ss_pred EEEcCCccceeccCCCc------------------------------------------------------ccccCCCCC
Confidence 99999999876532110 001122346
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+... ++.....+..+.+++.+||..||+
T Consensus 174 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~ 253 (279)
T cd05111 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN 253 (279)
T ss_pred cccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 778999999998889999999999999999998 99999887765543333221 222234567889999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
+|||+.|+++
T Consensus 254 ~Rps~~el~~ 263 (279)
T cd05111 254 VRPTFKELAN 263 (279)
T ss_pred cCcCHHHHHH
Confidence 9999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.30 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=209.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++.++|++++.||+|+||.||+|.+.. ++..||+|++.... .......+..|+.+++.++|||
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~~~ei~~l~~l~h~~ 69 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------------SADMQADFQREAALMAEFDHPN 69 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc------------CHHHHHHHHHHHHHHHhcCCCc
Confidence 456789999999999999999999753 67889999984321 1123456888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------------------QMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------------------~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
|+++++++..+...|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~ 149 (288)
T cd05050 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149 (288)
T ss_pred hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999998864321 2377888999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
|++||||||+|||++.++.++|+|||++..+......
T Consensus 150 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~------------------------------------------- 186 (288)
T cd05050 150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY------------------------------------------- 186 (288)
T ss_pred CeecccccHhheEecCCCceEECccccceecccCccc-------------------------------------------
Confidence 9999999999999999999999999998755321100
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC--CCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPP--DLV 304 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~--~~~ 304 (426)
.......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+..... ...
T Consensus 187 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (288)
T cd05050 187 -----------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPD 255 (288)
T ss_pred -----------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 00111234567999999999999999999999999999997 8899988887776666543321 223
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
..+..+.+||.+||+.+|++|||+.|+++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 256 NCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 45788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=338.22 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=210.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.+.+..++|.++++||+|+||.||+|++. .+++.||+|++.... .......+..|+.+|.++.
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~------------~~~~~~~~~~E~~~l~~l~ 98 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA------------RSSEKQALMSELKIMSHLG 98 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC------------ChhHHHHHHHHHHHHHhcC
Confidence 46778889999999999999999999864 345689999985321 1122356888999999998
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-----------------------------------------
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE----------------------------------------- 122 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~----------------------------------------- 122 (426)
||||+++++++.....+++|||||.+|+|.+++.....
T Consensus 99 ~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (401)
T cd05107 99 PHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGY 178 (401)
T ss_pred CCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccc
Confidence 99999999999999999999999999999998865321
Q ss_pred -------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 123 -------------------------------------------------------QMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 123 -------------------------------------------------------~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
..++...+..++.||+.||+|||+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 258 (401)
T cd05107 179 MDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK 258 (401)
T ss_pred cccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 1366777889999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
||+||||||+|||++.++.+||+|||+++.......
T Consensus 259 ~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~-------------------------------------------- 294 (401)
T cd05107 259 NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN-------------------------------------------- 294 (401)
T ss_pred CcCcccCCcceEEEeCCCEEEEEecCcceecccccc--------------------------------------------
Confidence 999999999999999999999999999875432110
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDL 303 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~ 303 (426)
.......++++.|+|||.+.+..++.++|||||||++|||++ |..||......+.....+.. ++..
T Consensus 295 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p 364 (401)
T cd05107 295 ----------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP 364 (401)
T ss_pred ----------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC
Confidence 001122357889999999999889999999999999999998 89999876655554443322 2223
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||.+||..+|.+||++++|+..
T Consensus 365 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=323.81 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=207.8
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+..|+.+|+.++||||+++++++..
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 69 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-----------EGIPKTALREIKLLKELNHPNIIKLLDVFRH 69 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-----------chhHHHHHHHHHHHHHhcCCCcchHHHhhcc
Confidence 67889999999999999999999999999988543211 1234577789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
...+|+|+||+.+ +|..++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+..
T Consensus 70 ~~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 70 KGDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred CCCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 9999999999974 8877766543 4589999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
..... .......++..|+|||.+.
T Consensus 148 ~~~~~--------------------------------------------------------~~~~~~~~~~~~~~PE~~~ 171 (283)
T cd05118 148 FGSPV--------------------------------------------------------RPYTHYVVTRWYRAPELLL 171 (283)
T ss_pred cCCCc--------------------------------------------------------ccccCccCcccccCcHHHh
Confidence 64221 0011234788899999998
Q ss_pred CC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C----------------------------CCCCC
Q 014344 258 GK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P----------------------------PDLVG 305 (426)
Q Consensus 258 ~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~----------------------------~~~~~ 305 (426)
+. .++.++|+|||||++|+|++|+.||...+..+.+..+... + .....
T Consensus 172 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (283)
T cd05118 172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPN 251 (283)
T ss_pred cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhh
Confidence 76 7899999999999999999999999887765554443211 0 00112
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.+..+.+||.+||.+||.+||++.+++.||||
T Consensus 252 ~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 252 ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 35678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=334.08 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=204.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEE-----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
+.+..++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+|..+ .
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~~ 69 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------THSEHRALMSELKILIHIGH 69 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC------------ChHHHHHHHHHHHHHHhccC
Confidence 456677899999999999999999985 3567899999984321 112345688899999999 5
Q ss_pred CCCcceeeeeeec-CCeEEEEEeccCCCChHHHHHHhc------------------------------------------
Q 014344 85 HPLLPRLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQS------------------------------------------ 121 (426)
Q Consensus 85 hp~iv~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~------------------------------------------ 121 (426)
||||+++++++.. +..+++|||||++|+|.+++....
T Consensus 70 h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (343)
T cd05103 70 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSAS 149 (343)
T ss_pred CccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccccccccc
Confidence 8999999998754 457899999999999999876432
Q ss_pred -----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 122 -----------------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 122 -----------------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
...++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 150 SGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred ccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 123678888999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
..... ........+++.|+|||++.+
T Consensus 230 ~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 230 YKDPD------------------------------------------------------YVRKGDARLPLKWMAPETIFD 255 (343)
T ss_pred ccCcc------------------------------------------------------hhhcCCCCCCcceECcHHhcC
Confidence 32110 001112235678999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 259 KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
..++.++|||||||++|+|++ |..||........+...+.. .+.....++.+.+++.+||+.||.+|||+.+|++|
T Consensus 256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999996 99999876543333332211 11122346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=333.43 Aligned_cols=260 Identities=30% Similarity=0.482 Sum_probs=208.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
.++|++.+.||+|+||.||+|.+..+++.+|+|++.+... .......+..|+.+++++ +||||+++++
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~ 74 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-----------NATDAQRTFREIMFLQELGDHPNIVKLLN 74 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-----------cchhhhhhhHHHHHHHHhcCCCCccceee
Confidence 4579999999999999999999999999999998843211 112234566799999999 9999999999
Q ss_pred eeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++... ...|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 75 VIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred eeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEee
Confidence 98643 46899999997 5888877643 588999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+....... .......++||+.|+
T Consensus 151 ~g~~~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~~~y~ 179 (337)
T cd07852 151 FGLARSLSELEENP---------------------------------------------------ENPVLTDYVATRWYR 179 (337)
T ss_pred ccchhccccccccc---------------------------------------------------cCcchhccccccccc
Confidence 99988664221000 001223456899999
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------------------
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------------------------------ 300 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------------ 300 (426)
|||++.+ ..++.++|+|||||++|+|++|+.||.+........++....
T Consensus 180 aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (337)
T cd07852 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKP 259 (337)
T ss_pred CceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccc
Confidence 9998765 457889999999999999999999998776554433321110
Q ss_pred --CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 301 --PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 301 --~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
......+..+.+||.+||+.||++|||+.+++.||||+.+
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 260 LDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0112346789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=312.77 Aligned_cols=249 Identities=31% Similarity=0.586 Sum_probs=212.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++.+.||+|++|.||++.+..+++.+++|++..... .....+..|+.+++.++||+++.+++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 67 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-------------EKKEKIINEIQILKKCKHPNIVKYYGSYL 67 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-------------hHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence 58999999999999999999998999999999854321 24567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+...++++||++|++|.+++.... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+.
T Consensus 68 ~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~ 146 (253)
T cd05122 68 KKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA 146 (253)
T ss_pred cCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccc
Confidence 9999999999999999999877643 458999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... .....|+..|+|||.+
T Consensus 147 ~~~~~~~---------------------------------------------------------~~~~~~~~~~~~PE~~ 169 (253)
T cd05122 147 QLSDTKA---------------------------------------------------------RNTMVGTPYWMAPEVI 169 (253)
T ss_pred ccccccc---------------------------------------------------------ccceecCCcccCHHHH
Confidence 6532110 1234588899999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCC-C--CCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLV-G--EPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~-~--~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+..++.++|+|||||++|+|++|+.||...+........... .+... . .+..+.++|.+||+.||++|||+.+++
T Consensus 170 ~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l 249 (253)
T cd05122 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLL 249 (253)
T ss_pred cCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 9888899999999999999999999999887555444333221 11111 2 267899999999999999999999999
Q ss_pred cCCC
Q 014344 333 GHEF 336 (426)
Q Consensus 333 ~hp~ 336 (426)
.|||
T Consensus 250 ~~~~ 253 (253)
T cd05122 250 KHPF 253 (253)
T ss_pred cCCC
Confidence 9998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.15 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=205.2
Q ss_pred CcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
+|++.+.||+|+||.||+|.+.. ....+|+|++.... .......+.+|+.+++.+.||||+++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 68 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA------------SSSELRDLLSEFNLLKQVNHPHVIKL 68 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC------------CHHHHHHHHHHHHHHhhCCCCCEeeE
Confidence 48899999999999999998753 23568999874322 11234678889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhc----------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQS----------------------EQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~----------------------~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
++.+..+...+++|||+.+++|.+++.... ...++...+..++.|++.||.|||++||
T Consensus 69 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i 148 (290)
T cd05045 69 YGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL 148 (290)
T ss_pred EEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999999999999999999999999876421 1347889999999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
+||||||+|||+++++.+||+|||++.........
T Consensus 149 vH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~--------------------------------------------- 183 (290)
T cd05045 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY--------------------------------------------- 183 (290)
T ss_pred ehhhhhhheEEEcCCCcEEeccccccccccCccch---------------------------------------------
Confidence 99999999999999999999999998765321100
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGE 306 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~ 306 (426)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.+..+.. ..+.....
T Consensus 184 ---------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T cd05045 184 ---------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENC 254 (290)
T ss_pred ---------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCC
Confidence 00112235678999999998889999999999999999998 9999998877665554432 22233456
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+..+.+||.+||+.+|.+||++.++++
T Consensus 255 ~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 255 SEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.00 Aligned_cols=261 Identities=20% Similarity=0.312 Sum_probs=213.2
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcCC-------CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVES-------SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il 80 (426)
.+.+++...+|++++.||+|+||.||+|++... +..||+|++.... .......+..|+.++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l 71 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA------------TDKDLSDLVSEMEMM 71 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc------------CHHHHHHHHHHHHHH
Confidence 356778888999999999999999999987532 2368999874321 112356788899999
Q ss_pred Hhc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 014344 81 RNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLH 145 (426)
Q Consensus 81 ~~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH 145 (426)
+++ +||||+++++++..+..+|++|||+.+|+|.+++.... ...++...+..++.||+.||.|||
T Consensus 72 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 151 (334)
T cd05100 72 KMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA 151 (334)
T ss_pred HhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH
Confidence 999 79999999999999999999999999999999887532 224777888999999999999999
Q ss_pred HCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCC
Q 014344 146 NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRI 225 (426)
Q Consensus 146 ~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (426)
++||+||||||+|||++.++.+||+|||+++.......
T Consensus 152 ~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~------------------------------------------ 189 (334)
T cd05100 152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDY------------------------------------------ 189 (334)
T ss_pred HCCeeccccccceEEEcCCCcEEECCcccceecccccc------------------------------------------
Confidence 99999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CC
Q 014344 226 GPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PD 302 (426)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~ 302 (426)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+.... ..
T Consensus 190 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (334)
T cd05100 190 ------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK 257 (334)
T ss_pred ------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 000111234567999999999999999999999999999998 899999888777766654332 22
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
....+..+.+||.+||..+|.+||++.+++.+
T Consensus 258 ~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 258 PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33557889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.85 Aligned_cols=259 Identities=26% Similarity=0.363 Sum_probs=218.3
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCc---e-EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSE---S-FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~-vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 83 (426)
++.|.|.-++..+.++||+|+||.||+++-+..+. . ||+|....+. ........++.+|+++|+++
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~----------~~~~~~~~e~m~EArvMr~l 218 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS----------ELTKEQIKEFMKEARVMRQL 218 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc----------cccHHHHHHHHHHHHHHHhC
Confidence 34678888999999999999999999999865422 3 8999874311 12235678999999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+|||||+++|+...+..+|+|||+|.||+|.++++.... .++..+...++.+.+.||+|||++++|||||-.+|+|++.
T Consensus 219 ~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~ 297 (474)
T KOG0194|consen 219 NHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK 297 (474)
T ss_pred CCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC
Confidence 999999999999999999999999999999999987654 5999999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+||||++.-..-. .....
T Consensus 298 ~~~vKISDFGLs~~~~~~~--------------------------------------------------------~~~~~ 321 (474)
T KOG0194|consen 298 KGVVKISDFGLSRAGSQYV--------------------------------------------------------MKKFL 321 (474)
T ss_pred CCeEEeCccccccCCccee--------------------------------------------------------ecccc
Confidence 9999999999987542000 00000
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhc
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~ 319 (426)
.--...|+|||.+...-|++++|||||||++||+.+ |..||.+....+...+|.. +.+.....|..+..++.+|+.
T Consensus 322 ~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~ 401 (474)
T KOG0194|consen 322 KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWK 401 (474)
T ss_pred ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhcc
Confidence 114567999999999999999999999999999997 8999999999998888843 233344667888999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
.+|++||++.++.+
T Consensus 402 ~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 402 KDPEDRPTMSTIKK 415 (474)
T ss_pred CChhhccCHHHHHH
Confidence 99999999998875
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=324.68 Aligned_cols=255 Identities=23% Similarity=0.286 Sum_probs=204.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCC--------------ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESS--------------ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~--------------~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 78 (426)
++.++|++.+.||+|+||.||+|++..++ ..||+|++.... .......+.+|++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~ei~ 69 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV------------TKTARNDFLKEIK 69 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC------------CHHHHHHHHHHHH
Confidence 45568999999999999999999875432 358999984321 1123456888999
Q ss_pred HHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc----------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014344 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS----------EQMFSDDTIRFYAAELVLALEYLHNMG 148 (426)
Q Consensus 79 il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~----------~~~l~~~~~~~~~~qil~aL~~LH~~g 148 (426)
++++++||||+++++++......++||||+.+++|.+++.... ...++...+..++.|++.||.|||++|
T Consensus 70 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 149 (295)
T cd05097 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN 149 (295)
T ss_pred HHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999875432 113678889999999999999999999
Q ss_pred CcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCC
Q 014344 149 IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPD 228 (426)
Q Consensus 149 iiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (426)
++||||||+|||++.++.+||+|||++..+.....
T Consensus 150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--------------------------------------------- 184 (295)
T cd05097 150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY--------------------------------------------- 184 (295)
T ss_pred eeccccChhhEEEcCCCcEEecccccccccccCcc---------------------------------------------
Confidence 99999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc------C-
Q 014344 229 PPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY--GATPFRGSSRKETFYRILC------R- 299 (426)
Q Consensus 229 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~i~~------~- 299 (426)
........+++.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+.. .
T Consensus 185 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T cd05097 185 ---------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQ 255 (295)
T ss_pred ---------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccc
Confidence 001122345778999999998889999999999999999987 7789988776554443321 0
Q ss_pred --CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 300 --PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 300 --~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.......+..+.+||.+||+.||++||++++|++
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 256 IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1122235788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.05 Aligned_cols=255 Identities=23% Similarity=0.334 Sum_probs=210.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+..++|++++.||+|+||.||+|+.+. +.+.+|+|.+.... .......+..|++++++++|||
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~ 69 (275)
T cd05046 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------------DENLQSEFRRELDMFRKLSHKN 69 (275)
T ss_pred CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc------------chHHHHHHHHHHHHHHhcCCcc
Confidence 445789999999999999999999754 34679999873321 1124567888999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
|+++++++......|+||||+++++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+|||
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nil 149 (275)
T cd05046 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCL 149 (275)
T ss_pred eeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEE
Confidence 99999999999999999999999999999876542 15899999999999999999999999999999999999
Q ss_pred eccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 161 l~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
++.++.++|+|||++....... ...
T Consensus 150 i~~~~~~~l~~~~~~~~~~~~~-------------------------------------------------------~~~ 174 (275)
T cd05046 150 VSSQREVKVSLLSLSKDVYNSE-------------------------------------------------------YYK 174 (275)
T ss_pred EeCCCcEEEcccccccccCccc-------------------------------------------------------ccc
Confidence 9999999999999886432110 011
Q ss_pred ccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHH
Q 014344 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRR 316 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~ 316 (426)
.....+++.|+|||.+.+..++.++|||||||++|+|++ |..||........+..+.... +.....+..+.++|.+
T Consensus 175 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 254 (275)
T cd05046 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTR 254 (275)
T ss_pred cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHH
Confidence 123346788999999988888999999999999999998 889998777666665554222 1223557889999999
Q ss_pred HhccCCCCCCChHHHhcC
Q 014344 317 LLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~h 334 (426)
||..+|++||++.+++++
T Consensus 255 ~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 255 CWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HcCCCcccCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=341.11 Aligned_cols=255 Identities=21% Similarity=0.312 Sum_probs=211.8
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
..|.+..+...++..||+|+||+||++++. ..||||++.... ..+++.+.|.+|+.++++-+|.||
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~-----------pt~~qlqaFKnEVa~lkkTRH~NI 450 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDD-----------PTPEQLQAFKNEVAVLKKTRHENI 450 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCC-----------CCHHHHHHHHHHHHHHhhcchhhh
Confidence 467888899999999999999999999874 379999995543 234578899999999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+-+.|++..+.. .||+.+|+|.+|+.+++... ..|.....+.|++||+.|+.|||.++|||||||..||++.+++.||
T Consensus 451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred eeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEE
Confidence 999999988887 99999999999999988665 3489999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++..-..-. + ........|..
T Consensus 529 IgDFGLatvk~~w~---------------------------g---------------------------~~q~~qp~gsi 554 (678)
T KOG0193|consen 529 IGDFGLATVKTRWS---------------------------G---------------------------EQQLEQPHGSL 554 (678)
T ss_pred Eecccceeeeeeec---------------------------c---------------------------ccccCCCccch
Confidence 99999987532110 0 01112224788
Q ss_pred CCccchhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CC----CCCCCHHHHHHHHHHhc
Q 014344 249 EYVAPEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PD----LVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 249 ~y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~----~~~~~~~~~~li~~~L~ 319 (426)
.|||||+++. .+|++.+|||||||++|||++|..||...+....+..+-... ++ ...++.++++|+..||.
T Consensus 555 lwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~ 634 (678)
T KOG0193|consen 555 LWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWK 634 (678)
T ss_pred hhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHh
Confidence 9999999974 568999999999999999999999999766665544332221 11 12456689999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
+++++||.+.+||.
T Consensus 635 ~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 635 FDREERPLFPQLLS 648 (678)
T ss_pred cCcccCccHHHHHH
Confidence 99999999999986
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=315.48 Aligned_cols=247 Identities=26% Similarity=0.358 Sum_probs=209.0
Q ss_pred eeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 22 SALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
+.||+|+||.||+|.+... +..||+|++..... ....+.+..|+.+++.++|+||+++++++.+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 68 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS------------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEE 68 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc------------hhHHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence 4699999999999999866 88999999854321 11356788899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQS-------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~-------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
..+++||||+++++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|
T Consensus 69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d 148 (262)
T cd00192 69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD 148 (262)
T ss_pred CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc
Confidence 99999999999999999987641 24599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||.+........ ........+++.|+
T Consensus 149 fg~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~ 174 (262)
T cd00192 149 FGLSRDVYDDDY------------------------------------------------------YRKKTGGKLPIRWM 174 (262)
T ss_pred cccccccccccc------------------------------------------------------cccccCCCcCcccc
Confidence 999876642210 01122345788999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+....++.++|+|||||++|+|++ |..||......+....+... .......+..+.++|.+||..+|++|||+
T Consensus 175 aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 254 (262)
T cd00192 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTF 254 (262)
T ss_pred CHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCH
Confidence 9999998889999999999999999998 69999998877776666532 22234557889999999999999999999
Q ss_pred HHHhcC
Q 014344 329 EEIKGH 334 (426)
Q Consensus 329 ~eil~h 334 (426)
.+++++
T Consensus 255 ~~l~~~ 260 (262)
T cd00192 255 SELVER 260 (262)
T ss_pred HHHHHh
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=315.11 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=206.7
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
+..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+..|+++++.++||+++++++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i~~~~~ 66 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--------------SEEDFIEEAQVMMKLSHPKLVQLYG 66 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--------------CHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4568999999999999999999875 467899998743211 1235677999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++......|+||||+.+++|.+++.... ..++++.++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||
T Consensus 67 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 67 VCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred EEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999876543 358899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++........ .......++..|+||
T Consensus 146 ~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~~aP 170 (256)
T cd05112 146 MTRFVLDDQY-------------------------------------------------------TSSTGTKFPVKWSSP 170 (256)
T ss_pred ceeecccCcc-------------------------------------------------------cccCCCccchhhcCH
Confidence 9875421100 001112356789999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+|||||++|+|++ |+.||...........+... .......+..+.+|+.+||..+|.+|||+.+
T Consensus 171 e~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred hHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 99998889999999999999999998 99999887776666555422 1222335788999999999999999999999
Q ss_pred HhcC
Q 014344 331 IKGH 334 (426)
Q Consensus 331 il~h 334 (426)
++++
T Consensus 251 ~l~~ 254 (256)
T cd05112 251 LLHQ 254 (256)
T ss_pred HHHh
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.21 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=203.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcC----------------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHH
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVE----------------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 77 (426)
..++|++.+.||+|+||.||+|.+.. ++..+|+|++.... .......+..|+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~------------~~~~~~~~~~E~ 70 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA------------NKNARNDFLKEI 70 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC------------CHHHHHHHHHHH
Confidence 34679999999999999999996532 34469999884321 112345788899
Q ss_pred HHHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014344 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE---------QMFSDDTIRFYAAELVLALEYLHNMG 148 (426)
Q Consensus 78 ~il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~---------~~l~~~~~~~~~~qil~aL~~LH~~g 148 (426)
.+|+.++||||+++++++..+...|+||||+.+++|.+++..... ..++...+..++.||+.||+|||+.|
T Consensus 71 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 150 (296)
T cd05095 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN 150 (296)
T ss_pred HHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999999999999999999998865421 23677889999999999999999999
Q ss_pred CcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCC
Q 014344 149 IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPD 228 (426)
Q Consensus 149 iiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (426)
|+||||||+|||++.++.++|+|||++..+.....
T Consensus 151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--------------------------------------------- 185 (296)
T cd05095 151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY--------------------------------------------- 185 (296)
T ss_pred eecccCChheEEEcCCCCEEeccCcccccccCCcc---------------------------------------------
Confidence 99999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHh---------
Q 014344 229 PPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY--GATPFRGSSRKETFYRIL--------- 297 (426)
Q Consensus 229 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~~~~~i~--------- 297 (426)
........+++.|+|||+..+..++.++|+|||||++|||++ |..||...+..+......
T Consensus 186 ---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 256 (296)
T cd05095 186 ---------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQ 256 (296)
T ss_pred ---------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhcccc
Confidence 001112235678999999888889999999999999999998 789998776655443221
Q ss_pred cCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 298 CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
...+.....+..+.+||.+||+.||.+||++.+|++
T Consensus 257 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 257 VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 011223345788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=346.38 Aligned_cols=258 Identities=26% Similarity=0.464 Sum_probs=228.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
..-..|+|..+||.|.+|.||+++.+.+++..|+|++.... +.-.++..|++||+.+. |||++.+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--------------d~deEiE~eynil~~~~~hpnv~~f 81 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--------------DEEEEIELEYNMLKKYSHHPNVATF 81 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--------------cccHHHHHHHHHHHhccCCCCcceE
Confidence 34467999999999999999999999999999999985432 23456777999999885 9999999
Q ss_pred eeeee-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 92 RGVLS-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 92 ~~~~~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++|. .++.+|||||||.||+..++++...+..+.+..+..|++.++.||.+||.+.++|||||-.|||++.+|.
T Consensus 82 yg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~ 161 (953)
T KOG0587|consen 82 YGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE 161 (953)
T ss_pred EEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc
Confidence 99984 4678999999999999999999887888999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
|||+|||++..+..+ ..+.++++|
T Consensus 162 VKLvDFGvSaQldsT--------------------------------------------------------~grRnT~iG 185 (953)
T KOG0587|consen 162 VKLVDFGVSAQLDST--------------------------------------------------------VGRRNTFIG 185 (953)
T ss_pred EEEeeeeeeeeeecc--------------------------------------------------------cccccCcCC
Confidence 999999999887422 246788999
Q ss_pred CCCCccchhhcCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHHH
Q 014344 247 TEEYVAPEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRRL 317 (426)
Q Consensus 247 t~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~ 317 (426)
||.|||||++.+. .|+..+|+||||++..||.-|.+|+.+..+...+..|-..||..+ .++..+.+||..|
T Consensus 186 tP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~c 265 (953)
T KOG0587|consen 186 TPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTC 265 (953)
T ss_pred CcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHH
Confidence 9999999999874 367899999999999999999999999999988888877665543 3467789999999
Q ss_pred hccCCCCCCChHHHhcCCCcCCC
Q 014344 318 LEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 318 L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
|.+|..+||+..++|.|||++..
T Consensus 266 L~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 266 LVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred HhhccccCcchhhhccCCccccc
Confidence 99999999999999999999854
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=315.82 Aligned_cols=244 Identities=24% Similarity=0.326 Sum_probs=204.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+.+.+|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.+++.++||||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---------------~~~~~~~e~~~l~~~~~~~i~~~~ 65 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---------------TAQAFLEETAVMTKLHHKNLVRLL 65 (254)
T ss_pred ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---------------hHHHHHHHHHHHHhCCCCCcCeEE
Confidence 456789999999999999999986 578899999874321 234677899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++..+ ..|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+||
T Consensus 66 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Df 144 (254)
T cd05083 66 GVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDF 144 (254)
T ss_pred EEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCC
Confidence 998654 4799999999999999987665556899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... .....+..|+|
T Consensus 145 g~~~~~~~~~-----------------------------------------------------------~~~~~~~~y~~ 165 (254)
T cd05083 145 GLARVGSMGV-----------------------------------------------------------DNSKLPVKWTA 165 (254)
T ss_pred ccceeccccC-----------------------------------------------------------CCCCCCceecC
Confidence 9886532110 01123567999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||.+.+..++.++|+|||||++|+|++ |++||...+..+....+... .......+..+.++|++||..+|.+||+++
T Consensus 166 pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 245 (254)
T cd05083 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFH 245 (254)
T ss_pred HHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999998889999999999999999997 99999988876665555432 222335578899999999999999999999
Q ss_pred HHhc
Q 014344 330 EIKG 333 (426)
Q Consensus 330 eil~ 333 (426)
+++.
T Consensus 246 ~l~~ 249 (254)
T cd05083 246 KLRE 249 (254)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.52 Aligned_cols=250 Identities=27% Similarity=0.465 Sum_probs=205.7
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLS 96 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~ 96 (426)
|++.+.||+|++|+||+|....+++.||||.+...... .......+|+..++++. ||||+++++++.
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~------------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 68 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS------------WEECMNLREVKSLRKLNEHPNIVKLKEVFR 68 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc------------hhHHHHHHHHHHHHhccCCCCchhHHHHhh
Confidence 78999999999999999999989999999988543210 11123345888999999 999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+...|+||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus 69 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 69 ENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence 999999999999 7899888776554568999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... ......|+..|+|||++
T Consensus 148 ~~~~~~---------------------------------------------------------~~~~~~~~~~~~aPE~~ 170 (283)
T cd07830 148 EIRSRP---------------------------------------------------------PYTDYVSTRWYRAPEIL 170 (283)
T ss_pred eccCCC---------------------------------------------------------CcCCCCCcccccCceee
Confidence 543211 11223578899999988
Q ss_pred cC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC----------------------------CCC
Q 014344 257 EG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP----------------------------DLV 304 (426)
Q Consensus 257 ~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~----------------------------~~~ 304 (426)
.+ ..++.++|+||||+++|+|++|++||...+..+.+..+.. .+. ...
T Consensus 171 ~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (283)
T cd07830 171 LRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP 250 (283)
T ss_pred ecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcc
Confidence 54 4578999999999999999999999988776555443321 100 011
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
..+..+.+||++||+.+|++|||++|++.||||
T Consensus 251 ~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 251 NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 225678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=314.92 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=207.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
++..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+..|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~i~~~ 66 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--------------MSVEAFLAEANVMKTLQHDKLVKL 66 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh--------------hHHHHHHHHHHHHHhcCCCCcceE
Confidence 456778999999999999999999864 45679999874321 123467789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++.+.. ...|++|||+++++|.+++.......++...+..++.||+.||.|||+.|++||||||+||+++.++.+||+|
T Consensus 67 ~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d 145 (260)
T cd05073 67 HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 145 (260)
T ss_pred EEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECC
Confidence 999877 7889999999999999998775555688899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+..... .......++..|+
T Consensus 146 ~~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y~ 170 (260)
T cd05073 146 FGLARVIEDNEY-------------------------------------------------------TAREGAKFPIKWT 170 (260)
T ss_pred CcceeeccCCCc-------------------------------------------------------ccccCCccccccc
Confidence 999876532110 0001123567799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||++.+..++.++|+|||||++|++++ |..||.+.+.......+.... +.....+..+.+++.+||..+|++||++
T Consensus 171 ~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 250 (260)
T cd05073 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTF 250 (260)
T ss_pred CHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCH
Confidence 9999998889999999999999999998 999999887766655554332 2233557889999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.+++.
T Consensus 251 ~~l~~ 255 (260)
T cd05073 251 EYIQS 255 (260)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=322.73 Aligned_cols=251 Identities=30% Similarity=0.464 Sum_probs=208.4
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++.+.||+|++|.||+|....+++.||+|++..... .......+..|+.+++.++||||+++++++..
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 69 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-----------EEGIPSTALREISLLKELKHPNIVKLLDVIHT 69 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-----------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc
Confidence 6788999999999999999999999999999855421 12234567789999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
....++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..
T Consensus 70 ~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 70 ERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred CCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 999999999997 58999887653 3599999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
...... ......++..|+|||.+.
T Consensus 148 ~~~~~~--------------------------------------------------------~~~~~~~~~~~~aPE~~~ 171 (282)
T cd07829 148 FGIPLR--------------------------------------------------------TYTHEVVTLWYRAPEILL 171 (282)
T ss_pred cCCCcc--------------------------------------------------------ccCccccCcCcCChHHhc
Confidence 532110 111223577899999987
Q ss_pred CC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C---------------------------CCCCCC
Q 014344 258 GK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P---------------------------PDLVGE 306 (426)
Q Consensus 258 ~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~---------------------------~~~~~~ 306 (426)
+. .++.++|+|||||++|+|++|++||.+.+....+.++... + ......
T Consensus 172 ~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd07829 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRL 251 (282)
T ss_pred CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccc
Confidence 76 7889999999999999999999999887765554433210 0 001123
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
+..+.++|.+||..||++||++.+++.||||
T Consensus 252 ~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 252 DPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 5679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=326.25 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=208.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|...+.||+|+||.||+|++..+++.+|+|.+..... .......++..|+.+++.++|+|++++++++
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 84 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK----------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc----------cChHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 448889999999999999999999999999998853211 1112345677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
......|+||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++
T Consensus 85 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 162 (308)
T cd06634 85 LREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (308)
T ss_pred EcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccc
Confidence 99999999999996 67777665433 45899999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..... .....|++.|+|||.
T Consensus 163 ~~~~~------------------------------------------------------------~~~~~~~~~y~aPE~ 182 (308)
T cd06634 163 SIMAP------------------------------------------------------------ANXFVGTPYWMAPEV 182 (308)
T ss_pred eeecC------------------------------------------------------------cccccCCccccCHHH
Confidence 65421 112358889999999
Q ss_pred hcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC--CCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 256 IEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-PD--LVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 256 ~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~--~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+.+ ..++.++|||||||++|+|++|..||...+..+....+.... +. ....+..+.+||.+||..+|.+||+++
T Consensus 183 ~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~ 262 (308)
T cd06634 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 262 (308)
T ss_pred HhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHH
Confidence 853 457889999999999999999999998776655544443322 11 224577899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
+++.|||+..
T Consensus 263 ~ll~~~~~~~ 272 (308)
T cd06634 263 VLLKHRFVLR 272 (308)
T ss_pred HHhhCccccc
Confidence 9999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.90 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=219.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
..++..++.++.++||+|+||+||+|+... ....||||.++.. ...+...+|++|+++|..|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~------------a~~~~~~dF~REaeLla~l~ 547 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK------------AENQARQDFRREAELLAELQ 547 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc------------ccHHHHHHHHHHHHHHHhcc
Confidence 556788899999999999999999998642 3457999988433 23346789999999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE------------QMFSDDTIRFYAAELVLALEYLHNMGIVYR 152 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~------------~~l~~~~~~~~~~qil~aL~~LH~~giiHr 152 (426)
|||||+|+|++..++.+|+|+|||..|||..+++.... .+++..+...++.||+.|++||-++.+|||
T Consensus 548 H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHR 627 (774)
T KOG1026|consen 548 HPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHR 627 (774)
T ss_pred CCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccccc
Confidence 99999999999999999999999999999999875421 128889999999999999999999999999
Q ss_pred CCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCC
Q 014344 153 DLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR 232 (426)
Q Consensus 153 DlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (426)
||..+|+||.++..|||+||||++......-
T Consensus 628 DLATRNCLVge~l~VKIsDfGLsRdiYssDY------------------------------------------------- 658 (774)
T KOG1026|consen 628 DLATRNCLVGENLVVKISDFGLSRDIYSSDY------------------------------------------------- 658 (774)
T ss_pred chhhhhceeccceEEEecccccchhhhhhhh-------------------------------------------------
Confidence 9999999999999999999999997753220
Q ss_pred CCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHH
Q 014344 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTP 309 (426)
Q Consensus 233 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~ 309 (426)
.+....-.-..+||+||.|.-..|+.+|||||+||+|||+.+ |..||.+.+..+....|.... +-+.++|..
T Consensus 659 -----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~ 733 (774)
T KOG1026|consen 659 -----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTE 733 (774)
T ss_pred -----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHH
Confidence 001101124678999999999999999999999999999985 999999999999988886443 344567999
Q ss_pred HHHHHHHHhccCCCCCCChHHHh
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil 332 (426)
+.+||..||+.+|.+||++.||-
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=317.09 Aligned_cols=229 Identities=30% Similarity=0.428 Sum_probs=187.8
Q ss_pred cCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEEEEe
Q 014344 27 GAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAID 106 (426)
Q Consensus 27 G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~E 106 (426)
|.+|.||+|+++.+++.||+|++.+.. ....|...+....||||+++++++......|+|||
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 65 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQ 65 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEe
Confidence 899999999999999999999985432 11224455556679999999999999999999999
Q ss_pred ccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCC
Q 014344 107 YCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186 (426)
Q Consensus 107 y~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~ 186 (426)
|++|++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 66 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----- 138 (237)
T cd05576 66 HAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----- 138 (237)
T ss_pred cCCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----
Confidence 999999999876543 4899999999999999999999999999999999999999999999999987654311
Q ss_pred cchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhH
Q 014344 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVD 266 (426)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 266 (426)
.....++..|+|||.+.+..++.++|
T Consensus 139 ------------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 164 (237)
T cd05576 139 ------------------------------------------------------CDGEAVENMYCAPEVGGISEETEACD 164 (237)
T ss_pred ------------------------------------------------------cccCCcCccccCCcccCCCCCCchhh
Confidence 11123567799999998888999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCCh-----HHHhcCCCc
Q 014344 267 WWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGV-----EEIKGHEFF 337 (426)
Q Consensus 267 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~-----~eil~hp~f 337 (426)
+||+||++|+|++|+.||......... ..........+..+++||.+||+.||++|+++ +++++||||
T Consensus 165 vwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 165 WWSLGAILFELLTGKTLVECHPSGINT---HTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHHHHHHCcchhhcCchhccc---ccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999999988643321100 00111112347789999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=317.05 Aligned_cols=239 Identities=22% Similarity=0.238 Sum_probs=189.9
Q ss_pred eeecccCceEEEEEEEcC------------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 22 SALGRGAKGVVFLVKDVE------------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~------------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
+.||+|+||.||++.... ....+|+|++.... ......+..|+.+++.++||||+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------------~~~~~~~~~~~~~l~~l~hp~iv 67 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-------------RDISLAFFETASMMRQVSHKHIV 67 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-------------hhHHHHHHHHHHHHHhCCCCCEe
Confidence 368999999999998432 22358888874321 12334677789999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH--- 166 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~--- 166 (426)
++++++..+...++||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 68 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 68 LLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred eEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCC
Confidence 99999999999999999999999988876543 45899999999999999999999999999999999999987664
Q ss_pred ----EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 167 ----IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 167 ----ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
++++|||++..... ..
T Consensus 147 ~~~~~~l~d~g~~~~~~~------------------------------------------------------------~~ 166 (262)
T cd05077 147 CGPFIKLSDPGIPITVLS------------------------------------------------------------RQ 166 (262)
T ss_pred CCceeEeCCCCCCccccC------------------------------------------------------------cc
Confidence 89999998765421 11
Q ss_pred ccccCCCCccchhhc-CCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhcc
Q 014344 243 SFVGTEEYVAPEIIE-GKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~ 320 (426)
..+|+..|+|||++. +..++.++|||||||++|+|+ .|..||......+...............+..+.+||.+||+.
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 246 (262)
T cd05077 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNY 246 (262)
T ss_pred cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCC
Confidence 235788899999987 567899999999999999998 589999876554432211111122223357789999999999
Q ss_pred CCCCCCChHHHhcC
Q 014344 321 DPTKRIGVEEIKGH 334 (426)
Q Consensus 321 dP~~R~s~~eil~h 334 (426)
||.+||++.+|+.+
T Consensus 247 dp~~Rp~~~~il~~ 260 (262)
T cd05077 247 DPNQRPFFRAIMRD 260 (262)
T ss_pred ChhhCcCHHHHHHh
Confidence 99999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=320.00 Aligned_cols=239 Identities=21% Similarity=0.260 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEEcCCCc-------eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 22 SALGRGAKGVVFLVKDVESSE-------SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+.||+|+||+||+|.+...+. .+|+|++.... ....+.+..|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-------------~~~~~~~~~e~~~l~~~~h~~iv~~~~~ 67 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-------------RNYSESFFEAASMMSQLSHKHLVLNYGV 67 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-------------HHHHHHHHHHHHHHHhCCCCChhheeeE
Confidence 368999999999999865543 37777763321 1234567789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc--------
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH-------- 166 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~-------- 166 (426)
+..+...++||||+.+|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 68 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 68 CVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred EEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCce
Confidence 9999999999999999999999875443 5899999999999999999999999999999999999987765
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
++++|||++..... .....+
T Consensus 147 ~~l~d~g~~~~~~~------------------------------------------------------------~~~~~~ 166 (258)
T cd05078 147 IKLSDPGISITVLP------------------------------------------------------------KEILLE 166 (258)
T ss_pred EEecccccccccCC------------------------------------------------------------chhccc
Confidence 68999998754321 112357
Q ss_pred CCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 247 TEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 247 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
++.|+|||++.+ ..++.++|||||||++|+|++| .+||...+..................+..+.+||.+||+.||++
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (258)
T cd05078 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDF 246 (258)
T ss_pred cCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhh
Confidence 888999999987 4578999999999999999998 57776665544332222222222234578999999999999999
Q ss_pred CCChHHHhcC
Q 014344 325 RIGVEEIKGH 334 (426)
Q Consensus 325 R~s~~eil~h 334 (426)
|||+++|++.
T Consensus 247 Rps~~~il~~ 256 (258)
T cd05078 247 RPSFRAIIRD 256 (258)
T ss_pred CCCHHHHHHh
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=320.65 Aligned_cols=274 Identities=16% Similarity=0.182 Sum_probs=198.3
Q ss_pred CCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh
Q 014344 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82 (426)
Q Consensus 6 ~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 82 (426)
++.+...+.-.+|++.+.||+|+||+||+|.+..+ +..+|+|+.............. ...........+...+..
T Consensus 2 ~~~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~--~~~~~~~~~~~~~~~~~~ 79 (294)
T PHA02882 2 EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV--YNNIYDIDKIALWKNIHN 79 (294)
T ss_pred CCeeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHH--HHhhhhHHHHHHHHHhcc
Confidence 34445556667899999999999999999998877 6778888643211000000000 000001112234445667
Q ss_pred cCCCCcceeeeeeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCC
Q 014344 83 VEHPLLPRLRGVLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPEN 158 (426)
Q Consensus 83 l~hp~iv~l~~~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~N 158 (426)
++|++++.++++..... ..+++++++. .++.+++... ..+++..++.++.|++.||+|||++||+||||||+|
T Consensus 80 ~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~N 156 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPEN 156 (294)
T ss_pred CCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 78999999998765443 4578888874 5666665543 236788899999999999999999999999999999
Q ss_pred eeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 159 iLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
||++.++.++|+|||+|+.+........ ...
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~-------------------------------------------------~~~ 187 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIE-------------------------------------------------YSK 187 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccc-------------------------------------------------ccc
Confidence 9999999999999999987642211000 000
Q ss_pred CCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHhcCCCCCCCCCHH
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE---------TFYRILCRPPDLVGEPTP 309 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---------~~~~i~~~~~~~~~~~~~ 309 (426)
.......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+... ...++..........+..
T Consensus 188 ~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (294)
T PHA02882 188 EQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKF 267 (294)
T ss_pred ccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHH
Confidence 11233469999999999999999999999999999999999999998773221 122233233334556788
Q ss_pred HHHHHHHHhccCCCCCCChHHHhc
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+++..|+..+|++||++++|++
T Consensus 268 ~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 268 IYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999999875
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=313.12 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=204.0
Q ss_pred eeecccCceEEEEEEEcC-CCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 22 SALGRGAKGVVFLVKDVE-SSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~-~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
+.||+|++|.||+|.+.. +++ .||||++...... ...+.+..|+.++++++||||+++++.+..
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 67 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS------------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT- 67 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH------------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-
Confidence 468999999999999865 333 6999998554321 345788899999999999999999999988
Q ss_pred CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
...++||||+++++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 68 HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 89999999999999999987654356899999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
...... ........++..|+|||.+.+
T Consensus 148 ~~~~~~-----------------------------------------------------~~~~~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 148 PQNEDH-----------------------------------------------------YVMEEHLKVPFAWCAPESLRT 174 (257)
T ss_pred cccccc-----------------------------------------------------eecccCCCCCceecCHHHhcc
Confidence 321100 000112346788999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 259 KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
..++.++|||||||++|+|++ |..||...+..+....+.... ......+..+.+++.+||..+|++||++.+++.
T Consensus 175 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 899999999999999999998 999998888777666554322 222345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=316.13 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=198.4
Q ss_pred eeecccCceEEEEEEEcCCCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecC
Q 014344 22 SALGRGAKGVVFLVKDVESSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTD 98 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~ 98 (426)
+.||+|+||.||+|++..++. .+|+|.+.... .......+..|+.++.++ +||||+++++++...
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 68 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 68 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC------------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC
Confidence 368999999999999988776 46888774211 112345678899999999 799999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
..+|+||||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++||||||+|||++.+
T Consensus 69 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~ 148 (270)
T cd05047 69 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148 (270)
T ss_pred CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC
Confidence 99999999999999999986532 1247899999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++....... .....
T Consensus 149 ~~~kl~dfgl~~~~~~~~---------------------------------------------------------~~~~~ 171 (270)
T cd05047 149 YVAKIADFGLSRGQEVYV---------------------------------------------------------KKTMG 171 (270)
T ss_pred CeEEECCCCCccccchhh---------------------------------------------------------hccCC
Confidence 999999999875321000 00111
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~d 321 (426)
..+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+.+..+.... ......+.++.+|+.+||..+
T Consensus 172 ~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 251 (270)
T cd05047 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 251 (270)
T ss_pred CCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccC
Confidence 24567999999998889999999999999999996 999998887776666554321 222345678999999999999
Q ss_pred CCCCCChHHHhc
Q 014344 322 PTKRIGVEEIKG 333 (426)
Q Consensus 322 P~~R~s~~eil~ 333 (426)
|.+|||+.+++.
T Consensus 252 p~~Rps~~~il~ 263 (270)
T cd05047 252 PYERPSFAQILV 263 (270)
T ss_pred hhhCCCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=313.32 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=199.5
Q ss_pred eeecccCceEEEEEEEcCCC---ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 22 SALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
++||+|+||.||+|....++ ..+|+|.+...... ...+.+..|+.+++.++||||+++++++. .
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 67 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA------------AGKKEFLREASVMAQLDHPCIVRLIGVCK-G 67 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch------------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-C
Confidence 47999999999999876544 78999998543221 23456788999999999999999999876 4
Q ss_pred CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
...++||||+.+++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++..+
T Consensus 68 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 68 EPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 56799999999999999987654 5899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
....... .......++..|+|||.+.+
T Consensus 146 ~~~~~~~-----------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 172 (257)
T cd05060 146 GAGSDYY-----------------------------------------------------RATTAGRWPLKWYAPECINY 172 (257)
T ss_pred ecCCccc-----------------------------------------------------ccccCccccccccCHHHhcC
Confidence 3221000 00011124567999999999
Q ss_pred CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 259 KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
..++.++|||||||++|+|++ |.+||...+..+....+.... +.....+..++++|.+||..+|++||++.++++
T Consensus 173 ~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999997 999998887766655554332 233355788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=357.73 Aligned_cols=270 Identities=27% Similarity=0.412 Sum_probs=205.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|+.+..||+||||.||+|+.+-+|+.||||.+.... . ...+..+.+|+.+|.+|+|||||+++..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s-----------~~~~skI~rEVk~LArLnHpNVVRYysA 545 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-S-----------DKLYSKILREVKLLARLNHPNVVRYYSA 545 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-H-----------HHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence 357899999999999999999999999999999985443 1 2356789999999999999999999964
Q ss_pred eec-----------------------------------------------------------------------------
Q 014344 95 LST----------------------------------------------------------------------------- 97 (426)
Q Consensus 95 ~~~----------------------------------------------------------------------------- 97 (426)
|..
T Consensus 546 WVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de 625 (1351)
T KOG1035|consen 546 WVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE 625 (1351)
T ss_pred hhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccc
Confidence 411
Q ss_pred ----------------------------------C--------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHH
Q 014344 98 ----------------------------------D--------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135 (426)
Q Consensus 98 ----------------------------------~--------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~ 135 (426)
+ ..+||-||||+..+|.++++++.... ....++.+++
T Consensus 626 dg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFr 704 (1351)
T KOG1035|consen 626 DGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFR 704 (1351)
T ss_pred cccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHH
Confidence 0 24799999999888888887654211 4788999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCC
Q 014344 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGIS 215 (426)
Q Consensus 136 qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (426)
||+.||.|+|++|||||||||.||++++++.|||+|||+++........ ... .
T Consensus 705 eIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~-----~d~---------------~------- 757 (1351)
T KOG1035|consen 705 EILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES-----IDQ---------------D------- 757 (1351)
T ss_pred HHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh-----Hhh---------------c-------
Confidence 9999999999999999999999999999999999999999874310000 000 0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014344 216 LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG---HDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292 (426)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 292 (426)
..+-.+.........++.+||--|+|||++.+.. |+.++|+||||+|++||+ .||...-....
T Consensus 758 -----------~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~ 823 (1351)
T KOG1035|consen 758 -----------LSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS 823 (1351)
T ss_pred -----------cCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHH
Confidence 0000000112223567789999999999998765 999999999999999999 56765444333
Q ss_pred HHHHhcCCC---C---CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 293 FYRILCRPP---D---LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 293 ~~~i~~~~~---~---~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
.-..+.... . +.+.-+.-..+|++||+.||++||||.|+|++.||-
T Consensus 824 iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 824 ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 222232211 1 111223456899999999999999999999999997
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=314.63 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=207.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
+...+|.+.+.||+|+||.||+|.+... ...||||.+..... ....+.+..|+.+++.++||||+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~ 70 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS------------PSVREKFLQEAYIMRQFDHPHIV 70 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC------------HHHHHHHHHHHHHHHhCCCCchh
Confidence 4556799999999999999999987644 34699998743321 12345788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+ ...|+||||+++++|.+++.... ..++...+..++.||+.||+|||+.|++||||||+|||++.++.++|
T Consensus 71 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 71 KLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred ceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEE
Confidence 99998875 45789999999999999987643 34899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++........ .......+++.
T Consensus 149 ~d~g~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 173 (270)
T cd05056 149 GDFGLSRYLEDESY-------------------------------------------------------YKASKGKLPIK 173 (270)
T ss_pred ccCceeeecccccc-------------------------------------------------------eecCCCCcccc
Confidence 99999876532100 00111124567
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+....+... .+.....+..+.++|.+||..+|.+||
T Consensus 174 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 253 (270)
T cd05056 174 WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRP 253 (270)
T ss_pred ccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 999999998889999999999999999986 99999988877666655432 233445678999999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|+.+++..
T Consensus 254 t~~~~~~~ 261 (270)
T cd05056 254 RFTELKAQ 261 (270)
T ss_pred CHHHHHHH
Confidence 99999863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=315.37 Aligned_cols=255 Identities=22% Similarity=0.280 Sum_probs=209.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
+.++..+|++++.||+|+||+||+|.++.+++ .+|+|++.+... ......+.+|+.+++.++||
T Consensus 2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~------------~~~~~~~~~e~~~l~~l~h~ 69 (279)
T cd05057 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS------------PKANKEILDEAYVMASVDHP 69 (279)
T ss_pred cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC------------HHHHHHHHHHHHHHHhCCCC
Confidence 34567789999999999999999999877665 589998744321 22446788899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++.. ...++||||+.+|+|.+++.... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.
T Consensus 70 ~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~ 147 (279)
T cd05057 70 HVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH 147 (279)
T ss_pred CcceEEEEEec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe
Confidence 99999999877 78899999999999999887653 34899999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++..+....... ......+
T Consensus 148 ~kL~dfg~~~~~~~~~~~~------------------------------------------------------~~~~~~~ 173 (279)
T cd05057 148 VKITDFGLAKLLDVDEKEY------------------------------------------------------HAEGGKV 173 (279)
T ss_pred EEECCCcccccccCcccce------------------------------------------------------ecCCCcc
Confidence 9999999998654211000 0001124
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+..|+|||.+....++.++|+|||||++||+++ |+.||.+....+....+.... +.....+..+.+++.+||..+|.
T Consensus 174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~ 253 (279)
T cd05057 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAE 253 (279)
T ss_pred cccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 567999999988889999999999999999998 999999888776665554322 22334567899999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
.||++.++++
T Consensus 254 ~Rp~~~~l~~ 263 (279)
T cd05057 254 SRPTFKELIN 263 (279)
T ss_pred hCCCHHHHHH
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=312.89 Aligned_cols=244 Identities=18% Similarity=0.250 Sum_probs=196.8
Q ss_pred eecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCe
Q 014344 23 ALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
.||+|+||.||+|... ..+..||+|++.... .....+.+.+|+.++++++||||++++++++ ...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~ 68 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN------------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEA 68 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc------------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCC
Confidence 4899999999999775 345579999884321 1123456888999999999999999999885 457
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
.++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..+..
T Consensus 69 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 69 LMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred eEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 899999999999999876543 4589999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
..... .......+++.|+|||.+.+..
T Consensus 148 ~~~~~-----------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 148 DDSYY-----------------------------------------------------KARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred Cccce-----------------------------------------------------eccCCCCCCcccCCHHHHccCC
Confidence 11000 0001112467899999999888
Q ss_pred CChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 261 HDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
++.++|||||||++|+|++ |..||......+....+.... ......+.++.++|.+||..+|++||++.+|++
T Consensus 175 ~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999996 999999887776655554322 223345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=317.23 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=198.1
Q ss_pred CCcEEEeeecccCceEEEEEE----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 16 SCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+|++++.||+|+||+||+|. +..+++.||+|++.... ....+.+..|+.+++.++||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~iv~~ 70 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-------------AEHLRDFEREIEILKSLQHDNIVKY 70 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-------------HHHHHHHHHHHHHHHhCCCCCeeEE
Confidence 579999999999999999997 44678899999974321 2235678889999999999999999
Q ss_pred eeeee--cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 92 RGVLS--TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 92 ~~~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++. ....+++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l 149 (284)
T cd05081 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKI 149 (284)
T ss_pred EEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEE
Confidence 99764 3457899999999999999986543 34899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+....... .......++..
T Consensus 150 ~dfg~~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 176 (284)
T cd05081 150 GDFGLTKVLPQDKEYY-----------------------------------------------------KVREPGESPIF 176 (284)
T ss_pred CCCcccccccCCCcce-----------------------------------------------------eecCCCCCceE
Confidence 9999988653211000 00011123456
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHhc---CCCCCCCCCHHHH
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE---------------TFYRILC---RPPDLVGEPTPLR 311 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---------------~~~~i~~---~~~~~~~~~~~~~ 311 (426)
|+|||++.+..++.++|||||||++|||++|..|+....... ....++. ..+.....+..+.
T Consensus 177 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd05081 177 WYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIY 256 (284)
T ss_pred eeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHH
Confidence 999999999889999999999999999999887764432210 0111111 1122334578899
Q ss_pred HHHHHHhccCCCCCCChHHHhc
Q 014344 312 NLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 312 ~li~~~L~~dP~~R~s~~eil~ 333 (426)
+||.+||..+|++|||+.+|++
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 257 AIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=317.40 Aligned_cols=248 Identities=20% Similarity=0.282 Sum_probs=195.3
Q ss_pred cEEEeeecccCceEEEEEEE----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 18 LRIVSALGRGAKGVVFLVKD----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
|++++.||+|+||+||++.. ..+++.||+|++..... ......+.+|+++|+.++||||+++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~ 73 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG------------QQNTSGWKKEINILKTLYHENIVKYKG 73 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC------------hHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 49999999999999988753 35678999999843311 123456778999999999999999999
Q ss_pred eeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++.. ...+|+||||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 74 CCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred EEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEee
Confidence 8764 44689999999999999988653 399999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++......... ........++..|+
T Consensus 151 fg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~~ 177 (283)
T cd05080 151 FGLAKAVPEGHEY-----------------------------------------------------YRVREDGDSPVFWY 177 (283)
T ss_pred cccccccCCcchh-----------------------------------------------------hccCCCCCCCceee
Confidence 9998765321100 00011123566799
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHh---cCCCCCCCCCHHHHHHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE--------------TFYRIL---CRPPDLVGEPTPLRNLI 314 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------------~~~~i~---~~~~~~~~~~~~~~~li 314 (426)
|||.+.+..++.++|||||||++|+|++|..||....... ...... ...+.....+..+.+++
T Consensus 178 ~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 257 (283)
T cd05080 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILM 257 (283)
T ss_pred CHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHH
Confidence 9999998889999999999999999999999986543210 001111 11111234578899999
Q ss_pred HHHhccCCCCCCChHHHhc
Q 014344 315 RRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~ 333 (426)
.+||..+|++|||+++++.
T Consensus 258 ~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 258 KNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhccChhhCCCHHHHHH
Confidence 9999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.74 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=208.8
Q ss_pred cEEEeeecccCceEEEEEEEcCCC----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESS----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
+++.+.||.|+||.||++.+..++ ..||+|++.... .....+.+..|+.+++.++|+||+++++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 68 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA------------DEQQIEEFLREARIMRKLDHPNIVKLLG 68 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC------------ChHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 467899999999999999998766 889999984321 1114567888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.+.+..|++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||
T Consensus 69 ~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 69 VCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred EEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccC
Confidence 99999999999999999999999876544338999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++......... ......+++.|+||
T Consensus 149 ~~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~y~~P 173 (258)
T smart00219 149 LSRDLYDDDYY-------------------------------------------------------KKKGGKLPIRWMAP 173 (258)
T ss_pred Cceeccccccc-------------------------------------------------------ccccCCCcccccCh
Confidence 98765421100 00011267889999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|.+.+..++.++|+|||||++|+|++ |++||...+....+..+.... ......+..+.+++.+||..+|++|||+.+
T Consensus 174 e~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred HHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 99988889999999999999999998 899998877777666665332 223345788999999999999999999999
Q ss_pred Hhc
Q 014344 331 IKG 333 (426)
Q Consensus 331 il~ 333 (426)
+++
T Consensus 254 ll~ 256 (258)
T smart00219 254 LVE 256 (258)
T ss_pred HHh
Confidence 985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=308.44 Aligned_cols=243 Identities=21% Similarity=0.327 Sum_probs=200.3
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
+.||+|+||.||+|.. .+++.+|+|++..... ......+..|+.+++.++||||+++++++......
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 67 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLP------------QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPI 67 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCC------------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCcc
Confidence 3689999999999986 4688999998743221 12234678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 68 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 68 YIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999999999876543 35889999999999999999999999999999999999999999999999998654211
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
.. .......+++.|+|||++.+..+
T Consensus 147 ~~-------------------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 171 (250)
T cd05085 147 IY-------------------------------------------------------SSSGLKQIPIKWTAPEALNYGRY 171 (250)
T ss_pred cc-------------------------------------------------------ccCCCCCCcccccCHHHhccCCC
Confidence 10 00011124567999999998889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 262 DFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.++|+|||||++|+|++ |..||.+.........+.... ......+..+.+++.+||..+|++||++.++++
T Consensus 172 ~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999998 999999887766655554332 223346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=315.86 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=201.1
Q ss_pred EEEeeecccCceEEEEEEEc----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 19 RIVSALGRGAKGVVFLVKDV----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.+.+.||.|+||.||+|... ..+..|+||++... ........+..|++++++++||||++++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~------------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~ 69 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS------------SSEEEEEEFLNEIQILRKLRHPNIVKLYGF 69 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT------------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc------------cccccceeeeeccccccccccccccccccc
Confidence 57899999999999999987 34567999998321 122235788889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+...+.+++|||||++|+|.+++.......++...+..++.||+.||.|||+++|+||||+++|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 70 CIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp EESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99888899999999999999999887455699999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+........ ........+...|+|||
T Consensus 150 ~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~~~aPE 175 (259)
T PF07714_consen 150 SRPISEKSK------------------------------------------------------YKNDSSQQLPLRYLAPE 175 (259)
T ss_dssp GEETTTSSS------------------------------------------------------EEESTTSESGGGGS-HH
T ss_pred ccccccccc------------------------------------------------------ccccccccccccccccc
Confidence 876521110 00111223667899999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
.+.+..++.++||||||+++|||++ |+.||...+..+....+... .+.....+..+.++|.+||..||.+|||+.+|
T Consensus 176 ~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 176 VLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp HHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999889999999999999999999 78999998887766666432 22334568889999999999999999999999
Q ss_pred hc
Q 014344 332 KG 333 (426)
Q Consensus 332 l~ 333 (426)
++
T Consensus 256 ~~ 257 (259)
T PF07714_consen 256 LQ 257 (259)
T ss_dssp HH
T ss_pred Hh
Confidence 74
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=317.18 Aligned_cols=238 Identities=21% Similarity=0.208 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEEcCC------------------------CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH
Q 014344 23 ALGRGAKGVVFLVKDVES------------------------SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~~~------------------------~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 78 (426)
.||+|+||.||++....+ ...||+|++..... .....+..|+.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-------------~~~~~~~~~~~ 68 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-------------DIALAFFETAS 68 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-------------HHHHHHHHHHH
Confidence 699999999999974321 13488888743321 22346777899
Q ss_pred HHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCC
Q 014344 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPEN 158 (426)
Q Consensus 79 il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~N 158 (426)
+++.++||||+++++++..+...|+|||||++|+|..++.... +.+++..+..++.||+.||+|||++||+||||||+|
T Consensus 69 ~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N 147 (274)
T cd05076 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKN 147 (274)
T ss_pred HHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence 9999999999999999999999999999999999998876533 458999999999999999999999999999999999
Q ss_pred eeeccCC-------cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENG-------HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPS 231 (426)
Q Consensus 159 iLl~~~g-------~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (426)
||++..+ .+|++|||++......
T Consensus 148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------------------------------------------------- 177 (274)
T cd05076 148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR-------------------------------------------------- 177 (274)
T ss_pred EEEeccCcccCccceeeecCCccccccccc--------------------------------------------------
Confidence 9998644 4899999987543210
Q ss_pred CCCCCCCCCccccccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCCCCCCCCHH
Q 014344 232 RSDSDSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILCRPPDLVGEPTP 309 (426)
Q Consensus 232 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 309 (426)
....+++.|+|||.+.+ ..++.++|||||||++|||+ +|..||......+...............+..
T Consensus 178 ----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (274)
T cd05076 178 ----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKE 247 (274)
T ss_pred ----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChH
Confidence 11246788999998876 56899999999999999995 6999998776554322222222222233567
Q ss_pred HHHHHHHHhccCCCCCCChHHHhcC
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+.++|.+||+.+|++|||+.+|+++
T Consensus 248 ~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 248 LATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHcccChhhCcCHHHHHHh
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.53 Aligned_cols=255 Identities=19% Similarity=0.227 Sum_probs=208.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
++.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~------------~~~~~~~~~~~e~~~l~~l~h~ni 70 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH------------ASEIQVTLLLQESCLLYGLSHQNI 70 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC------------CCHHHHHHHHHHHHHHHhCCCCCC
Confidence 456789999999999999999999876 3578999987421 122345678889999999999999
Q ss_pred ceeeeeeec-CCeEEEEEeccCCCChHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee
Q 014344 89 PRLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQSE------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI 161 (426)
Q Consensus 89 v~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~~------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl 161 (426)
+++++++.. ....+++++|+.+++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+||++
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~ 150 (280)
T cd05043 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI 150 (280)
T ss_pred CeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE
Confidence 999998654 5788999999999999998865432 458999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+.++.+||+|||+++.+....... ..
T Consensus 151 ~~~~~~kl~d~g~~~~~~~~~~~~------------------------------------------------------~~ 176 (280)
T cd05043 151 DEELQVKITDNALSRDLFPMDYHC------------------------------------------------------LG 176 (280)
T ss_pred cCCCcEEECCCCCcccccCCceEE------------------------------------------------------eC
Confidence 999999999999997653221000 00
Q ss_pred cccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHh
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLL 318 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L 318 (426)
....++..|+|||++.+..++.++|||||||++|++++ |+.||...+..+....+... .......+..+.+++.+||
T Consensus 177 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (280)
T cd05043 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCW 256 (280)
T ss_pred CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence 11125667999999999889999999999999999998 99999988776655544332 2233345788999999999
Q ss_pred ccCCCCCCChHHHhc
Q 014344 319 EKDPTKRIGVEEIKG 333 (426)
Q Consensus 319 ~~dP~~R~s~~eil~ 333 (426)
..||++|||+.+++.
T Consensus 257 ~~~p~~Rps~~~~~~ 271 (280)
T cd05043 257 ALDPEERPSFSQLVQ 271 (280)
T ss_pred CCChhhCCCHHHHHH
Confidence 999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=310.13 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=211.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...+.|+-+.+||+|.||.||+|+.+.+++.||+|++..+. .....-....+|+++|..|+|+|++.++
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-----------eKeGfpitalreikiL~~lkHenv~nli 82 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-----------EKEGFPITALREIKILQLLKHENVVNLI 82 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-----------cccCCcHHHHHHHHHHHHhcchhHHHHH
Confidence 45577999999999999999999999999999999763321 1122334567799999999999999998
Q ss_pred eeeec--------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 93 GVLST--------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 93 ~~~~~--------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+++.+ ...+|+|+.+|+ -||.-++... ...|+..+++.++.+++.||.|+|...|+|||+||+|+||+.+
T Consensus 83 Eic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d 160 (376)
T KOG0669|consen 83 EICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD 160 (376)
T ss_pred HHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC
Confidence 87643 235899999997 7888876543 3459999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
|.+||+|||+++.+....... ..+-+..
T Consensus 161 gilklADFGlar~fs~~~n~~----------------------------------------------------kprytnr 188 (376)
T KOG0669|consen 161 GILKLADFGLARAFSTSKNVV----------------------------------------------------KPRYTNR 188 (376)
T ss_pred ceEEeeccccccceecccccC----------------------------------------------------CCCcccc
Confidence 999999999998775322111 1123455
Q ss_pred ccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--C---------------------C
Q 014344 245 VGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC--R---------------------P 300 (426)
Q Consensus 245 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~--~---------------------~ 300 (426)
+-|..|++||.+.| ..|+.+.|||+.|||+.||++|.+.|.+.+...++..|.. . +
T Consensus 189 vvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~e 268 (376)
T KOG0669|consen 189 VVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELE 268 (376)
T ss_pred eeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCC
Confidence 78999999999987 5689999999999999999999999999998877665520 0 0
Q ss_pred CCCC-------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 301 PDLV-------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 301 ~~~~-------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
|-.. ...+.+.||+.+||..||.+|+.++++++|.||.
T Consensus 269 Pl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 269 PLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred CCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 0000 0123577999999999999999999999999994
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=318.19 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=200.3
Q ss_pred CCcEEEeeecccCceEEEEEEE----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKD----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+.||||+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES------------GGNHIADLKKEIEILRNLYHENIVKY 71 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc------------cHHHHHHHHHHHHHHHhCCCCCeeee
Confidence 3489999999999999999984 4678899999974321 12234578889999999999999999
Q ss_pred eeeeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 92 RGVLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 92 ~~~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++... ...++||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 72 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l 150 (284)
T cd05079 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 150 (284)
T ss_pred eeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEE
Confidence 9998765 67899999999999999886543 34899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+...... ........|+..
T Consensus 151 ~dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 177 (284)
T cd05079 151 GDFGLTKAIETDKEY-----------------------------------------------------YTVKDDLDSPVF 177 (284)
T ss_pred CCCccccccccCccc-----------------------------------------------------eeecCCCCCCcc
Confidence 999998865321100 001122346778
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHh---cCCCCCCCCCHHHHH
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--------------KETFYRIL---CRPPDLVGEPTPLRN 312 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--------------~~~~~~i~---~~~~~~~~~~~~~~~ 312 (426)
|+|||++.+..++.++|||||||++|+|++++.|+..... .......+ ...+.....+..+.+
T Consensus 178 y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (284)
T cd05079 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQ 257 (284)
T ss_pred ccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHH
Confidence 9999999988899999999999999999998776532211 01111111 112223456788999
Q ss_pred HHHHHhccCCCCCCChHHHhcC
Q 014344 313 LIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 313 li~~~L~~dP~~R~s~~eil~h 334 (426)
||.+||+.+|.+||++++++.+
T Consensus 258 li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 258 LMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.35 Aligned_cols=256 Identities=21% Similarity=0.291 Sum_probs=205.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
+.+..++|++++.||+|+||.||+|.+..+++ .+|+|++.... .......+..|+.+++.++||
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~h~ 69 (303)
T cd05110 2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT------------GPKANVEFMDEALIMASMDHP 69 (303)
T ss_pred cccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC------------CHHHHHHHHHHHHHHHhCCCC
Confidence 35677889999999999999999999987776 46888764321 112234678899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++... ..++++||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 70 niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~ 147 (303)
T cd05110 70 HLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH 147 (303)
T ss_pred CcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc
Confidence 999999998654 4679999999999999876543 34889999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++..+..... ........+
T Consensus 148 ~kL~Dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~~ 173 (303)
T cd05110 148 VKITDFGLARLLEGDEK------------------------------------------------------EYNADGGKM 173 (303)
T ss_pred eEEccccccccccCccc------------------------------------------------------ccccCCCcc
Confidence 99999999976532110 001112235
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+..|+|||.+.+..++.++|||||||++|||++ |..||.+.........+.. ..+.....+..+.++|.+||..+|+
T Consensus 174 ~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~ 253 (303)
T cd05110 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDAD 253 (303)
T ss_pred ccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 778999999999999999999999999999997 9999988765544333322 2222334577899999999999999
Q ss_pred CCCChHHHhcC
Q 014344 324 KRIGVEEIKGH 334 (426)
Q Consensus 324 ~R~s~~eil~h 334 (426)
+||++++++..
T Consensus 254 ~Rp~~~~l~~~ 264 (303)
T cd05110 254 SRPKFKELAAE 264 (303)
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=311.21 Aligned_cols=245 Identities=19% Similarity=0.253 Sum_probs=191.5
Q ss_pred eeecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 22 SALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
+.||+|+||.||+|... .++..+|+|.+.... .......+..|+.+++.++||||+++++++.+..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 68 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA------------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT 68 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC------------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 46899999999999864 455679999874321 1122346778999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQS---EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~---~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+++||||+++|+|.+++.... ...++...++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 69 PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 9999999999999999886532 1235677888999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... ........|++.|+|||++
T Consensus 149 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 149 NKYKEDY------------------------------------------------------YVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred cccCcce------------------------------------------------------eecCCCcCCcccccCHhHh
Confidence 4321100 0011223578889999998
Q ss_pred cCC-------CCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-------CCCCCCCCHHHHHHHHHHhccC
Q 014344 257 EGK-------GHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR-------PPDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 257 ~~~-------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-------~~~~~~~~~~~~~li~~~L~~d 321 (426)
.+. .++.++|+|||||++|+|++ |+.||......+........ +......+..+.++|.+|+ .+
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~ 253 (269)
T cd05087 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQ 253 (269)
T ss_pred ccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cC
Confidence 643 35789999999999999996 99999877665544332211 1112234677899999998 68
Q ss_pred CCCCCChHHHhc
Q 014344 322 PTKRIGVEEIKG 333 (426)
Q Consensus 322 P~~R~s~~eil~ 333 (426)
|++|||+++|+.
T Consensus 254 P~~Rpt~~~l~~ 265 (269)
T cd05087 254 PEQRPSAEEVHL 265 (269)
T ss_pred cccCCCHHHHHH
Confidence 999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=310.84 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEEcC--CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 22 SALGRGAKGVVFLVKDVE--SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
++||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~ 68 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA------------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI 68 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC------------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC
Confidence 468999999999997533 34568888763221 1123456788999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSE---QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~---~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+|+||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 69 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 69 PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred ceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEecccccc
Confidence 99999999999999998876432 235678889999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... ........+++.|+|||++
T Consensus 149 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 149 EQYPEDY------------------------------------------------------YITKDCHAVPLRWLAPELV 174 (269)
T ss_pred ccccchh------------------------------------------------------eeccCCCCCcccccCHHHH
Confidence 5321100 0001122467789999997
Q ss_pred cC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-------CCCCCCCHHHHHHHHHHhccC
Q 014344 257 EG-------KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP-------PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 257 ~~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~li~~~L~~d 321 (426)
.. ..++.++|||||||++|+|++ |..||......+....+.... ......+..+.+++..|+ .|
T Consensus 175 ~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d 253 (269)
T cd05042 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LD 253 (269)
T ss_pred hhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cC
Confidence 53 346789999999999999998 889998887766655543221 112244677889999998 59
Q ss_pred CCCCCChHHHhc
Q 014344 322 PTKRIGVEEIKG 333 (426)
Q Consensus 322 P~~R~s~~eil~ 333 (426)
|++|||+++|+.
T Consensus 254 p~~Rpt~~~v~~ 265 (269)
T cd05042 254 PETRPTAEEVHE 265 (269)
T ss_pred cccccCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=307.44 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=201.9
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
++||.|+||.||+|.+.. ++.||+|++...... .....+..|+.++++++||||+++++++......
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 67 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP------------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPI 67 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH------------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCe
Confidence 479999999999999877 999999988543211 2345788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
|+||||+.|++|.+++.... ..++...+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++......
T Consensus 68 ~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 68 YIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999999999886543 35889999999999999999999999999999999999999999999999998754311
Q ss_pred CCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCC
Q 014344 182 TPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261 (426)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 261 (426)
... .......++..|+|||.+.+..+
T Consensus 147 ~~~------------------------------------------------------~~~~~~~~~~~y~~PE~~~~~~~ 172 (251)
T cd05041 147 IYT------------------------------------------------------VSDGLKQIPIKWTAPEALNYGRY 172 (251)
T ss_pred cce------------------------------------------------------eccccCcceeccCChHhhccCCC
Confidence 100 00011124567999999998889
Q ss_pred ChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 262 DFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.++|+|||||++|+|++ |..||...........+... .+.....+..+.++|.+||..+|.+|||+.|+++
T Consensus 173 ~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999998 89999887766655555432 2223355788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.37 Aligned_cols=236 Identities=24% Similarity=0.224 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEEcCCC----------ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 22 SALGRGAKGVVFLVKDVESS----------ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~----------~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++||||+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~ 66 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--------------RDSLAFFETASLMSQLSHKHLVKL 66 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch--------------hhHHHHHHHHHHHHcCCCcchhhe
Confidence 46899999999999998776 347777763221 114577889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC------
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG------ 165 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g------ 165 (426)
++++.. ...++||||+++++|.+++..... .++...+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 67 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~ 144 (259)
T cd05037 67 YGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYV 144 (259)
T ss_pred eeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCc
Confidence 999887 778999999999999998876543 589999999999999999999999999999999999999888
Q ss_pred -cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 166 -HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 166 -~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
.+||+|||++..... ....
T Consensus 145 ~~~kl~Dfg~a~~~~~------------------------------------------------------------~~~~ 164 (259)
T cd05037 145 PFIKLSDPGIPITVLS------------------------------------------------------------REER 164 (259)
T ss_pred eeEEeCCCCccccccc------------------------------------------------------------cccc
Confidence 899999999876431 1122
Q ss_pred ccCCCCccchhhcCC--CCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccC
Q 014344 245 VGTEEYVAPEIIEGK--GHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~d 321 (426)
.++..|+|||++.+. .++.++|+|||||++|+|++ |..||...+..+..................+.++|.+||..+
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 244 (259)
T cd05037 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYD 244 (259)
T ss_pred ccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccC
Confidence 466789999999877 78999999999999999998 688887765433322222221112222478899999999999
Q ss_pred CCCCCChHHHhc
Q 014344 322 PTKRIGVEEIKG 333 (426)
Q Consensus 322 P~~R~s~~eil~ 333 (426)
|.+|||+.++++
T Consensus 245 p~~Rpt~~~il~ 256 (259)
T cd05037 245 PTKRPSFRAILR 256 (259)
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=312.27 Aligned_cols=246 Identities=21% Similarity=0.323 Sum_probs=200.0
Q ss_pred eeecccCceEEEEEEEcCCC------ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 22 SALGRGAKGVVFLVKDVESS------ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~------~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.||+|+||.||+|++.... +.+|+|.+.+.. .......+.+|+.+++.++||||+++++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 68 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA------------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc------------chhhHHHHHHHHHHHHhcCCCCeeeEeeee
Confidence 36899999999999986543 679999874321 112345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-----
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQS-----EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----- 165 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~-----~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----- 165 (426)
......++||||++|++|.+++.... ...++...+..++.||+.||.|||+.+++||||||+||+++.++
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 69 LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred cCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCc
Confidence 99999999999999999999886532 23478899999999999999999999999999999999999887
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++..+...... .......
T Consensus 149 ~~~l~dfg~~~~~~~~~~~------------------------------------------------------~~~~~~~ 174 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYY------------------------------------------------------RKEGEGL 174 (269)
T ss_pred ceEECCccccccccccccc------------------------------------------------------ccCcccC
Confidence 8999999998765321100 0011223
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP 322 (426)
++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..+....+... .......+..+.+||.+||..+|
T Consensus 175 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 254 (269)
T cd05044 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDP 254 (269)
T ss_pred CCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCc
Confidence 5678999999999889999999999999999997 99999887776665554322 22233457889999999999999
Q ss_pred CCCCChHHHhc
Q 014344 323 TKRIGVEEIKG 333 (426)
Q Consensus 323 ~~R~s~~eil~ 333 (426)
.+||+++++++
T Consensus 255 ~~Rp~~~~i~~ 265 (269)
T cd05044 255 SERPTFDRIQE 265 (269)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=307.84 Aligned_cols=248 Identities=20% Similarity=0.280 Sum_probs=195.5
Q ss_pred eeecccCceEEEEEEEcC---CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee-c
Q 014344 22 SALGRGAKGVVFLVKDVE---SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS-T 97 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~-~ 97 (426)
+.||+|+||.||+|.+.. .+..+|||.+.... .......+..|+.+++.++||||+++++++. .
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 68 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT------------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC------------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence 468999999999998753 34579999873211 1123457778999999999999999999764 5
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+...++||||+.+++|.+++.... ..++...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 69 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~ 147 (262)
T cd05058 69 EGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARD 147 (262)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCcccccc
Confidence 667899999999999999987543 3367788888999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
+...... .........+++.|+|||.+.
T Consensus 148 ~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 175 (262)
T cd05058 148 IYDKEYY----------------------------------------------------SVHNHTGAKLPVKWMALESLQ 175 (262)
T ss_pred ccCCcce----------------------------------------------------eecccccCcCCccccChhHhc
Confidence 5321100 000011223577899999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 258 GKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 258 ~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+..++.++|||||||++|||++ |.+||...+..+....+.... +.....+..+.+++.+||..+|++||++.+++..
T Consensus 176 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8889999999999999999999 577888777666555554322 2222347889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=317.52 Aligned_cols=131 Identities=24% Similarity=0.330 Sum_probs=115.7
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-----C---CCc
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-----H---PLL 88 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----h---p~i 88 (426)
+|.+.++||+|-|++||||.|..+.++||+||.+... ...+....|+++|+++. | .+|
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--------------hYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--------------HYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--------------HHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 4999999999999999999999999999999985432 23345677999999983 2 479
Q ss_pred ceeeeeee----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeec
Q 014344 89 PRLRGVLS----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQ 162 (426)
Q Consensus 89 v~l~~~~~----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~ 162 (426)
|+|++.|. ...++|+|+|++ |..|..+|.....+.++...++.|++||+.||+|||. .||||-||||+|||+.
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99999995 456899999999 7899999998888889999999999999999999996 6999999999999994
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.32 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=216.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCC-C----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVES-S----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-~----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
+.++....++++.||+|+||.||.+.-... + ..||||.+.+. ...+....|.+|..+|+.++|
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~------------~~~~~~~~Fl~Ea~~m~~f~H 754 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL------------SSEQEVSDFLKEALLMSKFDH 754 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc------------CCHHHHHHHHHHHHHHhcCCC
Confidence 456678899999999999999999987533 2 24999988443 233456789999999999999
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-----EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-----~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
||||+++|+..+....++++|||+||||.++++..+ ...++......++.||+.|++||+++++|||||..+|+|
T Consensus 755 pNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 755 PNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCL 834 (1025)
T ss_pred cceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhhee
Confidence 999999999999999999999999999999998652 234888999999999999999999999999999999999
Q ss_pred eccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 161 l~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
|+....+||+|||||+.+....- .++
T Consensus 835 L~~~r~VKIaDFGlArDiy~~~y------------------------------------------------------yr~ 860 (1025)
T KOG1095|consen 835 LDERRVVKIADFGLARDIYDKDY------------------------------------------------------YRK 860 (1025)
T ss_pred ecccCcEEEcccchhHhhhhchh------------------------------------------------------eec
Confidence 99999999999999995543210 001
Q ss_pred ccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHH
Q 014344 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~ 317 (426)
...-.-...|||||.+....++.++|||||||+|||+++ |..||.+.+..+.+...+. +.+.+..+|..+.++|..|
T Consensus 861 ~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~C 940 (1025)
T KOG1095|consen 861 HGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQC 940 (1025)
T ss_pred cCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHH
Confidence 111123457999999999999999999999999999997 9999999998888765543 3455567789999999999
Q ss_pred hccCCCCCCChHHHhc
Q 014344 318 LEKDPTKRIGVEEIKG 333 (426)
Q Consensus 318 L~~dP~~R~s~~eil~ 333 (426)
|..+|++||++..|++
T Consensus 941 W~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 941 WKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ccCChhhCccHHHHHh
Confidence 9999999999999987
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=309.03 Aligned_cols=258 Identities=25% Similarity=0.351 Sum_probs=208.9
Q ss_pred CcEEEeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh-cCCCCcceeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN-VEHPLLPRLRGV 94 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~~~ 94 (426)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+......... ..........++..|+.++.+ ++||||++++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~---~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 77 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGK---DKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKT 77 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccc---ccccchHHHHHHHHHHHHHhhcCCCCCeeeEEee
Confidence 48899999999999999999987 7889999998544322110 001122345567778888875 789999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+..+...++||||++|++|.+++... ....+++..+..++.|++.||.|||+ .|++||||||+|||++.++.++|+|
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 78 FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred EccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999999887542 33468999999999999999999996 7899999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... ......|+..|+
T Consensus 158 fg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~~~ 180 (269)
T cd08528 158 FGLAKQKQPES---------------------------------------------------------KLTSVVGTILYS 180 (269)
T ss_pred ccceeeccccc---------------------------------------------------------ccccccCcccCc
Confidence 99987543210 112345888999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.+.+..++.++|+|||||++|+|++|++||...........+..... .....+..+.++|.+||+.||++||++
T Consensus 181 ~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 260 (269)
T cd08528 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDI 260 (269)
T ss_pred ChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCH
Confidence 99999998899999999999999999999999988776655555443221 112357889999999999999999999
Q ss_pred HHHhcC
Q 014344 329 EEIKGH 334 (426)
Q Consensus 329 ~eil~h 334 (426)
.|+..+
T Consensus 261 ~e~~~~ 266 (269)
T cd08528 261 IQVSAM 266 (269)
T ss_pred HHHHHH
Confidence 998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=308.76 Aligned_cols=252 Identities=19% Similarity=0.300 Sum_probs=202.2
Q ss_pred cEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
|++.+.||+|+||.||+|... .+++.||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 69 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-----------SSSDIEEFLREAACMKEFDHPNVIKLIGV 69 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-----------ChHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 678899999999999999865 3578999999844321 12235668889999999999999999998
Q ss_pred eecCC------eEEEEEeccCCCChHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 95 LSTDK------FVGYAIDYCPGRDLHSLRKQQS----EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 95 ~~~~~------~~~lV~Ey~~gg~L~~l~~~~~----~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+...+ ..+++++|+.+|+|..++.... ...++...+..++.||+.||+|||+.||+||||||+||+++.+
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~ 149 (273)
T cd05074 70 SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN 149 (273)
T ss_pred EccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC
Confidence 85432 3578999999999988764321 1247899999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++........ .......
T Consensus 150 ~~~kl~dfg~~~~~~~~~~------------------------------------------------------~~~~~~~ 175 (273)
T cd05074 150 MTVCVADFGLSKKIYSGDY------------------------------------------------------YRQGCAS 175 (273)
T ss_pred CCEEECcccccccccCCcc------------------------------------------------------eecCCCc
Confidence 9999999999876532110 0011122
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~d 321 (426)
.+++.|++||.+.+..++.++|||||||++|+|++ |.+||.+.+..+.+..+.... ......+..+.+++.+||..+
T Consensus 176 ~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~ 255 (273)
T cd05074 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPE 255 (273)
T ss_pred cCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCC
Confidence 35678999999999889999999999999999998 999998887766665554322 223355788999999999999
Q ss_pred CCCCCChHHHhcC
Q 014344 322 PTKRIGVEEIKGH 334 (426)
Q Consensus 322 P~~R~s~~eil~h 334 (426)
|++|||+.+++.+
T Consensus 256 p~~Rps~~~~~~~ 268 (273)
T cd05074 256 PKCRPSFQHLRDQ 268 (273)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=305.68 Aligned_cols=245 Identities=17% Similarity=0.231 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEEcCC--CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 22 SALGRGAKGVVFLVKDVES--SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
+.||+|+||.||++..... ...+++|.+.... .......+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 68 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA------------SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI 68 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC------------ChHHHHHHHHHHHHHhccCCcchhheEEEecCCC
Confidence 3699999999999976433 2346666653321 1123467888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
..|+|||||++|+|.+++.... ...++...++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++..
T Consensus 69 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 69 PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred ccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 9999999999999999887542 23467778889999999999999999999999999999999999999999998754
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
..... ........+|++.|+|||++.
T Consensus 149 ~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~ 174 (268)
T cd05086 149 RYKED------------------------------------------------------YIETEDDKCVPLRWLAPELVG 174 (268)
T ss_pred cCcch------------------------------------------------------hhhcccCCcCcccccCchhcc
Confidence 32100 001112345888999999985
Q ss_pred C-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-------CCCCCCCHHHHHHHHHHhccCC
Q 014344 258 G-------KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP-------PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 258 ~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-------~~~~~~~~~~~~li~~~L~~dP 322 (426)
. ..++.++|||||||++|||++ |..||...+..+.+..++... ......+..+.+++..|| .+|
T Consensus 175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P 253 (268)
T cd05086 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSP 253 (268)
T ss_pred cccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCc
Confidence 3 235779999999999999996 678998877776666554321 122245677899999999 679
Q ss_pred CCCCChHHHhc
Q 014344 323 TKRIGVEEIKG 333 (426)
Q Consensus 323 ~~R~s~~eil~ 333 (426)
.+||++++|++
T Consensus 254 ~~Rp~~~~i~~ 264 (268)
T cd05086 254 EKRATAEEVHR 264 (268)
T ss_pred ccCCCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.28 Aligned_cols=242 Identities=31% Similarity=0.448 Sum_probs=196.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
..|..-+.||+||||.||+++++.+|+.||||.+.+.. .....++..+|+++|++|+|||||+++++=
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~------------~~r~~e~~~~EieilkKLnh~NIVk~f~ie 80 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES------------SLRPRERWCREIEILKKLNHPNIVKLFDIE 80 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc------------ccchHHHHHHHHHHHHHcCchhhhhhcccC
Confidence 34678899999999999999999999999999986543 112356778899999999999999999986
Q ss_pred ecCC------eEEEEEeccCCCChHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--CC-
Q 014344 96 STDK------FVGYAIDYCPGRDLHSLRKQQ-SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--NG- 165 (426)
Q Consensus 96 ~~~~------~~~lV~Ey~~gg~L~~l~~~~-~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--~g- 165 (426)
++.. ...+|||||.||||...++.- ....+++.+++.++..+..||.|||++|||||||||+||++.. +|
T Consensus 81 e~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq 160 (732)
T KOG4250|consen 81 ETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQ 160 (732)
T ss_pred CccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCc
Confidence 5544 467999999999999987642 1234999999999999999999999999999999999999863 34
Q ss_pred -cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 166 -HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 166 -~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
.-||+|||.|+.+.. +...+++
T Consensus 161 ~IyKLtDfG~Arel~d---------------------------------------------------------~s~~~S~ 183 (732)
T KOG4250|consen 161 SIYKLTDFGAARELDD---------------------------------------------------------NSLFTSL 183 (732)
T ss_pred eEEeeecccccccCCC---------------------------------------------------------CCeeeee
Confidence 359999999997743 2357789
Q ss_pred ccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCC---------------
Q 014344 245 VGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILCRPPDLV--------------- 304 (426)
Q Consensus 245 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~--------------- 304 (426)
+||+.|.+||++.. ..|+..+|.|||||++|+++||..||.... ..+...++..+.+...
T Consensus 184 vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s 263 (732)
T KOG4250|consen 184 VGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWS 263 (732)
T ss_pred cCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeee
Confidence 99999999999984 889999999999999999999999996432 3345555554433321
Q ss_pred -------CCC----HHHHHHHHHHhccCCCCCC
Q 014344 305 -------GEP----TPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 305 -------~~~----~~~~~li~~~L~~dP~~R~ 326 (426)
..+ ..+...+..+|..+|.+|.
T Consensus 264 ~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 264 STLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 111 1245788999999999999
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=338.23 Aligned_cols=260 Identities=21% Similarity=0.216 Sum_probs=181.8
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCC----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVES----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
.+.+..++|++.+.||+|+||.||+|++..+ +..||+|.+..... ......| .++...+
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---------------~e~~~~e--~l~~~~~ 188 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---------------VEIWMNE--RVRRACP 188 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---------------hHHHHHH--HHHhhch
Confidence 3456788999999999999999999999988 89999998743110 0001111 1111122
Q ss_pred CCcceeeee------eecCCeEEEEEeccCCCChHHHHHHhccC------------------CCCHHHHHHHHHHHHHHH
Q 014344 86 PLLPRLRGV------LSTDKFVGYAIDYCPGRDLHSLRKQQSEQ------------------MFSDDTIRFYAAELVLAL 141 (426)
Q Consensus 86 p~iv~l~~~------~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~------------------~l~~~~~~~~~~qil~aL 141 (426)
.++..+... ...+..+++||||+.+++|.+++...... ......++.++.||+.||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 189 NSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred hhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHH
Confidence 222222221 24567899999999999999987643210 112345778999999999
Q ss_pred HHHHHCCCcccCCCCCCeeecc-CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCC
Q 014344 142 EYLHNMGIVYRDLKPENIMIQE-NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPV 220 (426)
Q Consensus 142 ~~LH~~giiHrDlKp~NiLl~~-~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (426)
.|||++||+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-------------------------------------- 310 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-------------------------------------- 310 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc--------------------------------------
Confidence 9999999999999999999986 5899999999997653211
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC----------------------CChhhHHHHHHHHHHHHH
Q 014344 221 HSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG----------------------HDFAVDWWSLGVVLHEML 278 (426)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~DiwSlG~il~ell 278 (426)
......++||+.|||||.+.... ++.++|||||||++|||+
T Consensus 311 -----------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~ 373 (566)
T PLN03225 311 -----------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373 (566)
T ss_pred -----------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence 11223467899999999764322 344679999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhcCC------------CCC-----------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 279 YGATPFRGSSRKETFYRILCRP------------PDL-----------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 279 ~g~~pf~~~~~~~~~~~i~~~~------------~~~-----------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
++..|+. +....+.+++... +.. ........+||.+||++||++|||++++|+||
T Consensus 374 ~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 374 FPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred hCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 8766543 2222222221110 000 00123356899999999999999999999999
Q ss_pred CcCCCChh
Q 014344 336 FFKGVNWE 343 (426)
Q Consensus 336 ~f~~~~~~ 343 (426)
||++..+.
T Consensus 452 ff~~~~~~ 459 (566)
T PLN03225 452 YFDREGLL 459 (566)
T ss_pred CcCCCCcc
Confidence 99987765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.71 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=202.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEc----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDV----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+|++++.||+|+||.||+|... .+++.||+|++...... .....+..|+.+++.+.||||++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~------------~~~~~~~~ei~~l~~l~~~~i~~ 70 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE------------QHRSDFEREIEILRTLDHENIVK 70 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch------------HHHHHHHHHHHHHHhCCCCChhe
Confidence 457899999999999999999864 34789999998543211 24567888999999999999999
Q ss_pred eeeeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 91 LRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 91 l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++++.. ....++||||+++++|.+++..... .++...+..++.||+.||+|||++||+||||||+||+++.++.++
T Consensus 71 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred EEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEE
Confidence 9999877 6689999999999999999876543 489999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++......... ........++.
T Consensus 150 l~dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~ 176 (284)
T cd05038 150 ISDFGLAKVLPEDKDY-----------------------------------------------------YYVKEPGESPI 176 (284)
T ss_pred EcccccccccccCCcc-----------------------------------------------------eeccCCCCCcc
Confidence 9999998876421100 00011112456
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHhcC---CCCCCCCCHHHH
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE--------------TFYRILCR---PPDLVGEPTPLR 311 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------------~~~~i~~~---~~~~~~~~~~~~ 311 (426)
.|+|||.+.+..++.++|+|||||++|+|++|..||....... .....+.. .+.....+..+.
T Consensus 177 ~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (284)
T cd05038 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY 256 (284)
T ss_pred cccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHH
Confidence 6999999998889999999999999999999999987643221 11222211 122234567899
Q ss_pred HHHHHHhccCCCCCCChHHHhc
Q 014344 312 NLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 312 ~li~~~L~~dP~~R~s~~eil~ 333 (426)
+|+.+||..+|.+|||+.||+.
T Consensus 257 ~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 257 DLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=289.88 Aligned_cols=248 Identities=28% Similarity=0.492 Sum_probs=204.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~ 92 (426)
+.++|++.+++|+|.|+.||.+....+.+.++||+++. ...+.+.+|+.||+.|. ||||++++
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----------------VkkkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----------------VKKKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----------------HHHHHHHHHHHHHHhccCCCCeeehh
Confidence 56789999999999999999999999999999999843 24567888999999997 99999999
Q ss_pred eeeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-CcEEE
Q 014344 93 GVLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-GHIML 169 (426)
Q Consensus 93 ~~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g~ikL 169 (426)
++..++ +...+|+||+++.|...+-. .++...++.|+.|++.||+|||++||+|||+||.|++|+.. ..++|
T Consensus 100 DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 100 DIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeee
Confidence 998654 56789999999988876643 38899999999999999999999999999999999999964 57999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|+|+|...+++.. -+-.+.+..
T Consensus 175 IDWGLAEFYHp~~e---------------------------------------------------------YnVRVASRy 197 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKE---------------------------------------------------------YNVRVASRY 197 (338)
T ss_pred eecchHhhcCCCce---------------------------------------------------------eeeeeehhh
Confidence 99999998876431 223356677
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHh-----------------cCCCCC-------
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFR-GSSRKETFYRIL-----------------CRPPDL------- 303 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~-~~~~~~~~~~i~-----------------~~~~~~------- 303 (426)
|-.||++-. ..|+++-|+|||||++..|+..+-||. |.+..+++.+|. ..++.+
T Consensus 198 fKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~ 277 (338)
T KOG0668|consen 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRH 277 (338)
T ss_pred cCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcc
Confidence 889999876 568999999999999999999888874 444444433331 001110
Q ss_pred --------------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 --------------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 --------------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.-.++++.|||.++|.+|-.+|+|++|++.||||..
T Consensus 278 ~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 278 SRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 012577899999999999999999999999999964
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=303.49 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=210.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
..+|.-++-+|.|+- .|..|.|.-.++.||+|.+... ..+....++..+|..++..+.|+||++++.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-----------f~n~~~akra~rel~l~~~v~~~nii~l~n~ 83 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-----------FQNQTHAKRAYRELKLMKCVNHKNIISLLNV 83 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-----------cccCccchhhhhhhhhhhhhcccceeeeeec
Confidence 457888999999999 8889999999999999987443 2234567888999999999999999999999
Q ss_pred eecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
|... ..+|+||||+. .+|+..+.. .+.-..++.++.|+++|++|||+.||+||||||+||++..++.+|
T Consensus 84 ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 84 FTPQKTLEEFQEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred cCccccHHHHHhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhhee
Confidence 9544 36899999996 888887762 277899999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|.|||+|+.-... -..+.++.|.
T Consensus 159 i~dfg~ar~e~~~---------------------------------------------------------~~mtpyVvtR 181 (369)
T KOG0665|consen 159 ILDFGLARTEDTD---------------------------------------------------------FMMTPYVVTR 181 (369)
T ss_pred eccchhhcccCcc---------------------------------------------------------cccCchhhee
Confidence 9999999865321 1345668899
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------------------
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--------------------------- 301 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------------- 301 (426)
.|.|||++.+.+|...+||||+||++.||++|+..|.|.+.-+++.++.....
T Consensus 182 yyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~ 261 (369)
T KOG0665|consen 182 YYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAI 261 (369)
T ss_pred eccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhcc
Confidence 99999999999999999999999999999999999999887776655521100
Q ss_pred ----CCC------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 302 ----DLV------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 302 ----~~~------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
.++ .....++||+.+||..||++|.+++++|.||||+
T Consensus 262 ~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 262 SFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred chhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 000 1123489999999999999999999999999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=301.65 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=210.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
..++..++.+=+..||.|+||+|++..++.+|+..|||.+...... ...+++..|.+...+- +.|||
T Consensus 58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~------------keq~rll~e~d~~mks~~cp~I 125 (361)
T KOG1006|consen 58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE------------KEQKRLLMEHDTVMKSSNCPNI 125 (361)
T ss_pred ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch------------HHHHHHHHHHHHHHhhcCCcHH
Confidence 4556667788889999999999999999999999999999554332 2345677777765554 68999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHH---HhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccC
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRK---QQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~---~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~ 164 (426)
|+++|+...++.+|+.||+|+ .+|..+-+ .-....+++..+-.++.-.+.||+||-+ ..|||||+||+|||++..
T Consensus 126 VkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 126 VKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH 204 (361)
T ss_pred HHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC
Confidence 999999999999999999995 77766432 2223459999999999999999999985 699999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
|.|||||||.+..+..+.. .+.-
T Consensus 205 G~vKLCDFGIcGqLv~SiA---------------------------------------------------------kT~d 227 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDSIA---------------------------------------------------------KTVD 227 (361)
T ss_pred CCEeeecccchHhHHHHHH---------------------------------------------------------hhhc
Confidence 9999999999987743210 1112
Q ss_pred ccCCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCC-------CCCCHHHHHHH
Q 014344 245 VGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRPPDL-------VGEPTPLRNLI 314 (426)
Q Consensus 245 ~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~-------~~~~~~~~~li 314 (426)
.|...|||||.+.. .+|+-++|+||||++|||+.||..|+++-+. .+++..+....+.. ...+..+..||
T Consensus 228 aGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fi 307 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFI 307 (361)
T ss_pred cCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHH
Confidence 48889999999864 5689999999999999999999999998654 34555554433322 23567899999
Q ss_pred HHHhccCCCCCCChHHHhcCCCcCC
Q 014344 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
..||.+|-+.||...+++++||++.
T Consensus 308 ntCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 308 NTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred HHHhhcccccCcchhhhhcCchhhh
Confidence 9999999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.17 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=210.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC--Cc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES--SE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~--~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
+..+...+.+.||.|.||.||.+.-... |+ .||||.++.++ ..+..+.|..|..+|+.++||||
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~------------t~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC------------TPDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC------------ChhhHHHHHHHHHHHHhCCCcch
Confidence 3444455667899999999999986432 22 49999985543 33456789999999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++|++ .+...|+|||+++-|.|..|++.+.. .++......|+.||+.||.|||+..+|||||..+|||+.+...||
T Consensus 454 ikLIGv~-~e~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVK 531 (974)
T KOG4257|consen 454 IKLIGVC-VEQPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVK 531 (974)
T ss_pred hheeeee-eccceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceee
Confidence 9999998 56778999999999999999987764 499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.+....- .++....-..
T Consensus 532 LaDFGLSR~~ed~~y-------------------------------------------------------YkaS~~kLPI 556 (974)
T KOG4257|consen 532 LADFGLSRYLEDDAY-------------------------------------------------------YKASRGKLPI 556 (974)
T ss_pred ecccchhhhccccch-------------------------------------------------------hhccccccce
Confidence 999999998754321 1111112356
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
.|||||.+.-..++.++|||.|||.+||++. |..||.+-...+...++.. +.|.++.+|+.+..|+.+||.++|.+|
T Consensus 557 KWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 557 KWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred eecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccC
Confidence 7999999999999999999999999999985 9999999887777666553 456677889999999999999999999
Q ss_pred CChHHHh
Q 014344 326 IGVEEIK 332 (426)
Q Consensus 326 ~s~~eil 332 (426)
|++.+|.
T Consensus 637 Prftei~ 643 (974)
T KOG4257|consen 637 PRFTEIK 643 (974)
T ss_pred CcHHHHH
Confidence 9987764
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.31 Aligned_cols=267 Identities=26% Similarity=0.398 Sum_probs=214.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|-++..||+|||+.||+|.|....++||+|+-....-=+. .......+...+|.+|.+.|+||-||++|++|
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wrd------EKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRD------EKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhh------HhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 569999999999999999999999999999998632111000 01123467788999999999999999999999
Q ss_pred e-cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCCeeec---cCCcEEE
Q 014344 96 S-TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM--GIVYRDLKPENIMIQ---ENGHIML 169 (426)
Q Consensus 96 ~-~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~--giiHrDlKp~NiLl~---~~g~ikL 169 (426)
. +...+|-|+|||+|.||.-|++.+. .+++.+++.|+.||+.||.||.+. .|||-||||.|||+- ..|.|||
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 6 5567899999999999999988764 499999999999999999999975 699999999999995 4578999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+||||++.+...... .....+.+..+.||.+
T Consensus 615 TDFGLSKIMdddSy~-------------------------------------------------~vdGmeLTSQgAGTYW 645 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYN-------------------------------------------------SVDGMELTSQGAGTYW 645 (775)
T ss_pred eecchhhhccCCccC-------------------------------------------------cccceeeecccCceee
Confidence 999999987643211 0122345566789999
Q ss_pred CccchhhcCC----CCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHH--HHhc----CCCCCCCCCHHHHHHHHHHh
Q 014344 250 YVAPEIIEGK----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFY--RILC----RPPDLVGEPTPLRNLIRRLL 318 (426)
Q Consensus 250 y~aPE~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~--~i~~----~~~~~~~~~~~~~~li~~~L 318 (426)
|++||.+.-. ..+.++||||+|||+|.+++|+.||...-.. .++. -|+. ..|..+-.++++++||++||
T Consensus 646 YLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCL 725 (775)
T KOG1151|consen 646 YLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCL 725 (775)
T ss_pred ecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHH
Confidence 9999987533 3588999999999999999999999765433 2222 1221 12333455788999999999
Q ss_pred ccCCCCCCChHHHhcCCCcCC
Q 014344 319 EKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 319 ~~dP~~R~s~~eil~hp~f~~ 339 (426)
++.-++|..+.++-.||||..
T Consensus 726 aYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 726 AYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HhhhhhhhhHHHHccCccccc
Confidence 999999999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=325.42 Aligned_cols=259 Identities=26% Similarity=0.368 Sum_probs=225.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.++++.+...|.++||.|.||.|+.++.+..|+ .||||.++... ...+...|..|+.||-+++||
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy------------tekqrrdFL~EAsIMGQFdHP 690 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY------------TEKQRRDFLSEASIMGQFDHP 690 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc------------cHHHHhhhhhhhhhcccCCCC
Confidence 457888899999999999999999999987664 59999985432 223567899999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||++|.|+....+.+.||+|||++|+|..+++.+.++ |+..++.-+++.|+.|++||-++|+|||||..+|||++.+-.
T Consensus 691 NIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv 769 (996)
T KOG0196|consen 691 NIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV 769 (996)
T ss_pred cEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE
Confidence 9999999999999999999999999999999887755 999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+|++|||+++.+....+... .+.----
T Consensus 770 CKVsDFGLSRvledd~~~~y-----------------------------------------------------tt~GGKI 796 (996)
T KOG0196|consen 770 CKVSDFGLSRVLEDDPEAAY-----------------------------------------------------TTLGGKI 796 (996)
T ss_pred EEeccccceeecccCCCccc-----------------------------------------------------cccCCcc
Confidence 99999999997754321100 0000012
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh--cCCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
..+|.|||.|....++.++||||+|+++||.+ +|..||-..+..+....|. .+.|.++++|..+.+|+..||++|-.
T Consensus 797 PiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~ 876 (996)
T KOG0196|consen 797 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRN 876 (996)
T ss_pred ceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhh
Confidence 46799999999999999999999999999976 6999999999999988886 45677889999999999999999999
Q ss_pred CCCChHHHhcC
Q 014344 324 KRIGVEEIKGH 334 (426)
Q Consensus 324 ~R~s~~eil~h 334 (426)
+||.+.+|+++
T Consensus 877 ~RP~F~qiV~~ 887 (996)
T KOG0196|consen 877 RRPKFAQIVST 887 (996)
T ss_pred cCCCHHHHHHH
Confidence 99999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.37 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=206.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC------CC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE------HP 86 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~------hp 86 (426)
+--++|.+....|+|-||+|..|.+..-|+.||||+|.... ...+.=..|++||++|. .-
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE--------------~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE--------------VMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch--------------HHhhhhhHHHHHHHHhhccCchhhh
Confidence 33455999999999999999999999999999999995432 23445566999999995 34
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN- 164 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~- 164 (426)
|+++|+-.|...+++|||+|-+. .+|.++++..+ +-.|....++.|+.|++.||..|-..||+|.||||+|||+++.
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 89999999999999999999884 88999887653 2348899999999999999999999999999999999999975
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
..+||||||.|...... ..+.+
T Consensus 574 ~iLKLCDfGSA~~~~en----------------------------------------------------------eitPY 595 (752)
T KOG0670|consen 574 NILKLCDFGSASFASEN----------------------------------------------------------EITPY 595 (752)
T ss_pred ceeeeccCccccccccc----------------------------------------------------------cccHH
Confidence 46899999998765421 11223
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------------
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP------------------------ 300 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 300 (426)
.-+..|.|||++.|.+|++..|+||+||+||||.||+..|+|.+...++...+...
T Consensus 596 LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf 675 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNF 675 (752)
T ss_pred HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccce
Confidence 34566999999999999999999999999999999999999988766543221000
Q ss_pred ---------------------C------------CCCCC----CHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 301 ---------------------P------------DLVGE----PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 301 ---------------------~------------~~~~~----~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
| .+++. -..+++||.+||..||++|+|+.++|+||||++
T Consensus 676 ~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 676 LYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred EEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0 00000 123889999999999999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=312.32 Aligned_cols=258 Identities=20% Similarity=0.253 Sum_probs=214.0
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
...++..+...+.++||+|-||.|.+|.-. .+..||+|++.... +......|..|+++|.+|+||||
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a------------~~~~r~~F~kEIkiLsqLkhPNI 597 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA------------TKNARNDFLKEIKILSRLKHPNI 597 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc------------chhHHHHHHHHHHHHhccCCCCe
Confidence 356677788999999999999999999863 36899999984432 22345789999999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++++++..++.+++||||++.|+|..++..+............++.||+.|++||.+.++|||||.+.|+|++.++++|
T Consensus 598 veLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iK 677 (807)
T KOG1094|consen 598 VELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIK 677 (807)
T ss_pred eEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEE
Confidence 99999999999999999999999999998876332234455556999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.+..+. ..+-...++-..
T Consensus 678 iadfgmsR~lysg~------------------------------------------------------yy~vqgr~vlpi 703 (807)
T KOG1094|consen 678 IADFGMSRNLYSGD------------------------------------------------------YYRVQGRAVLPI 703 (807)
T ss_pred ecCcccccccccCC------------------------------------------------------ceeeecceeeee
Confidence 99999999775432 111223446678
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHh---------cCCCCCCCCCHHHHHHHHHH
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEML--YGATPFRGSSRKETFYRIL---------CRPPDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~i~---------~~~~~~~~~~~~~~~li~~~ 317 (426)
+|||||.+.-..++.++|+|+||+++||++ +...||...+.++...+.- .-++.+.-+|..+.++|.+|
T Consensus 704 RwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~C 783 (807)
T KOG1094|consen 704 RWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRC 783 (807)
T ss_pred eehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHH
Confidence 899999999999999999999999999986 5889999888777655432 11233445688899999999
Q ss_pred hccCCCCCCChHHHhc
Q 014344 318 LEKDPTKRIGVEEIKG 333 (426)
Q Consensus 318 L~~dP~~R~s~~eil~ 333 (426)
|.+|.++||+++++-.
T Consensus 784 w~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 784 WRRESEQRPSFEQLHL 799 (807)
T ss_pred hchhhhcCCCHHHHHH
Confidence 9999999999999854
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.96 Aligned_cols=247 Identities=25% Similarity=0.292 Sum_probs=193.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|.--..||+|+||.||++.-.. +..||||.+.... ... .++|.+|+.+|.+++|||+|+|+|++
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~------------~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNS------------GQG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCC------------Ccc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 356666899999999999998744 4899999773321 111 45699999999999999999999999
Q ss_pred ecCC-eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCCeeeccCCcEEEec
Q 014344 96 STDK-FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM---GIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 96 ~~~~-~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~---giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
.+.+ ..+||+||+++|+|.+.+.......+++.....|+.+++.||+|||+. .||||||||.|||||++...||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9888 599999999999999988765432689999999999999999999985 399999999999999999999999
Q ss_pred ccccccCCC-CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc-ccCCC
Q 014344 172 FDLSTKLSP-KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF-VGTEE 249 (426)
Q Consensus 172 Fgls~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~ 249 (426)
||+|+.... .. ...+. .||..
T Consensus 221 FGLa~~~~~~~~---------------------------------------------------------~~~~~~~gt~g 243 (361)
T KOG1187|consen 221 FGLAKLGPEGDT---------------------------------------------------------SVSTTVMGTFG 243 (361)
T ss_pred ccCcccCCcccc---------------------------------------------------------ceeeecCCCCc
Confidence 999954421 10 00111 59999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---H---HHHHHHHhcC-------CCCC--CCCC-----HH
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---R---KETFYRILCR-------PPDL--VGEP-----TP 309 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~---~~~~~~i~~~-------~~~~--~~~~-----~~ 309 (426)
|+|||.+.....+.++|||||||+|.||++|+.|.+... . .+.....+.. .+.+ ...+ ..
T Consensus 244 Y~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~ 323 (361)
T KOG1187|consen 244 YLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKK 323 (361)
T ss_pred cCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHH
Confidence 999999998889999999999999999999998887532 1 1111111111 1111 1222 12
Q ss_pred HHHHHHHHhccCCCCCCChHHHhc
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+..+..+|++.+|..||++.++++
T Consensus 324 ~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 324 LAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHcCcCCCcCcCHHHHHH
Confidence 456788999999999999999754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=293.04 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=208.6
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+.+--+-||.|+||+||.+.|..+|+.||+|.+..-. .+-...+++.+|+++|.-++|.|+...++..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-----------q~L~s~krvFre~kmLcfFkHdNVLSaLDILQ 122 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-----------QNLASCKRVFREIKMLSSFRHDNVLSLLDILQ 122 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-----------HHHHHHHHHHHHHHHHHhhccccHHHHHHhcC
Confidence 4556678999999999999999999999999884321 12234678999999999999999999999886
Q ss_pred cCC-----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 97 TDK-----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 97 ~~~-----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
... .+|.++|++. .||+.++-. .+.++.+.++.+++||+.||+|||+.||.||||||.|+|++++-.+||||
T Consensus 123 Pph~dfFqEiYV~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 123 PANPSFFQELYVLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred CCCchHHHHHHHHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecc
Confidence 554 4678999985 888887653 46699999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++...... ....+.-+-|-.|+
T Consensus 200 FGLARvee~d~-------------------------------------------------------~~hMTqEVVTQYYR 224 (449)
T KOG0664|consen 200 FGLARTWDQRD-------------------------------------------------------RLNMTHEVVTQYYR 224 (449)
T ss_pred cccccccchhh-------------------------------------------------------hhhhHHHHHHHHhc
Confidence 99998754221 12334456788999
Q ss_pred cchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------------cCCCCCCC--
Q 014344 252 APEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----------------------CRPPDLVG-- 305 (426)
Q Consensus 252 aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-----------------------~~~~~~~~-- 305 (426)
|||++.|. .|+.++||||+|||+.||+..+..|...++.+++..|. ..+...+.
T Consensus 225 APEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~ 304 (449)
T KOG0664|consen 225 APELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQ 304 (449)
T ss_pred cHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCcc
Confidence 99999984 58999999999999999999999999888777665442 11111111
Q ss_pred ----------CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 306 ----------EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 306 ----------~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
...+..+++..+|..||.+|++..+++.|+|.....
T Consensus 305 vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 305 RLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 123467899999999999999999999999987643
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=304.70 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=220.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.|+++..+..+-++||-|.||.||.+.++...--||||.++-+ ...+.+|..|..+|+.++|||+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--------------tMeveEFLkEAAvMKeikHpNLV 326 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--------------TMEVEEFLKEAAVMKEIKHPNLV 326 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--------------chhHHHHHHHHHHHHhhcCccHH
Confidence 4677888889999999999999999999988888999987332 23567899999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+|++++..+-.+|||+|||..|+|.+|++...+..++.-....++.||..|++||..+++|||||...|+|+.++..||+
T Consensus 327 qLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv 406 (1157)
T KOG4278|consen 327 QLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV 406 (1157)
T ss_pred HHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe
Confidence 99999999999999999999999999999888778888888899999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+||||++.+...+..+. .|. --.+.
T Consensus 407 ADFGLsRlMtgDTYTAH-------------------------AGA------------------------------KFPIK 431 (1157)
T KOG4278|consen 407 ADFGLSRLMTGDTYTAH-------------------------AGA------------------------------KFPIK 431 (1157)
T ss_pred eccchhhhhcCCceecc-------------------------cCc------------------------------cCccc
Confidence 99999998864331110 000 02456
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|.|||-+.-..++.++|||+|||+|||+.| |..||.+-+....|..+.. +-....++|+.+..|++.||++.|++||
T Consensus 432 WTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRP 511 (1157)
T KOG4278|consen 432 WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRP 511 (1157)
T ss_pred ccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCc
Confidence 999999999999999999999999999985 9999999988777665543 3345668899999999999999999999
Q ss_pred ChHHHh
Q 014344 327 GVEEIK 332 (426)
Q Consensus 327 s~~eil 332 (426)
++.||-
T Consensus 512 sFaeiH 517 (1157)
T KOG4278|consen 512 SFAEIH 517 (1157)
T ss_pred cHHHHH
Confidence 998884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.10 Aligned_cols=272 Identities=17% Similarity=0.184 Sum_probs=188.6
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEc----------------CCCceEEEEEeehhhHHhhhhhccc-CCCchhhHHHH
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDV----------------ESSESFALKVIWRDLIEKKSKELTN-NDNGDKYRRIS 74 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~~~~vAiK~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 74 (426)
.++.++|++.++||+|+||+||++... ..++.||||.+.............. ...........
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 367889999999999999999999752 3456799999854321111000000 00001112344
Q ss_pred HHHHHHHhcCCCCc-----ceeeeeeec--------CCeEEEEEeccCCCChHHHHHHhcc-------------------
Q 014344 75 FEQRVLRNVEHPLL-----PRLRGVLST--------DKFVGYAIDYCPGRDLHSLRKQQSE------------------- 122 (426)
Q Consensus 75 ~E~~il~~l~hp~i-----v~l~~~~~~--------~~~~~lV~Ey~~gg~L~~l~~~~~~------------------- 122 (426)
.|+.++.++.|.++ ++++++|.. +...++||||+.+++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57778888876554 566666532 4568999999999999998764211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhcccccccc
Q 014344 123 ---QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199 (426)
Q Consensus 123 ---~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~ 199 (426)
..++...++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---------------- 364 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---------------- 364 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc----------------
Confidence 1245678899999999999999999999999999999999999999999999865432110
Q ss_pred ccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC-------------------
Q 014344 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG------------------- 260 (426)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------------------- 260 (426)
.......+|+.|+|||.+....
T Consensus 365 ---------------------------------------~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~ 405 (507)
T PLN03224 365 ---------------------------------------FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAW 405 (507)
T ss_pred ---------------------------------------cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHH
Confidence 0011123588999999986432
Q ss_pred -C--ChhhHHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCC
Q 014344 261 -H--DFAVDWWSLGVVLHEMLYGAT-PFRGSSRK-----------ETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 261 -~--~~~~DiwSlG~il~ell~g~~-pf~~~~~~-----------~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP 322 (426)
| ....|+||+||++|+|++|.. ||...... ..+..+... .+.....+...+|||.+||..+|
T Consensus 406 ~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~ 485 (507)
T PLN03224 406 LYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRD 485 (507)
T ss_pred hcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCC
Confidence 1 124799999999999999875 77543211 111111111 12223457789999999999876
Q ss_pred ---CCCCChHHHhcCCCcC
Q 014344 323 ---TKRIGVEEIKGHEFFK 338 (426)
Q Consensus 323 ---~~R~s~~eil~hp~f~ 338 (426)
.+|+|++|+|+||||.
T Consensus 486 ~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 486 QANRGRLSVGQALSHRFFL 504 (507)
T ss_pred CCcccCCCHHHHhCCCCcC
Confidence 6899999999999995
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=323.80 Aligned_cols=264 Identities=30% Similarity=0.428 Sum_probs=205.8
Q ss_pred eeecccCceE-EEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 014344 22 SALGRGAKGV-VFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~-V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 99 (426)
+.+|.|+.|+ ||++. ..|+.||||.+-.+ ....+.+|+..|+.-+ |||||++++.-++.+
T Consensus 515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e----------------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGV--YEGREVAVKRLLEE----------------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred HHcccCCCCcEEEEEe--eCCceehHHHHhhH----------------hHHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 5679999986 78777 56889999987332 3456788999999986 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CC--cEEEecc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NG--HIMLVDF 172 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g--~ikL~DF 172 (426)
.+||+.|+|. .+|.++++.. ..........+..+.|++.||++||+.+||||||||.||||+. ++ .++|+||
T Consensus 577 F~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDf 655 (903)
T KOG1027|consen 577 FLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDF 655 (903)
T ss_pred eEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccc
Confidence 9999999996 9999999874 1111222456788999999999999999999999999999986 34 6899999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+..+.. +-.+.....||-+|+|
T Consensus 656 glsKkl~~~~s-----------------------------------------------------S~~r~s~~sGt~GW~A 682 (903)
T KOG1027|consen 656 GLSKKLAGGKS-----------------------------------------------------SFSRLSGGSGTSGWQA 682 (903)
T ss_pred ccccccCCCcc-----------------------------------------------------hhhcccCCCCcccccC
Confidence 99999864321 1122344569999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCCCCCCC--CCH--HHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILCRPPDLVG--EPT--PLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~--~~~--~~~~li~~~L~~dP~~R~s 327 (426)
||++....-+.++||+|+||++|..++| ..||......+ .+|+........ .-. .+.|||.+||.++|..||+
T Consensus 683 PE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs 760 (903)
T KOG1027|consen 683 PEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS 760 (903)
T ss_pred HHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC
Confidence 9999998888899999999999999885 99997654433 456544433221 112 7899999999999999999
Q ss_pred hHHHhcCCCcCCCChhhhhhccCCCCCCCCCCCCCC
Q 014344 328 VEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENN 363 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (426)
|.++|.|||| |+...+......+..+++.++.
T Consensus 761 a~~VL~HPlF----W~~ekrL~Fl~dvSDRvE~e~r 792 (903)
T KOG1027|consen 761 ATDVLNHPLF----WDSEKRLSFLRDVSDRVEKENR 792 (903)
T ss_pred HHHHhCCCcc----CChHHHHHHHHhhhhhhhhhhc
Confidence 9999999999 6555444444455555544433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=279.75 Aligned_cols=239 Identities=43% Similarity=0.720 Sum_probs=200.6
Q ss_pred CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEEEEec
Q 014344 28 AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDY 107 (426)
Q Consensus 28 ~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~Ey 107 (426)
+||.||+|.+..+++.+|+|++...... ...+.+..|+.++++++|+||+++++.+......++++||
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 68 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK------------KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEY 68 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc------------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeC
Confidence 5899999999989999999998543211 1156788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCc
Q 014344 108 CPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187 (426)
Q Consensus 108 ~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~ 187 (426)
+.+++|.+++..... ++...+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.......
T Consensus 69 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 69 CDGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred CCCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 999999998875433 8899999999999999999999999999999999999999999999999987764211
Q ss_pred chhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHH
Q 014344 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDW 267 (426)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 267 (426)
......++..|+|||.+.+..++.++|+
T Consensus 142 ----------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di 169 (244)
T smart00220 142 ----------------------------------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDV 169 (244)
T ss_pred ----------------------------------------------------ccccccCCcCCCCHHHHccCCCCchhhH
Confidence 1223457888999999998888999999
Q ss_pred HHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCC-C---CCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 268 WSLGVVLHEMLYGATPFRG-SSRKETFYRILCRPPDLV-G---EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 268 wSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~-~---~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
||||+++|+|++|..||.. .........+........ . .+..+.+++.+||..+|++||++.++++||||
T Consensus 170 ~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 170 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999988 443333333322222211 1 67889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=308.32 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=212.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcC-CCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVE-SSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.++..++++||+|+||+||.+.+.. +|+ .||||++....+ ......|.+|+.+|.+|+|||+++|
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l------------~~~mddflrEas~M~~L~H~hliRL 176 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSL------------NAIMDDFLREASHMLKLQHPHLIRL 176 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCcc------------chhHHHHHHHHHHHHhccCcceeEE
Confidence 3457788999999999999998864 343 599999844322 1256789999999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
||+..+ ..+.+|+|+|++|+|.+.++......|.......|+.||+.|+.||.++++|||||...|+||-....|||+|
T Consensus 177 yGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 177 YGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred eeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence 999877 7889999999999999988776666799999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
|||.+.+....... ......--...|+
T Consensus 256 FGLmRaLg~ned~Y-----------------------------------------------------vm~p~rkvPfAWC 282 (1039)
T KOG0199|consen 256 FGLMRALGENEDMY-----------------------------------------------------VMAPQRKVPFAWC 282 (1039)
T ss_pred ccceeccCCCCcce-----------------------------------------------------EecCCCcCccccc
Confidence 99998875322100 0001111344699
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||.++...++.++|+|++||++|||++ |..||.|.....++.+|-.. .+....++.++.+++..||..+|++|||+
T Consensus 283 aPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptF 362 (1039)
T KOG0199|consen 283 APESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTF 362 (1039)
T ss_pred CHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccH
Confidence 9999999999999999999999999995 99999999998888887522 24445678999999999999999999999
Q ss_pred HHHhcC
Q 014344 329 EEIKGH 334 (426)
Q Consensus 329 ~eil~h 334 (426)
..|...
T Consensus 363 sair~~ 368 (1039)
T KOG0199|consen 363 SAIRED 368 (1039)
T ss_pred HHHHHh
Confidence 888643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=304.77 Aligned_cols=210 Identities=26% Similarity=0.451 Sum_probs=185.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLL 88 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~i 88 (426)
.-++.+|..++.||.|+||.|++|.++.+...|+||.+.|+++-..+.-. ...+-.+-.|+.||..|+ |+||
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvr-----DrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVR-----DRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhc-----ccccCccchhHHHHHHhhhcCccch
Confidence 35678899999999999999999999999999999999998876554332 223446777999999998 9999
Q ss_pred ceeeeeeecCCeEEEEEecc-CCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 89 PRLRGVLSTDKFVGYAIDYC-PGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~-~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
++++++|++++++||+||-- +|.||++++....+ ++|.+++.|++||+.|+++||++||||||||-||+.++.+|.+
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeE
Confidence 99999999999999999965 46799999987654 9999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||.|.....+ -...|+||
T Consensus 710 klidfgsaa~~ksg----------------------------------------------------------pfd~f~gt 731 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSG----------------------------------------------------------PFDVFVGT 731 (772)
T ss_pred EEeeccchhhhcCC----------------------------------------------------------Ccceeeee
Confidence 99999998765422 24578999
Q ss_pred CCCccchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCC
Q 014344 248 EEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRG 286 (426)
Q Consensus 248 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~ 286 (426)
..|.|||++.|..| +..-||||||++||.+++..-||..
T Consensus 732 v~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 732 VDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999888 6889999999999999999999863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.92 Aligned_cols=268 Identities=27% Similarity=0.458 Sum_probs=226.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.-.+|+++.++|+|+||-||+|+++.+++..|+|+++.. ..+.+.-++.|+-+++-++|||||.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-------------p~dd~~~iqqei~~~~dc~h~nivay~g 79 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-------------PGDDFSGIQQEIGMLRDCRHPNIVAYFG 79 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc-------------CCccccccccceeeeecCCCcChHHHHh
Confidence 456899999999999999999999999999999999442 3345677888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.+-....+++.||||.||+|.+.-+ ..+++++.++.+.+++.+.||+|||++|=+|||||-.|||+++.|.+||+|||
T Consensus 80 sylr~dklwicMEycgggslQdiy~--~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfg 157 (829)
T KOG0576|consen 80 SYLRRDKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFG 157 (829)
T ss_pred hhhhhcCcEEEEEecCCCcccceee--ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccC
Confidence 9999999999999999999998743 34569999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
.+..+... ..+..+|.|||.||||
T Consensus 158 vsaqitat--------------------------------------------------------i~KrksfiGtpywmap 181 (829)
T KOG0576|consen 158 VSAQITAT--------------------------------------------------------IAKRKSFIGTPYWMAP 181 (829)
T ss_pred chhhhhhh--------------------------------------------------------hhhhhcccCCccccch
Confidence 99877422 2456788999999999
Q ss_pred hhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCC---CCCHHHHHHHHHHhccCCCC
Q 014344 254 EII---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLV---GEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 254 E~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~---~~~~~~~~li~~~L~~dP~~ 324 (426)
|+- +..+|...+|+|++|++..|+.--++|.....+......... .++.+. .+++.+.+|++.+|.++|.+
T Consensus 182 Evaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKk 261 (829)
T KOG0576|consen 182 EVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKK 261 (829)
T ss_pred hHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCcc
Confidence 985 457799999999999999999998999877777665554432 233222 34677899999999999999
Q ss_pred CCChHHHhcCCCcCCC-----ChhhhhhccCCC
Q 014344 325 RIGVEEIKGHEFFKGV-----NWELLLKISRPP 352 (426)
Q Consensus 325 R~s~~eil~hp~f~~~-----~~~~~~~~~~~~ 352 (426)
||+++.+|.|||...- .-+.+.+...|+
T Consensus 262 RptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 262 RPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred CCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 9999999999999753 223344455554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=286.23 Aligned_cols=291 Identities=25% Similarity=0.388 Sum_probs=205.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcC---CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcce
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVE---SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPR 90 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~ 90 (426)
.+.|.++.+||.|+|++||++.+.. .++.||+|.+... ....++..|+++|..+. +.||+.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t---------------s~p~ri~~El~~L~~~gG~~ni~~ 99 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT---------------SSPSRILNELEMLYRLGGSDNIIK 99 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc---------------cCchHHHHHHHHHHHhccchhhhc
Confidence 4568999999999999999999987 7889999988432 23457889999999996 899999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIML 169 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL 169 (426)
+.+++...+.+.+||||++..+..++... ++...++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|
T Consensus 100 ~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 100 LNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred chhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceE
Confidence 99999999999999999999988887653 778999999999999999999999999999999999985 578899
Q ss_pred ecccccccCCCCCCCCCcchhhcccc---ccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANT---RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+|||+|.................-.. ........+.....++.|..... ........-...|
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~---------------~~~r~~~~anrAG 239 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRC---------------NDGRPSERANRAG 239 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceecc---------------CCCccceecccCC
Confidence 99999985322111111000000000 00000000000000011100000 0111123335579
Q ss_pred CCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH----------------------------
Q 014344 247 TEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRI---------------------------- 296 (426)
Q Consensus 247 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i---------------------------- 296 (426)
|++|+|||++.. ...+.++||||.|||+..+++++.||...... .....+
T Consensus 240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~ 319 (418)
T KOG1167|consen 240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIP 319 (418)
T ss_pred CCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccccc
Confidence 999999999765 55788999999999999999999998543211 100000
Q ss_pred -----------h-----cCCCC-------CCC-CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 297 -----------L-----CRPPD-------LVG-EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 297 -----------~-----~~~~~-------~~~-~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
+ ..... ..+ .+..+.||+.+||+.||.+|+|++++|+||||...
T Consensus 320 ~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 320 TIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0 00000 001 13468899999999999999999999999999854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=325.83 Aligned_cols=235 Identities=25% Similarity=0.330 Sum_probs=184.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|...+.||+|+||.||+|++..++..||+|.+.... .....|+.++++++||||+++++++.
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----------------~~~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-----------------SIPSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-----------------cccHHHHHHHhhCCCCCcceEEEEEE
Confidence 4566788999999999999999999999999874211 01123688999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH---NMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH---~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++...|+|||||+||+|.++++. +++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 99999999999999999998852 788999999999999999999 6699999999999999988887775 55
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
....... .....||+.||||
T Consensus 828 ~~~~~~~------------------------------------------------------------~~~~~~t~~y~aP 847 (968)
T PLN00113 828 LPGLLCT------------------------------------------------------------DTKCFISSAYVAP 847 (968)
T ss_pred ccccccc------------------------------------------------------------CCCccccccccCc
Confidence 4432210 1122588999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcC--------CCCCC-------CCCHHHHHHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCR--------PPDLV-------GEPTPLRNLI 314 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~--------~~~~~-------~~~~~~~~li 314 (426)
|++.+..++.++|||||||++|||++|+.||..... ...+.+.... .+... .....+.+++
T Consensus 848 E~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred ccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence 999999999999999999999999999999854321 1111111000 01110 1122467899
Q ss_pred HHHhccCCCCCCChHHHhcC
Q 014344 315 RRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~h 334 (426)
.+||+.||++|||+.|+++.
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HhhCcCCchhCcCHHHHHHH
Confidence 99999999999999999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=254.63 Aligned_cols=222 Identities=26% Similarity=0.428 Sum_probs=181.6
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~ 90 (426)
++.-++..-+..||+|+||.|=+.++..+|...|+|.+.... +....++...|+++.... .+|++|.
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv------------n~q~q~r~L~dldi~~r~~~CPf~V~ 109 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV------------NSQEQKRLLMDLDIIMRTVDCPFTVH 109 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc------------ChHHHHHHHHhhhhhccCCCCCeEEE
Confidence 344456677889999999999999999999999999884432 223456677788876665 6899999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~i 167 (426)
+++....+..+++.||.|. .+|..+-+. ..++.++|..+-.++..++.||.|||++ .+||||+||.|||++.+|+|
T Consensus 110 FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqV 188 (282)
T KOG0984|consen 110 FYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQV 188 (282)
T ss_pred eehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcE
Confidence 9999999999999999995 778776432 2356699999999999999999999975 99999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
|+||||.+..+..+.. .+.-.|.
T Consensus 189 KiCDFGIsG~L~dSiA---------------------------------------------------------kt~daGC 211 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIA---------------------------------------------------------KTMDAGC 211 (282)
T ss_pred EEcccccceeehhhhH---------------------------------------------------------HHHhcCC
Confidence 9999999987743210 0012378
Q ss_pred CCCccchhhcC----CCCChhhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC
Q 014344 248 EEYVAPEIIEG----KGHDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILCRPPDL 303 (426)
Q Consensus 248 ~~y~aPE~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~ 303 (426)
..|||||.+.. .+|+-++||||||+++.||.+++.||.. .++-+++.+++..++..
T Consensus 212 kpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 212 KPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred CccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 88999999753 4789999999999999999999999975 56778888888766543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.46 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=207.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCc----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSE----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
++-...+-.++||+|+||+||++.....|+ +||||++..... .....++..|+-+|.+|+|||+
T Consensus 693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~------------~~~s~e~LdeAl~masldHpnl 760 (1177)
T KOG1025|consen 693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS------------PKASIELLDEALRMASLDHPNL 760 (1177)
T ss_pred chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC------------chhhHHHHHHHHHHhcCCCchH
Confidence 344456677899999999999999865555 588888744322 2335678889999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++..... +.||++|+++|.|.++.+.++ ..+-......|..||+.|+.|||++.++||||-.+|||+....++|
T Consensus 761 ~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvk 838 (1177)
T KOG1025|consen 761 LRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVK 838 (1177)
T ss_pred HHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEE
Confidence 99999997766 889999999999999988765 4588899999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.+.+...... ....--.+
T Consensus 839 itdfgla~ll~~d~~ey~------------------------------------------------------~~~gK~pi 864 (1177)
T KOG1025|consen 839 ITDFGLAKLLAPDEKEYS------------------------------------------------------APGGKVPI 864 (1177)
T ss_pred EEecchhhccCccccccc------------------------------------------------------ccccccCc
Confidence 999999998865432111 01111356
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh--cCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
.|||-|.+....|+.++||||+||++||++| |..|+.+....++-..+. .+.+.++.++-++..++.+||..|+..|
T Consensus 865 kwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 865 KWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred HHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 7999999999999999999999999999997 999999988776543332 2234455667889999999999999999
Q ss_pred CChHHHh
Q 014344 326 IGVEEIK 332 (426)
Q Consensus 326 ~s~~eil 332 (426)
|+++++.
T Consensus 945 p~fkel~ 951 (1177)
T KOG1025|consen 945 PTFKELA 951 (1177)
T ss_pred ccHHHHH
Confidence 9998874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=271.29 Aligned_cols=245 Identities=22% Similarity=0.355 Sum_probs=191.4
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh--cCCCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN--VEHPL 87 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~ 87 (426)
.+-+++...+++..||+|.||.||+|.- +++.||||++.. ...+.+..|.+|.+. ++|+|
T Consensus 204 spl~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----------------~~kqs~~~Ek~Iy~lp~m~h~n 265 (534)
T KOG3653|consen 204 SPLLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----------------QEKQSFQNEKNIYSLPGMKHEN 265 (534)
T ss_pred cccccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----------------HHHHHHHhHHHHHhccCccchh
Confidence 4556777899999999999999999985 459999999833 345667778888776 57999
Q ss_pred cceeeeeeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCC
Q 014344 88 LPRLRGVLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM---------GIVYRDL 154 (426)
Q Consensus 88 iv~l~~~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~---------giiHrDl 154 (426)
|++++++-+... .++||++|.+.|+|.+|+..+. ++.....+++..|+.||+|||+- .|+||||
T Consensus 266 Il~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDl 342 (534)
T KOG3653|consen 266 ILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDL 342 (534)
T ss_pred HHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccc
Confidence 999999876554 7899999999999999998754 89999999999999999999963 5999999
Q ss_pred CCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 155 KPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSD 234 (426)
Q Consensus 155 Kp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (426)
|..||||.+|+..-|+|||||..+.++.+..
T Consensus 343 kSkNVLvK~DlTccIaDFGLAl~~~p~~~~~------------------------------------------------- 373 (534)
T KOG3653|consen 343 KSKNVLVKNDLTCCIADFGLALRLEPGKPQG------------------------------------------------- 373 (534)
T ss_pred cccceEEccCCcEEeeccceeEEecCCCCCc-------------------------------------------------
Confidence 9999999999999999999999987543221
Q ss_pred CCCCCCccccccCCCCccchhhcCC-CCC-----hhhHHHHHHHHHHHHHhCCCCCC-C----------------CCHHH
Q 014344 235 SDSSEKSNSFVGTEEYVAPEIIEGK-GHD-----FAVDWWSLGVVLHEMLYGATPFR-G----------------SSRKE 291 (426)
Q Consensus 235 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwSlG~il~ell~g~~pf~-~----------------~~~~~ 291 (426)
.+..-|||.+|||||++.|. .+. .+.||||+|.+||||+++..-+. + ++..+
T Consensus 374 -----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 374 -----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred -----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 12235899999999999773 222 47899999999999997543332 1 12222
Q ss_pred HHHHHhc--CCCCCCC------CCHHHHHHHHHHhccCCCCCCChH
Q 014344 292 TFYRILC--RPPDLVG------EPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 292 ~~~~i~~--~~~~~~~------~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+...++. ..|.++. ....+++.|..||..||+.|+|+.
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 2222222 2222221 134578999999999999999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.05 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=209.4
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc---C----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV---E----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 82 (426)
.+++..++..+.+.||+|+||.|++|.-. . ....||+|.+.... .....+.+..|+.+|+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~------------~~~~~~~~~~El~~m~~ 357 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA------------SSSEKKDLMSELNVLKE 357 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc------------CcHHHHHHHHHHHHHHH
Confidence 56677777788899999999999999753 1 13469999874432 22456789999999999
Q ss_pred cC-CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc------------c--CCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 83 VE-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS------------E--QMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 83 l~-hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~------------~--~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+. ||||+.+++++.....+++|+|||..|+|.++++..+ . ..++......++.||+.|++||++.
T Consensus 358 ~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~ 437 (609)
T KOG0200|consen 358 LGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV 437 (609)
T ss_pred hcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC
Confidence 85 9999999999999999999999999999999987655 0 1388899999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
.+|||||-.+|||++.+..+||+|||+|+.........
T Consensus 438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~------------------------------------------ 475 (609)
T KOG0200|consen 438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYR------------------------------------------ 475 (609)
T ss_pred CccchhhhhhhEEecCCCEEEEccccceeccCCCCceE------------------------------------------
Confidence 99999999999999999999999999998654322110
Q ss_pred CCCCCCCCCCCCCcccccc--CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHh--cCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVG--TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSS-RKETFYRIL--CRPP 301 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~-~~~~~~~i~--~~~~ 301 (426)
...-.| ...|||||.+....|+.++||||+||+|||+.+ |..||.+.. ..+.+..+. .+..
T Consensus 476 -------------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~ 542 (609)
T KOG0200|consen 476 -------------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRME 542 (609)
T ss_pred -------------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 000012 334999999999999999999999999999986 999999855 444444333 2344
Q ss_pred CCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+..++.++.++++.||..+|++||++.++..
T Consensus 543 ~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 543 QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55566899999999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=260.06 Aligned_cols=245 Identities=22% Similarity=0.291 Sum_probs=185.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH--HhcCCCCcceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL--RNVEHPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il--~~l~hp~iv~l~~ 93 (426)
.+.++.+.||+|.||.||+++. -|+.||||++.... -+...+|.+|. ..|+|+||+.+++
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd----------------E~SWfrEtEIYqTvmLRHENILgFIa 272 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD----------------ERSWFRETEIYQTVMLRHENILGFIA 272 (513)
T ss_pred heeEEEEEecCccccceeeccc--cCCceEEEEecccc----------------hhhhhhHHHHHHHHHhccchhhhhhh
Confidence 3578999999999999999985 57899999994321 12334455554 4579999999998
Q ss_pred eeecC----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCCeee
Q 014344 94 VLSTD----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM--------GIVYRDLKPENIMI 161 (426)
Q Consensus 94 ~~~~~----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~--------giiHrDlKp~NiLl 161 (426)
.-..+ ..+|||++|.+.|+|++++.+. .++.+....++..++.||++||.. .|+|||||..|||+
T Consensus 273 aD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV 349 (513)
T KOG2052|consen 273 ADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 349 (513)
T ss_pred ccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE
Confidence 76443 3689999999999999999874 389999999999999999999963 49999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
..+|..-|+|+|||......... -....
T Consensus 350 Kkn~~C~IADLGLAv~h~~~t~~----------------------------------------------------idi~~ 377 (513)
T KOG2052|consen 350 KKNGTCCIADLGLAVRHDSDTDT----------------------------------------------------IDIPP 377 (513)
T ss_pred ccCCcEEEeeceeeEEecccCCc----------------------------------------------------ccCCC
Confidence 99999999999999876533211 12245
Q ss_pred cccccCCCCccchhhcCCC----C--ChhhHHHHHHHHHHHHHh----------CCCCCCCCC----HHHHHHHHhc---
Q 014344 242 NSFVGTEEYVAPEIIEGKG----H--DFAVDWWSLGVVLHEMLY----------GATPFRGSS----RKETFYRILC--- 298 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlG~il~ell~----------g~~pf~~~~----~~~~~~~i~~--- 298 (426)
+..|||.+|||||++...- + -..+||||||.++||++- -++||.+.- ..+...+++.
T Consensus 378 N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~ 457 (513)
T KOG2052|consen 378 NPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQK 457 (513)
T ss_pred CCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecc
Confidence 6779999999999986432 1 146899999999999984 257775432 2233344432
Q ss_pred -CCCCCCCC--C---HHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 299 -RPPDLVGE--P---TPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 299 -~~~~~~~~--~---~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+|.....+ . ..+..+|+.||..+|.-|.|+--|.+
T Consensus 458 ~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 458 LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 12111111 1 23567999999999999999877754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=284.93 Aligned_cols=256 Identities=39% Similarity=0.673 Sum_probs=215.7
Q ss_pred eecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 014344 23 ALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTD 98 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~ 98 (426)
++|.|+||.|++++.. ..+..||+|+..+.....+.+. ....|..++.... ||++++++..|+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-----------~t~~er~il~~~~~~~f~v~lhyafqt~ 69 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-----------HTKQERIILAFVHNTPFLVKLHYAFQTD 69 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-----------ccccHHHHHhhccCCCceeeeeeeeccc
Confidence 4799999999999864 4577899999977655433211 3445788888887 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
..+++++++..||+|...... ..++.+...+++..+++.|++++|+.||+|||+|++||+++.+|++++.|||+++..
T Consensus 70 ~kl~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 70 GKLYLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred cchhHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHh
Confidence 999999999999999876543 456999999999999999999999999999999999999999999999999998865
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
... ...|||..|||||++.
T Consensus 148 v~~------------------------------------------------------------~~~cgt~eymApEI~~- 166 (612)
T KOG0603|consen 148 VKE------------------------------------------------------------KIACGTYEYRAPEIIN- 166 (612)
T ss_pred Hhh------------------------------------------------------------hhcccchhhhhhHhhh-
Confidence 311 1117999999999998
Q ss_pred CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCHHHHHHHHHHhccCCCCCCC-----hHHHh
Q 014344 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-RPPDLVGEPTPLRNLIRRLLEKDPTKRIG-----VEEIK 332 (426)
Q Consensus 259 ~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~s-----~~eil 332 (426)
++..++|+||+|++++||++|..||.+ ++..+|+. ....+...+..++++++.++..+|.+|.. +.|++
T Consensus 167 -gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 167 -GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred -ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 678899999999999999999999998 66777776 34444455778899999999999999996 57999
Q ss_pred cCCCcCCCChhhhhhccCCCCCCCC
Q 014344 333 GHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 333 ~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
+|+||+.++|..+....+++.+.+.
T Consensus 242 ~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 242 QHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred ccchheeeeHhhHhhcCCCCCCCCc
Confidence 9999999999988776666555443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.97 Aligned_cols=233 Identities=18% Similarity=0.233 Sum_probs=160.6
Q ss_pred HhcCC-CCcceeeeee-------ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 014344 81 RNVEH-PLLPRLRGVL-------STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYR 152 (426)
Q Consensus 81 ~~l~h-p~iv~l~~~~-------~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHr 152 (426)
+.+.| +||..++++| ..+..+++++||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 34456 5777788877 3345788889987 57999998643 3459999999999999999999999999999
Q ss_pred CCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC-CCCCCCC
Q 014344 153 DLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR-IGPDPPS 231 (426)
Q Consensus 153 DlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (426)
||||+||||+..|.+|++|||++........ ...+.++.|........... .......
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~---------------------~~~ki~DfG~a~~~~~~~~~~~~~~~~~ 163 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDED---------------------ATTKSREIGSSRREEILSERRIEKLEEV 163 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCccccccc---------------------Ccccccccccccccccccccchhhhhcc
Confidence 9999999999999999999998765321100 01122222222111000000 0000000
Q ss_pred CCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCCCCCCCCHH
Q 014344 232 RSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTP 309 (426)
Q Consensus 232 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~ 309 (426)
. ...........+||+.|||||++.+..|+.++|||||||+||||++|.+|+..... .+..+. ..++......+.
T Consensus 164 ~-~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 240 (793)
T PLN00181 164 K-KQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPK 240 (793)
T ss_pred c-cCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHH
Confidence 0 00001112235799999999999999999999999999999999999998764322 111111 112222233456
Q ss_pred HHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
..+++.+||.++|.+||++.||++||||..
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 779999999999999999999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-31 Score=239.41 Aligned_cols=213 Identities=37% Similarity=0.642 Sum_probs=184.7
Q ss_pred ecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEEE
Q 014344 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGY 103 (426)
Q Consensus 24 LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~l 103 (426)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~ 68 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS------------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYL 68 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh------------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEE
Confidence 689999999999998889999999985432110 24578889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEEecccccccCCCCC
Q 014344 104 AIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIMLVDFDLSTKLSPKT 182 (426)
Q Consensus 104 V~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL~DFgls~~~~~~~ 182 (426)
++||+.|++|.+++.... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 69 ~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 69 VMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999999999999987542 34899999999999999999999999999999999999999 8999999999987654221
Q ss_pred CCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC-CC
Q 014344 183 PQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK-GH 261 (426)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~ 261 (426)
. ......+...|++||.+... .+
T Consensus 148 ~--------------------------------------------------------~~~~~~~~~~~~~pe~~~~~~~~ 171 (215)
T cd00180 148 S--------------------------------------------------------LLKTIVGTPAYMAPEVLLGKGYY 171 (215)
T ss_pred c--------------------------------------------------------hhhcccCCCCccChhHhcccCCC
Confidence 0 11223477889999999887 78
Q ss_pred ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 262 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
+.+.|+|++|+++++| ..+.+++.+|+..+|++||++.++++|+
T Consensus 172 ~~~~D~~~lg~~~~~l------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 172 SEKSDIWSLGVILYEL------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred CchhhhHHHHHHHHHH------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8999999999999999 5678999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-30 Score=238.12 Aligned_cols=216 Identities=36% Similarity=0.608 Sum_probs=181.1
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... .....+..|+..++.++|+|++++++.+..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~ 68 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE------------KQREEFLREIRILKKLKHPNIVKLYGVFED 68 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch------------HHHHHHHHHHHHHHhCCCCChhhheeeeec
Confidence 67889999999999999999988999999998554321 145678889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
....++++||+++++|.+++...... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||++..
T Consensus 69 ~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 69 PEPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred CCceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 99999999999999999998765432 78999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh-
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII- 256 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~- 256 (426)
..... ........++..|++||.+
T Consensus 148 ~~~~~-------------------------------------------------------~~~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 148 IHRDL-------------------------------------------------------AALLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred ecCcc-------------------------------------------------------cccccceeccCCcCCHhHhc
Confidence 64211 0012234578889999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHhcCCC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRG-SSRK-ETFYRILCRPP 301 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~-~~~~~i~~~~~ 301 (426)
....++.++|+||||+++|+|++|+.||.. .+.. .....+....+
T Consensus 173 ~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 219 (225)
T smart00221 173 GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP 219 (225)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence 667788899999999999999999999987 4444 44555554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=241.85 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=190.3
Q ss_pred CCCCCCC-CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCC
Q 014344 10 IRSLDFS-CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPL 87 (426)
Q Consensus 10 ~~~l~~~-~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~ 87 (426)
.+.+++. .|.|.+.||.|.||.+.+|+++.+...+++|.+.+... ..+.|.+|...--.|. |.|
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--------------t~~dF~rEfhY~~~Ls~H~h 82 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--------------TQADFVREFHYSFFLSPHQH 82 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--------------hHHHHHHHhccceeeccchh
Confidence 3344443 59999999999999999999999999999999855432 3456777776655565 899
Q ss_pred cceeee-eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--C
Q 014344 88 LPRLRG-VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--N 164 (426)
Q Consensus 88 iv~l~~-~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--~ 164 (426)
|+.-|+ .|++.+.++++||||+.|||.+-+.. ..+-+...+.++.|+++||+|+|++++||||||.+||||-. .
T Consensus 83 Ii~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df 159 (378)
T KOG1345|consen 83 IIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF 159 (378)
T ss_pred hhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc
Confidence 998776 57889999999999999999876554 33888999999999999999999999999999999999953 3
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
-.|||||||+++....... . .
T Consensus 160 ~rvKlcDFG~t~k~g~tV~--------------------------------------------------------~---~ 180 (378)
T KOG1345|consen 160 YRVKLCDFGLTRKVGTTVK--------------------------------------------------------Y---L 180 (378)
T ss_pred cEEEeeecccccccCceeh--------------------------------------------------------h---h
Confidence 4899999999876532110 0 0
Q ss_pred ccCCCCccchhhcCC---C--CChhhHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhc-----CCCCCCCCCHHH
Q 014344 245 VGTEEYVAPEIIEGK---G--HDFAVDWWSLGVVLHEMLYGATPFRGSSRKE----TFYRILC-----RPPDLVGEPTPL 310 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~---~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~-----~~~~~~~~~~~~ 310 (426)
--+..|.+||+..-. . ....+|+|.||+++|.+++|.+||....... .+.+.+. .|..+...++.+
T Consensus 181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a 260 (378)
T KOG1345|consen 181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA 260 (378)
T ss_pred hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence 023458899976432 2 3578999999999999999999998554321 1222222 233334457788
Q ss_pred HHHHHHHhccCCCCCC---ChHHHhcCCCc
Q 014344 311 RNLIRRLLEKDPTKRI---GVEEIKGHEFF 337 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~---s~~eil~hp~f 337 (426)
..+.++-|..+|++|- ++..-....|.
T Consensus 261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 8999999999999994 45444444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=231.37 Aligned_cols=255 Identities=20% Similarity=0.219 Sum_probs=204.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCc-----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSE-----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+...+++....+-+|.||.||.+..+.... .|-+|.+ .....+-+...+..|-..+..+.|||
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTv------------k~~AS~iQv~~~L~es~lly~~sH~n 348 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTV------------KQHASQIQVNLLLQESMLLYGASHPN 348 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHH------------HhcccHHHHHHHHHHHHHHhcCcCCC
Confidence 444568888899999999999996653322 2333332 12234456778899999999999999
Q ss_pred cceeeeee-ecCCeEEEEEeccCCCChHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 88 LPRLRGVL-STDKFVGYAIDYCPGRDLHSLRKQQ------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 88 iv~l~~~~-~~~~~~~lV~Ey~~gg~L~~l~~~~------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
+..+.++. ++....+.++.+..-|+|..++... ..+.++..+...++.|+.+|++|||.+|+||.||..+|.+
T Consensus 349 ll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 349 LLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCV 428 (563)
T ss_pred ccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcce
Confidence 99999986 4556677888888889999987732 2334777888889999999999999999999999999999
Q ss_pred eccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 161 l~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
|++.-.+||+|=.+++.+-+..-...
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcL------------------------------------------------------ 454 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCL------------------------------------------------------ 454 (563)
T ss_pred ehhheeEEeccchhccccCccccccc------------------------------------------------------
Confidence 99999999999999988765431110
Q ss_pred ccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh--cCCCCCCCCCHHHHHHHHHH
Q 014344 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~~~~li~~~ 317 (426)
...--....|||||.+....|+.++|+|||||++|||++ |+.|+..-++.++..-+. .+...+.++|+++..++..|
T Consensus 455 GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacC 534 (563)
T KOG1024|consen 455 GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACC 534 (563)
T ss_pred CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHH
Confidence 000013567999999999999999999999999999997 999999999888776665 34566778999999999999
Q ss_pred hccCCCCCCChHHHhc
Q 014344 318 LEKDPTKRIGVEEIKG 333 (426)
Q Consensus 318 L~~dP~~R~s~~eil~ 333 (426)
|...|++||+++++..
T Consensus 535 WallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 535 WALLPEERPSFSQLVI 550 (563)
T ss_pred HhcCcccCCCHHHHHH
Confidence 9999999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=265.25 Aligned_cols=243 Identities=35% Similarity=0.599 Sum_probs=185.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
-.-++|..++.|..|+||.||+++|+.+.+.+|+| ++++.+.-+ .||.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR--------------------nilt~a~npfvv--- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR--------------------NILTFAGNPFVV--- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh--------------------ccccccCCccee---
Confidence 34468999999999999999999999999999995 443322111 144445566655
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
||-..+++..+ .++. +++.|++|||+-||+|||+||+|++|+.-|++|++||
T Consensus 136 ------------------gDc~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDf 187 (1205)
T KOG0606|consen 136 ------------------GDCATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDF 187 (1205)
T ss_pred ------------------chhhhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccch
Confidence 55555555432 2443 3389999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++.......... .+..|... ...-.....||||.|.|
T Consensus 188 gLsk~GLms~atnl--------~eg~I~k~---------------------------------t~Ef~dKqvcgTPeyia 226 (1205)
T KOG0606|consen 188 GLSKKGLMSLATNL--------KEGHIEKD---------------------------------THEFQDKQVCGTPEYIA 226 (1205)
T ss_pred hhhhhhhhhccchh--------hhcchHHH---------------------------------HHHhhhccccCCccccC
Confidence 99976533221100 00001100 00112234589999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCCC-
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRIG- 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~s- 327 (426)
||++...+|+..+|||++|+|+||.+.|+.||.+.++++.|...+.....+ ...+++++++|.+||+.+|..|..
T Consensus 227 PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 227 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 999999999999999999999999999999999999999998876543333 345788999999999999999984
Q ss_pred --hHHHhcCCCcCCCChhhhhhc
Q 014344 328 --VEEIKGHEFFKGVNWELLLKI 348 (426)
Q Consensus 328 --~~eil~hp~f~~~~~~~~~~~ 348 (426)
+-++.+|+||+.+||..+++.
T Consensus 307 ~ga~evk~h~ff~~LDw~~llRq 329 (1205)
T KOG0606|consen 307 GGALEVKQHGFFQLLDWKSLLRQ 329 (1205)
T ss_pred chhhhhhhccceeecccchhhhh
Confidence 779999999999999977653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=222.67 Aligned_cols=158 Identities=20% Similarity=0.241 Sum_probs=127.3
Q ss_pred CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchh
Q 014344 111 RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190 (426)
Q Consensus 111 g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~ 190 (426)
|+|.+++.... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------- 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------- 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---------
Confidence 68899887543 45999999999999999999999998 999999999999999 9988654210
Q ss_pred hccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHH
Q 014344 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSL 270 (426)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 270 (426)
...||+.|||||++.+..++.++|||||
T Consensus 63 ----------------------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSl 90 (176)
T smart00750 63 ----------------------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSL 90 (176)
T ss_pred ----------------------------------------------------cCCCcccccChHHhcCCCCcchhhHHHH
Confidence 1148899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCC--------CCCCH--HHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 271 GVVLHEMLYGATPFRGSSRK-ETFYRILCRPPDL--------VGEPT--PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 271 G~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~--------~~~~~--~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
||++|||++|+.||...... ..+..+....... ...+. .+.++|.+||..+|.+||++.+++.|+|+.
T Consensus 91 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 91 GITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 99999999999999765443 2222322211111 01122 589999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=268.06 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=201.4
Q ss_pred EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
.....+|.|++|.|+.+......+.++.|..... .. ...........+..|..+-..|.|||++.....+...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~------~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK------PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC------CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 4668899999999999988777777777755311 00 0001111223377788889999999998887777666
Q ss_pred CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
...+-+||||++ ||+.++... ..++...+..+++|++.||+|||++||.||||||+|++++.+|.+||+|||.+..+
T Consensus 394 ~~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 394 DGILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred ccchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 666666999998 999987764 34889999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
.... .........++|+..|+|||++.+
T Consensus 471 ~~~~----------------------------------------------------e~~~~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 471 RYPW----------------------------------------------------EKNIHESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred ccCc----------------------------------------------------chhhhhhcCcccCCcCcCcccccc
Confidence 4211 011123456789999999999999
Q ss_pred CCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhc--------CCCC-CCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 259 KGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETF-YRILC--------RPPD-LVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 259 ~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~--------~~~~-~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
..|+ ..+||||.|+++..|.+|+.||......+.. ..... .+.. ....+...+.+|.+||+.||.+|.|
T Consensus 499 ~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t 578 (601)
T KOG0590|consen 499 KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT 578 (601)
T ss_pred cccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec
Confidence 9996 6799999999999999999999876544321 11111 1111 1123566789999999999999999
Q ss_pred hHHHhcCCCcCCCC
Q 014344 328 VEEIKGHEFFKGVN 341 (426)
Q Consensus 328 ~~eil~hp~f~~~~ 341 (426)
+++|++.+||+.++
T Consensus 579 i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 579 IEQILNDEWIRSIE 592 (601)
T ss_pred HHHHhhChHhhhcc
Confidence 99999999998765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-28 Score=232.55 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=197.2
Q ss_pred CcEEEeeecccCceEEEEEEEcCCC-ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC----CCccee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESS-ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH----PLLPRL 91 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h----p~iv~l 91 (426)
+|++.+.||+|+||.||+|.+..++ ..+|+|+....... ....+..|..++..+.. ++++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-------------~~~~l~~E~~vl~~l~~~~~~~~~~~~ 85 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-------------KPSVLKIEIQVLKKLEKKNGPSHFPKL 85 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-------------CCccchhHHHHHHHHhhhcCCCCCCEE
Confidence 7999999999999999999998775 67999987432111 11146668889988872 699999
Q ss_pred eeee-ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-----C
Q 014344 92 RGVL-STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-----G 165 (426)
Q Consensus 92 ~~~~-~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-----g 165 (426)
++.+ ..+.+.|+||+.+ |.+|.+++.....+.|+..++..++.|++.+|++||+.|++||||||+|+++... .
T Consensus 86 ~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 86 LDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred EEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccc
Confidence 9999 5888999999988 8999999877766779999999999999999999999999999999999999865 3
Q ss_pred cEEEecccccccCC--CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-cc
Q 014344 166 HIMLVDFDLSTKLS--PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK-SN 242 (426)
Q Consensus 166 ~ikL~DFgls~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 242 (426)
.+.|.|||+++... ...... ....+. ..
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~-------------------------------------------------~~~~r~~~~ 195 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGN-------------------------------------------------LRPPRPQKG 195 (322)
T ss_pred eEEEEecCCCccccccCCCCcc-------------------------------------------------cccCCCCcc
Confidence 69999999999432 111100 000011 23
Q ss_pred ccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCC---CCCCCCHHHHHHHHH
Q 014344 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE---TFYRILCRPP---DLVGEPTPLRNLIRR 316 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~---~~~~~~~~~~~li~~ 316 (426)
.+.||..|+++.+..+...+.+.|+||++.++.+++.|..||.+..... .+.+...... .....+..+..+...
T Consensus 196 ~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (322)
T KOG1164|consen 196 LFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEY 275 (322)
T ss_pred CCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHH
Confidence 5679999999999999999999999999999999999999997765322 2222211111 122345677788888
Q ss_pred HhccCCCCCCChHHHhc
Q 014344 317 LLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~ 333 (426)
+-..+...+|....+..
T Consensus 276 ~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 276 IDSLDYEDKPDYEKLAE 292 (322)
T ss_pred hhccCCcCCCCHHHHHH
Confidence 87889999998776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=208.35 Aligned_cols=272 Identities=20% Similarity=0.301 Sum_probs=211.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i 88 (426)
...+-.++|+++++||+|+||-+|++....+|+.||||+=... .....+..|.++.+.|.+ ..|
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---------------a~hpqL~yEskvY~iL~~g~Gi 73 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---------------AKHPQLLYESKVYRILQGGVGI 73 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---------------CCCcchhHHHHHHHHhccCCCC
Confidence 3456678899999999999999999999999999999985322 223456679999999985 799
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---C
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---G 165 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g 165 (426)
+.+..++.+..+-.+||+++ |.+|.++..-.. +.|+-.++..++-|++.-++|+|.+++|||||||+|+|..-+ .
T Consensus 74 P~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~ 151 (341)
T KOG1163|consen 74 PHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCN 151 (341)
T ss_pred chhhhhccccccceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccc
Confidence 99999999999999999998 899999876544 459999999999999999999999999999999999999743 4
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+.|+|||+|+.+....+... ...+......
T Consensus 152 kl~LIDFGLaKky~d~~t~~H-------------------------------------------------Ipyre~r~lt 182 (341)
T KOG1163|consen 152 KLYLIDFGLAKKYRDIRTRQH-------------------------------------------------IPYREDRNLT 182 (341)
T ss_pred eEEEEeccchhhhcccccccc-------------------------------------------------CccccCCccc
Confidence 689999999998754221100 0122344567
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC------CCCCCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRILCRPP------DLVGEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~------~~~~~~~~~~~li~~ 316 (426)
||..|.+-....|...+.+.|+=|+|.+|..+.-|..||.+... .+.+.+|..... -+.+.|.++.-.|.-
T Consensus 183 GTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y 262 (341)
T KOG1163|consen 183 GTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNY 262 (341)
T ss_pred eeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHH
Confidence 99999998888888888999999999999999999999998654 333445542221 234678888888888
Q ss_pred HhccCCCCCCChH---HH-------hcCCCcCCCChhhhhh
Q 014344 317 LLEKDPTKRIGVE---EI-------KGHEFFKGVNWELLLK 347 (426)
Q Consensus 317 ~L~~dP~~R~s~~---ei-------l~hp~f~~~~~~~~~~ 347 (426)
|-..--++-|... ++ |+|.+=--.||..+.+
T Consensus 263 ~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkq 303 (341)
T KOG1163|consen 263 CRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQ 303 (341)
T ss_pred HhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHH
Confidence 8777777777633 22 2333222258988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-26 Score=218.58 Aligned_cols=259 Identities=32% Similarity=0.543 Sum_probs=205.9
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC-Ccceeeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP-LLPRLRGVLS 96 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~iv~l~~~~~ 96 (426)
|.+.+.||.|+||.||++.+. ..+|+|++........ .....+.+|+.++..+.|+ +++++.+.+.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~----------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 68 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS----------KEVERFLREIQILASLNHPPNIVKLYDFFQ 68 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch----------hHHHHHHHHHHHHHHccCCcceeeEEEEEe
Confidence 789999999999999999987 7899999865432211 2456788899999999988 7999999998
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEEecccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIMLVDFDL 174 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL~DFgl 174 (426)
.....+++++|+.++++..++..... ..++...+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||+
T Consensus 69 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 69 DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 88889999999999999976654331 2589999999999999999999999999999999999999988 799999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+......... .......+||+.|+|||
T Consensus 149 ~~~~~~~~~~~~~--------------------------------------------------~~~~~~~~~t~~~~~pe 178 (384)
T COG0515 149 AKLLPDPGSTSSI--------------------------------------------------PALPSTSVGTPGYMAPE 178 (384)
T ss_pred ceecCCCCccccc--------------------------------------------------cccccccccccccCCHH
Confidence 8754322100000 01235567999999999
Q ss_pred hhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCC--C--CCCC------HHHHHHHHHH
Q 014344 255 IIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRPPD--L--VGEP------TPLRNLIRRL 317 (426)
Q Consensus 255 ~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~--~--~~~~------~~~~~li~~~ 317 (426)
.+.+ ..+....|+||+|++++++++|..||..... ......+...... . .... ..+.+++.++
T Consensus 179 ~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (384)
T COG0515 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKL 258 (384)
T ss_pred HhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHH
Confidence 9988 5788999999999999999999999887763 3333333322211 1 1111 4688999999
Q ss_pred hccCCCCCCChHHHhcCCCcCC
Q 014344 318 LEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 318 L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+..+|..|.+..+...++|...
T Consensus 259 ~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 259 LAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred HhcCchhcCCHHHHhhchHhhC
Confidence 9999999999999888866643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=227.32 Aligned_cols=147 Identities=19% Similarity=0.130 Sum_probs=116.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce-
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR- 90 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~- 90 (426)
.-.++|++.+.||+|+||+||+|++.. +++.+|||++...... .........+.+|+++|+.++|+|++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~--------~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW--------WSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc--------cccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 345679999999999999999999876 6788899987422100 001123456889999999999999985
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCCeeeccCCcEEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDL-KPENIMIQENGHIML 169 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDl-Kp~NiLl~~~g~ikL 169 (426)
+++. ...|+|||||+|++|... . . .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||
T Consensus 87 l~~~----~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 87 LLAT----GKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred EEEc----CCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEE
Confidence 4432 457999999999999632 1 1 11 1467889999999999999999999 999999999999999
Q ss_pred ecccccccCCC
Q 014344 170 VDFDLSTKLSP 180 (426)
Q Consensus 170 ~DFgls~~~~~ 180 (426)
+|||+|+.+..
T Consensus 154 iDFGlA~~~~~ 164 (365)
T PRK09188 154 IDFQLASVFRR 164 (365)
T ss_pred EECccceeccc
Confidence 99999987753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-26 Score=208.92 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=193.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
.-.|+|+++||.|+||+.+++...-++++||||.=.+.. ....+.-|.+..+.|. .++|+.++.
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---------------~APQLrdEYr~YKlL~g~~GIP~vYY 91 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---------------EAPQLRDEYRTYKLLGGTEGIPQVYY 91 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC---------------CcchHHHHHHHHHHHcCCCCCCceee
Confidence 347999999999999999999999999999999742211 1234556888888886 699999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-----cEE
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-----HIM 168 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-----~ik 168 (426)
+.+...+-.||||++ |-+|.++..-.++ .|+..++..++.|++.-++|+|++.+|+|||||+|+||...+ .|-
T Consensus 92 FGqeG~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ih 169 (449)
T KOG1165|consen 92 FGQEGKYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIH 169 (449)
T ss_pred eccccchhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEE
Confidence 999999999999998 8999999877654 599999999999999999999999999999999999998654 589
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+.+....+... ...+...+..||.
T Consensus 170 iiDFGmAK~YrDp~TkqH-------------------------------------------------IPYrE~KSLsGTA 200 (449)
T KOG1165|consen 170 IIDFGMAKEYRDPKTKQH-------------------------------------------------IPYREHKSLSGTA 200 (449)
T ss_pred EEeccchhhhcCcccccc-------------------------------------------------Cccccccccccce
Confidence 999999998754221100 0112334566999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCC------CCCCCCHHHHHHHHHHhc
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS---SRKETFYRILCRPP------DLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~------~~~~~~~~~~~li~~~L~ 319 (426)
+||+-.-..|...+.+.|+=|||-++...|-|..||.+. +.++.+.+|-.... -+.+.|.++...|+-.-.
T Consensus 201 RYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~ 280 (449)
T KOG1165|consen 201 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRR 280 (449)
T ss_pred eeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999875 55666776632211 122445555555555544
Q ss_pred cCCCCCCC
Q 014344 320 KDPTKRIG 327 (426)
Q Consensus 320 ~dP~~R~s 327 (426)
.+-.+-|.
T Consensus 281 L~F~E~PD 288 (449)
T KOG1165|consen 281 LDFFETPD 288 (449)
T ss_pred cCcccCCC
Confidence 45555554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=200.56 Aligned_cols=146 Identities=18% Similarity=0.178 Sum_probs=112.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||.|+||.||++.+ +++.+|||++............ ....-..+.+|++.+.++.||+|+.+.+++
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~----~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLK----SFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHH----hhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 4599999999999999999765 4678999999654322110000 000012267899999999999999999886
Q ss_pred ecC--------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 96 STD--------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 96 ~~~--------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
... ...++||||++|.+|.++.. +++. ...+++.+|..||+.|++|||+||+||+++.+| +
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-E
Confidence 543 35889999999999987632 3332 356999999999999999999999999999999 9
Q ss_pred EEecccccccC
Q 014344 168 MLVDFDLSTKL 178 (426)
Q Consensus 168 kL~DFgls~~~ 178 (426)
+|+|||.+...
T Consensus 174 ~liDfg~~~~~ 184 (232)
T PRK10359 174 RIIDLSGKRCT 184 (232)
T ss_pred EEEECCCcccc
Confidence 99999987654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=201.29 Aligned_cols=236 Identities=25% Similarity=0.349 Sum_probs=147.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC----------CC
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE----------HP 86 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~----------hp 86 (426)
.+.....||.|+++.||.|+|..|++.+|+|+...... .....++.+.+|.-....+. |-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~----------~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~ 82 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD----------ASANEYEQLKEEQLAITLFPGVKNPKEAYRHL 82 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST----------THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccc----------cchHHHHHHHHHHHHhhhhccCCCHHHHHHhc
Confidence 36788999999999999999999999999999854331 11123444444443332221 11
Q ss_pred Ccceeeeee---------ecC---C-----eEEEEEeccCCCChHHHHHH---hccC--CCCHHHHHHHHHHHHHHHHHH
Q 014344 87 LLPRLRGVL---------STD---K-----FVGYAIDYCPGRDLHSLRKQ---QSEQ--MFSDDTIRFYAAELVLALEYL 144 (426)
Q Consensus 87 ~iv~l~~~~---------~~~---~-----~~~lV~Ey~~gg~L~~l~~~---~~~~--~l~~~~~~~~~~qil~aL~~L 144 (426)
.++..++.. ... . +.+++|+-+. +||.+++.. .... .+.......+..|++..+++|
T Consensus 83 r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~L 161 (288)
T PF14531_consen 83 RFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANL 161 (288)
T ss_dssp -B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHH
Confidence 222222221 111 1 2367788774 888887542 2111 122233344568999999999
Q ss_pred HHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC
Q 014344 145 HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR 224 (426)
Q Consensus 145 H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (426)
|..|++|+||||+|++++.+|.++|+||+.........
T Consensus 162 h~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~------------------------------------------ 199 (288)
T PF14531_consen 162 HSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY------------------------------------------ 199 (288)
T ss_dssp HHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE------------------------------------------
T ss_pred hhcceEecccceeeEEEcCCCCEEEcChHHHeecCcee------------------------------------------
Confidence 99999999999999999999999999998776543110
Q ss_pred CCCCCCCCCCCCCCCCccccccCCCCccchhhcCC--------CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 014344 225 IGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK--------GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI 296 (426)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 296 (426)
.....+..|.+||..... .++++.|.|+||+++|.|++|+.||...........
T Consensus 200 -----------------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~- 261 (288)
T PF14531_consen 200 -----------------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW- 261 (288)
T ss_dssp -----------------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-
T ss_pred -----------------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-
Confidence 001245668999987542 468999999999999999999999986654322111
Q ss_pred hcCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 297 LCRPPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 297 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
....+.+.|..+++||++||++||.+|
T Consensus 262 --~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred --cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 122344668999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=194.80 Aligned_cols=152 Identities=15% Similarity=0.228 Sum_probs=112.2
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-hcc----------cCCCch--hhHHHHHHHHHHHhcCCCC
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-ELT----------NNDNGD--KYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-~~~----------~~~~~~--~~~~~~~E~~il~~l~hp~ 87 (426)
...||+|++|.||+|.+. +|+.||||++.......... ... ...... .......|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 89999999997653221110 000 000000 0123456999999998887
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCCeeeccCCc
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYL-HNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~L-H~~giiHrDlKp~NiLl~~~g~ 166 (426)
+........ .. .++||||++|+++...... ...++...+..++.|++.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 754333222 22 3899999998877654322 24589999999999999999999 799999999999999998 588
Q ss_pred EEEecccccccC
Q 014344 167 IMLVDFDLSTKL 178 (426)
Q Consensus 167 ikL~DFgls~~~ 178 (426)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=204.91 Aligned_cols=269 Identities=20% Similarity=0.290 Sum_probs=181.2
Q ss_pred CCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCC-----------------------------------ceEEEEEeeh
Q 014344 7 DRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESS-----------------------------------ESFALKVIWR 51 (426)
Q Consensus 7 ~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----------------------------------~~vAiK~~~~ 51 (426)
++.-..+.+++|+|+.-||+|....||.|+-...| -+.|||.|..
T Consensus 148 ~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN 227 (598)
T KOG4158|consen 148 NRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN 227 (598)
T ss_pred chhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc
Confidence 34455678899999999999999999999754311 1256676632
Q ss_pred hhHHhhhhhcccCCCchhhHHHHHH------------H-----HHHH-----hcCCCCcceeeeeeec------------
Q 014344 52 DLIEKKSKELTNNDNGDKYRRISFE------------Q-----RVLR-----NVEHPLLPRLRGVLST------------ 97 (426)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~~~E------------~-----~il~-----~l~hp~iv~l~~~~~~------------ 97 (426)
-..... ....++...+| . +.+. ..+|||||+++.+|.+
T Consensus 228 ~~~~s~--------~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~Y 299 (598)
T KOG4158|consen 228 FEHDSG--------DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERY 299 (598)
T ss_pred cccCCc--------hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhC
Confidence 111100 00011111111 0 0111 1369999999998844
Q ss_pred ---------------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec
Q 014344 98 ---------------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 98 ---------------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~ 162 (426)
...+|+||.-+. .+|..|+-.+. .+....+.++.|+++|+.|||++||.|||+|.+|||+.
T Consensus 300 Pdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~E 375 (598)
T KOG4158|consen 300 PDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLE 375 (598)
T ss_pred cccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEE
Confidence 346899999885 78888876543 67788889999999999999999999999999999995
Q ss_pred --cCC--cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 163 --ENG--HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 163 --~~g--~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
.|+ .+.|+|||.|-...... .+..+.+.
T Consensus 376 lddD~~P~LVvaDFGCcLAd~~hG------------------lqlpy~S~------------------------------ 407 (598)
T KOG4158|consen 376 LDDDEIPQLVVADFGCCLADDNHG------------------LQLPYESD------------------------------ 407 (598)
T ss_pred ecCCCCcEEEEcccceeeeccccc------------------cccccccc------------------------------
Confidence 333 58999999875432111 00000000
Q ss_pred CCccccccCCCCccchhhcCCCC------ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCCCCCCCHH
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKGH------DFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---YRILCRPPDLVGEPTP 309 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~ 309 (426)
.-..-|.-..||||+....+- -.++|.|+.|.+.||++...-||.+......- ++--..|+....+++.
T Consensus 408 --~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 408 --EVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPV 485 (598)
T ss_pred --cccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChH
Confidence 011126777899999865331 14899999999999999999999875432211 2222345555567899
Q ss_pred HHHHHHHHhccCCCCCCCh---HHHhcCCCc
Q 014344 310 LRNLIRRLLEKDPTKRIGV---EEIKGHEFF 337 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~---~eil~hp~f 337 (426)
+++++..+|+.||++|+++ ..+|+--.|
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 9999999999999999994 455544333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=226.53 Aligned_cols=245 Identities=24% Similarity=0.264 Sum_probs=179.1
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|...+.||++.|=+|.+|++.. | .|+|||+-+....- .-..+.+-..|++ ...+++||++.+.-+..
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~---------sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~ 91 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTI---------SLRPFKQRLEEIK-FALMKAPNCLPFQKVLV 91 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCC---------CchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence 68899999999999999999754 3 59999996543110 1112333334555 66678999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+++..|||-+|.. .+|++-+..+ ..+..-+.+.|+.||+.||..+|..||+|||||.|||||++-..+.|+||..-+
T Consensus 92 t~kAAylvRqyvk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 92 TDKAAYLVRQYVK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred hhHHHHHHHHHHh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 9999999999995 7888866543 337888899999999999999999999999999999999999999999998765
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...-.. .++ ++.+.. ..+...-.+|.|||.+
T Consensus 169 PtYLPe----------DNP--------------adf~fF-------------------------FDTSrRRtCYiAPERF 199 (1431)
T KOG1240|consen 169 PTYLPE----------DNP--------------ADFTFF-------------------------FDTSRRRTCYIAPERF 199 (1431)
T ss_pred CccCCC----------CCc--------------ccceEE-------------------------EecCCceeeecChHhh
Confidence 332110 000 000000 0011123469999987
Q ss_pred cCCC-----------CChhhHHHHHHHHHHHHHh-CCCCCCCC-----------CHHHHHHHHhcCCCCCCCCCHHHHHH
Q 014344 257 EGKG-----------HDFAVDWWSLGVVLHEMLY-GATPFRGS-----------SRKETFYRILCRPPDLVGEPTPLRNL 313 (426)
Q Consensus 257 ~~~~-----------~~~~~DiwSlG~il~ell~-g~~pf~~~-----------~~~~~~~~i~~~~~~~~~~~~~~~~l 313 (426)
.... .+.+.||||+||+++||++ |++||.-. +....+.+| ....+++|
T Consensus 200 v~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I---------ed~~~Rnl 270 (1431)
T KOG1240|consen 200 VSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI---------EDVSLRNL 270 (1431)
T ss_pred hccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC---------cCccHHHH
Confidence 5422 4678999999999999986 89999421 111111111 13468999
Q ss_pred HHHHhccCCCCCCChHHHhcC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~h 334 (426)
|..|++.||++|.+|++.|+.
T Consensus 271 il~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 271 ILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHccCchhccCHHHHHHh
Confidence 999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=188.98 Aligned_cols=155 Identities=16% Similarity=0.227 Sum_probs=114.7
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhh-hhc-c------c---CCCc--hhhHHHHHHHHHHHhcCCC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS-KEL-T------N---NDNG--DKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~-~~~-~------~---~~~~--~~~~~~~~E~~il~~l~hp 86 (426)
|+..||+|++|.||+|.+. +|+.||||++......... ... . . ..+. ........|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 4578999999999999987 8999999999765321100 000 0 0 0000 0122346799999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCC
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g 165 (426)
++.....+.... .|+||||++|+++...... ...++...+..++.|++.+|.+||+ .||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 885544443332 4899999998865433222 2347889999999999999999999 9999999999999998 89
Q ss_pred cEEEecccccccCCC
Q 014344 166 HIMLVDFDLSTKLSP 180 (426)
Q Consensus 166 ~ikL~DFgls~~~~~ 180 (426)
.++|+|||++..+..
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=179.46 Aligned_cols=204 Identities=18% Similarity=0.204 Sum_probs=141.4
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLS 96 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~ 96 (426)
..+...|++|+||+|+++.. .+..++.+.+.....-. .......+.+|+++|++|. |++++.++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~---------~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-- 70 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWL---------RGVAWWLARREALALRQLDGLPRTPRLLHW-- 70 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhh---------hhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--
Confidence 34678999999999998875 67777777663221100 0012236788999999996 5889999886
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCCeeeccCCcEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDL-KPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDl-Kp~NiLl~~~g~ikL~DFgls 175 (426)
...|++|||+.|.+|..... .. ...++.|++.+|+++|++||+|||| ||+|||++.+|.++|+|||++
T Consensus 71 --~~~~lvmeyI~G~~L~~~~~--------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 71 --DGRHLDRSYLAGAAMYQRPP--------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred --cCEEEEEeeecCccHHhhhh--------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 34699999999999864321 11 1346789999999999999999999 799999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
.......... ..+. ...+..... . ....++.|++|+.
T Consensus 140 ~~~~~~~~~~---r~L~---~rDl~~llk------------------------------------~-~~~y~~~~l~~~~ 176 (218)
T PRK12274 140 VRGNPRARWM---RLLA---REDLRHLLK------------------------------------H-KRMYCPAALTPVE 176 (218)
T ss_pred eecCCcchHH---HHHH---HHHHHHHHH------------------------------------H-HHhcCCCCCCHHH
Confidence 8554221000 0000 000000000 0 1125778899986
Q ss_pred hcCC-CCC-hhhHHHHHHHHHHHHHhCCCCCCCCC
Q 014344 256 IEGK-GHD-FAVDWWSLGVVLHEMLYGATPFRGSS 288 (426)
Q Consensus 256 ~~~~-~~~-~~~DiwSlG~il~ell~g~~pf~~~~ 288 (426)
.... ..+ .+.++++.|+-+|.++|++.|+-+.+
T Consensus 177 ~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 177 RRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 5432 233 57899999999999999998875443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=179.96 Aligned_cols=137 Identities=23% Similarity=0.330 Sum_probs=107.1
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-----CCCCcceeeeee
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-----EHPLLPRLRGVL 95 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~l~~~~ 95 (426)
.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ +||||+++++++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~-------------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~ 70 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD-------------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTV 70 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc-------------chHHHHHHHHHHHHHhhccCCCCcccceeeEEE
Confidence 46799999999995 6666665 6998844211 1235688899999999 679999999999
Q ss_pred ecCC---eEE-EEEec--cCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCCeeecc----C
Q 014344 96 STDK---FVG-YAIDY--CPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL-EYLHNMGIVYRDLKPENIMIQE----N 164 (426)
Q Consensus 96 ~~~~---~~~-lV~Ey--~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL-~~LH~~giiHrDlKp~NiLl~~----~ 164 (426)
+++. .++ +|||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+|||++. +
T Consensus 71 et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 71 ETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred EeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCC
Confidence 8874 434 78999 5579999998652 26666 35678888888 9999999999999999999974 3
Q ss_pred CcEEEecccccccC
Q 014344 165 GHIMLVDFDLSTKL 178 (426)
Q Consensus 165 g~ikL~DFgls~~~ 178 (426)
+.++|+||+-+..+
T Consensus 146 ~~~~LiDg~G~~~~ 159 (210)
T PRK10345 146 VIPVVCDNIGESTF 159 (210)
T ss_pred CcEEEEECCCCcce
Confidence 47999994444443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-22 Score=179.67 Aligned_cols=247 Identities=20% Similarity=0.284 Sum_probs=196.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+++++..++.+|...-.|..|+++.. |.-++.|++.-..... ...+.|..|.--|+.+.||||+
T Consensus 184 ~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-----------risrdfneefp~lrifshpnil 250 (448)
T KOG0195|consen 184 YTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-----------RISRDFNEEFPALRIFSHPNIL 250 (448)
T ss_pred ccCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-----------hhcchhhhhCcceeeecCCchh
Confidence 44577788889999999999999999864 4456677764332211 2345677788889999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCccc-CCCCCCeeeccCCcE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYR-DLKPENIMIQENGHI 167 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHr-DlKp~NiLl~~~g~i 167 (426)
.+++.+..+..+.++..||+-|+|+.+++.+..-..+..++.+++.+|+.|+.|||+. .++-| -|....+++|++-+.
T Consensus 251 pvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedlta 330 (448)
T KOG0195|consen 251 PVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTA 330 (448)
T ss_pred hhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhh
Confidence 9999999999999999999999999999988777788899999999999999999997 34443 588889999988654
Q ss_pred EE--ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 168 ML--VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 168 kL--~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
+| +|--++-+.. ...
T Consensus 331 rismad~kfsfqe~---------------------------------------------------------------gr~ 347 (448)
T KOG0195|consen 331 RISMADTKFSFQEV---------------------------------------------------------------GRA 347 (448)
T ss_pred heecccceeeeecc---------------------------------------------------------------ccc
Confidence 44 4433222110 011
Q ss_pred cCCCCccchhhcCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhc
Q 014344 246 GTEEYVAPEIIEGKGHD---FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~ 319 (426)
=.|.||+||.++..+-+ .++|+|||++++|||.|...||...++.+.-.+|.- +...+++.+.....|+.-|+.
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~icmn 427 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMN 427 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhc
Confidence 35789999999887654 589999999999999999999999999988777742 233456778889999999999
Q ss_pred cCCCCCCChHHHh
Q 014344 320 KDPTKRIGVEEIK 332 (426)
Q Consensus 320 ~dP~~R~s~~eil 332 (426)
.||.+||.++.|+
T Consensus 428 edpgkrpkfdmiv 440 (448)
T KOG0195|consen 428 EDPGKRPKFDMIV 440 (448)
T ss_pred CCCCcCCCcceeh
Confidence 9999999988764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=205.94 Aligned_cols=198 Identities=21% Similarity=0.364 Sum_probs=158.5
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLL 88 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~i 88 (426)
++....|.|-+.||.|+||+||+|.+.. |+.||||+=.... ..++.--.+++.+|+ -+.|
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~----------------~WEfYI~~q~~~RLk~~~~~~~ 756 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN----------------PWEFYICLQVMERLKPQMLPSI 756 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC----------------ceeeeehHHHHHhhchhhhcch
Confidence 4556789999999999999999999866 9999999853221 112222233455554 2456
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-----
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE----- 163 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~----- 163 (426)
..+..++.-.+.-++|+||.+.|+|.+++. ..+.+++..+.+++.|++..++.||..+|||+||||+|+||..
T Consensus 757 ~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 757 MHISSAHVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred HHHHHHHccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCC
Confidence 666666666777889999999999999987 4566999999999999999999999999999999999999963
Q ss_pred --CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 164 --NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 164 --~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
.--++|+|||-+..+.... ...+.
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp------------------------------------------------------~~~~F 860 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFP------------------------------------------------------DGTKF 860 (974)
T ss_pred CcccceEEEecccceeeeEcC------------------------------------------------------CCcEE
Confidence 2359999999987664221 11245
Q ss_pred cccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCC
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGAT 282 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 282 (426)
...++|-.+-.+|+..|.++++.+|.|.|+.+++-||.|++
T Consensus 861 ~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 861 KAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 55678888999999999999999999999999999999964
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=178.50 Aligned_cols=156 Identities=17% Similarity=0.188 Sum_probs=116.0
Q ss_pred CcEEEeeecccCceEEEEEE-EcCCCceEEEEEeehhhHHhhhhh--c--c-----cCCCc--hhhHHHHHHHHHHHhcC
Q 014344 17 CLRIVSALGRGAKGVVFLVK-DVESSESFALKVIWRDLIEKKSKE--L--T-----NNDNG--DKYRRISFEQRVLRNVE 84 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~-~~~~~~~vAiK~~~~~~~~~~~~~--~--~-----~~~~~--~~~~~~~~E~~il~~l~ 84 (426)
-|++.+.||+|++|.||+|. +..+|+.||||++........... . . ..... .....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 678999999999975432111000 0 0 00000 01234678999999997
Q ss_pred CC--CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCCeee
Q 014344 85 HP--LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG-IVYRDLKPENIMI 161 (426)
Q Consensus 85 hp--~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g-iiHrDlKp~NiLl 161 (426)
+. .++++++. . ..++||||+.|.+|..+... ...+....+..++.||+.+|.+||+.| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 53 34455442 2 34899999999888765322 233667778899999999999999999 9999999999999
Q ss_pred ccCCcEEEecccccccCC
Q 014344 162 QENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~ 179 (426)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999988654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-22 Score=206.09 Aligned_cols=295 Identities=30% Similarity=0.444 Sum_probs=222.1
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..+.+.+.+-+-+|+++.++.+.-..+|...++|+..+...... ..++.+..+-.++-...+|.++....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~----------~~~~s~r~~s~~~i~p~~P~v~~~~~ 871 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT----------NDYESIRSKSNILITPRSPAVVRSFP 871 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhcc----------ccccccCCccCccccCCCCceecccC
Confidence 56778899999999999999999888888888887644322111 12233333444444445677777766
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
.|......+++++|+.|++|.+.++... ..+.+.++.++..+..+++|||...+.|||++|.|+|...+|+.+++|||
T Consensus 872 s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 872 SFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccc
Confidence 6667788999999999999999877654 47888999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC-CCCCCCCCC-CCCCCCCccccccCCCCc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR-IGPDPPSRS-DSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~gt~~y~ 251 (426)
.......-.+.....+. .+- ..++ ......... .....++....+||+.|.
T Consensus 950 t~~~vg~~~p~~~~sg~--------------------~~~-------~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~l 1002 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGP--------------------SSS-------GTPRRLSRSERRPQLSADEARRKHAVVGTPDYL 1002 (1205)
T ss_pred cccccccccCcCCcccc--------------------ccc-------CccccccccccccccccchhhccccccCCCccc
Confidence 65544321111110000 000 0000 000000000 011224456778999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHHHhccCCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~s 327 (426)
|||...+..++..+|||++|++++|.++|.+||........+..|+.....++ ..++...+++.++|..+|.+|..
T Consensus 1003 aPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1003 APEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred CCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence 99999999999999999999999999999999999999999999886654444 33677899999999999999999
Q ss_pred hH---HHhcCCCcCCCChhhhhh
Q 014344 328 VE---EIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 328 ~~---eil~hp~f~~~~~~~~~~ 347 (426)
+. ++..||||++++|+.+..
T Consensus 1083 a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1083 AKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred cccccccccCCccCCCCcccccc
Confidence 87 999999999999999843
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-22 Score=206.33 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=206.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLR 92 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~ 92 (426)
...|++.+.||+|+|+.|-++.... +...+|.|.+.... ........+..|..+-+.+. |+|++.++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-----------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~ 87 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-----------KSEDSSEHIDTETDIQKKLSKHSNTVHMI 87 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-----------CccchhhhcCccccccccccccccccccC
Confidence 5679999999999999999887643 34457777664322 12233445566777777787 99999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeeeccCC-cEEEe
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENG-HIMLV 170 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp~NiLl~~~g-~ikL~ 170 (426)
+.....+..+++++|..|+++++-+........+...+.+++.|+..+|.|+| ..++.||||||+|.+++..+ .++++
T Consensus 88 ~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~ 167 (601)
T KOG0590|consen 88 EPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIA 167 (601)
T ss_pred CccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCC
Confidence 99999999999999999999998763222224788889999999999999999 99999999999999999999 99999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc-CCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG-TEE 249 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~ 249 (426)
|||+|..+.... .........+| ++.
T Consensus 168 df~~At~~~~~~-----------------------------------------------------g~~~~~~~~~g~s~~ 194 (601)
T KOG0590|consen 168 DFGLATAYRNKN-----------------------------------------------------GAERSLKDRCGSSPP 194 (601)
T ss_pred CchhhccccccC-----------------------------------------------------CcceeeecccCCCCC
Confidence 999998875411 11223445568 999
Q ss_pred CccchhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cC-----CCCCCCCCHHHHHHHHHHhccCC
Q 014344 250 YVAPEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CR-----PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 250 y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~-----~~~~~~~~~~~~~li~~~L~~dP 322 (426)
|+|||...+.. .....|+||+|+++..+++|..||.........+.-. .. ...+...+....+++.++|..+|
T Consensus 195 y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~ 274 (601)
T KOG0590|consen 195 YGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENP 274 (601)
T ss_pred CCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCc
Confidence 99999998854 4688999999999999999999998776554322111 11 22233456778899999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
..|.+.+++..+||+..
T Consensus 275 ~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 275 SNRLSIEELKLDNWLSS 291 (601)
T ss_pred hhccccccccccccccc
Confidence 99999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=165.68 Aligned_cols=144 Identities=19% Similarity=0.216 Sum_probs=115.0
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCe
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~ 100 (426)
++.||+|++|.||+|.. .+..+++|+........... .......++.+|+.++..+.|++++....++.....
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPEL-----DERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHH-----HHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence 36799999999999986 67889999864321110000 000123467789999999999998877777777788
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
.+++|||++|++|.+++.... . ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++...
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 899999999999999875421 2 7788899999999999999999999999999999 889999999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=187.74 Aligned_cols=186 Identities=25% Similarity=0.401 Sum_probs=139.0
Q ss_pred CCeEEEEEeccCCCChHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQ-SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~-~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
..++||.|++|.-.+|.+++.+. .....+......++.|+..|++| +|.+|||+||.||++..+..+||.|||+..
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence 34689999999999999998743 33346778888999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
......+.. ....+.+..+||..||+||.+
T Consensus 405 s~~~~~~~~--------------------------------------------------~~~a~~t~~~gt~~YmsPEQi 434 (516)
T KOG1033|consen 405 SQDKDETVA--------------------------------------------------PAAASHTQQVGTLLYMSPEQI 434 (516)
T ss_pred ecccCCccc--------------------------------------------------chhhhhhhcccccccCCHHHH
Confidence 764322110 011234455799999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
.+..|+.++||||||+||+|++. -..+|........+.. -.-|+.+....+.-.+|+..||...|.+||++.+.--|+
T Consensus 435 ~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~-g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~ 513 (516)
T KOG1033|consen 435 RGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRD-GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHE 513 (516)
T ss_pred hhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhc-CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence 99999999999999999999996 3333322111111111 111222333334456999999999999999887777777
Q ss_pred Cc
Q 014344 336 FF 337 (426)
Q Consensus 336 ~f 337 (426)
|.
T Consensus 514 ~~ 515 (516)
T KOG1033|consen 514 FL 515 (516)
T ss_pred hc
Confidence 64
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=163.01 Aligned_cols=139 Identities=19% Similarity=0.236 Sum_probs=107.0
Q ss_pred eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeEE
Q 014344 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVG 102 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~ 102 (426)
.||+|++|+||++. .++..+++|+.......... ........++.+|+++++.+.|+++....-++......+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPE-----LDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCch-----HHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence 38999999999998 46788999986432110000 000112356788999999999887655554555666779
Q ss_pred EEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 103 YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 103 lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
+||||++|++|.+++..... .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999999999987653210 6788999999999999999999999999999 899999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=162.54 Aligned_cols=150 Identities=17% Similarity=0.169 Sum_probs=111.2
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-----hcccCCC----chhhHHHHHHHHHHHhcCCC--
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-----ELTNNDN----GDKYRRISFEQRVLRNVEHP-- 86 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-----~~~~~~~----~~~~~~~~~E~~il~~l~hp-- 86 (426)
|.+.+.||.|+||.||++... +|+.||||++.......... ....... .........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999874 79999999976532100000 0000000 01122467789999999877
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
.++..++ ....++||||++|++|..+.. ...+..++.+++.++.++|+.||+||||||+||+++.++.
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4445443 245589999999999876532 1345678889999999999999999999999999999999
Q ss_pred EEEecccccccCCC
Q 014344 167 IMLVDFDLSTKLSP 180 (426)
Q Consensus 167 ikL~DFgls~~~~~ 180 (426)
++|+|||++..+..
T Consensus 164 ~~liDfg~~~~~~~ 177 (198)
T cd05144 164 IYIIDWPQMVSTDH 177 (198)
T ss_pred EEEEECCccccCCC
Confidence 99999999977643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.5e-19 Score=181.44 Aligned_cols=143 Identities=18% Similarity=0.184 Sum_probs=111.9
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|...+.||+|+||+||++... +..+++|+.......... ........++.+|+++++.++|++++....+...
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPE-----LDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cCccceeccCCcEEEEEEeec--CccceeEEEecccccchh-----HHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 456789999999999998864 344555543221111100 0011234578889999999999999888777777
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
....++||||++|++|.+++. ....++.|++.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 778899999999999998765 245688999999999999999999999999999 678999999999987
Q ss_pred C
Q 014344 178 L 178 (426)
Q Consensus 178 ~ 178 (426)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 5
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=154.25 Aligned_cols=151 Identities=16% Similarity=0.217 Sum_probs=103.6
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhc-------ccCCC----chhhHHHHHHHHHHHhcCCC--
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL-------TNNDN----GDKYRRISFEQRVLRNVEHP-- 86 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~E~~il~~l~hp-- 86 (426)
+++.||+|+||+||+|.+. +++.||||++............ ..... .........|...+..+.+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 8999999998653221110000 00000 00011224567777777544
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHH-HHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccC
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~-l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~ 164 (426)
.+++++++ ...++||||++|+++.. .+.... . ...++.++.+++.++.++|. .||+||||||+||+++ +
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 35555543 23589999999855431 111111 1 16678899999999999999 9999999999999999 9
Q ss_pred CcEEEecccccccCCC
Q 014344 165 GHIMLVDFDLSTKLSP 180 (426)
Q Consensus 165 g~ikL~DFgls~~~~~ 180 (426)
+.++|+|||++.....
T Consensus 151 ~~~~liDfg~a~~~~~ 166 (187)
T cd05119 151 GKVYIIDVPQAVEIDH 166 (187)
T ss_pred CcEEEEECcccccccC
Confidence 9999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=156.72 Aligned_cols=148 Identities=22% Similarity=0.298 Sum_probs=108.1
Q ss_pred eeec-ccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc--ceeeeeeecC
Q 014344 22 SALG-RGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL--PRLRGVLSTD 98 (426)
Q Consensus 22 ~~LG-~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i--v~l~~~~~~~ 98 (426)
..|| .|+.|+||.+.. .+..++||.+.+..+..+..............++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5677 888899998876 3788999988653321111000000111234678889999999998775 6677664332
Q ss_pred -CeE---EEEEeccCC-CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 99 -KFV---GYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 99 -~~~---~lV~Ey~~g-g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
... ++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 222 599999997 689887653 2355543 5689999999999999999999999999999999999999
Q ss_pred ccccC
Q 014344 174 LSTKL 178 (426)
Q Consensus 174 ls~~~ 178 (426)
.+...
T Consensus 188 ~~~~~ 192 (239)
T PRK01723 188 RGELR 192 (239)
T ss_pred CcccC
Confidence 98765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.5e-18 Score=167.21 Aligned_cols=199 Identities=24% Similarity=0.360 Sum_probs=152.4
Q ss_pred HHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCCC
Q 014344 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGI-VYRDLKPEN 158 (426)
Q Consensus 80 l~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~gi-iHrDlKp~N 158 (426)
|+.+.|.|+.++++...++...+.|.+||..|+|.+.+... ...++.--...++++|+.||.|||...| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45688999999999999999999999999999999998763 3447777888899999999999998755 999999999
Q ss_pred eeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 159 iLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
.+++....+||+|||+...........
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~----------------------------------------------------- 106 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPE----------------------------------------------------- 106 (484)
T ss_pred ceeeeeEEEEechhhhccccccccccc-----------------------------------------------------
Confidence 999999999999999987653200000
Q ss_pred CCccccccCCCCccchhhcCCC-------CChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhc-CC----CC
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKG-------HDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILC-RP----PD 302 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~-~~----~~ 302 (426)
......-...|.|||.+.+.. .+.+.|+||+|++++|+++...||.... ..+...++.. .. |.
T Consensus 107 -~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~ 185 (484)
T KOG1023|consen 107 -AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPS 185 (484)
T ss_pred -ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcc
Confidence 000001233589999998742 3567999999999999999999997632 2344444433 11 11
Q ss_pred CC---CCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 303 LV---GEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 303 ~~---~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.. ..++.+..+++.||..+|..||+++.+..
T Consensus 186 i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 186 IELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred hhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 11 23456889999999999999999988753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=136.02 Aligned_cols=134 Identities=19% Similarity=0.273 Sum_probs=112.0
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--CCcceeeeeeec
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--PLLPRLRGVLST 97 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~ 97 (426)
+++.||.|.++.||++.... ..+++|+...... ...+..|+.+++.+.| +++++++.++..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---------------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~ 64 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK---------------GADREREVAILQLLARKGLPVPKVLASGES 64 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc---------------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence 56889999999999999744 7899998733210 2457779999999976 599999999888
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCCeeeccCCcEEEecccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM---GIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~---giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.+..+++|||+.|+.+..+ +......++.+++.+|.+||.. +++|||++|+|||++..+.++++|||.
T Consensus 65 ~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~ 135 (155)
T cd05120 65 DGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY 135 (155)
T ss_pred CCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence 8899999999998877654 4455667788999999999985 799999999999999989999999999
Q ss_pred cccCC
Q 014344 175 STKLS 179 (426)
Q Consensus 175 s~~~~ 179 (426)
+....
T Consensus 136 ~~~~~ 140 (155)
T cd05120 136 AGYGP 140 (155)
T ss_pred ccCCC
Confidence 87643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-17 Score=162.98 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=200.3
Q ss_pred CCCCCCCCCcEEEeeecc--cCceEEEEEEE--cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 9 PIRSLDFSCLRIVSALGR--GAKGVVFLVKD--VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~--G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
+.-.+.-..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-..-. ..+..-.+-.+|....++++
T Consensus 107 ~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-----------s~p~~~~~k~~~~~s~~~i~ 175 (524)
T KOG0601|consen 107 PFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-----------SPPLDSKRKLREFLSHHKID 175 (524)
T ss_pred CccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-----------CCccccccccchhhcccccC
Confidence 334455556889999999 99999999999 8899999999732111 00111122333555566665
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHH----HHHHHHHCCCcccCCCCCCe
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL----ALEYLHNMGIVYRDLKPENI 159 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~----aL~~LH~~giiHrDlKp~Ni 159 (426)
|++.++.+..++..+.+|+-+|+| |.+|.++.... ...+++..++.++.+... ||.++|+.+++|-|+||+||
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANI 253 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhe
Confidence 899999999999999999999999 48888776543 344889999999999999 99999999999999999999
Q ss_pred eeccC-CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQEN-GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 160 Ll~~~-g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
++..+ ...+++|||+...+....-... .
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~---------------------------------------------------~ 282 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSV---------------------------------------------------F 282 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccc---------------------------------------------------e
Confidence 99999 7899999999988764321000 0
Q ss_pred CCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 014344 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS--SRKETFYRILCRPPDLVGEPTPLRNLIRR 316 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~li~~ 316 (426)
.....--|...|++||+..+. +++..|++|+|.+..+..++..+.... +....+.+.......+.+.+..+...+..
T Consensus 283 ~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~ 361 (524)
T KOG0601|consen 283 KVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQ 361 (524)
T ss_pred eeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHH
Confidence 001111366779999998765 688999999999999999887766544 33333333332222333456667779999
Q ss_pred HhccCCCCCCChHHHhcCCCcCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
|+..+|..|++++.+++|++...
T Consensus 362 ~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 362 MLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHHhccccccc
Confidence 99999999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-15 Score=154.28 Aligned_cols=158 Identities=11% Similarity=0.177 Sum_probs=100.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhh-----------------hhcccCCCc----hhhHH-
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS-----------------KELTNNDNG----DKYRR- 72 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~-----------------~~~~~~~~~----~~~~~- 72 (426)
+.+|.. +.||+|++|.||.|+.+.+|+.||||+..+.....-. ......... +..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 7899999999999999888999999999754321100 000000000 11222
Q ss_pred -----HHHHHHHHHhcC----CCCcceeeeeee-cCCeEEEEEeccCCCChHHHHHHhccC----CCCHHHHHHHHHHHH
Q 014344 73 -----ISFEQRVLRNVE----HPLLPRLRGVLS-TDKFVGYAIDYCPGRDLHSLRKQQSEQ----MFSDDTIRFYAAELV 138 (426)
Q Consensus 73 -----~~~E~~il~~l~----hp~iv~l~~~~~-~~~~~~lV~Ey~~gg~L~~l~~~~~~~----~l~~~~~~~~~~qil 138 (426)
+..|...+.++. +...+.+-.++. -....++||||++|+.+.++..-...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 333444444432 332233333332 244567999999999998753211111 244555555665554
Q ss_pred HHHHHHHHCCCcccCCCCCCeeeccCC----cEEEecccccccCCC
Q 014344 139 LALEYLHNMGIVYRDLKPENIMIQENG----HIMLVDFDLSTKLSP 180 (426)
Q Consensus 139 ~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~DFgls~~~~~ 180 (426)
..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999888 999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=1e-14 Score=145.77 Aligned_cols=152 Identities=16% Similarity=0.237 Sum_probs=100.4
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhc-------------cc----CCCchh----hH------HHH
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL-------------TN----NDNGDK----YR------RIS 74 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~-------------~~----~~~~~~----~~------~~~ 74 (426)
+.||+|++|.||+|+. .+|+.||||+........-...+ .. ...... .. .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999987 47899999998654211110000 00 000000 01 255
Q ss_pred HHHHHHHhcC-----CCCc--ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHH-HHHHHHH
Q 014344 75 FEQRVLRNVE-----HPLL--PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL-ALEYLHN 146 (426)
Q Consensus 75 ~E~~il~~l~-----hp~i--v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~-aL~~LH~ 146 (426)
.|...+.++. ++++ ++++. ...+..++||||++|++|.++......+ .. ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG-LD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC-CC---HHHHHHHHHHHHHHHHHh
Confidence 5666666652 3332 33332 2234568999999999998875532211 22 2334555555 4788999
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
.|++|+|+||.||+++.+|.++|+|||++..+.+
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999988753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.9e-14 Score=123.67 Aligned_cols=151 Identities=15% Similarity=0.214 Sum_probs=105.6
Q ss_pred EeeecccCceEEEEEEEcC------CCceEEEEEeehhhHH--hhhhhcccCC-------CchhhHH----HHHHHHHHH
Q 014344 21 VSALGRGAKGVVFLVKDVE------SSESFALKVIWRDLIE--KKSKELTNND-------NGDKYRR----ISFEQRVLR 81 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~--~~~~~~~~~~-------~~~~~~~----~~~E~~il~ 81 (426)
...||.|--+.||.|.... .+..+|||+..-.... .......... .....+. ...|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 3579999998643221 1111110000 0111223 337999999
Q ss_pred hcCC--CCcceeeeeeecCCeEEEEEeccCCCChHH-HHHHhccCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCC
Q 014344 82 NVEH--PLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLALEYL-HNMGIVYRDLKPE 157 (426)
Q Consensus 82 ~l~h--p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~-l~~~~~~~~l~~~~~~~~~~qil~aL~~L-H~~giiHrDlKp~ 157 (426)
++.. -.++.++++ ..-++||||+.+..+.. .++. ..+++..+..+..|++.+|..| |+.|||||||++.
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9963 567777764 45679999997654432 2221 2356667778889999999999 8999999999999
Q ss_pred CeeeccCCcEEEecccccccCC
Q 014344 158 NIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 158 NiLl~~~g~ikL~DFgls~~~~ 179 (426)
|||++ ++.+.|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 5789999999887663
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=144.10 Aligned_cols=253 Identities=23% Similarity=0.234 Sum_probs=187.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPL 87 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~ 87 (426)
...-...+|..+..||.|.|+.|+.+... .++..|++|...+....... ...-..|+.+...+. |.+
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~-----------di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS-----------DIFSLGEVILEAILGSHLP 327 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh-----------hhcchhhhhHhhHhhcccc
Confidence 35566788999999999999999998865 67888999987554332221 112233666666664 899
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-Cc
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-GH 166 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g~ 166 (426)
++.++..|......|+-.|||.++++..-+ ....++.+...+.+..|++.++.++|++.++|+|+||.||++..+ +.
T Consensus 328 ~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred cCCCCCCccccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhh
Confidence 999999888888888999999999887544 233568899999999999999999999999999999999999986 78
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
.++.|||..+.+.-.. ..+..
T Consensus 406 ~~~~~~~~~t~~~~~~-----------------------------------------------------------~~~~~ 426 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSS-----------------------------------------------------------GVFHH 426 (524)
T ss_pred hhccccccccccceec-----------------------------------------------------------ccccc
Confidence 8999999886532111 11112
Q ss_pred CCCCc--cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYV--APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~--aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+-.+. +|+......+..+.|++|||..+++.++|.+.-...... ..+. ...+...+....+..+...++..++.
T Consensus 427 ~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~ 503 (524)
T KOG0601|consen 427 IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTIRSGDTPNLPGLKLQLQVLLKVMINPDRK 503 (524)
T ss_pred cccccccchhhccccccccccccccccccccccccCcccCcccccc---eeeecccccCCCchHHhhhhhhhhhcCCccc
Confidence 22333 555566677889999999999999999986543222211 1222 12334444457788899999999999
Q ss_pred CCCChHHHhcCCCc
Q 014344 324 KRIGVEEIKGHEFF 337 (426)
Q Consensus 324 ~R~s~~eil~hp~f 337 (426)
.|+.+.++..|+=|
T Consensus 504 ~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 504 RRPSAVELSLHSEF 517 (524)
T ss_pred cchhhhhhcccchh
Confidence 99999999888644
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.4e-14 Score=130.45 Aligned_cols=209 Identities=19% Similarity=0.230 Sum_probs=147.8
Q ss_pred HHHHhcCCCCcceeeeeeecCC-----eEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC--C
Q 014344 78 RVLRNVEHPLLPRLRGVLSTDK-----FVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNM--G 148 (426)
Q Consensus 78 ~il~~l~hp~iv~l~~~~~~~~-----~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~--g 148 (426)
.-|-++.|.||++++.++.+.+ ...+++||+..|+|..++++.. ...+.....++|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 3456677999999999986654 4789999999999999876432 33588889999999999999999987 5
Q ss_pred CcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCC
Q 014344 149 IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPD 228 (426)
Q Consensus 149 iiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (426)
|+|+++..+-|++..+|-||+.--....... . . .++
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~-s-----------~-----------------~~~--------------- 234 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-S-----------V-----------------NST--------------- 234 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccch-h-----------h-----------------hhh---------------
Confidence 9999999999999999999885422111100 0 0 000
Q ss_pred CCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCC-CCCCH---HHHHHHHhcCCCCCC
Q 014344 229 PPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPF-RGSSR---KETFYRILCRPPDLV 304 (426)
Q Consensus 229 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~---~~~~~~i~~~~~~~~ 304 (426)
. ......-.|-+.|.|||.=.....+-++|||++|....+|..+..-- .+.+. .+...+......
T Consensus 235 -------~-~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le--- 303 (458)
T KOG1266|consen 235 -------R-EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE--- 303 (458)
T ss_pred -------h-HhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---
Confidence 0 00001112567799999877677788999999999999999876542 22221 122222221111
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
...-+++|++||+-.|..||++.+++.||-+=++.-.
T Consensus 304 --n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 304 --NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSL 340 (458)
T ss_pred --CccccCcCcccccCCCCCCcchhhhhcCceeeecchH
Confidence 1223689999999999999999999999987655443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=3.6e-13 Score=134.76 Aligned_cols=141 Identities=13% Similarity=0.158 Sum_probs=109.9
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|.+ ....-++.+..-.+..+.++.+|.+.+++...- .....+.+-++-|+.++||+|+++++.++.
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~-------------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~ 80 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG-------------EVTELAKRAVKRLKTLRHPNILSYLDTTEE 80 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCc-------------hhhHHHHHHHHHhhhccCchhhhhhhhhcc
Confidence 444 333333333332456678889999998844321 233445556788999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
++.+|+|+|-+ ..|..+++.. ....+..-+.||+.||.+|| +.+++|++|.-.-|+++..|..||++|.++.
T Consensus 81 ~~~~ylvTErV--~Pl~~~lk~l-----~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 81 EGTLYLVTERV--RPLETVLKEL-----GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred cCceEEEeecc--ccHHHHHHHh-----HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 99999999998 5777777754 36777788899999999998 6799999999999999999999999999886
Q ss_pred cCC
Q 014344 177 KLS 179 (426)
Q Consensus 177 ~~~ 179 (426)
...
T Consensus 154 ~~~ 156 (690)
T KOG1243|consen 154 KAS 156 (690)
T ss_pred ccc
Confidence 543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=119.42 Aligned_cols=128 Identities=16% Similarity=0.204 Sum_probs=96.2
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cceeeeeeecCC
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPRLRGVLSTDK 99 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~~ 99 (426)
++.|+.|.++.||+++.. ++.|++|+...... .......|+.+++.+.+.+ +++++.... .
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--------------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~ 64 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--------------LLINRENEAENSKLAAEAGIGPKLYYFDP--E 64 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--------------cccCHHHHHHHHHHHHHhCCCCceEEEeC--C
Confidence 467899999999999864 78899998733210 1123466889999886544 456666543 3
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCCeeeccCCcEEEecccc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGI-----VYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~gi-----iHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
..++||||++|.++... . .. ...++.+++.+|..||+.++ +|||++|.||+++ ++.++++|||.
T Consensus 65 ~~~lv~e~i~G~~l~~~------~-~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 65 TGVLITEFIEGSELLTE------D-FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCeEEEEecCCCccccc------c-cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 35799999999887643 0 11 13456789999999999985 9999999999999 67899999999
Q ss_pred ccc
Q 014344 175 STK 177 (426)
Q Consensus 175 s~~ 177 (426)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.7e-11 Score=101.44 Aligned_cols=152 Identities=20% Similarity=0.220 Sum_probs=110.0
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
.+..|-+|+-+.|+.+. ..|+.+.||.=.......... +..-..++..+|+++|.++.--.|.-..=+|.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~L-----D~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPAL-----DQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHH-----HHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 67788899999999887 578888888532221111100 01112467788999999987555554444556666
Q ss_pred eEEEEEeccCC-CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC---cEEEeccccc
Q 014344 100 FVGYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG---HIMLVDFDLS 175 (426)
Q Consensus 100 ~~~lV~Ey~~g-g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g---~ikL~DFgls 175 (426)
.-.|+|||++| .++.+++.........+.....++.+|=..+.-||..+|||+||..+||++..+| .+.|+|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 77899999987 4677777655444344445477888999999999999999999999999998766 3589999998
Q ss_pred ccC
Q 014344 176 TKL 178 (426)
Q Consensus 176 ~~~ 178 (426)
..-
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-10 Score=112.21 Aligned_cols=214 Identities=18% Similarity=0.228 Sum_probs=154.1
Q ss_pred CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec----CCeEEE
Q 014344 28 AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST----DKFVGY 103 (426)
Q Consensus 28 ~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~----~~~~~l 103 (426)
-..+.|+|....+|..|++|.+.-..... ......-+++++++.|+|||.+.++|.+ +..+++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-------------~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvl 354 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-------------TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVL 354 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC-------------cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEE
Confidence 45689999999999999999983322111 1123345788999999999999999973 557999
Q ss_pred EEeccCC-CChHHHHHHh-------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 104 AIDYCPG-RDLHSLRKQQ-------------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 104 V~Ey~~g-g~L~~l~~~~-------------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
|++|.++ ++|.++--.. .+...++..++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+|+|
T Consensus 355 vYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIri 434 (655)
T KOG3741|consen 355 VYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRI 434 (655)
T ss_pred EEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEE
Confidence 9999986 5666642111 1224788999999999999999999999999999999999999889999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
...|....+.... +
T Consensus 435 S~C~i~Dvl~~d~---------------------------------------------------------------~--- 448 (655)
T KOG3741|consen 435 SGCGIMDVLQEDP---------------------------------------------------------------T--- 448 (655)
T ss_pred ecccceeeecCCC---------------------------------------------------------------C---
Confidence 8887665442210 0
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKET-FYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+-+.+ -.+-|.=.||.++..|.+|+.- +......+. ...|. ...+.+++++|.-+...++.. -+
T Consensus 449 ----~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------~~yS~D~rn~v~yl~s~~~~~-ks 514 (655)
T KOG3741|consen 449 ----EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------TTYSTDLRNVVEYLESLNFRE-KS 514 (655)
T ss_pred ----cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------hhhhHHHHHHHHHHHhcCccc-cc
Confidence 11111 1356888999999999999643 222222222 22221 234678899999999888886 67
Q ss_pred hHHHhcC
Q 014344 328 VEEIKGH 334 (426)
Q Consensus 328 ~~eil~h 334 (426)
+.+++.|
T Consensus 515 I~~llp~ 521 (655)
T KOG3741|consen 515 IQDLLPM 521 (655)
T ss_pred HHHHHHH
Confidence 7777755
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.4e-11 Score=101.55 Aligned_cols=140 Identities=19% Similarity=0.188 Sum_probs=97.0
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCCeE
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~ 101 (426)
..+++|+-+.++.+.. -|..+.+|.=.+....... .+..-...+..+|.+++.++.--.|+...=++.+...-
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~-----LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPE-----LDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChH-----HHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence 3578999999998854 3445666643222111110 00011245677899999998755554444344566677
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
.|+|||++|-.|.+++... . ..++..+=.-+.-||..||||+||.+.||++..++ +.++||||+..-
T Consensus 75 ~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 7999999998888887654 1 23456666777889999999999999999997654 999999998753
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.9e-11 Score=107.96 Aligned_cols=141 Identities=20% Similarity=0.252 Sum_probs=104.1
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--CCcceeeeeeecC-
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--PLLPRLRGVLSTD- 98 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~~~~~- 98 (426)
+.||.|..+.||++... +|+.+++|+...... ......+..|..+++.+.+ ..+++++.+....
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~------------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~ 70 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL------------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS 70 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCccc------------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC
Confidence 67899999999999874 368999998743211 0123467789999999975 4467777776553
Q ss_pred --CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH------------------------------
Q 014344 99 --KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN------------------------------ 146 (426)
Q Consensus 99 --~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~------------------------------ 146 (426)
+..++||||++|.++...... ..+++.....++.+++.+|..||+
T Consensus 71 ~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (223)
T cd05154 71 VLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD 147 (223)
T ss_pred ccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence 367899999999888764321 225666666677777777777773
Q ss_pred --------------------------CCCcccCCCCCCeeecc--CCcEEEecccccccC
Q 014344 147 --------------------------MGIVYRDLKPENIMIQE--NGHIMLVDFDLSTKL 178 (426)
Q Consensus 147 --------------------------~giiHrDlKp~NiLl~~--~g~ikL~DFgls~~~ 178 (426)
..++|+|++|.||+++. ++.+.|+||+.+..-
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 24699999999999998 677899999988653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.1e-10 Score=102.85 Aligned_cols=137 Identities=20% Similarity=0.217 Sum_probs=86.7
Q ss_pred EEEEEEcCCCceEEEEEeehhhHHhhh-h-hccc-----------CCCchhhHHHHHHHHHHHhcCCC--Ccceeeeeee
Q 014344 32 VFLVKDVESSESFALKVIWRDLIEKKS-K-ELTN-----------NDNGDKYRRISFEQRVLRNVEHP--LLPRLRGVLS 96 (426)
Q Consensus 32 V~~a~~~~~~~~vAiK~~~~~~~~~~~-~-~~~~-----------~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~~ 96 (426)
||.|.. ..|+.+|||+.......-+. . .... ...........+|.+.|.++..- ++++++++.
T Consensus 2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 888887 55789999998643211110 0 0000 01111234677899999999855 577777553
Q ss_pred cCCeEEEEEeccC--CCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 97 TDKFVGYAIDYCP--GRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY-LHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 97 ~~~~~~lV~Ey~~--gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~-LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
..++||||+. |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~ 151 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFG 151 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecC
Confidence 2369999998 76776654422 2245566777888886655 579999999999999999877 99999999
Q ss_pred ccccC
Q 014344 174 LSTKL 178 (426)
Q Consensus 174 ls~~~ 178 (426)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.2e-11 Score=122.60 Aligned_cols=160 Identities=21% Similarity=0.279 Sum_probs=116.2
Q ss_pred HHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCC
Q 014344 135 AELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSG 213 (426)
Q Consensus 135 ~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (426)
.++..||.|+|. .++||+.|.|++|.++..|..||+.|+++....+.......
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~-------------------------- 159 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFS-------------------------- 159 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccc--------------------------
Confidence 345599999996 59999999999999999999999999998765432210000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHH-hCCCCCCCCCHHHH
Q 014344 214 ISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKET 292 (426)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~ 292 (426)
..+ ....-...-...|.|||++.+...+.++|++|+||++|.+. .|+..+...+....
T Consensus 160 --~yd-------------------~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~ 218 (700)
T KOG2137|consen 160 --EYD-------------------PPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS 218 (700)
T ss_pred --cCC-------------------CCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcch
Confidence 000 00011112345799999999988899999999999999998 67777766543333
Q ss_pred HHHHh--c---CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 293 FYRIL--C---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 293 ~~~i~--~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
+.... . ..-.....|+++++-|.++|..++..||++.+++..|||.+.-
T Consensus 219 ~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 219 YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred hhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 22211 1 1111134578999999999999999999999999999998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=2e-09 Score=100.45 Aligned_cols=142 Identities=11% Similarity=-0.003 Sum_probs=95.5
Q ss_pred EEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc--ceeeeeeec-----CCeEEEE
Q 014344 32 VFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL--PRLRGVLST-----DKFVGYA 104 (426)
Q Consensus 32 V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i--v~l~~~~~~-----~~~~~lV 104 (426)
|+.+. ..|+.|.||...........+..... ..-...+.+|.+.+.+|..-+| +.+..+++. ...-+||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~--~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSL--RMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhccc--ccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 44443 45778999976332211100000000 0011246778888888853333 344444432 2357899
Q ss_pred EeccCCC-ChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-------CCcEEEecccccc
Q 014344 105 IDYCPGR-DLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-------NGHIMLVDFDLST 176 (426)
Q Consensus 105 ~Ey~~gg-~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-------~g~ikL~DFgls~ 176 (426)
||+++|. +|.+++........+......++.+++..+.-||+.||+|||+++.|||++. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999876 7888875432344667788899999999999999999999999999999985 4689999999885
Q ss_pred c
Q 014344 177 K 177 (426)
Q Consensus 177 ~ 177 (426)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-08 Score=92.01 Aligned_cols=106 Identities=24% Similarity=0.271 Sum_probs=84.5
Q ss_pred HHHHHHHHHHHhcCCC--CcceeeeeeecC----CeEEEEEeccCCC-ChHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Q 014344 71 RRISFEQRVLRNVEHP--LLPRLRGVLSTD----KFVGYAIDYCPGR-DLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143 (426)
Q Consensus 71 ~~~~~E~~il~~l~hp--~iv~l~~~~~~~----~~~~lV~Ey~~gg-~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~ 143 (426)
.+..+|...+..|..- ..+..+++.+.. ...++|+|+++|. +|.+++..... .+......++.++...+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4677788888887533 345566665442 2458999999974 78888775433 6677788999999999999
Q ss_pred HHHCCCcccCCCCCCeeeccCC---cEEEecccccccC
Q 014344 144 LHNMGIVYRDLKPENIMIQENG---HIMLVDFDLSTKL 178 (426)
Q Consensus 144 LH~~giiHrDlKp~NiLl~~~g---~ikL~DFgls~~~ 178 (426)
||++||+|+|++|.|||++.++ .+.|+||+-+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999999999999999887 8999999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-08 Score=89.09 Aligned_cols=147 Identities=17% Similarity=0.236 Sum_probs=91.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|.+++++-......|.+.. -+|+.+.+|+...........-.+.... ....+.......++...-..+..++-+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg-~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKG-SEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhcc-HHHHHHHHHHHHHHHcCccccccceeee
Confidence 458899999888888887776 5678999998854332111111111111 1122222222222222222222222222
Q ss_pred -----ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 -----STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 -----~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
.-....+++|||++|..|.++.. +++. +...|..++.-||+.|+.|+|.+|.|++++.+ .++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 22345568999999999877632 3332 34567788999999999999999999999855 59999
Q ss_pred cccccc
Q 014344 171 DFDLST 176 (426)
Q Consensus 171 DFgls~ 176 (426)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=93.21 Aligned_cols=149 Identities=17% Similarity=0.231 Sum_probs=107.1
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhh----hhc-ccCCC----chhhHHHHHHHHHHHhcCCC--
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS----KEL-TNNDN----GDKYRRISFEQRVLRNVEHP-- 86 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~----~~~-~~~~~----~~~~~~~~~E~~il~~l~hp-- 86 (426)
+.++..||-|--|.||.|.+. .|.++|||.-.-...+-+. +.. ..... ........+|.++|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 357789999999999999985 6899999976432221110 111 01111 11234577899999999754
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
.+++.++ .+...+||||++|-.|..+. +..+.+..++..|+.-+.-+-..||||+|+.+=||+++++|.
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 7777765 46678999999998876542 234445556666777776666899999999999999999999
Q ss_pred EEEecccccccC
Q 014344 167 IMLVDFDLSTKL 178 (426)
Q Consensus 167 ikL~DFgls~~~ 178 (426)
+.++||.-+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999876654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=9.4e-11 Score=116.82 Aligned_cols=241 Identities=20% Similarity=0.164 Sum_probs=168.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~ 94 (426)
..+...+-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------------------l~~rl~~eLLdK~n~P~~~v~~~~d 302 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------------------LSRRLAIELLDKVNNPNPVVRYLED 302 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------------------hhhHHHHHHHHHccCCCCccccccc
Confidence 34777888999999999999876665555 6666322 12334788999999999 7777777
Q ss_pred eecCCeEEEEEeccCCC-ChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 95 LSTDKFVGYAIDYCPGR-DLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg-~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.+.+.+++|++|.++ +-...+.. ..-.+.+-+...+.+.-..+|++||+.-=+||| ||+..+ +..++.||+
T Consensus 303 ~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~ 376 (829)
T KOG0576|consen 303 YDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFA 376 (829)
T ss_pred CCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-ccccccccc
Confidence 88889999999999877 22111110 011133344445566677889999988668999 887765 788999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
....+.... +.+++.+|+.++||
T Consensus 377 v~~~L~~~~---------------------------------------------------------~~~t~~~~~~~~~p 399 (829)
T KOG0576|consen 377 VPPQLTRTM---------------------------------------------------------KPRTAIGTPEPLAP 399 (829)
T ss_pred CCcccCccc---------------------------------------------------------ccccCCCCCCCCCc
Confidence 877664321 34567799999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCC---CCHHH-HHHHHHHhccCCCCCCC
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVG---EPTPL-RNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~-~~li~~~L~~dP~~R~s 327 (426)
|++....+..+.|.|++|+-..+|.-|.+|-..+... ...+-..+ +.+.. ..+.. .++...|+..-|..|+.
T Consensus 400 ev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv 477 (829)
T KOG0576|consen 400 EVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV 477 (829)
T ss_pred hhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc
Confidence 9999999999999999999888888887775432110 00000000 00000 01111 25788899999999999
Q ss_pred hHHHhcCCCcCCC
Q 014344 328 VEEIKGHEFFKGV 340 (426)
Q Consensus 328 ~~eil~hp~f~~~ 340 (426)
..+++.|.+|.+.
T Consensus 478 ~mgacfsKvfngC 490 (829)
T KOG0576|consen 478 HMGACFSKVFNGC 490 (829)
T ss_pred hhhHHHHHHhccC
Confidence 9999999988764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-08 Score=100.63 Aligned_cols=156 Identities=17% Similarity=0.197 Sum_probs=93.7
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-------------hccc----CCCchh----hH------HHH
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-------------ELTN----NDNGDK----YR------RIS 74 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-------------~~~~----~~~~~~----~~------~~~ 74 (426)
.-|+.++-|.||.|+-+. |+.|||||.....-..-.. .... ..-... .+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 567899999999999855 9999999985432211110 0000 000011 11 134
Q ss_pred HHHHHHHhcC-----CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 75 FEQRVLRNVE-----HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 75 ~E~~il~~l~-----hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
+|...+.++. .|.+.--.=+++-.+.-.++|||++|-.+.+...... ..++...+.....++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 4555555542 3433211112233455679999999988888743222 2244333322222211 233334799
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~ 181 (426)
+|.|.+|.||+++.+|.+.+.|||+...+.+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 99999999999999999999999999888653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.6e-07 Score=82.16 Aligned_cols=145 Identities=14% Similarity=0.137 Sum_probs=101.2
Q ss_pred cccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC--cceeeeeeec----C
Q 014344 25 GRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL--LPRLRGVLST----D 98 (426)
Q Consensus 25 G~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~~~~~----~ 98 (426)
|+||-|-|+.... .|+.|-+|.-...... .. ..+--...+.+|...|+.|..-+ ++.+...-.. .
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~----s~---r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~ 97 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFH----SV---RYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGE 97 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccc----cc---cCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCc
Confidence 5688899998763 3446778865211100 00 00224567888999999986333 4444422111 2
Q ss_pred CeEEEEEeccCC-CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc--EEEeccccc
Q 014344 99 KFVGYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH--IMLVDFDLS 175 (426)
Q Consensus 99 ~~~~lV~Ey~~g-g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~--ikL~DFgls 175 (426)
-.-+||+|-+.| -||.+++....-...++...+.++.+|..+|.-||+.|+.|+|+-+.|||++.+|. ++++||--+
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 246799997754 57888766544334677777889999999999999999999999999999987777 999999877
Q ss_pred ccC
Q 014344 176 TKL 178 (426)
Q Consensus 176 ~~~ 178 (426)
+..
T Consensus 178 r~~ 180 (216)
T PRK09902 178 RRR 180 (216)
T ss_pred chh
Confidence 654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-07 Score=84.92 Aligned_cols=136 Identities=13% Similarity=0.121 Sum_probs=84.7
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC--CcceeeeeeecCC
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP--LLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~~~~~ 99 (426)
..||.|..+.||+. .+..+++|...... ....+.+|.++++.+..- .+++.+++....+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~---------------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~ 67 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF---------------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGG 67 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC---------------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC
Confidence 56799999999973 25567899873211 223467799999998643 3578888888888
Q ss_pred eEEEEEeccCCCC-hH--------------HHH----HHhcc---CCCCHH-HHHHHHHH----------HHHH-HHHHH
Q 014344 100 FVGYAIDYCPGRD-LH--------------SLR----KQQSE---QMFSDD-TIRFYAAE----------LVLA-LEYLH 145 (426)
Q Consensus 100 ~~~lV~Ey~~gg~-L~--------------~l~----~~~~~---~~l~~~-~~~~~~~q----------il~a-L~~LH 145 (426)
..++|||+++|.+ +. ..+ ..-.. ...+.. ....+..+ +... ..+|.
T Consensus 68 ~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~ 147 (226)
T TIGR02172 68 RLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIK 147 (226)
T ss_pred eeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHH
Confidence 8899999999864 11 100 00000 001100 01111101 1111 22222
Q ss_pred H----CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 146 N----MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 146 ~----~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
. ..++|+|+.|.||+++.++ +.++||+.+..
T Consensus 148 ~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 148 EVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred hCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 1 2578999999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.8e-07 Score=98.23 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHhcCCCCcceeeeeeecCCeEE----EEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Q 014344 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVG----YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN 146 (426)
Q Consensus 71 ~~~~~E~~il~~l~hp~iv~l~~~~~~~~~~~----lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~ 146 (426)
.....|...+.+..|+|++.++.+-....... +..++|.+-++..++..- ...+...++.+..+++.||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 34455777788889999999988875544333 455889989998887654 348899999999999999999999
Q ss_pred CCCcccCCCCC---CeeeccCCcEEEe--cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCC
Q 014344 147 MGIVYRDLKPE---NIMIQENGHIMLV--DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVH 221 (426)
Q Consensus 147 ~giiHrDlKp~---NiLl~~~g~ikL~--DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (426)
....|.-|-.. +-..+..+.+.++ ||+.+..+....
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--------------------------------------- 345 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--------------------------------------- 345 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCcc---------------------------------------
Confidence 85555544444 3333455566666 887776553211
Q ss_pred CCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChh--hHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Q 014344 222 SPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFA--VDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR 299 (426)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 299 (426)
...+..-+..+.|||......+.++ .|+|.+|.....+..|..+-....... ..+..
T Consensus 346 ------------------~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~---~~l~~ 404 (1351)
T KOG1035|consen 346 ------------------KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPV---SLLDV 404 (1351)
T ss_pred ------------------cchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccchh---hhhcc
Confidence 1222234556788888877766554 699999999999988765432211111 11100
Q ss_pred CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 300 PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 300 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.......+++.+|+..++++|+++.+++.|+|.+.
T Consensus 405 -----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 405 -----LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred -----ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 01115678999999999999999999999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.5e-07 Score=88.73 Aligned_cols=234 Identities=22% Similarity=0.326 Sum_probs=146.4
Q ss_pred EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh-cCCCCcce-------
Q 014344 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN-VEHPLLPR------- 90 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~------- 90 (426)
...+.||+|+-+-+|-.-.. .-.+-|++.+--..... .-+..|.. -+||-+-.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a----------------qk~a~la~~p~~p~~~~rvaWPqa 74 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA----------------QKVAELAATPDAPLLNYRVAWPQA 74 (637)
T ss_pred CCCccccCCccceeeecchh---hchhheeecCCCchHHH----------------HHHHHhccCCCCcchhhhhcccHH
Confidence 35678999999999865432 22345777442211110 01122322 24554332
Q ss_pred -eeeeeecCCeEEEEEeccCCCC-hHHHH----HHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 91 -LRGVLSTDKFVGYAIDYCPGRD-LHSLR----KQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 91 -l~~~~~~~~~~~lV~Ey~~gg~-L~~l~----~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+++- .....+.+.|..+.|.. ...+. +++....+...-+...++.++.|..-||..|.+-+|+.++|+|++++
T Consensus 75 ~L~G~-~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~ 153 (637)
T COG4248 75 TLHGG-RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD 153 (637)
T ss_pred HhhCC-CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC
Confidence 1111 12334788888887642 22221 22333446778889999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.|.|.|=..-... .. +......
T Consensus 154 ~~V~LVdsDsfqi~--------------------------------~n-------------------------g~~~~cp 176 (637)
T COG4248 154 SKVVLVDSDSFQIN--------------------------------AN-------------------------GTLHLCP 176 (637)
T ss_pred ceEEEEcccceeec--------------------------------cC-------------------------CceEecc
Confidence 99999985432111 11 1112233
Q ss_pred ccCCCCccchhhc-----CCCCChhhHHHHHHHHHHHHHhC-CCCCCCCC-------HHHH-HHHHh------cC---CC
Q 014344 245 VGTEEYVAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSS-------RKET-FYRIL------CR---PP 301 (426)
Q Consensus 245 ~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~-------~~~~-~~~i~------~~---~~ 301 (426)
+|.+.|.+||.-. +-.-+...|.|.||+++++++.| +.||.+-. ..++ ...-. .. .+
T Consensus 177 Vg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p 256 (637)
T COG4248 177 VGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKP 256 (637)
T ss_pred cCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCC
Confidence 6899999999754 34446789999999999999986 99997542 2221 10000 00 01
Q ss_pred -----CCCCCCHHHHHHHHHHhcc--CCCCCCChH
Q 014344 302 -----DLVGEPTPLRNLIRRLLEK--DPTKRIGVE 329 (426)
Q Consensus 302 -----~~~~~~~~~~~li~~~L~~--dP~~R~s~~ 329 (426)
.+.-.++.+..|..+|++. ++.-|||++
T Consensus 257 ~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 257 PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 1112367788888999865 367899964
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-06 Score=78.58 Aligned_cols=151 Identities=16% Similarity=0.184 Sum_probs=100.4
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhh---------cccCCCchh--hHHHHHHHHHHHhcC--CCC
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE---------LTNNDNGDK--YRRISFEQRVLRNVE--HPL 87 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~---------~~~~~~~~~--~~~~~~E~~il~~l~--hp~ 87 (426)
.-.|++|--+.||+|.. .++..+|+|++......-+... .....+... ..=...|..-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34777888899999986 5688999999976544332210 000001111 112455788888875 445
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCc
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ 166 (426)
+++.+.+. .-.|||||+... -.-. -....-.+.+..+..+..+++..+.-|-. .|+||+||..=|||+. ++.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~-g~pA-P~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDD-GLPA-PRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCC-CCCC-CCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 55666554 236999999533 1110 00111124444788888999999988876 8999999999999999 899
Q ss_pred EEEecccccccCC
Q 014344 167 IMLVDFDLSTKLS 179 (426)
Q Consensus 167 ikL~DFgls~~~~ 179 (426)
+.++|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.3e-06 Score=88.14 Aligned_cols=153 Identities=18% Similarity=0.209 Sum_probs=92.0
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-------------hcccCCC-----chhhH------HHHHHH
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-------------ELTNNDN-----GDKYR------RISFEQ 77 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-------------~~~~~~~-----~~~~~------~~~~E~ 77 (426)
+.||.-+.|.|+.|+-+. |+.|||||-....-..-.. .....-+ .+..+ .+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568999999999999866 9999999975422111000 0000000 00011 122333
Q ss_pred H----HHHhcCCCC------cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 78 R----VLRNVEHPL------LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 78 ~----il~~l~hp~------iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+ +.+.+.|-. |++++--+ ...-.|+||||+|.-+.++-.-... .++...+...+.+... .-+=..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhc
Confidence 3 333344555 55555433 3456799999999888776332222 2565544433333222 223356
Q ss_pred CCcccCCCCCCeeecc----CCcEEEecccccccCCC
Q 014344 148 GIVYRDLKPENIMIQE----NGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 148 giiHrDlKp~NiLl~~----~g~ikL~DFgls~~~~~ 180 (426)
|++|.|-+|.||++.. ++.+.+.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999994 66899999999987754
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.4e-06 Score=77.94 Aligned_cols=140 Identities=26% Similarity=0.369 Sum_probs=83.7
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC--Ccceeeeee---
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP--LLPRLRGVL--- 95 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~~--- 95 (426)
++.|+.|..+.||++.... ..+++|+.... .....+..|..+++.|... .+++++...
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---------------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~ 64 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---------------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD 64 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH---------------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---------------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc
Confidence 5789999999999999754 59999997433 1345677788898888633 356777643
Q ss_pred ecCCeEEEEEeccCCCChHH----------------HHH---Hhc--cCCCCHHH------HHHH---------------
Q 014344 96 STDKFVGYAIDYCPGRDLHS----------------LRK---QQS--EQMFSDDT------IRFY--------------- 133 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~----------------l~~---~~~--~~~l~~~~------~~~~--------------- 133 (426)
......+++|++++|..+.. .+. ... ...+.... ....
T Consensus 65 ~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (239)
T PF01636_consen 65 EFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDD 144 (239)
T ss_dssp EETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHH
T ss_pred cccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhh
Confidence 23445799999999987776 111 110 00011000 0000
Q ss_pred HHHHHH-HHHHHHH-------CCCcccCCCCCCeeec-cCCcEEEeccccccc
Q 014344 134 AAELVL-ALEYLHN-------MGIVYRDLKPENIMIQ-ENGHIMLVDFDLSTK 177 (426)
Q Consensus 134 ~~qil~-aL~~LH~-------~giiHrDlKp~NiLl~-~~g~ikL~DFgls~~ 177 (426)
...+.. .+..+++ ..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 145 LEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 111222 3333432 3699999999999999 667778999998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.4e-06 Score=76.71 Aligned_cols=137 Identities=15% Similarity=0.103 Sum_probs=83.8
Q ss_pred eecccCc-eEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecCCe
Q 014344 23 ALGRGAK-GVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDKF 100 (426)
Q Consensus 23 ~LG~G~~-g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~ 100 (426)
.|-.|.+ +.||++... +..+.+|+..... ...+..|+++++.+. +--+++++++....+.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----------------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 66 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----------------TYELEREAERLRWLAGKLPVPEVIDYGSDDGR 66 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----------------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc
Confidence 3444555 789998753 4688889863211 234566888988885 4556788888877777
Q ss_pred EEEEEeccCCCChHHHH----------------HHhcc-----CCCCHH------HHHHHHH----------------HH
Q 014344 101 VGYAIDYCPGRDLHSLR----------------KQQSE-----QMFSDD------TIRFYAA----------------EL 137 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~----------------~~~~~-----~~l~~~------~~~~~~~----------------qi 137 (426)
.++|||+++|.+|.... ..... ..+... .....+. .+
T Consensus 67 ~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 146 (244)
T cd05150 67 AWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSA 146 (244)
T ss_pred cEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCH
Confidence 89999999987765321 10000 011100 0000000 01
Q ss_pred HHHHHHH-------HHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 138 VLALEYL-------HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 138 l~aL~~L-------H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
...+..| ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 147 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 147 EELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred HHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1112222 123489999999999999988889999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=71.34 Aligned_cols=138 Identities=25% Similarity=0.314 Sum_probs=92.2
Q ss_pred CCcEEEeeecccCc-eEEEEEEEcCCCceEEEEEeehhhHHhh--------hhhcccCCCchhhHHHHHHHHHHHhcC--
Q 014344 16 SCLRIVSALGRGAK-GVVFLVKDVESSESFALKVIWRDLIEKK--------SKELTNNDNGDKYRRISFEQRVLRNVE-- 84 (426)
Q Consensus 16 ~~y~i~~~LG~G~~-g~V~~a~~~~~~~~vAiK~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~E~~il~~l~-- 84 (426)
.+++.++.||.|.- |.||+++. .|+.||||+...-..... ..............-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999984 678999999321110000 000000111123446777877766664
Q ss_pred -CCCc--ceeeeeeecC------------------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Q 014344 85 -HPLL--PRLRGVLSTD------------------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143 (426)
Q Consensus 85 -hp~i--v~l~~~~~~~------------------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~ 143 (426)
+.++ |+++|++.-. ....||-||.+... .++... +.+|+.-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHHH
Confidence 5566 8999987322 12367888776443 133333 3568888889
Q ss_pred HHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 144 LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
+|..||+-+|+++.|.. .=+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999986 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.5e-05 Score=86.57 Aligned_cols=148 Identities=20% Similarity=0.331 Sum_probs=91.0
Q ss_pred EEeeecccCceEEEEEEEcCCC--ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCc--ceeeee
Q 014344 20 IVSALGRGAKGVVFLVKDVESS--ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLL--PRLRGV 94 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~--~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i--v~l~~~ 94 (426)
-++.|+.|.+..+|++.....+ ..+++|+...... ......+.+|+++|+.+. |+++ ++++.+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~------------~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~ 109 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL------------LQSAHAVEREYQVLRALGEHTDVPVPKVYCL 109 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc------------CccHHHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 4678899999999998764432 3677777532210 011235778999999996 6655 777777
Q ss_pred eecC---CeEEEEEeccCCCChHH--------------------HHH---HhccC-----------CCCHHHHHHHHHH-
Q 014344 95 LSTD---KFVGYAIDYCPGRDLHS--------------------LRK---QQSEQ-----------MFSDDTIRFYAAE- 136 (426)
Q Consensus 95 ~~~~---~~~~lV~Ey~~gg~L~~--------------------l~~---~~~~~-----------~l~~~~~~~~~~q- 136 (426)
+.+. +..|+||||++|..+.+ .+. ..... .+....+..+..|
T Consensus 110 ~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~ 189 (822)
T PLN02876 110 CTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQY 189 (822)
T ss_pred ecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHH
Confidence 6654 46789999999864321 011 00000 0111233222222
Q ss_pred --------------HHHHHHHHHH-----------CCCcccCCCCCCeeeccC-C-cEEEecccccccCC
Q 014344 137 --------------LVLALEYLHN-----------MGIVYRDLKPENIMIQEN-G-HIMLVDFDLSTKLS 179 (426)
Q Consensus 137 --------------il~aL~~LH~-----------~giiHrDlKp~NiLl~~~-g-~ikL~DFgls~~~~ 179 (426)
+...+.+|.. ..+||+|++|.|||++.+ + .+-|.||.++..-.
T Consensus 190 ~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 190 LASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred HHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2233566633 249999999999999853 3 35799999987643
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1e-05 Score=69.30 Aligned_cols=130 Identities=23% Similarity=0.292 Sum_probs=91.4
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc-eeeeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP-RLRGVLS 96 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv-~l~~~~~ 96 (426)
.++.+.||+|.+|.||++.. .|..+|+|+-..+ .....+..|+++|..+.-.++. +++.+-.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d---------------s~r~~l~kEakiLeil~g~~~~p~vy~yg~ 86 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD---------------SPRRNLEKEAKILEILAGEGVTPEVYFYGE 86 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCC---------------cchhhHHHHHHHHHHhhhcCCCceEEEech
Confidence 45678899999999999984 5669999986332 2455788899999999866554 4554432
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC-CCCeeeccCCcEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLK-PENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlK-p~NiLl~~~g~ikL~DFgls 175 (426)
+ ++.|||+.|-.|.++... .....+ ..++.+---|-..||-|+.|. |...+|..++.+.|+||..|
T Consensus 87 ~----~i~me~i~G~~L~~~~~~-----~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~A 153 (201)
T COG2112 87 D----FIRMEYIDGRPLGKLEIG-----GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSA 153 (201)
T ss_pred h----hhhhhhhcCcchhhhhhc-----ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccch
Confidence 2 345999999898876432 122222 235555444556799999885 56666666779999999988
Q ss_pred cc
Q 014344 176 TK 177 (426)
Q Consensus 176 ~~ 177 (426)
+.
T Consensus 154 t~ 155 (201)
T COG2112 154 TF 155 (201)
T ss_pred hh
Confidence 73
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.2e-05 Score=67.03 Aligned_cols=144 Identities=22% Similarity=0.366 Sum_probs=95.2
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh---hcccCCCchhhHHHHHHHHHHHhcC------CCCcceee
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK---ELTNNDNGDKYRRISFEQRVLRNVE------HPLLPRLR 92 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~il~~l~------hp~iv~l~ 92 (426)
..||+|+.-.||. + ......+|||+.......... -..........+...+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4689999999994 3 344567899997665111100 0000011123455666666655554 88999999
Q ss_pred eeeecCCeEEEEEeccCC------CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-
Q 014344 93 GVLSTDKFVGYAIDYCPG------RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG- 165 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~g------g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g- 165 (426)
|+.+++....+|+|.+.+ -+|.++++. +.+++ .++. .+-.-.+||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998853 357777643 23655 3333 333445788899999999999999997432
Q ss_pred ---cEEEec-cccc
Q 014344 166 ---HIMLVD-FDLS 175 (426)
Q Consensus 166 ---~ikL~D-Fgls 175 (426)
.+.|+| ||..
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 578888 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.8e-05 Score=72.86 Aligned_cols=73 Identities=12% Similarity=0.156 Sum_probs=45.9
Q ss_pred eeecccCce-EEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC---Ccceeeeeeec
Q 014344 22 SALGRGAKG-VVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP---LLPRLRGVLST 97 (426)
Q Consensus 22 ~~LG~G~~g-~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp---~iv~l~~~~~~ 97 (426)
..|+.|+.. .||++. ..+.+|+.... .....+..|.++|+.|... -++.+++....
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~---------------~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~ 62 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA---------------GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEP 62 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc---------------chHHHHHHHHHHHHHHhccCCCCCCceeecCCC
Confidence 457777766 588762 35777875321 1223677799999888632 45555554433
Q ss_pred C---CeEEEEEeccCCCChH
Q 014344 98 D---KFVGYAIDYCPGRDLH 114 (426)
Q Consensus 98 ~---~~~~lV~Ey~~gg~L~ 114 (426)
. ...+++|++++|.++.
T Consensus 63 ~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 63 GEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred ccCCCcceEEEEeecCCCCC
Confidence 2 2458899999987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.1e-07 Score=98.30 Aligned_cols=258 Identities=14% Similarity=-0.031 Sum_probs=164.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+..+++.-.+|.|.++.--.-+.+. ..+.+|+...-.+....+ ...+....|..-++...|+++.....
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~ki--d~Fk~~I~ke~d~e~Lse--------Plkemll~e~de~~~~~h~~~~~~p~ 1296 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKI--DWFKFSIYKEYDFENLSE--------PLKEMLLSERDELREAKHYLTEVDPL 1296 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhh--ceeEEEeehhhhHHHHhh--------HHHHhhhhhhhhhhhhhceeeecccc
Confidence 34566777667766665432222221 235566653333322211 23345556666777788998877666
Q ss_pred eee--cCCeEEEEEeccCCCChHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC-C----CcccCCCCCCeeeccC
Q 014344 94 VLS--TDKFVGYAIDYCPGRDLHSLRKQQSE--QMFSDDTIRFYAAELVLALEYLHNM-G----IVYRDLKPENIMIQEN 164 (426)
Q Consensus 94 ~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~~--~~l~~~~~~~~~~qil~aL~~LH~~-g----iiHrDlKp~NiLl~~~ 164 (426)
-.. .....|.+++||.+|.+++.+-.... ..+.+.-+.....+.+.+..-+|+. + .+|++||+-|.+|..+
T Consensus 1297 rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn 1376 (2724)
T KOG1826|consen 1297 RIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN 1376 (2724)
T ss_pred cCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC
Confidence 553 34567899999999999998654322 2233444444444558888888864 2 6899999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
..+|++++|+.+...+. .......
T Consensus 1377 y~v~~gk~gLdKIknp~--------------------------------------------------------~sf~Gl~ 1400 (2724)
T KOG1826|consen 1377 YNVKLGKGGLDKIKNPV--------------------------------------------------------LSFFGLE 1400 (2724)
T ss_pred CcccccccccccccCch--------------------------------------------------------Hhhhhhh
Confidence 99999999998833211 1123456
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--C-CCCCHHHHHHHHHHhccC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD--L-VGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--~-~~~~~~~~~li~~~L~~d 321 (426)
++++.|++|++...-.++.++|+|..|+.+|+...|..+|........ ..++..... . .-.|.++-.....+|-+.
T Consensus 1401 l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~L-kgiidn~tf~sIe~l~pgdaNve~~~~Ll~K 1479 (2724)
T KOG1826|consen 1401 LCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPAL-KGIIDNHTFFSIEKLKPGDANVEALHRLLWK 1479 (2724)
T ss_pred hCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHH-cCcccccccccccccCCCcccHHHHHHHHHH
Confidence 788999999999988899889999999999999999887743222111 111111000 0 011233333444555556
Q ss_pred CCCCCChHHHhcCCCcC
Q 014344 322 PTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 322 P~~R~s~~eil~hp~f~ 338 (426)
-..||.-..++.-+.|.
T Consensus 1480 ~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1480 YMERPGQYISLSRDHFA 1496 (2724)
T ss_pred hhhcchhhhhccccccc
Confidence 67899888888877764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=67.36 Aligned_cols=140 Identities=19% Similarity=0.269 Sum_probs=82.4
Q ss_pred EeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecC
Q 014344 21 VSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTD 98 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~ 98 (426)
++.|..|-...+|++.... .++.|++|+..... ...-....|+.+++.+. +...+++++.+.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~--------------~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-- 66 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT--------------ELIIDRERELRIHKLLSKHGLAPKLYATFQ-- 66 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc--------------cceecHHHHHHHHHHHHhCCCCCeEEEEeC--
Confidence 4677888889999997543 35788999763211 01112345888898885 334556665443
Q ss_pred CeEEEEEeccCCCChHH-----------H---HHH---hc-cC--------CCC-HHHHHHHHHH---------------
Q 014344 99 KFVGYAIDYCPGRDLHS-----------L---RKQ---QS-EQ--------MFS-DDTIRFYAAE--------------- 136 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~-----------l---~~~---~~-~~--------~l~-~~~~~~~~~q--------------- 136 (426)
+ .++|||++|.++.. + +.+ .. .. ... ...+..+...
T Consensus 67 ~--~~l~e~i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 144 (235)
T cd05157 67 N--GLIYEFIPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKT 144 (235)
T ss_pred C--cEEEEeeCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhh
Confidence 2 47999999876521 1 110 00 00 011 1222222211
Q ss_pred -------HH---HHHH-HHH----HCCCcccCCCCCCeeecc-CCcEEEecccccccC
Q 014344 137 -------LV---LALE-YLH----NMGIVYRDLKPENIMIQE-NGHIMLVDFDLSTKL 178 (426)
Q Consensus 137 -------il---~aL~-~LH----~~giiHrDlKp~NiLl~~-~g~ikL~DFgls~~~ 178 (426)
+. ..|. .+- ..+++|+|+.+.|||++. ++.+.|+||..|..-
T Consensus 145 ~~~~~~~l~~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 145 KAISFEQLRDEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred ccccHHHHHHHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 11 1111 111 136999999999999997 578999999988753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00034 Score=66.71 Aligned_cols=79 Identities=13% Similarity=0.106 Sum_probs=56.0
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC---CCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH---PLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---p~iv~l~~~ 94 (426)
..-.+.||.|..+.||..... +..+.+|+. +.. .....+..|...|+.|.. -.+++++++
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~-~~~--------------~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~ 78 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QGNPMPLMA-RSF--------------STPGVAQQEAWKLSMLARSGTVRMPTVYGV 78 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CCCEEEEEe-ccc--------------ccchHHHHHHHHHHHHccCCCCCcCcEEEE
Confidence 445678999999999998642 235677774 210 012367779999999853 468888887
Q ss_pred eec---CCeEEEEEeccCCCCh
Q 014344 95 LST---DKFVGYAIDYCPGRDL 113 (426)
Q Consensus 95 ~~~---~~~~~lV~Ey~~gg~L 113 (426)
+.. .+..+||||+++|.++
T Consensus 79 ~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 79 MTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred eccCCcCCCeEEEEeccCCEec
Confidence 754 3668999999998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00035 Score=67.02 Aligned_cols=147 Identities=16% Similarity=0.274 Sum_probs=86.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC--ccee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL--LPRL 91 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l 91 (426)
+++...-++.++.|....+|++.. ++..+++|+..... ....+..|..++..|...+ ++++
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~---------------~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV---------------KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred CCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCC---------------CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 334455678888888899999864 34468889863310 1224455777787774322 4454
Q ss_pred eeee------ecCCeEEEEEeccCCCChH--------HH------HHHhccCCCC--------HHH-----HH-------
Q 014344 92 RGVL------STDKFVGYAIDYCPGRDLH--------SL------RKQQSEQMFS--------DDT-----IR------- 131 (426)
Q Consensus 92 ~~~~------~~~~~~~lV~Ey~~gg~L~--------~l------~~~~~~~~l~--------~~~-----~~------- 131 (426)
+..- ...+..+++++|++|..+. .+ ++.... .++ ... ..
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~-~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGA-HFPENRKNSLRLEAWHILAEKCFEAAPQ 161 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhc-cCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence 4421 2245678999999985431 10 111111 010 000 00
Q ss_pred ---HHHHHHHHHHHHHHH-------CCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 132 ---FYAAELVLALEYLHN-------MGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 132 ---~~~~qil~aL~~LH~-------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
.....+...++++.. .+++|+|+++.||+++.++.+.|+||+.+..-
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~~ 218 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACTD 218 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccCc
Confidence 001123334555542 58999999999999998887789999988653
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.80 E-value=2.6e-05 Score=73.12 Aligned_cols=148 Identities=16% Similarity=0.200 Sum_probs=101.3
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-----hcccCCC--chhh--HHHHHHHHHHHhcC-C-C
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-----ELTNNDN--GDKY--RRISFEQRVLRNVE-H-P 86 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-----~~~~~~~--~~~~--~~~~~E~~il~~l~-h-p 86 (426)
+.++..||-|.-+-||.+-+ ..|++.++|+-.....+-++- ....... ...+ -...+|...|+.|. | -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 57889999999999999987 558899999764333221110 0000000 1111 24567999999996 3 2
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
-+++.++ .+..++|||++.|-.|....+- .. +..+...++.-+--|-.+|+||+|..-=||+++.++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 3445543 4667899999999998765332 12 2233445556667788999999999999999999999
Q ss_pred EEEecccccccC
Q 014344 167 IMLVDFDLSTKL 178 (426)
Q Consensus 167 ikL~DFgls~~~ 178 (426)
++++||.-....
T Consensus 241 i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 241 IVVIDFPQMVST 252 (465)
T ss_pred EEEeechHhhcc
Confidence 999999865443
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.78 E-value=8.2e-05 Score=65.86 Aligned_cols=97 Identities=22% Similarity=0.252 Sum_probs=77.4
Q ss_pred HHHHHHhcCC-CCcceeeeeeecCCeEEEEEeccCCCChHHH---HHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 014344 76 EQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL---RKQQSEQMFSDDTIRFYAAELVLALEYLHN---MG 148 (426)
Q Consensus 76 E~~il~~l~h-p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l---~~~~~~~~l~~~~~~~~~~qil~aL~~LH~---~g 148 (426)
|.-+|+.+.+ +++++++|++.. ++|.||...+++... +... ...++.....++.+++..+++|+. ..
T Consensus 9 E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 9 EPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred HHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 7888999976 699999998722 678999987766421 0111 125788888999999999999987 35
Q ss_pred CcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 149 IVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 149 iiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
+.-.|++|+|+-++++|++|++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 778899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00032 Score=66.85 Aligned_cols=139 Identities=16% Similarity=0.230 Sum_probs=84.3
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC--Ccceeeee---
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP--LLPRLRGV--- 94 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~--- 94 (426)
-++.|..|....+|++.. .+..+++|+... .....+..|+.++..|.+- .+++++..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~----------------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g 79 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK----------------VSAEELPFFLALLDHLAERGLPVPRPIADRDG 79 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC----------------CChHhccHHHHHHHHHHHCCCCCCccccCCCC
Confidence 366788888899999864 345789998732 0123455688888887532 24454432
Q ss_pred ---eecCCeEEEEEeccCCCChHH--------H------HHHhccCCCCH--------HHHH------------HHHHHH
Q 014344 95 ---LSTDKFVGYAIDYCPGRDLHS--------L------RKQQSEQMFSD--------DTIR------------FYAAEL 137 (426)
Q Consensus 95 ---~~~~~~~~lV~Ey~~gg~L~~--------l------~~~~~~~~l~~--------~~~~------------~~~~qi 137 (426)
...++..++|+++++|..+.. + ++..... +.. .... .....+
T Consensus 80 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 158 (296)
T cd05153 80 EYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQS-FPGERNNLRGLAWIRELGKDLLPLLSAEDRALL 158 (296)
T ss_pred cEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhcc-CCccCCCcCCcHHHHHHHHHhccccCHHHHHHH
Confidence 233456789999999876421 1 1111000 000 0000 011112
Q ss_pred HHHHHHHHH-------CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 138 VLALEYLHN-------MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 138 l~aL~~LH~-------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
..++.++.+ .+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 159 ~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 159 ADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 334444443 4799999999999999887789999998865
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00037 Score=66.65 Aligned_cols=140 Identities=19% Similarity=0.303 Sum_probs=83.2
Q ss_pred EeeecccCceEEEEEEEcC------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCcceeee
Q 014344 21 VSALGRGAKGVVFLVKDVE------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLLPRLRG 93 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~ 93 (426)
++.|..|-...||++.... +++.|++|+..... ........|..+++.+.. .-.+++++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--------------~~~~~r~~E~~~~~~l~~~g~~P~~~~ 68 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--------------ELLIDRERELVVFARLSERNLGPKLYG 68 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--------------cceechHHHHHHHHHHHhCCCCCceEE
Confidence 4566677777999987543 25789999973321 112245568888888863 23456666
Q ss_pred eeecCCeEEEEEeccCCCChHHH--------------HHH---hccC-------CCCH--HHHHH---------------
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSL--------------RKQ---QSEQ-------MFSD--DTIRF--------------- 132 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l--------------~~~---~~~~-------~l~~--~~~~~--------------- 132 (426)
++.. .+|+||++|..+... +.+ .... ..+. ..+..
T Consensus 69 ~~~~----~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (302)
T cd05156 69 IFPN----GRIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSD 144 (302)
T ss_pred EeCC----CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccc
Confidence 6642 368999988765321 110 0000 0000 01100
Q ss_pred -----------HHHHHHHHHHHHHH---------CCCcccCCCCCCeeeccC----CcEEEecccccccC
Q 014344 133 -----------YAAELVLALEYLHN---------MGIVYRDLKPENIMIQEN----GHIMLVDFDLSTKL 178 (426)
Q Consensus 133 -----------~~~qil~aL~~LH~---------~giiHrDlKp~NiLl~~~----g~ikL~DFgls~~~ 178 (426)
+..++...+..|-. ..++|+|+.|.|||++.+ +.+.++||..|..-
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 145 SEKLLEVELSLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred hhhhhhhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 11222233344432 268999999999999985 88999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0016 Score=64.22 Aligned_cols=84 Identities=17% Similarity=0.237 Sum_probs=56.2
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCC-chhhHHHHHHHHHHHhcC---CCCcceeeeee
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDN-GDKYRRISFEQRVLRNVE---HPLLPRLRGVL 95 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~il~~l~---hp~iv~l~~~~ 95 (426)
-.+.||-|.+..||.+.+...++.++||.-.... .. .... +....+...|.+.|+.+. -.++++++.+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~-r~------~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~- 101 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYV-RV------VGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY- 101 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCccc-cc------ccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence 3578999999999999986444689999742110 00 0000 123457777888888864 3467888876
Q ss_pred ecCCeEEEEEeccCCCC
Q 014344 96 STDKFVGYAIDYCPGRD 112 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~ 112 (426)
++...++||||+++..
T Consensus 102 -D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEELAVTVMEDLSDHK 117 (401)
T ss_pred -CCCCCEEEEecCCCcc
Confidence 4466789999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.0013 Score=63.32 Aligned_cols=140 Identities=11% Similarity=0.171 Sum_probs=77.6
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC--Ccceeeee----
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP--LLPRLRGV---- 94 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~---- 94 (426)
++.|+.|....+|++... +..+++|++... ....+..|..+++.|... .+++++..
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~----------------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~ 88 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFERL----------------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGA 88 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEeccC----------------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCC
Confidence 456778888899998753 347899987310 112334466666666422 23444421
Q ss_pred --eecCCeEEEEEeccCCCChH-----HH------H---HHhccC-------CCCH----HHH-----------HHHHHH
Q 014344 95 --LSTDKFVGYAIDYCPGRDLH-----SL------R---KQQSEQ-------MFSD----DTI-----------RFYAAE 136 (426)
Q Consensus 95 --~~~~~~~~lV~Ey~~gg~L~-----~l------~---~~~~~~-------~l~~----~~~-----------~~~~~q 136 (426)
....+..+++++|++|..+. .+ + +..... .... ..+ ...+.+
T Consensus 89 ~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (319)
T PRK05231 89 ALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEA 168 (319)
T ss_pred EeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHH
Confidence 23355678999999986431 11 1 111000 0000 000 011111
Q ss_pred -HHHHHHHHH-------HCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 137 -LVLALEYLH-------NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 137 -il~aL~~LH-------~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
+-..++.+. ..|+||+|++|.|||++.+...-|+||+.+..-
T Consensus 169 ~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 169 ELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred HHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 111223332 238999999999999986655689999988654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.0012 Score=61.57 Aligned_cols=136 Identities=15% Similarity=0.162 Sum_probs=78.8
Q ss_pred eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC-CcceeeeeeecCCeE
Q 014344 23 ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP-LLPRLRGVLSTDKFV 101 (426)
Q Consensus 23 ~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~iv~l~~~~~~~~~~ 101 (426)
.+..|-.+.+|++. .+++.+++|+..... ....-....|..+++.+... -.++++.... -
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~-------------~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~ 63 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC-------------KALGVDRQREYQILQALSALGLAPKPILVNE----H 63 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc-------------ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----C
Confidence 34567788899887 456788899753211 00001245688999988643 3355555432 2
Q ss_pred EEEEeccCCCChHH-----------H---HHHhc-----cCCCCH-HHHHHHHHHH---------HHHHHHHHH------
Q 014344 102 GYAIDYCPGRDLHS-----------L---RKQQS-----EQMFSD-DTIRFYAAEL---------VLALEYLHN------ 146 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~-----------l---~~~~~-----~~~l~~-~~~~~~~~qi---------l~aL~~LH~------ 146 (426)
++||||++|..+.. + +.+-. ...++. ..+..+..++ ...+..+-.
T Consensus 64 ~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 143 (256)
T TIGR02721 64 WLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAP 143 (256)
T ss_pred EEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCC
Confidence 68999999866531 1 11111 111111 1222322222 111222221
Q ss_pred --CCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 147 --MGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 147 --~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
..++|+|+.|.||+++.++ +.|+||..+..-
T Consensus 144 ~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 144 LPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCCeeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence 2589999999999999877 789999988653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0044 Score=60.06 Aligned_cols=80 Identities=19% Similarity=0.191 Sum_probs=51.8
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHH-hhhhhcccCCCchhhHHHHHHHHHHHhcC--CC-Ccceeeeeeec
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIE-KKSKELTNNDNGDKYRRISFEQRVLRNVE--HP-LLPRLRGVLST 97 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp-~iv~l~~~~~~ 97 (426)
+.||-|....||++.+...++.++||--..-.-. .. .-+-...+...|...|+... -| .+++++.+ +
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~-------~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D 71 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGE-------SWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D 71 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCC-------CCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c
Confidence 3579999999999998544468999964221110 01 11223456778888998875 34 56666553 5
Q ss_pred CCeEEEEEeccCC
Q 014344 98 DKFVGYAIDYCPG 110 (426)
Q Consensus 98 ~~~~~lV~Ey~~g 110 (426)
+....+|||+++.
T Consensus 72 ~e~~~~vMEdL~~ 84 (370)
T TIGR01767 72 TEMAVTVMEDLSH 84 (370)
T ss_pred cccceehHhhCcc
Confidence 6666799999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0031 Score=59.46 Aligned_cols=31 Identities=29% Similarity=0.423 Sum_probs=26.1
Q ss_pred CCcccCCCCCCeeeccCCc-EEEecccccccC
Q 014344 148 GIVYRDLKPENIMIQENGH-IMLVDFDLSTKL 178 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~-ikL~DFgls~~~ 178 (426)
.++|+|++|.|||++.++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0056 Score=58.67 Aligned_cols=30 Identities=27% Similarity=0.555 Sum_probs=26.4
Q ss_pred CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0058 Score=59.26 Aligned_cols=147 Identities=17% Similarity=0.215 Sum_probs=83.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc-
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL- 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i- 88 (426)
++.+..++....| |=...+|++..... +..|.+|+..... +..-.-.+|..+++.+..-++
T Consensus 12 ~~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--------------~~~IdR~~E~~il~~l~~~gl~ 76 (330)
T PLN02421 12 LDDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT--------------DYVIDRERELQAIKYLSAAGFG 76 (330)
T ss_pred CCcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc--------------CeEechHHHHHHHHHHHhcCCC
Confidence 3455666665544 77778998865332 3478999873211 111123458889998865444
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHH--------------HHHHhccCCC-------CHHHHHHHHHHH----------
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHS--------------LRKQQSEQMF-------SDDTIRFYAAEL---------- 137 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~--------------l~~~~~~~~l-------~~~~~~~~~~qi---------- 137 (426)
+++++++.. + +|.+|++|..|.. .+++.....+ ....+..+..++
T Consensus 77 P~~l~~~~~-G---~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~ 152 (330)
T PLN02421 77 AKLLGVFGN-G---MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEK 152 (330)
T ss_pred CceeEEeCC-c---EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHH
Confidence 567766632 2 5899998766521 1111111111 122333333222
Q ss_pred ------------HHHHHHHH----HC----CCcccCCCCCCeeecc-CCcEEEecccccccC
Q 014344 138 ------------VLALEYLH----NM----GIVYRDLKPENIMIQE-NGHIMLVDFDLSTKL 178 (426)
Q Consensus 138 ------------l~aL~~LH----~~----giiHrDlKp~NiLl~~-~g~ikL~DFgls~~~ 178 (426)
..-+..+. .. -++|.|+.+.|||++. ++.++++||..|..-
T Consensus 153 ~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 153 QKKYETISFEELRDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred hhhhcccCHHHHHHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 11122222 11 2799999999999975 578999999988653
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0016 Score=64.89 Aligned_cols=77 Identities=22% Similarity=0.240 Sum_probs=58.7
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCC----------CCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDL----------VGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 264 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~----------~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
++||||+|.++.++..|...+......+....+..- +... ...+..+.++..+|+...|..||...+
T Consensus 111 KsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 111 KSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred chhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence 899999999999999999888776655554444321 1111 122445678999999999999999999
Q ss_pred HhcCCCcCCC
Q 014344 331 IKGHEFFKGV 340 (426)
Q Consensus 331 il~hp~f~~~ 340 (426)
+.+|+-|.++
T Consensus 191 ~~k~~i~~ev 200 (725)
T KOG1093|consen 191 LSKRCSFTEV 200 (725)
T ss_pred HhcCccHHHH
Confidence 9999999765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0067 Score=59.55 Aligned_cols=82 Identities=21% Similarity=0.186 Sum_probs=55.2
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CC-Ccceeeeeee
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HP-LLPRLRGVLS 96 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp-~iv~l~~~~~ 96 (426)
.++.||-|.-..||++.+...++.++||--..-.-... .-+-...+...|..+|+.+. .| ++++++.+
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~-------swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-- 103 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISD-------EFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-- 103 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCC-------CCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--
Confidence 37889999999999999844456788885422111101 11234567888999999875 34 56667653
Q ss_pred cCCeEEEEEeccCC
Q 014344 97 TDKFVGYAIDYCPG 110 (426)
Q Consensus 97 ~~~~~~lV~Ey~~g 110 (426)
++....+|||+++.
T Consensus 104 D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 DSVMNCCVMEDLSD 117 (409)
T ss_pred CcHHhhHHHHhCcc
Confidence 56667789999853
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.003 Score=60.56 Aligned_cols=153 Identities=19% Similarity=0.260 Sum_probs=99.4
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhh-----------cccCCCchhhHH--HHHHHHHHHhcCCC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE-----------LTNNDNGDKYRR--ISFEQRVLRNVEHP 86 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~-----------~~~~~~~~~~~~--~~~E~~il~~l~hp 86 (426)
|-..|..|--+.||.|.. .+|..+|||++.-+.+.-+-+. .-...++...-. ...|++-|.+|..-
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677899999999886 5677899999864433211111 111223333323 34477788888755
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeeeccCC
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp~NiLl~~~g 165 (426)
.|+..--.. - ....|||+++. .+=+-.- ......++...++.+-.|++.-+.-|- ..++||.||.-=|+|+ .+|
T Consensus 227 GIP~PePIl-L-k~hVLVM~FlG-rdgw~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 227 GIPCPEPIL-L-KNHVLVMEFLG-RDGWAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCCCCcee-e-ecceEeeeecc-CCCCcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECC
Confidence 544321111 1 23469999995 3322211 112334888889998889998888885 5799999999999998 478
Q ss_pred cEEEecccccccC
Q 014344 166 HIMLVDFDLSTKL 178 (426)
Q Consensus 166 ~ikL~DFgls~~~ 178 (426)
.+.++|.+-+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 9999999877654
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0051 Score=59.98 Aligned_cols=146 Identities=19% Similarity=0.258 Sum_probs=84.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcC----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC-Cc
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVE----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP-LL 88 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-~i 88 (426)
+.+...+. .|-.|-...+|++.... .++.|.+|+..... ..... -..|..+++.+..- --
T Consensus 35 ~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-------------~~~id-R~~E~~~~~~l~~~gl~ 99 (344)
T PLN02236 35 DDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-------------ELFFD-RDDEIRTFECMSRHGQG 99 (344)
T ss_pred CcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-------------Ceeec-hHHHHHHHHHHHHcCCC
Confidence 33444444 45458888999987432 34689999873321 11122 25688999988643 34
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHH--------------HHHhccC-------CCCHHHHHHHHHHH----------
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSL--------------RKQQSEQ-------MFSDDTIRFYAAEL---------- 137 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l--------------~~~~~~~-------~l~~~~~~~~~~qi---------- 137 (426)
+++++.+... .|.+|++|.+|..- +.+.... ......+..+..++
T Consensus 100 P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~ 175 (344)
T PLN02236 100 PRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAK 175 (344)
T ss_pred CceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhh
Confidence 4677766432 58999987665311 1111000 11123333333222
Q ss_pred -------HHHHHHH----H----HCCCcccCCCCCCeeecc-CCcEEEecccccccC
Q 014344 138 -------VLALEYL----H----NMGIVYRDLKPENIMIQE-NGHIMLVDFDLSTKL 178 (426)
Q Consensus 138 -------l~aL~~L----H----~~giiHrDlKp~NiLl~~-~g~ikL~DFgls~~~ 178 (426)
...+..| . ...++|+|+++.|||+++ ++.+.|+||..+..-
T Consensus 176 ~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 176 EFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred hcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1111122 1 236899999999999986 478999999988753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.012 Score=56.09 Aligned_cols=150 Identities=18% Similarity=0.238 Sum_probs=87.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--CCcceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--PLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~ 93 (426)
....+++.+-.|....+|...+. ++.+++..-.... .........+|..+|+.+.- .-++..++
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~------------~~~~~~~~~re~~~i~~l~~~~vP~p~~~~ 90 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGD------------PVESAHDEKREYRVIAALLDVDVPVPRAFG 90 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEecCCccc------------cchhhhHHHhHHHHHHHhcCCCCCCccccc
Confidence 44566667655655666666644 7788888221111 11234455668888888754 23445555
Q ss_pred eeecCC--eEEEEEeccCCCChHH----------H--------HHHh------c----c--CCCCHHHHHHHHHHH----
Q 014344 94 VLSTDK--FVGYAIDYCPGRDLHS----------L--------RKQQ------S----E--QMFSDDTIRFYAAEL---- 137 (426)
Q Consensus 94 ~~~~~~--~~~lV~Ey~~gg~L~~----------l--------~~~~------~----~--~~l~~~~~~~~~~qi---- 137 (426)
.+.++. ..|.||+|++|..+.+ + +..- . . ..+....+..+..+.
T Consensus 91 ~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~ 170 (321)
T COG3173 91 LCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAK 170 (321)
T ss_pred ccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHH
Confidence 555554 6799999999732211 1 1100 0 0 001122222222232
Q ss_pred ----------HHHHHHHHHC--------CCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 138 ----------VLALEYLHNM--------GIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 138 ----------l~aL~~LH~~--------giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..-..+|+.+ .++|+|+++.||+++..+-+-+.||+++..-.
T Consensus 171 ~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 171 KELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 2224555543 48999999999999999899999999987643
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.0055 Score=55.25 Aligned_cols=30 Identities=33% Similarity=0.655 Sum_probs=21.9
Q ss_pred CCcccCCCCCCeee-ccCCcEEEeccccccc
Q 014344 148 GIVYRDLKPENIMI-QENGHIMLVDFDLSTK 177 (426)
Q Consensus 148 giiHrDlKp~NiLl-~~~g~ikL~DFgls~~ 177 (426)
.++|.||.|.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998865
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.043 Score=51.97 Aligned_cols=76 Identities=11% Similarity=0.079 Sum_probs=49.0
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCcceeeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~ 94 (426)
.+-.+.|+-|....+|.+. .+++.+-+|+-.. .....+..|..-|+.|. --.+++++.+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~----------------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~ 80 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE----------------SGRDMFEGEAEGLKALAEANPIRVPKVIAW 80 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG----------------GGCCHHHHHHHHHHHHCHTTTSBS--EEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh----------------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 3456778889999999988 6788999998642 12346777888888884 3468889998
Q ss_pred eecCCeEEEEEeccCCC
Q 014344 95 LSTDKFVGYAIDYCPGR 111 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg 111 (426)
...++.-||||||++.+
T Consensus 81 G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 81 GEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE-SSCCEEEEE-----
T ss_pred EeecCCceEEEEeecCC
Confidence 88777789999999866
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.037 Score=53.09 Aligned_cols=31 Identities=13% Similarity=0.189 Sum_probs=28.5
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
++||+|+.+.|+|++.++.+.++||..+..-
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.074 Score=52.61 Aligned_cols=80 Identities=20% Similarity=0.210 Sum_probs=52.7
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhH-HhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCcceeeeee
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLLPRLRGVL 95 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~ 95 (426)
-.+.||-|....||++.+. ++.++||.-..... ...+ =+....+...|...|+.+. ..++++++.+.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~-------wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d 106 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGES-------WPMTKERAYFEATALREHGRLCPDHVPEVYHFD 106 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCcc-------ccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC
Confidence 4788999999999999873 45688987532110 0000 0012445666778887764 24788888876
Q ss_pred ecCCeEEEEEeccCC
Q 014344 96 STDKFVGYAIDYCPG 110 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~g 110 (426)
. +..+++|||+++
T Consensus 107 e--d~~vlvME~L~~ 119 (418)
T PLN02756 107 R--TMALIGMRYLEP 119 (418)
T ss_pred C--CCCEEEEeecCC
Confidence 5 446788999976
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.018 Score=55.33 Aligned_cols=73 Identities=21% Similarity=0.274 Sum_probs=56.4
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
...+.|++|++- |+.+.. +.. -..+++..++.+.+..+.-+..+ .+-|||+...||||+ +|.|.|+||-+|
T Consensus 297 e~~y~yl~~kdh-gt~is~-ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-IKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeee-eec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeee
Confidence 345778888875 566543 221 33567778888888887777754 789999999999999 999999999999
Q ss_pred cc
Q 014344 176 TK 177 (426)
Q Consensus 176 ~~ 177 (426)
+.
T Consensus 369 Rl 370 (488)
T COG5072 369 RL 370 (488)
T ss_pred ec
Confidence 84
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.098 Score=51.68 Aligned_cols=82 Identities=10% Similarity=0.160 Sum_probs=48.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCC-Cce-----EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-C
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVES-SES-----FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-P 86 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~-----vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p 86 (426)
+.+..++. .|..|-...+|++..... +.. |.+++... .....-.-..|..+++.|.. .
T Consensus 49 ~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~--------------~~~l~IdR~~E~~i~~~Ls~~g 113 (383)
T PTZ00384 49 NPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST--------------YNSLVIDNDLQYNIAKLLGDNN 113 (383)
T ss_pred CcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC--------------CCceEeccHHHHHHHHHHHhCC
Confidence 44445554 555588889999875432 223 33333200 01111123458899999974 4
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChH
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLH 114 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~ 114 (426)
.=+++++.|.. +++.||++|.+|.
T Consensus 114 lgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 114 FGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred CCCeEEEecCC----EEEEEEeccccCC
Confidence 45677777743 6999999987663
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.043 Score=53.57 Aligned_cols=61 Identities=23% Similarity=0.145 Sum_probs=45.4
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeeecc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp~NiLl~~ 163 (426)
...++-+|..|.++..+++... .++...+.++.-...||-.+- -.+++|.|++|.||++.-
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 3457778999999988876533 566677777776667764443 468999999999999963
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.052 Score=48.74 Aligned_cols=84 Identities=24% Similarity=0.279 Sum_probs=57.5
Q ss_pred HHHHHHHHHhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH--CCCc
Q 014344 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN--MGIV 150 (426)
Q Consensus 73 ~~~E~~il~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~--~gii 150 (426)
+..+.+++.++. .|+++..- +.-.+.+++|+|...... + .-++.+ =+.+|.-.|+ .+.+
T Consensus 105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~----------~----~N~i~a-gi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN----------F----SNFITA-GIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc----------h----hHHHHH-hHHHHHHhhccCCCee
Confidence 455778887764 57777632 334577999999522110 1 111221 2467788894 4899
Q ss_pred ccCCCCCCeeeccCCcEEEeccccc
Q 014344 151 YRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 151 HrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
|+|-.|+|||-|..|.+||.|=+..
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCCCEEecChhhh
Confidence 9999999999999999999997743
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.28 Score=47.43 Aligned_cols=30 Identities=23% Similarity=0.227 Sum_probs=25.3
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
.++||+|+.+.|||++ + .+.|+||+.+..-
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~g 225 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARMG 225 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCCC
Confidence 3789999999999995 4 5789999988753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.24 Score=55.33 Aligned_cols=32 Identities=22% Similarity=0.407 Sum_probs=27.2
Q ss_pred CCCcccCCCCCCeeeccCC--cEE-EecccccccC
Q 014344 147 MGIVYRDLKPENIMIQENG--HIM-LVDFDLSTKL 178 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g--~ik-L~DFgls~~~ 178 (426)
.++||+|+.+.|||++.++ .+. |+|||.+..-
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 4799999999999999875 565 9999988653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.23 Score=50.03 Aligned_cols=81 Identities=19% Similarity=0.194 Sum_probs=49.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcC--------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVE--------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
+.++. -++.|..|-.-.+|++.... .++.|.+++.-... ...-.-..|..+++.+..
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--------------e~lIdR~~E~~v~~~ls~ 168 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--------------DELYNPISEFEVYKTMSK 168 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--------------cceeCHHHHHHHHHHHHH
Confidence 34455 56667777778889887542 14678999873211 111123447788888764
Q ss_pred CCc-ceeeeeeecCCeEEEEEeccCCCCh
Q 014344 86 PLL-PRLRGVLSTDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 86 p~i-v~l~~~~~~~~~~~lV~Ey~~gg~L 113 (426)
-+| +++++.|. -+.|.+|++|.+|
T Consensus 169 ~gi~P~l~~~f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 169 YRIAPQLLNTFS----GGRIEEWLYGDPL 193 (442)
T ss_pred CCCCCceEEEeC----CCEEEEeeCCccC
Confidence 444 35666653 2467899988644
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.078 Score=50.38 Aligned_cols=52 Identities=29% Similarity=0.410 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHHHHHH----CCCcccCCCCCCeeeccCC------------------cEEEecccccccC
Q 014344 127 DDTIRFYAAELVLALEYLHN----MGIVYRDLKPENIMIQENG------------------HIMLVDFDLSTKL 178 (426)
Q Consensus 127 ~~~~~~~~~qil~aL~~LH~----~giiHrDlKp~NiLl~~~g------------------~ikL~DFgls~~~ 178 (426)
.+-+++++.||+.-.-.+-+ .+++|-||||+|||+-... ..+|.||.+|..-
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 45678888888776544433 3699999999999984322 3567888887653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 426 | ||||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-35 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-35 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-30 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-30 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-28 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-28 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-27 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-27 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-26 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-25 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-23 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-23 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-21 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-20 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-19 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-19 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-18 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-15 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-15 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-15 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-15 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-12 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 6e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 7e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 |
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 426 | |||
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-92 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-87 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-83 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-83 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-83 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 7e-82 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-81 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 3e-80 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 4e-80 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 7e-80 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 8e-80 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-78 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-77 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-76 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-75 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-75 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 5e-75 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 7e-75 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-75 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-74 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-71 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-70 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-69 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-63 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-59 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-59 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-59 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-56 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-55 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-54 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-53 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-53 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-53 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-51 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-50 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-48 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-47 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 6e-47 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 9e-47 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-46 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-46 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-46 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-46 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-46 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-46 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-46 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-45 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-45 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-45 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 2e-45 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-45 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 3e-45 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-45 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-45 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-45 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-45 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 7e-45 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 9e-45 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-44 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-44 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-44 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 9e-44 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-43 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-43 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 4e-43 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-43 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 6e-43 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 7e-40 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-42 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-42 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-42 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-42 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-42 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-42 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-42 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 7e-42 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-41 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-41 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 4e-41 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-41 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-40 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-40 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-40 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-40 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 7e-40 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 9e-40 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-38 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-38 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-38 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-38 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 4e-37 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-37 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 9e-37 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-35 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 2e-31 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-29 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-29 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 6e-29 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-29 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 3e-28 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-28 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 7e-28 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 5e-22 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 1e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-26 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-26 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-26 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-25 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-22 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-25 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-21 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 7e-25 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-24 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-21 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 5e-24 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 7e-24 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-23 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-23 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-22 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-22 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-22 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-22 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-22 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-22 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 7e-22 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-21 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-21 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-20 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-20 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-07 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 6e-19 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-19 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 9e-19 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-18 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-18 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-12 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-17 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-08 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-16 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-15 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-06 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-15 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 2e-07 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-15 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-13 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-15 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-15 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 9e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-14 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-14 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-08 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-14 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-10 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-14 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-09 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 7e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-06 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 9e-14 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-13 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-07 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-13 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-09 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-13 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-13 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 4e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 7e-10 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-12 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-09 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-12 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 7e-07 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-09 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-12 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-09 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-12 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 1e-07 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-11 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-11 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-11 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-05 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 5e-11 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-06 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 8e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-04 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-08 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-08 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-08 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 5e-08 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-08 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-08 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-08 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-08 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 7e-08 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-07 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-07 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-07 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-07 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-07 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-07 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-07 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-07 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-07 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-07 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 2e-04 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 7e-07 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-06 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-04 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-06 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-06 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-06 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-06 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-06 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-06 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-06 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-06 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 5e-06 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-06 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-05 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-05 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-05 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-05 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-05 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 5e-05 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-05 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-05 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 6e-05 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 6e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-05 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-04 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-04 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-04 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-04 |
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 9e-92
Identities = 96/352 (27%), Positives = 155/352 (44%), Gaps = 81/352 (23%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-ELTNNDNGDKYRR 72
DF +I LG G+ V L +++ +S +A+K++ + I K++K
Sbjct: 31 DFKFGKI---LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTR-------- 79
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIR 131
E+ V+ ++HP +L D+ + + + Y +L +RK F + R
Sbjct: 80 ---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---IGSFDETCTR 133
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FY AE+V ALEYLH GI++RDLKPENI++ E+ HI + DF + LSP++ QA +
Sbjct: 134 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-- 191
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
F GT +YV
Sbjct: 192 -----------------FV-----------------------------------GTAQYV 199
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPL 310
+PE++ K + D W+LG ++++++ G PFR + F +I+ D
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 311 RNLIRRLLEKDPTKRIG------VEEIKGHEFFKGVNWELLLKISRPPNIPA 356
R+L+ +LL D TKR+G +K H FF+ V WE L + PP + A
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ-QTPPKLTA 310
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 1e-87
Identities = 106/351 (30%), Positives = 164/351 (46%), Gaps = 85/351 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRR 72
DF LR LG G+ G V L++ + +A+KV+ ++ K E TN+
Sbjct: 7 DFQILRT---LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND-------- 55
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIR 131
E+ +L V HP + R+ G + + +DY G +L S LRK Q F + +
Sbjct: 56 ---ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---SQRFPNPVAK 109
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FYAAE+ LALEYLH+ I+YRDLKPENI++ +NGHI + DF + + T
Sbjct: 110 FYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--------- 160
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
T C GT +Y+
Sbjct: 161 --YT-------------LC-----------------------------------GTPDYI 170
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-L 310
APE++ K ++ ++DWWS G++++EML G TPF S+ +T+ +IL +
Sbjct: 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 230
Query: 311 RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
++L+ RL+ +D ++R+G E++K H +FK V WE LL + P P
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 2e-83
Identities = 113/356 (31%), Positives = 168/356 (47%), Gaps = 88/356 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKY 70
F LR+ LG+G G VF V+ V + + FA+KV+ + +I + +K+
Sbjct: 18 CFELLRV---LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-------- 66
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDT 129
E+ +L V+HP + L T + ++Y G +L L + E +F +DT
Sbjct: 67 -HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER---EGIFMEDT 122
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
FY AE+ +AL +LH GI+YRDLKPENIM+ GH+ L DF L K
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC------------KE 170
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+ T + FC GT E
Sbjct: 171 SIHDGTVT---------HTFC-----------------------------------GTIE 186
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP 309
Y+APEI+ GH+ AVDWWSLG ++++ML GA PF G +RK+T +IL +L P
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNL---PPY 243
Query: 310 L----RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
L R+L+++LL+++ R+G E++ H FF+ +NWE LL + PP P
Sbjct: 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP 299
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 3e-83
Identities = 114/357 (31%), Positives = 171/357 (47%), Gaps = 90/357 (25%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK---DVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
F L++ LG+G+ G VFLVK ++ + +A+KV+ + ++ + + T
Sbjct: 25 QFELLKV---LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM------ 75
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDT 129
E+ +L V HP + +L T+ + +D+ G DL L K E MF+++
Sbjct: 76 -----ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK---EVMFTEED 127
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
++FY AEL LAL++LH++GI+YRDLKPENI++ E GHI L DF LS K
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS------------KE 175
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+ ++ FC GT E
Sbjct: 176 SIDHEKKA---------YSFC-----------------------------------GTVE 191
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP 309
Y+APE++ +GH + DWWS GV++ EML G PF+G RKET IL + P
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---PQF 248
Query: 310 L----RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIPA 356
L ++L+R L +++P R+G VEEIK H FF ++W L + PP PA
Sbjct: 249 LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPA 305
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 8e-83
Identities = 94/365 (25%), Positives = 161/365 (44%), Gaps = 87/365 (23%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-ELTN 63
+ D +++ D+ +++ +GRGA G V LV+ + + +A+K++ + + K+S
Sbjct: 61 IRDLRMKAEDYEVVKV---IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 117
Query: 64 NDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
E+ ++ P + +L D+++ ++Y PG DL +L S
Sbjct: 118 E-----------ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL---MSNY 163
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
+ RFY AE+VLAL+ +H+MG ++RD+KP+N+++ ++GH+ L DF K++ +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243
+T
Sbjct: 224 VRC-------DT-------------AV--------------------------------- 230
Query: 244 FVGTEEYVAPEIIEGKG----HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC- 298
GT +Y++PE+++ +G + DWWS+GV L+EML G TPF S T+ +I+
Sbjct: 231 --GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 288
Query: 299 ----RPPDLVGEPTPLRNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWE-LLLKISR 350
PD +NLI L D R+G VEEIK H FFK W L+ +
Sbjct: 289 KNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 347
Query: 351 PPNIP 355
P +P
Sbjct: 348 APVVP 352
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 7e-82
Identities = 107/354 (30%), Positives = 163/354 (46%), Gaps = 88/354 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF L++ LG+G G V LV++ + +A+K++ +++I K D+
Sbjct: 6 DFDYLKL---LGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHT 52
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIR 131
E RVL+N HP L L+ T + + ++Y G +L H E++F+++ R
Sbjct: 53 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH----LSRERVFTEERAR 108
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FY AE+V ALEYLH+ +VYRD+K EN+M+ ++GHI + DF L
Sbjct: 109 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL----------------- 151
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
C GIS +F GT EY+
Sbjct: 152 ------------------CKEGISDGA---------------------TMKTFCGTPEYL 172
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL- 310
APE++E + AVDWW LGVV++EM+ G PF + F IL P L
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF---PRTLS 229
Query: 311 ---RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
++L+ LL+KDP +R+G +E+ H FF +NW+ ++ K PP P
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-81
Identities = 85/355 (23%), Positives = 156/355 (43%), Gaps = 89/355 (25%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRD-LIEKKSKELTNNDNGDKYRR 72
F LR A+G+G+ G V +V+ ++ + +A+K + + +E+
Sbjct: 16 HFEILR---AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-------- 64
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIR 131
E ++++ +EHP L L ++ + +D G DL L++ F ++T++
Sbjct: 65 ---ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ---NVHFKEETVK 118
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
+ ELV+AL+YL N I++RD+KP+NI++ E+GH+ + DF+++ L +T +
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT----- 173
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
GT+ Y+
Sbjct: 174 -----------------MA-----------------------------------GTKPYM 181
Query: 252 APEII---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILCRP---PD 302
APE+ +G G+ FAVDWWSLGV +E+L G P+ S KE + P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIG-VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
+ + +L+++LLE +P +R + +++ + +NW+ + K P IP
Sbjct: 242 AWSQ--EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIP 294
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 3e-80
Identities = 92/367 (25%), Positives = 154/367 (41%), Gaps = 87/367 (23%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNN 64
+ + ++ DF L++ +GRGA V +VK ++ + +A+K++ + + K+
Sbjct: 53 LKEVRLQRDDFEILKV---IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR------- 102
Query: 65 DNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM 124
+ E+ VL N + + +L + ++ ++Y G DL +L + +
Sbjct: 103 ---GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL-SKFGER 158
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
+ RFY AE+V+A++ +H +G V+RD+KP+NI++ GHI L DF KL
Sbjct: 159 IPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218
Query: 185 ASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
S
Sbjct: 219 RS-------LV-------------AV---------------------------------- 224
Query: 245 VGTEEYVAPEIIEGKG-------HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL 297
GT +Y++PEI++ G + DWW+LGV +EM YG TPF S ET+ +I+
Sbjct: 225 -GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 298 CR------PPDLVGEPTPLRNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWELLLKI 348
P G P R+ I+RLL P R+G + + H FF G++W+ L
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFFGLDWDGLRDS 342
Query: 349 SRPPNIP 355
PP P
Sbjct: 343 -VPPFTP 348
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 4e-80
Identities = 117/355 (32%), Positives = 169/355 (47%), Gaps = 90/355 (25%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDNGDKYRR 72
DF L++ +G+G+ G V L + +A+KV+ + I +KK ++ +
Sbjct: 39 DFHFLKV---IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS-------- 87
Query: 73 ISFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTI 130
E+ VL +NV+HP L L T + + +DY G +L + L++ E+ F +
Sbjct: 88 ---ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR---ERCFLEPRA 141
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
RFYAAE+ AL YLH++ IVYRDLKPENI++ GHI+L DF L K
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC------------KEN 189
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
+ N+ + S FC GT EY
Sbjct: 190 IEHNSTT---------STFC-----------------------------------GTPEY 205
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL 310
+APE++ + +D VDWW LG VL+EMLYG PF + E + IL +P L +
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNI 262
Query: 311 ----RNLIRRLLEKDPTKRIG----VEEIKGHEFFKGVNWELLL--KISRPPNIP 355
R+L+ LL+KD TKR+G EIK H FF +NW+ L+ KI PP P
Sbjct: 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI-TPPFNP 316
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 7e-80
Identities = 96/354 (27%), Positives = 151/354 (42%), Gaps = 87/354 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF+ L + LG+G+ G V L + + E +A+K++ +D++ + D
Sbjct: 21 DFNFLMV---LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECT 67
Query: 74 SFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIR 131
E+RVL + P L +L T + + ++Y G DL + + Q F +
Sbjct: 68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV 124
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FYAAE+ + L +L + GI+YRDLK +N+M+ GHI + DF +
Sbjct: 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----------------- 167
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
C I + +F GT +Y+
Sbjct: 168 ------------------CKENIWDGV---------------------TTKTFCGTPDYI 188
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL- 310
APEII + + +VDWW+ GV+L+EML G PF G E F I+ P +
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSMS 245
Query: 311 ---RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
+ + L+ K P KR+G +IK H FF+ ++WE L K +PP P
Sbjct: 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 299
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 8e-80
Identities = 106/351 (30%), Positives = 166/351 (47%), Gaps = 85/351 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF ++ LG+G+ G VFL + ++++ FA+K + +D++ D
Sbjct: 18 DFILHKM---LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECT 64
Query: 74 SFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTI 130
E+RVL EHP L + T + + + ++Y G DL H QS F
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH----IQSCHKFDLSRA 120
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
FYAAE++L L++LH+ GIVYRDLK +NI++ ++GHI + DF +
Sbjct: 121 TFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGM---------------- 164
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
C + + K+N+F GT +Y
Sbjct: 165 -------------------CKENMLGDA---------------------KTNTFCGTPDY 184
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL 310
+APEI+ G+ ++ +VDWWS GV+L+EML G +PF G +E F+ I P P L
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY---PRWL 241
Query: 311 ----RNLIRRLLEKDPTKRIGV-EEIKGHEFFKGVNWELLL-KISRPPNIP 355
++L+ +L ++P KR+GV +I+ H F+ +NWE L K PP P
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP 292
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 8e-78
Identities = 96/355 (27%), Positives = 154/355 (43%), Gaps = 88/355 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
+F +R+ LG+G+ G V L + E+ + +A+KV+ +D+I + D
Sbjct: 24 NFEFIRV---LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD----------DDVECT 70
Query: 74 SFEQRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIR 131
E+R+L HP L +L T + + +++ G DL + Q + F + R
Sbjct: 71 MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI---QKSRRFDEARAR 127
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FYAAE++ AL +LH+ GI+YRDLK +N+++ GH L DF + K +
Sbjct: 128 FYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC------------KEGI 175
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
+ + FC GT +Y+
Sbjct: 176 CNGVTT---------ATFC-----------------------------------GTPDYI 191
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL- 310
APEI++ + AVDWW++GV+L+EML G PF + + F IL PT L
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLH 248
Query: 311 ---RNLIRRLLEKDPTKRIG------VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
+++ + K+PT R+G I H FFK ++W L + PP P
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP 303
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 4e-77
Identities = 109/355 (30%), Positives = 162/355 (45%), Gaps = 89/355 (25%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
+F L++ LG+G G V LVK+ + +A+K++ +++I K D+
Sbjct: 149 EFEYLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHT 195
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIR 131
E RVL+N HP L L+ T + + ++Y G +L H E++FS+D R
Sbjct: 196 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH----LSRERVFSEDRAR 251
Query: 132 FYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
FY AE+V AL+YLH+ +VYRDLK EN+M+ ++GHI + DF L
Sbjct: 252 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL---------------- 295
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
C GI +F GT EY
Sbjct: 296 -------------------CKEGIKDGA---------------------TMKTFCGTPEY 315
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL 310
+APE++E + AVDWW LGVV++EM+ G PF ++ F IL P L
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF---PRTL 372
Query: 311 ----RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
++L+ LL+KDP +R+G +EI H FF G+ W+ + K PP P
Sbjct: 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 3e-76
Identities = 115/363 (31%), Positives = 170/363 (46%), Gaps = 94/363 (25%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKY 70
+F L++ LG GA G VFLV+ + ++ +A+KV+ + I +K+K
Sbjct: 55 NFELLKV---LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT--------- 102
Query: 71 RRISFEQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDD 128
E++VL ++ P L L T+ + +DY G +L L + + F++
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---RERFTEH 159
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
++ Y E+VLALE+LH +GI+YRD+K ENI++ NGH++L DF LS K
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-KEFVADETERAY 218
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
FC GT
Sbjct: 219 D-------------------FC-----------------------------------GTI 224
Query: 249 EYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPF----RGSSRKETFYRILCRPPD 302
EY+AP+I+ G GHD AVDWWSLGV+++E+L GA+PF +S+ E RIL P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 303 LVGEPTPL----RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPP 352
P + ++LI+RLL KDP KR+G +EIK H FF+ +NW+ L K P
Sbjct: 285 Y---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341
Query: 353 NIP 355
P
Sbjct: 342 FKP 344
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 2e-75
Identities = 87/388 (22%), Positives = 152/388 (39%), Gaps = 94/388 (24%)
Query: 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDN 66
+P+ F R+ LGRG G VF + + + +A K + + + ++K +
Sbjct: 180 QPMGEDWFLDFRV---LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-- 234
Query: 67 GDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQM 124
E+++L V + L T + + G D+ H +
Sbjct: 235 ---------EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
F + FY A++V LE+LH I+YRDLKPEN+++ ++G++ + D L+
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA--------- 336
Query: 185 ASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
+ A T++ +
Sbjct: 337 ---VELKAGQTKT---------KGYA---------------------------------- 350
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK----ETFYRILCRP 300
GT ++APE++ G+ +DF+VD+++LGV L+EM+ PFR K E R+L +
Sbjct: 351 -GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409
Query: 301 PDL-VGEPTPLRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPN 353
++ LL+KDP KR+G + ++ H F+ ++W L + PP
Sbjct: 410 VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPF 469
Query: 354 IPARFEHENNESDGRGRDGTKEIDVEKF 381
+P D R DV F
Sbjct: 470 VP----------DSRTVYAKNIQDVGAF 487
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-75
Identities = 101/373 (27%), Positives = 163/373 (43%), Gaps = 99/373 (26%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNND 65
P+ DF LR+ +GRG+ V LV+ ++ +A+KV+ ++L+
Sbjct: 2 AMDPLGLQDFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-------- 50
Query: 66 NGDKYRRISFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSE 122
+ + E+ V + HP L L T+ + + I+Y G DL H Q +
Sbjct: 51 --EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH----MQRQ 104
Query: 123 QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
+ ++ RFY+AE+ LAL YLH GI+YRDLK +N+++ GHI L D+ +
Sbjct: 105 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC------- 157
Query: 183 PQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242
K L + S FC
Sbjct: 158 -----KEGLRPGDTT---------STFC-------------------------------- 171
Query: 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPF---------RGSSRKETF 293
GT Y+APEI+ G+ + F+VDWW+LGV++ EM+ G +PF ++ F
Sbjct: 172 ---GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
Query: 294 YRILCRPPDLVGEPTPL----RNLIRRLLEKDPTKRIG------VEEIKGHEFFKGVNWE 343
IL + + P L ++++ L KDP +R+G +I+GH FF+ V+W+
Sbjct: 229 QVILEKQIRI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285
Query: 344 LLL-KISRPPNIP 355
++ K PP P
Sbjct: 286 MMEQKQVVPPFKP 298
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 246 bits (628), Expect = 5e-75
Identities = 96/354 (27%), Positives = 151/354 (42%), Gaps = 87/354 (24%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF+ L + LG+G+ G V L + + E +A+K++ +D++ + D
Sbjct: 342 DFNFLMV---LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECT 388
Query: 74 SFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIR 131
E+RVL + P L +L T + + ++Y G DL + + Q F +
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAV 445
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
FYAAE+ + L +L + GI+YRDLK +N+M+ GHI + DF +
Sbjct: 446 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----------------- 488
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
C I + +F GT +Y+
Sbjct: 489 ------------------CKENIWDGV---------------------TTKTFCGTPDYI 509
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL- 310
APEII + + +VDWW+ GV+L+EML G PF G E F I+ P +
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSMS 566
Query: 311 ---RNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
+ + L+ K P KR+G +IK H FF+ ++WE L K +PP P
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKP 620
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 7e-75
Identities = 96/367 (26%), Positives = 160/367 (43%), Gaps = 89/367 (24%)
Query: 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTN 63
V + DF L++ +GRGA G V +VK + + FA+K++ +++++
Sbjct: 66 VKQMRLHREDFEILKV---IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 122
Query: 64 NDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
E+ VL N + + L D + +DY G DL +L + E
Sbjct: 123 E-----------ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFED 170
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
++ RFY AE+V+A++ +H + V+RD+KP+N +L+D
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN---------ILMD------------ 209
Query: 184 QASPKTVLAANTRSG-IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242
+G I+ L+ F G L+ D + +S+
Sbjct: 210 ------------MNGHIR-----LADF---GSCLKL---------------MEDGTVQSS 234
Query: 243 SFVGTEEYVAPEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL 297
VGT +Y++PEI++ + DWWSLGV ++EMLYG TPF S ET+ +I+
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294
Query: 298 ------CRPPDLVGEPTPLRNLIRRLLEKDPTKRIG---VEEIKGHEFFKGVNWELLLKI 348
P + ++LIRRL+ R+G +E+ K H FF G++W+ +
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFSGIDWDNIRNC 353
Query: 349 SRPPNIP 355
P IP
Sbjct: 354 -EAPYIP 359
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 7e-75
Identities = 88/360 (24%), Positives = 145/360 (40%), Gaps = 83/360 (23%)
Query: 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDN 66
+P+ F R+ LG+G G V + + + +A K + + I ++K + + N
Sbjct: 179 QPVTKNTFRQYRV---LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-- 233
Query: 67 GDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFS 126
E+++L V + L T + + G DL + F
Sbjct: 234 ---------EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+ FYAAE+ LE LH IVYRDLKPENI++ ++GHI + D L+ +
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 341
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
+ G
Sbjct: 342 --------IKG-----------RV-----------------------------------G 347
Query: 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRG----SSRKETFYRILCRPPD 302
T Y+APE+++ + + F+ DWW+LG +L+EM+ G +PF+ R+E + P +
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 303 LVGEPTP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
+P R+L +LL KDP +R+G E+K H FK +N++ L + PP P
Sbjct: 408 YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKP 467
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 6e-74
Identities = 99/365 (27%), Positives = 161/365 (44%), Gaps = 99/365 (27%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DF LR+ +GRG+ V LV+ ++ +A++V+ ++L+ + +
Sbjct: 53 DFDLLRV---IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----------EDIDWV 99
Query: 74 SFEQRVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTI 130
E+ V + HP L L T+ + + I+Y G DL H Q ++ ++
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH----MQRQRKLPEEHA 155
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
RFY+AE+ LAL YLH GI+YRDLK +N+++ GHI L D+ + K
Sbjct: 156 RFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC------------KEG 203
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
L + S FC GT Y
Sbjct: 204 LRPGDTT---------STFC-----------------------------------GTPNY 219
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPF---------RGSSRKETFYRILCRPP 301
+APEI+ G+ + F+VDWW+LGV++ EM+ G +PF ++ F IL +
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 302 DLVGEPTPL----RNLIRRLLEKDPTKRIG------VEEIKGHEFFKGVNWELLL-KISR 350
+ P L ++++ L KDP +R+G +I+GH FF+ V+W+++ K
Sbjct: 280 RI---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 336
Query: 351 PPNIP 355
PP P
Sbjct: 337 PPFKP 341
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-71
Identities = 101/384 (26%), Positives = 165/384 (42%), Gaps = 101/384 (26%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDNGDKYRR 72
DFS RI +GRG G V+ + ++ + +A+K + + I K+ + L N
Sbjct: 190 DFSVHRI---IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-------- 238
Query: 73 ISFEQRVL---RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDD 128
E+ +L + P + + T + + +D G DLH L + +FS+
Sbjct: 239 ---ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEA 292
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
+RFYAAE++L LE++HN +VYRDLKP NI++ E+GH+ + D L+ S K P A
Sbjct: 293 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--- 349
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
GT
Sbjct: 350 --------------------SV-----------------------------------GTH 354
Query: 249 EYVAPEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILCRPPDLV 304
Y+APE+++ G +D + DW+SLG +L ++L G +PFR K E L +L
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
Query: 305 GEPTP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIPAR 357
+P LR+L+ LL++D +R+G +E+K FF+ ++W+ + L+ PP IP
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP-- 472
Query: 358 FEHENNESDGRGRDGTKEIDVEKF 381
+ D+ F
Sbjct: 473 --------PRGEVNAADAFDIGSF 488
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 2e-70
Identities = 83/337 (24%), Positives = 138/337 (40%), Gaps = 82/337 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V+L ++ ++ ALKV+++ +EK+ E + RR E + ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE-------HQLRR---EIEIQSHL 71
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + R+ K + +++ P +L+ + Q F + + EL AL Y
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYK--ELQKHGRFDEQRSATFMEELADALHY 129
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
H +++RD+KPEN+++ G + + DF S
Sbjct: 130 CHERKVIHRDIKPENLLMGYKGELKIADFGWS---------------------------- 161
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
VH+P S + + GT +Y+ PE+IEGK HD
Sbjct: 162 ----------------VHAP--------------SLRRRTMCGTLDYLPPEMIEGKTHDE 191
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLE 319
VD W GV+ +E L G PF S ET RI+ PP L ++LI +LL
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL---SDGSKDLISKLLR 248
Query: 320 KDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPA 356
P +R+ ++ + H + K + PP +
Sbjct: 249 YHPPQRLPLKGVMEHPWVK-----ANSRRVLPPVYQS 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-69
Identities = 86/325 (26%), Positives = 139/325 (42%), Gaps = 79/325 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G V+L ++ +S ALKV+++ +EK E + RR E + ++
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE-------HQLRR---EVEIQSHL 66
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + RL G V ++Y P ++ L+K F + Y EL AL
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALS 123
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
Y H+ +++RD+KPEN+++ G + + DF S
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--------------------------- 156
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
VH+P S + GT +Y+ PE+IEG+ HD
Sbjct: 157 -----------------VHAP--------------SSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLL 318
VD WSLGV+ +E L G PF ++ +ET+ RI P + R+LI RLL
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV---TEGARDLISRLL 242
Query: 319 EKDPTKRIGVEEIKGHEFFKGVNWE 343
+ +P++R + E+ H + + +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSK 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-63
Identities = 73/347 (21%), Positives = 132/347 (38%), Gaps = 78/347 (22%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
++ LG+GA G V ++ S +A+K I + ++ +K I E +
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI------RHTE--------EKLSTILSEVML 55
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAI-------------DYCPGRDLHSLRKQQSEQMFS 126
L ++ H + R + + +YC L+ L ++
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQ 114
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
D +++ AL Y+H+ GI++RDLKP NI I E+ ++ + DF L+ +
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
S++ SS+ S +G
Sbjct: 175 ------------------------------------------LDSQNLPGSSDNLTSAIG 192
Query: 247 TEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PP 301
T YVA E+++G GH + +D +SLG++ EM+Y G R ++ PP
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPP 250
Query: 302 DLVGEPTP-LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK 347
D + +IR L++ DP KR G + + + + ++K
Sbjct: 251 DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-59
Identities = 79/319 (24%), Positives = 133/319 (41%), Gaps = 75/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G F + D ++ E FA K++ + L+ K + +K E + R++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-------EKMSM---EISIHRSL 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
H + G + FV ++ C R L L K++ + ++ R+Y ++VL +Y
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 130
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH +++RDLK N+ + E+ + + DF L+TK ++
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK---------------------VEYDG 169
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
C GT Y+APE++ KGH F
Sbjct: 170 ERKKVLC-----------------------------------GTPNYIAPEVLSKKGHSF 194
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLE 319
VD WS+G +++ +L G PF S KET+ RI P + +LI+++L+
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI---NPVAASLIQKMLQ 251
Query: 320 KDPTKRIGVEEIKGHEFFK 338
DPT R + E+ EFF
Sbjct: 252 TDPTARPTINELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 3e-59
Identities = 79/319 (24%), Positives = 133/319 (41%), Gaps = 75/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G F + D ++ E FA K++ + L+ K + +K E + R++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-------EKMSM---EISIHRSL 98
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
H + G + FV ++ C R L L K++ + ++ R+Y ++VL +Y
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQY 156
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH +++RDLK N+ + E+ + + DF L+TK ++
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK---------------------VEYDG 195
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
C GT Y+APE++ KGH F
Sbjct: 196 ERKKVLC-----------------------------------GTPNYIAPEVLSKKGHSF 220
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLE 319
VD WS+G +++ +L G PF S KET+ RI P + +LI+++L+
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI---NPVAASLIQKMLQ 277
Query: 320 KDPTKRIGVEEIKGHEFFK 338
DPT R + E+ EFF
Sbjct: 278 TDPTARPTINELLNDEFFT 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-59
Identities = 63/319 (19%), Positives = 123/319 (38%), Gaps = 74/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ V+ + + + A+K+I + + K + + E ++ +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV-------QRVQN---EVKIHCQL 68
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + L +V ++ C +++ K + + FS++ R + +++ + Y
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLY 127
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ GI++RDL N+++ N +I + DF L+T+ +K
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ---------------------LKMPH 166
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
C GT Y++PEI H
Sbjct: 167 EKHYTLC-----------------------------------GTPNYISPEIATRSAHGL 191
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRRLLE 319
D WSLG + + +L G PF + K T +++ P L ++LI +LL
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL---SIEAKDLIHQLLR 248
Query: 320 KDPTKRIGVEEIKGHEFFK 338
++P R+ + + H F
Sbjct: 249 RNPADRLSLSSVLDHPFMS 267
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-56
Identities = 71/367 (19%), Positives = 124/367 (33%), Gaps = 94/367 (25%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG----DKYRRIS 74
RI+ L +G + L + + ++ +ALK + L+EKK +N++ KY
Sbjct: 34 RIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL------HSLRKQQSEQMFSDD 128
E +++ ++++ G+++ V +Y + + +
Sbjct: 92 NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 129 TIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
I+ ++ + Y+HN I +RD+KP NI L+D + KL
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI---------LMDKNGRVKL--------- 193
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
S F G S + +K GT
Sbjct: 194 -------------------SDF---GES----EYMV--------------DKKIKGSRGT 213
Query: 248 EEYVAPEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRIL------- 297
E++ PE + + VD WSLG+ L+ M Y PF S E F I
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
Query: 298 -------------CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344
+ ++ L K+P +RI E+ HE+ N E
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
Query: 345 LLKISRP 351
L + S+
Sbjct: 334 LREFSKE 340
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-55
Identities = 46/342 (13%), Positives = 99/342 (28%), Gaps = 73/342 (21%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRD---------------LIEKKSKELTNNDNGD 68
LG+ D E+ ESF + V + L + + + N
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVG-YAIDYCPGRDLHSL-----RKQQSE 122
+ R F ++++ + + R+R + + + +L + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 123 QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
+ +++ L LH+ G+V+ L+P +I++ + G + L F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF---------- 250
Query: 183 PQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242
R S P P+
Sbjct: 251 ---------------EHLVRDGARVVSSVS------RGFEP---PE-------------- 272
Query: 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
++ F+ D W+LG+V++ + P + I +
Sbjct: 273 -LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN 331
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344
+ P P+R L+ L R+ + ++ + EL
Sbjct: 332 I---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 2e-54
Identities = 63/339 (18%), Positives = 116/339 (34%), Gaps = 75/339 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LGRG GVVF K+ ++A+K I E +++ E +
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR------------EVK 55
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI------------DYCPGRDLHS-LRKQQSEQMF 125
L +EHP + R C +L + + + +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
++ A+E+LH+ G+++RDLKP NI + + + DF L T + +
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
+ + + + V
Sbjct: 176 T--------------------------------------------VLTPMPAYARHTGQV 191
Query: 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPD 302
GT+ Y++PE I G + VD +SLG++L E+LY PF + + PP
Sbjct: 192 GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL 248
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
+ +++ +L P +R I + F+ ++
Sbjct: 249 FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-53
Identities = 52/383 (13%), Positives = 108/383 (28%), Gaps = 86/383 (22%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVI---------------WRDLIEKKSKELT 62
L + LG+ D E+ ESF + V L + + +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 63 NNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST----DKFVGYAIDYCPGRDLHSL-- 116
N + R F ++++ + + R+R +F Y + +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 117 RKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176
+ + +++ L LH+ G+V+ L+P +I++ + G +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV--------- 250
Query: 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236
FL+ F R +
Sbjct: 251 ----------------------------FLTGF---EHL---------------VRDGAS 264
Query: 237 SSEKSNSFVGTEEYVAPEIIEGKGHD-----FAVDWWSLGVVLHEMLYGATPFRGSSRKE 291
+ E A ++ H FA D W+LG+ ++ + P +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324
Query: 292 TFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL--LLKIS 349
I ++ P P+R L+ L R+ + ++ + EL L +
Sbjct: 325 GSEWIFRSCKNI---PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381
Query: 350 RPPNIPARFEHENNESDGRGRDG 372
+ P R + +
Sbjct: 382 QTDGEPTREGGAPPSGTSQPDEA 404
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-53
Identities = 69/330 (20%), Positives = 110/330 (33%), Gaps = 74/330 (22%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
S + +S LG G+ G VF V+ E +A+K K +
Sbjct: 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLA------ 105
Query: 71 RRISFEQRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
E V +HP RL + + C G L + +
Sbjct: 106 -----EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQ 158
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+ Y + +LAL +LH+ G+V+ D+KP NI + G L DF L +L
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG------- 211
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
A + G DP
Sbjct: 212 --AGEVQEG-------------------DP-----------------------------R 221
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGAT-PFRGSSRKETFYRILCRPPDLVGEPT 308
Y+APE+++G + A D +SLG+ + E+ P G ++ L P G +
Sbjct: 222 YMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL-PPEFTAGLSS 279
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
LR+++ +LE DP R E + +
Sbjct: 280 ELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 9e-53
Identities = 78/349 (22%), Positives = 132/349 (37%), Gaps = 69/349 (19%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G+ G LVK E + +K I ++ SKE + E
Sbjct: 27 VRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRR---------EVA 75
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
VL N++HP + + R + + +DYC G DL Q +F +D I + ++
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
LAL+++H+ I++RD+K +N I L T+ G
Sbjct: 136 LALKHVHDRKILHRDIKSQN--------IFL-------------------------TKDG 162
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ L F GI+ R + + E + + +GT Y++PEI E
Sbjct: 163 TVQ----LGDF---GIA----------------RVLNSTVELARACIGTPYYLSPEICEN 199
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--PTPLRNLIRR 316
K ++ D W+LG VL+E+ F S K +I+ V LR+L+ +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ 259
Query: 317 LLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNES 365
L +++P R V I F + L + +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQ 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-51
Identities = 60/329 (18%), Positives = 108/329 (32%), Gaps = 73/329 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG G V LV+ + +ALK I E++ +E E
Sbjct: 32 LFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQR-----------EAD 78
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI----DYCPGRDLHSL--RKQQSEQMFSDDTIRF 132
+ R HP + RL ++ + + L + R + ++D I +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+ LE +H G +RDLKP NI++ + G +L+D +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH----------- 187
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
+ + + + T Y A
Sbjct: 188 ------------------------------------VEGSRQALTLQDWAAQRCTISYRA 211
Query: 253 PEIIEGKGH---DFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILC---RPPDLVG 305
PE+ + H D D WSLG VL+ M++G P+ +K ++ + P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR 271
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334
+ L L+ ++ DP +R + +
Sbjct: 272 HSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 70/373 (18%), Positives = 129/373 (34%), Gaps = 108/373 (28%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G+ GVV + + ++ A+K++ K N + ++ + E R+++ +
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIM-----NKNKIRQINPKDVERIKT---EVRLMKKL 85
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL------------------------------ 113
HP + RL V ++++ ++ C G L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 114 --------HSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ--E 163
++ + + + I ++ AL YLHN GI +RD+KPEN + +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSP 223
+ I LVDF LS +
Sbjct: 206 SFEIKLVDFGLSKEFYKLNN---------------------------------------- 225
Query: 224 RIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH--DFAVDWWSLGVVLHEMLYGA 281
+ GT +VAPE++ D WS GV+LH +L GA
Sbjct: 226 ------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 282 TPFRGSSRKETFYRILCRPPDLVGEPTP-----LRNLIRRLLEKDPTKRIGVEEIKGHEF 336
PF G + +T ++L + R+L+ LL ++ +R H +
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 337 FKGVNWELLLKIS 349
+ + + K+S
Sbjct: 334 ISQFS-DKIYKMS 345
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-48
Identities = 73/336 (21%), Positives = 131/336 (38%), Gaps = 80/336 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEK-------------KSKELTNNDNGDKY 70
+G+G+ GVV L + + +A+KV+ + + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLS--TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
++ E +L+ ++HP + +L VL + + + + + + S+D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---LSED 137
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
RFY +L+ +EYLH I++RD+KP N+++ E+GHI + DF +S +
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD------ 191
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
+ LS GT
Sbjct: 192 ---------------ALLSNTV-----------------------------------GTP 201
Query: 249 EYVAPEIIEGKGHDF---AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PD 302
++APE + F A+D W++GV L+ ++G PF +I + PD
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261
Query: 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
L++LI R+L+K+P RI V EIK H +
Sbjct: 262 QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-47
Identities = 78/324 (24%), Positives = 135/324 (41%), Gaps = 79/324 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA G V LV++ S +K I +D + +++ E VL+++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA------------EIEVLKSL 77
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+HP + ++ V + ++ C G +L + Q + S+ + +++ AL
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 142 EYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
Y H+ +V++DLKPENI+ Q + I ++DF G
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF-------------------------G 172
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
L++ S E S + GT Y+APE+ +
Sbjct: 173 -------LAELFKSD-------------------------EHSTNAAGTALYMAPEVFKR 200
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL----RNLI 314
F D WS GVV++ +L G PF G+S +E + + P+ E PL +L+
Sbjct: 201 D-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLL 259
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFK 338
+++L KDP +R ++ HE+FK
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 6e-47
Identities = 70/326 (21%), Positives = 130/326 (39%), Gaps = 78/326 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G V L KD + + A+KVI K + + + + R E ++L+ +
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVI------SKRQ-VKQKTDKESLLR---EVQLLKQL 83
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + +L + + G +L + S + FS+ +++ + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+H IV+RDLKPEN++++ ++ +I ++DF G
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDF-------------------------G-- 174
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LS + +K +GT Y+APE++ G
Sbjct: 175 -----LSTHFEAS-------------------------KKMKDKIGTAYYIAPEVLHGT- 203
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+D D WS GV+L+ +L G PF G++ + ++ ++LIR
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKGVN 341
++L P+ RI + HE+ +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQTYT 289
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-47
Identities = 76/332 (22%), Positives = 115/332 (34%), Gaps = 75/332 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LGRG VV + + +A+K+I + + + E +LR V
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDV----TGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + +L+ T+ F D +L + S+ R L+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
LH + IV+RDLKPENI++ ++ +I L DF G
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDF-------------------------G---- 169
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG---- 258
S G L + GT Y+APEIIE
Sbjct: 170 ---FSCQLDPGEKLRE-------------------------VCGTPSYLAPEIIECSMND 201
Query: 259 --KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----R 311
G+ VD WS GV+++ +L G+ PF + I+ +
Sbjct: 202 NHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343
+L+ R L P KR EE H FF+ E
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 78/347 (22%), Positives = 140/347 (40%), Gaps = 78/347 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R++ +G+G V L + + + A+K+I + + S + ++ E R
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-----------KLFREVR 66
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+++ + HP + +L V+ T+K + ++Y G ++ + + R ++V
Sbjct: 67 IMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFD--YLVAHGRMKEKEARSKFRQIV 124
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
A++Y H IV+RDLK EN+++ + +I + DF S + +
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV------------------ 166
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
L FC G Y APE+ +G
Sbjct: 167 ----GGKLDAFC-----------------------------------GAPPYAAPELFQG 187
Query: 259 KGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----RPPDLVGEPTPLRNL 313
K +D VD WSLGV+L+ ++ G+ PF G + KE R+L P + T NL
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM---STDCENL 244
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEH 360
++R L +P KR +E+I + + E LK P + +
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQK 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-46
Identities = 67/324 (20%), Positives = 119/324 (36%), Gaps = 78/324 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA VV + FA K+I K L+ D K R E R+ R +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKII------NTKK-LSARDF-QKLER---EARICRKL 62
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + RL + + F D G +L + + +S+ +++ ++ Y
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 144 LHNMGIVYRDLKPENIMI---QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
H+ GIV+R+LKPEN+++ + + L DF L+ +++
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS------------------- 161
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
F GT Y++PE+++
Sbjct: 162 ---EAWHGFA-----------------------------------GTPGYLSPEVLKKDP 183
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+ VD W+ GV+L+ +L G PF + + +I D ++LI
Sbjct: 184 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
+L +P KRI ++ +
Sbjct: 244 SMLTVNPKKRITADQALKVPWICN 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 63/356 (17%), Positives = 106/356 (29%), Gaps = 114/356 (32%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA VF + ++ + FA+KV + E VL+ +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------------EFEVLKKL 64
Query: 84 EHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLA 140
H + +L + + ++CP L++ L + + + ++V
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 141 LEYLHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ +L GIV+R++KP NIM L DF + +L
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------------- 169
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
GTEEY+ P++
Sbjct: 170 -------EQFVSLY-----------------------------------GTEEYLHPDMY 187
Query: 257 EG--------KGHDFAVDWWSLGVVLHEMLYGATPFR----GSSRKETFYRILCRPPDLV 304
E K + VD WS+GV + G+ PFR KE Y+I+ P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 305 GEPT--------------------------PLRNLIRRLLEKDPTKRIGVEEIKGH 334
L ++ +LE D K G ++
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-46
Identities = 73/324 (22%), Positives = 124/324 (38%), Gaps = 68/324 (20%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA G V L K+ A+KVI + +K N + + I E +L+++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + +L V K+ ++ G +L + + F + +++ + Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKFDECDAANIMKQILSGICY 161
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
LH IV+RD+KPENI+++ +I +VDF G
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDF-------------------------G-- 194
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LS F S K +GT Y+APE+++ K
Sbjct: 195 -----LSSFFSKD-------------------------YKLRDRLGTAYYIAPEVLKKK- 223
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
++ D WS GV+++ +L G PF G + ++ ++ + LI+
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIK 283
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
+L D KR EE + K
Sbjct: 284 LMLTYDYNKRCTAEEALNSRWIKK 307
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-46
Identities = 70/378 (18%), Positives = 130/378 (34%), Gaps = 104/378 (27%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG G G V ++ E A+K ++L K + R E +
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE------------RWCLEIQ 64
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGY------AIDYCPGRDLHS-LRKQQSEQMFSDDTIR 131
+++ + HP + R V + + A++YC G DL L + ++ + IR
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVDFDLSTKLSPKTPQASPK 188
+++ AL YLH I++RDLKPENI++Q ++D + +L
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG------- 177
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
++F GT
Sbjct: 178 ---------------ELCTEFV-----------------------------------GTL 187
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-------- 300
+Y+APE++E K + VD+WS G + E + G PF + + ++ +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 301 ---------PDLVGEPTPL--------RNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343
++ P L ++ +L +R + F+ ++
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307
Query: 344 LLLKISRPPNIPARFEHE 361
L LK+ N+ + H
Sbjct: 308 LSLKLLSVMNMVSGRVHT 325
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-46
Identities = 74/336 (22%), Positives = 125/336 (37%), Gaps = 79/336 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G V KD + + +A+KVI K+ N D R E +L+ +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI------NKAS-AKNKDTSTILR----EVELLKKL 78
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + +L +L + G +L + + FS+ ++ + Y
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+H IV+RDLKPENI+++ ++ I ++DF G
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDF-------------------------G-- 169
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LS K +GT Y+APE++ G
Sbjct: 170 -----LSTCFQQN-------------------------TKMKDRIGTAYYIAPEVLRGT- 198
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+D D WS GV+L+ +L G PF G + + R+ ++LIR
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRP 351
++L P+ RI + H + + + E P
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLP 294
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-46
Identities = 67/383 (17%), Positives = 115/383 (30%), Gaps = 119/383 (31%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA VF + ++ + FA+KV + E VL+ +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR------------EFEVLKKL 64
Query: 84 EHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLA 140
H + +L + + ++CP L++ L + + + ++V
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 141 LEYLHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ +L GIV+R++KP NIM L DF + +L
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--------------- 169
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
GTEEY+ P++
Sbjct: 170 -------EQFVSLY-----------------------------------GTEEYLHPDMY 187
Query: 257 EG--------KGHDFAVDWWSLGVVLHEMLYGATPFR----GSSRKETFYRILCRPPDLV 304
E K + VD WS+GV + G+ PFR KE Y+I+ P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 305 GEPT--------------------------PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
L ++ +LE D K G + +FF
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD-----QFFA 302
Query: 339 GVNWELLLKISRPPNIPARFEHE 361
+ L + ++ H+
Sbjct: 303 ETSDILHRMVIHVFSLQQMTAHK 325
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 69/324 (21%), Positives = 123/324 (37%), Gaps = 79/324 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA G V L +D + A+K+I + + S E VL+ +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE-----------EVAVLKLL 93
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + +L + ++ G +L + F++ +++ + Y
Sbjct: 94 DHPNIMKLYDFFEDKRNYYLVMECYKGGEL--FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
LH IV+RDLKPEN++++ ++ I +VDF G
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDF-------------------------G-- 184
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LS + +K +GT Y+APE++ K
Sbjct: 185 -----LSAVFENQ-------------------------KKMKERLGTAYYIAPEVLRKK- 213
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+D D WS+GV+L +L G PF G + +E ++ ++LI+
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
++L+ D +RI ++ H + K
Sbjct: 274 QMLQFDSQRRISAQQALEHPWIKE 297
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-45
Identities = 72/321 (22%), Positives = 123/321 (38%), Gaps = 75/321 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRRISFEQ 77
RI +GRG V+ + ALK + DL++ K++ E
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-----------EI 83
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYAA 135
+L+ + HP + + D + ++ DL + ++ +++ + T+ Y
Sbjct: 84 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+L ALE++H+ +++RD+KP N+ I T
Sbjct: 144 QLCSALEHMHSRRVMHRDIKPANVFI---------------------------------T 170
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
+G+ K L G+ R S + ++S VGT Y++PE
Sbjct: 171 ATGVVK----LGDL---GLG----------------RFFSSKTTAAHSLVGTPYYMSPER 207
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRIL-CRPPDLVGE--PTPL 310
I G++F D WSLG +L+EM +PF G +I C P L + L
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 311 RNLIRRLLEKDPTKRIGVEEI 331
R L+ + DP KR V +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-45
Identities = 68/333 (20%), Positives = 124/333 (37%), Gaps = 74/333 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V LG GA G V L + + E+ A+K++ D + ++ E
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---------DCPENIKK---EIC 57
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ + + H + + G ++YC G +L + + + + + + +L+
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
+ YLH +GI +RD+KPEN+++ E ++ + DF L+T
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY------------------ 157
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
R L+K C GT YVAPE+++
Sbjct: 158 -NNRERLLNKMC-----------------------------------GTLPYVAPELLKR 181
Query: 259 KGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNL 313
+ VD WS G+VL ML G P+ S Y + L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFF-KGVNWELL 345
+ ++L ++P+ RI + +IK ++ K +
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKKGAK 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-45
Identities = 66/331 (19%), Positives = 116/331 (35%), Gaps = 78/331 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G G+ G ++ + K + D E + E
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVS---------EVN 57
Query: 79 VLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYA 134
+LR ++HP + R + T+ + ++YC G DL S+ + + Q ++ +
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 135 AELVLALEYLHNMG-----IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+L LAL+ H +++RDLKP N + L
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPAN--------VFL-------------------- 149
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
K L F G++ R + + + +FVGT
Sbjct: 150 -----DGKQNVK----LGDF---GLA----------------RILNHDTSFAKTFVGTPY 181
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--P 307
Y++PE + ++ D WSLG +L+E+ PF S+KE +I +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 308 TPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
L +I R+L R VEEI +
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 69/324 (21%), Positives = 122/324 (37%), Gaps = 79/324 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G+ G V KD + + +A+KVI + + K E +L+ +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-----------EVELLKKL 78
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + +L +L + G +L + + FS+ ++ + Y
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+H IV+RDLKPENI+++ ++ I ++DF G
Sbjct: 137 MHKHNIVHRDLKPENILLESKEKDCDIKIIDF-------------------------G-- 169
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LS ++D +GT Y+APE++ G
Sbjct: 170 -----LSTCFQQNTKMKD-------------------------RIGTAYYIAPEVLRGT- 198
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+D D WS GV+L+ +L G PF G + + R+ ++LIR
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
++L P+ RI + H + +
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-45
Identities = 76/325 (23%), Positives = 128/325 (39%), Gaps = 75/325 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G +V + + + +A K I KK + L+++ G I E +LR +
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFI------KKRR-LSSSRRGVSREEIEREVNILREI 65
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + L + V ++ G +L ++ ++D + +++ + Y
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEATQFLKQILDGVHY 123
Query: 144 LHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
LH+ I + DLKPENIM+ N I L+DF G
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF-------------------------G- 157
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
++ +G ++ GT E+VAPEI+ +
Sbjct: 158 ------IAHKIEAGNEFKN-------------------------IFGTPEFVAPEIVNYE 186
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
D WS+GV+ + +L GA+PF G +++ET I D E ++ I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339
RRLL KDP +R+ + + H + K
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKA 271
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-45
Identities = 75/338 (22%), Positives = 127/338 (37%), Gaps = 75/338 (22%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ G V V D E+ A+K++ KK K + ++ E ++LR +
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL------KKKKLRRIPNGEANVKK---EIQLLRRL 63
Query: 84 EHPLLPRLRGVLS--TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
H + +L VL + + ++YC + + E+ F Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
EYLH+ GIV++D+KP N+++ G + + ++ L P
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD----------------- 165
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG-KG 260
G+ + PEI G
Sbjct: 166 --DTCRTSQ-----------------------------------GSPAFQPPEIANGLDT 188
Query: 261 HD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIR 315
F VD WS GV L+ + G PF G + + F I P D PL +L++
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC---GPPLSDLLK 245
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPN 353
+LE +P KR + +I+ H +F+ + + PP+
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPS 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-45
Identities = 67/324 (20%), Positives = 124/324 (38%), Gaps = 81/324 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ G V + + A K I + +E D++++ E +++++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDV----------DRFKQ---EIEIMKSL 63
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + RL + + ++ C G +L + +++F + +++ A+ Y
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGEL--FERVVHKRVFRESDAARIMKDVLSAVAY 121
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
H + + +RDLKPEN + + + L+DF G
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF-------------------------G-- 154
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
L+ G + VGT YV+P+++EG
Sbjct: 155 -----LAARFKPGKMMRT-------------------------KVGTPYYVSPQVLEGL- 183
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+ D WS GV+++ +L G PF + E +I + +LIR
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
RLL K P +RI + HE+F+
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEK 267
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-45
Identities = 76/346 (21%), Positives = 133/346 (38%), Gaps = 83/346 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+S LG GA G V+ D E ++ +K I ++ + + K +++ E
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWI-----EDPKLGKVTLEIA 81
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDL--HSLRKQQSEQMFSDDTIRFYA 134
+L VEH + ++ + F + + G DL R + + +
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFF-QLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIF 136
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
+LV A+ YL I++RD+K ENI+I E+ I L+DF + L
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---------------- 180
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+R FC GT EY APE
Sbjct: 181 ------ERGKLFYTFC-----------------------------------GTIEYCAPE 199
Query: 255 IIEGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNL 313
++ G + ++ WSLGV L+ +++ PF +ET + PP LV L +L
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE--LEETVEAAI-HPPYLV--SKELMSL 254
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK------GVNWELLLKISRPPN 353
+ LL+ P +R +E++ + WE + ++++P +
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 6e-45
Identities = 60/369 (16%), Positives = 117/369 (31%), Gaps = 94/369 (25%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVI-------WRDLIEKKSKEL----------- 61
+ +GRG GVVF K+ ++A+K I R+ + ++ K L
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 62 -------------------TNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVG 102
D + S +V+ + + +
Sbjct: 70 FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 103 YAID--------YCPGRDLHSLRKQQSEQMFSD-DTIRFYAAELVLALEYLHNMGIVYRD 153
+ C +L ++ + ++ A+E+LH+ G+++RD
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSG 213
LKP NI + + + DF L T + + +
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT--------------------------- 222
Query: 214 ISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVV 273
+ + VGT+ Y++PE I G + VD +SLG++
Sbjct: 223 -----------------VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLI 265
Query: 274 LHEMLYGATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
L E+LY + R + P + +++ +L PT+R +I
Sbjct: 266 LFELLYSFST--QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI 323
Query: 332 KGHEFFKGV 340
+ F+ +
Sbjct: 324 IENAIFENL 332
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 7e-45
Identities = 75/322 (23%), Positives = 127/322 (39%), Gaps = 81/322 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V + + + A+K++ + K + + D K +R E + L+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL------NRQK-IRSLDVVGKIKR---EIQNLKLF 68
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP + +L V+ST ++Y G +L + + + + R +++ A+
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAV 124
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+Y H +V+RDLKPEN+++ + + + DF LS +
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSN----------------------MMS 162
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
FL C S P Y APE+I G+ +
Sbjct: 163 DGEFLRTSCGS----------------PN-------------------YAAPEVISGRLY 187
Query: 262 D-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPLRNLIRR 316
VD WS GV+L+ +L G PF F +I P L + L+
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYL---NRSVATLLMH 244
Query: 317 LLEKDPTKRIGVEEIKGHEFFK 338
+L+ DP KR +++I+ HE+FK
Sbjct: 245 MLQVDPLKRATIKDIREHEWFK 266
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-45
Identities = 74/325 (22%), Positives = 122/325 (37%), Gaps = 75/325 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G +V ++ + +A K I KK + + + I E +LR V
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFI------KKRQSRASRRGVSR-EEIEREVSILRQV 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
H + L V V ++ G +L ++ S++ + +++ + Y
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNY 130
Query: 144 LHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
LH I + DLKPENIM+ HI L+DF G
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF-------------------------G- 164
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
L+ G+ ++ GT E+VAPEI+ +
Sbjct: 165 ------LAHEIEDGVEFKN-------------------------IFGTPEFVAPEIVNYE 193
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
D WS+GV+ + +L GA+PF G +++ET I D E ++ I
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFI 253
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339
R+LL K+ KR+ ++E H +
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITP 278
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 67/324 (20%), Positives = 118/324 (36%), Gaps = 78/324 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA VV + FA K+I K L+ D R E R+ R +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKII------NTKK-LSARDFQKLER----EARICRKL 85
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + RL + + F D G +L + + +S+ +++ ++ Y
Sbjct: 86 QHPNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 144 LHNMGIVYRDLKPENIMI---QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
H+ GIV+R+LKPEN+++ + + L DF G
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADF-------------------------G-- 176
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
L+ + + F GT Y++PE+++
Sbjct: 177 -----LAIEVNDSEAWHG-------------------------FAGTPGYLSPEVLKKDP 206
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+ VD W+ GV+L+ +L G PF + + +I D ++LI
Sbjct: 207 YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 266
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
+L +P KRI ++ +
Sbjct: 267 SMLTVNPKKRITADQALKVPWICN 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 67/325 (20%), Positives = 123/325 (37%), Gaps = 73/325 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V LG GA G V L + + E+ A+K++ D + ++ E
Sbjct: 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---------DCPENIKK---EIC 57
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ + + H + + G ++YC G +L + + + + + + +L+
Sbjct: 58 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLM 115
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
+ YLH +GI +RD+KPEN+++ E ++ + DF L+T
Sbjct: 116 AGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY------------------ 157
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
R L+K C GT YVAPE+++
Sbjct: 158 -NNRERLLNKMC-----------------------------------GTLPYVAPELLKR 181
Query: 259 KGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR-ILCR---PPDLVGEPTPLRNL 313
+ VD WS G+VL ML G P+ S Y + + L
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338
+ ++L ++P+ RI + +IK ++
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYN 266
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-44
Identities = 73/325 (22%), Positives = 127/325 (39%), Gaps = 75/325 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G VV ++ + +A K I KK + ++ G I E +L+ +
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFI------KKRR-TKSSRRGVSREDIEREVSILKEI 71
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + L V V ++ G +L ++ +++ + +++ + Y
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
LH++ I + DLKPENIM+ I ++DF G
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF-------------------------G- 163
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
L+ G ++ GT E+VAPEI+ +
Sbjct: 164 ------LAHKIDFGNEFKN-------------------------IFGTPEFVAPEIVNYE 192
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
D WS+GV+ + +L GA+PF G +++ET + + E ++ I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339
RRLL KDP KR+ +++ H + K
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 76/325 (23%), Positives = 123/325 (37%), Gaps = 75/325 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G +V ++ + +A K I KK + + G I E +LR V
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFI------KKRQ-SRASRRGVCREEIEREVSILRQV 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + L V V ++ G +L ++ S++ + +++ + Y
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELF--DFLAQKESLSEEEATSFIKQILDGVNY 130
Query: 144 LHNMGIVYRDLKPENIMIQ----ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
LH I + DLKPENIM+ HI L+DF G
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF-------------------------G- 164
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
L+ G+ ++ GT E+VAPEI+ +
Sbjct: 165 ------LAHEIEDGVEFKN-------------------------IFGTPEFVAPEIVNYE 193
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
D WS+GV+ + +L GA+PF G +++ET I D E ++ I
Sbjct: 194 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFI 253
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339
R+LL K+ KR+ ++E H +
Sbjct: 254 RKLLVKETRKRLTIQEALRHPWITP 278
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 76/327 (23%), Positives = 116/327 (35%), Gaps = 76/327 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG VV + FA+K++ E ++ L+ + E +LR V
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIM-----EVTAERLSPEQLEEVREATRRETHILRQV 156
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + L + F+ D +L + S+ R L+ A+
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
+LH IV+RDLKPENI++ +N I L DF G
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDF-------------------------G---- 245
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG---- 258
S G L + GT Y+APEI++
Sbjct: 246 ---FSCHLEPGEKLRE-------------------------LCGTPGYLAPEILKCSMDE 277
Query: 259 --KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----R 311
G+ VD W+ GV+L +L G+ PF + I+ +
Sbjct: 278 THPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+LI RLL+ DP R+ E+ H FF+
Sbjct: 338 DLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 85/395 (21%), Positives = 141/395 (35%), Gaps = 86/395 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
V +G G GV L++D + E A+K I R + + E
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--------------NVQREII 68
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
R++ HP + R + V+ T + ++Y G +L+ + + FS+D RF+ +L+
Sbjct: 69 NHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARFFFQQLL 126
Query: 139 LALEYLHNMGIVYRDLKPENIMIQEN--GHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ Y H+M I +RDLK EN ++ + + + DF S
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------------------- 166
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
S GT Y+APE++
Sbjct: 167 --SSVLHSQPKSTV-----------------------------------GTPAYIAPEVL 189
Query: 257 EGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILC---RPPDLVGEPT 308
+ +D D WS GV L+ ML GA PF ++T RIL PD +
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFF-KGVNWELLLKISRPPN--IPARFEHENNES 365
+LI R+ DP RI + EIK H +F K + +L+ + + P + +
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTI 309
Query: 366 DGRGRDGTKEIDVEKFVQGIFAGGGDAEQKNEVND 400
+ T + + D + + D
Sbjct: 310 MQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD 344
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 64/326 (19%), Positives = 127/326 (38%), Gaps = 75/326 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G VV + E+ + FA+K++ +K T++ + E + +
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIV------DVAK-FTSSPGLST-EDLKREASICHML 83
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+HP + L S+D + ++ G DL +++ + ++S+ Y +++ AL
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 142 EYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
Y H+ I++RD+KP +++ + + L F ++
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---------------------- 181
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ SG+ V +P ++APE+++
Sbjct: 182 ---------QLGESGLVAGGRVGTP-------------------------HFMAPEVVKR 207
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNL 313
+ + VD W GV+L +L G PF G+ + F I+ + ++L
Sbjct: 208 EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDL 266
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKG 339
+RR+L DP +RI V E H + K
Sbjct: 267 VRRMLMLDPAERITVYEALNHPWLKE 292
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 5e-43
Identities = 80/325 (24%), Positives = 126/325 (38%), Gaps = 83/325 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA VFLVK + + FALK I KKS ++ + E VL+ +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCI------KKSPAFRDSS-------LENEIAVLKKI 63
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL-HSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+H + L + + + G +L + ++ +++ +++ A++
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVK 120
Query: 143 YLHNMGIVYRDLKPENIMI---QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
YLH GIV+RDLKPEN++ +EN IM+ DF LS
Sbjct: 121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN------------------- 161
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
+S C GT YVAPE++ K
Sbjct: 162 ----GIMSTAC-----------------------------------GTPGYVAPEVLAQK 182
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
+ AVD WS+GV+ + +L G PF + + F +I + ++ I
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFI 242
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339
LLEKDP +R E+ H + G
Sbjct: 243 CHLLEKDPNERYTCEKALSHPWIDG 267
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-43
Identities = 56/171 (32%), Positives = 94/171 (54%), Gaps = 19/171 (11%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIW-RDLIEKKSKELTNNDNGDKYRR 72
F ++ LG G+ G V LVK ES +A+K++ + +++ K E T N
Sbjct: 42 QFDRIKT---LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-------- 90
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIR 131
E+R+L+ V P L +L + + ++Y G ++ S LR+ FS+ R
Sbjct: 91 ---EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHAR 144
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
FYAA++VL EYLH++ ++YRDLKPEN++I + G+I + DF + ++ +T
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-40
Identities = 43/124 (34%), Positives = 68/124 (54%), Gaps = 7/124 (5%)
Query: 239 EKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC 298
++ + GT E +APEII KG++ AVDWW+LGV+++EM G PF + + +I+
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252
Query: 299 RPPDLVGEPTP-LRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLL-KISRP 351
+ L++L+R LL+ D TKR G V +IK H++F +W + +
Sbjct: 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312
Query: 352 PNIP 355
P IP
Sbjct: 313 PFIP 316
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-42
Identities = 59/323 (18%), Positives = 109/323 (33%), Gaps = 79/323 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LGRG G+V + S +++ K + K + ++ E +L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV------KVKGT-----DQVLVKK---EISILNIA 58
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
H + L + + + ++ G D+ R S ++ I Y ++ AL++
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQF 117
Query: 144 LHNMGIVYRDLKPENIMIQ--ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
LH+ I + D++PENI+ Q + I +++F G
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEF-------------------------G--- 149
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
++ G + EY APE+ +
Sbjct: 150 ----QARQLKPG-------------------------DNFRLLFTAPEYYAPEVHQHDVV 180
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIRR 316
A D WSLG +++ +L G PF + ++ I+ E + + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 317 LLEKDPTKRIGVEEIKGHEFFKG 339
LL K+ R+ E H + K
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQ 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 39/338 (11%), Positives = 94/338 (27%), Gaps = 89/338 (26%)
Query: 20 IVSALGRGAKGVVFLVK-----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRIS 74
+ LG GA V+ D ++ + F LKV K + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ------KPANP-------WEFYIGT 115
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL---RKQQSEQMFSDDTIR 131
L+ + + + L + K E++ +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQ-----------ENGHIMLVDFDLSTKLSP 180
+A ++ +E +H+ I++ D+KP+N ++ + + L+D S +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK- 234
Query: 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240
+ + + + C
Sbjct: 235 ------------------LFPKGTIFTAKC------------------------------ 246
Query: 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP 300
T + E++ K ++ +D++ + ++ ML+G + E L R
Sbjct: 247 -----ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+L + ++ + K
Sbjct: 302 LP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-42
Identities = 67/324 (20%), Positives = 121/324 (37%), Gaps = 77/324 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+GA VV V + + +A +I K L+ D+ R E R+ R +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMII------NTKK-LSARDHQKLER----EARICRLL 67
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + RL +S + D G +L + + +S+ +++ A+ +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 144 LHNMGIVYRDLKPENIMI---QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
H MG+V+R+LKPEN+++ + + L DF L+ ++ +
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ------------------ 167
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
F GT Y++PE++
Sbjct: 168 ---QAWFGFA-----------------------------------GTPGYLSPEVLRKDP 189
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIR 315
+ VD W+ GV+L+ +L G PF + + +I D ++LI
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 316 RLLEKDPTKRIGVEEIKGHEFFKG 339
++L +P+KRI E H +
Sbjct: 250 KMLTINPSKRITAAEALKHPWISH 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 74/329 (22%), Positives = 130/329 (39%), Gaps = 79/329 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA G V L + ++ + A+++I K+ + + D + E +L+ +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRII-----SKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 84 EHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + +++ + + Y + + G +L K + + T + Y +++LA++
Sbjct: 198 NHPCIIKIKNFFDAEDY--YIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 143 YLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
YLH GI++RDLKPEN+++ E+ I + DF S L
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------------------ 295
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258
S + C GT Y+APE++
Sbjct: 296 ----SLMRTLC-----------------------------------GTPTYLAPEVLVSV 316
Query: 259 --KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET-FYRILCRPPDLVGEPTPL----- 310
G++ AVD WSLGV+L L G PF + + +I + + E
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 376
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+L+++LL DP R EE H + +
Sbjct: 377 LDLVKKLLVVDPKARFTTEEALRHPWLQD 405
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 71/333 (21%), Positives = 122/333 (36%), Gaps = 77/333 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LGRG VV + + +A K + + + + + E VL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH-----------EIAVLELA 85
Query: 84 EH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+ P + L V + ++Y G ++ SL + +M S++ + +++ +
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 143 YLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
YLH IV+ DLKP+NI++ G I +VDF G
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF-------------------------G- 179
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
+S+ L + +GT EY+APEI+
Sbjct: 180 ------MSRKIGHACELRE-------------------------IMGTPEYLAPEILNYD 208
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
A D W++G++ + +L +PF G +ET+ I D E + I
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK 347
+ LL K+P KR E H + + ++E L
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFENLFH 301
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 76/331 (22%), Positives = 129/331 (38%), Gaps = 83/331 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA G V L + ++ + A+K+I K+ + + D + E +L+ +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKII-----SKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 84 EHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + +++ + + Y + + G +L K + + T + Y +++LA++
Sbjct: 73 NHPCIIKIKNFFDAEDY--YIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 143 YLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
YLH GI++RDLKPEN+++ E+ I + DF S L
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET------------------ 170
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258
S + C GT Y+APE++
Sbjct: 171 ----SLMRTLC-----------------------------------GTPTYLAPEVLVSV 191
Query: 259 --KGHDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILC-------RPPDLVGEPT 308
G++ AVD WSLGV+L L G PF ++ +I V E
Sbjct: 192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKA 251
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+L+++LL DP R EE H + +
Sbjct: 252 --LDLVKKLLVVDPKARFTTEEALRHPWLQD 280
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-42
Identities = 73/332 (21%), Positives = 129/332 (38%), Gaps = 90/332 (27%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ + +S+++FA+K+I K E ++ E L+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKII------SKRME-------ANTQK---EITALKLC 62
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
HP + +L V ++ G +L + + ++ FS+ + +LV A+
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 143 YLHNMGIVYRDLKPENIMI---QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
++H++G+V+RDLKPEN++ +N I ++DF + P
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--------------- 165
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
L+ P T Y APE++
Sbjct: 166 ----------------LKTPC-------------------------FTLHYAAPELLNQN 184
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRG-------SSRKETFYRILCRPPDLVGEPTPL-- 310
G+D + D WSLGV+L+ ML G PF+ +S E +I GE
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244
Query: 311 ---RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
++LI+ LL DP KR+ + ++ +E+ +
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-41
Identities = 72/345 (20%), Positives = 118/345 (34%), Gaps = 73/345 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ LG+G G VF + A+KVI R+ + S +D+ ++ +
Sbjct: 34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPL---SDSVTCPLEVALLWK 90
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDY-CPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
V HP + RL T + ++ P +DL + + R + ++
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL--FDYITEKGPLGEGPSRCFFGQV 148
Query: 138 VLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
V A+++ H+ G+V+RD+K ENI+I G L+DF L
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL------------------ 190
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+ F GT Y PE I
Sbjct: 191 -----HDEPYTDFD-----------------------------------GTRVYSPPEWI 210
Query: 257 EGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRPPDLVGEPTPLRNLI 314
+ WSLG++L++M+ G PF E P + LI
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF---PAHV---SPDCCALI 264
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFE 359
RR L P+ R +EEI + + ++ L S+ P +
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 78/328 (23%), Positives = 123/328 (37%), Gaps = 86/328 (26%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ V ++ FA+K+I KSK D I + +LR
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII------DKSKR-------DPTEEI---EILLRYG 73
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP + L+ V K+V + G +L L K ++ FS+ + +EY
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 144 LHNMGIVYRDLKPENIMIQENGH----IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
LH G+V+RDLKP NI+ + I + DF + +L +
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN----------------- 174
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
L C T +VAPE++E +
Sbjct: 175 ----GLLMTPC-----------------------------------YTANFVAPEVLERQ 195
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGS---SRKETFYRILCRPPDLVGEPTPL-----R 311
G+D A D WSLGV+L+ ML G TPF + +E RI L G +
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+L+ ++L DP +R+ + H +
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVH 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 84/322 (26%), Positives = 133/322 (41%), Gaps = 82/322 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G+ G V L ++ + ALK I + L +D + R E L+ +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFI------SRQL-LKKSDMHMRVER---EISYLKLL 66
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGR--DLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP + +L V++T + I+Y G D +K+ +E D R + +++ A+
Sbjct: 67 RHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE-----DEGRRFFQQIICAI 121
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
EY H IV+RDLKPEN+++ +N ++ + DF LS ++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-------------------- 161
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
+FL C S P Y APE+I GK +
Sbjct: 162 --NFLKTSCGS----------------PN-------------------YAAPEVINGKLY 184
Query: 262 D-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----RPPDLVGEPTPLRNLIRR 316
VD WS G+VL+ ML G PF F ++ P L ++LIRR
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFL---SPGAQSLIRR 241
Query: 317 LLEKDPTKRIGVEEIKGHEFFK 338
++ DP +RI ++EI+ +F
Sbjct: 242 MIVADPMQRITIQEIRRDPWFN 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-41
Identities = 59/359 (16%), Positives = 100/359 (27%), Gaps = 91/359 (25%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVI------WRDLIEKKSKEL--------TN 63
L++V L G + VVFLV+DVE E FALKV R +E+ + +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 64 NDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDY-CPGRDLHSL-----R 117
+ RR+ + P +L Y + DL L
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 118 KQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177
+ A+L+ L + G+V+ P +N + + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP------DN---LFIMPDGRLM 234
Query: 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDS 237
L +
Sbjct: 235 ----------------------------LGDV---SALWKV------------------- 244
Query: 238 SEKSNSFVGTEEYVAPEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSS--RKETF 293
+ + Y E + A++ W LG+ ++ + PF + K ++
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 294 YRILCRPPDLV--------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344
R R P P ++ LI R L D +R+ E F + E+
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 77/322 (23%), Positives = 129/322 (40%), Gaps = 81/322 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V + K + A+K++ + K + + D K RR E + L+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL------NRQK-IRSLDVVGKIRR---EIQNLKLF 73
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAELVLAL 141
HP + +L V+ST + ++Y G +L + + + + R +++ +
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGV 129
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+Y H +V+RDLKPEN+++ + + + DF LS G
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-----------------NMMSDG--- 169
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
FL C S P Y APE+I G+ +
Sbjct: 170 --EFLRTSCGS----------------PN-------------------YAAPEVISGRLY 192
Query: 262 D-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----RPPDLVGEPTPLRNLIRR 316
VD WS GV+L+ +L G PF F +I P L + +L++
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL---NPSVISLLKH 249
Query: 317 LLEKDPTKRIGVEEIKGHEFFK 338
+L+ DP KR +++I+ HE+FK
Sbjct: 250 MLQVDPMKRATIKDIREHEWFK 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-40
Identities = 66/325 (20%), Positives = 115/325 (35%), Gaps = 78/325 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V ++ + A K+I K + ++ + E V+ +
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKII------KTRGM----KDKEEVKN---EISVMNQL 143
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H L +L + + ++Y G +L R ++ + ++ + +
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFD-RIIDESYNLTELDTILFMKQICEGIRH 202
Query: 144 LHNMGIVYRDLKPENIMIQ--ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+H M I++ DLKPENI+ + I ++DF G
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDF-------------------------G--- 234
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
L++ L+ GT E++APE++
Sbjct: 235 ----LARRYKPREKLKV-------------------------NFGTPEFLAPEVVNYDFV 265
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIRR 316
F D WS+GV+ + +L G +PF G + ET IL DL E + I +
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325
Query: 317 LLEKDPTKRIGVEEIKGHEFFKGVN 341
LL K+ + RI E H +
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDHK 350
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 68/325 (20%), Positives = 111/325 (34%), Gaps = 78/325 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA GVV V + + +FA K + + E + + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFV------MTPH-------ESDKETVRKEIQTMSVL 211
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP L L D + ++ G +L + S+D Y ++ L +
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 144 LHNMGIVYRDLKPENIMIQ--ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+H V+ DLKPENIM + + L+DF G
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNELKLIDF-------------------------G--- 302
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
L+ + GT E+ APE+ EGK
Sbjct: 303 ----LTAHLDPK-------------------------QSVKVTTGTAEFAAPEVAEGKPV 333
Query: 262 DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIRR 316
+ D WS+GV+ + +L G +PF G + ET + ++ ++ IR+
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRK 393
Query: 317 LLEKDPTKRIGVEEIKGHEFFKGVN 341
LL DP R+ + + H + N
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGN 418
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 73/327 (22%), Positives = 124/327 (37%), Gaps = 83/327 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LGRGA +V+ K + + +ALKV+ +K + R E VL +
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVL-----KKTVDK-------KIVRT---EIGVLLRL 105
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + +L+ + T + ++ G +L + + +S+ +++ A+ Y
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGEL--FDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 144 LHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
LH GIV+RDLKPEN++ + + + DF G
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADF-------------------------G-- 196
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
LSK + ++ GT Y APEI+ G
Sbjct: 197 -----LSKIVEHQVLMKT-------------------------VCGTPGYCAPEILRGCA 226
Query: 261 HDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILCRPPDLVGEPTPL-----RNLI 314
+ VD WS+G++ + +L G PF + F RIL + ++L+
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVN 341
R+L+ DP KR+ + H + G
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGKA 313
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-40
Identities = 63/330 (19%), Positives = 110/330 (33%), Gaps = 81/330 (24%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ LG G G V+ V + A+K + +D I + R+ E
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL-------PNGTRVPMEVV 98
Query: 79 VLRNVEHPLLP---RLRGVLSTDKFVGYAIDYC-PGRDLHSLRKQQSEQMFSDDTIRFYA 134
+L+ V RL ++ P +DL ++ R +
Sbjct: 99 LLKKVSSGF-SGVIRLLDWFERPDSFVLILERPEPVQDL--FDFITERGALQEELARSFF 155
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
+++ A+ + HN G+++RD+K ENI+I G + L+DF L
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--------------- 200
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
+ + + F GT Y P
Sbjct: 201 --------KDTVYTDFD-----------------------------------GTRVYSPP 217
Query: 254 EIIEGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRPPDLVGEPTPLR 311
E I + + WSLG++L++M+ G PF + + +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF---RQRV---SSECQ 271
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
+LIR L P+ R EEI+ H + + V
Sbjct: 272 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-40
Identities = 76/367 (20%), Positives = 127/367 (34%), Gaps = 84/367 (22%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
LR+ L G V+ +DV S +ALK + +E K R I E
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRL-----LSNEEE--------KNRAIIQEV 76
Query: 78 RVLRNV-EHPLLPRLRGVLSTDKFVGYA--------IDYCPGRDLHSLRKQQSEQMFSDD 128
++ + HP + + S K + C G+ + L+K +S S D
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136
Query: 129 TIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
T+ + A++++H I++RDLK EN+++ G I L DF +T +S +
Sbjct: 137 TVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
S E+ +
Sbjct: 197 --------------------------------------------SAQRRALVEEEITRNT 212
Query: 247 TEEYVAPEIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRP 300
T Y PEII+ D W+LG +L+ + + PF + RI+
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRIVNGKYSI 268
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEH 360
P + T +LIR +L+ +P +R+ + E+ E+ + P P
Sbjct: 269 PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL------QEIAAARNVNPKSPITELL 322
Query: 361 ENNESDG 367
E N G
Sbjct: 323 EQNGGYG 329
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 73/356 (20%), Positives = 125/356 (35%), Gaps = 90/356 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA+G + + + + A+K I + +E+ ++LR
Sbjct: 32 LGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREV----------------QLLRES 74
Query: 84 -EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
EHP + R +F AI+ C L +Q + + L
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQE-YVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 143 YLHNMGIVYRDLKPENIMIQENGH-----IMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+LH++ IV+RDLKP NI+I M+ DF L KL+
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV----------------- 175
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
S + + GTE ++APE++
Sbjct: 176 ------------------------------------GRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 258 G---KGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI----LCRPPDLVGEPTP 309
+ + VD +S G V + ++ G+ PF S +++ + L E
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNES 365
R LI +++ DP KR + + H FF W L ++ ++ R E E+ +
Sbjct: 260 ARELIEKMIAMDPQKRPSAKHVLKHPFF----WSLEKQLQFFQDVSDRIEKESLDG 311
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 67/320 (20%), Positives = 109/320 (34%), Gaps = 76/320 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ G V +KD ++ A+K + L + +EL +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVEELV----------------ACAGL 107
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
P + L G + +V ++ G L L KQ +D +Y + + LEY
Sbjct: 108 SSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQALEGLEY 165
Query: 144 LHNMGIVYRDLKPENIMIQENG-HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKR 202
LH I++ D+K +N+++ +G L DF + L P
Sbjct: 166 LHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD--------------------- 204
Query: 203 RSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHD 262
S + GTE ++APE++ GK D
Sbjct: 205 ------------------------------GLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 263 FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP----TPLRNLIRRLL 318
VD WS ++ ML G P+ R +I PP + P I+ L
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGL 294
Query: 319 EKDPTKRIGVEEIKGHEFFK 338
K+P R E++
Sbjct: 295 RKEPVHRASAMELRRKVGKA 314
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-38
Identities = 60/332 (18%), Positives = 115/332 (34%), Gaps = 91/332 (27%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V + + ALK++ S + + +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLL------YDSP--------KARQEVDHHWQASG-- 80
Query: 84 EHPLLPRLRGVLSTDKFVGYAI----DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
P + + V + + G +L S +++ +Q F++ ++
Sbjct: 81 -GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 140 ALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
A+++LH+ I +RD+KPEN++ ++ + L DF
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF---------------------- 177
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+K + +L+ P T YVAPE++
Sbjct: 178 ----------AKETTQN-ALQTPC-------------------------YTPYYVAPEVL 201
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDLVGEPTPL-- 310
+ +D + D WSLGV+++ +L G PF ++ + + R
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 311 ---RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+ LIR LL+ DPT+R+ + + H +
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-38
Identities = 45/325 (13%), Positives = 89/325 (27%), Gaps = 59/325 (18%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G G VF +A+K + + D+ +
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRS----------KKPLAGSVDEQNALREVYA 63
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYAAE 136
+H + R + D + +YC G L + F + ++ +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L Y+H+M +V+ D+KP NI I +
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV------------ 171
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
+ K G G ++A E++
Sbjct: 172 ---------MFKIGDLGH--------------------VTRISSPQVEEGDSRFLANEVL 202
Query: 257 -EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRPPDLVGE-PTPLRNL 313
E H D ++L + + R + ++ I R P + L
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQGRLPRIPQVLSQEFTEL 259
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338
++ ++ DP +R + H
Sbjct: 260 LKVMIHPDPERRPSAMALVKHSVLL 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 69/333 (20%), Positives = 119/333 (35%), Gaps = 92/333 (27%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V + + + E FALK++ + E +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKML------------------QDCPKARREVELHWRA 111
Query: 84 -EHPLLPRLRGV----LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ P + R+ V + K + ++ G +L S + + +Q F++ +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171
Query: 139 LALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
A++YLH++ I +RD+KPEN++ N + L DF +
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 211
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
K +S SL P T YVAPE+
Sbjct: 212 ------------KETTSHNSLTTPC-------------------------YTPYYVAPEV 234
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRPPDLVGEPTPL- 310
+ + +D + D WSLGV+++ +L G PF + RI +
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 311 ----RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+ LIR LL+ +PT+R+ + E H +
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 72/377 (19%), Positives = 129/377 (34%), Gaps = 109/377 (28%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-N 82
LG G+ G V + A+K + D + E+ ++L +
Sbjct: 23 LGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALMEI----------------KLLTES 65
Query: 83 VEHPLLPRLRGVLSTDKFVGYAIDYCPG--RDLHSLRKQQSEQM--FSDDTIRFYAAELV 138
+HP + R +TD+F+ A++ C +DL + E + + ++
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 139 LALEYLHNMGIVYRDLKPENIMI-------------QENGHIMLVDFDLSTKLSPKTPQA 185
+ +LH++ I++RDLKP+NI++ EN I++ DF L KL
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS----- 180
Query: 186 SPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245
S N+
Sbjct: 181 -----------------------------------------------GQSSFRTNLNNPS 193
Query: 246 GTEEYVAPEIIEG-------KGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL 297
GT + APE++E + ++D +S+G V + +L G PF +E+ I+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NII 251
Query: 298 CRPPDLVGEPTPL--------RNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKIS 349
L +LI ++++ DP KR ++ H F W K+
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF----WPKSKKLE 307
Query: 350 RPPNIPARFEHENNESD 366
+ R E EN +
Sbjct: 308 FLLKVSDRLEIENRDPP 324
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-37
Identities = 68/345 (19%), Positives = 122/345 (35%), Gaps = 93/345 (26%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA V ++ +S+ +A+K+I +K + R E +L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKII------EKQPG----HIRSRVFR---EVEMLYQC 67
Query: 84 E-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE 142
+ H + L + + G + L + F++ ++ AL+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEASVVVQDVASALD 125
Query: 143 YLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
+LHN GI +RDLKPENI+ + + + + DFDL + +
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI--------------------- 164
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258
S+ + + G+ EY+APE++E
Sbjct: 165 ----------------------------KLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 259 ----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET---------------FYRILCR 299
+D D WSLGV+L+ +L G PF G + F I
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 300 PPDLVGEPTPL-----RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+ + ++LI +LL +D +R+ ++ H + +G
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 69/321 (21%), Positives = 117/321 (36%), Gaps = 74/321 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG GA GVV + + F K I DK + E ++ +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFI------NTPYP------LDK-YTVKNEISIMNQL 105
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP L L + +++ G +L R + S+ + Y + L++
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
+H IV+ D+KP EN IM S+ +K
Sbjct: 165 MHEHSIVHLDIKP------EN--IMCETKKASS----------------------VK--- 191
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
+ F G++ ++ PD E T E+ APEI++ + F
Sbjct: 192 --IIDF---GLAT-------KLNPD----------EIVKVTTATAEFAAPEIVDREPVGF 229
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPL-----RNLIRRLL 318
D W++GV+ + +L G +PF G ET + + + ++ I+ LL
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 289
Query: 319 EKDPTKRIGVEEIKGHEFFKG 339
+K+P KR+ V + H + KG
Sbjct: 290 QKEPRKRLTVHDALEHPWLKG 310
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 71/325 (21%), Positives = 131/325 (40%), Gaps = 81/325 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG+G G+V+ +D+ + A+K I ++ + + E + +++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI-----PERDSR--------YSQPLHEEIALHKHL 76
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM-FSDDTIRFYAAELVLALE 142
+H + + G S + F+ ++ PG L +L + + + ++ TI FY +++ L+
Sbjct: 77 KHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLK 136
Query: 143 YLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
YLH+ IV+RD+K +N++I +G + + DF S +L+ P
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-----------------C 179
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG--K 259
+F GT +Y+APEII+ +
Sbjct: 180 TETF---------------------------------------TGTLQYMAPEIIDKGPR 200
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---YRILC--RPPDLVGEPTP-LRNL 313
G+ A D WSLG + EM G PF E +++ P++ + +
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPF--YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338
I + E DP KR ++ EF K
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLK 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 72/319 (22%), Positives = 125/319 (39%), Gaps = 76/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+GA G V+ DV + + A++ + +L ++ KEL I E V+R
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKEL-----------IINEILVMREN 74
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
++P + + ++Y G SL +E + I E + ALE+
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAG---GSLTDVVTETCMDEGQIAAVCRECLQALEF 131
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH+ +++RD+K +NI++ +G + L DF +++P+ KR
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-----------------KRS 174
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
+ VGT ++APE++ K +
Sbjct: 175 T---------------------------------------MVGTPYWMAPEVVTRKAYGP 195
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----PLRNLIRRLLE 319
VD WSLG++ EM+ G P+ + Y I + P R+ + R LE
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 320 KDPTKRIGVEEIKGHEFFK 338
D KR +E+ H+F K
Sbjct: 256 MDVEKRGSAKELLQHQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 70/319 (21%), Positives = 132/319 (41%), Gaps = 76/319 (23%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ G+V L ++ S A+K++ DL +++ +EL N E ++R+
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFN-----------EVVIMRDY 99
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+H + + + + +++ G +L S+ +++ I ++ AL Y
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQG---GALTDIVSQVRLNEEQIATVCEAVLQALAY 156
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRR 203
LH G+++RD+K ++I++ +G + L DF ++S P KR+
Sbjct: 157 LHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-----------------KRK 199
Query: 204 SFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDF 263
S VGT ++APE+I +
Sbjct: 200 S---------------------------------------LVGTPYWMAPEVISRSLYAT 220
Query: 264 AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----PLRNLIRRLLE 319
VD WSLG+++ EM+ G P+ S + R+ PP + LR+ + R+L
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280
Query: 320 KDPTKRIGVEEIKGHEFFK 338
+DP +R +E+ H F
Sbjct: 281 RDPQERATAQELLDHPFLL 299
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 70/322 (21%), Positives = 123/322 (38%), Gaps = 73/322 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G+G+ G VF D + + A+K+I +L + D+ I E
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKII----------DLEEAE--DEIEDIQQEIT 72
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
VL + P + + G D + ++Y G L + + I E++
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREIL 129
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L+YLH+ ++RD+K N+++ E+G + L DF ++ +L+ T + NT
Sbjct: 130 KGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--------DTQIKRNT--- 178
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
FVGT ++APE+I+
Sbjct: 179 ---------------------------------------------FVGTPFWMAPEVIKQ 193
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-CRPPDLVGEPTP-LRNLIRR 316
+D D WSLG+ E+ G P + + I PP L G + L+ +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253
Query: 317 LLEKDPTKRIGVEEIKGHEFFK 338
L K+P+ R +E+ H+F
Sbjct: 254 CLNKEPSFRPTAKELLKHKFIL 275
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 69/358 (19%), Positives = 134/358 (37%), Gaps = 84/358 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ LG G+ G V+ E+ + A+K + +E +E+ E
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIK------------EIS 76
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPG---RDLHSLRKQQSEQMFSDDTIRFYAA 135
+++ + P + + G + + ++YC D+ LR + ++D I
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQ 132
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+ LEYLH M ++RD+K NI++ GH L DF ++ +L+ +T
Sbjct: 133 STLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT--------------DT 178
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
+ KR + +GT ++APE+
Sbjct: 179 MA---KRNT---------------------------------------VIGTPFWMAPEV 196
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----PLR 311
I+ G++ D WSLG+ EM G P+ + I PP +P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK--ISRPPNIPARFEHENNESDG 367
+ +++ L K P +R ++ H F + +L+ I+ ++ + + +G
Sbjct: 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREEG 314
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-29
Identities = 76/341 (22%), Positives = 113/341 (33%), Gaps = 85/341 (24%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+S LG G GVVF V S A K+I ++ +I E
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI------------KPAIRNQIIREL 82
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+VL P + G +D + +++ G L + K+ + + + +
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAV 140
Query: 138 VLALEYLHNMG-IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L YL I++RD+KP NI++ G I
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEI----------------------------- 171
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
K C G+S + DS +NSFVGT Y++PE +
Sbjct: 172 -----------KLCDFGVSGQ--------------LIDS----MANSFVGTRSYMSPERL 202
Query: 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRR 316
+G + D WS+G+ L EM G P KE C+ E P R
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 317 LLEKDPTKRIGVEEIKGHEFFKGVNWELLLKI--SRPPNIP 355
L K I +ELL I PP +P
Sbjct: 263 PLNKFGMDSRPPMAI----------FELLDYIVNEPPPKLP 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 76/350 (21%), Positives = 127/350 (36%), Gaps = 88/350 (25%)
Query: 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
I D+ + +G GA VV E A+K I +L EK +
Sbjct: 11 SINRDDY---ELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NL-EKCQTSMDE----- 59
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPG---RDL---HSLRKQQ 120
+ E + + HP + V+ + ++ + G D+ + +
Sbjct: 60 ----LLKEIQAMSQCHHPNIVSYYTSFVVKDELWL--VMKLLSGGSVLDIIKHIVAKGEH 113
Query: 121 SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
+ + TI E++ LEYLH G ++RD+K NI++ E+G + + DF +S L+
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA- 172
Query: 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240
+ D ++
Sbjct: 173 --------------------------------------------------TGGDITRNKV 182
Query: 241 SNSFVGTEEYVAPEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-C 298
+FVGT ++APE++E +G+DF D WS G+ E+ GA P+ + L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 299 RPPDLVGEPT----------PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
PP L R +I L+KDP KR E+ H+FF+
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 73/345 (21%), Positives = 122/345 (35%), Gaps = 92/345 (26%)
Query: 12 SLDFSC--LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
S++ L + LGRGA GVV ++ V S + A+K I T N +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI----------RATVNS--QE 48
Query: 70 YRRISFEQRV-LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRK-QQSEQMFSD 127
+R+ + + +R V+ P G L + V ++ ++ Q +
Sbjct: 49 QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPE 108
Query: 128 DTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
D + A +V ALE+LH + +++RD+KP N++I G +
Sbjct: 109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV------------------- 149
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
K C GIS L D +
Sbjct: 150 ---------------------KMCDFGISGYLVD-------------------DVAKDID 169
Query: 245 VGTEEYVAPEIIEG----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR- 299
G + Y+APE I KG+ D WSLG+ + E+ P+ T ++ L +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW---GTPFQQLKQV 226
Query: 300 ----PPDLVGE--PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P L + + + L+K+ +R E+ H FF
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 28/184 (15%), Positives = 64/184 (34%), Gaps = 33/184 (17%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ + +G G G VF K +++ +K + + +++ E +
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKAER------------EVK 56
Query: 79 VLRNVEHP----------------LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE 122
L ++H S K + +++C L +++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 123 QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
+ ++ ++Y+H+ ++ RDLKP NI + + + + DF L T L
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 183 PQAS 186
+
Sbjct: 177 KRTR 180
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-22
Identities = 24/104 (23%), Positives = 42/104 (40%), Gaps = 5/104 (4%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR 295
+ K GT Y++PE I + + VD ++LG++L E+L+ + F
Sbjct: 173 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--FETSKFFTD 230
Query: 296 ILCRP-PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+ D+ + L+++LL K P R EI
Sbjct: 231 LRDGIISDIF--DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 73/331 (22%), Positives = 127/331 (38%), Gaps = 79/331 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
IV LG GA G V+ K+ E+ A KVI + ++ E
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVI-------------ETKSEEELEDYIVEIE 68
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L +HP + +L G D + I++CPG + ++ + + ++ I+ +++
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL-TEPQIQVVCRQML 127
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL +LH+ I++RDLK N+++ G I L DF +S K T
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL--------------KTLQ- 172
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII-- 256
KR +SF+GT ++APE++
Sbjct: 173 --KR---------------------------------------DSFIGTPYWMAPEVVMC 191
Query: 257 ---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT----P 309
+ +D+ D WSLG+ L EM P + +I P + P+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
R+ ++ L+K+P R ++ H F +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 75/366 (20%), Positives = 134/366 (36%), Gaps = 103/366 (28%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L + +G G G V+ ++ ++ A+K + + N ++ +RI +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM----------RRSGNK--EENKRILMDL 74
Query: 78 RVL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
V+ ++ + P + + G T+ V A++ G L+K+ + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP-IPERILGKMTVA 132
Query: 137 LVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANT 195
+V AL YL G+++RD+KP NI++ E G I
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQI---------------------------- 164
Query: 196 RSGIKKRRSFLSKFCSSGIS--LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
K C GIS L D + + G Y+AP
Sbjct: 165 ------------KLCDFGISGRLVD-------------------DKAKDRSAGCAAYMAP 193
Query: 254 EIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDL 303
E I+ +D D WSLG+ L E+ G P++ +T + +L + PP L
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC---KTDFEVLTKVLQEEPPLL 250
Query: 304 VGEPT---PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG--------VNW--ELLLKISR 350
G ++ ++ L KD KR ++ H F K +W +++ K
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVMAKTES 310
Query: 351 PPNIPA 356
P + P+
Sbjct: 311 PRSGPS 316
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 75/370 (20%), Positives = 131/370 (35%), Gaps = 91/370 (24%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V +G G G V+ + V++ + A+KV+ D+ + +E+ E
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQ------------EIN 72
Query: 79 VLRNV-EHPLLPRLRGVLSTDKFVGY------AIDYCPGRDLHSLRKQQSEQMFSDDTIR 131
+L+ H + G G +++C + L K ++ I
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
+ E++ L +LH +++RD+K +N+++ EN + LVDF +S +L +TV
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--------RTVG 184
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
NT F+GT ++
Sbjct: 185 RRNT------------------------------------------------FIGTPYWM 196
Query: 252 APEII-----EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLVG 305
APE+I +DF D WSLG+ EM GA P + I P L
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 256
Query: 306 EP--TPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG------VNWELLLKISRPPNIPAR 357
+ ++ I L K+ ++R E++ H F + V +L I R
Sbjct: 257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGE 316
Query: 358 FEHENNESDG 367
+ E G
Sbjct: 317 KDETEYEYSG 326
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 53/325 (16%), Positives = 114/325 (35%), Gaps = 81/325 (24%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+GRG+ V+ D E++ A + + E +R E +L+ +
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSER---------QRFKEEAEMLKGL 82
Query: 84 EHP----LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
+HP + K + + L + K+ ++ +R + +++
Sbjct: 83 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILK 140
Query: 140 ALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
L++LH I++RDLK +NI I +
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFI--------------------------------TGPT 168
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
G K + + + + + + +GT E++APE+ E
Sbjct: 169 GSVK----IGDLGLATLK---------------------RASFAKAVIGTPEFMAPEMYE 203
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDLVGEPTP-LRNL 313
+D +VD ++ G+ + EM P+ YR + +P P ++ +
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338
I + ++ +R ++++ H FF+
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 69/376 (18%), Positives = 122/376 (32%), Gaps = 109/376 (28%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI-----WRD--LIEKKSKELTNNDNGDKYR 71
++ +G G G V L + +++ + +A+KV+ + IE + ND+ +
Sbjct: 38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 72 RISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
+ + + L + G L+ + + + F +
Sbjct: 98 IV----KYHGKFMY------YDHMCLIFEPL---------GPSLYEIITRNNYNGFHIED 138
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
I+ Y E++ AL YL M + + DLKPENI++ + + K K
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK- 197
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+GIK L F + + S+ S + T +
Sbjct: 198 ------STGIK-----LIDFGCA----------------------TFKSDYHGSIINTRQ 224
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--------------------- 288
Y APE+I G D + D WS G VL E+ G+ FR
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 289 ----RKETFY----------------------RILCRPPDLVGEPTPLRNLIRRLLEKDP 322
+ Y C P + + + + +L+ DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 323 TKRIGVEEIKGHEFFK 338
T R E+ H+F +
Sbjct: 345 TLRPSPAELLKHKFLE 360
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G VF V + E + +A+K + + + ++ + YR E L +
Sbjct: 36 IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD--------SYRN---EIAYLNKL 83
Query: 84 EHPLLP--RLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLA 140
+ RL TD+++ Y + C DL+S L+K++S + Y ++ A
Sbjct: 84 QQHSDKIIRLYDYEITDQYI-YMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEA 139
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ +H GIV+ DLKP N +I +G + L+DF ++ ++ P T +
Sbjct: 140 VHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 19/123 (15%)
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKG-----------HDFAVDWWSLGVVLHEMLYGA 281
+S +S VGT Y+ PE I+ D WSLG +L+ M YG
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 282 TPFRG-SSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335
TPF+ ++ + I+ PD+ L+++++ L++DP +RI + E+ H
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 336 FFK 338
+ +
Sbjct: 295 YVQ 297
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G VF V + E + +A+K + + + ++ + YR E L +
Sbjct: 17 IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD--------SYRN---EIAYLNKL 64
Query: 84 EHPLLP--RLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLA 140
+ RL TD+++ Y + C DL+S L+K++S + Y ++ A
Sbjct: 65 QQHSDKIIRLYDYEITDQYI-YMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEA 120
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ +H GIV+ DLKP N +I +G + L+DF ++ ++ P T +
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 39/195 (20%), Positives = 76/195 (38%), Gaps = 26/195 (13%)
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKG-----------HDFAVDWWSLGVVLHEMLYGA 281
+S +S VGT Y+ PE I+ D WSLG +L+ M YG
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 282 TPFRG-SSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335
TPF+ ++ + I+ PD+ L+++++ L++DP +RI + E+ H
Sbjct: 218 TPFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHP 275
Query: 336 FFKGVNWELLLKISRPPNIPARFEHENNESDGRGRDGTKEIDVEKFVQGIFAGGGDAEQK 395
+ + ++ + E G+ + K + ++ E
Sbjct: 276 YVQ-------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 328
Query: 396 NEVNDEMNKNRGGEK 410
N + + + + G+K
Sbjct: 329 NSSSSKTFEKKRGKK 343
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 71/328 (21%), Positives = 117/328 (35%), Gaps = 82/328 (25%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G+ G V+ +DV +SE A+K + + + +K++ I E R
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKM----------SYSGKQSNEKWQDIIKEVR 106
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPG--RDLHSLRKQQSEQMFSDDTIRFYAAE 136
L+ + HP + RG + ++YC G DL + K+ + I
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHG 162
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
+ L YLH+ +++RD+K NI++ E G + L DF ++ ++
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----------------- 205
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
SF VGT ++APE+I
Sbjct: 206 ----PANSF---------------------------------------VGTPYWMAPEVI 222
Query: 257 ---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLVGEP--TPL 310
+ +D VD WSLG+ E+ P + Y I P L
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 282
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
RN + L+K P R E + H F
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G VF V + E + +A+K + + + ++ + YR E L +
Sbjct: 64 IGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD--------SYRN---EIAYLNKL 111
Query: 84 EHPLLP--RLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFYAAELVLA 140
+ RL TD+++ Y + C DL+S L+K++S + Y ++ A
Sbjct: 112 QQHSDKIIRLYDYEITDQYI-YMVMECGNIDLNSWLKKKKS---IDPWERKSYWKNMLEA 167
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ +H GIV+ DLKP N +I +G + L+DF ++ ++ P T +
Sbjct: 168 VHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 38/195 (19%), Positives = 75/195 (38%), Gaps = 26/195 (13%)
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKG-----------HDFAVDWWSLGVVLHEMLYGA 281
+S +S VG Y+ PE I+ D WSLG +L+ M YG
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 282 TPFRG-SSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335
TPF+ ++ + I+ PD+ L+++++ L++DP +RI + E+ H
Sbjct: 265 TPFQQIINQISKLHAIIDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHP 322
Query: 336 FFKGVNWELLLKISRPPNIPARFEHENNESDGRGRDGTKEIDVEKFVQGIFAGGGDAEQK 395
+ + ++ + E G+ + K + ++ E
Sbjct: 323 YVQ-------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 375
Query: 396 NEVNDEMNKNRGGEK 410
N + + + + G+K
Sbjct: 376 NSSSSKTFEKKRGKK 390
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 58/416 (13%), Positives = 126/416 (30%), Gaps = 115/416 (27%)
Query: 19 RIVSALGRGAK--GVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFE 76
+++ +G+G + V L + + E ++ I +L + + + E
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NL---------EACSNEMVTFLQGE 76
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
V + HP + R D + + L ++ I +
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
++ AL+Y+H+MG V+R +K +I+I +G + L + +
Sbjct: 137 VLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI----------------- 179
Query: 197 SGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256
S +++R + V +++PE++
Sbjct: 180 SHGQRQRV--------------------------------VHDFPKYSVKVLPWLSPEVL 207
Query: 257 E--GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-PPDLVGEPTP---- 309
+ +G+D D +S+G+ E+ G PF+ + L P L+ T
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267
Query: 310 ------------------------------------------LRNLIRRLLEKDPTKRIG 327
+ + + L+++P R
Sbjct: 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
Query: 328 VEEIKGHEFFKGV----NWELLLKISRPPNIPARFEHENNESDGRGRDGTKEIDVE 379
+ H FFK + + L + I ++ + G T ++E
Sbjct: 328 ASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELE 383
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 74/330 (22%), Positives = 118/330 (35%), Gaps = 76/330 (23%)
Query: 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIE---KKSKELTNN 64
P R S L LG+G G KV R+ E K +
Sbjct: 2 MPHRIFRPSDLIHGEVLGKGCFGQAI-------------KVTHRETGEVMVMKELIRFDE 48
Query: 65 DNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQ 123
+ + + E +V+R +EHP + + GVL DK + I +Y G L + K Q
Sbjct: 49 ETQRTFLK---EVKVMRCLEHPNVLKFIGVLYKDKRL-NFITEYIKGGTLRGIIKSMDSQ 104
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
+ F A ++ + YLH+M I++RDL N +++EN ++++ DF L+ + +
Sbjct: 105 YPWSQRVSF-AKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243
Q L R K +
Sbjct: 164 QPEGLRSLKKPDRK------------------------------------------KRYT 181
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--------RKETFYR 295
VG ++APE+I G+ +D VD +S G+VL E++ F
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD 241
Query: 296 ILCRPPDLVGEPTPLRNLIRRLLEKDPTKR 325
PP+ P + R + DP KR
Sbjct: 242 -RYCPPNC---PPSFFPITVRCCDLDPEKR 267
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 79/395 (20%), Positives = 137/395 (34%), Gaps = 118/395 (29%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI--WRDLIEKKSKELTNNDNGDKYRRISFE 76
++ S LG GA GVV + E A+K I + + R E
Sbjct: 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL--------------RTLRE 59
Query: 77 QRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCP----GRDLHSLRKQQSEQMFSDDTIRF 132
++L++ +H + + + D F + Y DLH + Q SDD I++
Sbjct: 60 IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM---LSDDHIQY 116
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+ + + A++ LH +++RDLKP N++I N + + DF L+ + S T
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT--- 173
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
++S + + FV T Y A
Sbjct: 174 --------GQQSGMVE-----------------------------------FVATRWYRA 190
Query: 253 PEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-- 309
PE++ + A+D WS G +L E+ F G + I ++G P
Sbjct: 191 PEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF----GIIGTPHSDN 246
Query: 310 -------------LRN----------------------LIRRLLEKDPTKRIGVEEIKGH 334
+++ L++R+L DP KRI +E H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 335 EFFKG---VNWELLLKISRPPNIPARFEHENNESD 366
+ + N E P P+ FE ++ +
Sbjct: 307 PYLQTYHDPNDE----PEGEPIPPSFFEFDHYKEA 337
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 64/364 (17%), Positives = 117/364 (32%), Gaps = 100/364 (27%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK---DVESSESFALKVI-WRDLIEKKSKELTNNDNGDK 69
F L I +G+G G V+ + +V A+++I E + K
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNEDQLKAFKR------ 78
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFS 126
E R H + G AI C GR L+S +R + +
Sbjct: 79 ------EVMAYRQTRHENVVLFMGA-CMSPPH-LAIITSLCKGRTLYSVVRDA--KIVLD 128
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+ R A E+V + YLH GI+++DLK +N+ +NG +++ DF L +
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFS---------- 177
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
I + +K G
Sbjct: 178 ------------ISGVLQAGRR-----------------------------EDKLRIQNG 196
Query: 247 TEEYVAPEII---------EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL 297
++APEII + D ++LG + +E+ PF+ + +++
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256
Query: 298 C--RPPDLVGE-PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNI 354
+P + +++ + +R ++ E L K +R +
Sbjct: 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM-------LEKLPKRNRRLSH 309
Query: 355 PARF 358
P F
Sbjct: 310 PGHF 313
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 66/328 (20%), Positives = 112/328 (34%), Gaps = 78/328 (23%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDL---IEKKSKELTNNDNGDKY 70
DF+ L + +G G G V+ + W + K ++ + D
Sbjct: 5 DFAELTLEEIIGIGGFGKVY-------------RAFWIGDEVAV-KAARHDPDEDISQTI 50
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDT 129
+ E ++ ++HP + LRGV + + +++ G L+ L ++ D
Sbjct: 51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDI 106
Query: 130 IRFYAAELVLALEYLHNMG---IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
+ +A ++ + YLH+ I++RDLK NI L+ + S
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI---------LILQKVEN------GDLS 151
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
K + K G++ R +++ S G
Sbjct: 152 NKIL-----------------KITDFGLA----------------REWHRTTKMSA--AG 176
Query: 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDL 303
++APE+I D WS GV+L E+L G PFRG Y + P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236
Query: 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
P P L+ DP R I
Sbjct: 237 STCPEPFAKLMEDCWNPDPHSRPSFTNI 264
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 80/395 (20%), Positives = 131/395 (33%), Gaps = 117/395 (29%)
Query: 19 RIVSALGRGAKGVVFLVKD-VESSESFALKVI-----WRD--LIEKKS-KELTNNDNGDK 69
IV LG G G V D ALK+I +R+ +E K++ D +K
Sbjct: 22 EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENK 81
Query: 70 YRRISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD 127
+ + + G ++ + G++ K+ + Q +
Sbjct: 82 FLCV----LMSDWFNF------HGHMCIAFELL---------GKNTFEFLKENNFQPYPL 122
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
+R A +L AL +LH + + DLKPENI+ + +F+ + S
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS------EFETLYNEHKSCEEKSV 176
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
K + I+ ++ F S+ + E + V T
Sbjct: 177 K-------NTSIR-----VADFGSA----------------------TFDHEHHTTIVAT 202
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI---LCRPPD-- 302
Y PE+I G D WS+G +L E G T F+ +E + L P
Sbjct: 203 RHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262
Query: 303 --------------------------LVGEPTPLRN--------------LIRRLLEKDP 322
+ PL++ L+RR+LE DP
Sbjct: 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322
Query: 323 TKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPAR 357
+RI + E H FF G+ E + P+R
Sbjct: 323 AQRITLAEALLHPFFAGLTPE--ERSFHTSRNPSR 355
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 55/328 (16%), Positives = 109/328 (33%), Gaps = 96/328 (29%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVI-WRDLIEKKSKELTNNDNGD 68
DF L ++ L G ++ + D+ +KV+ RD +KS++
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGNDI------VVKVLKVRDWSTRKSRDFNE----- 56
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMF 125
E LR HP + + G + + + P L++ L + + +
Sbjct: 57 -------ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109
Query: 126 SDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTP 183
++F A ++ + +LH + I L ++ ++D D++ ++
Sbjct: 110 QSQAVKF-ALDMARGMAFLHTLEPLIPRHALNSRSV---------MIDEDMTARI----- 154
Query: 184 QASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243
+ + S +S
Sbjct: 155 --------------------------SMADVKF---------------------SFQSPG 167
Query: 244 FVGTEEYVAPEIIEGKGHDF---AVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-- 298
+ +VAPE ++ K D + D WS V+L E++ PF S E ++
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227
Query: 299 -RPPDLVGEPTPLRNLIRRLLEKDPTKR 325
RP G + L++ + +DP KR
Sbjct: 228 LRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 63/387 (16%), Positives = 114/387 (29%), Gaps = 97/387 (25%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR-ISFEQ 77
++ LG G V+L D++ + A+KV+ + + Y E
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---------------KSAEHYTETALDEI 84
Query: 78 RVLR-----NVEHPLLPRLRGVLSTDKFVGYAID------YC----P-GRDLHSLRKQQS 121
R+L+ + P + +L D F I C G L + +
Sbjct: 85 RLLKSVRNSDPNDPNREMVVQLL--DDFK---ISGVNGTHICMVFEVLGHHLLKWIIKSN 139
Query: 122 EQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
Q ++ +++ L+YLH I++ D+KPENI++ N +
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA-----EA 194
Query: 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240
Q S + + S + E +I + +
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL--KVKIADLGNACW---VHKH 249
Query: 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPF---------------- 284
+ T +Y + E++ G G++ D WS + E+ G F
Sbjct: 250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIA 309
Query: 285 ---------------RGSSRKETF-----------------YRILCRPPDLVG-EPTPLR 311
G KE F + +L + E
Sbjct: 310 LIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFT 369
Query: 312 NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+ + +LE P KR E H +
Sbjct: 370 DFLLPMLELIPEKRATAAECLRHPWLN 396
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 74/378 (19%), Positives = 125/378 (33%), Gaps = 115/378 (30%)
Query: 19 RIVSALGRGAKGVVFLVKDVES-SESFALKVI-----WRD--LIEKKS-KELTNNDNGDK 69
IV LG GA G V D ++ A+K++ + + E + + L D
Sbjct: 17 EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 70 YRRISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD 127
+R + ++L EH G + + G + K+ F
Sbjct: 77 FRCV----QMLEWFEH------HGHICIVFELL---------GLSTYDFIKENGFLPFRL 117
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
D IR A ++ ++ +LH+ + + DLKPENI+ ++ + +
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT-------------EAYNPKI 164
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
K IK + F S+ + E ++ V T
Sbjct: 165 KRDERTLINPDIK-----VVDFGSA----------------------TYDDEHHSTLVST 197
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS------------------- 288
Y APE+I G D WS+G +L E G T F
Sbjct: 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHM 257
Query: 289 -----RKETFYRILCRPPD-------LVGEPTPLR--------------NLIRRLLEKDP 322
+++ F+ + + PL+ +LI+++LE DP
Sbjct: 258 IQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317
Query: 323 TKRIGVEEIKGHEFFKGV 340
KRI + E H FF +
Sbjct: 318 AKRITLREALKHPFFDLL 335
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 74/407 (18%), Positives = 123/407 (30%), Gaps = 153/407 (37%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI-----WRD--LIEKKS-KELTNNDNGDKY 70
++ +G+G+ G V D + + ALK++ + E + + L D +
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 71 RRISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
I +L N R ++ + +L+ L K+ Q FS
Sbjct: 160 NVI----HMLENFTF------RNHICMTFELL---------SMNLYELIKKNKFQGFSLP 200
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
+R +A ++ L+ LH I++ DLKPENI++++ G
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG----------------------- 237
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
RSGIK + F SS E I SR
Sbjct: 238 -------RSGIK-----VIDFGSS--CYEHQRVYTYI----QSRF--------------- 264
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS-------------------- 288
Y APE+I G + +D WSLG +L E+L G G
Sbjct: 265 -YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323
Query: 289 ----RKETFYRILCRPPDLVGEPTP----------------------------------- 309
R + F P
Sbjct: 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383
Query: 310 -LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIP 355
+ +++ LE DP R+ + H + + ++ +PP
Sbjct: 384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRR-------RLPKPPTGE 423
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 61/328 (18%), Positives = 112/328 (34%), Gaps = 92/328 (28%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK---DVESSESFALKVI-WRDLIEKKSKELTNNDNGDK 69
+ + +G G+ G V+ K DV A+K++ ++ + N
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQLQAFKN------ 69
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHSLRKQQSEQMFSD 127
E VLR H + G + + AI +C G L+ +
Sbjct: 70 ------EVGVLRKTRHVNILLFMGYSTAPQL---AIVTQWCEGSSLYHHLHASETKFEMK 120
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
I A + ++YLH I++RDLK NI + E+ + + DF L
Sbjct: 121 KLIDI-ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL------------- 166
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
+ K R S S + G+
Sbjct: 167 ---------ATEKSRWS--------------------------------GSHQFEQLSGS 185
Query: 248 EEYVAPEIIEGKGH---DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP 301
++APE+I + F D ++ G+VL+E++ G P+ + ++ ++ P
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245
Query: 302 DLVGEPT----PLRNLIRRLLEKDPTKR 325
DL + ++ L+ L+K +R
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 76/390 (19%), Positives = 139/390 (35%), Gaps = 118/390 (30%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
I +GRG+ G V+L D + ++ A+K + R DLI+ K RI
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK--------------RILR 74
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYC----PGRDLHSLRKQQSEQMFSDDTIR 131
E +L ++ + RL ++ D + + Y DL L K + +++ I+
Sbjct: 75 EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFK--TPIFLTEEHIK 132
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
L+L ++H GI++RDLKP N ++ ++ + + DF L+
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA---------------- 176
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
R+ S+ ++ ++ + P + + V T Y
Sbjct: 177 -----------RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS-------HVVTRWYR 218
Query: 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATP-----------FRGSSRKETFYRILCR 299
APE+I + + ++D WS G + E+L F GSS +
Sbjct: 219 APELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSK 278
Query: 300 PP-------------DLVGEPT-------------------------PLR---------- 311
+++G PT L+
Sbjct: 279 KVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338
Query: 312 -NLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
NL+ +L+ +P KRI +++ H + K V
Sbjct: 339 INLLESMLKFNPNKRITIDQALDHPYLKDV 368
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 62/330 (18%), Positives = 118/330 (35%), Gaps = 76/330 (23%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L + + +G+G G+V + V+ A+K + + +K++
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSL------ILGDSEGETEMIEKFQE 69
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHSLRKQQSEQMFSDDTI 130
E ++ N+ HP + +L G+ + + ++ P DL+ ++ + +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGL-MHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 131 RFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
R ++ L +EY+ N IV+RDL+ N I L D + + K
Sbjct: 126 RL-MLDIALGIEYMQNQNPPIVHRDLRSPN--------IFLQSLDENAPVCAK------- 169
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
++ F G+S + S + +G
Sbjct: 170 -----------------VADF---GLS----------------QQSVHSV---SGLLGNF 190
Query: 249 EYVAPEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----CRPP 301
+++APE I + + D +S ++L+ +L G PF S + + + RP
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
P LRN+I DP KR I
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 75/382 (19%), Positives = 126/382 (32%), Gaps = 120/382 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V LG+GA G+V+ D + E A+K I D ++ + QR
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-----------------FDAFQNSTDAQR 54
Query: 79 VLRNV-------EHPLLPRLRGVLSTDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
R + H + L VL D Y + DLH++ +
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANI---LEPVHK 111
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
++ +L+ ++YLH+ G+++RD+KP NI++ H+ + DF LS + +
Sbjct: 112 QYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
+ L+ +V T Y
Sbjct: 172 SINENTENFDDDQPILTD-----------------------------------YVATRWY 196
Query: 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP 309
APEI+ G + +D WSLG +L E+L G F GSS RI+ ++ P+
Sbjct: 197 RAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII----GVIDFPSN 252
Query: 310 --------------LRNL--------------------------------------IRRL 317
+ +L + +L
Sbjct: 253 EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312
Query: 318 LEKDPTKRIGVEEIKGHEFFKG 339
L+ +P KRI + H F
Sbjct: 313 LQFNPNKRISANDALKHPFVSI 334
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 73/398 (18%), Positives = 126/398 (31%), Gaps = 126/398 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
I +G G+ G V D A+K I R DLI+ K RI
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK--------------RILR 101
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCP----GRDLHSLRKQQSEQMFSDDTIR 131
E +L + H + ++ ++ + Y D L + + ++ I+
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR--TPVYLTELHIK 159
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
L++ ++Y+H+ GI++RDLKP N ++ ++ + + DF L+
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA---------------- 203
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE-- 249
R+ P + + K+ T
Sbjct: 204 -----------RTV-------DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 250 ---YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATP-----------FRGSSRKETFY 294
Y APE+I + + A+D WS+G + E+L F GSS
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305
Query: 295 RILCRPP----------------DLVGEPT-------------------------PLR-- 311
+++G P+ L
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365
Query: 312 ---------NLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
+L++R+L +P KRI + E H FFK V
Sbjct: 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 25/159 (15%)
Query: 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
+V LGRG VF ++ ++E +K++ K +R E ++
Sbjct: 40 LVRKLGRGKYSEVFEAINITNNEKVVVKIL-------------KPVKKKKIKR---EIKI 83
Query: 80 LRNV-EHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAE 136
L N+ P + L ++ + ++ D L Q +D IRFY E
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE 138
Query: 137 LVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDL 174
++ AL+Y H+MGI++RD+KP N+MI E+ + L+D+ L
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 26/139 (18%), Positives = 44/139 (31%), Gaps = 40/139 (28%)
Query: 242 NSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRI--- 296
N V + + PE++ + +D+++D WSLG +L M++ P F G + RI
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 297 --------------LCRPPDLVG-----EPTPLRNLIRR------------LLEK----D 321
+ P + L+K D
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307
Query: 322 PTKRIGVEEIKGHEFFKGV 340
R+ E H +F V
Sbjct: 308 HQSRLTAREAMEHPYFYTV 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 60/315 (19%), Positives = 107/315 (33%), Gaps = 79/315 (25%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ +GRG G V+ +D ALK++ L + + R+ E R
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL----------SSDPVFRTRMQREAR 86
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
++ P + + D + + G DL ++ ++Q + + ++
Sbjct: 87 TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVA-IVRQIG 144
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL+ H G +RD+KPEN I++ +
Sbjct: 145 SALDAAHAAGATHRDVKPEN--------ILV-------------------------SADD 171
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE-KSNSFVGTEEYVAPEIIE 257
L F GI+ + +D + + VGT Y+APE
Sbjct: 172 FAY----LVDF---GIA----------------SATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-------KETFYRILCRPPDLVGEPTPL 310
+ D ++L VL+E L G+ P++G + R P + P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI---PVAF 265
Query: 311 RNLIRRLLEKDPTKR 325
+I R + K+P R
Sbjct: 266 DAVIARGMAKNPEDR 280
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 63/403 (15%), Positives = 120/403 (29%), Gaps = 136/403 (33%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRIS-FEQ 77
+V LG G V+L KD+ ++ A+K++ Y + E
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---------------RGDKVYTEAAEDEI 66
Query: 78 RVLRNV--------EHPLLPRLRGVLSTDKFVGYAIDYCP------GRDLHSLRKQQSEQ 123
++L+ V + + +L G + G +L +L K+ +
Sbjct: 67 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 126
Query: 124 MFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
++ + +L+L L+Y+H GI++ D+KPEN +++ D
Sbjct: 127 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN--------VLMEIVDSPEN----- 173
Query: 183 PQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242
IK ++ ++ E
Sbjct: 174 -------------LIQIK-----IADLGNA----------------------CWYDEHYT 193
Query: 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY-------- 294
+ + T EY +PE++ G D WS ++ E++ G F
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 295 -RILCRPP--------------DLVGE--------PTPLRN------------------L 313
+L P + G PL +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPA 356
+ +L+ DP KR + H + K L ++ R P+
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKD---TLGMEEIRVPDREL 353
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 67/333 (20%), Positives = 122/333 (36%), Gaps = 107/333 (32%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI-----WRD--LIEKKS-KELTNNDNGDKY 70
I S +G+G+ G V D E A+K+I + + IE + + + +D KY
Sbjct: 57 EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 71 RRISFEQRVLRNVEHPLLPRLRG--VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
+ + R+ R L + +L+ L + + + S +
Sbjct: 117 YIV----HLKRHFMF------RNHLCLVFEML---------SYNLYDLLRNTNFRGVSLN 157
Query: 129 TIRFYAAELVLALEYLHN--MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
R +A ++ AL +L + I++ DLKPENI++
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK--------------------- 196
Query: 187 PKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246
RS IK + F SS ++ ++
Sbjct: 197 ---------RSAIK-----IVDFGSS----------------------CQLGQRIYQYIQ 220
Query: 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE 306
+ Y +PE++ G +D A+D WSLG +L EM G F G++ + +I+ +++G
Sbjct: 221 SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV----EVLGI 276
Query: 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
P +L++ P K +FF+
Sbjct: 277 PP------AHILDQAP---------KARKFFEK 294
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 69/320 (21%), Positives = 121/320 (37%), Gaps = 87/320 (27%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+IV LG G V+L +D + A+K I+ + + +R E
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP----------REKEETLKRFEREVH 63
Query: 79 VLRNVEHPLLPRLRGVLS-----TDKFVGY-AIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
+ H ++S + Y ++Y G L + + D I F
Sbjct: 64 NSSQLSHQ------NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINF 116
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+++ +++ H+M IV+RD+KP+N I++
Sbjct: 117 -TNQILDGIKHAHDMRIVHRDIKPQN--------ILI----------------------- 144
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE-KSNSFVGTEEYV 251
+ K F GI+ ++ S++S ++N +GT +Y
Sbjct: 145 --DSNKTLKIFDF-------GIA----------------KALSETSLTQTNHVLGTVQYF 179
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR-ILCRPPDLVGE---- 306
+PE +G+ D D +S+G+VL+EML G PF G + + I P++ +
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 307 -PTPLRNLIRRLLEKDPTKR 325
P L N+I R EKD R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 36/166 (21%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L+ + +GRGA G V + S + A+K I T ++ + +++ +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI----------RSTVDE--KEQKQLLMDL 71
Query: 78 RV-LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPG--RDLHSLRKQQSEQMFSDDTIRFYA 134
V +R+ + P + + G L + ++ + + + ++ +
Sbjct: 72 DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKIT 131
Query: 135 AELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
V AL +L N+ I++RD+KP NI++ +G+I L DF +S +L
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 37/151 (24%), Positives = 60/151 (39%), Gaps = 28/151 (18%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEG----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
DS K+ G Y+APE I+ +G+D D WSLG+ L+E+ G P+
Sbjct: 177 VDSIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW--- 232
Query: 291 ETFYRILCR-----PPDLVGEPT-----PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340
+ + L + PP L N + L KD +KR +E+ H F
Sbjct: 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292
Query: 341 N--------W--ELLLKISRPPNIPARFEHE 361
+ ++L ++ P+ P +H
Sbjct: 293 EERAVEVACYVCKILDQMPATPSSPMYVDHH 323
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 52/227 (22%), Positives = 80/227 (35%), Gaps = 66/227 (29%)
Query: 107 YCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166
Y G L + + M I A+ AL + H GI++RD+KP N
Sbjct: 97 YVDGVTLRDIVHTEG-PMTPKRAIE-VIADACQALNFSHQNGIIHRDVKPAN-------- 146
Query: 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIG 226
IM+ + + K F GI+
Sbjct: 147 IMI-------------------------SATNAVKVMDF-------GIA----------- 163
Query: 227 PDPPSRSDSDSSE---KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP 283
R+ +DS ++ + +GT +Y++PE G D D +SLG VL+E+L G P
Sbjct: 164 -----RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
Query: 284 FRGSSRKETFYR----ILCRPPDLVGE-PTPLRNLIRRLLEKDPTKR 325
F G S Y+ P L ++ + L K+P R
Sbjct: 219 FTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 41/174 (23%), Positives = 84/174 (48%), Gaps = 27/174 (15%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+G G+ GVV+ K +S E A+K + L +K+ K R E +
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKR----------FKNR----ELQ 99
Query: 79 VLRNVEHPLLPRLRGVLST------DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTI 130
++R ++H + RLR + + ++ +DY P ++ + + +++Q +
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYV 158
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM-LVDFDLSTKLSPKTP 183
+ Y +L +L Y+H+ GI +RD+KP+N+++ + ++ L DF + +L P
Sbjct: 159 KLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 45/167 (26%), Positives = 60/167 (35%), Gaps = 46/167 (27%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
E + S++ + Y APE+I G + ++D WS G VL E+L G F G S +
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 295 RILCRPPDLVGEPT----------------------PLR------------NLIRRLLEK 320
I+ ++G PT P L RLLE
Sbjct: 268 EII----KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323
Query: 321 DPTKRIGVEEIKGHEFFKGVNWELLLKISRPPN---IPARFEHENNE 364
PT R+ E H FF EL + PN PA F E
Sbjct: 324 TPTARLTPLEACAHSFFD----ELRDPNVKLPNGRDTPALFNFTTQE 366
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 23/160 (14%)
Query: 19 RIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ + G G ++L D + LK L ++ + + E+
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKG------------LVHSGDAEAQAMAMAER 130
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAI-----DYCPGRDLHSLRKQQSEQMFSDDTIRF 132
+ L V HP + ++ + G + +Y G+ L + +++ + I
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIA- 186
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
Y E++ AL YLH++G+VY DLKPENIM+ E + L+D
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 19/85 (22%), Positives = 31/85 (36%), Gaps = 6/85 (7%)
Query: 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP 300
GT + APEI+ G A D +++G L + G L
Sbjct: 234 FGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----LPED 287
Query: 301 PDLVGEPTPLRNLIRRLLEKDPTKR 325
++ L+RR ++ DP +R
Sbjct: 288 DPVLKTYDSYGRLLRRAIDPDPRQR 312
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
+G G GVV+ ++ + E ALK I L G R IS +L
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKI----------RLDTETEGVPSTAIREIS----LL 56
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ + HP + +L V+ T+ + ++ +DL + I+ Y +L+
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
L + H+ +++RDLKP+N++I G I L DF L+
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 34/151 (22%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ GVVF ++ ++ + A+K + +D K + E R+L+ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF----------LESEDDPVIKKIALR-EIRMLKQL 59
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
+HP L L V + + +YC + + + + ++ + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNF 117
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
H ++RD+KPENI+I ++ I L DF
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 30/145 (20%), Positives = 54/145 (37%), Gaps = 35/145 (24%)
Query: 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------------ 296
Y +PE++ G VD W++G V E+L G + G S + Y I
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 297 --LCRPPDLVG-------EPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEF 336
G + PL L++ L DPT+R+ E++ H +
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 337 FKGVNWELLLKISRPPNIPARFEHE 361
F+ + + +++ + PA +
Sbjct: 288 FENIR--EIEDLAKEHDKPAENLYF 310
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 34/175 (19%), Positives = 71/175 (40%), Gaps = 25/175 (14%)
Query: 19 RIVSALGRGAKGVVFLVKDVESS--------ESFALKVIWRDLIEKKSKELTNNDNGDKY 70
++ S R +G+++ + + F+LK ++ K L N N +
Sbjct: 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQN--FF 96
Query: 71 RRISFEQRV-----LRNVEHPLLPRLRGV-LSTDKFVGYAIDYCPGRDLHSLRKQQSEQM 124
+R + +V L + +P G + DK+ + GR L S + +
Sbjct: 97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHV 155
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI--QENGHIMLVDFDLSTK 177
S+ ++ A L+ ALE+LH V+ ++ ENI + ++ + L + + +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 36/159 (22%), Positives = 66/159 (41%), Gaps = 26/159 (16%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RN 82
LG G G V + + + E FALK++ + E + R
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML------------------QDCPKARREVELHWRA 67
Query: 83 VEHPLLPRLRGV----LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ P + R+ V + K + ++ G +L S + + +Q F++ +
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127
Query: 139 LALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDFDL 174
A++YLH++ I +RD+KPEN++ N + L DF
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 10/97 (10%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRPPDLVGEP 307
A E G+ +D + D WSLGV+++ +L G PF + RI +
Sbjct: 167 AKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 225
Query: 308 TPL-----RNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
+ LIR LL+ +PT+R+ + E H +
Sbjct: 226 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 44/162 (27%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY------RRISFEQ 77
+G GA G V+ +D S ALK + + N G R ++ +
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV----------RVPNGGGGGGGLPISTVREVALLR 66
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAI-----DYCPGRDLHSLRKQQSEQMFSDDTIRF 132
R L EHP + RL V +T + ++ +DL + + +TI+
Sbjct: 67 R-LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKD 124
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
+ + L++LH IV+RDLKPENI++ G + L DF L
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 26/117 (22%), Positives = 40/117 (34%), Gaps = 28/117 (23%)
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD----- 302
Y APE++ + VD WS+G + EM F G+S + +I L P
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244
Query: 303 ----------LVGEPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P P++ L+ +L +P KRI H +
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 37/183 (20%), Positives = 72/183 (39%), Gaps = 32/183 (17%)
Query: 1 MNDVVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE 60
N+VV ++ +G G+ GV+F ++ +++ A+K E +
Sbjct: 4 QNNVVGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIK------FEPRR-- 46
Query: 61 LTNNDNGDKYRRISFEQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ 119
++ E R + + +P + ID G L L
Sbjct: 47 -------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL 98
Query: 120 QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----QENGH-IMLVDFDL 174
+ FS T+ A +++ ++ +H +VYRD+KP+N +I +N + I +VDF +
Sbjct: 99 CG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
Query: 175 STK 177
Sbjct: 158 VKF 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 34/163 (20%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ +G G+ G ++L D+ + E A+K +E K+ ++ E +
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIK------LECVK---------TKHPQLHIESK 56
Query: 79 VLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+ + ++ +P +R + + ++ G L L S + FS T+ A ++
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQM 114
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVDFDLSTK 177
+ +EY+H+ ++RD+KP+N ++ + ++DF L+ K
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 44/169 (26%), Positives = 83/169 (49%), Gaps = 28/169 (16%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G+ GVVF K VES E A+K + L +K+ K R + ++R V
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKV---LQDKR----------FKNRELQ----IMRIV 89
Query: 84 EHPLLPRLRGVLST------DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAA 135
+HP + L+ + + F+ ++Y P ++ + + +Q I+ Y
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMIQENGHIM-LVDFDLSTKLSPKTP 183
+L+ +L Y+H++GI +RD+KP+N+++ ++ L+DF + L P
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 46/169 (27%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
+ E + S++ + Y APE+I G + +D WS G V+ E++ G F G S +
Sbjct: 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 295 RILCRPPDLVGEPT----------------------PLR------------NLIRRLLEK 320
I+ ++G P+ P +LI RLLE
Sbjct: 253 EII----KVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308
Query: 321 DPTKRIGVEEIKGHEFFKGVNWELLLKISRPPN---IPARFEHENNESD 366
P+ R+ E H FF EL +R PN +P F E
Sbjct: 309 TPSARLTAIEALCHPFFD----ELRTGEARMPNGRELPPLFNWTKEELS 353
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 39/177 (22%), Positives = 78/177 (44%), Gaps = 27/177 (15%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ G+G G V L K+ + S A+K + +D + R + +
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN-------------RELQ-IMQ 71
Query: 79 VLRNVEHPLLPRLRGVLST-------DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDT 129
L + HP + +L+ T D ++ ++Y P LH + + +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130
Query: 130 IRFYAAELVLALEYLHN--MGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTP 183
I+ + +L+ ++ LH + + +RD+KP N+++ + +G + L DF + KLSP P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 40/183 (21%), Positives = 67/183 (36%), Gaps = 50/183 (27%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
SE + +++ + Y APE+I G + + AVD WS+G + EM+ G FRG + +
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 295 RILCRPPDLVGEPT----------------------PLRN---------------LIRRL 317
I+ ++G P+ P N L+ L
Sbjct: 243 EIV----RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 318 LEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNI----PARFEHENNESDGRGRDGT 373
L+ P +R+ E H +F EL ++ PN F NE +
Sbjct: 299 LQYLPEERMKPYEALCHPYFD----ELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQK 354
Query: 374 KEI 376
++
Sbjct: 355 AKL 357
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 30/155 (19%), Positives = 65/155 (41%), Gaps = 19/155 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY---RRISFEQRVL 80
+G G+ G+V ++ ++ A+K +++D K R I +L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKF----------LESDDDKMVKKIAMREIK----LL 78
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ + H L L V K ++ + + ++ Y +++
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFP-NGLDYQVVQKYLFQIING 136
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + H+ I++RD+KPENI++ ++G + L DF +
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 31/122 (25%), Positives = 45/122 (36%), Gaps = 33/122 (27%)
Query: 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD---- 302
Y APE++ G AVD W++G ++ EM G F G S + Y I
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 303 ---------------LVGEPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEF 336
+ E PL +L ++ L DP KR E+ H+F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 337 FK 338
F+
Sbjct: 310 FQ 311
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 40/173 (23%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ +G G G + L K++ ++E A+K +E + ++ E R
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMK---------SRAPQLHLEYR 56
Query: 79 VLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+ + +P++ K+ ++ G L L + FS T+ A +L
Sbjct: 57 FYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQL 114
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGH-----IMLVDFDLSTK-LSPKTPQ 184
+ +EY+H+ ++YRD+KPEN +I G+ I ++DF L+ + + P+T +
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK 167
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/167 (23%), Positives = 74/167 (44%), Gaps = 20/167 (11%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G GA G V D S E A+K + R + +R E
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-----------QSEIFAKRAYRELL 75
Query: 79 VLRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
+L++++H + L V S F Y + DL + + FS++ I++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYL 131
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
+++ L+Y+H+ G+V+RDLKP N+ + E+ + ++DF L+
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 46/160 (28%)
Query: 244 FVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
+V T Y APE+I ++ VD WS+G ++ EML G T F+G + +IL
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL----K 238
Query: 303 LVGEPTP--------------LRN----------------------LIRRLLEKDPTKRI 326
+ G P +++ L+ ++LE D KR+
Sbjct: 239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298
Query: 327 GVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
+ H FF+ F+
Sbjct: 299 TAAQALTHPFFEP-----FRDPEEETEAQQPFDDSLEHEK 333
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 10/162 (6%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ + G+ G V D E A+K ++ + + ++ + ++ K R+ E R
Sbjct: 25 TVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCK--RVLREIR 81
Query: 79 VLRNVEHPLLPRLRGVL---STDKFVG-YAIDYCPGRDLHS-LRKQQSEQMFSDDTIRFY 133
+L + HP + LR + Y + DL + Q+ S I+++
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV--ISPQHIQYF 139
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++L L LH G+V+RDL P NI++ +N I + DF+L+
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 47/174 (27%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR 289
+R D+ + K++ +V Y APE++ KG VD WS G V+ EM FRGS+
Sbjct: 181 AREDTADANKTH-YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 290 KETFYRILCRPPDLVGEPTP--------------LRN----------------------- 312
+I+ ++VG P LRN
Sbjct: 240 YNQLNKIV----EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 313 LIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
LI ++LE +P +RI E+ H +F+ L + + RF + + +D
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFE----SLFDPLDLTEGLSERFHFDESVTD 345
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
R + +G GA G V D + A+K ++R + K R
Sbjct: 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK--------------RAYR 73
Query: 76 EQRVLRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
E R+L+++ H + L V + D F Y + G DL L K + +D I
Sbjct: 74 ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK---LGEDRI 130
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
+F +++ L Y+H GI++RDLKP N+ + E+ + ++DF L+ +
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 29/133 (21%), Positives = 49/133 (36%), Gaps = 41/133 (30%)
Query: 244 FVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
+V T Y APE+I + VD WS+G ++ EM+ G T F+GS + I+
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM----K 240
Query: 303 LVGEPTP--------------LRN----------------------LIRRLLEKDPTKRI 326
+ G P ++ L+ ++L D +R+
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
Query: 327 GVEEIKGHEFFKG 339
E H +F+
Sbjct: 301 TAGEALAHPYFES 313
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G V+ +D +++ A+K I + ++K+ N R I +L+ +
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA---LREIK----LLQEL 69
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + L + D+ DL + K S + + I+ Y + LEY
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEY 127
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
LH I++RDLKP N+++ ENG + L DF L
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 29/119 (24%), Positives = 45/119 (37%), Gaps = 30/119 (25%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------------ 296
Y APE++ G + + VD W++G +L E+L G S + RI
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 297 --LCRPPDLVG----EPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+C PD V PL +LI+ L +P RI + ++F
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 37/173 (21%), Positives = 69/173 (39%), Gaps = 30/173 (17%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVI-WRDLIEKKSKELTNNDNGD 68
+ L I +G G+ G V + DV A+K++ +D ++ E
Sbjct: 35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDV------AVKILMEQDFHAERVNEFLR----- 83
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMF 125
E +++ + HP + G T +I +Y L+ L K + +
Sbjct: 84 -------EVAIMKRLRHPNIVLFMGA-VTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQL 134
Query: 126 SDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLST 176
+ A ++ + YLHN IV+R+LK N+++ + + + DF LS
Sbjct: 135 DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 22/98 (22%), Positives = 40/98 (40%), Gaps = 3/98 (3%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
SR + + S S GT E++APE++ + + D +S GV+L E+ P+ +
Sbjct: 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 245
Query: 291 ETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKR 325
+ + R + +I +P KR
Sbjct: 246 QVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 19/155 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
+G G G VF K+ E+ E ALK + L ++D G R I +L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALREIC----LL 55
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ ++H + RL VL +DK + ++C +DL + + ++ + +L+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCN-GDLDPEIVKSFLFQLLKG 113
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
L + H+ +++RDLKP+N++I NG + L +F L+
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 28/124 (22%), Positives = 46/124 (37%), Gaps = 32/124 (25%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRI--LCRPPD--- 302
Y P+++ G K + ++D WS G + E+ P F G+ + RI L P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 303 --------------LVGEPTPLR-----------NLIRRLLEKDPTKRIGVEEIKGHEFF 337
+ T L +L++ LL+ +P +RI EE H +F
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
Query: 338 KGVN 341
Sbjct: 287 SDFC 290
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 55/363 (15%), Positives = 104/363 (28%), Gaps = 126/363 (34%)
Query: 18 LRIVSALGRGAKGVVFLVK----DVESSESFALKVI-WRDLIEKKSKELTNNDNGDKYRR 72
+ ++ +G+G G V+ +V A+K+ RD
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGENV------AVKIFSSRDEKSWF--------------- 48
Query: 73 ISFEQRV--LRNVEHPLLPRLRGV--LSTDKFVGYAI--DYCPGRDLHSLRKQQSEQMFS 126
E + + H + S + Y L+ + +
Sbjct: 49 --RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LD 103
Query: 127 DDTIRFYAAELVLALEYLH--------NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178
+ + L +LH I +RDLK +NI++++NG + D L+
Sbjct: 104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH 163
Query: 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238
S S +
Sbjct: 164 SQ----------------------------------------------------STNQLD 171
Query: 239 EKSNSFVGTEEYVAPEIIEGK------GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292
+N VGT+ Y+APE+++ VD W+ G+VL E+ +
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231
Query: 293 FY--------------RILCR-------PPDLVGEPTP--LRNLIRRLLEKDPTKRIGVE 329
+ +++C P +PT L L++ ++P+ R+
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 330 EIK 332
IK
Sbjct: 292 RIK 294
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 32/163 (19%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ +G G+ G ++L +++++E A+K+ K+ ++ +E +
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------------TKHPQLLYESK 54
Query: 79 VLRNVE-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+ R ++ +P +R + +D G L L S + S T+ A ++
Sbjct: 55 IYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQM 112
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVDFDLSTK 177
+ +E++H+ ++RD+KP+N ++ + ++DF L+ K
Sbjct: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 25/170 (14%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
+ +S +G GA G V D ++ A+K + R +I K R
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK--------------RTYR 77
Query: 76 EQRVLRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
E R+L++++H + L V S ++F Y + + G DL+++ K Q +DD +
Sbjct: 78 ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHV 134
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
+F +++ L+Y+H+ I++RDLKP N+ + E+ + ++DF L+ +
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 41/132 (31%)
Query: 244 FVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302
+V T Y APEI+ ++ VD WS+G ++ E+L G T F G+ + IL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL----R 244
Query: 303 LVGEPTP--------------LRN----------------------LIRRLLEKDPTKRI 326
LVG P +++ L+ ++L D KRI
Sbjct: 245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
Query: 327 GVEEIKGHEFFK 338
+ H +F
Sbjct: 305 TAAQALAHAYFA 316
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 38/176 (21%), Positives = 71/176 (40%), Gaps = 34/176 (19%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDL---IEKKSKELTNNDNGDKY 70
D+ + + +GRGA GVV K WR I K++ + +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVC-------------KAKWRAKDVAI----KQIESESERKAF 48
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSD 127
E R L V HP + +L G + + +Y G L++ L + ++
Sbjct: 49 IV---ELRQLSRVNHPNIVKLYGA-CLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTA 101
Query: 128 DTIRFYAAELVLALEYLHNM---GIVYRDLKPENIMIQENGHIM-LVDFDLSTKLS 179
+ + + YLH+M +++RDLKP N+++ G ++ + DF + +
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 28/100 (28%), Positives = 46/100 (46%), Gaps = 4/100 (4%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR 295
D + G+ ++APE+ EG + D +S G++L E++ PF
Sbjct: 155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
Query: 296 ILC----RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
RPP + P P+ +L+ R KDP++R +EEI
Sbjct: 215 WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEI 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 35/159 (22%), Positives = 71/159 (44%), Gaps = 23/159 (14%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
LG G V+ + + ALK + +++ G R IS ++
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-----------KLDSEEGTPSTAIREIS----LM 57
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL----HSLRKQQSEQMFSDDTIRFYAAE 136
+ ++H + RL V+ T+ + ++ DL S + + + ++++ +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
L+ L + H I++RDLKP+N++I + G + L DF L+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 27/149 (18%), Positives = 51/149 (34%), Gaps = 41/149 (27%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD---- 302
Y AP+++ G + + ++D WS G +L EM+ G F G++ +E I + P+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 303 -------------LVGEPTPLRN----------------LIRRLLEKDPTKRIGVEEIKG 333
P LR + LL+ +P R+ ++
Sbjct: 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293
Query: 334 HEFFKGVNWELLLKISRPPNIPARFEHEN 362
H +F + + H +
Sbjct: 294 HPWFAEYY-----HHASMGGSRSHHHHHH 317
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 33/176 (18%), Positives = 66/176 (37%), Gaps = 30/176 (17%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G G+++L E A V+ ++ +NG + + F QR
Sbjct: 40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVV----------KVEYQENGPLFSELKFYQR 89
Query: 79 V-----------LRNVEHPLLPRLRG----VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ 123
V + +++ +P G + ++ G DL + Q
Sbjct: 90 VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--G 146
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI--QENGHIMLVDFDLSTK 177
F T+ ++ LEY+H V+ D+K N+++ + + L D+ LS +
Sbjct: 147 TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 33/171 (19%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWR---DLIEKKSKELTNNDNGDKYRRISF 75
+ + +G GA+G+V D + A+K + R + K R
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK--------------RAYR 110
Query: 76 EQRVLRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
E +++ V H + L V + ++F Y + +L + + + + +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERM 166
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
+ +++ +++LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 33/170 (19%), Positives = 59/170 (34%), Gaps = 55/170 (32%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ EM+ F G + + +++ +
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI----EQ 278
Query: 304 VGEPTP-----------------------------------------------LRNLIRR 316
+G P P R+L+ +
Sbjct: 279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 338
Query: 317 LLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
+L DP KRI V++ H + P ++ + +E +
Sbjct: 339 MLVIDPAKRISVDDALQHPYIN----VWYDPAEVEAPPPQIYDKQLDERE 384
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 37/177 (20%), Positives = 73/177 (41%), Gaps = 23/177 (12%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVI--WRDLIEKKSKELTNNDNGDKYRRISFE 76
+S +G GA G+V D + A+K I + + R E
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ--------------RTLRE 75
Query: 77 QRVLRNVEHPLLPRLRGVL---STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
++L H + + ++ + ++ Y + DL+ L K Q S+D I +
Sbjct: 76 IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICY 132
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+ +++ L+Y+H+ +++RDLKP N+++ + + DF L+ P T
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 39/176 (22%), Positives = 63/176 (35%), Gaps = 49/176 (27%)
Query: 231 SRSDSDSSEKSNS---FVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRG 286
+R + + +V T Y APEI+ KG+ ++D WS+G +L EML F G
Sbjct: 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234
Query: 287 SSRKETFYRILCRPPDLVGEPTP--------------LRN-------------------- 312
+ IL ++G P+ L +
Sbjct: 235 KHYLDQLNHIL----GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA 290
Query: 313 --LIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
L+ ++L +P KRI VE+ H + + S P A F+ + D
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQ-----YYDPSDEPIAEAPFKFDMELDD 341
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 57/366 (15%), Positives = 103/366 (28%), Gaps = 124/366 (33%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+++V +G+G G V++ K V A+KV E+ S
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKV------AVKVF--FTTEEASWF--------- 77
Query: 70 YRRISFEQRV--LRNVEHPLLPRLRGV--LSTDKFVGYAI--DYCPGRDLHSLRKQQSEQ 123
E + + H + T + + DY L+ K +
Sbjct: 78 -----RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-- 130
Query: 124 MFSDDTIRFYAAELVLALEYLH--------NMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ A V L +LH I +RDLK +NI++++NG + D L+
Sbjct: 131 -LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189
Query: 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235
K T +
Sbjct: 190 VKFISDT----------------------------------------------------N 197
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKGH------DFAVDWWSLGVVLHEMLYGATPFRGSSR 289
+ N+ VGT+ Y+ PE+++ + D +S G++L E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257
Query: 290 KETFYRILC------------------RPP-----DLVGEPTPLRNLIRRLLEKDPTKRI 326
+ Y L RP + L+ +P R+
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
Query: 327 GVEEIK 332
+K
Sbjct: 318 TALRVK 323
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 20/155 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
LG G V+ K + ALK I ++ G R +S +L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-----------RLEHEEGAPCTAIREVS----LL 54
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
++++H + L ++ T+K + +Y +DL + + ++ + +L+
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRG 112
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
L Y H +++RDLKP+N++I E G + L DF L+
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 30/142 (21%), Positives = 51/142 (35%), Gaps = 36/142 (25%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPDL--- 303
Y P+I+ G + +D W +G + +EM G F GS+ +E + I + P
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 304 ---------------VGEPTPLRN-----------LIRRLLEKDPTKRIGVEEIKGHEFF 337
L + L+ +LL+ + RI E+ H FF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285
Query: 338 KGVNWELLLKISRPPNIPARFE 359
L +I + P+ + F
Sbjct: 286 ----LSLGERIHKLPDTTSIFA 303
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 35/186 (18%), Positives = 72/186 (38%), Gaps = 32/186 (17%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALK-VIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
+ LG G G+VF D + + A+K ++ D K E
Sbjct: 14 MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK--------------HALREI 59
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGR-------------DLHSLRKQQSEQM 124
+++R ++H + ++ +L DL ++ +Q
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP--- 116
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTP 183
++ R + +L+ L+Y+H+ +++RDLKP N+ I E+ + + DF L+ + P
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 184 QASPKT 189
+
Sbjct: 177 HKGHLS 182
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 25/131 (19%), Positives = 43/131 (32%), Gaps = 40/131 (30%)
Query: 245 VGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+ T+ Y +P ++ + A+D W+ G + EML G T F G+ E IL +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL----ES 240
Query: 304 VGEPT------------------------PLR-----------NLIRRLLEKDPTKRIGV 328
+ PL + + ++L P R+
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300
Query: 329 EEIKGHEFFKG 339
EE H +
Sbjct: 301 EEALSHPYMSI 311
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 2e-12
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 20/155 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
+G G GVV+ ++ E+FALK I L D G R IS +L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKI----------RLEKEDEGIPSTTIREIS----IL 54
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ ++H + +L V+ T K + ++ +DL L T + + +L+
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNG 112
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ Y H+ +++RDLKP+N++I G + + DF L+
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 7e-07
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 31/123 (25%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD---- 302
Y AP+++ G K + +D WS+G + EM+ G F G S + RI + P+
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225
Query: 303 -------------LVGEPTPLRN-----------LIRRLLEKDPTKRIGVEEIKGHEFFK 338
V EP P + L+ ++L+ DP +RI ++ H +FK
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 339 GVN 341
N
Sbjct: 286 ENN 288
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 34/168 (20%), Positives = 74/168 (44%), Gaps = 20/168 (11%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ + +G GA+G+V D + A+K + R N +R E
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-----------QNQTHAKRAYRELV 76
Query: 79 VLRNVEHPLLPRLRGVL----STDKFVG-YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
+++ V H + L V S ++F Y + +L + + + + + +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME----LDHERMSYL 132
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPK 181
+++ +++LH+ GI++RDLKP NI+++ + + ++DF L+
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 51/143 (35%)
Query: 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL 303
+V T Y APE+I G G+ VD WS+G ++ EM+ G F G+ + + +++ +
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI----EQ 241
Query: 304 VGEPTP-----------------------------------------------LRNLIRR 316
+G P P R+L+ +
Sbjct: 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK 301
Query: 317 LLEKDPTKRIGVEEIKGHEFFKG 339
+L D +KRI V+E H +
Sbjct: 302 MLVIDASKRISVDEALQHPYINV 324
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 50/366 (13%), Positives = 98/366 (26%), Gaps = 124/366 (33%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+ + ++G+G G V+ K +V A+K+ + +
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKWRGEEV------AVKIF----------------SSRE 77
Query: 70 YRRISFEQRV--LRNVEHPLLPRLRGV--LSTDKFVGYAI--DYCPGRDLHSLRKQQSEQ 123
R E + + H + + + DY L + +
Sbjct: 78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-- 135
Query: 124 MFSDDTIRFYAAELVLALEYLH--------NMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + + A L +LH I +RDLK +NI++++NG + D L+
Sbjct: 136 -VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
Query: 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235
+ T
Sbjct: 195 VRHDSAT----------------------------------------------------D 202
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKG------HDFAVDWWSLGVVLHEMLYGATPFRGSSR 289
N VGT+ Y+APE+++ D +++G+V E+ +
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 290 KETFYRIL------------------CRPP-----DLVGEPTPLRNLIRRLLEKDPTKRI 326
+ Y L RP + ++R + R+
Sbjct: 263 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 327 GVEEIK 332
IK
Sbjct: 323 TALRIK 328
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 72/381 (18%), Positives = 120/381 (31%), Gaps = 137/381 (35%)
Query: 24 LGRGAKGVVF--LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81
+GRG G V+ KD + + +ALK I E ++ R I +LR
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSA------CREI----ALLR 73
Query: 82 NVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSL-------RKQQSEQMFSDDTIRF 132
++HP + L+ V D+ V DY DL + + + ++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMI----QENGHIMLVDFDLSTKLSPKTPQASPK 188
+++ + YLH +++RDLKP NI++ E G + + D +
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------------- 179
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
R F + P + +D V T
Sbjct: 180 --------------RLF----------------------NSPLKPLADLDPV----VVTF 199
Query: 249 EYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----- 302
Y APE++ G H A+D W++G + E+L F E D
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ--EDIKTSNPYHHDQLDRI 257
Query: 303 --LVGEPTP-------------------------------------------LRNLIRRL 317
++G P +L+++L
Sbjct: 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKL 317
Query: 318 LEKDPTKRIGVEEIKGHEFFK 338
L DP KRI E+ +F
Sbjct: 318 LTMDPIKRITSEQAMQDPYFL 338
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 44/190 (23%), Positives = 83/190 (43%), Gaps = 27/190 (14%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL----------------- 61
+ LG G+ G+V V D+ES + FALK + +D K++EL
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 62 ---TNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVG-YAI-DYCPGRDLHSL 116
T ++ + ++ +++ + I +Y P LH +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 117 RKQ--QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFD 173
K +S + + I Y +L A+ ++H++GI +RD+KP+N+++ ++ + L DF
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 174 LSTKLSPKTP 183
+ KL P P
Sbjct: 188 SAKKLIPSEP 197
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 9e-09
Identities = 39/184 (21%), Positives = 62/184 (33%), Gaps = 47/184 (25%)
Query: 236 DSSEKSNSFVGTEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY 294
SE S +++ + Y APE++ G ++D WS+G V E++ G F G + +
Sbjct: 193 IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLV 252
Query: 295 RILCRPPDLVGEPT----------------------PLRN------------LIRRLLEK 320
RI+ ++G PT R L+ ++L
Sbjct: 253 RII----QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308
Query: 321 DPTKRIGVEEIKGHEFFKG---VNWELLLKISRPPN-----IPARFEHENNESDGRGRDG 372
+P RI E H FF + S P+ IP F E +
Sbjct: 309 EPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNV 368
Query: 373 TKEI 376
I
Sbjct: 369 LNRI 372
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 24/167 (14%), Positives = 45/167 (26%), Gaps = 17/167 (10%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R++ G + D AL + D +
Sbjct: 34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG----------VLPDDVLQETLSRTL 83
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
L ++ P + R+ V+ T ++ G L + IR L
Sbjct: 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIR-AMQSLA 139
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQA 185
A + H G+ P + + +G ++L + PQ
Sbjct: 140 AAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---MPDANPQD 183
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 9/89 (10%), Positives = 21/89 (23%), Gaps = 15/89 (16%)
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV 304
+ + + D +G L+ +L P + +
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 305 --------GEPTPLRNLIRRLLEKDPTKR 325
P + + R ++ D R
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 20/155 (12%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRVL 80
+G G GVV+ KD ALK I L D G R IS +L
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRI----------RLDAEDEGIPSTAIREIS----LL 73
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ + HP + L V+ +++ + ++ +DL + + D I+ Y +L+
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRG 131
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + H I++RDLKP+N++I +G + L DF L+
Sbjct: 132 VAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 29/128 (22%), Positives = 49/128 (38%), Gaps = 40/128 (31%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT 308
Y AP+++ G K + +VD WS+G + EM+ G F G + + +I ++G P
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF----SILGTPN 240
Query: 309 ------------------------PLRN-----------LIRRLLEKDPTKRIGVEEIKG 333
P + L+ +L DP KRI +
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300
Query: 334 HEFFKGVN 341
H +FK ++
Sbjct: 301 HPYFKDLD 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 21/160 (13%)
Query: 24 LGRGAKGVVFLVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNG---DKYRRISFEQRV 79
+G GA G VF +D+++ F ALK + + + G R ++ +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV----------RVQTGEEGMPLSTIREVAVLRH- 67
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAI-----DYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
L EHP + RL V + + ++ +DL + + E +TI+
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
+L+ L++LH+ +V+RDLKP+NI++ +G I L DF L
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 31/145 (21%), Positives = 51/145 (35%), Gaps = 32/145 (22%)
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD----- 302
Y APE++ + VD WS+G + EM FRGSS + +I + P
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244
Query: 303 ----------LVGEPTPLRN-----------LIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
P+ L+ + L +P KRI H +F+ +
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
Query: 342 WELLLKISRPPNIPA-RFEHENNES 365
K + ++P + E N +
Sbjct: 305 ---RCKENLDSHLPPSQNTSELNTA 326
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 35/180 (19%), Positives = 71/180 (39%), Gaps = 35/180 (19%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G+G G ++L D+ SSES ++ +DNG + E +
Sbjct: 38 KVGLPIGQGGFGCIYLA-DMNSSESVGSD-------APCVVKVEPSDNG----PLFTELK 85
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGY-------------------AIDYCPGRDLHSLRKQ 119
+ P + K++G +D G DL + +
Sbjct: 86 FYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA 144
Query: 120 QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI--QENGHIMLVDFDLSTK 177
+ + FS T+ + ++ LEY+H V+ D+K N+++ + + LVD+ L+ +
Sbjct: 145 NA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 27/176 (15%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK---YRRISFEQRVL 80
+G+G G VF + ++ + ALK + + N G R I +L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV----------LMENEKEGFPITALREIK----IL 70
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAI--------DYCPGRDLHSLRKQQSEQMFSDDTIRF 132
+ ++H + L + T D+C DL L + F+ I+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVK-FTLSEIKR 128
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
L+ L Y+H I++RD+K N++I +G + L DF L+ S +
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 29/155 (18%), Positives = 53/155 (34%), Gaps = 39/155 (25%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPDL--- 303
Y PE++ G + + +D W G ++ EM + +G++ + I LC
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 253
Query: 304 ---------------VGEPTPLR-------------NLIRRLLEKDPTKRIGVEEIKGHE 335
G+ ++ +LI +LL DP +RI ++ H+
Sbjct: 254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313
Query: 336 FFKGVNWELLLKISRPPNIPARFEHENNESDGRGR 370
FF W + S + + E R
Sbjct: 314 FF----WSDPMP-SDLKGMLSTHLTSMFEYLAPPR 343
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 35/159 (22%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY---RRISFEQRVL 80
LG G G V+ D ++E+ A+K I L + + G R +S +L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI----------RLEHEEEGVPGTAIREVS----LL 87
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLA 140
+ ++H + L+ V+ + + +Y DL + + S I+ + +L+
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLING 144
Query: 141 LEYLHNMGIVYRDLKPENIMI-----QENGHIMLVDFDL 174
+ + H+ ++RDLKP+N+++ E + + DF L
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 29/121 (23%), Positives = 44/121 (36%), Gaps = 32/121 (26%)
Query: 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI--LCRPPD---- 302
Y PEI+ G + + +VD WS+ + EML F G S + ++I + PD
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262
Query: 303 -------------LVGEPTPLRN------------LIRRLLEKDPTKRIGVEEIKGHEFF 337
L+ L+ +LE DP KRI + H +F
Sbjct: 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322
Query: 338 K 338
Sbjct: 323 S 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 37/196 (18%), Positives = 59/196 (30%), Gaps = 67/196 (34%)
Query: 106 DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH---------NMGIVYRDLKP 156
+Y P SL K S + A + L YLH I +RDL
Sbjct: 92 EYYPNG---SLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNS 148
Query: 157 ENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISL 216
N++++ +G ++ DF LS
Sbjct: 149 RNVLVKNDGTCVISDFGLS----------------------------------------- 167
Query: 217 EDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG-------KGHDFAVDWWS 269
+ + S VGT Y+APE++EG + VD ++
Sbjct: 168 -------MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220
Query: 270 LGVVLHEMLYGATPFR 285
LG++ E+ T
Sbjct: 221 LGLIYWEIFMRCTDLF 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 18/167 (10%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
LD + + I +G G G V L + S A+K + EK+ ++
Sbjct: 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG------ 95
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDD 128
E ++ +HP + RL GV++ K V +Y L S LRK ++ F+
Sbjct: 96 ------EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVI 147
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + ++YL +MG V+RDL NI+I N + DF L
Sbjct: 148 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/124 (25%), Positives = 49/124 (39%), Gaps = 13/124 (10%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPDLVG 305
+PE I + A D WS G+VL E++ YG P+ S ++ + L P D
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC-- 275
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKG--HEFFKGVNWELLLKISRPPNIPARFEHENN 363
P L L+ +KD R E+I + + N L I+ P+ + +
Sbjct: 276 -PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR--NPGSLKIITSAAARPSNLLLDQS 332
Query: 364 ESDG 367
D
Sbjct: 333 NVDI 336
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 38/176 (21%), Positives = 75/176 (42%), Gaps = 22/176 (12%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVF---LVKDVESSESF-ALKVIWRDLIEKKSKEL 61
N +R L + + + LG GA G V+ + + E + A+K + K +KE+
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 62 TNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQ 119
+ E V+ +V++P + RL G+ T I P L +R+
Sbjct: 65 LD------------EAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREH 110
Query: 120 QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + + ++ + YL + +V+RDL N++++ H+ + DF L+
Sbjct: 111 KDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+ + + +G G G V + + + A+K + ++
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ------ 65
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
E +R +HP + +L GV++ + + I + C +L S L+ ++
Sbjct: 66 ------EALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKYS--LDL 115
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ YA +L AL YL + V+RD+ N+++ N + L DF LS
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 35/168 (20%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+ + + +G G G V + + + A+K + ++
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ------ 440
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
E +R +HP + +L GV++ + + I + C +L S L+ ++
Sbjct: 441 ------EALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFLQVRKFS--LDL 490
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ YA +L AL YL + V+RD+ N+++ N + L DF LS
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 37/165 (22%), Positives = 66/165 (40%), Gaps = 17/165 (10%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L+ L + +GRG G VF + + A+K L +
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ--------- 161
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDDTI 130
E R+L+ HP + RL GV + + + Y + + G D + LR + + T+
Sbjct: 162 ---EARILKQYSHPNIVRLIGVCTQKQPI-YIVMELVQGGDFLTFLRTEGAR--LRVKTL 215
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ +EYL + ++RDL N ++ E + + DF +S
Sbjct: 216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 35/167 (20%), Positives = 68/167 (40%), Gaps = 18/167 (10%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
++ S + I +G G G V L + A+K + E++ ++ +
Sbjct: 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS------ 99
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDD 128
E ++ +HP + RL GV++ + +Y L + LR + F+
Sbjct: 100 ------EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIM 151
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + + YL ++G V+RDL N+++ N + DF LS
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 21/169 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
+ SC+ +G G G V+ + A+K + EK+ +
Sbjct: 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG----- 95
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFS 126
E ++ H + RL GV+S K + I +Y L LR++ E FS
Sbjct: 96 -------EAGIMGQFSHHNIIRLEGVISKYKPM-MIITEYMENGALDKFLREKDGE--FS 145
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + ++YL NM V+RDL NI++ N + DF LS
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 32/169 (18%), Positives = 64/169 (37%), Gaps = 23/169 (13%)
Query: 14 DFSCLRIVSALGRGAKGVVF--LVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGDKY 70
+ +GRG G V+ + D + + A+K + N D
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--------------SLNRITDIG 68
Query: 71 RRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFS 126
F E ++++ HP + L G+ + + Y DL + +R + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + ++ ++YL + V+RDL N M+ E + + DF L+
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 30/164 (18%), Positives = 62/164 (37%), Gaps = 17/164 (10%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKV-IWRDLIEKKSKELTNNDNGDKYRRIS 74
L+ + LG G G V L +++ V + K K + +++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAV------KALKADAGPQHRSGWKQ-- 82
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDDTIR 131
E +LR + H + + +G + +Y P L L + +
Sbjct: 83 -EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLL 137
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+A ++ + YLH ++RDL N+++ + + + DF L+
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 7e-08
Identities = 58/323 (17%), Positives = 116/323 (35%), Gaps = 86/323 (26%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
++ + + + LG G G V+ + S + A+K + D +E +
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------------- 262
Query: 73 ISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDDT 129
F E V++ ++HP L +L GV + + ++ +L LR+ +++ +
Sbjct: 263 --FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 320
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+ A ++ A+EYL ++R+L N LV + K++
Sbjct: 321 LYM-ATQISSAMEYLEKKNFIHRNLAARNC---------LVGENHLVKVA---------- 360
Query: 190 VLAANTRSGIKKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
F LS+ + ++ G P +
Sbjct: 361 --------------DFGLSRL------MTGDTYTAHAGAKFPIK---------------- 384
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPD 302
+ APE + D W+ GV+L E+ YG +P+ G + + + + RP
Sbjct: 385 -WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443
Query: 303 LVGEPTPLRNLIRRLLEKDPTKR 325
P + L+R + +P+ R
Sbjct: 444 C---PEKVYELMRACWQWNPSDR 463
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 36/168 (21%), Positives = 73/168 (43%), Gaps = 21/168 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+ + + LG G G V+ + A+K K+ DN +K
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC---------KKDCTLDNKEK 59
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
+ E +++N++HP + +L G++ + + I + P +L L + ++
Sbjct: 60 FMS---EAVIMKNLDHPHIVKLIGIIEEEPT--WIIMELYPYGELGHYLERNKNS--LKV 112
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
T+ Y+ ++ A+ YL ++ V+RD+ NI++ + L DF LS
Sbjct: 113 LTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 33/168 (19%), Positives = 64/168 (38%), Gaps = 21/168 (12%)
Query: 14 DFSCLRIVSALGRGAKGVVF--LVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGDKY 70
+ +GRG G V+ + D + + A+K + N D
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--------------SLNRITDIG 132
Query: 71 RRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSD 127
F E ++++ HP + L G+ + + Y DL + + ++
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D I F ++ +++L + V+RDL N M+ E + + DF L+
Sbjct: 193 DLIGF-GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 30/169 (17%), Positives = 66/169 (39%), Gaps = 22/169 (13%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGD 68
+ LR + LG G G V + + ES + +KVI + + +T+
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD----- 64
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFS 126
+ +++H + RL G+ + Y P L +R+ +
Sbjct: 65 -------HMLAIGSLDHAHIVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQHRGA--LG 113
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + ++ + YL G+V+R+L N++++ + + DF ++
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 34/167 (20%), Positives = 68/167 (40%), Gaps = 22/167 (13%)
Query: 16 SCLRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYR 71
L+ + LG+G G V + + E A+K + + T D R
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------QHSTEEHLRDFER 91
Query: 72 RISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDD 128
E +L++++H + + +GV + + +Y P L L+K +
Sbjct: 92 ----EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHI 145
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ Y +++ +EYL ++RDL NI+++ + + DF L+
Sbjct: 146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 38/176 (21%), Positives = 75/176 (42%), Gaps = 22/176 (12%)
Query: 6 NDRPIRSLDFSCLRIVSALGRGAKGVVF---LVKDVESSESF-ALKVIWRDLIEKKSKEL 61
N +R L + + + LG GA G V+ + + E + A+K + K +KE+
Sbjct: 5 NQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 64
Query: 62 TNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQ 119
+ E V+ +V++P + RL G+ T I P L +R+
Sbjct: 65 LD------------EAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREH 110
Query: 120 QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + + ++ + YL + +V+RDL N++++ H+ + DF L+
Sbjct: 111 KDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 29/165 (17%), Positives = 62/165 (37%), Gaps = 20/165 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ L++ LG G G V+ + + K T
Sbjct: 185 IPRESLKLEKKLGAGQFGEVW-------------MATYNKHTKVAVK--TMKPGSMSVEA 229
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDDTI 130
E V++ ++H L +L V++ + Y I ++ L L+ + + I
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
F +A++ + ++ ++RDL+ NI++ + + DF L+
Sbjct: 288 DF-SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 33/169 (19%), Positives = 68/169 (40%), Gaps = 23/169 (13%)
Query: 14 DFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
+ +G+G GVV+ + ++ A+K + + +
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--------------SLSRITEMQ 64
Query: 71 RRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFS 126
+ +F E ++R + HP + L G++ + + + + Y DL +R Q
Sbjct: 65 QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK 124
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D + + ++ +EYL V+RDL N M+ E+ + + DF L+
Sbjct: 125 D--LISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 19/168 (11%)
Query: 13 LDFSCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
+ LR++ LG G+ GVV + S A+K + K L+ + D
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-------KPDVLSQPEAMDD 67
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
+ R E + +++H L RL GV+ T + + P L LRK Q F
Sbjct: 68 FIR---EVNAMHSLDHRNLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRKHQGH--FLL 120
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
T+ YA ++ + YL + ++RDL N+++ + + DF L
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 35/167 (20%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 16 SCLRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYR 71
L+ + LG G G V L + + E A+K + K + ++ +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL---------KPESGGNHIADLK 71
Query: 72 RISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDD 128
+ E +LRN+ H + + +G+ + D G + ++ P L L K +++ +
Sbjct: 72 K---EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLK 126
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
YA ++ ++YL + V+RDL N++++ + + DF L+
Sbjct: 127 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 36/165 (21%), Positives = 64/165 (38%), Gaps = 20/165 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ LR+ LG+G G V+ W K T
Sbjct: 181 IPRESLRLEVKLGQGCFGEVW-------------MGTWNGTTRVAIK--TLKPGTMSPEA 225
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDDTI 130
E +V++ + H L +L V+S + Y + +Y L L+ + + + +
Sbjct: 226 FLQEAQVMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLV 283
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
AA++ + Y+ M V+RDL+ NI++ EN + DF L+
Sbjct: 284 DM-AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 11/81 (13%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETF------YRILCRPPDLV 304
APE D WS G++L E+ G P+ G +E YR + PP+
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPEC- 406
Query: 305 GEPTPLRNLIRRLLEKDPTKR 325
P L +L+ + K+P +R
Sbjct: 407 --PESLHDLMCQCWRKEPEER 425
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 60/369 (16%), Positives = 111/369 (30%), Gaps = 128/369 (34%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L+++ RG G V+ K +E A+K+ + +K+S +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIF--PIQDKQSWQ------------ 64
Query: 73 ISFEQRV--LRNVEHPLLPRLRG--VLSTDKFVGYAI--DYCPGRDLHSLRKQQS---EQ 123
E V L ++H + + G T V + + L K +
Sbjct: 65 --NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNE 122
Query: 124 MFSDDTIRFYAAELVLALEYLH----------NMGIVYRDLKPENIMIQENGHIMLVDFD 173
+ A + L YLH I +RD+K +N+ L+ +
Sbjct: 123 LCH------IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV---------LLKNN 167
Query: 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSF-LSKFCSSGISLEDPVHSPRIGPDPPSR 232
L+ ++ F L+ +G S D
Sbjct: 168 LTACIA------------------------DFGLALKFEAGKSAGD-------------- 189
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGS 287
++ VGT Y+APE++EG + +D +++G+VL E+ T G
Sbjct: 190 --------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
Query: 288 SRK---------------ETFYRILC----RP--PDLVGEPTPLR---NLIRRLLEKDPT 323
+ E ++ RP D + + I + D
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301
Query: 324 KRIGVEEIK 332
R+ +
Sbjct: 302 ARLSAGCVG 310
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 36/165 (21%), Positives = 64/165 (38%), Gaps = 20/165 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ LR+ LG+G G V+ W K T
Sbjct: 264 IPRESLRLEVKLGQGCFGEVW-------------MGTWNGTTRVAIK--TLKPGTMSPEA 308
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDDTI 130
E +V++ + H L +L V+S + Y + +Y L L+ + + + +
Sbjct: 309 FLQEAQVMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLV 366
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
AA++ + Y+ M V+RDL+ NI++ EN + DF L+
Sbjct: 367 DM-AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 23/81 (28%), Positives = 35/81 (43%), Gaps = 11/81 (13%)
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETF------YRILCRPPDLV 304
APE D WS G++L E+ G P+ G +E YR + PP+
Sbjct: 432 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MPCPPEC- 489
Query: 305 GEPTPLRNLIRRLLEKDPTKR 325
P L +L+ + K+P +R
Sbjct: 490 --PESLHDLMCQCWRKEPEER 508
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 38/174 (21%)
Query: 13 LDFSCLRIVSALGRGAKGVVFL----VKDVESSESFALKVI-----WRDLIEKKSKELTN 63
L+ L+++ +G+G G V L V A+K I + +
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV------AVKCIKNDATAQAFLA-------- 63
Query: 64 NDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQS 121
E V+ + H L +L GV+ +K Y + +Y L LR +
Sbjct: 64 ------------EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 122 EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ D ++F + ++ A+EYL V+RDL N+++ E+ + DF L+
Sbjct: 112 SVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 39/167 (23%), Positives = 76/167 (45%), Gaps = 22/167 (13%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
++ + + + LG G G V+ + S + A+K + D +E +
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-------------- 55
Query: 73 ISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDD 128
F E V++ ++HP L +L GV + + Y I ++ +L LR+ +++ +
Sbjct: 56 --FLKEAAVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVSAVV 112
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ A ++ A+EYL ++RDL N ++ EN + + DF LS
Sbjct: 113 LLYM-ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 34/170 (20%), Positives = 69/170 (40%), Gaps = 22/170 (12%)
Query: 13 LDFSCLRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
+ L+ + LG+G G V + + E A+K + + T D
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL---------QHSTEEHLRD 57
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMF 125
R E +L++++H + + +GV + + +Y P L L+K +
Sbjct: 58 FER----EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--I 111
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ Y +++ +EYL ++RDL NI+++ + + DF L+
Sbjct: 112 DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 32/170 (18%), Positives = 69/170 (40%), Gaps = 25/170 (14%)
Query: 13 LDFSCLRIVS-ALGRGAKGVVF--LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
LD L + LG G G V + + ++ A+K++ K + D
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL---------KN----EANDP 59
Query: 70 YRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMF 125
+ E V++ +++P + R+ G+ + + + + L+ L++ +
Sbjct: 60 ALKDELLAEANVMQQLDNPYIVRMIGICEAESW--MLVMEMAELGPLNKYLQQNRH---V 114
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D I ++ + ++YL V+RDL N+++ + + DF LS
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 34/175 (19%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL----TNNDNGDKYR 71
+ + LG+G+ G+V+ + + + +++ + + T N+
Sbjct: 25 EKITMSRELGQGSFGMVY-------------EGVAKGVVKDEPETRVAIKTVNEAASMRE 71
Query: 72 RISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
RI F E V++ + RL GV+S + I + DL S LR + +
Sbjct: 72 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 128 DTIRFYAAELVL-------ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++++ + YL+ V+RDL N M+ E+ + + DF ++
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 32/171 (18%)
Query: 13 LDFSCLRIVSALGRGAKGVVFL----VKDVESSESFALKVIWRDLIEKKSKELTNNDNGD 68
L+ L+++ +G+G G V L V A+K I D +
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV------AVKCIKNDATAQA----------- 232
Query: 69 KYRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQM 124
F E V+ + H L +L GV+ +K Y + +Y L LR + +
Sbjct: 233 ------FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
D ++F + ++ A+EYL V+RDL N+++ E+ + DF L+
Sbjct: 287 GGDCLLKF-SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 37/175 (21%), Positives = 64/175 (36%), Gaps = 29/175 (16%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS----KELTNNDNGDKYR 71
+ L + LG G G V + + K + DN +
Sbjct: 34 NLLILGKILGEGEFGSVM-------------EGNLKQEDGTSLKVAVKTM-KLDNSSQRE 79
Query: 72 RISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAID-----YCPGRDLHS-LRK---QQ 120
F E +++ HP + RL GV G + DLH+ L +
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET 139
Query: 121 SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ T+ + ++ L +EYL N ++RDL N M++++ + + DF LS
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 13 LDFSCLRIVSA-LGRGAKGVVF--LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
L L I LG G G V + + + A+KV+ K+ T + ++
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL---------KQGTEKADTEE 56
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
R E +++ +++P + RL GV + + + G LH L ++ E
Sbjct: 57 MMR---EAQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGPLHKFLVGKREE--IPV 109
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ ++ + ++YL V+RDL N+++ + + DF LS
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 35/164 (21%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKV-IWRDLIEKKSKELTNNDNGDKYRRIS 74
L+ +S LG+G G V L + ++ V + K+ + + D R
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAV------KQLQHSGPDQQRDFQR--- 73
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI--DYCPGRDLHS-LRKQQSEQMFSDDTIR 131
E ++L+ + + + RGV + +Y P L L++ ++ +
Sbjct: 74 -EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLL 130
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
Y++++ +EYL + V+RDL NI+++ H+ + DF L+
Sbjct: 131 LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 35/175 (20%), Positives = 66/175 (37%), Gaps = 28/175 (16%)
Query: 16 SCLRIVSALGRGAKGVVF---LVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ LG+G G V L ++ S A+K++ D
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-------------KADIIASSDI 69
Query: 73 ISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAID------YCPGRDLHS-LRKQQSEQ 123
F E ++ +HP + +L GV + G + DLH+ L + +
Sbjct: 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129
Query: 124 MFSDDTIR---FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ ++ + ++ +EYL + ++RDL N M+ E+ + + DF LS
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 36/167 (21%), Positives = 67/167 (40%), Gaps = 24/167 (14%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIE---KKSKELTNNDNGDK 69
+D S L V +G G G+V W + + K +E ++ +
Sbjct: 5 IDPSELTFVQEIGSGQFGLVH-------------LGYWLNKDKVAIKTIREGAMSE--ED 49
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFSDD 128
+ E V+ + HP L +L GV + ++ L LR Q+ F+ +
Sbjct: 50 FIE---EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAE 104
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
T+ ++ + YL +++RDL N ++ EN I + DF ++
Sbjct: 105 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 37/181 (20%)
Query: 16 SCLRIVSALGRGAKGVVFL--VKDVESSESF---ALKVIWRDLIEKKSKELTNNDNGDKY 70
+ + LG GA G VFL ++ + A+K + KE + +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---------KEASESA----- 86
Query: 71 RRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFS 126
R F E +L ++H + R GV + + + + +Y DL+ LR +
Sbjct: 87 -RQDFQREAELLTMLQHQHIVRFFGVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 127 DDTIRFYAAELVLA------------LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
L L + YL + V+RDL N ++ + + + DF +
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 175 S 175
S
Sbjct: 205 S 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 16/40 (40%), Positives = 23/40 (57%), Gaps = 1/40 (2%)
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180
L YLH I++RD+K NI++ EN + DF +S K
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS-KKGT 190
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 31/170 (18%), Positives = 68/170 (40%), Gaps = 30/170 (17%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIE---KKSKELTNNDNGDK 69
+ L++V LG G G V+ + + K K+ + +
Sbjct: 10 VPRETLKLVERLGAGQFGEVW-------------MGYYNGHTKVAVKSLKQGSMS----- 51
Query: 70 YRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMF 125
+F E +++ ++H L RL V++ + Y I +Y L L+ ++
Sbjct: 52 --PDAFLAEANLMKQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT 107
Query: 126 SDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ + AA++ + ++ ++RDL+ NI++ + + DF L+
Sbjct: 108 INKLLDM-AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 21/102 (20%), Positives = 46/102 (45%), Gaps = 6/102 (5%)
Query: 76 EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSDDTIRFY 133
E +++ +++P + RL GV + + + G LH L ++ E +
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGPLHKFLVGKREE--IPVSNVAEL 441
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
++ + ++YL V+R+L N+++ + + DF LS
Sbjct: 442 LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 31/175 (17%), Positives = 59/175 (33%), Gaps = 29/175 (16%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL----TNNDNGDKYR 71
+ ++ LG GA G V+ + + S T + +
Sbjct: 71 KNITLIRGLGHGAFGEVY-------------EGQVSGMPNDPSPLQVAVKTLPEVCSEQD 117
Query: 72 RISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRK-----QQSEQ 123
+ F E ++ H + R GV ++ G DL S LR+ Q
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV---DFDLS 175
+ D + A ++ +YL ++RD+ N ++ G + DF ++
Sbjct: 178 LAMLDLLHV-ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 5e-05
Identities = 28/142 (19%), Positives = 46/142 (32%), Gaps = 59/142 (41%)
Query: 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIK 200
+ +LH ++RD+K NI++ E + DF L+
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLA------------------------- 180
Query: 201 KRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260
R + ++ VGT Y+APE + G+
Sbjct: 181 -----------------------RASEK------FAQTVMTSRIVGTTAYMAPEALRGE- 210
Query: 261 HDFAV--DWWSLGVVLHEMLYG 280
D +S GVVL E++ G
Sbjct: 211 --ITPKSDIYSFGVVLLEIITG 230
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 30/169 (17%), Positives = 62/169 (36%), Gaps = 28/169 (16%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIE---KKSKELTNNDNGDK 69
L + ++ LG G GVV W+ + K KE + +++
Sbjct: 5 LKREEITLLKELGSGQFGVVK-------------LGKWKGQYDVAVKMIKEGSMSED--- 48
Query: 70 YRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFS 126
F E + + + HP L + GV S + + +Y L + LR
Sbjct: 49 ----EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LE 102
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ ++ + +L + ++RDL N ++ + + + DF ++
Sbjct: 103 PSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 34/175 (19%), Positives = 64/175 (36%), Gaps = 29/175 (16%)
Query: 16 SCLRIVSALGRGAKGVVF--LVKDVESSESF---ALKVIWRDLIEKKSKELTNNDNGDKY 70
+ ++ LG GA G V+ V + + S A+K + E+ +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM------- 82
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRK-----QQSEQ 123
E ++ H + R GV S + + + G DL S LR+ Q
Sbjct: 83 -----EALIISKFNHQNIVRCIGV-SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 124 MFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV---DFDLS 175
+ D + A ++ +YL ++RD+ N ++ G + DF ++
Sbjct: 137 LAMLDLLHV-ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 28/169 (16%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIE---KKSKELTNNDNGDK 69
+D L + LG G GVV WR + K KE + +
Sbjct: 21 IDPKDLTFLKELGTGQFGVVK-------------YGKWRGQYDVAIKMIKEGSMS----- 62
Query: 70 YRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQMFS 126
F E +V+ N+ H L +L GV + + + +Y L + LR+ + F
Sbjct: 63 --EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQ 118
Query: 127 DDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175
+ ++ A+EYL + ++RDL N ++ + G + + DF LS
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 7e-05
Identities = 29/202 (14%), Positives = 56/202 (27%), Gaps = 44/202 (21%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
L+ +G G G VF A+K+I + +L N + + I E
Sbjct: 22 LQRCEKIGEGVFGEVFQTIA--DHTPVAIKII-----AIEGPDLVNGSHQKTFEEILPEI 74
Query: 78 RVLRNVE---------HPLLPRLRGV------------------LSTDKFVGYAIDYCPG 110
+ + + L V ST D+
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 111 RDLH---------SLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIM 160
L +Q ++ S T + +L +L + +RDL N++
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 161 IQENGHIMLVDFDLSTKLSPKT 182
+++ L + +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPS 216
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 35/181 (19%), Positives = 64/181 (35%), Gaps = 35/181 (19%)
Query: 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL----TNNDNGDKYR 71
S +R + LG G V+ K + + T D +
Sbjct: 9 SAVRFMEELGEDRFGKVY-------------KGHLFGPAPGEQTQAVAIKTLKDKAEGPL 55
Query: 72 RISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRKQQSEQMFSD 127
R F E + ++HP + L GV++ D+ + I YC DLH L +
Sbjct: 56 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 128 DTIRF-------------YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174
A++ +EYL + +V++DL N+++ + ++ + D L
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
Query: 175 S 175
Sbjct: 175 F 175
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 2e-04
Identities = 60/474 (12%), Positives = 124/474 (26%), Gaps = 145/474 (30%)
Query: 24 LGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79
LG G K + DV S K+ W +L S E + Q++
Sbjct: 159 LGSG-KTW--VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV----------LEMLQKL 205
Query: 80 LRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
L ++ R + +HS++ + + S + Y L
Sbjct: 206 LYQIDPNWTSRSDHSSNIK------------LRIHSIQAELRRLLKS----KPYENCL-- 247
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
+V +++ F+LS K+ T L+A T + I
Sbjct: 248 ---------LVLLNVQNAKA---------WNAFNLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 200 -----------KKRRSFLSKFCSSGISLED-PVHSPRIGP-----------DPPSRSD-- 234
+ +S L K+ +D P P D + D
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYL--DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 235 --SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAV---D-----------WWSLGVVLHEML 278
+ + + + + P +V W+ + ++
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 279 YGATPFRGSS-----RKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKR-------- 325
S KE+ I +L + L R +++ +
Sbjct: 408 --VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 326 -----------IG-----VEEIKGHEFFKGV----NWELLLKISRPPNIPARFEHENNES 365
IG +E + F+ V + + + H++
Sbjct: 466 PPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF-----------LEQKIRHDSTAW 514
Query: 366 DGRGRDGTKEIDVEKFVQGIFAGGGDAEQKNEVNDEMN-KNRGGEKVNNQRHAC 418
+ G ++ + I E+ VN ++ + E + ++
Sbjct: 515 NASGSILNTLQQLKFYKPYICDNDPKYERL--VNAILDFLPKIEENLICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 50/315 (15%), Positives = 89/315 (28%), Gaps = 107/315 (33%)
Query: 1 MNDVVNDRPIRSLDFSC--L---R---IVSALGRGAKGVVFLVKDVES---SES------ 43
+ +V N + + + SC L R + L + L + E
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 44 ------------------FALKVIWRDLIEKKSK-ELTNNDNGDKYRRI---------SF 75
L +I + + + + + N DK I
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 76 EQR-------VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--EQMFS 126
E R V +P +LS I ++ L K S E+
Sbjct: 370 EYRKMFDRLSVFP--PSAHIP--TILLSL--IWFDVIKSDVMVVVNKLHK-YSLVEKQPK 422
Query: 127 DDTIRFYAAELVLALE-----YLHNMGIV--YRDLK---PENIMIQEN--------GH-- 166
+ TI + L L ++ LH IV Y K ++++ GH
Sbjct: 423 ESTISIPSIYLELKVKLENEYALHRS-IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHL 481
Query: 167 -------------IMLVDFD-LSTKL-SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCS 211
++ +DF L K+ T + ++L NT +K + +
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL--NTLQQLKFYKPY------ 533
Query: 212 SGISLEDPVHSPRIG 226
I DP + +
Sbjct: 534 --ICDNDPKYERLVN 546
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 38/182 (20%), Positives = 71/182 (39%), Gaps = 38/182 (20%)
Query: 16 SCLRIVSALGRGAKGVVFL--VKDVESSESF---ALKVIWRDLIEKKSKELTNNDNGDKY 70
+ + LG GA G VFL ++ ++ A+K + K+ T
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---------KDPTLAA----- 60
Query: 71 RRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHS-LRK-------- 118
R F E +L N++H + + GV + + +Y DL+ LR
Sbjct: 61 -RKDFQREAELLTNLQHEHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 119 -----QQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173
+Q++ + A+++ + YL + V+RDL N ++ N + + DF
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 174 LS 175
+S
Sbjct: 179 MS 180
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 28/179 (15%), Positives = 59/179 (32%), Gaps = 31/179 (17%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTN-----NDNG 67
+ L +LG+G +F K + R++ + T D
Sbjct: 5 IRNEDLIFNESLGQGTFTKIF-------------KGVRREVGDYGQLHETEVLLKVLDKA 51
Query: 68 DKYRRISF--EQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-LRKQQSEQM 124
+ SF ++ + H L GV ++ L + L+K ++
Sbjct: 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-- 109
Query: 125 FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ--------ENGHIMLVDFDLS 175
+ A +L A+ +L +++ ++ +NI++ I L D +S
Sbjct: 110 INILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 26/116 (22%), Positives = 34/116 (29%), Gaps = 22/116 (18%)
Query: 252 APE-IIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI-----LCRPPDLV 304
PE I K + A D WS G L E+ G P + L P
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK--- 241
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEH 360
L NLI ++ +P R I L + P +P H
Sbjct: 242 --AAELANLINNCMDYEPDHRPSFRAII----------RDLNSLFTPDLVPRGSHH 285
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 426 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.82 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.51 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.36 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.99 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.8 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.53 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.42 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.93 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.2 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.88 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.92 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-72 Score=530.73 Aligned_cols=275 Identities=34% Similarity=0.605 Sum_probs=245.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
....++|++++.||+|+||+||+|+++.+++.||||++.+..+... ...+.+.+|+++|+.|+|||||++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~l 97 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERDVMSRLDHPFFVKL 97 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCH----------HHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3556789999999999999999999999999999999988765433 235678999999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|++++.+|||||||+||+|.++++... .+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 98 ~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~D 175 (311)
T 4aw0_A 98 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175 (311)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEE
Confidence 999999999999999999999999987654 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+.... ......++|||+.||
T Consensus 176 FGla~~~~~~~------------------------------------------------------~~~~~~~~~GTp~Ym 201 (311)
T 4aw0_A 176 FGTAKVLSPES------------------------------------------------------KQARANSFVGTAQYV 201 (311)
T ss_dssp CTTCEECCTTT------------------------------------------------------TCCCBCCCCSCGGGC
T ss_pred cCCceecCCCC------------------------------------------------------CcccccCcccCcccC
Confidence 99998764221 122456789999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.+|+.....+ ...++++++||.+||++||++|||++|
T Consensus 202 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp CHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence 9999999999999999999999999999999999999999999998665444 356889999999999999999999988
Q ss_pred ------HhcCCCcCCCChhhhhhccCCCC
Q 014344 331 ------IKGHEFFKGVNWELLLKISRPPN 353 (426)
Q Consensus 331 ------il~hp~f~~~~~~~~~~~~~~~~ 353 (426)
|++||||++++|+.+.+. .||.
T Consensus 282 ~~~~~~i~~Hp~F~~idw~~l~~~-~pP~ 309 (311)
T 4aw0_A 282 MEGYGPLKAHPFFESVTWENLHQQ-TPPK 309 (311)
T ss_dssp GTCHHHHHTSGGGTTCCCTTGGGS-CCCC
T ss_pred HcCCHHHHCCCCcCCCCHHHhcCC-CCCC
Confidence 589999999999998664 3444
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-69 Score=514.76 Aligned_cols=276 Identities=39% Similarity=0.729 Sum_probs=234.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
...+.++|++++.||+|+||+||+|++. .+++.||||++.+...... ...++.+|+.+|++++|||
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~E~~il~~l~Hpn 87 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-----------DRVRTKMERDILVEVNHPF 87 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-----------ECC------CCCCCCCCTT
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-----------HHHHHHHHHHHHHHCCCCC
Confidence 3456789999999999999999999984 4678999999976543221 1235777999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
||+++++|++++.+|+|||||+||+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.+|++
T Consensus 88 Iv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 88 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp EECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCE
T ss_pred CCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCE
Confidence 9999999999999999999999999999987654 49999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+|+..... .....+++||
T Consensus 166 Kl~DFGla~~~~~~--------------------------------------------------------~~~~~~~~GT 189 (304)
T 3ubd_A 166 KLTDFGLSKESIDH--------------------------------------------------------EKKAYSFCGT 189 (304)
T ss_dssp EEESSEEEEC-------------------------------------------------------------CCCCSCCCC
T ss_pred EecccccceeccCC--------------------------------------------------------CccccccccC
Confidence 99999999865321 1234567899
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.++......+ ...++++++||.+||++||++||
T Consensus 190 ~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ 269 (304)
T 3ubd_A 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRL 269 (304)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGST
T ss_pred cccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCC
Confidence 99999999999999999999999999999999999999999999999888665444 35689999999999999999999
Q ss_pred C-----hHHHhcCCCcCCCChhhhhhcc-CCCCCC
Q 014344 327 G-----VEEIKGHEFFKGVNWELLLKIS-RPPNIP 355 (426)
Q Consensus 327 s-----~~eil~hp~f~~~~~~~~~~~~-~~~~~~ 355 (426)
| ++||++||||++++|+.+.... .||++|
T Consensus 270 ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 270 GAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp TCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 8 4799999999999999987643 455544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-68 Score=515.57 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=227.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|+++++||+|+||+||+|+++.+|+.||||++.+..... ...+++.+|+.+|++|+|||||++++
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIV~~~~ 90 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-----------KEREESRREVAVLANMKHPNIVQYRE 90 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-----------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-----------HHHHHHHHHHHHHHHCCCCCCCcEEE
Confidence 4679999999999999999999999999999999997653322 24567889999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
+|++++.+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||
T Consensus 91 ~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 170 (350)
T 4b9d_A 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFG 170 (350)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTT
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccc
Confidence 99999999999999999999999987766678999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+|+.+... ....++.+||+.||||
T Consensus 171 la~~~~~~--------------------------------------------------------~~~~~~~~GT~~YmAP 194 (350)
T 4b9d_A 171 IARVLNST--------------------------------------------------------VELARACIGTPYYLSP 194 (350)
T ss_dssp EESCCCHH--------------------------------------------------------HHHHHHHHSCCTTCCH
T ss_pred cceeecCC--------------------------------------------------------cccccccCCCccccCH
Confidence 99875311 1123466899999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
|++.+..|+.++|||||||++|||++|++||.+.+..+.+.+++... +.....+.++++||.+||++||++|||++||
T Consensus 195 E~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 195 EICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999999999999998887543 3344678999999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
|+||||+.
T Consensus 275 l~hp~~~~ 282 (350)
T 4b9d_A 275 LEKGFIAK 282 (350)
T ss_dssp HTSHHHHT
T ss_pred hcCHHhhc
Confidence 99999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-67 Score=503.87 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=225.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|+++++||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-------------~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 140 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-------------QRRELLFNEVVIMRDYQHENVVEMYNSY 140 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-------------SSGGGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-------------hHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 569999999999999999999999999999999965321 1234678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
++++.+|||||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 141 ~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla 217 (346)
T 4fih_A 141 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 217 (346)
T ss_dssp EETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCc
Confidence 999999999999999999998865 34999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+... .....+++||+.|||||+
T Consensus 218 ~~~~~~--------------------------------------------------------~~~~~~~~GTp~YmAPEv 241 (346)
T 4fih_A 218 AQVSKE--------------------------------------------------------VPRRKSLVGTPYWMAPEL 241 (346)
T ss_dssp EECCSS--------------------------------------------------------SCCBCCCCSCGGGCCHHH
T ss_pred eecCCC--------------------------------------------------------CCcccccccCcCcCCHHH
Confidence 876421 123456789999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..|+.++|||||||++|||++|++||.+.+..+.+..+....+. ....++++++||.+||++||++|||++||
T Consensus 242 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 242 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999999999999999999999999888888654322 23468899999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
|+||||+.
T Consensus 322 l~Hp~~~~ 329 (346)
T 4fih_A 322 LKHPFLAK 329 (346)
T ss_dssp TTCGGGGG
T ss_pred hcCHhhcC
Confidence 99999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-67 Score=489.39 Aligned_cols=255 Identities=32% Similarity=0.475 Sum_probs=212.6
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...... ....++.+|+.+|+.++|||||++++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~HpnIv~~~~ 80 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----------DMQGRIEREISYLRLLRHPHIIKLYD 80 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCH----------HHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence 46799999999999999999999999999999999976543322 23567899999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
+|++++.+|+||||| +|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 81 ~~~~~~~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFG 157 (275)
T 3hyh_A 81 VIKSKDEIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFG 157 (275)
T ss_dssp EEECSSEEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred EEEECCEEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecC
Confidence 999999999999999 68999988764 459999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+|+..... ....+.+||+.||||
T Consensus 158 la~~~~~~---------------------------------------------------------~~~~~~~GT~~Y~AP 180 (275)
T 3hyh_A 158 LSNIMTDG---------------------------------------------------------NFLKTSCGSPNYAAP 180 (275)
T ss_dssp CC------------------------------------------------------------------------CTTSCH
T ss_pred CCeecCCC---------------------------------------------------------CccCCeeECcccCCh
Confidence 99765321 123456899999999
Q ss_pred hhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 254 EIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 254 E~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
|++.+..| +.++|||||||++|+|++|++||.+.+..+.+.++......+ ...++.+++||.+||++||++|||++|+
T Consensus 181 E~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ei 260 (275)
T 3hyh_A 181 EVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEI 260 (275)
T ss_dssp HHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999886 589999999999999999999999999988888887665444 3468899999999999999999999999
Q ss_pred hcCCCcC
Q 014344 332 KGHEFFK 338 (426)
Q Consensus 332 l~hp~f~ 338 (426)
++||||+
T Consensus 261 l~hpw~k 267 (275)
T 3hyh_A 261 MQDDWFK 267 (275)
T ss_dssp HHCHHHH
T ss_pred HcCcccc
Confidence 9999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-65 Score=505.72 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=226.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|+++++||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.|+|||||+++++|
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~-------------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~ 217 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK-------------QQRRELLFNEVVIMRDYQHENVVEMYNSY 217 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT-------------CSSGGGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc-------------hhHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 56999999999999999999999999999999995432 12245688899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|||||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|
T Consensus 218 ~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla 294 (423)
T 4fie_A 218 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC 294 (423)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccc
Confidence 999999999999999999999864 34999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+... .....+++||+.|||||+
T Consensus 295 ~~~~~~--------------------------------------------------------~~~~~~~~GTp~YmAPEv 318 (423)
T 4fie_A 295 AQVSKE--------------------------------------------------------VPRRKSLVGTPYWMAPEL 318 (423)
T ss_dssp EECCSS--------------------------------------------------------CCCBCCCEECTTTCCHHH
T ss_pred eECCCC--------------------------------------------------------CccccccccCcCcCCHHH
Confidence 876421 123456799999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..|+.++|||||||++|||++|++||.+.+..+.+..+....+ .....+..+++||.+||++||++|||++||
T Consensus 319 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 319 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999999999999999999999999999999988888865432 233568899999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
|+||||+.
T Consensus 399 l~Hp~~~~ 406 (423)
T 4fie_A 399 LKHPFLAK 406 (423)
T ss_dssp TTCGGGGG
T ss_pred hcCHHhcC
Confidence 99999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-64 Score=521.31 Aligned_cols=279 Identities=32% Similarity=0.586 Sum_probs=237.5
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+.+++|+++++||+|+||+||+|+++.+|+.||||++.+..+.... ..........++.+++.++|||||++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~-------~~~~~~~E~~~l~ll~~~~HP~IV~l 257 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-------GETLALNERIMLSLVSTGDCPFIVCM 257 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-------CHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhh-------hHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence 57789999999999999999999999999999999999887765432 11122233344666777899999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|++++.+|||||||+||+|.+++.... .|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~D 335 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISD 335 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecc
Confidence 999999999999999999999999987653 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+.. ....++||||.||
T Consensus 336 FGlA~~~~~----------------------------------------------------------~~~~t~~GTp~Ym 357 (689)
T 3v5w_A 336 LGLACDFSK----------------------------------------------------------KKPHASVGTHGYM 357 (689)
T ss_dssp CTTCEECSS----------------------------------------------------------CCCCSCCSCGGGC
T ss_pred cceeeecCC----------------------------------------------------------CCCCCccCCcCcc
Confidence 999986532 1345678999999
Q ss_pred cchhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGS---SRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++. +..|+.++|||||||++|||++|++||.+. +..+.+..+....... ...++++++||.+||++||.+|+
T Consensus 358 APEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl 437 (689)
T 3v5w_A 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRL 437 (689)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCT
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCC
Confidence 999996 568999999999999999999999999764 3345556666554433 45689999999999999999999
Q ss_pred C-----hHHHhcCCCcCCCChhhhhh-ccCCCCCCCC
Q 014344 327 G-----VEEIKGHEFFKGVNWELLLK-ISRPPNIPAR 357 (426)
Q Consensus 327 s-----~~eil~hp~f~~~~~~~~~~-~~~~~~~~~~ 357 (426)
+ ++||++||||++++|+.+.. ...||.+|..
T Consensus 438 ~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~ 474 (689)
T 3v5w_A 438 GCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 474 (689)
T ss_dssp TCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCT
T ss_pred CCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCC
Confidence 8 79999999999999999875 4456666643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-64 Score=477.17 Aligned_cols=252 Identities=21% Similarity=0.370 Sum_probs=213.8
Q ss_pred CCc-EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 16 SCL-RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.+| ++.++||+|+||+||+|+++.+++.||+|++.+..... ...+++.+|+.+|++|+|||||+++++
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIV~~~~~ 93 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-----------SERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-----------HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-----------HHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 344 78889999999999999999999999999996543222 235678999999999999999999999
Q ss_pred eec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeecc-CCcE
Q 014344 95 LST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQE-NGHI 167 (426)
Q Consensus 95 ~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~~-~g~i 167 (426)
|++ +..+|||||||+||+|.+++.... .+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+
T Consensus 94 ~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~v 171 (290)
T 3fpq_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171 (290)
T ss_dssp EEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCE
T ss_pred EeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCE
Confidence 965 457899999999999999987653 4999999999999999999999998 999999999999984 7999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+|+.... ....+.+||
T Consensus 172 Kl~DFGla~~~~~----------------------------------------------------------~~~~~~~GT 193 (290)
T 3fpq_A 172 KIGDLGLATLKRA----------------------------------------------------------SFAKAVIGT 193 (290)
T ss_dssp EECCTTGGGGCCT----------------------------------------------------------TSBEESCSS
T ss_pred EEEeCcCCEeCCC----------------------------------------------------------CccCCcccC
Confidence 9999999975321 134567899
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCC--C-CCCCCHHHHHHHHHHhccCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET-FYRILCRPP--D-LVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~--~-~~~~~~~~~~li~~~L~~dP~ 323 (426)
|.|||||++.+ .|+.++|||||||++|||++|++||.+.+.... +..+..... . ....++++++||.+||++||+
T Consensus 194 p~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 272 (290)
T 3fpq_A 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKD 272 (290)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGG
T ss_pred ccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChh
Confidence 99999999876 599999999999999999999999987655444 444443321 1 123567899999999999999
Q ss_pred CCCChHHHhcCCCcCC
Q 014344 324 KRIGVEEIKGHEFFKG 339 (426)
Q Consensus 324 ~R~s~~eil~hp~f~~ 339 (426)
+|||++|+|+||||++
T Consensus 273 ~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 273 ERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GSCCHHHHHTSGGGC-
T ss_pred HCcCHHHHhcCccccC
Confidence 9999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-65 Score=488.65 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=219.7
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..+.|++.++||+|+||+||+|+++.+|+.||||++.++.. ..+|+.+|+.|+|||||++++
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------------------~~~E~~il~~l~HpnIV~l~~ 117 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------------------RVEELVACAGLSSPRIVPLYG 117 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------------------CTHHHHTTTTCCCTTBCCEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------------------HHHHHHHHHhCCCCCCCcEEE
Confidence 45679999999999999999999999999999999965321 124999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEEecc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIMLVDF 172 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL~DF 172 (426)
+|++++.+|||||||+||+|.++++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+||
T Consensus 118 ~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DF 195 (336)
T 4g3f_A 118 AVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195 (336)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCC
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeC
Confidence 9999999999999999999999987654 499999999999999999999999999999999999999998 6999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+...... .......+++||+.|||
T Consensus 196 Gla~~~~~~~~~---------------------------------------------------~~~~~~~~~~GT~~YmA 224 (336)
T 4g3f_A 196 GHALCLQPDGLG---------------------------------------------------KSLLTGDYIPGTETHMA 224 (336)
T ss_dssp TTCEEC---------------------------------------------------------------CCCCCCGGGCC
T ss_pred CCCeEccCCCcc---------------------------------------------------cceecCCccccCccccC
Confidence 999876432100 01112345789999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++...++. ....++.+.+||.+||++||.+|||+
T Consensus 225 PE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa 304 (336)
T 4g3f_A 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASA 304 (336)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCH
Confidence 99999999999999999999999999999999998877777777765432 34568899999999999999999999
Q ss_pred HHH-------------hcCCCcCC
Q 014344 329 EEI-------------KGHEFFKG 339 (426)
Q Consensus 329 ~ei-------------l~hp~f~~ 339 (426)
.|| |+|||++.
T Consensus 305 ~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 305 MELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp HHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred HHHHHHHHHHHhhhhhccCCCcCC
Confidence 997 57888865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-62 Score=483.70 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=220.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.|+|||||++++++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 122 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-----------VVTNAKRTLRELKILKHFKHDNIIAIKDIL 122 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-----------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-----------chHHHHHHHHHHHHHHhcCCCCcceEeeee
Confidence 479999999999999999999999999999999954321 122456788999999999999999999987
Q ss_pred ec------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 ST------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
.. .+.+|||||||. |+|.+++... +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||
T Consensus 123 ~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 123 RPTVPYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CCSSCTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEE
T ss_pred ecccccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEE
Confidence 54 468999999996 7798887653 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+..... .......+++||+.
T Consensus 200 ~DFGla~~~~~~~~----------------------------------------------------~~~~~~~~~~GT~~ 227 (398)
T 4b99_A 200 GDFGMARGLCTSPA----------------------------------------------------EHQYFMTEYVATRW 227 (398)
T ss_dssp CCCTTCBCC-----------------------------------------------------------CCCCCSSCCCCT
T ss_pred eecceeeecccCcc----------------------------------------------------ccccccccceeChH
Confidence 99999987642110 11223456789999
Q ss_pred CccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC---------------------C--
Q 014344 250 YVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------------D-- 302 (426)
Q Consensus 250 y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------------~-- 302 (426)
|||||++.+. .|+.++||||+||++|||++|++||.+.+..+++..|+. .++ .
T Consensus 228 Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (398)
T 4b99_A 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQP 307 (398)
T ss_dssp TCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCC
T ss_pred hcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCC
Confidence 9999999875 569999999999999999999999999998888877642 111 0
Q ss_pred ------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 ------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
....++++.|||.+||++||.+|||++|+|+||||+....
T Consensus 308 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 308 VPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred CCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1234778999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-63 Score=468.94 Aligned_cols=270 Identities=23% Similarity=0.375 Sum_probs=201.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+++.+|+.+|++|+|||||+++++|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~ 72 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN------------RELAREKVMREVKALAKLEHPGIVRYFNAW 72 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC------------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 57999999999999999999999999999999985431 122346788999999999999999999999
Q ss_pred ecCC------------eEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec
Q 014344 96 STDK------------FVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 96 ~~~~------------~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~ 162 (426)
.+.+ ++|+|||||+||+|.+++..... ...+...++.|+.||+.||+|||++|||||||||+||||+
T Consensus 73 ~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~ 152 (299)
T 4g31_A 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152 (299)
T ss_dssp EEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred EecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC
Confidence 6544 47999999999999999875432 2245677899999999999999999999999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.+|.+||+|||+|+.+......... ..........+
T Consensus 153 ~~~~vKl~DFGla~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~ 188 (299)
T 4g31_A 153 MDDVVKVGDFGLVTAMDQDEEEQTV--------------------------------------------LTPMPAYARHT 188 (299)
T ss_dssp TTCCEEECCCCCC-------------------------------------------------------------------
T ss_pred CCCcEEEccCccceecCCCcccccc--------------------------------------------ccccccccccC
Confidence 9999999999999877532211000 00001123445
Q ss_pred ccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC--CCCCCCCCHHHHHHHHHHhc
Q 014344 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILCR--PPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~--~~~~~~~~~~~~~li~~~L~ 319 (426)
+.+||+.|||||++.+..|+.++|||||||++|||++ ||...... .....+... ++.+...++.+.+||.+||+
T Consensus 189 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~ 265 (299)
T 4g31_A 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265 (299)
T ss_dssp ---CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTC
T ss_pred CcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcC
Confidence 6789999999999999999999999999999999995 88654332 223333222 12222335667899999999
Q ss_pred cCCCCCCChHHHhcCCCcCCCChhh
Q 014344 320 KDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 320 ~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
+||++|||+.|||+||||++++|..
T Consensus 266 ~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 266 PSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp SSGGGSCCHHHHHTSGGGCCC----
T ss_pred CChhHCcCHHHHhcCHhhCCCCCCC
Confidence 9999999999999999999998843
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-61 Score=467.43 Aligned_cols=278 Identities=24% Similarity=0.344 Sum_probs=209.4
Q ss_pred CCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCccee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRL 91 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l 91 (426)
++|+++++||+|+||+||+|+++ .+++.||||++.+.. ...++.+|+++|+.+ +||||+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---------------~~~~~~~E~~~l~~~~~h~nIv~l 85 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---------------HPIRIAAELQCLTVAGGQDNVMGV 85 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---------------CHHHHHHHHHHHHHTCSBTTBCCC
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---------------CHHHHHHHHHHHHHhcCCCCCceE
Confidence 46999999999999999999975 467899999984321 234677899999998 59999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-CcEEEe
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-GHIMLV 170 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g~ikL~ 170 (426)
+++|++++.+|+|||||+||+|.+++. .+++..++.|+.||+.||+|||++|||||||||+|||++.+ +++||+
T Consensus 86 ~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~ 160 (361)
T 4f9c_A 86 KYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALV 160 (361)
T ss_dssp SEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred EEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence 999999999999999999999999873 39999999999999999999999999999999999999876 899999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+............ ..+....... ................+.+||+.|
T Consensus 161 DFGla~~~~~~~~~~~~~---------------------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~GT~~Y 212 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKF---------------------VQSEAQQERC-------SQNKCSICLSRRQQVAPRAGTPGF 212 (361)
T ss_dssp CCTTCEECTTCSCGGGGG---------------------C---------------------------------CCCCGGG
T ss_pred cCCCCcccCCcccccccc---------------------cccccccccc-------ccccccccccccccccccccCccc
Confidence 999998765332110000 0000000000 000000001112345677899999
Q ss_pred ccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc------------------------------
Q 014344 251 VAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILC------------------------------ 298 (426)
Q Consensus 251 ~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~------------------------------ 298 (426)
||||++.+. .|+.++||||+||++|||++|++||... +..+++.+|..
T Consensus 213 ~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~ 292 (361)
T 4f9c_A 213 RAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLR 292 (361)
T ss_dssp CCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHH
T ss_pred cCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhh
Confidence 999999875 5899999999999999999999999654 44444433321
Q ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 299 -------------------------RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 299 -------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
........+++++|||.+||++||++|+|++|+|+||||++++
T Consensus 293 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 293 KLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0011234578899999999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-60 Score=490.64 Aligned_cols=259 Identities=28% Similarity=0.437 Sum_probs=230.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.|+|||||+++++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-------------~~~~~~~~Ei~il~~l~hpnIv~l~~~ 222 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------------SDKETVRKEIQTMSVLRHPTLVNLHDA 222 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------------HHHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-------------hhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999855322 223567889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC--CcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN--GHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~--g~ikL~DF 172 (426)
|+++..+|||||||+||+|.+++.... ..+++..++.|++||+.||+|||++||+||||||+|||++.+ |++||+||
T Consensus 223 ~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DF 301 (573)
T 3uto_A 223 FEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301 (573)
T ss_dssp EECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeec
Confidence 999999999999999999999876433 459999999999999999999999999999999999999854 89999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+... ....+.+||+.|||
T Consensus 302 G~a~~~~~~---------------------------------------------------------~~~~~~~GT~~y~A 324 (573)
T 3uto_A 302 GLTAHLDPK---------------------------------------------------------QSVKVTTGTAEFAA 324 (573)
T ss_dssp SSCEECCTT---------------------------------------------------------SEEEEECSSGGGCC
T ss_pred cceeEccCC---------------------------------------------------------CceeeeEECccccC
Confidence 999876421 23446689999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|++||.+.+..+++.++......+ ...+..+++||.+||++||.+|||
T Consensus 325 PEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t 404 (573)
T 3uto_A 325 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 404 (573)
T ss_dssp HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999999887654332 356889999999999999999999
Q ss_pred hHHHhcCCCcCCCChhh
Q 014344 328 VEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~ 344 (426)
++|+|+||||+..+|..
T Consensus 405 ~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 405 IHQALEHPWLTPGNAPG 421 (573)
T ss_dssp HHHHHHSTTTSCCCCTT
T ss_pred HHHHhcCcCcCCCCCCC
Confidence 99999999999887754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=450.69 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=220.8
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.+.++.++|.+.++||+|+||+||+|++. .++..||||++... .....+.+.+|+++|++|+
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-------------~~~~~~~f~~E~~il~~l~ 73 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-------------SDNARKDFHREAELLTNLQ 73 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-------------CHHHHHHHHHHHHHHTTCC
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-------------ChHHHHHHHHHHHHHHhCC
Confidence 45678899999999999999999999875 46788999998532 1234567899999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-----------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-----------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRD 153 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-----------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrD 153 (426)
|||||++++++.+++.+|+|||||+||+|.++++... ...+++..+..++.||+.||+|||+++|||||
T Consensus 74 HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 153 (299)
T 4asz_A 74 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRD 153 (299)
T ss_dssp CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCc
Confidence 9999999999999999999999999999999987642 34699999999999999999999999999999
Q ss_pred CCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 154 lKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
|||+||||+.++.+||+|||+|+......
T Consensus 154 lKp~NILl~~~~~~Ki~DFGla~~~~~~~--------------------------------------------------- 182 (299)
T 4asz_A 154 LATRNCLVGENLLVKIGDFGMSRDVYSTD--------------------------------------------------- 182 (299)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG---------------------------------------------------
T ss_pred cCHhhEEECCCCcEEECCcccceecCCCC---------------------------------------------------
Confidence 99999999999999999999998653211
Q ss_pred CCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPL 310 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~ 310 (426)
........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+... ++.+..+|..+
T Consensus 183 ---~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~ 259 (299)
T 4asz_A 183 ---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEV 259 (299)
T ss_dssp ---CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred ---ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHH
Confidence 0112234569999999999999999999999999999999998 99999999998888877643 33445678999
Q ss_pred HHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
.+||.+||+.||++|||+++|+ +|+
T Consensus 260 ~~li~~cl~~dP~~RPs~~~i~--~~L 284 (299)
T 4asz_A 260 YELMLGCWQREPHMRKNIKGIH--TLL 284 (299)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHH--HHH
T ss_pred HHHHHHHcCCChhHCcCHHHHH--HHH
Confidence 9999999999999999999994 455
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=452.01 Aligned_cols=262 Identities=19% Similarity=0.287 Sum_probs=217.2
Q ss_pred CCCCCCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH
Q 014344 6 NDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80 (426)
Q Consensus 6 ~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il 80 (426)
++.....++.++|.+.++||+|+||+||+|+.. .+++.||||++... .....+.+.+|+++|
T Consensus 31 ~~~~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-------------~~~~~~~f~~E~~il 97 (329)
T 4aoj_A 31 SDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------------SESARQDFQREAELL 97 (329)
T ss_dssp --CCSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-------------SHHHHHHHHHHHHHH
T ss_pred chhhhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-------------CHHHHHHHHHHHHHH
Confidence 344456678889999999999999999999864 46889999998432 123456799999999
Q ss_pred HhcCCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc-------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 81 RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-------------EQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 81 ~~l~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-------------~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
++|+|||||++++++.+++.+|||||||+||+|.++++... ...+++..+..|+.||+.||+|||++
T Consensus 98 ~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 177 (329)
T 4aoj_A 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177 (329)
T ss_dssp TTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999987542 24599999999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
+||||||||+||||+.++.+||+|||+|+.+....
T Consensus 178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~--------------------------------------------- 212 (329)
T 4aoj_A 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD--------------------------------------------- 212 (329)
T ss_dssp TCCCSCCCGGGEEEETTTEEEECCCC------------------------------------------------------
T ss_pred CeecccccHhhEEECCCCcEEEcccccceeccCCC---------------------------------------------
Confidence 99999999999999999999999999998653211
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLV 304 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~ 304 (426)
........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+.+..+... ++.+.
T Consensus 213 ---------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~ 283 (329)
T 4aoj_A 213 ---------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT
T ss_pred ---------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 0112334579999999999999999999999999999999998 99999999988888777643 34445
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+++.+.+||.+||+.||++|||++||+.+
T Consensus 284 ~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 678999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=447.47 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=208.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.|+++.+++++.++||+|+||+||+|+.. ..||||++.... ......+.+.+|+.+|++++|||||
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~-----------~~~~~~~~f~~E~~il~~l~HpNIV 95 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD-----------PTPEQFQAFRNEVAVLRKTRHVNIL 95 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS-----------CCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC-----------CCHHHHHHHHHHHHHHHhCCCCCEe
Confidence 46889999999999999999999999854 359999984321 1233567899999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++. ++.+|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||
T Consensus 96 ~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki 173 (307)
T 3omv_A 96 LFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKI 173 (307)
T ss_dssp CEEEEEC-SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEE
T ss_pred eEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEE
Confidence 9999875 456899999999999999987543 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+...... ......+.+||+.
T Consensus 174 ~DFGla~~~~~~~------------------------------------------------------~~~~~~~~~GT~~ 199 (307)
T 3omv_A 174 GDFGLATVKSRWS------------------------------------------------------GSQQVEQPTGSVL 199 (307)
T ss_dssp CCCSSCBC------------------------------------------------------------------CCCCTT
T ss_pred eeccCceecccCC------------------------------------------------------cceeecccccCCC
Confidence 9999998653211 1123445689999
Q ss_pred CccchhhcCC---CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC----CCCCCCHHHHHHHHHHhc
Q 014344 250 YVAPEIIEGK---GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP----DLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 250 y~aPE~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~----~~~~~~~~~~~li~~~L~ 319 (426)
|||||++.+. .|+.++|||||||++|||++|+.||.+.+.......++.. .+ ....++..+.+||.+||+
T Consensus 200 ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~ 279 (307)
T 3omv_A 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVK 279 (307)
T ss_dssp SCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTC
T ss_pred ccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcC
Confidence 9999999753 5899999999999999999999999987766555544422 11 123568899999999999
Q ss_pred cCCCCCCChHHHhcC
Q 014344 320 KDPTKRIGVEEIKGH 334 (426)
Q Consensus 320 ~dP~~R~s~~eil~h 334 (426)
.||++|||+.||+++
T Consensus 280 ~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 280 KVKEERPLFPQILSS 294 (307)
T ss_dssp SSSTTSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999988643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-59 Score=447.18 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=222.7
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 83 (426)
..+++.+++++++++||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.+|++|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~------------~~~~~~~f~~E~~il~~l 86 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA------------EGPLREEFRHEAMLRARL 86 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C------------CC-CHHHHHHHHHHHHHC
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc------------ChHHHHHHHHHHHHHHhC
Confidence 356788999999999999999999999853 467899999984321 122356789999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
+|||||++++++.+++.+|+|||||++|+|.+++.... ...+++..+..++.||+.||+|||+++|
T Consensus 87 ~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i 166 (308)
T 4gt4_A 87 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV 166 (308)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999999999986532 2358999999999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
|||||||+||||+.++.+||+|||+|+.+....
T Consensus 167 iHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~----------------------------------------------- 199 (308)
T 4gt4_A 167 VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----------------------------------------------- 199 (308)
T ss_dssp CCSCCSGGGEEECGGGCEEECCSCCBCGGGGGG-----------------------------------------------
T ss_pred CCCCccccceEECCCCCEEECCcccceeccCCC-----------------------------------------------
Confidence 999999999999999999999999998653211
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGE 306 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~ 306 (426)
........+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+... ++.+..+
T Consensus 200 -------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 272 (308)
T 4gt4_A 200 -------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDC 272 (308)
T ss_dssp -------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred -------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 1122345579999999999999999999999999999999998 89999999988888777643 3445577
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
|..+.+||.+||+.||++|||+.||+++
T Consensus 273 ~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 273 PAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 8999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-58 Score=451.97 Aligned_cols=279 Identities=32% Similarity=0.576 Sum_probs=237.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
...+.+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..+|+.+ +||||
T Consensus 17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~hp~I 86 (353)
T 3txo_A 17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD----------DDVECTMTEKRILSLARNHPFL 86 (353)
T ss_dssp ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHH----------TTHHHHHHHHHHHHHTTTCTTB
T ss_pred cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcch----------hHHHHHHHHHHHHHhccCCCce
Confidence 456888999999999999999999999999999999999987654332 2345678899999998 69999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++|.+.+.+|+|||||+||+|..++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++|
T Consensus 87 v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ik 164 (353)
T 3txo_A 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164 (353)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEE
Confidence 999999999999999999999999999887653 499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+..... .....+++||+
T Consensus 165 L~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~gt~ 188 (353)
T 3txo_A 165 LADFGMCKEGICN--------------------------------------------------------GVTTATFCGTP 188 (353)
T ss_dssp ECCCTTCBCSCC-----------------------------------------------------------------CCG
T ss_pred EccccceeecccC--------------------------------------------------------CccccccCCCc
Confidence 9999998753211 12344568999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s 327 (426)
.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.++.......+ ..+..+.+||++||++||.+||+
T Consensus 189 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp GGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred CeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccC
Confidence 99999999999999999999999999999999999999999999998886654443 35788999999999999999999
Q ss_pred h------HHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 328 V------EEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 328 ~------~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
+ ++|++||||++++|+.+... ..||..|.
T Consensus 269 ~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 269 SLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp SGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 8 89999999999999998754 34455543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-58 Score=444.72 Aligned_cols=276 Identities=34% Similarity=0.648 Sum_probs=241.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+.+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|+.+|+.++||||++++
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~l~ 71 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh----------hHHHHHHHHHHHHHhCCCCcCcceE
Confidence 567899999999999999999999999999999999987654322 2345778899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|.+.+.+|+|||||+||+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+||
T Consensus 72 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 72 YAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999999988764 34999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++..... .....+.+||+.|+|
T Consensus 150 G~a~~~~~~--------------------------------------------------------~~~~~~~~gt~~y~a 173 (337)
T 1o6l_A 150 GLCKEGISD--------------------------------------------------------GATMKTFCGTPEYLA 173 (337)
T ss_dssp TTCBCSCCT--------------------------------------------------------TCCBCCCEECGGGCC
T ss_pred cchhhcccC--------------------------------------------------------CCcccccccChhhCC
Confidence 998754211 112345689999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI----- 326 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~----- 326 (426)
||++.+..|+.++|||||||++|||++|+.||.+.+....+..+......+ ...++.+.+||.+||+.||.+||
T Consensus 174 PE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~ 253 (337)
T 1o6l_A 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred hhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCC
Confidence 999999999999999999999999999999999999888888887554433 35688999999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhhhcc-CCCCCCC
Q 014344 327 GVEEIKGHEFFKGVNWELLLKIS-RPPNIPA 356 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~~~~-~~~~~~~ 356 (426)
+++||++||||++++|+.+.... .||..|.
T Consensus 254 ~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~ 284 (337)
T 1o6l_A 254 DAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CHHHHHcCCCcCCCCHHHHHhCCCCCCCCCC
Confidence 89999999999999999987644 4454443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-58 Score=451.62 Aligned_cols=279 Identities=32% Similarity=0.663 Sum_probs=234.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
...+.+++|+++++||+|+||+||+|+++.+++.||||++.+...... .....+..|..+|.++ +||||
T Consensus 46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~----------~~~~~~~~E~~il~~~~~hp~I 115 (396)
T 4dc2_A 46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----------EDIDWVQTEKHVFEQASNHPFL 115 (396)
T ss_dssp ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------CCHHHHHHHHHHHHTTCTTB
T ss_pred ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH----------HHHHHHHHHHHHHHhcCCCCCc
Confidence 456788999999999999999999999999999999999976543221 2345678899999887 79999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++|.+++.+|+|||||+||+|..++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.+|++|
T Consensus 116 v~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEE
Confidence 999999999999999999999999999887653 499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+..... .....+++||+
T Consensus 194 L~DFGla~~~~~~--------------------------------------------------------~~~~~~~~gt~ 217 (396)
T 4dc2_A 194 LTDYGMCKEGLRP--------------------------------------------------------GDTTSTFCGTP 217 (396)
T ss_dssp ECCCTTCBCCCCT--------------------------------------------------------TCCBCCCCBCG
T ss_pred EeecceeeecccC--------------------------------------------------------CCccccccCCc
Confidence 9999999753211 12345678999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHh
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS---------SRKETFYRILCRPPDL-VGEPTPLRNLIRRLL 318 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L 318 (426)
.|+|||++.+..|+.++|||||||++|||++|++||... .....+..+....... ...+..+++||++||
T Consensus 218 ~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 297 (396)
T 4dc2_A 218 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 297 (396)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHh
Confidence 999999999999999999999999999999999999643 2233455555444333 356889999999999
Q ss_pred ccCCCCCCCh------HHHhcCCCcCCCChhhhhhcc-CCCCCCC
Q 014344 319 EKDPTKRIGV------EEIKGHEFFKGVNWELLLKIS-RPPNIPA 356 (426)
Q Consensus 319 ~~dP~~R~s~------~eil~hp~f~~~~~~~~~~~~-~~~~~~~ 356 (426)
++||.+||++ +||++||||++++|+.+.... .||..|.
T Consensus 298 ~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~ 342 (396)
T 4dc2_A 298 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 342 (396)
T ss_dssp CSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCC
T ss_pred cCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCC
Confidence 9999999995 799999999999999987644 4455543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=443.76 Aligned_cols=277 Identities=35% Similarity=0.640 Sum_probs=237.9
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcc
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLP 89 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv 89 (426)
..+.+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..+|+.+ +||||+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~il~~~~~hp~iv 81 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLT 81 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBC
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhh----------hhHHHHHHHHHHHHhcCCCCCCC
Confidence 45788999999999999999999999999999999999987654322 1345677899999887 899999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+++++|++.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||
T Consensus 82 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL 159 (345)
T 1xjd_A 82 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 159 (345)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEE
T ss_pred cEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEE
Confidence 99999999999999999999999999987653 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++..... .....+.+||+.
T Consensus 160 ~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~gt~~ 183 (345)
T 1xjd_A 160 ADFGMCKENMLG--------------------------------------------------------DAKTNTFCGTPD 183 (345)
T ss_dssp CCCTTCBCCCCT--------------------------------------------------------TCCBCCCCSCGG
T ss_pred eEChhhhhcccC--------------------------------------------------------CCcccCCCCCcc
Confidence 999998754211 112446689999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCCh
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+..+....+..+ ..+..+.+||.+||+.||++||++
T Consensus 184 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~ 263 (345)
T 1xjd_A 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 263 (345)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTT
T ss_pred cCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCC
Confidence 9999999999999999999999999999999999999999888888876554433 468899999999999999999999
Q ss_pred H-HHhcCCCcCCCChhhhhhcc-CCCCCC
Q 014344 329 E-EIKGHEFFKGVNWELLLKIS-RPPNIP 355 (426)
Q Consensus 329 ~-eil~hp~f~~~~~~~~~~~~-~~~~~~ 355 (426)
. +|++||||++++|+.+.... .||..|
T Consensus 264 ~~~i~~hp~f~~~~w~~l~~~~~~~p~~p 292 (345)
T 1xjd_A 264 RGDIRQHPLFREINWEELERKEIDPPFRP 292 (345)
T ss_dssp BSCGGGSGGGTTCCHHHHHTTCSCC----
T ss_pred hHHHHcCccccCCCHHHHhhCCCCCCcCC
Confidence 8 99999999999999987644 344444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=443.24 Aligned_cols=282 Identities=32% Similarity=0.580 Sum_probs=240.4
Q ss_pred CCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CC
Q 014344 7 DRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EH 85 (426)
Q Consensus 7 ~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 85 (426)
......+.+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..+|..+ .|
T Consensus 11 ~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~----------~~~~~~~~E~~~l~~~~~h 80 (353)
T 2i0e_A 11 NGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECTMVEKRVLALPGKP 80 (353)
T ss_dssp --------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTCTTCC
T ss_pred CCCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcc----------hHHHHHHHHHHHHHhcCCC
Confidence 334567889999999999999999999999999999999999987654332 2345678899999988 79
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
|||++++++|++.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 81 p~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS
T ss_pred CEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC
Confidence 999999999999999999999999999999987653 499999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
++||+|||+++..... .....+++
T Consensus 159 ~vkL~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~ 182 (353)
T 2i0e_A 159 HIKIADFGMCKENIWD--------------------------------------------------------GVTTKTFC 182 (353)
T ss_dssp CEEECCCTTCBCCCCT--------------------------------------------------------TCCBCCCC
T ss_pred cEEEEeCCcccccccC--------------------------------------------------------Cccccccc
Confidence 9999999998753211 11234568
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~ 324 (426)
||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.+++...... ...+..+.+||.+||+.||.+
T Consensus 183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp SCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTS
T ss_pred CCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999999999999999888887654433 356889999999999999999
Q ss_pred CCC-----hHHHhcCCCcCCCChhhhhhcc-CCCCCCC
Q 014344 325 RIG-----VEEIKGHEFFKGVNWELLLKIS-RPPNIPA 356 (426)
Q Consensus 325 R~s-----~~eil~hp~f~~~~~~~~~~~~-~~~~~~~ 356 (426)
||+ +++|++||||++++|+.+.... .||..|.
T Consensus 263 R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~ 300 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 300 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCC
Confidence 995 6999999999999999987643 4555543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=436.71 Aligned_cols=274 Identities=34% Similarity=0.653 Sum_probs=241.3
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...... .....+..|+.+|+.++||||+++
T Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~Iv~~ 71 (318)
T 1fot_A 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL----------KQVEHTNDERLMLSIVTHPFIIRM 71 (318)
T ss_dssp -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCBTTBCCE
T ss_pred CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------hHHHHHHHHHHHHhhCCCCCCceE
Confidence 4678899999999999999999999999999999999987654332 134567789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|.+...+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~D 149 (318)
T 1fot_A 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 149 (318)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeCCEEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEee
Confidence 99999999999999999999999998764 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++.... ...+.+||+.|+
T Consensus 150 fg~a~~~~~-----------------------------------------------------------~~~~~~gt~~y~ 170 (318)
T 1fot_A 150 FGFAKYVPD-----------------------------------------------------------VTYTLCGTPDYI 170 (318)
T ss_dssp CSSCEECSS-----------------------------------------------------------CBCCCCSCTTTC
T ss_pred cCcceecCC-----------------------------------------------------------ccccccCCcccc
Confidence 999876421 123457999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC----
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI---- 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~---- 326 (426)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.+++...... ...+..+.+||.+||+.||++|+
T Consensus 171 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~ 250 (318)
T 1fot_A 171 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ 250 (318)
T ss_dssp CHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcC
Confidence 9999999999999999999999999999999999999988888887654433 34578999999999999999999
Q ss_pred -ChHHHhcCCCcCCCChhhhhhcc-CCCCCCC
Q 014344 327 -GVEEIKGHEFFKGVNWELLLKIS-RPPNIPA 356 (426)
Q Consensus 327 -s~~eil~hp~f~~~~~~~~~~~~-~~~~~~~ 356 (426)
++++|++||||++++|+.+.... .||..|.
T Consensus 251 ~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 251 NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred CCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence 89999999999999999987643 3455543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-57 Score=438.54 Aligned_cols=276 Identities=33% Similarity=0.612 Sum_probs=244.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+.+++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+
T Consensus 35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv 104 (350)
T 1rdq_E 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL----------KQIEHTLNEKRILQAVNFPFLV 104 (350)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccH----------HHHHHHHHHHHHHHhCCCCCCC
Confidence 445788999999999999999999999999999999999977654332 2346788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+...+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred eEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEE
Confidence 99999999999999999999999999987653 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.... ...+.+||+.
T Consensus 183 ~DFg~a~~~~~-----------------------------------------------------------~~~~~~gt~~ 203 (350)
T 1rdq_E 183 TDFGFAKRVKG-----------------------------------------------------------RTWTLCGTPE 203 (350)
T ss_dssp CCCTTCEECSS-----------------------------------------------------------CBCCCEECGG
T ss_pred cccccceeccC-----------------------------------------------------------CcccccCCcc
Confidence 99999876521 1234579999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC-
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG- 327 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s- 327 (426)
|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+.++......+ ...+..+.+||.+||+.||.+||+
T Consensus 204 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~ 283 (350)
T 1rdq_E 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred ccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCC
Confidence 999999999999999999999999999999999999999988888887654433 356889999999999999999998
Q ss_pred ----hHHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 328 ----VEEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 328 ----~~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
+++|++||||++++|+.+... ..||.+|.
T Consensus 284 ~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~ 317 (350)
T 1rdq_E 284 LKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp STTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred ccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCC
Confidence 999999999999999998754 34455553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-57 Score=450.24 Aligned_cols=277 Identities=32% Similarity=0.562 Sum_probs=238.9
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|++++.||+|+||+||+|+++.+++.||+|++.+....... ....+..|+.+|+.++||||+++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~----------~~~~~~~E~~il~~l~hp~Iv~l 134 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS----------DSAFFWEERDIMAFANSPWVVQL 134 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTC----------CCSTHHHHHHHHHHCCCTTBCCE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhH----------HHHHHHHHHHHHHhCCCCCCCeE
Confidence 45678999999999999999999999999999999999775543321 23457789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|.++..+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|
T Consensus 135 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp EEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEec
Confidence 99999999999999999999999988653 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+.... .....+.+||+.|+
T Consensus 212 FG~a~~~~~~~-------------------------------------------------------~~~~~~~~gt~~Y~ 236 (410)
T 3v8s_A 212 FGTCMKMNKEG-------------------------------------------------------MVRCDTAVGTPDYI 236 (410)
T ss_dssp CTTCEECCTTS-------------------------------------------------------EEECCSCCSCGGGC
T ss_pred cceeEeeccCC-------------------------------------------------------cccccCCcCCcccc
Confidence 99997653211 11234568999999
Q ss_pred cchhhcCCC----CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----CCCCCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIEGKG----HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR-----PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~li~~~L~~dP 322 (426)
|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.+++.. .+.....+..+++||++||+.+|
T Consensus 237 APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~ 316 (410)
T 3v8s_A 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDRE 316 (410)
T ss_dssp CHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGG
T ss_pred CHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChh
Confidence 999998766 789999999999999999999999999999888888642 23334678999999999999999
Q ss_pred CC--CCChHHHhcCCCcCCCChhhhhh-ccCCCCCCC
Q 014344 323 TK--RIGVEEIKGHEFFKGVNWELLLK-ISRPPNIPA 356 (426)
Q Consensus 323 ~~--R~s~~eil~hp~f~~~~~~~~~~-~~~~~~~~~ 356 (426)
.+ |++++||++||||++++|+.+.. ...||.+|.
T Consensus 317 ~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~ 353 (410)
T 3v8s_A 317 VRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPD 353 (410)
T ss_dssp GCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCC
T ss_pred hhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCc
Confidence 88 99999999999999999986644 345555554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=437.14 Aligned_cols=278 Identities=32% Similarity=0.667 Sum_probs=236.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
...+.+++|++++.||+|+||.||+|+++.+++.||||++.+.... .......+..|+.+|+++ +||||
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~~E~~~l~~~~~hp~i 72 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN----------DDEDIDWVQTEKHVFEQASNHPFL 72 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSC----------SHHHHHHHHHHHHHHHHTTTCTTB
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhc----------chHHHHHHHHHHHHHHhcCCCCcc
Confidence 3567889999999999999999999999999999999999765432 123456788899999988 89999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++|.++..+|+|||||+||+|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++|
T Consensus 73 v~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 73 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEE
Confidence 999999999999999999999999999887653 499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++..... .....+.+||+
T Consensus 151 L~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~gt~ 174 (345)
T 3a8x_A 151 LTDYGMCKEGLRP--------------------------------------------------------GDTTSTFCGTP 174 (345)
T ss_dssp ECCGGGCBCSCCT--------------------------------------------------------TCCBCCCCSCG
T ss_pred EEeccccccccCC--------------------------------------------------------CCcccccCCCc
Confidence 9999998753211 11234568999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHh
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRG---------SSRKETFYRILCRPPD-LVGEPTPLRNLIRRLL 318 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~---------~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L 318 (426)
.|+|||++.+..|+.++|||||||++|||++|+.||.. ......+..+...... ....+..+.+||.+||
T Consensus 175 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 254 (345)
T 3a8x_A 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 254 (345)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999999975 2334445555544333 2356889999999999
Q ss_pred ccCCCCCCCh------HHHhcCCCcCCCChhhhhhcc-CCCCCC
Q 014344 319 EKDPTKRIGV------EEIKGHEFFKGVNWELLLKIS-RPPNIP 355 (426)
Q Consensus 319 ~~dP~~R~s~------~eil~hp~f~~~~~~~~~~~~-~~~~~~ 355 (426)
+.||.+||++ ++|++||||++++|+.+.+.. .||..|
T Consensus 255 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p 298 (345)
T 3a8x_A 255 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKP 298 (345)
T ss_dssp CSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCC
Confidence 9999999996 799999999999999987644 344444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-58 Score=444.54 Aligned_cols=258 Identities=21% Similarity=0.337 Sum_probs=216.7
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCC-----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVES-----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
|+++.++|++++.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|+++.|
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~------------~~~~~~~~~~E~~il~~l~h 126 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------THSEHRALMSELKILIHIGH 126 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHCC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc------------ChHHHHHHHHHHHHHHHcCC
Confidence 467788999999999999999999997654 3679999985432 12345678999999999976
Q ss_pred -CCcceeeeeeec-CCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 86 -PLLPRLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 86 -p~iv~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
||||++++++.. ++.+|+|||||+||+|.++++... ...+++..+..|+.||+.||+|||+++|
T Consensus 127 hpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~i 206 (353)
T 4ase_A 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 206 (353)
T ss_dssp CTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCe
Confidence 899999999865 567999999999999999987643 2348999999999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
|||||||+|||++.++.+||+|||+|+.+....
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~----------------------------------------------- 239 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDP----------------------------------------------- 239 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCT-----------------------------------------------
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCC-----------------------------------------------
Confidence 999999999999999999999999998764221
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh---cCCCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRIL---CRPPDLVG 305 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~---~~~~~~~~ 305 (426)
......+.+||+.|||||++.+..|+.++|||||||++|||++ |+.||.+.+..+.+.+.+ ..++.+..
T Consensus 240 -------~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~ 312 (353)
T 4ase_A 240 -------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 312 (353)
T ss_dssp -------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred -------CceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCcc
Confidence 1113345679999999999999999999999999999999998 999999876544444433 22344456
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.++++.+||.+||+.||++|||+.||++|
T Consensus 313 ~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 313 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 78999999999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-57 Score=449.59 Aligned_cols=279 Identities=34% Similarity=0.570 Sum_probs=239.8
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|+++++||+|+||+||+|+++.+++.||||++.+....... ....+..|+.+|..++||||+++
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~----------~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA----------ETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT----------TTCCHHHHHHHHHHSCTTTBCCE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHH----------HHHHHHHHHHHHHhCCCCCEEEE
Confidence 35567899999999999999999999999999999999775543321 23457789999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|.+++.+|+|||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcc
Confidence 999999999999999999999999987532 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+.... .......+||+.|+
T Consensus 219 FGla~~~~~~~-------------------------------------------------------~~~~~~~~GT~~Y~ 243 (437)
T 4aw2_A 219 FGSCLKLMEDG-------------------------------------------------------TVQSSVAVGTPDYI 243 (437)
T ss_dssp CTTCEECCTTS-------------------------------------------------------CEECCSCCSCGGGC
T ss_pred hhhhhhcccCC-------------------------------------------------------CcccccccCCcCee
Confidence 99997653211 11223457999999
Q ss_pred cchhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CCCCCCCCCHHHHHHHHHHhcc
Q 014344 252 APEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC------RPPDLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 252 aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~------~~~~~~~~~~~~~~li~~~L~~ 320 (426)
|||++. ...|+.++|||||||++|||++|++||.+.+..+.+.+++. .+......+..+++||++||+.
T Consensus 244 APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~ 323 (437)
T 4aw2_A 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS 323 (437)
T ss_dssp CHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSC
T ss_pred ChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcc
Confidence 999997 45689999999999999999999999999999888888753 2233345789999999999999
Q ss_pred CCCC--CCChHHHhcCCCcCCCChhhhhhccCCCCCCCC
Q 014344 321 DPTK--RIGVEEIKGHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 321 dP~~--R~s~~eil~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
+|.+ |++++||++||||++++|+.+. ...||.+|..
T Consensus 324 ~~~r~~r~~~~eil~Hpff~~i~w~~l~-~~~~p~~P~~ 361 (437)
T 4aw2_A 324 REHRLGQNGIEDFKKHPFFSGIDWDNIR-NCEAPYIPEV 361 (437)
T ss_dssp GGGCTTTTTTHHHHTSGGGTTCCTTTGG-GSCCSCCCCC
T ss_pred cccccCCCCHHHHhCCCccCCCCHHHHh-hCCCCCCCcC
Confidence 8888 9999999999999999999984 4456666644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-57 Score=441.25 Aligned_cols=277 Identities=39% Similarity=0.667 Sum_probs=233.3
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHH-HHhcCCCCcc
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV-LRNVEHPLLP 89 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~i-l~~l~hp~iv 89 (426)
..+..++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..+ ++.++||||+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~----------~~~~~~~~e~~~ll~~~~hp~Iv 102 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK----------KEEKHIMSERNVLLKNVKHPFLV 102 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------------CCBCCCCCTTBC
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh----------HHHHHHHHHHHHHHHhCCCCCCC
Confidence 45778899999999999999999999999999999999977543222 123455667776 5678999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+++++|.+.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||
T Consensus 103 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL 180 (373)
T 2r5t_A 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180 (373)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE
T ss_pred CEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999887653 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++..... .....+++||+.
T Consensus 181 ~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~gt~~ 204 (373)
T 2r5t_A 181 TDFGLCKENIEH--------------------------------------------------------NSTTSTFCGTPE 204 (373)
T ss_dssp CCCCBCGGGBCC--------------------------------------------------------CCCCCSBSCCCC
T ss_pred eeCccccccccC--------------------------------------------------------CCccccccCCcc
Confidence 999998753211 113445689999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.+++..+... ...+..+++||.+||+.||.+||++
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~ 284 (373)
T 2r5t_A 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGA 284 (373)
T ss_dssp CCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTT
T ss_pred ccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCC
Confidence 999999999999999999999999999999999999999999998888665443 3568899999999999999999986
Q ss_pred ----HHHhcCCCcCCCChhhhhhcc-CCCCCC
Q 014344 329 ----EEIKGHEFFKGVNWELLLKIS-RPPNIP 355 (426)
Q Consensus 329 ----~eil~hp~f~~~~~~~~~~~~-~~~~~~ 355 (426)
.+|++||||++++|+.+.... .||..|
T Consensus 285 ~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p 316 (373)
T 2r5t_A 285 KDDFMEIKSHVFFSLINWDDLINKKITPPFNP 316 (373)
T ss_dssp TTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCCHHHHhCCccccCCCHHHHHhCCCCCCCCC
Confidence 699999999999999987644 445554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=444.17 Aligned_cols=277 Identities=33% Similarity=0.578 Sum_probs=237.5
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|+.+|..++||||+++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~----------~~~~~~~~E~~il~~~~hp~Iv~l 126 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR----------GEVSCFREERDVLVNGDRRWITQL 126 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH----------GGGCCHHHHHHHHHHSCTTTBCCE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhH----------HHHHHHHHHHHHHHhcCCCCeeeE
Confidence 4667899999999999999999999999999999999987554332 134567889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
+++|++++.+|+|||||+||+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|
T Consensus 127 ~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999999987653 3599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++.+.... .......+||+.|+
T Consensus 206 FGla~~~~~~~-------------------------------------------------------~~~~~~~~Gt~~Y~ 230 (412)
T 2vd5_A 206 FGSCLKLRADG-------------------------------------------------------TVRSLVAVGTPDYL 230 (412)
T ss_dssp CTTCEECCTTS-------------------------------------------------------CEECSSCCSCGGGC
T ss_pred chhheeccCCC-------------------------------------------------------ccccceeccccCcC
Confidence 99998653211 01233567999999
Q ss_pred cchhhc-------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------CCCCCCCCHHHHHHHHHHh
Q 014344 252 APEIIE-------GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR------PPDLVGEPTPLRNLIRRLL 318 (426)
Q Consensus 252 aPE~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~~~~~~~~~~~~li~~~L 318 (426)
|||++. +..|+.++|||||||++|||++|++||.+.+..+.+.+++.. +......+..+++||++||
T Consensus 231 APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL 310 (412)
T 2vd5_A 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL 310 (412)
T ss_dssp CHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTS
T ss_pred CHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHc
Confidence 999997 356899999999999999999999999999998888877631 1112357899999999999
Q ss_pred ccCCCCCC---ChHHHhcCCCcCCCChhhhhhccCCCCCCC
Q 014344 319 EKDPTKRI---GVEEIKGHEFFKGVNWELLLKISRPPNIPA 356 (426)
Q Consensus 319 ~~dP~~R~---s~~eil~hp~f~~~~~~~~~~~~~~~~~~~ 356 (426)
+ +|.+|+ +++||++||||++++|+.+.+ ..||..|.
T Consensus 311 ~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~-~~~p~~p~ 349 (412)
T 2vd5_A 311 C-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD-SVPPFTPD 349 (412)
T ss_dssp S-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTT-SCCSCCCC
T ss_pred C-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhh-cCCCCCCc
Confidence 9 999984 899999999999999999854 45666654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-56 Score=435.80 Aligned_cols=278 Identities=29% Similarity=0.577 Sum_probs=238.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+.+++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv 78 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER----------NEVRNVFKELQIMQGLEHPFLV 78 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCCCTTBC
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccH----------HHHHHHHHHHHHHHhCCCCCCC
Confidence 467889999999999999999999999999999999999977654332 2356788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+++++|.+...+|+|||||.||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||
T Consensus 79 ~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 79 NLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp CEEEEEECSSEEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEE
T ss_pred cEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEE
Confidence 9999999999999999999999999988754 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+... ....+.+||+.
T Consensus 157 ~DFG~a~~~~~~---------------------------------------------------------~~~~~~~gt~~ 179 (384)
T 4fr4_A 157 TDFNIAAMLPRE---------------------------------------------------------TQITTMAGTKP 179 (384)
T ss_dssp CCCTTCEECCTT---------------------------------------------------------CCBCCCCSCGG
T ss_pred eccceeeeccCC---------------------------------------------------------CceeccCCCcc
Confidence 999999765321 12345679999
Q ss_pred CccchhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCC-CCCCCCHHHHHHHHHHhccCC
Q 014344 250 YVAPEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGS---SRKETFYRILCRPP-DLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 250 y~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~-~~~~~~~~~~~li~~~L~~dP 322 (426)
|+|||++.+ ..|+.++|||||||++|+|++|+.||... ...+.+..+..... .....+..+.+||.+||+.||
T Consensus 180 Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp GCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSG
T ss_pred ccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCH
Confidence 999999974 45899999999999999999999999753 33444444443333 334568899999999999999
Q ss_pred CCCCC-hHHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 323 TKRIG-VEEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 323 ~~R~s-~~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
.+||+ ++++++||||++++|+.+... ..||.+|.
T Consensus 260 ~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp GGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred hHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 99998 899999999999999998764 44555554
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=424.64 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=229.7
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
....+++|++++.||+|+||+||+|++..+|+.||||++.+... .....+++.+|+.+|+.++||||++
T Consensus 10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~ 78 (328)
T 3fe3_A 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-----------NPTSLQKLFREVRIMKILNHPNIVK 78 (328)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-----------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-----------CHHHHHHHHHHHHHHHhCCCCCEee
Confidence 44567899999999999999999999999999999999966432 1234567889999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.+.+.+|+|||||+|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 79 l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~ 156 (328)
T 3fe3_A 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIA 156 (328)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred EEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEe
Confidence 9999999999999999999999999987653 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++...... ......+||+.|
T Consensus 157 DFG~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y 179 (328)
T 3fe3_A 157 DFGFSNEFTVG---------------------------------------------------------GKLDAFCGAPPY 179 (328)
T ss_dssp STTCCGGGSSS---------------------------------------------------------CGGGTTSSSGGG
T ss_pred eccCceecCCC---------------------------------------------------------CccccccCCcce
Confidence 99998765321 123456799999
Q ss_pred ccchhhcCCCCC-hhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 251 VAPEIIEGKGHD-FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 251 ~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+....... ...++.+.+||++||+.||.+|||+
T Consensus 180 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 259 (328)
T 3fe3_A 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTL 259 (328)
T ss_dssp CCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCH
T ss_pred eCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCH
Confidence 999999988874 89999999999999999999999999888888877554333 3458899999999999999999999
Q ss_pred HHHhcCCCcCCCC
Q 014344 329 EEIKGHEFFKGVN 341 (426)
Q Consensus 329 ~eil~hp~f~~~~ 341 (426)
+|+++||||+...
T Consensus 260 ~eil~h~~~~~~~ 272 (328)
T 3fe3_A 260 EQIMKDRWINAGH 272 (328)
T ss_dssp HHHTTCTTTTTTC
T ss_pred HHHhcCHhhcCCC
Confidence 9999999998654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=441.69 Aligned_cols=278 Identities=35% Similarity=0.634 Sum_probs=231.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||.||+|++..+++.||||++.+...... .....+..|+.+|+.++||||+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv 211 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK----------DEVAHTLTENRVLQNSRHPFLT 211 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------------CCCCCSCTTSC
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhh----------HHHHHHHHHHHHHHhCCCCeEe
Confidence 345677899999999999999999999999999999999976543221 2345667799999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++.+.+.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+|
T Consensus 212 ~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~k 289 (446)
T 4ejn_A 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 289 (446)
T ss_dssp CEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEE
T ss_pred eEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999887653 59999999999999999999998 9999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++..... .......+||+
T Consensus 290 l~DFG~a~~~~~~--------------------------------------------------------~~~~~~~~gt~ 313 (446)
T 4ejn_A 290 ITDFGLCKEGIKD--------------------------------------------------------GATMKTFCGTP 313 (446)
T ss_dssp ECCCCCCCTTCC-------------------------------------------------------------CCSSSCG
T ss_pred EccCCCceeccCC--------------------------------------------------------CcccccccCCc
Confidence 9999998754211 11234567999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI- 326 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~- 326 (426)
.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+....+..+....... ...++.+.+||.+||+.||.+||
T Consensus 314 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 393 (446)
T 4ejn_A 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLG 393 (446)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred cccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCC
Confidence 9999999999999999999999999999999999999999888888877554433 35688999999999999999999
Q ss_pred ----ChHHHhcCCCcCCCChhhhhhccCC-CCCC
Q 014344 327 ----GVEEIKGHEFFKGVNWELLLKISRP-PNIP 355 (426)
Q Consensus 327 ----s~~eil~hp~f~~~~~~~~~~~~~~-~~~~ 355 (426)
+++|+++||||++++|+.+.....+ |..|
T Consensus 394 ~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p 427 (446)
T 4ejn_A 394 GGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKP 427 (446)
T ss_dssp CSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCCCCHHHHHhCccccCCCHHHHhhCcCCCCccC
Confidence 9999999999999999998765444 4444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=459.70 Aligned_cols=279 Identities=32% Similarity=0.586 Sum_probs=242.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
...+.+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..+|..+ .||+|
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~----------~~~~~~~~E~~~l~~~~~~~~i 404 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD----------DDVECTMVEKRVLALPGKPPFL 404 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHT----------TTTHHHHHHHHHHTCTTCCTTB
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccH----------HHHHHHHHHHHHHHhccCCCeE
Confidence 345778999999999999999999999999999999999987654332 2345678899999988 69999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+.++++|++.+.+|+||||++||+|..++.... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++|
T Consensus 405 ~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ik 482 (674)
T 3pfq_A 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482 (674)
T ss_dssp CCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEE
T ss_pred EEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEE
Confidence 999999999999999999999999999987654 499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++..... .....+++||+
T Consensus 483 L~DFGla~~~~~~--------------------------------------------------------~~~~~~~~GT~ 506 (674)
T 3pfq_A 483 IADFGMCKENIWD--------------------------------------------------------GVTTKTFCGTP 506 (674)
T ss_dssp ECCCTTCEECCCT--------------------------------------------------------TCCBCCCCSCS
T ss_pred EeecceeeccccC--------------------------------------------------------CcccccccCCC
Confidence 9999999753211 12345678999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..|+.....+ ...+..+.+||++||++||.+|++
T Consensus 507 ~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~ 586 (674)
T 3pfq_A 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLG 586 (674)
T ss_dssp SSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTT
T ss_pred cccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCC
Confidence 9999999999999999999999999999999999999999999999998765444 356889999999999999999999
Q ss_pred h-----HHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 328 V-----EEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 328 ~-----~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
+ +||++||||++++|+.+... ..||..|.
T Consensus 587 ~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~ 621 (674)
T 3pfq_A 587 CGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621 (674)
T ss_dssp CSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCB
T ss_pred CCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCc
Confidence 7 99999999999999998764 34555553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-55 Score=421.75 Aligned_cols=275 Identities=36% Similarity=0.660 Sum_probs=227.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
...+..++|++++.||+|+||.||+|++. .+++.||||++.+...... ......+..|+.+|+.++||
T Consensus 11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hp 81 (327)
T 3a62_A 11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN---------AKDTAHTKAERNILEEVKHP 81 (327)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------HHHHHHHCCCT
T ss_pred CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh---------hhHHHHHHHHHHHHHhCCCC
Confidence 45678899999999999999999999985 6899999999976543211 12334567799999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++.+++.+|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 82 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~ 159 (327)
T 3a62_A 82 FIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH 159 (327)
T ss_dssp TBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC
T ss_pred CccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc
Confidence 99999999999999999999999999999887653 4999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++...... .......+|
T Consensus 160 ~kl~Dfg~~~~~~~~--------------------------------------------------------~~~~~~~~g 183 (327)
T 3a62_A 160 VKLTDFGLCKESIHD--------------------------------------------------------GTVTHTFCG 183 (327)
T ss_dssp EEECCCSCC------------------------------------------------------------------CTTSS
T ss_pred EEEEeCCcccccccC--------------------------------------------------------CccccccCC
Confidence 999999998754211 112334579
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R 325 (426)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.++....... ...+..+.+||.+||..||.+|
T Consensus 184 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R 263 (327)
T 3a62_A 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263 (327)
T ss_dssp CCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGS
T ss_pred CcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhc
Confidence 999999999999999999999999999999999999999999888888877544333 3457899999999999999999
Q ss_pred C-----ChHHHhcCCCcCCCChhhhhhccCC
Q 014344 326 I-----GVEEIKGHEFFKGVNWELLLKISRP 351 (426)
Q Consensus 326 ~-----s~~eil~hp~f~~~~~~~~~~~~~~ 351 (426)
| ++.++++||||++++|+.+......
T Consensus 264 ~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~ 294 (327)
T 3a62_A 264 LGAGPGDAGEVQAHPFFRHINWEELLARKVE 294 (327)
T ss_dssp TTSSTTTHHHHHHSGGGSSCCHHHHHTTCSC
T ss_pred cCCCCCCHHHHHcCCcccCCCHHHHhhccCC
Confidence 9 7899999999999999988764333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=426.62 Aligned_cols=265 Identities=28% Similarity=0.448 Sum_probs=231.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||+||+|+++.+|+.||+|++.+...... ........+.+|+.+|+.++||||++++++|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~-------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS-------RRGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTC-------SSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccc-------cchhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 459999999999999999999999999999999966432111 1112346788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC----cEEEec
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~D 171 (426)
.+...+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999999988643 4599999999999999999999999999999999999998877 799999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+... ......+||+.|+
T Consensus 163 FG~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 185 (361)
T 2yab_A 163 FGLAHEIEDG---------------------------------------------------------VEFKNIFGTPEFV 185 (361)
T ss_dssp CSSCEECCTT---------------------------------------------------------CCCCCCCSCGGGC
T ss_pred cCCceEcCCC---------------------------------------------------------CccccCCCCccEE
Confidence 9999865321 1123457999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+......+ ...+..+++||.+||..||.+||
T Consensus 186 aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 265 (361)
T 2yab_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL 265 (361)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred CchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc
Confidence 9999999999999999999999999999999999999988888887554333 35578899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhh
Q 014344 327 GVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~ 346 (426)
|+.|+|+||||++++|....
T Consensus 266 t~~e~l~hp~~~~~~~~~~~ 285 (361)
T 2yab_A 266 TIQEALRHPWITPVDTQQAM 285 (361)
T ss_dssp CHHHHHTSTTTSCSSHHHHH
T ss_pred CHHHHhcCcCcCCCchhhhh
Confidence 99999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-55 Score=447.16 Aligned_cols=279 Identities=30% Similarity=0.479 Sum_probs=240.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+..+... .....+..|+.+|+.++||||++
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~ 248 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR----------KGEAMALNEKQILEKVNSRFVVS 248 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhh----------HHHHHHHHHHHHHHHcCCCCEee
Confidence 34677899999999999999999999999999999999987655432 12456788999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++++|.+.+.+|+|||||+||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+
T Consensus 249 l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~ 328 (576)
T 2acx_A 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRIS 328 (576)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEE
Confidence 99999999999999999999999998876655569999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+... ......+||+.|
T Consensus 329 DFGla~~~~~~---------------------------------------------------------~~~~~~~GT~~Y 351 (576)
T 2acx_A 329 DLGLAVHVPEG---------------------------------------------------------QTIKGRVGTVGY 351 (576)
T ss_dssp CCTTCEECCTT---------------------------------------------------------CCEECCCSCGGG
T ss_pred ecccceecccC---------------------------------------------------------ccccccCCCccc
Confidence 99999765321 112345799999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R 325 (426)
+|||++.+..|+.++|||||||++|||++|++||.+.+ .......+...+... ...+..+++||.+||+.||.+|
T Consensus 352 ~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R 431 (576)
T 2acx_A 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431 (576)
T ss_dssp CCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHc
Confidence 99999999999999999999999999999999998763 344555555444333 3568899999999999999999
Q ss_pred C-----ChHHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 326 I-----GVEEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 326 ~-----s~~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
| +++||++||||++++|+.+... ..||..|.
T Consensus 432 ~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 432 LGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp TTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence 9 7899999999999999998763 44555554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=442.01 Aligned_cols=281 Identities=28% Similarity=0.521 Sum_probs=241.7
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+..++|++++.||+|+||+||+|+++.+|+.||||++.+...... .....+..|+.+|+.++||||++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~ 249 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR----------KGYQGAMVEKKILAKVHSRFIVS 249 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhh----------HHHHHHHHHHHHHHhcCCCCEee
Confidence 45778899999999999999999999999999999999987655432 13457888999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++|++...+|+|||||+||+|..++.... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+|++|
T Consensus 250 l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp EEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEE
T ss_pred EEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEE
Confidence 9999999999999999999999999887543 34699999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.+.... ......+||+
T Consensus 330 L~DFGla~~~~~~~--------------------------------------------------------~~~~~~~GT~ 353 (543)
T 3c4z_A 330 ISDLGLAVELKAGQ--------------------------------------------------------TKTKGYAGTP 353 (543)
T ss_dssp ECCCTTCEECCTTC--------------------------------------------------------CCBCCCCSCT
T ss_pred EeecceeeeccCCC--------------------------------------------------------cccccccCCc
Confidence 99999998653211 1233457999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~ 323 (426)
.|+|||++.+..|+.++|||||||++|||++|++||.+. ...+....++...... ...+..+.+||.+||++||.
T Consensus 354 ~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~ 433 (543)
T 3c4z_A 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPE 433 (543)
T ss_dssp TTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred cccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHh
Confidence 999999999999999999999999999999999999875 3455666666544333 35688999999999999999
Q ss_pred CCCC-----hHHHhcCCCcCCCChhhhhh-ccCCCCCCCC
Q 014344 324 KRIG-----VEEIKGHEFFKGVNWELLLK-ISRPPNIPAR 357 (426)
Q Consensus 324 ~R~s-----~~eil~hp~f~~~~~~~~~~-~~~~~~~~~~ 357 (426)
+||+ +++|++||||++++|..+.. ...||..|..
T Consensus 434 ~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 434 KRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp GSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred HCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 9996 58999999999999999875 3456666643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=405.92 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=221.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||+|+||+||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-------------PKKELIINEILVMRENKNPNIVNYLD 84 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-------------SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-------------cHHHHHHHHHHHHhcCCCCCCCeEeE
Confidence 34679999999999999999999999999999999854321 12356788999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++...+.+|+|||||+|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 161 (297)
T 3fxz_A 85 SYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (297)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999999999998753 49999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... ......+||+.|+||
T Consensus 162 ~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aP 185 (297)
T 3fxz_A 162 FCAQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAP 185 (297)
T ss_dssp TCEECCSTT--------------------------------------------------------CCBCCCCSCGGGCCH
T ss_pred CceecCCcc--------------------------------------------------------cccCCccCCcCccCh
Confidence 987654211 123345799999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----CCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP----PDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|++.+..++.++|||||||++|+|++|+.||.+.+.......+.... ......+..+.+||.+||+.||.+|||++
T Consensus 186 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 265 (297)
T 3fxz_A 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK 265 (297)
T ss_dssp HHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHH
Confidence 99999999999999999999999999999999988877666554221 12234578899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
|+++||||+.
T Consensus 266 ell~h~~~~~ 275 (297)
T 3fxz_A 266 ELLQHQFLKI 275 (297)
T ss_dssp HHTTCGGGGG
T ss_pred HHhhChhhcc
Confidence 9999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-53 Score=406.83 Aligned_cols=265 Identities=26% Similarity=0.447 Sum_probs=228.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||+||+|++..+++.||+|++.+...... ........+.+|+.+|+.++||||+++++++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS-------RRGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTC-------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccc-------cchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 469999999999999999999999999999999965432111 1112356788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC----cEEEec
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~D 171 (426)
.+...+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999999987643 4599999999999999999999999999999999999999887 899999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .....+||+.|+
T Consensus 162 fg~a~~~~~~~---------------------------------------------------------~~~~~~gt~~y~ 184 (326)
T 2y0a_A 162 FGLAHKIDFGN---------------------------------------------------------EFKNIFGTPEFV 184 (326)
T ss_dssp CTTCEECCTTS---------------------------------------------------------CCCCCCSCTTTC
T ss_pred CCCCeECCCCC---------------------------------------------------------ccccccCCcCcC
Confidence 99997653211 122346999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+....... ...+..+.+||.+||+.||.+||
T Consensus 185 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 264 (326)
T 2y0a_A 185 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 264 (326)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC
Confidence 9999999999999999999999999999999999998888777765433322 35578899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhh
Q 014344 327 GVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~ 346 (426)
|+.++|+||||++.+|....
T Consensus 265 t~~e~l~hp~~~~~~~~~~~ 284 (326)
T 2y0a_A 265 TIQDSLQHPWIKPKDTQQAL 284 (326)
T ss_dssp CHHHHHHSTTTSCCSHHHHH
T ss_pred CHHHHhcCCCccCCcchhhh
Confidence 99999999999998886553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=409.59 Aligned_cols=248 Identities=20% Similarity=0.217 Sum_probs=189.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|.+.++||+|+||+||+|++ +|+.||||++..... .......|+..+.+++|||||++++++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--------------~~~~~e~Ei~~~~~l~HpNIv~l~g~~ 66 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE--------------RSWFREAEIYQTVMLRHENILGFIAAD 66 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch--------------hhHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 3589999999999999999986 689999999854321 111223466666788999999999999
Q ss_pred ecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCCeeecc
Q 014344 96 STDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM--------GIVYRDLKPENIMIQE 163 (426)
Q Consensus 96 ~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~--------giiHrDlKp~NiLl~~ 163 (426)
..++ .+|||||||+||+|.++++.. .++++.+..++.|++.||+|||++ +||||||||+||||+.
T Consensus 67 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~ 143 (303)
T 3hmm_A 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred EecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC
Confidence 7653 689999999999999998753 489999999999999999999987 9999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++++||+|||+|+....... .......+
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~----------------------------------------------------~~~~~~~~ 171 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATD----------------------------------------------------TIDIAPNH 171 (303)
T ss_dssp TSCEEECCCTTCEEEETTTT----------------------------------------------------EESCC---
T ss_pred CCCEEEEeCCCCccccCCCC----------------------------------------------------ceeeeccc
Confidence 99999999999986532110 00112345
Q ss_pred cccCCCCccchhhcCC------CCChhhHHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhcCC--
Q 014344 244 FVGTEEYVAPEIIEGK------GHDFAVDWWSLGVVLHEMLYGATPFRGS---------------SRKETFYRILCRP-- 300 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~---------------~~~~~~~~i~~~~-- 300 (426)
.+||+.|||||++.+. .|+.++|||||||++|||++|.+||... ........+....
T Consensus 172 ~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r 251 (303)
T 3hmm_A 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251 (303)
T ss_dssp --CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred ccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCC
Confidence 6899999999999765 3578999999999999999998766322 1222222332221
Q ss_pred CCCCC------CCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 301 PDLVG------EPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 301 ~~~~~------~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+..+. .+..+.+||.+||+.||++|||+.||++.
T Consensus 252 p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 22211 12357899999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=422.97 Aligned_cols=255 Identities=24% Similarity=0.414 Sum_probs=222.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+|+.||+|++.+..... .....+.+|+.+|+.++||||+++++++
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-----------~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-----------RDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-----------HHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-----------HHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 46999999999999999999999999999999996543322 2345788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec---cCCcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~---~~g~ikL~DF 172 (426)
.+++..|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccC
Confidence 9999999999999999999988764 3499999999999999999999999999999999999998 4578999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... ......+||+.|+|
T Consensus 158 G~a~~~~~~~--------------------------------------------------------~~~~~~~gt~~Y~A 181 (444)
T 3soa_A 158 GLAIEVEGEQ--------------------------------------------------------QAWFGFAGTPGYLS 181 (444)
T ss_dssp SSCBCCCTTC--------------------------------------------------------CBCCCSCSCGGGCC
T ss_pred ceeEEecCCC--------------------------------------------------------ceeecccCCcccCC
Confidence 9997653211 12234579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+..... .....++.+.+||.+||+.||.+|||
T Consensus 182 PE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 261 (444)
T 3soa_A 182 PEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261 (444)
T ss_dssp HHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999999999999999999998888888764432 22356889999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
+.|+|+||||+.
T Consensus 262 a~e~L~hp~~~~ 273 (444)
T 3soa_A 262 AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCTTHH
T ss_pred HHHHhcCccccC
Confidence 999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=418.30 Aligned_cols=274 Identities=18% Similarity=0.293 Sum_probs=223.9
Q ss_pred CCCCCCCcEEEeeeccc--CceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 11 RSLDFSCLRIVSALGRG--AKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G--~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
-..+.++|++++.||+| +||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni 88 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-----------NEMVTFLQGELHVSKLFNHPNI 88 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-----------hHHHHHHHHHHHHHHhCCCCCC
Confidence 34567889999999999 9999999999999999999999654321 2345678889999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++|.+++.+|+|||||+||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|
T Consensus 89 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~k 168 (389)
T 3gni_B 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVY 168 (389)
T ss_dssp CCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEE
T ss_pred CcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEE
Confidence 99999999999999999999999999998877556699999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++.......... ..........+||+
T Consensus 169 l~dfg~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~gt~ 199 (389)
T 3gni_B 169 LSGLRSNLSMISHGQRQ-------------------------------------------------RVVHDFPKYSVKVL 199 (389)
T ss_dssp ECCGGGCEECEETTEEC-------------------------------------------------SCBCCCCTTCTTTG
T ss_pred Ecccccceeeccccccc-------------------------------------------------cccccccccccccc
Confidence 99999987553211000 00011223347999
Q ss_pred CCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------
Q 014344 249 EYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-------------------------- 300 (426)
Q Consensus 249 ~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-------------------------- 300 (426)
.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......++...
T Consensus 200 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (389)
T 3gni_B 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 279 (389)
T ss_dssp GGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------------------
T ss_pred cccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccccccc
Confidence 9999999988 678999999999999999999999998876554443332111
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 301 ---------------------PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 301 ---------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
+.....+..+.+||.+||+.||++|||++|+|+||||+.+.|..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp --------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred ccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence 11223467799999999999999999999999999999877643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-54 Score=414.84 Aligned_cols=258 Identities=31% Similarity=0.457 Sum_probs=220.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
...+++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+++
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l 74 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS----------DMHMRVEREISYLKLLRHPHIIKL 74 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccch----------hHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456889999999999999999999999999999999977654322 123578889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.+++.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~D 151 (336)
T 3h4j_B 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIAD 151 (336)
T ss_dssp EEEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECC
T ss_pred EEEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEE
Confidence 99999999999999999 689988876653 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++...... ......+||+.|+
T Consensus 152 FG~s~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 174 (336)
T 3h4j_B 152 FGLSNIMTDG---------------------------------------------------------NFLKTSCGSPNYA 174 (336)
T ss_dssp SSCTBTTTTS---------------------------------------------------------BTTCCCTTSTTTS
T ss_pred eccceeccCC---------------------------------------------------------cccccccCCcCcC
Confidence 9998765321 1223457999999
Q ss_pred cchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 252 APEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-DLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 252 aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|||++.+..+ +.++|||||||++|+|++|+.||.+......+..+..... .....++.+.+||++||+.||.+|||++
T Consensus 175 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ 254 (336)
T 3h4j_B 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQ 254 (336)
T ss_dssp CGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9999998876 7899999999999999999999988765444333322222 2234578899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
||++||||+.
T Consensus 255 eil~hp~~~~ 264 (336)
T 3h4j_B 255 EIRRDPWFNV 264 (336)
T ss_dssp HHTTCHHHHT
T ss_pred HHHhChhhcc
Confidence 9999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=405.61 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=214.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
-.++|++++.||+|+||+||+|++. +++.||+|++..... .......+.+|+.+|+.++||||+++++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 86 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-----------DEGIPSTAIREISLLKELHHPNIVSLID 86 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-----------------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-----------cchhhHHHHHHHHHHHHcCCCCEeeeee
Confidence 3577999999999999999999985 589999999854321 1123467888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.++..+|+|||||. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 87 VIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 9999999999999998 57877766543 459999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... ......+||+.|+||
T Consensus 165 ~a~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 165 LARAFGIPV--------------------------------------------------------RSYTHEVVTLWYRAP 188 (311)
T ss_dssp TCEETTSCC--------------------------------------------------------C---CCCCCCTTCCH
T ss_pred CceecCCCc--------------------------------------------------------ccccCCcccCCcCCH
Confidence 997653211 112234689999999
Q ss_pred hhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCC---------------------------
Q 014344 254 EIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPD--------------------------- 302 (426)
Q Consensus 254 E~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~--------------------------- 302 (426)
|++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+. ..+..
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS 268 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHH
Confidence 99987 568999999999999999999999998877665554443 11110
Q ss_pred -CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 303 -LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 303 -~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
....+.++.+||.+||++||++|||++|+|+||||+++++.
T Consensus 269 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 269 IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 11346788999999999999999999999999999987753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-53 Score=409.35 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=223.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||++++++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~~~~~ 69 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--------------TDQVLVKKEISILNIARHRNILHLHES 69 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--------------HHHHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--------------ccHHHHHHHHHHHHhCCCCCCCeEeEE
Confidence 357999999999999999999999999999999984321 223467889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--CCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--NGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--~g~ikL~DF 172 (426)
+.+.+.+|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 70 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Df 148 (321)
T 1tki_A 70 FESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEEC
Confidence 999999999999999999999876432 45999999999999999999999999999999999999997 789999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+... ......+||+.|+|
T Consensus 149 g~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 171 (321)
T 1tki_A 149 GQARQLKPG---------------------------------------------------------DNFRLLFTAPEYYA 171 (321)
T ss_dssp TTCEECCTT---------------------------------------------------------CEEEEEESCGGGSC
T ss_pred CCCeECCCC---------------------------------------------------------CccccccCChhhcC
Confidence 999866321 12234579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......+ ...+..+.+||.+||..||.+|||
T Consensus 172 PE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt 251 (321)
T 1tki_A 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred cHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC
Confidence 999999889999999999999999999999999999888888877554433 256889999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
+.|+|+||||+.
T Consensus 252 ~~e~l~hp~~~~ 263 (321)
T 1tki_A 252 ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHSHHHHS
T ss_pred HHHHhcChhhcc
Confidence 999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=414.71 Aligned_cols=277 Identities=28% Similarity=0.438 Sum_probs=210.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
+++|++++.||+|+||+||+|.+..+++.||||++.+.. .......++.+|+.+|+.+. ||||+++++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-----------~~~~~~~~~~~E~~~l~~l~~h~niv~l~~ 76 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-----------QNSTDAQRTFREIMILTELSGHENIVNLLN 76 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC-------------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-----------cChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence 467999999999999999999999999999999985432 12234567788999999997 999999999
Q ss_pred eeecCC--eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLSTDK--FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~~~--~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++..++ .+|+|||||. ++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~D 152 (388)
T 3oz6_A 77 VLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD 152 (388)
T ss_dssp EEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecC
Confidence 997544 7999999997 689888765 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+............. ..................+||+.|+
T Consensus 153 FG~a~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~~~~~gt~~y~ 197 (388)
T 3oz6_A 153 FGLSRSFVNIRRVTNNIPLS-----------------------------------INENTENFDDDQPILTDYVATRWYR 197 (388)
T ss_dssp CTTCEESSSCCCCCCCGGGC-----------------------------------CC---------------CCCGGGGC
T ss_pred Cccccccccccccccccccc-----------------------------------ccccccccccccccccCCcccCCcC
Confidence 99998764321110000000 0000000011123345678999999
Q ss_pred cchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC--------------------------
Q 014344 252 APEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP-------------------------- 301 (426)
Q Consensus 252 aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~-------------------------- 301 (426)
|||++.+ ..|+.++|||||||++|||++|++||.+.+...++.+++. .+.
T Consensus 198 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (388)
T 3oz6_A 198 APEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIR 277 (388)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC--
T ss_pred CHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCccccccc
Confidence 9999987 6789999999999999999999999999988877766642 110
Q ss_pred -------------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 302 -------------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 302 -------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.....++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 278 QSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp ---CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred CCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 0114578899999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-53 Score=411.01 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=220.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
-++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+.+|+.+|+.++||||++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 94 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS--------PGLSTEDLKREASICHMLKHPHIVELLET 94 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS--------SSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc--------ccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3569999999999999999999999999999999976543221 11234678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---EEE
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IML 169 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---ikL 169 (426)
+.+++.+|+|||||+|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl 174 (351)
T 3c0i_A 95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKL 174 (351)
T ss_dssp EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEE
Confidence 99999999999999999998876543 2345899999999999999999999999999999999999987654 999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ......+||+.
T Consensus 175 ~Dfg~a~~~~~~~--------------------------------------------------------~~~~~~~gt~~ 198 (351)
T 3c0i_A 175 GGFGVAIQLGESG--------------------------------------------------------LVAGGRVGTPH 198 (351)
T ss_dssp CCCTTCEECCTTS--------------------------------------------------------CBCCCCCSCGG
T ss_pred ecCcceeEecCCC--------------------------------------------------------eeecCCcCCcC
Confidence 9999997653211 11234579999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~ 324 (426)
|+|||++.+..++.++|||||||++|+|++|+.||.+.. .+.+..+....... ...+..+.+||.+||+.||++
T Consensus 199 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 277 (351)
T 3c0i_A 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAE 277 (351)
T ss_dssp GCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred ccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhH
Confidence 999999999999999999999999999999999998754 44555554433222 356788999999999999999
Q ss_pred CCChHHHhcCCCcCCCC
Q 014344 325 RIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 325 R~s~~eil~hp~f~~~~ 341 (426)
|||+.++|+||||++.+
T Consensus 278 R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 278 RITVYEALNHPWLKERD 294 (351)
T ss_dssp SCCHHHHHTSHHHHTHH
T ss_pred CcCHHHHhcChhhcCCc
Confidence 99999999999998643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=396.74 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=213.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||++++++
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 69 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----------DDEGVPSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-----------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC-----------CcCCcchHHHHHHHHHhcCCCCCEeeEEeE
Confidence 468999999999999999999999999999999995432 122345678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+++.+|+|||||.| +|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 70 LHSDKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeCCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 9999999999999975 555555443 34599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......+||+.|+|||
T Consensus 148 ~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 148 ARAFGIPV--------------------------------------------------------RCYSAEVVTLWYRPPD 171 (292)
T ss_dssp CEECCSCC--------------------------------------------------------SCCCSCCSCGGGCCHH
T ss_pred ceecCCcc--------------------------------------------------------ccccCCccccCCcChH
Confidence 97653211 1123346899999999
Q ss_pred hhcCCC-CChhhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhc---CCC---------------------------C
Q 014344 255 IIEGKG-HDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRILC---RPP---------------------------D 302 (426)
Q Consensus 255 ~~~~~~-~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~---~~~---------------------------~ 302 (426)
++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.. .+. .
T Consensus 172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T 3o0g_A 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhc
Confidence 998765 79999999999999999987766 566666666555431 110 0
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
....+..+++||.+||+.||++|||++|+|+||||+++
T Consensus 252 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11346789999999999999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=411.17 Aligned_cols=254 Identities=25% Similarity=0.443 Sum_probs=221.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+|+.++||||+++++++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----------ARDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-----------HHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4699999999999999999999999999999999654321 22456788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~DF 172 (426)
.+++..|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeec
Confidence 9999999999999999999887643 459999999999999999999999999999999999999865 45999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++...... ......+||+.|+|
T Consensus 176 G~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 198 (362)
T 2bdw_A 176 GLAIEVNDS---------------------------------------------------------EAWHGFAGTPGYLS 198 (362)
T ss_dssp TTCBCCTTC---------------------------------------------------------CSCCCSCSCTTTCC
T ss_pred CcceEecCC---------------------------------------------------------cccccCCCCccccC
Confidence 998765321 11234579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+..+....... ...+..+.+||.+||+.||.+|||
T Consensus 199 PE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 278 (362)
T 2bdw_A 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278 (362)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC
Confidence 999999999999999999999999999999999999888887776543322 245788999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
+.++|+||||+.
T Consensus 279 ~~e~l~hp~~~~ 290 (362)
T 2bdw_A 279 ADQALKVPWICN 290 (362)
T ss_dssp HHHHTTSHHHHT
T ss_pred HHHHhcCcccCC
Confidence 999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=398.36 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=212.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++ .+++.||+|++...... ......+.+|+.+++.++||||++++++
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-----------EGIPSTTIREISILKELKHSNIVKLYDV 68 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-----------GCCCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-----------cccchhHHHHHHHHHhcCCCCEeeeeeE
Confidence 46899999999999999999998 67899999998543211 1123567789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+++.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 69 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 69 IHTKKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EECSSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EccCCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999999999997 58888876543 4599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......+||+.|+|||
T Consensus 147 ~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aPE 170 (288)
T 1ob3_A 147 ARAFGIPV--------------------------------------------------------RKYTHEIVTLWYRAPD 170 (288)
T ss_dssp HHHHCC-----------------------------------------------------------------CCCTTCCHH
T ss_pred ccccCccc--------------------------------------------------------cccccccccccccCch
Confidence 87653110 1122346899999999
Q ss_pred hhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC---------------------------CC
Q 014344 255 IIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP---------------------------DL 303 (426)
Q Consensus 255 ~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~---------------------------~~ 303 (426)
++.+. .++.++|||||||++|+|++|++||.+.+..+...++.. .+. ..
T Consensus 171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (288)
T 1ob3_A 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (288)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred heeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHh
Confidence 99764 589999999999999999999999999888776665532 110 01
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.+.+..+.+||.+||+.||++|||++|+++||||++.
T Consensus 251 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 2357789999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=408.76 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=213.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.....+++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv 96 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-----------EGVPGTAIREVSLLKELQHRNII 96 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------------CHHHHHHGGGCCCTTBC
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-----------cccchhHHHHHHHHHHcCCCCcc
Confidence 3456778999999999999999999999999999999998543211 12344567899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-----cC
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-----EN 164 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-----~~ 164 (426)
++++++.++..+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ..
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 97 ELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp CEEEEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----C
T ss_pred eEEEEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCcc
Confidence 99999999999999999997 59999887653 499999999999999999999999999999999999994 45
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++..+.... ......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~--------------------------------------------------------~~~~~~ 197 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPI--------------------------------------------------------RQFTHE 197 (329)
T ss_dssp CEEEECCTTHHHHHC-----------------------------------------------------------------
T ss_pred ceEEECcCCCccccCCcc--------------------------------------------------------cccCCC
Confidence 569999999997653211 112334
Q ss_pred ccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCC--C--------------
Q 014344 245 VGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDL--V-------------- 304 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~--~-------------- 304 (426)
+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +... .
T Consensus 198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
T 3gbz_A 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277 (329)
T ss_dssp --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh
Confidence 689999999999874 4899999999999999999999999999887776665421 1100 0
Q ss_pred ------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 305 ------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 305 ------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
..+..+.+||.+||+.||.+|||++|+|+||||++.+|+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 046788999999999999999999999999999999885
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-52 Score=403.00 Aligned_cols=262 Identities=23% Similarity=0.367 Sum_probs=205.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||+|++.... .......+.+|+.+|+.++||||++++++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 71 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------------EEGTPSTAIREISLMKELKHENIVRLYDV 71 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS------------TTCSCHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc------------ccccHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 467999999999999999999999999999999985432 11223567789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQS----EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~----~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+.+++.+|+|||||. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 72 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 72 IHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp ECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred EEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEEC
Confidence 999999999999998 68998876543 2358999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++....... ......+||+.|
T Consensus 151 Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y 174 (317)
T 2pmi_A 151 DFGLARAFGIPV--------------------------------------------------------NTFSSEVVTLWY 174 (317)
T ss_dssp CCSSCEETTSCC--------------------------------------------------------CCCCCCCSCCTT
T ss_pred cCccceecCCCc--------------------------------------------------------ccCCCCcccccc
Confidence 999997653211 112234689999
Q ss_pred ccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC-------------------------
Q 014344 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP------------------------- 301 (426)
Q Consensus 251 ~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~------------------------- 301 (426)
+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. .+.
T Consensus 175 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (317)
T 2pmi_A 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDL 254 (317)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCS
T ss_pred cCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhH
Confidence 99999987 4689999999999999999999999999988777665531 110
Q ss_pred -------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhh
Q 014344 302 -------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 302 -------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
.....+..+.+||.+||+.||++|||++|+|+||||++..|...
T Consensus 255 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 255 RQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp HHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC---
T ss_pred HHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhh
Confidence 01134678999999999999999999999999999988766543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=398.75 Aligned_cols=263 Identities=28% Similarity=0.381 Sum_probs=214.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~ 87 (426)
..+..++|++++.||+|+||+||+|++..+++.||||++....... ........+.+|+.+++.+. |||
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~h~n 75 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG--------GGGGLPISTVREVALLRRLEAFEHPN 75 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT--------TSSCCCHHHHHHHHHHHHHHHHCCTT
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc--------cccccchhHHHHHHHHHHHhhcCCCC
Confidence 3455667999999999999999999999999999999985432111 11112235566777777664 999
Q ss_pred cceeeeeeecCC-----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec
Q 014344 88 LPRLRGVLSTDK-----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 88 iv~l~~~~~~~~-----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~ 162 (426)
|+++++++.... .+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 76 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~ 154 (308)
T 3g33_A 76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT 154 (308)
T ss_dssp BCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC
T ss_pred eEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 999999997765 5899999997 6999998876656699999999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.++.+||+|||++...... ....
T Consensus 155 ~~~~~kl~Dfg~a~~~~~~---------------------------------------------------------~~~~ 177 (308)
T 3g33_A 155 SGGTVKLADFGLARIYSYQ---------------------------------------------------------MALT 177 (308)
T ss_dssp TTSCEEECSCSCTTTSTTC---------------------------------------------------------CCSG
T ss_pred CCCCEEEeeCccccccCCC---------------------------------------------------------cccC
Confidence 9999999999998765321 1223
Q ss_pred ccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC-----------------
Q 014344 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD----------------- 302 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~----------------- 302 (426)
..+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+...++.. .++.
T Consensus 178 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (308)
T 3g33_A 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPR 257 (308)
T ss_dssp GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCC
T ss_pred CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCC
Confidence 45799999999999999999999999999999999999999999998877766642 1110
Q ss_pred --------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 --------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 --------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....+..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 258 GPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp CCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred CCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 1234678899999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=404.90 Aligned_cols=282 Identities=38% Similarity=0.692 Sum_probs=230.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 86 (426)
..+.+++|++++.||+|+||+||+|++. .+++.||||++.+...... ......+..|+.+|+.+ .||
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~~h~ 119 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK---------AKTTEHTRTERQVLEHIRQSP 119 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE---------ESSGGGCCCHHHHHHHHHTCT
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh---------hhHHHHHHHHHHHHHHccCCC
Confidence 4567789999999999999999999985 5899999999865432111 11223455699999999 699
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++..+..+|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 120 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 197 (355)
T 1vzo_A 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 197 (355)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred ceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc
Confidence 99999999999999999999999999999987653 4999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+++.+.... .......+|
T Consensus 198 ~kl~DfG~a~~~~~~~-------------------------------------------------------~~~~~~~~g 222 (355)
T 1vzo_A 198 VVLTDFGLSKEFVADE-------------------------------------------------------TERAYDFCG 222 (355)
T ss_dssp EEESCSSEEEECCGGG-------------------------------------------------------GGGGCGGGS
T ss_pred EEEeeCCCCeecccCC-------------------------------------------------------CCcccCccc
Confidence 9999999997653110 112335679
Q ss_pred CCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcC-CCCCCCCCHHHHHHHHHHhc
Q 014344 247 TEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILCR-PPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 247 t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~-~~~~~~~~~~~~~li~~~L~ 319 (426)
|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .......+... ++.....+..+.+||.+||.
T Consensus 223 t~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 302 (355)
T 1vzo_A 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLM 302 (355)
T ss_dssp CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhh
Confidence 999999999986 347899999999999999999999997543 33444444433 33344668889999999999
Q ss_pred cCCCCCC-----ChHHHhcCCCcCCCChhhhhhccCCCCCCCCC
Q 014344 320 KDPTKRI-----GVEEIKGHEFFKGVNWELLLKISRPPNIPARF 358 (426)
Q Consensus 320 ~dP~~R~-----s~~eil~hp~f~~~~~~~~~~~~~~~~~~~~~ 358 (426)
.||.+|| +++++++||||+.++|+.+.....|+...+..
T Consensus 303 ~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~ 346 (355)
T 1vzo_A 303 KDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 346 (355)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred hCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhccCCCCCCCcc
Confidence 9999999 99999999999999999987766555544443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=422.46 Aligned_cols=261 Identities=27% Similarity=0.399 Sum_probs=229.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+.+++|++++.||+|+||+||+|++..+|+.||||++.+...... .....+.+|+.+|+.++||||+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv 79 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL----------DVVGKIRREIQNLKLFRHPHII 79 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHT----------TTHHHHHHHHHHHTTCCCTTBC
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH----------HHHHHHHHHHHHHHhCCCCCCC
Confidence 456788999999999999999999999999999999999977544321 2346788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 80 ~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL 157 (476)
T 2y94_A 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKI 157 (476)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEEECCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEE
Confidence 9999999999999999999999999987643 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++...... ....+.+||+.
T Consensus 158 ~DFG~a~~~~~~---------------------------------------------------------~~~~~~~gt~~ 180 (476)
T 2y94_A 158 ADFGLSNMMSDG---------------------------------------------------------EFLRTSCGSPN 180 (476)
T ss_dssp CCCSSCEECCTT---------------------------------------------------------CCBCCCCSCST
T ss_pred Eeccchhhcccc---------------------------------------------------------ccccccCCCcC
Confidence 999999765321 12234579999
Q ss_pred CccchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 250 y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+....+.++....... ...++.+.+||.+||+.||.+|||
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt 260 (476)
T 2y94_A 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRAT 260 (476)
T ss_dssp TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcC
Confidence 999999998776 789999999999999999999999988888888877554333 345789999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
+++|++||||+.
T Consensus 261 ~~eil~hp~~~~ 272 (476)
T 2y94_A 261 IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHHTCHHHHT
T ss_pred HHHHHhCHHhhh
Confidence 999999999975
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=398.58 Aligned_cols=270 Identities=26% Similarity=0.441 Sum_probs=216.4
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhh-------------cccCCCchhhHHHHHH
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKE-------------LTNNDNGDKYRRISFE 76 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~E 76 (426)
...+.+++|++++.||+|+||+||+|++..+++.||||++.+......... ..........+.+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 345678899999999999999999999999999999999976543221100 0000111234678899
Q ss_pred HHHHHhcCCCCcceeeeeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 014344 77 QRVLRNVEHPLLPRLRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDL 154 (426)
Q Consensus 77 ~~il~~l~hp~iv~l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDl 154 (426)
+.+|+.++||||+++++++.+ ...+|+|||||++++|.++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999999999999999999986 678999999999999987643 345999999999999999999999999999999
Q ss_pred CCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 155 KPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSD 234 (426)
Q Consensus 155 Kp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (426)
||+|||++.++.+||+|||++..+....
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------------------------------------------------- 191 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD---------------------------------------------------- 191 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS----------------------------------------------------
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc----------------------------------------------------
Confidence 9999999999999999999997653211
Q ss_pred CCCCCCccccccCCCCccchhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCH
Q 014344 235 SDSSEKSNSFVGTEEYVAPEIIEGKG---HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPT 308 (426)
Q Consensus 235 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~ 308 (426)
......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+..... .....+.
T Consensus 192 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (298)
T 2zv2_A 192 ----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAE 267 (298)
T ss_dssp ----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCH
T ss_pred ----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCH
Confidence 1122346999999999998765 37899999999999999999999999887776666654332 2345688
Q ss_pred HHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 309 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
.+.+||.+||+.||++|||+.|+++||||+
T Consensus 268 ~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 268 DLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999999999999999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=419.26 Aligned_cols=289 Identities=24% Similarity=0.356 Sum_probs=204.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+.. ......+++.+|+.+|+.++||||+++++++
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 121 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-----------EDLIDCKRILREIAILNRLNHDHVVKVLDIV 121 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-----------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-----------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 67999999999999999999999999999999985431 1223456788999999999999999999999
Q ss_pred e-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 S-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 ~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
. ....+|+||||+ +++|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+
T Consensus 122 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~ 198 (458)
T 3rp9_A 122 IPKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVC 198 (458)
T ss_dssp CCSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred ecCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeec
Confidence 4 346799999998 58899887643 459999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+++................. ...... ................+||+.|
T Consensus 199 DFGla~~~~~~~~~~~~~~~~~~-----------------~~~~~~------------~~~~~~~~~~~~~~~~~gt~~Y 249 (458)
T 3rp9_A 199 DFGLARTVDYPENGNSQLPISPR-----------------EDDMNL------------VTFPHTKNLKRQLTGHVVTRWY 249 (458)
T ss_dssp CCTTCBCTTSCTTCCCCCC--------------------------------------------------------CCCTT
T ss_pred ccccchhccCccccccccccCcc-----------------cccccc------------ccccccccccccccCCcccccc
Confidence 99999876432211000000000 000000 0000000112345567899999
Q ss_pred ccchhh-cCCCCChhhHHHHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHH--
Q 014344 251 VAPEII-EGKGHDFAVDWWSLGVVLHEMLY-----------GATPFRGSSR--------------------KETFYRI-- 296 (426)
Q Consensus 251 ~aPE~~-~~~~~~~~~DiwSlG~il~ell~-----------g~~pf~~~~~--------------------~~~~~~i-- 296 (426)
+|||++ .+..|+.++|||||||++|||++ |+++|.+.+. ..++..+
T Consensus 250 ~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~ 329 (458)
T 3rp9_A 250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFN 329 (458)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHH
T ss_pred cChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHH
Confidence 999986 56679999999999999999998 7888877542 1122111
Q ss_pred -hcCCC-----------------------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhhh
Q 014344 297 -LCRPP-----------------------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 297 -~~~~~-----------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~ 346 (426)
+..++ .+...+..+.+||.+||+.||.+|||++|+|+||||++++|....
T Consensus 330 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 330 ILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVE 409 (458)
T ss_dssp HHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGC
T ss_pred HcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccC
Confidence 11110 123457889999999999999999999999999999999988764
Q ss_pred h
Q 014344 347 K 347 (426)
Q Consensus 347 ~ 347 (426)
.
T Consensus 410 ~ 410 (458)
T 3rp9_A 410 T 410 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=390.80 Aligned_cols=259 Identities=31% Similarity=0.507 Sum_probs=226.0
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.+.+++|++++.||+|+||+||+|.+..+++.||+|++.+...... .....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~ 73 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA----------GVEHQLRREVEIQSHLRHPNILR 73 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHH----------TCHHHHHHHHHHHTTCCCTTBCC
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchh----------hHHHHHHHHHHHHHcCCCCCCcc
Confidence 46788999999999999999999999999999999999977554332 12456888999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.+....|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 151 (279)
T 3fdn_A 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151 (279)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEEC
T ss_pred hhheEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEE
Confidence 9999999999999999999999999887653 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++...... .....+||+.|
T Consensus 152 Dfg~~~~~~~~----------------------------------------------------------~~~~~~~~~~y 173 (279)
T 3fdn_A 152 DFGWSVHAPSS----------------------------------------------------------RRTDLCGTLDY 173 (279)
T ss_dssp SCCEESCC------------------------------------------------------------------CCCCTT
T ss_pred eccccccCCcc----------------------------------------------------------cccccCCCCCc
Confidence 99988543211 12234689999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ...+..+.+||.+||..||.+|||++
T Consensus 174 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 253 (279)
T 3fdn_A 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLR 253 (279)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred cCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHH
Confidence 99999999999999999999999999999999999999888877776544333 34678899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
||++||||+.
T Consensus 254 e~l~h~~~~~ 263 (279)
T 3fdn_A 254 EVLEHPWITA 263 (279)
T ss_dssp HHHHCHHHHH
T ss_pred HHhhCccccC
Confidence 9999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-52 Score=397.90 Aligned_cols=265 Identities=28% Similarity=0.441 Sum_probs=229.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||+|++.+...... ........+.+|+.+|+.+.||||+++++++
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRAS-------RRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSC-------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccc-------ccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 469999999999999999999999999999999965432111 1112356788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC----cEEEec
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~D 171 (426)
.+...+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999999998653 4589999999999999999999999999999999999999888 899999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .....+||+.|+
T Consensus 163 fg~~~~~~~~~---------------------------------------------------------~~~~~~gt~~y~ 185 (321)
T 2a2a_A 163 FGLAHEIEDGV---------------------------------------------------------EFKNIFGTPEFV 185 (321)
T ss_dssp CTTCEECCTTC---------------------------------------------------------CCCCCCSCGGGC
T ss_pred CccceecCccc---------------------------------------------------------cccccCCCCCcc
Confidence 99987653211 122346999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ...+..+.+||.+||..||.+||
T Consensus 186 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 265 (321)
T 2a2a_A 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL 265 (321)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC
T ss_pred CcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCc
Confidence 9999999999999999999999999999999999998888877776543332 35678899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhh
Q 014344 327 GVEEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~ 346 (426)
|++|+++||||+.++|....
T Consensus 266 s~~e~l~hp~~~~~~~~~~~ 285 (321)
T 2a2a_A 266 TIQEALRHPWITPVDNQQAM 285 (321)
T ss_dssp CHHHHHHSTTTSCSSHHHHH
T ss_pred CHHHHhcCccccCCCccccc
Confidence 99999999999999887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-52 Score=396.15 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=214.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++..+++.||||++.... ......+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 70 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----------DDPVIKKIALREIRMLKQLKHPNLVNLLEV 70 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-----------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-----------cchHHHHHHHHHHHHHHhCCCCCccchhhe
Confidence 467999999999999999999999999999999984432 122345677889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+...+..++|||||++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 71 ~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 148 (311)
T 4agu_A 71 FRRKRRLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148 (311)
T ss_dssp EEETTEEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred eecCCeEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence 99999999999999999999886643 4499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......+||+.|+|||
T Consensus 149 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE 172 (311)
T 4agu_A 149 ARLLTGPS--------------------------------------------------------DYYDDEVATRWYRSPE 172 (311)
T ss_dssp CEECC--------------------------------------------------------------------GGGCCHH
T ss_pred chhccCcc--------------------------------------------------------cccCCCcCCccccChH
Confidence 97653211 1122346899999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------------CCC---------
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----------------------PPD--------- 302 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------~~~--------- 302 (426)
++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+... .+.
T Consensus 173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 4agu_A 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252 (311)
T ss_dssp HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHH
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhh
Confidence 9986 66899999999999999999999999998877665443210 000
Q ss_pred -CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 303 -LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 303 -~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
....+..+.+||.+||..||.+|||++|+++||||+++.+..
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred hcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 124577899999999999999999999999999999887654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=421.36 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=208.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++.+... .....+++.+|+.+|+.++||||++++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 129 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIISLLNV 129 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-----------SHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-----------ChHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4689999999999999999999999999999999965421 12345678899999999999999999999
Q ss_pred eecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
|... ..+|+|||||.++ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 130 ~~~~~~~~~~~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~k 204 (464)
T 3ttj_A 130 FTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204 (464)
T ss_dssp ECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEE
T ss_pred EccCCccccCCeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEE
Confidence 9654 4679999999754 555543 2399999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++..... ......+||+
T Consensus 205 l~DFG~a~~~~~~---------------------------------------------------------~~~~~~~gt~ 227 (464)
T 3ttj_A 205 ILDFGLARTAGTS---------------------------------------------------------FMMTPYVVTR 227 (464)
T ss_dssp ECCCCCC-----C---------------------------------------------------------CCC----CCC
T ss_pred EEEEEeeeecCCC---------------------------------------------------------cccCCCcccc
Confidence 9999999765321 1234467999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-------------------CCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-------------------PDLVGE 306 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------------~~~~~~ 306 (426)
.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+++.+++.. + +.....
T Consensus 228 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (464)
T 3ttj_A 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 307 (464)
T ss_dssp TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCC
T ss_pred cccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCC
Confidence 999999999999999999999999999999999999999887777665421 0 000000
Q ss_pred ---------------------CHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 307 ---------------------PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 307 ---------------------~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
++.+++||.+||++||.+|||++|+|+||||+.
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 308 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp CHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred ChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 345899999999999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-52 Score=408.87 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=222.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+|+.++||||++++++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-------------~~~~~~~~E~~il~~l~hpnIv~~~~~ 116 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-------------LDKYTVKNEISIMNQLHHPKLINLHDA 116 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------------HHHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-------------hhHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 4579999999999999999999999999999999854321 123467889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--CCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--NGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--~g~ikL~DF 172 (426)
+.+...+|+|||||.||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+||
T Consensus 117 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DF 195 (387)
T 1kob_A 117 FEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 195 (387)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEec
Confidence 999999999999999999999876432 35999999999999999999999999999999999999974 478999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+... ......+||+.|+|
T Consensus 196 G~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 218 (387)
T 1kob_A 196 GLATKLNPD---------------------------------------------------------EIVKVTTATAEFAA 218 (387)
T ss_dssp TTCEECCTT---------------------------------------------------------SCEEEECSSGGGCC
T ss_pred ccceecCCC---------------------------------------------------------cceeeeccCCCccC
Confidence 999865321 11233469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+.... ......+..+.+||.+||+.||.+|||
T Consensus 219 PE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 298 (387)
T 1kob_A 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 298 (387)
T ss_dssp HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred chhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999999999999999999999999999998888777765432 222356889999999999999999999
Q ss_pred hHHHhcCCCcCCCC
Q 014344 328 VEEIKGHEFFKGVN 341 (426)
Q Consensus 328 ~~eil~hp~f~~~~ 341 (426)
+.++|+||||++..
T Consensus 299 ~~ell~hp~~~~~~ 312 (387)
T 1kob_A 299 VHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHHTSTTTSSCC
T ss_pred HHHHhhCccccCCc
Confidence 99999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-52 Score=404.78 Aligned_cols=254 Identities=32% Similarity=0.473 Sum_probs=207.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...++|++++.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.+++.++||||++++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~~~ 82 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA--------------AIDENVQREIINHRSLRHPNIVRFK 82 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST--------------TSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc--------------cccHHHHHHHHHHHhCCCCCCCcEE
Confidence 45678999999999999999999999999999999985432 1124577899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc--EEEe
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH--IMLV 170 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~--ikL~ 170 (426)
+++.+.+.+|+|||||.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~ 160 (361)
T 3uc3_A 83 EVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160 (361)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred EEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEe
Confidence 99999999999999999999999887643 4999999999999999999999999999999999999987765 9999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+++..... ......+||+.|
T Consensus 161 Dfg~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y 183 (361)
T 3uc3_A 161 DFGYSKSSVLH---------------------------------------------------------SQPKSTVGTPAY 183 (361)
T ss_dssp CCCCC------------------------------------------------------------------------CTT
T ss_pred ecCcccccccc---------------------------------------------------------CCCCCCcCCCCc
Confidence 99998743211 122344699999
Q ss_pred ccchhhcCCCCChh-hHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCC
Q 014344 251 VAPEIIEGKGHDFA-VDWWSLGVVLHEMLYGATPFRGSSR----KETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 251 ~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP 322 (426)
+|||++.+..++.+ +|||||||++|+|++|+.||.+... ......+.... +.....+..+.+||.+||+.||
T Consensus 184 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP 263 (361)
T 3uc3_A 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADP 263 (361)
T ss_dssp SCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCT
T ss_pred CChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCCh
Confidence 99999998887655 8999999999999999999987543 34444444333 2233468899999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
.+|||+.||++||||..
T Consensus 264 ~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 264 ATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TTSCCHHHHHTSHHHHT
T ss_pred hHCcCHHHHHhCcchhc
Confidence 99999999999999953
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=402.05 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=224.0
Q ss_pred CcEEE-eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeee
Q 014344 17 CLRIV-SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGV 94 (426)
Q Consensus 17 ~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~ 94 (426)
.|.+. +.||+|+||+||+|++..+++.||+|++.+... .......+.+|+.+++.+. ||||++++++
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-----------GQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-----------TEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-----------chHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 47777 899999999999999999999999999865321 1123467888999999995 6999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g~ikL~D 171 (426)
+.+...+|+|||||.||+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999999999876555567999999999999999999999999999999999999997 78999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .....+||+.|+
T Consensus 178 fg~a~~~~~~~---------------------------------------------------------~~~~~~gt~~y~ 200 (327)
T 3lm5_A 178 FGMSRKIGHAC---------------------------------------------------------ELREIMGTPEYL 200 (327)
T ss_dssp GGGCEEC------------------------------------------------------------------CCCGGGC
T ss_pred CccccccCCcc---------------------------------------------------------ccccccCCcCcc
Confidence 99998653211 122346999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-----PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ......+..+.+||.+||+.||.+||
T Consensus 201 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 280 (327)
T 3lm5_A 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280 (327)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred CCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc
Confidence 9999999999999999999999999999999999998888777665322 22335678899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhhh
Q 014344 327 GVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~~ 347 (426)
|++++|+||||++.+|+.+..
T Consensus 281 t~~~ll~h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 281 TAEICLSHSWLQQWDFENLFH 301 (327)
T ss_dssp CHHHHTTCGGGCCCCTTCC--
T ss_pred CHHHHhCCHhhcccccccccC
Confidence 999999999999999987644
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=403.05 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=215.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+++.++||||++++++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~~~ 73 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------------DCPENIKKEICINKMLNHENVVKFYGH 73 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc------------chHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999999999999999998543211 123467789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+++..|+|||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 74 RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EECSSEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCeEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999999999987543 3499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+.... ........+||+.|+|||
T Consensus 152 a~~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 152 ATVFRYNN------------------------------------------------------RERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp CEECEETT------------------------------------------------------EECCBCSCCSCGGGSCHH
T ss_pred cceeccCC------------------------------------------------------cccccCCCccCcCccCcH
Confidence 97653111 011233457999999999
Q ss_pred hhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKET-FYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 255 ~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
++.+..+ +.++|||||||++|+|++|+.||...+.... +....... ......+..+.+||.+||+.||++|||++
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 257 (323)
T 3tki_A 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 257 (323)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHH
Confidence 9988775 7899999999999999999999987665322 22222221 22234678899999999999999999999
Q ss_pred HHhcCCCcCCC
Q 014344 330 EIKGHEFFKGV 340 (426)
Q Consensus 330 eil~hp~f~~~ 340 (426)
|+++||||+..
T Consensus 258 eil~h~~~~~~ 268 (323)
T 3tki_A 258 DIKKDRWYNKP 268 (323)
T ss_dssp HHTTCTTTTCC
T ss_pred HHhhChhhccc
Confidence 99999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=402.55 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=215.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-----CCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-----HPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-----hp~ 87 (426)
+-.++|+++++||+|+||+||+|++..+++.||||++.... .....+..|+.+++.+. |||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--------------KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH--------------HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch--------------hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 33467999999999999999999999999999999985321 23345677999999986 999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc----
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---- 163 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---- 163 (426)
|+++++++...+.+|+||||| |++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 899999988776667999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCC
Q 014344 164 ---------------------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHS 222 (426)
Q Consensus 164 ---------------------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (426)
++.+||+|||++.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~------------------------------------------ 214 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD------------------------------------------ 214 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS------------------------------------------
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC------------------------------------------
Confidence 78999999999875421
Q ss_pred CCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Q 014344 223 PRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD 302 (426)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 302 (426)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 215 -----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 277 (360)
T 3llt_A 215 -----------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQP 277 (360)
T ss_dssp -----------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCC
T ss_pred -----------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCC
Confidence 112346999999999999999999999999999999999999999988877665544311100
Q ss_pred CC-----------------------------------------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 303 LV-----------------------------------------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 303 ~~-----------------------------------------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
.+ ..+..+.+||.+||+.||++|||++|+|+||
T Consensus 278 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp 357 (360)
T 3llt_A 278 IPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357 (360)
T ss_dssp CCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred CCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCc
Confidence 00 1125677999999999999999999999999
Q ss_pred CcC
Q 014344 336 FFK 338 (426)
Q Consensus 336 ~f~ 338 (426)
||+
T Consensus 358 ~f~ 360 (360)
T 3llt_A 358 FLE 360 (360)
T ss_dssp GGC
T ss_pred ccC
Confidence 995
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=387.06 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=223.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+++.++||||++++++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-----------ARDFQKLEREARICRKLQHPNIVRLHDS 73 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-----------HHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 35699999999999999999999999999999999654321 2245678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---EEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---ikL~D 171 (426)
+..+...|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 74 ~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~D 151 (284)
T 3kk8_A 74 IQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 151 (284)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEee
Confidence 99999999999999999999887665 34999999999999999999999999999999999999987655 99999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++...... .......||+.|+
T Consensus 152 fg~~~~~~~~---------------------------------------------------------~~~~~~~~~~~y~ 174 (284)
T 3kk8_A 152 FGLAIEVNDS---------------------------------------------------------EAWHGFAGTPGYL 174 (284)
T ss_dssp CTTCEECCSS---------------------------------------------------------CBCCCSCSCGGGC
T ss_pred ceeeEEcccC---------------------------------------------------------ccccCCCCCcCCc
Confidence 9998765321 1122346999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..... .....++.+.+||.+||+.||++||
T Consensus 175 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 254 (284)
T 3kk8_A 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254 (284)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCC
Confidence 99999999999999999999999999999999999988877777654322 2235688999999999999999999
Q ss_pred ChHHHhcCCCcCCCCh
Q 014344 327 GVEEIKGHEFFKGVNW 342 (426)
Q Consensus 327 s~~eil~hp~f~~~~~ 342 (426)
|++|+++||||+...+
T Consensus 255 s~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 255 TADQALKVPWICNRER 270 (284)
T ss_dssp CHHHHTTSHHHHSCCC
T ss_pred CHHHHhcCccccCChh
Confidence 9999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=404.63 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=215.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. .....|+.+|.++ +||||+++++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-----------------~~~~~E~~~l~~~~~hp~iv~~~~ 83 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-----------------RDPTEEIEILLRYGQHPNIITLKD 83 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-----------------CCCHHHHHHHHHHTTSTTBCCEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-----------------CChHHHHHHHHHhcCCCCcCeEEE
Confidence 346999999999999999999999999999999995432 1223588888887 7999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC----CcEEE
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN----GHIML 169 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~----g~ikL 169 (426)
++.+...+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+... +.+||
T Consensus 84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 84 VYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence 999999999999999999999987654 459999999999999999999999999999999999998543 35999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ....+.+||+.
T Consensus 162 ~Dfg~a~~~~~~~--------------------------------------------------------~~~~~~~gt~~ 185 (342)
T 2qr7_A 162 CDFGFAKQLRAEN--------------------------------------------------------GLLMTPCYTAN 185 (342)
T ss_dssp CCCTTCEECBCTT--------------------------------------------------------CCBCCSSCCSS
T ss_pred EECCCcccCcCCC--------------------------------------------------------CceeccCCCcc
Confidence 9999998653211 12334579999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRG---SSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~---~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~d 321 (426)
|+|||++.+..|+.++|||||||++|+|++|..||.+ .+..+.+..+...... +...+..+.+||++||..|
T Consensus 186 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 265 (342)
T 2qr7_A 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVD 265 (342)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSS
T ss_pred ccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCC
Confidence 9999999988899999999999999999999999986 3455666666543322 2356889999999999999
Q ss_pred CCCCCChHHHhcCCCcCCCChhhh
Q 014344 322 PTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 322 P~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
|.+|||+.++++||||. +|+.+
T Consensus 266 P~~R~t~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 266 PHQRLTAALVLRHPWIV--HWDQL 287 (342)
T ss_dssp TTTSCCHHHHTTSHHHH--TGGGS
T ss_pred hhHCcCHHHHhcCCeec--Ccccc
Confidence 99999999999999995 46654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=388.62 Aligned_cols=265 Identities=28% Similarity=0.489 Sum_probs=227.9
Q ss_pred CCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 5 VNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 5 ~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
+.+.+.+.+.+++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+++.++
T Consensus 3 l~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~ 72 (284)
T 2vgo_A 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKE----------GVEHQLRREIEIQSHLR 72 (284)
T ss_dssp -------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCC
T ss_pred hhhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchH----------HHHHHHHHHHHHHhcCC
Confidence 34567788999999999999999999999999999999999999976544322 12356888999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
||||+++++++.+.+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 73 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 150 (284)
T 2vgo_A 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK 150 (284)
T ss_dssp CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT
T ss_pred CCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC
Confidence 9999999999999999999999999999999887653 49999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++...... .....
T Consensus 151 ~~~kl~Dfg~~~~~~~~----------------------------------------------------------~~~~~ 172 (284)
T 2vgo_A 151 GELKIADFGWSVHAPSL----------------------------------------------------------RRRTM 172 (284)
T ss_dssp CCEEECCCTTCEECSSS----------------------------------------------------------CBCCC
T ss_pred CCEEEecccccccCccc----------------------------------------------------------ccccc
Confidence 99999999998654211 12234
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~ 323 (426)
+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....... ...+..+.+||.+||..||.
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 252 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPP 252 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGG
T ss_pred cCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHh
Confidence 68999999999999999999999999999999999999999988888777776543332 34688999999999999999
Q ss_pred CCCChHHHhcCCCcCC
Q 014344 324 KRIGVEEIKGHEFFKG 339 (426)
Q Consensus 324 ~R~s~~eil~hp~f~~ 339 (426)
+|||++++++||||+.
T Consensus 253 ~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 253 QRLPLKGVMEHPWVKA 268 (284)
T ss_dssp GSCCHHHHHTCHHHHH
T ss_pred hCCCHHHHhhCHHHHh
Confidence 9999999999999963
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=410.88 Aligned_cols=285 Identities=24% Similarity=0.390 Sum_probs=213.3
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++.+.. ......+++.+|+.+|+.++||||++++++
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-----------EDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-----------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-----------cChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 357999999999999999999999999999999995421 122345688899999999999999999999
Q ss_pred eecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 95 LSTD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 95 ~~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+... ..+|+|||||. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEE
Confidence 9766 67999999996 6999987653 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++................ ..................+||+.
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~~~~~~gt~~ 216 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEE----------------------------------NEEPGPHNKNLKKQLTSHVVTRW 216 (432)
T ss_dssp CCCTTCEEC-----------------------------------------------------------------CCCCCT
T ss_pred ccCCCcccccccccccccccccc----------------------------------cccccccccchhccccCCCCCcc
Confidence 99999987643221100000000 00000000011124567789999
Q ss_pred Cccchhh-cCCCCChhhHHHHHHHHHHHHHh-----------CCCCCCCCCH-----------------HHHHHHH---h
Q 014344 250 YVAPEII-EGKGHDFAVDWWSLGVVLHEMLY-----------GATPFRGSSR-----------------KETFYRI---L 297 (426)
Q Consensus 250 y~aPE~~-~~~~~~~~~DiwSlG~il~ell~-----------g~~pf~~~~~-----------------~~~~~~i---~ 297 (426)
|+|||++ .+..|+.++|||||||++|||++ |.++|.+.+. ..++..+ +
T Consensus 217 Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~ 296 (432)
T 3n9x_A 217 YRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNII 296 (432)
T ss_dssp TCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHH
T ss_pred ccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhc
Confidence 9999986 56679999999999999999998 5555555431 1122111 1
Q ss_pred cCCC-----------------------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhhhh
Q 014344 298 CRPP-----------------------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 298 ~~~~-----------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
..++ .....++.+.+||.+||+.||.+|||++|+|+||||++++|.....
T Consensus 297 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 297 GTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC-
T ss_pred CCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCc
Confidence 1110 0134688899999999999999999999999999999998876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=404.20 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=211.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+++.+|+.+|+.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 92 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-----------QSELFAKRAYRELRLLKHMRHENVIGLLDV 92 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-----------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-----------cCHHHHHHHHHHHHHHHhCCCcCCCCceee
Confidence 367999999999999999999999999999999985432 122345678899999999999999999999
Q ss_pred eecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+.... .+|+||||+ |++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 93 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred EecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEE
Confidence 97663 469999999 8999998875 3499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.... .....+||+
T Consensus 169 l~Dfg~a~~~~~-----------------------------------------------------------~~~~~~~t~ 189 (367)
T 1cm8_A 169 ILDFGLARQADS-----------------------------------------------------------EMTGYVVTR 189 (367)
T ss_dssp ECCCTTCEECCS-----------------------------------------------------------SCCSSCSCG
T ss_pred EEeeeccccccc-----------------------------------------------------------ccCcCcCCC
Confidence 999999876421 123356899
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC------------------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP------------------------ 300 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~------------------------ 300 (426)
.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+...++..+.. .+
T Consensus 190 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 1cm8_A 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269 (367)
T ss_dssp GGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC
T ss_pred CcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCC
Confidence 9999999987 7799999999999999999999999999988776665531 11
Q ss_pred -----CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 301 -----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 301 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
..+...++.+.+||.+||+.||.+|||++|+|+||||+...+.
T Consensus 270 ~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 0123457889999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=397.82 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=210.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++..+++.||||++....... ....+.+|+.+|+.++||||++++++
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------~~~~~~~E~~~l~~l~h~~iv~~~~~ 68 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG------------APCTAIREVSLLKDLKHANIVTLHDI 68 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------------CCCCCCCHHHHSCCCCTTBCCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc------------cchhHHHHHHHHHhcCCCCCCeeeeE
Confidence 468999999999999999999999999999999985432111 11123458999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+++.+|+|||||. ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 69 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 146 (324)
T 3mtl_A 69 IHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146 (324)
T ss_dssp EECSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSE
T ss_pred EeeCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcc
Confidence 999999999999997 68888876653 4599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......+||+.|+|||
T Consensus 147 a~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 147 ARAKSIPT--------------------------------------------------------KTYDNEVVTLWYRPPD 170 (324)
T ss_dssp EECC--------------------------------------------------------------------CGGGCCHH
T ss_pred cccccCCc--------------------------------------------------------cccccccCcccccChh
Confidence 87543111 1123346899999999
Q ss_pred hhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC----------------------------
Q 014344 255 IIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD---------------------------- 302 (426)
Q Consensus 255 ~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~---------------------------- 302 (426)
++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. .+..
T Consensus 171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (324)
T 3mtl_A 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250 (324)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH
T ss_pred hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh
Confidence 9987 6689999999999999999999999999988776655532 1110
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
....+..+.+||.+||+.||.+|||++|+|+||||+++..
T Consensus 251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 1134677899999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=417.29 Aligned_cols=266 Identities=27% Similarity=0.389 Sum_probs=220.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|+++.+++.||||++.+...................+.+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46799999999999999999999999999999999765543211000011112345678899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC---cEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG---HIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g---~ikL~D 171 (426)
+.+...+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 999999999999999999999877653 499999999999999999999999999999999999999876 699999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+... ......+||+.|+
T Consensus 193 fg~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 215 (504)
T 3q5i_A 193 FGLSSFFSKD---------------------------------------------------------YKLRDRLGTAYYI 215 (504)
T ss_dssp CTTCEECCTT---------------------------------------------------------SCBCCCCSCTTTC
T ss_pred CCCCEEcCCC---------------------------------------------------------CccccccCCcCCC
Confidence 9999765321 1223456999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+....... ...+..+++||++||++||.+||
T Consensus 216 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 294 (504)
T 3q5i_A 216 APEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC 294 (504)
T ss_dssp CHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred CHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC
Confidence 9999875 58999999999999999999999999999988888877554332 35688999999999999999999
Q ss_pred ChHHHhcCCCcCCC
Q 014344 327 GVEEIKGHEFFKGV 340 (426)
Q Consensus 327 s~~eil~hp~f~~~ 340 (426)
|++|+|+||||+..
T Consensus 295 t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 295 TAEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHHTSHHHHHT
T ss_pred CHHHHhcCHhhhhc
Confidence 99999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=401.21 Aligned_cols=267 Identities=27% Similarity=0.430 Sum_probs=221.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+++.||+|++.+...... .....+.+.+|+.+|+.++||||+++++++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI--------NPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC-----------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc--------CHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 469999999999999999999999999999999977654321 123457889999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhc--------------------------------------cCCCCHHHHHHHHHHH
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQS--------------------------------------EQMFSDDTIRFYAAEL 137 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------------------------------~~~l~~~~~~~~~~qi 137 (426)
.+.+..|+|||||+||+|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999999999998864110 1124678899999999
Q ss_pred HHHHHHHHHCCCcccCCCCCCeeeccCC--cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCC
Q 014344 138 VLALEYLHNMGIVYRDLKPENIMIQENG--HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGIS 215 (426)
Q Consensus 138 l~aL~~LH~~giiHrDlKp~NiLl~~~g--~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (426)
+.||+|||++||+||||||+|||++.++ .+||+|||++..+.....
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------- 225 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN-------------------------------- 225 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC--------------------------------
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc--------------------------------
Confidence 9999999999999999999999998776 899999999976532110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 014344 216 LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF 293 (426)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 293 (426)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..
T Consensus 226 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 285 (345)
T 3hko_A 226 --------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI 285 (345)
T ss_dssp --------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred --------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH
Confidence 00112234569999999999976 67899999999999999999999999999988888
Q ss_pred HHHhcCCCCCC-----CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 294 YRILCRPPDLV-----GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 294 ~~i~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
..++....... ..+..+.+||.+||+.||.+|||+.++|+||||++..|
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 286 SQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 87765543322 35788999999999999999999999999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=416.20 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=220.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+.+|+.++||||+++++++
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~ 90 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-----------KDTSTILREVELLKKLDHPNIMKLFEIL 90 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-----------SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-----------hHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 46999999999999999999999999999999996643211 1346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec---cCCcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~---~~g~ikL~DF 172 (426)
.+...+|+|||||.|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 91 EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 99999999999999999999876653 499999999999999999999999999999999999995 4568999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+... ......+||+.|+|
T Consensus 169 g~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 191 (486)
T 3mwu_A 169 GLSTCFQQN---------------------------------------------------------TKMKDRIGTAYYIA 191 (486)
T ss_dssp SCTTTBCCC-------------------------------------------------------------CCTTGGGGCC
T ss_pred CcCeECCCC---------------------------------------------------------CccCCCcCCCCCCC
Confidence 999765321 11234469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...... +...+..+++||.+||+.||.+|||
T Consensus 192 PE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t 270 (486)
T 3mwu_A 192 PEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270 (486)
T ss_dssp GGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC
Confidence 999987 4999999999999999999999999999988888877654322 2345788999999999999999999
Q ss_pred hHHHhcCCCcCCC
Q 014344 328 VEEIKGHEFFKGV 340 (426)
Q Consensus 328 ~~eil~hp~f~~~ 340 (426)
+.++|+||||+..
T Consensus 271 ~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 271 ATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHHHCHHHHHT
T ss_pred HHHHhcCHhhccC
Confidence 9999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=391.73 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=219.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|...+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-------------QQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------------CCSHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-------------hhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 4888999999999999999999999999999985421 123456788999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
..+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 113 ~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 113 VGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189 (321)
T ss_dssp ETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeee
Confidence 99999999999999999998753 349999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
...... ......+||+.|+|||++
T Consensus 190 ~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 190 QISKDV--------------------------------------------------------PKRKSLVGTPYWMAPEVI 213 (321)
T ss_dssp ECCSSS--------------------------------------------------------CCBCCCCSCGGGCCHHHH
T ss_pred ecccCc--------------------------------------------------------cccccccCCccccCHhhh
Confidence 653211 112345799999999999
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
.+..++.++|||||||++|+|++|+.||.+.+..+....+....+.. ...+..+.+||.+||+.||++|||+++++
T Consensus 214 ~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp TTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 99999999999999999999999999999988887777665443322 23578899999999999999999999999
Q ss_pred cCCCcCCC
Q 014344 333 GHEFFKGV 340 (426)
Q Consensus 333 ~hp~f~~~ 340 (426)
+||||...
T Consensus 294 ~hp~~~~~ 301 (321)
T 2c30_A 294 DHPFLLQT 301 (321)
T ss_dssp TSGGGGGC
T ss_pred cChhhccC
Confidence 99999753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=384.15 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=215.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||+||+|++..+++.+|+|++.+... ....+.+..|+.+|+.++||||+++++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 89 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS------------QVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC------------CSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc------------chhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence 579999999999999999999999999999999865421 12346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEe
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLV 170 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~ 170 (426)
.+....|+|||||+|++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~ 169 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKII 169 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence 9999999999999999999887543 23569999999999999999999999999999999999999 456889999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++..+... ......+||+.|
T Consensus 170 Dfg~a~~~~~~---------------------------------------------------------~~~~~~~~t~~y 192 (285)
T 3is5_A 170 DFGLAELFKSD---------------------------------------------------------EHSTNAAGTALY 192 (285)
T ss_dssp CCCCCCC-------------------------------------------------------------------CTTGGG
T ss_pred eeecceecCCc---------------------------------------------------------ccCcCcccccCc
Confidence 99998765321 112334699999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
+|||++. ..++.++|||||||++|+|++|+.||.+.+..+....+....+.. ...++.+.+||.+||+.||++||
T Consensus 193 ~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 271 (285)
T 3is5_A 193 MAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP 271 (285)
T ss_dssp CCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSC
T ss_pred CChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCc
Confidence 9999986 468999999999999999999999999988877766665433222 23578899999999999999999
Q ss_pred ChHHHhcCCCcCC
Q 014344 327 GVEEIKGHEFFKG 339 (426)
Q Consensus 327 s~~eil~hp~f~~ 339 (426)
|+.|+|+||||+.
T Consensus 272 s~~e~l~hp~f~~ 284 (285)
T 3is5_A 272 SAAQVLHHEWFKQ 284 (285)
T ss_dssp CHHHHHTSGGGGC
T ss_pred CHHHHhcCHHhhc
Confidence 9999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=394.27 Aligned_cols=250 Identities=27% Similarity=0.454 Sum_probs=195.9
Q ss_pred CCcEEE---eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 16 SCLRIV---SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 16 ~~y~i~---~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
.+|++. +.||+|+||+||+|++..+++.||||++.+. ....+.+|+.+++.+. ||||+++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~e~~~l~~l~~h~niv~~ 71 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----------------MEANTQKEITALKLCEGHPNIVKL 71 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----------------GHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----------------hhhhHHHHHHHHHHhcCCCCeeEE
Confidence 457775 7899999999999999999999999998543 2245667999999997 9999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC---cEE
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG---HIM 168 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g---~ik 168 (426)
++++.++...|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~k 149 (325)
T 3kn6_A 72 HEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIK 149 (325)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEE
T ss_pred EEEEEcCCEEEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEE
Confidence 99999999999999999999999998764 4599999999999999999999999999999999999998766 899
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... ......+||+
T Consensus 150 l~Dfg~a~~~~~~~--------------------------------------------------------~~~~~~~~t~ 173 (325)
T 3kn6_A 150 IIDFGFARLKPPDN--------------------------------------------------------QPLKTPCFTL 173 (325)
T ss_dssp ECCCTTCEECCC--------------------------------------------------------------------
T ss_pred EeccccceecCCCC--------------------------------------------------------CcccccCCCc
Confidence 99999997653211 1223456899
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCC-----CCCHHHHHHHHH
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-------KETFYRILCRPPDLV-----GEPTPLRNLIRR 316 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~~-----~~~~~~~~li~~ 316 (426)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+....+........ ..+..+++||.+
T Consensus 174 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 253 (325)
T 3kn6_A 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253 (325)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHH
T ss_pred CccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999987543 345555554433322 457889999999
Q ss_pred HhccCCCCCCChHHHhcCCCcCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
||+.||.+|||++++++||||++
T Consensus 254 ~L~~dP~~Rpt~~ell~h~w~~~ 276 (325)
T 3kn6_A 254 LLTVDPNKRLKMSGLRYNEWLQD 276 (325)
T ss_dssp HHCCCTTTCCCTTTSTTCGGGCT
T ss_pred HCCCChhHCCCHHHHhcChhhcc
Confidence 99999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=399.21 Aligned_cols=252 Identities=28% Similarity=0.458 Sum_probs=204.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++.+.||+|+||+||+|++..+++.||||++.+.. ..+.+.+|+.+|+.++||||++++++
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~~~~~ 116 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---------------DKKIVRTEIGVLLRLSHPNIIKLKEI 116 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------CHHHHHCCCTTBCCEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---------------hHHHHHHHHHHHHhCCCCCCcceeee
Confidence 356999999999999999999999999999999985432 12356679999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g~ikL~D 171 (426)
+.+...+|+||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 117 FETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred EecCCeEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999999999987653 45999999999999999999999999999999999999975 88999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++...... ......+||+.|+
T Consensus 195 fg~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 217 (349)
T 2w4o_A 195 FGLSKIVEHQ---------------------------------------------------------VLMKTVCGTPGYC 217 (349)
T ss_dssp CC-------------------------------------------------------------------------CGGGS
T ss_pred CccccccCcc---------------------------------------------------------cccccccCCCCcc
Confidence 9998764311 1123456999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE-TFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
|||++.+..++.++|||||||++|+|++|..||....... .+..+..... .....+..+.+||.+||+.||++|
T Consensus 218 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (349)
T 2w4o_A 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297 (349)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999999999998766544 4555554322 223568899999999999999999
Q ss_pred CChHHHhcCCCcCCC
Q 014344 326 IGVEEIKGHEFFKGV 340 (426)
Q Consensus 326 ~s~~eil~hp~f~~~ 340 (426)
||+.++|+||||++.
T Consensus 298 pt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 298 LTTFQALQHPWVTGK 312 (349)
T ss_dssp CCHHHHHHSTTTTST
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=403.62 Aligned_cols=255 Identities=25% Similarity=0.396 Sum_probs=216.3
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
..+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 159 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-------------KDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH-------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 36789999999999999999999999999854321 23457888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee--ccCCcEEEeccccccc
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI--QENGHIMLVDFDLSTK 177 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl--~~~g~ikL~DFgls~~ 177 (426)
.+|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 160 ~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 160 DIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 9999999999999998876543 349999999999999999999999999999999999999 5667999999999986
Q ss_pred CCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhc
Q 014344 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257 (426)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 257 (426)
+.... .....+||+.|+|||++.
T Consensus 239 ~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE~~~ 261 (373)
T 2x4f_A 239 YKPRE---------------------------------------------------------KLKVNFGTPEFLAPEVVN 261 (373)
T ss_dssp CCTTC---------------------------------------------------------BCCCCCSSCTTCCHHHHT
T ss_pred cCCcc---------------------------------------------------------ccccccCCCcEeChhhcc
Confidence 53211 122346999999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 258 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
+..++.++|||||||++|+|++|+.||.+.+..+.+..++..... ....+..+.+||.+||+.||.+|||+.|+|
T Consensus 262 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 262 YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 999999999999999999999999999999988888887654322 235688999999999999999999999999
Q ss_pred cCCCcCCCChhhh
Q 014344 333 GHEFFKGVNWELL 345 (426)
Q Consensus 333 ~hp~f~~~~~~~~ 345 (426)
+||||++..|...
T Consensus 342 ~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 342 KHPWLSDHKLHSR 354 (373)
T ss_dssp HSHHHHCHHHHHH
T ss_pred cCcCcCCCchhhh
Confidence 9999998765543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=385.48 Aligned_cols=259 Identities=24% Similarity=0.473 Sum_probs=199.8
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|++++.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+++.++||||+++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~ 78 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKA----------GMVQRVQNEVKIHCQLKHPSILELYN 78 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTBCCTTBCCEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhh----------hHHHHHHHHHHHHHhCCCCCeEeEEE
Confidence 45789999999999999999999999999999999976543221 23467888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.+.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg 157 (278)
T 3cok_A 79 YFEDSNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFG 157 (278)
T ss_dssp EEECSSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred EEccCCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence 999999999999999999999988754 3459999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++....... ......+||+.|+||
T Consensus 158 ~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aP 181 (278)
T 3cok_A 158 LATQLKMPH--------------------------------------------------------EKHYTLCGTPNYISP 181 (278)
T ss_dssp TCEECC--------------------------------------------------------------------------
T ss_pred ceeeccCCC--------------------------------------------------------CcceeccCCCCcCCc
Confidence 987653211 112234689999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCHHHHHHHHHHhccCCCCCCChHHHh
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIK 332 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~s~~eil 332 (426)
|++.+..++.++|||||||++|+|++|+.||...+.......+..... .....+..+.+||.+||..||++|||+++++
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp ----------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 999999999999999999999999999999988776555555443322 2234578899999999999999999999999
Q ss_pred cCCCcCC
Q 014344 333 GHEFFKG 339 (426)
Q Consensus 333 ~hp~f~~ 339 (426)
+||||..
T Consensus 262 ~h~~~~~ 268 (278)
T 3cok_A 262 DHPFMSR 268 (278)
T ss_dssp TSTTTC-
T ss_pred cCccccC
Confidence 9999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=390.46 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=208.9
Q ss_pred CCcEEE-eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 16 SCLRIV-SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
+.|++. +.||+|+||+||+|++..+++.||||++.+.. ......+.+|+.+|.++ +||||+++++
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~~~~h~~i~~~~~ 78 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-------------GHIRSRVFREVEMLYQCQGHRNVLELIE 78 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-------------SCCHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-------------chhHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 569996 78999999999999999999999999985421 12346788899999985 7999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---EEEe
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IMLV 170 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---ikL~ 170 (426)
++.+++.+|+|||||+|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 79 FFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 9999999999999999999999987653 4999999999999999999999999999999999999998776 9999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........... .........+||+.|
T Consensus 157 Dfg~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~gt~~y 187 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSP-------------------------------------------------ISTPELLTPCGSAEY 187 (316)
T ss_dssp CTTCCC--------------------------------------------------------------------CCSGGG
T ss_pred EccCccccccCCcccc-------------------------------------------------ccccccccccCCcCc
Confidence 9999876532110000 001122345699999
Q ss_pred ccchhhcC-----CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHhcCCCCC-----CC
Q 014344 251 VAPEIIEG-----KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---------------KETFYRILCRPPDL-----VG 305 (426)
Q Consensus 251 ~aPE~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------------~~~~~~i~~~~~~~-----~~ 305 (426)
+|||++.+ ..++.++|||||||++|+|++|+.||.+... ...+..+....... ..
T Consensus 188 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 267 (316)
T 2ac3_A 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAH 267 (316)
T ss_dssp CCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTT
T ss_pred cChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhccc
Confidence 99999975 4578899999999999999999999987642 23344444333222 24
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
.+..+.+||.+||+.||.+|||+.|+++||||++..++.
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC------
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcc
Confidence 578899999999999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=380.70 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=220.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||+||+|.+..++..+|+|++.+... ...+.+.+|+.+++.++||||+++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-------------EDVDRFKQEIEIMKSLDHPNIIRLYETF 75 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-------------SCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-------------chHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 469999999999999999999999999999999854321 1245788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~DF 172 (426)
.+....|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 76 EDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 99999999999999999999877643 49999999999999999999999999999999999999 78899999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+... ......+||+.|+|
T Consensus 154 g~~~~~~~~---------------------------------------------------------~~~~~~~~t~~y~a 176 (277)
T 3f3z_A 154 GLAARFKPG---------------------------------------------------------KMMRTKVGTPYYVS 176 (277)
T ss_dssp TTCEECCTT---------------------------------------------------------SCBCCCCSCTTTCC
T ss_pred ccceeccCc---------------------------------------------------------cchhccCCCCCccC
Confidence 998765321 11233469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-----GEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+. ++.++|||||||++|+|++|+.||...+..+....+........ ..+..+.+||.+||+.||.+|||
T Consensus 177 PE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s 255 (277)
T 3f3z_A 177 PQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT 255 (277)
T ss_dssp HHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred hHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC
Confidence 9998765 89999999999999999999999999998888777765543333 56889999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
+.++|+||||+.
T Consensus 256 ~~~~l~h~~~~~ 267 (277)
T 3f3z_A 256 SLQALEHEWFEK 267 (277)
T ss_dssp HHHHTTSHHHHH
T ss_pred HHHHhcCHHHhc
Confidence 999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=396.85 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=213.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..++|++++.||+|+||+||+|++..+|+.||||++........ .....+.+.+|+.+++.++||||+++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 79 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA--------KDGINRTALREIKLLQELSHPNIIGLLD 79 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEE
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh--------hhhhhHHHHHHHHHHhhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999865432111 1122356788999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.....+|+|||||.+ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 80 ~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 80 AFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp EECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred EEeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999999999985 888776543 3458999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+.... ......+||+.|+||
T Consensus 158 ~a~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~aP 181 (346)
T 1ua2_A 158 LAKSFGSPN--------------------------------------------------------RAYTHQVVTRWYRAP 181 (346)
T ss_dssp GGSTTTSCC--------------------------------------------------------CCCCCSCCCCTTCCH
T ss_pred cceeccCCc--------------------------------------------------------ccCCcccccccccCc
Confidence 998653211 122344689999999
Q ss_pred hhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC--------------------------C
Q 014344 254 EIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD--------------------------L 303 (426)
Q Consensus 254 E~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~--------------------------~ 303 (426)
|++.+. .++.++|||||||++|+|++|.+||.+.+..+.+.++.. .+.. .
T Consensus 182 E~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (346)
T 1ua2_A 182 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261 (346)
T ss_dssp HHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC
T ss_pred hHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhh
Confidence 999764 589999999999999999999999999998877776642 1100 0
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
...+..+.+||.+||+.||.+|||++|+|+||||+...|
T Consensus 262 ~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 262 SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 233578999999999999999999999999999987544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=408.61 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=204.2
Q ss_pred CCCCcEEE-eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHH-hcCCCCccee
Q 014344 14 DFSCLRIV-SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-NVEHPLLPRL 91 (426)
Q Consensus 14 ~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~l 91 (426)
.+++|.++ +.||+|+||+||+|++..+++.||||++... ..+.+|+.++. ..+||||+++
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------------------~~~~~E~~~~~~~~~hp~iv~l 120 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRI 120 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------------------hhHHHHHHHHHHhcCCCCcceE
Confidence 45678887 7899999999999999999999999998421 24556888874 4579999999
Q ss_pred eeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---C
Q 014344 92 RGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---N 164 (426)
Q Consensus 92 ~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~ 164 (426)
+++|.. ...+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. +
T Consensus 121 ~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~ 200 (400)
T 1nxk_A 121 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 200 (400)
T ss_dssp EEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTT
T ss_pred eEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCC
Confidence 999875 678999999999999999988655556999999999999999999999999999999999999997 7
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||+++..... ......
T Consensus 201 ~~~kl~DFG~a~~~~~~---------------------------------------------------------~~~~~~ 223 (400)
T 1nxk_A 201 AILKLTDFGFAKETTSH---------------------------------------------------------NSLTTP 223 (400)
T ss_dssp CCEEECCCTTCEECC-----------------------------------------------------------------
T ss_pred ccEEEEecccccccCCC---------------------------------------------------------CccccC
Confidence 89999999998764311 122345
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCC-----CCCCCCCHHHHHHHH
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE----TFYRILCRP-----PDLVGEPTPLRNLIR 315 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~~-----~~~~~~~~~~~~li~ 315 (426)
+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..... ....+.... +.....+..+.+||+
T Consensus 224 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 303 (400)
T 1nxk_A 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303 (400)
T ss_dssp ---CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred CCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHH
Confidence 79999999999999999999999999999999999999998764321 222332211 222456889999999
Q ss_pred HHhccCCCCCCChHHHhcCCCcCC
Q 014344 316 RLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 316 ~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+||+.||.+|||+.||++||||..
T Consensus 304 ~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 304 NLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHCCCChhHCcCHHHHhcCccccC
Confidence 999999999999999999999964
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=406.37 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=214.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc------CCCCc
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV------EHPLL 88 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l------~hp~i 88 (426)
..+|++++.||+|+||+||+|.+..+++.||||++.... .....+..|+.+++.+ .|+||
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~~i 161 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--------------RFHRQAAEEIRILEHLRKQDKDNTMNV 161 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHTTCTTSCSCB
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--------------chHHHHHHHHHHHHHHhhccccCCcCE
Confidence 356999999999999999999999999999999985432 2234566788888877 57799
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc--
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH-- 166 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~-- 166 (426)
+++++++.....+|+||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 162 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~ 240 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSG 240 (429)
T ss_dssp CCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCC
T ss_pred EEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcc
Confidence 999999999999999999996 68999888776666999999999999999999999999999999999999999987
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++..... ...+.+|
T Consensus 241 vkL~DFG~a~~~~~-----------------------------------------------------------~~~~~~g 261 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQ-----------------------------------------------------------RVYTYIQ 261 (429)
T ss_dssp EEECCCTTCEETTC-----------------------------------------------------------CCCSSCS
T ss_pred eEEeecccceecCC-----------------------------------------------------------cccccCC
Confidence 99999999865421 1234579
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CC----------------------
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PP---------------------- 301 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~---------------------- 301 (426)
|+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+... ++
T Consensus 262 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 341 (429)
T 3kvw_A 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRY 341 (429)
T ss_dssp CGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTT
T ss_pred CCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccc
Confidence 99999999999999999999999999999999999999999887766554310 00
Q ss_pred ---------------------------C--------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 302 ---------------------------D--------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 302 ---------------------------~--------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
. ....++.+.+||.+||++||++|||++|+|+||||+.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 342 CTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp SCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-
T ss_pred ccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhcc
Confidence 0 0012567899999999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=397.58 Aligned_cols=267 Identities=22% Similarity=0.348 Sum_probs=207.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+|++++||||++++++|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 73 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN------------RELAREKVMREVKALAKLEHPGIVRYFNAW 73 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS------------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEE
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC------------chhHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 57999999999999999999999999999999985321 123456788999999999999999999998
Q ss_pred ecCC---------------------------------------------------------eEEEEEeccCCCChHHHHH
Q 014344 96 STDK---------------------------------------------------------FVGYAIDYCPGRDLHSLRK 118 (426)
Q Consensus 96 ~~~~---------------------------------------------------------~~~lV~Ey~~gg~L~~l~~ 118 (426)
.+.. .+|+|||||+|++|.+++.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 153 (332)
T 3qd2_B 74 LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMN 153 (332)
T ss_dssp EECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHH
T ss_pred EEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHh
Confidence 5543 4899999999999999987
Q ss_pred Hhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhcccccc
Q 014344 119 QQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197 (426)
Q Consensus 119 ~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~ 197 (426)
.... ...++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............
T Consensus 154 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~-------- 225 (332)
T 3qd2_B 154 RRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT-------- 225 (332)
T ss_dssp TCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------------
T ss_pred cccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc--------
Confidence 5432 2355667899999999999999999999999999999999999999999999987653321100000
Q ss_pred ccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHH
Q 014344 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEM 277 (426)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 277 (426)
...........+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 226 ------------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 269 (332)
T 3qd2_B 226 ------------------------------------PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269 (332)
T ss_dssp ------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHH
T ss_pred ------------------------------------cccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHH
Confidence 00001223455799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 278 LYGATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 278 l~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
++|..|+... ......+... +......++.+.+||.+||+.||.+|||++|+++||||+++
T Consensus 270 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 270 LYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred HHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 9987775321 1122222211 11112335778999999999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=414.25 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=215.8
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|++++.||+|+||+||+|+++.++..||||++.+..... .....+.+|+.+|+.++||||+++++++.
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 106 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-----------SSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC----------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-----------hHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 6999999999999999999999999999999996543221 12456888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEeccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLVDFD 173 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~DFg 173 (426)
+...+|+|||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||
T Consensus 107 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 107 DKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 9999999999999999998876653 49999999999999999999999999999999999999764 559999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++..+... ......+||+.|+||
T Consensus 185 ~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~aP 207 (494)
T 3lij_A 185 LSAVFENQ---------------------------------------------------------KKMKERLGTAYYIAP 207 (494)
T ss_dssp TCEECBTT---------------------------------------------------------BCBCCCCSCTTTCCH
T ss_pred CCeECCCC---------------------------------------------------------ccccccCCCcCeeCH
Confidence 98765321 122345799999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+...... +...+..+++||.+||+.||.+|||+
T Consensus 208 E~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~ 286 (494)
T 3lij_A 208 EVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286 (494)
T ss_dssp HHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccH
Confidence 99874 6899999999999999999999999999998888877644322 23568899999999999999999999
Q ss_pred HHHhcCCCcCCC
Q 014344 329 EEIKGHEFFKGV 340 (426)
Q Consensus 329 ~eil~hp~f~~~ 340 (426)
.++|+||||+..
T Consensus 287 ~e~l~hp~~~~~ 298 (494)
T 3lij_A 287 QQALEHPWIKEM 298 (494)
T ss_dssp HHHHTCHHHHHH
T ss_pred HHHhcCcccccC
Confidence 999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=418.63 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=224.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++.+.... .......+.+|+.+|+.++||||++++++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK----------QKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----------BSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc----------cchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 35699999999999999999999999999999999654321 12235678899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~D 171 (426)
+.+...+|+|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 172 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIID 172 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence 99999999999999999999987654 459999999999999999999999999999999999999 4678999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+... ......+||+.|+
T Consensus 173 fg~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 195 (484)
T 3nyv_A 173 FGLSTHFEAS---------------------------------------------------------KKMKDKIGTAYYI 195 (484)
T ss_dssp TTHHHHBCCC---------------------------------------------------------CSHHHHTTGGGTC
T ss_pred eeeeEEcccc---------------------------------------------------------cccccCCCCcccc
Confidence 9999765321 1223456999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+ .|+.++|||||||++|+|++|++||.+.+..+.+..+...... +...+..+++||.+||++||.+||
T Consensus 196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~ 274 (484)
T 3nyv_A 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274 (484)
T ss_dssp CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC
T ss_pred CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc
Confidence 9999987 6899999999999999999999999999998888887654322 234678899999999999999999
Q ss_pred ChHHHhcCCCcCCCCh
Q 014344 327 GVEEIKGHEFFKGVNW 342 (426)
Q Consensus 327 s~~eil~hp~f~~~~~ 342 (426)
|+.|+|+||||+...+
T Consensus 275 s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 275 SARDALDHEWIQTYTK 290 (484)
T ss_dssp CHHHHHTSHHHHHHTC
T ss_pred CHHHHhhChhhccccc
Confidence 9999999999975443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=395.21 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=216.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
-.+++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++||||++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 82 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----------KEGFPITALREIKILQLLKHENVVNLI 82 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-----------SSSSCHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-----------cccchHHHHHHHHHHHhccCCCcccHh
Confidence 457899999999999999999999999999999999854321 112345677899999999999999999
Q ss_pred eeeec--------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 93 GVLST--------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 93 ~~~~~--------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+++.. .+.+|+|||||. ++|...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~ 160 (351)
T 3mi9_A 83 EICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 160 (351)
T ss_dssp EEEEEC--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred heeeccccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC
Confidence 99977 457899999997 57777665443 459999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++..+..... .........
T Consensus 161 ~~~kl~Dfg~a~~~~~~~~----------------------------------------------------~~~~~~~~~ 188 (351)
T 3mi9_A 161 GVLKLADFGLARAFSLAKN----------------------------------------------------SQPNRYTNR 188 (351)
T ss_dssp SCEEECCCTTCEECCCCSS----------------------------------------------------SSCCCCCSS
T ss_pred CCEEEccchhccccccccc----------------------------------------------------ccccccCCc
Confidence 9999999999987642210 011223445
Q ss_pred ccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC-C-CCC-------------
Q 014344 245 VGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP-D-LVG------------- 305 (426)
Q Consensus 245 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~-~-~~~------------- 305 (426)
+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+.. ..+ . ...
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (351)
T 3mi9_A 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELV 268 (351)
T ss_dssp CSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCC
T ss_pred ccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccc
Confidence 79999999999986 4589999999999999999999999999988777665532 111 1 110
Q ss_pred ---------------CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 306 ---------------EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 306 ---------------~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 269 KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp SSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred cccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 146689999999999999999999999999997643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=398.39 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=206.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++.+.. ........+.+|+.+++.++||||++++++
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 92 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-----------QNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-----------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-----------CChHHHHHHHHHHHHHHhcCCCCccceEEe
Confidence 478999999999999999999999999999999985432 122345678889999999999999999999
Q ss_pred eecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+.... .+|+|||||. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 93 FTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp ECSCCSTTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred eccccccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEE
Confidence 97665 7899999997 57777764 2489999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++...... ......+||+
T Consensus 168 l~Dfg~a~~~~~~---------------------------------------------------------~~~~~~~gt~ 190 (371)
T 2xrw_A 168 ILDFGLARTAGTS---------------------------------------------------------FMMTPYVVTR 190 (371)
T ss_dssp ECCCCC-------------------------------------------------------------------------C
T ss_pred EEEeecccccccc---------------------------------------------------------cccCCceecC
Confidence 9999998754311 1123456999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------------------CCC-
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----------------------LVG- 305 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------------~~~- 305 (426)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..++..... ...
T Consensus 191 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (371)
T 2xrw_A 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY 270 (371)
T ss_dssp TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCC
T ss_pred CccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCcccccc
Confidence 999999999999999999999999999999999999999888777766532110 000
Q ss_pred --------------------CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 306 --------------------EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 306 --------------------~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.+..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 271 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp CHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred chhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 03468899999999999999999999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=379.21 Aligned_cols=261 Identities=27% Similarity=0.385 Sum_probs=218.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+++.++||||+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~ 74 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL----------DVVGKIKREIQNLKLFRHPHII 74 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCCCTTBC
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccch----------hHHHHHHHHHHHHhcCCCCCEe
Confidence 345678899999999999999999999999999999999976543221 2346788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++...+..|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l 152 (276)
T 2h6d_A 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKI 152 (276)
T ss_dssp CEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEE
Confidence 99999999999999999999999999987653 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... .....+||+.
T Consensus 153 ~dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~ 175 (276)
T 2h6d_A 153 ADFGLSNMMSDGE---------------------------------------------------------FLRTSCGSPN 175 (276)
T ss_dssp CCCCGGGCCCC---------------------------------------------------------------------
T ss_pred eecccccccCCCc---------------------------------------------------------ceecccCCcc
Confidence 9999987653211 1123468999
Q ss_pred CccchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 250 YVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 250 y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
|+|||++.+..+ +.++|||||||++|+|++|+.||...+....+..+...... ....+..+.+||.+||+.||.+|||
T Consensus 176 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 176 YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp -CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCC
Confidence 999999988766 68999999999999999999999998887777766544332 2345788999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
++++++||||+.
T Consensus 256 ~~~~l~h~~~~~ 267 (276)
T 2h6d_A 256 IKDIREHEWFKQ 267 (276)
T ss_dssp HHHHHHSHHHHT
T ss_pred HHHHHhChhhcc
Confidence 999999999964
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-51 Score=390.27 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=203.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 94 (426)
++|+++++||+|+||+||+|++..+++.||||++..... ..........|+..+..+ .||||++++++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~ 125 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-----------GPKDRARKLAEVGSHEKVGQHPCCVRLEQA 125 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-----------SHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-----------ChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence 569999999999999999999999999999998743211 112223444455555554 89999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+.+.+|+||||| +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 126 WEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 99999999999999 678888876654 4599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+....... ......||+.|+|||
T Consensus 204 a~~~~~~~---------------------------------------------------------~~~~~~gt~~y~aPE 226 (311)
T 3p1a_A 204 LVELGTAG---------------------------------------------------------AGEVQEGDPRYMAPE 226 (311)
T ss_dssp CEECC---------------------------------------------------------------CCCCCGGGCCGG
T ss_pred eeecccCC---------------------------------------------------------CCcccCCCccccCHh
Confidence 87653211 122345999999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
++.+ .++.++|||||||++|||++|..|+.+.............+......+..+.+||.+||+.||++|||++|+|+|
T Consensus 227 ~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 227 LLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp GGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 9987 689999999999999999999777765433222211111111123457889999999999999999999999999
Q ss_pred CCcCC
Q 014344 335 EFFKG 339 (426)
Q Consensus 335 p~f~~ 339 (426)
|||+.
T Consensus 306 p~~~~ 310 (311)
T 3p1a_A 306 PVLRQ 310 (311)
T ss_dssp GGGSC
T ss_pred ccccC
Confidence 99974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=396.98 Aligned_cols=267 Identities=25% Similarity=0.411 Sum_probs=218.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.+........ ........+..|+.+|+.++||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW-----IEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSE-----EEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 46999999999999999999999999999999996653221100 0111334567799999999999999999999
Q ss_pred ecCCeEEEEEeccCCC-ChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 STDKFVGYAIDYCPGR-DLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg-~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.+.+.+++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999999766 999987654 3499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+...... ......+||+.|+|||
T Consensus 177 a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~aPE 199 (335)
T 3dls_A 177 AAYLERG---------------------------------------------------------KLFYTFCGTIEYCAPE 199 (335)
T ss_dssp CEECCTT---------------------------------------------------------CCBCEECSCGGGCCHH
T ss_pred ceECCCC---------------------------------------------------------CceeccCCCccccChh
Confidence 9765321 1223457999999999
Q ss_pred hhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 255 ~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
++.+..+ +.++|||||||++|+|++|..||...... ...........+..+.+||.+||+.||.+|||++++++
T Consensus 200 ~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9998877 89999999999999999999999763321 11112223345889999999999999999999999999
Q ss_pred CCCcCC------CChhhhhhccCC
Q 014344 334 HEFFKG------VNWELLLKISRP 351 (426)
Q Consensus 334 hp~f~~------~~~~~~~~~~~~ 351 (426)
||||+. ..|+.+.....|
T Consensus 275 hp~~~~~~~~~~~~~~~~~~~~~~ 298 (335)
T 3dls_A 275 DPWVTQPVNLADYTWEEVFRVNKP 298 (335)
T ss_dssp CTTTTCCCCGGGCCHHHHC-----
T ss_pred CccccCCccccccCHHHHhhhcCC
Confidence 999965 567776554443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=408.21 Aligned_cols=266 Identities=26% Similarity=0.418 Sum_probs=209.2
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|.+..+++.||||++.+....... .........+.+|+.+|++++||||++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGS-----AREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccc-----cccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 36799999999999999999999999999999999765432211 0112233467889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC---cEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG---HIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g---~ikL~D 171 (426)
+.. +..|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred Eec-CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 854 5579999999999999876543 4599999999999999999999999999999999999997544 599999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++..... ......+||+.|+
T Consensus 286 FG~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~ 308 (419)
T 3i6u_A 286 FGHSKILGET---------------------------------------------------------SLMRTLCGTPTYL 308 (419)
T ss_dssp SSTTTSCC--------------------------------------------------------------------CTTC
T ss_pred cccceecCCC---------------------------------------------------------ccccccCCCCCcc
Confidence 9999765321 1223457999999
Q ss_pred cchhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhcCCCC-----CCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET-FYRILCRPPD-----LVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP 322 (426)
|||++.+ ..|+.++|||||||++|+|++|++||........ ...+...... ....+..+.+||.+||+.||
T Consensus 309 aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 388 (419)
T 3i6u_A 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388 (419)
T ss_dssp CTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred CceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCCh
Confidence 9999864 5678999999999999999999999987544322 2223222211 13457889999999999999
Q ss_pred CCCCChHHHhcCCCcCCCChhhh
Q 014344 323 TKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
.+|||++|+|+||||++.+|...
T Consensus 389 ~~Rps~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 389 KARFTTEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp TTSCCHHHHHHSGGGCCHHHHHH
T ss_pred hHCcCHHHHhCCcccCChhHHHH
Confidence 99999999999999998777654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=398.53 Aligned_cols=262 Identities=28% Similarity=0.449 Sum_probs=220.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||+||+|++..+++.||+|++.... .....+.+.+|+.+|+.++||||+
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv 94 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI------------KPAIRNQIIRELQVLHECNSPYIV 94 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC------------CHHHHHHHHHHHGGGGGCCCTTBC
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc------------CHHHHHHHHHHHHHHHHCCCCCEE
Confidence 45677788999999999999999999999999999999985431 123456788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++..++.+|+|||||+|++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~k 172 (360)
T 3eqc_A 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIK 172 (360)
T ss_dssp CEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEE
T ss_pred EEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEE
Confidence 99999999999999999999999999987654 499999999999999999999996 999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++...... .....+||+
T Consensus 173 l~Dfg~~~~~~~~----------------------------------------------------------~~~~~~gt~ 194 (360)
T 3eqc_A 173 LCDFGVSGQLIDS----------------------------------------------------------MANSFVGTR 194 (360)
T ss_dssp ECCCCCCHHHHHH----------------------------------------------------------C----CCCC
T ss_pred EEECCCCcccccc----------------------------------------------------------cccCCCCCC
Confidence 9999998654210 122346999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------------------------
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYR--------------------------------- 295 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--------------------------------- 295 (426)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....
T Consensus 195 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (360)
T 3eqc_A 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPP 274 (360)
T ss_dssp TTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------C
T ss_pred CeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCc
Confidence 99999999999999999999999999999999999988765443211
Q ss_pred ---------HhcC-CCCC--CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 296 ---------ILCR-PPDL--VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 296 ---------i~~~-~~~~--~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
+... .+.. ...+..+.+||.+||+.||++|||++|+|+||||++.+|+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 275 MAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp CCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 1111 1111 1247789999999999999999999999999999865544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=381.16 Aligned_cols=261 Identities=30% Similarity=0.516 Sum_probs=227.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
....++|++++.||+|+||.||+|.+..+++.||+|++.+.... .......+..|+.+++.+.||||+++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~ 80 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL----------KPHQREKMSMEISIHRSLAHQHVVGF 80 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC----------SHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc----------CHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 34567899999999999999999999999999999998654321 12345678889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.+.+..|+||||++|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 158 (294)
T 2rku_A 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158 (294)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEe
Confidence 999999999999999999999999877643 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... ......+||+.|+
T Consensus 159 fg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~ 182 (294)
T 2rku_A 159 FGLATKVEYDG--------------------------------------------------------ERKKVLCGTPNYI 182 (294)
T ss_dssp CTTCEECCSTT--------------------------------------------------------CCBCCCCSCCSSC
T ss_pred ccCceecccCc--------------------------------------------------------cccccccCCCCcC
Confidence 99987653211 1123346999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|||++.+..++.++|||||||++|+|++|+.||......+.+..+...... ....+..+.+||.+||+.||++|||+++
T Consensus 183 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 262 (294)
T 2rku_A 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 262 (294)
T ss_dssp CHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHH
Confidence 999999999999999999999999999999999999888877777654433 3356788999999999999999999999
Q ss_pred HhcCCCcCCC
Q 014344 331 IKGHEFFKGV 340 (426)
Q Consensus 331 il~hp~f~~~ 340 (426)
+++||||+..
T Consensus 263 ll~~~~~~~~ 272 (294)
T 2rku_A 263 LLNDEFFTSG 272 (294)
T ss_dssp GGGSHHHHTS
T ss_pred HhhChheecC
Confidence 9999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=393.11 Aligned_cols=265 Identities=24% Similarity=0.371 Sum_probs=219.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.-.+++|++++.||+|+||.||+|++..+++.||||++.... ......+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 89 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----------DDKMVKKIAMREIKLLKQLRHENLVNL 89 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-----------SCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-----------CchHHHHHHHHHHHHHhhCCCCCEeeE
Confidence 346788999999999999999999999999999999984432 122234567889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.+.+..|+||||+.+++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~D 167 (331)
T 4aaa_A 90 LEVCKKKKRWYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCD 167 (331)
T ss_dssp EEEEEETTEEEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EEEeecCCEEEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEe
Confidence 99999999999999999999998875543 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+.... ......+||+.|+
T Consensus 168 fg~~~~~~~~~--------------------------------------------------------~~~~~~~~t~~y~ 191 (331)
T 4aaa_A 168 FGFARTLAAPG--------------------------------------------------------EVYDDEVATRWYR 191 (331)
T ss_dssp CTTC--------------------------------------------------------------------CCCCCTTC
T ss_pred CCCceeecCCc--------------------------------------------------------cccCCCcCCcccc
Confidence 99987653211 1122346899999
Q ss_pred cchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------------CCC------
Q 014344 252 APEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----------------------PPD------ 302 (426)
Q Consensus 252 aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------~~~------ 302 (426)
|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... .+.
T Consensus 192 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (331)
T 4aaa_A 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREP 271 (331)
T ss_dssp CHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCC
T ss_pred CcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccch
Confidence 99999875 6899999999999999999999999998877665554310 000
Q ss_pred ----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhh
Q 014344 303 ----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 303 ----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
....+..+.+||.+||+.||.+|||+.|+|+||||+...|...
T Consensus 272 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 272 LERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAER 318 (331)
T ss_dssp HHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGGHHHH
T ss_pred hhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCChhhh
Confidence 1245788999999999999999999999999999987665543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=399.25 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=200.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|.+..+|+.||||++.... ......+++.+|+.+|+.++||||+++++++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 97 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-----------QSIIHAKRTYRELRLLKHMKHENVIGLLDVF 97 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-----------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-----------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 67999999999999999999999999999999985421 1223456788899999999999999999998
Q ss_pred ecC------CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STD------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
... ..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL 173 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 173 (367)
T ss_dssp CSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEE
Confidence 654 6689999999 7999988764 35999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.... .....+||+.
T Consensus 174 ~DFG~a~~~~~-----------------------------------------------------------~~~~~~~t~~ 194 (367)
T 2fst_X 174 LDFGLARHTAD-----------------------------------------------------------EMTGYVATRW 194 (367)
T ss_dssp CC--------------------------------------------------------------------------CCCT
T ss_pred eeccccccccc-----------------------------------------------------------cCCCcCcCcC
Confidence 99999875421 1223579999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC--------------------CC---
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP--------------------PD--- 302 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~--------------------~~--- 302 (426)
|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....+..++. .+ +.
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (367)
T 2fst_X 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK 274 (367)
T ss_dssp TCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCC
T ss_pred ccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCC
Confidence 999999987 6789999999999999999999999999888776655532 11 00
Q ss_pred ------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 ------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
..+.++.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 275 ~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 275 MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 1244678999999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=388.77 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=226.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
....+|++++.||+|+||.||+|++..+++.||+|++.+.... .......+..|+.+++.++||||++++
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 107 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL----------KPHQREKMSMEISIHRSLAHQHVVGFH 107 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC----------SHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc----------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 4456899999999999999999999999999999999654321 123456788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++.+.+.+|+|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 108 GFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred EEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeec
Confidence 9999999999999999999999987764 34999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... ......+||+.|+|
T Consensus 186 g~~~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~a 209 (335)
T 2owb_A 186 GLATKVEYDG--------------------------------------------------------ERKKVLCGTPNYIA 209 (335)
T ss_dssp TTCEECCSTT--------------------------------------------------------CCBCCCCSCCSSCC
T ss_pred cCceecccCc--------------------------------------------------------ccccccCCCccccC
Confidence 9987653211 11233569999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
||++.+..++.++|||||||++|+|++|+.||......+.+..+...... ....+..+.+||.+||+.||++|||++++
T Consensus 210 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 289 (335)
T 2owb_A 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINEL 289 (335)
T ss_dssp HHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999999999999999999999999998888777766544333 33557889999999999999999999999
Q ss_pred hcCCCcCCC
Q 014344 332 KGHEFFKGV 340 (426)
Q Consensus 332 l~hp~f~~~ 340 (426)
++||||+..
T Consensus 290 l~~~~~~~~ 298 (335)
T 2owb_A 290 LNDEFFTSG 298 (335)
T ss_dssp GGSHHHHTS
T ss_pred hcCccccCC
Confidence 999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=378.66 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=214.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
..+...|++.+.||+|+||+||+|.+..++..||+|++...... ....+.+.+|+.+|+.++||||+++
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~ 90 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRF 90 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-----------HHHHHHHHHHHHHHHhCCCCCeeee
Confidence 34455699999999999999999999999999999998654322 2245678899999999999999999
Q ss_pred eeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeec-cC
Q 014344 92 RGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQ-EN 164 (426)
Q Consensus 92 ~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~-~~ 164 (426)
++++.. ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .+
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 168 (290)
T 1t4h_A 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp EEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTT
T ss_pred eeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCC
Confidence 999865 46799999999999999998765 34999999999999999999999999 99999999999998 78
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++...... .....
T Consensus 169 ~~~kl~Dfg~~~~~~~~----------------------------------------------------------~~~~~ 190 (290)
T 1t4h_A 169 GSVKIGDLGLATLKRAS----------------------------------------------------------FAKAV 190 (290)
T ss_dssp SCEEECCTTGGGGCCTT----------------------------------------------------------SBEES
T ss_pred CCEEEeeCCCccccccc----------------------------------------------------------ccccc
Confidence 99999999998654211 12344
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCCC---CCCCCCHHHHHHHHHHhcc
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF-YRILCRPP---DLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~---~~~~~~~~~~~li~~~L~~ 320 (426)
+||+.|+|||++.+ .++.++|||||||++|+|++|+.||......... ..+..... .....++.+.+||.+||+.
T Consensus 191 ~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 191 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred cCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccC
Confidence 69999999999875 4899999999999999999999999885554444 33332211 1123467899999999999
Q ss_pred CCCCCCChHHHhcCCCcCC
Q 014344 321 DPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~~ 339 (426)
||.+|||++++++||||++
T Consensus 270 dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 270 NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHTSGGGC-
T ss_pred ChhhCCCHHHHhhCccccc
Confidence 9999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=382.29 Aligned_cols=260 Identities=27% Similarity=0.485 Sum_probs=222.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||+|++.+...... ........+.+|+.+++.++||||+++++++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS-------RRGVSREEIEREVNILREIRHPNIITLHDIF 77 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC-------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccc-------ccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence 459999999999999999999999999999999965432211 1112356788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC----cEEEec
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~D 171 (426)
.+....|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 99999999999999999999987643 499999999999999999999999999999999999999877 899999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... ......||+.|+
T Consensus 156 fg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~ 178 (283)
T 3bhy_A 156 FGIAHKIEAGN---------------------------------------------------------EFKNIFGTPEFV 178 (283)
T ss_dssp CTTCEECC-----------------------------------------------------------------CCCGGGC
T ss_pred cccceeccCCC---------------------------------------------------------cccccCCCcCcc
Confidence 99987653211 122346899999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....... ...+..+.+||.+||..||++||
T Consensus 179 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 258 (283)
T 3bhy_A 179 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM 258 (283)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC
T ss_pred CcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc
Confidence 9999999999999999999999999999999999998888777765443322 35578899999999999999999
Q ss_pred ChHHHhcCCCcCCCC
Q 014344 327 GVEEIKGHEFFKGVN 341 (426)
Q Consensus 327 s~~eil~hp~f~~~~ 341 (426)
|+.++++||||+.+.
T Consensus 259 s~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 259 TIAQSLEHSWIKAIR 273 (283)
T ss_dssp CHHHHHHCHHHHHHH
T ss_pred CHHHHHhCHHHHHHH
Confidence 999999999997643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=401.44 Aligned_cols=253 Identities=29% Similarity=0.532 Sum_probs=209.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...++|++++.||+|+||+||+|++..+++.||||++.... ....+|+.+|+.++||||++++
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-----------------~~~~~E~~il~~l~hpnIv~l~ 66 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----------------RYKNRELDIMKVLDHVNIIKLV 66 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-----------------TSCCHHHHHHTTCCCTTBCCEE
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-----------------chHHHHHHHHHHcCCCCccchh
Confidence 34567999999999999999999999999999999984321 1122599999999999999999
Q ss_pred eeeec--------------------------------------CCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHH
Q 014344 93 GVLST--------------------------------------DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRF 132 (426)
Q Consensus 93 ~~~~~--------------------------------------~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~ 132 (426)
++|.. ..++++|||||+ ++|.+++.. .....+++..++.
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~ 145 (383)
T 3eb0_A 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISI 145 (383)
T ss_dssp EEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHH
T ss_pred heeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHH
Confidence 99843 445899999998 587776653 2345699999999
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCCcEEEecccccccCCCCCCCCCcchhhcccccccccccccccccccc
Q 014344 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCS 211 (426)
Q Consensus 133 ~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (426)
++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+....
T Consensus 146 i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~----------------------------- 196 (383)
T 3eb0_A 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE----------------------------- 196 (383)
T ss_dssp HHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------------------------
T ss_pred HHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------------------------
Confidence 999999999999999999999999999998 68999999999998653211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHH
Q 014344 212 SGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290 (426)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 290 (426)
.....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..
T Consensus 197 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 248 (383)
T 3eb0_A 197 ----------------------------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248 (383)
T ss_dssp ----------------------------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Confidence 12344689999999998875 4899999999999999999999999999888
Q ss_pred HHHHHHhc---CC-----------------C----------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 291 ETFYRILC---RP-----------------P----------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 291 ~~~~~i~~---~~-----------------~----------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
+.+.+++. .+ + .....+..+.+||.+||++||.+|||+.|+|+||||+.+
T Consensus 249 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 249 DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 77766642 10 0 112357789999999999999999999999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=378.66 Aligned_cols=270 Identities=29% Similarity=0.394 Sum_probs=224.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
--.++|++++.||+|+||.||+|++..+++.||||++.......... .......+.+.+|+.+|+++. ||||+++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA----EEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH----HHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCH----HHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 34678999999999999999999999999999999996532100000 000123467888999999996 9999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++..+...|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999999998764 3499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .....+||+.|+
T Consensus 168 fg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~ 190 (298)
T 1phk_A 168 FGFSCQLDPGE---------------------------------------------------------KLREVCGTPSYL 190 (298)
T ss_dssp CTTCEECCTTC---------------------------------------------------------CBCCCCSCGGGC
T ss_pred ccchhhcCCCc---------------------------------------------------------ccccccCCcccc
Confidence 99987653211 123346899999
Q ss_pred cchhhc------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhcc
Q 014344 252 APEIIE------GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 252 aPE~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~ 320 (426)
|||++. ...++.++|||||||++|+|++|+.||...+.......+...... ....+..+.+||.+||..
T Consensus 191 aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 270 (298)
T 1phk_A 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270 (298)
T ss_dssp CHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCS
T ss_pred CHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccC
Confidence 999985 456789999999999999999999999998887777766543322 234578899999999999
Q ss_pred CCCCCCChHHHhcCCCcCCCChhhh
Q 014344 321 DPTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
||.+|||+.++++||||++..++.+
T Consensus 271 dp~~Rps~~~ll~h~~~~~~~~~~~ 295 (298)
T 1phk_A 271 QPQKRYTAEEALAHPFFQQYVVEEV 295 (298)
T ss_dssp SGGGSCCHHHHTTSGGGCTTC----
T ss_pred CcccCCCHHHHHhChHhhhccchhh
Confidence 9999999999999999998877654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=390.51 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=216.5
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|+||+||+|++..+++.||||++..... ......+.+.+|+.+|+.++||||+++++++.
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 124 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK----------QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS----------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc----------cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 49999999999999999999999999999999854321 11234567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.++..|+|||||. |+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 202 (348)
T 1u5q_A 125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 202 (348)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCce
Confidence 9999999999997 67877765443 459999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.... ....+||+.|+|||++
T Consensus 203 ~~~~------------------------------------------------------------~~~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 203 IMAP------------------------------------------------------------ANSFVGTPYWMAPEVI 222 (348)
T ss_dssp SSSS------------------------------------------------------------BCCCCSCGGGCCHHHH
T ss_pred ecCC------------------------------------------------------------CCcccCCcceeCHhhh
Confidence 5421 1234699999999998
Q ss_pred c---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 257 E---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 257 ~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
. +..++.++|||||||++|||++|+.||.+.+.......+..... .....+..+.+||.+||+.||++|||+++
T Consensus 223 ~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp HTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 5 46789999999999999999999999999888777666654322 22356788999999999999999999999
Q ss_pred HhcCCCcCC
Q 014344 331 IKGHEFFKG 339 (426)
Q Consensus 331 il~hp~f~~ 339 (426)
+++||||..
T Consensus 303 ll~h~~~~~ 311 (348)
T 1u5q_A 303 LLKHRFVLR 311 (348)
T ss_dssp HTTCHHHHS
T ss_pred HhhChhhhc
Confidence 999999954
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=387.72 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=210.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
...++|++++.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|+.+. ||||+++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~~l~~l~~~~~i~~~ 96 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----------------KKKKIKREIKILENLRGGPNIITL 96 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----------------CHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----------------chHHHHHHHHHHHHcCCCCCEEEe
Confidence 3457899999999999999999999999999999998421 2356788999999997 9999999
Q ss_pred eeeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEE
Q 014344 92 RGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIM 168 (426)
Q Consensus 92 ~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ik 168 (426)
++++.+ ....++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 97 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~k 171 (330)
T 3nsz_A 97 ADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLR 171 (330)
T ss_dssp EEEEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEE
T ss_pred eeeeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEE
Confidence 999987 678999999999999988763 289999999999999999999999999999999999999777 899
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... .....+||+
T Consensus 172 l~Dfg~a~~~~~~~---------------------------------------------------------~~~~~~~~~ 194 (330)
T 3nsz_A 172 LIDWGLAEFYHPGQ---------------------------------------------------------EYNVRVASR 194 (330)
T ss_dssp ECCCTTCEECCTTC---------------------------------------------------------CCCSCCSCG
T ss_pred EEeCCCceEcCCCC---------------------------------------------------------ccccccccc
Confidence 99999997653211 123346899
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHh-------------cCC-------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRIL-------------CRP------------- 300 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~-------------~~~------------- 300 (426)
.|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+. ...
T Consensus 195 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (330)
T 3nsz_A 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 274 (330)
T ss_dssp GGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCC
T ss_pred cccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhh
Confidence 9999999987 67899999999999999999999999543 3322222211 000
Q ss_pred ------------CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 301 ------------PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 301 ------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
......+..+.+||.+||+.||.+|||++|+|+||||+++.|+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 275 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp CCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred ccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 0011147889999999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=380.40 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=212.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||+|++.... .......+++.+|+.+++.++||||+++++++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP----------REKEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS----------SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc----------cccHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 45999999999999999999999999999999985432 12234467889999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..++.+|+|||||+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 158 (294)
T 4eqm_A 81 EEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA 158 (294)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred eeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCc
Confidence 99999999999999999999987653 4999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... .......+||+.|+|||+
T Consensus 159 ~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~aPE~ 183 (294)
T 4eqm_A 159 KALSETS-------------------------------------------------------LTQTNHVLGTVQYFSPEQ 183 (294)
T ss_dssp TTC--------------------------------------------------------------------CCSSCCHHH
T ss_pred ccccccc-------------------------------------------------------ccccCccccCccccCHhH
Confidence 7653211 112334579999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC------CCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD------LVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
+.+..++.++|||||||++|+|++|+.||.+.+......+....... ....+..+.++|.+||+.||.+||+..
T Consensus 184 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~ 263 (294)
T 4eqm_A 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTI 263 (294)
T ss_dssp HHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSH
T ss_pred hcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccH
Confidence 99999999999999999999999999999999887766555543221 235688899999999999999999655
Q ss_pred HHhcCCC
Q 014344 330 EIKGHEF 336 (426)
Q Consensus 330 eil~hp~ 336 (426)
+.+.+.|
T Consensus 264 ~~l~~~l 270 (294)
T 4eqm_A 264 QEMKDDL 270 (294)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 5555544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=391.60 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=219.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 94 (426)
++|++.+.||+|+||.||+|++..+|+.||||++......... .......+.+.+|+.+++.+ +||||++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP-----EQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCH-----HHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCH-----HHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 4699999999999999999999999999999998653210000 00012346788899999999 79999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+......|+||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999999999998754 3499999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
+..+... ......+||+.|+|||
T Consensus 247 ~~~~~~~---------------------------------------------------------~~~~~~~gt~~y~aPE 269 (365)
T 2y7j_A 247 SCHLEPG---------------------------------------------------------EKLRELCGTPGYLAPE 269 (365)
T ss_dssp CEECCTT---------------------------------------------------------CCBCCCCSCGGGCCHH
T ss_pred ccccCCC---------------------------------------------------------cccccCCCCCCccChh
Confidence 8766421 1223457999999999
Q ss_pred hhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCC
Q 014344 255 IIEG------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 255 ~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~ 323 (426)
++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....... ...+..+.+||.+||+.||+
T Consensus 270 ~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 349 (365)
T 2y7j_A 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPE 349 (365)
T ss_dssp HHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTT
T ss_pred hccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence 9864 357899999999999999999999999988877777665443222 35578899999999999999
Q ss_pred CCCChHHHhcCCCcC
Q 014344 324 KRIGVEEIKGHEFFK 338 (426)
Q Consensus 324 ~R~s~~eil~hp~f~ 338 (426)
+|||++++|+||||+
T Consensus 350 ~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 350 ARLTAEQALQHPFFE 364 (365)
T ss_dssp TSCCHHHHHHSGGGC
T ss_pred HCcCHHHHhcCcccC
Confidence 999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=381.50 Aligned_cols=251 Identities=30% Similarity=0.453 Sum_probs=218.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-------------FRDSSLENEIAVLKKIKHENIVTLEDIY 75 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------------------HHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-------------cchHHHHHHHHHHHhCCCCCeeehhhhc
Confidence 469999999999999999999999999999999854321 1224677899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~DF 172 (426)
.+...+|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 76 ESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred ccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 99999999999999999999876643 49999999999999999999999999999999999999 77899999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..... ......+||+.|+|
T Consensus 154 g~~~~~~~----------------------------------------------------------~~~~~~~~~~~y~a 175 (304)
T 2jam_A 154 GLSKMEQN----------------------------------------------------------GIMSTACGTPGYVA 175 (304)
T ss_dssp STTCCCCC----------------------------------------------------------BTTHHHHSCCCBCC
T ss_pred CcceecCC----------------------------------------------------------CccccccCCCCccC
Confidence 99864321 11233469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..++.++|||||||++|+|++|..||...+....+..+..... .....+..+.+||.+||..||.+|||
T Consensus 176 PE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 255 (304)
T 2jam_A 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT 255 (304)
T ss_dssp TTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred hHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999999999999999888877777654322 22356889999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
++++++||||++
T Consensus 256 ~~~~l~h~~~~~ 267 (304)
T 2jam_A 256 CEKALSHPWIDG 267 (304)
T ss_dssp HHHHHTSHHHHS
T ss_pred HHHHhcCccccC
Confidence 999999999965
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=389.87 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=216.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
..-.++|++++.||+|+||.||+|++..+++.||||++..... ........+.+|+.+++.++||||+++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~ 77 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA----------RDPSFYLRFRREAQNAAALNHPAIVAV 77 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT----------TSHHHHHHHHHHHTTCCCCCCTTBCCE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc----------CCHHHHHHHHHHHHHHHcCCCCCcceE
Confidence 4445779999999999999999999999999999999965322 122345678899999999999999999
Q ss_pred eeeeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 92 RGVLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 92 ~~~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
++++.... ..|+|||||+|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 155 (311)
T 3ork_A 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAV 155 (311)
T ss_dssp EEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCE
T ss_pred EEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCE
Confidence 99987654 3499999999999999987653 49999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++..+..... ........+||
T Consensus 156 kl~Dfg~a~~~~~~~~-----------------------------------------------------~~~~~~~~~gt 182 (311)
T 3ork_A 156 KVMDFGIARAIADSGN-----------------------------------------------------SVTQTAAVIGT 182 (311)
T ss_dssp EECCCSCC-----------------------------------------------------------------------C
T ss_pred EEeeccCccccccccc-----------------------------------------------------ccccccccCcC
Confidence 9999999976542110 01123345799
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP 322 (426)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....... .+.+..+.+||.+||+.||
T Consensus 183 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 262 (311)
T 3ork_A 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNP 262 (311)
T ss_dssp CTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSG
T ss_pred cccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCH
Confidence 99999999999999999999999999999999999999998887766665443322 3468889999999999999
Q ss_pred CCCCChHHHhcCCCcC
Q 014344 323 TKRIGVEEIKGHEFFK 338 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~ 338 (426)
.+||++.+++.|+|++
T Consensus 263 ~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 263 ENRYQTAAEMRADLVR 278 (311)
T ss_dssp GGSCSSHHHHHHHHHH
T ss_pred hhChhhHHHHHHHHHH
Confidence 9999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=381.26 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=220.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||.||+|.+..+++.||+|++.+...... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI---------PNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS---------TTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc---------chhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 4679999999999999999999999999999999976544321 1235678899999999999999999999
Q ss_pred e--ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 95 L--STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 95 ~--~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+ ......|+|||||.++ |.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~df 153 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL 153 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecc
Confidence 8 4556899999999866 777777665667999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++........ ........||+.|+|
T Consensus 154 g~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~~y~a 179 (305)
T 2wtk_C 154 GVAEALHPFAA------------------------------------------------------DDTCRTSQGSPAFQP 179 (305)
T ss_dssp TTCEECCTTCS------------------------------------------------------SCEECCCCSCGGGCC
T ss_pred ccccccCcccc------------------------------------------------------ccccccCCCCCCCcC
Confidence 99976542110 112234469999999
Q ss_pred chhhcCCCC--ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGH--DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-LVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||++.+... +.++|||||||++|+|++|+.||.+.+..+.+..+...... ....+..+.+||.+||..||.+|||++
T Consensus 180 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 259 (305)
T 2wtk_C 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIR 259 (305)
T ss_dssp HHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHH
Confidence 999987543 78999999999999999999999998888777776654333 335688999999999999999999999
Q ss_pred HHhcCCCcCCCC
Q 014344 330 EIKGHEFFKGVN 341 (426)
Q Consensus 330 eil~hp~f~~~~ 341 (426)
++++||||+...
T Consensus 260 ~ll~~~~~~~~~ 271 (305)
T 2wtk_C 260 QIRQHSWFRKKH 271 (305)
T ss_dssp HHHHSHHHHSCC
T ss_pred HHhcCcccccCC
Confidence 999999998654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=391.73 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=212.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-----------QSEIFAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-----------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-----------cchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 57999999999999999999999999999999985432 1223456788999999999999999999999
Q ss_pred ecCCeE------EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STDKFV------GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~~~~------~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
...... |+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL 185 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 185 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEE
Confidence 877665 99999997 67776642 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... .....+||+.
T Consensus 186 ~Dfg~a~~~~~-----------------------------------------------------------~~~~~~~t~~ 206 (371)
T 4exu_A 186 LDFGLARHADA-----------------------------------------------------------EMTGYVVTRW 206 (371)
T ss_dssp CSTTCC-------------------------------------------------------------------CTTCCCT
T ss_pred EecCccccccc-----------------------------------------------------------CcCCcccCcc
Confidence 99999875421 1223468999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------------------C-
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-----------------------P- 301 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------------------~- 301 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..++.. + +
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 4exu_A 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 286 (371)
T ss_dssp TSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCC
T ss_pred ccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcc
Confidence 999999987 77899999999999999999999999998877766655320 0 0
Q ss_pred -----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 302 -----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 302 -----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
.....++.+.+||.+||+.||.+|||++|+|+||||+......
T Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 0124578899999999999999999999999999998765443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=391.00 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=214.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.... .......+.+|+.+|+.++||||+++++++
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 94 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE------------HQTYCQRTLREIKILLRFRHENIIGINDII 94 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT------------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc------------CcHHHHHHHHHHHHHHhcCCCCCccceeEE
Confidence 57999999999999999999999999999999985321 223456788999999999999999999999
Q ss_pred ecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 STD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 ~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
... ..+|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 95 ~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~ 170 (364)
T 3qyz_A 95 RAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170 (364)
T ss_dssp CCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEEC
T ss_pred ecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEE
Confidence 654 47999999997 689888765 349999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........ ........+||+.|
T Consensus 171 Dfg~a~~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y 197 (364)
T 3qyz_A 171 DFGLARVADPDHD-----------------------------------------------------HTGFLTEYVATRWY 197 (364)
T ss_dssp CCTTCEECCGGGC-----------------------------------------------------BCCTTCCCCSCGGG
T ss_pred eCcceEecCCCCC-----------------------------------------------------ccccccccccccCC
Confidence 9999976532110 01122345799999
Q ss_pred ccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC-------------------------
Q 014344 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP------------------------- 301 (426)
Q Consensus 251 ~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~------------------------- 301 (426)
+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.. .+.
T Consensus 198 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (364)
T 3qyz_A 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKV 277 (364)
T ss_dssp CCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCC
T ss_pred CCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCC
Confidence 99998754 5589999999999999999999999998876665554431 110
Q ss_pred ----CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ----DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ----~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....+..+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 278 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 278 PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred CHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 013457889999999999999999999999999999875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=382.48 Aligned_cols=262 Identities=27% Similarity=0.446 Sum_probs=219.6
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..++|++++.||+|+||.||+|++..+++.||+|++.... ......+..|+.+++.++||||+++++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 83 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-------------EEELEDYIVEIEILATCDHPYIVKLLG 83 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----------------CCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-------------HHHHHHHHHHHHHHhcCCCCCEeeeee
Confidence 3457999999999999999999999999999999985431 123567888999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++..++.+|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 162 (302)
T 2j7t_A 84 AYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162 (302)
T ss_dssp EEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCH
T ss_pred eeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999999999876543 459999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
++...... ........||+.|+||
T Consensus 163 ~~~~~~~~--------------------------------------------------------~~~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 163 VSAKNLKT--------------------------------------------------------LQKRDSFIGTPYWMAP 186 (302)
T ss_dssp HHHHHHHH--------------------------------------------------------HHC-----CCGGGCCH
T ss_pred CCcccccc--------------------------------------------------------ccccccccCChhhcCC
Confidence 87542100 0011234689999999
Q ss_pred hhh-----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCC
Q 014344 254 EII-----EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 254 E~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~ 324 (426)
|++ .+..++.++|||||||++|+|++|..||...+.......+...... ....+..+.+||.+||..||.+
T Consensus 187 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 266 (302)
T 2j7t_A 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPET 266 (302)
T ss_dssp HHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTT
T ss_pred eeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhh
Confidence 998 4677899999999999999999999999998887776666543322 2245778999999999999999
Q ss_pred CCChHHHhcCCCcCCCChhhh
Q 014344 325 RIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 325 R~s~~eil~hp~f~~~~~~~~ 345 (426)
|||+.++++||||+.+.|...
T Consensus 267 Rps~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 267 RPSAAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp SCCHHHHTTSTTTTTCCCCHH
T ss_pred CCCHHHHhcChHHhhhccchh
Confidence 999999999999998877553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=385.64 Aligned_cols=272 Identities=25% Similarity=0.386 Sum_probs=200.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++||||+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~ 76 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC------------QTSMDELLKEIQAMSQCHHPNIV 76 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------CCCCCCCTTBC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc------------chhHHHHHHHHHHHhhcCCCCEe
Confidence 466788999999999999999999999999999999999854321 12245677899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
++++++..++..|+||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 156 (303)
T 2vwi_A 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156 (303)
T ss_dssp CEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred eEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC
Confidence 9999999999999999999999999987642 2345999999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+|||++......... ........
T Consensus 157 ~~~~kl~dfg~~~~~~~~~~~---------------------------------------------------~~~~~~~~ 185 (303)
T 2vwi_A 157 DGSVQIADFGVSAFLATGGDI---------------------------------------------------TRNKVRKT 185 (303)
T ss_dssp TCCEEECCCHHHHHCC----------------------------------------------------------------
T ss_pred CCCEEEEeccchheeccCCCc---------------------------------------------------cchhhhcc
Confidence 999999999998765422100 00112234
Q ss_pred cccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------CCCCCCHHHH
Q 014344 244 FVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----------DLVGEPTPLR 311 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~ 311 (426)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................. .....+..+.
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (303)
T 2vwi_A 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFR 265 (303)
T ss_dssp --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHH
T ss_pred cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHH
Confidence 569999999999876 5689999999999999999999999998776655544432221 1234577899
Q ss_pred HHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 312 NLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 312 ~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
+||.+||..||.+|||+.++++||||+...+..
T Consensus 266 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 266 KMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred HHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 999999999999999999999999998765543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=377.13 Aligned_cols=252 Identities=17% Similarity=0.227 Sum_probs=208.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~ 94 (426)
++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..+ +||||++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-----------GSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-----------TSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-----------ccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 579999999999999999999999999999999854321 122345778899999999 89999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC--------
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-------- 164 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-------- 164 (426)
+.+++.+|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~ 159 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASE 159 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccc
Confidence 999999999999999999999987543 2569999999999999999999999999999999999999844
Q ss_pred -----------CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCC
Q 014344 165 -----------GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRS 233 (426)
Q Consensus 165 -----------g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (426)
..+||+|||++......
T Consensus 160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---------------------------------------------------- 187 (289)
T 1x8b_A 160 EGDEDDWASNKVMFKIGDLGHVTRISSP---------------------------------------------------- 187 (289)
T ss_dssp ----------CCCEEECCCTTCEETTCS----------------------------------------------------
T ss_pred ccccccccCCceEEEEcccccccccCCc----------------------------------------------------
Confidence 47999999998765321
Q ss_pred CCCCCCCccccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHH
Q 014344 234 DSDSSEKSNSFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRN 312 (426)
Q Consensus 234 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 312 (426)
....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+........... ...+......+..+.+
T Consensus 188 --------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 258 (289)
T 1x8b_A 188 --------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ-GRLPRIPQVLSQEFTE 258 (289)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHT-TCCCCCSSCCCHHHHH
T ss_pred --------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHc-CCCCCCCcccCHHHHH
Confidence 122489999999999876 567899999999999999999988765543222211 1122233456889999
Q ss_pred HHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 313 LIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 313 li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
||.+||..||++|||+.++++||||++
T Consensus 259 li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 259 LLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp HHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred HHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 999999999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=388.25 Aligned_cols=258 Identities=27% Similarity=0.424 Sum_probs=208.9
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--CCcc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--PLLP 89 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv 89 (426)
++...+|++++.||+|+||+||+|.+ .+++.||||++..... .......+.+|+.+|+.+.| |||+
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~~~~~iv 72 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-----------DNQTLDSYRNEIAYLNKLQQHSDKII 72 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHTTTCTTBC
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-----------chHHHHHHHHHHHHHHhhhhcCCceE
Confidence 45667899999999999999999998 4688999999854321 22345678899999999986 9999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.++..+|+||| +.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 73 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl 148 (343)
T 3dbq_A 73 RLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 148 (343)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEeeeEeeCCEEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEE
Confidence 99999999999999999 5579999998764 4599999999999999999999999999999999999996 689999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+..... .......+||+.
T Consensus 149 ~DFG~a~~~~~~~~------------------------------------------------------~~~~~~~~gt~~ 174 (343)
T 3dbq_A 149 IDFGIANQMQPDTT------------------------------------------------------SVVKDSQVGTVN 174 (343)
T ss_dssp CCCSSSCCC------------------------------------------------------------------CCCCS
T ss_pred eecccccccCcccc------------------------------------------------------cccCCCCcCCcC
Confidence 99999986642210 012234579999
Q ss_pred CccchhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC---CCCCCCCHHHHHHH
Q 014344 250 YVAPEIIEG-----------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILCRP---PDLVGEPTPLRNLI 314 (426)
Q Consensus 250 y~aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~---~~~~~~~~~~~~li 314 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+.... ......+..+.+||
T Consensus 175 y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (343)
T 3dbq_A 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 254 (343)
T ss_dssp SCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHH
T ss_pred cCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHH
Confidence 999999875 67899999999999999999999999875433 3444443221 12223467899999
Q ss_pred HHHhccCCCCCCChHHHhcCCCcCC
Q 014344 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.+||+.||.+|||+.|+|+||||+.
T Consensus 255 ~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 255 KCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHcCCChhHCCCHHHHHhCccccc
Confidence 9999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=377.83 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=202.5
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+..++|++++.||+|+||+||+|++..+++.||+|++....... ...+.+..+...++.++||||+++
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~~~~~~h~~iv~~ 71 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-----------EQKRLLMDLDISMRTVDCPFTVTF 71 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-----------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-----------HHHHHHHHHHHHHHhCCCCeEEEE
Confidence 467788999999999999999999999999999999985432111 123344445556888899999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEE
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ik 168 (426)
++++.+++..|+||||++ |+|.+++.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 72 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp EEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEE
T ss_pred eeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEE
Confidence 999999999999999997 588776653 2345699999999999999999999998 999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++....... ......||+
T Consensus 151 l~Dfg~~~~~~~~~---------------------------------------------------------~~~~~~~t~ 173 (290)
T 3fme_A 151 MCDFGISGYLVDDV---------------------------------------------------------AKDIDAGCK 173 (290)
T ss_dssp BCCC------------------------------------------------------------------------CCCC
T ss_pred EeecCCcccccccc---------------------------------------------------------cccccCCCc
Confidence 99999987653211 112235899
Q ss_pred CCccchhh----cCCCCChhhHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC-CC--CCCCCHHHHHHHHHHhcc
Q 014344 249 EYVAPEII----EGKGHDFAVDWWSLGVVLHEMLYGATPFRG-SSRKETFYRILCRP-PD--LVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 249 ~y~aPE~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~~i~~~~-~~--~~~~~~~~~~li~~~L~~ 320 (426)
.|+|||++ .+..++.++|||||||++|+|++|+.||.. .............. +. ....+..+.+||.+||+.
T Consensus 174 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 253 (290)
T 3fme_A 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKK 253 (290)
T ss_dssp CCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCS
T ss_pred cccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhc
Confidence 99999996 566789999999999999999999999986 34444444443222 22 234688999999999999
Q ss_pred CCCCCCChHHHhcCCCcC
Q 014344 321 DPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 321 dP~~R~s~~eil~hp~f~ 338 (426)
||.+|||+.|+++||||+
T Consensus 254 ~p~~Rpt~~e~l~hp~f~ 271 (290)
T 3fme_A 254 NSKERPTYPELMQHPFFT 271 (290)
T ss_dssp SGGGSCCHHHHTTSHHHH
T ss_pred ChhhCcCHHHHHhCcccc
Confidence 999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=397.42 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=208.9
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
...+|++++.||+|+||+||+|++..+++ +|+|++.... ....+|+.+|+.++||||+++++
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-----------------~~~~~E~~il~~l~h~niv~l~~ 99 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-----------------RFKNRELQIMRIVKHPNVVDLKA 99 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-----------------TSCCHHHHHHHTCCCTTBCCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-----------------chHHHHHHHHHhCCCCCcceEEE
Confidence 34579999999999999999999987766 8888774321 01125999999999999999999
Q ss_pred eeecC------CeEEEEEeccCCCChHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCC
Q 014344 94 VLSTD------KFVGYAIDYCPGRDLHSLRK-QQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENG 165 (426)
Q Consensus 94 ~~~~~------~~~~lV~Ey~~gg~L~~l~~-~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g 165 (426)
+|... .++|+|||||.++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~ 179 (394)
T 4e7w_A 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179 (394)
T ss_dssp EEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred EEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC
Confidence 99543 34899999998655444432 22345699999999999999999999999999999999999999 799
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+++.+.... .....+
T Consensus 180 ~~kL~DFG~a~~~~~~~---------------------------------------------------------~~~~~~ 202 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGE---------------------------------------------------------PNVSYI 202 (394)
T ss_dssp EEEECCCTTCEECCTTC---------------------------------------------------------CCCSSC
T ss_pred cEEEeeCCCcccccCCC---------------------------------------------------------CCcccc
Confidence 99999999998653211 123456
Q ss_pred cCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------------C---
Q 014344 246 GTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-----------------P--- 301 (426)
Q Consensus 246 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------------~--- 301 (426)
||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+... + +
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 282 (394)
T 4e7w_A 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR 282 (394)
T ss_dssp SCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCC
T ss_pred cCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcccccc
Confidence 89999999999775 5899999999999999999999999999887776655421 0 0
Q ss_pred -------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 302 -------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 302 -------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
.....++.+.+||.+||++||.+|||+.|+++||||+++.|..
T Consensus 283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 0113578899999999999999999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=380.06 Aligned_cols=262 Identities=23% Similarity=0.423 Sum_probs=219.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.++||||++++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE---------------SDLQEIIKEISIMQQCDSPHVVKYY 90 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT---------------SCCHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch---------------HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 4456799999999999999999999999999999998542 1235678899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++.....+|+||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 169 (314)
T 3com_A 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADF 169 (314)
T ss_dssp EEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeec
Confidence 99999999999999999999999986443 45999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... .......||+.|+|
T Consensus 170 g~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~a 193 (314)
T 3com_A 170 GVAGQLTDTM--------------------------------------------------------AKRNTVIGTPFWMA 193 (314)
T ss_dssp TTCEECBTTB--------------------------------------------------------SCBCCCCSCGGGCC
T ss_pred ccchhhhhhc--------------------------------------------------------cccCccCCCCCccC
Confidence 9987653210 11234468999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD----LVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
||++.+..++.++|||||||++|+|++|..||...+.......+...... ....+..+.+||.+||..||.+|||+
T Consensus 194 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~ 273 (314)
T 3com_A 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATA 273 (314)
T ss_dssp HHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCH
T ss_pred hhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999999999999999999999999988877665555433322 12347889999999999999999999
Q ss_pred HHHhcCCCcCCCChhhhh
Q 014344 329 EEIKGHEFFKGVNWELLL 346 (426)
Q Consensus 329 ~eil~hp~f~~~~~~~~~ 346 (426)
.++++||||++..+....
T Consensus 274 ~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 274 TQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp HHHTTSHHHHTCCCGGGG
T ss_pred HHHHhCHHHhcCCcchHH
Confidence 999999999987665544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=401.16 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=208.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
..+|++++.||+|+||+||+|++..+++.||||++.... ....+|+.+|+.++||||++++++
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~il~~l~hpniv~l~~~ 115 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----------------RFKNRELQIMRKLDHCNIVRLRYF 115 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----------------TSCCHHHHHHHTCCCTTBCCEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----------------hhHHHHHHHHHHcCCCCccceeeE
Confidence 347999999999999999999999999999999984321 112359999999999999999999
Q ss_pred eec------CCeEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC-C
Q 014344 95 LST------DKFVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN-G 165 (426)
Q Consensus 95 ~~~------~~~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~-g 165 (426)
|.. ..++++||||+.+ +|..++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 116 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~ 194 (420)
T 1j1b_A 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194 (420)
T ss_dssp EEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT
T ss_pred EeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC
Confidence 843 2357899999975 66665443 234569999999999999999999999999999999999999965 5
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+++.+.... .....+
T Consensus 195 ~~kl~DFG~a~~~~~~~---------------------------------------------------------~~~~~~ 217 (420)
T 1j1b_A 195 VLKLCDFGSAKQLVRGE---------------------------------------------------------PNVSYI 217 (420)
T ss_dssp EEEECCCTTCEECCTTC---------------------------------------------------------CCCSCC
T ss_pred eEEeccchhhhhcccCC---------------------------------------------------------Cceeee
Confidence 78999999998653211 123457
Q ss_pred cCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------------CC--
Q 014344 246 GTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P-----------------PD-- 302 (426)
Q Consensus 246 gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-----------------~~-- 302 (426)
||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+.+++.. + +.
T Consensus 218 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~ 297 (420)
T 1j1b_A 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 297 (420)
T ss_dssp SCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCC
T ss_pred eCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccC
Confidence 99999999999775 7899999999999999999999999999887776655421 0 00
Q ss_pred --------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 303 --------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 303 --------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
....+..+.+||.+||++||.+|||+.|+++||||+++.+.
T Consensus 298 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 298 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred CCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 12346789999999999999999999999999999875443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=383.60 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=217.2
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
..++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.+ .||||++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~h~~i~~~~ 87 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--------------DEEEEIKQEINMLKKYSHHRNIATYY 87 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------------STTHHHHHHHHHHHHHCCSTTBCCEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--------------ccHHHHHHHHHHHHhccCCCCeeeee
Confidence 4568999999999999999999999999999999984321 1235678899999999 799999999
Q ss_pred eeeec------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 93 GVLST------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 93 ~~~~~------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++.. ...+|+|||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp EEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC
T ss_pred eEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC
Confidence 99976 568999999999999999988765567999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++....... ......+|
T Consensus 168 ~kl~Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~ 191 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTV--------------------------------------------------------GRRNTFIG 191 (326)
T ss_dssp EEECCCTTTC---------------------------------------------------------------------C
T ss_pred EEEeeCcCceecCcCc--------------------------------------------------------cccccccC
Confidence 9999999987653210 11234469
Q ss_pred CCCCccchhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHh
Q 014344 247 TEEYVAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLL 318 (426)
Q Consensus 247 t~~y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L 318 (426)
|+.|+|||++. +..++.++|||||||++|+|++|..||.+.+.......+...+. .....+..+.+||.+||
T Consensus 192 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 271 (326)
T 2x7f_A 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 271 (326)
T ss_dssp CGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHC
T ss_pred CccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHh
Confidence 99999999997 56688999999999999999999999998887776666544322 22356789999999999
Q ss_pred ccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 319 EKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 319 ~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
..||.+|||++++++||||++..+..
T Consensus 272 ~~dp~~Rps~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 272 VKNHSQRPATEQLMKHPFIRDQPNER 297 (326)
T ss_dssp CSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred ccChhhCCCHHHHhhChHHhhCcccc
Confidence 99999999999999999998766544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=390.42 Aligned_cols=277 Identities=24% Similarity=0.372 Sum_probs=229.7
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhc----ccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKEL----TNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~----~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
..+..++|++++.||+|+||.||+|.+ +++.||||++............ ...........+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345568999999999999999999998 8999999999765543221000 0001112237888999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHH------HHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCe
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSL------RKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENI 159 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l------~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~Ni 159 (426)
||+++++++.+.+.+|+|||||+|++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999987 554335679999999999999999999999 9999999999999
Q ss_pred eeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239 (426)
Q Consensus 160 Ll~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (426)
|++.++.+||+|||++......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---------------------------------------------------------- 205 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---------------------------------------------------------- 205 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT----------------------------------------------------------
T ss_pred EEcCCCcEEEeccccccccccc----------------------------------------------------------
Confidence 9999999999999998765311
Q ss_pred CccccccCCCCccchhhcCC-CCCh-hhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCC-------------
Q 014344 240 KSNSFVGTEEYVAPEIIEGK-GHDF-AVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRPPDL------------- 303 (426)
Q Consensus 240 ~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~------------- 303 (426)
......||+.|+|||++.+. .++. ++|||||||++|+|++|+.||...+. .+....+.......
T Consensus 206 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 285 (348)
T 2pml_X 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTN 285 (348)
T ss_dssp EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC
T ss_pred cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccc
Confidence 12234689999999999887 6666 99999999999999999999998776 66666665443222
Q ss_pred -------CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhhhh
Q 014344 304 -------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 304 -------~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
...+..+.+||.+||+.||.+|||+.|+++||||++.+|..+.+
T Consensus 286 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp --------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHH
T ss_pred cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHH
Confidence 34578899999999999999999999999999999999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=374.69 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=215.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA------------VDCPENIKKEICINKMLNHENVVKFYGHR 74 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC------------TTHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc------------hhhhHHHHHHHHHHHhcCCCCceeeeeEE
Confidence 579999999999999999999999999999999854321 12346788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+.+..|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 75 REGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp EETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EcCCEEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999999999999887543 34999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
..+.... ........+||+.|+|||+
T Consensus 153 ~~~~~~~------------------------------------------------------~~~~~~~~~~~~~y~aPE~ 178 (276)
T 2yex_A 153 TVFRYNN------------------------------------------------------RERLLNKMCGTLPYVAPEL 178 (276)
T ss_dssp EECEETT------------------------------------------------------EECCBCCCCSCGGGCCGGG
T ss_pred cccCCCc------------------------------------------------------chhcccCCccccCccChHH
Confidence 7653111 0011234569999999999
Q ss_pred hcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 256 IEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 256 ~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
+.+..+ +.++|||||||++|+|++|+.||...... ..+..+.... ......+..+.+||.+||..||.+|||+++
T Consensus 179 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp GTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 988775 78999999999999999999999876543 2233332222 122345788999999999999999999999
Q ss_pred HhcCCCcCCC
Q 014344 331 IKGHEFFKGV 340 (426)
Q Consensus 331 il~hp~f~~~ 340 (426)
+++||||+..
T Consensus 259 il~~~~~~~~ 268 (276)
T 2yex_A 259 IKKDRWYNKP 268 (276)
T ss_dssp HTTCTTTTCC
T ss_pred HhcCccccCh
Confidence 9999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=393.22 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=211.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CC-----Cc
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HP-----LL 88 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp-----~i 88 (426)
.++|++++.||+|+||+||+|++..+++.||||++.... .....+..|+.+++.+. |+ +|
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~~i 118 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--------------AFLNQAQIEVRLLELMNKHDTEMKYYI 118 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--------------HHHHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--------------HHHHHHHHHHHHHHHHHhcccccceeE
Confidence 578999999999999999999999999999999985321 23456677888888885 45 49
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCCeeec--cC
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH--NMGIVYRDLKPENIMIQ--EN 164 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH--~~giiHrDlKp~NiLl~--~~ 164 (426)
+.+++++...+.+|+||||+. ++|.+++.......+++..++.++.||+.||.||| +.||+||||||+|||++ .+
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred EEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 999999999999999999996 59999988766566999999999999999999999 57999999999999995 47
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++..... .....
T Consensus 198 ~~~kL~DFG~a~~~~~-----------------------------------------------------------~~~~~ 218 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQ-----------------------------------------------------------RIYQY 218 (382)
T ss_dssp CCEEECCCTTCEETTC-----------------------------------------------------------CCCSS
T ss_pred CcEEEEeccCceeccc-----------------------------------------------------------ccccc
Confidence 8899999999976531 12234
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCC-------------------
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPD------------------- 302 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~------------------- 302 (426)
+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+.+..+... ++.
T Consensus 219 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (382)
T 2vx3_A 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDG 298 (382)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTS
T ss_pred cCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccc
Confidence 6999999999999999999999999999999999999999999887776655421 000
Q ss_pred ---------------CC---------------------C-------CCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 ---------------LV---------------------G-------EPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 ---------------~~---------------------~-------~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.. + ....+.+||.+||++||++|||++|+|+||||++
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~ 378 (382)
T 2vx3_A 299 TWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378 (382)
T ss_dssp CEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC
T ss_pred ccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccccc
Confidence 00 0 0036889999999999999999999999999987
Q ss_pred CCh
Q 014344 340 VNW 342 (426)
Q Consensus 340 ~~~ 342 (426)
..+
T Consensus 379 ~~~ 381 (382)
T 2vx3_A 379 TAD 381 (382)
T ss_dssp ---
T ss_pred CCC
Confidence 543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=385.32 Aligned_cols=254 Identities=28% Similarity=0.357 Sum_probs=212.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEE-cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC-----
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKD-VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP----- 86 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~-~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp----- 86 (426)
+-.++|++++.||+|+||+||+|.+ ..+++.||||++.... .....+.+|+.+++.+.|+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~ 76 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--------------RYCEAARSEIQVLEHLNTTDPNST 76 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--------------HHHHHHHHHHHHHHHHHHHCTTCT
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--------------chhHHHHHHHHHHHHhhhcCCCCc
Confidence 3446799999999999999999998 5688999999984321 2345677899999988765
Q ss_pred -CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--
Q 014344 87 -LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-- 163 (426)
Q Consensus 87 -~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-- 163 (426)
+++++++++...+.+|+||||| +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 77 ~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 77 FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp TCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCC
T ss_pred eeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccc
Confidence 4999999999999999999999 899999988776567999999999999999999999999999999999999987
Q ss_pred -----------------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCC
Q 014344 164 -----------------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIG 226 (426)
Q Consensus 164 -----------------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (426)
++.+||+|||++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---------------------------------------------- 189 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---------------------------------------------- 189 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTS----------------------------------------------
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcc----------------------------------------------
Confidence 66899999999875421
Q ss_pred CCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCC-
Q 014344 227 PDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPD- 302 (426)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~- 302 (426)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+. ...+.
T Consensus 190 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~ 256 (339)
T 1z57_A 190 -------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKH 256 (339)
T ss_dssp -------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHH
T ss_pred -------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 1123469999999999999999999999999999999999999999888766543331 11110
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 -----------------------------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 -----------------------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
....+..+.+||.+||..||.+|||+.|+++||||+.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 257 MIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 00113568899999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=396.34 Aligned_cols=251 Identities=21% Similarity=0.312 Sum_probs=205.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--------CC
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--------HP 86 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--------hp 86 (426)
.++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+.+. ||
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~~~ 101 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--------------HYTETALDEIRLLKSVRNSDPNDPNRE 101 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHSCTTCGGGG
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--------------cchHHHHHHHHHHHHHhhcCCCCCCcc
Confidence 467999999999999999999999999999999985321 23456788999999985 78
Q ss_pred Ccceeeeeee----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeee
Q 014344 87 LLPRLRGVLS----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMI 161 (426)
Q Consensus 87 ~iv~l~~~~~----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl 161 (426)
||++++++|. ....+|+||||| +++|.+++.....+.+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 102 ~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll 180 (397)
T 1wak_A 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILL 180 (397)
T ss_dssp GBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEE
T ss_pred eeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeE
Confidence 8999999997 567899999999 56666666655556699999999999999999999998 99999999999999
Q ss_pred ccCC-------------------------------------------------cEEEecccccccCCCCCCCCCcchhhc
Q 014344 162 QENG-------------------------------------------------HIMLVDFDLSTKLSPKTPQASPKTVLA 192 (426)
Q Consensus 162 ~~~g-------------------------------------------------~ikL~DFgls~~~~~~~~~~~~~~~~~ 192 (426)
+.++ .+||+|||++.....
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------------ 248 (397)
T 1wak_A 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------------ 248 (397)
T ss_dssp CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------------
T ss_pred eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------------
Confidence 9775 799999999876531
Q ss_pred cccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHH
Q 014344 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGV 272 (426)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 272 (426)
.....+||+.|+|||++.+..++.++|||||||
T Consensus 249 -----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 281 (397)
T 1wak_A 249 -----------------------------------------------HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTAC 281 (397)
T ss_dssp -----------------------------------------------CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred -----------------------------------------------cCccCCCCCcccCChhhcCCCCCcHHHHHHHHH
Confidence 122346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC------HHHHHHHH---hcCCCC----------------------------------------C
Q 014344 273 VLHEMLYGATPFRGSS------RKETFYRI---LCRPPD----------------------------------------L 303 (426)
Q Consensus 273 il~ell~g~~pf~~~~------~~~~~~~i---~~~~~~----------------------------------------~ 303 (426)
++|+|++|+.||.+.+ .......+ +...+. .
T Consensus 282 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 361 (397)
T 1wak_A 282 MAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS 361 (397)
T ss_dssp HHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCC
T ss_pred HHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccc
Confidence 9999999999998654 22222222 111100 0
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
...+..+.+||.+||+.||.+|||++|||+||||++
T Consensus 362 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 362 QEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 011345789999999999999999999999999963
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=387.55 Aligned_cols=258 Identities=28% Similarity=0.361 Sum_probs=214.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCC-ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-----
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESS-ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL----- 87 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~----- 87 (426)
-.++|++++.||+|+||+||+|.+..++ +.||+|++.... .....+..|+.+++.+.|++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG--------------KYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH--------------HHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc--------------cchhHHHHHHHHHHHHhhcCCCCce
Confidence 3467999999999999999999998777 689999985321 23456777999999987655
Q ss_pred -cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee-----
Q 014344 88 -LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----- 161 (426)
Q Consensus 88 -iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl----- 161 (426)
++.+++++...+.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~ 161 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEF 161 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCE
T ss_pred eEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccc
Confidence 899999999999999999999 5677777666555669999999999999999999999999999999999999
Q ss_pred --------------ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 162 --------------QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 162 --------------~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
+.++.+||+|||++.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~----------------------------------------------- 194 (355)
T 2eu9_A 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE----------------------------------------------- 194 (355)
T ss_dssp EEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----------------------------------------------
T ss_pred cccccccccccccccCCCcEEEeecCccccccc-----------------------------------------------
Confidence 5678999999999875321
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCC--
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPD-- 302 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~-- 302 (426)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.
T Consensus 195 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~ 262 (355)
T 2eu9_A 195 ------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHM 262 (355)
T ss_dssp ------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHH
Confidence 1123469999999999999999999999999999999999999999888765543322 11110
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 303 ----------------------------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 303 ----------------------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
....+..+.+||.+||+.||++|||+.|+|+||||++++|
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 263 IHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp HHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred hhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence 0011246889999999999999999999999999999988
Q ss_pred hhh
Q 014344 343 ELL 345 (426)
Q Consensus 343 ~~~ 345 (426)
+..
T Consensus 343 ~~~ 345 (355)
T 2eu9_A 343 EER 345 (355)
T ss_dssp HHH
T ss_pred hhc
Confidence 764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=381.45 Aligned_cols=260 Identities=29% Similarity=0.391 Sum_probs=217.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEc-CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCcce
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDV-ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPR 90 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~ 90 (426)
.++|++++.||+|+||+||+|++. .+++.||+|++...... ......+.+|+.+++.+ .||||++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~h~~i~~ 78 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-----------EGMPLSTIREVAVLRHLETFEHPNVVR 78 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-----------TSCBCTHHHHHHHHHHHHHTCCTTBCC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-----------ccCCchhhHHHHHHHhhhccCCCCeEe
Confidence 367999999999999999999995 67899999998543211 11123455677777766 8999999
Q ss_pred eeeeee-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 91 LRGVLS-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 91 l~~~~~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
+++++. ....+++||||+. |+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 79 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC
T ss_pred eeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC
Confidence 999987 5678999999997 6999998876656699999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++...... .......
T Consensus 158 ~~kl~Dfg~~~~~~~~---------------------------------------------------------~~~~~~~ 180 (326)
T 1blx_A 158 QIKLADFGLARIYSFQ---------------------------------------------------------MALTSVV 180 (326)
T ss_dssp CEEECSCCSCCCCCGG---------------------------------------------------------GGGCCCC
T ss_pred CEEEecCcccccccCC---------------------------------------------------------CCccccc
Confidence 9999999998754311 0122346
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C----------------------
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P---------------------- 300 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~---------------------- 300 (426)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......++.. +
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 1blx_A 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 260 (326)
T ss_dssp CCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCC
T ss_pred cccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcc
Confidence 899999999999999999999999999999999999999999887776665421 0
Q ss_pred ---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 301 ---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 301 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
......+..+.+||.+||..||.+|||+.++++||||+++++.
T Consensus 261 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 261 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 0112457789999999999999999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=403.86 Aligned_cols=250 Identities=17% Similarity=0.238 Sum_probs=202.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH---HHHhcCCCCccee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR---VLRNVEHPLLPRL 91 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~---il~~l~hp~iv~l 91 (426)
.++|++++.||+|+||+||+|++..+|+.||||++.+... ......+.+.+|+. +|+.++||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~~l~hpniv~~ 141 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER----------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-----------CCTTHHHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc----------cchHHHHHHHHHHHHHHhccccCCHHHHHH
Confidence 4679999999999999999999999999999999964321 12234577888995 4555579999999
Q ss_pred e-------eeeecCC-----------------eEEEEEeccCCCChHHHHHHhccCCCCH-------HHHHHHHHHHHHH
Q 014344 92 R-------GVLSTDK-----------------FVGYAIDYCPGRDLHSLRKQQSEQMFSD-------DTIRFYAAELVLA 140 (426)
Q Consensus 92 ~-------~~~~~~~-----------------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~-------~~~~~~~~qil~a 140 (426)
+ +++.+.+ ..|+||||| +|+|.+++..... +++ ..+..++.||+.|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~a 218 (377)
T 3byv_A 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRL 218 (377)
T ss_dssp HHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHH
T ss_pred HhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHH
Confidence 8 6666554 389999999 6899999876532 444 7888899999999
Q ss_pred HHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCC
Q 014344 141 LEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPV 220 (426)
Q Consensus 141 L~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (426)
|+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 219 L~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------- 258 (377)
T 3byv_A 219 LASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------------------------------------- 258 (377)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC----------------------------------------
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC----------------------------------------
Confidence 9999999999999999999999999999999999875321
Q ss_pred CCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC-----------CCChhhHHHHHHHHHHHHHhCCCCCCCCCH
Q 014344 221 HSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK-----------GHDFAVDWWSLGVVLHEMLYGATPFRGSSR 289 (426)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 289 (426)
.....+| +.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 259 -------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 259 -------------------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318 (377)
T ss_dssp -------------------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred -------------------cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc
Confidence 2234468 999999999987 899999999999999999999999987765
Q ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 290 KETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 290 ~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
......+.... ...+..+.+||.+||+.||.+|||+.++++||||+++
T Consensus 319 ~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 319 LGGSEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp -CCSGGGGSSC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred ccchhhhhhhc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 55444444332 4558999999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=387.05 Aligned_cols=259 Identities=19% Similarity=0.306 Sum_probs=219.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-------CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-------ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 82 (426)
.+.+..++|++++.||+|+||+||+|++. .++..||||++.... .......+.+|+.+|+.
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~ 142 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA------------TEKDLSDLVSEMEMMKM 142 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC------------BHHHHHHHHHHHHHHHH
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc------------CHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999975 345679999985431 12345678899999999
Q ss_pred c-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 83 V-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 83 l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+ +||||+++++++..++.+|+|||||+||+|.+++.... ...++...+..++.||+.||+|||++
T Consensus 143 l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 222 (370)
T 2psq_A 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222 (370)
T ss_dssp SCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9 89999999999999999999999999999999987653 23488999999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 223 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-------------------------------------------- 258 (370)
T 2psq_A 223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY-------------------------------------------- 258 (370)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCT--------------------------------------------
T ss_pred CeeccccchhhEEECCCCCEEEccccCCcccCcccc--------------------------------------------
Confidence 999999999999999999999999999986542110
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLV 304 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~ 304 (426)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... +....
T Consensus 259 ----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 328 (370)
T 2psq_A 259 ----------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA 328 (370)
T ss_dssp ----------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ----------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 011223457899999999999999999999999999999998 99999998877776665533 23344
Q ss_pred CCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 305 ~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
..+..+.+||.+||..||.+|||+.|++++
T Consensus 329 ~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 329 NCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 668899999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=383.91 Aligned_cols=268 Identities=27% Similarity=0.361 Sum_probs=216.2
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|++..+++.||||++... ........+.+|+.+|+.++||||++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 77 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF------------DKPLFALRTLREIKILKHFKHENIITIFNI 77 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC------------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc------------ccchHHHHHHHHHHHHHhCcCCCcCCeeee
Confidence 36799999999999999999999999999999998432 122345577889999999999999999998
Q ss_pred eecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 95 LSTD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 95 ~~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+..+ ...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 78 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 78 QRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp CCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEE
T ss_pred ecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEE
Confidence 7654 78999999997 689888765 35999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+......... ...........+||+.
T Consensus 154 ~Dfg~a~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~gt~~ 187 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSE----------------------------------------------PTGQQSGMVEFVATRW 187 (353)
T ss_dssp CCCTTCEECC--------------------------------------------------------------CCCCCCGG
T ss_pred EecccccccccccccccC----------------------------------------------ccccccchhhcccccc
Confidence 999999876432110000 0000112334679999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCC------------------------
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPP------------------------ 301 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~------------------------ 301 (426)
|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+. ..+.
T Consensus 188 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (353)
T 2b9h_A 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP 267 (353)
T ss_dssp GCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC
T ss_pred ccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC
Confidence 999998765 678999999999999999999999999988766554432 1111
Q ss_pred ------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 302 ------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 302 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
.....+..+.+||.+||..||++|||++|+++||||+...+..
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 268 AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 0124578899999999999999999999999999999876544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=373.04 Aligned_cols=259 Identities=25% Similarity=0.354 Sum_probs=219.9
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+..|+.+++.++||||+++++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 72 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-----------TEAEKQMLVSEVNLLRELKHPNIVRYYD 72 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-----------CHHHHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 46789999999999999999999999999999999965422 1234567889999999999999999999
Q ss_pred eee--cCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCCeeeccC
Q 014344 94 VLS--TDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMG-----IVYRDLKPENIMIQEN 164 (426)
Q Consensus 94 ~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~g-----iiHrDlKp~NiLl~~~ 164 (426)
++. ....+|+||||++|++|.+++.... ...+++..+..++.||+.||.|||++| |+||||||+|||++.+
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~ 152 (279)
T 2w5a_A 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 152 (279)
T ss_dssp EEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS
T ss_pred EEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC
Confidence 874 4678999999999999999887543 345999999999999999999999999 9999999999999999
Q ss_pred CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccc
Q 014344 165 GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244 (426)
Q Consensus 165 g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (426)
+.+||+|||++....... ......
T Consensus 153 ~~~kl~dfg~~~~~~~~~--------------------------------------------------------~~~~~~ 176 (279)
T 2w5a_A 153 QNVKLGDFGLARILNHDT--------------------------------------------------------SFAKTF 176 (279)
T ss_dssp SCEEECCCCHHHHC---C--------------------------------------------------------HHHHHH
T ss_pred CCEEEecCchheeecccc--------------------------------------------------------cccccc
Confidence 999999999987653210 012234
Q ss_pred ccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCC
Q 014344 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 245 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP 322 (426)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ......+..+.+||.+||..||
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p 256 (279)
T 2w5a_A 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKD 256 (279)
T ss_dssp HSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred CCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCc
Confidence 68999999999999999999999999999999999999999988877766665332 2333568899999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
.+|||+.||++|+|+.+
T Consensus 257 ~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 257 YHRPSVEEILENPLILE 273 (279)
T ss_dssp GGSCCHHHHHTSTTCCG
T ss_pred ccCCCHHHHHhChhhhh
Confidence 99999999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=390.43 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=209.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCccee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLPRL 91 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l 91 (426)
...+|++++.||+|+||+||+|.+.. ++.||||++.+... .......+.+|+.+|+.+. ||||+++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-----------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~ 121 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-----------DNQTLDSYRNEIAYLNKLQQHSDKIIRL 121 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-----------cHHHHHHHHHHHHHHHHcccCCCeEEEE
Confidence 34569999999999999999999865 89999999865321 2234567889999999997 5999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++..++.+|+||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 122 ~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~D 197 (390)
T 2zmd_A 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 197 (390)
T ss_dssp EEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECC
T ss_pred EEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEe
Confidence 999999999999999 56899999987643 589999999999999999999999999999999999995 68999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++..+..... .......+||+.|+
T Consensus 198 FG~a~~~~~~~~------------------------------------------------------~~~~~~~~gt~~y~ 223 (390)
T 2zmd_A 198 FGIANQMQPDTT------------------------------------------------------SVVKDSQVGAVNYM 223 (390)
T ss_dssp CSSSCCC---------------------------------------------------------------CCSCCCGGGC
T ss_pred cCccccccCCCc------------------------------------------------------cccCCCCCcCCCcc
Confidence 999986642110 01123457999999
Q ss_pred cchhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC---CCCCCCCHHHHHHHHH
Q 014344 252 APEIIEG-----------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRP---PDLVGEPTPLRNLIRR 316 (426)
Q Consensus 252 aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~---~~~~~~~~~~~~li~~ 316 (426)
|||++.+ ..++.++|||||||++|+|++|+.||..... ...+..++... ......+..+.+||.+
T Consensus 224 aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 303 (390)
T 2zmd_A 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC 303 (390)
T ss_dssp CHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHH
T ss_pred ChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHH
Confidence 9999975 3689999999999999999999999987643 34455554322 1122346789999999
Q ss_pred HhccCCCCCCChHHHhcCCCcCCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
||+.||.+|||+.|+|+||||+..
T Consensus 304 ~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 304 CLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HcccChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999999743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=378.53 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=210.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++.+.||+|+||+||+|++ +++.||||++..... .....+.+.+|+.+|++++||||+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv 97 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-----------HAERVNEFLREVAIMKRLRHPNIV 97 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-----------SHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhCCCCCEe
Confidence 4567788999999999999999999986 688999999854321 223456788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeeccCCc
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGH 166 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~~~g~ 166 (426)
++++++.....+|+|||||+|++|.+++.... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp CEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred eEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence 99999999999999999999999999887532 123899999999999999999999999 999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++...... .......+|
T Consensus 178 ~kL~Dfg~a~~~~~~--------------------------------------------------------~~~~~~~~g 201 (309)
T 3p86_A 178 VKVCDFGLSRLKAST--------------------------------------------------------FLSSKSAAG 201 (309)
T ss_dssp EEECCCC-------------------------------------------------------------------------
T ss_pred EEECCCCCCcccccc--------------------------------------------------------ccccccCCC
Confidence 999999998754211 011234569
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ........++.+.+||.+||+.||.
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 281 (309)
T 3p86_A 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPW 281 (309)
T ss_dssp CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChh
Confidence 9999999999999999999999999999999999999999988877666532 2233345688999999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
+|||+.++++
T Consensus 282 ~Rps~~~ll~ 291 (309)
T 3p86_A 282 KRPSFATIMD 291 (309)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=380.50 Aligned_cols=272 Identities=20% Similarity=0.280 Sum_probs=203.9
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
....+..++|++++.||+|+||+||+|++..+++ .||||++...... ....+.+.+|+.+++.++|
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h 84 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-----------SSDIEEFLREAACMKEFDH 84 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-----------------CHHHHHHHHHHHHHTTCCC
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-----------HHHHHHHHHHHHHHHHCCC
Confidence 3445677889999999999999999999887765 8999998544321 2245678899999999999
Q ss_pred CCcceeeeeeecCCeE------EEEEeccCCCChHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 014344 86 PLLPRLRGVLSTDKFV------GYAIDYCPGRDLHSLRKQQSE----QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLK 155 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~------~lV~Ey~~gg~L~~l~~~~~~----~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlK 155 (426)
|||+++++++...... ++||||+.+++|.+++..... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 85 ~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dik 164 (323)
T 3qup_A 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLA 164 (323)
T ss_dssp TTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCC
Confidence 9999999999877655 999999999999998765432 248999999999999999999999999999999
Q ss_pred CCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 156 PENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235 (426)
Q Consensus 156 p~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (426)
|+|||++.++.+||+|||++........
T Consensus 165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~---------------------------------------------------- 192 (323)
T 3qup_A 165 ARNCMLAEDMTVCVADFGLSRKIYSGDY---------------------------------------------------- 192 (323)
T ss_dssp GGGEEECTTSCEEECCCCC-------------------------------------------------------------
T ss_pred cceEEEcCCCCEEEeecccccccccccc----------------------------------------------------
Confidence 9999999999999999999976532110
Q ss_pred CCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHH
Q 014344 236 DSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRN 312 (426)
Q Consensus 236 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~ 312 (426)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... .......+..+.+
T Consensus 193 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 270 (323)
T 3qup_A 193 --YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYD 270 (323)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred --ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHH
Confidence 011122347889999999999999999999999999999999 99999998887777776643 3344566889999
Q ss_pred HHHHHhccCCCCCCC-------hHHHhcCCCcCCCChhhh
Q 014344 313 LIRRLLEKDPTKRIG-------VEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 313 li~~~L~~dP~~R~s-------~~eil~hp~f~~~~~~~~ 345 (426)
||.+||+.||.+||| +++++.|||+....++.+
T Consensus 271 li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 271 LMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 999999999999999 778889999976554433
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=385.25 Aligned_cols=264 Identities=26% Similarity=0.434 Sum_probs=210.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||||++.+....... .........+.+|+.+|+.++||||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS-----AREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--------------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcc-----cccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 4699999999999999999999999999999999664432110 01112345678899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc---EEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---IMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---ikL~DF 172 (426)
..+. .|+||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+||
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred cCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 7665 89999999999999887643 45999999999999999999999999999999999999987664 999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++...... ......+||+.|+|
T Consensus 162 g~~~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 184 (322)
T 2ycf_A 162 GHSKILGET---------------------------------------------------------SLMRTLCGTPTYLA 184 (322)
T ss_dssp TTCEECCCC---------------------------------------------------------HHHHHHHSCCTTCC
T ss_pred ccceecccc---------------------------------------------------------cccccccCCcCccC
Confidence 998765311 11234469999999
Q ss_pred chhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCC
Q 014344 253 PEIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE-TFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 253 PE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~ 323 (426)
||++. ...++.++|||||||++|+|++|..||....... ....+...... ....+..+.+||.+||..||.
T Consensus 185 PE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 264 (322)
T 2ycf_A 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264 (322)
T ss_dssp HHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred chhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHh
Confidence 99974 4668899999999999999999999998654332 22222222111 134578899999999999999
Q ss_pred CCCChHHHhcCCCcCCCChhh
Q 014344 324 KRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 324 ~R~s~~eil~hp~f~~~~~~~ 344 (426)
+|||+.++++||||++.+|..
T Consensus 265 ~Rps~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 265 ARFTTEEALRHPWLQDEDMKR 285 (322)
T ss_dssp TSCCHHHHHTSGGGCCHHHHH
T ss_pred hCCCHHHHhhCcCcCCHHHHH
Confidence 999999999999999876653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=398.43 Aligned_cols=260 Identities=22% Similarity=0.247 Sum_probs=197.1
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc--CCCCcceee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV--EHPLLPRLR 92 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hp~iv~l~ 92 (426)
..+|++++.||+|+||+||+|++..+++.||||++.+..... ......+..|+.+++.| +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~~~~l~~~hp~iv~~~ 130 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS----------RSELERLHEATFAAARLLGESPEEARDR 130 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH----------HHHHHHHHHHHHHHHHHHC---------
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc----------ccHHHHHHHHHHHHHHhcccChhhhhhc
Confidence 345999999999999999999999999999999996643211 12345677785555555 699988755
Q ss_pred -------eeeecC-----------------CeEEEEEeccCCCChHHHHHHhccCCCCHHHH------HHHHHHHHHHHH
Q 014344 93 -------GVLSTD-----------------KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI------RFYAAELVLALE 142 (426)
Q Consensus 93 -------~~~~~~-----------------~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~------~~~~~qil~aL~ 142 (426)
+++..+ ..+|+|||||+ |+|.+++..... .++.... ..++.||+.||+
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~ 208 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAA 208 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHH
Confidence 444433 34899999998 899999876533 2455555 567799999999
Q ss_pred HHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCC
Q 014344 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHS 222 (426)
Q Consensus 143 ~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (426)
|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 209 ~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~------------------------------------------ 246 (371)
T 3q60_A 209 NLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT------------------------------------------ 246 (371)
T ss_dssp HHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC------------------------------------------
T ss_pred HHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC------------------------------------------
Confidence 99999999999999999999999999999999976521
Q ss_pred CCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC--CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH--
Q 014344 223 PRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG--KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET--FYRI-- 296 (426)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i-- 296 (426)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... +...
T Consensus 247 -----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 309 (371)
T 3q60_A 247 -----------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309 (371)
T ss_dssp -----------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCT
T ss_pred -----------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhh
Confidence 1113357799999999987 7799999999999999999999999987743211 1100
Q ss_pred ---h---cCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhhh
Q 014344 297 ---L---CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELL 345 (426)
Q Consensus 297 ---~---~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~~ 345 (426)
. ...+.....+..+.+||.+||+.||++|||+.++|+||||+++.|..-
T Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence 0 011222356889999999999999999999999999999998777654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=395.64 Aligned_cols=258 Identities=26% Similarity=0.383 Sum_probs=193.2
Q ss_pred CcEE-EeeecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 17 CLRI-VSALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 17 ~y~i-~~~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.|++ .++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.++||||+++++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~E~~~l~~l~hpniv~~~~ 85 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---------------ISMSACREIALLRELKHPNVISLQK 85 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---------------CCHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---------------CCHHHHHHHHHHHhcCCCCeeeEee
Confidence 3666 468999999999999966 578899999984321 2245778999999999999999999
Q ss_pred eee--cCCeEEEEEeccCCCChHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---
Q 014344 94 VLS--TDKFVGYAIDYCPGRDLHSLRKQQS-------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI--- 161 (426)
Q Consensus 94 ~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~-------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl--- 161 (426)
+|. .+..+|+|||||. ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~ 164 (405)
T 3rgf_A 86 VFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164 (405)
T ss_dssp EEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCS
T ss_pred EEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecC
Confidence 994 5789999999996 67877765322 1249999999999999999999999999999999999999
Q ss_pred -ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 162 -QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 162 -~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
+.++.+||+|||+++.+..... ....
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~-----------------------------------------------------~~~~ 191 (405)
T 3rgf_A 165 GPERGRVKIADMGFARLFNSPLK-----------------------------------------------------PLAD 191 (405)
T ss_dssp STTTTCEEECCTTCCC----------------------------------------------------------------
T ss_pred CCCCCcEEEEECCCceecCCCCc-----------------------------------------------------cccc
Confidence 6778999999999986532110 0112
Q ss_pred ccccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh---cCCCC-----
Q 014344 241 SNSFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---------ETFYRIL---CRPPD----- 302 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~i~---~~~~~----- 302 (426)
....+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.... +.+.+++ ..+..
T Consensus 192 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~ 271 (405)
T 3rgf_A 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWED 271 (405)
T ss_dssp -----CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGG
T ss_pred CCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcch
Confidence 3445799999999999874 5899999999999999999999999876542 3333322 11111
Q ss_pred -------------------------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 303 -------------------------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 303 -------------------------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
....+..+.+||.+||+.||.+|||++|+|+||||++..|.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 272 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp GGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred hhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 01125678899999999999999999999999999875443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=379.56 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=209.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 76 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-------------DPQSVKHALREIKIIRRLDHDNIVKVFEI 76 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-------------SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-------------ChHHHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence 35799999999999999999999999999999998432 12345678889999999999999999998
Q ss_pred ee--------------cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 95 LS--------------TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 95 ~~--------------~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
+. ....+|+||||+. |+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 152 (320)
T 2i6l_A 77 LGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF 152 (320)
T ss_dssp ECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEE
T ss_pred ccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 73 4478999999997 689888753 45999999999999999999999999999999999999
Q ss_pred ec-cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQ-ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239 (426)
Q Consensus 161 l~-~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (426)
++ .++.+||+|||++........ ...
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------------~~~ 179 (320)
T 2i6l_A 153 INTEDLVLKIGDFGLARIMDPHYS-----------------------------------------------------HKG 179 (320)
T ss_dssp EETTTTEEEECCCTTCBCC-------------------------------------------------------------
T ss_pred EcCCCCeEEEccCccccccCCCcc-----------------------------------------------------ccc
Confidence 97 567999999999986532110 011
Q ss_pred CccccccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------------
Q 014344 240 KSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD---------------- 302 (426)
Q Consensus 240 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------- 302 (426)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....+.
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (320)
T 2i6l_A 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259 (320)
T ss_dssp CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHH
T ss_pred ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCccc
Confidence 2234468999999999876 67899999999999999999999999998877766555422110
Q ss_pred ---------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChhh
Q 014344 303 ---------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 303 ---------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~~ 344 (426)
....+..+.+||.+||+.||.+|||++++++||||+...|..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred ccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 124578899999999999999999999999999998776644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=390.99 Aligned_cols=263 Identities=17% Similarity=0.241 Sum_probs=220.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEE-----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVK-----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
...+..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|+.++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 132 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC------------SEQDELDFLMEALIISKFN 132 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC------------CHHHHHHHHHHHHHHHHCC
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc------------ChhhHHHHHHHHHHHHhCC
Confidence 345677899999999999999999999 45678899999984321 1223456788999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCe
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-----QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENI 159 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-----~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~Ni 159 (426)
||||+++++++......|+|||||+||+|.+++..... ..++...+..++.||+.||+|||++||+||||||+||
T Consensus 133 hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 212 (367)
T 3l9p_A 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212 (367)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 99999999999999999999999999999999876542 3589999999999999999999999999999999999
Q ss_pred eeccCC---cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQENG---HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 160 Ll~~~g---~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
|++.+| .+||+|||+++.+....
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~------------------------------------------------------ 238 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAG------------------------------------------------------ 238 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHS------------------------------------------------------
T ss_pred EEecCCCCceEEECCCcccccccccc------------------------------------------------------
Confidence 999655 59999999997542110
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l 313 (426)
........+||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ......+..+.+|
T Consensus 239 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 318 (367)
T 3l9p_A 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI 318 (367)
T ss_dssp SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 0112334568999999999999999999999999999999998 999999999888877776432 3344668899999
Q ss_pred HHHHhccCCCCCCChHHHhcCCCcC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
|.+||+.||.+|||+.+|++|.++-
T Consensus 319 i~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 319 MTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999997653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=382.04 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=211.8
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++.+.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||+++++++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 92 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-----------QSEIFAKRAYRELLLLKHMQHENVIGLLDVF 92 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-----------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-----------cchHHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence 57999999999999999999999999999999985432 1223456788899999999999999999999
Q ss_pred ecCCe------EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 STDKF------VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~~~~~------~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
..... +|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp CSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEE
T ss_pred ecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEE
Confidence 87654 499999997 68877653 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..... .....+||+.
T Consensus 168 ~Dfg~~~~~~~-----------------------------------------------------------~~~~~~~t~~ 188 (353)
T 3coi_A 168 LDFGLARHADA-----------------------------------------------------------EMTGYVVTRW 188 (353)
T ss_dssp CSTTCTTC-------------------------------------------------------------------CCSBC
T ss_pred eecccccCCCC-----------------------------------------------------------CccccccCcC
Confidence 99999875421 1123468999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------------------
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----------------------------- 299 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----------------------------- 299 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 3coi_A 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268 (353)
T ss_dssp CSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS
T ss_pred cCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC
Confidence 999999987 67899999999999999999999999998876665544310
Q ss_pred ---CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 300 ---PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 300 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
.......+..+.+||.+||..||.+|||++++++||||+.....
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 269 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp CCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 01123457889999999999999999999999999999876543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=374.04 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=219.4
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|+.++++++||||+++++++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 90 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-----------NKDTSTILREVELLKKLDHPNIMKLFEIL 90 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-----------SSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-----------hHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence 5799999999999999999999999999999998654311 12356788899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC---CcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN---GHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~---g~ikL~DF 172 (426)
.....+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+||
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 91 EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred eCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999999999998876543 49999999999999999999999999999999999999764 47999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++....... ......||+.|+|
T Consensus 169 g~~~~~~~~~---------------------------------------------------------~~~~~~~~~~y~a 191 (287)
T 2wei_A 169 GLSTCFQQNT---------------------------------------------------------KMKDRIGTAYYIA 191 (287)
T ss_dssp TGGGTBCCCS---------------------------------------------------------SCSCHHHHHTTCC
T ss_pred CcceeecCCC---------------------------------------------------------ccccccCcccccC
Confidence 9987653211 1223458999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----CCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----DLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+. ++.++|||||||++|+|++|..||.+.+..+....+..... .....+..+.+||.+||..||.+|||
T Consensus 192 PE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 270 (287)
T 2wei_A 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270 (287)
T ss_dssp HHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC
Confidence 9999765 89999999999999999999999999888877776654322 12356888999999999999999999
Q ss_pred hHHHhcCCCcCCCCh
Q 014344 328 VEEIKGHEFFKGVNW 342 (426)
Q Consensus 328 ~~eil~hp~f~~~~~ 342 (426)
+.++++||||++..|
T Consensus 271 ~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 271 ATQCLEHPWIQKYSS 285 (287)
T ss_dssp HHHHHHSHHHHHHCC
T ss_pred HHHHhcCHHHhcccc
Confidence 999999999976443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=382.73 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=209.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
..-++|++++.||+|+||+||+|++..+++.||||++...... ...+.+.+|+.+|+.++||||++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~~iv~~~ 73 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------------RPVDVQMREFEVLKKLNHKNIVKLF 73 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc------------chHHHHHHHHHHHHhcCCCCcceEE
Confidence 3446799999999999999999999999999999999643221 1245677899999999999999999
Q ss_pred eeeecCC--eEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee----ccCC
Q 014344 93 GVLSTDK--FVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----QENG 165 (426)
Q Consensus 93 ~~~~~~~--~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl----~~~g 165 (426)
+++.... .+|+|||||+|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp EEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE
T ss_pred EEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc
Confidence 9997655 88999999999999999876433 339999999999999999999999999999999999999 7788
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++....... .....+
T Consensus 154 ~~kL~Dfg~a~~~~~~~---------------------------------------------------------~~~~~~ 176 (319)
T 4euu_A 154 VYKLTDFGAARELEDDE---------------------------------------------------------QFVSLY 176 (319)
T ss_dssp EEEECCCTTCEECCTTC---------------------------------------------------------CBCCCC
T ss_pred eEEEccCCCceecCCCC---------------------------------------------------------ceeecc
Confidence 89999999997653211 123456
Q ss_pred cCCCCccchhhc--------CCCCChhhHHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCC-----------
Q 014344 246 GTEEYVAPEIIE--------GKGHDFAVDWWSLGVVLHEMLYGATPFRGSS----RKETFYRILCRPPD----------- 302 (426)
Q Consensus 246 gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~----------- 302 (426)
||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ..+...+++...+.
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 256 (319)
T 4euu_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256 (319)
T ss_dssp SCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTT
T ss_pred cCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccC
Confidence 999999999986 5778999999999999999999999997433 23444454432221
Q ss_pred --------CC-------CCCHHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 303 --------LV-------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 303 --------~~-------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
.. ..+..+.+||++||+.||++|||++|+|+||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 00 1134688999999999999999999999997
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=373.82 Aligned_cols=252 Identities=26% Similarity=0.414 Sum_probs=219.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||.||+|++..+++.||||++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 89 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE------------AEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT------------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc------------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 46999999999999999999999999999999985432 122456788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
..+..+|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 90 LKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccc
Confidence 999999999999999999998753 45999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
....... ......+||+.|+|||+
T Consensus 167 ~~~~~~~--------------------------------------------------------~~~~~~~~~~~y~aPE~ 190 (303)
T 3a7i_A 167 GQLTDTQ--------------------------------------------------------IKRNTFVGTPFWMAPEV 190 (303)
T ss_dssp EECBTTB--------------------------------------------------------CCBCCCCSCGGGCCHHH
T ss_pred eecCccc--------------------------------------------------------cccCccCCCcCccCHHH
Confidence 7653211 11234569999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+..++.++|||||||++|+|++|+.||...........+.... ......+..+.+||.+||..||.+|||+.++++
T Consensus 191 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 999999999999999999999999999999888777665554322 223356888999999999999999999999999
Q ss_pred CCCcC
Q 014344 334 HEFFK 338 (426)
Q Consensus 334 hp~f~ 338 (426)
||||.
T Consensus 271 ~~~~~ 275 (303)
T 3a7i_A 271 HKFIL 275 (303)
T ss_dssp CHHHH
T ss_pred Chhhh
Confidence 99995
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=386.28 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=199.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
..+++|++++.||+|+||+||+|++..+++.||||++.... ....+...|+..++.++||||++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~~l~~l~h~niv~~~ 85 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--------------RFRNRELQIMQDLAVLHHPNIVQLQ 85 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--------------TCCCHHHHHHHHHHHHCCTTBCCEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--------------cccHHHHHHHHHHHhcCCCCcccHH
Confidence 45678999999999999999999999999999999884321 1123456678888999999999999
Q ss_pred eeeecCC-------eEEEEEeccCCCChHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCCCCeee
Q 014344 93 GVLSTDK-------FVGYAIDYCPGRDLHSLRKQ--QSEQMFSDDTIRFYAAELVLALEYLH--NMGIVYRDLKPENIMI 161 (426)
Q Consensus 93 ~~~~~~~-------~~~lV~Ey~~gg~L~~l~~~--~~~~~l~~~~~~~~~~qil~aL~~LH--~~giiHrDlKp~NiLl 161 (426)
++|.... ++++|||||.++ |...+.. .....+++..++.++.||+.||.||| ++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE
T ss_pred HhhhccccccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE
Confidence 9996533 389999999864 4443332 23456899999999999999999999 9999999999999999
Q ss_pred cc-CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 162 QE-NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 162 ~~-~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
+. ++.+||+|||++..+.... .
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~---------------------------------------------------------~ 187 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSE---------------------------------------------------------P 187 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTS---------------------------------------------------------C
T ss_pred eCCCCcEEEeeCCCceecCCCC---------------------------------------------------------C
Confidence 97 8999999999998654211 1
Q ss_pred ccccccCCCCccchhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C----------------
Q 014344 241 SNSFVGTEEYVAPEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P---------------- 300 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~---------------- 300 (426)
....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+... +
T Consensus 188 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3e3p_A 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD 267 (360)
T ss_dssp CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG
T ss_pred cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhcc
Confidence 22446899999999997654 899999999999999999999999999887776655321 0
Q ss_pred --------------CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 301 --------------PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 301 --------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
......+..+.+||.+||+.||.+|||+.|+|+||||+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 268 LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 01112356799999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=368.05 Aligned_cols=254 Identities=20% Similarity=0.285 Sum_probs=217.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.++.++|++++.||+|+||+||+|++. +++.||+|++..... ..+.+.+|+.++++++||||+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~ 68 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--------------SEEDFIEEAEVMMKLSHPKLV 68 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB--------------CHHHHHHHHHHHHTCCCTTBC
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc--------------CHHHHHHHHHHHHhCCCCCEe
Confidence 35678889999999999999999999986 577899999854321 224678899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.++...|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 147 (269)
T 4hcu_A 69 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKV 147 (269)
T ss_dssp CEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEE
T ss_pred eEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEe
Confidence 99999999999999999999999999986543 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ........||+.
T Consensus 148 ~Dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 172 (269)
T 4hcu_A 148 SDFGMTRFVLDDQ-------------------------------------------------------YTSSTGTKFPVK 172 (269)
T ss_dssp CCTTGGGGBCCHH-------------------------------------------------------HHSTTSTTCCGG
T ss_pred ccccccccccccc-------------------------------------------------------cccccCcccccc
Confidence 9999997653210 001122347888
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... .......+..+.+||.+||+.||++||
T Consensus 173 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 173 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCc
Confidence 999999999999999999999999999999 99999999988887777643 223334588899999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|+.++++|
T Consensus 253 s~~~ll~~ 260 (269)
T 4hcu_A 253 AFSRLLRQ 260 (269)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=378.16 Aligned_cols=257 Identities=23% Similarity=0.344 Sum_probs=217.9
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+.+..++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|+.++|||
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~ 111 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY------------TERQRRDFLSEASIMGQFDHPN 111 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 45778899999999999999999999986655 49999985421 1234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++.+.+..|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp BCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE
T ss_pred CCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCE
Confidence 9999999999999999999999999999986543 459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++..+...... ........+|
T Consensus 191 kl~Dfg~a~~~~~~~~~-----------------------------------------------------~~~~~~~~~t 217 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDA-----------------------------------------------------AYTTTGGKIP 217 (325)
T ss_dssp EECCCSSCEECC----C-----------------------------------------------------CEECC---CC
T ss_pred EECCCCcccccccCccc-----------------------------------------------------eeeccCCCCc
Confidence 99999999876432100 0011223468
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... .+.....+..+.+||.+||..||.+
T Consensus 218 ~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 297 (325)
T 3kul_A 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297 (325)
T ss_dssp GGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhh
Confidence 89999999999999999999999999999998 99999999888877776543 3444567899999999999999999
Q ss_pred CCChHHHhc
Q 014344 325 RIGVEEIKG 333 (426)
Q Consensus 325 R~s~~eil~ 333 (426)
|||+.+|++
T Consensus 298 Rps~~eil~ 306 (325)
T 3kul_A 298 RPRFSQIVS 306 (325)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=376.14 Aligned_cols=269 Identities=25% Similarity=0.367 Sum_probs=215.0
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
.+.+.+..++|++++.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+|+.++|||
T Consensus 2 ~p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-------------~~~~~~~~~~E~~~l~~l~hp~ 68 (310)
T 3s95_A 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-------------DEETQRTFLKEVKVMRCLEHPN 68 (310)
T ss_dssp CCCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred CcceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-------------CHHHHHHHHHHHHHHHhCCCcC
Confidence 345667889999999999999999999999999999999988332 2234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++.+++..|+|||||+|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 69 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~ 147 (310)
T 3s95_A 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147 (310)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCE
T ss_pred cccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCE
Confidence 9999999999999999999999999999987643 459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++.............. .............+||
T Consensus 148 kl~Dfg~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~gt 185 (310)
T 3s95_A 148 VVADFGLARLMVDEKTQPEGLR------------------------------------------SLKKPDRKKRYTVVGN 185 (310)
T ss_dssp EECCCTTCEECC--------------------------------------------------------------CCCCSC
T ss_pred EEeecccceecccccccccccc------------------------------------------cccccccccccccCCC
Confidence 9999999987643221100000 0000111233456899
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhcCCCCCCCCCHHHHHHHHHHhccCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET-----FYRILCRPPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~~~~~~~~~~~~li~~~L~~dP 322 (426)
+.|+|||++.+..++.++|||||||++|+|++|..||........ ..... ........+..+.+||.+||..||
T Consensus 186 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP 264 (310)
T 3s95_A 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-DRYCPPNCPPSFFPITVRCCDLDP 264 (310)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-HHTCCTTCCTTHHHHHHHHTCSSG
T ss_pred cceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-cccCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999999999875422110 00111 111234557889999999999999
Q ss_pred CCCCChHHHhc
Q 014344 323 TKRIGVEEIKG 333 (426)
Q Consensus 323 ~~R~s~~eil~ 333 (426)
++|||+.++++
T Consensus 265 ~~Rps~~~l~~ 275 (310)
T 3s95_A 265 EKRPSFVKLEH 275 (310)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=383.29 Aligned_cols=265 Identities=26% Similarity=0.428 Sum_probs=208.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||.||+|.+.. ++.||||++......... ..........+.+.+|+.+|+.++||||++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRT--VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSC--EEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccch--hhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 3679999999999999999999855 899999998553321110 0011123345789999999999999999999999
Q ss_pred ee-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 95 LS-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 95 ~~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
+. ....+|+|||||. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 84 3457899999997 6888777643 345999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++...... ......+||+.
T Consensus 176 ~Dfg~~~~~~~~---------------------------------------------------------~~~~~~~~t~~ 198 (362)
T 3pg1_A 176 CDFNLAREDTAD---------------------------------------------------------ANKTHYVTHRW 198 (362)
T ss_dssp CCTTC------------------------------------------------------------------------CGG
T ss_pred EecCcccccccc---------------------------------------------------------cccceecccce
Confidence 999998754211 11233468999
Q ss_pred CccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCC------------------------
Q 014344 250 YVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP------------------------ 301 (426)
Q Consensus 250 y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~------------------------ 301 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.. .+.
T Consensus 199 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (362)
T 3pg1_A 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP 278 (362)
T ss_dssp GCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCC
T ss_pred ecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCC
Confidence 999999987 6789999999999999999999999999887766655531 000
Q ss_pred ------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 302 ------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 302 ------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.....++.+.+||.+||+.||.+|||+.|+++||||+.+.
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 279 ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0123467799999999999999999999999999998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=377.63 Aligned_cols=261 Identities=18% Similarity=0.250 Sum_probs=210.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.++.++|++++.||+|+||+||+|++..+++.+|+|+..|.... .........+..|+.+++.++||||+
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv 78 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED--------KSGRQSFQAVTDHMLAIGSLDHAHIV 78 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECC--------TTSCSCBCSCCHHHHHHHTCCCTTBC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccc--------cccHHHHHHHHHHHHHHhcCCCCCcC
Confidence 3567788999999999999999999999988887444433221100 01112334566799999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++. +...++||||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 79 ~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 156 (325)
T 3kex_A 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQV 156 (325)
T ss_dssp CEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEE
T ss_pred eEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEE
Confidence 9999986 566899999999999999887543 35999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.+..... ........||+.
T Consensus 157 ~Dfg~a~~~~~~~~------------------------------------------------------~~~~~~~~~~~~ 182 (325)
T 3kex_A 157 ADFGVADLLPPDDK------------------------------------------------------QLLYSEAKTPIK 182 (325)
T ss_dssp CSCSGGGGSCCCTT------------------------------------------------------CCC-----CCTT
T ss_pred CCCCcccccCcccc------------------------------------------------------cccccCCCCccc
Confidence 99999987643211 011233458889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |+.||.+....+....+... .......+..+.+||.+||..||.+||
T Consensus 183 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 262 (325)
T 3kex_A 183 WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRP 262 (325)
T ss_dssp TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSC
T ss_pred ccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCc
Confidence 999999999999999999999999999999 99999988776666555433 233334577899999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|+.++++|
T Consensus 263 s~~el~~~ 270 (325)
T 3kex_A 263 TFKELANE 270 (325)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999886
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=379.17 Aligned_cols=260 Identities=20% Similarity=0.306 Sum_probs=221.4
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCC-------CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHH
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVES-------SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 81 (426)
+.+++..++|++++.||+|+||+||+|++..+ +..||||++.... .......+.+|+.+++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~ 129 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA------------TEKDLSDLISEMEMMK 129 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHH
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc------------CHHHHHHHHHHHHHHH
Confidence 35567788999999999999999999997643 3579999985431 1234567889999999
Q ss_pred hc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 014344 82 NV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------------QMFSDDTIRFYAAELVLALEYLHN 146 (426)
Q Consensus 82 ~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------------~~l~~~~~~~~~~qil~aL~~LH~ 146 (426)
.+ +||||+++++++..++.+|+|||||+||+|.+++..... ..+++..++.++.||+.||.|||+
T Consensus 130 ~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 209 (382)
T 3tt0_A 130 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209 (382)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 99 899999999999999999999999999999999886542 359999999999999999999999
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIG 226 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (426)
+||+||||||+|||++.++.+||+|||++........
T Consensus 210 ~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~------------------------------------------- 246 (382)
T 3tt0_A 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------------------------------------------- 246 (382)
T ss_dssp TTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT-------------------------------------------
T ss_pred CCEecCCCCcceEEEcCCCcEEEcccCcccccccccc-------------------------------------------
Confidence 9999999999999999999999999999986542110
Q ss_pred CCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCC
Q 014344 227 PDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDL 303 (426)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~ 303 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... ....
T Consensus 247 -----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (382)
T 3tt0_A 247 -----------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 315 (382)
T ss_dssp -----------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred -----------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 011223357899999999999999999999999999999999 99999999888777766543 2334
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||.+||+.||++|||+++|+++
T Consensus 316 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 316 SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4668899999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=385.82 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=208.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-----
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE----- 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~----- 84 (426)
...+..++|++++.||+|+||+||+|++..+++.||||++..... ....+..|+.+++.+.
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~e~~~l~~l~~~~~~ 78 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------YTEAAEDEIKLLQRVNDADNT 78 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHTCCS
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--------------chhhhhHHHHHHHHhhccccc
Confidence 455677899999999999999999999999999999999854321 2345677899988886
Q ss_pred ------CCCcceeeeeeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccC
Q 014344 85 ------HPLLPRLRGVLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRD 153 (426)
Q Consensus 85 ------hp~iv~l~~~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrD 153 (426)
||||+++++++.... .+++||||+ |++|.+++.......+++..++.++.||+.||+|||++ ||+|||
T Consensus 79 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~D 157 (373)
T 1q8y_A 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTD 157 (373)
T ss_dssp HHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSC
T ss_pred chhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 899999999997654 899999999 89999998876666699999999999999999999998 999999
Q ss_pred CCCCCeeecc------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 154 LKPENIMIQE------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 154 lKp~NiLl~~------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
|||+|||++. .+.+||+|||++.....
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~----------------------------------------------- 190 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE----------------------------------------------- 190 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----------------------------------------------
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCC-----------------------------------------------
Confidence 9999999953 34899999999876531
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh---c
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR------KETFYRIL---C 298 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~i~---~ 298 (426)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ......+. .
T Consensus 191 ------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (373)
T 1q8y_A 191 ------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 258 (373)
T ss_dssp ------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred ------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcC
Confidence 11233689999999999999999999999999999999999999986542 22222221 1
Q ss_pred CCC----------------------------------------CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcC
Q 014344 299 RPP----------------------------------------DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338 (426)
Q Consensus 299 ~~~----------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~ 338 (426)
..+ .....+..+.+||.+||+.||.+|||++|||+||||+
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 338 (373)
T 1q8y_A 259 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 338 (373)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGT
T ss_pred CCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhh
Confidence 110 0011245688999999999999999999999999998
Q ss_pred CC
Q 014344 339 GV 340 (426)
Q Consensus 339 ~~ 340 (426)
+.
T Consensus 339 ~~ 340 (373)
T 1q8y_A 339 DT 340 (373)
T ss_dssp TC
T ss_pred cc
Confidence 64
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=375.88 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=213.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~ 93 (426)
.++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.+++.+ +||||+++++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~E~~~l~~l~~h~~i~~~~~ 72 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---------------RAPQLHLEYRFYKQLGSGDGIPQVYY 72 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---------------SSCCHHHHHHHHHHHCSCTTSCCEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---------------chHHHHHHHHHHHHhhCCCCCCEEEE
Confidence 357999999999999999999999999999999984321 123577899999999 8999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc-----EE
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH-----IM 168 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~-----ik 168 (426)
++...+..|+||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~k 150 (330)
T 2izr_A 73 FGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIH 150 (330)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEE
T ss_pred EEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEE
Confidence 999999999999999 99999998765 346999999999999999999999999999999999999998887 99
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++..+....... ..........+||+
T Consensus 151 l~DFg~a~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~gt~ 181 (330)
T 2izr_A 151 IIDFALAKEYIDPETKK-------------------------------------------------HIPYREHKSLTGTA 181 (330)
T ss_dssp ECCCTTCEESBCTTTCC-------------------------------------------------BCCCCCCCCCCSCT
T ss_pred EEEcccceeeecCCCCc-------------------------------------------------cccccccCCcCCCc
Confidence 99999998764221100 00011234567999
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhc----CCC-C-CCCCCHHHHHHHHHHhc
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILC----RPP-D-LVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~----~~~-~-~~~~~~~~~~li~~~L~ 319 (426)
.|+|||++.+..++.++|||||||++|+|++|+.||.+.+ ..+.+..+.. .+. . ....| .+.+||..||.
T Consensus 182 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~ 260 (330)
T 2izr_A 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRR 260 (330)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHH
T ss_pred cccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHh
Confidence 9999999999999999999999999999999999998743 3344444421 111 1 11234 89999999999
Q ss_pred cCCCCCCChHHHhc----------CCCcCCCChhh
Q 014344 320 KDPTKRIGVEEIKG----------HEFFKGVNWEL 344 (426)
Q Consensus 320 ~dP~~R~s~~eil~----------hp~f~~~~~~~ 344 (426)
.||.+||++++|++ ..+....+|+.
T Consensus 261 ~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 261 LDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred CCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 99999999988864 34445677873
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.87 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=213.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEE-----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVK-----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
+++..++|++++.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|+++ .
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~~ 84 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------THSEHRALMSELKILIHIGH 84 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHCC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC------------CHHHHHHHHHHHHHHHhhcC
Confidence 45677899999999999999999999 55677899999985432 122356788999999999 7
Q ss_pred CCCcceeeeeeecCC-eEEEEEeccCCCChHHHHHHhcc-----------------------------------------
Q 014344 85 HPLLPRLRGVLSTDK-FVGYAIDYCPGRDLHSLRKQQSE----------------------------------------- 122 (426)
Q Consensus 85 hp~iv~l~~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~----------------------------------------- 122 (426)
||||+++++++.... .+++|||||+||+|.+++.....
T Consensus 85 hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (359)
T 3vhe_A 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS 164 (359)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------
T ss_pred CcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccc
Confidence 899999999987754 59999999999999999875432
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 123 -----------------------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 123 -----------------------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 165 SGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp -------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred cccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 128999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 259 (426)
.... ........||+.|+|||++.+.
T Consensus 245 ~~~~------------------------------------------------------~~~~~~~~~t~~y~aPE~~~~~ 270 (359)
T 3vhe_A 245 KDPD------------------------------------------------------YVRKGDARLPLKWMAPETIFDR 270 (359)
T ss_dssp SCTT------------------------------------------------------CEEC--CEECGGGCCHHHHHHC
T ss_pred cccc------------------------------------------------------chhccccCCCceeEChhhhcCC
Confidence 2110 1122344689999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc---CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 260 GHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 260 ~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.++.++|||||||++|+|++ |..||.+....+.....+. ........++.+.+||.+||..||.+|||+.++++|
T Consensus 271 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 271 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999998 9999998765444433321 223334568899999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=367.21 Aligned_cols=272 Identities=26% Similarity=0.413 Sum_probs=208.5
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++||||+++++++
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 71 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--------------EKLSTILSEVMLLASLNHQYVVRYYAAW 71 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--------------HHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH--------------HHHHHHHHHHHHHHhcCchHHHHHHHHH
Confidence 46999999999999999999999999999999985321 2346788899999999999999999988
Q ss_pred ec-------------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec
Q 014344 96 ST-------------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 96 ~~-------------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~ 162 (426)
.+ ...+|+|||||+|++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 72 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~ 150 (303)
T 1zy4_A 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID 150 (303)
T ss_dssp EECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred HhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc
Confidence 54 467899999999999999987643 3488899999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 163 ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
.++.+||+|||++............. ............
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~ 188 (303)
T 1zy4_A 151 ESRNVKIGDFGLAKNVHRSLDILKLD------------------------------------------SQNLPGSSDNLT 188 (303)
T ss_dssp TTSCEEECCCCCCSCTTC--------------------------------------------------------------
T ss_pred CCCCEEEeeCcchhhcccccchhccc------------------------------------------cccccccccccc
Confidence 99999999999998764321100000 000000112334
Q ss_pred ccccCCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCC----CC-CCCCCHHHHHHHH
Q 014344 243 SFVGTEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSS-RKETFYRILCRP----PD-LVGEPTPLRNLIR 315 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~i~~~~----~~-~~~~~~~~~~li~ 315 (426)
..+||+.|+|||++.+. .++.++|||||||++|+|++ ||.... .......+.... +. ....+..+.+||.
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 265 (303)
T 1zy4_A 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR 265 (303)
T ss_dssp -----CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHH
T ss_pred cCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHH
Confidence 56799999999999875 68999999999999999998 665432 233333433221 11 1234667899999
Q ss_pred HHhccCCCCCCChHHHhcCCCcCCCChhhhhh
Q 014344 316 RLLEKDPTKRIGVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 316 ~~L~~dP~~R~s~~eil~hp~f~~~~~~~~~~ 347 (426)
+||..||.+|||+.++++||||+...++...+
T Consensus 266 ~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~ 297 (303)
T 1zy4_A 266 LLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297 (303)
T ss_dssp HHTCSSGGGSCCHHHHHHSSCSCCCCHHHHHH
T ss_pred HHHhcCcccCcCHHHHhCCCCcCCCChHHHHH
Confidence 99999999999999999999999887776543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=363.10 Aligned_cols=253 Identities=17% Similarity=0.222 Sum_probs=216.3
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..+..++|++++.||+|+||+||+|.+. ++..||+|++..... ....+.+|+.+++.++||||++
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~~ 67 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM--------------SEDEFFQEAQTMMKLSHPKLVK 67 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB--------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC--------------cHHHHHHHHHHHHhCCCCCEee
Confidence 3577789999999999999999999875 567899999854321 2346788999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.++...|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~ 146 (268)
T 3sxs_A 68 FYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVS 146 (268)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEEC
T ss_pred EEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEc
Confidence 9999999999999999999999999987653 349999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........ .......||+.|
T Consensus 147 Dfg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~y 171 (268)
T 3sxs_A 147 DFGMTRYVLDDQY-------------------------------------------------------VSSVGTKFPVKW 171 (268)
T ss_dssp CTTCEEECCTTCE-------------------------------------------------------EECCSCCCCGGG
T ss_pred cCccceecchhhh-------------------------------------------------------hcccCCCcCccc
Confidence 9999876532110 011223467889
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||++.+..++.++|||||||++|+|++ |..||...+.......+.... ......+..+.+||.+||+.||++|||
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 251 (268)
T 3sxs_A 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPT 251 (268)
T ss_dssp CCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCC
T ss_pred CCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcC
Confidence 99999999899999999999999999998 999999998887777665443 223345788999999999999999999
Q ss_pred hHHHhcC
Q 014344 328 VEEIKGH 334 (426)
Q Consensus 328 ~~eil~h 334 (426)
+.++++|
T Consensus 252 ~~~ll~~ 258 (268)
T 3sxs_A 252 FQQLLSS 258 (268)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=365.60 Aligned_cols=254 Identities=20% Similarity=0.244 Sum_probs=214.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++++.||+|+||+||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~h~~i~ 82 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--------------SEDEFIEEAKVMMNLSHEKLV 82 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB--------------CHHHHHHHHHHHHTCCCTTBC
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC--------------CHHHHHHHHHHHhcCCCCCEe
Confidence 56678889999999999999999999875 677899999854321 224678899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+.+.+|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl 161 (283)
T 3gen_A 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKV 161 (283)
T ss_dssp CEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEE
T ss_pred eEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEE
Confidence 99999999999999999999999999987543 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ........||+.
T Consensus 162 ~Dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 186 (283)
T 3gen_A 162 SDFGLSRYVLDDE-------------------------------------------------------YTSSVGSKFPVR 186 (283)
T ss_dssp CSTTGGGGBCCHH-------------------------------------------------------HHSTTSTTSCGG
T ss_pred ccccccccccccc-------------------------------------------------------cccccCCccCcc
Confidence 9999997653210 001112247888
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.... ......+..+.+||.+||+.||.+||
T Consensus 187 y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 266 (283)
T 3gen_A 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP 266 (283)
T ss_dssp GCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred cCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCc
Confidence 999999999999999999999999999998 999999998888777776442 23334578899999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|++++++|
T Consensus 267 s~~~ll~~ 274 (283)
T 3gen_A 267 TFKILLSN 274 (283)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=367.70 Aligned_cols=250 Identities=20% Similarity=0.223 Sum_probs=211.8
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc-------eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE-------SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-------~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 83 (426)
..+..++|++.+.||+|+||+||+|++..+++ .||+|++.+.. ....+.+.+|+.+++.+
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-------------~~~~~~~~~E~~~l~~l 69 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-------------RNYSESFFEAASMMSKL 69 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-------------GGGHHHHHHHHHHHHTS
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-------------HHHHHHHHHHHHHHHhC
Confidence 35667889999999999999999999988774 69999985432 12346788899999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+||||+++++++.+++..|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 70 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 148 (289)
T 4fvq_A 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR 148 (289)
T ss_dssp CCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE
T ss_pred CCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec
Confidence 99999999999999999999999999999999987654 34899999999999999999999999999999999999998
Q ss_pred CCc--------EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 164 NGH--------IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235 (426)
Q Consensus 164 ~g~--------ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (426)
++. +||+|||++.....
T Consensus 149 ~~~~~~~~~~~~kl~Dfg~~~~~~~------------------------------------------------------- 173 (289)
T 4fvq_A 149 EEDRKTGNPPFIKLSDPGISITVLP------------------------------------------------------- 173 (289)
T ss_dssp CCBGGGTBCCEEEECCCCSCTTTSC-------------------------------------------------------
T ss_pred CCcccccccceeeeccCcccccccC-------------------------------------------------------
Confidence 887 99999999865421
Q ss_pred CCCCCccccccCCCCccchhhcC-CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHH
Q 014344 236 DSSEKSNSFVGTEEYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPPDLVGEPTPLRNL 313 (426)
Q Consensus 236 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 313 (426)
.....||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||......................+..+.+|
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (289)
T 4fvq_A 174 -----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANL 248 (289)
T ss_dssp -----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHH
T ss_pred -----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHH
Confidence 123458899999999988 778999999999999999999 5566666665554444444444444557889999
Q ss_pred HHHHhccCCCCCCChHHHhcC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~h 334 (426)
|.+||+.||.+|||+.++++|
T Consensus 249 i~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 249 INNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=383.06 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=218.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.++.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++||||+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~hpniv 175 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL------------PPDLKAKFLQEARILKQYSHPNIV 175 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS------------CHHHHTTTTHHHHHHTTCCCTTBC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC------------CHHHHHHHHHHHHHHHhCCCCCEE
Confidence 45678889999999999999999999999999999999985321 122345677899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++..++.+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 176 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEE
Confidence 99999999999999999999999999987653 34899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++....... ........+|+.
T Consensus 255 ~DfG~s~~~~~~~~------------------------------------------------------~~~~~~~~~~~~ 280 (377)
T 3cbl_A 255 SDFGMSREEADGVY------------------------------------------------------AASGGLRQVPVK 280 (377)
T ss_dssp CCGGGCEECTTSEE------------------------------------------------------ECCSSCCEEEGG
T ss_pred CcCCCceecCCCce------------------------------------------------------eecCCCCCCCcC
Confidence 99999875432100 000112236778
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... .+.....+..+.+||.+||+.||++||
T Consensus 281 y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp GSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc
Confidence 999999998899999999999999999998 99999998887766555432 233445688999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|+++|++
T Consensus 361 s~~~i~~ 367 (377)
T 3cbl_A 361 SFSTIYQ 367 (377)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=367.05 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=211.8
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
...++|.....||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||++++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 85 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-------------DSRYSQPLHEEIALHKHLKHKNIVQYL 85 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-------------CC---HHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-------------chHHHHHHHHHHHHHHhCCCCCEeeEe
Confidence 4455566666999999999999999999999999998532 122346788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEEe
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIMLV 170 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL~ 170 (426)
+++...+.+++||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~ 165 (295)
T 2clq_A 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165 (295)
T ss_dssp EEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEEC
T ss_pred eEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEe
Confidence 99999999999999999999999987653 234678999999999999999999999999999999999997 8999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++....... .......||+.|
T Consensus 166 Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 189 (295)
T 2clq_A 166 DFGTSKRLAGIN--------------------------------------------------------PCTETFTGTLQY 189 (295)
T ss_dssp CTTTCEESCC-------------------------------------------------------------CCCCCCGGG
T ss_pred ecccccccCCCC--------------------------------------------------------CcccccCCCccc
Confidence 999987653211 012234689999
Q ss_pred ccchhhcCCC--CChhhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH--hc-CCCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 251 VAPEIIEGKG--HDFAVDWWSLGVVLHEMLYGATPFRGSSRKE-TFYRI--LC-RPPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 251 ~aPE~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i--~~-~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+|||++.+.. ++.++|||||||++|+|++|+.||....... ..... .. .+......+..+.+||.+||..||++
T Consensus 190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 269 (295)
T 2clq_A 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDK 269 (295)
T ss_dssp CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTT
T ss_pred cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhh
Confidence 9999997643 8899999999999999999999997654322 22211 12 22333456889999999999999999
Q ss_pred CCChHHHhcCCCcCCC
Q 014344 325 RIGVEEIKGHEFFKGV 340 (426)
Q Consensus 325 R~s~~eil~hp~f~~~ 340 (426)
|||+.++++||||+..
T Consensus 270 Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 270 RACANDLLVDEFLKVS 285 (295)
T ss_dssp SCCHHHHHTSGGGCC-
T ss_pred CCCHHHHhcChhhhhc
Confidence 9999999999999753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=370.83 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=220.3
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l 83 (426)
+...+..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+|+.+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l 83 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA------------SPSELRDLLSEFNVLKQV 83 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC------------CHHHHHHHHHHHHHHTTC
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC------------CHHHHHHHHHHHHHHhhC
Confidence 456778889999999999999999999984 455889999985321 223456788999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc----------------------CCCCHHHHHHHHHHHHHHH
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE----------------------QMFSDDTIRFYAAELVLAL 141 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~----------------------~~l~~~~~~~~~~qil~aL 141 (426)
+||||+++++++...+.+|+|||||+|++|.+++..... ..+++..+..++.||+.||
T Consensus 84 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 163 (314)
T 2ivs_A 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGM 163 (314)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHH
T ss_pred CCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999876432 3489999999999999999
Q ss_pred HHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCC
Q 014344 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVH 221 (426)
Q Consensus 142 ~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (426)
.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 164 ~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------- 205 (314)
T 2ivs_A 164 QYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------------------- 205 (314)
T ss_dssp HHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC--------------------------------------
T ss_pred HHHHHCCCcccccchheEEEcCCCCEEEcccccccccccccc--------------------------------------
Confidence 999999999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC-
Q 014344 222 SPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR- 299 (426)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~- 299 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+...
T Consensus 206 ----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 269 (314)
T 2ivs_A 206 ----------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH 269 (314)
T ss_dssp ----------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred ----------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC
Confidence 001223357889999999999999999999999999999999 99999988877666655433
Q ss_pred -CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 300 -PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 300 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 270 RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 23344668899999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=365.15 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=222.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.++||||+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~~E~~~l~~l~h~~i~ 72 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--------------TMEVEEFLKEAAVMKEIKHPNLV 72 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--------------STHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--------------HHHHHHHHHHHHHHHhCCCCCEe
Confidence 5677888999999999999999999999999999999998432 12356788899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.++..+|+||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 73 ~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l 152 (288)
T 3kfa_A 73 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKV 152 (288)
T ss_dssp CEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEE
T ss_pred eEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEE
Confidence 99999999999999999999999999998766677999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ........||+.
T Consensus 153 ~Dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 177 (288)
T 3kfa_A 153 ADFGLSRLMTGDT-------------------------------------------------------YTAHAGAKFPIK 177 (288)
T ss_dssp CCCCGGGTSCSSS-------------------------------------------------------SEEETTEEECGG
T ss_pred ccCccceeccCCc-------------------------------------------------------cccccCCccccC
Confidence 9999997653211 011223357889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+... .......+..+.+||.+||..||.+||
T Consensus 178 y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 257 (288)
T 3kfa_A 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 257 (288)
T ss_dssp GCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCc
Confidence 999999999999999999999999999999 99999988876665555433 333446688999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|++++++
T Consensus 258 s~~~~~~ 264 (288)
T 3kfa_A 258 SFAEIHQ 264 (288)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=378.82 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=185.3
Q ss_pred CCCCcEEEe-eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 14 DFSCLRIVS-ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
-.++|++++ .||+|+||+||+|++..+++.||||++..... ........++.+.||||++++
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~e~~~~~~~~~h~~i~~~~ 88 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----------------ARQEVDHHWQASGGPHIVCIL 88 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----------------HHHHHHHHHHHTTSTTBCCEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----------------HHHHHHHHHHhcCCCChHHHH
Confidence 346799976 59999999999999999999999999854211 111223346677999999999
Q ss_pred eeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CC
Q 014344 93 GVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NG 165 (426)
Q Consensus 93 ~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g 165 (426)
+++.. ...+|+|||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred HHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence 99976 556899999999999999988766567999999999999999999999999999999999999986 45
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++...... .....+
T Consensus 169 ~~kl~Dfg~~~~~~~~----------------------------------------------------------~~~~~~ 190 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQN----------------------------------------------------------ALQTPC 190 (336)
T ss_dssp CEEECCCTTCEEC-------------------------------------------------------------------
T ss_pred eEEEeccccceecccc----------------------------------------------------------ccccCC
Confidence 6999999998754311 122346
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHh-----cCCCCCCCCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY----RIL-----CRPPDLVGEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~----~i~-----~~~~~~~~~~~~~~~li~~ 316 (426)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+. ...+.....+..+.+||.+
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 270 (336)
T 3fhr_A 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL 270 (336)
T ss_dssp -------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHH
T ss_pred CCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHH
Confidence 8999999999998889999999999999999999999998766543311 111 1112234568899999999
Q ss_pred HhccCCCCCCChHHHhcCCCcCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
||..||.+|||++|+++||||++
T Consensus 271 ~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 271 LLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp HSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HCCCChhHCcCHHHHhcCccccc
Confidence 99999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=373.00 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=223.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.+.+..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 86 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA------------SMRERIEFLNEASVMKEFN 86 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS------------CHHHHHHHHHHHHHGGGCC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc------------CHHHHHHHHHHHHHHHhcC
Confidence 44566788999999999999999999886 467889999985321 1123456888999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKP 156 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp 156 (426)
||||+++++++.+.+..|+|||||+|++|.+++..... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 87 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 166 (322)
T 1p4o_A 87 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 166 (322)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG
T ss_pred CCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCcc
Confidence 99999999999999999999999999999998875421 3578999999999999999999999999999999
Q ss_pred CCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 157 ENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 157 ~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
+|||++.++.+||+|||++.......
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------------ 192 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETD------------------------------------------------------ 192 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGG------------------------------------------------------
T ss_pred ceEEEcCCCeEEECcCcccccccccc------------------------------------------------------
Confidence 99999999999999999987543110
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~l 313 (426)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... ......+..+.+|
T Consensus 193 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 272 (322)
T 1p4o_A 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 272 (322)
T ss_dssp CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence 0011223457899999999999999999999999999999999 899999988887777665432 3344668899999
Q ss_pred HHHHhccCCCCCCChHHHhcC------CCcCCCChh
Q 014344 314 IRRLLEKDPTKRIGVEEIKGH------EFFKGVNWE 343 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~h------p~f~~~~~~ 343 (426)
|.+||..||.+|||+.++++| ++|+.++|.
T Consensus 273 i~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 273 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 999999999999999999876 666554443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=363.87 Aligned_cols=256 Identities=20% Similarity=0.274 Sum_probs=210.9
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcce
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPR 90 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~ 90 (426)
.+..++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+ .|++++.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~e~~~~~~l~~~~~i~~ 70 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---------------DAPQLRDEYRTYKLLAGCTGIPN 70 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---------------TSCCHHHHHHHHHHTTTCTTCCC
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---------------ccHHHHHHHHHHHHHhcCCCCCe
Confidence 344567999999999999999999999999999999984321 223577799999999 7999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc----
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH---- 166 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~---- 166 (426)
+++++......|+||||+ |++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 71 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 71 VYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTT
T ss_pred EEeecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCC
Confidence 999999999999999999 999999987653 45999999999999999999999999999999999999987776
Q ss_pred -EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 167 -IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 167 -ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
+||+|||++.......... ..........+
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~ 179 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQ-------------------------------------------------HIPYREKKNLS 179 (298)
T ss_dssp CEEECCCTTCEESBCTTTCC-------------------------------------------------BCCCCCCCCCC
T ss_pred eEEEEECccccccccccccc-------------------------------------------------cccccCccCCC
Confidence 9999999998764321100 00011234567
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcC---C---CCCCCCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS---SRKETFYRILCR---P---PDLVGEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~---~~~~~~~~i~~~---~---~~~~~~~~~~~~li~~ 316 (426)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. .....+..+... . ......+..+.+||.+
T Consensus 180 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 259 (298)
T 1csn_A 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHY 259 (298)
T ss_dssp SCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred CCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHH
Confidence 999999999999999999999999999999999999999874 333444333211 1 1123568899999999
Q ss_pred HhccCCCCCCChHHHhc
Q 014344 317 LLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~ 333 (426)
||+.||++||++++|++
T Consensus 260 ~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 260 ARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHCCTTCCCCHHHHHH
T ss_pred HhcCCcccCCCHHHHHH
Confidence 99999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=373.85 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=218.1
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.+..++|++++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+++.++||
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~hp 110 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------------SADMQADFQREAALMAEFDNP 110 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc------------CHHHHHHHHHHHHHHHhCCCC
Confidence 456789999999999999999999997 455899999985431 123456788999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc----------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS----------------------EQMFSDDTIRFYAAELVLALEYL 144 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~----------------------~~~l~~~~~~~~~~qil~aL~~L 144 (426)
||+++++++.+.+.+|+|||||+|++|.+++.... ...+++..++.++.||+.||.||
T Consensus 111 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~L 190 (343)
T 1luf_A 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 190 (343)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999987642 14699999999999999999999
Q ss_pred HHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC
Q 014344 145 HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR 224 (426)
Q Consensus 145 H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (426)
|++||+||||||+|||++.++.+||+|||++........
T Consensus 191 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------- 229 (343)
T 1luf_A 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----------------------------------------- 229 (343)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----------------------------------------
T ss_pred HhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc-----------------------------------------
Confidence 999999999999999999999999999999876532100
Q ss_pred CCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--C
Q 014344 225 IGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--P 301 (426)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~ 301 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.... .
T Consensus 230 -------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 296 (343)
T 1luf_A 230 -------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296 (343)
T ss_dssp -------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred -------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC
Confidence 011223458999999999999999999999999999999998 999999998888777765433 2
Q ss_pred CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.....+..+.+||.+||+.||.+|||+.+++++
T Consensus 297 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 297 CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 334568899999999999999999999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=361.33 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=214.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+++++|++++.||+|+||+||+|++. ++.||+|++..... .....+.+.+|+.+++.++||||+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv 70 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-----------STRKSRDFNEECPRLRIFSHPNVL 70 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-----------CHHHHHHHHHHGGGGCCCSCTTEE
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-----------CHHHHHHHHHHHHHHHhcCCCchh
Confidence 35788999999999999999999999974 88999999854321 223456788999999999999999
Q ss_pred eeeeeeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeeccCC
Q 014344 90 RLRGVLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENG 165 (426)
Q Consensus 90 ~l~~~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~~~g 165 (426)
++++++.+. ...++||||++||+|.+++.......+++..+..++.||+.||.|||++| |+||||||+|||++.++
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~ 150 (271)
T 3kmu_A 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM 150 (271)
T ss_dssp CEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS
T ss_pred heEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc
Confidence 999999877 78999999999999999998765556999999999999999999999999 99999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.++|+|||++.... ....+
T Consensus 151 ~~~l~~~~~~~~~~-------------------------------------------------------------~~~~~ 169 (271)
T 3kmu_A 151 TARISMADVKFSFQ-------------------------------------------------------------SPGRM 169 (271)
T ss_dssp CEEEEGGGSCCTTS-------------------------------------------------------------CTTCB
T ss_pred ceeEEeccceeeec-------------------------------------------------------------ccCcc
Confidence 99999999865431 12235
Q ss_pred cCCCCccchhhcCCCCC---hhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhc
Q 014344 246 GTEEYVAPEIIEGKGHD---FAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~ 319 (426)
||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+... +......+..+.+||.+||+
T Consensus 170 ~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 249 (271)
T 3kmu_A 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMN 249 (271)
T ss_dssp SCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 89999999999876554 4899999999999999999999998888776666532 23334568899999999999
Q ss_pred cCCCCCCChHHHhc
Q 014344 320 KDPTKRIGVEEIKG 333 (426)
Q Consensus 320 ~dP~~R~s~~eil~ 333 (426)
.||.+|||++++++
T Consensus 250 ~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 250 EDPAKRPKFDMIVP 263 (271)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=363.34 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=207.0
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
+...+..++|++++.||+|+||+||+|++..+ +..||+|++.... .....+.+.+|+.+++.++|
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~l~~l~h 75 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------------SDSVREKFLQEALTMRQFDH 75 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------------SHHHHHHHHHHHHHHHTCCC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC------------CHHHHHHHHHHHHHHHhCCC
Confidence 34567788999999999999999999998754 4569999974321 12345678899999999999
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
|||+++++++ .++..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 153 (281)
T 1mp8_A 76 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 153 (281)
T ss_dssp TTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT
T ss_pred CccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC
Confidence 9999999998 4567899999999999999987653 4599999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++........ .......
T Consensus 154 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------~~~~~~~ 178 (281)
T 1mp8_A 154 CVKLGDFGLSRYMEDSTY-------------------------------------------------------YKASKGK 178 (281)
T ss_dssp EEEECC--------------------------------------------------------------------------
T ss_pred CEEECccccccccCcccc-------------------------------------------------------cccccCC
Confidence 999999999976532110 0112234
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP 322 (426)
+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... .+.....+..+.+||.+||..||
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p 258 (281)
T 1mp8_A 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDP 258 (281)
T ss_dssp CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 7889999999999999999999999999999996 99999988877776666543 23445678999999999999999
Q ss_pred CCCCChHHHhcC
Q 014344 323 TKRIGVEEIKGH 334 (426)
Q Consensus 323 ~~R~s~~eil~h 334 (426)
.+|||+.+++++
T Consensus 259 ~~Rps~~~l~~~ 270 (281)
T 1mp8_A 259 SRRPRFTELKAQ 270 (281)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=374.27 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=215.8
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCcc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLP 89 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv 89 (426)
..-.++|++++.||+|+||+||+|++..+++.||||++......... .......+..|+.+++.+. ||||+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-------ELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEE-------ECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhh-------hhhhhhHHHHHHHHHHhhccCCCCce
Confidence 34456799999999999999999999999999999999665432110 0012245667999999996 59999
Q ss_pred eeeeeeecCCeEEEEEeccCC-CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCCcE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENGHI 167 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~g-g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g~i 167 (426)
++++++..++..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCE
Confidence 999999999999999999986 8999988764 3499999999999999999999999999999999999999 78999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++...... ......||
T Consensus 190 kL~Dfg~~~~~~~~----------------------------------------------------------~~~~~~gt 211 (320)
T 3a99_A 190 KLIDFGSGALLKDT----------------------------------------------------------VYTDFDGT 211 (320)
T ss_dssp EECCCTTCEECCSS----------------------------------------------------------CBCCCCSC
T ss_pred EEeeCccccccccc----------------------------------------------------------cccCCCCC
Confidence 99999998765321 12234599
Q ss_pred CCCccchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 248 EEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 248 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... .. ..........+..+.+||.+||..||.+||
T Consensus 212 ~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 286 (320)
T 3a99_A 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--II---RGQVFFRQRVSSECQHLIRWCLALRPSDRP 286 (320)
T ss_dssp GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--HH---HCCCCCSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--hh---cccccccccCCHHHHHHHHHHccCChhhCc
Confidence 99999999987766 7899999999999999999999976422 11 122223345688999999999999999999
Q ss_pred ChHHHhcCCCcCCCChhh
Q 014344 327 GVEEIKGHEFFKGVNWEL 344 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~ 344 (426)
|+++|++||||++..+..
T Consensus 287 s~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 287 TFEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp CHHHHHTSGGGSSCCCHH
T ss_pred CHHHHhcCHhhcCccCcc
Confidence 999999999999876543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=365.85 Aligned_cols=257 Identities=19% Similarity=0.309 Sum_probs=207.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEE----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
...+..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++|
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h 70 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-------------TEEHLRDFEREIEILKSLQH 70 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-------------CHHHHHHHHHHHHHHHTCCC
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-------------CHHHHHHHHHHHHHHHhCCC
Confidence 356777889999999999999999998 5678999999998432 22345678899999999999
Q ss_pred CCcceeeeeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 86 PLLPRLRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 86 p~iv~l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
|||+++++++.. ...+|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 71 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 149 (295)
T 3ugc_A 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 149 (295)
T ss_dssp TTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred CCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC
Confidence 999999999854 466899999999999999987654 34999999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+|||++......... ......
T Consensus 150 ~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~ 176 (295)
T 3ugc_A 150 ENRVKIGDFGLTKVLPQDKEF-----------------------------------------------------FKVKEP 176 (295)
T ss_dssp TTEEEECCCCSCC------------------------------------------------------------------C
T ss_pred CCeEEEccCcccccccCCcce-----------------------------------------------------eeeccC
Confidence 999999999999865422100 011223
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHh--cCCCCCCC
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK----------------ETFYRIL--CRPPDLVG 305 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----------------~~~~~i~--~~~~~~~~ 305 (426)
..||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+. ...+....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (295)
T 3ugc_A 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG 256 (295)
T ss_dssp TTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTT
T ss_pred CCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcC
Confidence 34788899999999999999999999999999999999998654321 1111111 22334456
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+..+.+||.+||..||++|||+.|+++
T Consensus 257 ~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 257 CPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7899999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=359.86 Aligned_cols=251 Identities=26% Similarity=0.432 Sum_probs=204.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.++.++|++.+.||+|+||+||+|.+. ++.||+|++....... .....+.+.+|+.+++.++||||+++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDED---------ISQTIENVRQEAKLFAMLKHPNIIAL 71 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC-------------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCccc---------HHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 467889999999999999999999974 8899999985532211 11235678889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCCeeecc-----
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG---IVYRDLKPENIMIQE----- 163 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g---iiHrDlKp~NiLl~~----- 163 (426)
++++.+++..|+||||++|++|.+++. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 72 RGVCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp EEEECCC--CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred EEEEecCCceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccc
Confidence 999999999999999999999998875 345999999999999999999999999 999999999999986
Q ss_pred ---CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 164 ---NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 164 ---~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
++.+||+|||++...... .
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~----------------------------------------------------------~ 170 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRT----------------------------------------------------------T 170 (271)
T ss_dssp CCSSCCEEECCCCC------------------------------------------------------------------
T ss_pred cccCcceEEccCCcccccccc----------------------------------------------------------c
Confidence 778999999998755321 1
Q ss_pred ccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHH
Q 014344 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~ 317 (426)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.... +.....+..+.+||.+|
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 250 (271)
T 3dtc_A 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDC 250 (271)
T ss_dssp -----CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHH
Confidence 123358999999999999999999999999999999999999999988877766655332 23345688899999999
Q ss_pred hccCCCCCCChHHHhcC
Q 014344 318 LEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 318 L~~dP~~R~s~~eil~h 334 (426)
|..||.+|||+.|+++|
T Consensus 251 l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 251 WNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred hcCCcccCcCHHHHHHH
Confidence 99999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=373.11 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=208.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceE----EEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESF----ALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----AiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
...+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++|
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h 76 (327)
T 3poz_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT------------SPKANKEILDEAYVMASVDN 76 (327)
T ss_dssp SEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------------------CHHHHHHHHHHHHHCCB
T ss_pred HhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc------------CHHHHHHHHHHHHHHHhCCC
Confidence 45577889999999999999999999998888766 555553211 12234678899999999999
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
|||+++++++.+.. .++|+||+.+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 77 ~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~ 154 (327)
T 3poz_A 77 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154 (327)
T ss_dssp TTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT
T ss_pred CCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC
Confidence 99999999998755 789999999999999987654 4599999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+++.+..... ........
T Consensus 155 ~~kl~Dfg~a~~~~~~~~------------------------------------------------------~~~~~~~~ 180 (327)
T 3poz_A 155 HVKITDFGLAKLLGAEEK------------------------------------------------------EYHAEGGK 180 (327)
T ss_dssp EEEECCTTHHHHHTTTCC-------------------------------------------------------------C
T ss_pred CEEEccCcceeEccCCcc------------------------------------------------------cccccCCC
Confidence 999999999987642210 01122334
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP 322 (426)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... .+.....+..+.+||.+||+.||
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCG
T ss_pred ccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCh
Confidence 7889999999999999999999999999999999 99999988776655554432 33445568899999999999999
Q ss_pred CCCCChHHHhcC
Q 014344 323 TKRIGVEEIKGH 334 (426)
Q Consensus 323 ~~R~s~~eil~h 334 (426)
.+|||+.+++.+
T Consensus 261 ~~Rps~~ell~~ 272 (327)
T 3poz_A 261 DSRPKFRELIIE 272 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=367.78 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=199.6
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
....+++|++++.||+|+||.||+|++..+++.||||++....... ...+.+..+..+++.++||||++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~~~~~~~~~h~~i~~ 88 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-----------ENKRILMDLDVVLKSHDCPYIVQ 88 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-----------HHHHHHHHHHHHHHTTTCTTBCC
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-----------HHHHHHHHHHHHHHhcCCCceee
Confidence 3467789999999999999999999999999999999996542111 12234444556788889999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeeccCCcEEE
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~~g~ikL 169 (426)
+++++..++.+|+||||+ ++.+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl 166 (318)
T 2dyl_A 89 CFGTFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166 (318)
T ss_dssp EEEEEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEE
Confidence 999999999999999999 56666665443 35599999999999999999999995 9999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... ......||+.
T Consensus 167 ~dfg~~~~~~~~~---------------------------------------------------------~~~~~~~~~~ 189 (318)
T 2dyl_A 167 CDFGISGRLVDDK---------------------------------------------------------AKDRSAGCAA 189 (318)
T ss_dssp CCCTTC-----------------------------------------------------------------------CCT
T ss_pred EECCCchhccCCc---------------------------------------------------------cccccCCCcc
Confidence 9999987653211 1123358999
Q ss_pred Cccchhhc-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCC----CCCCCHHHHHHHHHHhc
Q 014344 250 YVAPEIIE-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILCRPPD----LVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 250 y~aPE~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~----~~~~~~~~~~li~~~L~ 319 (426)
|+|||++. +..++.++|||||||++|+|++|+.||... ...+.+..+...... ....+..+.+||.+||.
T Consensus 190 y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 269 (318)
T 2dyl_A 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT 269 (318)
T ss_dssp TCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTC
T ss_pred ccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHcc
Confidence 99999994 556889999999999999999999999874 445555555543322 22468899999999999
Q ss_pred cCCCCCCChHHHhcCCCcCC
Q 014344 320 KDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 320 ~dP~~R~s~~eil~hp~f~~ 339 (426)
.||.+|||+++|++||||+.
T Consensus 270 ~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 270 KDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SCTTTSCCHHHHTTSHHHHH
T ss_pred CChhHCcCHHHHhhCHHHHh
Confidence 99999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=374.44 Aligned_cols=259 Identities=18% Similarity=0.288 Sum_probs=215.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
.+.+..++|++++.||+|+||+||+|++. .++..||||++.... .......+.+|+.+|+++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 106 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA------------DSSEREALMSELKMMTQLG 106 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHC
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc------------CHHHHHHHHHHHHHHHhhc
Confidence 45677789999999999999999999973 456789999985432 112346788999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc---------------------CCCCHHHHHHHHHHHHHHHH
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE---------------------QMFSDDTIRFYAAELVLALE 142 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~---------------------~~l~~~~~~~~~~qil~aL~ 142 (426)
+||||+++++++...+.+|+|||||+||+|.+++..... ..+++..+..++.||+.||.
T Consensus 107 ~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 186 (344)
T 1rjb_A 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 186 (344)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999876432 23789999999999999999
Q ss_pred HHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCC
Q 014344 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHS 222 (426)
Q Consensus 143 ~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (426)
|||++||+||||||+|||++.++.+||+|||++........
T Consensus 187 ~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------- 227 (344)
T 1rjb_A 187 FLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--------------------------------------- 227 (344)
T ss_dssp HHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT---------------------------------------
T ss_pred HHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcc---------------------------------------
Confidence 99999999999999999999999999999999976532110
Q ss_pred CCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--
Q 014344 223 PRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR-- 299 (426)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~-- 299 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..++..
T Consensus 228 ---------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 292 (344)
T 1rjb_A 228 ---------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 292 (344)
T ss_dssp ---------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTC
T ss_pred ---------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCC
Confidence 011223458899999999999999999999999999999998 99999987765555554432
Q ss_pred -CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 300 -PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 300 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.......+..+.+||.+||..||.+|||+.++++|
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 293 KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 23334568899999999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=366.81 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=217.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEE-----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
.+.+..++|++++.||+|+||+||+|++ ..+++.||+|++.... .....+.+.+|+.+|+++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 84 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA------------HLTEREALMSELKVLSYLG 84 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHC
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch------------hHHHHHHHHHHHHHHhhcc
Confidence 4557778999999999999999999985 4577899999985432 112346788999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccC----------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQ----------------MFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~----------------~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+||||+++++++..++..++|||||++|+|.+++...... .+++..+..++.||+.||.|||++
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 8999999999999999999999999999999998765422 489999999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
||+||||||+|||++.++.+||+|||++........
T Consensus 165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------- 200 (313)
T 1t46_A 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-------------------------------------------- 200 (313)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT--------------------------------------------
T ss_pred CeecCCCccceEEEcCCCCEEEcccccccccccccc--------------------------------------------
Confidence 999999999999999999999999999986642210
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc---CCCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC---RPPDL 303 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~---~~~~~ 303 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+..........+. .....
T Consensus 201 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 270 (313)
T 1t46_A 201 ----------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270 (313)
T ss_dssp ----------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred ----------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc
Confidence 011223457889999999999999999999999999999998 9999988765544444332 22333
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||.+||..||.+|||+.+++++
T Consensus 271 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4568899999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=374.80 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=194.6
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHH-HHHhcCCCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR-VLRNVEHPL 87 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~ 87 (426)
..+.+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+..|+. +++.++|||
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~e~~~~~~~~~h~n 82 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD------------EKEQKQLLMDLDVVMRSSDCPY 82 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC------------HHHHHHHHHHHHHHHSSCCCTT
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC------------chHHHHHHHHHHHHHHcCCCCc
Confidence 3567888999999999999999999999999999999999854321 112334455555 777789999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeeecc
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ---QSEQMFSDDTIRFYAAELVLALEYLHNM-GIVYRDLKPENIMIQE 163 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~---~~~~~l~~~~~~~~~~qil~aL~~LH~~-giiHrDlKp~NiLl~~ 163 (426)
|+++++++..++..|+||||+. ++|.+++.. .....+++..+..++.|++.||.|||+. ||+||||||+|||++.
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~ 161 (327)
T 3aln_A 83 IVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161 (327)
T ss_dssp BCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET
T ss_pred EeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC
Confidence 9999999999999999999998 477776653 2245699999999999999999999998 9999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+|||++....... ....
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~---------------------------------------------------------~~~~ 184 (327)
T 3aln_A 162 SGNIKLCDFGISGQLVDSI---------------------------------------------------------AKTR 184 (327)
T ss_dssp TTEEEECCCSSSCC------------------------------------------------------------------
T ss_pred CCCEEEccCCCceeccccc---------------------------------------------------------cccc
Confidence 9999999999987653211 1122
Q ss_pred cccCCCCccchhh----cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcC-CCCC-----CCCCHHHHH
Q 014344 244 FVGTEEYVAPEII----EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILCR-PPDL-----VGEPTPLRN 312 (426)
Q Consensus 244 ~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~-~~~~-----~~~~~~~~~ 312 (426)
..||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+.... +....+... ++.. ...+..+.+
T Consensus 185 ~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 264 (327)
T 3aln_A 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFIN 264 (327)
T ss_dssp ---------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHH
T ss_pred CCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHH
Confidence 3589999999998 4667899999999999999999999999875432 222222221 1111 246788999
Q ss_pred HHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 313 LIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 313 li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
||.+||..||.+|||+.+|++||||...+
T Consensus 265 li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 265 FVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp HHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 99999999999999999999999997543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=383.53 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=213.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.++.++|++++.||+|+||.||+|... ++.||||++... ...+.+.+|+.+|++++||||+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~h~niv 249 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---------------ATAQAFLAEASVMTQLRHSNLV 249 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC---------------TTSHHHHHHHHHHHTCCCTTBC
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc---------------hHHHHHHHHHHHHHhccCCCEE
Confidence 45788899999999999999999999874 779999998432 1345788899999999999999
Q ss_pred eeeeeeecCC-eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLSTDK-FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++.... .+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 250 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp CEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEE
T ss_pred EEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEE
Confidence 9999976654 799999999999999999877655689999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++..... .....+|+
T Consensus 330 l~DfG~a~~~~~~-----------------------------------------------------------~~~~~~~~ 350 (450)
T 1k9a_A 330 VSDFGLTKEASST-----------------------------------------------------------QDTGKLPV 350 (450)
T ss_dssp ECCCTTCEECC-----------------------------------------------------------------CCCT
T ss_pred EeeCCCccccccc-----------------------------------------------------------ccCCCCCc
Confidence 9999998754211 11124788
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... .+.....+..+.+||.+||..||.+|
T Consensus 351 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~R 430 (450)
T 1k9a_A 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430 (450)
T ss_dssp TTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999999999999998 99999988777666665432 33445678999999999999999999
Q ss_pred CChHHHhc
Q 014344 326 IGVEEIKG 333 (426)
Q Consensus 326 ~s~~eil~ 333 (426)
||+.+|+.
T Consensus 431 pt~~~l~~ 438 (450)
T 1k9a_A 431 PTFLQLRE 438 (450)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=357.25 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=216.9
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+.++.++|++++.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i~~ 67 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--------------SEEDFIEEAEVMMKLSHPKLVQ 67 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB--------------CHHHHHHHHHHHHTCCCTTBCC
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC--------------CHHHHHHHHHHHHhCCCCCEee
Confidence 4577889999999999999999999986 678899999854321 1246788999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.+++..|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 68 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~ 146 (267)
T 3t9t_A 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS 146 (267)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEEC
T ss_pred EEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEc
Confidence 9999999999999999999999999987653 458999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++....... ........||+.|
T Consensus 147 dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~y 171 (267)
T 3t9t_A 147 DFGMTRFVLDDQ-------------------------------------------------------YTSSTGTKFPVKW 171 (267)
T ss_dssp CTTGGGGBCCHH-------------------------------------------------------HHSTTSTTCCGGG
T ss_pred cccccccccccc-------------------------------------------------------ccccccccccccc
Confidence 999987653210 0011223478899
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+.... ......+..+.+||.+||..||.+|||
T Consensus 172 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 251 (267)
T 3t9t_A 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPA 251 (267)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcC
Confidence 99999999999999999999999999999 999999988888777765432 233345788999999999999999999
Q ss_pred hHHHhcC
Q 014344 328 VEEIKGH 334 (426)
Q Consensus 328 ~~eil~h 334 (426)
+.+++++
T Consensus 252 ~~~ll~~ 258 (267)
T 3t9t_A 252 FSRLLRQ 258 (267)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=368.84 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=210.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
...+..++|++++.||+|+||+||+|++..+++.+|+|+..|... ..........+.+|+.+++.++||||+
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~--------~~~~~~~~~~~~~E~~~l~~l~hp~iv 80 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--------EATSPKANKEILDEAYVMASVDNPHVC 80 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEEC--------CCSSCCCHHHHHHHHHHHTTCCBTTBC
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeec--------cccCHHHHHHHHHHHHHHHhCCCCCee
Confidence 445778899999999999999999999999988775555433211 111223456788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.... .++|++|+.+|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL 158 (327)
T 3lzb_A 81 RLLGICLTST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 158 (327)
T ss_dssp CCCEEEESSS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEE
T ss_pred EEEEEEecCC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEE
Confidence 9999998765 789999999999999987654 45999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++........ ........||+.
T Consensus 159 ~DfG~a~~~~~~~~------------------------------------------------------~~~~~~~~~t~~ 184 (327)
T 3lzb_A 159 TDFGLAKLLGAEEK------------------------------------------------------EYHAEGGKVPIK 184 (327)
T ss_dssp CCTTC----------------------------------------------------------------------CCCGG
T ss_pred ccCcceeEccCccc------------------------------------------------------cccccCCCcccc
Confidence 99999986532110 011122347889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... .+.....+..+.+||.+||..||.+||
T Consensus 185 y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 264 (327)
T 3lzb_A 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRP 264 (327)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999999999 99999988877665555433 334445688999999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|+.|+++.
T Consensus 265 s~~ell~~ 272 (327)
T 3lzb_A 265 KFRELIIE 272 (327)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=368.50 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=217.3
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceE--EEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESF--ALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EH 85 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--AiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 85 (426)
..+.+++++|++.+.||+|+||.||+|++..++..+ |+|++.... .....+.+.+|+.+|+++ +|
T Consensus 18 ~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~------------~~~~~~~~~~E~~~l~~l~~h 85 (327)
T 1fvr_A 18 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------------SKDDHRDFAGELEVLCKLGHH 85 (327)
T ss_dssp CSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCC
T ss_pred ccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc------------chHHHHHHHHHHHHHHhccCC
Confidence 356688899999999999999999999999888865 999885321 112345788899999999 89
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGIVY 151 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~giiH 151 (426)
|||+++++++.+.+.+|+|||||+|++|.+++.... ...+++..++.++.||+.||.|||++||+|
T Consensus 86 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 165 (327)
T 1fvr_A 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 165 (327)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 999999999999999999999999999999987542 246999999999999999999999999999
Q ss_pred cCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCC
Q 014344 152 RDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPS 231 (426)
Q Consensus 152 rDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (426)
|||||+|||++.++.+||+|||++......
T Consensus 166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-------------------------------------------------- 195 (327)
T 1fvr_A 166 RDLAARNILVGENYVAKIADFGLSRGQEVY-------------------------------------------------- 195 (327)
T ss_dssp SCCSGGGEEECGGGCEEECCTTCEESSCEE--------------------------------------------------
T ss_pred CCCccceEEEcCCCeEEEcccCcCcccccc--------------------------------------------------
Confidence 999999999999999999999998743210
Q ss_pred CCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCH
Q 014344 232 RSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPT 308 (426)
Q Consensus 232 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~ 308 (426)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... .......+.
T Consensus 196 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (327)
T 1fvr_A 196 -------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD 268 (327)
T ss_dssp -------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCH
T ss_pred -------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCCCCCCH
Confidence 01122347889999999999889999999999999999998 99999999888877776543 233345688
Q ss_pred HHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 309 PLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 309 ~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+.+||.+||..||.+|||+++++++
T Consensus 269 ~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 269 EVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=363.67 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=204.7
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.....+++|++++.||+|+||.||+|++..+++.||||++...... .....+.+.+|+.+++.++||||+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~hp~iv 97 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS----------DPVFRTRMQREARTAGRLQEPHVV 97 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG----------SHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc----------CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3456788999999999999999999999999999999998554321 123456788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++..++.+|+||||++|++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 98 PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp CEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEE
Confidence 99999999999999999999999999987653 4999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++....... .......+||+.
T Consensus 176 ~Dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 200 (309)
T 2h34_A 176 VDFGIASATTDEK-------------------------------------------------------LTQLGNTVGTLY 200 (309)
T ss_dssp CSCCC-----------------------------------------------------------------------CCGG
T ss_pred ecCccCccccccc-------------------------------------------------------cccccccCCCcC
Confidence 9999987653211 011234469999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----CCCCCCHHHHHHHHHHhccCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP----DLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+....+ .....+..+.+||.+||..||.+|
T Consensus 201 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 201 YMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp GCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred ccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHH
Confidence 9999999999999999999999999999999999998776544444433222 123568889999999999999999
Q ss_pred C-ChHHHhc
Q 014344 326 I-GVEEIKG 333 (426)
Q Consensus 326 ~-s~~eil~ 333 (426)
| +++++++
T Consensus 281 p~s~~~l~~ 289 (309)
T 2h34_A 281 YVTCGDLSA 289 (309)
T ss_dssp CSSHHHHHH
T ss_pred HHhHHHHHH
Confidence 9 7888875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=367.83 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=219.3
Q ss_pred CCCCCCCCCCCcEEEeeecccCceEEEEEEEc-------CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHH
Q 014344 7 DRPIRSLDFSCLRIVSALGRGAKGVVFLVKDV-------ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV 79 (426)
Q Consensus 7 ~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~i 79 (426)
..+.+.+..++|++++.||+|+||+||+|++. .++..||||++.... .......+.+|+.+
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~ 93 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA------------TEKDLSDLVSEMEM 93 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC------------CHHHHHHHHHHHHH
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC------------cHHHHHHHHHHHHH
Confidence 34566778899999999999999999999986 456789999985432 12345678899999
Q ss_pred HHhc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHH
Q 014344 80 LRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE--------------QMFSDDTIRFYAAELVLALEYL 144 (426)
Q Consensus 80 l~~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~--------------~~l~~~~~~~~~~qil~aL~~L 144 (426)
++.+ +||||+++++++..++.+|+|||||+|++|.+++..... ..+++..+..++.||+.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 9999 899999999999999999999999999999999875432 2489999999999999999999
Q ss_pred HHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC
Q 014344 145 HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR 224 (426)
Q Consensus 145 H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (426)
|++||+||||||+|||++.++.+||+|||++........
T Consensus 174 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----------------------------------------- 212 (334)
T 2pvf_A 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----------------------------------------- 212 (334)
T ss_dssp HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSS-----------------------------------------
T ss_pred HhCCeeCCCCccceEEEcCCCCEEEcccccccccccccc-----------------------------------------
Confidence 999999999999999999999999999999976532110
Q ss_pred CCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CC
Q 014344 225 IGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PP 301 (426)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~ 301 (426)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+... ..
T Consensus 213 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (334)
T 2pvf_A 213 -------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 279 (334)
T ss_dssp -------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC
T ss_pred -------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCC
Confidence 001122347889999999999889999999999999999999 99999998887776665433 23
Q ss_pred CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.....+..+.+||.+||..||.+|||+.+++++
T Consensus 280 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 280 KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 344668899999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=359.26 Aligned_cols=257 Identities=24% Similarity=0.334 Sum_probs=209.8
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
..+.+..++|++.+.||+|+||+||+|++..+++.||+|++........... ....+.+.+|+.+++.++||||
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i 85 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM------IEKFQEFQREVFIMSNLNHPNI 85 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH------HCCSHHHHHHHHHHTTCCCTTB
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH------HHHHHHHHHHHHHHHhCCCCCc
Confidence 3566788999999999999999999999999999999999854322111000 0123678899999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeeccCCc
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGH 166 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~~~g~ 166 (426)
+++++++.+.. ++||||++|++|.+++.... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 86 VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp CCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred hhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 99999997665 69999999999988876543 45999999999999999999999999 999999999999988776
Q ss_pred -----EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 167 -----IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 167 -----ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+||+|||++..... ..
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~-----------------------------------------------------------~~ 183 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVH-----------------------------------------------------------SV 183 (287)
T ss_dssp TCSCCEEECCCTTCBCCSS-----------------------------------------------------------CE
T ss_pred CCceeEEeCCCCccccccc-----------------------------------------------------------cc
Confidence 99999999874321 12
Q ss_pred cccccCCCCccchhhc--CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh---cCCCCCCCCCHHHHHHH
Q 014344 242 NSFVGTEEYVAPEIIE--GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET--FYRIL---CRPPDLVGEPTPLRNLI 314 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~i~---~~~~~~~~~~~~~~~li 314 (426)
...+||+.|+|||++. ...++.++|||||||++|+|++|+.||...+.... ...+. ..+......++.+.+||
T Consensus 184 ~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (287)
T 4f0f_A 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVI 263 (287)
T ss_dssp ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHH
Confidence 2346999999999994 45578999999999999999999999987654322 22222 12233346688999999
Q ss_pred HHHhccCCCCCCChHHHhc
Q 014344 315 RRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~ 333 (426)
.+||+.||.+|||++++++
T Consensus 264 ~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 264 ELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 9999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=375.03 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=207.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
...+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|++++||
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ 106 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY------------TEKQRRDFLGEASIMGQFDHP 106 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC------------CHHHHHHHHHHHHHHTTCCCT
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc------------CHHHHHHHHHHHHHHHhCCCC
Confidence 34677789999999999999999999987 467789999985421 122456788999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++.....+|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 107 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 185 (373)
T 2qol_A 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185 (373)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC
Confidence 99999999999999999999999999999987543 45999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++......... ........+
T Consensus 186 ~kl~Dfg~a~~~~~~~~~-----------------------------------------------------~~~~~~~~~ 212 (373)
T 2qol_A 186 CKVSDFGLGRVLEDDPEA-----------------------------------------------------AYTTRGGKI 212 (373)
T ss_dssp EEECCC--------------------------------------------------------------------------
T ss_pred EEECcCccccccccCCcc-----------------------------------------------------ceeccCCCc
Confidence 999999999765421100 001112236
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
|+.|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+... .+.....+..+.+||.+||+.||.
T Consensus 213 ~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 292 (373)
T 2qol_A 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRN 292 (373)
T ss_dssp -CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGG
T ss_pred CCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChh
Confidence 788999999999999999999999999999997 99999998887777666533 334456788999999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
+||++.+|++
T Consensus 293 ~RPs~~~i~~ 302 (373)
T 2qol_A 293 NRPKFEQIVS 302 (373)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=389.96 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=220.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++.+.||+|+||.||+|++..++..||||++.... ...+.+.+|+.+|++++||||+
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv 279 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMKEIKHPNLV 279 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--------------SCHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--------------cchHHHHHHHHHHHhcCCCCEe
Confidence 35677789999999999999999999999999999999984321 1346788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.....+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 280 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 359 (495)
T 1opk_A 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKV 359 (495)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred eEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEE
Confidence 99999999999999999999999999998766667999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++...... ........+|+.
T Consensus 360 ~DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 384 (495)
T 1opk_A 360 ADFGLSRLMTGDT-------------------------------------------------------YTAHAGAKFPIK 384 (495)
T ss_dssp CCTTCEECCTTCC-------------------------------------------------------EECCTTCCCCGG
T ss_pred eecccceeccCCc-------------------------------------------------------eeecCCCcCCcc
Confidence 9999998653211 001112246788
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... .+.....+..+.+||.+||+.||.+||
T Consensus 385 y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 464 (495)
T 1opk_A 385 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP 464 (495)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred eeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCc
Confidence 999999999999999999999999999998 99999998877666555432 233446789999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|+.+|++
T Consensus 465 s~~el~~ 471 (495)
T 1opk_A 465 SFAEIHQ 471 (495)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999976
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.70 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=201.2
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
+...++.++|++++.||+|+||+||+|++. ++.||||++..... .......|+.+|+.++||||
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--------------~~~~~~~E~~~l~~l~hpni 80 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK--------------QSWQNEYEVYSLPGMKHENI 80 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH--------------HHHHHHHHHHTSTTCCCTTB
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch--------------HHHHHHHHHHHHhcCCCCCc
Confidence 344577889999999999999999999875 78999999854321 22344558899999999999
Q ss_pred ceeeeeeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----------CCcccCC
Q 014344 89 PRLRGVLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM----------GIVYRDL 154 (426)
Q Consensus 89 v~l~~~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~----------giiHrDl 154 (426)
+++++++.... .+|+|||||++|+|.++++.. .+++..+..++.||+.||.|||+. ||+||||
T Consensus 81 v~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dl 157 (322)
T 3soc_A 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157 (322)
T ss_dssp CCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCC
T ss_pred hhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCC
Confidence 99999997744 479999999999999998753 399999999999999999999999 9999999
Q ss_pred CCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 155 KPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSD 234 (426)
Q Consensus 155 Kp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (426)
||+|||++.++.+||+|||++..+.....
T Consensus 158 kp~Nill~~~~~~kL~DFg~a~~~~~~~~--------------------------------------------------- 186 (322)
T 3soc_A 158 KSKNVLLKNNLTACIADFGLALKFEAGKS--------------------------------------------------- 186 (322)
T ss_dssp SGGGEEECTTCCEEECCCTTCEEECTTSC---------------------------------------------------
T ss_pred ChHhEEECCCCeEEEccCCcccccccccC---------------------------------------------------
Confidence 99999999999999999999976642210
Q ss_pred CCCCCCccccccCCCCccchhhcCC-----CCChhhHHHHHHHHHHHHHhCCCCCCCCCH----------------HHHH
Q 014344 235 SDSSEKSNSFVGTEEYVAPEIIEGK-----GHDFAVDWWSLGVVLHEMLYGATPFRGSSR----------------KETF 293 (426)
Q Consensus 235 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~----------------~~~~ 293 (426)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+... ....
T Consensus 187 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (322)
T 3soc_A 187 ---AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263 (322)
T ss_dssp ---CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH
T ss_pred ---ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhh
Confidence 1122335799999999999873 456789999999999999999999976431 1222
Q ss_pred HHHhcCC--CCCCC------CCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 294 YRILCRP--PDLVG------EPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 294 ~~i~~~~--~~~~~------~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
..+.... +.... .+..+.+||.+||+.||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 264 EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2222111 11111 1234899999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=367.71 Aligned_cols=259 Identities=19% Similarity=0.299 Sum_probs=216.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCc-----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSE-----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
...+..++|++++.||+|+||+||+|.+..+++ .||+|++.... .......+.+|+.+|+.+
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 107 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA------------HADEKEALMSELKIMSHLG 107 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHC
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc------------ChHHHHHHHHHHHHHHhhc
Confidence 345677899999999999999999999977664 79999985432 123456788999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS------------EQMFSDDTIRFYAAELVLALEYLHNMGIVY 151 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~------------~~~l~~~~~~~~~~qil~aL~~LH~~giiH 151 (426)
+||||+++++++...+.+|+|||||++|+|.+++.... ...+++..+..++.||+.||.|||++||+|
T Consensus 108 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 187 (333)
T 2i1m_A 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIH 187 (333)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 89999999999999999999999999999999887542 345899999999999999999999999999
Q ss_pred cCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCC
Q 014344 152 RDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPS 231 (426)
Q Consensus 152 rDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (426)
|||||+|||++.++.+||+|||++........
T Consensus 188 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------ 219 (333)
T 2i1m_A 188 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSN------------------------------------------------ 219 (333)
T ss_dssp SCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT------------------------------------------------
T ss_pred CCcccceEEECCCCeEEECccccccccccccc------------------------------------------------
Confidence 99999999999999999999999976532110
Q ss_pred CCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc---CCCCCCCCC
Q 014344 232 RSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC---RPPDLVGEP 307 (426)
Q Consensus 232 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~---~~~~~~~~~ 307 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+..+.. ........+
T Consensus 220 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (333)
T 2i1m_A 220 ------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP 293 (333)
T ss_dssp ------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCC
T ss_pred ------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCC
Confidence 011223457889999999999999999999999999999998 9999988765554444432 223334568
Q ss_pred HHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 308 TPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 308 ~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
..+.+||.+||+.||.+|||+.+++++
T Consensus 294 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 294 KNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 899999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=366.65 Aligned_cols=257 Identities=27% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc----CCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV----EHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l----~hp~i 88 (426)
.-.++|++++.||+|+||.||+|++..+++.||||++......... .......+..|+.+++++ +||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~h~~i 100 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS-------PLSDSVTCPLEVALLWKVGAGGGHPGV 100 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc-------cchhhHHHHHHHHHHHhhcccCCCCCe
Confidence 3456799999999999999999999999999999999654321110 011223455688999998 89999
Q ss_pred ceeeeeeecCCeEEEEEec-cCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-cCCc
Q 014344 89 PRLRGVLSTDKFVGYAIDY-CPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ-ENGH 166 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey-~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~-~~g~ 166 (426)
+++++++...+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 9999999999999999999 78999999987653 499999999999999999999999999999999999999 8899
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++...... ......|
T Consensus 179 ~kl~dfg~~~~~~~~----------------------------------------------------------~~~~~~~ 200 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE----------------------------------------------------------PYTDFDG 200 (312)
T ss_dssp EEECCCSSCEECCSS----------------------------------------------------------CBCCCCS
T ss_pred EEEEEcchhhhcccC----------------------------------------------------------cccccCC
Confidence 999999998765321 1223458
Q ss_pred CCCCccchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 247 TEEYVAPEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 247 t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... +... .........+..+.+||.+||..||++|
T Consensus 201 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R 275 (312)
T 2iwi_A 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILE---AELHFPAHVSPDCCALIRRCLAPKPSSR 275 (312)
T ss_dssp CTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--HHHH---TCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred cccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--HHhh---hccCCcccCCHHHHHHHHHHccCChhhC
Confidence 999999999987666 469999999999999999999997542 1111 1222234568899999999999999999
Q ss_pred CChHHHhcCCCcCCCC
Q 014344 326 IGVEEIKGHEFFKGVN 341 (426)
Q Consensus 326 ~s~~eil~hp~f~~~~ 341 (426)
||++|+++||||+...
T Consensus 276 ps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 276 PSLEEILLDPWMQTPA 291 (312)
T ss_dssp CCHHHHHHSTTTCC--
T ss_pred cCHHHHhcChhhcCch
Confidence 9999999999998643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=363.43 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=207.5
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCcc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLP 89 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv 89 (426)
.+...+|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.+. ||||+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~~~~~~iv 91 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-----------DNQTLDSYRNEIAYLNKLQQHSDKII 91 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-----------CHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-----------cccchHHHHHHHHHHHhccccCCceE
Confidence 345567999999999999999999985 588999999854321 2234567888999999997 59999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++..+..+|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||
T Consensus 92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL 167 (313)
T 3cek_A 92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKL 167 (313)
T ss_dssp CEEEEEECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEE
T ss_pred EEEEEeecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEE
Confidence 99999999999999999 5589999998764 3589999999999999999999999999999999999996 589999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++..+..... .......+||+.
T Consensus 168 ~Dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~gt~~ 193 (313)
T 3cek_A 168 IDFGIANQMQPDTT------------------------------------------------------SVVKDSQVGTVN 193 (313)
T ss_dssp CCCSSSCC--------------------------------------------------------------------CCGG
T ss_pred eeccccccccCccc------------------------------------------------------cccccCCCCCCC
Confidence 99999986542110 011224469999
Q ss_pred CccchhhcC-----------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCC---CCCCCCCHHHHHHH
Q 014344 250 YVAPEIIEG-----------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR-KETFYRILCRP---PDLVGEPTPLRNLI 314 (426)
Q Consensus 250 y~aPE~~~~-----------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~---~~~~~~~~~~~~li 314 (426)
|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......+.... ......+..+.+||
T Consensus 194 y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 273 (313)
T 3cek_A 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVL 273 (313)
T ss_dssp GCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHH
T ss_pred cCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHH
Confidence 999999976 4688999999999999999999999987643 33344443221 22234477899999
Q ss_pred HHHhccCCCCCCChHHHhcCCCcCC
Q 014344 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.+||..||.+|||+.|+++||||+.
T Consensus 274 ~~~l~~dp~~Rps~~ell~h~~~~~ 298 (313)
T 3cek_A 274 KCCLKRDPKQRISIPELLAHPYVQI 298 (313)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred HHHccCCcccCcCHHHHhcCccccC
Confidence 9999999999999999999999974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=382.54 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=215.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~iv 246 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS--------------MSVEAFLAEANVMKTLQHDKLV 246 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS--------------BCHHHHHHHHHHHTTCCCTTBC
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC--------------ccHHHHHHHHHHHhhCCCCCEe
Confidence 45677889999999999999999999985 46789999985421 1246788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++. .+.+|+|||||.+|+|.++++......++...+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 247 ~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 247 KLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp CEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEE
T ss_pred eEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEE
Confidence 9999986 667899999999999999987654445899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++...... ........+|+.
T Consensus 326 ~DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 350 (454)
T 1qcf_A 326 ADFGLARVIEDNE-------------------------------------------------------YTAREGAKFPIK 350 (454)
T ss_dssp CSTTGGGGBCCHH-------------------------------------------------------HHTTCSSSSCGG
T ss_pred eeCCCceEcCCCc-------------------------------------------------------eeccCCCccccc
Confidence 9999998653210 000112236788
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.. ..+.....+..+.+||.+||..||.+||
T Consensus 351 y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 430 (454)
T 1qcf_A 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERP 430 (454)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCc
Confidence 999999999999999999999999999999 9999999988877766653 3344456789999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|+++|+.
T Consensus 431 t~~~i~~ 437 (454)
T 1qcf_A 431 TFEYIQS 437 (454)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=367.91 Aligned_cols=262 Identities=17% Similarity=0.238 Sum_probs=215.5
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEE-----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVK-----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
...+..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~ 91 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC------------SEQDELDFLMEALIISKFN 91 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC------------CHHHHHHHHHHHHHHHHCC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc------------chhhHHHHHHHHHHHhhCC
Confidence 456778899999999999999999999 55778899999984321 1223457888999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCe
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-----QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENI 159 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-----~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~Ni 159 (426)
||||+++++++......|+|||||+|++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 92 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NI 171 (327)
T 2yfx_A 92 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 171 (327)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHE
Confidence 99999999999999999999999999999999886532 3489999999999999999999999999999999999
Q ss_pred eeccC---CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQEN---GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 160 Ll~~~---g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
|++.+ +.+||+|||++.......
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~------------------------------------------------------ 197 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRAS------------------------------------------------------ 197 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC--------------------------------------------------------
T ss_pred EEecCCCcceEEECcccccccccccc------------------------------------------------------
Confidence 99944 469999999987542211
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l 313 (426)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+....+... .......+..+.+|
T Consensus 198 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 277 (327)
T 2yfx_A 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRI 277 (327)
T ss_dssp ----CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 0012234468999999999999999999999999999999998 99999998887776666543 23334568899999
Q ss_pred HHHHhccCCCCCCChHHHhcCCCc
Q 014344 314 IRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~hp~f 337 (426)
|.+||..||.+|||+.+|++|.|+
T Consensus 278 i~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 278 MTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHhcCChhhCcCHHHHHHHHHH
Confidence 999999999999999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=355.91 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=212.3
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcC---CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVE---SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
+...+..++|++.+.||+|+||+||+|++.. ++..||+|++.+.. .....+.+.+|+.+++.++|
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h 72 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC------------TLDNKEKFMSEAVIMKNLDH 72 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS------------CHHHHHHHHHHHHHHHHHCC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc------------CchHHHHHHHHHHHHHhCCC
Confidence 3457788899999999999999999999754 34469999985432 12245678899999999999
Q ss_pred CCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC
Q 014344 86 PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG 165 (426)
Q Consensus 86 p~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g 165 (426)
|||+++++++.++ ..|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 73 ~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 150 (281)
T 3cc6_A 73 PHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE 150 (281)
T ss_dssp TTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT
T ss_pred CCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC
Confidence 9999999998654 5689999999999999987654 4599999999999999999999999999999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++........ .......
T Consensus 151 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------~~~~~~~ 175 (281)
T 3cc6_A 151 CVKLGDFGLSRYIEDEDY-------------------------------------------------------YKASVTR 175 (281)
T ss_dssp EEEECCCCGGGCC----------------------------------------------------------------CCC
T ss_pred cEEeCccCCCcccccccc-------------------------------------------------------cccccCC
Confidence 999999999876532110 0112234
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP 322 (426)
||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+.. ..+.....+..+.+||.+||..||
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 255 (281)
T 3cc6_A 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDP 255 (281)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 7889999999999999999999999999999998 9999987776655544432 233344568899999999999999
Q ss_pred CCCCChHHHhcC
Q 014344 323 TKRIGVEEIKGH 334 (426)
Q Consensus 323 ~~R~s~~eil~h 334 (426)
.+|||+.+++++
T Consensus 256 ~~Rps~~ell~~ 267 (281)
T 3cc6_A 256 SDRPRFTELVCS 267 (281)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=361.82 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=211.9
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCC----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESS----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.++..++|++.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++.++||
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ 106 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY------------TEKQRVDFLGEAGIMGQFSHH 106 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC------------CHHHHHHHHHHHHHHHhCCCC
Confidence 4677889999999999999999999987654 359999985431 122345788899999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++...+.+|+|||||+|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 107 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc
Confidence 99999999999999999999999999999987643 45999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++......... ........+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~ 212 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEA-----------------------------------------------------TYTTSGGKI 212 (333)
T ss_dssp EEECCCCC----------------------------------------------------------------------CC
T ss_pred EEECCCCcchhhcccccc-----------------------------------------------------ccccCCCCc
Confidence 999999999865421100 001112246
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... .+.....+..+.+||.+||+.||.
T Consensus 213 ~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 292 (333)
T 1mqb_A 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 292 (333)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTT
T ss_pred cccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChh
Confidence 889999999999999999999999999999998 99999998887777666543 334456788999999999999999
Q ss_pred CCCChHHHhcC
Q 014344 324 KRIGVEEIKGH 334 (426)
Q Consensus 324 ~R~s~~eil~h 334 (426)
+||++.+++++
T Consensus 293 ~Rps~~~l~~~ 303 (333)
T 1mqb_A 293 RRPKFADIVSI 303 (333)
T ss_dssp TSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=358.01 Aligned_cols=245 Identities=21% Similarity=0.311 Sum_probs=208.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|+||.||+|++..+++.||+|++.... ..+.+|+.+++.++||||+++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~ 73 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----------------EKAEREVKALAKLDHVNIVHYNGCW 73 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----------------GGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----------------HHHHHHHHHHHhCCCCCEEEEeeeE
Confidence 46999999999999999999999999999999984321 2456799999999999999999988
Q ss_pred ec----------------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCe
Q 014344 96 ST----------------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENI 159 (426)
Q Consensus 96 ~~----------------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~Ni 159 (426)
.. ...+|+|||||++++|.+++.......+++..+..++.||+.||.|||++||+||||||+||
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Ni 153 (284)
T 2a19_B 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNI 153 (284)
T ss_dssp EEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred eccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHE
Confidence 54 45689999999999999999876666799999999999999999999999999999999999
Q ss_pred eeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 160 MIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239 (426)
Q Consensus 160 Ll~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (426)
|++.++.+||+|||++.......
T Consensus 154 l~~~~~~~kl~Dfg~~~~~~~~~--------------------------------------------------------- 176 (284)
T 2a19_B 154 FLVDTKQVKIGDFGLVTSLKNDG--------------------------------------------------------- 176 (284)
T ss_dssp EEEETTEEEECCCTTCEESSCCS---------------------------------------------------------
T ss_pred EEcCCCCEEECcchhheeccccc---------------------------------------------------------
Confidence 99999999999999987653211
Q ss_pred CccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhc
Q 014344 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 240 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~ 319 (426)
......||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+..+ .........+..+.+||.+||.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 253 (284)
T 2a19_B 177 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDL-RDGIISDIFDKKEKTLLQKLLS 253 (284)
T ss_dssp CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHH-HTTCCCTTSCHHHHHHHHHHTC
T ss_pred cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHh-hcccccccCCHHHHHHHHHHcc
Confidence 112335899999999999999999999999999999999999988532 2222222 2222334568889999999999
Q ss_pred cCCCCCCChHHHhcCCCc
Q 014344 320 KDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 320 ~dP~~R~s~~eil~hp~f 337 (426)
.||.+|||+.|+++|.+.
T Consensus 254 ~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 254 KKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp SSGGGSCCHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHH
Confidence 999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=359.01 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=200.1
Q ss_pred CCCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 8 ~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
.+..++.-++|++++.||+|+||+||+|++. ..||+|++.... ......+.+.+|+.+|+.++|||
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~ 81 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-----------PTPQQLQAFKNEVGVLRKTRHVN 81 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-----------CCHHHHHHHHHHHHHHTTCCCTT
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-----------CCHHHHHHHHHHHHHHHhCCCCc
Confidence 3456788889999999999999999999864 359999985432 12234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|++++++. .....++|||||.|++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp BCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEeec-cCCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCE
Confidence 99999954 566789999999999999987544 3459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++........ ........||
T Consensus 160 kl~Dfg~~~~~~~~~~------------------------------------------------------~~~~~~~~gt 185 (289)
T 3og7_A 160 KIGDFGLATEKSRWSG------------------------------------------------------SHQFEQLSGS 185 (289)
T ss_dssp EECCCC------------------------------------------------------------------------CC
T ss_pred EEccceeccccccccc------------------------------------------------------cccccccCCC
Confidence 9999999875532110 1122344699
Q ss_pred CCCccchhhc---CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCC----CCCCCHHHHHHHHHH
Q 014344 248 EEYVAPEIIE---GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPD----LVGEPTPLRNLIRRL 317 (426)
Q Consensus 248 ~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~----~~~~~~~~~~li~~~ 317 (426)
+.|+|||++. +..++.++|||||||++|+|++|+.||.+............. .+. ....+..+.+||.+|
T Consensus 186 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 265 (289)
T 3og7_A 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAEC 265 (289)
T ss_dssp CTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHH
T ss_pred ccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHH
Confidence 9999999997 667899999999999999999999999887665554444321 111 225678899999999
Q ss_pred hccCCCCCCChHHHhc
Q 014344 318 LEKDPTKRIGVEEIKG 333 (426)
Q Consensus 318 L~~dP~~R~s~~eil~ 333 (426)
|..||.+|||+.++++
T Consensus 266 l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 266 LKKKRDERPSFPRILA 281 (289)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred ccCChhhCCCHHHHHH
Confidence 9999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=361.69 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=211.3
Q ss_pred cCCCCCCCCCCCCCcEEEeeecccCceEEEEEEEcC---CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH
Q 014344 4 VVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVE---SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80 (426)
Q Consensus 4 ~~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il 80 (426)
+-+......+..++|++.+.||+|+||+||+|.+.. +++.||+|++..... .....+.+.+|+.++
T Consensus 22 l~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l 90 (313)
T 3brb_A 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-----------SQREIEEFLSEAACM 90 (313)
T ss_dssp --CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-----------CHHHHHHHHHHHHHH
T ss_pred hhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-----------chhHHHHHHHHHHHH
Confidence 444455566778899999999999999999998765 556899999854321 223456788999999
Q ss_pred HhcCCCCcceeeeeeecCC-----eEEEEEeccCCCChHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 014344 81 RNVEHPLLPRLRGVLSTDK-----FVGYAIDYCPGRDLHSLRKQQ----SEQMFSDDTIRFYAAELVLALEYLHNMGIVY 151 (426)
Q Consensus 81 ~~l~hp~iv~l~~~~~~~~-----~~~lV~Ey~~gg~L~~l~~~~----~~~~l~~~~~~~~~~qil~aL~~LH~~giiH 151 (426)
+.++||||+++++++.... ..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 170 (313)
T 3brb_A 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLH 170 (313)
T ss_dssp HTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred hcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 9999999999999997654 459999999999999987542 3356999999999999999999999999999
Q ss_pred cCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCC
Q 014344 152 RDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPS 231 (426)
Q Consensus 152 rDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (426)
|||||+|||++.++.+||+|||++........
T Consensus 171 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------------ 202 (313)
T 3brb_A 171 RDLAARNCMLRDDMTVCVADFGLSKKIYSGDY------------------------------------------------ 202 (313)
T ss_dssp CCCSGGGEEECTTSCEEECSCSCC--------------------------------------------------------
T ss_pred CCCCcceEEEcCCCcEEEeecCcceecccccc------------------------------------------------
Confidence 99999999999999999999999876532110
Q ss_pred CCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCH
Q 014344 232 RSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPT 308 (426)
Q Consensus 232 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~ 308 (426)
........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+... +......+.
T Consensus 203 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (313)
T 3brb_A 203 ------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLD 276 (313)
T ss_dssp --------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCH
T ss_pred ------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccH
Confidence 011123347889999999999999999999999999999999 99999998877776666543 333446688
Q ss_pred HHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 309 PLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 309 ~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+.+||.+||..||.+|||+.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=357.82 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=208.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEE----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
...+....|++++.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+|+.++|
T Consensus 15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h 82 (302)
T 4e5w_A 15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES------------GGNHIADLKKEIEILRNLYH 82 (302)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----------------CCHHHHHHHHHHHHTCCC
T ss_pred hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc------------cchhHHHHHHHHHHHHhCCC
Confidence 344556679999999999999999999 57789999999985432 11234678889999999999
Q ss_pred CCcceeeeeeecC--CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 86 PLLPRLRGVLSTD--KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 86 p~iv~l~~~~~~~--~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
|||+++++++..+ ..+|+||||++|++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 83 ~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~ 161 (302)
T 4e5w_A 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161 (302)
T ss_dssp TTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred CCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC
Confidence 9999999999876 77999999999999999986554 45999999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+|||++......... ......
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~ 188 (302)
T 4e5w_A 162 EHQVKIGDFGLTKAIETDKEY-----------------------------------------------------YTVKDD 188 (302)
T ss_dssp TTEEEECCCTTCEECCTTCCE-----------------------------------------------------EECCCC
T ss_pred CCCEEECcccccccccCCCcc-----------------------------------------------------eeccCC
Confidence 999999999999876432100 011223
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHh---cCCCCCCCC
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--------------RKETFYRIL---CRPPDLVGE 306 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------------~~~~~~~i~---~~~~~~~~~ 306 (426)
..||+.|+|||++.+..++.++|||||||++|+|++|..|+.... ........+ ...+.....
T Consensus 189 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T 4e5w_A 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNC 268 (302)
T ss_dssp TTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCC
Confidence 458889999999999999999999999999999999998864321 112222222 122334466
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+..+.+||.+||..||.+|||+.++++
T Consensus 269 ~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 269 PDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 889999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=356.21 Aligned_cols=248 Identities=21% Similarity=0.337 Sum_probs=206.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.++.++|++++.||+|+||+||+|.+ +++.||+|++... ...+.+.+|+.+++.++||||+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~h~~iv 77 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---------------ATAQAFLAEASVMTQLRHSNLV 77 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---------------C--HHHHHTHHHHTTCCCTTBC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch---------------hHHHHHHHHHHHHHhCCCCCEe
Confidence 4568889999999999999999999986 4889999998432 1345788899999999999999
Q ss_pred eeeeeeec-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++.. ...+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 157 (278)
T 1byg_A 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 157 (278)
T ss_dssp CEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred eEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEE
Confidence 99998654 45799999999999999998766544589999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++...... .....+|+
T Consensus 158 l~Dfg~~~~~~~~-----------------------------------------------------------~~~~~~~~ 178 (278)
T 1byg_A 158 VSDFGLTKEASST-----------------------------------------------------------QDTGKLPV 178 (278)
T ss_dssp ECCCCC-----------------------------------------------------------------------CCT
T ss_pred Eeecccccccccc-----------------------------------------------------------ccCCCccc
Confidence 9999998754211 11224788
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... .......++.+.++|.+||..||.+|
T Consensus 179 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (278)
T 1byg_A 179 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 258 (278)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhC
Confidence 9999999999999999999999999999998 99999988877766666533 23344668899999999999999999
Q ss_pred CChHHHhc
Q 014344 326 IGVEEIKG 333 (426)
Q Consensus 326 ~s~~eil~ 333 (426)
||+.++++
T Consensus 259 ps~~~l~~ 266 (278)
T 1byg_A 259 PSFLQLRE 266 (278)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=363.39 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=212.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEE-----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EH 85 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h 85 (426)
.+..++|++++.||+|+||+||+|++ ..+++.||||++.... .....+.+.+|+.+++.+ .|
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~~h 90 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA------------THSEHRALMSELKILIHIGHH 90 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHCCC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC------------CcHHHHHHHHHHHHHHhcccC
Confidence 46678999999999999999999985 3567899999985432 122346788899999999 68
Q ss_pred CCcceeeeeeecCC-eEEEEEeccCCCChHHHHHHhcc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 014344 86 PLLPRLRGVLSTDK-FVGYAIDYCPGRDLHSLRKQQSE--------------QMFSDDTIRFYAAELVLALEYLHNMGIV 150 (426)
Q Consensus 86 p~iv~l~~~~~~~~-~~~lV~Ey~~gg~L~~l~~~~~~--------------~~l~~~~~~~~~~qil~aL~~LH~~gii 150 (426)
|||+++++++...+ .+|+|||||+|++|.+++..... ..+++..+..++.||+.||.|||++||+
T Consensus 91 p~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~ 170 (316)
T 2xir_A 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170 (316)
T ss_dssp TTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 99999999987654 59999999999999999875432 1288999999999999999999999999
Q ss_pred ccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCC
Q 014344 151 YRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230 (426)
Q Consensus 151 HrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (426)
||||||+|||++.++.+||+|||++........
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----------------------------------------------- 203 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPD----------------------------------------------- 203 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-----------------------------------------------
T ss_pred cccCccceEEECCCCCEEECCCccccccccCcc-----------------------------------------------
Confidence 999999999999999999999999986532110
Q ss_pred CCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh-c--CCCCCCCC
Q 014344 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRIL-C--RPPDLVGE 306 (426)
Q Consensus 231 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~-~--~~~~~~~~ 306 (426)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+......+...+ . ........
T Consensus 204 -------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (316)
T 2xir_A 204 -------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYT 276 (316)
T ss_dssp -------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTC
T ss_pred -------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCC
Confidence 112234468999999999999999999999999999999998 999998876444333332 2 22233456
Q ss_pred CHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 307 ~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
++.+.++|.+||..||.+|||+.++++|
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8899999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=355.69 Aligned_cols=258 Identities=20% Similarity=0.230 Sum_probs=215.9
Q ss_pred CCCCCCCcEEEe-eecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVS-ALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
..++.++|.++. .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++|||
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~ 71 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT------------EKADTEEMMREAQIMHQLDNPY 71 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC------------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc------------chhHHHHHHHHHHHHHhCCCCC
Confidence 346678899998 9999999999999864 467889999985421 2234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++ ..+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 72 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 72 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEE
T ss_pred EeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCE
Confidence 99999999 456689999999999999987643 3459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++......... ........||
T Consensus 150 kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 176 (287)
T 1u59_A 150 KISDFGLSKALGADDSY-----------------------------------------------------YTARSAGKWP 176 (287)
T ss_dssp EECCCTTCEECTTCSCE-----------------------------------------------------ECCCCSSCCC
T ss_pred EECcccceeeeccCcce-----------------------------------------------------eecccccccc
Confidence 99999999876422100 0011223478
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|+|||++.+..++.++|||||||++|+|++ |+.||...+..+....+... +......+..+.+||.+||..||.+
T Consensus 177 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 256 (287)
T 1u59_A 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWED 256 (287)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhh
Confidence 99999999998889999999999999999998 99999998877776666543 2334567899999999999999999
Q ss_pred CCChHHHhcCC
Q 014344 325 RIGVEEIKGHE 335 (426)
Q Consensus 325 R~s~~eil~hp 335 (426)
||++.++++|.
T Consensus 257 Rps~~~l~~~l 267 (287)
T 1u59_A 257 RPDFLTVEQRM 267 (287)
T ss_dssp SCCHHHHHHHH
T ss_pred CcCHHHHHHHH
Confidence 99999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=380.42 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=199.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~ 92 (426)
.-.+|++.+.||+|+||+||. ....+++.||||++.+.. ...+.+|+.+|+.+ +||||++++
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~----------------~~~~~~E~~~l~~l~~HpnIv~l~ 84 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC----------------FSFADREVQLLRESDEHPNVIRYF 84 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT----------------EEECHHHHHHHHHSCCCTTBCCEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH----------------HHHHHHHHHHHHhccCCCCcCeEE
Confidence 334699999999999999764 455789999999985421 12345699999999 799999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CC--cE
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NG--HI 167 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g--~i 167 (426)
+++.+...+|+|||||. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++ .+
T Consensus 85 ~~~~~~~~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 85 CTEKDRQFQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEEETTEEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEEecCCEEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 99999999999999996 69999887554 33566677889999999999999999999999999999953 23 57
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+++.+..... ........+||
T Consensus 163 kL~DFG~a~~~~~~~~-----------------------------------------------------~~~~~~~~~gt 189 (432)
T 3p23_A 163 MISDFGLCKKLAVGRH-----------------------------------------------------SFSRRSGVPGT 189 (432)
T ss_dssp EECCTTEEECC-----------------------------------------------------------------CCSC
T ss_pred EEecccceeeccCCCc-----------------------------------------------------ceeeccccCCC
Confidence 8999999987642110 01123345799
Q ss_pred CCCccchhhc---CCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCC----CCCHHHHHHHHHHhc
Q 014344 248 EEYVAPEIIE---GKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRPPDLV----GEPTPLRNLIRRLLE 319 (426)
Q Consensus 248 ~~y~aPE~~~---~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~li~~~L~ 319 (426)
+.|+|||++. +..++.++|||||||++|+|++ |..||...........+........ ..+..+.+||.+||+
T Consensus 190 ~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 269 (432)
T 3p23_A 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269 (432)
T ss_dssp TTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSC
T ss_pred cCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHh
Confidence 9999999998 4567889999999999999999 9999976655443322221111111 113457899999999
Q ss_pred cCCCCCCChHHHhcCCCcCCCChh
Q 014344 320 KDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 320 ~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
.||.+|||++++++||||..++|.
T Consensus 270 ~dP~~Rps~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 270 MDPQKRPSAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp SSGGGSCCHHHHHTSTTTCCHHHH
T ss_pred CCHhhCCCHHHHHhCccccChHHH
Confidence 999999999999999999988774
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.97 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=212.2
Q ss_pred CCCCCCCcEEEe-eecccCceEEEEEEE--cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVS-ALGRGAKGVVFLVKD--VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~-~LG~G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
..++.++|++.+ .||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+++.++|||
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~ 79 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----------DPALKDELLAEANVMQQLDNPY 79 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTT
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-----------CHHHHHHHHHHHHHHHhCCCCC
Confidence 345667899998 999999999999954 56778999999854321 1234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++ ..+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 80 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~ 156 (291)
T 1xbb_A 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156 (291)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred EEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcE
Confidence 99999999 567789999999999999998764 349999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++......... ........||
T Consensus 157 kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 183 (291)
T 1xbb_A 157 KISDFGLSKALRADENY-----------------------------------------------------YKAQTHGKWP 183 (291)
T ss_dssp EECCCTTCEECCTTCSE-----------------------------------------------------EEC----CCC
T ss_pred EEccCCcceeeccCCCc-----------------------------------------------------ccccccCCCC
Confidence 99999999866422100 0011123478
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... +......+..+.++|.+||..||.+
T Consensus 184 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 263 (291)
T 1xbb_A 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVEN 263 (291)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred ceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 89999999999889999999999999999999 99999998887776665533 2333466889999999999999999
Q ss_pred CCChHHHhc
Q 014344 325 RIGVEEIKG 333 (426)
Q Consensus 325 R~s~~eil~ 333 (426)
|||+.++++
T Consensus 264 Rps~~~l~~ 272 (291)
T 1xbb_A 264 RPGFAAVEL 272 (291)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=379.16 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=206.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
..-++|++.+.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||++++
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~ 73 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL------------RPVDVQMREFEVLKKLNHKNIVKLF 73 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc------------chHHHHHHHHHHHHhcCCCCCCeEE
Confidence 3446799999999999999999999999999999999643221 1245677899999999999999999
Q ss_pred eeeecCC--eEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee----ccCC
Q 014344 93 GVLSTDK--FVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI----QENG 165 (426)
Q Consensus 93 ~~~~~~~--~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl----~~~g 165 (426)
+++.... ..|+|||||+||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp EEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE
T ss_pred EeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce
Confidence 9998655 78999999999999998765432 339999999999999999999999999999999999999 7778
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||++...... ......+
T Consensus 154 ~~kL~DFG~a~~~~~~---------------------------------------------------------~~~~~~~ 176 (396)
T 4eut_A 154 VYKLTDFGAARELEDD---------------------------------------------------------EQFVSLY 176 (396)
T ss_dssp EEEECCGGGCEECCCG---------------------------------------------------------GGSSCSS
T ss_pred eEEEecCCCceEccCC---------------------------------------------------------Ccccccc
Confidence 8999999999765321 1123456
Q ss_pred cCCCCccchhhcC--------CCCChhhHHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCC----------
Q 014344 246 GTEEYVAPEIIEG--------KGHDFAVDWWSLGVVLHEMLYGATPFRGS----SRKETFYRILCRPPDL---------- 303 (426)
Q Consensus 246 gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~i~~~~~~~---------- 303 (426)
||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+...+++...+..
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 256 (396)
T 4eut_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN 256 (396)
T ss_dssp SCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTT
T ss_pred CCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccC
Confidence 9999999999875 56788999999999999999999999642 3345555555433210
Q ss_pred ----------------CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 ----------------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ----------------~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||++||+.||++|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 257 GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 0113467899999999999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=366.91 Aligned_cols=268 Identities=18% Similarity=0.243 Sum_probs=204.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC-----CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES-----SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
+..++|++++.||+|+||+||+|.+..+ ++.||||++......... +... ........+..|+..++.+.|||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-e~~~-~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKF-YQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHH-HHHH-HHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHH-HHHH-HHhhhhhHHHHHHHHHhhccCCC
Confidence 4456899999999999999999998764 588999998654321110 0000 00001123555777888899999
Q ss_pred cceeeeeeecC----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec-
Q 014344 88 LPRLRGVLSTD----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ- 162 (426)
Q Consensus 88 iv~l~~~~~~~----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~- 162 (426)
|+++++++... ...|+||||| |++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 99999998764 5689999999 999999987643 4599999999999999999999999999999999999999
Q ss_pred -cCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 163 -ENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 163 -~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
.++.+||+|||+++.+....... .......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~-------------------------------------------------~~~~~~~ 218 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHK-------------------------------------------------AYAADPK 218 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCC-------------------------------------------------CSSCCSS
T ss_pred CCCCeEEEEECCcceecccCCccc-------------------------------------------------ccccCcc
Confidence 88999999999998764221100 0011123
Q ss_pred cccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------hcCCCCCCCCCHH
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI------------LCRPPDLVGEPTP 309 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i------------~~~~~~~~~~~~~ 309 (426)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+... +.........+..
T Consensus 219 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (364)
T 3op5_A 219 RCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGE 298 (364)
T ss_dssp CCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHH
T ss_pred cccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHH
Confidence 4557999999999999999999999999999999999999999864322211111 1111112456889
Q ss_pred HHHHHHHHhccCCCCCCChHHHhc
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+||..||..||.+||++++|++
T Consensus 299 ~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 299 IAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Confidence 999999999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=379.65 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=212.2
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++||||+
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hp~iv 242 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--------------MSPEAFLQEAQVMKKLRHEKLV 242 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS--------------SCHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC--------------CCHHHHHHHHHHHHhCCCCCEe
Confidence 456778899999999999999999999865 4679999985421 1235688899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.. +.+|+|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 243 ~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl 321 (452)
T 1fmk_A 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 321 (452)
T ss_dssp CEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred eEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEE
Confidence 99999866 77899999999999999987655556999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++....... .......+|+.
T Consensus 322 ~DfG~a~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 346 (452)
T 1fmk_A 322 ADFGLARLIEDNEY-------------------------------------------------------TARQGAKFPIK 346 (452)
T ss_dssp CCCCTTC---------------------------------------------------------------------CCGG
T ss_pred CCCccceecCCCce-------------------------------------------------------ecccCCccccc
Confidence 99999976532110 01112347888
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... .+.....+..+.+||.+||..||++||
T Consensus 347 y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 426 (452)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999999 99999999888877776543 233456788999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|+++|++
T Consensus 427 t~~~l~~ 433 (452)
T 1fmk_A 427 TFEYLQA 433 (452)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=363.53 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=212.4
Q ss_pred CCCCCCCCCCCcEEEeeecccCceEEEEEE----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh
Q 014344 7 DRPIRSLDFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN 82 (426)
Q Consensus 7 ~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~ 82 (426)
.....-++.++|++++.||+|+||.||+|+ +..+++.||||++.... ....+.+.+|+.+++.
T Consensus 14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~ 80 (327)
T 3lxl_A 14 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-------------PDQQRDFQREIQILKA 80 (327)
T ss_dssp ---CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-------------HHHHHHHHHHHHHHHT
T ss_pred cChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-------------HHHHHHHHHHHHHHHh
Confidence 334455777899999999999999999999 56789999999985431 2334678899999999
Q ss_pred cCCCCcceeeeeee--cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 83 VEHPLLPRLRGVLS--TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 83 l~hp~iv~l~~~~~--~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
++||||+++++++. ....+|+|||||+|++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 81 l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 159 (327)
T 3lxl_A 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 159 (327)
T ss_dssp CCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEE
Confidence 99999999999886 56779999999999999999876543 4999999999999999999999999999999999999
Q ss_pred eccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 161 l~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
++.++.+||+|||++........ ....
T Consensus 160 ~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------------------~~~~ 186 (327)
T 3lxl_A 160 VESEAHVKIADFGLAKLLPLDKD-----------------------------------------------------YYVV 186 (327)
T ss_dssp EEETTEEEECCGGGCEECCTTCS-----------------------------------------------------EEEC
T ss_pred ECCCCCEEEcccccceecccCCc-----------------------------------------------------ccee
Confidence 99999999999999987642110 0011
Q ss_pred ccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHh--cCCCCC
Q 014344 241 SNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---------------ETFYRIL--CRPPDL 303 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------------~~~~~i~--~~~~~~ 303 (426)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+. ...+..
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lxl_A 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAP 266 (327)
T ss_dssp SSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCC
T ss_pred eccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCC
Confidence 22345889999999999999999999999999999999999999654432 1111111 123334
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
...+..+.+||.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 267 PACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4668899999999999999999999999654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=354.06 Aligned_cols=253 Identities=19% Similarity=0.282 Sum_probs=213.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++++.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+|+.++||||+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~ 71 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--------------MSPDAFLAEANLMKQLQHQRLV 71 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--------------SCHHHHHHHHHHHHHCCCTTBC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc--------------ccHHHHHHHHHHHHhCCCcCcc
Confidence 35677889999999999999999999975 56789999984321 1235688899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++. ++..|+||||++|++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 72 ~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl 150 (279)
T 1qpc_A 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (279)
T ss_dssp CEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred eEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEE
Confidence 9999986 456899999999999999876544335999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||++........ .......+|+.
T Consensus 151 ~Dfg~~~~~~~~~~-------------------------------------------------------~~~~~~~~~~~ 175 (279)
T 1qpc_A 151 ADFGLARLIEDNEY-------------------------------------------------------TAREGAKFPIK 175 (279)
T ss_dssp CCCTTCEECSSSCE-------------------------------------------------------ECCTTCCCCTT
T ss_pred CCCcccccccCccc-------------------------------------------------------ccccCCCCccC
Confidence 99999976532110 01122347889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... .......+..+.+||.+||..||++||
T Consensus 176 y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 255 (279)
T 1qpc_A 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255 (279)
T ss_dssp TSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCC
Confidence 999999998889999999999999999999 99999998887777666543 233345688999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
|++++++
T Consensus 256 s~~~l~~ 262 (279)
T 1qpc_A 256 TFDYLRS 262 (279)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=353.43 Aligned_cols=264 Identities=19% Similarity=0.323 Sum_probs=207.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee-e
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG-V 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~-~ 94 (426)
++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.+++.+.|++++..+. +
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---------------KHPQLHIESKIYKMMQGGVGIPTIRWC 73 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------------------CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---------------cchHHHHHHHHHHHhcCCCCCCeeeee
Confidence 57999999999999999999999999999999864321 1235777999999999877665554 4
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~D 171 (426)
+......++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 74 GAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred cCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEec
Confidence 57788999999999 999999987543 459999999999999999999999999999999999999 7899999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++........... ..........||+.|+
T Consensus 152 fg~a~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~gt~~y~ 182 (296)
T 4hgt_A 152 FGLAKKYRDARTHQH-------------------------------------------------IPYRENKNLTGTARYA 182 (296)
T ss_dssp CTTCEECBCTTTCCB-------------------------------------------------CCCCCSCCCCSCGGGC
T ss_pred CccceeccCcccCcc-------------------------------------------------CCCCcccccCCCcccc
Confidence 999987643211000 0011234557999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----hcCCC--CCCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRI----LCRPP--DLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i----~~~~~--~~~~~~~~~~~li~~~L~~dP 322 (426)
|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+..+ ...+. .....+..+.+||.+||+.||
T Consensus 183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred chHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCC
Confidence 999999999999999999999999999999999874321 112221 11111 113457899999999999999
Q ss_pred CCCCChHHHhc----------CCCcCCCChhhh
Q 014344 323 TKRIGVEEIKG----------HEFFKGVNWELL 345 (426)
Q Consensus 323 ~~R~s~~eil~----------hp~f~~~~~~~~ 345 (426)
++|||++++++ .+|-..++|+.+
T Consensus 263 ~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 263 DDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred CCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 99999998875 345555566543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=355.32 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=202.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
..+.+|++++.||+|+||.||+|.+..+++.||||++..... ........+.+|+.+++.++||||++++
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 98 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL----------MDAKARADCIKEIDLLKQLNHPNVIKYY 98 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS----------CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc----------cCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 456789999999999999999999999999999999854211 1223456788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++..++..++||||+.+++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEE
Confidence 9999999999999999999999987643 34569999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++....... .......||+.|
T Consensus 179 Dfg~~~~~~~~~--------------------------------------------------------~~~~~~~~~~~y 202 (310)
T 2wqm_A 179 DLGLGRFFSSKT--------------------------------------------------------TAAHSLVGTPYY 202 (310)
T ss_dssp CC--------------------------------------------------------------------------CCSS
T ss_pred eccceeeecCCC--------------------------------------------------------ccccccCCCeeE
Confidence 999987653211 112234689999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcC--CC-CCCCCCHHHHHHHHHHhccCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--RKETFYRILCR--PP-DLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~--~~-~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
+|||++.+..++.++|||||||++|+|++|..||.+.. .......+... ++ .....+..+.+||.+||..||.+|
T Consensus 203 ~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 282 (310)
T 2wqm_A 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282 (310)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGS
T ss_pred eChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhC
Confidence 99999999999999999999999999999999997643 23333333322 11 123568899999999999999999
Q ss_pred CChHHHhcC
Q 014344 326 IGVEEIKGH 334 (426)
Q Consensus 326 ~s~~eil~h 334 (426)
||+.+++++
T Consensus 283 ps~~~il~~ 291 (310)
T 2wqm_A 283 PDVTYVYDV 291 (310)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.12 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=194.0
Q ss_pred CCCCCCC-cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCc
Q 014344 11 RSLDFSC-LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLL 88 (426)
Q Consensus 11 ~~l~~~~-y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i 88 (426)
.+..+.+ |.+.+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+.+|+.+ +||||
T Consensus 9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----------------~~~~~~E~~~l~~l~~HpnI 71 (434)
T 2rio_A 9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----------------CDIALMEIKLLTESDDHPNV 71 (434)
T ss_dssp CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----------------HHHHHHHHHHHHHHTTSTTB
T ss_pred hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----------------HHHHHHHHHHHHhccCCCCc
Confidence 3344444 455688999999999875 45679999999985431 23567799999876 89999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCC-----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM-----FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~-----l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
+++++++.+++.+|+|||||. |+|.+++....... .++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 72 v~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 72 IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp CCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred CeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 999999999999999999996 69999987543211 123345679999999999999999999999999999975
Q ss_pred C-------------CcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCC
Q 014344 164 N-------------GHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230 (426)
Q Consensus 164 ~-------------g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (426)
+ +.+||+|||++..+......
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~---------------------------------------------- 184 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSS---------------------------------------------- 184 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------------------------------------------
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCcc----------------------------------------------
Confidence 4 48999999999876432100
Q ss_pred CCCCCCCCCCccccccCCCCccchhhcC-------CCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--
Q 014344 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEG-------KGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP-- 300 (426)
Q Consensus 231 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~-- 300 (426)
........+||+.|+|||++.+ ..++.++|||||||++|||++ |..||......+. .++...
T Consensus 185 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~ 256 (434)
T 2rio_A 185 ------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFS 256 (434)
T ss_dssp ----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCC
T ss_pred ------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCC
Confidence 0011234579999999999976 568999999999999999998 9999987654432 222211
Q ss_pred -CCCC-----CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 301 -PDLV-----GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 301 -~~~~-----~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
+... ..+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 1111 123678999999999999999999999999999653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=353.42 Aligned_cols=254 Identities=19% Similarity=0.265 Sum_probs=206.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCC---ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
..+|++.+.||+|+||+||+|++..++ ..+|+|++... ......+.+.+|+.++++++||||+++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 91 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI------------TDIGEVSQFLTEGIIMKDFSHPNVLSL 91 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC------------CSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC------------CCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 446999999999999999999976443 35899988432 122345678899999999999999999
Q ss_pred eeee-ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 92 RGVL-STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 92 ~~~~-~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++++ ..++..|+|||||.|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 92 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 170 (298)
T 3f66_A 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVA 170 (298)
T ss_dssp CEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred eeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEEC
Confidence 9985 56678899999999999999986543 458999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++......... .........||+.|
T Consensus 171 Dfg~a~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y 198 (298)
T 3f66_A 171 DFGLARDMYDKEYY----------------------------------------------------SVHNKTGAKLPVKW 198 (298)
T ss_dssp SCGGGCCCSCGGGC----------------------------------------------------BC-----CCBCGGG
T ss_pred cccccccccccchh----------------------------------------------------ccccccCCCCCccc
Confidence 99999865421100 01122334588999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP--PDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+....+.... ......+..+.++|.+||..||.+|||
T Consensus 199 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 278 (298)
T 3f66_A 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS 278 (298)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999999999 778888777666655554332 223456888999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
+.++++
T Consensus 279 ~~ell~ 284 (298)
T 3f66_A 279 FSELVS 284 (298)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=351.13 Aligned_cols=246 Identities=26% Similarity=0.454 Sum_probs=200.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
..++.++|++.+.||+|+||+||+|++. ++.||||++... ...+.+..|+.+|+.++||||++
T Consensus 3 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---------------~~~~~~~~E~~~l~~l~hp~iv~ 65 (307)
T 2eva_A 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---------------SERKAFIVELRQLSRVNHPNIVK 65 (307)
T ss_dssp CBCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---------------THHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---------------hHHHHHHHHHHHHhcCCCCCcCe
Confidence 3567889999999999999999999874 788999998422 23467888999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCCCCeeeccCCc
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE-QMFSDDTIRFYAAELVLALEYLHN---MGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~-~~l~~~~~~~~~~qil~aL~~LH~---~giiHrDlKp~NiLl~~~g~ 166 (426)
+++++.+ ..|+||||++|++|.+++..... ..++...+..++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 66 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~ 143 (307)
T 2eva_A 66 LYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143 (307)
T ss_dssp EEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT
T ss_pred EEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC
Confidence 9998864 47899999999999999875432 247889999999999999999999 89999999999999998886
Q ss_pred -EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 167 -IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 167 -ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
+||+|||++...... .....
T Consensus 144 ~~kl~Dfg~~~~~~~~-----------------------------------------------------------~~~~~ 164 (307)
T 2eva_A 144 VLKICDFGTACDIQTH-----------------------------------------------------------MTNNK 164 (307)
T ss_dssp EEEECCCCC-----------------------------------------------------------------------
T ss_pred EEEEcccccccccccc-----------------------------------------------------------cccCC
Confidence 799999998754211 11235
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHh--cCCCCCCCCCHHHHHHHHHHhccC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR--KETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~i~--~~~~~~~~~~~~~~~li~~~L~~d 321 (426)
||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ......+. ..++.....+..+.+||.+||+.|
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 244 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKD 244 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSS
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCC
Confidence 89999999999999999999999999999999999999986432 22222222 223334567889999999999999
Q ss_pred CCCCCChHHHhcC
Q 014344 322 PTKRIGVEEIKGH 334 (426)
Q Consensus 322 P~~R~s~~eil~h 334 (426)
|.+|||+++++++
T Consensus 245 p~~Rps~~ell~~ 257 (307)
T 2eva_A 245 PSQRPSMEEIVKI 257 (307)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=356.13 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=195.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh--cCCCCcce
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN--VEHPLLPR 90 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~iv~ 90 (426)
.-.++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. ++||||++
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~l~h~niv~ 66 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----------------EKSWFRETELYNTVMLRHENILG 66 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----------------HHHHHHHHHHHHHTCCCCTTBCC
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----------------chhhHHHHHHHHHhhccCcCeee
Confidence 3456799999999999999999987 68999999985431 2344556777766 78999999
Q ss_pred eeeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCC
Q 014344 91 LRGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH--------NMGIVYRDLKPEN 158 (426)
Q Consensus 91 l~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH--------~~giiHrDlKp~N 158 (426)
+++++.. ...+|+|||||++|+|.++++. ..+++..+..++.||+.||+||| ++||+||||||+|
T Consensus 67 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~N 143 (301)
T 3q4u_A 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143 (301)
T ss_dssp EEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGG
T ss_pred EEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHh
Confidence 9998643 4568999999999999999853 35999999999999999999999 9999999999999
Q ss_pred eeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 159 IMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSS 238 (426)
Q Consensus 159 iLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (426)
||++.++.+||+|||++......... ..
T Consensus 144 ill~~~~~~kl~Dfg~a~~~~~~~~~----------------------------------------------------~~ 171 (301)
T 3q4u_A 144 ILVKKNGQCCIADLGLAVMHSQSTNQ----------------------------------------------------LD 171 (301)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTE----------------------------------------------------EE
T ss_pred EEEcCCCCEEEeeCCCeeeccccccc----------------------------------------------------cc
Confidence 99999999999999998765321100 00
Q ss_pred CCccccccCCCCccchhhcCC------CCChhhHHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHhc
Q 014344 239 EKSNSFVGTEEYVAPEIIEGK------GHDFAVDWWSLGVVLHEMLYG----------ATPFRGSS----RKETFYRILC 298 (426)
Q Consensus 239 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~ell~g----------~~pf~~~~----~~~~~~~i~~ 298 (426)
......+||+.|+|||++.+. .++.++|||||||++|||++| ..||.... ..........
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~ 251 (301)
T 3q4u_A 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVC 251 (301)
T ss_dssp CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT
T ss_pred ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHh
Confidence 112344799999999999876 455799999999999999999 88986532 2233333332
Q ss_pred CCCCCCC---------CCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 299 RPPDLVG---------EPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 299 ~~~~~~~---------~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
....... .+..+.+||.+||+.||++|||+.+|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 252 VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2111111 2356899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.28 Aligned_cols=253 Identities=21% Similarity=0.288 Sum_probs=207.3
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.|++.+.||+|+||+||+|++..+++ .||+|++... ......+.+.+|+.+++.++||||+++++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~------------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 89 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI------------TEMQQVEAFLREGLLMRGLNHPNVLALIG 89 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC------------CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc------------ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 46778999999999999999765554 7999998432 12234567889999999999999999999
Q ss_pred eeecCCeE-EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 94 VLSTDKFV-GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 94 ~~~~~~~~-~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++.+.+.. ++||||+.+++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Df 168 (298)
T 3pls_A 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168 (298)
T ss_dssp EECCSSSCCEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCT
T ss_pred EEecCCCCcEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcC
Confidence 99776655 9999999999999998653 345899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|++..+..... ..........||+.|+|
T Consensus 169 g~~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~~y~a 196 (298)
T 3pls_A 169 GLARDILDREY----------------------------------------------------YSVQQHRHARLPVKWTA 196 (298)
T ss_dssp TSSCTTTTGGG----------------------------------------------------GCSCCSSCTTCGGGGSC
T ss_pred CCcccccCCcc----------------------------------------------------cccccCcCCCCCccccC
Confidence 99976532110 00112234468999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||++.+..++.++|||||||++|+|++ |.+||...+..+....+... .+.....+..+.+||.+||..||.+|||++
T Consensus 197 PE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 276 (298)
T 3pls_A 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFR 276 (298)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHH
Confidence 999999999999999999999999999 56667666665555554432 233445688999999999999999999999
Q ss_pred HHhcC
Q 014344 330 EIKGH 334 (426)
Q Consensus 330 eil~h 334 (426)
++++.
T Consensus 277 ~ll~~ 281 (298)
T 3pls_A 277 VLVGE 281 (298)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99863
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=363.61 Aligned_cols=268 Identities=16% Similarity=0.200 Sum_probs=202.7
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcC---CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVE---SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
.+..++|++++.||+|+||+||+|++.. ++..+|||++......... +... ........+..|+.+++.++||||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-e~~~-~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKF-YQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-HHHH-HHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-HHHH-HHHHhhhHHHHHHHhhccccccCc
Confidence 3456789999999999999999999987 7889999998654211100 0000 000112346778999999999999
Q ss_pred ceeeeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 89 PRLRGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 89 v~l~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
+++++++.. ...+|+||||| |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 999999987 78999999999 999999876554 59999999999999999999999999999999999999988
Q ss_pred C--cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 014344 165 G--HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSN 242 (426)
Q Consensus 165 g--~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (426)
+ .+||+|||+++.+....... ........
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~-------------------------------------------------~~~~~~~~ 218 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHK-------------------------------------------------QYQENPRK 218 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCC-------------------------------------------------CCCCCGGG
T ss_pred CCCcEEEEeCCCceecccccccc-------------------------------------------------cchhcccc
Confidence 7 99999999998764221000 00011224
Q ss_pred ccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC--CHHHHHH---HHhcCCCC-------CCCCCHHH
Q 014344 243 SFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS--SRKETFY---RILCRPPD-------LVGEPTPL 310 (426)
Q Consensus 243 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~---~i~~~~~~-------~~~~~~~~ 310 (426)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +...... ......+. ....+..+
T Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (345)
T 2v62_A 219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEI 298 (345)
T ss_dssp CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHH
T ss_pred ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHH
Confidence 557999999999999999999999999999999999999999652 2222111 11111111 11568899
Q ss_pred HHHHHHHhccCCCCCCChHHHhc
Q 014344 311 RNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 311 ~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.+||.+||..||.+|||+++|++
T Consensus 299 ~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 299 AQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=362.75 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=203.6
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCC--------CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVES--------SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH 85 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~--------~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h 85 (426)
..++|++++.||+|+||+||+|++..+ ++.||||++.+. ..+.+|+.+++.++|
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------------------~~~~~E~~~l~~l~h 101 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------------------GRLFNEQNFFQRAAK 101 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------------------STHHHHHHHHHHHCC
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------------------chHHHHHHHHHHhcc
Confidence 347899999999999999999999874 889999998432 356779999999999
Q ss_pred CCcce---------------eeeeeec-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 86 PLLPR---------------LRGVLST-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 86 p~iv~---------------l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
|||++ +++++.. +...|+||||| |++|.+++.......+++..+..++.||+.||.|||++||
T Consensus 102 ~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 180 (352)
T 2jii_A 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180 (352)
T ss_dssp HHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 99887 5666655 78999999999 9999999987644569999999999999999999999999
Q ss_pred cccCCCCCCeeeccCC--cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENG--HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g--~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
+||||||+|||++.++ .+||+|||++..+.......
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------------------ 218 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV------------------------------------------ 218 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCC------------------------------------------
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccc------------------------------------------
Confidence 9999999999999998 99999999998764221000
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH---HhcCCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--RKETFYR---ILCRPPD 302 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~---i~~~~~~ 302 (426)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....... ....+..
T Consensus 219 -------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 291 (352)
T 2jii_A 219 -------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291 (352)
T ss_dssp -------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC
T ss_pred -------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh
Confidence 000112234579999999999999999999999999999999999999998764 2222221 1222222
Q ss_pred C-------CCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 303 L-------VGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 303 ~-------~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
. ...+..+.+||.+||..||.+|||+++|++
T Consensus 292 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 292 FVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp EECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 1 135789999999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=351.56 Aligned_cols=253 Identities=19% Similarity=0.309 Sum_probs=203.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee-
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG- 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~- 93 (426)
.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+.|++++..+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---------------~~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---------------KHPQLHIESKIYKMMQGGVGIPTIRW 72 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---------------SCCHHHHHHHHHHHHTTSTTCCCEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---------------chhHHHHHHHHHHHhhcCCCCCcccc
Confidence 367999999999999999999999999999999984321 1235778999999999877655444
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEe
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLV 170 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~ 170 (426)
++......++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~ 150 (296)
T 3uzp_A 73 CGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYII 150 (296)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred ccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence 457788899999999 899999987543 459999999999999999999999999999999999999 488999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++........... ..........||+.|
T Consensus 151 Dfg~~~~~~~~~~~~~-------------------------------------------------~~~~~~~~~~gt~~y 181 (296)
T 3uzp_A 151 DFGLAKKYRDARTHQH-------------------------------------------------IPYRENKNLTGTARY 181 (296)
T ss_dssp CCTTCEECBCTTTCCB-------------------------------------------------CCCCCSCCCCSCTTT
T ss_pred eCCCcccccccccccc-------------------------------------------------ccccccccccccccc
Confidence 9999987643211000 001123455799999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----hcCC--CCCCCCCHHHHHHHHHHhccC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRI----LCRP--PDLVGEPTPLRNLIRRLLEKD 321 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i----~~~~--~~~~~~~~~~~~li~~~L~~d 321 (426)
+|||++.+..++.++|||||||++|+|++|+.||.+.+. .+.+..+ ...+ ......+..+.+||.+||+.|
T Consensus 182 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSC
T ss_pred CChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999987432 1222222 1111 112356889999999999999
Q ss_pred CCCCCChHHHhc
Q 014344 322 PTKRIGVEEIKG 333 (426)
Q Consensus 322 P~~R~s~~eil~ 333 (426)
|.+|||++++++
T Consensus 262 p~~Rps~~~l~~ 273 (296)
T 3uzp_A 262 FDDKPDYSYLRQ 273 (296)
T ss_dssp TTCCCCHHHHHH
T ss_pred cCcCCCHHHHHH
Confidence 999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=366.11 Aligned_cols=253 Identities=21% Similarity=0.193 Sum_probs=205.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
..++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.+|+.++||||+++++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE-------------SSQGIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC-------------CSSHHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc-------------ChHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 346899999999999999999996 46899999987432 1234567889999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++...+..|+|||||+||+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp ECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECC
T ss_pred EEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEee
Confidence 9999999999999999999999875432 23489999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .........||+.|+
T Consensus 183 fg~~~~~~~~~------------------------------------------------------~~~~~~~~~gt~~y~ 208 (321)
T 2qkw_B 183 FGISKKGTELD------------------------------------------------------QTHLSTVVKGTLGYI 208 (321)
T ss_dssp CTTCEECSSSS------------------------------------------------------CCCCBCCCEEETTTC
T ss_pred ccccccccccc------------------------------------------------------ccccccccCCCcccc
Confidence 99987643211 011223446999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHh-cC-C-----CCC-----CCCCHHHHHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET------FYRIL-CR-P-----PDL-----VGEPTPLRNL 313 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~------~~~i~-~~-~-----~~~-----~~~~~~~~~l 313 (426)
|||++.+..++.++|||||||++|+|++|+.||.+....+. ..... .. . +.. ...+..+.++
T Consensus 209 aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (321)
T 2qkw_B 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT 288 (321)
T ss_dssp CHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHH
T ss_pred CHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHH
Confidence 99999999999999999999999999999999976543211 00000 00 0 000 1123568899
Q ss_pred HHHHhccCCCCCCChHHHhcC
Q 014344 314 IRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~h 334 (426)
|.+||+.||++|||+.++++|
T Consensus 289 i~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 289 AVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=353.52 Aligned_cols=259 Identities=22% Similarity=0.307 Sum_probs=207.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcC-CCc--eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVE-SSE--SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
..+..++|++++.||+|+||+||+|++.. +++ .||||++...... .....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~ 82 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS----------QPEAMDDFIREVNAMHSLDHRN 82 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------------CHHHHHHHHHHHHHHHCCCTT
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC----------CHHHHHHHHHHHHHHHhCCCCC
Confidence 34667789999999999999999998643 333 6899998554321 1235678889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++..+. .++||||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 83 i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~ 160 (291)
T 1u46_A 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160 (291)
T ss_dssp BCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEE
T ss_pred cccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCE
Confidence 999999997765 899999999999999887653 349999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++......... ........||
T Consensus 161 kl~Dfg~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 187 (291)
T 1u46_A 161 KIGDFGLMRALPQNDDH-----------------------------------------------------YVMQEHRKVP 187 (291)
T ss_dssp EECCCTTCEECCC-CCE-----------------------------------------------------EEC-----CC
T ss_pred EEccccccccccccccc-----------------------------------------------------hhhhccCCCC
Confidence 99999998876422100 0011233578
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CCCCCCCCHHHHHHHHHHhccCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR---PPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+... .+.....+..+.++|.+||..||.
T Consensus 188 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 267 (291)
T 1u46_A 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPE 267 (291)
T ss_dssp GGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred ceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcc
Confidence 89999999999889999999999999999999 99999999988877777543 233346688999999999999999
Q ss_pred CCCChHHHhcC
Q 014344 324 KRIGVEEIKGH 334 (426)
Q Consensus 324 ~R~s~~eil~h 334 (426)
+|||+.+++++
T Consensus 268 ~Rps~~~l~~~ 278 (291)
T 1u46_A 268 DRPTFVALRDF 278 (291)
T ss_dssp GSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999873
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.25 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=205.7
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
++.++|++++.||+|+||.||+|++..+++.||||++.... ......+.+|+.+++.++||||++++
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~~~ 92 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-------------QQDREEAQREADMHRLFNHPNILRLV 92 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-------------HHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-------------HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 56678999999999999999999999999999999984421 22456788899999999999999999
Q ss_pred eeee----cCCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 93 GVLS----TDKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 93 ~~~~----~~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++. .....|+|||||.+++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~ 172 (317)
T 2buj_A 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ 172 (317)
T ss_dssp EEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred EEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC
Confidence 9986 345889999999999999988753 3456999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++............. ..........|
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~g 205 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQA-----------------------------------------------LTLQDWAAQRC 205 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHH-----------------------------------------------HHHHHHHHHHS
T ss_pred EEEEecCcchhccccccccccc-----------------------------------------------ccccccccccC
Confidence 9999999987653110000000 00001123458
Q ss_pred CCCCccchhhcCCC---CChhhHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCCCCCCCCHHHHHHHHHHh
Q 014344 247 TEEYVAPEIIEGKG---HDFAVDWWSLGVVLHEMLYGATPFRGS-----SRKETFYRILCRPPDLVGEPTPLRNLIRRLL 318 (426)
Q Consensus 247 t~~y~aPE~~~~~~---~~~~~DiwSlG~il~ell~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L 318 (426)
|+.|+|||++.+.. ++.++|||||||++|+|++|+.||... ........ ....+.....+..+.+||.+||
T Consensus 206 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l 284 (317)
T 2buj_A 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLSIPQSPRHSSALWQLLNSMM 284 (317)
T ss_dssp CGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--CCCCTTSCHHHHHHHHHHT
T ss_pred CcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCCCCccccCCHHHHHHHHHHh
Confidence 99999999998654 688999999999999999999999532 11111111 1223334456889999999999
Q ss_pred ccCCCCCCChHHHhcC
Q 014344 319 EKDPTKRIGVEEIKGH 334 (426)
Q Consensus 319 ~~dP~~R~s~~eil~h 334 (426)
+.||.+|||+++++++
T Consensus 285 ~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 285 TVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred hcChhhCCCHHHHHHH
Confidence 9999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=374.38 Aligned_cols=266 Identities=21% Similarity=0.349 Sum_probs=216.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~ 94 (426)
++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.|.| ++|+.+..+
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------------~~~~~~~E~~il~~L~~~~~i~~i~~~ 71 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLLYESKIYRILQGGTGIPNVRWF 71 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---------------SSCCHHHHHHHHHHTTTSTTCCCEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---------------ccHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 56999999999999999999999999999999874321 12347789999999987 666677777
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeee---ccCCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMI---QENGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl---~~~g~ikL~D 171 (426)
+......|+||||| |++|.+++.... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|
T Consensus 72 ~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 72 GVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred EeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEe
Confidence 78889999999999 999999987543 459999999999999999999999999999999999999 6889999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++.+....... ..........+||+.|+
T Consensus 150 FGla~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~gt~~Y~ 180 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQ-------------------------------------------------HIPYRENKNLTGTARYA 180 (483)
T ss_dssp CTTCEECBCTTTCC-------------------------------------------------BCCCCCCCCCCSCTTTC
T ss_pred CCcceeccCCcccc-------------------------------------------------ccccccccccCCCcccc
Confidence 99998764321100 00011233567999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcC----C--CCCCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---KETFYRILCR----P--PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~----~--~~~~~~~~~~~~li~~~L~~dP 322 (426)
|||++.+..++.++|||||||++|+|++|+.||.+... .+.+..+... . ....+.+..+.+||.+||..||
T Consensus 181 aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP 260 (483)
T 3sv0_A 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRF 260 (483)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred CHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCh
Confidence 99999999999999999999999999999999987543 3333333211 1 1113568899999999999999
Q ss_pred CCCCChHHHh----------cCCCcCCCChhhhhh
Q 014344 323 TKRIGVEEIK----------GHEFFKGVNWELLLK 347 (426)
Q Consensus 323 ~~R~s~~eil----------~hp~f~~~~~~~~~~ 347 (426)
.+||++++|+ .++|+..++|+.+..
T Consensus 261 ~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 261 DDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp TCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred hhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 9999988774 489999999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=354.24 Aligned_cols=231 Identities=26% Similarity=0.422 Sum_probs=191.3
Q ss_pred CCCCCcEEE-eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHH-HhcCCCCcce
Q 014344 13 LDFSCLRIV-SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL-RNVEHPLLPR 90 (426)
Q Consensus 13 l~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il-~~l~hp~iv~ 90 (426)
.-+++|.++ +.||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.+.||||++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~e~~~~~~~~~h~~i~~ 75 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVR 75 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCC
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------------------HHHHHHHHHHHHhccCCCchh
Confidence 445679998 7899999999999999999999999998431 2455688887 5668999999
Q ss_pred eeeeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---
Q 014344 91 LRGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--- 163 (426)
Q Consensus 91 l~~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--- 163 (426)
+++++.. ...+|+|||||+|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~ 155 (299)
T 3m2w_A 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 155 (299)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST
T ss_pred HHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCC
Confidence 9999977 778999999999999999998776667999999999999999999999999999999999999998
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
++.+||+|||++....
T Consensus 156 ~~~~kl~Dfg~a~~~~---------------------------------------------------------------- 171 (299)
T 3m2w_A 156 NAILKLTDFGFAKETT---------------------------------------------------------------- 171 (299)
T ss_dssp TCCEEECCCTTCEECT----------------------------------------------------------------
T ss_pred CCcEEEeccccccccc----------------------------------------------------------------
Confidence 7899999999886431
Q ss_pred cccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----CCCC-----CCCCHHHHHHH
Q 014344 244 FVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR----PPDL-----VGEPTPLRNLI 314 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~-----~~~~~~~~~li 314 (426)
+..++.++|||||||++|+|++|+.||.+............. .... ...+..+.+||
T Consensus 172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (299)
T 3m2w_A 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 237 (299)
T ss_dssp --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHH
T ss_pred --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHH
Confidence 133678999999999999999999999876654432221111 1111 24578899999
Q ss_pred HHHhccCCCCCCChHHHhcCCCcCC
Q 014344 315 RRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 315 ~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
.+||+.||.+|||+.|+++||||+.
T Consensus 238 ~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 238 RNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp HHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HHHcccChhhCCCHHHHhcChhhcc
Confidence 9999999999999999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=381.98 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=215.9
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.+.+..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv 325 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT--------------MSPEAFLQEAQVMKKLRHEKLV 325 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS--------------SCHHHHHHHHHHHHHCCCTTBC
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC--------------CCHHHHHHHHHHHHhCCCCCEe
Confidence 466788899999999999999999999865 4679999985422 1235688899999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.. +.+|+|||||.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 326 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl 404 (535)
T 2h8h_A 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 404 (535)
T ss_dssp CEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred eEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEE
Confidence 99999866 77899999999999999987655556999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.+.... ........+|+.
T Consensus 405 ~DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~~~~~ 429 (535)
T 2h8h_A 405 ADFGLARLIEDNE-------------------------------------------------------YTARQGAKFPIK 429 (535)
T ss_dssp CCTTSTTTCCCHH-------------------------------------------------------HHTTCSTTSCGG
T ss_pred cccccceecCCCc-------------------------------------------------------eecccCCcCccc
Confidence 9999997653110 000112246788
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+... .+....++..+.+||.+||..||++||
T Consensus 430 y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 509 (535)
T 2h8h_A 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 509 (535)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999999999 99999999888877776543 233446788999999999999999999
Q ss_pred ChHHHhcC
Q 014344 327 GVEEIKGH 334 (426)
Q Consensus 327 s~~eil~h 334 (426)
|+++|++.
T Consensus 510 t~~~l~~~ 517 (535)
T 2h8h_A 510 TFEYLQAF 517 (535)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=357.39 Aligned_cols=265 Identities=19% Similarity=0.323 Sum_probs=208.9
Q ss_pred CCcCCCCCCCCCCCCCcEEEeeecccCceEEEEEE----EcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHH
Q 014344 2 NDVVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVK----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77 (426)
Q Consensus 2 ~~~~~~~~~~~l~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 77 (426)
.+.+.+.....+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+
T Consensus 27 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~ 93 (326)
T 2w1i_A 27 GSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-------------TEEHLRDFEREI 93 (326)
T ss_dssp ----------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-------------CSHHHHHHHHHH
T ss_pred HHHhcccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-------------CHHHHHHHHHHH
Confidence 34555666777888899999999999999999998 4678999999998432 223456788999
Q ss_pred HHHHhcCCCCcceeeeeeecCC--eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 014344 78 RVLRNVEHPLLPRLRGVLSTDK--FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLK 155 (426)
Q Consensus 78 ~il~~l~hp~iv~l~~~~~~~~--~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlK 155 (426)
.+|+.++||||+++++++...+ .+++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 94 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dik 172 (326)
T 2w1i_A 94 EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLA 172 (326)
T ss_dssp HHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCC
Confidence 9999999999999999986544 7899999999999999987653 459999999999999999999999999999999
Q ss_pred CCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 156 PENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDS 235 (426)
Q Consensus 156 p~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (426)
|+|||++.++.+||+|||++.........
T Consensus 173 p~NIli~~~~~~kL~Dfg~~~~~~~~~~~--------------------------------------------------- 201 (326)
T 2w1i_A 173 TRNILVENENRVKIGDFGLTKVLPQDKEY--------------------------------------------------- 201 (326)
T ss_dssp GGGEEEEETTEEEECCCTTCEECCSSCSE---------------------------------------------------
T ss_pred cceEEEcCCCcEEEecCcchhhccccccc---------------------------------------------------
Confidence 99999999999999999999876422100
Q ss_pred CCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH------------H---HHHHHh---
Q 014344 236 DSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK------------E---TFYRIL--- 297 (426)
Q Consensus 236 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------------~---~~~~i~--- 297 (426)
........+|+.|+|||++.+..++.++|||||||++|+|++|..||...... . .....+
T Consensus 202 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 202 --YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp --EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred --cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 00112234788899999999988999999999999999999999998643211 0 011111
Q ss_pred cCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 298 CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
...+.....+..+.+||.+||..||++|||+.++++
T Consensus 280 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123344567899999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=366.94 Aligned_cols=255 Identities=21% Similarity=0.221 Sum_probs=204.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+..++|++.+.||+|+||+||+|++ .+++.||||++...... .....+.+|+.+++.++||||++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------------~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ------------GGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----------------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc------------hHHHHHHHHHHHHHhccCCCccceE
Confidence 4457899999999999999999985 46899999998553211 1123578899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCCeeeccCCcE
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQS--EQMFSDDTIRFYAAELVLALEYLHNM---GIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--~~~l~~~~~~~~~~qil~aL~~LH~~---giiHrDlKp~NiLl~~~g~i 167 (426)
+++.+.+..++|||||.||+|.+++.... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999987543 23489999999999999999999999 99999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++....... .......+||
T Consensus 174 kl~Dfg~~~~~~~~~-------------------------------------------------------~~~~~~~~gt 198 (326)
T 3uim_A 174 VVGDFGLAKLMDYKD-------------------------------------------------------THVTTAVRGT 198 (326)
T ss_dssp EECCCSSCEECCSSS-------------------------------------------------------SCEECCCCSC
T ss_pred EeccCccccccCccc-------------------------------------------------------ccccccccCC
Confidence 999999997653211 1122344699
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC--CCC----------CCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS--------RKETFYRILCRP--PDL----------VGEP 307 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~--~~~----------~~~~ 307 (426)
+.|+|||++.+..++.++|||||||++|+|++|+.||.... ............ ... ...+
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 3uim_A 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278 (326)
T ss_dssp GGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHH
T ss_pred cCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHH
Confidence 99999999999889999999999999999999999995211 011111111100 000 0112
Q ss_pred HHHHHHHHHHhccCCCCCCChHHHhcCC
Q 014344 308 TPLRNLIRRLLEKDPTKRIGVEEIKGHE 335 (426)
Q Consensus 308 ~~~~~li~~~L~~dP~~R~s~~eil~hp 335 (426)
..+.+||.+||+.||.+|||+.+|++|-
T Consensus 279 ~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 279 EQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 5688999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=365.14 Aligned_cols=253 Identities=19% Similarity=0.270 Sum_probs=199.5
Q ss_pred CcEEEeeecccCceEEEEEEEcCCC---ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.|++.+.||+|+||+||+|.+..++ ..||+|++... ......+.+.+|+.+|+.++||||+++++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC------------SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC------------CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 5889999999999999999976443 46899987431 12345678889999999999999999999
Q ss_pred ee-ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 94 VL-STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 94 ~~-~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++ ..++..|+|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DF 236 (373)
T 3c1x_A 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADF 236 (373)
T ss_dssp EECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeec
Confidence 86 45668899999999999999986543 45889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++.+...... .........||+.|+|
T Consensus 237 G~a~~~~~~~~~----------------------------------------------------~~~~~~~~~~~~~y~a 264 (373)
T 3c1x_A 237 GLARDMYDKEFD----------------------------------------------------SVHNKTGAKLPVKWMA 264 (373)
T ss_dssp -------------------------------------------------------------------------CCGGGSC
T ss_pred cccccccccccc----------------------------------------------------cccccCCCCCcccccC
Confidence 999865321100 0011223357889999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .......+..+.++|.+||..||.+|||+.
T Consensus 265 PE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ 344 (373)
T 3c1x_A 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 344 (373)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 999999999999999999999999999 78899877665555444432 233345688999999999999999999999
Q ss_pred HHhcC
Q 014344 330 EIKGH 334 (426)
Q Consensus 330 eil~h 334 (426)
+++++
T Consensus 345 ell~~ 349 (373)
T 3c1x_A 345 ELVSR 349 (373)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=357.52 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=189.8
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
+.-.+|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|+.+++++. ||||+++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~~h~~iv~~ 91 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-------------EEKNRAIIQEVCFMKKLSGHPNIVQF 91 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-------------HHHHHHHHHHHHHHHHHTTSTTBCCE
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-------------hHHHHHHHHHHHHHHHhccCCChhhc
Confidence 44558999999999999999999999999999999884432 223467888999999996 9999999
Q ss_pred eeee--------ecCCeEEEEEeccCCCChHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCee
Q 014344 92 RGVL--------STDKFVGYAIDYCPGRDLHSLRKQ-QSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIM 160 (426)
Q Consensus 92 ~~~~--------~~~~~~~lV~Ey~~gg~L~~l~~~-~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiL 160 (426)
++++ .....+++|||||. |+|.+++.. .....+++..++.++.||+.||.|||++| |+||||||+|||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl 170 (337)
T 3ll6_A 92 CSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170 (337)
T ss_dssp EEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCE
T ss_pred cccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEE
Confidence 9998 34456899999996 788887764 23456999999999999999999999999 999999999999
Q ss_pred eccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEK 240 (426)
Q Consensus 161 l~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (426)
++.++.+||+|||++............ .........
T Consensus 171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~ 206 (337)
T 3ll6_A 171 LSNQGTIKLCDFGSATTISHYPDYSWS--------------------------------------------AQRRALVEE 206 (337)
T ss_dssp ECTTSCEEBCCCTTCBCCSSCC----------------------------------------------------------
T ss_pred ECCCCCEEEecCccceeccccCccccc--------------------------------------------ccccccchh
Confidence 999999999999999876432210000 000000112
Q ss_pred ccccccCCCCccchhh---cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHH
Q 014344 241 SNSFVGTEEYVAPEII---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRL 317 (426)
Q Consensus 241 ~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~ 317 (426)
....+||+.|+|||++ .+..++.++|||||||++|+|++|+.||.............. .+.....+..+.+||.+|
T Consensus 207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~ 285 (337)
T 3ll6_A 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS-IPPHDTQYTVFHSLIRAM 285 (337)
T ss_dssp -----------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CC-CCTTCCSSGGGHHHHHHH
T ss_pred hccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCccc-CCcccccchHHHHHHHHH
Confidence 2345699999999998 566789999999999999999999999987665544333322 223344567899999999
Q ss_pred hccCCCCCCChHHHhcC
Q 014344 318 LEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 318 L~~dP~~R~s~~eil~h 334 (426)
|+.||.+|||+.|+++|
T Consensus 286 l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 286 LQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp SCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=366.25 Aligned_cols=250 Identities=13% Similarity=0.192 Sum_probs=199.3
Q ss_pred CCCCCCcEEEeeecccCceEEEEE-----EEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLV-----KDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-- 84 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a-----~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-- 84 (426)
.+..++|++.+.||+|+||+||+| .+..+++.||||++... ....+..|+.+++.+.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----------------~~~~~~~e~~~~~~l~~~ 124 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----------------NPWEFYIGTQLMERLKPS 124 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----------------CHHHHHHHHHHHHHSCGG
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----------------ChhHHHHHHHHHHHhhhh
Confidence 355678999999999999999999 46788999999998432 2345667888888887
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCee
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ---SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIM 160 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~---~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiL 160 (426)
|+||+.+++++...+..|+|||||+||+|.+++... ....+++..++.++.||+.||+|||++|||||||||+|||
T Consensus 125 ~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIl 204 (365)
T 3e7e_A 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFI 204 (365)
T ss_dssp GGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred hhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEE
Confidence 899999999999999999999999999999998753 2456999999999999999999999999999999999999
Q ss_pred ecc-----------CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 161 IQE-----------NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 161 l~~-----------~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
++. ++.+||+|||+|+.+....
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----------------------------------------------- 237 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP----------------------------------------------- 237 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSC-----------------------------------------------
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccC-----------------------------------------------
Confidence 998 8999999999997542110
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHH
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP 309 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 309 (426)
........+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ . ..........+..
T Consensus 238 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~-~~~~~~~~~~~~~ 307 (365)
T 3e7e_A 238 -------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--K-PEGLFRRLPHLDM 307 (365)
T ss_dssp -------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--E-ECSCCTTCSSHHH
T ss_pred -------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--e-echhccccCcHHH
Confidence 01123445799999999999999999999999999999999999999965432110 0 0111111123567
Q ss_pred HHHHHHHHhccCCCCCCChHHHhcC
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+.+++..||..+|.+|++..+.+.+
T Consensus 308 ~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 308 WNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCcchHHHHHHH
Confidence 8899999999999999765544443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=382.69 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=206.8
Q ss_pred CCCcEEE-eeecccCceEEEEEEE--cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 15 FSCLRIV-SALGRGAKGVVFLVKD--VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 15 ~~~y~i~-~~LG~G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
...+.+. +.||+|+||+||+|.+ ..+++.||||++..... .....+.+.+|+.+|+.++||||+++
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~E~~il~~l~hpnIv~l 435 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----------DPALKDELLAEANVMQQLDNPYIVRM 435 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-----------CGGGHHHHHHHHHHHHHCCCTTBCCE
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-----------CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3345544 4899999999999955 46678999999855421 12245678999999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.. +.+++|||||.||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|
T Consensus 436 ~~~~~~-~~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~D 512 (635)
T 4fl3_A 436 IGICEA-ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISD 512 (635)
T ss_dssp EEEEES-SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEec-CCEEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEE
Confidence 999965 4588999999999999998754 4599999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+++.+...... ........||+.|+
T Consensus 513 FGla~~~~~~~~~-----------------------------------------------------~~~~~~~~~t~~y~ 539 (635)
T 4fl3_A 513 FGLSKALRADENY-----------------------------------------------------YKAQTHGKWPVKWY 539 (635)
T ss_dssp TTHHHHTTC------------------------------------------------------------------CGGGS
T ss_pred cCCccccccCccc-----------------------------------------------------cccccCCCCceeee
Confidence 9999876432100 01122234788999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCCh
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGV 328 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~ 328 (426)
|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... .......+..+.+||.+||..||++|||+
T Consensus 540 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~ 619 (635)
T 4fl3_A 540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 619 (635)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCH
Confidence 9999999999999999999999999998 99999999988877776543 23344678999999999999999999999
Q ss_pred HHHhc
Q 014344 329 EEIKG 333 (426)
Q Consensus 329 ~eil~ 333 (426)
.+|++
T Consensus 620 ~~l~~ 624 (635)
T 4fl3_A 620 AAVEL 624 (635)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.16 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=190.8
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHH--HHhcCCC
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRV--LRNVEHP 86 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~i--l~~l~hp 86 (426)
..+.+++++|++++.||+|+||+||+|++ +++.||||++..... ..+..|..+ +..++||
T Consensus 6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----------------~~~~~e~~~~~~~~~~h~ 67 (336)
T 3g2f_A 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----------------QNFINEKNIYRVPLMEHD 67 (336)
T ss_dssp ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----------------HHHHHHHHHHTSTTCCCT
T ss_pred cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----------------hhHHHHHHHHHHHhccCc
Confidence 45678999999999999999999999975 689999999854321 223334444 4558999
Q ss_pred Ccceeeeeee-----cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---------CCccc
Q 014344 87 LLPRLRGVLS-----TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM---------GIVYR 152 (426)
Q Consensus 87 ~iv~l~~~~~-----~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~---------giiHr 152 (426)
||+++++.+. ....+|+|||||+||+|.+++.... +++..+..++.||+.||.|||+. ||+||
T Consensus 68 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~ 144 (336)
T 3g2f_A 68 NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144 (336)
T ss_dssp TBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECS
T ss_pred chhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeec
Confidence 9999997543 3346899999999999999986543 68899999999999999999999 99999
Q ss_pred CCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCC
Q 014344 153 DLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR 232 (426)
Q Consensus 153 DlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (426)
||||+|||++.++.+||+|||++..+........
T Consensus 145 Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~---------------------------------------------- 178 (336)
T 3g2f_A 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP---------------------------------------------- 178 (336)
T ss_dssp SCSGGGEEECTTSCEEECCCTTCEECSSSSCC------------------------------------------------
T ss_pred ccccceEEEcCCCcEEEeeccceeecccccccCc----------------------------------------------
Confidence 9999999999999999999999987643211000
Q ss_pred CCCCCCCCccccccCCCCccchhhcC-------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCH----------------
Q 014344 233 SDSDSSEKSNSFVGTEEYVAPEIIEG-------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSR---------------- 289 (426)
Q Consensus 233 ~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---------------- 289 (426)
..........+||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 179 --~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~ 256 (336)
T 3g2f_A 179 --GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHP 256 (336)
T ss_dssp ---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSC
T ss_pred --cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCc
Confidence 001122335579999999999987 3566899999999999999999766533211
Q ss_pred -HHHHHHHhcC---CCCCCC-------CCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 290 -KETFYRILCR---PPDLVG-------EPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 290 -~~~~~~i~~~---~~~~~~-------~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.......... .+..+. .+..+.+||.+||..||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 257 TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 1111122211 111111 1236999999999999999999999954
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=379.56 Aligned_cols=254 Identities=20% Similarity=0.236 Sum_probs=208.6
Q ss_pred CCCCCcEEEe-eecccCceEEEEEEEcC--CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVS-ALGRGAKGVVFLVKDVE--SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~-~LG~G~~g~V~~a~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
+..+++.+.+ .||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.+|+.++||||+
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------------~~~~~~~~~~E~~il~~l~hpniv 399 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT------------EKADTEEMMREAQIMHQLDNPYIV 399 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC------------SSTTHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC------------ChHHHHHHHHHHHHHHhCCCCCEe
Confidence 4556677777 89999999999998763 45679999985421 123456788999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.. +.+|+|||||.||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 400 ~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL 477 (613)
T 2ozo_A 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKI 477 (613)
T ss_dssp CEEEEEES-SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred eEEEEecc-CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEE
Confidence 99999976 5689999999999999988644 345999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.+...... ........+|+.
T Consensus 478 ~DFGla~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~ 504 (613)
T 2ozo_A 478 SDFGLSKALGADDSY-----------------------------------------------------YTARSAGKWPLK 504 (613)
T ss_dssp CCCSTTTTCC-------------------------------------------------------------------CCT
T ss_pred eeccCcccccCCCce-----------------------------------------------------eeeccCCCCccc
Confidence 999999866321100 001112236789
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... .+....++..+.+||.+||..||.+||
T Consensus 505 y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP 584 (613)
T 2ozo_A 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRP 584 (613)
T ss_dssp TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSC
T ss_pred eeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999999998 99999998888877776543 233446789999999999999999999
Q ss_pred ChHHHhc
Q 014344 327 GVEEIKG 333 (426)
Q Consensus 327 s~~eil~ 333 (426)
++.+|++
T Consensus 585 s~~~l~~ 591 (613)
T 2ozo_A 585 DFLTVEQ 591 (613)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=354.40 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=204.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEE----cCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKD----VESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~----~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
+.-..|++++.||+|+||+||++.. ..+++.||||++.... .......+.+|+.+|+.++||||
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i 95 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA------------GPQHRSGWKQEIDILRTLYHEHI 95 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc------------ChHHHHHHHHHHHHHHhCCCcch
Confidence 4444469999999999999988753 4578999999985431 12345678899999999999999
Q ss_pred ceeeeeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 89 PRLRGVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 89 v~l~~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++++++.+ ...+|+|||||++++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 v~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~ 172 (318)
T 3lxp_A 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL 172 (318)
T ss_dssp CCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred hhEEEEEecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC
Confidence 999999987 46899999999999999987643 3999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++........ .........|
T Consensus 173 ~kl~Dfg~a~~~~~~~~-----------------------------------------------------~~~~~~~~~~ 199 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHE-----------------------------------------------------YYRVREDGDS 199 (318)
T ss_dssp EEECCGGGCEECCTTCS-----------------------------------------------------EEEC---CCC
T ss_pred EEECCcccccccccccc-----------------------------------------------------ccccccCCCC
Confidence 99999999987643210 0011223458
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHh---cCCCCCCCCCHH
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE--------------TFYRIL---CRPPDLVGEPTP 309 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------------~~~~i~---~~~~~~~~~~~~ 309 (426)
|+.|+|||++.+..++.++|||||||++|+|++|+.||....... .....+ ...+.....+..
T Consensus 200 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (318)
T 3lxp_A 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE 279 (318)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHH
Confidence 889999999999999999999999999999999999997643221 111111 223344566889
Q ss_pred HHHHHHHHhccCCCCCCChHHHhc
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
+.+||.+||+.||.+|||++++++
T Consensus 280 l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 280 VYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=386.89 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=206.3
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
...+++|++++.||+|+||+||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~------------~~~~~~~~~~Ei~iL~~L~HpnIV~l 77 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL------------SPKNRERWCLEIQIMKKLNHPNVVSA 77 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC------------CHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC------------CHHHHHHHHHHHHHHHhCCCCCCCce
Confidence 445688999999999999999999999999999999984421 22345678889999999999999999
Q ss_pred eeeeec------CCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC
Q 014344 92 RGVLST------DKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN 164 (426)
Q Consensus 92 ~~~~~~------~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~ 164 (426)
++++.. .+..|+|||||+||+|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 78 ~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~ 157 (676)
T 3qa8_A 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG 157 (676)
T ss_dssp EECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECC
T ss_pred eeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecC
Confidence 999765 778899999999999999987543 2359999999999999999999999999999999999999977
Q ss_pred Cc---EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 165 GH---IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 165 g~---ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+. +||+|||++...... ...
T Consensus 158 g~~~~vKL~DFG~a~~~~~~---------------------------------------------------------~~~ 180 (676)
T 3qa8_A 158 PQRLIHKIIDLGYAKELDQG---------------------------------------------------------ELC 180 (676)
T ss_dssp SSSCEEEECSCCCCCBTTSC---------------------------------------------------------CCC
T ss_pred CCceeEEEcccccccccccc---------------------------------------------------------ccc
Confidence 65 999999999765321 112
Q ss_pred cccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------------cCC-------
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--------------CRP------- 300 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~--------------~~~------- 300 (426)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+.... ...
T Consensus 181 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~l 260 (676)
T 3qa8_A 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260 (676)
T ss_dssp CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSS
T ss_pred ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccccc
Confidence 34569999999999999999999999999999999999999998764433221110 000
Q ss_pred CCC----CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 301 PDL----VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 301 ~~~----~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
+.. ...+..+.+||.+||.+||++|||+.+++.||||+.
T Consensus 261 p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 261 PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000 012467899999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=351.93 Aligned_cols=258 Identities=21% Similarity=0.287 Sum_probs=208.4
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i 88 (426)
..+.+..++|++++.||+|+||.||+|.+.. .+|+|++..... .....+.+.+|+.+++.++||||
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i 91 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-----------NEDQLKAFKREVMAYRQTRHENV 91 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-----------CCCCCCCCCTTGGGGTTCCCTTB
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-----------CHHHHHHHHHHHHHHhcCCCCCE
Confidence 3567888999999999999999999999753 599999854321 11223456668999999999999
Q ss_pred ceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 89 PRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 89 v~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
+++++++.....+++||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 92 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~ 169 (319)
T 2y4i_B 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169 (319)
T ss_dssp CCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCE
T ss_pred eEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEE
Confidence 999999999999999999999999999876533 4599999999999999999999999999999999999998 78999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++........ ...........||+
T Consensus 170 l~Dfg~~~~~~~~~~---------------------------------------------------~~~~~~~~~~~g~~ 198 (319)
T 2y4i_B 170 ITDFGLFSISGVLQA---------------------------------------------------GRREDKLRIQNGWL 198 (319)
T ss_dssp ECCCSCCC-------------------------------------------------------------CCSCBCCSGGG
T ss_pred EeecCCccccccccc---------------------------------------------------cccccccccCCCcc
Confidence 999999875431110 00111233446999
Q ss_pred CCccchhhcC---------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHH
Q 014344 249 EYVAPEIIEG---------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRR 316 (426)
Q Consensus 249 ~y~aPE~~~~---------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~ 316 (426)
.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..... .....+..+.+||.+
T Consensus 199 ~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 278 (319)
T 2y4i_B 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLF 278 (319)
T ss_dssp GTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHH
T ss_pred cccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHH
Confidence 9999999975 4578999999999999999999999999888877766653322 122467889999999
Q ss_pred HhccCCCCCCChHHHhc
Q 014344 317 LLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~ 333 (426)
||..||.+|||+.++++
T Consensus 279 ~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 279 CWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHCSSTTTSCCHHHHHH
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=348.40 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=192.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc--CCCCcceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV--EHPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l--~hp~iv~l~~ 93 (426)
++|++++.||+|+||.||+|++. ++.||||++.... ......|.+++..+ +||||+++++
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----------------~~~~~~e~~~~~~~~~~h~~i~~~~~ 98 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----------------EASWFRETEIYQTVLMRHENILGFIA 98 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----------------HHHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----------------cchhhhHHHHHHHHhhcCCCeeeEEE
Confidence 57999999999999999999874 8999999985432 12334455565554 8999999999
Q ss_pred eeecC----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCCeee
Q 014344 94 VLSTD----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM--------GIVYRDLKPENIMI 161 (426)
Q Consensus 94 ~~~~~----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~--------giiHrDlKp~NiLl 161 (426)
++... ..+|+|||||+||+|.++++.. .+++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 99 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 99877 7899999999999999998653 499999999999999999999998 99999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+.++.+||+|||++..+...... .....
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~----------------------------------------------------~~~~~ 203 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNE----------------------------------------------------VDIPP 203 (337)
T ss_dssp CTTSCEEECCCTTCEECC-------------------------------------------------------------C
T ss_pred CCCCCEEEEeCCCceeecccccc----------------------------------------------------ccCCC
Confidence 99999999999999766422110 00112
Q ss_pred cccccCCCCccchhhcCCCCChh------hHHHHHHHHHHHHHhC----------CCCCCCCC----HHHHHHHHhcC--
Q 014344 242 NSFVGTEEYVAPEIIEGKGHDFA------VDWWSLGVVLHEMLYG----------ATPFRGSS----RKETFYRILCR-- 299 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~ell~g----------~~pf~~~~----~~~~~~~i~~~-- 299 (426)
...+||+.|+|||++.+..++.. +|||||||++|||++| ..||.... ...........
T Consensus 204 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 283 (337)
T 3mdy_A 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283 (337)
T ss_dssp CSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred CCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc
Confidence 34579999999999988766554 9999999999999999 77775432 12222222211
Q ss_pred -CCCCC------CCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 300 -PPDLV------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 300 -~~~~~------~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.+... ..+..+.+||.+||+.||.+|||+.++++|
T Consensus 284 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11111 224568999999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=377.14 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=212.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCC---CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVES---SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
..+..++|++++.||+|+||+||+|.+..+ +..||||++.... .......+.+|+.+|+.++|||
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~Hpn 452 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT------------SDSVREKFLQEALTMRQFDHPH 452 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT------------CHHHHHHHHHHHHHHHHCCCTT
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 345667899999999999999999998654 4579999874321 2234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++. ++.+|+|||||+||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 453 Iv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred CCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCE
Confidence 999999984 567899999999999999987543 358999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||++........ .......||
T Consensus 531 kL~DFG~a~~~~~~~~-------------------------------------------------------~~~~~~~~t 555 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTY-------------------------------------------------------YKASKGKLP 555 (656)
T ss_dssp EECCCCCCCSCCC-----------------------------------------------------------------CC
T ss_pred EEEecCCCeecCCCcc-------------------------------------------------------eeccCCCCC
Confidence 9999999986532110 011223478
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... .+.....+..+.+||.+||..||.+
T Consensus 556 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhH
Confidence 89999999999999999999999999999997 99999999888877776543 3344567899999999999999999
Q ss_pred CCChHHHhcC
Q 014344 325 RIGVEEIKGH 334 (426)
Q Consensus 325 R~s~~eil~h 334 (426)
|||+.+|++.
T Consensus 636 RPs~~el~~~ 645 (656)
T 2j0j_A 636 RPRFTELKAQ 645 (656)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=365.92 Aligned_cols=249 Identities=16% Similarity=0.200 Sum_probs=192.2
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--------
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-------- 84 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-------- 84 (426)
+..++|++++.||+|+||+||+|++ +++.||||++.+...... ........+.+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLV-----NGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCB-----TTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCcccc-----ccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 4567899999999999999999998 789999999965432100 0012233467888999999886
Q ss_pred -CCCcceeeee-----------------eec-------------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHH
Q 014344 85 -HPLLPRLRGV-----------------LST-------------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133 (426)
Q Consensus 85 -hp~iv~l~~~-----------------~~~-------------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~ 133 (426)
||||+++.++ |.+ ...+|+|||||++|++.+.+.. +.+++..++.+
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i 166 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSI 166 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHH
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHH
Confidence 6666655554 433 7899999999999976555432 45899999999
Q ss_pred HHHHHHHHHHHH-HCCCcccCCCCCCeeeccCC--------------------cEEEecccccccCCCCCCCCCcchhhc
Q 014344 134 AAELVLALEYLH-NMGIVYRDLKPENIMIQENG--------------------HIMLVDFDLSTKLSPKTPQASPKTVLA 192 (426)
Q Consensus 134 ~~qil~aL~~LH-~~giiHrDlKp~NiLl~~~g--------------------~ikL~DFgls~~~~~~~~~~~~~~~~~ 192 (426)
+.||+.||+||| ++||+||||||+|||++.+| .+||+|||+|+....
T Consensus 167 ~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------ 234 (336)
T 2vuw_A 167 LHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------ 234 (336)
T ss_dssp HHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------
T ss_pred HHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------
Confidence 999999999999 99999999999999999987 899999999986521
Q ss_pred cccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHH
Q 014344 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGV 272 (426)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 272 (426)
...+||+.|+|||++.+.. +.++||||+|+
T Consensus 235 -------------------------------------------------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~ 264 (336)
T 2vuw_A 235 -------------------------------------------------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMK 264 (336)
T ss_dssp -------------------------------------------------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHH
T ss_pred -------------------------------------------------CcEEEeecccChhhhcCCC-ccceehhhhhC
Confidence 1337999999999999877 99999999877
Q ss_pred H-HHHHHhCCCCCCCCCH-HHHHHHHh---cCCCCC-----CCCCHHHHHHHHHHhccCCCCCCChHHHh-cCCCcC
Q 014344 273 V-LHEMLYGATPFRGSSR-KETFYRIL---CRPPDL-----VGEPTPLRNLIRRLLEKDPTKRIGVEEIK-GHEFFK 338 (426)
Q Consensus 273 i-l~ell~g~~pf~~~~~-~~~~~~i~---~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s~~eil-~hp~f~ 338 (426)
+ .++++.|..||.+... ......+. ...... ...++.+++||++||++| |++|+| +||||+
T Consensus 265 ~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 265 KENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred CCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 7 7888899999954321 11122222 111111 123567899999999987 999999 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=348.25 Aligned_cols=251 Identities=20% Similarity=0.222 Sum_probs=200.5
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|...+.||+|+||+||+|.+ +++.||+|++..... .......+.+.+|+.+++.++||||+++++++.+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 101 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD---------ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTT---------SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccC---------cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec
Confidence 45568999999999999985 688999999854211 1122345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 98 DKFVGYAIDYCPGRDLHSLRKQQS-EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 98 ~~~~~lV~Ey~~gg~L~~l~~~~~-~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
.+..|+||||++|++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 181 (307)
T 2nru_A 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR 181 (307)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999999999999999999887432 3469999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
....... .......+||+.|+|||++
T Consensus 182 ~~~~~~~------------------------------------------------------~~~~~~~~g~~~y~aPE~~ 207 (307)
T 2nru_A 182 ASEKFAQ------------------------------------------------------TVMTSRIVGTTAYMAPEAL 207 (307)
T ss_dssp ECCSCSS------------------------------------------------------CEECSSCCSCGGGCCHHHH
T ss_pred ccccccc------------------------------------------------------cccccccCCCcCcCChHHh
Confidence 6532110 0112234699999999998
Q ss_pred cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCC--------CCCC----CCCHHHHHHHHHHhcc
Q 014344 257 EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET----FYRILCRP--------PDLV----GEPTPLRNLIRRLLEK 320 (426)
Q Consensus 257 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~~~--------~~~~----~~~~~~~~li~~~L~~ 320 (426)
.+. ++.++|||||||++|+|++|..||........ ...+.... .... ..+..+.++|.+||..
T Consensus 208 ~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 286 (307)
T 2nru_A 208 RGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHE 286 (307)
T ss_dssp TTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCS
T ss_pred cCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCC
Confidence 764 78999999999999999999999987543221 11111110 0111 1235688999999999
Q ss_pred CCCCCCChHHHhcC
Q 014344 321 DPTKRIGVEEIKGH 334 (426)
Q Consensus 321 dP~~R~s~~eil~h 334 (426)
||.+|||+++++++
T Consensus 287 ~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 287 KKNKRPDIKKVQQL 300 (307)
T ss_dssp STTTSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=368.21 Aligned_cols=252 Identities=17% Similarity=0.201 Sum_probs=196.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCcc----
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLLP---- 89 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv---- 89 (426)
...|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+.+|+.+++.+.| +++.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~----------~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~ 146 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER----------PPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC--------------CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC----------ccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence 3458899999999999999999999999999999852211 111235678889999999987 2211
Q ss_pred -----------------eeeeeeec-----CCeEEEEEeccCCCChHHHHHHh-----ccCCCCHHHHHHHHHHHHHHHH
Q 014344 90 -----------------RLRGVLST-----DKFVGYAIDYCPGRDLHSLRKQQ-----SEQMFSDDTIRFYAAELVLALE 142 (426)
Q Consensus 90 -----------------~l~~~~~~-----~~~~~lV~Ey~~gg~L~~l~~~~-----~~~~l~~~~~~~~~~qil~aL~ 142 (426)
.+..++.. ...++++|+++ +++|.++++.. ....+++..+..++.||+.||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 225 (413)
T 3dzo_A 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA 225 (413)
T ss_dssp HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence 11111111 23467788876 69999987522 2334778889999999999999
Q ss_pred HHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCC
Q 014344 143 YLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHS 222 (426)
Q Consensus 143 ~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (426)
|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 226 ~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~------------------------------------------ 263 (413)
T 3dzo_A 226 SLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------------------------------------------ 263 (413)
T ss_dssp HHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTE------------------------------------------
T ss_pred HHHhCCcccCCcccceEEEecCCeEEEEeccceeecCC------------------------------------------
Confidence 99999999999999999999999999999999875421
Q ss_pred CCCCCCCCCCCCCCCCCCccccccCCCCccchhh----------cCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 014344 223 PRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII----------EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292 (426)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 292 (426)
.....+| +.|+|||++ .+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 264 -----------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~ 325 (413)
T 3dzo_A 264 -----------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325 (413)
T ss_dssp -----------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC
T ss_pred -----------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 1234468 999999999 555688999999999999999999999988776555
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 293 FYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 293 ~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
...++... ...+..+.+||.+||+.||.+|||+.++++||||+.+
T Consensus 326 ~~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 326 SEWIFRSC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp SGGGGSSC---CCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHhhc---ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 44444332 3558999999999999999999999999999999765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=346.05 Aligned_cols=246 Identities=20% Similarity=0.271 Sum_probs=197.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh--cCCCCcceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN--VEHPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~--l~hp~iv~l~~ 93 (426)
++|++.+.||+|+||+||+|++ +++.||||++... ....+..|+++++. ++||||+++++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----------------~~~~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----------------EERSWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----------------GHHHHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----------------hHHHHHHHHHHHHHhhcCCCcEEEEEe
Confidence 5799999999999999999997 5899999998432 12456678888888 78999999999
Q ss_pred eeecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--------HCCCcccCCCCCCeee
Q 014344 94 VLSTDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH--------NMGIVYRDLKPENIMI 161 (426)
Q Consensus 94 ~~~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH--------~~giiHrDlKp~NiLl 161 (426)
++.... .+|+||||+++|+|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||+
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence 998776 899999999999999998653 4899999999999999999999 8999999999999999
Q ss_pred ccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCc
Q 014344 162 QENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKS 241 (426)
Q Consensus 162 ~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (426)
+.++.+||+|||++......... .....
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~----------------------------------------------------~~~~~ 208 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDT----------------------------------------------------IDIAP 208 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTE----------------------------------------------------EEECC
T ss_pred CCCCCEEEEECCCceeccccccc----------------------------------------------------ccccc
Confidence 99999999999999765321100 00012
Q ss_pred cccccCCCCccchhhcCCC------CChhhHHHHHHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHhcCC
Q 014344 242 NSFVGTEEYVAPEIIEGKG------HDFAVDWWSLGVVLHEMLYG----------ATPFRGSS-----RKETFYRILCRP 300 (426)
Q Consensus 242 ~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~g----------~~pf~~~~-----~~~~~~~i~~~~ 300 (426)
...+||+.|+|||++.+.. ++.++|||||||++|+|++| ..||.... .......+....
T Consensus 209 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 288 (342)
T 1b6c_B 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288 (342)
T ss_dssp CSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC
T ss_pred ccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH
Confidence 3446999999999998763 34789999999999999999 78987642 233333332211
Q ss_pred --CCCC------CCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 301 --PDLV------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 301 --~~~~------~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+... ..+..+.+||.+||+.||++|||+.+|++|
T Consensus 289 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 289 LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1111 112468899999999999999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=333.07 Aligned_cols=223 Identities=14% Similarity=0.111 Sum_probs=185.6
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+-.++|++++.||+|+||.||+|++..+++.||||++..... ......+.+.+|+.+++.++||||++++
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~hp~iv~~~ 97 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV----------LPDDVLQETLSRTLRLSRIDKPGVARVL 97 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC----------SCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc----------cCHHHHHHHHHHHHHHhcCCCCCcceee
Confidence 344679999999999999999999999999999999954321 1223457788999999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++..++..|+|||||+|++|.++++. + .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~ 173 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSC
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEec
Confidence 999999999999999999999999743 2 456678889999999999999999999999999999999999999854
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
| |++
T Consensus 174 ~----------------------------------------------------------------------------~~~ 177 (286)
T 3uqc_A 174 A----------------------------------------------------------------------------TMP 177 (286)
T ss_dssp C----------------------------------------------------------------------------CCT
T ss_pred c----------------------------------------------------------------------------ccC
Confidence 3 333
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhcCCCC-----CCCCCHHHHHHHHHHhccCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFY---RILCRPPD-----LVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~ 324 (426)
| ++.++|||||||++|+|++|+.||.+.+..+... +....... ....+..+.+||.+||+.||.+
T Consensus 178 ~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 250 (286)
T 3uqc_A 178 D-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI 250 (286)
T ss_dssp T-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSC
T ss_pred C-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCcc
Confidence 2 6889999999999999999999998876533111 11111111 1356788999999999999999
Q ss_pred CCChHHHhc
Q 014344 325 RIGVEEIKG 333 (426)
Q Consensus 325 R~s~~eil~ 333 (426)
| |+.|+++
T Consensus 251 R-s~~el~~ 258 (286)
T 3uqc_A 251 R-SASTLLN 258 (286)
T ss_dssp C-CHHHHHH
T ss_pred C-CHHHHHH
Confidence 9 9999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=373.69 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=197.9
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
+-.++|++++.||+|+||+||+|.+.. +++.||||++.... .......+..|+.+|+.++||||+++
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~hp~iv~~ 144 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG------------DAEAQAMAMAERQFLAEVVHPSIVQI 144 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC------------CHHHHHHHHHHHGGGGGCCCTTBCCE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC------------CHHHHHHHHHHHHHHHhcCCCCcCeE
Confidence 334789999999999999999999976 78999999984321 12345578889999999999999999
Q ss_pred eeeeecCCe-----EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 92 RGVLSTDKF-----VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 92 ~~~~~~~~~-----~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
++++...+. .|+|||||+|++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .
T Consensus 145 ~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~ 219 (681)
T 2pzi_A 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q 219 (681)
T ss_dssp EEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C
T ss_pred eeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c
Confidence 999987655 7999999999999887543 59999999999999999999999999999999999999875 9
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+++.... ....+|
T Consensus 220 ~kl~DFG~a~~~~~------------------------------------------------------------~~~~~g 239 (681)
T 2pzi_A 220 LKLIDLGAVSRINS------------------------------------------------------------FGYLYG 239 (681)
T ss_dssp EEECCCTTCEETTC------------------------------------------------------------CSCCCC
T ss_pred EEEEecccchhccc------------------------------------------------------------CCccCC
Confidence 99999999876531 123469
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+.|+|||++.+. ++.++|||||||++|+|++|.+||.+..... +.........+..+.+||.+||..||.+||
T Consensus 240 t~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~R~ 313 (681)
T 2pzi_A 240 TPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----LPEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313 (681)
T ss_dssp CTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----CCTTCHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred CccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----ccccccccccCHHHHHHHhhhccCChhhCC
Confidence 9999999999775 4899999999999999999999987532110 000000011246789999999999999999
Q ss_pred ChHHHhcCCCcC
Q 014344 327 GVEEIKGHEFFK 338 (426)
Q Consensus 327 s~~eil~hp~f~ 338 (426)
+..+.+.|+|+.
T Consensus 314 ~~~~~l~~~l~~ 325 (681)
T 2pzi_A 314 TTAEEMSAQLTG 325 (681)
T ss_dssp SSHHHHHHHHHH
T ss_pred CHHHHHHHHHHH
Confidence 999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.31 Aligned_cols=239 Identities=14% Similarity=0.121 Sum_probs=158.4
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCCCcceeeeeeecCCe
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKF 100 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~l~~~~~~~~~ 100 (426)
..++.|++|.+..++....|+.||+|++.+....... .........+++.+|+++|+++ .|+||+++++++++++.
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~ 316 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGIL---TAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS 316 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCS---CHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccc---hhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE
Confidence 3456788888888888889999999999765322110 0001123456799999999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCCC
Q 014344 101 VGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 101 ~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~ 180 (426)
+|||||||+|++|.+++... +++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999999998764 346654 4789999999999999999999999999999999999999999986532
Q ss_pred CCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCC
Q 014344 181 KTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKG 260 (426)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 260 (426)
. .....+.+||+.|||||++.+.
T Consensus 392 ~--------------------------------------------------------~~~~~t~vGTp~YmAPE~l~g~- 414 (569)
T 4azs_A 392 D--------------------------------------------------------CSWPTNLVQSFFVFVNELFAEN- 414 (569)
T ss_dssp ----------------------------------------------------------CCSHHHHHHHHHHHHHHC----
T ss_pred C--------------------------------------------------------CccccCceechhhccHHHhCCC-
Confidence 1 1234567899999999999875
Q ss_pred CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCc
Q 014344 261 HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFF 337 (426)
Q Consensus 261 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f 337 (426)
+..++|+||+|+++|+|.++..++. ..+...+.. ...+.++...++..+|..|+.......|+|.
T Consensus 415 ~~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~~~~~----~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 415 KSWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQEPVE----RWNFVLLLALFEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp --------------CCCCTTHHHHH--------HHHHTSCGG----GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred CCCcccccccccchhhhccccchhH--------HHhhcCCCC----CCcHHHHHHHHhCCCCCCCCChhhhccchhH
Confidence 6778999999999988876644331 111111111 1224566667777777777766655555544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=263.81 Aligned_cols=198 Identities=16% Similarity=0.122 Sum_probs=146.1
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
..+.||+|+||+||+|. ..++.+|+|+........... ......+++.+|+++|++++||||+.+..++....
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~-----~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERL-----DENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHH-----HHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhh-----hhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 45689999999999994 567899999874432211100 01113457899999999999999995555555677
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..|+|||||+|++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+++...
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 77999999999999988653 5688999999999999999999999999999998 99999999998764
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC-
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG- 258 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 258 (426)
....... +......+++||+.|||||++.+
T Consensus 481 ~~~~~~~-------------------------------------------------~~~~~~~~~~GT~~y~APEv~~~~ 511 (540)
T 3en9_A 481 LDEDKAV-------------------------------------------------DLIVFKKAVLSTHHEKFDEIWERF 511 (540)
T ss_dssp CHHHHHH-------------------------------------------------HHHHHHHHHHHHCGGGHHHHHHHH
T ss_pred Ccccccc-------------------------------------------------chhhhhhhhcCCCCcCCHHHHHHH
Confidence 2100000 00001245679999999999987
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCC
Q 014344 259 -KGHDFAVDWWSLGVVLHEMLYGATPFR 285 (426)
Q Consensus 259 -~~~~~~~DiwSlG~il~ell~g~~pf~ 285 (426)
..|+..+|+||..+-..+...++.+|.
T Consensus 512 ~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 512 LEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred HHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 678888999999988888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=225.46 Aligned_cols=143 Identities=17% Similarity=0.157 Sum_probs=109.1
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCC-------chhhHHHHHHHHHHHhcCCCCcce
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDN-------GDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
|++++.||+|+||.||+|.+ .+|+.||||++.......... ..... ......+.+|+.+|+.+. | +.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~--~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKV--KEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CC--CC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhh--hhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34449999999999999999 889999999996543211100 00000 013456889999999999 4 66
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+.+++.. +..|+|||||+|++|.++ . . ..+..++.||+.||.|||++||+||||||+|||++ +|.+||+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~l-~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYRV-R------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGGC-C------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHHc-c------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 6665544 556999999999999872 1 1 23557999999999999999999999999999999 9999999
Q ss_pred ccccccc
Q 014344 171 DFDLSTK 177 (426)
Q Consensus 171 DFgls~~ 177 (426)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999863
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-23 Score=189.99 Aligned_cols=151 Identities=16% Similarity=0.186 Sum_probs=110.3
Q ss_pred cEEEeeecccCceEEEEEEEcCCCce--EEEEEeehhhHHhhh--hhccc---------CCCchhhHHHHHHHHHHHhcC
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSES--FALKVIWRDLIEKKS--KELTN---------NDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~~~~~~~~~~~--~~~~~---------~~~~~~~~~~~~E~~il~~l~ 84 (426)
|++.+.||+|+||.||+|.+..+|+. ||||++......... ..... .........+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999888999 999997543211110 00000 000011236788999999998
Q ss_pred CCCc--ceeeeeeecCCeEEEEEeccCC-C----ChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCC
Q 014344 85 HPLL--PRLRGVLSTDKFVGYAIDYCPG-R----DLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKP 156 (426)
Q Consensus 85 hp~i--v~l~~~~~~~~~~~lV~Ey~~g-g----~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp 156 (426)
|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +.||+||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8754 444442 356899999932 3 56554221 335678889999999999999 99999999999
Q ss_pred CCeeeccCCcEEEecccccccCC
Q 014344 157 ENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 157 ~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
+|||++. .++|+|||+|....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETT
T ss_pred HHEEEcC--cEEEEECcccccCC
Confidence 9999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.9e-21 Score=185.69 Aligned_cols=147 Identities=16% Similarity=0.206 Sum_probs=102.4
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhh----hh-cccCCCch--hh--HHHHHHHHHHHhcCCCCc
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKS----KE-LTNNDNGD--KY--RRISFEQRVLRNVEHPLL 88 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~----~~-~~~~~~~~--~~--~~~~~E~~il~~l~hp~i 88 (426)
|+|+..||+|++|.||+|.+. +|+.||||++......-+. .. ........ .. -....|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 899999999999999999984 6999999998643221110 00 00000000 00 112457777887765544
Q ss_pred c--eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-
Q 014344 89 P--RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG- 165 (426)
Q Consensus 89 v--~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g- 165 (426)
. ..++. . ..+|||||++|++|..+. ..+.+..++.||+.+|.+||++|||||||||.|||++.+|
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 3 22222 1 237999999999886542 2234567889999999999999999999999999999877
Q ss_pred ---------cEEEeccccccc
Q 014344 166 ---------HIMLVDFDLSTK 177 (426)
Q Consensus 166 ---------~ikL~DFgls~~ 177 (426)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-13 Score=128.18 Aligned_cols=141 Identities=13% Similarity=0.111 Sum_probs=112.4
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
+..|++...+|.|+.+.||++.. .++.+++|+...... .....+..|+.+|+.+. +..++++++
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~-------------~~~~~~~~E~~~l~~l~~~~~vP~v~~ 77 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK-------------GTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT-------------TSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC-------------CCHHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 35699999999999999999974 368999999843211 01235778999999985 678889999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---------------------------
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN--------------------------- 146 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~--------------------------- 146 (426)
++...+..|+||||++|.+|.+.. .+......++.++..+|..||+
T Consensus 78 ~~~~~~~~~lv~e~i~G~~l~~~~-------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T 3tm0_A 78 FERHDGWSNLLMSEADGVLCSEEY-------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHC-------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEecCCceEEEEEecCCeehhhcc-------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccc
Confidence 999999999999999999987641 1222344678899999999999
Q ss_pred --------------------------------CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 147 --------------------------------MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 147 --------------------------------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-12 Score=118.93 Aligned_cols=136 Identities=13% Similarity=0.074 Sum_probs=100.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC--cceee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL--LPRLR 92 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~ 92 (426)
+..|.+....+.|..+.||++.. .+|+.+++|+.... ....+..|+.+|+.+.+.+ +++++
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----------------~~~~~~~E~~~l~~l~~~~~~vP~~~ 81 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----------------ALNELQDEAARLSWLATTGVPCAAVL 81 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----------------TTSCHHHHHHHHHHHHTTTCCBCCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----------------cchhhhHHHHHHHHHHhCCCCCCeEE
Confidence 44577765555677799999964 56778999997321 1235677999999986433 67789
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG------------------------ 148 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g------------------------ 148 (426)
++...++..|+||||++|.+|. + . .... ..++.++...|..||+..
T Consensus 82 ~~~~~~~~~~~v~e~i~G~~l~-~-~-----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (264)
T 1nd4_A 82 DVVTEAGRDWLLLGEVPGQDLL-S-S-----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAG 151 (264)
T ss_dssp EEEECSSCEEEEEECCSSEETT-T-S-----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTT
T ss_pred EeccCCCCCEEEEEecCCcccC-c-C-----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcC
Confidence 9888888899999999998884 1 1 0121 245567777777777643
Q ss_pred ----------------------------------CcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 149 ----------------------------------IVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 149 ----------------------------------iiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
++|||++|.|||++.++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 152 LVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=2.7e-11 Score=117.47 Aligned_cols=142 Identities=17% Similarity=0.234 Sum_probs=107.0
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEee--hhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCcceeee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIW--RDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLPRLRG 93 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~--~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~ 93 (426)
..-++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~------------~~~~~~~~E~~~l~~L~~~~vpvP~~~~ 105 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL------------PSAHAIEREYRVMDALAGTDVPVAKMYA 105 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------------------CHHHHHHHHHHHTTSSSCCCCEEE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC------------CcHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 345788999999999998853 4688899874 22110 11236777999999997 456788998
Q ss_pred eeecC---CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH------------------------
Q 014344 94 VLSTD---KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN------------------------ 146 (426)
Q Consensus 94 ~~~~~---~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~------------------------ 146 (426)
++.+. +..|+||||++|..+.+- ....+++.....++.+++.+|..||+
T Consensus 106 ~~~~~~~~g~~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3dxp_A 106 LCEDESVIGRAFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIER 181 (359)
T ss_dssp EECCTTTTSSCEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHH
T ss_pred ECCCCCccCCeEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHH
Confidence 88766 458999999999888531 11237788888899999999999997
Q ss_pred ----------------------------------CCCcccCCCCCCeeeccCCc--EEEeccccccc
Q 014344 147 ----------------------------------MGIVYRDLKPENIMIQENGH--IMLVDFDLSTK 177 (426)
Q Consensus 147 ----------------------------------~giiHrDlKp~NiLl~~~g~--ikL~DFgls~~ 177 (426)
.+++|||++|.|||++.++. +.|+||+.+..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 182 WTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=5.1e-11 Score=112.76 Aligned_cols=134 Identities=15% Similarity=0.189 Sum_probs=99.4
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCC--cceeeeeeec
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPL--LPRLRGVLST 97 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~--iv~l~~~~~~ 97 (426)
++.++.|....||++. ..+++|+.... .....+..|..+|+.+. +.. +++++.....
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~ 84 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP 84 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH---------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc---------------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC
Confidence 3458999999999864 56899986322 12356778999998884 332 4556555433
Q ss_pred CC---eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH----------------------------
Q 014344 98 DK---FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN---------------------------- 146 (426)
Q Consensus 98 ~~---~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~---------------------------- 146 (426)
.. ..|+||++++|.+|..... ..++......++.|+...|..||+
T Consensus 85 ~~~~~~~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (304)
T 3sg8_A 85 SETYQMSFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKL 160 (304)
T ss_dssp CSSCSCSCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHH
Confidence 33 3589999999998875322 127788888888999999999986
Q ss_pred ------------------------------CCCcccCCCCCCeeecc--CCcEEEecccccccC
Q 014344 147 ------------------------------MGIVYRDLKPENIMIQE--NGHIMLVDFDLSTKL 178 (426)
Q Consensus 147 ------------------------------~giiHrDlKp~NiLl~~--~g~ikL~DFgls~~~ 178 (426)
..++|+|++|.||+++. .+.+.|+||+.+..-
T Consensus 161 ~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 161 LSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred hcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 456789999987653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=5.4e-08 Score=91.97 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=94.6
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC---Ccceeeeeee-
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP---LLPRLRGVLS- 96 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp---~iv~l~~~~~- 96 (426)
++.++.|....||++ ++.+++|+.... .....+..|..+|+.|.+. .+++++.+..
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~---------------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~ 83 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ---------------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR 83 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH---------------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc---------------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc
Confidence 455789999999988 577899986221 2345678899999999742 3667777664
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM----------------------------- 147 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~----------------------------- 147 (426)
..+..|+|||+++|.+|....- ..++......++.|+...|..||+.
T Consensus 84 ~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~ 159 (306)
T 3tdw_A 84 SDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQ 159 (306)
T ss_dssp TTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHH
T ss_pred CCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHh
Confidence 4566789999999988865311 1144555555555555555555542
Q ss_pred -------------------------------CCcccCCCCCCeeecc---CCcE-EEecccccccC
Q 014344 148 -------------------------------GIVYRDLKPENIMIQE---NGHI-MLVDFDLSTKL 178 (426)
Q Consensus 148 -------------------------------giiHrDlKp~NiLl~~---~g~i-kL~DFgls~~~ 178 (426)
.++|+|++|.|||++. ++.+ .|+||+.+..-
T Consensus 160 ~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 160 VFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp TGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred cccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.80 E-value=8.1e-08 Score=88.77 Aligned_cols=132 Identities=16% Similarity=0.150 Sum_probs=96.2
Q ss_pred ecccCce-EEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecCCeE
Q 014344 24 LGRGAKG-VVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDKFV 101 (426)
Q Consensus 24 LG~G~~g-~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~~~ 101 (426)
+..|..+ .||.......+..+.+|+-... ....+..|..+|+.|. +--+++++.+..+++..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS----------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH----------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC----------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 3445444 7999888777888999986432 2345677999999885 33478899999999999
Q ss_pred EEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------
Q 014344 102 GYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNM---------------------------------- 147 (426)
Q Consensus 102 ~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~---------------------------------- 147 (426)
|+|||+++|.++.+..... ......+..++...|..||+.
T Consensus 96 ~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp EEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred EEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 9999999998887654321 112233455555666666632
Q ss_pred ------------------------CCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 148 ------------------------GIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 148 ------------------------giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877778999998875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=1.1e-06 Score=85.97 Aligned_cols=83 Identities=17% Similarity=0.152 Sum_probs=51.8
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhH-HhhhhhcccCCCchhhHHHHHHHHHHHhcCC--C-Ccceeeeee
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLI-EKKSKELTNNDNGDKYRRISFEQRVLRNVEH--P-LLPRLRGVL 95 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p-~iv~l~~~~ 95 (426)
-++.||.|..+.||++....+++.++||......- ... .......++..|.++|+.+.. | .+++++.+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~-------~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~- 105 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-------SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS- 105 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC--------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC-------CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-
Confidence 46789999999999998766678999998642110 000 001123456779999988742 3 45566654
Q ss_pred ecCCeEEEEEeccCCC
Q 014344 96 STDKFVGYAIDYCPGR 111 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg 111 (426)
+....++||||++|.
T Consensus 106 -d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 106 -DTEMAVTVMEDLSHL 120 (397)
T ss_dssp -ETTTTEEEECCCTTS
T ss_pred -cCCccEEEEEeCCCc
Confidence 344568999999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.40 E-value=4.2e-06 Score=79.65 Aligned_cols=138 Identities=17% Similarity=0.177 Sum_probs=80.5
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCcceeee----
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLPRLRG---- 93 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~---- 93 (426)
-++.|+.|..+.||++... +..+++|+.... ...+..|..+++.|. .-.+++++.
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-----------------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g 96 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRP-----------------EKKALFSIFAQDYLAKKGMNVPGILPNKKG 96 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSC-----------------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTS
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCC-----------------HHHHHHHHHHHHHHHHcCCCCCceeecCCC
Confidence 3456677788999999753 345999998431 122334566666553 123444443
Q ss_pred --eeecCCeEEEEEeccCCCChH-----H------H---HHHhccCCC--C-----------HH--------H-------
Q 014344 94 --VLSTDKFVGYAIDYCPGRDLH-----S------L---RKQQSEQMF--S-----------DD--------T------- 129 (426)
Q Consensus 94 --~~~~~~~~~lV~Ey~~gg~L~-----~------l---~~~~~~~~l--~-----------~~--------~------- 129 (426)
+....+..+++|+|++|..+. . . ++..... + + .. .
T Consensus 97 ~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 175 (346)
T 2q83_A 97 SLYSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVG-YQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLM 175 (346)
T ss_dssp CSCEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTT-CCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCC-CCCCccchhcccccchHHHHHHHHHHHHHHHHH
Confidence 123467789999999986542 1 0 1111110 1 1 00 0
Q ss_pred ----------------HHHHHHHHHHHHHHHHH-------------CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 130 ----------------IRFYAAELVLALEYLHN-------------MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 130 ----------------~~~~~~qil~aL~~LH~-------------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+..+..++..++++|++ .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 176 AEAEKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHCSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHhccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11122234445666652 5799999999999998888999999998763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=8.9e-07 Score=85.24 Aligned_cols=87 Identities=16% Similarity=0.160 Sum_probs=57.1
Q ss_pred cEEEeee-cccCceEEEEEEEc--C----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-C--CC
Q 014344 18 LRIVSAL-GRGAKGVVFLVKDV--E----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-H--PL 87 (426)
Q Consensus 18 y~i~~~L-G~G~~g~V~~a~~~--~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h--p~ 87 (426)
...++.| +.|....+|++... . +++.+++|+...... ... .....+..|+.+|+.|. + ..
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~------~~~----~~~~~~~~E~~~l~~L~~~~~vp 91 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAED------VPV----FPTYRLDHQFEVIRLVGELTDVP 91 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGG------CCS----SSCCCHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCc------ccc----CchhHHHHHHHHHHHHhhcCCCC
Confidence 3456778 89999999998753 1 256789998633210 000 00135677888888885 3 35
Q ss_pred cceeeeeeecC---CeEEEEEeccCCCChH
Q 014344 88 LPRLRGVLSTD---KFVGYAIDYCPGRDLH 114 (426)
Q Consensus 88 iv~l~~~~~~~---~~~~lV~Ey~~gg~L~ 114 (426)
+++++.+..+. +..|+||||++|..+.
T Consensus 92 vP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 92 VPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred CCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 77888877655 3568999999986653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.03 E-value=4.6e-05 Score=71.88 Aligned_cols=77 Identities=13% Similarity=0.101 Sum_probs=60.7
Q ss_pred EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC---CCCcceeeeee
Q 014344 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE---HPLLPRLRGVL 95 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~---hp~iv~l~~~~ 95 (426)
.-++.|+.|....+|++.. +++.+++|+.... ....+..|...|+.|. ...+++++.+.
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~ 100 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS----------------YRSMFRAEADQLALLAKTNSINVPLVYGIG 100 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEe
Confidence 3467789999999999985 4678899987432 1345777989998884 35788999888
Q ss_pred ecCCeEEEEEeccCCCCh
Q 014344 96 STDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L 113 (426)
...+..|+||||++|..+
T Consensus 101 ~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 101 NSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp ECSSEEEEEEECCCCCCC
T ss_pred ecCCceEEEEEeccCCCC
Confidence 888899999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.7e-05 Score=75.68 Aligned_cols=32 Identities=16% Similarity=0.351 Sum_probs=28.0
Q ss_pred HHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 145 HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 145 H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+...++|+|++|.|||++.++ +.|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 346899999999999998777 99999998865
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.77 E-value=7e-05 Score=70.14 Aligned_cols=134 Identities=15% Similarity=0.140 Sum_probs=76.8
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeeeeeecCC
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDK 99 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~~~~~~~ 99 (426)
++.|+.|....+|++ +.+++|+..... ...-....|..+++.+. +.-.+++++.. ..
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~--------------~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~ 80 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT--------------EEYINRANEAVAAREAAKAGVSPEVLHVD--PA 80 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC------------------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc--------------cceeCHHHHHHHHHHHHHcCCCCceEEEE--CC
Confidence 788999999999998 578999874321 01112345888888775 22225676654 33
Q ss_pred eEEEEEecc-CCCChHHH---------------HHH-hc-cCCCC-----HHHHHHHHHH--------------HHHHHH
Q 014344 100 FVGYAIDYC-PGRDLHSL---------------RKQ-QS-EQMFS-----DDTIRFYAAE--------------LVLALE 142 (426)
Q Consensus 100 ~~~lV~Ey~-~gg~L~~l---------------~~~-~~-~~~l~-----~~~~~~~~~q--------------il~aL~ 142 (426)
.-++++||+ +|.+|... +.+ +. ...++ ...+..+..+ +...+.
T Consensus 81 ~~~~v~e~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 160 (301)
T 3dxq_A 81 TGVMVTRYIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAG 160 (301)
T ss_dssp TCCEEEECCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHH
T ss_pred CCEEEEeecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHH
Confidence 346899999 76554310 110 00 00011 1111112111 111122
Q ss_pred HHH----H----CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 143 YLH----N----MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 143 ~LH----~----~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.|. . ..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 161 ~l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 161 GVRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 221 1 24899999999999 5677889999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00024 Score=66.99 Aligned_cols=145 Identities=17% Similarity=0.218 Sum_probs=82.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC--cceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL--LPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~--iv~l~~ 93 (426)
....-++.|+.|....+|++... +..+++|+..... ....+..|..+++.|...+ +++++.
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~---------------~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV---------------EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC------------------CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCC---------------CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34445677888999999999753 3368899884310 1234556888887774212 344442
Q ss_pred e------eecCCeEEEEEeccCCCChHH-----H---------HHHhccC---C----CCHHHHHH--------------
Q 014344 94 V------LSTDKFVGYAIDYCPGRDLHS-----L---------RKQQSEQ---M----FSDDTIRF-------------- 132 (426)
Q Consensus 94 ~------~~~~~~~~lV~Ey~~gg~L~~-----l---------~~~~~~~---~----l~~~~~~~-------------- 132 (426)
. ....+..+++|+|++|..+.. + ++..... . .....-..
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 2 123456789999999865311 0 1111100 0 00000000
Q ss_pred -HHHHHHHHHHHHHH-------CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 133 -YAAELVLALEYLHN-------MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 133 -~~~qil~aL~~LH~-------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+...+...++.+++ .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 00113444555553 3799999999999998776668999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00043 Score=64.21 Aligned_cols=80 Identities=15% Similarity=0.115 Sum_probs=56.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC---CCcceee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH---PLLPRLR 92 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h---p~iv~l~ 92 (426)
....-++.+|.|..+.||+++. .+|+.|.+|+..... ......+..|...|+.|.. --+++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-------------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~ 80 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-------------PALDGLFRAEALGLDWLGRSFGSPVPQVA 80 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-------------CCCTTHHHHHHHHHHHHTCSTTCCSCCEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-------------cchhhHHHHHHHHHHHHHhhCCCCcceEE
Confidence 4467788999999999999985 578899999863211 1122356779999998852 2455666
Q ss_pred eeeecCCeEEEEEeccCCCCh
Q 014344 93 GVLSTDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L 113 (426)
.+. + -++||||++++..
T Consensus 81 ~~~--~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 81 GWD--D--RTLAMEWVDERPP 97 (288)
T ss_dssp EEE--T--TEEEEECCCCCCC
T ss_pred ecc--C--ceEEEEeecccCC
Confidence 542 2 3789999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00089 Score=58.84 Aligned_cols=136 Identities=13% Similarity=0.048 Sum_probs=88.5
Q ss_pred CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcch
Q 014344 111 RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH-NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189 (426)
Q Consensus 111 g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH-~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~ 189 (426)
-+|.++++.. ++++++++++.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ ..+..
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~------------ 98 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADDA------------ 98 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-ccccc------------
Confidence 4688887665 467999999999999999987762 12212344557889999999888774 21110
Q ss_pred hhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHH
Q 014344 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWS 269 (426)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 269 (426)
....+.|||... ...+.+.=|+|
T Consensus 99 --------------------------------------------------------~~~~~~~pe~~~-~~~te~~~Iys 121 (229)
T 2yle_A 99 --------------------------------------------------------GEPPPVAGKLGY-SQCMETEVIES 121 (229)
T ss_dssp ----------------------------------------------------------------CCSS-SSSCHHHHHHH
T ss_pred --------------------------------------------------------cccCCCChhhcc-ccchHHHHHHH
Confidence 112356777763 34568899999
Q ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCHHHHHHHHHHhcc-------------------------CCCC
Q 014344 270 LGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRLLEK-------------------------DPTK 324 (426)
Q Consensus 270 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~li~~~L~~-------------------------dP~~ 324 (426)
||+++|..+--..|= ......++++.+||..|..- .+..
T Consensus 122 LG~tLY~ALDygL~e----------------~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~ 185 (229)
T 2yle_A 122 LGIIIYKALDYGLKE----------------NEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISA 185 (229)
T ss_dssp HHHHHHHHHTTTCCT----------------TEEECCCHHHHHHHHHHTTCCC--------------------CCSCCCC
T ss_pred HHHHHHHHhhcCCCc----------------ccchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccC
Confidence 999999988422221 12234478899999988755 2467
Q ss_pred CCChHHHhc
Q 014344 325 RIGVEEIKG 333 (426)
Q Consensus 325 R~s~~eil~ 333 (426)
|.++++|++
T Consensus 186 ~~sl~~Vi~ 194 (229)
T 2yle_A 186 IRSYRDVMK 194 (229)
T ss_dssp CCSHHHHHH
T ss_pred cCCHHHHHH
Confidence 788888774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00025 Score=67.26 Aligned_cols=32 Identities=22% Similarity=0.340 Sum_probs=27.8
Q ss_pred CCCcccCCCCCCeeeccC----CcEEEecccccccC
Q 014344 147 MGIVYRDLKPENIMIQEN----GHIMLVDFDLSTKL 178 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~----g~ikL~DFgls~~~ 178 (426)
..++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999874 68999999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00027 Score=69.76 Aligned_cols=75 Identities=24% Similarity=0.414 Sum_probs=50.3
Q ss_pred EEeeecccCceEEEEEEEcC-------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 20 IVSALGRGAKGVVFLVKDVE-------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
-++.|+.|....||++.... .++.+.+|+.... . ....+..|..+++.|. +...+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------------~--~~~~li~E~~~l~~L~~~g~~P~l 141 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------------E--TESHLVAESVIFTLLSERHLGPKL 141 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------------C--CHHHHHHHHHHHHHHHHTTSSSCE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------------C--cHHHHHHHHHHHHHHHhCCCCCcE
Confidence 35678889899999998643 2578999987221 0 0123446888888885 3334778
Q ss_pred eeeeecCCeEEEEEeccCCCCh
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L 113 (426)
++.+.+ .+|+||++|.+|
T Consensus 142 ~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 142 YGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp EEEETT----EEEECCCCEEEC
T ss_pred EEEeCC----CEEEEEeCCccc
Confidence 877643 389999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00024 Score=68.73 Aligned_cols=146 Identities=21% Similarity=0.301 Sum_probs=87.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcC-------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVE-------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE- 84 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~- 84 (426)
+..+.+++ +.|..|-...+|++.... .++.|.+|+.-... .......+|..+++.|.
T Consensus 48 ~~~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--------------~~~~~~~rE~~vl~~L~~ 112 (379)
T 3feg_A 48 VQPEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--------------QGVDSLVLESVMFAILAE 112 (379)
T ss_dssp CCGGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----------------CCHHHHHHHHHHHHHHHH
T ss_pred CCcCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--------------chHHHHHHHHHHHHHHHh
Confidence 33445553 567778888999998642 35789999862210 11234457999998885
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHH-----------H---HHHh-c-----cCCC--CHHHHHHHHHHHHH---
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHS-----------L---RKQQ-S-----EQMF--SDDTIRFYAAELVL--- 139 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~-----------l---~~~~-~-----~~~l--~~~~~~~~~~qil~--- 139 (426)
+.-.+++++++.+ .+||||++|..|.. + +... . .+.. -...+..+..++-.
T Consensus 113 ~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~ 188 (379)
T 3feg_A 113 RSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPP 188 (379)
T ss_dssp TTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCC
T ss_pred cCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccC
Confidence 4444778877654 39999999855421 1 1111 1 1111 13556666655422
Q ss_pred ----------------HHHHHH----H----CCCcccCCCCCCeeeccC----CcEEEeccccccc
Q 014344 140 ----------------ALEYLH----N----MGIVYRDLKPENIMIQEN----GHIMLVDFDLSTK 177 (426)
Q Consensus 140 ----------------aL~~LH----~----~giiHrDlKp~NiLl~~~----g~ikL~DFgls~~ 177 (426)
.++.|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 189 ~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 189 TGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233333 2 259999999999999876 7899999998865
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00042 Score=66.76 Aligned_cols=76 Identities=17% Similarity=0.199 Sum_probs=46.1
Q ss_pred EEeeecccCceEEEEEEEcC--------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cce
Q 014344 20 IVSALGRGAKGVVFLVKDVE--------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPR 90 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~ 90 (426)
-++.|+.|....+|++.... .++.+++|+..... ........|..+++.|...+ .++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~--------------~~~~~~~~E~~~l~~L~~~g~~P~ 102 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV--------------DELYNTISEFEVYKTMSKYKIAPQ 102 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG--------------GGTSCHHHHHHHHHHHHHTTSSCC
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc--------------cceecHHHHHHHHHHHHhcCCCCc
Confidence 35678888889999998643 13688999874321 01112356888888885323 567
Q ss_pred eeeeeecCCeEEEEEeccCCCCh
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L 113 (426)
+++.+ .+ ++||||++|..+
T Consensus 103 ~~~~~--~~--~~v~e~i~G~~l 121 (369)
T 3c5i_A 103 LLNTF--NG--GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEE--TT--EEEEECCCSEEC
T ss_pred eEEec--CC--cEEEEEecCCcC
Confidence 77665 22 689999997543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0016 Score=64.67 Aligned_cols=76 Identities=12% Similarity=0.197 Sum_probs=49.3
Q ss_pred EEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cceeeeeeecC
Q 014344 20 IVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPRLRGVLSTD 98 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~~~~~ 98 (426)
-++.|+.|-...+|++.....++.+++|+..... ...-....|..+|+.|...+ .+++++++.
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--------------~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-- 175 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--------------DEIINREREKKISCILYNKNIAKKIYVFFT-- 175 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--------------CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--------------hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--
Confidence 3567888999999999875445789999873210 00111246899999987444 467888773
Q ss_pred CeEEEEEeccCCCCh
Q 014344 99 KFVGYAIDYCPGRDL 113 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L 113 (426)
+ .+||||++|.+|
T Consensus 176 ~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 176 N--GRIEEFMDGYAL 188 (458)
T ss_dssp T--EEEEECCCSEEC
T ss_pred C--eEEEEeeCCccC
Confidence 2 359999987444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0011 Score=62.58 Aligned_cols=138 Identities=17% Similarity=0.165 Sum_probs=78.2
Q ss_pred eeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC--Ccceeeee-----
Q 014344 22 SALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP--LLPRLRGV----- 94 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp--~iv~l~~~----- 94 (426)
..|+ |....||++.. .+|+.+++|+..... .....+..|..+++.|... .+++++..
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~--------------~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~ 95 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER--------------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTL 95 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT--------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC--------------CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEE
Confidence 4566 88889998764 346689999984221 0123556688888877422 24444443
Q ss_pred eecCCeEEEEEeccCCCChH-----HH---------HHHhc-c------CCCCHHHH----------------------H
Q 014344 95 LSTDKFVGYAIDYCPGRDLH-----SL---------RKQQS-E------QMFSDDTI----------------------R 131 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~-----~l---------~~~~~-~------~~l~~~~~----------------------~ 131 (426)
....+..+++|++++|..+. .+ ++... . ..++.... .
T Consensus 96 ~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 175 (328)
T 1zyl_A 96 LNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFL 175 (328)
T ss_dssp EEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHH
T ss_pred EEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHH
Confidence 22355678999999875431 11 11110 0 01111110 1
Q ss_pred HHHHHHHHHHHHH----HHCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 132 FYAAELVLALEYL----HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 132 ~~~~qil~aL~~L----H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
..+.+++..+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 176 ~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 176 KATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111222222221 123589999999999998 4 899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0036 Score=59.54 Aligned_cols=32 Identities=16% Similarity=0.350 Sum_probs=28.1
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
..++|+|+.+.||+++.++.+.|+||+.+..-
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999877653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.022 Score=55.81 Aligned_cols=139 Identities=17% Similarity=0.302 Sum_probs=84.7
Q ss_pred EEeeecccCceEEEEEEEcCC-------CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCccee
Q 014344 20 IVSALGRGAKGVVFLVKDVES-------SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRL 91 (426)
Q Consensus 20 i~~~LG~G~~g~V~~a~~~~~-------~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l 91 (426)
-++.|..|-...+|++..... ++.|++|+..... +..-...+|..+++.|. +.-.+++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--------------~~~idR~~E~~~l~~L~~~gi~P~l 139 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--------------GKFYDSKVELDVFRYLSNINIAPNI 139 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---------------CCCCHHHHHHHHHHHHHTTSSCCE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--------------chhcCHHHHHHHHHHHHhcCCCCCE
Confidence 456677788899999987521 5789999863210 11112345888888885 4445677
Q ss_pred eeeeecCCeEEEEEeccCCCChHH-----------H---H---HHh-c----------cCCCCHHHHHHHHHHH------
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHS-----------L---R---KQQ-S----------EQMFSDDTIRFYAAEL------ 137 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~-----------l---~---~~~-~----------~~~l~~~~~~~~~~qi------ 137 (426)
++.+. + ++||||++|..|.. + + +.. . ..+.....+..+..++
T Consensus 140 ~~~~~--~--~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~ 215 (424)
T 3mes_A 140 IADFP--E--GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSK 215 (424)
T ss_dssp EEEET--T--EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHT
T ss_pred EEEcC--C--CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcc
Confidence 76543 2 78999999865321 0 0 000 0 0111134444444332
Q ss_pred -------------HHHHHHHH------------------------HCCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 138 -------------VLALEYLH------------------------NMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 138 -------------l~aL~~LH------------------------~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
...++.|. ...++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 216 ~~~~~~~~~~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 216 NNFQIDKELYSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CC--CCHHHHHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cchhhccccHHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 12233332 125899999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.20 E-value=0.088 Score=51.05 Aligned_cols=30 Identities=30% Similarity=0.523 Sum_probs=25.6
Q ss_pred CCcccCCCCCCeee------ccCCcEEEeccccccc
Q 014344 148 GIVYRDLKPENIMI------QENGHIMLVDFDLSTK 177 (426)
Q Consensus 148 giiHrDlKp~NiLl------~~~g~ikL~DFgls~~ 177 (426)
.++|+|+.+.|||+ +.++.+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 3467899999998865
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.88 E-value=1.1 Score=38.99 Aligned_cols=85 Identities=11% Similarity=0.082 Sum_probs=59.2
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE 163 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~ 163 (426)
.||+++.. .+-++++.+.+.++.-. ...++-.- +.++.....+++.+|+....+++. =+|=-|+|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 47888876 56667777766666543 22222211 127788888888888887754433 366678999999999
Q ss_pred CCcEEEecccccc
Q 014344 164 NGHIMLVDFDLST 176 (426)
Q Consensus 164 ~g~ikL~DFgls~ 176 (426)
++.+++.--|+-.
T Consensus 115 ~~~p~i~~RGik~ 127 (215)
T 4ann_A 115 DGLPIAKTRGLQN 127 (215)
T ss_dssp TSCEEESCCEETT
T ss_pred CCCEEEEEccCcc
Confidence 9999999888644
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.92 E-value=1.9 Score=37.65 Aligned_cols=88 Identities=15% Similarity=0.070 Sum_probs=60.7
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHH-HHHHCCCcccCCCCCCeeec
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALE-YLHNMGIVYRDLKPENIMIQ 162 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~-~LH~~giiHrDlKp~NiLl~ 162 (426)
.||++ -..+-.+++.+.+.++.-+++.=+.-++ .++.....+++.+|+.... +++ .-+|=-|+|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEe
Confidence 47888 3344467777777777653332222222 2778888888887777655 333 346667899999999
Q ss_pred cCCcEEEecccccccCCC
Q 014344 163 ENGHIMLVDFDLSTKLSP 180 (426)
Q Consensus 163 ~~g~ikL~DFgls~~~~~ 180 (426)
.++.+++.-.|+-..+.|
T Consensus 119 ~~~~p~i~hRGi~~~lpP 136 (219)
T 4ano_A 119 RALEPFFLHVGVKESLPP 136 (219)
T ss_dssp TTCCEEESCCEETTTBSS
T ss_pred CCCcEEEEEcCCcccCCC
Confidence 999999999998665543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 426 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-54 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-50 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-41 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-32 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-29 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-23 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-24 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-17 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 1e-58
Identities = 81/322 (25%), Positives = 134/322 (41%), Gaps = 71/322 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I LG+G G V+L ++ +S ALKV+++ +EK E ++ E
Sbjct: 9 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE----------HQLRREVE 58
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ ++ HP + RL G V ++Y P ++ ++ S+ F + Y EL
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELA 116
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL Y H+ +++RD+KPEN+++ G +
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSAGEL------------------------------- 145
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K G S+ P S + + GT +Y+ PE+IEG
Sbjct: 146 ---------KIADFGWSVHAP------------------SSRRTTLCGTLDYLPPEMIEG 178
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-PTPLRNLIRRL 317
+ HD VD WSLGV+ +E L G PF ++ +ET+ RI R+LI RL
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 238
Query: 318 LEKDPTKRIGVEEIKGHEFFKG 339
L+ +P++R + E+ H +
Sbjct: 239 LKHNPSQRPMLREVLEHPWITA 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-54
Identities = 95/344 (27%), Positives = 153/344 (44%), Gaps = 75/344 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG+G G V LV++ + +A+K++ +++I K D+ E R
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESR 57
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
VL+N HP L L+ T + + ++Y G +L ++ ++F+++ RFY AE+V
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIV 115
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
ALEYLH+ +VYRD+K EN+M+ ++GHI
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHI------------------------------- 144
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K G+ + +F GT EY+APE++E
Sbjct: 145 ---------KITDFGLC----------------KEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-PTPLRNLIRRL 317
+ AVDWW LGVV++EM+ G PF + F IL ++L+ L
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239
Query: 318 LEKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
L+KDP +R+G +E+ H FF +NW+ ++ K PP P
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-54
Identities = 73/341 (21%), Positives = 130/341 (38%), Gaps = 69/341 (20%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
LG G VV ++ + +A K I K + ++ G I E
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFI-------KKRRTKSSRRGVSREDIEREVS 65
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ ++HP + L V V ++ G +L ++ +++ + +++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELF--DFLAEKESLTEEEATEFLKQIL 123
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
+ YLH++ I + DLKPENIM+ +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRN--------------------------------- 150
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ K R + F + D + + GT E+VAPEI+
Sbjct: 151 VPKPRIKIIDFGLA--------------------HKIDFGNEFKNIFGTPEFVAPEIVNY 190
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-----PTPLRNL 313
+ D WS+GV+ + +L GA+PF G +++ET + + E ++
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLL--KISRPP 352
IRRLL KDP KR+ +++ H + K + + L S P
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQ 291
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 179 bits (454), Expect = 2e-53
Identities = 93/354 (26%), Positives = 165/354 (46%), Gaps = 78/354 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+I+ LG G+ G V L++ + +A+KV+ ++++ + + + E+
Sbjct: 7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL----------KQVEHTNDERL 56
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L V HP + R+ G + + +DY G +L SL ++ Q F + +FYAAE+
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVC 114
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
LALEYLH+ I+YRDLKPENI L+D + K++
Sbjct: 115 LALEYLHSKDIIYRDLKPENI---------LLDKNGHIKIT------------------- 146
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
D + + + + + GT +Y+APE++
Sbjct: 147 -------------------DFGFAKYV------------PDVTYTLCGTPDYIAPEVVST 175
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-PTPLRNLIRRL 317
K ++ ++DWWS G++++EML G TPF S+ +T+ +IL +++L+ RL
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 235
Query: 318 LEKDPTKRIG-----VEEIKGHEFFKGVNWE-LLLKISRPPNIPARFEHENNES 365
+ +D ++R+G E++K H +FK V WE LL + P P + + + S
Sbjct: 236 ITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTS 289
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (456), Expect = 2e-53
Identities = 70/353 (19%), Positives = 124/353 (35%), Gaps = 74/353 (20%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I+ LG GA GVV + + F K I K + E
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-------------YTVKNEIS 78
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
++ + HP L L + +++ G +L + + S+ + Y +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQAC 137
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L+++H IV+ D+KPENIM +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKA-------------------------------- 165
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
S + + D + ++ PD E T E+ APEI++
Sbjct: 166 -------------SSVKIIDFGLATKLNPD----------EIVKVTTATAEFAAPEIVDR 202
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-----LRNL 313
+ F D W++GV+ + +L G +PF G ET + + + ++
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 262
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
I+ LL+K+P KR+ V + H + KG + L +I R + + +D
Sbjct: 263 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (456), Expect = 2e-53
Identities = 74/362 (20%), Positives = 123/362 (33%), Gaps = 79/362 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I LG GA GVV V + + +FA K + + + E +
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFV-------------MTPHESDKETVRKEIQ 75
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ + HP L L D + ++ G +L + + S+D Y ++
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVC 134
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L ++H V+ DLKPENI + S +L
Sbjct: 135 KGLCHMHENNYVHLDLKPENI---------MFTTKRSNEL-------------------- 165
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K G++ + D + GT E+ APE+ EG
Sbjct: 166 ---------KLIDFGLT-----------------AHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-----LRNL 313
K + D WS+GV+ + +L G +PF G + ET + ++ ++
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDGRGRDGT 373
IR+LL DP R+ + + H + N R IP+ + +S D
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAP-----GRDSQIPSSRYTKIRDSIKTKYDAW 314
Query: 374 KE 375
E
Sbjct: 315 PE 316
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-53
Identities = 67/330 (20%), Positives = 128/330 (38%), Gaps = 79/330 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I+ LG GA G V+ ++ E+S A KVI + + ++ E
Sbjct: 15 EIIGELGDGAFGKVYKAQNKETSVLAAAKVI-------------DTKSEEELEDYMVEID 61
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L + +HP + +L + + I++C G + ++ + E+ ++ I+ + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTL 120
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL YLH+ I++RDLK NI L D KL
Sbjct: 121 DALNYLHDNKIIHRDLKAGNI---------LFTLDGDIKL-------------------- 151
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII-- 256
G+S ++ + ++ +SF+GT ++APE++
Sbjct: 152 -----------ADFGVS----------------AKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 257 ---EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEP----TP 309
+ + +D+ D WSLG+ L EM P + +I P + +P +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 244
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339
++ +++ LEK+ R ++ H F
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (442), Expect = 3e-52
Identities = 79/332 (23%), Positives = 118/332 (35%), Gaps = 75/332 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
LGRG VV + + +A+K+I S E + + E
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE----EVQELREATLKEVD 61
Query: 79 VLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
+LR V HP + +L+ T+ F D +L ++ S+ R L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRAL 119
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
+ + LH + IV+RDLKPENI L+D D++ KL+
Sbjct: 120 LEVICALHKLNIVHRDLKPENI---------LLDDDMNIKLT------------------ 152
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
D D EK GT Y+APEIIE
Sbjct: 153 ------------------------------DFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 258 G------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----CRPPDLVGE 306
G+ VD WS GV+++ +L G+ PF + I+ P+
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242
Query: 307 PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
+++L+ R L P KR EE H FF+
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 3e-51
Identities = 74/329 (22%), Positives = 124/329 (37%), Gaps = 73/329 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
LG GA V L +D + + A+K I + +E K + N E
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMEN------------EIA 59
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
VL ++HP + L + + + + G +L ++ +++ +++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVL 117
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
A++YLH++GIV+RDLKPEN++ +D D +S
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLL------YYSLDEDSKIMIS------------------- 152
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
D D ++ GT YVAPE++
Sbjct: 153 -----------------------------DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ 183
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-----PTPLRNL 313
K + AVD WS+GV+ + +L G PF + + F +IL + ++
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342
IR L+EKDP KR E+ H + G
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 9e-50
Identities = 64/325 (19%), Positives = 114/325 (35%), Gaps = 73/325 (22%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V LG GA G V L + + E+ A+K++ + + E
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK------------EIC 55
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ + + H + + G ++YC G +L + + + + +L+
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLM 113
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
+ YLH +GI +RD+KPEN+ L+D + K+S
Sbjct: 114 AGVVYLHGIGITHRDIKPENL---------LLDERDNLKIS------------------- 145
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
L+ + N GT YVAPE+++
Sbjct: 146 ----DFGLATVFRYN----------------------NRERLLNKMCGTLPYVAPELLKR 179
Query: 259 KG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----RPPDLVGEPTPLRNL 313
+ H VD WS G+VL ML G P+ S Y + L
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFK 338
+ ++L ++P+ RI + +IK ++
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYN 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (426), Expect = 6e-49
Identities = 89/353 (25%), Positives = 149/353 (42%), Gaps = 81/353 (22%)
Query: 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRI 73
DFS RI +GRG G V+ + ++ + +A+K + + I+ K E
Sbjct: 5 DFSVHRI---IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-------TLALNE 54
Query: 74 SFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
++ + P + + T + + +D G DLH Q +FS+ +RFY
Sbjct: 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFY 112
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
AAE++L LE++HN +VYRDLKP +I+L
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPA--------NILL------------------------ 140
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
G + + S +K ++ VGT Y+AP
Sbjct: 141 -DEHGHVRISDL-------------------------GLACDFSKKKPHASVGTHGYMAP 174
Query: 254 EIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPT---- 308
E+++ G +D + DW+SLG +L ++L G +PFR K+ V P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 234
Query: 309 PLRNLIRRLLEKDPTKRI-----GVEEIKGHEFFKGVNWE-LLLKISRPPNIP 355
LR+L+ LL++D +R+ G +E+K FF+ ++W+ + L+ PP IP
Sbjct: 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 2e-48
Identities = 65/324 (20%), Positives = 110/324 (33%), Gaps = 75/324 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG G V L +D+ A+KV+ DL Y R E +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP----------SFYLRFRREAQ 59
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI----DYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
+ HP + + + G +Y G L + + +
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVI 117
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
A+ AL + H GI++RD+KP NIMI + ++DF ++ ++
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD-------------- 163
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+S ++ + +GT +Y++PE
Sbjct: 164 ---------------------------------------SGNSVTQTAAVIGTAQYLSPE 184
Query: 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE-----PTP 309
G D D +SLG VL+E+L G PF G S Y+ + P
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 310 LRNLIRRLLEKDPTKRIG-VEEIK 332
L ++ + L K+P R E++
Sbjct: 245 LDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-47
Identities = 59/361 (16%), Positives = 113/361 (31%), Gaps = 79/361 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
I LGRG G+V + S +++ K + G + E
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--------------KVKGTDQVLVKKEIS 53
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L H + L + + + ++ G D+ + + ++ I Y ++
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVC 112
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
AL++LH+ I + D++PENI + S+ +
Sbjct: 113 EALQFLHSHNIGHFDIRPENI---------IYQTRRSSTI-------------------- 143
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K G + + EY APE+ +
Sbjct: 144 ---------KIIEFGQA-----------------RQLKPGDNFRLLFTAPEYYAPEVHQH 177
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP-----LRNL 313
A D WSLG +++ +L G PF + ++ I+ E +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKG----VNWELLLKISRPPNIPARFEHENNESDGRG 369
+ RLL K+ R+ E H + K V+ +++ + + + N
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAA 297
Query: 370 R 370
R
Sbjct: 298 R 298
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-47
Identities = 72/371 (19%), Positives = 121/371 (32%), Gaps = 118/371 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+S LG G GVVF V S A K+I ++ ++ E +
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR------------ELQ 56
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
VL P + G +D + +++ G L + K+ + + + ++
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 139 LALEYLHNM-GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRS 197
L YL I++RD+KP N +LV+ KL
Sbjct: 115 KGLTYLREKHKIMHRDVKPSN---------ILVNSRGEIKL------------------- 146
Query: 198 GIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIE 257
C G+S + +NSFVGT Y++PE ++
Sbjct: 147 ------------CDFGVSGQLI------------------DSMANSFVGTRSYMSPERLQ 176
Query: 258 GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE-------------------------- 291
G + D WS+G+ L EM G P KE
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 292 -TFYRILCRPPDLVGE------------------PTPLRNLIRRLLEKDPTKRIGVEEIK 332
+ Y + RPP + E ++ + + L K+P +R ++++
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 333 GHEFFKGVNWE 343
H F K + E
Sbjct: 297 VHAFIKRSDAE 307
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 8e-47
Identities = 71/366 (19%), Positives = 130/366 (35%), Gaps = 92/366 (25%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G G V + + + E FALK++ D R + R +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML--------------QDCPKARREVELHWRASQ-- 63
Query: 84 EHPLLPRLRGVL----STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
P + R+ V + K + ++ G +L S + + +Q F++ +
Sbjct: 64 -CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
A++YLH++ I +RD+KPEN++ ++
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAIL----------------------------- 153
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
K G + ++ S + T YVAPE++ +
Sbjct: 154 --------KLTDFGFA-----------------KETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 260 GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---------PPDLVGEPTPL 310
+D + D WSLGV+++ +L G PF + + R P+ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 311 RNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESDGRGR 370
+ LIR LL+ +PT+R+ + E H + + ++ P P E R
Sbjct: 249 KMLIRNLLKTEPTQRMTITEFMNHPWIM--------QSTKVPQTPLHTSRVLKEDKERWE 300
Query: 371 DGTKEI 376
D +E+
Sbjct: 301 DVKEEM 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 9e-47
Identities = 57/338 (16%), Positives = 121/338 (35%), Gaps = 81/338 (23%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
S D L+ +GRG+ V+ D E++ A + + K ++
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---------- 53
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFS 126
R E +L+ ++HP + R + K + + L + K+ ++
Sbjct: 54 -RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMK 110
Query: 127 DDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
+R + +++ L++LH I++RDLK +N I + S K+
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN--------IFITGPTGSVKI------ 156
Query: 185 ASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSF 244
+ + + + +
Sbjct: 157 ----------------------GDLGLATL---------------------KRASFAKAV 173
Query: 245 VGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPP 301
+GT E++APE+ E K +D +VD ++ G+ + EM P+ YR + +P
Sbjct: 174 IGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232
Query: 302 DLVGEPTP-LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P ++ +I + ++ +R ++++ H FF+
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 5e-46
Identities = 64/329 (19%), Positives = 120/329 (36%), Gaps = 78/329 (23%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G G+ G ++ + K + + + K++ + E
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-----------EVN 55
Query: 79 VLRNVEHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSL--RKQQSEQMFSDDTIRFYA 134
+LR ++HP + R + T+ + ++YC G DL S+ + + Q ++ +
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 135 AELVLALEYLHNMG-----IVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
+L LAL+ H +++RDLKP N+ +D + KL
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANV---------FLDGKQNVKL----------- 155
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
G++ R + + + +FVGT
Sbjct: 156 --------------------GDFGLA----------------RILNHDTSFAKAFVGTPY 179
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGE--P 307
Y++PE + ++ D WSLG +L+E+ PF S+KE +I +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 308 TPLRNLIRRLLEKDPTKRIGVEEIKGHEF 336
L +I R+L R VEEI +
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-45
Identities = 58/340 (17%), Positives = 114/340 (33%), Gaps = 76/340 (22%)
Query: 13 LDFSCLRIVS-ALGRGAKGVVFLV--KDVESSESFALKVIWRDLIEKKSKELTNNDNGDK 69
LD L + LG G G V + + ++ A+K++ + + K+
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--------- 53
Query: 70 YRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDT 129
+ E V++ +++P + R+ G+ + ++ ++ L+ +Q + D
Sbjct: 54 --ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKN 108
Query: 130 IRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKT 189
I ++ + ++YL V+RDL N+++ + + DF LS L
Sbjct: 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR---------- 158
Query: 190 VLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249
+D + + +
Sbjct: 159 -------------------------------------------ADENYYKAQTHGKWPVK 175
Query: 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILC--RPPDLVGE 306
+ APE I D WS GV++ E YG P+RG E + R G
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC 235
Query: 307 PTPLRNLIRRLLEKDPTKRIGVEEIKG---HEFFKGVNWE 343
P + +L+ D R G ++ + ++ VN
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (392), Expect = 1e-44
Identities = 64/324 (19%), Positives = 109/324 (33%), Gaps = 64/324 (19%)
Query: 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKY 70
+ +D SC++I +G G G V + I K L + +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI---------KTLKSGYTEKQR 71
Query: 71 RRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTI 130
R E ++ +HP + L GV++ V ++ L S +Q Q + +
Sbjct: 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQL 130
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ ++YL +M V+RDL NI++ N + DF LS L T + +
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
L +
Sbjct: 191 L---------------------------------------------------GGKIPIRW 199
Query: 251 VAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEP 307
APE I+ + A D WS G+V+ E++ YG P+ + ++ I R P + P
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259
Query: 308 TPLRNLIRRLLEKDPTKRIGVEEI 331
+ L L+ +KD R +I
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQI 283
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 6e-43
Identities = 60/322 (18%), Positives = 106/322 (32%), Gaps = 72/322 (22%)
Query: 18 LRIVSALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRIS 74
LR++ LG G+ GVV + S S A+K + D++ + +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP----------EAMDDFI 59
Query: 75 FEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
E + +++H L RL GV+ T + P L ++ F T+ YA
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH-FLLGTLSRYA 117
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
++ + YL + ++RDL N+++ + + DF L L
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ-------------- 163
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+ D + APE
Sbjct: 164 ---------------------------------------NDDHYVMQEHRKVPFAWCAPE 184
Query: 255 IIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILC---RPPDLVGEPTPL 310
++ + A D W GV L EM YG P+ G + + ++I R P P +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 311 RNLIRRLLEKDPTKRIGVEEIK 332
N++ + P R ++
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALR 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-43
Identities = 53/313 (16%), Positives = 96/313 (30%), Gaps = 72/313 (23%)
Query: 24 LGRGAKGVVFLVKDVESSES--FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81
LG G G V + A+KV+ + + ++E+ E +++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR------------EAQIMH 64
Query: 82 NVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLAL 141
+++P + RL GV + + ++ G LH + E+ + ++ + +
Sbjct: 65 QLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGM 122
Query: 142 EYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKK 201
+YL V+RDL N+++ + + DF LS L
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--------------------- 161
Query: 202 RRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGH 261
D ++ ++ APE I +
Sbjct: 162 --------------------------------DDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 262 DFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRRLL 318
D WS GV + E L YG P++ E I R P L L+
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCW 249
Query: 319 EKDPTKRIGVEEI 331
R +
Sbjct: 250 IYKWEDRPDFLTV 262
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-43
Identities = 60/332 (18%), Positives = 112/332 (33%), Gaps = 80/332 (24%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ + + +G G+ G V+ K A+K++ + + N
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKN-------- 53
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E VLR H + G ST + +C G L+ E F +
Sbjct: 54 ---EVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLID 108
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
A + ++YLH I++RDLK NI + E+ +
Sbjct: 109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV------------------------- 143
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
K G++ +S S + G+ ++A
Sbjct: 144 ---------------KIGDFGLA--------------TVKSRWSGSHQFEQLSGSILWMA 174
Query: 253 PEIIEGKG---HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---PPDLV-- 304
PE+I + + F D ++ G+VL+E++ G P+ + ++ ++ R PDL
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 305 --GEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334
P ++ L+ L+K +R +I
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 2e-41
Identities = 73/383 (19%), Positives = 129/383 (33%), Gaps = 108/383 (28%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+S +G GA G+V D + A+K I + + E +
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR------------EIK 58
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVG----YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
+L H + + ++ Y + + G DL+ L K Q S+D I ++
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFL 115
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
+++ L+Y+H+ +++RDLKP N+++ + + DF L+ P
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP-------------- 161
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
D D + +V T Y APE
Sbjct: 162 ---------------------------------------DHDHTGFLTEYVATRWYRAPE 182
Query: 255 II-EGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP---- 309
I+ KG+ ++D WS+G +L EML F G + IL E
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 310 ----------------------------LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
+L+ ++L +P KRI VE+ H + +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 342 WELLLKISRPPNIPARFEHENNE 364
I+ P +F+ E ++
Sbjct: 303 DPSDEPIAEAPF---KFDMELDD 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-41
Identities = 58/379 (15%), Positives = 127/379 (33%), Gaps = 72/379 (18%)
Query: 8 RPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNG 67
R ++ +F +++ LG GA G V+ + E + V KEL +
Sbjct: 4 RILKETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAI--------KELREATSP 52
Query: 68 DKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSD 127
+ I E V+ +V++P + RL G+ T P L ++ +
Sbjct: 53 KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLD-YVREHKDNIGS 110
Query: 128 DTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASP 187
+ + ++ + YL + +V+RDL N++++ H+ + DF
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-------------- 156
Query: 188 KTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247
L+K + + +
Sbjct: 157 ------------------LAKLLGA----------------------EEKEYHAEGGKVP 176
Query: 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLV 304
+++A E I + + D WS GV + E++ +G+ P+ G E + R P
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 236
Query: 305 GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE--LLLKISRPPNIPARFEHEN 362
+ ++ + D R E+ + + L+++ ++P+ +
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNF 296
Query: 363 NESDGRGRDGTKEIDVEKF 381
+ D +D +++
Sbjct: 297 YRALMDEEDMDDVVDADEY 315
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-40
Identities = 48/348 (13%), Positives = 102/348 (29%), Gaps = 87/348 (25%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L LG GA G V S++ + K L + +
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-------AVKMLKEKADSSEREA 86
Query: 73 ISFEQRVLRNVE-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM------- 124
+ E +++ + H + L G + + +YC DL + + + E+
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 146
Query: 125 --------------FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170
+ + + +A ++ +E+L V+RDL N+++ + +
Sbjct: 147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206
Query: 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230
DF L++ S
Sbjct: 207 DFG--------------------------------LARDIMSD----------------- 217
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSR 289
+ + +++APE + + D WS G++L E+ G P+ G
Sbjct: 218 -----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 290 KETFYRILC---RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334
FY+++ + + +++ D KR +
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-40
Identities = 61/362 (16%), Positives = 115/362 (31%), Gaps = 107/362 (29%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ +G+G G VF + ++ + ALK + + N+ E +
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME-----------NEKEGFPITALREIK 61
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAI--------DYCPGRDLHSLRKQQSEQMFSDDTI 130
+L+ ++H + L + T D+C L F+ I
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEI 119
Query: 131 RFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
+ L+ L Y+H I++RD+K N++I +G + L DF L+ S
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL---------- 169
Query: 191 LAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250
+ + + + V T Y
Sbjct: 170 ------------------------------------------AKNSQPNRYTNRVVTLWY 187
Query: 251 VAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP 309
PE++ G + + +D W G ++ EM + +G++ + I + E P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 310 ---------------------------------LRNLIRRLLEKDPTKRIGVEEIKGHEF 336
+LI +LL DP +RI ++ H+F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 337 FK 338
F
Sbjct: 308 FW 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-40
Identities = 80/396 (20%), Positives = 135/396 (34%), Gaps = 116/396 (29%)
Query: 7 DRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDN 66
DRP + ++ ++ +G G+ GVV+ K +S E A+K + + K N
Sbjct: 15 DRPQE-VSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNR-- 62
Query: 67 GDKYRRISFEQRVLRNVEHPLLPRLRGVLST------DKFVGYAIDYCPGRDLHSLRK-Q 119
E +++R ++H + RLR + + ++ +DY P R
Sbjct: 63 ---------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 120 QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
+++Q ++ Y +L +L Y+H+ GI +RD+KP+ +++L KL
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ--------NLLLDPDTAVLKLC 165
Query: 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239
D S E
Sbjct: 166 ------------------------------------------------DFGSAKQLVRGE 177
Query: 240 KSNSFVGTEEYVAP-EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL- 297
+ S++ + Y AP I + ++D WS G VL E+L G F G S + I+
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
Query: 298 -------------------CRPPDLVGEPTP----------LRNLIRRLLEKDPTKRIGV 328
+ P + P L RLLE PT R+
Sbjct: 238 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297
Query: 329 EEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
E H FF + +K+ + PA F E
Sbjct: 298 LEACAHSFFDELRDP-NVKLPNGRDTPALFNFTTQE 332
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 56/331 (16%), Positives = 110/331 (33%), Gaps = 76/331 (22%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ LR+ LG+G G V++ ++ A+K + + +
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--------------A 58
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E +V++ + H L +L V+S + + +Y L K ++ + +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
AA++ + Y+ M V+RDL+ NI++ EN
Sbjct: 118 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVC------------------------- 152
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
K G++ + + ++ A
Sbjct: 153 ---------------KVADFGLA---------------RLIEDNEYTARQGAKFPIKWTA 182
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTP 309
PE D WS G++L E+ G P+ G +E ++ R P P
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKG--HEFFK 338
L +L+ + K+P +R E ++ ++F
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 53/325 (16%), Positives = 101/325 (31%), Gaps = 74/325 (22%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+D L + LG G GVV K A+K+I + +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSED--------------E 45
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E +V+ N+ H L +L GV + + + +Y L + ++ + F +
Sbjct: 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLE 104
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
++ A+EYL + ++RDL N ++ + G +
Sbjct: 105 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVK------------------------ 140
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
+S F S L+D S S +
Sbjct: 141 -------------VSDFGLSRYVLDDEYTS------------------SVGSKFPVRWSP 169
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTP 309
PE++ D W+ GV++ E+ G P+ + ET I R
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334
+ ++ + +R + + +
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-39
Identities = 75/354 (21%), Positives = 121/354 (34%), Gaps = 99/354 (27%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ V +G G GVV+ ++ + E ALK I D + E
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-----------EIS 53
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ + HP + +L V+ T+ + Y + +DL + I+ Y +L+
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKL-YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L + H+ +++RDLKP+N +L++ +
Sbjct: 113 QGLAFCHSHRVLHRDLKPQN---------LLINTE------------------------- 138
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
K G++ R+ V T Y APEI+ G
Sbjct: 139 ------GAIKLADFGLA----------------RAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 259 KGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--CRPPDLVGEPTP------ 309
+ AVD WSLG + EM+ F G S + +RI PD V P
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 310 ----------------------LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341
R+L+ ++L DP KRI + H FF+ V
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 56/326 (17%), Positives = 108/326 (33%), Gaps = 80/326 (24%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
L+ L+++ +G+G G V L A+K I N +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI---------------KNDATAQA 46
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIR 131
E V+ + H L +L GV+ +K Y + +Y L + + + D +
Sbjct: 47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106
Query: 132 FYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
++ ++ A+EYL V+RDL N+ LV D
Sbjct: 107 KFSLDVCEAMEYLEGNNFVHRDLAARNV---------LVSED------------------ 139
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
++K G++ ++S ++ ++
Sbjct: 140 -------------NVAKVSDFGLT-------------------KEASSTQDTGKLPVKWT 167
Query: 252 APEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPT 308
APE + K D WS G++L E+ +G P+ K+ R+ + G P
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227
Query: 309 PLRNLIRRLLEKDPTKRIGVEEIKGH 334
+ +++ D R +++
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 2e-39
Identities = 51/349 (14%), Positives = 107/349 (30%), Gaps = 87/349 (24%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R+ +G G+ G ++L D+ + E A+K+ K+ ++ E +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE---------------CVKTKHPQLHIESK 54
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+ + ++ + + + G L L S + FS T+ A +++
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMI 113
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLV---DFDLSTKLSPKTPQASPKTVLAANT 195
+EY+H+ ++RD+KP+N ++ LV DF L+ K
Sbjct: 114 SRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----------------- 156
Query: 196 RSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255
++ + GT Y +
Sbjct: 157 --------------------------------RDARTHQHIPYRENKNLTGTARYASINT 184
Query: 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI-------LCRPPDLVGE-- 306
G D SLG VL G+ P++G + + P +++ +
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244
Query: 307 PTPLRNLIRRLLEKDPTKRIGVEEIK----------GHEFFKGVNWELL 345
P+ + + ++ G + +W +L
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 137 bits (346), Expect = 4e-38
Identities = 51/368 (13%), Positives = 101/368 (27%), Gaps = 100/368 (27%)
Query: 3 DVVNDRPIRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELT 62
+VV ++ +G G+ GV+F ++ +++ A+K R + ++
Sbjct: 1 NVVGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-- 49
Query: 63 NNDNGDKYRRISFEQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS 121
E R + + +P + ID L
Sbjct: 50 -------------EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG- 95
Query: 122 EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-----NGHIMLVDFDLST 176
+ FS T+ A +++ ++ +H +VYRD+KP+N +I I +VDF +
Sbjct: 96 -RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236
P
Sbjct: 155 FY-------------------------------------------------RDPVTKQHI 165
Query: 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI 296
+ + GT Y++ G+ D +LG V L G+ P++G +
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 297 L--------CRPPDLVGE-PTPLRNLIRRLLEKDPTKRIGVEEIK----------GHEFF 337
+L P + + ++
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
Query: 338 KGVNWELL 345
+ +W LL
Sbjct: 286 ENFDWNLL 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-37
Identities = 58/326 (17%), Positives = 107/326 (32%), Gaps = 73/326 (22%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNNDNGD 68
+ SC+ +G G G V+ SS A+K + EK+ +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG----- 58
Query: 69 KYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDD 128
E ++ H + RL GV+S K + +Y L +++ + FS
Sbjct: 59 -------EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVL 110
Query: 129 TIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPK 188
+ + ++YL NM V+RDL NI++ N + DF LS L
Sbjct: 111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--------- 161
Query: 189 TVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248
D +++ ++
Sbjct: 162 --------------------------------------------DDPEATYTTSGGKIPI 177
Query: 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVG 305
+ APE I + A D WS G+V+ E++ + + R P +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237
Query: 306 EPTPLRNLIRRLLEKDPTKRIGVEEI 331
P+ + L+ + +++ +R +I
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADI 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-37
Identities = 64/325 (19%), Positives = 116/325 (35%), Gaps = 69/325 (21%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ + + +G G G V + I K K T++ +K+ +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAI------KTCKNCTSDSVREKFLQ 57
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E +R +HP + +L GV+ T+ V ++ C +L S + + + ++
Sbjct: 58 ---EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 112
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
YA +L AL YL + V+RD+ N+++ N +
Sbjct: 113 YAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV------------------------- 147
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
K G+S + + K++ +++A
Sbjct: 148 ---------------KLGDFGLS---------------RYMEDSTYYKASKGKLPIKWMA 177
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRILC--RPPDLVGEPTP 309
PE I + A D W GV + E+L +G PF+G + RI R P P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 237
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334
L +L+ + DP++R E+K
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-37
Identities = 56/330 (16%), Positives = 107/330 (32%), Gaps = 76/330 (23%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ L++V LG G G V++ A+K + + +
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPD--------------A 54
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E +++ ++H L RL V++ + +Y L K S + + +
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLD 113
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
AA++ + ++ ++RDL+ NI LV LS K++
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANI---------LVSDTLSCKIA------------- 151
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
D + I + + ++ A
Sbjct: 152 -------------------------DFGLARLI--------EDNEYTAREGAKFPIKWTA 178
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTP 309
PE I D WS G++L E++ +G P+ G + E + R P
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKG--HEFF 337
L L+R ++ P R + ++ +FF
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-37
Identities = 73/357 (20%), Positives = 118/357 (33%), Gaps = 98/357 (27%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESF-ALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQ 77
V+ +G GA G VF +D+++ F ALK + E+ R
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--------STIREVAVL 61
Query: 78 RVLRNVEHPLLPRLRGVLSTDKFVG----YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
R L EHP + RL V + + + +DL + + E +TI+
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
+L+ L++LH+ +V+RDLKP +N I++
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKP------QN--ILV------------------------ 149
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
+ IK L++ S V T Y AP
Sbjct: 150 TSSGQIKLADFGLARIY-------------------------SFQMALTSVVVTLWYRAP 184
Query: 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTP---- 309
E++ + VD WS+G + EM FRGSS + +IL E P
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 310 ------------------------LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342
++L+ + L +P KRI H +F+ +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 4e-36
Identities = 59/334 (17%), Positives = 111/334 (33%), Gaps = 74/334 (22%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
++ + + + LG G G V+ + S + A+K + D +E +
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--------------E 59
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E V++ ++HP L +L GV + + ++ +L ++ + Q S + +
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
A ++ A+EYL ++RDL N LV + K++
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNC---------LVGENHLVKVA------------- 157
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
D S + D+ ++ A
Sbjct: 158 -------------------------DFGLSRLM--------TGDTYTAHAGAKFPIKWTA 184
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPDLVGEPTP 309
PE + D W+ GV+L E+ Y +L R G P
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 244
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343
+ L+R + +P+ R EI H+ F+ + E
Sbjct: 245 VYELMRACWQWNPSDRPSFAEI--HQAFETMFQE 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 4e-36
Identities = 56/337 (16%), Positives = 109/337 (32%), Gaps = 85/337 (25%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
LD++ ++ +G G G V + + + K + + D +R
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAI----------KRMKEYASKDDHRD 56
Query: 73 ISFEQRVLRNVE-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQ------------ 119
+ E VL + HP + L G ++ AI+Y P +L ++
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 120 --QSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177
+ S + +AA++ ++YL ++RDL NI LV + K
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI---------LVGENYVAK 167
Query: 178 LSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDS 237
++ D +
Sbjct: 168 IA------------------------------------------------DFGLSRGQEV 179
Query: 238 SEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRI 296
K ++A E + + D WS GV+L E++ G TP+ G + E + ++
Sbjct: 180 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239
Query: 297 L--CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
R + + +L+R+ + P +R +I
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (331), Expect = 5e-36
Identities = 64/350 (18%), Positives = 113/350 (32%), Gaps = 99/350 (28%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G GVV+ ++ E+FALK I + ++ T E
Sbjct: 5 HGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR-----------EIS 52
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ ++H + +L V+ T K + ++ L E T + + +L+
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLL 110
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
+ Y H+ +++RDLKP+N++I G + + DF L+
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR---------------------- 148
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
F + + S
Sbjct: 149 ---------AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI----------------- 182
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-------------------CR 299
D WS+G + EM+ G F G S + RI
Sbjct: 183 -------DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 300 PPDLVGEPTPL-----------RNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
P V EP P +L+ ++L+ DP +RI ++ H +FK
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 8e-36
Identities = 53/325 (16%), Positives = 96/325 (29%), Gaps = 74/325 (22%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+D S L V +G G G+V L + + A+K I + ++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEE--------------D 46
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
E V+ + HP L +L GV + ++ L + Q +F+ +T+
Sbjct: 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLG 105
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
++ + YL +++RDL N LV + K+S
Sbjct: 106 MCLDVCEGMAYLEEACVIHRDLAARNC---------LVGENQVIKVS------------- 143
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
D S ++ +
Sbjct: 144 ---------------------------------DFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTP 309
PE+ + D WS GV++ E+ G P+ S E I R T
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTH 230
Query: 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334
+ ++ ++ P R +
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 51/318 (16%), Positives = 102/318 (32%), Gaps = 72/318 (22%)
Query: 24 LGRGAKGVVFLVKDVESSES---FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVL 80
+GRG G V+ +++ A+K + R + + E ++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT------------EGIIM 82
Query: 81 RNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
++ HP + L G+ + + Y DL + + ++ D I F ++
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-GLQVAK 141
Query: 140 ALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGI 199
+++L + V+RDL N M+ E + + DF L+ +
Sbjct: 142 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD------------------- 182
Query: 200 KKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259
+ DS +++A E ++ +
Sbjct: 183 ---------------------------------KEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 260 GHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL--CRPPDLVGEPTPLRNLIRR 316
D WS GV+L E++ GA P+ + + +L R P PL ++ +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269
Query: 317 LLEKDPTKRIGVEEIKGH 334
R E+
Sbjct: 270 CWHPKAEMRPSFSELVSR 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 4e-35
Identities = 60/329 (18%), Positives = 118/329 (35%), Gaps = 42/329 (12%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++V LGRG VF ++ ++E +K++ K ++I E +
Sbjct: 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKIL----------------KPVKKKKIKREIK 81
Query: 79 VLRNV-EHPLLPRLRGVL--STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAA 135
+L N+ P + L ++ + ++ D L + +D IRFY
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMY 136
Query: 136 ELVLALEYLHNMGIVYRDLKPENIMI-QENGHIMLVDFDLSTKLSPKTPQASPKTVLAAN 194
E++ AL+Y H+MGI++RD+KP N+MI E+ + L+D+ L+ P
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 196
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
+ + + SL + S +P + +
Sbjct: 197 GPELLVDYQMYDYS--LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR------------ 242
Query: 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLI 314
I + G + D+ + + + R S ++ + + + +
Sbjct: 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR---WERFVHSENQHLVSPEALDFL 299
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343
+LL D R+ E H +F V +
Sbjct: 300 DKLLRYDHQSRLTAREAMEHPYFYTVVKD 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-35
Identities = 64/351 (18%), Positives = 111/351 (31%), Gaps = 99/351 (28%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G G VF K+ E+ E ALK + D ++ E
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-----------EIC 53
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ ++H + RL VL +DK + ++C + ++ + +L+
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLL 111
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L + H+ +++RDLKP+N++I NG + L +F L+ S +
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE---------- 161
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
V + P S
Sbjct: 162 ---------------------VVTLWYRPPDVLFGAKLYSTS------------------ 182
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRILCRPPDLVGEPTP-------- 309
+D WS G + E+ P F G+ + RI E P
Sbjct: 183 ------IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 310 ----------------------LRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
R+L++ LL+ +P +RI EE H +F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-34
Identities = 65/397 (16%), Positives = 135/397 (34%), Gaps = 126/397 (31%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ + +G GA+G+V D + A+K + R + + R E
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-----------RAYRELV 68
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGY------AIDYCPGRDLHSLRKQQSEQMFSDDTIRF 132
+++ V H + L V + K + ++ ++ + + + +
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-----ERMSY 123
Query: 133 YAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLA 192
+++ +++LH+ GI++RDLKP NI+++ + + ++DF
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG------------------- 164
Query: 193 ANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252
L++ + + V + Y A
Sbjct: 165 -------------LARTAGTSFMMTPYVVTRY-------------------------YRA 186
Query: 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL--------------- 297
PE+I G G+ VD WS+G ++ EM+ F G + + +++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 298 -------CRPPDLVGEPTP---------------------LRNLIRRLLEKDPTKRIGVE 329
P G P R+L+ ++L DP KRI V+
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 330 EIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
+ H + W ++ PP P ++ + +E +
Sbjct: 307 DALQHPYIN--VWYDPAEVEAPP--PQIYDKQLDERE 339
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 46/131 (35%), Positives = 73/131 (55%), Gaps = 8/131 (6%)
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKET 292
S ++NSFVGT +YV+PE++ K + D W+LG ++++++ G PFR +
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 293 FYRILCRPPDLVGEPTP-LRNLIRRLLEKDPTKRIGVEE------IKGHEFFKGVNWELL 345
F +I+ D + P R+L+ +LL D TKR+G EE +K H FF+ V WE L
Sbjct: 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 346 LKISRPPNIPA 356
+ + PP + A
Sbjct: 279 HQQT-PPKLTA 288
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-32
Identities = 52/172 (30%), Positives = 91/172 (52%), Gaps = 12/172 (6%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG G+ V L +++ +S +A+K++ + I K+ +K ++ E+
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERD 60
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
V+ ++HP +L D+ + + + Y +L ++ F + RFY AE+V
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIV 118
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTV 190
ALEYLH GI++RDLKPENI++ E+ HI + DF + LSP++ QA +
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 170
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-33
Identities = 53/346 (15%), Positives = 108/346 (31%), Gaps = 89/346 (25%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNG 67
L++ LGRGA G V + + A+K++ + + L
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL------ 63
Query: 68 DKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAI-DYCPGRDLHSLRKQQSEQM-- 124
+S + ++ H + L G + I ++C +L + + + +
Sbjct: 64 -----MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 125 ------------FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172
+ + + Y+ ++ +E+L + ++RDL NI++ E + + DF
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
Query: 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR 232
L++
Sbjct: 179 G--------------------------------LARDIYK-------------------- 186
Query: 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKE 291
+ +++APE I + + D WS GV+L E+ A+P+ G E
Sbjct: 187 --DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 292 TFYRIL---CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334
F R L R + + +P++R E+ H
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (311), Expect = 5e-33
Identities = 61/344 (17%), Positives = 101/344 (29%), Gaps = 96/344 (27%)
Query: 18 LRIVSALGRGAKGVVFLVK-----DVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRR 72
+ V +G GA G VF + E A+K++ + +
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR--------- 65
Query: 73 ISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM-------- 124
E ++ ++P + +L GV + K + +Y DL+ + S
Sbjct: 66 ---EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 125 --------------FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170
S A ++ + YL V+RDL N LV
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC---------LV 173
Query: 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230
++ K++ D S I
Sbjct: 174 GENMVVKIA--------------------------------------DFGLSRNI----- 190
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSR 289
+D + + ++ PE I + D W+ GVVL E+ YG P+ G +
Sbjct: 191 --YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 290 KETFYRIL--CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
+E Y + P L NL+R K P R I
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 1e-32
Identities = 59/344 (17%), Positives = 115/344 (33%), Gaps = 91/344 (26%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSES-------FALKVIWRDLIEKKSKELTNND 65
L L + LG GA G V L + + + A+K++ D EK +L +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS-- 67
Query: 66 NGDKYRRISFEQRVLRNV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ---- 120
E +++ + +H + L G + D + ++Y +L + +
Sbjct: 68 ----------EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 121 ----------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170
E+ S + A ++ +EYL + ++RDL N +LV
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN---------VLV 168
Query: 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230
D K++ F +
Sbjct: 169 TEDNVMKIAD----------------------------FGLARDI--------------- 185
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSR 289
D +K+ + +++APE + + + D WS GV+L E+ G +P+ G
Sbjct: 186 --HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 290 KETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
+E F + R L ++R P++R +++
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 2e-32
Identities = 51/143 (35%), Positives = 79/143 (55%), Gaps = 3/143 (2%)
Query: 216 LEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLH 275
L D +I + + K+N+F GT +Y+APEI+ G+ ++ +VDWWS GV+L+
Sbjct: 135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLY 194
Query: 276 EMLYGATPFRGSSRKETFYRILCRPPDLVGE-PTPLRNLIRRLLEKDPTKRIGVE-EIKG 333
EML G +PF G +E F+ I P ++L+ +L ++P KR+GV +I+
Sbjct: 195 EMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
Query: 334 HEFFKGVNWELLL-KISRPPNIP 355
H F+ +NWE L K PP P
Sbjct: 255 HPLFREINWEELERKEIDPPFRP 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 7e-27
Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 13/167 (7%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG+G+ G VFL + ++++ FA+K + +D++ D E+R
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKR 54
Query: 79 VL-RNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAEL 137
VL EHP L + T + + + ++Y G DL + F FYAAE+
Sbjct: 55 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEI 112
Query: 138 VLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
+L L++LH+ GIVYRDLK +NI++ ++GHI + DF + + +
Sbjct: 113 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-31
Identities = 58/324 (17%), Positives = 103/324 (31%), Gaps = 54/324 (16%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
LG G V+ +D +++ A+K I + R E ++L+ +
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKI--------KLGHRSEAKDGINRTALREIKLLQEL 57
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
HP + L + D+ ++ + + I+ Y + LEY
Sbjct: 58 SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEY 115
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSP---------KTPQASPKTVLAAN 194
LH I++RDLKP N+++ ENG + L DF L+ T +L
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 195 TRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
G+ + G L + + P DSD + +
Sbjct: 176 RMYGVG------VDMWAVGCILAE-----LLLRVPFLPGDSDLDQLTR------------ 212
Query: 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLI 314
I E G W + + + + + P L +LI
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI------------FSAAGDDLLDLI 260
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFK 338
+ L +P RI + ++F
Sbjct: 261 QGLFLFNPCARITATQALKMKYFS 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 8e-31
Identities = 66/352 (18%), Positives = 125/352 (35%), Gaps = 49/352 (13%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
R + +G GA G V D + A+K ++R + + R E R
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-----------RAYRELR 69
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDL--HSLRKQQSEQMFSDDTIRFYAAE 136
+L+++ H + L V + D+ + D+ L K + +D I+F +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 137 LVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTR 196
++ L Y+H GI++RDLKP N+ + E+ + ++DF L+ + + A
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 197 SGIKKRRSFLSKFCSSGISLEDPV--HSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254
R + S G + + + + G D E
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-------------------QLKE 230
Query: 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLI 314
I++ G A L + P K+ F IL L NL+
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLP---ELEKKDFASILTNASPL------AVNLL 281
Query: 315 RRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNESD 366
++L D +R+ E H +F+ ++ P + +++ ++ D
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESLHDT-----EDEPQVQ-KYDDSFDDVD 327
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 59/351 (16%), Positives = 107/351 (30%), Gaps = 88/351 (25%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKD-----VESSESFALKVIWRDLIEKKSKELTNNDNG 67
+ + + LG+G+ G+V+ E A+K + ++ E N
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---- 72
Query: 68 DKYRRISFEQRVLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM--- 124
E V++ + RL GV+S + ++ DL S + M
Sbjct: 73 --------EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124
Query: 125 -----FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
S + A E+ + YL+ V+RDL N +V D + K+
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN---------CMVAEDFTVKIG 175
Query: 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSE 239
++D
Sbjct: 176 DFGMT---------------------------------------------RDIYETDYYR 190
Query: 240 KSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEML-YGATPFRGSSRKETFYRIL- 297
K + +++PE ++ D WS GVVL E+ P++G S ++ ++
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 298 -CRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI------KGHEFFKGVN 341
P L L+R + +P R EI + F+ V+
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-29
Identities = 39/164 (23%), Positives = 73/164 (44%), Gaps = 12/164 (7%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +G G+ G V+ +DV +SE A+K + + +K++ I E R
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN----------EKWQDIIKEVR 67
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
L+ + HP + RG + ++YC G L + + + I +
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGAL 125
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKT 182
L YLH+ +++RD+K NI++ E G + L DF ++ ++P
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.2 bits (239), Expect = 7e-23
Identities = 30/110 (27%), Positives = 43/110 (39%), Gaps = 6/110 (5%)
Query: 235 SDSSEKSNSFVGTEEYVAPEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKE 291
+ +NSFVGT ++APE+I +D VD WSLG+ E+ P +
Sbjct: 162 ASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 292 TFYRILCRPPDLVGE---PTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
Y I + RN + L+K P R E + H F
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-28
Identities = 37/168 (22%), Positives = 71/168 (42%), Gaps = 16/168 (9%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+G+GA G V+ DV + + A++ + N K I E
Sbjct: 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQM-------------NLQQQPKKELIINEIL 69
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
V+R ++P + + ++Y G L + E + I E +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECL 126
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQAS 186
ALE+LH+ +++RD+K +NI++ +G + L DF +++P+ + S
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 2e-27
Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 4/112 (3%)
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
+ K ++ VGT ++APE++ K + VD WSLG++ EM+ G P+ +
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 291 ETFYRILCRPPDLVGEP----TPLRNLIRRLLEKDPTKRIGVEEIKGHEFFK 338
Y I + P R+ + R L+ D KR +E+ H+F K
Sbjct: 223 RALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 2e-28
Identities = 62/351 (17%), Positives = 123/351 (35%), Gaps = 49/351 (13%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ +S +G GA G V D ++ A+K + R + T E R
Sbjct: 21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-----------ELR 69
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVG-----YAIDYCPGRDLHSLRKQQSEQMFSDDTIRFY 133
+L++++H + L V + + + Y + + G DL+++ K Q +DD ++F
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFL 126
Query: 134 AAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAA 193
+++ L+Y+H+ I++RDLKP N+ + E+ + ++DF L+ + A
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186
Query: 194 NTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253
+ S G + + + F GT+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG-----RTL-------------FPGTDHIDQL 228
Query: 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNL 313
++I + Y + + K F + L +L
Sbjct: 229 KLILRLVGTPGAELLKKISSESARNYIQSLTQ--MPKMNFANVFIGANPL------AVDL 280
Query: 314 IRRLLEKDPTKRIGVEEIKGHEFFKGVNWELLLKISRPPNIPARFEHENNE 364
+ ++L D KRI + H +F + P P E+ +
Sbjct: 281 LEKMLVLDSDKRITAAQALAHAYFA----QYHDPDDEPVADPYDQSFESRD 327
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 3e-27
Identities = 50/350 (14%), Positives = 95/350 (27%), Gaps = 112/350 (32%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G+G G V+ K E A+K+ +E E +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREA--------------EIYQTVML 54
Query: 84 EHPLLPRLRGVLSTDKFVGYAI----DYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVL 139
H + + D + DY L + + + + + A
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTAS 111
Query: 140 ALEYLH--------NMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVL 191
L +LH I +RDLK +NI++++NG + D L+ + T
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT--------- 162
Query: 192 AANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251
N VGT+ Y+
Sbjct: 163 -------------------------------------------DTIDIAPNHRVGTKRYM 179
Query: 252 APEIIEGKGH------DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL-------- 297
APE+++ + D +++G+V E+ + + Y L
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 298 ---------CRPPDLVGEPTP------LRNLIRRLLEKDPTKRIGVEEIK 332
P++ + ++R + R+ IK
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 5e-26
Identities = 61/323 (18%), Positives = 104/323 (32%), Gaps = 69/323 (21%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
++ LG G G V+ V + A+K + +D I + + R
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI-------------SDWGELPNGTR 53
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
V V L+ V S V +D+ D V
Sbjct: 54 VPMEVVL-----LKKVSSGFSGVIRLLDWFERPD-----------------------SFV 85
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L LE + ++ I E G + +L+ + +A + G
Sbjct: 86 LILERPEPVQDLFD-------FITERGAL---QEELARSFFWQVLEA-----VRHCHNCG 130
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
+ R I ++ ++ D+ F GT Y PE I
Sbjct: 131 VLHR-----DIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRY 183
Query: 259 -KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLVGEPTPLRNLIRRL 317
+ H + WSLG++L++M+ G PF E + + + ++LIR
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVFFRQRV---SSECQHLIRWC 238
Query: 318 LEKDPTKRIGVEEIKGHEFFKGV 340
L P+ R EEI+ H + + V
Sbjct: 239 LALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 2e-25
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 12/159 (7%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+ LG G+ G V LVK ES +A+K++ + + K + E+R
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL----------KQIEHTLNEKR 93
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ V P L +L + + ++Y G ++ S ++ FS+ RFYAA++V
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177
L EYLH++ ++YRDLKPEN++I + G+I + DF + +
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 9e-25
Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 6/130 (4%)
Query: 242 NSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP 301
+ GT E +APEII KG++ AVDWW+LGV+++EM G PF + + +I+
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
Query: 302 DLVGE-PTPLRNLIRRLLEKDPTKRIG-----VEEIKGHEFFKGVNWELLLKISRPPNIP 355
+ L++L+R LL+ D TKR G V +IK H++F +W + +
Sbjct: 256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFI 315
Query: 356 ARFEHENNES 365
+F+ + S
Sbjct: 316 PKFKGPGDTS 325
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 2e-24
Identities = 59/160 (36%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 209 FCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK--GHDFAVD 266
I L+ H +D +E++ F GT EY+AP+I+ G GHD AVD
Sbjct: 155 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVD 214
Query: 267 WWSLGVVLHEMLYGATPFRGSSRKETFYRIL-----CRPPDLVGEPTPLRNLIRRLLEKD 321
WWSLGV+++E+L GA+PF K + I PP ++LI+RLL KD
Sbjct: 215 WWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKD 274
Query: 322 PTKRIG-----VEEIKGHEFFKGVNWELLL-KISRPPNIP 355
P KR+G +EIK H FF+ +NW+ L K P P
Sbjct: 275 PKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKP 314
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 54/170 (31%), Positives = 93/170 (54%), Gaps = 15/170 (8%)
Query: 19 RIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISF 75
++ LG GA G VFLV+ + ++ + +A+KV+ + I +K+K
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT---------EHTRT 77
Query: 76 EQRVLRNVEH-PLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYA 134
E++VL ++ P L L T+ + +DY G +L + Q+ + F++ ++ Y
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYV 135
Query: 135 AELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQ 184
E+VLALE+LH +GI+YRD+K ENI++ NGH++L DF LS + +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 3e-22
Identities = 40/341 (11%), Positives = 95/341 (27%), Gaps = 84/341 (24%)
Query: 13 LDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNG 67
+ L LG GA G V +++ + A+K++ + + L +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---- 75
Query: 68 DKYRRISFEQRVLRNVE-HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQM-- 124
E +VL + H + L G + +YC DL + +++ +
Sbjct: 76 --------ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFIC 127
Query: 125 --------------FSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170
+ + ++ ++ + +L + ++RDL NI++ +
Sbjct: 128 SKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
Query: 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPP 230
DF L+ + + +
Sbjct: 188 DFGLARDIKNDSNYVVKGNA-----------------------------RLPVKWMAPES 218
Query: 231 SRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK 290
+ + E G E+ + + ++M+
Sbjct: 219 IFNCVYTFESDVWSYG---IFLWELFSLGSSPY--PGMPVDSKFYKMIKEGFRML----- 268
Query: 291 ETFYRILCRPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331
P E + ++++ + DP KR ++I
Sbjct: 269 --------SPEHAPAE---MYDIMKTCWDADPLKRPTFKQI 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (209), Expect = 9e-19
Identities = 51/386 (13%), Positives = 104/386 (26%), Gaps = 101/386 (26%)
Query: 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQR 78
+V LG G V+L KD+ ++ A+K++ D + ++ E E +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED--------------EIK 61
Query: 79 VLRNVEHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELV 138
+L+ V + + + H L+ + + V
Sbjct: 62 LLQRVNDADNTKEDSMGAN----------------HILKLLDHFNHKGPNGVHVVMVFEV 105
Query: 139 LALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSG 198
L L + P + Q + ++L + + R G
Sbjct: 106 LGENLLALIKKYEHRGIPLIYVKQISKQLLL-------------------GLDYMHRRCG 146
Query: 199 IKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258
I K + + + D + + E + + T EY +PE++ G
Sbjct: 147 IIHT---DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLG 203
Query: 259 KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF---------YRILCRPPDLV----- 304
D WS ++ E++ G F +L P +
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 263
Query: 305 -----------------------------------GEPTPLRNLIRRLLEKDPTKRIGVE 329
E + + + +L+ DP KR
Sbjct: 264 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323
Query: 330 EIKGHEFFKGVNWELLLKISRPPNIP 355
+ H + K +++
Sbjct: 324 GLVNHPWLKDTLGMEEIRVPDRELYG 349
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.0 bits (186), Expect = 8e-17
Identities = 31/156 (19%), Positives = 53/156 (33%), Gaps = 10/156 (6%)
Query: 24 LGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV 83
+G G + VF E +K K K D GD S
Sbjct: 8 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFK-KVKEKRDYGDL--HFSVLAIRSARN 63
Query: 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEY 143
E L +L+G+ V + L L + + ++ +
Sbjct: 64 EFRALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179
++ GIV+ DL N+++ E G I ++DF S ++
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 426 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.7 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.18 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.23 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-67 Score=493.64 Aligned_cols=278 Identities=34% Similarity=0.607 Sum_probs=242.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
+....++|++++.||+|+||+||+|+++.+++.||||++.+...... ...+.+.+|+.+|++++||||++
T Consensus 3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~ 72 (288)
T d1uu3a_ 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE----------NKVPYVTRERDVMSRLDHPFFVK 72 (288)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHCCSTTBCC
T ss_pred CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCH----------HHHHHHHHHHHHHHHcCCCCeeE
Confidence 44566889999999999999999999999999999999987654332 23467889999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++++|.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+
T Consensus 73 l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~ 150 (288)
T d1uu3a_ 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQIT 150 (288)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEec
Confidence 9999999999999999999999999877654 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.+.... ......+.+||+.|
T Consensus 151 DFG~a~~~~~~~------------------------------------------------------~~~~~~~~~GT~~Y 176 (288)
T d1uu3a_ 151 DFGTAKVLSPES------------------------------------------------------KQARANSFVGTAQY 176 (288)
T ss_dssp CCTTCEECC----------------------------------------------------------------CCCCGGG
T ss_pred ccccceecccCC------------------------------------------------------cccccccccCCccc
Confidence 999998764211 11234456899999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++......+ ...++.+++||.+||+.||++|||++
T Consensus 177 ~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~ 256 (288)
T d1uu3a_ 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256 (288)
T ss_dssp CCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSG
T ss_pred cCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 99999999999999999999999999999999999999999999988765544 35689999999999999999999998
Q ss_pred H------HhcCCCcCCCChhhhhhccCCCCCC
Q 014344 330 E------IKGHEFFKGVNWELLLKISRPPNIP 355 (426)
Q Consensus 330 e------il~hp~f~~~~~~~~~~~~~~~~~~ 355 (426)
| |++||||++++|+.+.+. .||.+|
T Consensus 257 e~~~~~~i~~Hpff~~i~w~~l~~~-~pP~l~ 287 (288)
T d1uu3a_ 257 EMEGYGPLKAHPFFESVTWENLHQQ-TPPKLT 287 (288)
T ss_dssp GGTCHHHHHTSGGGTTCCCTTGGGS-CCCCCC
T ss_pred HHcCCHHHHcCCccCCCCHHHhhcC-CCCCCC
Confidence 8 589999999999998665 455554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-66 Score=498.09 Aligned_cols=275 Identities=35% Similarity=0.657 Sum_probs=244.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++||||++++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~ 71 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK----------DEVAHTVTESRVLQNTRHPFLTALK 71 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCH----------HHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 568899999999999999999999999999999999987765433 2356788899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|++++.+|+|||||+||+|.+++.... .+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+||
T Consensus 72 ~~~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 72 YAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred eeeccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeec
Confidence 99999999999999999999999987654 4999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+..... .....+++||+.|||
T Consensus 150 G~a~~~~~~--------------------------------------------------------~~~~~~~~GT~~Y~a 173 (337)
T d1o6la_ 150 GLCKEGISD--------------------------------------------------------GATMKTFCGTPEYLA 173 (337)
T ss_dssp TTCBCSCCT--------------------------------------------------------TCCBCCCEECGGGCC
T ss_pred ccccccccC--------------------------------------------------------CcccccceeCHHHhh
Confidence 999865321 123456789999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC----
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG---- 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s---- 327 (426)
||++.+.+|+.++|||||||++|||++|++||.+.+..+.+..+......+ ...++.+++||++||++||.+|++
T Consensus 174 PE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~ 253 (337)
T d1o6la_ 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPS 253 (337)
T ss_dssp GGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTT
T ss_pred hhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccc
Confidence 999999999999999999999999999999999999999888887665444 356899999999999999999995
Q ss_pred -hHHHhcCCCcCCCChhhhhhcc-CCCCCC
Q 014344 328 -VEEIKGHEFFKGVNWELLLKIS-RPPNIP 355 (426)
Q Consensus 328 -~~eil~hp~f~~~~~~~~~~~~-~~~~~~ 355 (426)
++||++||||++++|+.+.... .||..|
T Consensus 254 ~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P 283 (337)
T d1o6la_ 254 DAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp THHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cHHHHHcCcccccCCHHHHHhCCCCCCCCC
Confidence 8999999999999999987644 344443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-65 Score=478.30 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=231.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
.+.+++|++++.||+|+||+||+|+++.+++.||+|++.+...... .....+.+|+.+|+.++||||+++
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~~ 71 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA----------GVEHQLRREVEIQSHLRHPNILRL 71 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccCh----------HHHHHHHHHHHHHHhcCCCCCCeE
Confidence 4567899999999999999999999999999999999987655432 234578889999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
++++.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 72 ~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~D 149 (263)
T d2j4za1 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIAD 149 (263)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecc
Confidence 999999999999999999999999987654 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|..... ......+||+.||
T Consensus 150 FG~a~~~~~----------------------------------------------------------~~~~~~~Gt~~Y~ 171 (263)
T d2j4za1 150 FGWSVHAPS----------------------------------------------------------SRRTTLCGTLDYL 171 (263)
T ss_dssp CCSCSCCCC----------------------------------------------------------CCCEETTEEGGGC
T ss_pred cceeeecCC----------------------------------------------------------CcccccCCCCccc
Confidence 999975431 1233457999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++.......+ ..++.+++||.+||++||++|||++|
T Consensus 172 APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp CHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 99999999999999999999999999999999999999998888876654443 46889999999999999999999999
Q ss_pred HhcCCCcC
Q 014344 331 IKGHEFFK 338 (426)
Q Consensus 331 il~hp~f~ 338 (426)
+|+||||+
T Consensus 252 il~hp~~~ 259 (263)
T d2j4za1 252 VLEHPWIT 259 (263)
T ss_dssp HHTCHHHH
T ss_pred HHcCcCcC
Confidence 99999996
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-65 Score=485.55 Aligned_cols=272 Identities=34% Similarity=0.651 Sum_probs=241.3
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRG 93 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~ 93 (426)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++||||+++++
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~~~~ 71 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL----------KQVEHTNDERLMLSIVTHPFIIRMWG 71 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCH----------HHHHHHHHHHHHHHhccCcChhheee
Confidence 46789999999999999999999999999999999987654332 23567889999999999999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
++.+++.+|+|||||.||+|..++.... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||
T Consensus 72 ~~~~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 72 TFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eEeeCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCc
Confidence 9999999999999999999999877654 48999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+|+.... ...+.+||+.||||
T Consensus 150 ~a~~~~~-----------------------------------------------------------~~~~~~Gt~~Y~AP 170 (316)
T d1fota_ 150 FAKYVPD-----------------------------------------------------------VTYTLCGTPDYIAP 170 (316)
T ss_dssp SCEECSS-----------------------------------------------------------CBCCCCSCTTTCCH
T ss_pred cceEecc-----------------------------------------------------------ccccccCcccccCH
Confidence 9986531 12345799999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC-----C
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI-----G 327 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~-----s 327 (426)
|++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.+++...... ...++.++++|.+||++||.+|+ |
T Consensus 171 E~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t 250 (316)
T d1fota_ 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 250 (316)
T ss_dssp HHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTT
T ss_pred HHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhh
Confidence 99999999999999999999999999999999999999998887665444 45688999999999999999996 8
Q ss_pred hHHHhcCCCcCCCChhhhhhc-cCCCCCCC
Q 014344 328 VEEIKGHEFFKGVNWELLLKI-SRPPNIPA 356 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~~~~~~-~~~~~~~~ 356 (426)
+++||+||||++++|+.+... ..+|..|.
T Consensus 251 ~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~ 280 (316)
T d1fota_ 251 TEDVKNHPWFKEVVWEKLLSRNIETPYEPP 280 (316)
T ss_dssp THHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHcCcccccCCHHHHHhCCCCcCCCCC
Confidence 999999999999999988653 34455543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-64 Score=487.92 Aligned_cols=275 Identities=33% Similarity=0.618 Sum_probs=244.0
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
....+++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+++|+.++||||++
T Consensus 36 ~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~ 105 (350)
T d1rdqe_ 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL----------KQIEHTLNEKRILQAVNFPFLVK 105 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHTTCCCTTBCC
T ss_pred CCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCH----------HHHHHHHHHHHHHHHcCCCcEee
Confidence 45667899999999999999999999999999999999987654332 23567889999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
++++|.+...+|+|||||.||+|..++.... .+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEee
Confidence 9999999999999999999999999887654 49999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.+.. ...+.+||+.|
T Consensus 184 DFG~a~~~~~-----------------------------------------------------------~~~~~~Gt~~Y 204 (350)
T d1rdqe_ 184 DFGFAKRVKG-----------------------------------------------------------RTWTLCGTPEA 204 (350)
T ss_dssp CCTTCEECSS-----------------------------------------------------------CBCCCEECGGG
T ss_pred eceeeeeccc-----------------------------------------------------------ccccccCcccc
Confidence 9999987531 12345799999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCC---
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRI--- 326 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~--- 326 (426)
||||++.+..|+.++|||||||++|+|++|++||.+.+....+.++....... ...++++.+||++||++||.+|+
T Consensus 205 ~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~ 284 (350)
T d1rdqe_ 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNL 284 (350)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSS
T ss_pred CCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccc
Confidence 99999999999999999999999999999999999999988888887655433 45689999999999999999995
Q ss_pred --ChHHHhcCCCcCCCChhhhhhcc-CCCCCCC
Q 014344 327 --GVEEIKGHEFFKGVNWELLLKIS-RPPNIPA 356 (426)
Q Consensus 327 --s~~eil~hp~f~~~~~~~~~~~~-~~~~~~~ 356 (426)
|+++|++||||++++|+.+.+.. .||.+|.
T Consensus 285 r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~ 317 (350)
T d1rdqe_ 285 KNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp TTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cccHHHHHcCccccCCCHHHHHhcCCCcCccCC
Confidence 89999999999999999987643 4455553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-64 Score=472.57 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=216.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ...+++.+|+.+|++++||||++++++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~------------~~~~~~~~Ei~~l~~l~HpnIv~~~~~ 71 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV------------DCPENIKKEICINKMLNHENVVKFYGH 71 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------------CHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc------------hHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 56899999999999999999999999999999999654211 123568889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+++.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 72 ~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 72 RREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEETTEEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred eccCceeEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999999999987543 4599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|+.+.... ......+.+||+.|||||
T Consensus 150 a~~~~~~~------------------------------------------------------~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 150 ATVFRYNN------------------------------------------------------RERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp CEECEETT------------------------------------------------------EECCBCCCCSCGGGSCTH
T ss_pred heeeccCC------------------------------------------------------ccccccceeeCcCccCHh
Confidence 98753211 012234568999999999
Q ss_pred hhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETF-YRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 255 ~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
++.+..+ +.++|||||||++|||++|++||...+..... ..+.... ......++.+.+||.+||+.||++|||++
T Consensus 176 ~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (271)
T d1nvra_ 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 255 (271)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 9998876 68899999999999999999999876544333 2332222 12235578899999999999999999999
Q ss_pred HHhcCCCcCC
Q 014344 330 EIKGHEFFKG 339 (426)
Q Consensus 330 eil~hp~f~~ 339 (426)
|+|+||||+.
T Consensus 256 eil~hpwf~~ 265 (271)
T d1nvra_ 256 DIKKDRWYNK 265 (271)
T ss_dssp HHTTCTTTTC
T ss_pred HHhcCHhhCc
Confidence 9999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-63 Score=475.49 Aligned_cols=269 Identities=35% Similarity=0.631 Sum_probs=235.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHH-hcCCCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR-NVEHPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~l~~ 93 (426)
+++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+..|..++. .++||||+++++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~----------~~~~~~~~e~~~l~~~~~hp~Iv~~~~ 70 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD----------DDVECTMVEKRVLSLAWEHPFLTHMFC 70 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT----------TCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh----------HHHHHHHHHHHHHHHhCCCCcEEEEEE
Confidence 4789999999999999999999999999999999987654332 13455666777765 689999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
+|.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||
T Consensus 71 ~~~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 71 TFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccc
Confidence 9999999999999999999999987654 49999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+++...... ......+||+.|+||
T Consensus 149 ~a~~~~~~~--------------------------------------------------------~~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 149 MCKENMLGD--------------------------------------------------------AKTNTFCGTPDYIAP 172 (320)
T ss_dssp TCBCCCCTT--------------------------------------------------------CCBCCCCSCGGGCCH
T ss_pred hhhhccccc--------------------------------------------------------ccccccCCCCCcCCH
Confidence 998653211 123345799999999
Q ss_pred hhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCHHHHHHHHHHhccCCCCCCChH-HH
Q 014344 254 EIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-GEPTPLRNLIRRLLEKDPTKRIGVE-EI 331 (426)
Q Consensus 254 E~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~li~~~L~~dP~~R~s~~-ei 331 (426)
|++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++....+..+ ..++.+.+||++||++||++|||+. ++
T Consensus 173 E~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred HHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHH
Confidence 999999999999999999999999999999999999999888876655443 4689999999999999999999995 89
Q ss_pred hcCCCcCCCChhhhhhccCC
Q 014344 332 KGHEFFKGVNWELLLKISRP 351 (426)
Q Consensus 332 l~hp~f~~~~~~~~~~~~~~ 351 (426)
++||||++++|+.+.....+
T Consensus 253 ~~hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 253 RQHPLFREINWEELERKEID 272 (320)
T ss_dssp GGSGGGTTCCHHHHHTTCSC
T ss_pred HhCchhccCCHHHHHhcCCC
Confidence 99999999999987654433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-64 Score=472.30 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=222.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++||||++++++|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~~~~~~ 86 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-------------PKKELIINEILVMRENKNPNIVNYLDSY 86 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC-------------SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC-------------hHHHHHHHHHHHHHhCCCCCEeeEeEEE
Confidence 479999999999999999999999999999999865321 1235688999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccccc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLS 175 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls 175 (426)
.+++.+|+|||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|
T Consensus 87 ~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a 163 (293)
T d1yhwa1 87 LVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (293)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhh
Confidence 999999999999999999998764 34999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchh
Q 014344 176 TKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEI 255 (426)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 255 (426)
+.+.... ......+||+.|||||+
T Consensus 164 ~~~~~~~--------------------------------------------------------~~~~~~~gt~~Y~aPE~ 187 (293)
T d1yhwa1 164 AQITPEQ--------------------------------------------------------SKRSTMVGTPYWMAPEV 187 (293)
T ss_dssp EECCSTT--------------------------------------------------------CCBCCCCSCGGGCCHHH
T ss_pred eeecccc--------------------------------------------------------ccccccccCCCccChhh
Confidence 8764211 12345579999999999
Q ss_pred hcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-C---CCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 256 IEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRP-P---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 256 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~---~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
+.+..|+.++|||||||++|+|++|++||.+.+..+....+.... + .....+..+++||.+||++||.+|||++|+
T Consensus 188 ~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp HSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 999999999999999999999999999999998887776665322 1 223457889999999999999999999999
Q ss_pred hcCCCcCC
Q 014344 332 KGHEFFKG 339 (426)
Q Consensus 332 l~hp~f~~ 339 (426)
|+||||+.
T Consensus 268 l~Hp~~~~ 275 (293)
T d1yhwa1 268 LQHQFLKI 275 (293)
T ss_dssp TTCGGGGG
T ss_pred hcCHhhCC
Confidence 99999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-63 Score=481.34 Aligned_cols=278 Identities=32% Similarity=0.590 Sum_probs=232.1
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
|.+++|++++.||+|+||+||+|+++.+|+.||||++.+..+..... .....+...|+.+++.++|||||+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-------ETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTC-------HHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhH-------HHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 46789999999999999999999999999999999998766544311 11223334457777888899999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++|.+++.+|+|||||+||+|.+++.... .+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+||
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCC
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeee
Confidence 99999999999999999999999987653 4899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+... .....+||+.|||
T Consensus 152 Gla~~~~~~----------------------------------------------------------~~~~~~GT~~y~A 173 (364)
T d1omwa3 152 GLACDFSKK----------------------------------------------------------KPHASVGTHGYMA 173 (364)
T ss_dssp TTCEECSSS----------------------------------------------------------CCCSCCSCGGGCC
T ss_pred ceeeecCCC----------------------------------------------------------cccccccccccch
Confidence 999865321 2334579999999
Q ss_pred chhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCCCC-CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK---ETFYRILCRPPDL-VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++. +..|+.++|||||||++|||++|+.||.+.+.. .....+...+... ...++.+++||.+||++||++|||
T Consensus 174 PE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 253 (364)
T d1omwa3 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253 (364)
T ss_dssp HHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTT
T ss_pred hHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCC
Confidence 99996 467899999999999999999999999875432 3333444443333 356899999999999999999999
Q ss_pred -----hHHHhcCCCcCCCChhhhhhcc-CCCCCCCC
Q 014344 328 -----VEEIKGHEFFKGVNWELLLKIS-RPPNIPAR 357 (426)
Q Consensus 328 -----~~eil~hp~f~~~~~~~~~~~~-~~~~~~~~ 357 (426)
++||++||||++++|..+.... .||.+|..
T Consensus 254 ~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~ 289 (364)
T d1omwa3 254 CLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289 (364)
T ss_dssp TSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCCC
Confidence 7999999999999999886543 44555543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-63 Score=468.07 Aligned_cols=266 Identities=26% Similarity=0.445 Sum_probs=228.0
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|+++.+|+.||||++.+...... ......+.+.+|+.+|++++|||||+++++|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS-------RRGVSREDIEREVSILKEIQHPNVITLHEVY 82 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTC-------SSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchh-------hhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 359999999999999999999999999999999976543221 1223456789999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC----cEEEec
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG----HIMLVD 171 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g----~ikL~D 171 (426)
.+++.+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|
T Consensus 83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 83 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecc
Confidence 99999999999999999999987654 499999999999999999999999999999999999999776 599999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|...... ....+.+||+.|+
T Consensus 161 fG~a~~~~~~---------------------------------------------------------~~~~~~~~t~~y~ 183 (293)
T d1jksa_ 161 FGLAHKIDFG---------------------------------------------------------NEFKNIFGTPEFV 183 (293)
T ss_dssp CTTCEECTTS---------------------------------------------------------CBCSCCCCCGGGC
T ss_pred hhhhhhcCCC---------------------------------------------------------ccccccCCCCccc
Confidence 9999876421 1233457999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..|+.++|||||||++|||++|+.||.+.+..+.+.++....... ...+..+++||.+||+.||++||
T Consensus 184 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 263 (293)
T d1jksa_ 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM 263 (293)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred CHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc
Confidence 9999999999999999999999999999999999999999888887654433 35678899999999999999999
Q ss_pred ChHHHhcCCCcCCCChhhhhh
Q 014344 327 GVEEIKGHEFFKGVNWELLLK 347 (426)
Q Consensus 327 s~~eil~hp~f~~~~~~~~~~ 347 (426)
|++|||+||||++.+|.....
T Consensus 264 s~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 264 TIQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp CHHHHHHSTTTCC--------
T ss_pred CHHHHhcCcccCCCChhHhhc
Confidence 999999999999999877654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-63 Score=470.65 Aligned_cols=253 Identities=30% Similarity=0.478 Sum_probs=209.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
+.|++++.||+|+||+||+|+++.+++.||||++.+..... ....+.+|+.+|+.++||||++++++|
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~~~~ 76 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG------------KEGSMENEIAVLHKIKHPNIVALDDIY 76 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh------------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 34999999999999999999999999999999997654321 124567899999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec---cCCcEEEecc
Q 014344 96 STDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ---ENGHIMLVDF 172 (426)
Q Consensus 96 ~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~---~~g~ikL~DF 172 (426)
.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+. .+|.+||+||
T Consensus 77 ~~~~~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 77 ESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EECCEEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEecc
Confidence 9999999999999999999998753 4599999999999999999999999999999999999995 4789999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+..... ....+.+||+.|||
T Consensus 155 G~a~~~~~~---------------------------------------------------------~~~~~~~GT~~y~A 177 (307)
T d1a06a_ 155 GLSKMEDPG---------------------------------------------------------SVLSTACGTPGYVA 177 (307)
T ss_dssp ---------------------------------------------------------------------------CTTSC
T ss_pred ceeEEccCC---------------------------------------------------------CeeeeeeeCccccC
Confidence 999754321 12345679999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|++||.+.+..+.+..+...... ....++.+.+||.+||++||++|||
T Consensus 178 PE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 257 (307)
T d1a06a_ 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT 257 (307)
T ss_dssp HHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred cHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC
Confidence 99999999999999999999999999999999999998888888754432 2356889999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
++|+|+||||++
T Consensus 258 ~~eil~hp~~~~ 269 (307)
T d1a06a_ 258 CEQALQHPWIAG 269 (307)
T ss_dssp HHHHHHSTTTTS
T ss_pred HHHHhcCHhhCC
Confidence 999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-63 Score=466.55 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=222.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|+||+||+|+++.+++.||||++.+. .....+.+.+|+++|++++|||||++++++.
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-------------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~ 79 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-------------SEEELEDYMVEIDILASCDHPNIVKLLDAFY 79 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC-------------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 589999999999999999999999999999998543 1234567888999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+++.+|+|||||+||+|.+++.... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 80 ~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 80 YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999999999876543 459999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
..... .....+.+||+.|||||++
T Consensus 159 ~~~~~--------------------------------------------------------~~~~~~~~Gt~~y~APE~l 182 (288)
T d2jfla1 159 KNTRT--------------------------------------------------------IQRRDSFIGTPYWMAPEVV 182 (288)
T ss_dssp ECHHH--------------------------------------------------------HHHHTCCCSCCTTCCHHHH
T ss_pred ccCCC--------------------------------------------------------cccccccccccccCCHHHH
Confidence 54210 0122345799999999998
Q ss_pred c-----CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 257 E-----GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL----VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 257 ~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
. +..|+.++|||||||++|||++|++||.+.+..+.+.++....+.. ...++++++||.+||+.||++|||
T Consensus 183 ~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t 262 (288)
T d2jfla1 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT 262 (288)
T ss_dssp TTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred hhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC
Confidence 4 4568999999999999999999999999999888888887553322 345789999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
++|||+||||+.
T Consensus 263 ~~ell~hp~~~~ 274 (288)
T d2jfla1 263 TSQLLQHPFVTV 274 (288)
T ss_dssp HHHHTTSGGGCC
T ss_pred HHHHhcCcccCC
Confidence 999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-63 Score=461.50 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=213.7
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+++|++++||||++++++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~~~ 71 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-----------EAEKQMLVSEVNLLRELKHPNIVRYYDR 71 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-----------HHHHHHHHHHHHHTTSCCCTTBCCEEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-----------HHHHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence 47899999999999999999999999999999999654322 2245678899999999999999999999
Q ss_pred eec--CCeEEEEEeccCCCChHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC-----CcccCCCCCCeeeccCC
Q 014344 95 LST--DKFVGYAIDYCPGRDLHSLRKQQ--SEQMFSDDTIRFYAAELVLALEYLHNMG-----IVYRDLKPENIMIQENG 165 (426)
Q Consensus 95 ~~~--~~~~~lV~Ey~~gg~L~~l~~~~--~~~~l~~~~~~~~~~qil~aL~~LH~~g-----iiHrDlKp~NiLl~~~g 165 (426)
+.+ ++.+|+|||||+||+|.+++... ....+++..++.++.||+.||+|||++| ||||||||+|||++.+|
T Consensus 72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 854 56799999999999999987643 3456999999999999999999999976 99999999999999999
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+|+.+.... ....+.+
T Consensus 152 ~vkl~DFG~a~~~~~~~--------------------------------------------------------~~~~~~~ 175 (269)
T d2java1 152 NVKLGDFGLARILNHDT--------------------------------------------------------SFAKAFV 175 (269)
T ss_dssp CEEECCHHHHHHC-------------------------------------------------------------------
T ss_pred cEEEeeccceeecccCC--------------------------------------------------------CccccCC
Confidence 99999999998764211 1234567
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCHHHHHHHHHHhccCCC
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP--DLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~li~~~L~~dP~ 323 (426)
||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...++..... .....++++.+||.+||+.||.
T Consensus 176 gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~ 255 (269)
T d2java1 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDY 255 (269)
T ss_dssp CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred CCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999999999999999888888764432 2345688999999999999999
Q ss_pred CCCChHHHhcCCCc
Q 014344 324 KRIGVEEIKGHEFF 337 (426)
Q Consensus 324 ~R~s~~eil~hp~f 337 (426)
+|||++|||+|||+
T Consensus 256 ~Rps~~ell~hp~i 269 (269)
T d2java1 256 HRPSVEEILENPLI 269 (269)
T ss_dssp GSCCHHHHHTSTTC
T ss_pred HCcCHHHHHhCCcC
Confidence 99999999999995
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-63 Score=478.14 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=217.8
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCccee
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRL 91 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l 91 (426)
++.-++|++++.||+|+||+||+|+++.+|+.||+|++.+.. .......+.+|+.+|+.++|||||++
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~------------~~~~~~~~~~Ei~il~~l~HpnIv~l 69 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI------------KPAIRNQIIRELQVLHECNSPYIVGF 69 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC------------CTTHHHHHHHHGGGGGGCCCTTBCCE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh------------CHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 355678999999999999999999999999999999985431 12234678899999999999999999
Q ss_pred eeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeeeccCCcEEEe
Q 014344 92 RGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 92 ~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++|.+++.+|+|||||+||+|.+++.+.. .+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+
T Consensus 70 ~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~ 147 (322)
T d1s9ja_ 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147 (322)
T ss_dssp EEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEe
Confidence 999999999999999999999999987654 49999999999999999999997 599999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.+.. ...++++||+.|
T Consensus 148 DFGla~~~~~----------------------------------------------------------~~~~~~~GT~~Y 169 (322)
T d1s9ja_ 148 DFGVSGQLID----------------------------------------------------------SMANSFVGTRSY 169 (322)
T ss_dssp CCCCCHHHHH----------------------------------------------------------HTC---CCSSCC
T ss_pred eCCCccccCC----------------------------------------------------------CccccccCCccc
Confidence 9999986521 123456899999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH-------------------------------------
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF------------------------------------- 293 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~------------------------------------- 293 (426)
||||++.+..|+.++||||+||++|||++|+.||.+.+..+..
T Consensus 170 ~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T d1s9ja_ 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249 (322)
T ss_dssp CCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCC
T ss_pred cCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchh
Confidence 9999999999999999999999999999999999876532210
Q ss_pred -----HHHhcCC-CCCC--CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 294 -----YRILCRP-PDLV--GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 294 -----~~i~~~~-~~~~--~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
..+.... +... ..+.++.|||.+||++||.+|||++|+|+||||+..+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 250 IFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp HHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred HHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111111 1111 23678999999999999999999999999999976544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.9e-62 Score=473.10 Aligned_cols=258 Identities=28% Similarity=0.444 Sum_probs=227.3
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|++|+|||||+++++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~~~~~ 91 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-------------SDKETVRKEIQTMSVLRHPTLVNLHDA 91 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-------------HHHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-------------hhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 4589999999999999999999999999999999854321 234578889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc--CCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE--NGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~--~g~ikL~DF 172 (426)
|.+++.+|+|||||+||+|.+++.... +.+++..++.|+.||+.||+|||++|||||||||+|||++. +|.+||+||
T Consensus 92 ~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DF 170 (350)
T d1koaa2 92 FEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 170 (350)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeec
Confidence 999999999999999999999875433 45999999999999999999999999999999999999964 588999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+... ....+.+||+.|||
T Consensus 171 G~a~~~~~~---------------------------------------------------------~~~~~~~gT~~Y~a 193 (350)
T d1koaa2 171 GLTAHLDPK---------------------------------------------------------QSVKVTTGTAEFAA 193 (350)
T ss_dssp TTCEECCTT---------------------------------------------------------SCEEEECSCTTTCC
T ss_pred chheecccc---------------------------------------------------------cccceecCcccccC
Confidence 999876421 12345679999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+.++....... ...+..+++||.+||+.||++|||
T Consensus 194 PEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 273 (350)
T d1koaa2 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273 (350)
T ss_dssp HHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 999999999999999999999999999999999999999888887544322 246788999999999999999999
Q ss_pred hHHHhcCCCcCCCChh
Q 014344 328 VEEIKGHEFFKGVNWE 343 (426)
Q Consensus 328 ~~eil~hp~f~~~~~~ 343 (426)
++|||+||||+..+|.
T Consensus 274 ~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 274 IHQALEHPWLTPGNAP 289 (350)
T ss_dssp HHHHHHSTTTSCTTCC
T ss_pred HHHHhcCcccCCCCCC
Confidence 9999999999876553
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-61 Score=451.52 Aligned_cols=249 Identities=21% Similarity=0.375 Sum_probs=212.0
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeec
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLST 97 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~ 97 (426)
|++.++||+|+||+||+|++..+++.||+|++...... ....+.+.+|+++|++++|||||+++++|.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-----------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-----------KSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-----------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 57888999999999999999999999999998654322 1235678899999999999999999999865
Q ss_pred ----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeeec-cCCcEEEe
Q 014344 98 ----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMG--IVYRDLKPENIMIQ-ENGHIMLV 170 (426)
Q Consensus 98 ----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~g--iiHrDlKp~NiLl~-~~g~ikL~ 170 (426)
+..+|+|||||+||+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 457899999999999999987653 4999999999999999999999998 99999999999997 57999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+.... ....+.+||+.|
T Consensus 158 DFGla~~~~~----------------------------------------------------------~~~~~~~GT~~Y 179 (270)
T d1t4ha_ 158 DLGLATLKRA----------------------------------------------------------SFAKAVIGTPEF 179 (270)
T ss_dssp CTTGGGGCCT----------------------------------------------------------TSBEESCSSCCC
T ss_pred ecCcceeccC----------------------------------------------------------CccCCcccCccc
Confidence 9999975321 123456799999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCC---CCCCCHHHHHHHHHHhccCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRILCRPPD---LVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~---~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
||||++.+ .|+.++|||||||++|||++|+.||.+.... +.+..+...... ....++++++||.+||++||++||
T Consensus 180 ~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~ 258 (270)
T d1t4ha_ 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 258 (270)
T ss_dssp CCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSC
T ss_pred cCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCc
Confidence 99999976 5999999999999999999999999876544 444555433221 124578899999999999999999
Q ss_pred ChHHHhcCCCcC
Q 014344 327 GVEEIKGHEFFK 338 (426)
Q Consensus 327 s~~eil~hp~f~ 338 (426)
|++|||+||||+
T Consensus 259 s~~ell~Hp~fk 270 (270)
T d1t4ha_ 259 SIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHTSGGGC
T ss_pred CHHHHhCCcccC
Confidence 999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-62 Score=471.58 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=225.3
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.+|++|+||||++++++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~~~~~ 94 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-------------LDKYTVKNEISIMNQLHHPKLINLHDA 94 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-------------HHHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch-------------hHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3569999999999999999999999999999999865322 123467889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeec--cCCcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQ--ENGHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~--~~g~ikL~DF 172 (426)
|.+++.+|+|||||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+||||+ .+|.+||+||
T Consensus 95 ~~~~~~~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 95 FEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred EEECCEEEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeec
Confidence 99999999999999999998876543 34599999999999999999999999999999999999998 5789999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+|+.+... ....+.+||+.|||
T Consensus 174 Gla~~~~~~---------------------------------------------------------~~~~~~~gt~~y~a 196 (352)
T d1koba_ 174 GLATKLNPD---------------------------------------------------------EIVKVTTATAEFAA 196 (352)
T ss_dssp TTCEECCTT---------------------------------------------------------SCEEEECSSGGGCC
T ss_pred ccceecCCC---------------------------------------------------------CceeeccCcccccC
Confidence 999876421 12345679999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.++...... ....++++++||.+||++||.+|||
T Consensus 197 PE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 276 (352)
T d1koba_ 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT 276 (352)
T ss_dssp HHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred HHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC
Confidence 99999999999999999999999999999999999999988888654322 2356889999999999999999999
Q ss_pred hHHHhcCCCcCCC
Q 014344 328 VEEIKGHEFFKGV 340 (426)
Q Consensus 328 ~~eil~hp~f~~~ 340 (426)
++|+|+||||++.
T Consensus 277 ~~eil~Hp~~~~~ 289 (352)
T d1koba_ 277 VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHTSTTTSSC
T ss_pred HHHHhcCHhhCCC
Confidence 9999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-62 Score=463.28 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=219.9
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
.|++++.||+|+||+||+|++..+++.||||++.+..... ....+.+.+|+.+|++++|||||+++++|.
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS----------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH----------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC----------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 3999999999999999999999999999999996543211 234567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccc
Q 014344 97 TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLST 176 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~ 176 (426)
+++.+|+|||||.||+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|.
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred ECCEEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccc
Confidence 999999999999999997665543 459999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhh
Q 014344 177 KLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEII 256 (426)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 256 (426)
.... ....+||+.|||||++
T Consensus 164 ~~~~------------------------------------------------------------~~~~~GT~~Y~APE~~ 183 (309)
T d1u5ra_ 164 IMAP------------------------------------------------------------ANSFVGTPYWMAPEVI 183 (309)
T ss_dssp SSSS------------------------------------------------------------BCCCCSCGGGCCHHHH
T ss_pred ccCC------------------------------------------------------------CCccccCccccCHHHH
Confidence 6421 2345799999999999
Q ss_pred cC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCHHHHHHHHHHhccCCCCCCChHH
Q 014344 257 EG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP---DLVGEPTPLRNLIRRLLEKDPTKRIGVEE 330 (426)
Q Consensus 257 ~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~li~~~L~~dP~~R~s~~e 330 (426)
.+ ..|+.++|||||||++|||++|+.||.+.+..+.+.++..... .....++.+++||.+||+.||.+|||++|
T Consensus 184 ~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp TTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 75 4589999999999999999999999999998888877764432 22346889999999999999999999999
Q ss_pred HhcCCCcCC
Q 014344 331 IKGHEFFKG 339 (426)
Q Consensus 331 il~hp~f~~ 339 (426)
+|+||||..
T Consensus 264 ll~Hp~~~~ 272 (309)
T d1u5ra_ 264 LLKHRFVLR 272 (309)
T ss_dssp HTTCHHHHS
T ss_pred HHhCHHhcC
Confidence 999999953
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-60 Score=446.36 Aligned_cols=262 Identities=30% Similarity=0.430 Sum_probs=225.6
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
.++|++++.||+|+||+||+|+++.+++.||||++.+......... ........+.+|+.+|++++ ||||+++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE----EVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHH----HHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHH----HHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 3679999999999999999999999999999999976532221100 00123457889999999997 999999999
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEeccc
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFD 173 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFg 173 (426)
+|.+++.+|+|||||+||+|.++++.+. .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999999987654 49999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccc
Q 014344 174 LSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAP 253 (426)
Q Consensus 174 ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 253 (426)
+++.+... ......+||+.|+||
T Consensus 156 ~a~~~~~~---------------------------------------------------------~~~~~~~gt~~y~~P 178 (277)
T d1phka_ 156 FSCQLDPG---------------------------------------------------------EKLREVCGTPSYLAP 178 (277)
T ss_dssp TCEECCTT---------------------------------------------------------CCBCCCCSCGGGCCH
T ss_pred heeEccCC---------------------------------------------------------CceeeeeccCCCCCH
Confidence 99876421 122345799999999
Q ss_pred hhhcC------CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCHHHHHHHHHHhccCC
Q 014344 254 EIIEG------KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPD-----LVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 254 E~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~li~~~L~~dP 322 (426)
|++.+ ..++.++||||+||++|+|++|+.||.+.+.......+...... ....++++++||.+||+.||
T Consensus 179 E~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p 258 (277)
T d1phka_ 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 258 (277)
T ss_dssp HHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSG
T ss_pred HHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCCh
Confidence 99863 34688999999999999999999999999998888887754322 22568899999999999999
Q ss_pred CCCCChHHHhcCCCcCC
Q 014344 323 TKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 323 ~~R~s~~eil~hp~f~~ 339 (426)
++|||++|||+||||+.
T Consensus 259 ~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 259 QKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGSCCHHHHTTSGGGCT
T ss_pred hHCcCHHHHHcCHHHHH
Confidence 99999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-60 Score=456.67 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=224.5
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|+++.+++.||||++.+... ....+.+|+.+|+.++||||++++++
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--------------~~~~~~~Ei~il~~l~HpnIv~~~~~ 69 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--------------DQVLVKKEISILNIARHRNILHLHES 69 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--------------HHHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--------------cHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999999999999999965422 12357789999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccC--CcEEEecc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQEN--GHIMLVDF 172 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~--g~ikL~DF 172 (426)
|++++.+|+|||||+||+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 70 ~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 70 FESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp EEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEccc
Confidence 999999999999999999999886543 359999999999999999999999999999999999999854 48999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++..... ....+.+||+.|+|
T Consensus 149 G~~~~~~~~---------------------------------------------------------~~~~~~~~t~~y~a 171 (321)
T d1tkia_ 149 GQARQLKPG---------------------------------------------------------DNFRLLFTAPEYYA 171 (321)
T ss_dssp TTCEECCTT---------------------------------------------------------CEEEEEESCGGGSC
T ss_pred chhhccccC---------------------------------------------------------Cccccccccccccc
Confidence 999865321 12345579999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCHHHHHHHHHHhccCCCCCCC
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDLV-----GEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~~~li~~~L~~dP~~R~s 327 (426)
||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+.++......+. ..+.++++||.+||++||.+|||
T Consensus 172 pe~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s 251 (321)
T d1tkia_ 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT 251 (321)
T ss_dssp HHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC
T ss_pred chhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC
Confidence 9999999999999999999999999999999999999999998876554433 46888999999999999999999
Q ss_pred hHHHhcCCCcCC
Q 014344 328 VEEIKGHEFFKG 339 (426)
Q Consensus 328 ~~eil~hp~f~~ 339 (426)
++|+|+||||+.
T Consensus 252 ~~eil~hp~~~~ 263 (321)
T d1tkia_ 252 ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHSHHHHS
T ss_pred HHHHhcCHhhcc
Confidence 999999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=444.61 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=216.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+++|++++||||++++++
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~ 69 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-----------EGVPSTAIREISLLKELNHPNIVKLLDV 69 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC------------------CCHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-----------hHHHHHHHHHHHHHHhCCCCcEEEeccc
Confidence 46899999999999999999999999999999999554321 1234678889999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|.++..+|+|||||.+ .+.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 70 IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred cccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCc
Confidence 9999999999999975 455555555556699999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|+..... .......+||+.|+|||
T Consensus 149 a~~~~~~--------------------------------------------------------~~~~~~~~gt~~y~apE 172 (298)
T d1gz8a_ 149 ARAFGVP--------------------------------------------------------VRTYTHEVVTLWYRAPE 172 (298)
T ss_dssp HHHHCCC--------------------------------------------------------SBCTTCCBCCCTTCCHH
T ss_pred ceeccCC--------------------------------------------------------cccceeecccceeeehh
Confidence 9765321 12334557999999999
Q ss_pred hhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC---------------------------C
Q 014344 255 IIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD---------------------------L 303 (426)
Q Consensus 255 ~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~---------------------------~ 303 (426)
++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++.. .+.. .
T Consensus 173 ~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T d1gz8a_ 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVV 252 (298)
T ss_dssp HHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHS
T ss_pred hhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhc
Confidence 9887664 7999999999999999999999999988877766531 1000 1
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
...+.++++||++||++||++|||++|||+||||+++
T Consensus 253 ~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 253 PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 1335778999999999999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-60 Score=448.38 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=212.0
Q ss_pred EEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecC
Q 014344 19 RIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTD 98 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~ 98 (426)
+.++.||+|+||+||+|+++.+|+.||||++.+...... .....+.+.+|+.+|+.++|||||+++++|.++
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA--------KDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh--------hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 357899999999999999999999999999965432211 112346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccC
Q 014344 99 KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKL 178 (426)
Q Consensus 99 ~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~ 178 (426)
+.+|+|||||.|+++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 73 ~~~~ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp TCCEEEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CceeehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence 99999999999887766543 3455999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcC
Q 014344 179 SPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEG 258 (426)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 258 (426)
.... ....+.+||+.|+|||++.+
T Consensus 151 ~~~~--------------------------------------------------------~~~~~~~gt~~y~aPE~~~~ 174 (299)
T d1ua2a_ 151 GSPN--------------------------------------------------------RAYTHQVVTRWYRAPELLFG 174 (299)
T ss_dssp TSCC--------------------------------------------------------CCCCCSCCCCTTCCHHHHTT
T ss_pred CCCc--------------------------------------------------------ccccceecChhhccHHHHcc
Confidence 3211 12334579999999999875
Q ss_pred -CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC--------------------------CCCCCH
Q 014344 259 -KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RPPD--------------------------LVGEPT 308 (426)
Q Consensus 259 -~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~--------------------------~~~~~~ 308 (426)
..|+.++|||||||++|||++|.+||.+.+..+++.++.. .+.. ....+.
T Consensus 175 ~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 254 (299)
T d1ua2a_ 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGD 254 (299)
T ss_dssp CSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCH
T ss_pred CCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCH
Confidence 5689999999999999999999999999998888776642 1100 013467
Q ss_pred HHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 309 PLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 309 ~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.+.+||.+||++||++|||++|+|+||||++.
T Consensus 255 ~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 255 DLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 89999999999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-60 Score=456.10 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=209.6
Q ss_pred CCCcEEEe-eecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHh-cCCCCcceee
Q 014344 15 FSCLRIVS-ALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRN-VEHPLLPRLR 92 (426)
Q Consensus 15 ~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~-l~hp~iv~l~ 92 (426)
+++|+|+. .||+|+||+||+|++..+++.||||++.+. ..+.+|+.++.+ ++|||||+++
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------------------~~~~~E~~~~~~~~~hpnIv~l~ 71 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------------------PKARREVELHWRASQCPHIVRIV 71 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------------------HHHHHHHHHHHHHTTSTTBCCEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------------------HHHHHHHHHHHHhcCCCCCCeEE
Confidence 57899986 599999999999999999999999998432 345669988765 5899999999
Q ss_pred eeeec----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CC
Q 014344 93 GVLST----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NG 165 (426)
Q Consensus 93 ~~~~~----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g 165 (426)
++|++ +..+|+|||||+||+|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. .+
T Consensus 72 ~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~ 151 (335)
T d2ozaa1 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 151 (335)
T ss_dssp EEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTC
T ss_pred EEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccc
Confidence 99975 567999999999999999998765567999999999999999999999999999999999999985 56
Q ss_pred cEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccc
Q 014344 166 HIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFV 245 (426)
Q Consensus 166 ~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (426)
.+||+|||+|+..... ......+
T Consensus 152 ~~Kl~DFG~a~~~~~~---------------------------------------------------------~~~~~~~ 174 (335)
T d2ozaa1 152 ILKLTDFGFAKETTSH---------------------------------------------------------NSLTTPC 174 (335)
T ss_dssp CEEECCCTTCEECCCC---------------------------------------------------------CCCCCCS
T ss_pred cccccccceeeeccCC---------------------------------------------------------Ccccccc
Confidence 8999999999866422 1233457
Q ss_pred cCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCC-----CCCHHHHHHHHH
Q 014344 246 GTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL----CRPPDLV-----GEPTPLRNLIRR 316 (426)
Q Consensus 246 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~~~~-----~~~~~~~~li~~ 316 (426)
||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.......+. .....++ ..++++.+||++
T Consensus 175 gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 254 (335)
T d2ozaa1 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 254 (335)
T ss_dssp CCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHH
T ss_pred CCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHH
Confidence 9999999999999999999999999999999999999998876544433332 2222222 357889999999
Q ss_pred HhccCCCCCCChHHHhcCCCcCC
Q 014344 317 LLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 317 ~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
||++||++|||+.|||+||||+.
T Consensus 255 ~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 255 LLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HccCChhHCcCHHHHHcCHHhhC
Confidence 99999999999999999999953
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-59 Score=442.71 Aligned_cols=258 Identities=29% Similarity=0.388 Sum_probs=213.1
Q ss_pred CCcEEEeeecccCceEEEEEEEcCC-CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc---CCCCccee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVES-SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV---EHPLLPRL 91 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l---~hp~iv~l 91 (426)
++|+++++||+|+||+||+|++..+ ++.||||++.+..... .....+.+|+.+|+.| +||||+++
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-----------~~~~~~~~E~~~l~~l~~~~HpnIv~~ 75 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-----------GMPLSTIREVAVLRHLETFEHPNVVRL 75 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-----------SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-----------hHHHHHHHHHHHHHHHhhcCCCCccee
Confidence 5799999999999999999999765 6689999986532111 1223455677777766 79999999
Q ss_pred eeeeec-----CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 92 RGVLST-----DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 92 ~~~~~~-----~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+++|.. ...+|++||||.++++... .......+++..++.++.||+.||+|||++|||||||||+|||++.+|.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~-~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp EEEEEEEECSSEEEEEEEEECCSCBHHHHH-HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeecccccccCceEEEEEEeccCCchhhh-hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC
Confidence 999853 4578999999987776544 3344456999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++..... .......+|
T Consensus 155 ~kl~dfg~~~~~~~---------------------------------------------------------~~~~~~~~g 177 (305)
T d1blxa_ 155 IKLADFGLARIYSF---------------------------------------------------------QMALTSVVV 177 (305)
T ss_dssp EEECSCCSCCCCCG---------------------------------------------------------GGGGCCCCC
T ss_pred eeecchhhhhhhcc---------------------------------------------------------cccCCCccc
Confidence 99999999875421 112345579
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C-----------------------
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P----------------------- 300 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~----------------------- 300 (426)
|+.|||||++.+..|+.++||||+||++|||++|++||.+.+..+++.+++.. +
T Consensus 178 T~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (305)
T d1blxa_ 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQP 257 (305)
T ss_dssp CCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCC
T ss_pred ChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccc
Confidence 99999999999999999999999999999999999999999988887766421 0
Q ss_pred --CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 301 --PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 301 --~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
......++.+++||.+||++||++|||++|+|+||||+++++
T Consensus 258 ~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 258 IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 011234678999999999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=438.48 Aligned_cols=253 Identities=26% Similarity=0.352 Sum_probs=211.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC--CCCcceeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE--HPLLPRLRG 93 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~--hp~iv~l~~ 93 (426)
++|++++.||+|+||+||+|++..+|+.||||++.+....... ......++.+|+.+|++++ ||||+++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-------~~~~~~~~~~E~~il~~l~~~h~nIv~~~~ 76 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG-------ELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 76 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEE-------ECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchh-------hhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence 4699999999999999999999999999999999765433211 0112234667999999997 899999999
Q ss_pred eeecCCeEEEEEeccCC-CChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-CCcEEEec
Q 014344 94 VLSTDKFVGYAIDYCPG-RDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-NGHIMLVD 171 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~g-g~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-~g~ikL~D 171 (426)
+|.+++.+|+||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECc
Confidence 99999999999999986 5777777654 34999999999999999999999999999999999999985 47999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.... ....+.+||+.|+
T Consensus 155 FG~a~~~~~----------------------------------------------------------~~~~~~~GT~~y~ 176 (273)
T d1xwsa_ 155 FGSGALLKD----------------------------------------------------------TVYTDFDGTRVYS 176 (273)
T ss_dssp CTTCEECCS----------------------------------------------------------SCBCCCCSCGGGS
T ss_pred cccceeccc----------------------------------------------------------ccccccccCCCcC
Confidence 999875421 1233567999999
Q ss_pred cchhhcCCCC-ChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 252 APEIIEGKGH-DFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 252 aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
|||++.+..+ +.++|||||||++|+|++|+.||.+.+ . +.. ........++++++||.+||+.||++|||++
T Consensus 177 aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~----i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ 250 (273)
T d1xwsa_ 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--E----IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFE 250 (273)
T ss_dssp CHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--H----HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--H----HhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHH
Confidence 9999987765 678999999999999999999997642 1 222 2222335689999999999999999999999
Q ss_pred HHhcCCCcCCCC
Q 014344 330 EIKGHEFFKGVN 341 (426)
Q Consensus 330 eil~hp~f~~~~ 341 (426)
|+|+||||+++.
T Consensus 251 eil~hp~~~~~~ 262 (273)
T d1xwsa_ 251 EIQNHPWMQDVL 262 (273)
T ss_dssp HHHTSGGGSSCC
T ss_pred HHhcCHhhCCCC
Confidence 999999998754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=442.45 Aligned_cols=281 Identities=38% Similarity=0.695 Sum_probs=231.5
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEc---CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDV---ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-P 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p 86 (426)
..+.+++|++++.||+|+||+||+|++. .+|+.||||++.+...... ....+.+.+|+.+|++++| |
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~---------~~~~~~~~~E~~il~~l~h~p 89 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK---------AKTTEHTRTERQVLEHIRQSP 89 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE---------ESSGGGCCCHHHHHHHHHTCT
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc---------hHHHHHHHHHHHHHHhccCCC
Confidence 4467899999999999999999999984 4789999999966443221 1123456779999999987 8
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
||+++++++.+...+|+|||||.||+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 90 nIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~ 167 (322)
T d1vzoa_ 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 167 (322)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC
T ss_pred eEEEeeeeeccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC
Confidence 99999999999999999999999999999987654 4889999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+|+.+.... .....+..|
T Consensus 168 vkL~DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~g 192 (322)
T d1vzoa_ 168 VVLTDFGLSKEFVADE-------------------------------------------------------TERAYDFCG 192 (322)
T ss_dssp EEESCSSEEEECCGGG-------------------------------------------------------GGGGCGGGS
T ss_pred EEEeeccchhhhcccc-------------------------------------------------------ccccccccc
Confidence 9999999998663211 122345679
Q ss_pred CCCCccchhhcCC--CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhc-CCCCCCCCCHHHHHHHHHHhc
Q 014344 247 TEEYVAPEIIEGK--GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETF----YRILC-RPPDLVGEPTPLRNLIRRLLE 319 (426)
Q Consensus 247 t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~----~~i~~-~~~~~~~~~~~~~~li~~~L~ 319 (426)
|+.|+|||.+.+. .++.++|||||||+||+|++|+.||.+.+..... ..... .++.....++.+.+||.+||+
T Consensus 193 ~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~ 272 (322)
T d1vzoa_ 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLM 272 (322)
T ss_dssp CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcc
Confidence 9999999999765 4678999999999999999999999876543332 22222 233344678999999999999
Q ss_pred cCCCCCC-----ChHHHhcCCCcCCCChhhhhhccCCCCCCCC
Q 014344 320 KDPTKRI-----GVEEIKGHEFFKGVNWELLLKISRPPNIPAR 357 (426)
Q Consensus 320 ~dP~~R~-----s~~eil~hp~f~~~~~~~~~~~~~~~~~~~~ 357 (426)
+||.+|| |++|+++||||++++|+.+.....|+++.+.
T Consensus 273 ~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~ 315 (322)
T d1vzoa_ 273 KDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315 (322)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred cCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCC
Confidence 9999999 4899999999999999999876666555433
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-58 Score=432.85 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=218.2
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
++++.++|+++++||+|+||+||+|+++.+++.||||++.++. ...+.+.+|+.+|++++|||||+
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--------------~~~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--------------MEVEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--------------SCHHHHHHHHHHHHHCCCTTBCC
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--------------chHHHHHHHHHHHHhCCCCCEec
Confidence 6788899999999999999999999999999999999985421 12457889999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++.+++.+|+|||||++|+|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 99999999999999999999999999887666779999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+...... ........||+.|
T Consensus 158 DFG~a~~~~~~~-------------------------------------------------------~~~~~~~~g~~~y 182 (287)
T d1opja_ 158 DFGLSRLMTGDT-------------------------------------------------------YTAHAGAKFPIKW 182 (287)
T ss_dssp CCCCTTTCCSSS-------------------------------------------------------SEEETTEEECGGG
T ss_pred cccceeecCCCC-------------------------------------------------------ceeeccccccccc
Confidence 999998653211 0112233589999
Q ss_pred ccchhhcCCCCChhhHHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCCC
Q 014344 251 VAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATP-FRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIG 327 (426)
Q Consensus 251 ~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s 327 (426)
+|||++.+..|+.++|||||||++|||++|..| |.+.+....+..+.. .++.....+..+.+||.+||+.||.+|||
T Consensus 183 ~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 262 (287)
T d1opja_ 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262 (287)
T ss_dssp CCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcC
Confidence 999999999999999999999999999996555 555565555544433 23344567899999999999999999999
Q ss_pred hHHHhc
Q 014344 328 VEEIKG 333 (426)
Q Consensus 328 ~~eil~ 333 (426)
++||++
T Consensus 263 ~~ei~~ 268 (287)
T d1opja_ 263 FAEIHQ 268 (287)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.8e-58 Score=432.11 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=212.8
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|+++++||+|+||+||+|+++ +|+.||||++...... .....++.+|+.+|++++||||++++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-----------~~~~~~~~~E~~il~~l~hpnIv~~~~~ 68 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-----------EGIPSTTIREISILKELKHSNIVKLYDV 68 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-----------GCCCHHHHHHHHGGGGCCCTTBCCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-----------hHHHHHHHHHHHHHHhCCCCcEEeeeee
Confidence 468999999999999999999985 7899999999554221 1234678899999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
|..++..|++|||+.++++..+... .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 69 ~~~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 69 IHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EECSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred cccCCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccc
Confidence 9999999999999987777666443 35599999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|...... .......+||+.|+|||
T Consensus 147 a~~~~~~--------------------------------------------------------~~~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 147 ARAFGIP--------------------------------------------------------VRKYTHEIVTLWYRAPD 170 (286)
T ss_dssp HHHHCC-----------------------------------------------------------------CCCTTCCHH
T ss_pred ceecccC--------------------------------------------------------ccccceecccchhhhHH
Confidence 9865321 11233456999999999
Q ss_pred hhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC---------------------------CCC
Q 014344 255 IIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP---------------------------PDL 303 (426)
Q Consensus 255 ~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~---------------------------~~~ 303 (426)
.+.+. .++.++|||||||++|||++|++||.+.+..+++.++.. .+ ...
T Consensus 171 ~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (286)
T d1ob3a_ 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250 (286)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTC
T ss_pred HHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhc
Confidence 99764 569999999999999999999999999988877766531 10 001
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
...++.+.|||++||++||++|||++|||+||||++
T Consensus 251 ~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 234677899999999999999999999999999973
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-57 Score=427.39 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=209.6
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc---eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE---SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++++.++|++.+.||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|++++|||
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~Hpn 88 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY------------TEKQRRDFLSEASIMGQFDHPN 88 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC------------CHHHHHHHHHHHHHHTTCCCTT
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 35778899999999999999999999987765 58888874321 2234567899999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
||++++++..++.+|+|||||+||+|.+++.... +.+++..+..++.||+.||+|||++||+||||||+||||+.++++
T Consensus 89 Iv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred CccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcE
Confidence 9999999999999999999999999999876543 459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+|+.+....... .........||
T Consensus 168 Kl~DFGla~~~~~~~~~~---------------------------------------------------~~~~~~~~~~t 196 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDP---------------------------------------------------TYTSALGGKIP 196 (299)
T ss_dssp EECCC--------------------------------------------------------------------------C
T ss_pred EECCcccceEccCCCCcc---------------------------------------------------eeeecccccCC
Confidence 999999998764321100 01112234589
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+....+... ++.....+..+.+||.+||+.||++
T Consensus 197 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 276 (299)
T d1jpaa_ 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNH 276 (299)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTT
T ss_pred ccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhH
Confidence 99999999999999999999999999999997 89999999988887777643 3445567899999999999999999
Q ss_pred CCChHHHhcC
Q 014344 325 RIGVEEIKGH 334 (426)
Q Consensus 325 R~s~~eil~h 334 (426)
|||+.||+++
T Consensus 277 RPs~~ei~~~ 286 (299)
T d1jpaa_ 277 RPKFGQIVNT 286 (299)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=427.41 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=208.1
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcce
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPR 90 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~ 90 (426)
|+++.++|++++.||+|+||+||+|+.. ..||||++.... ......+.+.+|+.+|++++||||++
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-----------~~~~~~~~~~~E~~~l~~l~HpnIv~ 68 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-----------PTPQQLQAFKNEVGVLRKTRHVNILL 68 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-----------CCTTHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-----------CCHHHHHHHHHHHHHHHhCCCCCEee
Confidence 5788899999999999999999999753 469999985432 12235678899999999999999999
Q ss_pred eeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 91 LRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 91 l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
+++++. +..+|+|||||+||+|.+++.... ..+++..+..++.||+.||+|||++|||||||||+|||++.++++||+
T Consensus 69 ~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~ 146 (276)
T d1uwha_ 69 FMGYST-APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIG 146 (276)
T ss_dssp EEEEEC-SSSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEEC
T ss_pred eeEEEe-ccEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEc
Confidence 999864 566899999999999999886543 459999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||+|+...... ......+.+||+.|
T Consensus 147 DFGla~~~~~~~------------------------------------------------------~~~~~~~~~gt~~y 172 (276)
T d1uwha_ 147 DFGLATVKSRWS------------------------------------------------------GSHQFEQLSGSILW 172 (276)
T ss_dssp CCCCSCC------------------------------------------------------------------CCCCGGG
T ss_pred cccceeeccccC------------------------------------------------------CcccccccccCccc
Confidence 999997653211 01123456799999
Q ss_pred ccchhhcC---CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-C--CC----CCCCCCHHHHHHHHHHhcc
Q 014344 251 VAPEIIEG---KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC-R--PP----DLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 251 ~aPE~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~--~~----~~~~~~~~~~~li~~~L~~ 320 (426)
||||++.+ ..|+.++|||||||++|||++|+.||.+.+........+. . .+ .....+..+.+||.+||..
T Consensus 173 ~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~ 252 (276)
T d1uwha_ 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKK 252 (276)
T ss_dssp CCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCS
T ss_pred CCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCC
Confidence 99999975 3489999999999999999999999998776655444432 1 11 1235678999999999999
Q ss_pred CCCCCCChHHHhcC
Q 014344 321 DPTKRIGVEEIKGH 334 (426)
Q Consensus 321 dP~~R~s~~eil~h 334 (426)
||++|||++||++|
T Consensus 253 dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 253 KRDERPLFPQILAS 266 (276)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=435.82 Aligned_cols=258 Identities=18% Similarity=0.298 Sum_probs=216.3
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCCc-----eEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESSE-----SFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
++++.++|++++.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|+++ +
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~~ 99 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA------------DSSEREALMSELKMMTQLGS 99 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------------------CHHHHHHHHHHHHHCC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc------------CHHHHHHHHHHHHHHHHhcC
Confidence 45777899999999999999999999876554 68999885432 112345788899999998 8
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhcc---------------------CCCCHHHHHHHHHHHHHHHHH
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSE---------------------QMFSDDTIRFYAAELVLALEY 143 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~---------------------~~l~~~~~~~~~~qil~aL~~ 143 (426)
|||||++++++.+.+.+|+|||||+||+|.++++.... ..+++..++.|+.||+.||+|
T Consensus 100 HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHH
T ss_pred CCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999875432 348999999999999999999
Q ss_pred HHHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCC
Q 014344 144 LHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSP 223 (426)
Q Consensus 144 LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (426)
||++|||||||||+|||++.++++||+|||+|+......
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~----------------------------------------- 218 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS----------------------------------------- 218 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCT-----------------------------------------
T ss_pred HHhCCeeeccCchhccccccCCeEEEeeccccccccCCC-----------------------------------------
Confidence 999999999999999999999999999999997653211
Q ss_pred CCCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---
Q 014344 224 RIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--- 299 (426)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--- 299 (426)
......+.+||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..+.+.+++..
T Consensus 219 -------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~ 285 (325)
T d1rjba_ 219 -------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK 285 (325)
T ss_dssp -------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCC
T ss_pred -------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 0112234568999999999999999999999999999999997 89999987776666666543
Q ss_pred CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 300 PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 300 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
++.....+..+++||.+||+.||++|||++||++|
T Consensus 286 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 286 MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33344668899999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-57 Score=425.60 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=210.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|++..+|+.||||++.+.... ......++.+|+.+|+.++||||+++++++
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----------~~~~~~~~~~E~~~l~~~~hpniv~~~~~~ 76 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR----------DPSFYLRFRREAQNAAALNHPAIVAVYDTG 76 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT----------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc----------CHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence 4699999999999999999999999999999999654321 223466889999999999999999999999
Q ss_pred ecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 96 STDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 96 ~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
..+. .+|+|||||+|++|..++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d 154 (277)
T d1o6ya_ 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 154 (277)
T ss_dssp EEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECC
T ss_pred eeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeeh
Confidence 7654 4899999999999999876653 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||++....... .......+.+||+.||
T Consensus 155 ~~~~~~~~~~~-----------------------------------------------------~~~~~~~~~~Gt~~Y~ 181 (277)
T d1o6ya_ 155 FGIARAIADSG-----------------------------------------------------NSVTQTAAVIGTAQYL 181 (277)
T ss_dssp CTTCEECC---------------------------------------------------------------------TTC
T ss_pred hhhhhhhcccc-----------------------------------------------------ccccccccccCccccc
Confidence 99987653211 0112344568999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCHHHHHHHHHHhccCCCCCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPPDL-----VGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||++.+..|+.++|||||||++|+|++|++||.+.+..+.+.+++...+.. ...|+.+.+||.+||++||++||
T Consensus 182 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~ 261 (277)
T d1o6ya_ 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY 261 (277)
T ss_dssp CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSC
T ss_pred CHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCH
Confidence 9999999999999999999999999999999999999988888777554332 35688999999999999999999
Q ss_pred -ChHHHhcCCC
Q 014344 327 -GVEEIKGHEF 336 (426)
Q Consensus 327 -s~~eil~hp~ 336 (426)
|+++++ |+|
T Consensus 262 ~sa~~l~-~~l 271 (277)
T d1o6ya_ 262 QTAAEMR-ADL 271 (277)
T ss_dssp SSHHHHH-HHH
T ss_pred hHHHHHH-HHH
Confidence 566654 444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=425.78 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=218.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.++++.++|++++.||+|+||+||+|+++ +++.||||++.+.. ...+.+.+|+.+|++++|||||
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~--------------~~~~~~~~E~~~l~~l~HpnIv 71 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS--------------MSPDAFLAEANLMKQLQHQRLV 71 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS--------------SCHHHHHHHHHHHHHCCCTTBC
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc--------------CCHHHHHHHHHHHHhCCCCCEe
Confidence 36778899999999999999999999975 57889999985421 1235688999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++. ++.+|+|||||++|+|.+++.......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 72 ~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl 150 (272)
T d1qpca_ 72 RLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150 (272)
T ss_dssp CEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceee
Confidence 9999875 456799999999999998766554456999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+.... ........||+.
T Consensus 151 ~DFGla~~~~~~~-------------------------------------------------------~~~~~~~~gt~~ 175 (272)
T d1qpca_ 151 ADFGLARLIEDNE-------------------------------------------------------YTAREGAKFPIK 175 (272)
T ss_dssp CCCTTCEECSSSC-------------------------------------------------------EECCTTCCCCTT
T ss_pred ccccceEEccCCc-------------------------------------------------------cccccccCCccc
Confidence 9999998764211 011223468999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||||++.+..|+.++|||||||++|||+| |.+||...+..+....+... ++.....+..+.+||.+||+.||++||
T Consensus 176 y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rp 255 (272)
T d1qpca_ 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP 255 (272)
T ss_dssp TSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred ccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCc
Confidence 999999999999999999999999999998 56777777777777776543 333446788999999999999999999
Q ss_pred ChHHHhc--CCCcC
Q 014344 327 GVEEIKG--HEFFK 338 (426)
Q Consensus 327 s~~eil~--hp~f~ 338 (426)
|+++|++ |+||+
T Consensus 256 t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 256 TFDYLRSVLEDFFT 269 (272)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHhhhhhh
Confidence 9999998 77874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-57 Score=419.72 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=207.5
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
++.++|++++.||+|+||+||+|++. +++.||||++.+.. ...+.+.+|+.+|++++||||++++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~--------------~~~~~~~~E~~~l~~l~HpnIv~~~ 66 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA--------------MSEEDFIEEAEVMMKLSHPKLVQLY 66 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS--------------SCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc--------------CcHHHHHHHHHHHHhcCCCCccccc
Confidence 45678999999999999999999985 56789999985421 1235688899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++..++.+|+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+||
T Consensus 67 g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DF 145 (263)
T d1sm2a_ 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 145 (263)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSC
T ss_pred ceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEeccc
Confidence 99999999999999999999999876543 45899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++...... ........||+.|+|
T Consensus 146 Gla~~~~~~~-------------------------------------------------------~~~~~~~~gt~~y~a 170 (263)
T d1sm2a_ 146 GMTRFVLDDQ-------------------------------------------------------YTSSTGTKFPVKWAS 170 (263)
T ss_dssp C-------------------------------------------------------------------------CTTSCC
T ss_pred chheeccCCC-------------------------------------------------------ceeecceecCcccCC
Confidence 9997653211 011223469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||++.+..|+.++|||||||++|||++ |.+||...+..+.+..+... +..+...++.+.+||.+||+.||++|||++
T Consensus 171 PE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred hHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999999998 67888888887777766543 333445688999999999999999999999
Q ss_pred HHhcC
Q 014344 330 EIKGH 334 (426)
Q Consensus 330 eil~h 334 (426)
||++|
T Consensus 251 ~il~~ 255 (263)
T d1sm2a_ 251 RLLRQ 255 (263)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=436.62 Aligned_cols=254 Identities=28% Similarity=0.465 Sum_probs=208.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
-++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~hpniv~l~~~ 85 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-----------SELFAKRAYRELRLLKHMRHENVIGLLDV 85 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-----------SHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-----------ChHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 3679999999999999999999999999999999964321 22345678899999999999999999999
Q ss_pred eecCC------eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 95 LSTDK------FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 95 ~~~~~------~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
|...+ .+|+||||| |.+|..+.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEE
T ss_pred eccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccc
Confidence 97654 579999999 6788777653 3499999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+|+.... ..+..+||+
T Consensus 162 l~Dfg~a~~~~~-----------------------------------------------------------~~~~~~~t~ 182 (346)
T d1cm8a_ 162 ILDFGLARQADS-----------------------------------------------------------EMTGYVVTR 182 (346)
T ss_dssp ECCCTTCEECCS-----------------------------------------------------------SCCSSCSCG
T ss_pred cccccceeccCC-----------------------------------------------------------ccccccccc
Confidence 999999976531 123457999
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CC------------------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---RP------------------------ 300 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~~------------------------ 300 (426)
.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+....+..+.. .+
T Consensus 183 ~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (346)
T d1cm8a_ 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262 (346)
T ss_dssp GGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCC
T ss_pred cccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCccc
Confidence 9999999876 4568999999999999999999999999887665443321 00
Q ss_pred -----CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 301 -----PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 301 -----~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
......++.+.+||.+||+.||++|||++|||+||||+.+.+
T Consensus 263 ~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 012345788999999999999999999999999999997653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=415.09 Aligned_cols=251 Identities=20% Similarity=0.255 Sum_probs=218.4
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
++.++|+++++||+|+||+||+|+. .+++.||||++.+... ..+.+.+|+.++++++||||++++
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~--------------~~~~~~~Ev~~~~~l~HpnIv~~~ 65 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM--------------SEDEFIEEAKVMMNLSHEKLVQLY 65 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS--------------CHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC--------------CHHHHHHHHHHHHhcCCCceeeEE
Confidence 4568999999999999999999998 4788999999864321 234688899999999999999999
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
+++.+++.+++|||||++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 66 g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~Df 144 (258)
T d1k2pa_ 66 GVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 144 (258)
T ss_dssp EEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcc
Confidence 99999999999999999999998876554 34899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCcc
Q 014344 173 DLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVA 252 (426)
Q Consensus 173 gls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 252 (426)
|+++.+.... ........||+.|+|
T Consensus 145 G~a~~~~~~~-------------------------------------------------------~~~~~~~~~t~~y~a 169 (258)
T d1k2pa_ 145 GLSRYVLDDE-------------------------------------------------------YTSSVGSKFPVRWSP 169 (258)
T ss_dssp SSCCBCSSSS-------------------------------------------------------CCCCCCSCCCGGGCC
T ss_pred hhheeccCCC-------------------------------------------------------ceeecccCCCCCcCC
Confidence 9997654211 011223469999999
Q ss_pred chhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChH
Q 014344 253 PEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVE 329 (426)
Q Consensus 253 PE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ 329 (426)
||++.+..|+.++|||||||++|||++ |+.||.+.+..+...++... ++.+...+..+.+||.+||+.||++|||++
T Consensus 170 PE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHH
Confidence 999999999999999999999999998 89999999998888777643 333445678999999999999999999999
Q ss_pred HHhcC
Q 014344 330 EIKGH 334 (426)
Q Consensus 330 eil~h 334 (426)
+|++|
T Consensus 250 eil~~ 254 (258)
T d1k2pa_ 250 ILLSN 254 (258)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-56 Score=431.51 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=209.5
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLR 92 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~ 92 (426)
+.++|+++++||+|+||+||+|+++.+++.||||++.+. ..+++.+|+.+|+.+. ||||++++
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----------------~~~~~~~Ei~il~~l~~hpnIv~~~ 96 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----------------KKKKIKREIKILENLRGGPNIITLA 96 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----------------CHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----------------HHHHHHHHHHHHHhccCCCCCcEEE
Confidence 457899999999999999999999999999999998432 2356788999999995 99999999
Q ss_pred eeeec--CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEEE
Q 014344 93 GVLST--DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIML 169 (426)
Q Consensus 93 ~~~~~--~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ikL 169 (426)
++|.. ...+|+|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 97 ~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl 171 (328)
T d3bqca1 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171 (328)
T ss_dssp EEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeee
Confidence 99974 46799999999999997652 3499999999999999999999999999999999999999765 6999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|...... ......+||+.
T Consensus 172 ~DFG~a~~~~~~---------------------------------------------------------~~~~~~~~t~~ 194 (328)
T d3bqca1 172 IDWGLAEFYHPG---------------------------------------------------------QEYNVRVASRY 194 (328)
T ss_dssp CCGGGCEECCTT---------------------------------------------------------CCCCSCCSCGG
T ss_pred cccccceeccCC---------------------------------------------------------CcccccccCcc
Confidence 999999865422 12334579999
Q ss_pred CccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHh---c------------C-------------
Q 014344 250 YVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRK-ETFYRIL---C------------R------------- 299 (426)
Q Consensus 250 y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~---~------------~------------- 299 (426)
|+|||++.+. .++.++||||+||++|+|++|+.||...... .....+. . .
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T d3bqca1 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274 (328)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCC
T ss_pred ccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccc
Confidence 9999998875 5799999999999999999999999765432 2211110 0 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCChh
Q 014344 300 ----------PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNWE 343 (426)
Q Consensus 300 ----------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~~ 343 (426)
.......++++.|||++||++||.+|||++|||+||||+.+.|+
T Consensus 275 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp CCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred cccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 00011236779999999999999999999999999999999885
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=429.43 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=209.9
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|+++++||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|++++||||++++++
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----------~~~~~~~~~~E~~il~~l~h~nii~~~~~ 77 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-----------KEGFPITALREIKILQLLKHENVVNLIEI 77 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-----------TTSSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-----------chHHHHHHHHHHHHHHHhcCCCccceEee
Confidence 6889999999999999999999999999999999855421 12245678889999999999999999999
Q ss_pred eec--------CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 95 LST--------DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 95 ~~~--------~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
+.. +..+|+|||||.++++..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~ 155 (318)
T d3blha1 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 155 (318)
T ss_dssp EEC----------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC
T ss_pred eecccccccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc
Confidence 855 45689999999877665442 23456999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||++..+..... .......+.+|
T Consensus 156 ~kl~dfg~~~~~~~~~~----------------------------------------------------~~~~~~~~~~g 183 (318)
T d3blha1 156 LKLADFGLARAFSLAKN----------------------------------------------------SQPNRYTNRVV 183 (318)
T ss_dssp EEECCCTTCEECCC---------------------------------------------------------CCCCCSCCS
T ss_pred EEeeecceeeecccccc----------------------------------------------------cccccccceec
Confidence 99999999976642210 00112334579
Q ss_pred CCCCccchhhcCC-CCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCCCC--C----------------
Q 014344 247 TEEYVAPEIIEGK-GHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRIL---CRPPDL--V---------------- 304 (426)
Q Consensus 247 t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~---~~~~~~--~---------------- 304 (426)
|+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+.......+. ..+... .
T Consensus 184 T~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T d3blha1 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG 263 (318)
T ss_dssp CGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSS
T ss_pred CHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhccccc
Confidence 9999999999865 68999999999999999999999999988877665542 111110 0
Q ss_pred ------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 305 ------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 305 ------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
..++.+.|||.+||++||++|||++|+|+||||+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 264 QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 01445789999999999999999999999999963
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=421.37 Aligned_cols=258 Identities=20% Similarity=0.239 Sum_probs=215.5
Q ss_pred CCCCCcEEEee-ecccCceEEEEEEEcCC--CceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSA-LGRGAKGVVFLVKDVES--SESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~-LG~G~~g~V~~a~~~~~--~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
++.++|.+... ||+|+||+||+|.++.+ +..||||++.+.. .....+++.+|+++|++++|||||
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~------------~~~~~~~~~~E~~il~~l~HpnIv 72 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT------------EKADTEEMMREAQIMHQLDNPYIV 72 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC------------CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc------------CHHHHHHHHHHHHHHHhCCCCCEe
Confidence 55577999985 99999999999987643 4579999985431 123456789999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+ +.+|+|||||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 73 ~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl 150 (285)
T d1u59a_ 73 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 150 (285)
T ss_dssp CEEEEEES-SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEE
T ss_pred eEeeeecc-CeEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceee
Confidence 99999865 4589999999999999986543 345999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+...... .......+||+.
T Consensus 151 ~DFGla~~~~~~~~~-----------------------------------------------------~~~~~~~~gt~~ 177 (285)
T d1u59a_ 151 SDFGLSKALGADDSY-----------------------------------------------------YTARSAGKWPLK 177 (285)
T ss_dssp CCCTTCEECTTCSCE-----------------------------------------------------ECCCCSSCCCGG
T ss_pred ccchhhhcccccccc-----------------------------------------------------cccccccccCcc
Confidence 999999876432100 011223468999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|||||++.+..++.++|||||||++|||++ |+.||.+.+..+....+... ++.+...|+.+.+||.+||+.||++||
T Consensus 178 y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RP 257 (285)
T d1u59a_ 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRP 257 (285)
T ss_dssp GCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred ccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCc
Confidence 999999999999999999999999999997 99999998888777776543 344456789999999999999999999
Q ss_pred ChHHH---hcCCCc
Q 014344 327 GVEEI---KGHEFF 337 (426)
Q Consensus 327 s~~ei---l~hp~f 337 (426)
|+.+| |+|+|+
T Consensus 258 s~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 258 DFLTVEQRMRACYY 271 (285)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHH
Confidence 99888 567776
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=432.47 Aligned_cols=250 Identities=30% Similarity=0.483 Sum_probs=208.0
Q ss_pred CcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeee
Q 014344 17 CLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLS 96 (426)
Q Consensus 17 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~ 96 (426)
+|+.+++||+|+||+||+|+++.+|+.||||++.+.. ....+|+.+|++++||||++++++|.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----------------~~~~~Ei~il~~l~h~niv~~~~~~~ 83 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----------------RFKNRELQIMRKLDHCNIVRLRYFFY 83 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----------------SSCCHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-----------------hHHHHHHHHHHhcCCCCCCcEEEEEE
Confidence 6999999999999999999999999999999985431 11235999999999999999999984
Q ss_pred c------CCeEEEEEeccCCCChHHHHH-HhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCC-cEE
Q 014344 97 T------DKFVGYAIDYCPGRDLHSLRK-QQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENG-HIM 168 (426)
Q Consensus 97 ~------~~~~~lV~Ey~~gg~L~~l~~-~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g-~ik 168 (426)
. ..++|+|||||+++.+..+.. ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 84 ~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp EC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEE
T ss_pred ecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCcee
Confidence 3 346899999998665554433 23345699999999999999999999999999999999999999775 899
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||++..+... ....+.+||+
T Consensus 164 l~DFG~a~~~~~~---------------------------------------------------------~~~~~~~gt~ 186 (350)
T d1q5ka_ 164 LCDFGSAKQLVRG---------------------------------------------------------EPNVSYICSR 186 (350)
T ss_dssp ECCCTTCEECCTT---------------------------------------------------------SCCCSCCSCT
T ss_pred EecccchhhccCC---------------------------------------------------------cccccccccc
Confidence 9999998865321 1223457999
Q ss_pred CCccchhhcC-CCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---C------------------------
Q 014344 249 EYVAPEIIEG-KGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCR---P------------------------ 300 (426)
Q Consensus 249 ~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------------------ 300 (426)
.|+|||++.+ ..|+.++||||+||++|||++|++||...+..+++.+++.. +
T Consensus 187 ~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (350)
T d1q5ka_ 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266 (350)
T ss_dssp TSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCC
T ss_pred cccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCc
Confidence 9999999875 56899999999999999999999999998887776655310 0
Q ss_pred ---CCCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 301 ---PDLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 301 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
......++++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 267 ~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 267 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0112347789999999999999999999999999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=418.76 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=207.3
Q ss_pred eeecccCceEEEEEEEc--CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeeeecCC
Q 014344 22 SALGRGAKGVVFLVKDV--ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVLSTDK 99 (426)
Q Consensus 22 ~~LG~G~~g~V~~a~~~--~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~~~~~ 99 (426)
++||+|+||+||+|... .+++.||||++..... .....+++.+|+.+|++++|||||++++++.++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~- 80 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-----------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE- 80 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC----------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-----------CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-
Confidence 47999999999999864 4567899999854321 123456889999999999999999999999654
Q ss_pred eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccccccCC
Q 014344 100 FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLS 179 (426)
Q Consensus 100 ~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~ 179 (426)
..|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcc
Confidence 578999999999999998754 349999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccchhhcCC
Q 014344 180 PKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGK 259 (426)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 259 (426)
.... .........||+.|||||++.+.
T Consensus 159 ~~~~-----------------------------------------------------~~~~~~~~~gt~~y~APE~l~~~ 185 (277)
T d1xbba_ 159 ADEN-----------------------------------------------------YYKAQTHGKWPVKWYAPECINYY 185 (277)
T ss_dssp TTCS-----------------------------------------------------EEEC----CCCGGGCCHHHHHHC
T ss_pred cccc-----------------------------------------------------ccccccccCCCceecCchhhcCC
Confidence 2210 01122344699999999999999
Q ss_pred CCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCCChHHH---hc
Q 014344 260 GHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI---KG 333 (426)
Q Consensus 260 ~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ei---l~ 333 (426)
.|+.++|||||||++|||++ |++||.+.+..+....+... ++.....|..+.+||.+||+.||++|||+++| |+
T Consensus 186 ~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 99999999999999999997 99999999888877776543 33445678999999999999999999999998 46
Q ss_pred CCCcC
Q 014344 334 HEFFK 338 (426)
Q Consensus 334 hp~f~ 338 (426)
|+|++
T Consensus 266 ~~~~~ 270 (277)
T d1xbba_ 266 NYYYD 270 (277)
T ss_dssp HHHHH
T ss_pred CHHhh
Confidence 66653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=427.18 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=208.2
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+++.+|+.+|++|+||||+++++++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~ 75 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE------------HQTYCQRTLREIKILLRFRHENIIGINDII 75 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT------------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc------------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEE
Confidence 35999999999999999999999999999999985432 123456788999999999999999999998
Q ss_pred ecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEec
Q 014344 96 STDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVD 171 (426)
Q Consensus 96 ~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~D 171 (426)
..+. ..+++++|+.||+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|
T Consensus 76 ~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 76 RAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp CCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcc
Confidence 6543 234445566699999998653 499999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|........ ........+||+.|+
T Consensus 153 fG~a~~~~~~~~-----------------------------------------------------~~~~~~~~~gt~~y~ 179 (345)
T d1pmea_ 153 FGLARVADPDHD-----------------------------------------------------HTGFLTEYVATRWYR 179 (345)
T ss_dssp CTTCEECCGGGC-----------------------------------------------------BCCTTCCCCSCGGGC
T ss_pred cCceeeccCCCc-----------------------------------------------------cceeeccccccceec
Confidence 999986542210 011234567999999
Q ss_pred cchhhc-CCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---C--------------------CC------
Q 014344 252 APEIIE-GKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC---R--------------------PP------ 301 (426)
Q Consensus 252 aPE~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~---~--------------------~~------ 301 (426)
|||++. +..++.++||||+||++|+|++|++||.+.+...+...... . .+
T Consensus 180 aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (345)
T d1pmea_ 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVP 259 (345)
T ss_dssp CGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCC
T ss_pred hHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCC
Confidence 999984 46679999999999999999999999998887655544321 0 00
Q ss_pred ---CCCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 302 ---DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 302 ---~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
.....++.+++||.+||++||.+|||++|+|+||||+..
T Consensus 260 ~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 260 WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 012446789999999999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=415.66 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=215.0
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGV 94 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~ 94 (426)
+++|+++++||+|+||+||+|++..+++.||||++.+.. .......++.+|+.+|+.++||||++++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 69 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----------DDEGVPSSALREICLLKELKHKNIVRLHDV 69 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-----------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-----------CChHHHHHHHHHHHHHHhcCcCCEEeeccc
Confidence 468999999999999999999999999999999995432 122356788999999999999999999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
+.+....++||+++.|++|..++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.
T Consensus 70 ~~~~~~~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 70 LHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EECSSEEEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred cccccceeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecch
Confidence 99999999999999999998876543 4589999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
|....... .......+++.|+|||
T Consensus 148 a~~~~~~~--------------------------------------------------------~~~~~~~~~~~~~~pe 171 (292)
T d1unla_ 148 ARAFGIPV--------------------------------------------------------RCYSAEVVTLWYRPPD 171 (292)
T ss_dssp CEECCSCC--------------------------------------------------------SCCCSCCSCGGGCCHH
T ss_pred hhcccCCC--------------------------------------------------------ccceeeccccchhhhh
Confidence 98764221 1122335788899999
Q ss_pred hhcCCC-CChhhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHh---cCC---------------------------CC
Q 014344 255 IIEGKG-HDFAVDWWSLGVVLHEMLYGATPF-RGSSRKETFYRIL---CRP---------------------------PD 302 (426)
Q Consensus 255 ~~~~~~-~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~---~~~---------------------------~~ 302 (426)
++.+.. ++.++||||+||++|||++|+.|| .+.+..+.+.++. ..+ ..
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTT
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhc
Confidence 988765 699999999999999999999885 4555555555432 110 01
Q ss_pred CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCC
Q 014344 303 LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKG 339 (426)
Q Consensus 303 ~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~ 339 (426)
....++.+.+||++||++||.+|||++|||+||||++
T Consensus 252 ~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 252 VPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1233677999999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=415.46 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=216.0
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.++++.++|++++.||+|+||+||+|++..+ +.||||++..... ..+.+.+|+.+|++++|||||
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--------------~~~~~~~E~~~l~~l~h~nIv 75 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--------------SPEAFLQEAQVMKKLRHEKLV 75 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--------------CHHHHHHHHHHHHhcccCCEe
Confidence 4678889999999999999999999998655 5799999854321 235688999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+ +.+|+|||||++|+|..++.....+.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||
T Consensus 76 ~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 76 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp CEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEE
Confidence 99999854 56799999999999998877665566999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+.... ........||+.
T Consensus 155 ~DfGla~~~~~~~-------------------------------------------------------~~~~~~~~gt~~ 179 (285)
T d1fmka3 155 ADFGLARLIEDNE-------------------------------------------------------YTARQGAKFPIK 179 (285)
T ss_dssp CCCCTTC---------------------------------------------------------------------CCGG
T ss_pred cccchhhhccCCC-------------------------------------------------------ceeecccccccc
Confidence 9999997653211 011233469999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTKRI 326 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~ 326 (426)
|+|||++.+..++.++|||||||++|||++ |.+|+.+....+.+..+... ++.....+..+++||.+||+.||++||
T Consensus 180 y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 259 (285)
T d1fmka3 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP 259 (285)
T ss_dssp GSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCc
Confidence 999999999999999999999999999998 56667777777777766533 344556789999999999999999999
Q ss_pred ChHHHhc--CCCcCC
Q 014344 327 GVEEIKG--HEFFKG 339 (426)
Q Consensus 327 s~~eil~--hp~f~~ 339 (426)
|+++|++ |+||+.
T Consensus 260 s~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 260 TFEYLQAFLEDYFTS 274 (285)
T ss_dssp CHHHHHHHHHTTTSC
T ss_pred CHHHHHHHHhhhhcC
Confidence 9999988 888864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=412.84 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=208.3
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCC---ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
++++.++|++++.||+|+||+||+|++..++ ..||||++.... .......+.+|+.+|++++|||
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~------------~~~~~~~~~~E~~~l~~l~Hpn 69 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT------------SDSVREKFLQEALTMRQFDHPH 69 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT------------SHHHHHHHHHHHHHHHTCCCTT
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 5677789999999999999999999987554 458888874321 2234567889999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
|+++++++. ++.+|+|||||++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 70 Iv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~ 147 (273)
T d1mp8a_ 70 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 147 (273)
T ss_dssp BCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEE
T ss_pred EeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcE
Confidence 999999995 567899999999999999876543 459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+|+.+.... ........||
T Consensus 148 Kl~DfG~a~~~~~~~-------------------------------------------------------~~~~~~~~gt 172 (273)
T d1mp8a_ 148 KLGDFGLSRYMEDST-------------------------------------------------------YYKASKGKLP 172 (273)
T ss_dssp EECC--------------------------------------------------------------------------CC
T ss_pred EEccchhheeccCCc-------------------------------------------------------ceeccceecC
Confidence 999999998654211 1122344689
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+.++... ++.....|..+.+||.+||..||++
T Consensus 173 ~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhH
Confidence 99999999999999999999999999999997 89999999988888777643 3445577899999999999999999
Q ss_pred CCChHHHhcC
Q 014344 325 RIGVEEIKGH 334 (426)
Q Consensus 325 R~s~~eil~h 334 (426)
|||++||++|
T Consensus 253 Rps~~ei~~~ 262 (273)
T d1mp8a_ 253 RPRFTELKAQ 262 (273)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=428.27 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=202.9
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|+++++||+|+||+||+|+++.+|+.||||++.+... +.....++.+|+.+|++++||||++++++|
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f 85 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-----------NQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-----------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-----------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 579999999999999999999999999999999965432 223456788999999999999999999999
Q ss_pred e------cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 96 S------TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 96 ~------~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
. +...+|+|||||.|+.+. .+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+|+
T Consensus 86 ~~~~~~~~~~~~~iv~Ey~~~~l~~-~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 86 TPQKTLEEFQDVYLVMELMDANLCQ-VIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp CSCCSTTTCCEEEEEEECCSEEHHH-HHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE
T ss_pred ecccccccCceeEEEEeccchHHHH-hhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceee
Confidence 5 347899999999765444 332 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++..... ......+||+.
T Consensus 161 ~df~~~~~~~~~---------------------------------------------------------~~~~~~~~t~~ 183 (355)
T d2b1pa1 161 LDFGLARTAGTS---------------------------------------------------------FMMTPYVVTRY 183 (355)
T ss_dssp CCCCC------------------------------------------------------------------------CCT
T ss_pred echhhhhccccc---------------------------------------------------------ccccccccccc
Confidence 999998765321 12345579999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------------CCCCCC---
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILC----------------------RPPDLV--- 304 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~----------------------~~~~~~--- 304 (426)
|+|||++.+..++.++||||+||++|+|++|++||.+.+......+++. ......
T Consensus 184 y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (355)
T d2b1pa1 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 263 (355)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCC
T ss_pred ccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccc
Confidence 9999999999999999999999999999999999998887666544421 100000
Q ss_pred ------------------CCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCCh
Q 014344 305 ------------------GEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVNW 342 (426)
Q Consensus 305 ------------------~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~~ 342 (426)
..++++.+||++||.+||++||||+|||+||||+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 264 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred cccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 01345889999999999999999999999999987433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=407.23 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=208.8
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcCCC----ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVESS----ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
.+++.++|++.+.||+|+||+||+|..+.++ ..||||++.... .......+.+|+.+|++++||
T Consensus 2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~------------~~~~~~~~~~E~~il~~l~H~ 69 (283)
T d1mqba_ 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY------------TEKQRVDFLGEAGIMGQFSHH 69 (283)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc------------ChHHHHHHHHHHHHHHhcCCC
Confidence 4677789999999999999999999987654 369999985432 112345688999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGH 166 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ 166 (426)
|||++++++.+...+++|||||.++++.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.
T Consensus 70 nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp TBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC
T ss_pred CEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe
Confidence 99999999999999999999999999998876543 45999999999999999999999999999999999999999999
Q ss_pred EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccc
Q 014344 167 IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVG 246 (426)
Q Consensus 167 ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 246 (426)
+||+|||+|+.+..... .........|
T Consensus 149 ~Kl~DFGla~~~~~~~~-----------------------------------------------------~~~~~~~~~g 175 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPE-----------------------------------------------------ATYTTSGGKI 175 (283)
T ss_dssp EEECCCCC----------------------------------------------------------------------CC
T ss_pred EEEcccchhhcccCCCc-----------------------------------------------------cceEeccCCC
Confidence 99999999987642210 0111223458
Q ss_pred CCCCccchhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCC
Q 014344 247 TEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPT 323 (426)
Q Consensus 247 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~ 323 (426)
|+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.+..+.. .++.....+..+.+||.+||..||+
T Consensus 176 t~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 255 (283)
T d1mqba_ 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255 (283)
T ss_dssp CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTT
T ss_pred CccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHh
Confidence 9999999999999999999999999999999984 566666777766666543 3344456788999999999999999
Q ss_pred CCCChHHHhc
Q 014344 324 KRIGVEEIKG 333 (426)
Q Consensus 324 ~R~s~~eil~ 333 (426)
+|||+.||++
T Consensus 256 ~RPt~~eil~ 265 (283)
T d1mqba_ 256 RRPKFADIVS 265 (283)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=427.75 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=209.7
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .....+++.+|+.+|+.++||||++++++|
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~ 86 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-----------SIIHAKRTYRELRLLKHMKHENVIGLLDVF 86 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-----------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-----------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 679999999999999999999999999999999965321 223456788999999999999999999998
Q ss_pred ecC-----CeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEe
Q 014344 96 STD-----KFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLV 170 (426)
Q Consensus 96 ~~~-----~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~ 170 (426)
... ...+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++
T Consensus 87 ~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccccc
Confidence 633 344666777889999998753 359999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCC
Q 014344 171 DFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEY 250 (426)
Q Consensus 171 DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 250 (426)
|||++.... ....+.+||+.|
T Consensus 164 dfg~a~~~~-----------------------------------------------------------~~~~~~~g~~~y 184 (348)
T d2gfsa1 164 DFGLARHTD-----------------------------------------------------------DEMTGYVATRWY 184 (348)
T ss_dssp CC----CCT-----------------------------------------------------------GGGSSSCHHHHT
T ss_pred ccchhcccC-----------------------------------------------------------cccccccccccc
Confidence 999986542 122345699999
Q ss_pred ccchhhcCCC-CChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------------C----
Q 014344 251 VAPEIIEGKG-HDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRILCRPP-----------------------D---- 302 (426)
Q Consensus 251 ~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------------~---- 302 (426)
+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......++.... .
T Consensus 185 ~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (348)
T d2gfsa1 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKM 264 (348)
T ss_dssp SCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC
T ss_pred cCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCc
Confidence 9999977754 68999999999999999999999999887776655531100 0
Q ss_pred -----CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCC
Q 014344 303 -----LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGV 340 (426)
Q Consensus 303 -----~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~ 340 (426)
..+.++.++|||.+||+.||.+|||++|||+||||+..
T Consensus 265 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 265 NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 12457889999999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-55 Score=406.09 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=210.3
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
.|+++.++|++++.||+|+||.||+|+. .|+.||||++.++ ...+.+.+|+++|++++||||+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~---------------~~~~~~~~E~~~l~~l~HpnIv 63 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---------------ATAQAFLAEASVMTQLRHSNLV 63 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---------------C--HHHHHTHHHHTTCCCTTBC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH---------------HHHHHHHHHHHHHHhCCCCCEe
Confidence 3788999999999999999999999997 4778999998432 1335688899999999999999
Q ss_pred eeeeeee-cCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEE
Q 014344 90 RLRGVLS-TDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIM 168 (426)
Q Consensus 90 ~l~~~~~-~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ik 168 (426)
++++++. .++.+|+|||||++|+|.+++.......+++..++.++.||+.||.|||+.+|+||||||+|||++.+|.+|
T Consensus 64 ~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~k 143 (262)
T d1byga_ 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 143 (262)
T ss_dssp CEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred eEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEe
Confidence 9999884 456789999999999999998765555699999999999999999999999999999999999999999999
Q ss_pred EecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCC
Q 014344 169 LVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTE 248 (426)
Q Consensus 169 L~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 248 (426)
|+|||+++.... ......+|+
T Consensus 144 l~dfg~s~~~~~-----------------------------------------------------------~~~~~~~~~ 164 (262)
T d1byga_ 144 VSDFGLTKEASS-----------------------------------------------------------TQDTGKLPV 164 (262)
T ss_dssp ECCCCC-----------------------------------------------------------------------CCT
T ss_pred ecccccceecCC-----------------------------------------------------------CCccccccc
Confidence 999999876432 122335889
Q ss_pred CCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 249 EYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 249 ~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
.|+|||++.+..++.++|||||||++|||++ |++||...+..+....+.. .++.....++.+.+||.+||..||.+|
T Consensus 165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 244 (262)
T d1byga_ 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244 (262)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHC
Confidence 9999999999999999999999999999998 8999999888887777753 344455678999999999999999999
Q ss_pred CChHHHhcC
Q 014344 326 IGVEEIKGH 334 (426)
Q Consensus 326 ~s~~eil~h 334 (426)
||+.+|+++
T Consensus 245 ps~~~l~~~ 253 (262)
T d1byga_ 245 PSFLQLREQ 253 (262)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=413.01 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=208.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcCCCce----EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVESSES----FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL 87 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~ 87 (426)
-++-++|++++.||+|+||+||+|++..+|+. ||+|.+.... .....+.+.+|+.+|++++|||
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~Hpn 72 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT------------SPKANKEILDEAYVMASVDNPH 72 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----------------CTHHHHHHHHHHHHHCCCTT
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc------------CHHHHHHHHHHHHHHHhCCCCC
Confidence 45667899999999999999999999888874 6666663221 1224567899999999999999
Q ss_pred cceeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcE
Q 014344 88 LPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHI 167 (426)
Q Consensus 88 iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~i 167 (426)
||++++++.++ ..+++||||.+|+|.+++.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++++
T Consensus 73 Iv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 73 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp BCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEE
T ss_pred EeeEEEEEecC-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCe
Confidence 99999999765 5678899999999998876653 459999999999999999999999999999999999999999999
Q ss_pred EEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccC
Q 014344 168 MLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGT 247 (426)
Q Consensus 168 kL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 247 (426)
||+|||+|+.+..... .......+||
T Consensus 151 kl~DFGla~~~~~~~~------------------------------------------------------~~~~~~~~gt 176 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEK------------------------------------------------------EYHAEGGKVP 176 (317)
T ss_dssp EECCCSHHHHTTTTCC--------------------------------------------------------------CC
T ss_pred Eeeccccceecccccc------------------------------------------------------cccccccccC
Confidence 9999999987643210 1122334689
Q ss_pred CCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCC
Q 014344 248 EEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTK 324 (426)
Q Consensus 248 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (426)
+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+....+.. .++.....+..+.+||.+||..||.+
T Consensus 177 ~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~ 256 (317)
T d1xkka_ 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADS 256 (317)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGG
T ss_pred ccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhh
Confidence 99999999999999999999999999999998 8999998887766655543 23444567899999999999999999
Q ss_pred CCChHHHhcC
Q 014344 325 RIGVEEIKGH 334 (426)
Q Consensus 325 R~s~~eil~h 334 (426)
|||+.||+.|
T Consensus 257 RPs~~eil~~ 266 (317)
T d1xkka_ 257 RPKFRELIIE 266 (317)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=409.49 Aligned_cols=258 Identities=21% Similarity=0.324 Sum_probs=204.4
Q ss_pred CCCCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-C
Q 014344 11 RSLDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-E 84 (426)
Q Consensus 11 ~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~ 84 (426)
++++.++|++++.||+|+||+||+|++.. +++.||||++..... ....+.+..|..++.++ .
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~------------~~~~~~~~~e~~~l~~~~~ 75 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT------------HSEHRALMSELKILIHIGH 75 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C------------HHHHHHHHHHHHHHHHHCC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC------------cHHHHHHHHHHHHHHhhcC
Confidence 45777899999999999999999999754 456899999854321 12345677788888777 5
Q ss_pred CCCcceeeeeeec-CCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 014344 85 HPLLPRLRGVLST-DKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHNMGI 149 (426)
Q Consensus 85 hp~iv~l~~~~~~-~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~~gi 149 (426)
|+||+.+++++.. +..+++|||||+||+|.++++... ...+++..+..++.||+.||+|||++||
T Consensus 76 h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i 155 (299)
T d1ywna1 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 155 (299)
T ss_dssp CTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 8999999998755 457899999999999999987543 2348899999999999999999999999
Q ss_pred cccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCC
Q 014344 150 VYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDP 229 (426)
Q Consensus 150 iHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (426)
|||||||+||||+.++++||+|||+|+......
T Consensus 156 vHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~----------------------------------------------- 188 (299)
T d1ywna1 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDP----------------------------------------------- 188 (299)
T ss_dssp CCSCCCGGGEEECGGGCEEECC------CCSCT-----------------------------------------------
T ss_pred cCCcCCccceeECCCCcEEEccCcchhhccccc-----------------------------------------------
Confidence 999999999999999999999999998653221
Q ss_pred CCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhc---CCCCCCC
Q 014344 230 PSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILC---RPPDLVG 305 (426)
Q Consensus 230 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~---~~~~~~~ 305 (426)
......+.+||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..+.+..++. .++....
T Consensus 189 -------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (299)
T d1ywna1 189 -------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 261 (299)
T ss_dssp -------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred -------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 11123456799999999999999999999999999999999986 678988765555544432 2333445
Q ss_pred CCHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 306 EPTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 306 ~~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
.++.+.+||.+||+.||++|||++||++|
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 262 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 68899999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=403.25 Aligned_cols=256 Identities=22% Similarity=0.306 Sum_probs=206.3
Q ss_pred CCCCCcEEEeeecccCceEEEEEEEcCC-C--ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc
Q 014344 13 LDFSCLRIVSALGRGAKGVVFLVKDVES-S--ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP 89 (426)
Q Consensus 13 l~~~~y~i~~~LG~G~~g~V~~a~~~~~-~--~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv 89 (426)
++.++|++++.||+|+||.||+|+...+ + ..||||++.+..... ....+++.+|+.+|++++||||+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~----------~~~~~~~~~Ei~~l~~l~H~nIv 74 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ----------PEAMDDFIREVNAMHSLDHRNLI 74 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC------------------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC----------HHHHHHHHHHHHHHHhCCCCCEE
Confidence 4567899999999999999999986533 3 368999986544322 23457899999999999999999
Q ss_pred eeeeeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEE
Q 014344 90 RLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIML 169 (426)
Q Consensus 90 ~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL 169 (426)
++++++.+ ..+++|||||++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 75 ~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl 152 (273)
T d1u46a_ 75 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKI 152 (273)
T ss_dssp CEEEEECS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred EEEEEEee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceee
Confidence 99999965 46789999999999998776554 34999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+++.+..... .........||+.
T Consensus 153 ~DfGl~~~~~~~~~-----------------------------------------------------~~~~~~~~~~~~~ 179 (273)
T d1u46a_ 153 GDFGLMRALPQNDD-----------------------------------------------------HYVMQEHRKVPFA 179 (273)
T ss_dssp CCCTTCEECCC-CC-----------------------------------------------------EEEC-----CCGG
T ss_pred ccchhhhhcccCCC-----------------------------------------------------cceecCccccCcc
Confidence 99999987643211 0112234458889
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC---CCCCCCCHHHHHHHHHHhccCCCCC
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCRP---PDLVGEPTPLRNLIRRLLEKDPTKR 325 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~li~~~L~~dP~~R 325 (426)
|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+...++.... +.....|..+.+||.+||..||++|
T Consensus 180 ~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 259 (273)
T d1u46a_ 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259 (273)
T ss_dssp GCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 999999999999999999999999999997 899999999999888876443 3345678999999999999999999
Q ss_pred CChHHHhc
Q 014344 326 IGVEEIKG 333 (426)
Q Consensus 326 ~s~~eil~ 333 (426)
||+.+|++
T Consensus 260 Pt~~ei~~ 267 (273)
T d1u46a_ 260 PTFVALRD 267 (273)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999863
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=403.95 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=215.9
Q ss_pred CCCCCCCCCcEEEeeecccCceEEEEEEEcCCC-------ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHH
Q 014344 9 PIRSLDFSCLRIVSALGRGAKGVVFLVKDVESS-------ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLR 81 (426)
Q Consensus 9 ~~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~ 81 (426)
+.+++..++|++++.||+|+||.||+|++..++ ..||||++.+... ......+..|..++.
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~------------~~~~~~~~~e~~~l~ 73 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT------------EKDLSDLISEMEMMK 73 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC------------HHHHHHHHHHHHHHH
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC------------hHHHHHHHHHHHHHH
Confidence 457788899999999999999999999986554 3699999855321 223567888988998
Q ss_pred hc-CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------------cCCCCHHHHHHHHHHHHHHHHHHHH
Q 014344 82 NV-EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------------EQMFSDDTIRFYAAELVLALEYLHN 146 (426)
Q Consensus 82 ~l-~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------------~~~l~~~~~~~~~~qil~aL~~LH~ 146 (426)
++ +|||||++++++.++..+|+|||||++|+|.+++.... ...+++..+..++.||+.||+|||+
T Consensus 74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 88 79999999999999999999999999999999987543 2458999999999999999999999
Q ss_pred CCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCC
Q 014344 147 MGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIG 226 (426)
Q Consensus 147 ~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (426)
+|||||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~-------------------------------------------- 189 (299)
T d1fgka_ 154 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-------------------------------------------- 189 (299)
T ss_dssp TTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCC--------------------------------------------
T ss_pred CCEEeeeecccceeecCCCCeEeccchhhccccccc--------------------------------------------
Confidence 999999999999999999999999999998664211
Q ss_pred CCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC--CCCC
Q 014344 227 PDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILCR--PPDL 303 (426)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~ 303 (426)
........+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+... ++..
T Consensus 190 ----------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p 259 (299)
T d1fgka_ 190 ----------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP 259 (299)
T ss_dssp ----------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred ----------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 1123345579999999999999999999999999999999997 79999998888777666533 3334
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
...++.+.+||.+||+.||++|||+.||++
T Consensus 260 ~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 260 SNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 466899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-53 Score=403.05 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=216.2
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHP 86 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp 86 (426)
++..++|++++.||+|+||+||+|+.+ .+++.||||++.... .....+++.+|+.+|++++||
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~------------~~~~~~~~~~E~~il~~l~h~ 76 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA------------SADMQADFQREAALMAEFDNP 76 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC------------CHHHHHHHHHHHHHHHTCCCT
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc------------ChHHHHHHHHHHHHHHhcCCC
Confidence 345678999999999999999999975 356789999985432 123456789999999999999
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc----------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS----------------------EQMFSDDTIRFYAAELVLALEYL 144 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~----------------------~~~l~~~~~~~~~~qil~aL~~L 144 (426)
||+++++++.....+++|||||.+|+|.+++.... ...++...+..++.||+.||+||
T Consensus 77 niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl 156 (301)
T d1lufa_ 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156 (301)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred CcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999886432 22488999999999999999999
Q ss_pred HHCCCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCC
Q 014344 145 HNMGIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPR 224 (426)
Q Consensus 145 H~~giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (426)
|++|||||||||+|||++.++.+||+|||+|+.+....
T Consensus 157 H~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~------------------------------------------ 194 (301)
T d1lufa_ 157 SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD------------------------------------------ 194 (301)
T ss_dssp HHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG------------------------------------------
T ss_pred ccCCeEeeEEcccceEECCCCcEEEccchhheeccCCc------------------------------------------
Confidence 99999999999999999999999999999997653211
Q ss_pred CCCCCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCC--C
Q 014344 225 IGPDPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILCRP--P 301 (426)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~--~ 301 (426)
......+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+....+.... +
T Consensus 195 ------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~ 262 (301)
T d1lufa_ 195 ------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 262 (301)
T ss_dssp ------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred ------------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 01123455699999999999999999999999999999999998 47899999888887776443 3
Q ss_pred CCCCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 302 DLVGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
.....++.+.+||.+||+.||++|||+.||++
T Consensus 263 ~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 263 CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 34467899999999999999999999999965
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=405.60 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=216.8
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcCCCce--EEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-CCC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVESSES--FALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV-EHP 86 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp 86 (426)
.+.+++++|++.++||+|+||+||+|+++.++.. ||||.+.... .....+.+.+|+++|+++ +||
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~E~~~l~~l~~Hp 71 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA------------SKDDHRDFAGELEVLCKLGHHP 71 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------------------CHHHHHHHHHTTCCCCT
T ss_pred CCccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc------------ChHHHHHHHHHHHHHHhccCCC
Confidence 4568899999999999999999999999988875 6677663221 112346789999999998 699
Q ss_pred CcceeeeeeecCCeEEEEEeccCCCChHHHHHHh--------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 014344 87 LLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQ--------------SEQMFSDDTIRFYAAELVLALEYLHNMGIVYR 152 (426)
Q Consensus 87 ~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~--------------~~~~l~~~~~~~~~~qil~aL~~LH~~giiHr 152 (426)
||+++++++.+++.+|+|||||+||+|.++++.. ....+++..+..++.||+.||.|||++||+||
T Consensus 72 nIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHr 151 (309)
T d1fvra_ 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHR 151 (309)
T ss_dssp TBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcccc
Confidence 9999999999999999999999999999998643 23569999999999999999999999999999
Q ss_pred CCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCC
Q 014344 153 DLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSR 232 (426)
Q Consensus 153 DlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (426)
||||+|||++.++.+||+|||+|+.....
T Consensus 152 Dlkp~NIL~~~~~~~kl~DfG~a~~~~~~--------------------------------------------------- 180 (309)
T d1fvra_ 152 DLAARNILVGENYVAKIADFGLSRGQEVY--------------------------------------------------- 180 (309)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEESSCEE---------------------------------------------------
T ss_pred ccccceEEEcCCCceEEcccccccccccc---------------------------------------------------
Confidence 99999999999999999999999765321
Q ss_pred CCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhc--CCCCCCCCCHH
Q 014344 233 SDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILC--RPPDLVGEPTP 309 (426)
Q Consensus 233 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~ 309 (426)
.......||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+.+..+.. .++.....++.
T Consensus 181 ------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 254 (309)
T d1fvra_ 181 ------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDE 254 (309)
T ss_dssp ------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHH
T ss_pred ------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHH
Confidence 112344689999999999999999999999999999999996 568998888888877764 33444567899
Q ss_pred HHHHHHHHhccCCCCCCChHHHhcC
Q 014344 310 LRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 310 ~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+.+||.+||+.||++|||++||++|
T Consensus 255 ~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 255 VYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=402.58 Aligned_cols=263 Identities=21% Similarity=0.232 Sum_probs=222.6
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEcC-----CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDVE-----SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.++++.++|++++.||+|+||+||+|.+.. ++..||||++.+.. .......+.+|+.++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~------------~~~~~~~~~~E~~il~~l~ 81 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA------------SMRERIEFLNEASVMKEFN 81 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS------------CHHHHHHHHHHHHHGGGCC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc------------ChHHHHHHHHHHHHHHHcC
Confidence 467888999999999999999999998853 35789999985432 1123457889999999999
Q ss_pred CCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 014344 85 HPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS--------EQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKP 156 (426)
Q Consensus 85 hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~--------~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp 156 (426)
||||+++++++..+..+++|||||++|+|.+++.... ...++...+..++.|++.||.|||+++|+||||||
T Consensus 82 h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~ 161 (308)
T d1p4oa_ 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161 (308)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG
T ss_pred CCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcC
Confidence 9999999999999999999999999999999876432 12468899999999999999999999999999999
Q ss_pred CCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 157 ENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSD 236 (426)
Q Consensus 157 ~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (426)
+|||++.++++||+|||+|+.+....
T Consensus 162 ~NiLld~~~~~Kl~DFGla~~~~~~~------------------------------------------------------ 187 (308)
T d1p4oa_ 162 RNCMVAEDFTVKIGDFGMTRDIYETD------------------------------------------------------ 187 (308)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGG------------------------------------------------------
T ss_pred CceeecCCceEEEeecccceeccCCc------------------------------------------------------
Confidence 99999999999999999997653211
Q ss_pred CCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcC--CCCCCCCCHHHHHH
Q 014344 237 SSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYG-ATPFRGSSRKETFYRILCR--PPDLVGEPTPLRNL 313 (426)
Q Consensus 237 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~l 313 (426)
........+||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+.+..+... ++.....+..+.+|
T Consensus 188 ~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 267 (308)
T d1p4oa_ 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFEL 267 (308)
T ss_dssp CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHH
Confidence 01123345699999999999999999999999999999999998 5899999998888877643 23344668899999
Q ss_pred HHHHhccCCCCCCChHHHhc------CCCcC
Q 014344 314 IRRLLEKDPTKRIGVEEIKG------HEFFK 338 (426)
Q Consensus 314 i~~~L~~dP~~R~s~~eil~------hp~f~ 338 (426)
|.+||+.||++|||+++|++ +|+|+
T Consensus 268 i~~cl~~~P~~RPs~~~il~~L~~~~~~~~~ 298 (308)
T d1p4oa_ 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298 (308)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence 99999999999999999987 56654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=398.28 Aligned_cols=258 Identities=20% Similarity=0.313 Sum_probs=217.1
Q ss_pred CCCCCCCCcEEEeeecccCceEEEEEEEc-----CCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhc-
Q 014344 10 IRSLDFSCLRIVSALGRGAKGVVFLVKDV-----ESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNV- 83 (426)
Q Consensus 10 ~~~l~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l- 83 (426)
.|++..++|++++.||+|+||.||+|+.. .+++.||||++.+.. .......+.+|+.+++.+
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~------------~~~~~~~~~~E~~~~~~l~ 84 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA------------HLTEREALMSELKVLSYLG 84 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC------------CHHHHHHHHHHHHHHHHHC
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc------------CHHHHHHHHHHHHHHHhcc
Confidence 35677899999999999999999999863 466789999995432 123455788999999999
Q ss_pred CCCCcceeeeeeecCCeEEEEEeccCCCChHHHHHHhc----------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 014344 84 EHPLLPRLRGVLSTDKFVGYAIDYCPGRDLHSLRKQQS----------------EQMFSDDTIRFYAAELVLALEYLHNM 147 (426)
Q Consensus 84 ~hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~----------------~~~l~~~~~~~~~~qil~aL~~LH~~ 147 (426)
+|||||++++++.++..+|+|||||+||+|.++++... ...+++..+..++.||+.||+|||++
T Consensus 85 ~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~ 164 (311)
T d1t46a_ 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (311)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 69999999999999999999999999999999987543 22589999999999999999999999
Q ss_pred CCcccCCCCCCeeeccCCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCC
Q 014344 148 GIVYRDLKPENIMIQENGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGP 227 (426)
Q Consensus 148 giiHrDlKp~NiLl~~~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (426)
|||||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~-------------------------------------------- 200 (311)
T d1t46a_ 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-------------------------------------------- 200 (311)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT--------------------------------------------
T ss_pred CeeecccccccccccccCcccccccchheeccCCCc--------------------------------------------
Confidence 999999999999999999999999999986542110
Q ss_pred CCCCCCCCCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc---CCCCC
Q 014344 228 DPPSRSDSDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLY-GATPFRGSSRKETFYRILC---RPPDL 303 (426)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~i~~---~~~~~ 303 (426)
.......+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+.+.+++. .+...
T Consensus 201 ----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~ 270 (311)
T d1t46a_ 201 ----------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270 (311)
T ss_dssp ----------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred ----------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 112334579999999999999999999999999999999998 7777877776666655542 23333
Q ss_pred CCCCHHHHHHHHHHhccCCCCCCChHHHhc
Q 014344 304 VGEPTPLRNLIRRLLEKDPTKRIGVEEIKG 333 (426)
Q Consensus 304 ~~~~~~~~~li~~~L~~dP~~R~s~~eil~ 333 (426)
...+..+.+||.+||+.||.+|||+++|++
T Consensus 271 ~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 456889999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=384.02 Aligned_cols=251 Identities=18% Similarity=0.247 Sum_probs=201.5
Q ss_pred EEEeeecccCceEEEEEEEcCCC---ceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 19 RIVSALGRGAKGVVFLVKDVESS---ESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 19 ~i~~~LG~G~~g~V~~a~~~~~~---~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
++.++||+|+||+||+|++..++ ..||||++.+. ......+++.+|+++|++++||||+++++++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~------------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 97 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI------------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 97 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC------------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc------------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEE
Confidence 34678999999999999986643 35899998432 1233567899999999999999999999987
Q ss_pred ec-CCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecccc
Q 014344 96 ST-DKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDFDL 174 (426)
Q Consensus 96 ~~-~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DFgl 174 (426)
.. +..+++|||||++|+|.+++.... ..++...+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+
T Consensus 98 ~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 98 LRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp EETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred EecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccc
Confidence 54 568999999999999999876543 4478888999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCccch
Q 014344 175 STKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYVAPE 254 (426)
Q Consensus 175 s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 254 (426)
++.+....... ........||+.|+|||
T Consensus 177 ~~~~~~~~~~~----------------------------------------------------~~~~~~~~gt~~y~aPE 204 (311)
T d1r0pa_ 177 ARDMYDKEFDS----------------------------------------------------VHNKTGAKLPVKWMALE 204 (311)
T ss_dssp GCCTTTTTCCC----------------------------------------------------TTCTTCSSCCGGGSCHH
T ss_pred hhhcccccccc----------------------------------------------------ceecccccccccccChH
Confidence 98764322110 11122346899999999
Q ss_pred hhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc--CCCCCCCCCHHHHHHHHHHhccCCCCCCChHHH
Q 014344 255 IIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGS-SRKETFYRILC--RPPDLVGEPTPLRNLIRRLLEKDPTKRIGVEEI 331 (426)
Q Consensus 255 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~i~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~ei 331 (426)
++.+..++.++|||||||++|||++|..||... +..+....+.. .+......+..+.+||.+||..||++|||+.||
T Consensus 205 ~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei 284 (311)
T d1r0pa_ 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284 (311)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 999999999999999999999999977776554 33333444432 333344567899999999999999999999999
Q ss_pred hcC
Q 014344 332 KGH 334 (426)
Q Consensus 332 l~h 334 (426)
++|
T Consensus 285 ~~~ 287 (311)
T d1r0pa_ 285 VSR 287 (311)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-50 Score=379.37 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=205.6
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC-CCcceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH-PLLPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~l~~~ 94 (426)
++|+|++.||+|+||+||+|++..+|+.||||++.+.. ....+..|+++++.|.| +|++.++++
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------------~~~~~~~e~~~~~~l~~~~~i~~~~~~ 69 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---------------DAPQLRDEYRTYKLLAGCTGIPNVYYF 69 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---------------TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---------------CcHHHHHHHHHHHHhcCCCCCCEEEEE
Confidence 45999999999999999999999999999999984321 12346678999999985 899999999
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc-----CCcEEE
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE-----NGHIML 169 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~-----~g~ikL 169 (426)
+..+...|+||||| |++|.+++.... ..++...+..++.|++.||+|||++||+||||||+|||++. ++.+||
T Consensus 70 ~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 70 GQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred eecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEE
Confidence 99999999999999 789998876543 46999999999999999999999999999999999999974 578999
Q ss_pred ecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCC
Q 014344 170 VDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEE 249 (426)
Q Consensus 170 ~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 249 (426)
+|||+|+.+....... ........+++||+.
T Consensus 148 ~DFG~a~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~GT~~ 178 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQ-------------------------------------------------HIPYREKKNLSGTAR 178 (293)
T ss_dssp CCCTTCEESBCTTTCC-------------------------------------------------BCCCCCCCCCCSCTT
T ss_pred cccceeEEcccCcccc-------------------------------------------------ceeecccCceEEchh
Confidence 9999998764321110 001123456789999
Q ss_pred CccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhc----CC--CCCCCCCHHHHHHHHHHhcc
Q 014344 250 YVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSS---RKETFYRILC----RP--PDLVGEPTPLRNLIRRLLEK 320 (426)
Q Consensus 250 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~----~~--~~~~~~~~~~~~li~~~L~~ 320 (426)
|||||++.+..++.++|||||||++|||++|+.||.+.. ....+.++.. .+ ....+.|+++.+++..|+..
T Consensus 179 y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~ 258 (293)
T d1csna_ 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL 258 (293)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred hcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999998653 3333333321 11 11235688999999999999
Q ss_pred CCCCCCChHHHhc
Q 014344 321 DPTKRIGVEEIKG 333 (426)
Q Consensus 321 dP~~R~s~~eil~ 333 (426)
+|++||+++.+.+
T Consensus 259 ~~~~rP~y~~l~~ 271 (293)
T d1csna_ 259 AFDATPDYDYLQG 271 (293)
T ss_dssp CTTCCCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999776643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-50 Score=382.72 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=200.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCC-cceeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPL-LPRLRGV 94 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~l~~~ 94 (426)
++|++++.||+|+||+||+|++..+|+.||||++.... ...++..|+++++.+.|++ |+.+.++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------------~~~~~~~E~~i~~~l~~~~~i~~~~~~ 71 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---------------KHPQLHIESKIYKMMQGGVGIPTIRWC 71 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---------------TSCCHHHHHHHHHHSTTSTTCCCEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---------------cCHHHHHHHHHHHHccCCCcccEEEEE
Confidence 36999999999999999999999999999999975321 1234678999999998765 5566677
Q ss_pred eecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeecc---CCcEEEec
Q 014344 95 LSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQE---NGHIMLVD 171 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~---~g~ikL~D 171 (426)
+.+.+..++||||| +++|...+... .+.+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|
T Consensus 72 ~~~~~~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~D 149 (299)
T d1ckia_ 72 GAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 149 (299)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred EecCCEEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeec
Confidence 78889999999999 46666655443 356999999999999999999999999999999999999864 45799999
Q ss_pred ccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccccccCCCCc
Q 014344 172 FDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNSFVGTEEYV 251 (426)
Q Consensus 172 Fgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 251 (426)
||+|+.+....... ........+.+||+.||
T Consensus 150 FG~a~~~~~~~~~~-------------------------------------------------~~~~~~~~~~~gt~~y~ 180 (299)
T d1ckia_ 150 FGLAKKYRDARTHQ-------------------------------------------------HIPYRENKNLTGTARYA 180 (299)
T ss_dssp CSSCEECBCTTTCC-------------------------------------------------BCCCCBCCSCCCCSSSC
T ss_pred cCcceecccccccc-------------------------------------------------ceeccccCCcCCCcccc
Confidence 99998764322110 00112345668999999
Q ss_pred cchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hcCC--CCCCCCCHHHHHHHHHHhccCC
Q 014344 252 APEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRKETFYRI-------LCRP--PDLVGEPTPLRNLIRRLLEKDP 322 (426)
Q Consensus 252 aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i-------~~~~--~~~~~~~~~~~~li~~~L~~dP 322 (426)
|||++.+..++.++|||||||++|||++|+.||...........+ ...+ ....+.|+++.+||.+||..||
T Consensus 181 aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p 260 (299)
T d1ckia_ 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF 260 (299)
T ss_dssp CHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCT
T ss_pred CHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCCh
Confidence 999999999999999999999999999999999876654332211 1111 1134568999999999999999
Q ss_pred CCCCChHH---HhcCCCc
Q 014344 323 TKRIGVEE---IKGHEFF 337 (426)
Q Consensus 323 ~~R~s~~e---il~hp~f 337 (426)
++||++++ +|+|+|.
T Consensus 261 ~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 261 DDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TCCCCHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHHHHHHH
Confidence 99999874 4666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=376.53 Aligned_cols=248 Identities=20% Similarity=0.241 Sum_probs=189.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcceeeeee
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLPRLRGVL 95 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~l~~~~ 95 (426)
.+|.+.+.||+|+||+||+|+. +|+.||||++...... ......|+..+.+++||||+++++++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~--------------~~~~e~ei~~~~~~~HpnIv~~~~~~ 66 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--------------SWFREAEIYQTVMLRHENILGFIAAD 66 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH--------------HHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--------------HHHHHHHHHHHhhCCCCcCcceEEEE
Confidence 4689999999999999999985 6899999998543211 11122355555678999999999999
Q ss_pred ecCC----eEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH--------CCCcccCCCCCCeeecc
Q 014344 96 STDK----FVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHN--------MGIVYRDLKPENIMIQE 163 (426)
Q Consensus 96 ~~~~----~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~--------~giiHrDlKp~NiLl~~ 163 (426)
.++. .+|+|||||++|+|.++++.. .+++..+..++.|++.||.|||+ +|||||||||+||||+.
T Consensus 67 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~ 143 (303)
T d1vjya_ 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143 (303)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred EeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC
Confidence 7644 689999999999999998754 38999999999999999999996 59999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 014344 164 NGHIMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSDSDSSEKSNS 243 (426)
Q Consensus 164 ~g~ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (426)
+|.+||+|||+++....... ........
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~----------------------------------------------------~~~~~~~~ 171 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATD----------------------------------------------------TIDIAPNH 171 (303)
T ss_dssp TSCEEECCCTTCEEEETTTT----------------------------------------------------EECC----
T ss_pred CCCeEEEecCccccccCCCc----------------------------------------------------ceeccccc
Confidence 99999999999987642210 00112334
Q ss_pred cccCCCCccchhhcCCC------CChhhHHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHhcCC---
Q 014344 244 FVGTEEYVAPEIIEGKG------HDFAVDWWSLGVVLHEMLYGATPFRGSS--------------RKETFYRILCRP--- 300 (426)
Q Consensus 244 ~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~ell~g~~pf~~~~--------------~~~~~~~i~~~~--- 300 (426)
.+||+.|||||++.+.. ++.++|||||||++|||++|.+||.... ..+.........
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (303)
T d1vjya_ 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR 251 (303)
T ss_dssp CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC
T ss_pred eecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccC
Confidence 67999999999987653 5678999999999999999988874321 112222222211
Q ss_pred CCCCCC------CHHHHHHHHHHhccCCCCCCChHHHhcC
Q 014344 301 PDLVGE------PTPLRNLIRRLLEKDPTKRIGVEEIKGH 334 (426)
Q Consensus 301 ~~~~~~------~~~~~~li~~~L~~dP~~R~s~~eil~h 334 (426)
+..+.. +..+.+||.+||+.||++|||+.||+++
T Consensus 252 p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 252 PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111111 1348899999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.5e-49 Score=381.30 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=196.3
Q ss_pred CCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-----------
Q 014344 16 SCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE----------- 84 (426)
Q Consensus 16 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~----------- 84 (426)
++|+++++||+|+||+||+|+++.+|+.||||++.+... ..+.+.+|+.+|+.+.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--------------~~~~~~~Ei~~l~~l~~~~~~~~~~~~ 78 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--------------YTEAAEDEIKLLQRVNDADNTKEDSMG 78 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--------------HHHHHHHHHHHHHHHHHTCCSHHHHHH
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--------------chHHHHHHHHHHHHhcchhhhhhhhcC
Confidence 349999999999999999999999999999999965432 2345667888888774
Q ss_pred CCCcceeeeeee--cCCeEEEEEeccCCCChH-HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCee
Q 014344 85 HPLLPRLRGVLS--TDKFVGYAIDYCPGRDLH-SLRKQQSEQMFSDDTIRFYAAELVLALEYLHN-MGIVYRDLKPENIM 160 (426)
Q Consensus 85 hp~iv~l~~~~~--~~~~~~lV~Ey~~gg~L~-~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~-~giiHrDlKp~NiL 160 (426)
|+||+++++++. .....+++|+++..+... .+........+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus 79 ~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIl 158 (362)
T d1q8ya_ 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 158 (362)
T ss_dssp HTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred cCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHee
Confidence 578999998875 456777777777655443 33444455679999999999999999999998 89999999999999
Q ss_pred eccCCc------EEEecccccccCCCCCCCCCcchhhccccccccccccccccccccCCCCCCCCCCCCCCCCCCCCCCC
Q 014344 161 IQENGH------IMLVDFDLSTKLSPKTPQASPKTVLAANTRSGIKKRRSFLSKFCSSGISLEDPVHSPRIGPDPPSRSD 234 (426)
Q Consensus 161 l~~~g~------ikL~DFgls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (426)
++.++. ++++|||.+.....
T Consensus 159 l~~~~~~~~~~~~kl~dfg~s~~~~~------------------------------------------------------ 184 (362)
T d1q8ya_ 159 MEIVDSPENLIQIKIADLGNACWYDE------------------------------------------------------ 184 (362)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB------------------------------------------------------
T ss_pred eeccCcccccceeeEeeccccccccc------------------------------------------------------
Confidence 987653 99999999875431
Q ss_pred CCCCCCccccccCCCCccchhhcCCCCChhhHHHHHHHHHHHHHhCCCCCCCCCHH------HHHH---HHhcCC-----
Q 014344 235 SDSSEKSNSFVGTEEYVAPEIIEGKGHDFAVDWWSLGVVLHEMLYGATPFRGSSRK------ETFY---RILCRP----- 300 (426)
Q Consensus 235 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~---~i~~~~----- 300 (426)
.....+||+.|+|||++.+..|+.++|+||+||++++|++|+.||...... .... .++...
T Consensus 185 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~ 259 (362)
T d1q8ya_ 185 -----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259 (362)
T ss_dssp -----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred -----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHh
Confidence 123456999999999999999999999999999999999999999765321 1111 111000
Q ss_pred -------------------CC----------------CCCCCHHHHHHHHHHhccCCCCCCChHHHhcCCCcCCCC
Q 014344 301 -------------------PD----------------LVGEPTPLRNLIRRLLEKDPTKRIGVEEIKGHEFFKGVN 341 (426)
Q Consensus 301 -------------------~~----------------~~~~~~~~~~li~~~L~~dP~~R~s~~eil~hp~f~~~~ 341 (426)
.. ....+..+.|||.+||.+||.+|||++|+|+||||+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 260 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred hcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 00 001135689999999999999999999999999998654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2e-27 Score=208.92 Aligned_cols=146 Identities=18% Similarity=0.180 Sum_probs=108.9
Q ss_pred cEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhh-hcccCC----CchhhHHHHHHHHHHHhcCCCCcceee
Q 014344 18 LRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSK-ELTNND----NGDKYRRISFEQRVLRNVEHPLLPRLR 92 (426)
Q Consensus 18 y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~l~ 92 (426)
+.+.++||+|+||+||+|++ .+|+.||||++.......+.. ...... ..........|..+|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999998 478999999986433221110 000000 011223456788999999999999988
Q ss_pred eeeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeeeccCCcEEEecc
Q 014344 93 GVLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLHNMGIVYRDLKPENIMIQENGHIMLVDF 172 (426)
Q Consensus 93 ~~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH~~giiHrDlKp~NiLl~~~g~ikL~DF 172 (426)
++.. .+++|||+++..+.. ++...+..++.||+.||.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 7632 279999998766532 4556677899999999999999999999999999999865 5899999
Q ss_pred cccccC
Q 014344 173 DLSTKL 178 (426)
Q Consensus 173 gls~~~ 178 (426)
|+|...
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 998764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.70 E-value=5.5e-08 Score=87.22 Aligned_cols=141 Identities=13% Similarity=0.108 Sum_probs=94.2
Q ss_pred CCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC-CCCcceeee
Q 014344 15 FSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE-HPLLPRLRG 93 (426)
Q Consensus 15 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~l~~ 93 (426)
++.|++.+..+-++.+.||++. ..++.+.+|+...... .....+..|..+++.|. +--+++++.
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~-------------~~~~~~~~E~~~l~~l~~~vpvP~vl~ 77 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK-------------GTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT-------------TSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc-------------cchhhHHHHHHHHHHHhccCCCCcEEE
Confidence 3578888876666678999876 4566788898743211 11234667888888875 444788898
Q ss_pred eeecCCeEEEEEeccCCCChHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----------------------------
Q 014344 94 VLSTDKFVGYAIDYCPGRDLHSLRKQQSEQMFSDDTIRFYAAELVLALEYLH---------------------------- 145 (426)
Q Consensus 94 ~~~~~~~~~lV~Ey~~gg~L~~l~~~~~~~~l~~~~~~~~~~qil~aL~~LH---------------------------- 145 (426)
+...++..|+||++++|.++..... +......++.++...|..||
T Consensus 78 ~~~~~~~~~lv~~~l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (263)
T d1j7la_ 78 FERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDL 150 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTC
T ss_pred EEecCCceEEEEEeccccccccccc-------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHh
Confidence 8888999999999999877754211 00001112222223333333
Q ss_pred -------------------------HC------CCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 146 -------------------------NM------GIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 146 -------------------------~~------giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+. .++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 151 ADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 21 279999999999998776677999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.18 E-value=3.1e-06 Score=74.98 Aligned_cols=142 Identities=13% Similarity=0.068 Sum_probs=85.7
Q ss_pred cEEEeeecccC-ceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCC--CCcceeeee
Q 014344 18 LRIVSALGRGA-KGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEH--PLLPRLRGV 94 (426)
Q Consensus 18 y~i~~~LG~G~-~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h--p~iv~l~~~ 94 (426)
+++. .+..|. .+.||++.. .++..+.+|..... ....+..|...|+.|.. -.+++++.+
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~----------------~~~~l~~E~~~l~~L~~~gvpvP~v~~~ 74 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----------------ALNELQDEAARLSWLATTGVPCAAVLDV 74 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----------------TTSCHHHHHHHHHHHHTTTCCBCCEEEE
T ss_pred CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc----------------CHhHHHHHHHHHHHHHhcCCCCCceeee
Confidence 4443 334444 468998875 45667888976321 12346678888887753 346788888
Q ss_pred eecCCeEEEEEeccCCCChHH--------------HHHHhc-----cCCCCHHHH---H----HH---------------
Q 014344 95 LSTDKFVGYAIDYCPGRDLHS--------------LRKQQS-----EQMFSDDTI---R----FY--------------- 133 (426)
Q Consensus 95 ~~~~~~~~lV~Ey~~gg~L~~--------------l~~~~~-----~~~l~~~~~---~----~~--------------- 133 (426)
..+++..++||++++|.++.. .+.+.. ...+..... . .+
T Consensus 75 ~~~~~~~~~v~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 75 VTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EECSSCEEEEEECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred cccccceEEEEEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 888889999999999866532 111110 000100000 0 00
Q ss_pred HHHHHHHHHHHHHC-------CCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 134 AAELVLALEYLHNM-------GIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 134 ~~qil~aL~~LH~~-------giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.......+..+.+. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 00112223444332 379999999999999876778999998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=7.5e-06 Score=77.62 Aligned_cols=84 Identities=17% Similarity=0.174 Sum_probs=51.6
Q ss_pred EeeecccCceEEEEEEEcCCCceEEEEEeehhh-HHhhhhhcccCCCchhhHHHHHHHHHHHhcC-C--CCcceeeeeee
Q 014344 21 VSALGRGAKGVVFLVKDVESSESFALKVIWRDL-IEKKSKELTNNDNGDKYRRISFEQRVLRNVE-H--PLLPRLRGVLS 96 (426)
Q Consensus 21 ~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h--p~iv~l~~~~~ 96 (426)
.+.||-|....||++.+..+++.+++|.-.... .... .-.....+...|...|+.+. + ..+++++.+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-------~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-- 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-------SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-- 101 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-------CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-------CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--
Confidence 567899999999999988888899999643211 0000 00112345667888888763 2 356666654
Q ss_pred cCCeEEEEEeccCCCCh
Q 014344 97 TDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 97 ~~~~~~lV~Ey~~gg~L 113 (426)
++...++|||++.+..+
T Consensus 102 d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp ETTTTEEEECCCTTSEE
T ss_pred cCCCCEEEEeccCCccc
Confidence 44556789999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.44 E-value=0.00025 Score=66.85 Aligned_cols=82 Identities=26% Similarity=0.449 Sum_probs=55.4
Q ss_pred CCCCCCcEEEeeecccCceEEEEEEEcC-------CCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcC
Q 014344 12 SLDFSCLRIVSALGRGAKGVVFLVKDVE-------SSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVE 84 (426)
Q Consensus 12 ~l~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~ 84 (426)
.++.++++| +.|+-|-.-.+|++.... ..+.|.+++.-.. ...-...+|..+++.+.
T Consensus 39 ~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---------------~~~idr~~E~~i~~~ls 102 (395)
T d1nw1a_ 39 TVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---------------ETESHLVAESVIFTLLS 102 (395)
T ss_dssp HCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---------------CCHHHHHHHHHHHHHHH
T ss_pred CCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---------------chhhHHHHHHHHHHHHH
Confidence 355566665 578889999999998653 2456788886211 11123456888999885
Q ss_pred -CCCcceeeeeeecCCeEEEEEeccCCCCh
Q 014344 85 -HPLLPRLRGVLSTDKFVGYAIDYCPGRDL 113 (426)
Q Consensus 85 -hp~iv~l~~~~~~~~~~~lV~Ey~~gg~L 113 (426)
+.-.+++++++.+ ++|+||++|..|
T Consensus 103 ~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 103 ERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred hCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 5555688888753 689999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.25 E-value=0.00055 Score=62.54 Aligned_cols=132 Identities=16% Similarity=0.183 Sum_probs=75.6
Q ss_pred ceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCcc--eee-----eeeecCCeE
Q 014344 29 KGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLLP--RLR-----GVLSTDKFV 101 (426)
Q Consensus 29 ~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv--~l~-----~~~~~~~~~ 101 (426)
--.||++.. .+|+.|++|+..... .....+..|...|..|....++ ... ..+..+...
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~--------------~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~ 99 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER--------------WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 99 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT--------------SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC--------------CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEE
Confidence 458999886 568889999984321 1234567788888887532221 111 123456778
Q ss_pred EEEEeccCCCChH-----HH---------HHHh-c-------------------------cCCCCHHHHHHHHHHHHHHH
Q 014344 102 GYAIDYCPGRDLH-----SL---------RKQQ-S-------------------------EQMFSDDTIRFYAAELVLAL 141 (426)
Q Consensus 102 ~lV~Ey~~gg~L~-----~l---------~~~~-~-------------------------~~~l~~~~~~~~~~qil~aL 141 (426)
+.+++++.|..+. .+ ++.. . ...++......+...+-..+
T Consensus 100 ~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 179 (325)
T d1zyla1 100 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI 179 (325)
T ss_dssp EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred EEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHH
Confidence 8999999863321 11 0100 0 00112222222222222333
Q ss_pred HHHHH-------CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 142 EYLHN-------MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 142 ~~LH~-------~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
+.+.. .++||+|+.|.|||++. + ..++||+.+..
T Consensus 180 ~~l~~~~~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 180 AAVTAHWREDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp HHHHHHCCSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred HHHHHhccccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 33322 36899999999999974 3 45899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.23 E-value=0.00072 Score=61.26 Aligned_cols=147 Identities=15% Similarity=0.159 Sum_probs=80.4
Q ss_pred CCCCcEEEeeecccCceEEEEEEEcCCCceEEEEEeehhhHHhhhhhcccCCCchhhHHHHHHHHHHHhcCCCCc--cee
Q 014344 14 DFSCLRIVSALGRGAKGVVFLVKDVESSESFALKVIWRDLIEKKSKELTNNDNGDKYRRISFEQRVLRNVEHPLL--PRL 91 (426)
Q Consensus 14 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i--v~l 91 (426)
+++...-++.|..|---+.|++... +..|++|++.... ....+..|+.+|..|...++ +..
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~---------------~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV---------------EKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC------------------CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC---------------CHHHHHHHHHHHHhhhhcccccccc
Confidence 3455555667778888999998854 3458999983321 12345667778887753222 111
Q ss_pred ee------eeecCCeEEEEEeccCCCChHH-----H---------HHHhc-------------------------cCCCC
Q 014344 92 RG------VLSTDKFVGYAIDYCPGRDLHS-----L---------RKQQS-------------------------EQMFS 126 (426)
Q Consensus 92 ~~------~~~~~~~~~lV~Ey~~gg~L~~-----l---------~~~~~-------------------------~~~l~ 126 (426)
.- +.......+.++.++.|..... . .+... .....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11 1223455666777776543211 0 00000 00001
Q ss_pred HHHHHHHHHHHHHHHHHHHH----CCCcccCCCCCCeeeccCCcEEEeccccccc
Q 014344 127 DDTIRFYAAELVLALEYLHN----MGIVYRDLKPENIMIQENGHIMLVDFDLSTK 177 (426)
Q Consensus 127 ~~~~~~~~~qil~aL~~LH~----~giiHrDlKp~NiLl~~~g~ikL~DFgls~~ 177 (426)
.......+..+...+.-.+. .|+||+|+.++||+++.+...-+.||+.+..
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 11122223333333333332 3799999999999999887779999999875
|